{
  "file_name": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
  "total_pages": 22,
  "pdf_type": "normal",
  "font_analysis": {
    "font_sizes_frequency": {
      "17.03999900817871": 3,
      "15.59999942779541": 2,
      "14.15999984741211": 3,
      "12.119999885559082": 1,
      "7.799999713897705": 74,
      "9.960000038146973": 39,
      "8.519999504089355": 421,
      "7.079999923706055": 1005,
      "10.679999351501465": 6,
      "9.239999771118164": 29,
      "6.0": 15,
      "6.359999656677246": 205,
      "4.559999942779541": 5,
      "5.639999866485596": 54,
      "6.900730133056641": 5,
      "7.3997297286987305": 67,
      "4.920000076293945": 94,
      "4.795422554016113": 15,
      "6.960999488830566": 772,
      "6.241110801696777": 41,
      "11.698615074157715": 1,
      "3.841764211654663": 1,
      "5.759999752044678": 1
    },
    "heading_sizes": [
      17.03999900817871,
      15.59999942779541,
      14.15999984741211,
      10.679999351501465,
      9.960000038146973,
      9.239999771118164,
      8.519999504089355,
      7.799999713897705,
      7.3997297286987305
    ]
  },
  "table_analysis": {
    "total_tables": 20,
    "tables_info": [
      {
        "bbox": [
          155.39999389648438,
          121.59064483642578,
          798.626220703125,
          431.7252502441406
        ],
        "num_rows": 9,
        "num_cols": 2
      },
      {
        "bbox": [
          57.119998931884766,
          169.9199981689453,
          803.27978515625,
          567.5225219726562
        ],
        "num_rows": 4,
        "num_cols": 3
      },
      {
        "bbox": [
          40.20000076293945,
          50.1123046875,
          805.3978881835938,
          567.5225219726562
        ],
        "num_rows": 19,
        "num_cols": 5
      },
      {
        "bbox": [
          40.20000076293945,
          51.839996337890625,
          803.0398559570312,
          567.5225219726562
        ],
        "num_rows": 25,
        "num_cols": 4
      },
      {
        "bbox": [
          40.20000076293945,
          48.839996337890625,
          807.5398559570312,
          567.5225219726562
        ],
        "num_rows": 12,
        "num_cols": 5
      },
      {
        "bbox": [
          40.20000076293945,
          48.959999084472656,
          802.7485961914062,
          567.5225219726562
        ],
        "num_rows": 11,
        "num_cols": 3
      },
      {
        "bbox": [
          45.84000015258789,
          51.839996337890625,
          807.5399780273438,
          567.5225219726562
        ],
        "num_rows": 24,
        "num_cols": 5
      },
      {
        "bbox": [
          40.20000076293945,
          52.235626220703125,
          810.798095703125,
          567.5225219726562
        ],
        "num_rows": 36,
        "num_cols": 3
      },
      {
        "bbox": [
          40.20000076293945,
          48.839996337890625,
          802.6807250976562,
          567.5225219726562
        ],
        "num_rows": 36,
        "num_cols": 4
      },
      {
        "bbox": [
          40.20000076293945,
          48.839996337890625,
          807.5399780273438,
          567.5225219726562
        ],
        "num_rows": 23,
        "num_cols": 4
      },
      {
        "bbox": [
          40.20000076293945,
          50.1123046875,
          801.8387451171875,
          567.5225219726562
        ],
        "num_rows": 27,
        "num_cols": 3
      },
      {
        "bbox": [
          45.84000015258789,
          53.7599983215332,
          801.8392944335938,
          567.5225219726562
        ],
        "num_rows": 42,
        "num_cols": 4
      },
      {
        "bbox": [
          45.84000015258789,
          53.202537536621094,
          801.8387451171875,
          567.5225219726562
        ],
        "num_rows": 44,
        "num_cols": 4
      },
      {
        "bbox": [
          45.84000015258789,
          53.202537536621094,
          801.8389892578125,
          567.5225219726562
        ],
        "num_rows": 44,
        "num_cols": 4
      },
      {
        "bbox": [
          45.84000015258789,
          53.202537536621094,
          801.8392944335938,
          567.5225219726562
        ],
        "num_rows": 45,
        "num_cols": 4
      },
      {
        "bbox": [
          45.84000015258789,
          48.599998474121094,
          806.8216552734375,
          567.5225219726562
        ],
        "num_rows": 48,
        "num_cols": 4
      },
      {
        "bbox": [
          40.20000076293945,
          49.19999694824219,
          806.8212890625,
          567.5225219726562
        ],
        "num_rows": 39,
        "num_cols": 4
      },
      {
        "bbox": [
          39.739524841308594,
          49.19999694824219,
          806.821044921875,
          567.5225219726562
        ],
        "num_rows": 40,
        "num_cols": 4
      },
      {
        "bbox": [
          40.20000076293945,
          49.19999694824219,
          784.5599975585938,
          567.5225219726562
        ],
        "num_rows": 41,
        "num_cols": 4
      },
      {
        "bbox": [
          60.3599967956543,
          200.99998474121094,
          338.0396423339844,
          341.1646728515625
        ],
        "num_rows": 5,
        "num_cols": 2
      }
    ]
  },
  "text_blocks": [
    {
      "text": "방사성의약품 품목허가를 위한 안내서",
      "font_size": 17.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        63.599998474121094,
        196.69288635253906,
        358.92047119140625,
        213.73287963867188
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[민원인 안내서]",
      "font_size": 17.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        155.39999389648438,
        226.0928955078125,
        272.7939453125,
        243.1328887939453
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2015.7.",
      "font_size": 15.59999942779541,
      "font_name": "H2hdrM",
      "bbox": [
        185.27999877929688,
        310.7289733886719,
        237.24375915527344,
        326.3289794921875
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품심사부",
      "font_size": 14.15999984741211,
      "font_name": "T2",
      "bbox": [
        172.1999969482422,
        479.15997314453125,
        250.3207244873047,
        496.1519775390625
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "종양약품과",
      "font_size": 14.15999984741211,
      "font_name": "T2",
      "bbox": [
        178.55999755859375,
        505.4399719238281,
        243.84043884277344,
        522.4319458007812
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침·안내서 제‧개정 점검표",
      "font_size": 12.119999885559082,
      "font_name": "H2hdrM",
      "bbox": [
        553.2000122070312,
        58.116207122802734,
        712.3200073242188,
        70.2362060546875
      ],
      "page_num": 1,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명칭",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothicBold",
      "bbox": [
        480.5999755859375,
        86.91064453125,
        652.7999877929688,
        97.2852554321289
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방사성의약품 품목허가를 위한 안내서",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        480.5999755859375,
        86.91064453125,
        652.7999877929688,
        97.2852554321289
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아래에 해당하는 사항에 체크하여 주시기 바랍니다.",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothicBold",
      "bbox": [
        540.1199951171875,
        107.07064056396484,
        725.641357421875,
        117.44525146484375
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등록대상",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothicBold",
      "bbox": [
        472.1999816894531,
        213.39064025878906,
        503.52008056640625,
        223.76524353027344
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여부",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothicBold",
      "bbox": [
        480.0,
        225.8706512451172,
        495.7200927734375,
        236.24525451660156
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 이미 등록된 지침·안내서 중 동일·유사한 내용의",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        121.59064483642578,
        701.8621826171875,
        131.9652557373047
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침·안내서가 있습니까?",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        528.3599853515625,
        133.35064697265625,
        618.4618530273438,
        143.72525024414062
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        746.5199584960938,
        121.95064544677734,
        781.6799926757812,
        143.24525451660156
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        746.5199584960938,
        121.95064544677734,
        781.6799926757812,
        143.24525451660156
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        149.19064331054688,
        801.4622802734375,
        159.56524658203125
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려하시기 바랍니다. 그럼에도 불구하고 동 지침·안내서의 제정이 필요한",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        527.8800048828125,
        160.8306427001953,
        801.4622802734375,
        171.2052459716797
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 그 사유를 아래에 기재해 주시기 바랍니다.",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        527.8800048828125,
        172.5906524658203,
        701.3062133789062,
        182.9652557373047
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(사유 :                                                                 )",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        184.35064697265625,
        795.0965576171875,
        194.72525024414062
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        198.15065002441406,
        730.7821655273438,
        208.52525329589844
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내용을 단순 편집 또는 나열한 것입니까?",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        528.3599853515625,
        209.91064453125,
        673.421875,
        220.28524780273438
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        746.5199584960938,
        198.51065063476562,
        781.6799926757812,
        219.9252471923828
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        746.5199584960938,
        198.51065063476562,
        781.6799926757812,
        219.9252471923828
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        219.75064086914062,
        781.6799926757812,
        241.0452423095703
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        219.75064086914062,
        781.6799926757812,
        241.0452423095703
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        219.75064086914062,
        781.6799926757812,
        241.0452423095703
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        240.51065063476562,
        735.7021484375,
        250.88525390625
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내용입니까?",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        527.8800048828125,
        251.43063354492188,
        570.5877075195312,
        261.80523681640625
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        746.5199584960938,
        240.51065063476562,
        781.6799926757812,
        261.80523681640625
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        746.5199584960938,
        240.51065063476562,
        781.6799926757812,
        261.80523681640625
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 외국 규정을 번역하거나 설명하는 내용입니까?",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        261.150634765625,
        781.6799926757812,
        282.56524658203125
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        261.150634765625,
        781.6799926757812,
        282.56524658203125
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        261.150634765625,
        781.6799926757812,
        282.56524658203125
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 정보제공 등 직원 교육용 자료입니까?",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        281.91064453125,
        781.6799926757812,
        303.20526123046875
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        281.91064453125,
        781.6799926757812,
        303.20526123046875
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        281.91064453125,
        781.6799926757812,
        303.20526123046875
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        305.4306335449219,
        797.622314453125,
        327.44525146484375
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        305.4306335449219,
        797.622314453125,
        327.44525146484375
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침·안내서",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothicBold",
      "bbox": [
        467.5199890136719,
        349.23065185546875,
        510.9421691894531,
        359.6052551269531
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구분",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothicBold",
      "bbox": [
        480.0,
        361.83062744140625,
        495.7200927734375,
        372.2052307128906
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        332.1906433105469,
        739.3202514648438,
        342.56524658203125
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사무의 세부기준이나 절차를 제시하는 것입니까? (공무원용)",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        528.0,
        343.11065673828125,
        728.3765869140625,
        353.4852600097656
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예(☞지침)",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        746.5199584960938,
        332.1906433105469,
        797.022216796875,
        353.4852600097656
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        746.5199584960938,
        332.1906433105469,
        797.022216796875,
        353.4852600097656
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        357.6306457519531,
        741.9423828125,
        368.0052490234375
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        528.0,
        368.5506286621094,
        742.0623168945312,
        389.8452453613281
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식약처의 입장을 기술하는 것입니까? (민원인용)",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        528.0,
        368.5506286621094,
        742.0623168945312,
        389.8452453613281
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 예(☞안내서)",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        746.5199584960938,
        363.0306396484375,
        801.4622192382812,
        384.32525634765625
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 아니오",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        746.5199584960938,
        363.0306396484375,
        801.4622192382812,
        384.32525634765625
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기타 확인",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothicBold",
      "bbox": [
        470.2799987792969,
        406.9506530761719,
        505.4399719238281,
        417.32525634765625
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사항",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothicBold",
      "bbox": [
        480.0,
        419.4306335449219,
        495.7200927734375,
        429.80523681640625
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        394.9506530761719,
        723.5821533203125,
        405.32525634765625
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민원인을 구속하는 내용이 있습니까?",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        528.0,
        405.8706359863281,
        660.3477172851562,
        416.2452392578125
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        746.5199584960938,
        394.9506530761719,
        781.6799926757812,
        416.2452392578125
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        746.5199584960938,
        394.9506530761719,
        781.6799926757812,
        416.2452392578125
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침·",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        516.239990234375,
        421.35064697265625,
        798.626220703125,
        431.7252502441406
      ],
      "page_num": 1,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안내서 제·개정 절차를 진행하시기 바랍니다.",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        527.8800048828125,
        433.1106262207031,
        687.5062255859375,
        443.4852294921875
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상기 사항에 대하여 확인하였음.",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothicBold",
      "bbox": [
        574.4400024414062,
        445.83062744140625,
        692.0413818359375,
        456.2052307128906
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2017  년   5  월   25  일",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothicBold",
      "bbox": [
        579.1199951171875,
        468.150634765625,
        679.199951171875,
        478.5252380371094
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "담당자",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothicBold",
      "bbox": [
        655.6799926757812,
        488.5506286621094,
        771.719970703125,
        509.125244140625
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확  인(부서장)",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothicBold",
      "bbox": [
        655.6799926757812,
        488.5506286621094,
        771.719970703125,
        509.125244140625
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "오 호 정",
      "font_size": 7.799999713897705,
      "font_name": "MalgunGothic",
      "bbox": [
        655.6799926757812,
        488.5506286621094,
        771.719970703125,
        509.125244140625
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 안내서는 방사성의약품의 품목허가와 관련하여 허가 전반적인",
      "font_size": 9.960000038146973,
      "font_name": "T8",
      "bbox": [
        66.83999633789062,
        79.91999816894531,
        370.681396484375,
        91.87199401855469
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사항에 대하여 절차, 내용 등을 알기 쉽게 풀어 설명한 것입니다.",
      "font_size": 9.960000038146973,
      "font_name": "T8",
      "bbox": [
        51.84000015258789,
        95.76000213623047,
        340.8401794433594,
        107.71199798583984
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의",
      "font_size": 9.960000038146973,
      "font_name": "T8",
      "bbox": [
        61.79999923706055,
        111.72000122070312,
        370.67999267578125,
        123.6719970703125
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시",
      "font_size": 9.960000038146973,
      "font_name": "T8",
      "bbox": [
        51.84000015258789,
        127.56000518798828,
        370.67999267578125,
        139.5120086669922
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "준수하셔야 하는 사항이 아님을 알려드립니다. 또한, 본 안내서는",
      "font_size": 9.960000038146973,
      "font_name": "T8",
      "bbox": [
        51.84000015258789,
        143.51998901367188,
        370.67999267578125,
        155.4720001220703
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2015년 7월 30일 현재의 과학적·기술적 사실 및 유효한 법규를 토대",
      "font_size": 9.960000038146973,
      "font_name": "T8",
      "bbox": [
        51.84000015258789,
        159.3599853515625,
        370.67999267578125,
        171.31199645996094
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계",
      "font_size": 9.960000038146973,
      "font_name": "T8",
      "bbox": [
        51.84000015258789,
        175.3199920654297,
        370.67999267578125,
        187.27200317382812
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등에 따라 달리 적용될 수 있음을 알려드립니다.",
      "font_size": 9.960000038146973,
      "font_name": "T8",
      "bbox": [
        51.84000015258789,
        191.2799835205078,
        273.0401916503906,
        203.23199462890625
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등",
      "font_size": 9.960000038146973,
      "font_name": "T8",
      "bbox": [
        56.87999725341797,
        223.07998657226562,
        370.67999267578125,
        235.03199768066406
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(이하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한",
      "font_size": 9.960000038146973,
      "font_name": "T8",
      "bbox": [
        51.84000015258789,
        238.91998291015625,
        370.67999267578125,
        250.8719940185547
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사안에 대하여 식품의약품안전처의 입장을 기술하는 것",
      "font_size": 9.960000038146973,
      "font_name": "T8",
      "bbox": [
        51.84000015258789,
        254.87998962402344,
        305.3999938964844,
        266.8320007324219
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 본 해설서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원 의약품심사부",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        46.68000030517578,
        433.9181213378906,
        386.58148193359375,
        442.904052734375
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "종양약품과로 문의하시기 바랍니다.",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        59.87999725341797,
        448.0799865722656,
        190.032958984375,
        458.2954406738281
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전화번호: 043-719-3057",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        60.84000015258789,
        478.79998779296875,
        150.999267578125,
        489.01544189453125
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "팩스번호: 043-719-3050",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        60.84000015258789,
        495.8399963378906,
        150.999267578125,
        506.0554504394531
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목  차",
      "font_size": 17.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        608.3999633789062,
        54.25288772583008,
        656.0399780273438,
        71.29288482666016
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 서론 ······································································································1",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        481.3199768066406,
        85.08000183105469,
        783.1600952148438,
        97.03199768066406
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.1 배경 ····································································································1",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        486.239990234375,
        100.91999816894531,
        783.1600952148438,
        112.87199401855469
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.2 국내 방사성의약품 품목허가 현황 ··············································1",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        486.239990234375,
        116.87999725341797,
        783.1600952148438,
        128.83200073242188
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 허가처리 절차 ······················································································4",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        481.3199768066406,
        132.71998596191406,
        783.1600952148438,
        144.6719970703125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.1 주요 관련 법규 및 규정 ································································4",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        486.239990234375,
        148.67999267578125,
        783.1600952148438,
        160.6320037841797
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2 품목허가 신청 및 처리 절차 ························································4",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        486.239990234375,
        164.51998901367188,
        783.1600952148438,
        176.4720001220703
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2.1 품목허가 신청 및 처리 흐름도 ···············································4",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        180.47999572753906,
        783.1600952148438,
        192.4320068359375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2.2 구비서류 ·······················································································5",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        196.3199920654297,
        783.1600952148438,
        208.27200317382812
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2.3 수수료 및 처리기한 ···································································6",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        212.2799835205078,
        783.1600952148438,
        224.23199462890625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2.4 전자민원 신청방법 ·····································································7",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        228.1199951171875,
        783.1600952148438,
        240.07200622558594
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3 품목허가 신청서 작성 요령 ··························································8",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        486.239990234375,
        244.07998657226562,
        783.1600952148438,
        256.031982421875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.1 제품명 ···························································································8",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        259.9200134277344,
        783.1600952148438,
        271.87200927734375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.2 분류번호 및 분류 ·······································································9",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        275.8800048828125,
        783.1600952148438,
        287.8320007324219
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.3 원료약품 및 그 분량 ·································································9",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        291.8399963378906,
        783.1600952148438,
        303.7919921875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.4 성상 ·····························································································10",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        307.67999267578125,
        783.1602783203125,
        319.6319885253906
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.5 제조방법 ·····················································································11",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        323.6400146484375,
        783.1602783203125,
        335.5920104980469
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.6 효능․효과 ·················································································13",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        339.4800109863281,
        783.1602783203125,
        351.4320068359375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.7 용법․용량 ·················································································13",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        355.44000244140625,
        783.1602783203125,
        367.3919982910156
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.8 사용상의 주의사항 ···································································13",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        371.2799987792969,
        783.1602783203125,
        383.23199462890625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.9 포장단위 ·····················································································13",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        387.239990234375,
        783.1602783203125,
        399.1919860839844
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.10 저장방법 및 사용기간 ···························································13",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        403.0799865722656,
        783.1602783203125,
        415.031982421875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.11 기준 및 시험방법 ···································································14",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        419.0400085449219,
        783.1602783203125,
        430.99200439453125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.12 제조원 ·······················································································15",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        434.8800048828125,
        783.1602783203125,
        446.8320007324219
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.3.13 허가조건 ···················································································16",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        491.1600036621094,
        450.8399963378906,
        783.1602783203125,
        462.7919921875
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.4 심사자료의 종류 및 범위 ····························································17",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        486.239990234375,
        466.67999267578125,
        783.1602783203125,
        478.6319885253906
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.5 GMP 평가자료의 종류 및 범위 ·················································19",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        486.239990234375,
        482.6399841308594,
        783.1602783203125,
        494.59197998046875
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부록1. 관련 법규 ····················································································21",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        481.3199768066406,
        498.4800109863281,
        783.1602783203125,
        510.4320068359375
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부록2. 유럽약전 방사성의약품 번역 ··················································31",
      "font_size": 9.960000038146973,
      "font_name": "T3",
      "bbox": [
        481.3199768066406,
        514.43994140625,
        783.1602783203125,
        526.3919677734375
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 1 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        201.239990234375,
        560.4425048828125,
        221.26499938964844,
        567.5225219726562
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제·개정 이력",
      "font_size": 14.15999984741211,
      "font_name": "MalgunGothicBold",
      "bbox": [
        170.63999938964844,
        75.06855010986328,
        251.88037109375,
        93.90245819091797
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연번",
      "font_size": 8.519999504089355,
      "font_name": "MalgunGothicBold",
      "bbox": [
        50.7599983215332,
        128.84701538085938,
        312.47998046875,
        140.1792755126953
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제·개정번호",
      "font_size": 8.519999504089355,
      "font_name": "MalgunGothicBold",
      "bbox": [
        50.7599983215332,
        128.84701538085938,
        312.47998046875,
        140.1792755126953
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "승인일자",
      "font_size": 8.519999504089355,
      "font_name": "MalgunGothicBold",
      "bbox": [
        50.7599983215332,
        128.84701538085938,
        312.47998046875,
        140.1792755126953
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주요내용",
      "font_size": 8.519999504089355,
      "font_name": "MalgunGothicBold",
      "bbox": [
        50.7599983215332,
        128.84701538085938,
        312.47998046875,
        140.1792755126953
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        57.119998931884766,
        151.79998779296875,
        303.9599914550781,
        162.01547241210938
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "C0-2015-2-008",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        57.119998931884766,
        151.79998779296875,
        303.9599914550781,
        162.01547241210938
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2015.07.30",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        57.119998931884766,
        151.79998779296875,
        303.9599914550781,
        162.01547241210938
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제정",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        57.119998931884766,
        151.79998779296875,
        303.9599914550781,
        162.01547241210938
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        57.119998931884766,
        183.59999084472656,
        180.1886444091797,
        193.8154754638672
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안내서-0231-01",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        57.119998931884766,
        183.59999084472656,
        180.1886444091797,
        193.8154754638672
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        57.119998931884766,
        183.59999084472656,
        180.1886444091797,
        193.8154754638672
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "「식약처 지침서등의 관리에 관한",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        229.44000244140625,
        169.9199981689453,
        365.82000732421875,
        180.1439971923828
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규정」 개정에 따른 등록번호 일괄 정비",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        216.72000122070312,
        183.59999084472656,
        378.5400085449219,
        193.82398986816406
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(규제개혁담당관실-3761호,2017.5.16)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        228.59999084472656,
        197.1599884033203,
        366.6680603027344,
        207.37547302246094
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 2 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        622.2000122070312,
        560.4425048828125,
        642.2249755859375,
        567.5225219726562
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품 품목허가를 위한 안내서",
      "font_size": 15.59999942779541,
      "font_name": "T15",
      "bbox": [
        489.239990234375,
        48.0,
        774.4785766601562,
        66.72000122070312
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 서론",
      "font_size": 10.679999351501465,
      "font_name": "H2hdrM",
      "bbox": [
        461.1600036621094,
        97.5123062133789,
        496.2003479003906,
        108.19230651855469
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.1 배경",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        134.51998901367188,
        495.719970703125,
        145.5987548828125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 안내서는 방사성의약품 허가에 대한 경험이 적어 허가 신청 시 어려움을 느끼는",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        155.2781219482422,
        807.5398559570312,
        164.26405334472656
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "민원인들에게 허가 전반적인 사항에 대해 알기 쉽게 안내하고자 마련하였으며 허가심사",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        170.63812255859375,
        803.27978515625,
        179.62405395507812
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "절차, 신청방법, 신청서 항목 작성 요령 및 기타 유용한 정보 등을 담아 품목허가 신청을",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        184.79998779296875,
        803.2794189453125,
        195.01547241210938
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용이하게 하고자 하였다. 아울러 PET용 방사성의약품의 심사 평가 시 요구되는 일반적인",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        200.0399932861328,
        803.2788696289062,
        210.25547790527344
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정보에 대해서는 2012년도에 발간한 ｢",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        461.1600036621094,
        215.39999389648438,
        605.8200073242188,
        225.62399291992188
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PET용 방사성의약품 평가 가이드라인｣",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        605.6400146484375,
        215.39999389648438,
        753.0599975585938,
        225.62399291992188
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "을 참고한다.",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        753.0,
        215.39999389648438,
        800.4729614257812,
        225.615478515625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.2 국내 방사성의약품 품목허가 현황",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        248.87998962402344,
        620.2799682617188,
        259.958740234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국내 방사성의약품의 연도별 품목허가 수는 표 1과 그림 1에서 나타나듯이 특정 년도를",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        268.44000244140625,
        803.2794189453125,
        278.65545654296875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제외하고 매년 10품목 이내로 허가되었으며 2000년도에 55품목으로 가장 많이",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        283.67999267578125,
        807.5399780273438,
        293.89544677734375
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허가되었고,",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        299.0400085449219,
        807.5399780273438,
        309.2554626464844
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기타 2001년 및 2005년도에 각각 34,",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        299.0400085449219,
        807.5399780273438,
        309.2554626464844
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "29품목이 허가되었고 최근의",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        299.0400085449219,
        807.5399780273438,
        309.2554626464844
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2014년도에는 16품목이 허가되었다. 이와 같이 특정 년도에 품목허가 수가 증가된",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        314.3999938964844,
        807.5399780273438,
        324.6154479980469
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주된 이유는 신규업체의 등장에 따른 품목신청이 늘어났기 때문인 것으로 확인된다.",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        329.760009765625,
        803.3529663085938,
        339.9754638671875
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조와 수입의 비율(%)은 55 : 45 로 제조가 20 품목 더 많이 허가되었다.",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        345.1199951171875,
        750.6729736328125,
        355.33544921875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 1. 연도별 방사성의약품 품목허가 수 (15.01.12. 품목대장 기준)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        381.4800109863281,
        701.1094970703125,
        391.6954650878906
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연도",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        401.760009765625,
        790.5599975585938,
        411.9840087890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        401.760009765625,
        790.5599975585938,
        411.9840087890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수입",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        401.760009765625,
        790.5599975585938,
        411.9840087890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        401.760009765625,
        790.5599975585938,
        411.9840087890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연도",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        401.760009765625,
        790.5599975585938,
        411.9840087890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        401.760009765625,
        790.5599975585938,
        411.9840087890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수입",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        401.760009765625,
        790.5599975585938,
        411.9840087890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        401.760009765625,
        790.5599975585938,
        411.9840087890625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1968",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        415.32000732421875,
        784.1400146484375,
        425.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        415.32000732421875,
        784.1400146484375,
        425.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        415.32000732421875,
        784.1400146484375,
        425.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        415.32000732421875,
        784.1400146484375,
        425.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        415.32000732421875,
        784.1400146484375,
        425.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        415.32000732421875,
        784.1400146484375,
        425.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        415.32000732421875,
        784.1400146484375,
        425.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        425.8800048828125,
        784.1400146484375,
        436.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        425.8800048828125,
        784.1400146484375,
        436.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        425.8800048828125,
        784.1400146484375,
        436.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        425.8800048828125,
        784.1400146484375,
        436.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2008",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        425.8800048828125,
        784.1400146484375,
        436.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        425.8800048828125,
        784.1400146484375,
        436.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        425.8800048828125,
        784.1400146484375,
        436.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        425.8800048828125,
        784.1400146484375,
        436.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1998",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        436.32000732421875,
        784.1400146484375,
        446.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        436.32000732421875,
        784.1400146484375,
        446.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        436.32000732421875,
        784.1400146484375,
        446.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2009",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        436.32000732421875,
        784.1400146484375,
        446.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        436.32000732421875,
        784.1400146484375,
        446.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        436.32000732421875,
        784.1400146484375,
        446.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        436.32000732421875,
        784.1400146484375,
        446.54400634765625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1999",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        446.8800048828125,
        784.1400146484375,
        457.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        446.8800048828125,
        784.1400146484375,
        457.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        446.8800048828125,
        784.1400146484375,
        457.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        446.8800048828125,
        784.1400146484375,
        457.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2010",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        446.8800048828125,
        784.1400146484375,
        457.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        446.8800048828125,
        784.1400146484375,
        457.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        446.8800048828125,
        784.1400146484375,
        457.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        446.8800048828125,
        784.1400146484375,
        457.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2000",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        457.44000244140625,
        784.1400146484375,
        467.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "16",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        457.44000244140625,
        784.1400146484375,
        467.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "39",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        457.44000244140625,
        784.1400146484375,
        467.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "55",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        457.44000244140625,
        784.1400146484375,
        467.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2011",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        457.44000244140625,
        784.1400146484375,
        467.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        457.44000244140625,
        784.1400146484375,
        467.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        457.44000244140625,
        784.1400146484375,
        467.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        457.44000244140625,
        784.1400146484375,
        467.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2001",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        467.8800048828125,
        784.1400146484375,
        478.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "23",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        467.8800048828125,
        784.1400146484375,
        478.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        467.8800048828125,
        784.1400146484375,
        478.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "34",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        467.8800048828125,
        784.1400146484375,
        478.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2012",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        467.8800048828125,
        784.1400146484375,
        478.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        467.8800048828125,
        784.1400146484375,
        478.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        467.8800048828125,
        784.1400146484375,
        478.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        467.8800048828125,
        784.1400146484375,
        478.10400390625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2002",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        478.44000244140625,
        784.1400146484375,
        488.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        478.44000244140625,
        784.1400146484375,
        488.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        478.44000244140625,
        784.1400146484375,
        488.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        478.44000244140625,
        784.1400146484375,
        488.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2013",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        478.44000244140625,
        784.1400146484375,
        488.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        478.44000244140625,
        784.1400146484375,
        488.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        478.44000244140625,
        784.1400146484375,
        488.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        478.44000244140625,
        784.1400146484375,
        488.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2003",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        489.0,
        786.3003540039062,
        499.2239990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        489.0,
        786.3003540039062,
        499.2239990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        489.0,
        786.3003540039062,
        499.2239990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        489.0,
        786.3003540039062,
        499.2239990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2014",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        489.0,
        786.3003540039062,
        499.2239990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        489.0,
        786.3003540039062,
        499.2239990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        489.0,
        786.3003540039062,
        499.2239990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "16",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        489.0,
        786.3003540039062,
        499.2239990234375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2004",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        499.44000244140625,
        788.4600219726562,
        509.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        499.44000244140625,
        788.4600219726562,
        509.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        499.44000244140625,
        788.4600219726562,
        509.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        499.44000244140625,
        788.4600219726562,
        509.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "합계",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        499.44000244140625,
        788.4600219726562,
        509.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "116",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        499.44000244140625,
        788.4600219726562,
        509.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "96",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        499.44000244140625,
        788.4600219726562,
        509.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "212",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        499.44000244140625,
        788.4600219726562,
        509.66400146484375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        509.9999694824219,
        786.3599853515625,
        530.7839965820312
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        509.9999694824219,
        786.3599853515625,
        530.7839965820312
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        509.9999694824219,
        786.3599853515625,
        530.7839965820312
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "29",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        509.9999694824219,
        786.3599853515625,
        530.7839965820312
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비율(%)",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        509.9999694824219,
        786.3599853515625,
        530.7839965820312
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "55",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        509.9999694824219,
        786.3599853515625,
        530.7839965820312
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "45",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        509.9999694824219,
        786.3599853515625,
        530.7839965820312
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2006",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        509.9999694824219,
        786.3599853515625,
        530.7839965820312
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        509.9999694824219,
        786.3599853515625,
        530.7839965820312
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        509.9999694824219,
        786.3599853515625,
        530.7839965820312
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        474.3599853515625,
        509.9999694824219,
        786.3599853515625,
        530.7839965820312
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 3 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        201.239990234375,
        560.4425048828125,
        221.26499938964844,
        567.5225219726562
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0",
      "font_size": 6.0,
      "font_name": "Gulim",
      "bbox": [
        88.08000183105469,
        260.64959716796875,
        91.52531433105469,
        266.64959716796875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20",
      "font_size": 6.0,
      "font_name": "Gulim",
      "bbox": [
        86.4000015258789,
        231.60960388183594,
        93.32530975341797,
        237.60960388183594
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40",
      "font_size": 6.0,
      "font_name": "Gulim",
      "bbox": [
        86.4000015258789,
        202.56961059570312,
        93.32530975341797,
        208.56961059570312
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60",
      "font_size": 6.0,
      "font_name": "Gulim",
      "bbox": [
        86.4000015258789,
        173.52960205078125,
        93.32530975341797,
        179.52960205078125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80",
      "font_size": 6.0,
      "font_name": "Gulim",
      "bbox": [
        86.4000015258789,
        144.48960876464844,
        93.32530975341797,
        150.48960876464844
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "100",
      "font_size": 6.0,
      "font_name": "Gulim",
      "bbox": [
        84.5999984741211,
        115.4496078491211,
        95.00531005859375,
        121.4496078491211
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "120",
      "font_size": 6.0,
      "font_name": "Gulim",
      "bbox": [
        84.5999984741211,
        86.28960418701172,
        95.00531005859375,
        92.28960418701172
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "140",
      "font_size": 6.0,
      "font_name": "Gulim",
      "bbox": [
        84.5999984741211,
        57.24960708618164,
        95.00531005859375,
        63.24960708618164
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품목수(건)",
      "font_size": 6.0,
      "font_name": "Gulim",
      "bbox": [
        46.20000076293945,
        159.00961303710938,
        74.72999572753906,
        165.00961303710938
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1968 1996 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014",
      "font_size": 6.0,
      "font_name": "Gulim",
      "bbox": [
        102.0,
        268.9295959472656,
        388.5252990722656,
        274.9295959472656
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "년도",
      "font_size": 6.0,
      "font_name": "Gulim",
      "bbox": [
        239.39999389648438,
        285.7296142578125,
        251.39999389648438,
        291.7296142578125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조품목",
      "font_size": 6.0,
      "font_name": "H2hdrM",
      "bbox": [
        333.0,
        181.20960998535156,
        357.0,
        187.20960998535156
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수입품목",
      "font_size": 6.0,
      "font_name": "H2hdrM",
      "bbox": [
        333.0,
        192.24960327148438,
        357.0,
        198.24960327148438
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조품목누적량",
      "font_size": 6.0,
      "font_name": "H2hdrM",
      "bbox": [
        333.0,
        202.44960021972656,
        375.0,
        208.44960021972656
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수입품목누적량",
      "font_size": 6.0,
      "font_name": "H2hdrM",
      "bbox": [
        333.0,
        212.64959716796875,
        375.0,
        218.64959716796875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그림 1. 연도별 방사성의약품 품목허가 그래프 (15.01.12. 품목대장 기준)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        78.47999572753906,
        303.9599914550781,
        343.9894714355469,
        314.1754455566406
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국내 방사성의약품의 방사성동위원소 별 품목허가 수를 표 2와 그림 2에 나타내었다.",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        44.52000045776367,
        336.1199951171875,
        382.3929443359375,
        346.33544921875
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전체 허가된 방사성의약품 중 테크네튬(99mTc(콜드),",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        350.760009765625,
        386.5799865722656,
        361.6954650878906
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "99mTc(제너레이터),",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        350.760009765625,
        386.5799865722656,
        361.6954650878906
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "99mTc)과 관련된",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        350.760009765625,
        386.5799865722656,
        361.6954650878906
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방사성의약품이 47.1%로 가장 높은 비율을 차지하였고,",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        366.1199951171875,
        382.2731628417969,
        376.9354553222656
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "131I과 18F이 각각 21.7%,",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        366.1199951171875,
        382.2731628417969,
        376.9354553222656
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "15.1%로 그 다음 높은 비율을 차지하였다.",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        382.08001708984375,
        204.79295349121094,
        392.29547119140625
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 2. 방사성동위원소 별 품목허가 수 (15.01.12. 품목대장 기준)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        418.44000244140625,
        271.62945556640625,
        428.65545654296875
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방사성동위원소",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        52.79999923706055,
        437.6400146484375,
        378.1138610839844,
        447.864013671875
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품목수",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        52.79999923706055,
        437.6400146484375,
        378.1138610839844,
        447.864013671875
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백분율(%)",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        52.79999923706055,
        437.6400146484375,
        378.1138610839844,
        447.864013671875
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방사성동위원소",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        52.79999923706055,
        437.6400146484375,
        378.1138610839844,
        447.864013671875
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품목수",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        52.79999923706055,
        437.6400146484375,
        378.1138610839844,
        447.864013671875
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백분율(%)",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        52.79999923706055,
        437.6400146484375,
        378.1138610839844,
        447.864013671875
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "13N",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        76.91999816894531,
        447.4800109863281,
        364.49932861328125,
        458.42401123046875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        76.91999816894531,
        447.4800109863281,
        364.49932861328125,
        458.42401123046875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.4",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        76.91999816894531,
        447.4800109863281,
        364.49932861328125,
        458.42401123046875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "201Tl",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        76.91999816894531,
        447.4800109863281,
        364.49932861328125,
        458.42401123046875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        76.91999816894531,
        447.4800109863281,
        364.49932861328125,
        458.42401123046875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.7",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        76.91999816894531,
        447.4800109863281,
        364.49932861328125,
        458.42401123046875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99mTc(콜드)",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        62.03999710083008,
        459.47998046875,
        366.6598205566406,
        471.7439880371094
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "45",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        62.03999710083008,
        459.47998046875,
        366.6598205566406,
        471.7439880371094
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "21.2",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        62.03999710083008,
        459.47998046875,
        366.6598205566406,
        471.7439880371094
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18F",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        62.03999710083008,
        459.47998046875,
        366.6598205566406,
        471.7439880371094
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "32",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        62.03999710083008,
        459.47998046875,
        366.6598205566406,
        471.7439880371094
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15.1",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        62.03999710083008,
        459.47998046875,
        366.6598205566406,
        471.7439880371094
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "99mTc(제너레이터)",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        49.20000076293945,
        472.79998779296875,
        364.49932861328125,
        485.0639953613281
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "14",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        49.20000076293945,
        472.79998779296875,
        364.49932861328125,
        485.0639953613281
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6.6",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        49.20000076293945,
        472.79998779296875,
        364.49932861328125,
        485.0639953613281
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "14C",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        49.20000076293945,
        472.79998779296875,
        364.49932861328125,
        485.0639953613281
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        49.20000076293945,
        472.79998779296875,
        364.49932861328125,
        485.0639953613281
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.9",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        49.20000076293945,
        472.79998779296875,
        364.49932861328125,
        485.0639953613281
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "99mTc",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.19999694824219,
        484.79998779296875,
        366.6598205566406,
        495.6239929199219
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "41",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.19999694824219,
        484.79998779296875,
        366.6598205566406,
        495.6239929199219
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "19.3",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.19999694824219,
        484.79998779296875,
        366.6598205566406,
        495.6239929199219
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "131I",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.19999694824219,
        484.79998779296875,
        366.6598205566406,
        495.6239929199219
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "46",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.19999694824219,
        484.79998779296875,
        366.6598205566406,
        495.6239929199219
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "21.7",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.19999694824219,
        484.79998779296875,
        366.6598205566406,
        495.6239929199219
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "89Sr",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        75.83999633789062,
        495.239990234375,
        364.49932861328125,
        506.1839904785156
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        75.83999633789062,
        495.239990234375,
        364.49932861328125,
        506.1839904785156
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        75.83999633789062,
        495.239990234375,
        364.49932861328125,
        506.1839904785156
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "123I",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        75.83999633789062,
        495.239990234375,
        364.49932861328125,
        506.1839904785156
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        75.83999633789062,
        495.239990234375,
        364.49932861328125,
        506.1839904785156
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.3",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        75.83999633789062,
        495.239990234375,
        364.49932861328125,
        506.1839904785156
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "67Ga",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        74.4000015258789,
        505.79998779296875,
        364.49932861328125,
        516.6239624023438
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        74.4000015258789,
        505.79998779296875,
        364.49932861328125,
        516.6239624023438
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.4",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        74.4000015258789,
        505.79998779296875,
        364.49932861328125,
        516.6239624023438
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "111In",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        74.4000015258789,
        505.79998779296875,
        364.49932861328125,
        516.6239624023438
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        74.4000015258789,
        505.79998779296875,
        364.49932861328125,
        516.6239624023438
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.9",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        74.4000015258789,
        505.79998779296875,
        364.49932861328125,
        516.6239624023438
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "51Cr",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.31999969482422,
        516.3599853515625,
        324.17999267578125,
        537.7439575195312
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.31999969482422,
        516.3599853515625,
        324.17999267578125,
        537.7439575195312
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.4",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.31999969482422,
        516.3599853515625,
        324.17999267578125,
        537.7439575195312
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.31999969482422,
        516.3599853515625,
        324.17999267578125,
        537.7439575195312
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "212",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.31999969482422,
        516.3599853515625,
        324.17999267578125,
        537.7439575195312
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "223Ra",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.31999969482422,
        516.3599853515625,
        324.17999267578125,
        537.7439575195312
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.31999969482422,
        516.3599853515625,
        324.17999267578125,
        537.7439575195312
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5",
      "font_size": 8.519999504089355,
      "font_name": "T8",
      "bbox": [
        73.31999969482422,
        516.3599853515625,
        324.17999267578125,
        537.7439575195312
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 4 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        622.2000122070312,
        560.4425048828125,
        642.2249755859375,
        567.5225219726562
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그림 2. 방사성동위원소 별 품목허가 그래프 (15.01.12. 품목대장 기준)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        503.7599792480469,
        530.0399780273438,
        760.74951171875,
        540.2554931640625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 5 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        201.239990234375,
        560.4425048828125,
        221.26499938964844,
        567.5225219726562
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 허가 처리 절차",
      "font_size": 10.679999351501465,
      "font_name": "H2hdrM",
      "bbox": [
        40.20000076293945,
        50.1123046875,
        128.51998901367188,
        60.79230499267578
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.1 주요 관련 법규 및 규정 (부록1 참조)",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        40.20000076293945,
        80.87999725341797,
        202.63055419921875,
        91.95875549316406
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ü 약사법 제31조, 제42조",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.7599983215332,
        98.52000427246094,
        144.83999633789062,
        108.83718872070312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ü 의약품 등의 안전에 관한 규칙 제2조, 제4조, 제5조, 제8조, 제9조, 제10조",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.7599983215332,
        113.87999725341797,
        344.7599792480469,
        124.19718170166016
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ü 의약품의 품목허가․신고․심사 규정",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.7599983215332,
        129.239990234375,
        202.44000244140625,
        139.5571746826172
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ü 의약품 제조 및 품질관리에 관한 규정",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.7599983215332,
        145.46115112304688,
        206.63999938964844,
        154.91717529296875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2 품목허가 신청 및 처리 절차",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        174.1199951171875,
        176.27999877929688,
        185.19876098632812
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2.1 품목허가 신청 및 처리 흐름도",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        193.67999267578125,
        180.60000610351562,
        203.89547729492188
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1단계",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        67.79999542236328,
        210.239990234375,
        86.2796630859375,
        218.73599243164062
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⇨",
      "font_size": 8.519999504089355,
      "font_name": "T18",
      "bbox": [
        117.47999572753906,
        218.51998901367188,
        125.99999237060547,
        228.74398803710938
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2단계",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        157.3199920654297,
        210.239990234375,
        175.79966735839844,
        218.73599243164062
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⇨",
      "font_size": 8.519999504089355,
      "font_name": "T18",
      "bbox": [
        207.0,
        218.51998901367188,
        215.52000427246094,
        228.74398803710938
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3단계",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        246.72000122070312,
        210.239990234375,
        265.19964599609375,
        218.73599243164062
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⇨",
      "font_size": 8.519999504089355,
      "font_name": "T18",
      "bbox": [
        296.3999938964844,
        218.51998901367188,
        304.91998291015625,
        228.74398803710938
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4단계",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        336.239990234375,
        210.239990234375,
        354.71966552734375,
        218.73599243164062
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "회원가입 및 로그인",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        43.79999923706055,
        219.36000061035156,
        185.0390167236328,
        232.53599548339844
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민원서식기",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        43.79999923706055,
        219.36000061035156,
        185.0390167236328,
        232.53599548339844
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다운로드 및 설치",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        137.0399932861328,
        228.59999084472656,
        196.0800323486328,
        237.0959930419922
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민원서식 작성",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        231.95999145507812,
        219.36000061035156,
        279.95965576171875,
        227.8560028076172
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(신청서, 구비서류)",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        224.87998962402344,
        224.0399932861328,
        369.4796447753906,
        237.0959930419922
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전자민원 신청",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        224.87998962402344,
        224.0399932861328,
        369.4796447753906,
        237.0959930419922
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⇩",
      "font_size": 7.079999923706055,
      "font_name": "T18",
      "bbox": [
        341.8800048828125,
        237.71998596191406,
        348.9599914550781,
        246.2159881591797
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8단계",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        67.79999542236328,
        246.83999633789062,
        86.2796630859375,
        255.33599853515625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⇦",
      "font_size": 8.519999504089355,
      "font_name": "T18",
      "bbox": [
        117.47999572753906,
        255.11997985839844,
        125.99999237060547,
        265.343994140625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7단계",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        157.3199920654297,
        246.83999633789062,
        175.79966735839844,
        255.33599853515625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⇦",
      "font_size": 8.519999504089355,
      "font_name": "T18",
      "bbox": [
        207.0,
        255.11997985839844,
        215.52000427246094,
        265.343994140625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6단계",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        246.72000122070312,
        246.83999633789062,
        265.19964599609375,
        255.33599853515625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⇦",
      "font_size": 8.519999504089355,
      "font_name": "T18",
      "bbox": [
        296.3999938964844,
        255.11997985839844,
        304.91998291015625,
        265.343994140625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5단계",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        336.239990234375,
        246.83999633789062,
        354.71966552734375,
        255.33599853515625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가증 발급",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        56.87999725341797,
        255.9600067138672,
        278.15869140625,
        269.135986328125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "면허세 납부",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        56.87999725341797,
        255.9600067138672,
        278.15869140625,
        269.135986328125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목허가처리",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        56.87999725341797,
        255.9600067138672,
        278.15869140625,
        269.135986328125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(진행상황 확인)",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        229.67999267578125,
        260.6400146484375,
        365.760009765625,
        273.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수수료 납부",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        229.67999267578125,
        260.6400146484375,
        365.760009765625,
        273.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 품목허가 처리(6단계) 상세 절차",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        288.1199951171875,
        182.16000366210938,
        298.343994140625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처리부서",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        76.08000183105469,
        304.67999267578125,
        279.83935546875,
        313.17596435546875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민원접수",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        76.08000183105469,
        304.67999267578125,
        279.83935546875,
        313.17596435546875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품심사조정과",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        61.19999694824219,
        338.760009765625,
        120.47799682617188,
        347.2559814453125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예비심사 (제출된 서류의 적절성 평가)",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        199.8000030517578,
        323.8800048828125,
        330.4294738769531,
        332.3759765625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "① 안전성․유효성 및",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        180.0,
        343.08001708984375,
        350.2796630859375,
        351.57598876953125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준및시험방법 심사 의뢰",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        180.0,
        343.08001708984375,
        350.2796630859375,
        351.57598876953125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② GMP　실시상황 평가 의뢰(평가 대상에 한함*)",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        180.72000122070312,
        353.6400146484375,
        349.5092468261719,
        362.135986328125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "①",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        44.7599983215332,
        372.8399963378906,
        66.83968353271484,
        399.81597900390625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "종양",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        44.7599983215332,
        372.8399963378906,
        66.83968353271484,
        399.81597900390625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품과",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        44.7599983215332,
        372.8399963378906,
        66.83968353271484,
        399.81597900390625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "②",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        76.55999755859375,
        372.8399963378906,
        136.92002868652344,
        409.05596923828125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(수입)의약품품질과/",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        76.55999755859375,
        372.8399963378906,
        136.92002868652344,
        409.05596923828125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조)제조소 관할",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        76.55999755859375,
        372.8399963378906,
        136.92002868652344,
        409.05596923828125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지방청",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        76.55999755859375,
        372.8399963378906,
        136.92002868652344,
        409.05596923828125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "① 안전성․유효성 및",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        170.0399932861328,
        372.8399963378906,
        363.71966552734375,
        390.57598876953125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준및시험방법 심사",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        170.0399932861328,
        372.8399963378906,
        363.71966552734375,
        390.57598876953125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② GMP　실시상황 평가",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        170.0399932861328,
        372.8399963378906,
        363.71966552734375,
        390.57598876953125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "① 및 ② 자료가 적합한가?",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        160.8000030517578,
        401.1600036621094,
        358.6793518066406,
        414.4559631347656
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니오",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        160.8000030517578,
        401.1600036621094,
        358.6793518066406,
        414.4559631347656
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보완회신",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        160.8000030517578,
        401.1600036621094,
        358.6793518066406,
        414.4559631347656
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        231.0,
        420.6000061035156,
        362.6390075683594,
        429.0959777832031
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과반영",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        231.0,
        420.6000061035156,
        362.6390075683594,
        429.0959777832031
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품심사조정과",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        61.19999694824219,
        458.0400085449219,
        120.47799682617188,
        466.5359802246094
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심사조정이",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        163.3199920654297,
        434.3999938964844,
        200.27902221679688,
        442.8959655761719
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "필요한가",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        167.0399932861328,
        443.6400146484375,
        196.55935668945312,
        452.135986328125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        221.87998962402344,
        429.8399963378906,
        277.079345703125,
        438.3359680175781
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "회사와",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        221.87998962402344,
        429.8399963378906,
        277.079345703125,
        438.3359680175781
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의견조율이",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        247.55999755859375,
        439.08001708984375,
        284.51904296875,
        456.81597900390625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "필요한가?",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        247.55999755859375,
        439.08001708984375,
        284.51904296875,
        456.81597900390625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        305.1600036621094,
        429.8399963378906,
        312.239990234375,
        438.3359680175781
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "회의 개최",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        334.79998779296875,
        439.08001708984375,
        367.9200134277344,
        447.57598876953125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니오",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        187.3199920654297,
        458.1600036621094,
        282.8393249511719,
        466.6559753417969
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니요",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        187.3199920654297,
        458.1600036621094,
        282.8393249511719,
        466.6559753417969
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가 처리",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        165.36000061035156,
        476.760009765625,
        198.3596649169922,
        485.2559814453125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당과 협의",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        245.75999450683594,
        467.5199890136719,
        286.3196716308594,
        485.2559814453125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 조정결과",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        245.75999450683594,
        467.5199890136719,
        286.3196716308594,
        485.2559814453125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반영",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        258.8399963378906,
        486.0,
        273.3596496582031,
        494.4959716796875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "회사 의견",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        334.79998779296875,
        472.20001220703125,
        367.9200134277344,
        480.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수렴",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        344.03997802734375,
        481.44000244140625,
        358.6800231933594,
        489.93597412109375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* ㉮「의약품 등의 안전에 관한 규칙」제4조제2항제2호애 따라 제조소에 동 규칙 제48조의2에 따른 GMP",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        40.20000076293945,
        502.1225280761719,
        384.6777038574219,
        509.2025146484375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합판정서가 있는 경우 GMP 실시상황 평가자료를 제출하지 않을 수 있음(신약, 생물학적제제등, 주사제,",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        54.84000015258789,
        511.362548828125,
        384.67779541015625,
        546.1625366210938
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이식제 제외) 단, ‘15.7.1부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        54.84000015258789,
        511.362548828125,
        384.67779541015625,
        546.1625366210938
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동 규칙 제48조의2에 따른 GMP 적합판정서가 있더라도 관류제, 복막투석제, 점안제, 안연고제,",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        54.84000015258789,
        511.362548828125,
        384.67779541015625,
        546.1625366210938
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        54.84000015258789,
        511.362548828125,
        384.67779541015625,
        546.1625366210938
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 6 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        622.2000122070312,
        560.4425048828125,
        642.2249755859375,
        567.5225219726562
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "㉯ ‘14.8.21자 개정된 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라, 이 규칙",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        461.1600036621094,
        50.202537536621094,
        805.3978881835938,
        57.28253936767578
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시행 전에 종전의 규정에 따라 방사성의약품 제조판매‧수입품목허가를 받은 제조업자‧수입자가 허가받은 품목에",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        475.3199768066406,
        59.4605827331543,
        808.5181274414062,
        82.5005874633789
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대하여 2015.07.01 이후부터 이 규칙 시행일부터 2년이 경과한 날까지 품목변경허가(신고)를 신청하는 경우에는",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        475.3199768066406,
        59.4605827331543,
        808.5181274414062,
        82.5005874633789
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "GMP 실시상황에 평가에 필요한 자료를 제출하지 않음",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        475.3199768066406,
        59.4605827331543,
        808.5181274414062,
        82.5005874633789
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2.2.2 구비서류",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        91.55999755859375,
        516.3599853515625,
        101.77547454833984
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "「의약품등의 안전에 관한 규칙 」(총리령) 제4조 및  별지 제4호 서식",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.7200012207031,
        117.36000061035156,
        744.0,
        127.58399963378906
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "① 의약품 제조판매품목 허가 신청서",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.7200012207031,
        135.47999572753906,
        610.5599975585938,
        145.70399475097656
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 안전성유효성에 관한 자료",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.7200012207031,
        153.71998596191406,
        580.7999877929688,
        163.94398498535156
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 기준 및 시험방법에 관한 자료",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.7200012207031,
        171.83999633789062,
        597.8400268554688,
        182.06399536132812
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료(해당하는 경우)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        465.7200012207031,
        189.95999145507812,
        790.7485961914062,
        200.18399047851562
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑤ 등록대상원료의약품에 관한 자료(해당하는 경우)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        465.7200012207031,
        208.1999969482422,
        667.3886108398438,
        218.4239959716797
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑥ 주성분 제조업자의 명칭 및 소재지 등에 관한 자료",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.7200012207031,
        226.3199920654297,
        678.7200317382812,
        236.5439910888672
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑦ 위탁․수탁제조계약서(위탁제조하는 경우)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        465.7200012207031,
        244.55999755859375,
        641.82861328125,
        254.78399658203125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑧ 별지 제5호서식 특허관계확인서 및 사유서",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.7200012207031,
        262.67999267578125,
        644.6400146484375,
        272.90399169921875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(의약품 특허목록에 등재된 의약품의 안전성․유효성에 관한 자료를 근거로 신청하는 경우)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        465.7200012207031,
        280.9200134277344,
        796.5086059570312,
        291.1440124511719
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 상기 구비 서류 중,",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        308.3999938964844,
        533.1016845703125,
        316.8959655761719
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 안전성유효성에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        324.0,
        791.214599609375,
        332.4959716796875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 기준 및 시험방법에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        339.6000061035156,
        801.6546020507812,
        348.0959777832031
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "*",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        355.20001220703125,
        803.280029296875,
        363.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수입품의",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        355.20001220703125,
        803.280029296875,
        363.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우에는",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        355.20001220703125,
        803.280029296875,
        363.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "「의약품등의",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        355.20001220703125,
        803.280029296875,
        363.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전에",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        355.20001220703125,
        803.280029296875,
        363.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관한",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        355.20001220703125,
        803.280029296875,
        363.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규칙」(총리령)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        355.20001220703125,
        803.280029296875,
        363.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제4조제1항제4호에",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        355.20001220703125,
        803.280029296875,
        363.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "따라,",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        355.20001220703125,
        803.280029296875,
        363.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품등을",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        355.20001220703125,
        803.280029296875,
        363.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생산하는 국가의 정부 또는 공공기관에서 그 품목이 생산국의 법령에 적합하게 제조되고 있음을",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        470.2799987792969,
        368.0400085449219,
        803.2796630859375,
        376.5359802246094
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "증명하는",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        470.2799987792969,
        380.760009765625,
        803.1607055664062,
        389.2559814453125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "“제조증명서” 및 해당 품목이 허가 또는 등록된 국가의 정부 또는 공공기관에서 그 국가의",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        470.2799987792969,
        380.760009765625,
        803.1607055664062,
        389.2559814453125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "법령에 적합하게 판매되고 있음을 증명하는 “판매증명서”를 제출하여야 함.",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        470.2799987792969,
        393.6000061035156,
        714.4146118164062,
        402.0959777832031
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료 : GMP 적합판정서를 제출하는 경우에는",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        409.20001220703125,
        803.2807006835938,
        417.69598388671875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동 자료를 제출하지 않을 수 있음(신약, 주사제, 이식제, 생물학적제제 등 제외)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        472.1999816894531,
        421.9200134277344,
        726.7894897460938,
        430.4159851074219
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 단, ‘15.7.1 부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 「의약품등의",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        468.239990234375,
        437.5199890136719,
        803.1603393554688,
        446.0159606933594
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전에",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        474.47998046875,
        450.3600158691406,
        803.2216796875,
        458.8559875488281
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관한",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        474.47998046875,
        450.3600158691406,
        803.2216796875,
        458.8559875488281
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규칙",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        474.47998046875,
        450.3600158691406,
        803.2216796875,
        458.8559875488281
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "」제48조의2에",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        474.47998046875,
        450.3600158691406,
        803.2216796875,
        458.8559875488281
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "따른",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        474.47998046875,
        450.3600158691406,
        803.2216796875,
        458.8559875488281
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GMP",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        474.47998046875,
        450.3600158691406,
        803.2216796875,
        458.8559875488281
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합판정서가",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        474.47998046875,
        450.3600158691406,
        803.2216796875,
        458.8559875488281
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있더라도",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        474.47998046875,
        450.3600158691406,
        803.2216796875,
        458.8559875488281
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관류제,",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        474.47998046875,
        450.3600158691406,
        803.2216796875,
        458.8559875488281
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "복막투석제,",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        474.47998046875,
        450.3600158691406,
        803.2216796875,
        458.8559875488281
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "점안제,",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        474.47998046875,
        450.3600158691406,
        803.2216796875,
        458.8559875488281
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안연고제, 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        474.47998046875,
        463.08001708984375,
        687.1199951171875,
        471.57598876953125
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 방사성의약품은 ‘15.7.1 부터 품목허가를 신청하는 경우 GMP 실시상황 평가대상이며, ‘14.8.21.자 개정된",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        468.239990234375,
        478.79998779296875,
        803.2802734375,
        487.29595947265625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라 이 규칙이 시행되는",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        491.5199890136719,
        803.1599731445312,
        500.0159606933594
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘15.7.1 전에 종전의 규정에 따라 방사성의약품 제조판매‧",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        475.79998779296875,
        504.3600158691406,
        666.7799682617188,
        512.8560180664062
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수입품목허가를 받은 제조업자․수입자가",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        666.719970703125,
        504.3600158691406,
        803.2796630859375,
        512.8560180664062
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가받은",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        517.0799560546875,
        803.2796630859375,
        525.5759887695312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목에",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        517.0799560546875,
        803.2796630859375,
        525.5759887695312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대하여",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        517.0799560546875,
        803.2796630859375,
        525.5759887695312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "’15.7.1",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        517.0799560546875,
        803.2796630859375,
        525.5759887695312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이후부터",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        517.0799560546875,
        803.2796630859375,
        525.5759887695312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        517.0799560546875,
        803.2796630859375,
        525.5759887695312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규칙",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        517.0799560546875,
        803.2796630859375,
        525.5759887695312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시행일부터",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        517.0799560546875,
        803.2796630859375,
        525.5759887695312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2년이",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        517.0799560546875,
        803.2796630859375,
        525.5759887695312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경과한",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        517.0799560546875,
        803.2796630859375,
        525.5759887695312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "날까지",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        517.0799560546875,
        803.2796630859375,
        525.5759887695312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목변경허가(신고)를 신청하는 경우에는 GMP 실시상황 평가에 필요한 자료를 제출하지 않음",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        475.79998779296875,
        529.9199829101562,
        782.8800048828125,
        538.416015625
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 7 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        201.239990234375,
        560.4425048828125,
        221.26499938964844,
        567.5225219726562
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2.3 수수료 및 처리기한",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        51.839996337890625,
        138.0,
        62.055477142333984
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구분",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        60.23999786376953,
        72.23999786376953,
        375.239990234375,
        86.3759994506836
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민원사무명",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        60.23999786376953,
        72.23999786376953,
        375.239990234375,
        86.3759994506836
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수수료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        60.23999786376953,
        72.23999786376953,
        375.239990234375,
        86.3759994506836
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처리",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        60.23999786376953,
        72.23999786376953,
        375.239990234375,
        86.3759994506836
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기한",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        361.0799865722656,
        83.63999938964844,
        375.239990234375,
        92.13600158691406
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신약",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        60.23999786376953,
        100.43999481201172,
        74.4000015258789,
        108.93599700927734
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품-신약-품목허가-기시-안유",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        97.19999694824219,
        94.67999267578125,
        216.6000213623047,
        103.17599487304688
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-GMP",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        97.19999694824219,
        106.07999420166016,
        116.47035217285156,
        114.57599639892578
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․전자민원의 경우: 3,726,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        223.9199981689453,
        94.67999267578125,
        325.0799865722656,
        103.17599487304688
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․방문, 우편 민원의 경우: 4,140,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        223.9199981689453,
        100.43999481201172,
        374.8799743652344,
        114.57599639892578
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "90일",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        223.9199981689453,
        100.43999481201172,
        374.8799743652344,
        114.57599639892578
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "희귀의약품",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        49.68000030517578,
        117.23999786376953,
        216.59970092773438,
        131.37599182128906
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "희 귀 의 약 품 - 품 목 허 가 -기 시 -안 유",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        49.68000030517578,
        117.23999786376953,
        216.59970092773438,
        131.37599182128906
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-GMP",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        97.19999694824219,
        128.51998901367188,
        116.47035217285156,
        137.0159912109375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․전자민원의 경우: 2,895,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        223.9199981689453,
        117.23999786376953,
        325.0799865722656,
        125.73600006103516
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․방문, 우편 민원의 경우: 3,217,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        223.9199981689453,
        122.87998962402344,
        374.8799743652344,
        137.0159912109375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "70일",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        223.9199981689453,
        122.87998962402344,
        374.8799743652344,
        137.0159912109375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신약, 희귀 외",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        45.23999786376953,
        139.67999267578125,
        325.0799865722656,
        153.8159942626953
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품-품목허가-안유-기시-GMP",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        45.23999786376953,
        139.67999267578125,
        325.0799865722656,
        153.8159942626953
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․전자민원의 경우: 1,134,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        45.23999786376953,
        139.67999267578125,
        325.0799865722656,
        153.8159942626953
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․방문, 우편 민원의 경우: 1,260,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        223.9199981689453,
        151.0800018310547,
        348.1199645996094,
        159.5760040283203
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "90일",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        360.7200012207031,
        145.3199920654297,
        374.8799743652344,
        153.8159942626953
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심사항목",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        59.7599983215332,
        171.83999633789062,
        361.67962646484375,
        185.8560028076172
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처리기한",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        59.7599983215332,
        171.83999633789062,
        361.67962646484375,
        185.8560028076172
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각 항목 심사 불필요시 위 수수료에서 아래 해당금액 제외",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        59.7599983215332,
        171.83999633789062,
        361.67962646484375,
        185.8560028076172
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구분",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        182.87998962402344,
        365.9999694824219,
        191.37599182128906
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전자민원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        182.87998962402344,
        365.9999694824219,
        191.37599182128906
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문․우편 민원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        182.87998962402344,
        365.9999694824219,
        191.37599182128906
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성․유효성",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        49.20000076293945,
        205.07998657226562,
        136.67999267578125,
        213.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "70일",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        49.20000076293945,
        205.07998657226562,
        136.67999267578125,
        213.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신약",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        194.0399932861328,
        375.5999755859375,
        202.53599548339844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1,935,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        194.0399932861328,
        375.5999755859375,
        202.53599548339844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2,150,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        194.0399932861328,
        375.5999755859375,
        202.53599548339844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "희귀",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        205.07998657226562,
        375.5999755859375,
        213.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1,449,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        205.07998657226562,
        375.5999755859375,
        213.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1,610,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        205.07998657226562,
        375.5999755859375,
        213.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신약, 희귀 외",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        163.9199981689453,
        216.239990234375,
        375.5999755859375,
        224.73599243164062
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "513,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        163.9199981689453,
        216.239990234375,
        375.5999755859375,
        224.73599243164062
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "570,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        163.9199981689453,
        216.239990234375,
        375.5999755859375,
        224.73599243164062
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준및시험방법",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        49.20000076293945,
        238.4399871826172,
        136.67999267578125,
        246.9359893798828
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "55일",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        49.20000076293945,
        238.4399871826172,
        136.67999267578125,
        246.9359893798828
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신약",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        227.39999389648438,
        375.5999755859375,
        235.89599609375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1,170,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        227.39999389648438,
        375.5999755859375,
        235.89599609375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1,300,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        227.39999389648438,
        375.5999755859375,
        235.89599609375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "희귀",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        238.4399871826172,
        375.5999755859375,
        246.9359893798828
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "877,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        238.4399871826172,
        375.5999755859375,
        246.9359893798828
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "975,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        179.0399932861328,
        238.4399871826172,
        375.5999755859375,
        246.9359893798828
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신약, 희귀 외",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        163.9199981689453,
        249.59999084472656,
        375.5999755859375,
        258.0959777832031
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "306,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        163.9199981689453,
        249.59999084472656,
        375.5999755859375,
        258.0959777832031
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "340,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        163.9199981689453,
        249.59999084472656,
        375.5999755859375,
        258.0959777832031
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GMP",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        66.23999786376953,
        266.3999938964844,
        81.79051208496094,
        274.8959655761719
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "90일(원료의",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        110.75999450683594,
        260.6400146484375,
        148.3199920654297,
        269.135986328125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품 60일)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        112.55999755859375,
        266.3999938964844,
        375.5999755859375,
        280.5359802246094
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "207,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        112.55999755859375,
        266.3999938964844,
        375.5999755859375,
        280.5359802246094
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "230,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        112.55999755859375,
        266.3999938964844,
        375.5999755859375,
        280.5359802246094
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 의약품 품목허가 처리기한 및 수수료는 민원 신청 품목에 따라 상이합니다.",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        290.760009765625,
        294.6545715332031,
        299.2559814453125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<처리기한>",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        322.08001708984375,
        76.48056030273438,
        330.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 처리기한은 단순 합산이 아니라 처리기한이 긴 민원을 기준으로 산정됩니다.",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        337.67999267578125,
        294.77459716796875,
        346.17596435546875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예1)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        353.2799987792969,
        382.26873779296875,
        361.7759704589844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성유효성에",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        353.2799987792969,
        382.26873779296875,
        361.7759704589844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관한",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        353.2799987792969,
        382.26873779296875,
        361.7759704589844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료(70일),",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        353.2799987792969,
        382.26873779296875,
        361.7759704589844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        353.2799987792969,
        382.26873779296875,
        361.7759704589844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        353.2799987792969,
        382.26873779296875,
        361.7759704589844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법에",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        353.2799987792969,
        382.26873779296875,
        361.7759704589844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관한",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        353.2799987792969,
        382.26873779296875,
        361.7759704589844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료(55일)의",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        353.2799987792969,
        382.26873779296875,
        361.7759704589844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검토가",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        353.2799987792969,
        382.26873779296875,
        361.7759704589844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "필요한",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        353.2799987792969,
        382.26873779296875,
        361.7759704589844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민원:",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        353.2799987792969,
        382.26873779296875,
        361.7759704589844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 처리기한 70일",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        57.84000015258789,
        366.1199951171875,
        114.0,
        374.615966796875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예2) 안전성유효성에 관한 자료(70일), GMP실시상황 평가(완제의약품:90일) 대상 민원 : 총 처리기한 90일",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        381.7200012207031,
        382.1999816894531,
        390.2159729003906
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(완제의약품)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        56.39999771118164,
        394.44000244140625,
        95.5894775390625,
        402.93597412109375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<수수료>",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        425.760009765625,
        69.52056121826172,
        434.2559814453125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예1)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        441.3600158691406,
        382.3199768066406,
        449.8559875488281
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료제출의약품으로,",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        441.3600158691406,
        382.3199768066406,
        449.8559875488281
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘안전성유효성",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        441.3600158691406,
        382.3199768066406,
        449.8559875488281
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료,",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        441.3600158691406,
        382.3199768066406,
        449.8559875488281
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        441.3600158691406,
        382.3199768066406,
        449.8559875488281
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        441.3600158691406,
        382.3199768066406,
        449.8559875488281
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법에",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        441.3600158691406,
        382.3199768066406,
        449.8559875488281
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관한",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        441.3600158691406,
        382.3199768066406,
        449.8559875488281
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료,",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        441.3600158691406,
        382.3199768066406,
        449.8559875488281
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GMP실시상황평가’가",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        441.3600158691406,
        382.3199768066406,
        449.8559875488281
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "필요한 경우, 총 민원사무 처리기한은 90일, 수수료는 1,134,000원(전자민원)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        58.55999755859375,
        454.08001708984375,
        301.26947021484375,
        462.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예2) 자료제출의약품으로, ‘안전성유효성 자료, 기준 및 시험방법에 관한 자료, GMP실시상황평가’가 제출",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        469.67999267578125,
        382.3199768066406,
        478.17596435546875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료 요건이며, 사전검토 민원 ‘기준 및 시험방법에 관한 자료’ 적합 통지서를 제출하는 경우, 총",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        56.63999938964844,
        482.5199890136719,
        382.3199768066406,
        491.0159606933594
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처리기한은 90일, 수수료(전자민원)는 1,134,000원에서 306,000원을 제외한 828,000원",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        56.63999938964844,
        495.239990234375,
        325.79998779296875,
        503.7359619140625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상세한",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        510.9599914550781,
        382.3199768066406,
        519.4559936523438
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수수료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        510.9599914550781,
        382.3199768066406,
        519.4559936523438
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정보는",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        510.9599914550781,
        382.3199768066406,
        519.4559936523438
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "「의약품",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        510.9599914550781,
        382.3199768066406,
        519.4559936523438
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등의",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        510.9599914550781,
        382.3199768066406,
        519.4559936523438
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가등에",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        510.9599914550781,
        382.3199768066406,
        519.4559936523438
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관한",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        510.9599914550781,
        382.3199768066406,
        519.4559936523438
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수수료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        510.9599914550781,
        382.3199768066406,
        519.4559936523438
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규정",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        510.9599914550781,
        382.3199768066406,
        519.4559936523438
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "」(식품의약품안전처",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        510.9599914550781,
        382.3199768066406,
        519.4559936523438
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고시)를",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        510.9599914550781,
        382.3199768066406,
        519.4559936523438
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "참고하시기 바랍니다.",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        523.6799926757812,
        108.53459167480469,
        532.176025390625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 8 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        622.2000122070312,
        560.4425048828125,
        642.2249755859375,
        567.5225219726562
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2.4 전자민원 신청방법",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        51.839996337890625,
        554.760009765625,
        62.055477142333984
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2.4.1 전자민원신청 사전 절차",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        67.20000457763672,
        582.3599853515625,
        77.41548156738281
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "① 의약품민원홈페이지(http://ezdrug.mfds.go.kr)에서 회원가입 및 민원서식기 설치",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        82.55999755859375,
        794.52001953125,
        92.78399658203125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 개인 공인인증서/대표자 공인인증서(개인사업자)/법인명 공인인증서(법인회원) 필요",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        473.8799743652344,
        97.80000305175781,
        803.0398559570312,
        108.0154800415039
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2.4.2 전자민원신청 절차",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        113.16000366210938,
        561.1199951171875,
        123.37548065185547
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 민원서식기를 이용하여 신청하고자 하는 신청서와 구비서류 작성",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        469.3199768066406,
        132.59999084472656,
        688.6799926757812,
        141.0959930419922
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 신규서식 선택 → 의약품 검색버튼을 활용하여 해당 민원서식 선택",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        472.79998779296875,
        144.72000122070312,
        699.47998046875,
        153.21600341796875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 민원종류 선택 → 업종 / 신약, 희귀의약품 여부 / 본부 ․ 지방청 대상 확인 / 기시법, 안유심사,",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        472.79998779296875,
        156.72000122070312,
        796.6217041015625,
        165.21600341796875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GMP 평가 여부",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        483.5999755859375,
        165.95999145507812,
        534.239990234375,
        174.45599365234375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 참고 - 방사성의약품의 허가심사 종류",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        465.7200012207031,
        175.1999969482422,
        600.8396606445312,
        183.6959991455078
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구분",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        484.91998291015625,
        201.239990234375,
        554.52001953125,
        209.73599243164062
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 7.079999923706055,
      "font_name": "T20",
      "bbox": [
        484.91998291015625,
        201.239990234375,
        554.52001953125,
        209.73599243164062
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당 국가의",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        586.6799926757812,
        192.0,
        625.7999877929688,
        209.73599243164062
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품집 등",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        586.6799926757812,
        192.0,
        625.7999877929688,
        209.73599243164062
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용현황",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        592.0800170898438,
        210.47999572753906,
        620.4000244140625,
        218.9759979248047
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가심사종류",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        691.4400024414062,
        187.4399871826172,
        733.9199829101562,
        195.9359893798828
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        646.5599975585938,
        201.1199951171875,
        700.0800170898438,
        218.8560028076172
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        646.5599975585938,
        201.1199951171875,
        700.0800170898438,
        218.8560028076172
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기시",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        646.5599975585938,
        201.1199951171875,
        700.0800170898438,
        218.8560028076172
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        725.2799682617188,
        201.1199951171875,
        739.4400024414062,
        218.8560028076172
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안유",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        725.2799682617188,
        201.1199951171875,
        739.4400024414062,
        218.8560028076172
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        764.6399536132812,
        196.55999755859375,
        778.7999877929688,
        223.53599548339844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기시",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        764.6399536132812,
        196.55999755859375,
        778.7999877929688,
        223.53599548339844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안유",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        764.6399536132812,
        196.55999755859375,
        778.7999877929688,
        223.53599548339844
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국내최초",
      "font_size": 7.079999923706055,
      "font_name": "T20",
      "bbox": [
        477.8399963378906,
        237.71998596191406,
        506.15997314453125,
        246.2159881591797
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "KP",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        542.8800048828125,
        223.44000244140625,
        658.1612548828125,
        232.65599060058594
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        542.8800048828125,
        223.44000244140625,
        658.1612548828125,
        232.65599060058594
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oa)",
      "font_size": 4.559999942779541,
      "font_name": "T8",
      "bbox": [
        542.8800048828125,
        223.44000244140625,
        658.1612548828125,
        232.65599060058594
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정서",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        536.760009765625,
        232.55999755859375,
        658.1612548828125,
        246.2159881591797
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 7.079999923706055,
      "font_name": "T20",
      "bbox": [
        536.760009765625,
        232.55999755859375,
        658.1612548828125,
        246.2159881591797
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oa)",
      "font_size": 4.559999942779541,
      "font_name": "T8",
      "bbox": [
        536.760009765625,
        232.55999755859375,
        658.1612548828125,
        246.2159881591797
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "X",
      "font_size": 7.079999923706055,
      "font_name": "T20",
      "bbox": [
        604.0799560546875,
        242.27999877929688,
        735.0228881835938,
        250.7760009765625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 7.079999923706055,
      "font_name": "T20",
      "bbox": [
        604.0799560546875,
        242.27999877929688,
        735.0228881835938,
        250.7760009765625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사기준",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        533.1599731445312,
        250.8000030517578,
        776.2413330078125,
        259.8959655761719
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        533.1599731445312,
        250.8000030517578,
        776.2413330078125,
        259.8959655761719
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ob)",
      "font_size": 4.559999942779541,
      "font_name": "T8",
      "bbox": [
        533.1599731445312,
        250.8000030517578,
        776.2413330078125,
        259.8959655761719
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제네릭",
      "font_size": 7.079999923706055,
      "font_name": "T20",
      "bbox": [
        481.3199768066406,
        260.52001953125,
        656.3029174804688,
        273.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "KP, 공정서",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        481.3199768066406,
        260.52001953125,
        656.3029174804688,
        273.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        481.3199768066406,
        260.52001953125,
        656.3029174804688,
        273.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 7.079999923706055,
      "font_name": "T20",
      "bbox": [
        481.3199768066406,
        260.52001953125,
        656.3029174804688,
        273.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사기준",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        533.1599731445312,
        269.6400146484375,
        695.6629028320312,
        278.135986328125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        533.1599731445312,
        269.6400146484375,
        695.6629028320312,
        278.135986328125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 7.079999923706055,
      "font_name": "T20",
      "bbox": [
        533.1599731445312,
        269.6400146484375,
        695.6629028320312,
        278.135986328125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "a) 허가규정 제25조제2항에 따른 안유면제대상",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        471.3599853515625,
        281.52001953125,
        618.1199951171875,
        290.0159912109375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "b) 신약",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        471.3599853515625,
        293.6400146484375,
        494.40032958984375,
        302.135986328125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 방사성의약품의 경우 ‘15.7.1부터는 GMP 평가대상",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        471.3599853515625,
        305.6400146484375,
        639.3603515625,
        314.135986328125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 업소정보 입력",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        472.79998779296875,
        321.2400207519531,
        527.52001953125,
        329.7359924316406
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 자가점검표 항목 입력 (민원인이 직접 제출자료의 타당성 여부 점검)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        472.79998779296875,
        333.2400207519531,
        703.3894653320312,
        341.7359924316406
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 신청서 내용 작성하기 (신청인, 상세내용, 원료약품 및 그 분량, 담당자 등 2.3 품목허가 신청서",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        472.79998779296875,
        345.3600158691406,
        796.5603637695312,
        353.8559875488281
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "작성 요령 참조)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        482.3999938964844,
        354.6000061035156,
        533.469482421875,
        363.0959777832031
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 신청서 작성 중",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        490.44000244140625,
        366.6000061035156,
        620.4000244140625,
        375.0959777832031
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "확인 선택기재 사항",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        490.44000244140625,
        366.6000061035156,
        620.4000244140625,
        375.0959777832031
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(1) 의약품 허가전 보험등재 동시진행(허가-약가 연계) 관련",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        483.3599853515625,
        378.7200012207031,
        674.0403442382812,
        387.2159729003906
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(2) 과거 신청 이력 여부",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        483.3599853515625,
        390.8399963378906,
        561.120361328125,
        399.3359680175781
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(3) 민원설명회 개최 여부",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        483.3599853515625,
        402.8399963378906,
        564.600341796875,
        411.3359680175781
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 안전성·유효성 심사/기준및시험방법 심사/기타구비서류 작성하기",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        472.79998779296875,
        414.9599914550781,
        688.20068359375,
        423.4559631347656
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 허가증 수령방법(온라인, 방문, 웹수령) 선택",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        472.79998779296875,
        426.9599914550781,
        622.6799926757812,
        435.4559631347656
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8) 파일 저장(“*.flz\" 파일 생성)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        472.79998779296875,
        439.08001708984375,
        568.989501953125,
        447.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 제출파일 생성하기",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        469.3199768066406,
        451.08001708984375,
        537.720703125,
        459.57598876953125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 저장완료된 파일을 ezdrug 전자민원창구를 통해 접수할 수 있는 형태로 생성",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        476.2799987792969,
        463.20001220703125,
        732.2403564453125,
        471.69598388671875
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 전자민원 접속/로그인",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        469.3199768066406,
        475.32000732421875,
        546.600341796875,
        483.81597900390625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 민원접수(민원종류 선택, 담당부서 선택, 파일 접수)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        469.3199768066406,
        487.32000732421875,
        643.3894653320312,
        495.81597900390625
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 수수료납부 (수수료 납부 완료 시 민원신청 완료)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        469.3199768066406,
        499.44000244140625,
        636.4295043945312,
        507.93597412109375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6, 민원신청완료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        469.3199768066406,
        511.4399719238281,
        520.2010498046875,
        519.9359741210938
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 자세한 사항은 의약품민원홈페이지(http://ezdrug.mfds.go.kr)의 하단에 있는 “민원신청 우수작성 서식",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        465.7200012207031,
        523.5599975585938,
        796.5599975585938,
        532.0560302734375
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 민원신청 작성요령” 및 “전자민원신청매뉴얼” 자료 참조 및 시스템 문의(043-234-3100)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        477.3599853515625,
        532.7999877929688,
        760.8692626953125,
        541.2960205078125
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 9 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        201.239990234375,
        560.4425048828125,
        221.26499938964844,
        567.5225219726562
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3 품목허가 신청서 작성 요령",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        48.839996337890625,
        171.60000610351562,
        59.918758392333984
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "｢",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        180.47999572753906,
        66.83999633789062,
        184.01998901367188,
        75.33599853515625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품의 품목허가․신고․심사 규정｣",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        183.95999145507812,
        66.83999633789062,
        308.2200012207031,
        75.33599853515625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제9조～제22조 관련",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        311.7599792480469,
        66.83999633789062,
        375.719970703125,
        75.33599853515625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 품목허가 항목",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.7599983215332,
        78.0,
        112.91999053955078,
        88.2239990234375
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제품명",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.279998779296875,
        91.55999755859375,
        89.5199966430664,
        101.77547454833984
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 분류번호 및 분류(전문 또는 일반의약품)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        53.279998779296875,
        105.23999786376953,
        222.9086456298828,
        115.45547485351562
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 원료약품 및 그 분량",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.279998779296875,
        118.91999816894531,
        144.83999633789062,
        129.13546752929688
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 성상",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.279998779296875,
        132.47999572753906,
        80.99999237060547,
        142.6954803466797
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 제조방법(주성분의 제조소와 모든 제조공정의 소재지를 기재한다)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        53.279998779296875,
        146.1599884033203,
        320.9486389160156,
        156.37547302246094
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 효능ㆍ효과",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.279998779296875,
        159.71998596191406,
        106.55999755859375,
        169.9354705810547
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 용법ㆍ용량",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.279998779296875,
        173.39999389648438,
        106.55999755859375,
        183.615478515625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. 사용상의 주의사항",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.279998779296875,
        187.07998657226562,
        136.3199920654297,
        197.29547119140625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. 포장단위",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.279998779296875,
        200.63998413085938,
        102.30000305175781,
        210.85546875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10. 저장방법 및 사용(유효)기간",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.279998779296875,
        214.3199920654297,
        180.29998779296875,
        224.5354766845703
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11. 기준 및 시험방법",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.279998779296875,
        227.87998962402344,
        140.57998657226562,
        238.09547424316406
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12. 제조업자 중 제조판매품목허가증ㆍ신고증을 보유한 자, 위탁제조판매업자 및",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.279998779296875,
        241.55999755859375,
        379.9800109863281,
        251.77548217773438
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위탁제조판매업자로부터 수탁을 받아 제조하는 제조업자, 수입자(제조원을 포",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.23999786376953,
        255.23997497558594,
        375.719970703125,
        265.4554443359375
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함한다)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        69.23999786376953,
        268.8000183105469,
        97.6286392211914,
        279.0154724121094
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13. 허가조건",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.279998779296875,
        282.4800109863281,
        102.23999786376953,
        292.6954650878906
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.1 제품명",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        318.8399963378906,
        86.87999725341797,
        329.0554504394531
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기재순서",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        44.52000045776367,
        337.3556213378906,
        72.84000396728516,
        344.7398376464844
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▷ 상표명 있는 경우",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        356.3999938964844,
        121.19999694824219,
        366.6239929199219
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "업소명생략가능 + 상표명 + 제형 + (주성분명단일제 또는 식약처고시명칭)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        74.04000091552734,
        374.6400146484375,
        346.3886413574219,
        385.9354553222656
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예) 식약처테크네주사액(과테크네튬산나트륨)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        393.0,
        214.86863708496094,
        403.2154541015625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▷ 상표명 없는 경우",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        423.7200012207031,
        121.19999694824219,
        433.9440002441406
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "업소명 + 주성분명단일제 + 제형",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        150.0,
        442.0799865722656,
        270.47998046875,
        453.2554626464844
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예) 식약처과테크네튬산나트륨주사액",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        460.44000244140625,
        183.60000610351562,
        470.65545654296875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▷ 시리즈 제품(유사 효능․효과 품목들)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        491.0400085449219,
        199.26864624023438,
        501.2640075683594
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상표명 + 문자 또는 숫자",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        160.8000030517578,
        509.3999938964844,
        259.67999267578125,
        519.615478515625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예) 식약처테크네100주사액(과테크네튬산나트륨), 식약처테크네200주사액(과테크네튬산나트륨)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        527.7599487304688,
        381.42864990234375,
        537.9754638671875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 10 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유의사항",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        465.47998046875,
        52.235626220703125,
        493.79998779296875,
        59.619842529296875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 기허가된 다른 의약품 명칭과 동일하지 않아야 함",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        71.16000366210938,
        668.52001953125,
        81.37548065185547
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 서로 다른 수입자가 제조원이 같은 동일 품목을 수입하는 경우 수입자명 병기하여 구분",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        86.52000427246094,
        800.6395874023438,
        96.73548126220703
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 제형은 ｢",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        465.239990234375,
        101.87999725341797,
        505.260009765625,
        112.10399627685547
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한민국약전｣",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        504.9599914550781,
        101.87999725341797,
        557.8200073242188,
        112.10399627685547
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제제총칙에서 정한 제형으로 표기. 단, 제제학적으로 구분관리할",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        561.9599609375,
        101.87999725341797,
        807.5398559570312,
        112.09547424316406
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "필요가 있는 경우 이를 기재 (예: 주사액, 분말주사 등)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        472.3199768066406,
        117.23999786376953,
        675.9085693359375,
        127.45547485351562
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 단일제로서 필요한 경우 주성분의 분량을 제형 다음에 단위 포함하여 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.239990234375,
        132.59999084472656,
        751.4403686523438,
        142.8154754638672
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.2 분류번호 및 분류(전문 또는 일반의약품)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        166.07998657226562,
        641.3485717773438,
        176.29547119140625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분류번호",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        465.47998046875,
        184.59561157226562,
        493.79998779296875,
        191.97984313964844
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 방사성의약품의 분류번호: 431 방사성 의약품",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        203.63998413085938,
        649.2000122070312,
        213.85546875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(｢",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        469.67999267578125,
        218.87998962402344,
        476.82000732421875,
        229.10398864746094
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품등분류번호에관한규정 (식품의약품안전처 예규)｣",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        476.5199890136719,
        218.87998962402344,
        691.02001953125,
        229.10398864746094
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "참조)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        695.0399780273438,
        218.87998962402344,
        714.9085693359375,
        229.09547424316406
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분류",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        472.55999755859375,
        237.51560974121094,
        486.719970703125,
        244.89984130859375
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 전문/일반의약품 중 방사성의약품은 전문의약품에 해당",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        256.44000244140625,
        690.7200317382812,
        266.65545654296875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(｢",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        469.67999267578125,
        271.8000183105469,
        476.82000732421875,
        282.0240173339844
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품분류기준에관한규정 (식품의약품안전처 고시)｣",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        476.7599792480469,
        271.8000183105469,
        682.6199951171875,
        282.0240173339844
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "참조)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        686.8800048828125,
        271.8000183105469,
        706.7485961914062,
        282.0154724121094
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.3 원료약품 및 그 분량",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        305.2799987792969,
        563.280029296875,
        315.4954528808594
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기재순서",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        465.47998046875,
        456.6356201171875,
        493.79998779296875,
        464.01983642578125
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 일반적으로 실제 제조시의 투입순서 등에 따라 주성분부터 첨가제의 순서로 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        475.55999755859375,
        792.0,
        485.77545166015625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "배합목적",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        465.47998046875,
        494.19561767578125,
        493.79998779296875,
        501.579833984375
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 별표 7의 제형별 의약품 첨가제 또는 그 외의 첨가제로서 국내ㆍ외의 공인할 수 있는",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        513.1199951171875,
        803.1597290039062,
        523.3355102539062
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용예 등으로 제제학적으로 타당한 배합목적 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        472.55999755859375,
        529.6781005859375,
        672.8400268554688,
        538.6640625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료약품 및 그 분량",
      "font_size": 8.519999504089355,
      "font_name": "H2gtrE",
      "bbox": [
        471.1199951171875,
        324.846435546875,
        555.6000366210938,
        333.366455078125
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체단위",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        463.91998291015625,
        341.1005859375,
        489.4801940917969,
        347.4605712890625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세부구성",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        463.91998291015625,
        355.3805847167969,
        489.4801940917969,
        361.7405700683594
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "배합",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        498.8399963378906,
        350.2205810546875,
        513.798095703125,
        356.58056640625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목적",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        498.8399963378906,
        355.3805847167969,
        554.8799438476562,
        366.78057861328125
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료명",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        498.8399963378906,
        355.3805847167969,
        554.8799438476562,
        366.78057861328125
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "활성물질",
      "font_size": 5.639999866485596,
      "font_name": "Gulim",
      "bbox": [
        574.0800170898438,
        351.1986083984375,
        596.7601318359375,
        356.838623046875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용량",
      "font_size": 5.639999866485596,
      "font_name": "Gulim",
      "bbox": [
        579.719970703125,
        355.3805847167969,
        758.2282104492188,
        365.9586486816406
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규 격",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        579.719970703125,
        355.3805847167969,
        758.2282104492188,
        365.9586486816406
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분 량",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        579.719970703125,
        355.3805847167969,
        758.2282104492188,
        365.9586486816406
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "단 위",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        579.719970703125,
        355.3805847167969,
        758.2282104492188,
        365.9586486816406
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조원",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        579.719970703125,
        355.3805847167969,
        758.2282104492188,
        365.9586486816406
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DMF",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        579.719970703125,
        355.3805847167969,
        758.2282104492188,
        365.9586486816406
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반제",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        764.2799682617188,
        350.2205810546875,
        776.9999389648438,
        356.58056640625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여부",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        764.2799682617188,
        355.3805847167969,
        796.6799926757812,
        366.78057861328125
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비고",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        764.2799682617188,
        355.3805847167969,
        796.6799926757812,
        366.78057861328125
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 11 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 방사성의약품에 사용되는 주요 첨가제의 배합목적",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        48.959999084472656,
        247.55999755859375,
        59.175479888916016
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "계면활성제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        54.71999740600586,
        68.4000015258789,
        370.4399719238281,
        78.615478515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등장(화)제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        54.71999740600586,
        68.4000015258789,
        370.4399719238281,
        78.615478515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보존제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        54.71999740600586,
        68.4000015258789,
        370.4399719238281,
        78.615478515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부형제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        54.71999740600586,
        68.4000015258789,
        370.4399719238281,
        78.615478515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안정(화)제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        54.71999740600586,
        68.4000015258789,
        370.4399719238281,
        78.615478515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "완충제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.23999786376953,
        85.078125,
        359.03997802734375,
        94.0640640258789
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.23999786376953,
        85.078125,
        359.03997802734375,
        94.0640640258789
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용해보조제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.23999786376953,
        85.078125,
        359.03997802734375,
        94.0640640258789
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "충전제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.23999786376953,
        85.078125,
        359.03997802734375,
        94.0640640258789
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "캡슐",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        63.23999786376953,
        85.078125,
        359.03997802734375,
        94.0640640258789
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "킬레이트화제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        50.39999771118164,
        99.4800033569336,
        369.3599853515625,
        109.69548034667969
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항산화제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        50.39999771118164,
        99.4800033569336,
        369.3599853515625,
        109.69548034667969
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "환원제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        50.39999771118164,
        99.4800033569336,
        369.3599853515625,
        109.69548034667969
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "흡착제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        50.39999771118164,
        99.4800033569336,
        369.3599853515625,
        109.69548034667969
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "pH조절제",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        50.39999771118164,
        99.4800033569336,
        369.3599853515625,
        109.69548034667969
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        51.599998474121094,
        122.07563018798828,
        65.76000213623047,
        129.45985412597656
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 공정서 품목 : 해당 공정서의 명칭(또는 약칭) 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        141.0,
        251.0399932861328,
        151.21548461914062
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정서 명칭",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        58.55999755859375,
        160.55812072753906,
        359.8799743652344,
        169.54405212402344
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약칭",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        58.55999755859375,
        160.55812072753906,
        359.8799743652344,
        169.54405212402344
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정서 명칭",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        58.55999755859375,
        160.55812072753906,
        359.8799743652344,
        169.54405212402344
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정서 명칭",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        58.55999755859375,
        160.55812072753906,
        359.8799743652344,
        169.54405212402344
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한민국약전",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.52000045776367,
        173.87998962402344,
        341.6172790527344,
        184.09547424316406
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약전 또는 KP",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        56.52000045776367,
        173.87998962402344,
        341.6172790527344,
        184.09547424316406
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유럽약전",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.52000045776367,
        173.87998962402344,
        341.6172790527344,
        184.09547424316406
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "EP",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        56.52000045776367,
        173.87998962402344,
        341.6172790527344,
        184.09547424316406
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국약전",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        65.04000091552734,
        188.39999389648438,
        345.62786865234375,
        198.615478515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USP, NF",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        65.04000091552734,
        188.39999389648438,
        345.62786865234375,
        198.615478515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "독일약전",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        65.04000091552734,
        188.39999389648438,
        345.62786865234375,
        198.615478515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DAB",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        65.04000091552734,
        188.39999389648438,
        345.62786865234375,
        198.615478515625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일본약전",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        65.04000091552734,
        202.9199981689453,
        341.3775939941406,
        213.13548278808594
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "JP",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        65.04000091552734,
        202.9199981689453,
        341.3775939941406,
        213.13548278808594
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "프랑스약전",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        65.04000091552734,
        202.9199981689453,
        341.3775939941406,
        213.13548278808594
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FP",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        65.04000091552734,
        202.9199981689453,
        341.3775939941406,
        213.13548278808594
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "영국약전",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        65.04000091552734,
        217.55999755859375,
        168.93739318847656,
        227.77548217773438
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BP",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        65.04000091552734,
        217.55999755859375,
        168.93739318847656,
        227.77548217773438
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 신청업소에서 직접 작성한 성분규격 : “별첨규격” 또는 “별규”로 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        235.91998291015625,
        326.15997314453125,
        246.13546752929688
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성분명",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        48.0,
        254.43560791015625,
        69.23999786376953,
        261.81982421875
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 공정서 및 고시 품목 : 해당 규격의 의약품명",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        273.3600158691406,
        228.36000061035156,
        283.5754699707031
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 별첨규격 : 일반명",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        288.7200012207031,
        121.79999542236328,
        298.9354553222656
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        40.20000076293945,
        304.32000732421875,
        237.17999267578125,
        312.81597900390625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품 명명법 가이드라인｣",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        237.239990234375,
        304.32000732421875,
        325.9800109863281,
        312.81597900390625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "참조",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        329.5199890136719,
        304.32000732421875,
        343.67999267578125,
        312.81597900390625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분량 및 단위",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        50.15999984741211,
        320.07562255859375,
        92.63999938964844,
        327.4598388671875
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 전체단위(기준단위) : 액상주사제(1 밀리리터*), 분말주사제(단위제형; 1 바이알, 1 앰플),",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        44.52000045776367,
        339.0,
        382.27294921875,
        349.2154541015625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기타(1 제너레이터 등)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        51.84000015258789,
        354.3600158691406,
        138.78863525390625,
        364.5754699707031
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 분할사용 하는 경우 기준단위를 ‘단위량’으로 기재 가능(｢",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        40.20000076293945,
        369.9599914550781,
        235.49998474121094,
        378.4559631347656
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품의 품목허가․신고․심사규정｣",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        235.55999755859375,
        369.9599914550781,
        356.5799865722656,
        378.4559631347656
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "별표 8",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        360.6000061035156,
        369.9599914550781,
        382.260009765625,
        378.4559631347656
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의2 참조)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        46.79999923706055,
        382.67999267578125,
        77.1094741821289,
        391.17596435546875
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 방사능량 단위 : “MBq”, 필요시 mCi를 괄호로 병기(방사능농도는 범위로 설정 가능)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        44.52000045776367,
        395.2799987792969,
        381.66864013671875,
        405.4954528808594
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 원칙적으로 모든 첨가제의 분량을 기재. 단 용해보조제, 안정제, 등장제, pH조절제,",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        44.52000045776367,
        410.6400146484375,
        382.27294921875,
        420.85546875
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용제, 기제(캡슐제 포함) 등의 미량투입 첨가제는 “적량”으로 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        52.07999801635742,
        426.0,
        311.15997314453125,
        436.2154541015625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 보존제의 종류 및 함량 사용범위는 ｢",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        44.52000045776367,
        441.239990234375,
        192.05999755859375,
        451.4639892578125
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품의 품목허가․신고․심사규정｣",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        192.0,
        441.239990234375,
        332.58001708984375,
        451.4639892578125
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "별표 8 참조",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        336.6000061035156,
        441.239990234375,
        382.19970703125,
        451.4554443359375
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.4 성상",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        474.8399963378906,
        78.35999298095703,
        485.0554504394531
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 색 + 형상 + 제형 순으로 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        490.0799865722656,
        172.6800079345703,
        500.2954406738281
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        40.20000076293945,
        505.6800231933594,
        233.45999145507812,
        514.176025390625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품의 성상 표기에 대한 가이드라인｣",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        233.39999389648438,
        505.6800231933594,
        362.1000061035156,
        514.176025390625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "참조",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        365.5199890136719,
        505.6800231933594,
        379.5603332519531,
        514.176025390625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 제형은 ｢",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        44.279998779296875,
        518.2799682617188,
        84.30000305175781,
        528.5039672851562
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한민국약전｣",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        84.0,
        518.2799682617188,
        136.8599853515625,
        528.5039672851562
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제제총칙에서 정한 제형으로 표기. 단, 제제학적으로 구분관리할",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        141.0,
        518.2799682617188,
        386.579833984375,
        528.4954833984375
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "필요가 있는 경우 이를 기재 (예: 쓸 때 녹여 쓰는 주사제 등)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        51.36000061035156,
        533.5199584960938,
        281.2286376953125,
        543.7354736328125
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 12 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 캡슐제는 내용약품의 성상 기재 (예: 흰색의 가루가 든 상부청색, 하부노란색의 경질캡슐 등)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        465.239990234375,
        48.959999084472656,
        802.7485961914062,
        59.175479888916016
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 주사제 등은 용기의 형상(바이알, 앰플, 플라스틱용기, 프리필드시린지 등)을 기재 (예:",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        465.239990234375,
        64.31999969482422,
        803.2329711914062,
        74.53547668457031
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무색투명한 액이 무색투명한 바이알에 든 주사제)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        472.3199768066406,
        79.68000030517578,
        657.1885986328125,
        89.89547729492188
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.5 제조방법",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        113.16000366210938,
        516.3599853515625,
        123.37548065185547
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기재요령",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        465.47998046875,
        131.7956085205078,
        493.79998779296875,
        139.17984008789062
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 아래 서식으로 작성하되, 방사성의약품의 특성에 맞게 제조공정도나 다른 기술방식을",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        150.71998596191406,
        807.5386962890625,
        160.9354705810547
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용하여 작성",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        473.1600036621094,
        167.2781219482422,
        527.1597290039062,
        176.26405334472656
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※｢",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        461.1600036621094,
        181.67999267578125,
        471.7799987792969,
        190.17599487304688
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품의 품목허가․신고․심사규정｣",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        471.7200012207031,
        181.67999267578125,
        588.6599731445312,
        190.17599487304688
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "별표 8의3 참조",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        591.9599609375,
        181.67999267578125,
        640.3203735351562,
        190.17599487304688
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정 번호",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        464.8799743652344,
        196.1999969482422,
        666.9600219726562,
        211.94398498535156
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공정 명칭",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        464.8799743652344,
        196.1999969482422,
        666.9600219726562,
        211.94398498535156
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료․시약․용매 등",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        464.8799743652344,
        196.1999969482422,
        666.9600219726562,
        211.94398498535156
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(명칭기재)",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        613.2000122070312,
        201.71998596191406,
        753.8400268554688,
        217.4639892578125
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비고",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        613.2000122070312,
        201.71998596191406,
        753.8400268554688,
        217.4639892578125
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        481.91998291015625,
        217.79998779296875,
        773.0399780273438,
        233.5439910888672
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료칭량",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        481.91998291015625,
        217.79998779296875,
        773.0399780273438,
        233.5439910888672
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주성분 제조원",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        481.91998291015625,
        217.79998779296875,
        773.0399780273438,
        233.5439910888672
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(명칭 및 소재지)",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        712.2000122070312,
        228.83999633789062,
        778.5064697265625,
        239.06399536132812
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ː",
      "font_size": 8.519999504089355,
      "font_name": "Batang",
      "bbox": [
        629.1599731445312,
        240.48643493652344,
        637.6799926757812,
        266.04644775390625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ː",
      "font_size": 8.519999504089355,
      "font_name": "Batang",
      "bbox": [
        629.1599731445312,
        240.48643493652344,
        637.6799926757812,
        266.04644775390625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ː",
      "font_size": 8.519999504089355,
      "font_name": "Batang",
      "bbox": [
        629.1599731445312,
        240.48643493652344,
        637.6799926757812,
        266.04644775390625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포장",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        532.2000122070312,
        277.9200134277344,
        549.239990234375,
        288.1440124511719
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직접 용기․포장의 재질",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        702.0,
        266.8800048828125,
        788.6400146484375,
        277.10400390625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(주사제의 경우 용기 규격",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        694.6799926757812,
        277.9200134277344,
        796.0800170898438,
        288.1440124511719
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포함)",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        735.239990234375,
        289.08001708984375,
        755.4664306640625,
        299.30401611328125
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유의사항",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        465.47998046875,
        308.43560791015625,
        493.79998779296875,
        315.81982421875
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 유기용매를 사용할 경우 사용목적과 용매의 명칭, 규격, 단위제형당 사용량 등 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        327.3600158691406,
        800.52001953125,
        337.5754699707031
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 전부 또는 일부 공정 위탁하여 제조시 단위공정별 수탁자명, 소재지 등을 명확하게 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        342.7200012207031,
        802.5603637695312,
        352.9354553222656
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 동물유래성분 사용 시 기원동물 및 사용부위 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        358.08001708984375,
        668.52001953125,
        368.29547119140625
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 반추동물유래성분의 경우 전염성해면상뇌증(TSE)감염을 방지하기 위한 원료선택 또는",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        373.44000244140625,
        803.2799072265625,
        383.65545654296875
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처리방법 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        472.67999267578125,
        389.99810791015625,
        528.1199951171875,
        398.9840393066406
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 제제의 특성상 필요한 경우 제제설계에 관한 자료 제출",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        404.0400085449219,
        689.760009765625,
        414.2554626464844
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 제제설계 시 분할사용 하는 경우 아래 관련 정보를 참고하여 설계",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        419.3999938964844,
        732.3599853515625,
        429.6154479980469
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 13 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성제제 분할사용 관련 정보",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        52.91999816894531,
        52.235626220703125,
        155.8800048828125,
        59.619842529296875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "◯ 보존제 사용 관련",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        75.83999633789062,
        113.63999938964844,
        84.33599853515625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한민국약전",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        92.07562255859375,
        344.7599792480469,
        99.54280853271484
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유럽약전",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        92.07562255859375,
        344.7599792480469,
        99.54280853271484
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국약전",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        92.07562255859375,
        344.7599792480469,
        99.54280853271484
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[제제총칙 - 주사제 항]",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        45.84000015258789,
        103.19999694824219,
        120.31056213378906,
        111.68891906738281
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 제제에서 분할사용을 목적으",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        115.47562408447266,
        153.9596405029297,
        122.94281005859375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로 하는 것은 따로 규정이 없는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        126.87561798095703,
        157.4996337890625,
        134.34280395507812
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 미생물의 증식을 억제하기 위",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        138.27561950683594,
        153.95999145507812,
        145.74281311035156
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해 적절한 보존제를 넣는다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        45.84000015258789,
        148.55999755859375,
        136.39584350585938,
        157.04891967773438
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[제제총칙 - 주사제 항]",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        161.16000366210938,
        103.19999694824219,
        235.75054931640625,
        111.68891906738281
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분할사용을 목적으로 하는 주사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        161.16000366210938,
        115.47562408447266,
        269.27996826171875,
        122.94281005859375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제는 그 자체가 보존효과가 없을",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        161.16000366210938,
        126.87561798095703,
        272.82000732421875,
        134.34280395507812
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우 적절한 보존제를 포함한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        161.16000366210938,
        137.27999877929688,
        265.8758239746094,
        145.7689208984375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[제제총칙 - 방사성제제 항]",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        161.16000366210938,
        159.95999145507812,
        249.91055297851562,
        168.44891357421875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주사제 항에서 보존제 사용에 대",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        161.16000366210938,
        172.35562133789062,
        269.27996826171875,
        179.82281494140625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해 언급되었음에도 불구하고, 각",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        161.16000366210938,
        182.63999938964844,
        269.27996826171875,
        191.12892150878906
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조에 언급되어 있지 않은 경우 분",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        161.16000366210938,
        195.03561401367188,
        269.27996826171875,
        202.5028076171875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "할사용 방사성제제에 보존제를 사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        161.16000366210938,
        206.43560791015625,
        269.27996826171875,
        213.90280151367188
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용하는 것이 필수적이지는 않다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        161.16000366210938,
        216.71998596191406,
        263.8358154296875,
        225.2089080810547
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[제제총칙 - 주사제 항]",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        276.6000061035156,
        103.19999694824219,
        351.070556640625,
        111.68891906738281
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분할사용 용기로 포장되는 주사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        276.6000061035156,
        115.47562408447266,
        384.5999755859375,
        122.94281005859375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제는 다음의 경우를 제외하고,",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        276.6000061035156,
        125.87998962402344,
        384.6758117675781,
        134.36891174316406
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미생물성장을 막기 위해 적절한",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        276.6000061035156,
        138.27561950683594,
        388.1400146484375,
        145.74281311035156
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보존제를 넣는다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        276.6000061035156,
        148.55999755859375,
        331.51580810546875,
        157.04891967773438
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(1) 각조에 별도로 언급한 경우",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        276.6000061035156,
        159.95999145507812,
        377.03997802734375,
        168.44891357421875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(2) 반감기가 24시간 미만의 방사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        276.6000061035156,
        171.36000061035156,
        384.5999755859375,
        179.8489227294922
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성제제",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        276.6000061035156,
        183.6356201171875,
        297.8399658203125,
        191.10281372070312
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(3) 주성분 자체가 보존효과가 있",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        276.6000061035156,
        194.0399932861328,
        384.5999755859375,
        202.52891540527344
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 경우",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        276.6000061035156,
        206.43560791015625,
        301.3199768066406,
        213.90280151367188
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품의 특성*을 감안하여 다음 사항을 고려",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        231.83999633789062,
        215.39999389648438,
        240.32891845703125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 방사성의약품의 반감기가 24시간 미만인가?",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        49.439998626708984,
        243.239990234375,
        196.81643676757812,
        251.72891235351562
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 반감기가 24시간 이상의 방사성제제에서 보존제를 사용하지 않는 타당한 근거는?",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        49.439998626708984,
        254.63999938964844,
        321.1364440917969,
        263.12890625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 방사성의약품의 특성: 방사성 핵종의 반감기로 인하여 개봉시 즉시 또는 수시간 내로 사용해야 하므로 보존제의 사용이 필수적",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        45.84000015258789,
        277.5599670410156,
        384.6000061035156,
        284.3279724121094
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이지 않음(투여 전 방사능 농도 확인 후 해당 농도로 희석하여 환자에게 투여)",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        50.7599983215332,
        286.67999267578125,
        255.6248321533203,
        293.447998046875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "◯ 용기 관련",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        303.1199951171875,
        88.80000305175781,
        311.615966796875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한민국약전",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        319.2356262207031,
        344.7599792480469,
        326.70281982421875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유럽약전",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        319.2356262207031,
        344.7599792480469,
        326.70281982421875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국약전",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        78.5999984741211,
        319.2356262207031,
        344.7599792480469,
        326.70281982421875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[일반시험법 - 주사제용유리용기",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        330.3600158691406,
        153.9596405029297,
        338.8489074707031
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험법]",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        45.84000015258789,
        341.760009765625,
        69.4305648803711,
        350.2489013671875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분할사용을 목적으로 하는 용기",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        354.0356140136719,
        153.9596405029297,
        361.5028076171875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 고무마개 또는 다른 적당한",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        365.43560791015625,
        157.4996337890625,
        372.9028015136719
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마개로 밀봉한다. 마개는 내용의",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        375.8399963378906,
        153.9596405029297,
        384.3288879394531
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품과 물리적 또는 화학적으로",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        388.1156005859375,
        157.4996337890625,
        395.5827941894531
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "작용하지 않는 것으로 주사바늘",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        399.515625,
        153.9596405029297,
        406.9828186035156
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "을 삽입할 때 마개 파편이 혼입",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        410.9156188964844,
        153.9596405029297,
        418.3828125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "되지 않고 또 주사바늘을 뺄 때",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        422.19561767578125,
        157.49998474121094,
        429.6628112792969
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "곧 외부로부터의 오염을 막을 수",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        433.5956115722656,
        157.49998474121094,
        441.06280517578125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있는 것이다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        45.84000015258789,
        444.0,
        86.59583282470703,
        452.4888916015625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[제제총칙 - 주사제 항]",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        161.16000366210938,
        330.3600158691406,
        235.75054931640625,
        338.8489074707031
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분할사용 용기는 주사바늘을 뺄",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        161.16000366210938,
        342.755615234375,
        272.82000732421875,
        350.2228088378906
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "때 구멍이 다시 닫히도록 충분한",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        161.16000366210938,
        354.0356140136719,
        272.82000732421875,
        361.5028076171875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "탄성이 있어야 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        161.16000366210938,
        364.44000244140625,
        226.87583923339844,
        372.92889404296875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[일반사항 - 고무마개 항]",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        161.16000366210938,
        387.1199951171875,
        242.83055114746094,
        395.60888671875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분할사용 용기를 사용하는 경우",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        161.16000366210938,
        399.515625,
        272.82000732421875,
        406.9828186035156
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재밀봉시험(self-sealing test)을 수",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        161.16000366210938,
        409.9200134277344,
        269.27996826171875,
        418.4089050292969
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행하였을 때 적합하여야 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        161.16000366210938,
        421.20001220703125,
        258.79583740234375,
        429.68890380859375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "*시험방법 - 검체 10개에 대해 주",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        161.16000366210938,
        432.6000061035156,
        269.27996826171875,
        441.0888977050781
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사바늘로 10회 반복하여 찌른",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        163.8000030517578,
        444.0,
        272.82000732421875,
        452.4888916015625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "후 메틸렌블루(색소) 용액에 담",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        163.8000030517578,
        455.2799987792969,
        269.27996826171875,
        463.7688903808594
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그고 외부 압력을 변화시켰을",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        163.8000030517578,
        467.67559814453125,
        272.81964111328125,
        475.1427917480469
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "때 제품 안의 색이 변하지 않아",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        163.8000030517578,
        479.07562255859375,
        269.27996826171875,
        486.5428161621094
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "야 함(상세시험은 EP 참조)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        163.8000030517578,
        489.3600158691406,
        251.71055603027344,
        497.8489074707031
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[제제총칙 - 주사제 항]",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        276.6000061035156,
        330.3600158691406,
        351.070556640625,
        338.8489074707031
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분할사용 용기의 경우 용기시스",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        276.6000061035156,
        342.755615234375,
        384.5999755859375,
        350.2228088378906
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "템의 변형 없이 내용물을 취할",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        276.6000061035156,
        354.0356140136719,
        388.2596435546875,
        361.5028076171875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수 있어야 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        276.6000061035156,
        364.44000244140625,
        328.03582763671875,
        372.92889404296875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[일반사항 - 고무마개 항]",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        276.6000061035156,
        387.1199951171875,
        358.1505432128906,
        395.60888671875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분할사용 용기를 사용하는 경우",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        276.6000061035156,
        399.515625,
        388.1400146484375,
        406.9828186035156
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재밀봉시험(self-sealing",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        276.6000061035156,
        409.9200134277344,
        384.66937255859375,
        418.4089050292969
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "capacity)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        276.6000061035156,
        409.9200134277344,
        384.66937255859375,
        418.4089050292969
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "을 수행하였을 때 적합하여야 한",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        276.6000061035156,
        422.19561767578125,
        384.5999755859375,
        429.6628112792969
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        276.6000061035156,
        432.6000061035156,
        285.4358215332031,
        441.0888977050781
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "*시험방법 - 좌동",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        276.6000061035156,
        444.0,
        331.3199768066406,
        452.4888916015625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분할사용 하는 용기의 특성을 감안하여 다음 사항을 고려",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        45.84000015258789,
        505.4756164550781,
        234.0,
        512.9428100585938
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 제조방법에서 주사제 용기의 규격(고무마개 등)을 기재했는가?",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        49.439998626708984,
        515.8799438476562,
        258.3764343261719,
        524.368896484375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 설정된 규격은 재밀봉시험(self-sealing test) 항목이 포함되었는가? 그 결과는 적합한가?",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        49.439998626708984,
        527.2799682617188,
        339.9764404296875,
        535.7689208984375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 14 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.6 효능․효과",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        51.839996337890625,
        524.8800048828125,
        62.063995361328125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 유효성이 명확히 실증될 수 있는 질환명, 증상명을 의약학적으로 인정되는 범위에서",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        67.20000457763672,
        807.5399780273438,
        77.41548156738281
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가능한 한 구체적으로 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        472.55999755859375,
        83.75811767578125,
        579.1199951171875,
        92.74405670166016
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 근거 불명확, 막연하고 광범위한 의미 표현, 중복, 지나치게 강조, 오해 또는 오남용",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        97.80000305175781,
        807.5399780273438,
        108.0154800415039
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "우려가 있는 표현은 제외",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        472.79998779296875,
        114.35812377929688,
        570.7200317382812,
        123.34406280517578
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 성별, 연령층 등으로 적용대상이 한정되는 경우 그 내용 명시",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        128.51998901367188,
        713.1600341796875,
        138.7354736328125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 조제하여 사용하는 방사성의약품(일명: Cold Vial)은 표지품목의 효능․효과를 함께 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        143.87998962402344,
        799.920166015625,
        154.10398864746094
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.7 용법․용량",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        177.3599853515625,
        524.8800048828125,
        187.583984375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 약리학, 제제학, 임상성적자료 등 명확한 근거 바탕, 합리적, 타당해야 하며, 원료약품",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        192.71998596191406,
        803.2794799804688,
        202.9354705810547
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 그 분량, 효능효과에 맞추어 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        472.79998779296875,
        208.07998657226562,
        615.47998046875,
        218.29547119140625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 사용량, 사용시간과 사용횟수 등을 구체적으로 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        223.4399871826172,
        674.8800048828125,
        233.6554718017578
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 사용 시에 방사성 물질을 표지하는 경우 “용법” 항에 방사성 물질 표지하는 조제방법",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        238.67999267578125,
        803.2794799804688,
        248.89547729492188
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        472.55999755859375,
        255.23812866210938,
        489.5999755859375,
        264.22406005859375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 적응증에 따른 사용량 “용량” 항에 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        269.3999938964844,
        630.1199951171875,
        279.6154479980469
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 동위원소가 포함된 방사성의약품은 반감기에 따른 방사선량을 구할 수 있는 계산식",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        284.760009765625,
        807.5399780273438,
        294.9754638671875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 효능․효과별 적정 방사선조사량 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        472.79998779296875,
        300.1199951171875,
        634.6799926757812,
        310.343994140625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 오용의 여지가 없는 명확한 표현 사용, 남용의 위험성, 특성을 강조하는 표현 제외",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        315.3600158691406,
        796.2000122070312,
        325.5754699707031
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.8 사용상의 주의사항",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        348.9599914550781,
        554.760009765625,
        359.1754455566406
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 의약품의 일반적인 사용상의 주의사항 이외에 방사성의약품 조제 시 주의할 사항을",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        364.20001220703125,
        807.5399780273438,
        374.41546630859375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "“적용상의 주의사항”으로 구분하여 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        472.79998779296875,
        379.55999755859375,
        630.3599853515625,
        389.77545166015625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.9 포장단위",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        413.0400085449219,
        516.3599853515625,
        423.2554626464844
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        465.3599853515625,
        428.3999938964844,
        807.53955078125,
        438.6154479980469
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "액상주사제의 경우 제조(수입)되는 바이알 또는 앰플 등의 용량.",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        465.3599853515625,
        428.3999938964844,
        807.53955078125,
        438.6154479980469
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다만,",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        465.3599853515625,
        428.3999938964844,
        807.53955078125,
        438.6154479980469
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제형이나",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        428.3999938964844,
        807.53955078125,
        438.6154479980469
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용법･",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        475.91998291015625,
        443.760009765625,
        496.3800048828125,
        453.9840087890625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용량 등으로 보아 특수성이 있거나 사용목적으로 보아 그 타당성이 인정되는",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        496.0799865722656,
        444.9581298828125,
        807.53955078125,
        453.9440612792969
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우 예외",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        475.91998291015625,
        460.318115234375,
        512.7595825195312,
        469.3040466308594
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 방사성의약품은 반감기로 인해 사용시점에 따라 용량이 가변적이므로 용량을 기재하는 대신 ‘자사",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        474.7200012207031,
        803.2796630859375,
        483.2159729003906
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포장단위’ 또는 ‘제조원 포장단위’로 기재 가능",
      "font_size": 7.079999923706055,
      "font_name": "T20",
      "bbox": [
        468.7200012207031,
        487.44000244140625,
        618.9600219726562,
        495.93597412109375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 기타의 경우 제조는 “자사 포장단위”, 수입은 “제조원 포장단위”로 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        500.0400085449219,
        755.6400146484375,
        510.2554626464844
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.10 저장방법 및 사용기간",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        536.3999633789062,
        571.7999877929688,
        546.615478515625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 15 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "저장방법",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        44.52000045776367,
        52.235626220703125,
        72.84000396728516,
        59.619842529296875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 방사성의약품 : “밀봉용기”, “차폐용기 : 원자력법령에 의함”",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        44.52000045776367,
        71.16000366210938,
        287.8029479980469,
        81.37548065185547
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 구체적인 보관조건(2～8℃, 냉장보관 등)․유의사항(예 : 빛을 피하여 보관 등) 병기",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        86.52000427246094,
        377.9999694824219,
        96.74400329589844
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        40.20000076293945,
        102.1199951171875,
        382.26165771484375,
        110.61599731445312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품의",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        102.1199951171875,
        382.26165771484375,
        110.61599731445312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        102.1199951171875,
        382.26165771484375,
        110.61599731445312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대부분",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        102.1199951171875,
        382.26165771484375,
        110.61599731445312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주사제로",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        102.1199951171875,
        382.26165771484375,
        110.61599731445312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        102.1199951171875,
        382.26165771484375,
        110.61599731445312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용기는",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        102.1199951171875,
        382.26165771484375,
        110.61599731445312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바이알을",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        102.1199951171875,
        382.26165771484375,
        110.61599731445312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용하므로",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        102.1199951171875,
        382.26165771484375,
        110.61599731445312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "“밀봉용기”에",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        102.1199951171875,
        382.26165771484375,
        110.61599731445312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당하고,",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        102.1199951171875,
        382.26165771484375,
        110.61599731445312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사선을 차폐하기 위하여 추가적인 차폐용기가 필요함. 단, 콜드바이알(Cold Vial)의 경우 방사능이",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        53.15999984741211,
        114.83999633789062,
        382.3199768066406,
        123.33599853515625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "없으므로 “차폐용기”는 미설정할 수 있음.",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        53.15999984741211,
        127.67999267578125,
        187.97459411621094,
        136.17599487304688
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 참고 - 대한민국약전(제11개정) 통칙 중 방사선을 차폐하는 용기의 조건",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        140.39999389648438,
        285.719970703125,
        148.89599609375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "52. 방사성의약품에서 방사선을 차폐하는 용기는 충분한 차폐능력이 있는 것을 쓴다. 용기의 외장은 쉽게",
      "font_size": 6.900730133056641,
      "font_name": "T8",
      "bbox": [
        44.87999725341797,
        158.27999877929688,
        361.5661315917969,
        166.7760009765625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "파손되지 않는 것을 쓴다. 용기 외장에서의 최대 방사선량율은 다음과 같이 한다.",
      "font_size": 6.900730133056641,
      "font_name": "T8",
      "bbox": [
        56.52000045776367,
        171.0,
        296.24786376953125,
        179.49600219726562
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 용기의 외장 표면에서 시간당 2 mSv 이하이다. 다만, 전용운반인 경우에는 시간당 10 mSv 이하로 한다.",
      "font_size": 6.900730133056641,
      "font_name": "T8",
      "bbox": [
        44.87999725341797,
        183.83999633789062,
        360.4478454589844,
        192.33599853515625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 용기의 외장 표면으로부터 1 m 떨어진 위치에 있어서는 시간당 0.1 mSv 이하이다. 다만, 전용운반인",
      "font_size": 6.900730133056641,
      "font_name": "T8",
      "bbox": [
        44.87999725341797,
        196.55999755859375,
        361.5661315917969,
        205.05599975585938
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우에는 제외한다.",
      "font_size": 6.900730133056641,
      "font_name": "T8",
      "bbox": [
        53.7599983215332,
        209.39999389648438,
        109.76786804199219,
        217.89599609375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용기간",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        44.52000045776367,
        231.27561950683594,
        72.84000396728516,
        238.65985107421875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 안전성․유효성 심사결과 인정된 기간으로 설정",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        250.1999969482422,
        239.0399932861328,
        260.42401123046875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 안전성․유효성 심사 비대상 품목 : 기허 품목의 사용기간 준용(단, 36개월 이하로",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        265.55999755859375,
        386.5799865722656,
        275.78399658203125
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "준용하고, 제제학적으로 안정성 확인이 필요한 품목의 경우 안정성 시험자료 등",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        52.31999969482422,
        280.9200134277344,
        386.5799865722656,
        291.1354675292969
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입증자료 제시)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        52.31999969482422,
        296.2799987792969,
        110.58863830566406,
        306.4954528808594
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 조제하여 사용하는 방사성의약품(Cold Vial)의 경우 조제 후의 사용기간도 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        311.6400146484375,
        363.5999755859375,
        321.85546875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기타",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        51.599998474121094,
        330.1556091308594,
        65.76000213623047,
        337.5398254394531
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 방사성의약품은 다음 사항을 추가로 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        349.08001708984375,
        213.47999572753906,
        359.29547119140625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․의약품의 용기․포장에 ‘제조일자(필요시 시각기재한다) : 제조시 표기’와 같이 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        48.71999740600586,
        364.44000244140625,
        381.5998229980469,
        374.66400146484375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "․제조시(또는 검정시)의 방사선량",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        48.71999740600586,
        379.79998779296875,
        182.16000366210938,
        390.02398681640625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.11 기준 및 시험방법",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        397.9200134277344,
        133.8000030517578,
        408.1354675292969
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 약전, 공정서 품목 : 해당 공정서 각조에 따름",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        413.2799987792969,
        230.39999389648438,
        423.4954528808594
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 약전, 공정서 외 품목 : 자사기준",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        428.6400146484375,
        179.27999877929688,
        438.85546875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 자사에서 근거자료를 바탕으로 직접 기준 및 시험방법을 작성할 경우 방사성의약품의 특성에 맞게",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        444.239990234375,
        382.3199768066406,
        452.7359619140625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약전의 각조 또는 공정서를 참고하여 작성하도록 함",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        51.599998474121094,
        456.9599914550781,
        221.87998962402344,
        465.4559631347656
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<예> 대한민국약전 각조 중,",
      "font_size": 7.799999713897705,
      "font_name": "H2gtrM",
      "bbox": [
        44.87999725341797,
        472.5845031738281,
        145.96499633789062,
        480.3844909667969
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과테크네튬산나트륨(99mTc) 주사액",
      "font_size": 7.799999713897705,
      "font_name": "H2gtrM",
      "bbox": [
        64.68000030517578,
        497.6336669921875,
        188.27999877929688,
        506.54449462890625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sodium Pertechnetate (99mTc) Injection",
      "font_size": 7.799999713897705,
      "font_name": "H2gtrM",
      "bbox": [
        51.0,
        510.1136779785156,
        202.1554412841797,
        519.0244750976562
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 약은 수성의 주사제로서 테크네튬-99m을 과테크",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        51.23999786376953,
        537.3005981445312,
        208.2001953125,
        543.6605834960938
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "네튬산나트륨의 형태로 함유한다.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        224.27999877929688,
        472.6205749511719,
        322.0108642578125,
        478.9805603027344
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 약은 정량할 때 시험 당시 표시된 테크네튬-99m",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        230.75999450683594,
        482.8205871582031,
        387.7649230957031,
        489.1805725097656
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사능의 90.0 ~ 110.0 %를 함유한다.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        224.27999877929688,
        493.02056884765625,
        341.93084716796875,
        499.38055419921875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제   법",
      "font_size": 6.359999656677246,
      "font_name": "H2gtrM",
      "bbox": [
        224.27999877929688,
        504.2177429199219,
        389.8381042480469,
        511.38055419921875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 약은 과테크네튬산나트륨(99mTc) 주사액",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        224.27999877929688,
        504.2177429199219,
        389.8381042480469,
        511.38055419921875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제너레이터 또는 이에 따라 제조한 제너레이터로부터",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        230.75999450683594,
        516.9005737304688,
        389.83831787109375,
        523.2605590820312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생리식염액으로 과테크네튬산나트륨(99mTc)을 용출",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        230.75999450683594,
        526.2977294921875,
        387.719970703125,
        533.4605712890625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시켜 주사제의 제법에 따라 만든다.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        230.75999450683594,
        537.3005981445312,
        334.7308654785156,
        543.6605834960938
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 16 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.12 제조원",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        293.2799987792969,
        512.1599731445312,
        303.4954528808594
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 아래 표를 참고로 구분하여 기재",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        465.3599853515625,
        308.6400146484375,
        600.3599853515625,
        318.85546875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "명칭",
      "font_size": 7.3997297286987305,
      "font_name": "T15",
      "bbox": [
        465.239990234375,
        326.0400085449219,
        691.8596801757812,
        335.3999938964844
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기재항목",
      "font_size": 7.3997297286987305,
      "font_name": "T15",
      "bbox": [
        465.239990234375,
        326.0400085449219,
        691.8596801757812,
        335.3999938964844
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용어 정의",
      "font_size": 7.3997297286987305,
      "font_name": "T15",
      "bbox": [
        465.239990234375,
        326.0400085449219,
        691.8596801757812,
        335.3999938964844
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조",
      "font_size": 7.3997297286987305,
      "font_name": "T15",
      "bbox": [
        465.239990234375,
        424.44000244140625,
        479.2203063964844,
        433.79998779296875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구분",
      "font_size": 7.3997297286987305,
      "font_name": "T15",
      "bbox": [
        465.239990234375,
        438.4800109863281,
        479.2203063964844,
        447.8399963378906
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사제조",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        501.9599914550781,
        343.67999267578125,
        529.0206298828125,
        353.03997802734375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조판매품목허가권자와 제조자 동일",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        336.6000061035156,
        666.0601806640625,
        345.9599914550781
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(수입, 제조품목 공통)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        350.6400146484375,
        617.8125610351562,
        360.0
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전공정위탁제조",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        492.0,
        361.20001220703125,
        539.1002197265625,
        370.55999755859375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조의뢰자)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        496.91998291015625,
        375.9599914550781,
        534.172607421875,
        385.3199768066406
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목허가권자이면서, 전공정을 다른 제조업자에게 의뢰하여 제조하는 자",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        361.55999755859375,
        774.4199829101562,
        370.91998291015625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(수입, 제조품목 공통)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        375.6000061035156,
        617.8125610351562,
        384.9599914550781
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전공정위탁제조",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        492.0,
        386.5199890136719,
        539.1002197265625,
        395.8799743652344
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조자)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        503.5199890136719,
        401.2799987792969,
        527.4525756835938,
        410.6399841308594
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목허가권자로부터 동 품목에 대하여 전공정을 제조 의뢰받아 실제 제조하는 자",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        386.760009765625,
        802.8599853515625,
        396.1199951171875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(수입, 제조품목 공통)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        400.9200134277344,
        617.8125610351562,
        410.2799987792969
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일부공정위탁제조",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        488.6399841308594,
        418.44000244140625,
        542.3402099609375,
        427.79998779296875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조의뢰자)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        496.91998291015625,
        433.20001220703125,
        534.172607421875,
        442.55999755859375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목허가권자이면서, 동 품목에 대하여 일부공정은 직접제조하고, 일부공정은",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        411.7200012207031,
        803.2208251953125,
        421.0799865722656
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다른 제조업자에게 의뢰하여 제조하는 자",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        425.760009765625,
        679.3800048828125,
        435.1199951171875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(수입, 제조품목 공통)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        439.9200134277344,
        617.8125610351562,
        449.2799987792969
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일부공정위탁제조",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        488.6399841308594,
        450.3600158691406,
        542.3402099609375,
        459.7200012207031
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조자)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        503.5199890136719,
        465.1199951171875,
        527.4525756835938,
        474.47998046875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목허가권자로부터 동 품목에 대하여 일부공정만을 제조 의뢰받아 실제 제조하는 자",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        450.7200012207031,
        802.02001953125,
        460.0799865722656
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(수입, 제조품목 공통)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        464.760009765625,
        617.8125610351562,
        474.1199951171875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수입(수입자)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        496.91998291015625,
        475.67999267578125,
        672.780029296875,
        485.03997802734375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국내에서 동 수입품목에 대한 허가권자",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        496.91998291015625,
        475.67999267578125,
        672.780029296875,
        485.03997802734375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소분포장",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        501.9599914550781,
        486.239990234375,
        529.02001953125,
        495.5999755859375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(소분제조자)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        496.91998291015625,
        501.0,
        534.172607421875,
        510.3599853515625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소분품목의 허가권자이면서 소분․포장 제조하는 자",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        493.55999755859375,
        712.739990234375,
        502.91998291015625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소분제조",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        501.9599914550781,
        511.44000244140625,
        529.0206298828125,
        520.7999877929688
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조자)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        503.5199890136719,
        526.3200073242188,
        527.4525756835938,
        535.6799926757812
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소분품목의 벌크(bulk) 제조자",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        511.79998779296875,
        641.3404541015625,
        521.1599731445312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(해당 생산국의 원제조자)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        552.3599853515625,
        525.9600219726562,
        629.5725708007812,
        535.3200073242188
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성    상  이 약은 무색의 맑은 액이다.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        465.8399963378906,
        52.260581970214844,
        582.5308227539062,
        58.620582580566406
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "확인시험  1) 이 약을 가지고 감마선측정법의 감마선",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        465.8399963378906,
        62.4605827331543,
        629.16015625,
        68.82058715820312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스펙트로미터에 의한 스펙트럼측정법에 따라 시험할",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        72.66058349609375,
        631.2778930664062,
        79.02058410644531
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "때 0.141 MeV에 피크를 확인한다.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        82.98058319091797,
        576.5308227539062,
        89.34058380126953
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 순도시험 1)에 따라 확인한다.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        465.8399963378906,
        93.18058776855469,
        571.4908447265625,
        99.54058837890625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "pH  4.5 ∼ 7.0",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        465.8399963378906,
        103.38058471679688,
        513.3745727539062,
        109.74058532714844
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "순도시험",
      "font_size": 6.359999656677246,
      "font_name": "H2gtrM",
      "bbox": [
        465.8399963378906,
        115.38058471679688,
        631.2781372070312,
        121.74058532714844
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 방사화학적이물",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        465.8399963378906,
        115.38058471679688,
        631.2781372070312,
        121.74058532714844
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 약을 가지고 75 %",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        465.8399963378906,
        115.38058471679688,
        631.2781372070312,
        121.74058532714844
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메탄올을 전개용매로 하여 여지크로마토그래프법에",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        127.26058959960938,
        631.2782592773438,
        133.62059020996094
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "따라 약 3 시간 전개할 때 과테크네튬산나트륨",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        137.46058654785156,
        629.1603393554688,
        143.82058715820312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(99mTc) 반점(Rƒ 값 약 0.6 ~ 0.7) 이외의 방사능",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        146.8577423095703,
        629.1599731445312,
        154.0205841064453
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "은 총방사능의 5 % 이하이다.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        157.86058044433594,
        560.4508056640625,
        164.2205810546875
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 몰리브덴-99  이 약 일정량을 바이알에 정밀하",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        465.8399963378906,
        168.1805877685547,
        629.16015625,
        174.54058837890625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "게 취하여 특정 두께의 납용기에 넣고 감마선측정법",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        178.38058471679688,
        629.16015625,
        184.74058532714844
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 정량법에 따라 몰리브덴-99의 방사능을 산출한",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        188.58058166503906,
        629.1599731445312,
        194.94058227539062
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 감마선스펙트로미터에 의한 정량법에 따라 방사",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        198.78057861328125,
        629.1599731445312,
        205.1405792236328
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "능을 측정할 경우 0.739 MeV의 방사능 피크를 계수",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        208.9805908203125,
        629.1599731445312,
        215.34059143066406
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하여 몰리브덴-99의 방사능을 산출한다. 이 때 몰리",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        219.3005828857422,
        629.1599731445312,
        225.66058349609375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "브덴-99의 방사능은 총방사능의 0.015 % 이하이다.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        229.50057983398438,
        629.2108154296875,
        235.86058044433594
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 알루미늄  이 약 3.0 mL 및 알루미늄표준액 1.5",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        465.8399963378906,
        239.70057678222656,
        631.2774047851562,
        246.06057739257812
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mL를 취하여 각각 물 2 mL, 3.5 mL 및 용시 조제",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        249.9005889892578,
        629.1599731445312,
        256.2605895996094
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 L-아스코르브산용액 (1 → 20) 2.4 mL 씩을 넣",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        260.1005859375,
        629.1599731445312,
        266.4605712890625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고 흔들어 섞어 15 분간 방치한다. 다음 각각에 물",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        472.1999816894531,
        270.42059326171875,
        631.2778930664062,
        276.78057861328125
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5 mL 및 암모니아수(28)를 넣어 pH를 8로 조정하",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        52.260581970214844,
        808.6801147460938,
        58.620582580566406
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고 묽은염산을 넣어 pH를 7로 조정한다. 여기에 아",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        62.4605827331543,
        808.6799926757812,
        68.82058715820312
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세트산·아세트산나트륨완충액(pH 3.8) 5 mL, 알루",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        72.66058349609375,
        808.6799926757812,
        79.02058410644531
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미논시액 1 mL및 물을 넣어 25.0 mL로 하고 20",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        82.98058319091797,
        810.7973022460938,
        89.34058380126953
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분간 방치하여 각각 검액 및 표준액으로 한다. 따로",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        93.18058776855469,
        810.798095703125,
        99.54058837890625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물 5.0 mL에 용시 조제한 L-아스코르브산용액 (1",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        103.38058471679688,
        810.79736328125,
        109.74058532714844
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "→ 20) 2.4 mL를 넣고 같은 방법으로 조작하여 얻",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        113.5805892944336,
        808.6799926757812,
        119.94058990478516
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "은 액을 대조로 하여 자외가시부흡광도측정법에 따라",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        123.78057861328125,
        810.7979125976562,
        130.1405792236328
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "층장 1 cm, 파장 530 nm에서 흡광도를 측정할 때",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        134.1005859375,
        810.7979125976562,
        140.46058654785156
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검액의 흡광도는 표준액의 흡광도보다 작다 (10",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        144.3005828857422,
        810.7970581054688,
        150.66058349609375
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ppm 이하).",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        154.50057983398438,
        685.7305908203125,
        160.86058044433594
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무균시험  시험할 때 적합하다.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        645.239990234375,
        164.70059204101562,
        736.61083984375,
        171.0605926513672
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "엔도톡신  이 약 1 mL 당 엔도톡신으로서 175/V EU",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        645.239990234375,
        174.9005889892578,
        810.79833984375,
        181.26058959960938
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미만이다. 다만, V는 유효시간에 mL 당 최대권장량",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        185.2205810546875,
        808.6801147460938,
        191.58058166503906
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이다.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        195.4205780029297,
        666.2908325195312,
        201.78057861328125
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "불용성이물시험  시험할 때 적합하다.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        645.239990234375,
        205.62059020996094,
        755.6907958984375,
        211.9805908203125
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정 량 법  이 약을 가지고 감마선측정법의 정량법에 따",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        645.239990234375,
        215.82058715820312,
        808.6799926757812,
        222.1805877685547
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라 시험한다.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        651.719970703125,
        226.0205841064453,
        688.61083984375,
        232.38058471679688
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "저 장 법  밀봉용기, 차폐.",
      "font_size": 6.359999656677246,
      "font_name": "H2mjsM",
      "bbox": [
        645.239990234375,
        247.62059020996094,
        722.4508056640625,
        253.9805908203125
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 17 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3.13 허가조건",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        51.839996337890625,
        99.7199935913086,
        62.055477142333984
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▷ 주요 허가조건 예시",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        67.20000457763672,
        129.72000122070312,
        77.42400360107422
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 지위승계(양도․양수) :「약사법」제89조 및「의약품 등의 안전에 관한 규칙」제103",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        44.52000045776367,
        82.55999755859375,
        382.3629150390625,
        92.78399658203125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조 규정에 따라 양도자의 모든 허가․신고사항을 승계받는 조건으로 허가",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        52.07999801635742,
        97.80000305175781,
        341.7599792480469,
        108.02400207519531
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○「약사법」제89조제3항 및「의약품 등의 안전에 관한 규칙」제103조 규정에 의거 양수받은 품목의",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        47.7599983215332,
        116.03999328613281,
        375.6604309082031,
        125.39999389648438
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우, 종전에 제조된 제품의 품질관리 및 행정조치는 양수자인 ○○제약(주)에서 승계·책임질 것.",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        47.7599983215332,
        130.07998657226562,
        344.19989013671875,
        139.4399871826172
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 재심사 부여",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        161.87998962402344,
        98.39999389648438,
        172.09547424316406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<신약에 따른 재심사 부여>",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        47.7599983215332,
        180.1199951171875,
        132.48562622070312,
        189.47999572753906
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.「약사법」제32조",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        194.87998962402344,
        375.6601867675781,
        204.239990234375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및「의약품",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        194.87998962402344,
        375.6601867675781,
        204.239990234375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등의",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        194.87998962402344,
        375.6601867675781,
        204.239990234375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전에",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        194.87998962402344,
        375.6601867675781,
        204.239990234375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관한",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        194.87998962402344,
        375.6601867675781,
        204.239990234375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규칙」제22조제1항제1호가목의",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        194.87998962402344,
        375.6601867675781,
        204.239990234375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규정에",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        194.87998962402344,
        375.6601867675781,
        204.239990234375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의한",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        194.87998962402344,
        375.6601867675781,
        204.239990234375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "재심사대상 품목임",
      "font_size": 7.3997297286987305,
      "font_name": "T20",
      "bbox": [
        56.03999710083008,
        208.9199981689453,
        113.09999084472656,
        218.27999877929688
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 재심사 기간 : 2013.7.2. ~ 2019. 7.1.(6년)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        57.71999740600586,
        223.67999267578125,
        186.29261779785156,
        233.0399932861328
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 재심사 신청기간 : 2019.7.2. ~ 2019.10.1.",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        57.71999740600586,
        238.4399871826172,
        185.7979278564453,
        247.79998779296875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<특정 효능․효과 추가에 따른 재심사 부여>",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        47.7599983215332,
        253.1999969482422,
        185.765625,
        262.55999755859375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1-1.",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        267.9599914550781,
        375.6601867675781,
        277.3199768066406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "효능․효과",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        267.9599914550781,
        375.6601867675781,
        277.3199768066406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        267.9599914550781,
        375.6601867675781,
        277.3199768066406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘편두통의",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        267.9599914550781,
        375.6601867675781,
        277.3199768066406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예방’에",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        267.9599914550781,
        375.6601867675781,
        277.3199768066406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대하여는「약사법」제32조",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        267.9599914550781,
        375.6601867675781,
        277.3199768066406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및「의약품",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        267.9599914550781,
        375.6601867675781,
        277.3199768066406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등의",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        267.9599914550781,
        375.6601867675781,
        277.3199768066406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전에",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        267.9599914550781,
        375.6601867675781,
        277.3199768066406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관한",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        267.9599914550781,
        375.6601867675781,
        277.3199768066406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규칙」제22조제1항제2호가목의 규정에 의한 재심사대상 품목임",
      "font_size": 7.3997297286987305,
      "font_name": "T20",
      "bbox": [
        47.7599983215332,
        282.0,
        241.5,
        291.3599853515625
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 재심사 기간 : 2014. 10. 4. ~ 2018. 10. 3.(4년)",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        57.71999740600586,
        296.760009765625,
        202.8526153564453,
        306.1199951171875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 재심사 신청기간 : 2018. 10. 4. ~ 2019. 1. 3.",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        57.71999740600586,
        311.52001953125,
        199.11965942382812,
        320.8800048828125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.「신약 등의 재심사 기준」(식품의약품안전처 고시)을 준수할 것",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        326.3999938964844,
        253.6199951171875,
        335.7599792480469
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 만일, 정당한 사유 없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        51.119998931884766,
        341.1600036621094,
        340.3598937988281,
        350.5199890136719
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 조건부허가:「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조 규정에",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        372.9599914550781,
        386.5799865722656,
        383.1839904785156
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "따라 시설을 갖출 것을 조건으로 허가",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.52000045776367,
        389.51812744140625,
        202.55999755859375,
        398.5040588378906
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 동 품목은「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조제2항의 규정에 의한 조건부",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        47.7599983215332,
        406.44000244140625,
        375.6604309082031,
        415.79998779296875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조판매품목으로서 201○.○.○까지 약사법 제31조제1항에 적합한 시설을 갖추고 우리처에 이행통보할 것",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        47.7599983215332,
        418.9200134277344,
        374.8199768066406,
        428.2799987792969
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 만일, 정당한 사유없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.",
      "font_size": 7.3997297286987305,
      "font_name": "T8",
      "bbox": [
        47.7599983215332,
        432.1199951171875,
        346.1199035644531,
        441.47998046875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수출용․군수용․관수용:「의약품 등의 안전에 관한 규칙」제12조 및「의약품등의",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        44.52000045776367,
        464.0400085449219,
        386.5799865722656,
        474.2640075683594
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목허가․신고․심사규정」제22조",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.03999710083008,
        479.3999938964844,
        386.5799865722656,
        489.6239929199219
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규정에",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.03999710083008,
        479.3999938964844,
        386.5799865722656,
        489.6239929199219
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "따라",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.03999710083008,
        479.3999938964844,
        386.5799865722656,
        489.6239929199219
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수출용․군수용․관수용으로",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        53.03999710083008,
        479.3999938964844,
        386.5799865722656,
        489.6239929199219
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가(예: 수출용에 한함)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        53.03999710083008,
        494.6400146484375,
        146.108642578125,
        504.85546875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 18 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.4 심사자료의 종류 및 범위",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        48.839996337890625,
        583.4400024414062,
        59.918758392333984
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심사자료의 종류",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        471.9599914550781,
        68.9156265258789,
        525.1199951171875,
        76.29984283447266
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "｢",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        635.8800048828125,
        86.5199966430664,
        639.4199829101562,
        95.01599884033203
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품의 품목허가․신고․심사 규정｣",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        639.3599853515625,
        86.5199966430664,
        763.6199340820312,
        95.01599884033203
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제5조 관련",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        767.1599731445312,
        86.5199966430664,
        802.6799926757812,
        95.01599884033203
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        465.7200012207031,
        95.63999938964844,
        626.1599731445312,
        104.13600158691406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성․유효성과",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        465.7200012207031,
        95.63999938964844,
        626.1599731445312,
        104.13600158691406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        465.7200012207031,
        95.63999938964844,
        626.1599731445312,
        104.13600158691406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        465.7200012207031,
        95.63999938964844,
        626.1599731445312,
        104.13600158691406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        465.7200012207031,
        95.63999938964844,
        626.1599731445312,
        104.13600158691406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심사",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        465.7200012207031,
        95.63999938964844,
        626.1599731445312,
        104.13600158691406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제출자료의 종류",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        479.3999938964844,
        108.35999298095703,
        532.6796264648438,
        116.85599517822266
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 기원 또는 발견 및 개발경위에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        465.7200012207031,
        121.19999694824219,
        609.47998046875,
        129.6959991455078
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 구조결정, 물리화학적 성질에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        472.91998291015625,
        133.9199981689453,
        611.280029296875,
        142.41600036621094
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(품질에 관한 자료)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        146.75999450683594,
        540.7894897460938,
        155.25599670410156
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 원료의약품에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        476.3999938964844,
        159.47999572753906,
        566.8800048828125,
        167.9759979248047
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 구조결정에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        172.3199920654297,
        560.0399780273438,
        180.8159942626953
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 물리화학적 성질에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        185.0399932861328,
        584.8800048828125,
        193.53599548339844
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 제조방법에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        197.87998962402344,
        560.0399780273438,
        206.37599182128906
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 기준 및 시험방법이 기재된 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        210.59999084472656,
        595.5599975585938,
        219.0959930419922
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 기준 및 시험방법에 관한 근거자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        223.4399871826172,
        602.6400146484375,
        231.9359893798828
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 시험성적에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        236.1599884033203,
        560.0399780273438,
        244.65599060058594
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 표준품 및 시약․시액에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        248.99998474121094,
        602.6400146484375,
        257.4959716796875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8) 용기 및 포장에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        261.7200012207031,
        574.2000122070312,
        270.2159729003906
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 완제의약품에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        476.3999938964844,
        274.55999755859375,
        566.8800048828125,
        283.05596923828125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 원료약품 및 그 분량에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        287.2799987792969,
        599.0399780273438,
        295.7759704589844
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 제조방법에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        300.1199951171875,
        560.0399780273438,
        308.615966796875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 기준 및 시험방법이 기재된 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        312.8399963378906,
        595.5599975585938,
        321.3359680175781
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 기준 및 시험방법에 관한 근거자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        325.67999267578125,
        602.6400146484375,
        334.17596435546875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 시험성적에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        338.3999938964844,
        560.0399780273438,
        346.8959655761719
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 표준품 및 시약․시액에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        351.239990234375,
        602.6400146484375,
        359.7359619140625
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 용기 및 포장에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        363.9599914550781,
        574.2000122070312,
        372.4559631347656
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 안정성에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        472.91998291015625,
        376.8000183105469,
        545.6396484375,
        385.2959899902344
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 원료의약품에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        476.3999938964844,
        389.52001953125,
        566.8800048828125,
        398.0159912109375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 장기보존시험 또는 가속시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        402.3600158691406,
        595.5596313476562,
        410.8559875488281
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 가혹시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        415.08001708984375,
        531.5999755859375,
        423.57598876953125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 완제의약품에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        476.3999938964844,
        427.9200134277344,
        566.8800048828125,
        436.4159851074219
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 장기보존시험 또는 가속시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        440.6400146484375,
        595.5596313476562,
        449.135986328125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 가혹시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        453.4800109863281,
        531.5999755859375,
        461.9759826660156
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 독성에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        472.91998291015625,
        466.20001220703125,
        538.4400024414062,
        474.69598388671875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 단회투여독성시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        476.3999938964844,
        479.0400085449219,
        559.7996826171875,
        487.5359802246094
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 반복투여독성시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        476.3999938964844,
        491.760009765625,
        559.7996826171875,
        500.2559814453125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 유전독성시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        476.3999938964844,
        504.6000061035156,
        545.6396484375,
        513.0960083007812
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 생식발생독성시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        476.3999938964844,
        517.3199462890625,
        559.7996826171875,
        525.8159790039062
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 발암성시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        652.9199829101562,
        95.63999938964844,
        714.9600219726562,
        104.13600158691406
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바. 기타독성시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        652.9199829101562,
        108.35999298095703,
        722.0399780273438,
        116.85599517822266
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 국소독성시험(국소내성시험포함)",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        121.19999694824219,
        769.0294799804688,
        129.6959991455078
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 의존성",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        133.9199981689453,
        686.8800048828125,
        142.41600036621094
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 항원성 및 면역독성",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        146.75999450683594,
        729.47998046875,
        155.25599670410156
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 작용기전독성",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        159.47999572753906,
        708.1199951171875,
        167.9759979248047
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 대사물",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        172.3199920654297,
        686.879638671875,
        180.8159942626953
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 불순물",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        185.0399932861328,
        686.879638671875,
        193.53599548339844
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 기타",
      "font_size": 7.079999923706055,
      "font_name": "T20",
      "bbox": [
        656.5199584960938,
        197.87998962402344,
        679.7999877929688,
        206.37599182128906
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 약리작용에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        649.4400024414062,
        210.59999084472656,
        729.2396240234375,
        219.0959930419922
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 효력시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        652.9199829101562,
        223.4399871826172,
        707.879638671875,
        231.9359893798828
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 일반약리시험자료 또는 안전성약리시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        652.9199829101562,
        236.1599884033203,
        801.8406982421875,
        244.65599060058594
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 흡수, 분포, 대사 및 배설시험자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        652.9199829101562,
        248.99998474121094,
        775.3196411132812,
        257.4959716796875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 분석방법과 밸리데이션 보고서",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        261.7200012207031,
        764.9996337890625,
        270.2159729003906
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 흡수",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        274.55999755859375,
        679.7999877929688,
        283.05596923828125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 분포",
      "font_size": 7.079999923706055,
      "font_name": "T20",
      "bbox": [
        656.5199584960938,
        287.2799987792969,
        679.7999877929688,
        295.7759704589844
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 대사",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        300.1199951171875,
        679.7996215820312,
        308.615966796875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 배설",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        312.8399963378906,
        679.7999877929688,
        321.3359680175781
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 약물상호작용 등에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        649.4400024414062,
        325.67999267578125,
        757.5599975585938,
        334.17596435546875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 임상시험성적에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        649.4400024414062,
        338.3999938964844,
        743.4000244140625,
        346.8959655761719
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 임상시험자료집",
      "font_size": 7.079999923706055,
      "font_name": "T20",
      "bbox": [
        652.9199829101562,
        351.239990234375,
        714.9600219726562,
        359.7359619140625
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 생물약제학 시험보고서",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        363.9599914550781,
        740.0399780273438,
        372.4559631347656
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 인체시료를 이용한 약동학 관련 시험 보고서",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        376.8000183105469,
        801.1199951171875,
        385.2959899902344
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 약동학(PK) 시험보고서",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        389.52001953125,
        738.9596557617188,
        398.0159912109375
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 약력학(PD) 시험 보고서",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        402.3600158691406,
        742.9199829101562,
        410.8559875488281
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 유효성과 안전성 시험 보고서",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        415.08001708984375,
        761.4000244140625,
        423.57598876953125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 시판후 사용경험에 대한 보고서",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        427.9200134277344,
        768.47998046875,
        436.4159851074219
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 증례기록서와 개별 환자 목록",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        656.5199584960938,
        440.6400146484375,
        761.4000244140625,
        449.135986328125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 가교자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        652.9199829101562,
        453.4800109863281,
        693.7200317382812,
        461.9759826660156
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 외국의 사용현황 등에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        649.4400024414062,
        466.20001220703125,
        764.6400146484375,
        474.69598388671875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. 국내 유사제품과의 비교검토 및 당해 의약품의",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        649.4400024414062,
        479.0400085449219,
        802.6807250976562,
        487.5359802246094
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특성에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        658.3200073242188,
        491.760009765625,
        715.0800170898438,
        500.2559814453125
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. 생물학적 동등성 시험에 관한 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        649.4400024414062,
        504.6000061035156,
        771.8396606445312,
        513.0960083007812
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 19 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심사자료의 범위",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        51.0,
        52.235626220703125,
        104.15999603271484,
        59.619842529296875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▷ 신약",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        71.76000213623047,
        70.07999420166016,
        81.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제출자료",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        68.63999938964844,
        96.4800033569336,
        88.44004821777344,
        102.38400268554688
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구분",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        42.959999084472656,
        105.36000061035156,
        52.9200439453125,
        111.26399993896484
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자 료 번 호",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        220.3199920654297,
        91.08000183105469,
        247.55999755859375,
        96.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        94.19999694824219,
        105.12000274658203,
        96.65999603271484,
        111.02400207519531
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        157.3199920654297,
        98.04000091552734,
        340.6199951171875,
        103.94400024414062
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        157.3199920654297,
        98.04000091552734,
        340.6199951171875,
        103.94400024414062
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        157.3199920654297,
        98.04000091552734,
        340.6199951171875,
        103.94400024414062
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        157.3199920654297,
        98.04000091552734,
        340.6199951171875,
        103.94400024414062
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        157.3199920654297,
        98.04000091552734,
        340.6199951171875,
        103.94400024414062
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8 비고",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가 나 다 라 마 바 가 나 다 라 가 나",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        101.5199966430664,
        105.12000274658203,
        375.4800109863281,
        117.98400115966797
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "I. 신약 방사성의약품",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        42.959999084472656,
        123.60000610351562,
        363.1199951171875,
        129.50399780273438
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○",
      "font_size": 4.920000076293945,
      "font_name": "T9",
      "bbox": [
        42.959999084472656,
        123.60000610351562,
        363.1199951171875,
        129.50399780273438
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        42.959999084472656,
        123.60000610351562,
        363.1199951171875,
        129.50399780273438
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        42.959999084472656,
        123.60000610351562,
        363.1199951171875,
        129.50399780273438
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        42.959999084472656,
        123.60000610351562,
        363.1199951171875,
        129.50399780273438
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        42.959999084472656,
        123.60000610351562,
        363.1199951171875,
        129.50399780273438
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        42.959999084472656,
        123.60000610351562,
        363.1199951171875,
        129.50399780273438
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "△ △ ○ ○ ○ ○ ○ ○",
      "font_size": 4.920000076293945,
      "font_name": "T9",
      "bbox": [
        42.959999084472656,
        123.60000610351562,
        363.1199951171875,
        129.50399780273438
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▷ 자료제출의약품",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        141.3599853515625,
        112.67999267578125,
        151.583984375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제출자료",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        70.68000030517578,
        168.47999572753906,
        90.48004913330078,
        174.3839874267578
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구분",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        42.959999084472656,
        177.47999572753906,
        52.9200439453125,
        183.3839874267578
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자 료 번 호",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        224.27999877929688,
        161.27999877929688,
        251.51998901367188,
        167.18399047851562
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        96.1199951171875,
        177.72000122070312,
        98.57999420166016,
        183.62399291992188
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        159.36000061035156,
        169.3199920654297,
        350.6999816894531,
        175.22398376464844
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        159.36000061035156,
        169.3199920654297,
        350.6999816894531,
        175.22398376464844
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        159.36000061035156,
        169.3199920654297,
        350.6999816894531,
        175.22398376464844
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        159.36000061035156,
        169.3199920654297,
        350.6999816894531,
        175.22398376464844
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        159.36000061035156,
        169.3199920654297,
        350.6999816894531,
        175.22398376464844
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        129.95999145507812,
        177.36000061035156,
        383.6400146484375,
        183.62399291992188
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8 비고",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        129.95999145507812,
        177.36000061035156,
        383.6400146484375,
        183.62399291992188
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        129.95999145507812,
        177.36000061035156,
        383.6400146484375,
        183.62399291992188
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        129.95999145507812,
        177.36000061035156,
        383.6400146484375,
        183.62399291992188
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        129.95999145507812,
        177.36000061035156,
        383.6400146484375,
        183.62399291992188
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        129.95999145507812,
        177.36000061035156,
        383.6400146484375,
        183.62399291992188
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가 나 다 라 마",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        255.72000122070312,
        181.67999267578125,
        292.8000183105469,
        187.583984375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        302.7599792480469,
        177.36000061035156,
        307.67999267578125,
        183.2639923095703
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가 나 다 가 나",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        320.03997802734375,
        181.67999267578125,
        357.0,
        187.583984375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(1) (2) (3)",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        103.55999755859375,
        185.75999450683594,
        317.1026306152344,
        191.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅱ.자료제출의약품",
      "font_size": 4.920000076293945,
      "font_name": "T15",
      "bbox": [
        45.119998931884766,
        192.59999084472656,
        88.08071899414062,
        198.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 새로운 투여경로",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        45.0,
        201.59999084472656,
        88.44004821777344,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품",
      "font_size": 4.920000076293945,
      "font_name": "T8",
      "bbox": [
        51.84000015258789,
        210.47999572753906,
        81.60009765625,
        216.3839874267578
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○",
      "font_size": 4.795422554016113,
      "font_name": "T9",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ ○ ○ △",
      "font_size": 4.920000076293945,
      "font_name": "T9",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "△ △ ○ ○ ○ △",
      "font_size": 4.920000076293945,
      "font_name": "T9",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○",
      "font_size": 4.795422554016113,
      "font_name": "T9",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.920000076293945,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.795422554016113,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.795422554016113,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.795422554016113,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.795422554016113,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.795422554016113,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.795422554016113,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.795422554016113,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.795422554016113,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.795422554016113,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.795422554016113,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ ○",
      "font_size": 4.795422554016113,
      "font_name": "T9",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 4.795422554016113,
      "font_name": "T20",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ ○",
      "font_size": 4.795422554016113,
      "font_name": "T9",
      "bbox": [
        95.04000091552734,
        201.59999084472656,
        372.9540100097656,
        207.5039825439453
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※기타 - ｢",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        40.20000076293945,
        222.95999145507812,
        75.77999877929688,
        231.45599365234375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품의 품목허가․신고․심사 규정｣",
      "font_size": 7.079999923706055,
      "font_name": "T9",
      "bbox": [
        75.83999633789062,
        222.95999145507812,
        200.09999084472656,
        231.45599365234375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "별표1 참조",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        203.63999938964844,
        222.95999145507812,
        239.16000366210938,
        231.45599365234375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▷ 제네릭의약품",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        235.4399871826172,
        104.15999603271484,
        245.6639862060547
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심사자료의 요건 등",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        45.599998474121094,
        470.07562255859375,
        109.55999755859375,
        477.4598388671875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품 심사자료의 요건 등 정보는 ｢",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        40.20000076293945,
        491.8800048828125,
        226.739990234375,
        502.10400390625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품의 품목허가․신고․심사 규정｣",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        226.79998779296875,
        491.8800048828125,
        382.260009765625,
        502.10400390625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제7조, 제2절, 제3절 및 2012년도에 발간한 ｢",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        40.20000076293945,
        507.2400207519531,
        219.41998291015625,
        517.4639892578125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PET용 방사성의약품 평가 가이드라인｣",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        219.47999572753906,
        507.2400207519531,
        373.739990234375,
        517.4639892578125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "을",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        373.79998779296875,
        508.4381408691406,
        386.5799865722656,
        517.424072265625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "참고한다.",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        522.47998046875,
        76.39295959472656,
        532.6954956054688
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료번호",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        115.43999481201172,
        252.71998596191406,
        138.1199951171875,
        259.48797607421875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구분",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        42.23999786376953,
        262.91998291015625,
        53.519996643066406,
        269.68798828125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        147.239990234375,
        257.8799743652344,
        167.6999969482422,
        264.6479797363281
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        147.239990234375,
        257.8799743652344,
        167.6999969482422,
        264.6479797363281
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        226.67999267578125,
        251.40000915527344,
        326.5799865722656,
        258.1679992675781
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        226.67999267578125,
        251.40000915527344,
        326.5799865722656,
        258.1679992675781
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        181.1999969482422,
        262.79998779296875,
        363.2400207519531,
        269.5679931640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        181.1999969482422,
        262.79998779296875,
        363.2400207519531,
        269.5679931640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        181.1999969482422,
        262.79998779296875,
        363.2400207519531,
        269.5679931640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        181.1999969482422,
        262.79998779296875,
        363.2400207519531,
        269.5679931640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마",
      "font_size": 5.639999866485596,
      "font_name": "T20",
      "bbox": [
        181.1999969482422,
        262.79998779296875,
        363.2400207519531,
        269.5679931640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        181.1999969482422,
        262.79998779296875,
        363.2400207519531,
        269.5679931640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가*",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        181.1999969482422,
        262.79998779296875,
        363.2400207519531,
        269.5679931640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        181.1999969482422,
        262.79998779296875,
        363.2400207519531,
        269.5679931640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        181.1999969482422,
        262.79998779296875,
        363.2400207519531,
        269.5679931640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        181.1999969482422,
        262.79998779296875,
        363.2400207519531,
        269.5679931640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마",
      "font_size": 5.639999866485596,
      "font_name": "T20",
      "bbox": [
        181.1999969482422,
        262.79998779296875,
        363.2400207519531,
        269.5679931640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 기허가의약품과 주성분의 규격 및",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        43.91999816894531,
        272.9999694824219,
        136.3199920654297,
        279.7679748535156
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분량, 제형이 동일한 의약품",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        51.36000061035156,
        283.1999816894531,
        120.35990142822266,
        289.9679870605469
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 5.639999866485596,
      "font_name": "T20",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○",
      "font_size": 5.639999866485596,
      "font_name": "T9",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 5.639999866485596,
      "font_name": "T20",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 5.639999866485596,
      "font_name": "T20",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "×",
      "font_size": 5.639999866485596,
      "font_name": "T20",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "△",
      "font_size": 5.639999866485596,
      "font_name": "T9",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○",
      "font_size": 5.639999866485596,
      "font_name": "T9",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "△",
      "font_size": 5.639999866485596,
      "font_name": "T9",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "△",
      "font_size": 5.639999866485596,
      "font_name": "T9",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "△",
      "font_size": 5.639999866485596,
      "font_name": "T9",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "△",
      "font_size": 5.639999866485596,
      "font_name": "T9",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○",
      "font_size": 5.639999866485596,
      "font_name": "T9",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "△",
      "font_size": 5.639999866485596,
      "font_name": "T9",
      "bbox": [
        147.0,
        278.15997314453125,
        363.2400207519531,
        284.927978515625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 기원 또는 발견 및 개발의 경위",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        52.07999801635742,
        290.8799743652344,
        137.2797393798828,
        297.6479797363281
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 국내외에서의 사용현황에 관한 자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        52.07999801635742,
        301.1999816894531,
        148.07972717285156,
        307.9679870605469
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 원료의약품에 관한 자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        52.07999801635742,
        311.39996337890625,
        118.43973541259766,
        318.16796875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 구조결정에 관한 자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        57.47999954223633,
        321.5999755859375,
        121.0797348022461,
        328.36798095703125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 물리화학적 성질에 관한 자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        57.47999954223633,
        331.79998779296875,
        139.92015075683594,
        338.5679931640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 제조방법에 관한 자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        57.47999954223633,
        341.9999694824219,
        121.0797348022461,
        348.7679748535156
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 기준및시험방법에 관한 근거자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        57.47999954223633,
        352.3199768066406,
        148.0794677734375,
        359.0879821777344
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 시험성적에 관한 자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        57.47999954223633,
        362.5199890136719,
        121.0797348022461,
        369.2879943847656
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바. 표준품 및 시약․시액에 관한 자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        57.47999954223633,
        372.719970703125,
        153.479736328125,
        379.48797607421875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 완제의약품에 관한 자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        52.07999801635742,
        382.91998291015625,
        118.43973541259766,
        389.68798828125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 원료약품 및 그 분량에 관한 자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        57.47999954223633,
        393.1199645996094,
        150.7197265625,
        399.8879699707031
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 제조방법에 관한 자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        57.47999954223633,
        403.4399719238281,
        121.0797348022461,
        410.2079772949219
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 기준및시험방법에 관한 근거자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        57.47999954223633,
        413.6399841308594,
        148.0794677734375,
        420.4079895019531
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 시험성적에 관한 자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        57.47999954223633,
        423.8399658203125,
        121.0797348022461,
        430.60797119140625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 표준품 및 시약․시액에 관한 자료",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        57.47999954223633,
        434.03997802734375,
        153.479736328125,
        440.8079833984375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "*첨가제의 규격이 별첨규격인 경우 첨가제 규격에 관한 근거자료를 제출",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        43.91999816894531,
        444.239990234375,
        224.27972412109375,
        451.00799560546875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 20 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.5 GMP 평가자료의 종류",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        48.839996337890625,
        573.5999755859375,
        59.918758392333984
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GMP 평가 11종 자료 목록(의약품 등의 안전에 관한 규칙 [별지 제4호서식])",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        493.79998779296875,
        75.15562438964844,
        753.595947265625,
        82.53984069824219
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GMP　평가자료의 요건 등",
      "font_size": 7.079999923706055,
      "font_name": "HeadlineR-HM",
      "bbox": [
        487.1999816894531,
        294.755615234375,
        577.0800170898438,
        302.13983154296875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GMP",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        322.20001220703125,
        807.5399780273438,
        332.42401123046875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가자료의 요건은 「의약품 등의 안전에 관한 규칙」",
      "font_size": 8.519999504089355,
      "font_name": "T13",
      "bbox": [
        461.1600036621094,
        322.20001220703125,
        807.5399780273438,
        332.42401123046875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "별표 1,",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        322.20001220703125,
        807.5399780273438,
        332.42401123046875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "별표",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        322.20001220703125,
        807.5399780273438,
        332.42401123046875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1의2(원료의약품에 한함)",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        337.55999755859375,
        807.5399780273438,
        347.78399658203125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 별표 3의2와 「의약품",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        337.55999755859375,
        807.5399780273438,
        347.78399658203125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조 및 품질관리에 관한",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        337.55999755859375,
        807.5399780273438,
        347.78399658203125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규정」별표 1(무균의약품에 한함) 및 별표 3의 실시상황 평가 및 2014년도에 발간한",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        352.9200134277344,
        807.5399780273438,
        363.1440124511719
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "｢",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        461.1600036621094,
        368.2799987792969,
        465.4200134277344,
        378.5039978027344
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품 제조 및 품질관리기준 가이던스｣",
      "font_size": 8.519999504089355,
      "font_name": "T9",
      "bbox": [
        465.3599853515625,
        368.2799987792969,
        648.5399780273438,
        378.5039978027344
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "를 참고한다.",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        648.5999755859375,
        368.2799987792969,
        697.512939453125,
        378.4954528808594
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 조제하여 사용하는 방사성물질이 포함되지 않은 방사성의약품(일명 ‘Cold Vial’ 또는 ‘Cold kit')의",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        383.8800048828125,
        803.280029296875,
        392.3759765625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우에는 「의약품 등의 안전에 관한 규칙」 별표 1을 적용하되, 동 규칙「의약품 등의 안전에 관한",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        473.6399841308594,
        396.6000061035156,
        803.2796630859375,
        405.0959777832031
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규칙」별표 3의2 및 「의약품 제조 및 품질관리에 관한 규정」별표 3은 적용하지 않음",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        473.6399841308594,
        409.44000244140625,
        757.5599975585938,
        417.93597412109375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ ‘청정도 관리현황’ 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        461.1600036621094,
        422.1600036621094,
        546.0,
        430.6559753417969
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 무균제제 방사성의약품의 ‘청정도 관리현황’ 자료에 대한 상세내용은 ‘방사성의약품 제조 및 품질관리 기준",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        469.67999267578125,
        437.8205871582031,
        805.3981323242188,
        444.1805725097656
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이던스’를 참조하시기 바람.",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        480.239990234375,
        449.58056640625,
        565.3978881835938,
        455.9405517578125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 비무균제제 방사성의약품의 ‘청정도 관리현황’과 관련하여, 국제적으로 청정등급을 별도로 규정하고 있지",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        461.1600036621094,
        459.78057861328125,
        805.3980712890625,
        466.14056396484375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "않으며, 중요공정(예시 : 칭량, 혼합, 타정, 충전 등), 원료 및 반제품이 작업실에서 노출되는 정도 등을",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        481.55999755859375,
        470.1005859375,
        805.3978881835938,
        476.4605712890625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려하여 교차오염 및 미생물 오염이 발생하지 않도록 국제표준화기구의 기준(예시 : ISO-14644 등)에 따라",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        481.55999755859375,
        480.3005676269531,
        805.3980712890625,
        486.6605529785156
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사에서 적절하게 설정할 수 있음",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        481.55999755859375,
        490.5005798339844,
        583.8001708984375,
        496.8605651855469
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 방사성의약품의 ‘청정도 관리현황’ 자료의 예시는 아래와 같음. 다만, 제조소별 및 품목별 현황에 따라 해당",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        461.1600036621094,
        500.7005920410156,
        805.3981323242188,
        507.0605773925781
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료는 달라질 수 있음",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        481.1999816894531,
        510.90057373046875,
        549.4381103515625,
        517.2605590820312
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 청정도 관리 기준서(SOP)",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        461.1600036621094,
        521.2205810546875,
        567.4650268554688,
        527.58056640625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균, 부유균, 표면균 등) 등 관리내용 포함",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        461.1600036621094,
        531.4205932617188,
        800.6399536132812,
        537.7805786132812
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 제조소 평면도: 각 작업소, 시험실, 보관소 및 기타 제조공정에 필요한 부대시설이 표시된",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        469.3199768066406,
        111.7199935913086,
        784.5599975585938,
        120.21599578857422
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조소 평면도",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        483.239990234375,
        123.0,
        529.4400024414062,
        131.49600219726562
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 신청품목과 관련된 작업소 시설 관련 자료",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        469.3199768066406,
        134.39999389648438,
        626.9996337890625,
        142.89599609375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(1) 청정등급, 작업실 간의 차압 및 인적ㆍ물적 동선이 표시된 작업소 평면도",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        145.79998779296875,
        730.6799926757812,
        154.29598999023438
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(2) 제조ㆍ시험에 사용되는 기계ㆍ설비 내역 및 기계배치도",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        157.0800018310547,
        672.1199951171875,
        165.5760040283203
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(3) 공조시설, 압축공기 및 용수처리 계통도",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        168.47999572753906,
        620.6400146484375,
        176.9759979248047
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 신청품목과 관련된 시설 및 환경 관리 관련 자료",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        469.3199768066406,
        179.87998962402344,
        649.0796508789062,
        188.37599182128906
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(1) 제조용수 관리현황",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        191.1599884033203,
        551.4000244140625,
        199.65599060058594
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(2) 자동화장치 등 관리현황",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        202.55999755859375,
        569.1600341796875,
        211.05599975585938
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(3) 청정도 관리현황",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        480.0,
        213.95999145507812,
        544.3200073242188,
        222.45599365234375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) GMP 조직도 및 품질관리(보증)체계 관련 자료",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        469.3199768066406,
        225.239990234375,
        640.919677734375,
        233.73599243164062
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마) 문서관리규정 및 문서 목록",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        469.3199768066406,
        236.63999938964844,
        575.15966796875,
        245.13600158691406
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바) 신청품목과 관련된 제품표준서 및 제조ㆍ품질관리기록서 사본",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        469.3199768066406,
        248.0399932861328,
        693.8396606445312,
        256.5359802246094
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사) 신청품목과 관련된 밸리데이션 자료",
      "font_size": 7.079999923706055,
      "font_name": "T15",
      "bbox": [
        469.3199768066406,
        259.32000732421875,
        605.0399780273438,
        267.81597900390625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 21 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (비무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균 또는 부유균 등) 관리내용 포함",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        40.20000076293945,
        50.220584869384766,
        375.719970703125,
        56.58058547973633
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 신청 품목 작업실(청정도별, 작업실별) 및 시험실(미생물한도 및 무균시험실 등)의 전년도 환경모니터링",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        40.20000076293945,
        60.42058181762695,
        384.4381103515625,
        66.78058624267578
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가자료 또는 최근 3개월간 자료",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        71.76000213623047,
        70.74058532714844,
        171.1199951171875,
        77.1005859375
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 위 조건에 부합하는 모니터링 자료가 없는 경우, GMP 적용을 시작한 날 이후부터의 GMP 자료 제출 가능",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        40.20000076293945,
        80.94058990478516,
        381.3597717285156,
        87.30059051513672
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 청정도 시험결과 부적합이 있는 경우 그 처리기준 및 조치결과",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        40.20000076293945,
        91.14058685302734,
        251.0402069091797,
        97.5005874633789
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 신청품목과 관련된 밸리데이션 자료",
      "font_size": 7.079999923706055,
      "font_name": "T8",
      "bbox": [
        40.20000076293945,
        110.6399917602539,
        168.0,
        119.13599395751953
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ ‘밸리데이션’ 자료는 아래와 같음. 다만, 제조소별 및 품목별 현황에 따라 해당 자료는 달라질 수 있음",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        48.71999740600586,
        124.74058532714844,
        358.9979248046875,
        131.1005859375
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 제조공정 밸리데이션 자료, 중요기계 적격성평가 자료, 시험방법 밸리데이션 자료, 세척방법 밸리데이션",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        40.20000076293945,
        136.62059020996094,
        384.4381103515625,
        142.9805908203125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료, 제조지원설비 밸리데이션 자료, 컴퓨터시스템 밸리데이션 자료",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        61.55999755859375,
        146.82058715820312,
        263.7599792480469,
        153.1805877685547
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 밸리데이션 실시계획서(Validation protocol) 및 밸리데이션 결과보고서(Validation report)제출(요약본)",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        40.20000076293945,
        157.0205841064453,
        359.2650146484375,
        163.38058471679688
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 적격성평가 자료는 운전적격성평가(OQ), 성능적격성평가(PQ)에 관한 자료 제출. 다만, 기존에 설치하여 현재",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        40.20000076293945,
        167.2205810546875,
        384.4378967285156,
        173.58058166503906
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용 중인 설비 또는 시스템에 관해서는 위 조건에 해당하는 적격성평가 자료를 반드시 제출할 필요는 없음.",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        62.03999710083008,
        177.54058837890625,
        384.3179016113281,
        183.9005889892578
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이러한 경우, GMP 적용 시점 이후 설비의 운전변수 및 중요변수에 대한 한계를 뒷받침하고 입증하는",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        62.03999710083008,
        187.74058532714844,
        384.4381103515625,
        194.1005859375
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료(예시 : 공정 밸리데이션, 제품품질평가 등), 교정, 세척, 예방적 유지관리, 작업절차, 작업원 훈련절차",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        62.03999710083008,
        197.94058227539062,
        384.318115234375,
        204.3005828857422
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 기록에 대한 자료를 제출하면 됨(‘15.7.1자 시행되는「의약품 제조 및 품질관리에 관한 규정」 [별표 13]",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        62.03999710083008,
        208.1405792236328,
        384.43768310546875,
        214.50057983398438
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.5 기존에 사용 중인 시설, 시스템 및 설비의 적격성 평가 참조)",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        62.03999710083008,
        218.340576171875,
        253.42498779296875,
        224.70057678222656
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 방사성의약품 밸리데이션 관련 상세내용은 「의약품 등의 안전에 관한 규칙」[별표 1] 6. 밸리데이션,",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        40.20000076293945,
        228.66058349609375,
        384.4377746582031,
        235.0205841064453
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "「의약품 제조 및 품질관리에 관한 규정」제4조 및 [별표 13] 적격성평가 및 밸리데이션, ‘방사성의약품 제조",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        61.439998626708984,
        238.86058044433594,
        384.4377136230469,
        245.2205810546875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 품질관리 기준 가이던스’를 참조",
      "font_size": 6.359999656677246,
      "font_name": "Gulim",
      "bbox": [
        61.439998626708984,
        249.06057739257812,
        163.55979919433594,
        255.4205780029297
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 22 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부록1. 관련 법규",
      "font_size": 10.679999351501465,
      "font_name": "H2hdrM",
      "bbox": [
        461.1600036621094,
        50.1123046875,
        544.199951171875,
        60.79230499267578
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<약사법>",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        612.239990234375,
        75.23999786376953,
        648.1145629882812,
        85.45547485351562
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[시행 2015.3.15.] [법률 제13219호, 2015.3.13., 일부개정]",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        531.719970703125,
        90.04253387451172,
        728.7019653320312,
        97.1225357055664
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제31조(제조업 허가 등) ① 의약품 제조를 업",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        107.44253540039062,
        625.083984375,
        114.52253723144531
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(業)으로 하려는 자는 대통령령으로 정하는 시",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        118.84253692626953,
        625.083984375,
        125.92253875732422
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설기준에 따라 필요한 시설을 갖추고 총리령으",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        130.24253845214844,
        625.0833740234375,
        137.32252502441406
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로 정하는 바에 따라 식품의약품안전처장의 허",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        141.5225372314453,
        625.083984375,
        148.60252380371094
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가를 받아야 한다. <개정 2008.2.29., 2010.1.18.,",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        152.92254638671875,
        627.1193237304688,
        160.00253295898438
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2013.3.23.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        164.34059143066406,
        509.8323059082031,
        170.70059204101562
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 제1항에 따른 제조업자가 그 제조(다른 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        174.5225372314453,
        625.083984375,
        181.60252380371094
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조업자에게 제조를 위탁하는 경우를 포함한다)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        185.92254638671875,
        625.1419677734375,
        193.00253295898438
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 의약품을 판매하려는 경우에는 총리령으로",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        197.20254516601562,
        627.3582763671875,
        204.28253173828125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정하는 바에 따라 품목별로 식품의약품안전처",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        208.6025390625,
        625.0827026367188,
        215.68252563476562
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "장의 제조판매품목허가(이하 \"품목허가\"라 한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        220.00254821777344,
        625.083984375,
        227.08253479003906
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다)를 받거나 제조판매품목 신고(이하 \"품목신",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        231.2825469970703,
        625.083740234375,
        238.36253356933594
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고\"라 한다)를 하여야 한다. <개정 2013.3.23.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        242.6825408935547,
        621.3121948242188,
        249.7625274658203
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 제1항에 따른 제조업자 외의 자가 제34조제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        254.08255004882812,
        625.0838623046875,
        261.16253662109375
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1항에 따라 임상시험계획의 승인을 받아 임상",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        265.362548828125,
        625.0838623046875,
        272.4425354003906
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험을 실시한 의약품을 제조업자에게 위탁제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        276.7625427246094,
        625.083740234375,
        283.842529296875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조하여 판매하려는 경우에는 총리령으로 정하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        288.16253662109375,
        625.0838623046875,
        295.2425231933594
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 바에 따라 식품의약품안전처장에게 위탁제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        299.4425354003906,
        625.083740234375,
        306.52252197265625
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조판매업신고를 하여야 하며, 품목별로 품목허",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        310.842529296875,
        625.083740234375,
        317.9225158691406
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가를",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        322.2425537109375,
        627.1193237304688,
        329.3225402832031
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "받아야",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        322.2425537109375,
        627.1193237304688,
        329.3225402832031
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        322.2425537109375,
        627.1193237304688,
        329.3225402832031
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<개정",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        322.2425537109375,
        627.1193237304688,
        329.3225402832031
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2008.2.29.,",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        322.2425537109375,
        627.1193237304688,
        329.3225402832031
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2010.1.18., 2013.3.23.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        333.54058837890625,
        548.712158203125,
        339.90057373046875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "④ 의약외품의 제조를 업으로 하려는 자는 대통",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        343.7225341796875,
        625.0838623046875,
        350.8025207519531
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "령령으로 정하는 시설기준에 따라 필요한 시설",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        355.1225280761719,
        625.0838623046875,
        362.2025146484375
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "을 갖추고 식품의약품안전처장에게 제조업신고",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        366.5225524902344,
        625.083251953125,
        373.6025390625
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "를 하여야 하며, 품목별로 품목허가를 받거나",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        377.80255126953125,
        627.3585205078125,
        384.8825378417969
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목신고를 하여야 한다. <개정 2013.3.23.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        389.2025451660156,
        611.5921630859375,
        396.28253173828125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑤ 제2항 및 제3항에 따라 품목허가를 받거나",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        400.6025390625,
        627.3585205078125,
        407.6825256347656
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목신고를 한 자(이하 \"품목허가를 받은 자\"",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        411.8825378417969,
        625.167236328125,
        418.9625244140625
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라 한다)는 총리령으로 정하는 바에 따라 영업",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        423.28253173828125,
        625.0838623046875,
        430.3625183105469
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소를",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        434.6825256347656,
        627.1193237304688,
        441.76251220703125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설치할",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        434.6825256347656,
        627.1193237304688,
        441.76251220703125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        434.6825256347656,
        627.1193237304688,
        441.76251220703125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        434.6825256347656,
        627.1193237304688,
        441.76251220703125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<개정",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        434.6825256347656,
        627.1193237304688,
        441.76251220703125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2008.2.29.,",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        434.6825256347656,
        627.1193237304688,
        441.76251220703125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2010.1.18., 2013.3.23.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        445.9805908203125,
        548.712158203125,
        452.340576171875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑥ 제1항부터 제4항까지의 규정에도 불구하고",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        456.28253173828125,
        627.3583984375,
        463.3625183105469
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제34조에 따른 임상시험용 의약품 등 총리령으",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        467.5625305175781,
        625.0833740234375,
        474.64251708984375
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로 정하는 의약품 또는 의약외품(이하 \"의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        478.9625244140625,
        625.08349609375,
        486.0425109863281
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등\"이라 한다)에 대하여는 제조업허가 또는 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        490.362548828125,
        625.083984375,
        497.4425354003906
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목허가를 받지 아니하거나 품목신고를 하지 아",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        501.6425476074219,
        625.083984375,
        508.7225341796875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "니할 수 있다. <신설 2011.3.30., 2013.3.23.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        513.0425415039062,
        614.5922241210938,
        520.12255859375
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑦ 제2항부터 제4항까지의 규정에도 불구하고",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        524.4425048828125,
        627.3583984375,
        531.5225219726562
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품등과 의료기기가 조합되어 있거나 복합",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        535.7225341796875,
        627.35888671875,
        542.8025512695312
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구성된 것으로서 주된 기능이 의료기기에 해당",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        103.96253967285156,
        799.44384765625,
        111.04254150390625
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하여 「의료기기법」에 따라 허가를 받거나 신",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        115.24253845214844,
        799.4439697265625,
        122.32254028320312
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고한 제품 또는 품목은 제2항부터 제4항까지의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        126.64253997802734,
        801.83837890625,
        133.7225341796875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규정에 따라 품목허가를 받거나 품목신고를 한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        138.04254150390625,
        801.8387451171875,
        145.12252807617188
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "것으로 본다. <신설 2011.3.30.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        149.32254028320312,
        748.272216796875,
        156.40252685546875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑧ 다음 각 호의 어느 하나에 해당하는 자는 의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        160.72254943847656,
        799.4439697265625,
        167.8025360107422
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품등의 제조업이나 위탁제조판매업에 대한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        172.12254333496094,
        801.838623046875,
        179.20252990722656
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가를 받거나 신고를 할 수 없다. <개정",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        183.4025421142578,
        801.599853515625,
        190.48252868652344
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2011.3.30.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        194.82058715820312,
        685.8721923828125,
        201.1805877685547
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제5조 각 호의 어느 하나에 해당하는 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        205.00254821777344,
        785.7639770507812,
        212.08253479003906
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 제76조에 따라 제조업 허가가 취소되거나",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        216.4025421142578,
        801.8380126953125,
        223.48252868652344
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위탁제조판매업소 또는 제조소(製造所)가 폐",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        227.8025360107422,
        799.56396484375,
        234.8825225830078
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "쇄된 날부터 1년이 지나지 아니한 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        239.08253479003906,
        775.2039794921875,
        246.1625213623047
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 파산선고를 받고 복권되지 아니한 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        250.4825439453125,
        774.60400390625,
        257.5625305175781
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑨ 제1항부터 제4항까지의 경우에 허가받은 사",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        261.8825378417969,
        799.56396484375,
        268.9625244140625
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항 또는 신고한 사항 중 총리령으로 정하는 사",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        273.16253662109375,
        799.56396484375,
        280.2425231933594
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항을 변경하려는 때에는 총리령으로 정하는 바",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        284.5625305175781,
        799.4439697265625,
        291.64251708984375
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 따라 변경허가를 받거나 변경신고를 하여야",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        295.9625244140625,
        801.8385009765625,
        303.0425109863281
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다. <개정 2011.3.30., 2013.3.23.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        307.2425537109375,
        761.47216796875,
        314.3225402832031
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑩ 제2항 및 제3항에 따라 허가를 받거나 신고",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        318.6425476074219,
        799.5635986328125,
        325.7225341796875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하려는 품목이 신약 또는 식품의약품안전처장",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        330.04254150390625,
        799.5623168945312,
        337.1225280761719
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 지정하는 의약품인 경우에는 안전성ᆞ유효",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        341.3225402832031,
        799.5629272460938,
        348.40252685546875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성에 관한 다음 각 호의 자료를 총리령으로 정",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        352.7225341796875,
        799.56396484375,
        359.8025207519531
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는 바에 따라 제출하여야 한다. 다만, 제2호",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        364.1225280761719,
        799.56396484375,
        371.2025146484375
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 제31조의2에 따라 원료의약품을 등록한 경",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        375.40252685546875,
        799.56396484375,
        382.4825134277344
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "우는 제외한다. <개정 2011.3.30., 2013.3.23.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        386.80255126953125,
        792.4322509765625,
        393.8825378417969
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 시험성적서와 그에 관한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        398.2025451660156,
        750.6036376953125,
        405.28253173828125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 원료의약품에 관한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        409.4825439453125,
        733.3238525390625,
        416.5625305175781
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 관계 문헌",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        420.8825378417969,
        688.683837890625,
        427.9625244140625
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 그 밖에 필요한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        432.28253173828125,
        723.1235961914062,
        439.3625183105469
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑪ 제1항부터 제4항까지 및 제9항에 따른 의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        443.5625305175781,
        799.44384765625,
        450.64251708984375
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품등의 제조업ᆞ위탁제조판매업 및 제조판매품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        454.9625244140625,
        799.5632934570312,
        462.0425109863281
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목의 허가 또는 신고를 할 때 허가 또는 신고",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        466.362548828125,
        799.44384765625,
        473.4425354003906
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 대상ᆞ기준ᆞ조건 및 관리 등에 관하여 필",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        477.6425476074219,
        799.4439697265625,
        484.7225341796875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요한 사항은 총리령으로 정한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        489.04254150390625,
        751.3916625976562,
        496.1225280761719
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제42조(의약품등의 수입허가 등) ①의약품등을",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        503.92254638671875,
        801.8380126953125,
        511.0025329589844
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수입하려는 자(이하 \"수입자\"라 한다)는 총리령",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        515.322509765625,
        799.5635375976562,
        522.4025268554688
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "으로 정하는 바에 따라 품목마다 식품의약품안",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        526.7225341796875,
        799.5629272460938,
        533.8025512695312
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 23 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전처장의 허가를 받거나 신고를 하여야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        56.202537536621094,
        206.39883422851562,
        63.28253936767578
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가받은 사항 또는 신고한 사항을 변경하려는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        67.48253631591797,
        206.39834594726562,
        74.56253814697266
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우에도",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        78.88253784179688,
        206.15965270996094,
        85.96253967285156
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        78.88253784179688,
        206.15965270996094,
        85.96253967285156
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "같다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        78.88253784179688,
        206.15965270996094,
        85.96253967285156
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<개정",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        78.88253784179688,
        206.15965270996094,
        85.96253967285156
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2008.2.29.,",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        78.88253784179688,
        206.15965270996094,
        85.96253967285156
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2010.1.18., 2013.3.23.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        90.30058288574219,
        126.07240295410156,
        96.66058349609375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 제1항에도 불구하고 국방부장관 또는 수입",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        100.48253631591797,
        204.12388610839844,
        107.56253814697266
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자는 다음 각 호의 어느 하나에 해당하는 경우",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        111.88253784179688,
        204.12388610839844,
        118.96253967285156
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에는 해당 의약품등에 대하여 제1항에 따른 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        123.16252899169922,
        204.12399291992188,
        130.24252319335938
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목별 허가를 받거나 신고를 하지 아니하고 수",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        134.5625457763672,
        204.12399291992188,
        141.6425323486328
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입할 수 있다. <개정 2011.3.30., 2013.3.23.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        145.96253967285156,
        193.63247680664062,
        153.0425262451172
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 국방부장관이 긴급히 군사 목적에 사용하기",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        157.24253845214844,
        206.39845275878906,
        164.32252502441406
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위하여 국내에서 생산되지 아니하는 의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        168.64254760742188,
        204.123779296875,
        175.7225341796875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등을 미리 식품의약품안전처장과 품목 및 수",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        180.04254150390625,
        204.12399291992188,
        187.12252807617188
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "량에 대한 협의를 거쳐 수입하려는 경우",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        191.32254028320312,
        189.24388122558594,
        198.40252685546875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 수입자가 의약품등의 제조를 위하여 원료의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        202.7225341796875,
        204.12355041503906,
        209.80252075195312
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품을 수입하거나 임상시험용 의약품 등 총",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        214.12254333496094,
        204.12399291992188,
        221.20252990722656
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "리령으로 정하는 의약품등을 수입하려는 경",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        225.4025421142578,
        204.12399291992188,
        232.48252868652344
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "우",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        236.8025360107422,
        69.00399780273438,
        243.8825225830078
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③수입자는 대통령령으로 정하는 시설 기준에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        248.20254516601562,
        206.39878845214844,
        255.28253173828125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "따라 필요한 시설을 갖추어야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        259.4825439453125,
        166.27171325683594,
        266.5625305175781
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "④제1항에 따라 수입되는 의약품등 또는 그 수",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        270.8825378417969,
        204.12399291992188,
        277.9625244140625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입자에 관하여는 제31조제7항ᆞ제10항ᆞ제11",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        282.28253173828125,
        204.1974334716797,
        289.3625183105469
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항, 제31조의2, 제31조의5, 제31조의3, 제31",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        293.5625305175781,
        204.1974334716797,
        300.64251708984375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조의4, 제32조, 제33조, 제35조의2, 제36조,",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        56.202537536621094,
        380.8793029785156,
        63.28253936767578
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제37조, 제37조의2부터 제37조의4까지, 제38",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        67.48253631591797,
        378.5574035644531,
        74.56253814697266
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조, 제50조의2부터 제50조의10까지, 제69조의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        78.88253784179688,
        378.6036682128906,
        85.96253967285156
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3 및 제75조를 준용한다. 이 경우 \"제조\" 또는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        90.28253936767578,
        380.8786926269531,
        97.36254119873047
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "\"생산\"은 각각 \"수입\"으로, \"제조업자\" 또는 \"품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        101.56253814697266,
        378.6039733886719,
        108.64253997802734
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목허가를 받은 자\"는 각각 \"수입자\"로 본다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        112.96253967285156,
        380.8793029785156,
        120.04254150390625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<개정",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        124.38058471679688,
        380.6395568847656,
        130.74058532714844
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2007.10.17.,",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        124.38058471679688,
        380.6395568847656,
        130.74058532714844
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2011.3.30.,",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        124.38058471679688,
        380.6395568847656,
        130.74058532714844
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2011.6.7.,",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        124.38058471679688,
        380.6395568847656,
        130.74058532714844
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2011.12.2., 2012.5.14., 2014.3.18., 2015.3.13.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        134.58058166503906,
        376.7524108886719,
        140.94058227539062
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑤제1항에 따른 의약품등의 수입 품목 허가 또",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        144.76254272460938,
        378.4839782714844,
        151.842529296875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 신고의 대상ᆞ기준ᆞ조건 및 관리 등에 필",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        156.16253662109375,
        378.4839782714844,
        163.24252319335938
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        167.5625457763672,
        380.6398620605469,
        174.6425323486328
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사항은",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        167.5625457763672,
        380.6398620605469,
        174.6425323486328
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총리령으로",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        167.5625457763672,
        380.6398620605469,
        174.6425323486328
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        167.5625457763672,
        380.6398620605469,
        174.6425323486328
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<개정",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        167.5625457763672,
        380.6398620605469,
        174.6425323486328
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2008.2.29., 2010.1.18., 2011.3.30., 2013.3.23.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        178.86058044433594,
        376.7524108886719,
        185.2205810546875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 24 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<의약품 등의 안전에 관한 규칙>",
      "font_size": 8.519999504089355,
      "font_name": "T3",
      "bbox": [
        566.3999633789062,
        53.7599983215332,
        695.9945678710938,
        63.97547912597656
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[시행 2015.3.15.] [총리령 제1149호, 2015.3.13., 일부개정]",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        531.3599853515625,
        68.68254089355469,
        730.9819946289062,
        75.76254272460938
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제2조(의약품등의 제조업 허가ᆞ신고 등) ①",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        81.28253936767578,
        627.3590087890625,
        88.36254119873047
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "「약사법」(이하 \"법\"이라 한다) 제31조제1항",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        92.68253326416016,
        625.083984375,
        99.76253509521484
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ᆞ제4항에 따라 의약품의 제조업 허가를 받거",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        103.96253967285156,
        625.0838623046875,
        111.04254150390625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나 의약외품의 제조업 신고를 하려는 자는 별지",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        115.36253356933594,
        627.35888671875,
        122.44253540039062
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제1호서식의 의약품 제조업 허가신청서(전자문",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        126.76253509521484,
        625.08349609375,
        133.842529296875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서로 된 신청서를 포함한다) 또는 별지 제2호",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        138.04254150390625,
        625.083984375,
        145.12252807617188
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서식의 의약외품 제조업 신고서(전자문서로 된",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        149.44253540039062,
        627.3590087890625,
        156.52252197265625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신고서를 포함한다)에 다음 각 호의 서류(전자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        160.84254455566406,
        625.0838623046875,
        167.9225311279297
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "문서를 포함한다)를 첨부하여 지방식품의약품안",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        172.12254333496094,
        625.0827026367188,
        179.20252990722656
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전청장(이하 \"지방청장\"이라 한다)에게 제출하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        183.5225372314453,
        625.08349609375,
        190.60252380371094
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        194.92254638671875,
        506.5916748046875,
        202.00253295898438
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 법 제5조제1호 본문에 해당하는 사람이 아",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        206.20254516601562,
        625.083984375,
        213.28253173828125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "님을 증명하는 의사의 진단서 또는 같은 호",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        217.6025390625,
        627.3590087890625,
        224.68252563476562
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "단서에 해당하는 사람임을 증명하는 전문의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        229.00254821777344,
        625.083740234375,
        236.08253479003906
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 진단서 및 같은 조 제3호에 해당하는 사",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        240.2825469970703,
        625.083984375,
        247.36253356933594
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "람이 아님을 증명하는 의사의 진단서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        251.68252563476562,
        599.8837280273438,
        258.76251220703125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 법 제36조에 따른 의약품 또는 의약외품(이",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        263.0825500488281,
        625.083984375,
        270.16253662109375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하 \"의약품등\"이라 한다)의 제조업무를 관리",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        274.362548828125,
        625.0838623046875,
        281.4425354003906
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는 자(이하 \"제조관리자\"라 한다)의 자격",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        285.7625427246094,
        625.0838623046875,
        292.842529296875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "을 확인할 수 있는 서류 또는 제42조제3항",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        297.16253662109375,
        625.083984375,
        304.2425231933594
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 따른 제조관리자 승인서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        308.4425354003906,
        569.0435180664062,
        315.52252197265625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 제1항에 따라 신청서 또는 신고서를 받은",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        319.842529296875,
        627.35888671875,
        326.9225158691406
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지방청장은 「전자정부법」 제36조제1항에 따",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        331.2425537109375,
        625.083984375,
        338.3225402832031
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "른 행정정보의 공동이용을 통하여 다음 각 호",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        342.5225524902344,
        625.083984375,
        349.6025390625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 서류를 확인하여야 한다. 다만, 제2호의 경",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        353.92254638671875,
        625.083984375,
        361.0025329589844
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "우 신청인 또는 신고인이 확인에 동의하지 아",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        365.3225402832031,
        625.083984375,
        372.40252685546875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "니하는 경우에는 그 사본을 첨부하게 하여야",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        376.6025390625,
        627.3585205078125,
        383.6825256347656
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        388.0025329589844,
        490.99169921875,
        395.08251953125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 법인 등기사항증명서(법인인 경우만 해당한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        399.40252685546875,
        625.083740234375,
        406.4825134277344
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        410.6825256347656,
        493.3819885253906,
        417.76251220703125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 약사 면허증(제조관리자가 약사인 경우만 해",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        422.0825500488281,
        625.083984375,
        429.16253662109375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "당한다)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        433.4825439453125,
        507.1819763183594,
        440.5625305175781
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 제1항에 따라 의약외품의 제조업 신고를 하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        444.7625427246094,
        625.083984375,
        451.842529296875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "려는 자는 그 업종에 속하는 1개 이상 품목의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        456.16253662109375,
        627.3585205078125,
        463.2425231933594
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조판매품목 허가를 동시에 신청하거나 1개",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        467.5625305175781,
        627.3590087890625,
        474.64251708984375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상 품목을 동시에 제조판매품목 신고하여야",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        478.842529296875,
        627.3582763671875,
        485.9225158691406
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        490.2425231933594,
        490.99169921875,
        497.322509765625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "④ 기업의 분리 또는 합병에 의하여 의약품등의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        501.6425476074219,
        627.3582763671875,
        508.7225341796875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목에 관한 제조시설ᆞ제조방법 등을 양수받",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        512.9225463867188,
        625.083740234375,
        520.0025634765625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "은 자가 동일장소ᆞ동일시설에서 해당 품목으",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        524.322509765625,
        625.083740234375,
        531.4025268554688
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로 새로운 제조업 허가를 받거나 신고를 하려",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        535.7225341796875,
        625.0838623046875,
        542.8025512695312
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고 이에 관한 사실을 증명하는 서류를 제출하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        77.80253601074219,
        799.4437255859375,
        84.88253784179688
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 경우에는 제48조제5호를 적용하지 아니한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        89.08253479003906,
        799.5635375976562,
        96.16253662109375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        100.48253631591797,
        658.6317138671875,
        107.56253814697266
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑤ 제1항에 따라 제조업의 허가를 받거나 신고",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        111.88253784179688,
        799.44384765625,
        118.96253967285156
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "를 하려는 자는 식품의약품안전처장이 정하여",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        123.16252899169922,
        801.8385009765625,
        130.24252319335938
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고시하는 수수료를 내야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        134.5625457763672,
        744.5516967773438,
        141.6425323486328
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제4조(제조판매ᆞ수입 품목의 허가 신청) ① 법",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        149.44253540039062,
        801.8387451171875,
        156.52252197265625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제31조제2항부터 제4항까지 또는 법 제42조제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        160.84254455566406,
        799.5635986328125,
        167.9225311279297
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1항에 따라 의약품등의 제조판매ᆞ수입 품목허",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        172.12254333496094,
        799.5635375976562,
        179.20252990722656
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가를 받으려는 자는 별지 제4호서식의 의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        183.5225372314453,
        799.4437255859375,
        190.60252380371094
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등 제조판매ᆞ수입 품목 허가신청서(전자문서로",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        194.92254638671875,
        801.8382568359375,
        202.00253295898438
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "된 신청서를 포함한다)에 다음 각 호의 서류(전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        206.20254516601562,
        799.56396484375,
        213.28253173828125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자문서를 포함한다)를 첨부하여 식품의약품안전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        217.6025390625,
        799.5628051757812,
        224.68252563476562
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처장(의약품 동등성의 입증이 필요한 의약품 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        229.00254821777344,
        799.56396484375,
        236.08253479003906
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조판매ᆞ수입 품목허가 및 제1호 각 목 외의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        240.2825469970703,
        801.838623046875,
        247.36253356933594
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부분 단서에 따라 자료를 제출하지 않아도 되는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        251.68252563476562,
        801.838623046875,
        258.76251220703125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약외품 제조판매ᆞ수입 품목허가의 경우에는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        263.0825500488281,
        801.83837890625,
        270.16253662109375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지방청장을 말한다)에게 제출하여야 한다. <개",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        274.362548828125,
        799.4444580078125,
        281.4425354003906
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정 2014.5.9., 2015.3.13.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        285.78057861328125,
        726.9121704101562,
        292.14056396484375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제9조에 따른 안전성ᆞ유효성에 관한 자료.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        295.9625244140625,
        801.8392944335938,
        303.0425109863281
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다만, 생물학적 제제, 유전자재조합의약품,",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        307.362548828125,
        801.8392944335938,
        314.4425354003906
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포배양의약품, 세포 치료제, 유전자 치료제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        318.7625427246094,
        801.8385009765625,
        325.842529296875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 이와 유사한 제제(이하 \"생물학적제제등\"",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        330.04254150390625,
        799.5272216796875,
        337.1225280761719
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이라 한다)가 아닌 것으로서 다음 각 목의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        341.4425354003906,
        801.838623046875,
        348.52252197265625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "어느 하나에 해당하는 품목과 국내에서 이미",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        352.842529296875,
        801.838623046875,
        359.9225158691406
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가된 품목을 제조하는 제조소와 동일한 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        364.1225280761719,
        799.56396484375,
        371.2025146484375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조소에서 제조되는 것으로서 해당 품목과 최",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        375.5225524902344,
        799.56396484375,
        382.6025390625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "종원액이 동일한 생물학적제제등은 제출하지",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        386.92254638671875,
        801.83837890625,
        394.0025329589844
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        398.2025451660156,
        687.0716552734375,
        405.28253173828125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 법 제51조제1항에 따른 대한민국약전(이",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        409.6025390625,
        799.56396484375,
        416.6825256347656
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하 \"대한민국약전\"이라 한다)에 실려 있",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        421.0025329589844,
        799.56396484375,
        428.08251953125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        432.28253173828125,
        691.8038330078125,
        439.3625183105469
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 식품의약품안전처장이 인정하는 공정서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        443.6825256347656,
        799.5635375976562,
        450.76251220703125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(公定書) 및 의약품집에 실려 있는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        455.0825500488281,
        795.0036010742188,
        462.16253662109375
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 대한민국약전에 실려 있지 아니한 의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        466.362548828125,
        801.8385009765625,
        473.4425354003906
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중 한약에 관한 기준[이하 \"대한민국약전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        477.7625427246094,
        799.5629272460938,
        484.842529296875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "외한약(생약)규격집\"이라 한다]에 실려",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        489.16253662109375,
        801.838623046875,
        496.2425231933594
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        500.4425354003906,
        698.7636108398438,
        507.52252197265625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 식품의약품안전처장이 성분의 종류ᆞ규격",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        511.842529296875,
        799.5632934570312,
        518.9225463867188
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ᆞ함량 및 처방 등을 표준화하여 고시한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        523.2425537109375,
        801.8385009765625,
        530.3225708007812
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표준제조기준에 맞는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        534.5225219726562,
        750.2438354492188,
        541.6025390625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 25 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 식품의약품안전처장이 따로 기준 및 시험",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        53.202537536621094,
        204.12388610839844,
        60.28253936767578
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방법을 고시한 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        64.6025390625,
        134.2838897705078,
        71.68254089355469
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바. 그 밖에 식품의약품안전처장이 자료의 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        76.0025405883789,
        204.12399291992188,
        83.0825424194336
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "출이 필요하지 아니하다고 인정하는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        87.28253936767578,
        203.0436553955078,
        94.36254119873047
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 제10조에 따른 기준 및 시험방법에 관한 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        98.68253326416016,
        204.12399291992188,
        105.76253509521484
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "료. 다만, 다음 각 목의 어느 하나에 해당하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        110.08253479003906,
        204.12355041503906,
        117.16253662109375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 품목의 경우에는 제출하지 아니한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        121.36253356933594,
        187.8717041015625,
        128.44253540039062
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 생물학적제제등이 아닌 것으로서 제1호가",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        132.76254272460938,
        204.12388610839844,
        139.842529296875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목ᆞ나목ᆞ다목 및 마목에 해당하는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        144.16253662109375,
        203.0436553955078,
        151.24252319335938
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 적절한 대체의약품이 없어 긴급히 도입하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        155.44253540039062,
        204.123779296875,
        162.52252197265625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여야 하는 의약품으로서 식품의약품안전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        166.84254455566406,
        204.12290954589844,
        173.9225311279297
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처장이 정하는 희귀의약품(이하 \"희귀의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        178.24253845214844,
        204.12355041503906,
        185.32252502441406
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품\"이라 한다)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        189.5225372314453,
        123.4219970703125,
        196.60252380371094
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 다음 각 목의 어느 하나에 해당하는 품목의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        200.92254638671875,
        206.3985595703125,
        208.00253295898438
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우에는 생물학적 동등성시험에 관한 시험",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        212.32254028320312,
        204.12388610839844,
        219.40252685546875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료 또는 비교임상시험 성적서에 관한 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        223.6025390625,
        204.12399291992188,
        230.68252563476562
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "료. 다만, 식품의약품안전처장이 고시하는 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        235.00254821777344,
        204.12399291992188,
        242.08253479003906
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목의 경우에는 비교용출시험자료 등 생체를",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        246.4025421142578,
        206.39878845214844,
        253.48252868652344
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이용하지 아니하는 시험자료로서 식품의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        257.6825256347656,
        204.12335205078125,
        264.76251220703125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전처장이 고시하는 자료를 제출한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        269.0825500488281,
        184.39170837402344,
        276.16253662109375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 1989년 1월 1일 이후 제조판매ᆞ수입 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        280.4825439453125,
        204.12399291992188,
        287.5625305175781
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목허가를 받은 전문의약품으로서 신약에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        291.7625427246094,
        206.3985595703125,
        298.842529296875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당하는 의약품(제형이 다른 동일투여경",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        303.16253662109375,
        204.12335205078125,
        310.2425231933594
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로의 품목을 포함한다)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        314.5625305175781,
        144.5419921875,
        321.64251708984375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 가목에 해당하는 품목을 제외한 전문의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        325.842529296875,
        204.12344360351562,
        332.9225158691406
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품으로서 이미 제조판매ᆞ수입 품목허가",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        337.2425537109375,
        204.12344360351562,
        344.3225402832031
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "를 받은 것과 성분이 동일한 정제ᆞ캡슐",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        348.6425476074219,
        204.12335205078125,
        355.7225341796875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제 또는 좌제. 다만, 상용(常用) 의약품,",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        359.92254638671875,
        206.39883422851562,
        367.0025329589844
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고가(高價) 의약품, 단일성분의 의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        371.3225402832031,
        206.39878845214844,
        378.40252685546875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는 의약품 동등성 확보가 필요한 의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        382.7225341796875,
        204.12388610839844,
        389.8025207519531
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품으로서 식품의약품안전처장이 고시하는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        394.0025329589844,
        206.39845275878906,
        401.08251953125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "것이어야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        405.40252685546875,
        119.11170959472656,
        412.4825134277344
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 수입품의 경우 그 품목의 제조 및 판매에 관",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        416.80255126953125,
        204.12399291992188,
        423.8825378417969
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 다음 각 목의 서류. 이 경우 첨부서류의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        428.0825500488281,
        206.39834594726562,
        435.16253662109375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요건 등에 관한 세부 사항은 식품의약품안전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        439.4825439453125,
        204.12290954589844,
        446.5625305175781
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처장이 고시하는 바에 따른다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        450.8825378417969,
        156.91171264648438,
        457.9625244140625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 의약품등을 생산하는 국가(이하 \"생산국\"",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        462.16253662109375,
        204.20721435546875,
        469.2425231933594
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이라 한다)의 정부 또는 공공기관에서 그",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        473.5625305175781,
        206.39898681640625,
        480.64251708984375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목이 생산국의 법령에 적합하게 제조되",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        484.9625244140625,
        204.123779296875,
        492.0425109863281
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고 있음을 증명하는 제조증명서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        496.2425231933594,
        172.08334350585938,
        503.322509765625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 해당 품목이 허가 또는 등록된 국가의 정",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        507.64251708984375,
        204.12399291992188,
        514.7225341796875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부 또는 공공기관에서 그 국가의 법령에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        519.0425415039062,
        206.3985595703125,
        526.12255859375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합하게 판매되고 있음을 증명하는 판매",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        530.322509765625,
        204.12388610839844,
        537.4025268554688
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "증명서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        53.202537536621094,
        267.48358154296875,
        60.28253936767578
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 일반의약품 중 단일성분의 의약품으로서 이",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        64.6025390625,
        378.4839782714844,
        71.68254089355469
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미 제조판매ᆞ수입 품목허가를 받은 정제ᆞ",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        76.0025405883789,
        378.60357666015625,
        83.0825424194336
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "캡슐제 또는 좌제와 성분이 동일한 의약품을",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        87.28253936767578,
        380.8785095214844,
        94.36254119873047
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가받으려는 경우에는 비교용출시험자료 등",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        98.68253326416016,
        380.8790283203125,
        105.76253509521484
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전처장이 고시하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        110.08253479003906,
        353.4039001464844,
        117.16253662109375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 다음 각 목의 구분에 따른 평가 자료. 다만,",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        121.36253356933594,
        380.8793029785156,
        128.44253540039062
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "희귀의약품의 경우에는 제출하지 아니한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        132.76254272460938,
        372.55169677734375,
        139.842529296875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 의약품[의료용 고압가스, 방사성의약품,",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        144.16253662109375,
        380.8793029785156,
        151.24252319335938
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료의약품 중 한약재 및 약리활성(약리",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        155.44253540039062,
        378.6036682128906,
        162.52252197265625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "활성: 약리작용상 인체에 미치는 작용)이",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        166.84254455566406,
        380.8790283203125,
        173.9225311279297
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "없는 성분(첨가제 등), 그 밖에 인체에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        178.24253845214844,
        380.87860107421875,
        185.32252502441406
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직접 적용하지 아니하는 제품(소독제 등)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        189.5225372314453,
        378.5419921875,
        196.60252380371094
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과 이에 사용되는 원료의약품은 제외한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        200.92254638671875,
        378.60357666015625,
        208.00253295898438
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다] 및 의약외품[내용고형제(內用固形濟)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        212.32254028320312,
        380.8792724609375,
        219.40252685546875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 내용액제(內用液劑)만 해당한다]의 경",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        223.6025390625,
        378.6039733886719,
        230.68252563476562
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "우에는 별표 1의 의약품 제조 및 품질관",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        235.00254821777344,
        378.60357666015625,
        242.08253479003906
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "리기준 실시상황 평가에 필요한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        246.4025421142578,
        363.7236633300781,
        253.48252868652344
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 생물학적제제등인 경우에는 별표 1의 의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        257.6825256347656,
        378.4839782714844,
        264.76251220703125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품 제조 및 품질관리기준 및 별표 3의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        269.0825500488281,
        380.8790283203125,
        276.16253662109375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생물학적제제등 제조 및 품질관리기준 실",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        280.4825439453125,
        378.6039733886719,
        287.5625305175781
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시상황 평가에 필요한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        291.7625427246094,
        332.7638854980469,
        298.842529296875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 한약재의 경우에는 별표 2의 한약재 제조",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        303.16253662109375,
        380.8786926269531,
        310.2425231933594
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 품질관리기준 실시상황 평가에 필요한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        314.5625305175781,
        380.87860107421875,
        321.64251708984375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료. 다만, 둘 이상의 제조판매ᆞ수입 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        325.842529296875,
        378.4839782714844,
        332.9225158691406
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목허가를 동시에 신청하는 경우에는 그",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        337.2425537109375,
        380.8790283203125,
        344.3225402832031
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중 하나의 품목에 관한 자료만을 제출할",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        348.6425476074219,
        380.87860107421875,
        355.7225341796875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수 있다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        359.92254638671875,
        272.9516906738281,
        367.0025329589844
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 법 제31조의2제1항에 따라 등록할 수 있는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        371.3225402832031,
        380.8786926269531,
        378.40252685546875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신약의 원료의약품 또는 식품의약품안전처장",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        382.7225341796875,
        378.6025695800781,
        389.8025207519531
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 정하여 고시하는 원료의약품(이하 \"등록",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        394.0025329589844,
        378.6036682128906,
        401.08251953125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대상 원료의약품\"이라 한다)을 사용하는 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        405.40252685546875,
        378.6039733886719,
        412.4825134277344
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목의 경우에는 원료의약품에 관한 다음 각",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        416.80255126953125,
        380.8787841796875,
        423.8825378417969
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목의 자료. 다만, 제15조제1항에 따라 이미",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        428.0825500488281,
        380.8786926269531,
        435.16253662109375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등록된 원료의약품의 경우에는 제출하지 아",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        439.4825439453125,
        378.6039733886719,
        446.5625305175781
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "니한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        450.8825378417969,
        259.1517028808594,
        457.9625244140625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 제조소의 명칭, 제조소의 소재지, 제조소",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        462.16253662109375,
        380.87860107421875,
        469.2425231933594
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "책임자의 성명을 적은 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        473.5625305175781,
        332.7638854980469,
        480.64251708984375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 저장방법 및 사용기간을 적은 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        484.9625244140625,
        356.2836608886719,
        492.0425109863281
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 제15조제1항 각 호의 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        496.2425231933594,
        331.32391357421875,
        503.322509765625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. 의약품의 주성분을 제조하는 제조업자의 명",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        507.64251708984375,
        378.4839782714844,
        514.7225341796875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "칭 및 소재지 등에 관한 자료로서 식품의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        519.0425415039062,
        378.4837341308594,
        526.12255859375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품안전처장이 고시하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        530.322509765625,
        325.92388916015625,
        537.4025268554688
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 26 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. 법 제31조제2항ᆞ제3항에 따라 의약품을 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        53.202537536621094,
        625.083984375,
        60.28253936767578
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조업자에게 위탁제조하여 판매하려는 의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        64.6025390625,
        625.083740234375,
        71.68254089355469
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 경우에는 수탁제조업자의 명칭 및 소재지",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        76.0025405883789,
        627.3585205078125,
        83.0825424194336
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등을 적어 넣은 위탁ᆞ수탁제조계약서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        87.28253936767578,
        603.3624877929688,
        94.36254119873047
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10. 법 제50조의2제4항(법 제42조제4항에 따",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        98.68253326416016,
        625.083984375,
        105.76253509521484
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라 준용되는 경우를 포함한다)에 따라 의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        110.08253479003906,
        625.0838623046875,
        117.16253662109375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품 특허목록(이하 \"특허목록\"이라 한다)에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        121.36253356933594,
        627.3590087890625,
        128.44253540039062
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품에 관한 특허권(이하 \"의약품특허권\"",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        132.76254272460938,
        625.167236328125,
        139.842529296875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이라 한다)이 등재된 의약품(이하 \"등재의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        144.16253662109375,
        625.0833740234375,
        151.24252319335938
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품\"이라 한다)의 안전성ᆞ유효성에 관한 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        155.44253540039062,
        625.083984375,
        162.52252197265625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "료를 근거로 의약품의 제조판매ᆞ수입 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        166.84254455566406,
        625.0838623046875,
        173.9225311279297
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가를 신청하는 경우에는 별지 제5호서식의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        178.24253845214844,
        627.3583984375,
        185.32252502441406
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특허관계 확인서와 그 사유를 적은 서류 및",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        189.5225372314453,
        627.3590087890625,
        196.60252380371094
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "근거자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        200.92254638671875,
        510.60345458984375,
        208.00253295898438
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 제1항에도 불구하고 다음 각 호의 어느 하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        212.32254028320312,
        625.083984375,
        219.40252685546875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나에 해당하는 경우에는 각 호의 구분에 따른",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        223.6025390625,
        627.35888671875,
        230.68252563476562
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료를",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        235.00254821777344,
        627.119873046875,
        242.08253479003906
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제출하지",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        235.00254821777344,
        627.119873046875,
        242.08253479003906
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니할",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        235.00254821777344,
        627.119873046875,
        242.08253479003906
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        235.00254821777344,
        627.119873046875,
        242.08253479003906
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        235.00254821777344,
        627.119873046875,
        242.08253479003906
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<개정",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        235.00254821777344,
        627.119873046875,
        242.08253479003906
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2014.10.10.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        246.4205780029297,
        515.2322998046875,
        252.78057861328125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제1항제1호 또는 제2호에 해당하는 자료로",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        256.6025390625,
        625.08349609375,
        263.6825256347656
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서 적합하다는 제41조제3항에 따른 사전 검",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        268.0025329589844,
        625.083984375,
        275.08251953125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "토 결과통지서를 제출한 경우: 제1항제1호",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        279.28253173828125,
        627.3590087890625,
        286.3625183105469
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는 제2호에 해당하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        290.6825256347656,
        573.2438354492188,
        297.76251220703125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 품목허가를 신청하는 품목(신약, 생물학적제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        302.0825500488281,
        625.083251953125,
        309.16253662109375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제등, 주사제, 이식제, 그 밖에 식품의약품안",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        313.362548828125,
        625.0829467773438,
        320.4425354003906
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전처장이 고시하는 의약품은 제외한다)을 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        324.7625427246094,
        625.083984375,
        331.842529296875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조하는 제조소에 제48조의2에 따른 제조 및",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        336.16253662109375,
        627.3590087890625,
        343.2425231933594
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품질관리 적합판정서가 있는 경우: 제1항제6",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        347.4425354003906,
        625.1575317382812,
        354.52252197265625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "호에 해당하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        358.842529296875,
        544.9238891601562,
        365.9225158691406
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 식품의약품안전처장이 고시하는 기준에 적합",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        370.2425231933594,
        625.0838623046875,
        377.322509765625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 경우: 제1항제4호에 해당하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        381.5225524902344,
        603.963623046875,
        388.6025390625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 제1항에도 불구하고 기업의 분리 또는 합병",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        392.92254638671875,
        627.35888671875,
        400.0025329589844
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등에 의하여 해당 제조시설ᆞ제조방법 등을 양",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        404.3225402832031,
        625.083984375,
        411.40252685546875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수받은 품목의 제조판매ᆞ수입 품목허가를 받",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        415.6025390625,
        625.083984375,
        422.6825256347656
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "으려는 자의 경우에는 제1항 각 호의 어느 하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        427.0025329589844,
        625.083984375,
        434.08251953125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나에 해당하는 첨부서류를 갈음하여 품목의 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        438.40252685546875,
        625.083984375,
        445.4825134277344
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조시설ᆞ제조방법 등에 관한 양도ᆞ양수계약서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        449.6825256347656,
        625.0827026367188,
        456.76251220703125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "를 제출할 수 있다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        461.0825500488281,
        535.751708984375,
        468.16253662109375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "④ 제3항에 따른 해당 품목의 허가 시에는 양",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        472.4825439453125,
        625.083984375,
        479.5625305175781
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "도인에 대한 제조판매ᆞ수입 품목허가에 붙여",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        483.7625427246094,
        625.0838623046875,
        490.842529296875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "진 조건에 상응하는 조건을 붙일 수 있다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        495.16253662109375,
        607.8717041015625,
        502.2425231933594
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑤ 식품의약품안전처장은 법 제31조제2항부터",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        506.56256103515625,
        627.3585205078125,
        513.642578125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제4항까지 또는 법 제42조제1항에 따른 의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        517.842529296875,
        625.0838623046875,
        524.9225463867188
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품등의 제조판매ᆞ수입 품목허가를 위하여 필",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        529.2425537109375,
        625.083984375,
        536.3225708007812
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요하다고 인정하는 경우에는 식품의약품안전평",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        53.202537536621094,
        799.5626831054688,
        60.28253936767578
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가원의 의견을 듣거나 법 제18조제1항에 따른",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        64.6025390625,
        801.838623046875,
        71.68254089355469
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중앙약사심의위원회에 자문을 할 수 있다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        76.0025405883789,
        782.3516845703125,
        83.0825424194336
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑥ 제1항에 따라 허가를 신청하는 자는 식품의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        87.28253936767578,
        799.4437255859375,
        94.36254119873047
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품안전처장이 정하여 고시하는 수수료(외국",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        98.68253326416016,
        799.5635986328125,
        105.76253509521484
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에서 현지실사를 할 필요가 있는 경우에는 이",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        110.08253479003906,
        799.4439697265625,
        117.16253662109375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 드는 경비를 포함한다)를 내야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        121.36253356933594,
        775.3916625976562,
        128.44253540039062
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제4조(제조판매·수입 품목의 허가 신청) ① 법",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        136.362548828125,
        801.8387451171875,
        143.44253540039062
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제31조제2항부터 제4항까지 또는 법 제42조제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        147.64254760742188,
        799.5635986328125,
        154.7225341796875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1항에 따라 의약품등의 제조판매·수입 품목허",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        159.04254150390625,
        799.5635375976562,
        166.12252807617188
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가를 받으려는 자는 별지 제4호서식의 의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        170.44253540039062,
        799.4437255859375,
        177.52252197265625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등 제조판매·수입 품목 허가신청서(전자문서로",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        181.72254943847656,
        801.8382568359375,
        188.8025360107422
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "된 신청서를 포함한다)에 다음 각 호의 서류(전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        193.12254333496094,
        799.56396484375,
        200.20252990722656
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자문서를 포함한다)를 첨부하여 식품의약품안전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        204.5225372314453,
        799.5628051757812,
        211.60252380371094
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처장(의약품 동등성의 입증이 필요한 의약품 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        215.8025360107422,
        799.56396484375,
        222.8825225830078
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조판매·수입 품목허가 및 제1호 각 목 외의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        227.20254516601562,
        801.838623046875,
        234.28253173828125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부분 단서에 따라 자료를 제출하지 않아도 되는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        238.6025390625,
        801.838623046875,
        245.68252563476562
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약외품 제조판매·수입 품목허가의 경우에는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        249.88253784179688,
        801.83837890625,
        256.9625244140625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지방청장을 말한다)에게 제출하여야 한다. <개",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        261.28253173828125,
        799.4444580078125,
        268.3625183105469
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정 2014.5.9., 2014.8.21., 2015.3.13.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        272.7005920410156,
        764.2322387695312,
        279.0605773925781
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제9조에 따른 안전성·유효성에 관한 자료.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        282.8825378417969,
        801.8392944335938,
        289.9625244140625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다만, 생물학적 제제, 유전자재조합의약품,",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        294.28253173828125,
        801.8392944335938,
        301.3625183105469
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세포배양의약품, 세포 치료제, 유전자 치료제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        305.5625305175781,
        801.8385009765625,
        312.64251708984375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 이와 유사한 제제(이하 \"생물학적제제등\"",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        316.9625244140625,
        799.5272216796875,
        324.0425109863281
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이라 한다)가 아닌 것으로서 다음 각 목의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        328.362548828125,
        801.838623046875,
        335.4425354003906
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "어느 하나에 해당하는 품목과 국내에서 이미",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        339.6425476074219,
        801.838623046875,
        346.7225341796875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가된 품목을 제조하는 제조소와 동일한 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        351.04254150390625,
        799.56396484375,
        358.1225280761719
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조소에서 제조되는 것으로서 해당 품목과 최",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        362.4425354003906,
        799.56396484375,
        369.52252197265625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "종원액이 동일한 생물학적제제등은 제출하지",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        373.7225341796875,
        801.83837890625,
        380.8025207519531
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        385.1225280761719,
        687.0716552734375,
        392.2025146484375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 법 제51조제1항에 따른 대한민국약전(이",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        396.5225524902344,
        799.56396484375,
        403.6025390625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하 \"대한민국약전\"이라 한다)에 실려 있",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        407.80255126953125,
        799.56396484375,
        414.8825378417969
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        419.2025451660156,
        691.8038330078125,
        426.28253173828125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 식품의약품안전처장이 인정하는 공정서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        430.6025390625,
        799.5635375976562,
        437.6825256347656
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(公定書) 및 의약품집에 실려 있는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        441.8825378417969,
        795.0036010742188,
        448.9625244140625
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 대한민국약전에 실려 있지 아니한 의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        453.28253173828125,
        801.8385009765625,
        460.3625183105469
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중 한약에 관한 기준[이하 \"대한민국약전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        464.6825256347656,
        799.5629272460938,
        471.76251220703125
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "외한약(생약)규격집\"이라 한다]에 실려",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        475.9625244140625,
        801.838623046875,
        483.0425109863281
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        487.362548828125,
        698.7636108398438,
        494.4425354003906
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 식품의약품안전처장이 성분의 종류·규",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        498.7625427246094,
        799.56396484375,
        505.842529296875
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "격·함량 및 처방 등을 표준화하여 고시",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        510.04254150390625,
        799.44384765625,
        517.12255859375
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 표준제조기준에 맞는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        667.7999877929688,
        521.4425048828125,
        760.5638427734375,
        528.5225219726562
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 식품의약품안전처장이 따로 기준 및 시험",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        532.842529296875,
        799.5635986328125,
        539.9225463867188
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 27 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방법을 고시한 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        53.202537536621094,
        134.2838897705078,
        60.28253936767578
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바. 그 밖에 식품의약품안전처장이 자료의 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        64.6025390625,
        204.12399291992188,
        71.68254089355469
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "출이 필요하지 아니하다고 인정하는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        76.0025405883789,
        203.0436553955078,
        83.0825424194336
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 제10조에 따른 기준 및 시험방법에 관한 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        87.28253936767578,
        204.12399291992188,
        94.36254119873047
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "료. 다만, 다음 각 목의 어느 하나에 해당하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        98.68253326416016,
        204.12355041503906,
        105.76253509521484
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 품목의 경우에는 제출하지 아니한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        110.08253479003906,
        187.8717041015625,
        117.16253662109375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 생물학적제제등이 아닌 것으로서 제1호가",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        121.36253356933594,
        204.12388610839844,
        128.44253540039062
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목·나목·다목 및 마목에 해당하는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        132.76254272460938,
        203.0436553955078,
        139.842529296875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 삭제 <2014.8.21.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        144.16253662109375,
        128.8323974609375,
        151.24252319335938
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 다음 각 목의 어느 하나에 해당하는 품목의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        155.44253540039062,
        206.3985595703125,
        162.52252197265625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우에는 생물학적 동등성시험에 관한 시험",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        166.84254455566406,
        204.12388610839844,
        173.9225311279297
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료 또는 비교임상시험 성적서에 관한 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        178.24253845214844,
        204.12399291992188,
        185.32252502441406
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "료. 다만, 식품의약품안전처장이 고시하는 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        189.5225372314453,
        204.12399291992188,
        196.60252380371094
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목의 경우에는 비교용출시험자료 등 생체를",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        200.92254638671875,
        206.39878845214844,
        208.00253295898438
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이용하지 아니하는 시험자료로서 식품의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        212.32254028320312,
        204.12335205078125,
        219.40252685546875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전처장이 고시하는 자료를 제출한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        223.6025390625,
        184.39170837402344,
        230.68252563476562
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 1989년 1월 1일 이후 제조판매·수입 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        235.00254821777344,
        204.12399291992188,
        242.08253479003906
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목허가를 받은 전문의약품으로서 신약에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        246.4025421142578,
        206.3985595703125,
        253.48252868652344
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당하는 의약품(제형이 다른 동일투여경",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        257.6825256347656,
        204.12335205078125,
        264.76251220703125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로의 품목을 포함한다)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        269.0825500488281,
        144.5419921875,
        276.16253662109375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 가목에 해당하는 품목을 제외한 전문의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        280.4825439453125,
        204.12344360351562,
        287.5625305175781
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품으로서 이미 제조판매·수입 품목허가",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        291.7625427246094,
        204.12344360351562,
        298.842529296875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "를 받은 것과 성분이 동일한 정제·캡슐",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        303.16253662109375,
        204.12388610839844,
        310.2425231933594
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제 또는 좌제. 다만, 상용(常用) 의약품,",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        314.5625305175781,
        206.39883422851562,
        321.64251708984375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고가(高價) 의약품, 단일성분의 의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        325.842529296875,
        206.39878845214844,
        332.9225158691406
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는 의약품 동등성 확보가 필요한 의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        337.2425537109375,
        204.12388610839844,
        344.3225402832031
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품으로서 식품의약품안전처장이 고시하는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        348.6425476074219,
        206.39845275878906,
        355.7225341796875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "것이어야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        359.92254638671875,
        119.11170959472656,
        367.0025329589844
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 수입품의 경우 그 품목의 제조 및 판매에 관",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        371.3225402832031,
        204.12399291992188,
        378.40252685546875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 다음 각 목의 서류. 이 경우 첨부서류의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        382.7225341796875,
        206.39834594726562,
        389.8025207519531
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요건 등에 관한 세부 사항은 식품의약품안전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        394.0025329589844,
        204.12290954589844,
        401.08251953125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처장이 고시하는 바에 따른다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        405.40252685546875,
        156.91171264648438,
        412.4825134277344
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 의약품등을 생산하는 국가(이하 \"생산국\"",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        416.80255126953125,
        204.20721435546875,
        423.8825378417969
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이라 한다)의 정부 또는 공공기관에서 그",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        428.0825500488281,
        206.39898681640625,
        435.16253662109375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목이 생산국의 법령에 적합하게 제조되",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        439.4825439453125,
        204.123779296875,
        446.5625305175781
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고 있음을 증명하는 제조증명서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        450.8825378417969,
        172.08334350585938,
        457.9625244140625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 해당 품목이 허가 또는 등록된 국가의 정",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        462.16253662109375,
        204.12399291992188,
        469.2425231933594
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부 또는 공공기관에서 그 국가의 법령에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        473.5625305175781,
        206.3985595703125,
        480.64251708984375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합하게 판매되고 있음을 증명하는 판매",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        484.9625244140625,
        204.12388610839844,
        492.0425109863281
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "증명서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        72.47999572753906,
        496.2425231933594,
        93.00377655029297,
        503.322509765625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 일반의약품 중 단일성분의 의약품으로서 이",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        507.64251708984375,
        204.12399291992188,
        514.7225341796875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미 제조판매·수입 품목허가를 받은 정제·",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        519.0425415039062,
        204.12399291992188,
        526.12255859375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "캡슐제 또는 좌제와 성분이 동일한 의약품을",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        530.322509765625,
        206.39845275878906,
        537.4025268554688
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가받으려는 경우에는 비교용출시험자료 등",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        53.202537536621094,
        380.8790283203125,
        60.28253936767578
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전처장이 고시하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        64.6025390625,
        353.4039001464844,
        71.68254089355469
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6.다음 각 목의 구분에 따른 평가 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        76.0025405883789,
        350.1639099121094,
        83.0825424194336
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 완제의약품[인체에 직접 적용하지 아니하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        87.28253936767578,
        378.60357666015625,
        94.36254119873047
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 제품(소독제 등)은 제외한다] 및 의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        98.68253326416016,
        378.6036682128906,
        105.76253509521484
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "외품[내용고형제(內用固形劑) 및 내용액",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        110.08253479003906,
        378.60357666015625,
        117.16253662109375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제(內用液劑)만 해당한다]의 경우에는 별",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        121.36253356933594,
        378.6039733886719,
        128.44253540039062
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 1의 의약품 제조 및 품질관리기준 실",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        132.76254272460938,
        378.6039733886719,
        139.842529296875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시상황 평가에 필요한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        144.16253662109375,
        332.7638854980469,
        151.24252319335938
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 원료의약품[원료의약품 중 한약재 및 약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        155.44253540039062,
        378.4839782714844,
        162.52252197265625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "리활성(약리활성: 약리작용상 인체에 미",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        166.84254455566406,
        378.6039733886719,
        173.9225311279297
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치는 작용)이 없는 성분(첨가제 등), 그",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        178.24253845214844,
        380.8787841796875,
        185.32252502441406
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "밖에 인체에 직접 적용하지 아니하는 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        189.5225372314453,
        378.4839782714844,
        196.60252380371094
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품(소독제 등)에 사용되는 원료의약품은",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        200.92254638671875,
        380.87811279296875,
        208.00253295898438
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제외한다]의 경우에는 별표 1의2의 원료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        212.32254028320312,
        378.6036682128906,
        219.40252685546875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품 제조 및 품질관리기준 실시 상황",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        223.6025390625,
        380.8786926269531,
        230.68252563476562
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가에 필요한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        235.00254821777344,
        308.6438903808594,
        242.08253479003906
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 생물학적제제등인 경우에는 별표 1의 의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        246.4025421142578,
        378.4839782714844,
        253.48252868652344
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품 제조 및 품질관리기준, 별표 1의2의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        257.6825256347656,
        380.8787841796875,
        264.76251220703125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료의약품 제조 및 품질관리기준 및 별",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        269.0825500488281,
        378.4839782714844,
        276.16253662109375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 3의 생물학적제제등 제조 및 품질관리",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        280.4825439453125,
        378.6034851074219,
        287.5625305175781
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기준 실시상황 평가에 필요한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        291.7625427246094,
        356.7638854980469,
        298.842529296875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 방사성의약품인 경우에는 별표 1의 의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        303.16253662109375,
        378.48388671875,
        310.2425231933594
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품 제조 및 품질관리기준, 별표 1의2의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        314.5625305175781,
        380.8790283203125,
        321.64251708984375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료의약품 제조 및 품질관리기준 및 별",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        325.842529296875,
        378.4839782714844,
        332.9225158691406
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 3의2의 방사성의약품 제조 및 품질관",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        337.2425537109375,
        378.4837951660156,
        344.3225402832031
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "리기준 실시상황 평가에 필요한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        348.6425476074219,
        363.7236633300781,
        355.7225341796875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 의료용 고압가스인 경우에는 별표 1의 의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        359.92254638671875,
        378.6039733886719,
        367.0025329589844
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품 제조 및 품질관리기준, 별표 1의2의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        371.3225402832031,
        380.8787841796875,
        378.40252685546875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원료의약품 제조 및 품질관리기준 및 별",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        382.7225341796875,
        378.4839782714844,
        389.8025207519531
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 3의3의 의료용 고압가스 제조 및 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        394.0025329589844,
        378.6039733886719,
        401.08251953125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "질관리기준 실시상황 평가에 필요한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        405.40252685546875,
        377.4039001464844,
        412.4825134277344
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바. 한약재의 경우에는 별표 2의 한약재 제조",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        416.80255126953125,
        380.8786926269531,
        423.8825378417969
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 품질관리기준 실시상황 평가에 필요한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        428.0825500488281,
        380.87860107421875,
        435.16253662109375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료. 다만, 둘 이상의 제조판매·수입 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        439.4825439453125,
        378.4839782714844,
        446.5625305175781
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목허가를 동시에 신청하는 경우에는 그",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        450.8825378417969,
        380.8790283203125,
        457.9625244140625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중 하나의 품목에 관한 자료만을 제출할",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        462.16253662109375,
        380.87860107421875,
        469.2425231933594
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수 있다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        246.83999633789062,
        473.5625305175781,
        272.9516906738281,
        480.64251708984375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 법 제31조의2제1항에 따라 등록할 수 있는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        484.9625244140625,
        380.8786926269531,
        492.0425109863281
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신약의 원료의약품 또는 식품의약품안전처장",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        496.2425231933594,
        378.6025695800781,
        503.322509765625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 정하여 고시하는 원료의약품(이하 \"등록",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        507.64251708984375,
        378.6036682128906,
        514.7225341796875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대상 원료의약품\"이라 한다)을 사용하는 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        519.0425415039062,
        378.6039733886719,
        526.12255859375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목의 경우에는 원료의약품에 관한 다음 각",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        530.322509765625,
        380.8787841796875,
        537.4025268554688
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 28 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목의 자료. 다만, 제15조제1항에 따라 이미",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        53.202537536621094,
        627.35888671875,
        60.28253936767578
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등록된 원료의약품의 경우에는 제출하지 아",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        64.6025390625,
        625.083984375,
        71.68254089355469
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "니한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        76.0025405883789,
        505.7516784667969,
        83.0825424194336
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 제조소의 명칭, 제조소의 소재지, 제조소",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        87.28253936767578,
        627.3585205078125,
        94.36254119873047
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "책임자의 성명을 적은 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        493.44000244140625,
        98.68253326416016,
        579.2438354492188,
        105.76253509521484
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 저장방법 및 사용기간을 적은 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        110.08253479003906,
        602.7638549804688,
        117.16253662109375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 제15조제1항 각 호의 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        121.36253356933594,
        577.8038940429688,
        128.44253540039062
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. 의약품의 주성분을 제조하는 제조업자의 명",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        132.76254272460938,
        625.083984375,
        139.842529296875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "칭 및 소재지 등에 관한 자료로서 식품의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        144.16253662109375,
        625.0833740234375,
        151.24252319335938
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품안전처장이 고시하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        155.44253540039062,
        572.4038696289062,
        162.52252197265625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. 법 제31조제2항·제3항에 따라 의약품을 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        166.84254455566406,
        625.083984375,
        173.9225311279297
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조업자에게 위탁제조하여 판매하려는 의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        178.24253845214844,
        625.083740234375,
        185.32252502441406
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 경우에는 수탁제조업자의 명칭 및 소재지",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        189.5225372314453,
        627.3585205078125,
        196.60252380371094
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등을 적어 넣은 위탁·수탁제조계약서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        200.92254638671875,
        603.36279296875,
        208.00253295898438
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10. 법 제50조의2제4항(법 제42조제4항에 따",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        212.32254028320312,
        625.083984375,
        219.40252685546875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라 준용되는 경우를 포함한다)에 따라 의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        223.6025390625,
        625.0838623046875,
        230.68252563476562
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품 특허목록(이하 \"특허목록\"이라 한다)에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        235.00254821777344,
        627.3590087890625,
        242.08253479003906
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품에 관한 특허권(이하 \"의약품특허권\"",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        246.4025421142578,
        625.167236328125,
        253.48252868652344
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이라 한다)이 등재된 의약품(이하 \"등재의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        257.6825256347656,
        625.0833740234375,
        264.76251220703125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품\"이라 한다)의 안전성·유효성에 관한 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        269.0825500488281,
        625.083984375,
        276.16253662109375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "료를 근거로 의약품의 제조판매·수입 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        280.4825439453125,
        625.0838623046875,
        287.5625305175781
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가를 신청하는 경우에는 별지 제5호서식의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        291.7625427246094,
        627.3583984375,
        298.842529296875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특허관계 확인서와 그 사유를 적은 서류 및",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        303.16253662109375,
        627.3590087890625,
        310.2425231933594
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "근거자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        314.5625305175781,
        510.60345458984375,
        321.64251708984375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11. 신약, 희귀의약품(적절한 대체의약품이 없",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        325.842529296875,
        625.083984375,
        332.9225158691406
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "어 긴급히 도입하여야 하는 의약품으로서 식",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        337.2425537109375,
        625.083984375,
        344.3225402832031
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품의약품안전처장이 정하는 의약품을 말하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        348.6425476074219,
        625.0838623046875,
        355.7225341796875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "며, 이하 같다) 등 식품의약품안전처장이 정",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        359.92254638671875,
        625.083984375,
        367.0025329589844
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는 의약품의 경우에는 환자용 사용설명서,",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        371.3225402832031,
        627.35888671875,
        378.40252685546875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전사용보장조치 등 식품의약품안전처장이",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        382.7225341796875,
        627.3574829101562,
        389.8025207519531
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정하는 위해성 완화 조치방법을 포함하는 종",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        394.0025329589844,
        625.083984375,
        401.08251953125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "합적인 의약품 안전관리 계획(이하 \"위해성",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        405.40252685546875,
        627.3587646484375,
        412.4825134277344
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관리 계획\"이라 한다)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        416.80255126953125,
        551.2219848632812,
        423.8825378417969
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 제1항에도 불구하고 다음 각 호의 어느 하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        428.0825500488281,
        625.083984375,
        435.16253662109375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나에 해당하는 경우에는 각 호의 구분에 따른",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        439.4825439453125,
        627.35888671875,
        446.5625305175781
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료를",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        450.8825378417969,
        627.119873046875,
        457.9625244140625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제출하지",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        450.8825378417969,
        627.119873046875,
        457.9625244140625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니할",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        450.8825378417969,
        627.119873046875,
        457.9625244140625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        450.8825378417969,
        627.119873046875,
        457.9625244140625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        450.8825378417969,
        627.119873046875,
        457.9625244140625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<개정",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        450.8825378417969,
        627.119873046875,
        457.9625244140625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2014.10.10.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        462.1805725097656,
        515.2322998046875,
        468.5405578613281
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제1항제1호 또는 제2호에 해당하는 자료로",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        472.4825439453125,
        625.08349609375,
        479.5625305175781
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서 적합하다는 제41조제3항에 따른 사전 검",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        483.7625427246094,
        625.083984375,
        490.842529296875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "토 결과통지서를 제출한 경우: 제1항제1호",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        495.16253662109375,
        627.3590087890625,
        502.2425231933594
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는 제2호에 해당하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        506.56256103515625,
        573.2438354492188,
        513.642578125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 품목허가를 신청하는 품목(신약, 생물학적제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        517.842529296875,
        625.083251953125,
        524.9225463867188
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제등, 주사제, 이식제, 그 밖에 식품의약품안",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        529.2425537109375,
        625.0829467773438,
        536.3225708007812
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전처장이 고시하는 의약품은 제외한다)을 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        53.202537536621094,
        799.56396484375,
        60.28253936767578
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조하는 제조소에 제48조의2에 따른 제조 및",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        64.6025390625,
        801.8389892578125,
        71.68254089355469
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품질관리 적합판정서가 있는 경우: 제1항제6",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        76.0025405883789,
        799.5175170898438,
        83.0825424194336
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "호에 해당하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        87.28253936767578,
        719.4038696289062,
        94.36254119873047
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 식품의약품안전처장이 고시하는 기준에 적합",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        98.68253326416016,
        799.5635986328125,
        105.76253509521484
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 경우: 제1항제4호에 해당하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        110.08253479003906,
        778.3238525390625,
        117.16253662109375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 제1항에도 불구하고 기업의 분리 또는 합병",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        121.36253356933594,
        801.838623046875,
        128.44253540039062
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등에 의하여 해당 제조시설·제조방법 등을 양",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        132.76254272460938,
        799.4439697265625,
        139.842529296875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수받은 품목의 제조판매·수입 품목허가를 받",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        144.16253662109375,
        799.56396484375,
        151.24252319335938
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "으려는 자의 경우에는 제1항 각 호의 어느 하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        155.44253540039062,
        799.56396484375,
        162.52252197265625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나에 해당하는 첨부서류를 갈음하여 품목의 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        166.84254455566406,
        799.4439697265625,
        173.9225311279297
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조시설·제조방법 등에 관한 양도·양수계약서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        178.24253845214844,
        799.5632934570312,
        185.32252502441406
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "를 제출할 수 있다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        189.5225372314453,
        710.1116943359375,
        196.60252380371094
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "④ 제3항에 따른 해당 품목의 허가 시에는 양",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        200.92254638671875,
        799.56396484375,
        208.00253295898438
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "도인에 대한 제조판매·수입 품목허가에 붙여",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        212.32254028320312,
        799.5635986328125,
        219.40252685546875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "진 조건에 상응하는 조건을 붙일 수 있다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        223.6025390625,
        782.3516845703125,
        230.68252563476562
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑤ 식품의약품안전처장은 법 제31조제2항부터",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        235.00254821777344,
        801.8385009765625,
        242.08253479003906
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제4항까지 또는 법 제42조제1항에 따른 의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        246.4025421142578,
        799.5635986328125,
        253.48252868652344
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품등의 제조판매·수입 품목허가를 위하여 필",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        257.6825256347656,
        799.56396484375,
        264.76251220703125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요하다고 인정하는 경우에는 식품의약품안전평",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        269.0825500488281,
        799.5626831054688,
        276.16253662109375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가원의 의견을 듣거나 법 제18조제1항에 따른",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        280.4825439453125,
        801.838623046875,
        287.5625305175781
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중앙약사심의위원회에 자문을 할 수 있다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        291.7625427246094,
        782.3516845703125,
        298.842529296875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑥ 제1항에 따라 허가를 신청하는 자는 식품의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        303.16253662109375,
        799.4437255859375,
        310.2425231933594
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품안전처장이 정하여 고시하는 수수료(외국",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        314.5625305175781,
        799.5635986328125,
        321.64251708984375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에서 현지실사를 할 필요가 있는 경우에는 이",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        325.842529296875,
        799.4439697265625,
        332.9225158691406
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 드는 경비를 포함한다)를 내야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        337.2425537109375,
        775.3916625976562,
        344.3225402832031
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[시행일 : 2015.7.1.] 제4조",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        348.66058349609375,
        728.284423828125,
        355.02056884765625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제5조(제조판매ᆞ수입 품목의 신고) ① 법 제31",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        362.4425354003906,
        799.5174560546875,
        369.52252197265625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조제2항ᆞ제4항 또는 법 제42조제1항에 따라",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        373.7225341796875,
        801.838623046875,
        380.8025207519531
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신고를 하여야 하는 의약품등의 품목은 다음 각",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        385.1225280761719,
        801.8389892578125,
        392.2025146484375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "호와 같다. 다만, 제4조제1항제1호에 따라 안전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        396.5225524902344,
        799.44384765625,
        403.6025390625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성ᆞ유효성에 관한 자료를 제출하여야 하는 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        407.80255126953125,
        799.56396484375,
        414.8825378417969
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목, 제4조제1항제10호에 따라 등재의약품의 안",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        419.2025451660156,
        799.56396484375,
        426.28253173828125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전성ᆞ유효성에 관한 자료를 근거로 신청하는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        430.6025390625,
        801.83837890625,
        437.6825256347656
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품, 제11조에 따라 제조판매ᆞ수입 품목허",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        441.8825378417969,
        799.5635375976562,
        448.9625244140625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가와 품목신고가 제한되는 품목, 생물학적제제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        453.28253173828125,
        799.5629272460938,
        460.3625183105469
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등 및 방사성의약품은 제외한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        648.1199951171875,
        464.6825256347656,
        749.711669921875,
        471.76251220703125
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 대한민국약전 또는 식품의약품안전처장이 인",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        475.9625244140625,
        799.56396484375,
        483.0425109863281
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정하는 공정서 및 의약품집에 실려 있는 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        487.362548828125,
        799.4439697265625,
        494.4425354003906
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목. 다만, 국내에서 허가되지 아니한 품목은",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        498.7625427246094,
        801.8385009765625,
        505.842529296875
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제외한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        510.04254150390625,
        687.0716552734375,
        517.12255859375
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 대한민국약전외한약(생약)규격집에 실려 있",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        521.4425048828125,
        799.56396484375,
        528.5225219726562
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        532.842529296875,
        681.6038818359375,
        539.9225463867188
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 29 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 식품의약품안전처장이 성분의 종류ᆞ규격ᆞ",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        53.202537536621094,
        204.1232452392578,
        60.28253936767578
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량 및 처방 등을 표준화하여 고시한 표준",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        64.6025390625,
        204.12388610839844,
        71.68254089355469
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조기준에 맞는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        76.0025405883789,
        130.80389404296875,
        83.0825424194336
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 식품의약품안전처장이 따로 기준 및 시험방",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        87.28253936767578,
        204.12355041503906,
        94.36254119873047
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "법을 고시한 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        98.68253326416016,
        117.12388610839844,
        105.76253509521484
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 식품의약품안전처장이 신고대상품목으로 고",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        110.08253479003906,
        204.12399291992188,
        117.16253662109375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시한 의약품등",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        121.36253356933594,
        106.8034439086914,
        128.44253540039062
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 제1항에 따라 의약품등의 제조판매ᆞ수입",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        132.76254272460938,
        206.3979034423828,
        139.842529296875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목신고를 하려는 자는 별지 제6호서식의 의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        144.16253662109375,
        204.12399291992188,
        151.24252319335938
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품등 제조판매ᆞ수입 품목신고서(전자문서로",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        155.44253540039062,
        206.39834594726562,
        162.52252197265625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "된 신고서를 포함한다)에 다음 각 호의 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        166.84254455566406,
        204.12388610839844,
        173.9225311279297
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(전자문서를 포함한다)를 첨부하여 지방청장에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        178.24253845214844,
        204.12335205078125,
        185.32252502441406
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "게 제출하여야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        189.5225372314453,
        118.1517105102539,
        196.60252380371094
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제1항에 따른 신고품목임을 입증하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        200.92254638671875,
        197.2838897705078,
        208.00253295898438
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 제4조제1항제2호에 따른 자료(이 조 제1항",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        212.32254028320312,
        204.12399291992188,
        219.40252685546875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제3호에 따른 품목 중 제48조제5호에 따른",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        223.6025390625,
        206.39889526367188,
        230.68252563476562
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "별표 1의 의약품 제조 및 품질관리기준에 적",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        235.00254821777344,
        204.12399291992188,
        242.08253479003906
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "합하다는 판정을 받지 못한 품목 및 이 조",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        246.4025421142578,
        206.39898681640625,
        253.48252868652344
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제1항제5호에 따른 품목만 해당한다)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        257.6825256347656,
        180.6619873046875,
        264.76251220703125
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 제4조제1항제3호 및 제5호에 해당하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        269.0825500488281,
        204.12388610839844,
        276.16253662109375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(법 제27조제2항제1호에 따라 의약품 동등",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        280.4825439453125,
        204.12388610839844,
        287.5625305175781
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성의 입증이 필요하다고 식품의약품안전처장",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        291.7625427246094,
        204.12269592285156,
        298.842529296875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 정한 의약품만 해당한다)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        303.16253662109375,
        151.5019989013672,
        310.2425231933594
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 제4조제1항제4호에 따른 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        314.5625305175781,
        157.6838836669922,
        321.64251708984375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 제4조제1항제6호에 따른 자료(이 조 제1항",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        325.842529296875,
        204.12399291992188,
        332.9225158691406
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제3호에 따른 품목은 제외한다)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        337.2425537109375,
        162.6619873046875,
        344.3225402832031
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 제4조제1항제7호부터 제9호까지에 따른 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        348.6425476074219,
        204.12399291992188,
        355.7225341796875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        62.15999984741211,
        359.92254638671875,
        69.00399780273438,
        367.0025329589844
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 기업의 분리 또는 합병 등에 의하여 해당 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        371.3225402832031,
        204.12399291992188,
        378.40252685546875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조시설ᆞ제조방법 등을 양수한 품목에 대한 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        382.7225341796875,
        204.12399291992188,
        389.8025207519531
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조판매ᆞ수입 품목신고를 하려는 자의 경우에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        394.0025329589844,
        204.123779296875,
        401.08251953125
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 제2항에 따른 첨부서류 또는 자료를 갈음하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        405.40252685546875,
        204.123779296875,
        412.4825134277344
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여 그 품목의 제조시설ᆞ제조방법 등에 관한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        416.80255126953125,
        206.39889526367188,
        423.8825378417969
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양도ᆞ양수계약서를 제출할 수 있다. 다만, 별",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        428.0825500488281,
        204.12399291992188,
        435.16253662109375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 1의 의약품 제조 및 품질관리기준 실시상황",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        439.4825439453125,
        206.39845275878906,
        446.5625305175781
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가가 필요한 경우에는 제4조제1항제6호의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        450.8825378417969,
        206.39889526367188,
        457.9625244140625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료를 제출하여야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        462.16253662109375,
        131.9517059326172,
        469.2425231933594
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "④ 제2항에 따라 신고를 하는 자는 식품의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        473.5625305175781,
        204.12335205078125,
        480.64251708984375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전처장이 정하여 고시하는 수수료(외국에서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        484.9625244140625,
        206.39845275878906,
        492.0425109863281
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "현지실사를 할 필요가 있는 경우에는 이에 드",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        496.2425231933594,
        204.12399291992188,
        503.322509765625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 경비를 포함한다)를 내야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        507.64251708984375,
        162.91171264648438,
        514.7225341796875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제5조(제조판매·수입 품목의 신고) ① 법 제31",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        522.5225219726562,
        204.07765197753906,
        529.6025390625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조제2항·제4항 또는 법 제42조제1항에 따라",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        533.9225463867188,
        206.39889526367188,
        541.0025634765625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신고를 하여야 하는 의약품등의 품목은 다음 각",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        53.202537536621094,
        380.8790283203125,
        60.28253936767578
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "호와 같다. 다만, 제4조제1항제1호에 따라 안전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        64.6025390625,
        378.48388671875,
        71.68254089355469
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성·유효성에 관한 자료를 제출하여야 하는 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        76.0025405883789,
        378.6039733886719,
        83.0825424194336
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목, 제4조제1항제10호에 따라 등재의약품의 안",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        87.28253936767578,
        378.6039733886719,
        94.36254119873047
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전성·유효성에 관한 자료를 근거로 신청하는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        98.68253326416016,
        380.8785095214844,
        105.76253509521484
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품, 제11조에 따라 제조판매·수입 품목허",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        110.08253479003906,
        378.60357666015625,
        117.16253662109375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가와 품목신고가 제한되는 품목, 생물학적제제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        121.36253356933594,
        378.60308837890625,
        128.44253540039062
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등 및 방사성의약품은 제외한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        132.76254272460938,
        328.7516784667969,
        139.842529296875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 대한민국약전 또는 식품의약품안전처장이 인",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        144.16253662109375,
        378.6039733886719,
        151.24252319335938
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정하는 공정서 및 의약품집에 실려 있는 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        155.44253540039062,
        378.4839782714844,
        162.52252197265625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목. 다만, 국내에서 허가되지 아니한 품목은",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        166.84254455566406,
        380.87860107421875,
        173.9225311279297
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제외한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        178.24253845214844,
        266.1116943359375,
        185.32252502441406
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 대한민국약전외한약(생약)규격집에 실려 있",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        189.5225372314453,
        378.6039733886719,
        196.60252380371094
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        200.92254638671875,
        260.6439208984375,
        208.00253295898438
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 식품의약품안전처장이 성분의 종류·규격·",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        212.32254028320312,
        378.6039733886719,
        219.40252685546875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함량 및 처방 등을 표준화하여 고시한 표준",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        223.6025390625,
        378.48388671875,
        230.68252563476562
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조기준에 맞는 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        235.00254821777344,
        305.2839050292969,
        242.08253479003906
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 식품의약품안전처장이 따로 기준 및 시험방",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        246.4025421142578,
        378.4837951660156,
        253.48252868652344
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "법을 고시한 품목",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        257.6825256347656,
        291.6036682128906,
        264.76251220703125
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 식품의약품안전처장이 신고대상품목으로 고",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        269.0825500488281,
        378.6039733886719,
        276.16253662109375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시한 의약품등",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        280.4825439453125,
        281.2834777832031,
        287.5625305175781
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 제1항에 따라 의약품등의 제조판매·수입",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        291.7625427246094,
        380.8786926269531,
        298.842529296875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목신고를 하려는 자는 별지 제6호서식의 의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        303.16253662109375,
        378.6039733886719,
        310.2425231933594
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품등 제조판매·수입 품목신고서(전자문서로",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        314.5625305175781,
        380.87841796875,
        321.64251708984375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "된 신고서를 포함한다)에 다음 각 호의 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        325.842529296875,
        378.6036682128906,
        332.9225158691406
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(전자문서를 포함한다)를 첨부하여 지방청장에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        337.2425537109375,
        378.6033935546875,
        344.3225402832031
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "게 제출하여야 한다. <개정 2014.8.21.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        348.6425476074219,
        351.3124084472656,
        355.7225341796875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제1항에 따른 신고품목임을 입증하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        359.92254638671875,
        371.6438903808594,
        367.0025329589844
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 제4조제1항제2호에 따른 자료(이 조 제1항",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        371.3225402832031,
        378.4839782714844,
        378.40252685546875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제3호에 따른 품목 중 제48조제5호에 따른",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        382.7225341796875,
        380.8786926269531,
        389.8025207519531
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "별표 1의 의약품 제조 및 품질관리기준에 적",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        394.0025329589844,
        378.6039733886719,
        401.08251953125
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "합하다는 판정을 받지 못한 품목 및 이 조",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        405.40252685546875,
        380.8787841796875,
        412.4825134277344
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제1항제5호에 따른 품목만 해당한다)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        416.80255126953125,
        355.1419982910156,
        423.8825378417969
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 제4조제1항제3호 및 제5호에 해당하는 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        428.0825500488281,
        378.48388671875,
        435.16253662109375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(법 제27조제2항제1호에 따라 의약품 동등",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        439.4825439453125,
        378.6036682128906,
        446.5625305175781
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성의 입증이 필요하다고 식품의약품안전처장",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        450.8825378417969,
        378.6025695800781,
        457.9625244140625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 정한 의약품만 해당한다)",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        462.16253662109375,
        325.98199462890625,
        469.2425231933594
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 제4조제1항제4호에 따른 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        473.5625305175781,
        332.1639099121094,
        480.64251708984375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 제4조제1항제6호에 따른 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        484.9625244140625,
        332.1639099121094,
        492.0425109863281
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 제4조제1항제7호부터 제9호까지에 따른 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        496.2425231933594,
        378.6039733886719,
        503.322509765625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        507.64251708984375,
        243.48399353027344,
        514.7225341796875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 기업의 분리 또는 합병 등에 의하여 해당 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        519.0425415039062,
        378.4839782714844,
        526.12255859375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조시설·제조방법 등을 양수한 품목에 대한 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        530.322509765625,
        378.4839782714844,
        537.4025268554688
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 30 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조판매·수입 품목신고를 하려는 자의 경우에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        53.202537536621094,
        625.083740234375,
        60.28253936767578
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 제2항에 따른 첨부서류 또는 자료를 갈음하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        64.6025390625,
        625.083740234375,
        71.68254089355469
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여 그 품목의 제조시설·제조방법 등에 관한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        76.0025405883789,
        627.35888671875,
        83.0825424194336
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양도·양수계약서를 제출할 수 있다. 다만, 별",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        87.28253936767578,
        625.083984375,
        94.36254119873047
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 1, 별표 1의2, 별표 2 또는 별표 3의3의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        98.68253326416016,
        627.3590087890625,
        105.76253509521484
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조 및 품질관리기준 실시상황 평가가 필요한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        110.08253479003906,
        627.3585205078125,
        117.16253662109375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우에는 제4조제1항제6호의 자료를 제출하여",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        121.36253356933594,
        625.0833740234375,
        128.44253540039062
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "야 한다. <개정 2014.8.21.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        132.76254272460938,
        560.1122436523438,
        139.842529296875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "④ 제2항에 따라 신고를 하는 자는 식품의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        144.16253662109375,
        625.083251953125,
        151.24252319335938
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전처장이 정하여 고시하는 수수료(외국에서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        155.44253540039062,
        627.3583984375,
        162.52252197265625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "현지실사를 할 필요가 있는 경우에는 이에 드",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        166.84254455566406,
        625.083984375,
        173.9225311279297
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 경비를 포함한다)를 내야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        475.3199768066406,
        178.24253845214844,
        583.8717041015625,
        185.32252502441406
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[시행일 : 2015.7.1.] 제5조",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        189.54058837890625,
        553.804443359375,
        195.9005889892578
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제8조(허가사항 등의 변경허가 신청 등) ① 법",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        203.32254028320312,
        627.3590087890625,
        210.40252685546875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제31조제9항 또는 법 제42조에 따라 의약품등",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        214.7225341796875,
        625.0833740234375,
        221.80252075195312
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 제조업자ᆞ수입자 또는 위탁제조판매업자가",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        226.12254333496094,
        627.3576049804688,
        233.20252990722656
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그 허가받거나 신고한 사항을 변경하려는 경우",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        237.4025421142578,
        625.0838623046875,
        244.48252868652344
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제4조제1항제7호 각 목 외의 부분 본문 또는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        248.8025360107422,
        627.35888671875,
        255.8825225830078
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제5조제2항제6호에 따라 제4조제1항제7호 각",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        260.2025451660156,
        627.3590087890625,
        267.28253173828125
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목의 자료를 제출한 경우에는 그 자료를 변경하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        271.4825439453125,
        625.083740234375,
        278.5625305175781
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 경우를 포함하며, 법 제89조제3항에 따른",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        282.8825378417969,
        627.35888671875,
        289.9625244140625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지위승계 신고 대상에 해당하는 변경은 제외한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        294.28253173828125,
        625.083740234375,
        301.3625183105469
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다)에는 다음 각 호의 구분에 따른 신청서(전자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        305.5625305175781,
        625.0838623046875,
        312.64251708984375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "문서로 된 신청서를 포함한다) 또는 신고서(전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        316.9625244140625,
        625.083984375,
        324.0425109863281
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자문서로 된 신고서를 포함한다)에 그 허가증",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        328.362548828125,
        627.3585205078125,
        335.4425354003906
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는 신고증과 변경사유서(전자문서로 된 사유",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        339.6425476074219,
        625.0838623046875,
        346.7225341796875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서를 포함한다) 및 그 근거서류(제4조제1항 각",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        351.04254150390625,
        627.3590087890625,
        358.1225280761719
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "호의 서류를 말하며, 전자문서를 포함한다)를",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        362.4425354003906,
        627.3590087890625,
        369.52252197265625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "첨부하여 식품의약품안전처장(의약품등 제조업",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        373.7225341796875,
        627.3587646484375,
        380.8025207519531
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가ᆞ신고의 변경, 위탁제조판매업 신고의 변",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        385.1225280761719,
        625.083984375,
        392.2025146484375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경, 의약품 동등성의 입증이 필요한 의약품의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        396.5225524902344,
        627.3583984375,
        403.6025390625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조판매ᆞ수입 품목허가의 변경, 안전성ᆞ유효",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        407.80255126953125,
        625.0831298828125,
        414.8825378417969
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성 검토 대상이 아닌 의약외품의 제조판매ᆞ수",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        419.2025451660156,
        625.0831298828125,
        426.28253173828125
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입 품목허가의 변경, 의약품등 제조판매ᆞ수입",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        430.6025390625,
        627.3577880859375,
        437.6825256347656
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목신고의 변경을 하려는 경우에는 지방청장을",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        441.8825378417969,
        627.3582763671875,
        448.9625244140625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "말한다)에게 제출하여야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        473.6399841308594,
        453.28253173828125,
        568.3916625976562,
        460.3625183105469
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제조업의 변경: 별지 제2호서식의 의약외품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        464.6825256347656,
        627.3583984375,
        471.76251220703125
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조업 변경신고서 또는 별지 제7호서식의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        475.9625244140625,
        627.3583984375,
        483.0425109863281
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품등의 제조업 허가사항 변경허가 신청",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        487.362548828125,
        625.0838623046875,
        494.4425354003906
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        498.7625427246094,
        489.9639892578125,
        505.842529296875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 위탁제조판매업의 변경: 별지 제3호서식의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        510.04254150390625,
        627.3583984375,
        517.12255859375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품 위탁제조판매업 변경신고서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        483.1199951171875,
        521.4425048828125,
        593.0432739257812,
        528.5225219726562
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 품목의 변경: 별지 제6호서식의 의약품등 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        466.79998779296875,
        532.842529296875,
        625.083984375,
        539.9225463867188
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조판매ᆞ수입 품목신고 변경신고서 또는 별",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        53.202537536621094,
        799.56396484375,
        60.28253936767578
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지 제8호서식의 의약품등 제조판매ᆞ수입 품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        64.6025390625,
        799.56396484375,
        71.68254089355469
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목 허가사항 변경허가 신청서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        76.0025405883789,
        750.363525390625,
        83.0825424194336
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 제1항의 경우에 법인의 대표자를 변경하려",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        87.28253936767578,
        799.443603515625,
        94.36254119873047
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 경우에는 변경신청서나 변경신고서에 대표",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        98.68253326416016,
        799.5635986328125,
        105.76253509521484
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자가 법 제5조제1호 본문에 해당되는 사람이",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        110.08253479003906,
        801.8385009765625,
        117.16253662109375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아님을 증명하는 의사의 진단서 또는 같은 호",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        121.36253356933594,
        801.8387451171875,
        128.44253540039062
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "단서에 해당하는 사람임을 증명하는 전문의의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        132.76254272460938,
        801.83837890625,
        139.842529296875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "진단서 및 같은 조 제3호에 해당되는 사람이",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        144.16253662109375,
        801.8385009765625,
        151.24252319335938
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아님을 증명하는 의사의 진단서를 첨부하여야",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        155.44253540039062,
        801.8382568359375,
        162.52252197265625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        166.84254455566406,
        665.4716796875,
        173.9225311279297
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 제1항에도 불구하고 식품의약품안전처장 또",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        178.24253845214844,
        799.56396484375,
        185.32252502441406
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 지방청장은 다음 각 호의 어느 하나에 해당",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        189.5225372314453,
        799.5635986328125,
        196.60252380371094
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는 경우 그 검토 결과 이미 제조판매ᆞ수입",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        200.92254638671875,
        801.8378295898438,
        208.00253295898438
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품목허가 또는 품목신고한 사항을 변경할 필요",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        212.32254028320312,
        799.44384765625,
        219.40252685546875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가 있어 법 제76조제1항 각 호 외의 부분 단",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        223.6025390625,
        799.56396484375,
        230.68252563476562
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서에 따라 일정기한까지 품목의 변경을 명령한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        235.00254821777344,
        801.8385009765625,
        242.08253479003906
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우에는 식품의약품안전처장 또는 지방청장이",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        246.4025421142578,
        801.8382568359375,
        253.48252868652344
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "변경허가를 하거나 변경신고를 수리한 것으로",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        257.6825256347656,
        801.8385009765625,
        264.76251220703125
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본다. <개정 2014.8.21.>",
      "font_size": 6.241110801696777,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        269.0825500488281,
        724.1521606445312,
        276.16253662109375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 법 제31조의5(법 제42조제4항에 따라 준용",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        280.4825439453125,
        799.44384765625,
        287.5625305175781
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "되는 경우를 포함한다)에 따른 의약품 제조",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        291.7625427246094,
        799.5635986328125,
        298.842529296875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "판매ᆞ수입 품목허가 및 품목신고의 갱신",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        303.16253662109375,
        788.1636352539062,
        310.2425231933594
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 법 제32조에 따른 신약 등의 재심사",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        314.5625305175781,
        772.9235229492188,
        321.64251708984375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 법 제33조에 따른 의약품 재평가",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        325.842529296875,
        762.603515625,
        332.9225158691406
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 제4조, 이 조 및 제41조에 따른 안전성ᆞ유",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        337.2425537109375,
        799.5632934570312,
        344.3225402832031
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "효성에 관한 자료 검토",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        348.6425476074219,
        729.7236328125,
        355.7225341796875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 제48조제3호에 따른 안전성 정보 보고",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        359.92254638671875,
        780.6038818359375,
        367.0025329589844
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 의약품의 적정사용 정보제공을 위한 안전성",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        371.3225402832031,
        799.4437255859375,
        378.40252685546875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과 효능ᆞ효과 등에 대한 평가",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        382.7225341796875,
        753.723876953125,
        389.8025207519531
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 대한민국약전 및 법 제52조에 따른 의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        394.0025329589844,
        799.5635375976562,
        401.08251953125
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등의 기준 개정",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        405.40252685546875,
        705.6038818359375,
        412.4825134277344
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. 의약품의 분류 등 국민보건을 위하여 필요하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        416.80255126953125,
        799.5635375976562,
        423.8825378417969
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다고 판단하여 실시한 안전성ᆞ유효성에 관",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        428.0825500488281,
        799.56396484375,
        435.16253662109375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 자료 검토",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        657.5999755859375,
        439.4825439453125,
        698.7638549804688,
        446.5625305175781
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "④ 제1항에도 불구하고 품질에 영향을 미치지",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        641.2799682617188,
        450.8825378417969,
        801.8385009765625,
        457.9625244140625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니하는 색상ᆞ포장재질 또는 제조원의 명칭",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        462.16253662109375,
        801.838623046875,
        469.2425231933594
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "변경 등 식품의약품안전처장이 정하여 고시하",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        473.5625305175781,
        799.5635375976562,
        480.64251708984375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 경미한 사항인 경우에는 식품의약품안전처",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        484.9625244140625,
        799.5626831054688,
        492.0425109863281
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "장이 정하여 고시하는 바에 따라 변경내용을",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        496.2425231933594,
        801.8382568359375,
        503.322509765625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적은 문서(전자문서를 포함한다)를 식품의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        507.64251708984375,
        799.5632934570312,
        514.7225341796875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전처장 또는 지방청장에게 제출하여야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        519.0425415039062,
        801.8392944335938,
        526.12255859375
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 경우 법 제31조제9항 또는 법 제42조에 따",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        649.7999877929688,
        530.322509765625,
        799.4439697265625,
        537.4025268554688
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 31 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라 변경허가를 받거나 변경신고를 한 것으로",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        53.202537536621094,
        206.3985595703125,
        60.28253936767578
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        64.6025390625,
        70.0317153930664,
        71.68254089355469
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑤ 제1항에 따른 신청서ᆞ신고서 또는 변경신",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        76.0025405883789,
        204.12355041503906,
        83.0825424194336
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "청서ᆞ변경신고서를 받은 식품의약품안전처장",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        87.28253936767578,
        206.397705078125,
        94.36254119873047
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는 지방청장은 「전자정부법」 제36조제1항",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        98.68253326416016,
        204.12399291992188,
        105.76253509521484
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 따른 행정정보의 공동이용을 통하여 법인",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        110.08253479003906,
        206.39889526367188,
        117.16253662109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등기사항증명서(법인인 경우만 해당한다)를 확",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        121.36253356933594,
        204.12399291992188,
        128.44253540039062
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인하여야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        132.76254272460938,
        100.99171447753906,
        139.842529296875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑥ 식품의약품안전처장 또는 지방청장은 제1항",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        144.16253662109375,
        204.12399291992188,
        151.24252319335938
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 따라 변경허가를 하거나 변경신고를 받을",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        155.44253540039062,
        206.39889526367188,
        162.52252197265625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우 또는 제103조제1항에 따라 지위 승계 신",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        166.84254455566406,
        204.12399291992188,
        173.9225311279297
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고를 받은 경우에는 제13조에 따른 허가대장ᆞ",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        178.24253845214844,
        204.12335205078125,
        185.32252502441406
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신고대장, 허가증ᆞ신고증에 변경사항을 적어야",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        189.5225372314453,
        206.3985595703125,
        196.60252380371094
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        200.92254638671875,
        70.0317153930664,
        208.00253295898438
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑦ 제1항에 따른 신청이나 신고를 하는 자는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        212.32254028320312,
        206.39889526367188,
        219.40252685546875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전처장이 정하여 고시하는 수수료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        223.6025390625,
        204.123779296875,
        230.68252563476562
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "를 내야 한다. 다만, 행정구역개편에 따라 소재",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        235.00254821777344,
        204.12388610839844,
        242.08253479003906
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지가 변경되는 경우에는 이를 적용하지 아니한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        246.4025421142578,
        204.12355041503906,
        253.48252868652344
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        257.6825256347656,
        63.191707611083984,
        264.76251220703125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⑧ 제1항에 따라 제조소의 소재지를 변경하는",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        269.0825500488281,
        206.39845275878906,
        276.16253662109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우에는 제48조제5호를 준용한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        54.36000061035156,
        280.4825439453125,
        165.4317169189453,
        287.5625305175781
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제9조(안전성ᆞ유효성에 관한 자료) 의약품등의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        295.362548828125,
        206.39834594726562,
        302.4425354003906
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조판매ᆞ수입 품목허가 또는 품목변경허가를",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        306.7625427246094,
        206.3979034423828,
        313.842529296875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "받거나 제조판매ᆞ수입 품목신고 또는 품목변경",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        318.04254150390625,
        204.12344360351562,
        325.1225280761719
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신고를 하려는 자가 제출하여야 하는 안전성ᆞ",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        329.4425354003906,
        204.12344360351562,
        336.52252197265625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유효성에 관한 자료는 다음 각 호의 자료(전자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        340.842529296875,
        204.12388610839844,
        347.9225158691406
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "문서를 포함한다)로 한다. 이 경우 자료제출 대",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        352.1225280761719,
        204.12399291992188,
        359.2025146484375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상 품목, 자료 작성요령, 각 자료의 요건 및 면",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        363.5225524902344,
        204.12399291992188,
        370.6025390625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제범위ᆞ심사기준 등에 관한 세부 규정과 독성",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        374.92254638671875,
        206.39889526367188,
        382.0025329589844
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 약리작용 등에 관한 자료의 작성을 위하여",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        386.2025451660156,
        206.3985595703125,
        393.28253173828125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실시하는 비임상시험의 관리에 필요한 사항은",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        397.6025390625,
        206.39878845214844,
        404.6825256347656
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전처장이 정하여 고시하는 바에 따",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        409.0025329589844,
        204.12399291992188,
        416.08251953125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "른다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        52.68000030517578,
        420.28253173828125,
        68.47171020507812,
        427.3625183105469
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 기원 또는 발견 및 개발 경위에 관한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        431.6825256347656,
        196.4436492919922,
        438.76251220703125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 구조결정, 물리화학적 성질에 관한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        443.0825500488281,
        188.04388427734375,
        450.16253662109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 안정성에 관한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        454.362548828125,
        124.20388793945312,
        461.4425354003906
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 독성에 관한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        45.84000015258789,
        465.7625427246094,
        117.3638916015625,
        472.842529296875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 약리작용에 관한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        53.202537536621094,
        305.5238952636719,
        60.28253936767578
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 임상시험성적에 관한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        64.6025390625,
        319.32366943359375,
        71.68254089355469
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 외국의 사용현황 등에 관한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        76.0025405883789,
        339.9636535644531,
        83.0825424194336
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. 국내 유사제품과의 비교검토 및 해당 의약품",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        87.28253936767578,
        378.60357666015625,
        94.36254119873047
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등의 특성에 관한 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        236.63999938964844,
        98.68253326416016,
        308.763671875,
        105.76253509521484
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제10조(기준 및 시험방법에 관한 자료) ① 법 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        113.56253814697266,
        378.4839782714844,
        120.64253997802734
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "31조제11항 또는 법 제42조제5항에 따라 의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        124.96253204345703,
        378.48388671875,
        132.0425262451172
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품등의 제조판매ᆞ수입 품목허가 또는 품목변경",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        136.362548828125,
        378.6034851074219,
        143.44253540039062
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가를 받으려는 자는 그 품목의 제조와 품질관",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        147.64254760742188,
        378.60357666015625,
        154.7225341796875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "리를 위한 기준 및 시험방법에 관한 자료를 제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        159.04254150390625,
        378.6039733886719,
        166.12252807617188
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "출하여야 한다. 이 경우 첨부자료의 종류, 자료",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        170.44253540039062,
        380.8786926269531,
        177.52252197265625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "작성요령과 각 자료의 요건 등에 관한 세부 사",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        181.72254943847656,
        378.6039733886719,
        188.8025360107422
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항은 식품의약품안전처장이 고시하는 바에 따른",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        193.12254333496094,
        378.6036682128906,
        200.20252990722656
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        227.1599884033203,
        204.5225372314453,
        235.99171447753906,
        211.60252380371094
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "② 제1항에 따라 기준 및 시험방법에 관한 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        215.8025360107422,
        378.6039733886719,
        222.8825225830078
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "료를 제출하려는 자는 심사대상물품(식품의약",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        227.20254516601562,
        378.6034851074219,
        234.28253173828125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품안전처장이 품질검사를 위하여 특별히 필요",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        238.6025390625,
        378.6036682128906,
        245.68252563476562
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하다고 인정하는 경우에만 해당한다)을 식품의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        249.88253784179688,
        378.60357666015625,
        256.9625244140625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약품안전처장에게 제출하여야 한다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        261.28253173828125,
        340.7516784667969,
        268.3625183105469
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부칙 <총리령 제1089호, 2014.8.21.>",
      "font_size": 6.960999488830566,
      "font_name": "H2gtrE",
      "bbox": [
        220.3199920654297,
        283.9625549316406,
        344.069580078125,
        291.04254150390625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제4조(희귀의약품의 기준 및 시험방법에 관한 자",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        295.362548828125,
        378.6039733886719,
        302.4425354003906
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "료 제출에 관한 경과조치) 이 규칙 시행 전에",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        306.7625427246094,
        380.8786926269531,
        313.842529296875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "종전의 규정에 따라 희귀의약품의 제조판매ᆞ",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        318.04254150390625,
        378.6033935546875,
        325.1225280761719
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수입 품목허가를 신청한 자에 대해서는 제4조",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        329.4425354003906,
        378.6039733886719,
        336.52252197265625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제1항제2호의 개정규정에도 불구하고 종전의",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        340.842529296875,
        380.87860107421875,
        347.9225158691406
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규정에 따른다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        352.1225280761719,
        275.4716796875,
        359.2025146484375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제5조(제조 및 품질관리 실시상황평가에 필요한",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        220.3199920654297,
        363.5225524902344,
        380.87860107421875,
        370.6025390625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료 제출에 관한 경과조치) 이 규칙 시행 전",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        374.92254638671875,
        378.6039733886719,
        382.0025329589844
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 종전의 규정에 따라 의약품등의 제조판매ᆞ",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        386.2025451660156,
        378.4833984375,
        393.28253173828125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수입 품목허가를 신청하거나 이 규칙 시행 당",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        397.6025390625,
        378.4839782714844,
        404.6825256347656
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시 의약품등의 제조판매ᆞ수입 품목신고의 절",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        409.0025329589844,
        378.6039733886719,
        416.08251953125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "차가 진행 중인 경우에 대해서는 제4조제1항제",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        420.28253173828125,
        378.48388671875,
        427.3625183105469
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6호, 제5조제2항제5호 및 같은 조 제3항 단서",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        431.6825256347656,
        378.48388671875,
        438.76251220703125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 개정규정에도 불구하고 종전의 규정에 따른",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        443.0825500488281,
        378.48388671875,
        450.16253662109375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다.",
      "font_size": 6.960999488830566,
      "font_name": "H2mjsM",
      "bbox": [
        228.83999633789062,
        454.362548828125,
        237.6717071533203,
        461.4425354003906
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 32 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부록2. 유럽약전 방사성의약품 번역",
      "font_size": 10.679999351501465,
      "font_name": "H2hdrM",
      "bbox": [
        461.1600036621094,
        50.1123046875,
        623.400146484375,
        60.79230499267578
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(EUROPEAN PHARMACOPOEIA 8.0)",
      "font_size": 10.679999351501465,
      "font_name": "H2hdrM",
      "bbox": [
        469.67999267578125,
        69.31230163574219,
        615.7070922851562,
        79.99230194091797
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "01/2014:0125",
      "font_size": 8.519999504089355,
      "font_name": "T16",
      "bbox": [
        581.0399780273438,
        87.36000061035156,
        624.1629028320312,
        97.57547760009766
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품",
      "font_size": 8.519999504089355,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        519.0,
        103.91812133789062,
        566.2800903320312,
        112.90406036376953
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RADIOPHARMACEUTICAL",
      "font_size": 8.519999504089355,
      "font_name": "T16",
      "bbox": [
        489.9599914550781,
        117.95999908447266,
        595.348876953125,
        128.17547607421875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PREPARATIONS",
      "font_size": 8.519999504089355,
      "font_name": "T16",
      "bbox": [
        510.8399963378906,
        133.3199920654297,
        573.7532958984375,
        143.5354766845703
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        524.760009765625,
        162.73687744140625,
        560.5199584960938,
        170.96343994140625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        524.760009765625,
        162.73687744140625,
        560.5199584960938,
        170.96343994140625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품은 1개 이상의 의학용 방사성 핵종(방사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        175.79998779296875,
        624.120361328125,
        184.28890991210938
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성동위원소)을 포함하는 의약품으로 다음 제제를 포함",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        188.51998901367188,
        624.120361328125,
        197.0089111328125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        201.36000061035156,
        475.8758239746094,
        209.8489227294922
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 방사성 핵종 제너레이터: 특정 방법을 통하여 고정",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        214.07998657226562,
        624.120361328125,
        222.56890869140625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "된 어미방사성핵종(parent radionuclide)으로부터 딸",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        470.2799987792969,
        226.9199981689453,
        624.1199951171875,
        235.40892028808594
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종(daughter radionuclide)을 유출시켜 얻",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        470.2799987792969,
        239.63999938964844,
        624.1199951171875,
        248.12892150878906
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "을 수 있도록 한 방사성의약품 시스템",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        470.2799987792969,
        253.47561645507812,
        583.9207153320312,
        260.94281005859375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 방사성의약품 키트: 보통 사용하기 전에 방사성핵종",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        265.20001220703125,
        624.1209716796875,
        273.68890380859375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과 혼합하거나 재용해하여 사용하는 제제",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        469.91998291015625,
        279.0356140136719,
        593.1603393554688,
        286.5028076171875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 방사성핵종 전구체: 화학물질 전구체에 방사능 표지",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        290.760009765625,
        624.120361328125,
        299.2489013671875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하기 위해 사용하는 방사성핵종을 포함한 물질",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        469.91998291015625,
        304.5956115722656,
        609.3603515625,
        312.06280517578125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 화학물질 전구체: 방사성핵종과 결합하는 방사능이",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        316.32000732421875,
        627.6605834960938,
        324.80889892578125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "없는 물질",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        470.5199890136719,
        330.1556091308594,
        500.28033447265625,
        337.622802734375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종 전구체는 방사능 표지를 위한 용액으로 공",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        342.8756103515625,
        624.1199951171875,
        350.3428039550781
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "급될 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        354.7200012207031,
        501.6758117675781,
        363.2088928222656
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핵종은 원자핵 내 양성자와 중성자 수(원자번호 Z와",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        367.44000244140625,
        627.6599731445312,
        375.92889404296875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "질량수 A에 따라) 또는 그 핵에너지 상태에 의해 특징",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        380.2799987792969,
        624.120361328125,
        388.7688903808594
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지어지는 원자의 종(species)이다. 원소의 동위원소는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        393.0,
        627.6609497070312,
        401.4888916015625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원자번호가 동일하나 질량수가 다른 핵종이다. 양성자",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        405.8399963378906,
        624.1207275390625,
        414.3288879394531
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "와 중성자가 불안정한 배열을 포함하는 핵종은 자연스",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        419.55560302734375,
        624.1203002929688,
        427.0227966308594
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "럽게 안정하게 되거나 지속적인 통계적 확률에 따라",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        432.3955993652344,
        627.6603393554688,
        439.86279296875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또 다른 양성자와 중성자의 불안정한 조합으로 변환될",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        445.1156005859375,
        627.6602783203125,
        452.5827941894531
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "것이다. 이러한 핵종들을 방사성핵종이라고 하는데 전",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        456.9599914550781,
        624.1199951171875,
        465.4488830566406
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자의 불안정한 핵종을 어미방사성핵종이라 하고 후자",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        470.67559814453125,
        624.120361328125,
        478.1427917480469
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 핵종을 딸방사성핵종이라 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        482.5199890136719,
        562.995849609375,
        491.0088806152344
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종의 붕괴 또는 변환 시 하전입자방출",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        496.235595703125,
        624.121337890625,
        503.7027893066406
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(charged particle emission), 전자포획(electron capture,",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        508.0799865722656,
        624.195556640625,
        516.5689086914062
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "EC) 또는 핵이성체전이(isomeric transition, IT)가 수반",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        520.7999877929688,
        624.120361328125,
        529.2889404296875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "될 수 있다. 핵으로부터 방출된 하전입자들은 알파입",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        533.6399536132812,
        624.1207275390625,
        542.12890625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자(헬륨원자(4He)의 핵) 또는 베타입자(전자 또는 양전",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        48.599998474121094,
        803.2803344726562,
        57.68891906738281
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자) 이다. 알파붕괴는 보통 중핵자(Z > 82)와 관련된",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        62.03999328613281,
        803.2807006835938,
        70.52891540527344
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 양성자가 결손된 방사성핵종들은 보통 전자방출",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        74.75999450683594,
        803.2810668945312,
        83.24891662597656
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(emitting electrons)에 의해 붕괴된다. 중성자가 결손된",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        87.5999984741211,
        806.8206787109375,
        96.08892059326172
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종들은 보통 전자포획 또는 양전자방출",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        101.31562042236328,
        803.281005859375,
        108.78280639648438
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(emitting prositrons)에 의해 붕괴된다. 후자의 경우",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        113.15999603271484,
        806.8203125,
        121.64891815185547
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종을 양전자방출핵(positron emitters)이라 한",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        125.87998962402344,
        803.280029296875,
        134.36891174316406
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 양전자들은 주위 전자들과 결합하여 소멸할 때 각",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        138.72000122070312,
        803.280029296875,
        147.20892333984375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각 0.511 MeV의 에너지를 가진 2개의 감마 광자를 방",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        151.4399871826172,
        803.280029296875,
        159.9289093017578
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "출하는데, 일반적으로 서로 180° 방향으로 방출한다",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        164.27999877929688,
        806.821044921875,
        172.7760009765625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(소멸방사선,",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        177.0,
        803.2806396484375,
        185.48892211914062
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "annihilation radiation). 모든 붕괴형식",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        177.0,
        803.2806396484375,
        185.48892211914062
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(decay modes)은 감마선 방출을 수반하는데, 감마선",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        189.83999633789062,
        806.8206787109375,
        198.32891845703125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방출 대신 부분적으로 또는 완전하게 내부전환전자",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        203.5556182861328,
        803.2813720703125,
        211.02281188964844
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(internal conversion electrons)로 알려진 전자의 방출",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        215.39999389648438,
        803.2803344726562,
        223.888916015625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로 대체될 수도 있다. 전자포획 과정과 동일하게 이러",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        228.1199951171875,
        803.2803344726562,
        236.60891723632812
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 현상은 원자 내 전자의 재편성으로 인한 이차적인",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        241.9556121826172,
        806.821044921875,
        249.4228057861328
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "X-선의 방출을 일으키고, 이러한 이차 방출은 스스로",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        253.6799774169922,
        806.8206787109375,
        262.16888427734375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부분적으로 오제전자(Auger electrons)로 알려진 전자",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        266.52001953125,
        803.2803344726562,
        275.0089111328125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 방출로 대체될 수도 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        279.2400207519531,
        725.9558715820312,
        287.7289123535156
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사능(Radioactivity): 일반적으로 ‘방사능(성)' 용어는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        304.8000183105469,
        806.8206787109375,
        313.2889099121094
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성붕괴 현상을 설명하거나 이러한 현상의 물리적",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        318.6356201171875,
        803.2807006835938,
        326.1028137207031
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인 양을 표현하는데 사용되었다. 제품의 방사능은 단",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        330.3600158691406,
        803.280029296875,
        338.8489074707031
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위시간 당 붕괴 또는 변환되는 핵의 수이다. 국제단위",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        343.20001220703125,
        803.2810668945312,
        351.68890380859375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "계(SI)로 방사능은 베크렐(Bq)로 나타내며, 1 베크렐은",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        355.9200134277344,
        806.821044921875,
        364.4089050292969
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1초 당 하나의 원자핵이 붕괴하는 것이다. 절대적인",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        368.760009765625,
        806.8206176757812,
        377.2489013671875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사능 측정은 전문적인 연구소가 필요하지만 관계기",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        382.4756164550781,
        803.2807006835938,
        389.94281005859375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관에서 인정한 연구소에서 제공된 표준검체와 검체를",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        395.31561279296875,
        806.8206787109375,
        402.7828063964844
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비교하거나 교정된 기기를 사용하여 상대적으로 방사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        408.0356140136719,
        803.2803344726562,
        415.5028076171875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "능 확인 및 정량적인 측정을 수행할 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        419.8800048828125,
        774.4358520507812,
        428.368896484375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성붕괴(Radioactive decay): 어느 방사성핵종이던",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        445.44000244140625,
        806.8216552734375,
        453.92889404296875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각각의 특정 붕괴상수(decay constant)에 해당하는 지",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        458.1600036621094,
        803.280029296875,
        466.6488952636719
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수의 속도(exponential rate)로 붕괴된다. 붕괴 곡선은",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        471.0,
        806.8206787109375,
        479.4888916015625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다음 식에 따라 나타낸다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        483.7200012207031,
        716.3558349609375,
        492.2088928222656
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "At = A0e-λt",
      "font_size": 4.559999942779541,
      "font_name": "T3",
      "bbox": [
        705.5999755859375,
        508.67999267578125,
        737.9174194335938,
        518.6089477539062
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "At = t 시간에서의 방사능",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        534.8399658203125,
        717.8406982421875,
        544.1689453125
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 33 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A0 = 초기 방사능",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        49.19999694824219,
        93.84064483642578,
        58.5289192199707
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "λ = 각 방사성핵종의 특성에 따른 붕괴상수",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        62.03999328613281,
        171.48097229003906,
        70.52891540527344
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "e = 자연로그의 밑",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        74.75999450683594,
        96.23999786376953,
        83.24891662597656
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반감기(T1/2)는 방사성핵종의 방사능이 초기 값의 반으",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        100.31999206542969,
        203.1603240966797,
        109.1474380493164
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로 붕괴되는데 걸리는 시간으로 다음 식과 같이 붕괴",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        114.15562438964844,
        203.1603240966797,
        121.62281036376953
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상수와 관련된다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        125.87998962402344,
        90.43583679199219,
        134.36891174316406
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "T1/2",
      "font_size": 4.559999942779541,
      "font_name": "T3",
      "bbox": [
        94.43999481201172,
        154.4399871826172,
        145.725830078125,
        167.8274383544922
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "=",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        94.43999481201172,
        154.4399871826172,
        145.725830078125,
        167.8274383544922
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ln 2",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        94.43999481201172,
        154.4399871826172,
        145.725830078125,
        167.8274383544922
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "λ",
      "font_size": 7.079999923706055,
      "font_name": "Batang",
      "bbox": [
        137.27999877929688,
        164.5625457763672,
        141.7050018310547,
        171.6425323486328
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 식은 t 시간 경과 후 남은 방사능을 빠르게 예측하",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        192.1199951171875,
        203.16029357910156,
        200.60891723632812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기 위하여 다음과 같이 나타낼 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        204.95999145507812,
        158.23583984375,
        213.44891357421875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "  ",
      "font_size": 8.519999504089355,
      "font_name": "HyhwpEQ",
      "bbox": [
        91.95478057861328,
        241.8173370361328,
        133.8249969482422,
        256.33734130859375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": " ",
      "font_size": 11.698615074157715,
      "font_name": "HyhwpEQ",
      "bbox": [
        128.27999877929688,
        236.65733337402344,
        150.36000061035156,
        250.33734130859375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "",
      "font_size": 3.841764211654663,
      "font_name": "HyhwpEQ",
      "bbox": [
        128.27999877929688,
        236.65733337402344,
        150.36000061035156,
        250.33734130859375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "",
      "font_size": 5.759999752044678,
      "font_name": "HyhwpEQ",
      "bbox": [
        143.39999389648438,
        231.90748596191406,
        145.47561645507812,
        237.66749572753906
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각 방사선의 투과력은 고유의 특성과 에너지에 따라",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        274.2356262207031,
        206.7003173828125,
        281.70281982421875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상당히 다르다. 알파입자는 물질의 수 마이크로 내지",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        286.08001708984375,
        206.7003173828125,
        294.56890869140625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수십 마이크로미터의 두께에서 완전히 흡수된다. 베타",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        298.8000183105469,
        203.1603240966797,
        307.2889099121094
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입자는 물질의 수 밀리미터 내지 수 센티미터의 두께",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        312.6356201171875,
        203.1603240966797,
        320.1028137207031
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에서 완전히 흡수된다. 감마선은 완전히 흡수되거나",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        324.3600158691406,
        206.700927734375,
        332.8489074707031
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "약화되는데 예를 들어 10배로 감소시키는데 수 센티미",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        337.20001220703125,
        203.16029357910156,
        345.68890380859375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "터의 납이 필요할 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        349.9200134277344,
        203.16029357910156,
        358.4089050292969
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "밀도가 높은 흡수체",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        349.9200134277344,
        203.16029357910156,
        358.4089050292969
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(absorbent)를 사용할수록 알파와 베타입자의 범위가",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        362.760009765625,
        206.70028686523438,
        371.2489013671875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "짧아지고 감마선의 약화가 증가한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        375.4800109863281,
        148.51583862304688,
        383.9689025878906
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각 방사성핵종은 고유의 반감기, 방사선 및 에너지 특",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        388.32000732421875,
        203.16000366210938,
        396.80889892578125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성을 가지고 있다. 에너지 단위는 전자볼트(eV), 킬로",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        401.0400085449219,
        203.1603240966797,
        409.5289001464844
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전자볼트(keV) 또는 메가전자볼트(MeV)로 사용한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        413.8800048828125,
        195.3158416748047,
        422.368896484375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종순도(Radionuclidic",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        40.20000076293945,
        439.44000244140625,
        203.1612548828125,
        447.92889404296875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "purity):",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        439.44000244140625,
        203.1612548828125,
        447.92889404296875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        439.44000244140625,
        203.1612548828125,
        447.92889404296875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 총 방사능 중 방사성핵종의 방사능 비율(%)과 관련",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        452.1600036621094,
        203.1603240966797,
        460.6488952636719
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "된다. 각조 규격에 상대적인 잠재적 방사성핵종 불순",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        465.0,
        203.1603240966797,
        473.4888916015625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물들의 기준이 기재되어 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        477.7200012207031,
        129.19583129882812,
        486.2088928222656
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사화학적순도(Radiochemical purity): 방사성의약품",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        503.2799987792969,
        203.1612548828125,
        511.7688903808594
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 존재하는 방사성핵종의 총 방사능 중 목적하는 화",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        517.1156616210938,
        203.16000366210938,
        524.5828247070312
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "합물로 존재하는 방사성핵종의 방사능 비율(%)과 관련",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        528.8399658203125,
        203.1603240966797,
        537.3289184570312
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "된다. 각조 규격에 상대적인 잠재적 방사화학적 불순",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        49.19999694824219,
        382.3203125,
        57.68891906738281
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물들의 기준이 기재되어 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        62.03999328613281,
        308.2358093261719,
        70.52891540527344
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화학적순도(Chemical purity): 화학적순도는 각조 규",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        87.5999984741211,
        382.3199768066406,
        96.08892059326172
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "격에 기재된 화학적 불순물에 대한 기준에 의해 관리",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        101.31562042236328,
        382.3203125,
        108.78280639648438
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "된다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        113.15999603271484,
        233.95584106445312,
        121.64891815185547
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※대한민국약전(KP)에서는 방사성핵종순도, 방사화학적순도, 화학적순",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        219.36000061035156,
        126.1199951171875,
        382.31982421875,
        132.88800048828125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "도에 대해 각각 이핵종, 방사화학적이물, 화학적이물의 용어를 사용.",
      "font_size": 5.639999866485596,
      "font_name": "T8",
      "bbox": [
        224.39999389648438,
        136.3199920654297,
        380.7017822265625,
        143.08799743652344
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동위원소담체(Isotopic",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        219.36000061035156,
        159.1199951171875,
        385.86029052734375,
        167.60891723632812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "carrier):",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        159.1199951171875,
        385.86029052734375,
        167.60891723632812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종의 원소와",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        159.1199951171875,
        385.86029052734375,
        167.60891723632812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동일한 화학적 형태이나 안정형 동위원소가 포함된 담",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        172.9556121826172,
        382.3199768066406,
        180.4228057861328
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체로서 방사성제제에 존재하거나 추가하는 물질",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        185.6756134033203,
        360.4799499511719,
        193.14280700683594
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무담체제제(Carrier-free",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        219.36000061035156,
        210.239990234375,
        385.86029052734375,
        218.72891235351562
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "preparation):",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        210.239990234375,
        385.86029052734375,
        218.72891235351562
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제제에 표시된",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        210.239990234375,
        385.86029052734375,
        218.72891235351562
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화합물 또는 분자 내 방사성핵종 위치에 있는 원소 중",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        224.0756072998047,
        385.8599853515625,
        231.5428009033203
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안정형 동위원소가 없는 제제",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        236.7956085205078,
        306.2399597167969,
        244.26280212402344
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "담체무첨가제제(No-carrier-added preparation): 제제에",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        261.3600158691406,
        385.86029052734375,
        269.8489074707031
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표시된 화합물 또는 분자 내 방사성핵종 위치에 있는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        275.19561767578125,
        385.8599853515625,
        282.6628112792969
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원소 중 고의로 첨가한 안정형 동위원소가 없는 제제",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        287.9156188964844,
        374.75994873046875,
        295.3828125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비방사능(Specific radioactivity): 물질 또는 화합물의",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        299.760009765625,
        385.8602600097656,
        308.2489013671875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "단위질량 당 방사성핵종의 방사능(예: Bq/g, Bq/mol)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        312.4800109863281,
        375.9095458984375,
        320.9689025878906
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사능농도(Radioactivity concentration): 제제의 단위",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        338.0400085449219,
        382.3199462890625,
        346.5289001464844
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부피 또는 단위질량 당 방사성핵종의 방사능으로 방사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        351.8756103515625,
        382.3199462890625,
        359.3428039550781
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성용액제제의 경우, 제제의 단위부피 당 방사능으로 표",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        363.6000061035156,
        382.3199768066406,
        372.0888977050781
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        376.44000244140625,
        240.19583129882812,
        384.92889404296875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총방사능(Total radioactivity): 단위제형(바이알, 캡슐,",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        402.0,
        382.27581787109375,
        410.4888916015625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "앰플, 제너레이터 등) 당 방사성핵종의 방사능",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        414.7200012207031,
        354.59991455078125,
        423.2088928222656
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성물질 합성을 위한 화학물질 전구체: 만일 방사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        440.2799987792969,
        382.3203125,
        448.7688903808594
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성의약품의 주성분이 분리되지 않을 경우 합성에 사용",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        454.1156005859375,
        382.3199462890625,
        461.5827941894531
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "되는 화학물질 전구체는 약제학적 용도의 물질로서 고",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        466.8356018066406,
        382.3199768066406,
        474.30279541015625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "려된다. 지정된 생산조건 하에서 목표로 하는 수율 및",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        478.67999267578125,
        385.8599853515625,
        487.16888427734375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품질을 얻기 위해 생산에 사용되는 화학물질 전구체는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        492.3955993652344,
        385.8602600097656,
        499.86279296875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품 제조에 사용하기 전에 매 배치 별 시험",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        505.235595703125,
        382.3203125,
        512.7027587890625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실시가 권고된다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        516.9599609375,
        268.9958190917969,
        525.4489135742188
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 34 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유효기간(Period of validity): 각조에 기술된 규격에",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        49.19999694824219,
        627.6598510742188,
        57.68891906738281
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합한 동안의 시간",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        63.035621643066406,
        519.3599243164062,
        70.5028076171875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        524.760009765625,
        89.77687072753906,
        560.5199584960938,
        98.00343322753906
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "산",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        524.760009765625,
        89.77687072753906,
        560.5199584960938,
        98.00343322753906
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품은 방사성핵종을 다음과 같은 형태로 포",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        103.95562744140625,
        624.1199951171875,
        111.42281341552734
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함하고 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        115.67999267578125,
        498.4358215332031,
        124.16891479492188
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 원자 또는 분자 형태의 원소 (예: 133Xe, [15O]O2)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        464.3999938964844,
        127.91999816894531,
        611.9505615234375,
        137.34744262695312
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 이온 (예: [131I]iodide, [99mTc]pertechnetate)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        464.3999938964844,
        140.63999938964844,
        595.1509399414062,
        149.72891235351562
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 킬레이트화에 의한 분자 내 포함, 흡착 또는 부착된",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        154.0800018310547,
        627.6602783203125,
        162.5689239501953
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "형태 (예: [111In]indium oxine) 또는 공유결합에 의",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        469.79998779296875,
        166.1999969482422,
        624.1199951171875,
        175.28890991210938
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 형태 (예: 2-[18F]fluoro-2-deoxy-D-glucose)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        469.79998779296875,
        179.0399932861328,
        602.47216796875,
        188.12892150878906
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종은 다음과 같은 방법으로 생산될 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        192.36000061035156,
        617.8358154296875,
        200.8489227294922
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        464.3999938964844,
        205.1999969482422,
        627.6602783203125,
        213.6889190673828
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(일반적으로 원자로 내의 표적물질과)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        464.3999938964844,
        205.1999969482422,
        627.6602783203125,
        213.6889190673828
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중성자",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        205.1999969482422,
        627.6602783203125,
        213.6889190673828
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(neutron)의 반응",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        473.8799743652344,
        217.9199981689453,
        524.1603393554688,
        226.40892028808594
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- (사이클로트론 등의 가속기 내의 표적물질과) 하전",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        230.75999450683594,
        624.120361328125,
        239.24891662597656
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입자(charged particle)들의 반응",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        470.5199890136719,
        243.47999572753906,
        565.2003784179688,
        251.9689178466797
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 방사성핵종 제너레이터로 부터의 유출",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        256.32000732421875,
        583.4403686523438,
        264.80889892578125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핵반응 발생 확률은 입사입자(양성자, 중성자, 중양성",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        269.0400085449219,
        624.1203002929688,
        277.5289001464844
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자 등)의 특성과 에너지 그리고 그로 인해 방사되는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        281.8800048828125,
        627.6605834960938,
        290.368896484375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핵의 특성에 따라 다르다. 또한 생산된 방사성핵종의",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        294.6000061035156,
        627.6613159179688,
        303.0888977050781
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수율은 표적물질의 원소 조성, 화학적 순도, 중성자선",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        307.44000244140625,
        624.1206665039062,
        315.92889404296875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "속(neutron flux) 및 빔전류(beam current)에서의 하전",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        320.1600036621094,
        624.120361328125,
        328.6488952636719
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입자 에 따라 다르다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        333.0,
        524.23583984375,
        341.4888916015625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보통 원하는 핵반응 이외에 부가적인 변환이 동시에 일",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        346.7156066894531,
        624.1199951171875,
        354.18280029296875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "어난다. 발생 확률은 상기 서술된 요인에 따라 다르다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        358.55999755859375,
        624.1958618164062,
        367.04888916015625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이러한 변환들로 인해 방사성핵종 불순물들이 생성될",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        372.2756042480469,
        627.6605224609375,
        379.7427978515625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수도 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        384.1199951171875,
        490.9958190917969,
        392.60888671875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핵반응(변환)은 다음과 같이 표현한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        409.67999267578125,
        570.1958618164062,
        418.16888427734375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표적원소(입사입자, 방출입자 또는 방사선)발생원소",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        469.0799865722656,
        435.239990234375,
        616.2008666992188,
        443.7288818359375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        460.1999816894531,
        556.46435546875,
        469.28887939453125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "58Fe(n, γ)59Fe",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        460.1999816894531,
        556.46435546875,
        469.28887939453125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18O(p, n)18F",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        517.9199829101562,
        472.91998291015625,
        551.9622802734375,
        482.0088806152344
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중성자 조사(NEUTRON IRRADIATION)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        460.69952392578125,
        499.08001708984375,
        582.5096435546875,
        507.56890869140625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보통 핵반응기 내에서 안정한 방사성핵종의 조사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        512.9156494140625,
        624.120361328125,
        520.3828125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(irradiation) 결과 양성자가 부족한 핵(proton-deficient",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        524.6399536132812,
        624.1342163085938,
        533.12890625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "nuclei), 즉 전자방출체(electron emitter)가 발생하는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        537.47998046875,
        627.6605834960938,
        545.9689331054688
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "데 (n, γ)로 표시한다(흔희 방사성 포획으로 일컬음).",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        49.19999694824219,
        803.2359619140625,
        57.68891906738281
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과물은 표적핵(target nucleus)을 가진 동위원소이고",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        62.03999328613281,
        806.8212890625,
        70.52891540527344
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "따라서 상당한 양의 담체(carrier)가 포함될 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        74.75999450683594,
        794.23583984375,
        83.24891662597656
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "높은 원자번호를 가진 여러 핵종들은 중성자에 의해",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        88.59562683105469,
        806.8203125,
        96.06281280517578
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핵분열(fission) 한다. 핵분열(nuclear fission)은 (n, f)로",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        100.31999206542969,
        806.8199462890625,
        108.80891418457031
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표시하고, 핵분열 결과 다양한 무게와 반감기를 가진",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        113.15999603271484,
        806.8203125,
        121.64891815185547
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다수의 방사성핵종들이 생성된다. 가장 흔하게 사용되",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        125.87998962402344,
        803.2807006835938,
        134.36891174316406
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "는 것은 235U의 핵분열이다. 핵반응기에서 우라늄(235U)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        138.1199951171875,
        803.2307739257812,
        147.20892333984375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "을 조사(irradiation)하여 생성된 200개 이상의 방사성",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        151.4399871826172,
        803.2807006835938,
        159.9289093017578
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핵종들로부터 분리하여 Iodine-131,",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        164.27999877929688,
        803.2069702148438,
        172.7689208984375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "molybdenum-99",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        164.27999877929688,
        803.2069702148438,
        172.7689208984375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 xenon-133을 얻을 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        177.0,
        729.5558471679688,
        185.48892211914062
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하전입자 조사(CHARGED PARTICLE IRRADIATION)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        639.8595581054688,
        202.55999755859375,
        801.86962890625,
        211.04891967773438
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하전입자들을",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        216.39561462402344,
        803.2803344726562,
        223.86280822753906
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가진",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        216.39561462402344,
        803.2803344726562,
        223.86280822753906
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안정한",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        216.39561462402344,
        803.2803344726562,
        223.86280822753906
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종의",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        216.39561462402344,
        803.2803344726562,
        223.86280822753906
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        216.39561462402344,
        803.2803344726562,
        223.86280822753906
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(irradiation)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        228.1199951171875,
        803.280029296875,
        236.60891723632812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        228.1199951171875,
        803.280029296875,
        236.60891723632812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보통",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        228.1199951171875,
        803.280029296875,
        236.60891723632812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중성자가",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        228.1199951171875,
        803.280029296875,
        236.60891723632812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부족한",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        228.1199951171875,
        803.280029296875,
        236.60891723632812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핵",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        228.1199951171875,
        803.280029296875,
        236.60891723632812
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(neutron-deficient nuclei)이 발생하며 이는 전자포획",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        240.95999145507812,
        803.2806396484375,
        249.44891357421875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(electron capture) 또는 양전자방출(positron emission)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        253.6799774169922,
        803.22998046875,
        262.16888427734375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 의해 붕괴된다. 이는 (p, xn)으로 표시(x는 방출된",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        266.52001953125,
        806.8206787109375,
        275.0089111328125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중성자 수)한다. 결과물은 표적핵(target nucleus)을 가",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        279.2400207519531,
        803.280029296875,
        287.7289123535156
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "진 동위원소가 아니며 그 방사능은 무담체제제",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        293.07562255859375,
        803.281005859375,
        300.5428161621094
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Carrier-free preparation)의 방사능과 비슷할 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        304.8000183105469,
        800.7158203125,
        313.2889099121094
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종 제너레이터(RADIONUCLIDE GENERATORS)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        639.8595581054688,
        330.3600158691406,
        800.7888793945312,
        338.8489074707031
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        343.20001220703125,
        803.2941284179688,
        351.68890380859375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제너레이터는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        343.20001220703125,
        803.2941284179688,
        351.68890380859375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "어미방사성핵종(parent",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        343.20001220703125,
        803.2941284179688,
        351.68890380859375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "radionuclide)이 반감기가 짧은 딸방사성핵종(daughter",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        355.9200134277344,
        803.309814453125,
        364.4089050292969
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "radionuclide)으로 붕괴되는 것을 이용한 시스템이다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        368.760009765625,
        796.8758544921875,
        377.2489013671875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제너레이터의 제조원으로부터 멀리 떨어진 지역에서도",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        382.4756164550781,
        806.8209838867188,
        389.94281005859375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "어미방사성핵종으로부터 물리화학적 방법을 이용하여",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        395.31561279296875,
        806.8206176757812,
        402.7828063964844
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반감기가 짧은 딸방사성핵종을 분리하여 얻음으로써",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        408.0356140136719,
        806.8209838867188,
        415.5028076171875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용이 가능하다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        419.8800048828125,
        690.4358520507812,
        428.368896484375
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표적물질(TARGET MATERIALS)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        639.8595581054688,
        445.44000244140625,
        732.3881225585938,
        453.92889404296875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입사입자(incident particle)의 특성과 에너지 같은 다른",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        458.1600036621094,
        806.8203125,
        466.6488952636719
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요인들과 함께 표적물질의 순도와 동위원소 조성은 조",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        471.99560546875,
        803.280029296875,
        479.4627990722656
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사(irradiation)에 의해 생성되는 주 방사성핵종과 방사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        483.7200012207031,
        803.2803344726562,
        492.2088928222656
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성핵종 불순물의 상대적인 비율을 결정할 것이다. 필",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        496.55999755859375,
        803.280029296875,
        505.04888916015625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요한 표적 핵종들을 인위적으로 증가시킨 동위원소농",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        510.2756042480469,
        803.281005859375,
        517.7427978515625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "축표적물질(isotopically enriched target material)은 원",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        522.1199951171875,
        803.280029296875,
        530.6089477539062
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는 방사성핵종의 수율과 순도를 향상시킬 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        534.8399658203125,
        796.995849609375,
        543.3289184570312
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 35 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표적물질 및 화학첨가제의 화학적 형태(chemical",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        49.19999694824219,
        203.1804962158203,
        57.68891906738281
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "form),",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        62.03999328613281,
        203.1603240966797,
        70.52891540527344
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "순도 및 물리적 상태 뿐 만 아니라 조사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        62.03999328613281,
        203.1603240966797,
        70.52891540527344
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(irradiation) 조건 및 직접적인 물리화학적 환경이 생",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        74.75999450683594,
        203.16000366210938,
        83.24891662597656
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "산되는 방사성핵종들의 화학적 상태와 순도를 결정한",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        88.59562683105469,
        203.16064453125,
        96.06281280517578
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 방사성핵종 특히 반감기가 짧은 방사성핵종의 생",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        100.31999206542969,
        203.16000366210938,
        108.80891418457031
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "산 시 방사성의약품의 이후 제조 공정 전에 이러한 어",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        114.15562438964844,
        203.16000366210938,
        121.62281036376953
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "떤 품질기준(quality criteria)을 정하는 것은 불가능할",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        125.87998962402344,
        206.7006072998047,
        134.36891174316406
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수도 있다. 그러므로 표적물질의 매 배치 품질관리는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        138.72000122070312,
        206.700927734375,
        147.20892333984375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방서성핵종의 일상적인 생산 및 방사성의약품의 제조",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        152.43560791015625,
        203.1603240966797,
        159.90280151367188
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 사용하기 전에 평가된다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        164.27999877929688,
        122.71583557128906,
        172.7689208984375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표적물질은 입자들의 빔에 의해 조사되기 위해 기체,",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        177.0,
        203.23583984375,
        185.48892211914062
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "액체 또는 고체 상태로 홀더에 담겨지며 중성자 조사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        190.8356170654297,
        206.7003173828125,
        198.3028106689453
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시 보통 표적물질을 석영 앰플, 고순도 알루미늄 또는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        202.55999755859375,
        206.7003173828125,
        211.04891967773438
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "티타늄 용기에 담는다. 조사(irradiation)하는 조건 하에",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        215.39999389648438,
        206.81996154785156,
        223.888916015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용기와 그 내용물 사이에 상호작용이 일어나지 않는지",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        229.11561584472656,
        206.70028686523438,
        236.5828094482422
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "확인이 필요하다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        240.95999145507812,
        90.43583679199219,
        249.44891357421875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하전입자 조사(irradiation)에 사용되는 표적물질의 홀",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        253.6799774169922,
        203.16000366210938,
        262.16888427734375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "더는 적절한 금속, 가능한 경우 주입구와 배출구, 주변",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        266.52001953125,
        206.7003173828125,
        275.0089111328125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "냉각장치,",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        279.2400207519531,
        203.17369079589844,
        287.7289123535156
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대개 얇은 금속호일의 표적 창판(target",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        279.2400207519531,
        203.17369079589844,
        287.7289123535156
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "window) 들로 구성된다. 질적 및 양적 면에서 방사성",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        292.08001708984375,
        203.16064453125,
        300.56890869140625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "핵종의 생산 효율에 미치는 모든 영향을 평가하기 위",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        305.7956237792969,
        203.16000366210938,
        313.2628173828125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해서는 제조방법이 명확하게 기술되어야 하고 다음을",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        318.6356201171875,
        206.7006378173828,
        326.1028137207031
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려해야 한다 : 표적물질, 표적물질의 홀더 구성, 조",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        330.3600158691406,
        203.16000366210938,
        338.8489074707031
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사(irradiation) 방법 및 원하는 방사성 핵종의 분리.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        343.20001220703125,
        193.1558380126953,
        351.68890380859375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.79999542236328,
        369.73687744140625,
        139.55999755859375,
        377.96343994140625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.79999542236328,
        369.73687744140625,
        139.55999755859375,
        377.96343994140625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유럽약전 각조의 제제에 사용된 방사성핵종의 가장 일",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        383.7956237792969,
        203.16000366210938,
        391.2628173828125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반적으로 받아들여지는 물리적 특성에 대해 방사성핵",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        396.515625,
        205.18670654296875,
        403.9828186035156
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "종의 물리적 특성표(5.7)에 요약되어 있다. 또한, 표는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        39.739524841308594,
        408.3600158691406,
        206.7003173828125,
        416.8489074707031
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각조에 언급된 방사성핵종의 주요 잠재적 방사성핵종",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        422.07562255859375,
        206.700927734375,
        429.5428161621094
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "불순물의 물리적 특성들에 대해 기술하고 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        433.9200134277344,
        180.79583740234375,
        442.4089050292969
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘전이확률(transition",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        446.6400146484375,
        203.1603240966797,
        455.12890625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "probability)'",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        446.6400146484375,
        203.1603240966797,
        455.12890625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용어는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        446.6400146484375,
        203.1603240966797,
        455.12890625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전이",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        446.6400146484375,
        203.1603240966797,
        455.12890625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(transition) 등을 통하여 특정 에너지 상태의 핵이 변",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        459.4800109863281,
        203.16000366210938,
        467.9689025878906
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "환(transformation)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        472.20001220703125,
        203.1603240966797,
        480.68890380859375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "되는 확률을 의미한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        472.20001220703125,
        203.1603240966797,
        480.68890380859375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "'확률",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        472.20001220703125,
        203.1603240966797,
        480.68890380859375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(probability)' 대신 ’존재도(abundance)' 용어를 사용하",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        485.0400085449219,
        203.16029357910156,
        493.5289001464844
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기도 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        497.760009765625,
        70.99583435058594,
        506.2489013671875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘방출확률(emission probability)'은 방사성 핵종의 원자",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        510.6000061035156,
        203.1603240966797,
        519.0889282226562
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가 입자 또는 방사선 등의 방출을 일으키는 확률을 의",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        524.3156127929688,
        203.16000366210938,
        531.7827758789062
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미한다. 어느 경우든 확률은 백분율로 표시한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        536.1599731445312,
        182.3558349609375,
        544.64892578125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "확",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        282.9599914550781,
        63.016876220703125,
        318.719970703125,
        71.24343872070312
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        282.9599914550781,
        63.016876220703125,
        318.719970703125,
        71.24343872070312
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품 각조에 규정된 방사성 핵종은 일반적으로 반감",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        77.07562255859375,
        382.3203125,
        84.54280853271484
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기 또는 방사선의 특성과 에너지 또는 두 가지 모두에",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        89.79562377929688,
        385.86065673828125,
        97.26280975341797
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의해 확인된다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        101.63999938964844,
        262.9958190917969,
        110.12892150878906
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반감기 근사치(Approximate half-life): 반감기는 방사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        127.19999694824219,
        382.3203125,
        135.6889190673828
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성의약품 사용을 위한 출하를 허용하기 위해 상대적으",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        140.91561889648438,
        382.3209533691406,
        148.3828125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로 짧은 시간에 걸쳐 결정된다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        152.75999450683594,
        311.475830078125,
        161.24891662597656
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "측정된 반감기 근사치는 각조에 명시된 기준 범위 내",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        166.47561645507812,
        382.3199768066406,
        173.94281005859375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 있어야 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        178.3199920654297,
        266.2358093261719,
        186.8089141845703
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사선의 특성과 에너지 측정(Determination of the",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        219.36000061035156,
        203.87998962402344,
        382.1045227050781,
        212.36891174316406
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "nature and energy of the radiation)",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        219.36000061035156,
        216.59999084472656,
        330.19049072265625,
        225.0889129638672
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방출된",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        230.43560791015625,
        382.3209228515625,
        237.90280151367188
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사선의",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        230.43560791015625,
        382.3209228515625,
        237.90280151367188
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특성과",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        230.43560791015625,
        382.3209228515625,
        237.90280151367188
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에너지는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        230.43560791015625,
        382.3209228515625,
        237.90280151367188
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분광광도법",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        230.43560791015625,
        382.3209228515625,
        237.90280151367188
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(spectrometry)을 이용하여 측정한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        242.1599884033203,
        382.32122802734375,
        250.64891052246094
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양전자방출핵",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        242.1599884033203,
        382.32122802734375,
        250.64891052246094
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(positron emitter)의 방사선 특성과 에너지는 보통 측",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        254.99998474121094,
        382.3199768066406,
        263.4888916015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정할 수 없고 반감기와 감마선 스펙트럼 측정을 통해",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        268.7156066894531,
        385.8603210449219,
        276.18280029296875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "확인한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        280.55999755859375,
        246.91583251953125,
        289.04888916015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        282.9599914550781,
        307.09686279296875,
        318.719970703125,
        315.32342529296875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "험",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        282.9599914550781,
        307.09686279296875,
        318.719970703125,
        315.32342529296875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다음 시험항목 중 일부는 제품의 방사성핵종의 반감기",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        218.89952087402344,
        321.1556091308594,
        384.3467102050781,
        328.622802734375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가 짧은 경우 배치 출하 전에 수행하기 어렵다. 각조",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        218.89952087402344,
        333.0,
        384.3464050292969,
        341.4888916015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에서 사용을 위한 출하 전에 완전하게 수행되지 않아",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        218.89952087402344,
        346.7156066894531,
        384.3464050292969,
        354.18280029296875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "도 되는 시험항목들을 표시했다. 이러한 시험항목들은",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        218.89952087402344,
        358.55999755859375,
        387.8873596191406,
        367.04888916015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그런 식으로 생산된 제품의 품질관리가 된다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        218.89952087402344,
        371.2799987792969,
        355.8334655761719,
        379.7688903808594
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비방사성물질과 유연물질",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        397.8356018066406,
        294.12060546875,
        405.30279541015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Non-radioactive substances and related substances).",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        219.36000061035156,
        409.67999267578125,
        381.19573974609375,
        418.16888427734375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 항은 존재할 수 있는 비방사성물질과 유연물질 측",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        423.3955993652344,
        382.3199768066406,
        430.86279296875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정에 대해 규정한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        435.239990234375,
        279.1958312988281,
        443.7288818359375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잔류용매(Residual solvents)",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        219.36000061035156,
        460.79998779296875,
        303.4306945800781,
        469.28887939453125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잔류용매는 일반사항 5.4. 잔류용매 항에 따라 기준이",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        473.5199890136719,
        385.86065673828125,
        482.0088806152344
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제한되고, 2.4.24. 잔류용매 확인 및 관리 항에 기재된",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        486.3600158691406,
        385.86065673828125,
        494.8489074707031
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법 또는 다른 적절한 방법을 사용하여 관리한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        499.08001708984375,
        382.39581298828125,
        507.56890869140625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종순도(RADIONUCLIDIC PURITY)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        218.89952087402344,
        524.6399536132812,
        351.0289611816406,
        533.12890625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종 불순물들은 생산 그리고 방사성핵종의 붕",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        538.4756469726562,
        382.3199768066406,
        545.9428100585938
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 36 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "괴 시 생길 수 있다. 잠재적인 방사성핵종 불순물들은",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        49.19999694824219,
        627.6609497070312,
        57.68891906738281
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각조에서 언급될 수 있고 그 특성들은 일반사항 5.7.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        62.03999328613281,
        626.4327392578125,
        70.52891540527344
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유럽약전에서 언급된 방사성핵종들의 물리적 특성표",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        460.69952392578125,
        75.75562286376953,
        629.6864013671875,
        83.22280883789062
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항에 기재되어 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        87.5999984741211,
        520.995849609375,
        96.08892059326172
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대부분의 경우 방사성의약품의 방사성핵종 순도를 설",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        101.31562042236328,
        624.1199951171875,
        108.78280639648438
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정하기 위해 모든 존재하는 방사성핵종을 확인하고 그",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        114.15562438964844,
        627.6599731445312,
        121.62281036376953
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사능(radioactivity)을 알아야 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        125.87998962402344,
        568.2758178710938,
        134.36891174316406
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일반적으로 감마선과 엑스선을 방출하는 방사성핵종의",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        139.7156219482422,
        627.6613159179688,
        147.1828155517578
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종순도 측정하는 가장 유용한 방법은 감마선",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        152.43560791015625,
        624.1207275390625,
        159.90280151367188
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스펙트럼측정법(gamma-ray spectrometry) 이다. 요오",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        164.27999877929688,
        624.120361328125,
        172.7689208984375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "드화나트륨 검출기(sodium iodide detector)는 문제를",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        177.0,
        627.6602783203125,
        185.48892211914062
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일으킬 수 있다. 감마선 방출 불순물들에 기인하는 피",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        189.83999633789062,
        624.1199951171875,
        198.32891845703125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "크들은 주 방사성핵종의 스펙트럼에 가려지거나 다른",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        203.5556182861328,
        627.6603393554688,
        211.02281188964844
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종 불순물 피크로부터 분리되지 않아 나타나",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        216.39561462402344,
        624.1207275390625,
        223.86280822753906
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지 않을 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        228.1199951171875,
        511.39581298828125,
        236.60891723632812
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감마선이나 엑스선을 방출하지 않는 알파 그리고 베타",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        241.9556121826172,
        627.6603393554688,
        249.4228057861328
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입자 방출 불순물들은 이러한 방법으로 측정할 수 없",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        254.67559814453125,
        624.1199951171875,
        262.1427917480469
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 알파 그리고 베타 방출체(emitter)들은 다른 방법들",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        266.52001953125,
        624.1203002929688,
        275.0089111328125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "을 사용해야 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        279.2400207519531,
        514.515869140625,
        287.7289123535156
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각조에서는 필요한 방사성핵종순도와 특정 방사성핵종",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        293.07562255859375,
        627.6609497070312,
        300.5428161621094
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "불순물(예를 들면 테크네튬-99m에서의 몰리브덴-99)에",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        304.8000183105469,
        627.6599731445312,
        313.2889099121094
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한 기준을 규정하고 있다. 이러한 요구사항이 필요",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        317.6400146484375,
        624.120361328125,
        326.12890625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 반면, 그것만으로 제품의 방사성핵종순도가 임상적",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        330.3600158691406,
        624.1207275390625,
        338.8489074707031
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인 사용에 충분함을 보장하지 않는다. 제조자는 상세",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        343.20001220703125,
        624.120361328125,
        351.68890380859375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 시험을 수행해야 하고 특히 짧은 반감기를 가진 방",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        356.9156188964844,
        624.1199951171875,
        364.3828125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사성핵종 제품은 적당한 붕괴 시간을 거친 후에 긴 반",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        369.755615234375,
        624.1199951171875,
        377.2228088378906
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감기를 가진 불순물들에 대해 시험해야 한다. 이런 식",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        381.4800109863281,
        624.1199951171875,
        389.9689025878906
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "으로 제조공정의 적합성과 시험방법의 타당성 정보가",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        395.31561279296875,
        627.66064453125,
        402.7828063964844
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "확보된다. 2개 이상의 양전자를 방출하는 방사성핵종",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        407.0400085449219,
        624.1209716796875,
        415.5289001464844
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "들은 확인 그리고/또는 구별이 필요하다(예를 들면",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        419.8800048828125,
        627.6603393554688,
        428.368896484375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13N 제제에서의 18F 불순물). 반감기 측정은 감마선스",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        432.0,
        624.1206665039062,
        441.0888977050781
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "펙트럼측정법에 더하여 확인할 필요가 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        445.44000244140625,
        592.0358276367188,
        453.92889404296875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품에 있는 서로 다른 방사성핵종의 반감기",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        459.1556091308594,
        627.66064453125,
        466.622802734375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "차이로 인해, 방사성핵종순도가 시간에 따라 변한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        471.0,
        616.2758178710938,
        479.4888916015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사화학적순도(RADIOCHEMICAL PURITY)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        460.69952392578125,
        496.55999755859375,
        595.34912109375,
        505.04888916015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사화학적 불순물들은 다음으로부터 유래될 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        509.2799987792969,
        621.0758666992188,
        517.7689208984375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 방사성핵종 생산",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        522.1199951171875,
        518.88037109375,
        530.6089477539062
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 이후 화학적 제조공정",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        534.8399658203125,
        534.9606323242188,
        543.3289184570312
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 불완전한 분리(separation)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        643.5599975585938,
        49.19999694824219,
        725.4702758789062,
        57.68891906738281
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 저장기간 동안의 화학적 변화",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        643.5599975585938,
        62.03999328613281,
        736.6803588867188,
        70.52891540527344
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사화학적 순도 분석은 방사성핵종이 들어있는 다른",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        75.75562286376953,
        806.8203125,
        83.22280883789062
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화학 성분(불순물)을 분리 분석하고, 표시된 화학적 형태",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        87.5999984741211,
        803.2803344726562,
        96.42743682861328
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(주성분 화학물질)와 관련된 핵종의 방사능 비율을 분석하는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        101.31562042236328,
        806.8206176757812,
        109.1474380493164
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "것이 필요하다. 각조의 방사화학적 순도 항은 이성체",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        113.15999603271484,
        803.2807006835938,
        121.64891815185547
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "를 포함한 특정 방사화학적 불순물에 대한 기준을 포",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        126.87561798095703,
        803.280029296875,
        134.34280395507812
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        138.72000122070312,
        661.3958740234375,
        147.20892333984375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원칙적으로 방사화학적 순도 분석에 분리분석 방법이",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        152.43560791015625,
        806.8206787109375,
        159.90280151367188
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용된다. 예를 들면, 방사성의약품 각조에서 여지크로",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        164.27999877929688,
        803.2806396484375,
        172.7689208984375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마토그래프법, 박층크로마토그래프법, 전기영동법, 크",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        177.0,
        803.280029296875,
        185.48892211914062
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기배지크로마토그래프법, 기체크로마토그래프법, 액체",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        189.83999633789062,
        803.2803344726562,
        198.32891845703125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "크로마토그래프법 등이 포함될 수 있다. 이러한 분석",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        202.55999755859375,
        803.2803344726562,
        211.04891967773438
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방법에 대한 기술적인 내용은 각조에 설정되어 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        215.39999389648438,
        803.23583984375,
        223.888916015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또한, 방사선 방호, 기하학적 측정, 검출기 선형성, 담",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        228.1199951171875,
        803.280029296875,
        236.60891723632812
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체(carrier) 사용, 검체희석 등 특별한 주의사항도 고려",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        240.95999145507812,
        803.2803344726562,
        249.44891357421875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "되었다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        253.6799774169922,
        661.3958740234375,
        262.16888427734375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비방사능(Specific radioactivity)",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        640.3200073242188,
        279.2400207519531,
        734.7110595703125,
        287.7289123535156
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비방사능은 일반적으로 방사능이 방사성핵종(방사성핵",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        292.08001708984375,
        803.2810668945312,
        300.56890869140625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "종 순도)과 화학물질들(방사화학적 순도)에 기인하는지",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        304.8000183105469,
        806.8209838867188,
        313.2889099121094
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검증한 후에 방사능의 농도와 화학물질의 농도를 고려",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        318.6356201171875,
        803.2803344726562,
        326.1028137207031
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하여 계산된다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        330.3600158691406,
        683.9558715820312,
        338.8489074707031
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비방사능은 시간에 따라 변하므로 비방사능 표기 시",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        344.19561767578125,
        806.8199462890625,
        351.6628112792969
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일자 또는 필요할 경우 시간을 함께 표시한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        355.9200134277344,
        777.6758422851562,
        364.4089050292969
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생리학적 분포(Physiological distribution)",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        640.3200073242188,
        381.4800109863281,
        765.19140625,
        389.9689025878906
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동물을 사용하는 시험은 가능한 피해야 한다. 확인 및",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        394.32000732421875,
        806.8199462890625,
        402.80889892578125
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사화학적순도 시험으로 방사성의약품의 방사화학적",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        408.0356140136719,
        806.8209838867188,
        415.5028076171875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "종(species)을 완전히 정의하고 관리하기에 적합하지",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        419.8800048828125,
        806.8206176757812,
        428.368896484375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "않을 경우 생리학적 분포 시험이 필요할 수 있다. 적",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        432.6000061035156,
        803.280029296875,
        441.0888977050781
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "절한 실험동물의 특정 기관, 조직 또는 다른 신체 부",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        445.44000244140625,
        803.280029296875,
        453.92889404296875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위에서의 방사능 분포 양상은 사용하려는 목적에 적합",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        459.1556091308594,
        803.2803344726562,
        466.622802734375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "함을 확인하는데 신뢰성을 높여줄 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        471.0,
        767.9558715820312,
        479.4888916015625
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다른 수단으로 생리학적 분포 시험은 임상적 유효성이",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        484.7156066894531,
        806.821044921875,
        492.18280029296875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "알려진 다른제제와 함께 시험 시 제제의 생물학적동등",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        497.55560302734375,
        803.2813720703125,
        505.0227966308594
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성을 확립하는데 도움을 줄 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        509.2799987792969,
        748.6358642578125,
        517.7689208984375
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각조에서 시험을 수행하는 데 필요한 상세내용과 요구",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        640.3200073242188,
        523.1156616210938,
        803.2803344726562,
        530.5828247070312
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "되는 기준을 규정한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        640.3200073242188,
        534.8399658203125,
        706.6358642578125,
        543.3289184570312
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 37 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        199.1999969482422,
        560.4425048828125,
        223.30499267578125,
        567.5225219726562
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일반적으로 시험은 아래와 같이 수행된다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        49.19999694824219,
        164.59584045410156,
        57.68891906738281
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3마리 실험동물 각각에 제제를 정맥 투여한다. 투여하",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        62.03999328613281,
        203.16029357910156,
        70.52891540527344
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기 바로 전에 희석하여 투여해야 할 경우도 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        74.75999450683594,
        187.2758331298828,
        83.24891662597656
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각 실험동물에 투여 후 각 동물 피부 표면의 오염을",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        88.59562683105469,
        206.7006378173828,
        96.06281280517578
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "막고 배설물을 채집하기 위해 우리(cage)에 분리하여",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        100.31999206542969,
        206.7006072998047,
        108.80891418457031
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "넣는다. 투여 후 지정된 시간에 적절한 방법으로 안락",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        113.15999603271484,
        203.1603240966797,
        121.64891815185547
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사 시키고 해부한다. 채집한 기관 및 조직들의 방사능",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        125.87998962402344,
        203.16064453125,
        134.36891174316406
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "을 측정한다. 생리학적 분포는 각 기관 또는 조직들에",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        138.72000122070312,
        203.16061401367188,
        147.20892333984375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서 확인되는 방사능 노출량의 비율로 계산하고 방사성",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        152.43560791015625,
        206.70028686523438,
        159.90280151367188
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "붕괴로 인한 양은 보정한다. 일부 방사성의약품에서는",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        164.27999877929688,
        206.7018585205078,
        172.7689208984375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "선택된 조직들의 무게 대비 방사능의 비로 계산한다",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        177.99562072753906,
        203.16061401367188,
        185.4628143310547
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(radioactivity/mass).",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        189.83999633789062,
        100.99454498291016,
        198.32891845703125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제제는 3마리 실험동물 중 최소 2마리에서 방사능 분",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        202.55999755859375,
        203.16000366210938,
        211.04891967773438
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포가 설정된 모든 기준을 만족할 때 적합하다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        215.39999389648438,
        177.55584716796875,
        223.888916015625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여 시 넘쳐 흘린 경우(투여 당시 발견되었거나 방사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        228.1199951171875,
        203.1603240966797,
        236.60891723632812
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "능 측정 이후 드러나게 된 경우)의 결과는 배제하고",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        240.95999145507812,
        206.7006072998047,
        249.44891357421875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다시 시험한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        253.6799774169922,
        83.9558334350586,
        262.16888427734375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무균시험(Sterility)",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        40.20000076293945,
        279.2400207519531,
        94.51045227050781,
        287.7289123535156
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비경구투여 방사성의약품은 무균시험에 적합하여야 한",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        293.07562255859375,
        203.16000366210938,
        300.5428161621094
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 이러한 제품들은 미생물 오염을 막고 무균을 보장",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        304.8000183105469,
        203.1603240966797,
        313.2889099121094
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하도록 주의 깊게 설계하여 제조되어야 한다. 무균시",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        317.6400146484375,
        203.16029357910156,
        326.12890625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "험은 일반시험법(2.6.1)에 따라 시험한다. 방사성의약품",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        330.3600158691406,
        203.1612548828125,
        338.8489074707031
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에서는 일부 방사성핵종의 반감기가 짧거나, 배치크기",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        343.20001220703125,
        203.16061401367188,
        351.68890380859375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가 작거나 방사선의 위험 때문에 실험이 어려울 수 있",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        356.9156188964844,
        203.16000366210938,
        364.3828125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 무균시험을 완료하기 전에 출하할 수 있도록 각조",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        368.760009765625,
        203.1603240966797,
        377.2489013671875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 명시된 경우에는 방사선과 관련하여 실제적으로 가",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        382.4756164550781,
        203.16000366210938,
        389.94281005859375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "능해지면 곧 무균시험을 시작하고 만약 바로 시작하지",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        395.31561279296875,
        206.7006072998047,
        402.7828063964844
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "않을 경우 검체를 위음성(false negative) 결과가 나오",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        407.0400085449219,
        203.1603240966797,
        415.5289001464844
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지 않도록 하기 위해 적절한 조건 하에 보관한다. 이",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        419.8800048828125,
        203.16000366210938,
        428.368896484375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "러한 경우 완전히 밸리데이션 된 공정으로 제조된 제",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        433.5956115722656,
        203.16000366210938,
        441.06280517578125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품의 매개변수기반출하(parametric release, 5.1.1)를 선",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        445.44000244140625,
        203.16000366210938,
        453.92889404296875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "택할 수 있다. 무균 제조 시 무균시험은 제품의 품질",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        458.1600036621094,
        203.1603240966797,
        466.6488952636719
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관리로서 수행되어야 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        471.0,
        119.475830078125,
        479.4888916015625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품의 배치크기가 1 내지 몇 개의 샘플로 적",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        483.7200012207031,
        203.16000366210938,
        492.2088928222656
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "을 때, 일반시험법(2.6.1)에 따른 검체 채취방법을 적용",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        496.55999755859375,
        203.1603240966797,
        505.04888916015625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "할 수 없을지도 모른다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        40.20000076293945,
        509.2799987792969,
        109.7558364868164,
        517.7689208984375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종의 반감기가 5분 미만일 경우 환자에게 밸",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        522.1199951171875,
        203.16000366210938,
        530.6089477539062
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "리데이션 된 제조 시스템을 통한 실시간 방사성의약품",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        40.20000076293945,
        535.8356323242188,
        206.7012481689453,
        543.3027954101562
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여가 이루어진다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        49.19999694824219,
        275.955810546875,
        57.68891906738281
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고방사능의 경우 안전상 이유로 일반시험법(2.6.1)에 따",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        62.03999328613281,
        382.3199768066406,
        70.52891540527344
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "른 검체량을 이용하는 것이 불가능하다. 멤브레인필터",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        74.75999450683594,
        382.32122802734375,
        83.24891662597656
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "법이 개인의 방사선 조사량을 제한하기 위해 선호된다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        87.5999984741211,
        382.39581298828125,
        96.08892059326172
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비경구용제제(Parenteral preparations, 0520) 제제총칙에",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        100.31999206542969,
        382.3209228515625,
        108.80891418457031
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서 보존제 사용과 관련한 요구사항에도 불구하고 다회",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        114.15562438964844,
        382.3203125,
        121.62281036376953
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "투여용기(multidose container)의 방사성의약품에 보존",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        125.87998962402344,
        382.3203125,
        134.36891174316406
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제를 첨가하는 것은 각조에 규정하지 않는 한 의무사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        139.7156219482422,
        382.32061767578125,
        147.1828155517578
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항이 아니다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        151.4399871826172,
        256.6358337402344,
        159.9289093017578
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "엔도톡신(Bacterial endotoxins - pyrogens)",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        219.36000061035156,
        177.0,
        347.1112365722656,
        185.48892211914062
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비경구용 방사성의약품은 엔도톡신시험(2.6.14) 또는 발",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        189.83999633789062,
        382.3199768066406,
        198.32891845703125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "열성물질시험(2.6.8)에 적합하여야 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        202.55999755859375,
        335.1158142089844,
        211.04891967773438
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종 제너레이터의 용출물, 방사성표지를 위한",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        215.39999389648438,
        385.8603210449219,
        223.888916015625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "용액 및 방사성의약품 제조를 위한 키트 또한 추가적",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        229.11561584472656,
        382.32061767578125,
        236.5828094482422
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인 정제 없이 비경구용으로 사용된다면 엔도톡신시험",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        241.9556121826172,
        382.32122802734375,
        249.4228057861328
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 적합하여야 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        253.6799774169922,
        279.1958312988281,
        262.16888427734375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종 전구체와 화학물질 전구체들은 엔도톡신을",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        267.515625,
        385.8609313964844,
        274.9828186035156
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제거하기 위한 적절한 추가 조치 없이 비경구용 제제",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        280.2356262207031,
        385.8603210449219,
        287.70281982421875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생산에 사용될 경우 엔도톡신시험에 적합하여야 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        292.08001708984375,
        379.27581787109375,
        300.56890869140625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "엔도톡신시험은 일반시험법(2.6.14) 항에 따라 시험하며",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        304.8000183105469,
        385.8606262207031,
        313.2889099121094
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험을 수행하는 개인의 방사선 조사량을 제한하기 위",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        318.6356201171875,
        382.3199768066406,
        326.1028137207031
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해 주의를 요한다. 엔도톡신 기준은 각조에 기재되어",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        330.3600158691406,
        385.8606262207031,
        338.8489074707031
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있거나 또는 일반항 5.1.10. 엔도톡신시험 수행을 위한",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        343.20001220703125,
        387.88641357421875,
        351.68890380859375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드라인에 따라 계산한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        218.89952087402344,
        355.9200134277344,
        304.9958190917969,
        364.4089050292969
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품 또는 전구체의 특성에 따라 엔도톡신시",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        369.755615234375,
        382.3209228515625,
        377.2228088378906
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "험에 간섭(억제 또는 활성화)을 일으키고 간섭요인의",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        381.4800109863281,
        385.8609313964844,
        389.9689025878906
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제거가 불가능 할 경우 특별히 발열성물질시험 항이",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        395.31561279296875,
        385.8603210449219,
        402.7828063964844
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설정되어 있을 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        407.0400085449219,
        288.91583251953125,
        415.5289001464844
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "저",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        282.9599914550781,
        433.5768737792969,
        318.719970703125,
        441.8034362792969
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "장",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        282.9599914550781,
        433.5768737792969,
        318.719970703125,
        441.8034362792969
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성물질을 포함하는 제제는 일차 또는 이차 방출에",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        447.6356201171875,
        385.86065673828125,
        455.1028137207031
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의한 방사선 조사로부터 개인을 충분히 보호하고 방사",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        460.4756164550781,
        382.3203125,
        467.94281005859375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성물질 저장과 관련한 국내외 규정에 적합한 밀봉용기",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        473.19561767578125,
        382.3209533691406,
        480.6628112792969
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 보관한다. 저장기간 동안 용기는 방사선 조사 때문",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        485.0400085449219,
        382.3203125,
        493.5289001464844
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 차광할 수 있다. 이러한 차광은 반드시 제제의 저",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        219.36000061035156,
        497.760009765625,
        382.3199768066406,
        506.2489013671875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하를 수반하지 않는다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        219.36000061035156,
        510.6000061035156,
        285.6758117675781,
        519.0889282226562
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        282.9599914550781,
        537.1368408203125,
        318.719970703125,
        545.3634033203125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "벨",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        282.9599914550781,
        537.1368408203125,
        318.719970703125,
        545.3634033203125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 38 -",
      "font_size": 7.079999923706055,
      "font_name": "Gulim",
      "bbox": [
        620.1599731445312,
        560.4425048828125,
        644.2649536132812,
        567.5225219726562
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성의약품의 라벨은 관련 국가 및 유럽의 법에 적",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        50.19562530517578,
        624.1199951171875,
        57.662811279296875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "합해야 한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        62.03999328613281,
        498.4358215332031,
        70.52891540527344
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용하는 나라에 따라 조정될 수 있다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        74.75999450683594,
        575.9558715820312,
        83.24891662597656
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품의 방사능은 특정 일자에 표시된다. 만약 반감기",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        87.5999984741211,
        624.1207275390625,
        96.08892059326172
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가 70일 미만일 경우 표준시간대를 참조하여 시간도",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        100.31999206542969,
        627.66064453125,
        108.80891418457031
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표시한다. 경과시간에서의 방사능은 붕괴 식 또는 표",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        113.15999603271484,
        624.1199951171875,
        121.64891815185547
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로부터 계산한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        125.87998962402344,
        511.39581298828125,
        134.36891174316406
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상기 이외에 용기, 포장, 포장에 있는 설명서, 방사성",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        138.72000122070312,
        624.1203002929688,
        147.20892333984375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품에 대한 분석 인증서에서의 라벨은 다음 사항을",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        152.43560791015625,
        627.66064453125,
        159.90280151367188
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기재한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        164.27999877929688,
        488.7158203125,
        172.7689208984375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 투여경로",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        177.0,
        496.2005920410156,
        185.48892211914062
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 필요 시 최대 권장 용량 (mL)",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        464.3999938964844,
        189.83999633789062,
        558.3108520507812,
        198.32891845703125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 첨가된 보존제 명칭 및 양",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        202.55999755859375,
        547.9199829101562,
        211.04891967773438
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 해당할 경우 특별한 저장 조건",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        464.3999938964844,
        215.39999389648438,
        560.88037109375,
        223.888916015625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화학물질 전구체들은 첨부정보로 목표로 하는 양과 질",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        229.11561584472656,
        624.1199951171875,
        236.5828094482422
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 방사성의약품을 생산하도록 보장하기 위해 방사성",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        241.9556121826172,
        624.1207275390625,
        249.4228057861328
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품 제조에 사용하기 전에 1개 이상의 제품을 시험",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        253.6799774169922,
        624.120361328125,
        262.16888427734375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "할 것을 권고한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        461.1600036621094,
        266.52001953125,
        514.515869140625,
        275.0089111328125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사능 검출 및 측정",
      "font_size": 7.799999713897705,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        508.55999755859375,
        293.0568542480469,
        576.7200317382812,
        301.2834167480469
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사능의 검출 및 측정은 일반 항 2.2.66. 방사능 검출",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        306.1199951171875,
        629.6864624023438,
        314.60888671875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 측정에 따라 수행한다.",
      "font_size": 7.079999923706055,
      "font_name": "T3",
      "bbox": [
        460.69952392578125,
        318.8399963378906,
        537.1958618164062,
        327.3288879394531
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "참고 - 5.7. 유럽약전에서 언급된 방사성핵종의 물리적",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        461.1600036621094,
        344.3999938964844,
        624.12060546875,
        352.8888854980469
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "특성 표 중 반감기 정보",
      "font_size": 7.079999923706055,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        482.8799743652344,
        358.235595703125,
        554.5203857421875,
        365.7027893066406
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "01/2008:50700",
      "font_size": 7.079999923706055,
      "font_name": "T16",
      "bbox": [
        584.760009765625,
        369.9599914550781,
        624.1632080078125,
        378.4488830566406
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방사성핵종",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        386.8205871582031,
        588.2401733398438,
        393.1805725097656
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반감기",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        386.8205871582031,
        588.2401733398438,
        393.1805725097656
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Tritium (3H)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        394.417724609375,
        595.3199462890625,
        401.58056640625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12.33 년",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        394.417724609375,
        595.3199462890625,
        401.58056640625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Carbon-11 (13C)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        402.6977233886719,
        599.0399780273438,
        409.9805603027344
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20.385 분",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        402.6977233886719,
        599.0399780273438,
        409.9805603027344
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nitrogen-13 (13N)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        411.09771728515625,
        595.3199462890625,
        418.38055419921875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9.965 분",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        411.09771728515625,
        595.3199462890625,
        418.38055419921875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oxygen-15 (15O)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        419.49774169921875,
        599.0399780273438,
        426.78057861328125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "122.24 초",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        419.49774169921875,
        599.0399780273438,
        426.78057861328125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Fluorine-18 (18F)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        427.8977355957031,
        599.0399780273438,
        435.1805725097656
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "109.77 분",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        427.8977355957031,
        599.0399780273438,
        435.1805725097656
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Phosphorus-32 (32P)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        436.2977294921875,
        595.3199462890625,
        443.58056640625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "14.26 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        436.2977294921875,
        595.3199462890625,
        443.58056640625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Phosphorus-33 (33P)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        444.6977233886719,
        595.3199462890625,
        451.9805603027344
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25.34 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        444.6977233886719,
        595.3199462890625,
        451.9805603027344
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sulfur-35 (35S)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        453.09771728515625,
        595.3199462890625,
        460.26055908203125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "87.51 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        453.09771728515625,
        595.3199462890625,
        460.26055908203125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Chromium-51 (51Cr)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        461.49774169921875,
        602.7599487304688,
        468.6605529785156
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "27.7025 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        461.49774169921875,
        602.7599487304688,
        468.6605529785156
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cobalt-56 (56Co)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        469.8977355957031,
        595.3199462890625,
        477.0605773925781
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "77.27 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        469.8977355957031,
        595.3199462890625,
        477.0605773925781
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cobalt-57 (57Co)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        478.2977294921875,
        599.0399780273438,
        485.4605712890625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "271.79 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        478.2977294921875,
        599.0399780273438,
        485.4605712890625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cobalt-58 (58Co)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        486.6977233886719,
        593.5199584960938,
        493.8605651855469
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7086 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        486.6977233886719,
        593.5199584960938,
        493.8605651855469
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cobalt-60 (60Co)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        495.09771728515625,
        599.0399780273438,
        502.26055908203125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.2714 년",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        495.09771728515625,
        599.0399780273438,
        502.26055908203125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Gallium-66 (66Ga)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        503.49774169921875,
        597.9599609375,
        510.6605529785156
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9.49 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        503.49774169921875,
        597.9599609375,
        510.6605529785156
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Gallium-67 (67Ga)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        511.897705078125,
        599.0399780273438,
        519.060546875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.2612 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        511.897705078125,
        599.0399780273438,
        519.060546875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Germanium-68 (68Ge)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        520.2977294921875,
        599.0399780273438,
        527.4605712890625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "270.82 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        520.2977294921875,
        599.0399780273438,
        527.4605712890625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Gallium-68 (68Ga)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        528.5777587890625,
        599.0399780273438,
        535.8605346679688
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "67.629 분",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        466.79998779296875,
        528.5777587890625,
        599.0399780273438,
        535.8605346679688
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Krypton-81m (81mKr)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        52.41773223876953,
        774.47998046875,
        59.58058547973633
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13.10 초",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        52.41773223876953,
        774.47998046875,
        59.58058547973633
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Rubidium-81 (81Rb)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        60.81773376464844,
        780.8399658203125,
        67.9805908203125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.576 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        60.81773376464844,
        780.8399658203125,
        67.9805908203125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Krypton-81m (81mKr)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        69.21773529052734,
        774.47998046875,
        76.38058471679688
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13.10 초",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        69.21773529052734,
        774.47998046875,
        76.38058471679688
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Strontium-89 (89Sr)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        77.61772918701172,
        774.47998046875,
        84.78058624267578
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "50.53 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        77.61772918701172,
        774.47998046875,
        84.78058624267578
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Yttrium-89m (89mY)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        86.01773071289062,
        774.47998046875,
        93.18058776855469
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "16.06 초",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        86.01773071289062,
        774.47998046875,
        93.18058776855469
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Strontium-90 (90Sr)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        94.41773223876953,
        774.47998046875,
        101.5805892944336
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "28.74 년",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        94.41773223876953,
        774.47998046875,
        101.5805892944336
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Yttrium-90 (90Y)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        102.81773376464844,
        780.8399658203125,
        109.98058319091797
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "64.10 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        102.81773376464844,
        780.8399658203125,
        109.98058319091797
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Molybdene-99 (99Mo)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        111.09773254394531,
        780.8399658203125,
        118.38058471679688
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "65.94 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        111.09773254394531,
        780.8399658203125,
        118.38058471679688
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Technetium-99m (99mTc)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        119.49773406982422,
        777.1199951171875,
        126.78058624267578
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6.01 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        119.49773406982422,
        777.1199951171875,
        126.78058624267578
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Technetium-99 (99Tc)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        127.8977279663086,
        785.7599487304688,
        135.1805877685547
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.11×105 년",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        127.8977279663086,
        785.7599487304688,
        135.1805877685547
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ruthenium-103 (103Ru)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        136.29774475097656,
        774.47998046875,
        143.58058166503906
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "39.26 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        136.29774475097656,
        774.47998046875,
        143.58058166503906
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Rhodium-103m (103mRh)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        144.69773864746094,
        778.199951171875,
        151.9805908203125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "56.114 분",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        144.69773864746094,
        778.199951171875,
        151.9805908203125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Indium-110 (110In)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        153.0977325439453,
        773.3999633789062,
        160.38058471679688
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4.9 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        153.0977325439453,
        773.3999633789062,
        160.38058471679688
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Indium-110m (110mIn)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        161.49774169921875,
        770.7599487304688,
        168.78057861328125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "69.1 분",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        161.49774169921875,
        770.7599487304688,
        168.78057861328125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Indium-111 (111In)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        169.89773559570312,
        778.199951171875,
        177.0605926513672
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.8047 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        169.89773559570312,
        778.199951171875,
        177.0605926513672
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Indium-114m (114mIn)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        178.29774475097656,
        774.47998046875,
        185.46058654785156
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "49.51 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        178.29774475097656,
        774.47998046875,
        185.46058654785156
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Indium-114 (114In)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        186.69773864746094,
        770.7599487304688,
        193.86058044433594
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "71.9 초",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        186.69773864746094,
        770.7599487304688,
        193.86058044433594
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Tellurium-121m (121mTe)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        195.0977325439453,
        774.47998046875,
        202.26058959960938
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "154.0 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        195.0977325439453,
        774.47998046875,
        202.26058959960938
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Tellure-121 (121Te)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        203.49774169921875,
        774.47998046875,
        210.66058349609375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "19.16 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        203.49774169921875,
        774.47998046875,
        210.66058349609375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Iodine-123 (123I)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        211.89773559570312,
        780.8399658203125,
        219.06057739257812
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13.27 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        211.89773559570312,
        780.8399658203125,
        219.06057739257812
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Iodine-125 (125I)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        220.2977294921875,
        778.199951171875,
        227.46058654785156
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "59.402 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        220.2977294921875,
        778.199951171875,
        227.46058654785156
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Iodine-126 (126I)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        228.69773864746094,
        774.47998046875,
        235.86058044433594
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13.11 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        228.69773864746094,
        774.47998046875,
        235.86058044433594
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Iodine-131 (131I)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        237.0977325439453,
        781.9199829101562,
        244.26058959960938
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8.02070 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        237.0977325439453,
        781.9199829101562,
        244.26058959960938
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Xenon-131m (131mXe)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        245.3777313232422,
        774.47998046875,
        252.66058349609375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11.84 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        245.3777313232422,
        774.47998046875,
        252.66058349609375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Iodine-133 (133I)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        253.77774047851562,
        777.1199951171875,
        261.0605773925781
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20.8 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        253.77774047851562,
        777.1199951171875,
        261.0605773925781
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Xenon-133 (133Xe)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        262.177734375,
        774.47998046875,
        269.4605712890625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5.243 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        262.177734375,
        774.47998046875,
        269.4605712890625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Xenon-133m (133mXe)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        270.5777282714844,
        770.7599487304688,
        277.8605651855469
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.19 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        270.5777282714844,
        770.7599487304688,
        277.8605651855469
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Iodine-135 (135I)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        278.97772216796875,
        777.1199951171875,
        286.26055908203125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6.57 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        278.97772216796875,
        777.1199951171875,
        286.26055908203125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Xenon-135 (135Xe)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        287.37774658203125,
        777.1199951171875,
        294.6605529785156
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9.14 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        287.37774658203125,
        777.1199951171875,
        294.6605529785156
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Caesium-137 (137Cs)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        295.7777404785156,
        774.47998046875,
        302.9405517578125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30.04 년",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        295.7777404785156,
        774.47998046875,
        302.9405517578125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Barium-137m (137mBa)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        304.177734375,
        774.47998046875,
        311.340576171875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.552 분",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        304.177734375,
        774.47998046875,
        311.340576171875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Thallium-200 (200TI)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        312.5777282714844,
        777.1199951171875,
        319.7405700683594
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "26.1 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        312.5777282714844,
        777.1199951171875,
        319.7405700683594
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lead-201 (201Pb)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        320.97772216796875,
        777.1199951171875,
        328.14056396484375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9.33 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        320.97772216796875,
        777.1199951171875,
        328.14056396484375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Thallium-201 (201Tl)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        329.37774658203125,
        784.5599975585938,
        336.5405578613281
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "72.912 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        329.37774658203125,
        784.5599975585938,
        336.5405578613281
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Thallium-202 (202Tl)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        337.7777404785156,
        774.47998046875,
        344.9405517578125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12.23 일",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        337.7777404785156,
        774.47998046875,
        344.9405517578125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Lead-203 (203Pb)",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        346.177734375,
        784.5599975585938,
        353.340576171875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "51.873 시간",
      "font_size": 6.359999656677246,
      "font_name": "Haansoft Batang",
      "bbox": [
        645.9599609375,
        346.177734375,
        784.5599975585938,
        353.340576171875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "“방사성의약품 품목허가를 위한 안내서”",
      "font_size": 10.679999351501465,
      "font_name": "Batang",
      "bbox": [
        116.5199966430664,
        164.71229553222656,
        305.94000244140625,
        175.3922882080078
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        202.2993621826172,
        120.71936798095703,
        212.044677734375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        202.2993621826172,
        120.71936798095703,
        212.044677734375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        202.2993621826172,
        120.71936798095703,
        212.044677734375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        220.65936279296875,
        120.71936798095703,
        230.40467834472656
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        220.65936279296875,
        120.71936798095703,
        230.40467834472656
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        220.65936279296875,
        120.71936798095703,
        230.40467834472656
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편 집 위 원 장",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        239.13937377929688,
        120.7193832397461,
        248.8846893310547
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        257.619384765625,
        120.7199935913086,
        267.36468505859375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "집",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        257.619384765625,
        120.7199935913086,
        267.36468505859375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        257.619384765625,
        120.7199935913086,
        267.36468505859375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        257.619384765625,
        120.7199935913086,
        267.36468505859375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "도 움 주 신  분",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        294.5793762207031,
        120.7199935913086,
        304.3246765136719
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        331.41937255859375,
        120.7199935913086,
        341.1646728515625
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        331.41937255859375,
        120.7199935913086,
        341.1646728515625
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        60.3599967956543,
        331.41937255859375,
        120.7199935913086,
        341.1646728515625
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2015년 7 월",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        136.8000030517578,
        200.99998474121094,
        187.44000244140625,
        212.07875061035156
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "손 여 원",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        136.8000030517578,
        220.65936279296875,
        172.32000732421875,
        230.40467834472656
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 선 희",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        136.8000030517578,
        239.13937377929688,
        172.32000732421875,
        248.8846893310547
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한의식, 김소희, 윤경은, 엄정윤, 박소라, 김동환, 전설희,",
      "font_size": 9.239999771118164,
      "font_name": "T3",
      "bbox": [
        136.8000030517578,
        256.32000732421875,
        362.7715148925781,
        267.39874267578125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "김미지",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        136.8000030517578,
        276.0993957519531,
        163.56088256835938,
        285.8446960449219
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전처 의약품안전국 의약품품질과",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        136.8000030517578,
        294.5793762207031,
        321.482177734375,
        304.3246765136719
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전평가원 의약품심사부 의약품심사조정과",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        136.8000030517578,
        313.05938720703125,
        365.5194091796875,
        322.8046875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전평가원 의약품심사부 종양약품과",
      "font_size": 9.239999771118164,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        136.8000030517578,
        331.41937255859375,
        338.0396423339844,
        341.1646728515625
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "【공직자 부조리 및 공익신고안내】   ** 신고자 및 신고내용은 보호됩니다.",
      "font_size": 7.079999923706055,
      "font_name": "Gungsuh",
      "bbox": [
        93.47999572753906,
        493.7742614746094,
        341.11767578125,
        503.19122314453125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자 부조리 신고” 코너",
      "font_size": 7.079999923706055,
      "font_name": "MalgunGothic",
      "bbox": [
        93.47999572753906,
        507.0942687988281,
        346.79998779296875,
        516.51123046875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너",
      "font_size": 7.079999923706055,
      "font_name": "MalgunGothic",
      "bbox": [
        93.47999572753906,
        518.4942626953125,
        374.24871826171875,
        527.9112548828125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    }
  ],
  "markdown_content": "<!-- PAGE_1 -->\n# 방사성의약품 품목허가를 위한 안내서\n\n**[표 시작]**\n\n| □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 제는 그 자체가 보존효과가 없을 | ※대한민국약전(KP)에서는 방사성핵종순도, 방사화학적순도, 화학적순 | 반감기 근사치(Approximate half-life): 반감기는 방사 | 투여용기(multidose container)의 방사성의약품에 보존 | ․방문, 우편 민원의 경우: 3,217,000원 | 70일 | 31조제11항 또는 법 제42조제5항에 따라 의약 | <개정 | 2007.10.17., | 2011.3.30., | 2011.6.7., | 제는 다음의 경우를 제외하고, | 방사능(radioactivity)을 알아야 한다. | 로부터 계산한다. | 메탄올을 전개용매로 하여 여지크로마토그래프법에 | 제1호서식의 의약품 제조업 허가신청서(전자문 | 제조소 평면도 |\n| - 원자 또는 분자 형태의 원소 (예: 133Xe, [15O]O2) | - 성별, 연령층 등으로 적용대상이 한정되는 경우 그 내용 명시 | 기재요령 | 설기준에 따라 필요한 시설을 갖추고 총리령으 | Technetium-99 (99Tc) | 2.11×105 년 |\n| 경우 적절한 보존제를 포함한다. | 도에 대해 각각 이핵종, 방사화학적이물, 화학적이물의 용어를 사용. | 등 및 방사성의약품은 제외한다. | 품등의 제조판매ᆞ수입 품목허가 또는 품목변경 | 2011.12.2., 2012.5.14., 2014.3.18., 2015.3.13.> | 희귀의약품의 경우에는 제출하지 아니한다. | 표 1의 의약품 제조 및 품질관리기준 실 | 1.1 배경 | - 단일제로서 필요한 경우 주성분의 분량을 제형 다음에 단위 포함하여 기재 | ① 의약품 제조판매품목 허가 신청서 | 8. 의약품의 주성분을 제조하는 제조업자의 명 | 1. 민원서식기를 이용하여 신청하고자 하는 신청서와 구비서류 작성 | 나) 신청품목과 관련된 작업소 시설 관련 자료 | 따라 약 3 시간 전개할 때 과테크네튬산나트륨 | 2. 구조결정, 물리화학적 성질에 관한 자료 | 야 한다. <개정 2014.8.21.> | 2. 허가처리 절차 ······················································································4 | 의약품에 관한 특허권(이하 \"의약품특허권\" | PREPARATIONS | 지침·안내서가 있습니까? | Ruthenium-103 (103Ru) | 39.26 일 | 고시하는 수수료를 내야 한다. | 2) 의존성 |\n| 성의약품 사용을 위한 출하를 허용하기 위해 상대적으 | 제를 첨가하는 것은 각조에 규정하지 않는 한 의무사 | 미생물성장을 막기 위해 적절한 | 일반적으로 감마선과 엑스선을 방출하는 방사성핵종의 | 상기 이외에 용기, 포장, 포장에 있는 설명서, 방사성 | - 이온 (예: [131I]iodide, [99mTc]pertechnetate) | 로 정하는 바에 따라 식품의약품안전처장의 허 | 서로 된 신청서를 포함한다) 또는 별지 제2호 | 함한다. |\n| ⑤제1항에 따른 의약품등의 수입 품목 허가 또 | 가. 의약품[의료용 고압가스, 방사성의약품, | 1. 대한민국약전 또는 식품의약품안전처장이 인 | 시상황 평가에 필요한 자료 | 90일 | ④ 제2항에 따라 신고를 하는 자는 식품의약품 | (99mTc) 반점(Rƒ 값 약 0.6 ~ 0.7) 이외의 방사능 | 1) 신규서식 선택 → 의약품 검색버튼을 활용하여 해당 민원서식 선택 | (품질에 관한 자료) | (1) 청정등급, 작업실 간의 차압 및 인적ㆍ물적 동선이 표시된 작업소 평면도 | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 칭 및 소재지 등에 관한 자료로서 식품의약 | Rhodium-103m (103mRh) | 56.114 분 | 3) 항원성 및 면역독성 |\n| 항이 아니다. | ․방문, 우편 민원의 경우: 1,260,000원 | 허가를 받으려는 자는 그 품목의 제조와 품질관 | 보존제를 넣는다. | 방사성핵종순도 측정하는 가장 유용한 방법은 감마선 | 의약품에 대한 분석 인증서에서의 라벨은 다음 사항을 | 서식의 의약외품 제조업 신고서(전자문서로 된 | 2.1 주요 관련 법규 및 규정 ································································4 | 것으로 본다. <신설 2011.3.30.> |\n| 로 짧은 시간에 걸쳐 결정된다. | 나. 원료의약품[원료의약품 중 한약재 및 약 | 는 신고의 대상ᆞ기준ᆞ조건 및 관리 등에 필 | 정하는 공정서 및 의약품집에 실려 있는 품 | 원료의약품 중 한약재 및 약리활성(약리 | - 킬레이트화에 의한 분자 내 포함, 흡착 또는 부착된 | ② 안전성유효성에 관한 자료 | 2) 민원종류 선택 → 업종 / 신약, 희귀의약품 여부 / 본부 ․ 지방청 대상 확인 / 기시법, 안유심사, | 가를 받아야 한다. <개정 2008.2.29., 2010.1.18., | 안전처장이 정하여 고시하는 수수료(외국에서 | (2) 제조ㆍ시험에 사용되는 기계ㆍ설비 내역 및 기계배치도 | 품\"이라 한다)의 안전성ᆞ유효성에 관한 자 | 품안전처장이 고시하는 자료 | Indium-110 (110In) | 4.9 시간 | ppm 이하). |\n| [제제총칙 - 방사성제제 항] | 동위원소담체(Isotopic | carrier): | 방사성핵종의 원소와 | 자 료 번 호 | 리를 위한 기준 및 시험방법에 관한 자료를 제 | (1) 각조에 별도로 언급한 경우 | 은 총방사능의 5 % 이하이다. | 신고서를 포함한다)에 다음 각 호의 서류(전자 | 가. 원료의약품에 관한 자료 | Indium-110m (110mIn) | 69.1 분 | 4) 작용기전독성 |\n| 측정된 반감기 근사치는 각조에 명시된 기준 범위 내 | 목. 다만, 국내에서 허가되지 아니한 품목은 | 활성: 약리작용상 인체에 미치는 작용)이 | 리활성(약리활성: 약리작용상 인체에 미 | 2.3.2 분류번호 및 분류(전문 또는 일반의약품) | 스펙트럼측정법(gamma-ray spectrometry) 이다. 요오 | 기재한다. | 9. 법 제31조제2항·제3항에 따라 의약품을 제 | 형태 (예: [111In]indium oxine) 또는 공유결합에 의 | 사용하여 작성 | 2013.3.23.> | 현지실사를 할 필요가 있는 경우에는 이에 드 | 료를 근거로 의약품의 제조판매ᆞ수입 품목 | GMP 평가 여부 | 2.2 품목허가 신청 및 처리 절차 ························································4 | 정 | 의 | 무균시험  시험할 때 적합하다. | 한다. |\n| 2 | 3 | 4 | 5 | 6 | 주사제 항에서 보존제 사용에 대 | 출하여야 한다. 이 경우 첨부자료의 종류, 자료 | 요한 | 사항은 | 총리령으로 | 정한다. | <개정 | 「식약처 지침서등의 관리에 관한 | (2) 반감기가 24시간 미만의 방사 | ③ 기준 및 시험방법에 관한 자료 | 2) 몰리브덴-99  이 약 일정량을 바이알에 정밀하 | 문서를 포함한다)를 첨부하여 지방식품의약품안 | 1) 구조결정에 관한 자료 | (3) 공조시설, 압축공기 및 용수처리 계통도 | Indium-111 (111In) | 2.8047 일 | 5) 대사물 |\n| 동일한 화학적 형태이나 안정형 동위원소가 포함된 담 | 엔도톡신(Bacterial endotoxins - pyrogens) | 바 | 2.3.7 용법․용량 | 방사성의약품은 1개 이상의 의학용 방사성 핵종(방사 | 드화나트륨 검출기(sodium iodide detector)는 문제를 | - 투여경로 | ※ 참고 - 방사성의약품의 허가심사 종류 | ② 제1항에 따른 제조업자가 그 제조(다른 제 | 경우 그 사유를 아래에 기재해 주시기 바랍니다. | 및 xenon-133을 얻을 수 있다. |\n| 에 있어야 한다. | 작성요령과 각 자료의 요건 등에 관한 세부 사 | 2008.2.29., 2010.1.18., 2011.3.30., 2013.3.23.> | 제외한다. | 없는 성분(첨가제 등), 그 밖에 인체에 | 치는 작용)이 없는 성분(첨가제 등), 그 | 가 나 다 라 마 | 가 나 다 가 나 | 제조품목 | ※｢ | 다) 신청품목과 관련된 시설 및 환경 관리 관련 자료 | 한 형태 (예: 2-[18F]fluoro-2-deoxy-D-glucose) | 의약품의 품목허가․신고․심사규정｣ | 게 취하여 특정 두께의 납용기에 넣고 감마선측정법 | 는 경비를 포함한다)를 내야 한다. | 허가를 신청하는 경우에는 별지 제5호서식의 | 조업자에게 위탁제조하여 판매하려는 의약품 | 2.2.1 품목허가 신청 및 처리 흐름도 ···············································4 | 별표 8의3 참조 | Indium-114m (114mIn) | 49.51 일 |\n| 해 언급되었음에도 불구하고, 각 | 구분 | 전자민원 | 방문․우편 민원 | 규정」 개정에 따른 등록번호 일괄 정비 | 체로서 방사성제제에 존재하거나 추가하는 물질 | 성제제 | 분류번호 | 전청장(이하 \"지방청장\"이라 한다)에게 제출하 | 조업자에게 제조를 위탁하는 경우를 포함한다) | 2) 물리화학적 성질에 관한 자료 | (사유 :                                                                 ) | Indium-114 (114In) | 71.9 초 | 6) 불순물 | 허가심사종류 |\n| 비경구용 방사성의약품은 엔도톡신시험(2.6.14) 또는 발 | 2. 대한민국약전외한약(생약)규격집에 실려 있 | 직접 적용하지 아니하는 제품(소독제 등) | 밖에 인체에 직접 적용하지 아니하는 제 | 수입품목 | 성동위원소)을 포함하는 의약품으로 다음 제제를 포함 | 방사성핵종은 다음과 같은 방법으로 생산될 수 있다. | 일으킬 수 있다. 감마선 방출 불순물들에 기인하는 피 | - 필요 시 최대 권장 용량 (mL) | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료(해당하는 경우) | [시행일 : 2015.7.1.] 제5조 | 의 정량법에 따라 몰리브덴-99의 방사능을 산출한 | (1) 제조용수 관리현황 | 특허관계 확인서와 그 사유를 적은 서류 및 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 해당 국가의 | 의약품집 등 | 를 제출할 수 있다. |\n| 조에 언급되어 있지 않은 경우 분 | 신약 | 1,935,000원 | 2,150,000원 | 항은 식품의약품안전처장이 고시하는 바에 따른 | (규제개혁담당관실-3761호,2017.5.16) | (3) 주성분 자체가 보존효과가 있 | 공정 번호 | 공정 명칭 | 원료․시약․용매 등 | 여야 한다. | 한 의약품을 판매하려는 경우에는 총리령으로 | 2.2.2 구비서류 ·······················································································5 | Tellurium-121m (121mTe) | 154.0 일 | 2011.3.30.> | 이다. | 허가 | 기시 | 안유 |\n| 는 품목 | 과 이에 사용되는 원료의약품은 제외한 | 품(소독제 등)에 사용되는 원료의약품은 | 제조품목누적량 | 한다. | 다. 감마선스펙트로미터에 의한 정량법에 따라 방사 | 3) 제조방법에 관한 자료 | 근거자료 | 등을 적어 넣은 위탁·수탁제조계약서 | 구분 | 규격 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 | (명칭기재) | 비고 | 허가 | 허가 | 기시 | 7) 기타 | 허가 | 안유 | □ 예 | ■ 아니오 |\n| 할사용 방사성제제에 보존제를 사 | 희귀 | 1,449,000원 | 1,610,000원 | 방사선의 특성과 에너지 측정(Determination of the | 열성물질시험(2.6.8)에 적합하여야 한다. | 다. | 는 경우 | 크들은 주 방사성핵종의 스펙트럼에 가려지거나 다른 | - | (일반적으로 원자로 내의 표적물질과) | 중성자 | - 첨가된 보존제 명칭 및 양 | - 방사성의약품의 분류번호: 431 방사성 의약품 | 1. 법 제5조제1호 본문에 해당하는 사람이 아 | 제8조(허가사항 등의 변경허가 신청 등) ① 법 | (2) 자동화장치 등 관리현황 | 1. 제5조 각 호의 어느 하나에 해당하는 자 | 불용성이물시험  시험할 때 적합하다. | Tellure-121 (121Te) | 19.16 일 |\n| 2단계 | 무담체제제(Carrier-free | preparation): | 제제에 표시된 | 3. 식품의약품안전처장이 성분의 종류·규격· | 3단계 | 다] 및 의약외품[내용고형제(內用固形濟) | 제외한다]의 경우에는 별표 1의2의 원료 | 4단계 | ⑤ 등록대상원료의약품에 관한 자료(해당하는 경우) | ② 제1항에도 불구하고 다음 각 호의 어느 하 | 10. 법 제50조의2제4항(법 제42조제4항에 따 | 능을 측정할 경우 0.739 MeV의 방사능 피크를 계수 | 및 그 분량, 효능효과에 맞추어 기재 | 정하는 바에 따라 품목별로 식품의약품안전처 | 4) 기준 및 시험방법이 기재된 자료 | 2.2.3 수수료 및 처리기한 ···································································6 | 내용을 단순 편집 또는 나열한 것입니까? | 사용현황 | Iodine-123 (123I) | 13.27 시간 | 5. 약리작용에 관한 자료 |\n| 용하는 것이 필수적이지는 않다. | 신약, 희귀 외 | 513,000원 | 570,000원 | nature and energy of the radiation) | 방사성핵종 제너레이터의 용출물, 방사성표지를 위한 | ② 제1항에 따라 기준 및 시험방법에 관한 자 | 수입품목누적량 | 정보에 대해서는 2012년도에 발간한 ｢ | 방사성핵종 불순물 피크로부터 분리되지 않아 나타나 | - 방사성 핵종 제너레이터: 특정 방법을 통하여 고정 | - 해당할 경우 특별한 저장 조건 | 등록대상 | 제31조제9항 또는 법 제42조에 따라 의약품등 | (3) 청정도 관리현황 | PET용 방사성의약품 평가 가이드라인｣ |\n| ⇨ | 민원서식 작성 | ⇨ | (｢ | 하여 몰리브덴-99의 방사능을 산출한다. 이 때 몰리 | (neutron)의 반응 | 장의 제조판매품목허가(이하 \"품목허가\"라 한 | 의약품등분류번호에관한규정 (식품의약품안전처 예규)｣ | 1 | 원료칭량 | 주성분 제조원 | 님을 증명하는 의사의 진단서 또는 같은 호 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? | □ 예 | ■ 아니오 | Iodine-125 (125I) | 59.402 일 | 참조) |\n| [민원인 안내서] | 신약 | 1,170,000원 | 1,300,000원 | 별표1 참조 | 화합물 또는 분자 내 방사성핵종 위치에 있는 원소 중 | (신청서, 구비서류) | 전자민원 신청 | 료를 제출하려는 자는 심사대상물품(식품의약 | 함량 및 처방 등을 표준화하여 고시한 표준 | 및 내용액제(內用液劑)만 해당한다]의 경 | 의약품 제조 및 품질관리기준 실시 상황 | - 사용량, 사용시간과 사용횟수 등을 구체적으로 기재 | ⑥ 주성분 제조업자의 명칭 및 소재지 등에 관한 자료 | 라) GMP 조직도 및 품질관리(보증)체계 관련 자료 | 된 어미방사성핵종(parent radionuclide)으로부터 딸 | 의 제조업자ᆞ수입자 또는 위탁제조판매업자가 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 여부 | 5) 기준 및 시험방법에 관한 근거자료 | 라 준용되는 경우를 포함한다)에 따라 의약 | KP | - | Oa) | 진 조건에 상응하는 조건을 붙일 수 있다. | 라 시험한다. | 가. 효력시험자료 |\n| 방출된 | 방사선의 | 특성과 | 에너지는 | 분광광도법 | 용액 및 방사성의약품 제조를 위한 키트 또한 추가적 | 지 않을 수 있다. | 화학물질 전구체들은 첨부정보로 목표로 하는 양과 질 | - (사이클로트론 등의 가속기 내의 표적물질과) 하전 | 브덴-99의 방사능은 총방사능의 0.015 % 이하이다. | 다)를 받거나 제조판매품목 신고(이하 \"품목신 | 단서에 해당하는 사람임을 증명하는 전문의 | 2.2.4 전자민원 신청방법 ·····································································7 | Iodine-126 (126I) | 13.11 일 | (명칭 및 소재지) |\n| 안정형 동위원소가 없는 제제 | 제조기준에 맞는 품목 | 우에는 별표 1의 의약품 제조 및 품질관 | 평가에 필요한 자료 | 마) 문서관리규정 및 문서 목록 | 그 허가받거나 신고한 사항을 변경하려는 경우 | 자료를 | 제출하지 | 아니할 | 수 | 있다. | <개정 | 6) 시험성적에 관한 자료 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | 공정서 | O | Oa) | Iodine-131 (131I) | 8.02070 일 |\n| 희귀 | 877,000원 | 975,000원 | (spectrometry)을 이용하여 측정한다. | 양전자방출핵 | 인 정제 없이 비경구용으로 사용된다면 엔도톡신시험 | 품안전처장이 품질검사를 위하여 특별히 필요 | ⇩ | 감마선이나 엑스선을 방출하지 않는 알파 그리고 베타 | 의 방사성의약품을 생산하도록 보장하기 위해 방사성 | 3) 알루미늄  이 약 3.0 mL 및 알루미늄표준액 1.5 | 방사성핵종(daughter radionuclide)을 유출시켜 얻 | 분류 | 국내최초 | 의 진단서 및 같은 조 제3호에 해당하는 사 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | X | O | ː | ː | ː | 쇄된 날부터 1년이 지나지 아니한 자 | □ 예 | ■ 아니오 |\n| 7단계 | 다. 생물학적제제등인 경우에는 별표 1의 의 | 4. 식품의약품안전처장이 따로 기준 및 시험방 | 6단계 | 리기준 실시상황 평가에 필요한 자료 | 5단계 | ⑦ 위탁․수탁제조계약서(위탁제조하는 경우) | 입자(charged particle)들의 반응 | 고\"라 한다)를 하여야 한다. <개정 2013.3.23.> | 2014.10.10.> | 의약품에 관한 특허권(이하 \"의약품특허권\" | 2.3 품목허가 신청서 작성 요령 ··························································8 | Xenon-131m (131mXe) | 11.84 일 |\n| 신약, 희귀 외 | 306,000원 | 340,000원 | 3 | 4 | 하다고 인정하는 경우에만 해당한다)을 식품의 | 1.2 국내 방사성의약품 품목허가 현황 | 바) 신청품목과 관련된 제품표준서 및 제조ㆍ품질관리기록서 사본 | mL를 취하여 각각 물 2 mL, 3.5 mL 및 용시 조제 | (제4조제1항제7호 각 목 외의 부분 본문 또는 | 7) 표준품 및 시약․시액에 관한 자료 | 람이 아님을 증명하는 의사의 진단서 | 내용입니까? | 자사기준 | - | Ob) | 3. 파산선고를 받고 복권되지 아니한 자 | 저 장 법  밀봉용기, 차폐. | 다. 흡수, 분포, 대사 및 배설시험자료 |\n| ⇦ | (positron emitter)의 방사선 특성과 에너지는 보통 측 | 에 적합하여야 한다. | ⇦ | 입자 방출 불순물들은 이러한 방법으로 측정할 수 없 | 의약품 제조에 사용하기 전에 1개 이상의 제품을 시험 | - 방사성핵종 제너레이터로 부터의 유출 | - 전문/일반의약품 중 방사성의약품은 전문의약품에 해당 | ③ 제1항에 따른 제조업자 외의 자가 제34조제 | 1. 제1항제1호 또는 제2호에 해당하는 자료로 | 을 수 있도록 한 방사성의약품 시스템 | 기재 | 되었다. | Iodine-133 (133I) | 20.8 시간 |\n| 담체무첨가제제(No-carrier-added preparation): 제제에 | 나. 생물학적제제등인 경우에는 별표 1의 의 | 약품안전처장에게 제출하여야 한다. | (진행상황 확인) | 수수료 납부 | 법을 고시한 품목 | 약품 제조 및 품질관리기준, 별표 1의2의 | 사) 신청품목과 관련된 밸리데이션 자료 | 한 L-아스코르브산용액 (1 → 20) 2.4 mL 씩을 넣 | 제5조제2항제6호에 따라 제4조제1항제7호 각 | 8) 용기 및 포장에 관한 자료 | 제네릭 | KP, 공정서 | - | O | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 2.3.1 제품명 ···························································································8 | □ 외국 규정을 번역하거나 설명하는 내용입니까? | □ 예 | ■ 아니오 | Xenon-133 (133Xe) | 5.243 일 | 1) 분석방법과 밸리데이션 보고서 |\n| 가 | 나 | 다 | 라 | 마 | 바 | 가* | 나 | 다 | 라 | 마 | 다. 알파 그리고 베타 방출체(emitter)들은 다른 방법들 | 할 것을 권고한다. | - 방사성의약품 키트: 보통 사용하기 전에 방사성핵종 | ⑧ 별지 제5호서식 특허관계확인서 및 사유서 | 2. 법 제36조에 따른 의약품 또는 의약외품(이 | 1항에 따라 임상시험계획의 승인을 받아 임상 | 직접 용기․포장의 재질 |\n| 정할 수 없고 반감기와 감마선 스펙트럼 측정을 통해 | 방사성핵종 전구체와 화학물질 전구체들은 엔도톡신을 | 5. 식품의약품안전처장이 신고대상품목으로 고 | 약품 제조 및 품질관리기준 및 별표 3의 | 원료의약품 제조 및 품질관리기준 및 별 | 핵반응 발생 확률은 입사입자(양성자, 중성자, 중양성 | - 적응증에 따른 사용량 “용량” 항에 기재 | (｢ | 고 흔들어 섞어 15 분간 방치한다. 다음 각각에 물 | 목의 자료를 제출한 경우에는 그 자료를 변경하 | 의약품분류기준에관한규정 (식품의약품안전처 고시)｣ | 서 적합하다는 제41조제3항에 따른 사전 검 | 품\"이라 한다)의 안전성·유효성에 관한 자 | 자사기준 | - | O | Xenon-133m (133mXe) | 2.19 일 | 본다. <개정 2014.8.21.> | 참조) |\n| 표시된 화합물 또는 분자 내 방사성핵종 위치에 있는 | 시험을 실시한 의약품을 제조업자에게 위탁제 | 나. 완제의약품에 관한 자료 | 하 \"의약품등\"이라 한다)의 제조업무를 관리 | 2.3.2 분류번호 및 분류 ·······································································9 | 정 2014.5.9., 2014.8.21., 2015.3.13.> | 2) 흡수 |\n| 확인한다. | 제거하기 위한 적절한 추가 조치 없이 비경구용 제제 | 시한 의약품등 | 생물학적제제등 제조 및 품질관리기준 실 | 표 3의 생물학적제제등 제조 및 품질관리 | 자 등)의 특성과 에너지 그리고 그로 인해 방사되는 | 을 사용해야 한다. | (의약품 특허목록에 등재된 의약품의 안전성․유효성에 관한 자료를 근거로 신청하는 경우) | 과 혼합하거나 재용해하여 사용하는 제제 | a) 허가규정 제25조제2항에 따른 안유면제대상 | 토 결과통지서를 제출한 경우: 제1항제1호 | 료를 근거로 의약품의 제조판매·수입 품목 | □ 정보제공 등 직원 교육용 자료입니까? | □ 예 | ■ 아니오 | 포장 | 의 방출로 대체될 수도 있다. | 비방사능(Specific radioactivity) | Iodine-135 (135I) | 6.57 시간 | (주사제의 경우 용기 규격 |\n| 부칙 <총리령 제1089호, 2014.8.21.> | 년도 | 는 경우를 포함하며, 법 제89조제3항에 따른 | 1) 원료약품 및 그 분량에 관한 자료 | 하는 자(이하 \"제조관리자\"라 한다)의 자격 | Xenon-135 (135Xe) | 9.14 시간 | 정 2014.5.9., 2015.3.13.> | 3) 분포 |\n| 원소 중 고의로 첨가한 안정형 동위원소가 없는 제제 | 생산에 사용될 경우 엔도톡신시험에 적합하여야 한다. | ② 제1항에 따라 의약품등의 제조판매·수입 | 시상황 평가에 필요한 자료 | 기준 실시상황 평가에 필요한 자료 | - 방사성핵종 전구체: 화학물질 전구체에 방사능 표지 | 조하여 판매하려는 경우에는 총리령으로 정하 | 또는 제2호에 해당하는 자료 | 허가를 신청하는 경우에는 별지 제5호서식의 | 2.3.3 원료약품 및 그 분량 ·································································9 | 중앙약사심의위원회에 자문을 할 수 있다. | 포함) |\n| 제4조(희귀의약품의 기준 및 시험방법에 관한 자 | 2.3.12 제조원 | 핵의 특성에 따라 다르다. 또한 생산된 방사성핵종의 | 각조에서는 필요한 방사성핵종순도와 특정 방사성핵종 | b) 신약 | 지위승계 신고 대상에 해당하는 변경은 제외한 | 을 확인할 수 있는 서류 또는 제42조제3항 | GMP　평가자료의 요건 등 | 방사능 검출 및 측정 | Caesium-137 (137Cs) | 30.04 년 |\n| 비방사능(Specific radioactivity): 물질 또는 화합물의 | 2. 품목허가를 신청하는 품목(신약, 생물학적제 | 및 효능․효과별 적정 방사선조사량 기재 | 는 바에 따라 식품의약품안전처장에게 위탁제 | 2) 제조방법에 관한 자료 | 4) 대사 |\n| 엔도톡신시험은 일반시험법(2.6.14) 항에 따라 시험하며 | 다. 한약재의 경우에는 별표 2의 한약재 제조 | 라. 방사성의약품인 경우에는 별표 1의 의약 | 품목신고를 하려는 자는 별지 제6호서식의 의 | 료 제출에 관한 경과조치) 이 규칙 시행 전에 | 의약품 명명법 가이드라인｣ | 시 | 험 | 참조 | 2.3.3 원료약품 및 그 분량 | 수율은 표적물질의 원소 조성, 화학적 순도, 중성자선 | 불순물(예를 들면 테크네튬-99m에서의 몰리브덴-99)에 | 방사능의 검출 및 측정은 일반 항 2.2.66. 방사능 검출 | 하기 위해 사용하는 방사성핵종을 포함한 물질 | ※ 방사성의약품의 경우 ‘15.7.1부터는 GMP 평가대상 | 다)에는 다음 각 호의 구분에 따른 신청서(전자 | 특허관계 확인서와 그 사유를 적은 서류 및 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다. | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다. | Barium-137m (137mBa) | 2.552 분 | 한다. <개정 2011.3.30., 2013.3.23.> | 판매ᆞ수입 품목허가 및 품목신고의 갱신 |\n| 2015.7. | 단위질량 당 방사성핵종의 방사능(예: Bq/g, Bq/mol) | ※ 상기 구비 서류 중, | - 아래 표를 참고로 구분하여 기재 | 유의사항 | 조판매업신고를 하여야 하며, 품목별로 품목허 | 에 따른 제조관리자 승인서 | 2.3.4 성상 ·····························································································10 |\n| 약품등 제조판매·수입 품목신고서(전자문서로 | 및 품질관리기준 실시상황 평가에 필요한 | 품 제조 및 품질관리기준, 별표 1의2의 | - 화학물질 전구체: 방사성핵종과 결합하는 방사능이 | - 오용의 여지가 없는 명확한 표현 사용, 남용의 위험성, 특성을 강조하는 표현 제외 | 문서로 된 신청서를 포함한다) 또는 신고서(전 | 3) 기준 및 시험방법이 기재된 자료 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 근거자료 | 2. 법 제32조에 따른 신약 등의 재심사 | Thallium-200 (200TI) | 26.1 시간 | 5) 배설 |\n| 다음 시험항목 중 일부는 제품의 방사성핵종의 반감기 | 시험을 수행하는 개인의 방사선 조사량을 제한하기 위 | 종전의 규정에 따라 희귀의약품의 제조판매ᆞ | 및 측정에 따라 수행한다. | 속(neutron flux) 및 빔전류(beam current)에서의 하전 | 대한 기준을 규정하고 있다. 이러한 요구사항이 필요 | ② 제1항에 따라 신청서 또는 신고서를 받은 | 3) 업소정보 입력 | 가를 | 받아야 | 한다. | <개정 | 2008.2.29., | Lead-201 (201Pb) | 9.33 시간 |\n| 예비심사 (제출된 서류의 적절성 평가) | 된 신고서를 포함한다)에 다음 각 호의 자료 | 자료. 다만, 둘 이상의 제조판매ᆞ수입 품 | 원료의약품 제조 및 품질관리기준 및 별 | ② 안전성유효성에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음. | 명칭 | 기재항목 | 용어 정의 | 11. 신약, 희귀의약품(적절한 대체의약품이 없 | 원료약품 및 그 분량 | 4) 기준 및 시험방법에 관한 근거자료 | 전처장이 고시하는 의약품은 제외한다)을 제 | 2.3.5 제조방법 ·····················································································11 | 3. 법 제33조에 따른 의약품 재평가 | 라. 약물상호작용 등에 관한 자료 |\n| [제제총칙 - 주사제 항] | 해 주의를 요한다. 엔도톡신 기준은 각조에 기재되어 | 수입 품목허가를 신청한 자에 대해서는 제4조 | [제제총칙 - 주사제 항] | 한 반면, 그것만으로 제품의 방사성핵종순도가 임상적 | 없는 물질 | 자문서로 된 신고서를 포함한다)에 그 허가증 | 지방청장은 「전자정부법」 제36조제1항에 따 | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 하여 계산된다. | Thallium-201 (201Tl) | 72.912 시간 | □ 예(☞지침) | ■ 아니오 |\n| 가 짧은 경우 배치 출하 전에 수행하기 어렵다. 각조 | (전자문서를 포함한다)를 첨부하여 지방청장에 | 목허가를 동시에 신청하는 경우에는 그 | 표 3의2의 방사성의약품 제조 및 품질관 | 입자 에 따라 다르다. | 4) 자가점검표 항목 입력 (민원인이 직접 제출자료의 타당성 여부 점검) | 2010.1.18., 2013.3.23.> | 조하는 제조소에 제48조의2에 따른 제조 및 | 어 긴급히 도입하여야 하는 의약품으로서 식 | 제조판매품목허가권자와 제조자 동일 | 에 드는 경비를 포함한다)를 내야 한다. |\n| 방사능농도(Radioactivity concentration): 제제의 단위 | 제1항제2호의 개정규정에도 불구하고 종전의 | 전체단위 | 또는 신고증과 변경사유서(전자문서로 된 사유 | 5) 시험성적에 관한 자료 | 2.3.6 효능․효과 ·················································································13 | Thallium-202 (202Tl) | 12.23 일 | 6. 임상시험성적에 관한 자료 |\n| 분할사용 용기는 주사바늘을 뺄 | ① 안전성․유효성 및 | 기준및시험방법 심사 의뢰 | 에서 사용을 위한 출하 전에 완전하게 수행되지 않아 | 있거나 또는 일반항 5.1.10. 엔도톡신시험 수행을 위한 | 분할사용 용기의 경우 용기시스 | 제조와 수입의 비율(%)은 55 : 45 로 제조가 20 품목 더 많이 허가되었다. | 방사성핵종 전구체는 방사능 표지를 위한 용액으로 공 | 보통 원하는 핵반응 이외에 부가적인 변환이 동시에 일 | 인 사용에 충분함을 보장하지 않는다. 제조자는 상세 | 참고 - 5.7. 유럽약전에서 언급된 방사성핵종의 물리적 | ④ 의약외품의 제조를 업으로 하려는 자는 대통 | 5) 신청서 내용 작성하기 (신청인, 상세내용, 원료약품 및 그 분량, 담당자 등 2.3 품목허가 신청서 | 른 행정정보의 공동이용을 통하여 다음 각 호 | 품질관리 적합판정서가 있는 경우: 제1항제6 | 자사제조 | 사무의 세부기준이나 절차를 제시하는 것입니까? (공무원용) | Lead-203 (203Pb) | 51.873 시간 |\n| 부피 또는 단위질량 당 방사성핵종의 방사능으로 방사 | 게 제출하여야 한다. <개정 2014.8.21.> | 규정에 따른다. | 중 하나의 품목에 관한 자료만을 제출할 | 리기준 실시상황 평가에 필요한 자료 | 2.3.8 사용상의 주의사항 | 지침·안내서 | 서를 포함한다) 및 그 근거서류(제4조제1항 각 | 6) 표준품 및 시약․시액에 관한 자료 | 품의약품안전처장이 정하는 의약품을 말하 | 배합 | (수입, 제조품목 공통) | 활성물질 | [시행일 : 2015.7.1.] 제4조 | 가. 임상시험자료집 | 효성에 관한 자료 검토 | 반제 |\n| 때 구멍이 다시 닫히도록 충분한 | ② GMP　실시상황 평가 의뢰(평가 대상에 한함*) | 가이드라인에 따라 계산한다. | 템의 변형 없이 내용물을 취할 | 급될 수 있다. | 한 시험을 수행해야 하고 특히 짧은 반감기를 가진 방 | 세부구성 | 령령으로 정하는 시설기준에 따라 필요한 시설 | 의 서류를 확인하여야 한다. 다만, 제2호의 경 | 작성 요령 참조) | 2.3.7 용법․용량 ·················································································13 | 목적 | 원료명 | 용량 | 규 격 | 분 량 | 단 위 | 제조원 | DMF | 일자 또는 필요할 경우 시간을 함께 표시한다. | 여부 | 비고 |\n| 도 되는 시험항목들을 표시했다. 이러한 시험항목들은 | 마. 의료용 고압가스인 경우에는 별표 1의 의 | 1. 제1항에 따른 신고품목임을 입증하는 자료 | 수 있다. | 어난다. 발생 확률은 상기 서술된 요인에 따라 다르다. | - 동물유래성분 사용 시 기원동물 및 사용부위 기재 | 호의 서류를 말하며, 전자문서를 포함한다)를 | 구분 | 특성 표 중 반감기 정보 | 호에 해당하는 자료 | 며, 이하 같다) 등 식품의약품안전처장이 정 | 전공정위탁제조 | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 품목허가권자이면서, 전공정을 다른 제조업자에게 의뢰하여 제조하는 자 | 5. 제48조제3호에 따른 안전성 정보 보고 |\n| 탄성이 있어야 한다. | 성용액제제의 경우, 제제의 단위부피 당 방사능으로 표 | 제5조(제조 및 품질관리 실시상황평가에 필요한 | 수 있어야 한다. | 핵종은 원자핵 내 양성자와 중성자 수(원자번호 Z와 | 을 갖추고 식품의약품안전처장에게 제조업신고 | 우 신청인 또는 신고인이 확인에 동의하지 아 | 7) 용기 및 포장에 관한 자료 | ※ 신청서 작성 중 | 확인 선택기재 사항 | 1) 생물약제학 시험보고서 |\n| 그런 식으로 생산된 제품의 품질관리가 된다. | 방사성의약품 또는 전구체의 특성에 따라 엔도톡신시 | 7. 법 제31조의2제1항에 따라 등록할 수 있는 | 2. 제4조제1항제2호에 따른 자료(이 조 제1항 | 의약품의 품목허가․신고․심사규정｣ | 약품 제조 및 품질관리기준, 별표 1의2의 | 별표 8 | ｢ | 이러한 변환들로 인해 방사성핵종 불순물들이 생성될 | 사성핵종 제품은 적당한 붕괴 시간을 거친 후에 긴 반 | 방사성의약품 제조 및 품질관리기준 가이던스｣ | 3. 식품의약품안전처장이 고시하는 기준에 적합 | 하는 의약품의 경우에는 환자용 사용설명서, | 2.3.8 사용상의 주의사항 ···································································13 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까? (민원인용) | 01/2008:50700 | radionuclide)으로 붕괴되는 것을 이용한 시스템이다. | 를 참고한다. |\n| ① 안전성․유효성 및 | 기준및시험방법 심사 | ② GMP　실시상황 평가 | 기한다. | 자료 제출에 관한 경과조치) 이 규칙 시행 전 | 3. 안정성에 관한 자료 | 첨부하여 식품의약품안전처장(의약품등 제조업 | 니하는 경우에는 그 사본을 첨부하게 하여야 | (제조의뢰자) | (수입, 제조품목 공통) |\n| 험에 간섭(억제 또는 활성화)을 일으키고 간섭요인의 | 표 1. 연도별 방사성의약품 품목허가 수 (15.01.12. 품목대장 기준) | 질량수 A에 따라) 또는 그 핵에너지 상태에 의해 특징 | 감기를 가진 불순물들에 대해 시험해야 한다. 이런 식 | “적용상의 주의사항”으로 구분하여 기재 | 를 하여야 하며, 품목별로 품목허가를 받거나 | 한 경우: 제1항제4호에 해당하는 자료 | (1) 의약품 허가전 보험등재 동시진행(허가-약가 연계) 관련 | 생리학적 분포(Physiological distribution) |\n| [일반사항 - 고무마개 항] | 에 종전의 규정에 따라 의약품등의 제조판매ᆞ | 신약의 원료의약품 또는 식품의약품안전처장 | 제3호에 따른 품목 중 제48조제5호에 따른 | 원료의약품 제조 및 품질관리기준 및 별 | [일반사항 - 고무마개 항] | 수도 있다. | 방사성핵종 | 반감기 | 허가ᆞ신고의 변경, 위탁제조판매업 신고의 변 | 안전사용보장조치 등 식품의약품안전처장이 | 2.3.9 포장단위 ·····················································································13 | 전공정위탁제조 | 우는 제외한다. <개정 2011.3.30., 2013.3.23.> | 아니한다. | 과 효능ᆞ효과 등에 대한 평가 |\n| 처리방법 기재 | 품목신고를 하여야 한다. <개정 2013.3.23.> | 한다. | 가. 원료의약품에 관한 자료 | (2) 과거 신청 이력 여부 | 3) 약동학(PK) 시험보고서 |\n| 제거가 불가능 할 경우 특별히 발열성물질시험 항이 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 별표 1의 의약품 제조 및 품질관리기준에 적 | 표 3의3의 의료용 고압가스 제조 및 품 | 지어지는 원자의 종(species)이다. 원소의 동위원소는 | 으로 제조공정의 적합성과 시험방법의 타당성 정보가 | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Tritium (3H) | 12.33 년 | 법령에 적합하게 판매되고 있음을 증명하는 “판매증명서”를 제출하여야 함. | 경, 의약품 동등성의 입증이 필요한 의약품의 | 정하는 위해성 완화 조치방법을 포함하는 종 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | □ 예 | ■ 아니오 |\n| ① 및 ② 자료가 적합한가? | 아니오 | 보완회신 | 분할사용 용기를 사용하는 경우 | 총방사능(Total radioactivity): 단위제형(바이알, 캡슐, | 비방사성물질과 유연물질 | 수입 품목허가를 신청하거나 이 규칙 시행 당 | 분할사용 용기를 사용하는 경우 | ⑤ 제2항 및 제3항에 따라 품목허가를 받거나 | 1. 법인 등기사항증명서(법인인 경우만 해당한 | 연도 | 제조 | 수입 | 전체 | 연도 | 제조 | 수입 | 전체 | 1) 장기보존시험 또는 가속시험자료 | (제조자) | (수입, 제조품목 공통) | 1. 시험성적서와 그에 관한 자료 | 4) 약력학(PD) 시험 보고서 | 아니한다. |\n| 설정되어 있을 수 있다. | 대상 원료의약품\"이라 한다)을 사용하는 품 | 합하다는 판정을 받지 못한 품목 및 이 조 | 질관리기준 실시상황 평가에 필요한 자료 | 원자번호가 동일하나 질량수가 다른 핵종이다. 양성자 | 확보된다. 2개 이상의 양전자를 방출하는 방사성핵종 | - 제제의 특성상 필요한 경우 제제설계에 관한 자료 제출 | Carbon-11 (13C) | 20.385 분 | 기타 확인 | 등에 의하여 해당 제조시설ᆞ제조방법 등을 양 | 합적인 의약품 안전관리 계획(이하 \"위해성 | (3) 민원설명회 개최 여부 | 2.3.10 저장방법 및 사용기간 ···························································13 | 민원인을 구속하는 내용이 있습니까? | 등의 기준 개정 |\n| 재밀봉시험(self-sealing test)을 수 | (Non-radioactive substances and related substances). | 시 의약품등의 제조판매ᆞ수입 품목신고의 절 | 재밀봉시험(self-sealing | capacity) | 핵반응(변환)은 다음과 같이 표현한다. | Nitrogen-13 (13N) | 9.965 분 | 규칙」별표 3의2 및 「의약품 제조 및 품질관리에 관한 규정」별표 3은 적용하지 않음 | 제조판매ᆞ수입 품목허가의 변경, 안전성ᆞ유효 | 품목신고를 한 자(이하 \"품목허가를 받은 자\" | 다) | 2. 원료의약품에 관한 자료 |\n| 앰플, 제너레이터 등) 당 방사성핵종의 방사능 | 바. 한약재의 경우에는 별표 2의 한약재 제조 | 목의 경우에는 원료의약품에 관한 다음 각 | 제1항제5호에 따른 품목만 해당한다) | 2.3.9 포장단위 | 6) 안전성·유효성 심사/기준및시험방법 심사/기타구비서류 작성하기 | 1968 | 1 | 1 | 2007 | 3 | 1 | 4 | 수받은 품목의 제조판매ᆞ수입 품목허가를 받 | 2) 가혹시험자료 | 관리 계획\"이라 한다) | 5) 유효성과 안전성 시험 보고서 |\n| 행하였을 때 적합하여야 한다. | 차가 진행 중인 경우에 대해서는 제4조제1항제 | 예 | 결과반영 | 을 수행하였을 때 적합하여야 한 | ※ ‘청정도 관리현황’ 자료 | 와 중성자가 불안정한 배열을 포함하는 핵종은 자연스 | 들은 확인 그리고/또는 구별이 필요하다(예를 들면 | - 제제설계 시 분할사용 하는 경우 아래 관련 정보를 참고하여 설계 | 2. 약사 면허증(제조관리자가 약사인 경우만 해 | Oxygen-15 (15O) | 122.24 초 | 동 자료를 제출하지 않을 수 있음(신약, 주사제, 이식제, 생물학적제제 등 제외) | 성 검토 대상이 아닌 의약외품의 제조판매ᆞ수 | 사항 | 일부공정위탁제조 | 2.3.11 기준 및 시험방법 ···································································14 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | 능 확인 및 정량적인 측정을 수행할 수 있다. | 사용이 가능하다. | 3. 관계 문헌 | 는 품목 |\n| 이 항은 존재할 수 있는 비방사성물질과 유연물질 측 | 라 한다)는 총리령으로 정하는 바에 따라 영업 |\n\n**[표 끝]**\n\n<!-- PAGE_1 -->\n### 의약품심사부\n\n<!-- PAGE_1 -->\n### 종양약품과\n\n지침·안내서 제‧개정 점검표\n\n<!-- PAGE_1 -->\n###### 명칭\n\n<!-- PAGE_1 -->\n###### 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_1 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n<!-- PAGE_1 -->\n###### ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로\n\n<!-- PAGE_1 -->\n###### 고려하시기 바랍니다. 그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n<!-- PAGE_1 -->\n###### ■ 예(☞안내서)\n\n<!-- PAGE_1 -->\n###### □ 아니오\n\n<!-- PAGE_1 -->\n###### 안내서 제·개정 절차를 진행하시기 바랍니다.\n\n<!-- PAGE_1 -->\n###### 상기 사항에 대하여 확인하였음.\n\n<!-- PAGE_1 -->\n###### 2017  년   5  월   25  일\n\n<!-- PAGE_1 -->\n###### 담당자\n\n<!-- PAGE_1 -->\n###### 확  인(부서장)\n\n<!-- PAGE_1 -->\n###### 오 호 정\n\n<!-- PAGE_2 -->\n##### 이 안내서는 방사성의약품의 품목허가와 관련하여 허가 전반적인\n\n<!-- PAGE_2 -->\n##### 사항에 대하여 절차, 내용 등을 알기 쉽게 풀어 설명한 것입니다.\n\n<!-- PAGE_2 -->\n##### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의\n\n<!-- PAGE_2 -->\n##### 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시\n\n<!-- PAGE_2 -->\n##### 준수하셔야 하는 사항이 아님을 알려드립니다. 또한, 본 안내서는\n\n<!-- PAGE_2 -->\n##### 2015년 7월 30일 현재의 과학적·기술적 사실 및 유효한 법규를 토대\n\n<!-- PAGE_2 -->\n##### 로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_2 -->\n##### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n<!-- PAGE_2 -->\n##### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_2 -->\n##### (이하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한\n\n<!-- PAGE_2 -->\n##### 사안에 대하여 식품의약품안전처의 입장을 기술하는 것\n\n<!-- PAGE_2 -->\n###### ※ 본 해설서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원 의약품심사부\n\n<!-- PAGE_2 -->\n###### 종양약품과로 문의하시기 바랍니다.\n\n<!-- PAGE_2 -->\n###### 전화번호: 043-719-3057\n\n<!-- PAGE_2 -->\n###### 팩스번호: 043-719-3050\n\n<!-- PAGE_2 -->\n# 목  차\n\n<!-- PAGE_2 -->\n##### 1. 서론 ······································································································1\n\n<!-- PAGE_2 -->\n##### 1.1 배경 ····································································································1\n\n<!-- PAGE_2 -->\n##### 1.2 국내 방사성의약품 품목허가 현황 ··············································1\n\n<!-- PAGE_2 -->\n##### 2.3.12 제조원 ·······················································································15\n\n<!-- PAGE_2 -->\n##### 2.3.13 허가조건 ···················································································16\n\n<!-- PAGE_2 -->\n##### 2.4 심사자료의 종류 및 범위 ····························································17\n\n<!-- PAGE_2 -->\n##### 2.5 GMP 평가자료의 종류 및 범위 ·················································19\n\n<!-- PAGE_2 -->\n##### 부록1. 관련 법규 ····················································································21\n\n<!-- PAGE_2 -->\n##### 부록2. 유럽약전 방사성의약품 번역 ··················································31\n\n**[표 시작]**\n\n| 심사항목 | 처리기한 | 각 항목 심사 불필요시 위 수수료에서 아래 해당금액 제외 | 민원인들에게 허가 전반적인 사항에 대해 알기 쉽게 안내하고자 마련하였으며 허가심사 | 1항에 따라 의약품등의 제조판매ᆞ수입 품목허 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 약품등의 제조업이나 위탁제조판매업에 대한 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 60 | 7 | 8 비고 | 가 | 나 | 가 | 나 |\n| 사용 중인 설비 또는 시스템에 관해서는 위 조건에 해당하는 적격성평가 자료를 반드시 제출할 필요는 없음. | 등을 미리 식품의약품안전처장과 품목 및 수 | 자료 또는 비교임상시험 성적서에 관한 자 | 처장이 정하는 희귀의약품(이하 \"희귀의 | 1 | ③ 제1항에도 불구하고 식품의약품안전처장 또 | 등 제조판매·수입 품목 허가신청서(전자문서로 | 조시설·제조방법 등에 관한 양도·양수계약서 |\n| 2 | 안내서-0231-01 | - | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | (1) (2) (3) | 절차, 신청방법, 신청서 항목 작성 요령 및 기타 유용한 정보 등을 담아 품목허가 신청을 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 허가를 받거나 신고를 할 수 없다. <개정 |\n| 이러한 경우, GMP 적용 시점 이후 설비의 운전변수 및 중요변수에 대한 한계를 뒷받침하고 입증하는 | 량에 대한 협의를 거쳐 수입하려는 경우 | 료. 다만, 식품의약품안전처장이 고시하는 품 | 미국약전 | USP, NF | 독일약전 | DAB | 약품\"이라 한다) | 는 지방청장은 다음 각 호의 어느 하나에 해당 |\n| - 약리학, 제제학, 임상성적자료 등 명확한 근거 바탕, 합리적, 타당해야 하며, 원료약품 | 등 제조판매ᆞ수입 품목 허가신청서(전자문서로 | 된 신청서를 포함한다)에 다음 각 호의 서류(전 |\n| 발 | 행 | 일 | 자료(예시 : 공정 밸리데이션, 제품품질평가 등), 교정, 세척, 예방적 유지관리, 작업절차, 작업원 훈련절차 | 목의 경우에는 비교용출시험자료 등 생체를 | ○ | × | × | × | ○ ○ ○ △ | × | △ △ ○ ○ ○ △ | × | × | × | ○ | × | × | × | × | × | × | × | × | × | × | × | ○ ○ | × | ○ ○ | 2015년 7 월 | 용이하게 하고자 하였다. 아울러 PET용 방사성의약품의 심사 평가 시 요구되는 일반적인 | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 하는 경우 그 검토 결과 이미 제조판매ᆞ수입 |\n| 일본약전 | JP | 프랑스약전 | FP | 40 | 하전입자 조사(CHARGED PARTICLE IRRADIATION) | 된 신청서를 포함한다)에 다음 각 호의 서류(전 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| 및 기록에 대한 자료를 제출하면 됨(‘15.7.1자 시행되는「의약품 제조 및 품질관리에 관한 규정」 [별표 13] | 경우에는 생물학적 동등성시험에 관한 시험 | 이용하지 아니하는 시험자료로서 식품의약품 | 1단계 | 도인에 대한 제조판매·수입 품목허가에 붙여 | 품목허가 또는 품목신고한 사항을 변경할 필요 |\n| 약품을 수입하거나 임상시험용 의약품 등 총 | 방법에 대한 기술적인 내용은 각조에 설정되어 있다. | 2. 제76조에 따라 제조업 허가가 취소되거나 | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 을 참고한다. |\n| 발 | 행 | 인 | 4.5 기존에 사용 중인 시설, 시스템 및 설비의 적격성 평가 참조) | 영국약전 | BP | ⇨ | 손 여 원 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| - 재심사 기간 : 2013.7.2. ~ 2019. 7.1.(6년) | 리령으로 정하는 의약품등을 수입하려는 경 | 자료 또는 비교임상시험 성적서에 관한 자 | 안전처장이 고시하는 자료를 제출한다. | 제3호에 따른 품목 중 제48조제5호에 따른 | 의약품의 품목허가․신고․심사 규정｣ | 조판매·수입 품목허가 및 제1호 각 목 외의 | 가 있어 법 제76조제1항 각 호 외의 부분 단 |\n| 20 | 다운로드 및 설치 |  | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 위탁제조판매업소 또는 제조소(製造所)가 폐 |\n| 우 | 료. 다만, 식품의약품안전처장이 고시하는 품 | 별표 1의 의약품 제조 및 품질관리기준에 적 |   |  | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | 서에 따라 일정기한까지 품목의 변경을 명령한 | 나. 일반약리시험자료 또는 안전성약리시험자료 |\n| - 재심사 신청기간 : 2019.7.2. ~ 2019.10.1. | 편 집 위 원 장 | 「의약품 제조 및 품질관리에 관한 규정」제4조 및 [별표 13] 적격성평가 및 밸리데이션, ‘방사성의약품 제조 |    | 이 선 희 | - 사용 시에 방사성 물질을 표지하는 경우 “용법” 항에 방사성 물질 표지하는 조제방법 | 조판매ᆞ수입 품목허가 및 제1호 각 목 외의 | 부분 단서에 따라 자료를 제출하지 않아도 되는 |\n| 목의 경우에는 비교용출시험자료 등 생체를 | 합하다는 판정을 받지 못한 품목 및 이 조 | 8단계 | 목허가를 받은 전문의약품으로서 신약에 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 경우에는 식품의약품안전처장 또는 지방청장이 |\n| 및 품질관리 기준 가이던스’를 참조 | 부분 단서에 따라 자료를 제출하지 않아도 되는 | 의약외품 제조판매·수입 품목허가의 경우에는 |\n| 위탁제조판매업자로부터 수탁을 받아 제조하는 제조업자, 수입자(제조원을 포 | 자료번호 | ⇦ | 한의식, 김소희, 윤경은, 엄정윤, 박소라, 김동환, 전설희, | (electron capture) 또는 양전자방출(positron emission) |\n| 편 | 집 | 위 | 원 | 이용하지 아니하는 시험자료로서 식품의약품 | 제1항제5호에 따른 품목만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 0 | 90일(원료의 | 1 | 2 | ⑨ 제1항부터 제4항까지의 경우에 허가받은 사 | 지방청장을 말한다)에게 제출하여야 한다. <개 | 품등의 제조판매·수입 품목허가를 위하여 필 | 변경허가를 하거나 변경신고를 수리한 것으로 |\n| GMP | 약품 60일) | 207,000원 | 230,000원 | 의약외품 제조판매ᆞ수입 품목허가의 경우에는 |\n| 안전처장이 고시하는 자료를 제출한다. | 함한다) | 로의 품목을 포함한다) | 1968 1996 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 | 국내 방사성의약품의 연도별 품목허가 수는 표 1과 그림 1에서 나타나듯이 특정 년도를 | 요하다고 인정하는 경우에는 식품의약품안전평 |\n| 김미지 | 지방청장을 말한다)에게 제출하여야 한다. <개 | 항 또는 신고한 사항 중 총리령으로 정하는 사 |\n| (법 제27조제2항제1호에 따라 의약품 동등 | × | ○ | × | × | × | △ | ○ | △ | △ | △ | △ | ○ | △ | 1. 법 제31조의5(법 제42조제4항에 따라 준용 | 가원의 의견을 듣거나 법 제18조제1항에 따른 |\n| 1. 제9조에 따른 안전성·유효성에 관한 자료. | 항을 변경하려는 때에는 총리령으로 정하는 바 |\n| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 받은 전문의약품으로서 신약에 | 품으로서 이미 제조판매·수입 품목허가 | 되는 경우를 포함한다)에 따른 의약품 제조 |\n| - 재심사 기간 : 2014. 10. 4. ~ 2018. 10. 3.(4년) | 도 움 주 신  분 | 식품의약품안전처 의약품안전국 의약품품질과 | 1. 제9조에 따른 안전성ᆞ유효성에 관한 자료. | 에 따라 변경허가를 받거나 변경신고를 하여야 | 다만, 생물학적 제제, 유전자재조합의약품, |\n| 이 정한 의약품만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 를 받은 것과 성분이 동일한 정제·캡슐 | 처리부서 | 민원접수 | 그림 1. 연도별 방사성의약품 품목허가 그래프 (15.01.12. 품목대장 기준) | (Carrier-free preparation)의 방사능과 비슷할 수 있다. | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | 다만, 생물학적 제제, 유전자재조합의약품, | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n**- 재심사 신청기간 : 2018. 10. 4. ~ 2019. 1. 3.**\n| 로의 품목을 포함한다) | 제 또는 좌제. 다만, 상용(常用) 의약품, | 식품의약품안전평가원 의약품심사부 의약품심사조정과 | 약품안전처장이 정하여 고시하는 수수료(외국 | 및 이와 유사한 제제(이하 \"생물학적제제등\" |\n| 가. 구조결정에 관한 자료 | 대한민국약전 | 유럽약전 | 미국약전 | ⑩ 제2항 및 제3항에 따라 허가를 받거나 신고 | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | - 유기용매를 사용할 경우 사용목적과 용매의 명칭, 규격, 단위제형당 사용량 등 기재 | 에서 현지실사를 할 필요가 있는 경우에는 이 |\n| 나. 물리화학적 성질에 관한 자료 | 발 | 행 | 처 | 식품의약품안전평가원 의약품심사부 종양약품과 | 방사성핵종 제너레이터(RADIONUCLIDE GENERATORS) | 하려는 품목이 신약 또는 식품의약품안전처장 | 및 이와 유사한 제제(이하 \"생물학적제제등\" | 이라 한다)가 아닌 것으로서 다음 각 목의 |\n| 제3호에 따른 품목은 제외한다) | 품으로서 이미 제조판매ᆞ수입 품목허가 | 또는 의약품 동등성 확보가 필요한 의약 | 4. 제4조, 이 조 및 제41조에 따른 안전성ᆞ유 |\n| 다. 제조방법에 관한 자료 | 의약품심사조정과 | ③ 기준 및 시험방법에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음. | 이 지정하는 의약품인 경우에는 안전성ᆞ유효 | 이라 한다)가 아닌 것으로서 다음 각 목의 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n**- 전부 또는 일부 공정 위탁하여 제조시 단위공정별 수탁자명, 소재지 등을 명확하게 기재**\n| 라. 기준및시험방법에 관한 근거자료 | 를 받은 것과 성분이 동일한 정제ᆞ캡슐 | 품으로서 식품의약품안전처장이 고시하는 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 성에 관한 다음 각 호의 자료를 총리령으로 정 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n| 료 | 제 또는 좌제. 다만, 상용(常用) 의약품, | 것이어야 한다. | 제5조(제조판매ᆞ수입 품목의 신고) ① 법 제31 | 조소에서 제조되는 것으로서 해당 품목과 최 |\n| 마. 시험성적에 관한 자료 | 총 처리기한 70일 | 하는 바에 따라 제출하여야 한다. 다만, 제2호 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | 특 | 성 | 생산하는 국가의 정부 또는 공공기관에서 그 품목이 생산국의 법령에 적합하게 제조되고 있음을 | 6. 의약품의 적정사용 정보제공을 위한 안전성 |\n| 바. 표준품 및 시약․시액에 관한 자료 | 업소명생략가능 + 상표명 + 제형 + (주성분명단일제 또는 식약처고시명칭) | ② | (수입)의약품품질과/ | (제조)제조소 관할 | 지방청 | 조제2항ᆞ제4항 또는 법 제42조제1항에 따라 | 는 제31조의2에 따라 원료의약품을 등록한 경 | 2) 인체시료를 이용한 약동학 관련 시험 보고서 | 조소에서 제조되는 것으로서 해당 품목과 최 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 증명하는 | “제조증명서” 및 해당 품목이 허가 또는 등록된 국가의 정부 또는 공공기관에서 그 국가의 |\n| 한 다음 각 목의 서류. 이 경우 첨부서류의 | 또는 의약품 동등성 확보가 필요한 의약 | 품목허가권자로부터 동 품목에 대하여 전공정을 제조 의뢰받아 실제 제조하는 자 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 가. 원료약품 및 그 분량에 관한 자료 | 요건 등에 관한 세부 사항은 식품의약품안전 | 품으로서 식품의약품안전처장이 고시하는 | 경우에는 「의약품 등의 안전에 관한 규칙」 별표 1을 적용하되, 동 규칙「의약품 등의 안전에 관한 | 가. 법 제51조제1항에 따른 대한민국약전(이 | 7. 대한민국약전 및 법 제52조에 따른 의약품 | 호와 같다. 다만, 제4조제1항제1호에 따라 안전 |\n| 나. 제조방법에 관한 자료 | 처장이 고시하는 바에 따른다. | 것이어야 한다. |\n| 품목허가권자이면서, 동 품목에 대하여 일부공정은 직접제조하고, 일부공정은 | 가. 법 제51조제1항에 따른 대한민국약전(이 | 성ᆞ유효성에 관한 자료를 제출하여야 하는 품 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 다. 기준및시험방법에 관한 근거자료 | 8. 의약품의 분류 등 국민보건을 위하여 필요하 |\n| 목, 제4조제1항제10호에 따라 등재의약품의 안 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 라. 시험성적에 관한 자료 | 제조 | 7) 허가증 수령방법(온라인, 방문, 웹수령) 선택 | 1996 | 1 | 1 | 2 | 2008 | 5 | 2 | 7 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 다른 제조업자에게 의뢰하여 제조하는 자 |\n| 한 다음 각 목의 서류. 이 경우 첨부서류의 | 이라 한다)의 정부 또는 공공기관에서 그 | 3. 제4조제1항제3호 및 제5호에 해당하는 자료 | 예 | 회사와 | 6호, 제5조제2항제5호 및 같은 조 제3항 단서 | 목의 자료. 다만, 제15조제1항에 따라 이미 | 및 품질관리기준 실시상황 평가에 필요한 | 예 | 럽게 안정하게 되거나 지속적인 통계적 확률에 따라 | 13N 제제에서의 18F 불순물). 반감기 측정은 감마선스 | ② 제1항에도 불구하고 다음 각 호의 어느 하 | Fluorine-18 (18F) | 109.77 분 | 입 품목허가의 변경, 의약품등 제조판매ᆞ수입 | 나. 완제의약품에 관한 자료 | 4. 그 밖에 필요한 자료 | 나. 식품의약품안전처장이 인정하는 공정서 | 전성ᆞ유효성에 관한 자료를 근거로 신청하는 | 6) 시판후 사용경험에 대한 보고서 | 다고 판단하여 실시한 안전성ᆞ유효성에 관 | 는 품목 |\n| 마. 표준품 및 시약․시액에 관한 자료 | *시험방법 - 검체 10개에 대해 주 | 심사조정이 | 정에 대해 규정한다. | 다. | 저 | 장 | Phosphorus-32 (32P) | 14.26 일 | 표적원소(입사입자, 방출입자 또는 방사선)발생원소 | 1998 | 6 | 6 | 2009 | 2 | 3 | 5 | 소를 | 설치할 | 수 | 있다. | <개정 | 2008.2.29., | 당한다) | (제조의뢰자) |\n| 요건 등에 관한 세부 사항은 식품의약품안전 | 품목이 생산국의 법령에 적합하게 제조되 | 업소명 + 주성분명단일제 + 제형 | 의약품의 품목허가․신고․심사규정｣ | 방사성물질 합성을 위한 화학물질 전구체: 만일 방사 | 등록된 원료의약품의 경우에는 제출하지 아 | (법 제27조제2항제1호에 따라 의약품 동등 | 자료. 다만, 둘 이상의 제조판매·수입 품 | 의견조율이 | 필요한가? | 회의 개최 | 별표 8 참조 | 구분 | * 단, ‘15.7.1 부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 「의약품등의 | 8) 파일 저장(“*.flz\" 파일 생성) | 품목신고의 변경을 하려는 경우에는 지방청장을 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 1) 장기보존시험 또는 가속시험자료 | (수입, 제조품목 공통) | 의약품, 제11조에 따라 제조판매ᆞ수입 품목허 | 7) 증례기록서와 개별 환자 목록 | 한 자료 검토 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 13N | 3 | 1.4 | 201Tl | 10 | 4.7 | 사바늘로 10회 반복하여 찌른 | 필요한가 | 의 개정규정에도 불구하고 종전의 규정에 따른 | *시험방법 - 좌동 | 또 다른 양성자와 중성자의 불안정한 조합으로 변환될 | 펙트럼측정법에 더하여 확인할 필요가 있다. | ③ 제1항에 따라 의약외품의 제조업 신고를 하 | Phosphorus-33 (33P) | 25.34 일 | 1999 | 2 | 1 | 3 | 2010 | 2 | 7 | 9 | 2010.1.18., 2013.3.23.> | 용법･ | 표적물질(TARGET MATERIALS) | ⑪ 제1항부터 제4항까지 및 제9항에 따른 의약 | 나. 식품의약품안전처장이 인정하는 공정서 |\n| 처장이 고시하는 바에 따른다. | 고 있음을 증명하는 제조증명서 | 방사성물질을 포함하는 제제는 일차 또는 이차 방출에 | 니한다. | 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 동시에 신청하는 경우에는 그 | 2. 제출파일 생성하기 | 안전에 | 관한 | 규칙 | 」제48조의2에 | 따른 | GMP | 적합판정서가 | 있더라도 | 관류제, | 복막투석제, | 점안제, | 조시설ᆞ제조방법 등에 관한 양도ᆞ양수계약서 | 자료를 | 제출하지 | 아니할 | 수 | 있다. | <개정 | 가이던스’를 참조하시기 바람. | 일부공정위탁제조 | 품목허가권자로부터 동 품목에 대하여 일부공정만을 제조 의뢰받아 실제 제조하는 자 | ④ 제1항에도 불구하고 품질에 영향을 미치지 |\n| 필요한 경우, 총 민원사무 처리기한은 90일, 수수료는 1,134,000원(전자민원) | 후 메틸렌블루(색소) 용액에 담 | 성의약품의 주성분이 분리되지 않을 경우 합성에 사용 | 다. | 것이다. 이러한 핵종들을 방사성핵종이라고 하는데 전 | 기재순서 | ⑥ 제1항부터 제4항까지의 규정에도 불구하고 | Sulfur-35 (35S) | 87.51 일 | 말한다)에게 제출하여야 한다. | 2000 | 16 | 39 | 55 | 2011 | 5 | 2 | 7 | 려는 자는 그 업종에 속하는 1개 이상 품목의 | 2) 가혹시험자료 | 다. 대한민국약전에 실려 있지 아니한 의약품 | 가와 품목신고가 제한되는 품목, 생물학적제제 | 품등의 제조업ᆞ위탁제조판매업 및 제조판매품 | 나. 가교자료 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 의약품심사조정과 | 99mTc(콜드) | 45 | 21.2 | 18F | 32 | 15.1 | 아니오 | 아니요 | 잔류용매(Residual solvents) | 의한 방사선 조사로부터 개인을 충분히 보호하고 방사 | 가. 제조소의 명칭, 제조소의 소재지, 제조소 | 이 정한 의약품만 해당한다) | 중 하나의 품목에 관한 자료만을 제출할 | 예) | 58Fe(n, γ)59Fe | 방사성의약품에 있는 서로 다른 방사성핵종의 반감기 | Chromium-51 (51Cr) | 27.7025 일 | 를 제출할 수 있다. | 2014.10.10.> | 경우 예외 | 아니하는 색상ᆞ포장재질 또는 제조원의 명칭 |\n| 되는 화학물질 전구체는 약제학적 용도의 물질로서 고 | 1. 제조업의 변경: 별지 제2호서식의 의약외품 | 4. 독성에 관한 자료 | 안연고제, 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | - 저장완료된 파일을 ezdrug 전자민원창구를 통해 접수할 수 있는 형태로 생성 | (제조자) | (수입, 제조품목 공통) | 다. 대한민국약전에 실려 있지 아니한 의약품 | 등 및 방사성의약품은 제외한다. | 7. 외국의 사용현황 등에 관한 자료 | 목의 허가 또는 신고를 할 때 허가 또는 신고 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 그고 외부 압력을 변화시켰을 | 해당과 협의 | 및 조정결과 | 회사 의견 | 자의 불안정한 핵종을 어미방사성핵종이라 하고 후자 | 차이로 인해, 방사성핵종순도가 시간에 따라 변한다. | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 1. 제1항제1호 또는 제2호에 해당하는 자료로 | Cobalt-56 (56Co) | 77.27 일 | 2001 | 23 | 11 | 34 | 2012 | 2 | 0 | 2 | 제34조에 따른 임상시험용 의약품 등 총리령으 | 제조판매품목 허가를 동시에 신청하거나 1개 | 함을 확인하는데 신뢰성을 높여줄 수 있다. |\n| 이라 한다)의 정부 또는 공공기관에서 그 | 부 또는 공공기관에서 그 국가의 법령에 | 허가 처리 | 잔류용매는 일반사항 5.4. 잔류용매 항에 따라 기준이 | 성물질 저장과 관련한 국내외 규정에 적합한 밀봉용기 | 4. 제4조제1항제4호에 따른 자료 | 네튬산나트륨의 형태로 함유한다. | 책임자의 성명을 적은 자료 | 수 있다. | * 방사성의약품은 반감기로 인해 사용시점에 따라 용량이 가변적이므로 용량을 기재하는 대신 ‘자사 | - 일반적으로 실제 제조시의 투입순서 등에 따라 주성분부터 첨가제의 순서로 기재 | 3. 전자민원 접속/로그인 | 제조업 변경신고서 또는 별지 제7호서식의 | 수입(수입자) | 국내에서 동 수입품목에 대한 허가권자 | 18O(p, n)18F | 1. 대한민국약전 또는 식품의약품안전처장이 인 | 변경 등 식품의약품안전처장이 정하여 고시하 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 때 제품 안의 색이 변하지 않아 | 려된다. 지정된 생산조건 하에서 목표로 하는 수율 및 | 수렴 | Cobalt-57 (57Co) | 271.79 일 | 2002 | 1 | 6 | 7 | 2013 | 5 | 2 | 7 | 로 정하는 의약품 또는 의약외품(이하 \"의약품 | 이상 품목을 동시에 제조판매품목 신고하여야 | 가. 단회투여독성시험자료 | 8. 국내 유사제품과의 비교검토 및 당해 의약품의 | 의 대상ᆞ기준ᆞ조건 및 관리 등에 관하여 필 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 품목이 생산국의 법령에 적합하게 제조되 | 적합하게 판매되고 있음을 증명하는 판매 | 99mTc | 41 | 19.3 | 131I | 46 | 21.7 | 제한되고, 2.4.24. 잔류용매 확인 및 관리 항에 기재된 | 에 보관한다. 저장기간 동안 용기는 방사선 조사 때문 | 나. 저장방법 및 사용기간을 적은 자료 | 7. 법 제31조의2제1항에 따라 등록할 수 있는 | 5. 제4조제1항제6호에 따른 자료 | 이 약은 정량할 때 시험 당시 표시된 테크네튬-99m | 반영 | 의 핵종을 딸방사성핵종이라 한다. | Cobalt-58 (58Co) | 7086 일 | 포장단위’ 또는 ‘제조원 포장단위’로 기재 가능 | 4. 민원접수(민원종류 선택, 담당부서 선택, 파일 접수) | 도인에 대한 제조판매ᆞ수입 품목허가에 붙여 | 서 적합하다는 제41조제3항에 따른 사전 검 | 의약품등의 제조업 허가사항 변경허가 신청 | 소분포장 | 다음 식에 따라 나타낸다. | 는 경미한 사항인 경우에는 식품의약품안전처 | 정하는 공정서 및 의약품집에 실려 있는 품 | 있는 품목 |\n| 야 함(상세시험은 EP 참조) | 품질을 얻기 위해 생산에 사용되는 화학물질 전구체는 | 의약품의 품목허가․신고․심사 규정｣ | 2003 | 4 | 3 | 7 | 2014 | 7 | 9 | 16 | 등\"이라 한다)에 대하여는 제조업허가 또는 품 | 한다. | 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라 이 규칙이 시행되는 | 나. 반복투여독성시험자료 | 자사에서 적절하게 설정할 수 있음 | 요한 사항은 총리령으로 정한다. | 특성에 관한 자료 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 고 있음을 증명하는 제조증명서 | 증명서 | 89Sr | 1 | 0.5 | 123I | 7 | 3.3 | 【공직자 부조리 및 공익신고안내】   ** 신고자 및 신고내용은 보호됩니다. | 다. 제15조제1항 각 호의 자료 | 6. 제4조제1항제7호부터 제9호까지에 따른 자 | 방사능의 90.0 ~ 110.0 %를 함유한다. | 신약의 원료의약품 또는 식품의약품안전처장 | 방사화학적순도(RADIOCHEMICAL PURITY) | 방사성핵종의 붕괴 또는 변환 시 하전입자방출 | 배합목적 | Cobalt-60 (60Co) | 5.2714 년 | 진 조건에 상응하는 조건을 붙일 수 있다. | 토 결과통지서를 제출한 경우: 제1항제1호 | 소분품목의 허가권자이면서 소분․포장 제조하는 자 | 장이 정하여 고시하는 바에 따라 변경내용을 |\n| 과테크네튬산나트륨(99mTc) 주사액 | 시험방법 또는 다른 적절한 방법을 사용하여 관리한다. | 에 차광할 수 있다. 이러한 차광은 반드시 제제의 저 | 중성자 조사(NEUTRON IRRADIATION) | - 기타의 경우 제조는 “자사 포장단위”, 수입은 “제조원 포장단위”로 기재 | ④ 기업의 분리 또는 합병에 의하여 의약품등의 | 5. 수수료납부 (수수료 납부 완료 시 민원신청 완료) | 2004 | 7 | 0 | 7 | 합계 | 116 | 96 | 212 | 목허가를 받지 아니하거나 품목신고를 하지 아 | 서 | (소분제조자) | 라. 식품의약품안전처장이 성분의 종류·규 | 목. 다만, 국내에서 허가되지 아니한 품목은 | 있는 품목 |\n| 67Ga | 5 | 2.4 | 111In | 2 | 0.9 | ▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자 부조리 신고” 코너 | 방사성의약품 제조에 사용하기 전에 매 배치 별 시험 | PET용 방사성의약품 평가 가이드라인｣ | 제   법 | 이 약은 과테크네튬산나트륨(99mTc) 주사액 | 의약품의 성상 표기에 대한 가이드라인｣ | 참조 | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | Gallium-66 (66Ga) | 9.49 시간 | ‘15.7.1 전에 종전의 규정에 따라 방사성의약품 제조판매‧ | 다. 유전독성시험자료 | 또는 제2호에 해당하는 자료 | 제42조(의약품등의 수입허가 등) ①의약품등을 | 9. 생물학적 동등성 시험에 관한 자료 | 수입품목허가를 받은 제조업자․수입자가 |\n| 상표명 + 문자 또는 숫자 | 하를 수반하지 않는다. | 8. 의약품의 주성분을 제조하는 제조업자의 명 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 료 | 을 | (charged particle emission), 전자포획(electron capture, | 방사화학적 불순물들은 다음으로부터 유래될 수 있다. | 2. 위탁제조판매업의 변경: 별지 제3호서식의 | Gallium-67 (67Ga) | 3.2612 일 | 6, 민원신청완료 | 2005 | 20 | 9 | 29 | 비율(%) | 55 | 45 | 2006 | 4 | 0 | 4 | 자료는 달라질 수 있음 | 소분제조 | 소분품목의 벌크(bulk) 제조자 | 성을 확립하는데 도움을 줄 수 있다. | 라. 식품의약품안전처장이 성분의 종류ᆞ규격 | 적은 문서(전자문서를 포함한다)를 식품의약품 | 제외한다. | 격·함량 및 처방 등을 표준화하여 고시 | At = A0e-λt |\n| 51Cr | 3 | 1.4 | 총 | 212 | 223Ra | 1 | 0.5 | 실시가 권고된다. | 제너레이터 또는 이에 따라 제조한 제너레이터로부터 | 보통 핵반응기 내에서 안정한 방사성핵종의 조사 | - 별표 7의 제형별 의약품 첨가제 또는 그 외의 첨가제로서 국내ㆍ외의 공인할 수 있는 | 니할 수 있다. <신설 2011.3.30., 2013.3.23.> | 품목에 관한 제조시설ᆞ제조방법 등을 양수받 | 허가받은 | 품목에 | 대하여 | ’15.7.1 | 이후부터 | 이 | 규칙 | 시행일부터 | 2년이 | 경과한 | 날까지 | 라. 생식발생독성시험자료 | 수입하려는 자(이하 \"수입자\"라 한다)는 총리령 |\n| 미 제조판매·수입 품목허가를 받은 정제· | 부 또는 공공기관에서 그 국가의 법령에 | 대한민국약전｣ | ▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너 | 제제총칙에서 정한 제형으로 표기. 단, 제제학적으로 구분관리할 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 | 칭 및 소재지 등에 관한 자료로서 식품의약 | 대상 원료의약품\"이라 한다)을 사용하는 품 | 가) 청정도 관리 기준서(SOP) | EC) 또는 핵이성체전이(isomeric transition, IT)가 수반 | - 방사성핵종 생산 | 2. 품목허가를 신청하는 품목(신약, 생물학적제 | Germanium-68 (68Ge) | 270.82 일 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 의약품 위탁제조판매업 변경신고서 | 2. 대한민국약전외한약(생약)규격집에 실려 있 | 안전처장 또는 지방청장에게 제출하여야 한다. | 한 표준제조기준에 맞는 품목 |\n| 방사성핵종순도(RADIONUCLIDIC PURITY) | 생리식염액으로 과테크네튬산나트륨(99mTc)을 용출 | (irradiation) 결과 양성자가 부족한 핵(proton-deficient | ※ 자세한 사항은 의약품민원홈페이지(http://ezdrug.mfds.go.kr)의 하단에 있는 “민원신청 우수작성 서식 | ⑦ 제2항부터 제4항까지의 규정에도 불구하고 | 은 자가 동일장소ᆞ동일시설에서 해당 품목으 | (제조자) | (해당 생산국의 원제조자) | 으로 정하는 바에 따라 품목마다 식품의약품안 | ᆞ함량 및 처방 등을 표준화하여 고시한 |\n| 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 적합하게 판매되고 있음을 증명하는 판매 | 조시설·제조방법 등을 양수한 품목에 대한 제 | 품안전처장이 고시하는 자료 | 목의 경우에는 원료의약품에 관한 다음 각 | - (무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균, 부유균, 표면균 등) 등 관리내용 포함 | Gallium-68 (68Ga) | 67.629 분 | 사용예 등으로 제제학적으로 타당한 배합목적 기재 | 품등의 제조판매ᆞ수입 품목허가를 위하여 필 | 품목변경허가(신고)를 신청하는 경우에는 GMP 실시상황 평가에 필요한 자료를 제출하지 않음 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 그림 2. 방사성동위원소 별 품목허가 그래프 (15.01.12. 품목대장 기준) | 이 경우 법 제31조제9항 또는 법 제42조에 따 |\n| 시켜 주사제의 제법에 따라 만든다. | 라 | 벨 | 2.3.10 저장방법 및 사용기간 | 될 수 있다. 핵으로부터 방출된 하전입자들은 알파입 | nuclei), 즉 전자방출체(electron emitter)가 발생하는 | - 이후 화학적 제조공정 | 3. 품목의 변경: 별지 제6호서식의 의약품등 제 | 의약품등과 의료기기가 조합되어 있거나 복합 | 로 새로운 제조업 허가를 받거나 신고를 하려 | 및 민원신청 작성요령” 및 “전자민원신청매뉴얼” 자료 참조 및 시스템 문의(043-234-3100) | At = t 시간에서의 방사능 | 하는 방사성핵종의 수율과 순도를 향상시킬 수 있다. | 되는 기준을 규정한다. | 마. 식품의약품안전처장이 따로 기준 및 시험 | 는 품목 | 표준제조기준에 맞는 품목 |\n**방사성핵종 불순물들은 생산 그리고 방사성핵종의 붕**\n| - 11 - | - 13 - | - 15 - | - 17 - | - 19 - | - 21 - | - 23 - | - 25 - | - 27 - | - 29 - | - 31 - | - 33 - | - 35 - | - 37 - | - 1 - | - 3 - | - 5 - | - 7 - | - 9 - | - 10 - | - 12 - | - 14 - | - 16 - | - 18 - | - 20 - | - 22 - | - 24 - | - 26 - | - 28 - | - 30 - | - 32 - | - 34 - | - 36 - | - 38 - | - 2 - | - 4 - | - 6 - | - 8 - |\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n### 제·개정 이력\n\n<!-- PAGE_3 -->\n###### 연번\n\n<!-- PAGE_3 -->\n###### 제·개정번호\n\n<!-- PAGE_3 -->\n###### 승인일자\n\n<!-- PAGE_3 -->\n###### 주요내용\n\n<!-- PAGE_3 -->\n###### 1\n\n<!-- PAGE_3 -->\n###### C0-2015-2-008\n\n<!-- PAGE_3 -->\n###### 2015.07.30\n\n<!-- PAGE_3 -->\n###### 제정\n\n<!-- PAGE_3 -->\n## 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_3 -->\n#### 1. 서론\n\n<!-- PAGE_3 -->\n###### 본 안내서는 방사성의약품 허가에 대한 경험이 적어 허가 신청 시 어려움을 느끼는\n\n<!-- PAGE_3 -->\n###### 제외하고 매년 10품목 이내로 허가되었으며 2000년도에 55품목으로 가장 많이\n\n<!-- PAGE_3 -->\n###### 허가되었고,\n\n<!-- PAGE_3 -->\n###### 기타 2001년 및 2005년도에 각각 34,\n\n<!-- PAGE_3 -->\n###### 29품목이 허가되었고 최근의\n\n<!-- PAGE_3 -->\n###### 2014년도에는 16품목이 허가되었다. 이와 같이 특정 년도에 품목허가 수가 증가된\n\n<!-- PAGE_3 -->\n###### 주된 이유는 신규업체의 등장에 따른 품목신청이 늘어났기 때문인 것으로 확인된다.\n\n80\n\n100\n\n120\n\n140\n\n품목수(건)\n\n<!-- PAGE_4 -->\n###### 국내 방사성의약품의 방사성동위원소 별 품목허가 수를 표 2와 그림 2에 나타내었다.\n\n<!-- PAGE_4 -->\n###### 전체 허가된 방사성의약품 중 테크네튬(99mTc(콜드),\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터),\n\n<!-- PAGE_4 -->\n###### 99mTc)과 관련된\n\n<!-- PAGE_4 -->\n###### 방사성의약품이 47.1%로 가장 높은 비율을 차지하였고,\n\n<!-- PAGE_4 -->\n###### 131I과 18F이 각각 21.7%,\n\n<!-- PAGE_4 -->\n###### 15.1%로 그 다음 높은 비율을 차지하였다.\n\n표 2. 방사성동위원소 별 품목허가 수 (15.01.12. 품목대장 기준)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터)\n\n<!-- PAGE_4 -->\n###### 14\n\n<!-- PAGE_4 -->\n###### 6.6\n\n<!-- PAGE_4 -->\n###### 14C\n\n<!-- PAGE_4 -->\n###### 2\n\n<!-- PAGE_4 -->\n###### 0.9\n\n**[표 시작]**\n\n| 2. 허가 처리 절차 | 2.2.3 수수료 및 처리기한 | 2.3.13 허가조건 | - (비무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균 또는 부유균 등) 관리내용 포함 | 저장방법 | 심사자료의 범위 | 방사성제제 분할사용 관련 정보 | ㉯ ‘14.8.21자 개정된 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라, 이 규칙 | 2.2.4 전자민원 신청방법 | 2.3.6 효능․효과 | 부록1. 관련 법규 | 부록2. 유럽약전 방사성의약품 번역 | 방사성의약품의 라벨은 관련 국가 및 유럽의 법에 적 | 유의사항 | 성    상  이 약은 무색의 맑은 액이다. | Krypton-81m (81mKr) | 13.10 초 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 마. 식품의약품안전처장이 따로 기준 및 시험 | 3. 식품의약품안전처장이 성분의 종류ᆞ규격ᆞ | 전처장의 허가를 받거나 신고를 하여야 한다. | 라 변경허가를 받거나 변경신고를 한 것으로 | 방법을 고시한 품목 | 5. 약리작용에 관한 자료 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 조의4, 제32조, 제33조, 제35조의2, 제36조, | 허가받으려는 경우에는 비교용출시험자료 등 | 증명서 | 9. 법 제31조제2항ᆞ제3항에 따라 의약품을 제 | 조판매·수입 품목신고를 하려는 자의 경우에 | 목의 자료. 다만, 제15조제1항에 따라 이미 | <의약품 등의 안전에 관한 규칙> | 요하다고 인정하는 경우에는 식품의약품안전평 | 전처장이 고시하는 의약품은 제외한다)을 제 | 조판매ᆞ수입 품목신고 변경신고서 또는 별 |\n| 나) 신청 품목 작업실(청정도별, 작업실별) 및 시험실(미생물한도 및 무균시험실 등)의 전년도 환경모니터링 | λ = 각 방사성핵종의 특성에 따른 붕괴상수 | form), | 순도 및 물리적 상태 뿐 만 아니라 조사 | 3마리 실험동물 각각에 제제를 정맥 투여한다. 투여하 | 물들의 기준이 기재되어 있다. | 고방사능의 경우 안전상 이유로 일반시험법(2.6.1)에 따 | 각조에서 언급될 수 있고 그 특성들은 일반사항 5.7. | 합해야 한다. | 확인시험  1) 이 약을 가지고 감마선측정법의 감마선 | 자) 이다. 알파붕괴는 보통 중핵자(Z > 82)와 관련된 | - 저장기간 동안의 화학적 변화 | Rubidium-81 (81Rb) | 4.576 시간 |\n| ▷ 주요 허가조건 예시 | 바. 그 밖에 식품의약품안전처장이 자료의 제 | 허가받은 사항 또는 신고한 사항을 변경하려는 | 본다. | 함량 및 처방 등을 표준화하여 고시한 표준 | 방법을 고시한 품목 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | 5. 일반의약품 중 단일성분의 의약품으로서 이 | 6. 임상시험성적에 관한 자료 | 호와 같다. 다만, 제4조제1항제1호에 따라 안전 | 제37조, 제37조의2부터 제37조의4까지, 제38 | 식품의약품안전처장이 고시하는 자료 | 확 | 인 | 제9조～제22조 관련 | 2.2.4.1 전자민원신청 사전 절차 | 적합한 동안의 시간 | - 주사제 등은 용기의 형상(바이알, 앰플, 플라스틱용기, 프리필드시린지 등)을 기재 (예: | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 | 조업자에게 위탁제조하여 판매하려는 의약품 | 등록된 원료의약품의 경우에는 제출하지 아 | 가원의 의견을 듣거나 법 제18조제1항에 따른 | 조하는 제조소에 제48조의2에 따른 제조 및 | 지 제8호서식의 의약품등 제조판매ᆞ수입 품 |\n| ▷ 신약 | - 방사성의약품 : “밀봉용기”, “차폐용기 : 원자력법령에 의함” | 계면활성제 | 등장(화)제 | 보존제 | 부형제 | 안정(화)제 | 구분 | 민원사무명 | 수수료 | 처리 | 평가자료 또는 최근 3개월간 자료 | - 기허가된 다른 의약품 명칭과 동일하지 않아야 함 | (EUROPEAN PHARMACOPOEIA 8.0) | 심사자료의 종류 | [시행 2015.3.15.] [총리령 제1149호, 2015.3.13., 일부개정] | Krypton-81m (81mKr) | 13.10 초 |\n| e = 자연로그의 밑 | (irradiation) 조건 및 직접적인 물리화학적 환경이 생 | 기 바로 전에 희석하여 투여해야 할 경우도 있다. | ◯ 보존제 사용 관련 | 바. 그 밖에 식품의약품안전처장이 자료의 제 | ⑤ 제1항에 따른 신청서ᆞ신고서 또는 변경신 | 제조기준에 맞는 품목 | 출이 필요하지 아니하다고 인정하는 품목 | 의약품 각조에 규정된 방사성 핵종은 일반적으로 반감 | 른 검체량을 이용하는 것이 불가능하다. 멤브레인필터 | 6.다음 각 목의 구분에 따른 평가 자료 | 7. 외국의 사용현황 등에 관한 자료 | 성·유효성에 관한 자료를 제출하여야 하는 품 | 미 제조판매ᆞ수입 품목허가를 받은 정제ᆞ | 유럽약전에서 언급된 방사성핵종들의 물리적 특성표 | 사용하는 나라에 따라 조정될 수 있다. | 스펙트로미터에 의한 스펙트럼측정법에 따라 시험할 | 여 그 품목의 제조시설·제조방법 등에 관한 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 니한다. | GMP 평가 11종 자료 목록(의약품 등의 안전에 관한 규칙 [별지 제4호서식]) | <약사법> | 다. 양성자가 결손된 방사성핵종들은 보통 전자방출 | 따라서 상당한 양의 담체(carrier)가 포함될 수 있다. | 중앙약사심의위원회에 자문을 할 수 있다. | 품질관리 적합판정서가 있는 경우: 제1항제6 | 목 허가사항 변경허가 신청서 |\n| 2.1 주요 관련 법규 및 규정 (부록1 참조) | - 위 조건에 부합하는 모니터링 자료가 없는 경우, GMP 적용을 시작한 날 이후부터의 GMP 자료 제출 가능 | □ 품목허가 항목 | 경우에도 | 또한 | 같다. | <개정 | 2008.2.29., | 조, 제50조의2부터 제50조의10까지, 제69조의 | 제2조(의약품등의 제조업 허가ᆞ신고 등) ① | 무색투명한 액이 무색투명한 바이알에 든 주사제) | Strontium-89 (89Sr) | 50.53 일 | 고 이에 관한 사실을 증명하는 서류를 제출하 |\n| - 구체적인 보관조건(2～8℃, 냉장보관 등)․유의사항(예 : 빛을 피하여 보관 등) 병기 | - 지위승계(양도․양수) :「약사법」제89조 및「의약품 등의 안전에 관한 규칙」제103 | 2. 제10조에 따른 기준 및 시험방법에 관한 자 | 4. 식품의약품안전처장이 따로 기준 및 시험방 | 청서ᆞ변경신고서를 받은 식품의약품안전처장 | 완충제 | 용제 | 용해보조제 | 충전제 | 캡슐 | 출이 필요하지 아니하다고 인정하는 품목 | 가. 완제의약품[인체에 직접 적용하지 아니하 | 8. 국내 유사제품과의 비교검토 및 해당 의약품 | 목, 제4조제1항제10호에 따라 등재의약품의 안 | 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 기한 | ① 의약품민원홈페이지(http://ezdrug.mfds.go.kr)에서 회원가입 및 민원서식기 설치 | - 서로 다른 수입자가 제조원이 같은 동일 품목을 수입하는 경우 수입자명 병기하여 구분 | 가. 제조소의 명칭, 제조소의 소재지, 제조소 | 때 0.141 MeV에 피크를 확인한다. | 가능한 한 구체적으로 기재 | 양도·양수계약서를 제출할 수 있다. 다만, 별 | 등을 적어 넣은 위탁ᆞ수탁제조계약서 | 01/2014:0125 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | ② 제1항의 경우에 법인의 대표자를 변경하려 | Yttrium-89m (89mY) | 16.06 초 | 호에 해당하는 자료 | 제5조 관련 |\n| 다) 청정도 시험결과 부적합이 있는 경우 그 처리기준 및 조치결과 | 산되는 방사성핵종들의 화학적 상태와 순도를 결정한 | 각 실험동물에 투여 후 각 동물 피부 표면의 오염을 | 2010.1.18., 2013.3.23.> | 1. 제품명 | 대한민국약전 | 유럽약전 | 미국약전 | 화학적순도(Chemical purity): 화학적순도는 각조 규 | 기 또는 방사선의 특성과 에너지 또는 두 가지 모두에 | 법이 개인의 방사선 조사량을 제한하기 위해 선호된다. | 자 료 번 호 | 3 및 제75조를 준용한다. 이 경우 \"제조\" 또는 | 2.2.2 구비서류 | 항에 기재되어 있다. | 제품의 방사능은 특정 일자에 표시된다. 만약 반감기 | 생 | 산 | [시행 2015.3.15.] [법률 제13219호, 2015.3.13., 일부개정] | 화학 성분(불순물)을 분리 분석하고, 표시된 화학적 형태 | 는 경우에는 제48조제5호를 적용하지 아니한 |\n| 제출자료 | 의약품-신약-품목허가-기시-안유 | ․전자민원의 경우: 3,726,000원 | □ | 안전성․유효성과 | 기준 | 및 | 시험방법 | 심사 | 2) 순도시험 1)에 따라 확인한다. | 「약사법」(이하 \"법\"이라 한다) 제31조제1항 | Strontium-90 (90Sr) | 28.74 년 | 마. 발암성시험자료 |\n| ※ | 방사성의약품의 | 경우 | 대부분 | 주사제로 | 그 | 용기는 | 바이알을 | 사용하므로 | “밀봉용기”에 | 해당하고, | 반감기(T1/2)는 방사성핵종의 방사능이 초기 값의 반으 | 다. 방사성핵종 특히 반감기가 짧은 방사성핵종의 생 | 막고 배설물을 채집하기 위해 우리(cage)에 분리하여 | ü 약사법 제31조, 제42조 | ② 제1항에도 불구하고 국방부장관 또는 수입 | 2. 제10조에 따른 기준 및 시험방법에 관한 자 | 킬레이트화제 | 항산화제 | 환원제 | 흡착제 | pH조절제 | 조 규정에 따라 양도자의 모든 허가․신고사항을 승계받는 조건으로 허가 | 또는 지방청장은 「전자정부법」 제36조제1항 | 신약 | 료. 다만, 다음 각 목의 어느 하나에 해당하 | 법을 고시한 품목 | 2 | 3 | 4 | 5 | 6 | 격에 기재된 화학적 불순물에 대한 기준에 의해 관리 | 의해 확인된다. | 비경구용제제(Parenteral preparations, 0520) 제제총칙에 | ․방문, 우편 민원의 경우: 4,140,000원 | 90일 | 전성·유효성에 관한 자료를 근거로 신청하는 | \"생산\"은 각각 \"수입\"으로, \"제조업자\" 또는 \"품 | 허가받으려는 경우에는 비교용출시험자료 등 | 등의 특성에 관한 자료 | 는 제품(소독제 등)은 제외한다] 및 의약 | 대부분의 경우 방사성의약품의 방사성핵종 순도를 설 | 가 70일 미만일 경우 표준시간대를 참조하여 시간도 | - 제형은 ｢ | 10. 법 제50조의2제4항(법 제42조제4항에 따 | - 개인 공인인증서/대표자 공인인증서(개인사업자)/법인명 공인인증서(법인회원) 필요 | 표 1, 별표 1의2, 별표 2 또는 별표 3의3의 | 책임자의 성명을 적은 자료 | 대한민국약전｣ | 방사성핵종들은 보통 전자포획 또는 양전자방출 | 3. 식품의약품안전처장이 고시하는 기준에 적합 | 다. | 약품안전처장이 정하여 고시하는 수수료(외국 | 는 경우에는 변경신청서나 변경신고서에 대표 |\n| 구분 | [제제총칙 - 주사제 항] | 2. 분류번호 및 분류(전문 또는 일반의약품) | 1 | -GMP | 7 | 8 비고 | 가 | 나 | 가 | 나 | 가 나 다 라 마 바 가 나 다 라 가 나 | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | [제제총칙 - 주사제 항] | [제제총칙 - 주사제 항] | 방사성의약품은 방사성핵종을 다음과 같은 형태로 포 | pH  4.5 ∼ 7.0 | 제31조(제조업 허가 등) ① 의약품 제조를 업 | ᆞ제4항에 따라 의약품의 제조업 허가를 받거 | 방사성의약품 | Yttrium-90 (90Y) | 64.10 시간 | 구성된 것으로서 주된 기능이 의료기기에 해당 |\n| ※ 신청품목과 관련된 밸리데이션 자료 | 5. 식품의약품안전처장이 신고대상품목으로 고 | 자는 다음 각 호의 어느 하나에 해당하는 경우 | 에 따른 행정정보의 공동이용을 통하여 법인 | 료. 다만, 다음 각 목의 어느 하나에 해당하 | 는 품목의 경우에는 제출하지 아니한다. | 의약품, 제11조에 따라 제조판매·수입 품목허 | 식품의약품안전처장이 고시하는 자료 | 외품[내용고형제(內用固形劑) 및 내용액 | 나. 저장방법 및 사용기간을 적은 자료 | 가) 제조소 평면도: 각 작업소, 시험실, 보관소 및 기타 제조공정에 필요한 부대시설이 표시된 | 제조 및 품질관리기준 실시상황 평가가 필요한 | 제출자료의 종류 | 라 준용되는 경우를 포함한다)에 따라 의약 | ⑤ 제1항에 따라 제조업의 허가를 받거나 신고 | Molybdene-99 (99Mo) | 65.94 시간 | 에서 현지실사를 할 필요가 있는 경우에는 이 | 자가 법 제5조제1호 본문에 해당되는 사람이 | 바. 기타독성시험자료 | 한 경우: 제1항제4호에 해당하는 자료 |\n| 로 붕괴되는데 걸리는 시간으로 다음 식과 같이 붕괴 | 산 시 방사성의약품의 이후 제조 공정 전에 이러한 어 | 넣는다. 투여 후 지정된 시간에 적절한 방법으로 안락 | ü 의약품 등의 안전에 관한 규칙 제2조, 제4조, 제5조, 제8조, 제9조, 제10조 | 이 제제에서 분할사용을 목적으 | ○「약사법」제89조제3항 및「의약품 등의 안전에 관한 규칙」제103조 규정에 의거 양수받은 품목의 | 희귀의약품 | 희 귀 의 약 품 - 품 목 허 가 -기 시 -안 유 | 방사선을 차폐하기 위하여 추가적인 차폐용기가 필요함. 단, 콜드바이알(Cold Vial)의 경우 방사능이 | 분할사용을 목적으로 하는 주사 | 된다. | 서 보존제 사용과 관련한 요구사항에도 불구하고 다회 | 제10조(기준 및 시험방법에 관한 자료) ① 법 제 | ․전자민원의 경우: 2,895,000원 | 목허가를 받은 자\"는 각각 \"수입자\"로 본다. | 분할사용 용기로 포장되는 주사 | 2.2.4.2 전자민원신청 절차 | 2.3.5 제조방법 | 함하고 있다. | 정하기 위해 모든 존재하는 방사성핵종을 확인하고 그 | 표시한다. 경과시간에서의 방사능은 붕괴 식 또는 표 | 「의약품등의 안전에 관한 규칙 」(총리령) 제4조 및  별지 제4호 서식 | 순도시험 | 1) 방사화학적이물 | 이 약을 가지고 75 % | 필요가 있는 경우 이를 기재 (예: 주사액, 분말주사 등) | 우려가 있는 표현은 제외 | 나 의약외품의 제조업 신고를 하려는 자는 별지 | 것이 필요하다. 각조의 방사화학적 순도 항은 이성체 | 하여 「의료기기법」에 따라 허가를 받거나 신 |\n| 가. 생물학적제제등이 아닌 것으로서 제1호가 | 규격 | 3. 원료약품 및 그 분량 | 등기사항증명서(법인인 경우만 해당한다)를 확 | 는 품목의 경우에는 제출하지 아니한다. | 시한 의약품등 | 6. 다음 각 목의 구분에 따른 평가 자료. 다만, | 가와 품목신고가 제한되는 품목, 생물학적제제 | 제(內用液劑)만 해당한다]의 경우에는 별 | 1. 기원 또는 발견 및 개발경위에 관한 자료 | 다. 제15조제1항 각 호의 자료 | (業)으로 하려는 자는 대통령령으로 정하는 시 | 경우에는 제4조제1항제6호의 자료를 제출하여 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | RADIOPHARMACEUTICAL | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Technetium-99m (99mTc) | 6.01 시간 | 에 드는 경비를 포함한다)를 내야 한다. | 아님을 증명하는 의사의 진단서 또는 같은 호 | 1) 국소독성시험(국소내성시험포함) |\n| 상수와 관련된다. | 떤 품질기준(quality criteria)을 정하는 것은 불가능할 | 사 시키고 해부한다. 채집한 기관 및 조직들의 방사능 | I. 신약 방사성의약품 | ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ | × | × | × | × | × | △ △ ○ ○ ○ ○ ○ ○ | 로 하는 것은 따로 규정이 없는 | ○ ‘밸리데이션’ 자료는 아래와 같음. 다만, 제조소별 및 품목별 현황에 따라 해당 자료는 달라질 수 있음 | 에는 해당 의약품등에 대하여 제1항에 따른 품 | 방사성핵종을 양전자방출핵(positron emitters)이라 한 | 다수의 방사성핵종들이 생성된다. 가장 흔하게 사용되 | 를 포함한 특정 방사화학적 불순물에 대한 기준을 포 | 고한 제품 또는 품목은 제2항부터 제4항까지의 | 를 하려는 자는 식품의약품안전처장이 정하여 |\n| ü 의약품의 품목허가․신고․심사 규정 | 경우, 종전에 제조된 제품의 품질관리 및 행정조치는 양수자인 ○○제약(주)에서 승계·책임질 것. | 없으므로 “차폐용기”는 미설정할 수 있음. | 4. 성상 | -GMP |\n| - 제조공정 밸리데이션 자료, 중요기계 적격성평가 자료, 시험방법 밸리데이션 자료, 세척방법 밸리데이션 | 가. 생물학적제제등이 아닌 것으로서 제1호가 | ② 제1항에 따라 의약품등의 제조판매ᆞ수입 | 목별 허가를 받거나 신고를 하지 아니하고 수 | 인하여야 한다. | 목·나목·다목 및 마목에 해당하는 품목 | 제4조(제조판매·수입 품목의 허가 신청) ① 법 | 등에 의하여 해당 제조시설·제조방법 등을 양 | 단서에 해당하는 사람임을 증명하는 전문의의 |\n| ※ 참고 - 대한민국약전(제11개정) 통칙 중 방사선을 차폐하는 용기의 조건 | ▷ 자료제출의약품 | 수도 있다. 그러므로 표적물질의 매 배치 품질관리는 | 을 측정한다. 생리학적 분포는 각 기관 또는 조직들에 | - 공정서 품목 : 해당 공정서의 명칭(또는 약칭) 기재 | 신약, 희귀 외 | 의약품-품목허가-안유-기시-GMP | ․전자민원의 경우: 1,134,000원 | 한 미생물의 증식을 억제하기 위 | 다. 양전자들은 주위 전자들과 결합하여 소멸할 때 각 | 는 것은 235U의 핵분열이다. 핵반응기에서 우라늄(235U) | 규정에 따라 품목허가를 받거나 품목신고를 한 |\n| ü 의약품 제조 및 품질관리에 관한 규정 | 나. 삭제 <2014.8.21.> | ⑥ 식품의약품안전처장 또는 지방청장은 제1항 | 5. 제조방법(주성분의 제조소와 모든 제조공정의 소재지를 기재한다) | 입할 수 있다. <개정 2011.3.30., 2013.3.23.> | 품목신고를 하려는 자는 별지 제6호서식의 의 | 자료, 제조지원설비 밸리데이션 자료, 컴퓨터시스템 밸리데이션 자료 | 목ᆞ나목ᆞ다목 및 마목에 해당하는 품목 | - 조제하여 사용하는 방사성의약품(일명: Cold Vial)은 표지품목의 효능․효과를 함께 기재 | 수받은 품목의 제조판매·수입 품목허가를 받 | 진단서 및 같은 조 제3호에 해당되는 사람이 |\n| 방서성핵종의 일상적인 생산 및 방사성의약품의 제조 | 서 확인되는 방사능 노출량의 비율로 계산하고 방사성 | 해 적절한 보존제를 넣는다. | 각 0.511 MeV의 에너지를 가진 2개의 감마 광자를 방 | 을 조사(irradiation)하여 생성된 200개 이상의 방사성 | 제4조(제조판매ᆞ수입 품목의 허가 신청) ① 법 | 제31조제2항부터 제4항까지 또는 법 제42조제 |\n| * 밸리데이션 실시계획서(Validation protocol) 및 밸리데이션 결과보고서(Validation report)제출(요약본) | 1. 국방부장관이 긴급히 군사 목적에 사용하기 | 나. 적절한 대체의약품이 없어 긴급히 도입하 | 3. 다음 각 목의 어느 하나에 해당하는 품목의 | 약품등 제조판매ᆞ수입 품목신고서(전자문서로 | 에 따라 변경허가를 하거나 변경신고를 받을 | T1/2 | = | ln 2 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 아님을 증명하는 의사의 진단서를 첨부하여야 |\n| - 재심사 부여 | 52. 방사성의약품에서 방사선을 차폐하는 용기는 충분한 차폐능력이 있는 것을 쓴다. 용기의 외장은 쉽게 | 6. 효능ㆍ효과 | 공정서 명칭 | 약칭 | 공정서 명칭 | 공정서 명칭 | ⑧ 다음 각 호의 어느 하나에 해당하는 자는 의 | 제31조제2항부터 제4항까지 또는 법 제42조제 | 1항에 따라 의약품등의 제조판매·수입 품목허 |\n| * 적격성평가 자료는 운전적격성평가(OQ), 성능적격성평가(PQ)에 관한 자료 제출. 다만, 기존에 설치하여 현재 | 에 사용하기 전에 평가된다. | 붕괴로 인한 양은 보정한다. 일부 방사성의약품에서는 | 된 신고서를 포함한다)에 다음 각 호의 자료 | 경우 또는 제103조제1항에 따라 지위 승계 신 | 경우에는 생물학적 동등성시험에 관한 시험 | 여야 하는 의약품으로서 식품의약품안전 | “방사성의약품 품목허가를 위한 안내서” | λ | 핵종들로부터 분리하여 Iodine-131, | molybdenum-99 | 사용된다. 예를 들면, 방사성의약품 각조에서 여지크로 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 |\n| 파손되지 않는 것을 쓴다. 용기 외장에서의 최대 방사선량율은 다음과 같이 한다. | 위하여 국내에서 생산되지 아니하는 의약품 | 제출자료 |\n| 2.2 품목허가 신청 및 처리 절차 | 표적물질은 입자들의 빔에 의해 조사되기 위해 기체, | 구분 | 7. 용법ㆍ용량 | 대한민국약전 | 약전 또는 KP | 유럽약전 | EP | (소멸방사선, | annihilation radiation). 모든 붕괴형식 | 마토그래프법, 박층크로마토그래프법, 전기영동법, 크 |\n| 선택된 조직들의 무게 대비 방사능의 비로 계산한다 | <신약에 따른 재심사 부여> | (전자문서를 포함한다)를 첨부하여 지방청장에 | 고를 받은 경우에는 제13조에 따른 허가대장ᆞ |\n| 1) 용기의 외장 표면에서 시간당 2 mSv 이하이다. 다만, 전용운반인 경우에는 시간당 10 mSv 이하로 한다. | 8. 사용상의 주의사항 |\n| 이 식은 t 시간 경과 후 남은 방사능을 빠르게 예측하 | 액체 또는 고체 상태로 홀더에 담겨지며 중성자 조사 | (radioactivity/mass). | 게 제출하여야 한다. | 신고대장, 허가증ᆞ신고증에 변경사항을 적어야 | 기배지크로마토그래프법, 기체크로마토그래프법, 액체 |\n| 2.2.1 품목허가 신청 및 처리 흐름도 | 2) 용기의 외장 표면으로부터 1 m 떨어진 위치에 있어서는 시간당 0.1 mSv 이하이다. 다만, 전용운반인 | Ⅱ.자료제출의약품 | 1.「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 | 규칙」제22조제1항제1호가목의 | 규정에 | 의한 |\n| 4. 새로운 투여경로 | 3. 다음 각 목의 어느 하나에 해당하는 품목의 | 1. 제1항에 따른 신고품목임을 입증하는 자료 | 9. 포장단위 | 한다. |\n| 기 위하여 다음과 같이 나타낼 수 있다. | 시 보통 표적물질을 석영 앰플, 고순도 알루미늄 또는 | 제제는 3마리 실험동물 중 최소 2마리에서 방사능 분 | 2. 수입자가 의약품등의 제조를 위하여 원료의 | 안전성․유효성 | 70일 | 방출 대신 부분적으로 또는 완전하게 내부전환전자 | 크로마토그래프법 등이 포함될 수 있다. 이러한 분석 |\n| 2. 제4조제1항제2호에 따른 자료(이 조 제1항 | ⑦ 제1항에 따른 신청이나 신고를 하는 자는 | 방사성의약품 | 경우에는 제외한다. | 재심사대상 품목임 |\n| 티타늄 용기에 담는다. 조사(irradiation)하는 조건 하에 | 포가 설정된 모든 기준을 만족할 때 적합하다. | 10. 저장방법 및 사용(유효)기간 | (internal conversion electrons)로 알려진 전자의 방출 | 하전입자들을 | 가진 | 안정한 | 방사성핵종의 | 조사 |\n| 회원가입 및 로그인 | 민원서식기 |\n| ※기타 - ｢ | 식품의약품안전처장이 정하여 고시하는 수수료 |\n| ○ 방사성의약품 밸리데이션 관련 상세내용은 「의약품 등의 안전에 관한 규칙」[별표 1] 6. 밸리데이션, | 용기와 그 내용물 사이에 상호작용이 일어나지 않는지 | 투여 시 넘쳐 흘린 경우(투여 당시 발견되었거나 방사 | 사용기간 | 방사성의약품의 특성*을 감안하여 다음 사항을 고려 | 11. 기준 및 시험방법 | 로 대체될 수도 있다. 전자포획 과정과 동일하게 이러 | (irradiation) | 결과 | 보통 | 중성자가 | 부족한 | 핵 | 또한, 방사선 방호, 기하학적 측정, 검출기 선형성, 담 |\n| ▷ 제네릭의약품 | - 신청업소에서 직접 작성한 성분규격 : “별첨규격” 또는 “별규”로 기재 | 가. 1989년 1월 1일 이후 제조판매·수입 품 | 를 내야 한다. 다만, 행정구역개편에 따라 소재 |\n| 확인이 필요하다. | 능 측정 이후 드러나게 된 경우)의 결과는 배제하고 | 기준및시험방법 | 55일 | 12. 제조업자 중 제조판매품목허가증ㆍ신고증을 보유한 자, 위탁제조판매업자 및 | (neutron-deficient nuclei)이 발생하며 이는 전자포획 | 체(carrier) 사용, 검체희석 등 특별한 주의사항도 고려 |\n| - 방사성의약품의 반감기가 24시간 미만인가? | 지가 변경되는 경우에는 이를 적용하지 아니한 |\n| - 안전성․유효성 심사결과 인정된 기간으로 설정 | ③수입자는 대통령령으로 정하는 시설 기준에 |\n| 하전입자 조사(irradiation)에 사용되는 표적물질의 홀 | 다시 시험한다. | <특정 효능․효과 추가에 따른 재심사 부여> | 성분명 | - 반감기가 24시간 이상의 방사성제제에서 보존제를 사용하지 않는 타당한 근거는? | 허가증 발급 | 면허세 납부 | 품목허가처리 |\n| 따라 필요한 시설을 갖추어야 한다. | 다. |\n| 더는 적절한 금속, 가능한 경우 주입구와 배출구, 주변 | 구분 | - 안전성․유효성 심사 비대상 품목 : 기허 품목의 사용기간 준용(단, 36개월 이하로 | 부분적으로 오제전자(Auger electrons)로 알려진 전자 |\n| ④제1항에 따라 수입되는 의약품등 또는 그 수 | 3. 제4조제1항제3호 및 제5호에 해당하는 자료 | ⑧ 제1항에 따라 제조소의 소재지를 변경하는 | 1-1. | 효능․효과 | 중 | ‘편두통의 | 예방’에 | 대하여는「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 |\n| 각 방사선의 투과력은 고유의 특성과 에너지에 따라 | 1. 기허가의약품과 주성분의 규격 및 | - 공정서 및 고시 품목 : 해당 규격의 의약품명 |\n| 냉각장치, | 대개 얇은 금속호일의 표적 창판(target | 무균시험(Sterility) | * 방사성의약품의 특성: 방사성 핵종의 반감기로 인하여 개봉시 즉시 또는 수시간 내로 사용해야 하므로 보존제의 사용이 필수적 | 가. 1989년 1월 1일 이후 제조판매ᆞ수입 품 | 나. 가목에 해당하는 품목을 제외한 전문의약 | 규칙」제22조제1항제2호가목의 규정에 의한 재심사대상 품목임 | 준용하고, 제제학적으로 안정성 확인이 필요한 품목의 경우 안정성 시험자료 등 | 13. 허가조건 | 입자에 관하여는 제31조제7항ᆞ제10항ᆞ제11 | 경우에는 제48조제5호를 준용한다. | 중성자 수)한다. 결과물은 표적핵(target nucleus)을 가 |\n| 상당히 다르다. 알파입자는 물질의 수 마이크로 내지 | 이지 않음(투여 전 방사능 농도 확인 후 해당 농도로 희석하여 환자에게 투여) | 분량, 제형이 동일한 의약품 |\n| ※ 의약품 품목허가 처리기한 및 수수료는 민원 신청 품목에 따라 상이합니다. | window) 들로 구성된다. 질적 및 양적 면에서 방사성 | □ 품목허가 처리(6단계) 상세 절차 | - 별첨규격 : 일반명 | 1. 기원 또는 발견 및 개발의 경위 | 비방사능은 일반적으로 방사능이 방사성핵종(방사성핵 |\n| 비경구투여 방사성의약품은 무균시험에 적합하여야 한 | 제9조(안전성ᆞ유효성에 관한 자료) 의약품등의 | 입증자료 제시) | 항, 제31조의2, 제31조의5, 제31조의3, 제31 | 진 동위원소가 아니며 그 방사능은 무담체제제 |\n| 수십 마이크로미터의 두께에서 완전히 흡수된다. 베타 | 2. 국내외에서의 사용현황에 관한 자료 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 핵종의 생산 효율에 미치는 모든 영향을 평가하기 위 | 다. 이러한 제품들은 미생물 오염을 막고 무균을 보장 | ◯ 용기 관련 | 제조판매ᆞ수입 품목허가 또는 품목변경허가를 |\n| - 조제하여 사용하는 방사성의약품(Cold Vial)의 경우 조제 후의 사용기간도 기재 | 3. 원료의약품에 관한 자료 |\n| 입자는 물질의 수 밀리미터 내지 수 센티미터의 두께 | 4. 제4조제1항제4호에 따른 자료 |\n| <처리기한> | 2.3.1 제품명 | 해서는 제조방법이 명확하게 기술되어야 하고 다음을 | 하도록 주의 깊게 설계하여 제조되어야 한다. 무균시 | 분량 및 단위 | 받거나 제조판매ᆞ수입 품목신고 또는 품목변경 | 방사성붕괴 현상을 설명하거나 이러한 현상의 물리적 | 검증한 후에 방사능의 농도와 화학물질의 농도를 고려 |\n| 에서 완전히 흡수된다. 감마선은 완전히 흡수되거나 | 나. 가목에 해당하는 품목을 제외한 전문의약 | 5. 제4조제1항제6호에 따른 자료(이 조 제1항 | 2.「신약 등의 재심사 기준」(식품의약품안전처 고시)을 준수할 것 |\n| 고려해야 한다 : 표적물질, 표적물질의 홀더 구성, 조 | 험은 일반시험법(2.6.1)에 따라 시험한다. 방사성의약품 | [일반시험법 - 주사제용유리용기 | 기타 | 신고를 하려는 자가 제출하여야 하는 안전성ᆞ | 인 양을 표현하는데 사용되었다. 제품의 방사능은 단 |\n| 약화되는데 예를 들어 10배로 감소시키는데 수 센티미 | 기재순서 |\n| - 처리기한은 단순 합산이 아니라 처리기한이 긴 민원을 기준으로 산정됩니다. | - 전체단위(기준단위) : 액상주사제(1 밀리리터*), 분말주사제(단위제형; 1 바이알, 1 앰플), | 시험법] | 3. 만일, 정당한 사유 없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다. | 유효성에 관한 자료는 다음 각 호의 자료(전자 |\n| 사(irradiation) 방법 및 원하는 방사성 핵종의 분리. | 에서는 일부 방사성핵종의 반감기가 짧거나, 배치크기 | 위시간 당 붕괴 또는 변환되는 핵의 수이다. 국제단위 | 방사성핵종 | 제너레이터는 | 어미방사성핵종(parent |\n| 터의 납이 필요할 수 있다. | 밀도가 높은 흡수체 | - 방사성의약품은 다음 사항을 추가로 기재 | 6. 제4조제1항제7호부터 제9호까지에 따른 자 | 문서를 포함한다)로 한다. 이 경우 자료제출 대 |\n| 예1) | 안전성유효성에 | 관한 | 자료(70일), | 기준 | 및 | 시험방법에 | 관한 | 자료(55일)의 | 검토가 | 필요한 | 민원: | ▷ 상표명 있는 경우 | 가 작거나 방사선의 위험 때문에 실험이 어려울 수 있 | 분할사용을 목적으로 하는 용기 | 기타(1 제너레이터 등) | * | 수입품의 | 경우에는 | 「의약품등의 | 안전에 | 관한 | 규칙」(총리령) | 제4조제1항제4호에 | 따라, | 의약품등을 | radionuclide)이 반감기가 짧은 딸방사성핵종(daughter |\n| (absorbent)를 사용할수록 알파와 베타입자의 범위가 | 는 고무마개 또는 다른 적당한 | ․의약품의 용기․포장에 ‘제조일자(필요시 시각기재한다) : 제조시 표기’와 같이 기재 | 상 품목, 자료 작성요령, 각 자료의 요건 및 면 |\n| * 분할사용 하는 경우 기준단위를 ‘단위량’으로 기재 가능(｢ | 다. 무균시험을 완료하기 전에 출하할 수 있도록 각조 | 4. 수입품의 경우 그 품목의 제조 및 판매에 관 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 |\n| 짧아지고 감마선의 약화가 증가한다. | - 조건부허가:「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조 규정에 | ① | 종양 | 약품과 | 마개로 밀봉한다. 마개는 내용의 | 제범위ᆞ심사기준 등에 관한 세부 규정과 독성 | - 반추동물유래성분의 경우 전염성해면상뇌증(TSE)감염을 방지하기 위한 원료선택 또는 |\n| 예2) 안전성유효성에 관한 자료(70일), GMP실시상황 평가(완제의약품:90일) 대상 민원 : 총 처리기한 90일 | 에 명시된 경우에는 방사선과 관련하여 실제적으로 가 | ․제조시(또는 검정시)의 방사선량 | 방사능 측정은 전문적인 연구소가 필요하지만 관계기 |\n| 유럽약전 각조의 제제에 사용된 방사성핵종의 가장 일 | 의2 참조) | 4. 완제의약품에 관한 자료 | 및 약리작용 등에 관한 자료의 작성을 위하여 | 조시설ᆞ제조방법 등을 양수한 품목에 대한 제 | ※ 조제하여 사용하는 방사성물질이 포함되지 않은 방사성의약품(일명 ‘Cold Vial’ 또는 ‘Cold kit')의 |\n| 각 방사성핵종은 고유의 반감기, 방사선 및 에너지 특 | 약품과 물리적 또는 화학적으로 | 따라 시설을 갖출 것을 조건으로 허가 |\n| 예) 식약처테크네주사액(과테크네튬산나트륨) | 반적으로 받아들여지는 물리적 특성에 대해 방사성핵 | 능해지면 곧 무균시험을 시작하고 만약 바로 시작하지 | - 방사능량 단위 : “MBq”, 필요시 mCi를 괄호로 병기(방사능농도는 범위로 설정 가능) | 조판매ᆞ수입 품목신고를 하려는 자의 경우에 | (완제의약품) |\n| 2.3.11 기준 및 시험방법 | 성을 가지고 있다. 에너지 단위는 전자볼트(eV), 킬로 | 작용하지 않는 것으로 주사바늘 | 실시하는 비임상시험의 관리에 필요한 사항은 |\n| 않을 경우 검체를 위음성(false negative) 결과가 나오 | 1. 동 품목은「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조제2항의 규정에 의한 조건부 | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 |\n| - 원칙적으로 모든 첨가제의 분량을 기재. 단 용해보조제, 안정제, 등장제, pH조절제, | 을 삽입할 때 마개 파편이 혼입 | 식품의약품안전처장이 정하여 고시하는 바에 따 | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료 : GMP 적합판정서를 제출하는 경우에는 | 비교하거나 교정된 기기를 사용하여 상대적으로 방사 |\n| 전자볼트(keV) 또는 메가전자볼트(MeV)로 사용한다. | - 약전, 공정서 품목 : 해당 공정서 각조에 따름 | 4. 수입품의 경우 그 품목의 제조 및 판매에 관 | 가. 의약품등을 생산하는 국가(이하 \"생산국\" | 여 그 품목의 제조시설ᆞ제조방법 등에 관한 |\n| 각조에 언급된 방사성핵종의 주요 잠재적 방사성핵종 | 지 않도록 하기 위해 적절한 조건 하에 보관한다. 이 | 되지 않고 또 주사바늘을 뺄 때 | 제조판매품목으로서 201○.○.○까지 약사법 제31조제1항에 적합한 시설을 갖추고 우리처에 이행통보할 것 | 른다. |\n| <수수료> | ▷ 상표명 없는 경우 | 용제, 기제(캡슐제 포함) 등의 미량투입 첨가제는 “적량”으로 기재 |\n| - 약전, 공정서 외 품목 : 자사기준 | 1. 기원 또는 발견 및 개발 경위에 관한 자료 | 2. 만일, 정당한 사유없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다. | 양도ᆞ양수계약서를 제출할 수 있다. 다만, 별 |\n| 불순물의 물리적 특성들에 대해 기술하고 있다. | 러한 경우 완전히 밸리데이션 된 공정으로 제조된 제 | 곧 외부로부터의 오염을 막을 수 | 않을 경우 생리학적 분포 시험이 필요할 수 있다. 적 |\n| 예1) | 자료제출의약품으로, | ‘안전성유효성 | 자료, | 기준 | 및 | 시험방법에 | 관한 | 자료, | GMP실시상황평가’가 | 방사성핵종순도(Radionuclidic | purity): | 방사성의약품 | - 보존제의 종류 및 함량 사용범위는 ｢ | 표 1의 의약품 제조 및 품질관리기준 실시상황 |\n| ※ 자사에서 근거자료를 바탕으로 직접 기준 및 시험방법을 작성할 경우 방사성의약품의 특성에 맞게 | ‘전이확률(transition | probability)' | 용어는 | 전이 | 품의 매개변수기반출하(parametric release, 5.1.1)를 선 | *첨가제의 규격이 별첨규격인 경우 첨가제 규격에 관한 근거자료를 제출 | 있는 것이다. | 2. 구조결정, 물리화학적 성질에 관한 자료 | 절한 실험동물의 특정 기관, 조직 또는 다른 신체 부 |\n| 의 총 방사능 중 방사성핵종의 방사능 비율(%)과 관련 | 평가가 필요한 경우에는 제4조제1항제6호의 |\n| 3. 안정성에 관한 자료 | 약전의 각조 또는 공정서를 참고하여 작성하도록 함 |\n| 예) 식약처과테크네튬산나트륨주사액 | (transition) 등을 통하여 특정 에너지 상태의 핵이 변 | 택할 수 있다. 무균 제조 시 무균시험은 제품의 품질 | 가. 의약품등을 생산하는 국가(이하 \"생산국\" | 나. 해당 품목이 허가 또는 등록된 국가의 정 | 자료를 제출하여야 한다. | 각각의 특정 붕괴상수(decay constant)에 해당하는 지 | 위에서의 방사능 분포 양상은 사용하려는 목적에 적합 |\n| 된다. 각조 규격에 상대적인 잠재적 방사성핵종 불순 | - 수출용․군수용․관수용:「의약품 등의 안전에 관한 규칙」제12조 및「의약품등의 | 4. 독성에 관한 자료 |\n| 예2) 자료제출의약품으로, ‘안전성유효성 자료, 기준 및 시험방법에 관한 자료, GMP실시상황평가’가 제출 | 환(transformation) | 되는 확률을 의미한다. | '확률 | 관리로서 수행되어야 한다. | 심사자료의 요건 등 | 않으며, 중요공정(예시 : 칭량, 혼합, 타정, 충전 등), 원료 및 반제품이 작업실에서 노출되는 정도 등을 | 요인들과 함께 표적물질의 순도와 동위원소 조성은 조 |\n| 2.3.4 성상 | <예> 대한민국약전 각조 중, | ④ 제2항에 따라 신고를 하는 자는 식품의약품 |\n| 물들의 기준이 기재되어 있다. | 품목허가․신고․심사규정」제22조 | 규정에 | 따라 | 수출용․군수용․관수용으로 | * 방사성의약품은 ‘15.7.1 부터 품목허가를 신청하는 경우 GMP 실시상황 평가대상이며, ‘14.8.21.자 개정된 |\n| (probability)' 대신 ’존재도(abundance)' 용어를 사용하 | 방사성의약품의 배치크기가 1 내지 몇 개의 샘플로 적 | 안전처장이 정하여 고시하는 수수료(외국에서 | 자료 요건이며, 사전검토 민원 ‘기준 및 시험방법에 관한 자료’ 적합 통지서를 제출하는 경우, 총 | 사(irradiation)에 의해 생성되는 주 방사성핵종과 방사 |\n| ▷ 시리즈 제품(유사 효능․효과 품목들) | 방사성의약품 심사자료의 요건 등 정보는 ｢ | - 색 + 형상 + 제형 순으로 기재 |\n| 을 때, 일반시험법(2.6.1)에 따른 검체 채취방법을 적용 | 허가(예: 수출용에 한함) | 현지실사를 할 필요가 있는 경우에는 이에 드 | 처리기한은 90일, 수수료(전자민원)는 1,134,000원에서 306,000원을 제외한 828,000원 | 성핵종 불순물의 상대적인 비율을 결정할 것이다. 필 |\n| * ㉮「의약품 등의 안전에 관한 규칙」제4조제2항제2호애 따라 제조소에 동 규칙 제48조의2에 따른 GMP | 기도 한다. | 알려진 다른제제와 함께 시험 시 제제의 생물학적동등 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 제7조, 제2절, 제3절 및 2012년도에 발간한 ｢ | 방사화학적순도(Radiochemical purity): 방사성의약품 | 분할사용 하는 용기의 특성을 감안하여 다음 사항을 고려 |\n| 상세한 | 수수료 | 정보는 | 「의약품 | 등의 | 허가등에 | 관한 | 수수료 | 규정 | 」(식품의약품안전처 | 고시)를 | ‘방출확률(emission probability)'은 방사성 핵종의 원자 | 할 수 없을지도 모른다. | 나. 해당 품목이 허가 또는 등록된 국가의 정 | 5. 일반의약품 중 단일성분의 의약품으로서 이 | Sodium Pertechnetate (99mTc) Injection | 는 경비를 포함한다)를 내야 한다. | 적합판정서가 있는 경우 GMP 실시상황 평가자료를 제출하지 않을 수 있음(신약, 생물학적제제등, 주사제, | 이식제 제외) 단, ‘15.7.1부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 | 동 규칙 제48조의2에 따른 GMP 적합판정서가 있더라도 관류제, 복막투석제, 점안제, 안연고제, | 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | 요한 표적 핵종들을 인위적으로 증가시킨 동위원소농 |\n| 에 존재하는 방사성핵종의 총 방사능 중 목적하는 화 | - 제조방법에서 주사제 용기의 규격(고무마개 등)을 기재했는가? |\n| 참고한다. | 방사성핵종의 반감기가 5분 미만일 경우 환자에게 밸 | - 제형은 ｢ | 축표적물질(isotopically enriched target material)은 원 |\n| 참고하시기 바랍니다. | 가 입자 또는 방사선 등의 방출을 일으키는 확률을 의 | 제5조(제조판매·수입 품목의 신고) ① 법 제31 | - 설정된 규격은 재밀봉시험(self-sealing test) 항목이 포함되었는가? 그 결과는 적합한가? | 각조에서 시험을 수행하는 데 필요한 상세내용과 요구 |\n| 예) 식약처테크네100주사액(과테크네튬산나트륨), 식약처테크네200주사액(과테크네튬산나트륨) | 합물로 존재하는 방사성핵종의 방사능 비율(%)과 관련 |\n| 미한다. 어느 경우든 확률은 백분율로 표시한다. | 리데이션 된 제조 시스템을 통한 실시간 방사성의약품 | 이 약은 수성의 주사제로서 테크네튬-99m을 과테크 | 필요가 있는 경우 이를 기재 (예: 쓸 때 녹여 쓰는 주사제 등) | 조제2항·제4항 또는 법 제42조제1항에 따라 |\n\n**[표 끝]**\n\n시행 전에 종전의 규정에 따라 방사성의약품 제조판매‧수입품목허가를 받은 제조업자‧수입자가 허가받은 품목에\n\n대하여 2015.07.01 이후부터 이 규칙 시행일부터 2년이 경과한 날까지 품목변경허가(신고)를 신청하는 경우에는\n\nGMP 실시상황에 평가에 필요한 자료를 제출하지 않음\n\n**[표 시작]**\n\n| 2.3 품목허가 신청서 작성 요령 | A0 = 초기 방사능 | 표적물질 및 화학첨가제의 화학적 형태(chemical | 일반적으로 시험은 아래와 같이 수행된다. | - 방사성의약품에 사용되는 주요 첨가제의 배합목적 | 된다. 각조 규격에 상대적인 잠재적 방사화학적 불순 | 투여가 이루어진다. | 2.4 심사자료의 종류 및 범위 | 2.5 GMP 평가자료의 종류 | 유효기간(Period of validity): 각조에 기술된 규격에 | 괴 시 생길 수 있다. 잠재적인 방사성핵종 불순물들은 | - 캡슐제는 내용약품의 성상 기재 (예: 흰색의 가루가 든 상부청색, 하부노란색의 경질캡슐 등) | 데 (n, γ)로 표시한다(흔희 방사성 포획으로 일컬음). | - 불완전한 분리(separation) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n**결과물은 표적핵(target nucleus)을 가진 동위원소이고**\n**방사화학적 순도 분석은 방사성핵종이 들어있는 다른**\n| (emitting electrons)에 의해 붕괴된다. 중성자가 결손된 | 높은 원자번호를 가진 여러 핵종들은 중성자에 의해 |\n| 제제총칙에서 정한 제형으로 표기. 단, 제제학적으로 구분관리할 | 핵분열(fission) 한다. 핵분열(nuclear fission)은 (n, f)로 | (주성분 화학물질)와 관련된 핵종의 방사능 비율을 분석하는 |\n| (emitting prositrons)에 의해 붕괴된다. 후자의 경우 | 표시하고, 핵분열 결과 다양한 무게와 반감기를 가진 |\n| - 아래 서식으로 작성하되, 방사성의약품의 특성에 맞게 제조공정도나 다른 기술방식을 | 원칙적으로 방사화학적 순도 분석에 분리분석 방법이 |\n**출하는데, 일반적으로 서로 180° 방향으로 방출한다**\n**(decay modes)은 감마선 방출을 수반하는데, 감마선**\n**한 현상은 원자 내 전자의 재편성으로 인한 이차적인**\n**X-선의 방출을 일으키고, 이러한 이차 방출은 스스로**\n**에 의해 붕괴된다. 이는 (p, xn)으로 표시(x는 방출된**\n| 방사능(Radioactivity): 일반적으로 ‘방사능(성)' 용어는 | 종 순도)과 화학물질들(방사화학적 순도)에 기인하는지 |\n**비방사능은 시간에 따라 변하므로 비방사능 표기 시**\n**계(SI)로 방사능은 베크렐(Bq)로 나타내며, 1 베크렐은**\n**1초 당 하나의 원자핵이 붕괴하는 것이다. 절대적인**\n**제너레이터의 제조원으로부터 멀리 떨어진 지역에서도**\n| 관에서 인정한 연구소에서 제공된 표준검체와 검체를 | 어미방사성핵종으로부터 물리화학적 방법을 이용하여 | 동물을 사용하는 시험은 가능한 피해야 한다. 확인 및 |\n| 반감기가 짧은 딸방사성핵종을 분리하여 얻음으로써 | 방사화학적순도 시험으로 방사성의약품의 방사화학적 |\n**종(species)을 완전히 정의하고 관리하기에 적합하지**\n| - | 액상주사제의 경우 제조(수입)되는 바이알 또는 앰플 등의 용량. | 다만, | 제형이나 |\n**○ 무균제제 방사성의약품의 ‘청정도 관리현황’ 자료에 대한 상세내용은 ‘방사성의약품 제조 및 품질관리 기준**\n| 용량 등으로 보아 특수성이 있거나 사용목적으로 보아 그 타당성이 인정되는 | 방사성붕괴(Radioactive decay): 어느 방사성핵종이던 |\n| ○ 비무균제제 방사성의약품의 ‘청정도 관리현황’과 관련하여, 국제적으로 청정등급을 별도로 규정하고 있지 | 입사입자(incident particle)의 특성과 에너지 같은 다른 |\n**수의 속도(exponential rate)로 붕괴된다. 붕괴 곡선은**\n**고려하여 교차오염 및 미생물 오염이 발생하지 않도록 국제표준화기구의 기준(예시 : ISO-14644 등)에 따라**\n**다른 수단으로 생리학적 분포 시험은 임상적 유효성이**\n**○ 방사성의약품의 ‘청정도 관리현황’ 자료의 예시는 아래와 같음. 다만, 제조소별 및 품목별 현황에 따라 해당**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**- 유효성이 명확히 실증될 수 있는 질환명, 증상명을 의약학적으로 인정되는 범위에서**\n**- 근거 불명확, 막연하고 광범위한 의미 표현, 중복, 지나치게 강조, 오해 또는 오남용**\n**- 동위원소가 포함된 방사성의약품은 반감기에 따른 방사선량을 구할 수 있는 계산식**\n| GMP | 평가자료의 요건은 「의약품 등의 안전에 관한 규칙」 | 별표 1, | 별표 |\n| 1의2(원료의약품에 한함) | 및 별표 3의2와 「의약품 | 제조 및 품질관리에 관한 |\n**규정」별표 1(무균의약품에 한함) 및 별표 3의 실시상황 평가 및 2014년도에 발간한**\n**- 의약품의 일반적인 사용상의 주의사항 이외에 방사성의약품 조제 시 주의할 사항을**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**5 mL 및 암모니아수(28)를 넣어 pH를 8로 조정하**\n**고 묽은염산을 넣어 pH를 7로 조정한다. 여기에 아**\n**세트산·아세트산나트륨완충액(pH 3.8) 5 mL, 알루**\n**미논시액 1 mL및 물을 넣어 25.0 mL로 하고 20**\n**분간 방치하여 각각 검액 및 표준액으로 한다. 따로**\n**물 5.0 mL에 용시 조제한 L-아스코르브산용액 (1**\n**→ 20) 2.4 mL를 넣고 같은 방법으로 조작하여 얻**\n**은 액을 대조로 하여 자외가시부흡광도측정법에 따라**\n**층장 1 cm, 파장 530 nm에서 흡광도를 측정할 때**\n**검액의 흡광도는 표준액의 흡광도보다 작다 (10**\n**미만이다. 다만, V는 유효시간에 mL 당 최대권장량**\n**정 량 법  이 약을 가지고 감마선측정법의 정량법에 따**\n\n**[표 끝]**\n\n엔도톡신  이 약 1 mL 당 엔도톡신으로서 175/V EU\n\n**[표 시작]**\n\n**자(헬륨원자(4He)의 핵) 또는 베타입자(전자 또는 양전**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**종의 물리적 특성표(5.7)에 요약되어 있다. 또한, 표는**\n\n**[표 끝]**\n",
  "chunks": [
    {
      "chunk_id": "chunk_001",
      "text": "<!-- PAGE_1 -->\n# 방사성의약품 품목허가를 위한 안내서\n\n**[표 시작]**\n\n| □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 제는 그 자체가 보존효과가 없을 | ※대한민국약전(KP)에서는 방사성핵종순도, 방사화학적순도, 화학적순 | 반감기 근사치(Approximate half-life): 반감기는 방사 | 투여용기(multidose container)의 방사성의약품에 보존 | ․방문, 우편 민원의 경우: 3,217,000원 | 70일 | 31조제11항 또는 법 제42조제5항에 따라 의약 | <개정 | 2007.10.17., | 2011.3.30., | 2011.6.7., | 제는 다음의 경우를 제외하고, | 방사능(radioactivity)을 알아야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 0,
        "window_size": 3,
        "char_count": 422,
        "word_count": 86,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n# 방사성의약품 품목허가를 위한 안내서\n\n**[표 시작]**\n\n| □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 제는 그 자체가 보존효과가 없을 | ※대한민국약전(KP)에서는 방사성핵종순도, 방사화학적순도, 화학적순 | 반감기 근사치(Approximate half-life): 반감기는 방사 | 투여용기(multidose container)의 방사성의약품에 보존 | ․방문, 우편 민원의 경우: 3,217,000원 | 70일 | 31조제11항 또는 법 제42조제5항에 따라 의약 | <개정 | 2007.10.17., | 2011.3.30., | 2011.6.7., | 제는 다음의 경우를 제외하고, | 방사능(radioactivity)을 알아야 한다.  | 로부터 계산한다.  | 메탄올을 전개용매로 하여 여지크로마토그래프법에 | 제1호서식의 의약품 제조업 허가신청서(전자문 | 제조소 평면도 |\n| - 원자 또는 분자 형태의 원소 (예: 133Xe, [15O]O2) | - 성별, 연령층 등으로 적용대상이 한정되는 경우 그 내용 명시 | 기재요령 | 설기준에 따라 필요한 시설을 갖추고 총리령으 | Technetium-99 (99Tc) | 2.11×105 년 |\n| 경우 적절한 보존제를 포함한다.  | 도에 대해 각각 이핵종, 방사화학적이물, 화학적이물의 용어를 사용. ",
        "original_sentence": "<!-- PAGE_1 -->\n# 방사성의약품 품목허가를 위한 안내서\n\n**[표 시작]**\n\n| □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 제는 그 자체가 보존효과가 없을 | ※대한민국약전(KP)에서는 방사성핵종순도, 방사화학적순도, 화학적순 | 반감기 근사치(Approximate half-life): 반감기는 방사 | 투여용기(multidose container)의 방사성의약품에 보존 | ․방문, 우편 민원의 경우: 3,217,000원 | 70일 | 31조제11항 또는 법 제42조제5항에 따라 의약 | <개정 | 2007.10.17., | 2011.3.30., | 2011.6.7., | 제는 다음의 경우를 제외하고, | 방사능(radioactivity)을 알아야 한다. "
      }
    },
    {
      "chunk_id": "chunk_002",
      "text": "| 로부터 계산한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 1,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 9,
        "window_text": "<!-- PAGE_1 -->\n# 방사성의약품 품목허가를 위한 안내서\n\n**[표 시작]**\n\n| □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 제는 그 자체가 보존효과가 없을 | ※대한민국약전(KP)에서는 방사성핵종순도, 방사화학적순도, 화학적순 | 반감기 근사치(Approximate half-life): 반감기는 방사 | 투여용기(multidose container)의 방사성의약품에 보존 | ․방문, 우편 민원의 경우: 3,217,000원 | 70일 | 31조제11항 또는 법 제42조제5항에 따라 의약 | <개정 | 2007.10.17., | 2011.3.30., | 2011.6.7., | 제는 다음의 경우를 제외하고, | 방사능(radioactivity)을 알아야 한다.  | 로부터 계산한다.  | 메탄올을 전개용매로 하여 여지크로마토그래프법에 | 제1호서식의 의약품 제조업 허가신청서(전자문 | 제조소 평면도 |\n| - 원자 또는 분자 형태의 원소 (예: 133Xe, [15O]O2) | - 성별, 연령층 등으로 적용대상이 한정되는 경우 그 내용 명시 | 기재요령 | 설기준에 따라 필요한 시설을 갖추고 총리령으 | Technetium-99 (99Tc) | 2.11×105 년 |\n| 경우 적절한 보존제를 포함한다.  | 도에 대해 각각 이핵종, 방사화학적이물, 화학적이물의 용어를 사용.  | 등 및 방사성의약품은 제외한다. ",
        "original_sentence": "| 로부터 계산한다. "
      }
    },
    {
      "chunk_id": "chunk_003",
      "text": "| 메탄올을 전개용매로 하여 여지크로마토그래프법에 | 제1호서식의 의약품 제조업 허가신청서(전자문 | 제조소 평면도 |\n| - 원자 또는 분자 형태의 원소 (예: 133Xe, [15O]O2) | - 성별, 연령층 등으로 적용대상이 한정되는 경우 그 내용 명시 | 기재요령 | 설기준에 따라 필요한 시설을 갖추고 총리령으 | Technetium-99 (99Tc) | 2.11×105 년 |\n| 경우 적절한 보존제를 포함한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 2,
        "window_size": 3,
        "char_count": 237,
        "word_count": 56,
        "page_number": 3,
        "window_text": "<!-- PAGE_1 -->\n# 방사성의약품 품목허가를 위한 안내서\n\n**[표 시작]**\n\n| □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 제는 그 자체가 보존효과가 없을 | ※대한민국약전(KP)에서는 방사성핵종순도, 방사화학적순도, 화학적순 | 반감기 근사치(Approximate half-life): 반감기는 방사 | 투여용기(multidose container)의 방사성의약품에 보존 | ․방문, 우편 민원의 경우: 3,217,000원 | 70일 | 31조제11항 또는 법 제42조제5항에 따라 의약 | <개정 | 2007.10.17., | 2011.3.30., | 2011.6.7., | 제는 다음의 경우를 제외하고, | 방사능(radioactivity)을 알아야 한다.  | 로부터 계산한다.  | 메탄올을 전개용매로 하여 여지크로마토그래프법에 | 제1호서식의 의약품 제조업 허가신청서(전자문 | 제조소 평면도 |\n| - 원자 또는 분자 형태의 원소 (예: 133Xe, [15O]O2) | - 성별, 연령층 등으로 적용대상이 한정되는 경우 그 내용 명시 | 기재요령 | 설기준에 따라 필요한 시설을 갖추고 총리령으 | Technetium-99 (99Tc) | 2.11×105 년 |\n| 경우 적절한 보존제를 포함한다.  | 도에 대해 각각 이핵종, 방사화학적이물, 화학적이물의 용어를 사용.  | 등 및 방사성의약품은 제외한다.  | 품등의 제조판매ᆞ수입 품목허가 또는 품목변경 | 2011.12.2., 2012.5.14., 2014.3.18., 2015.3.13.> | 희귀의약품의 경우에는 제출하지 아니한다. ",
        "original_sentence": "| 메탄올을 전개용매로 하여 여지크로마토그래프법에 | 제1호서식의 의약품 제조업 허가신청서(전자문 | 제조소 평면도 |\n| - 원자 또는 분자 형태의 원소 (예: 133Xe, [15O]O2) | - 성별, 연령층 등으로 적용대상이 한정되는 경우 그 내용 명시 | 기재요령 | 설기준에 따라 필요한 시설을 갖추고 총리령으 | Technetium-99 (99Tc) | 2.11×105 년 |\n| 경우 적절한 보존제를 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_004",
      "text": "| 도에 대해 각각 이핵종, 방사화학적이물, 화학적이물의 용어를 사용. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 3,
        "window_size": 3,
        "char_count": 40,
        "word_count": 9,
        "page_number": 5,
        "window_text": "<!-- PAGE_1 -->\n# 방사성의약품 품목허가를 위한 안내서\n\n**[표 시작]**\n\n| □ 이미 등록된 지침·안내서 중 동일·유사한 내용의 | □ 예 | ■ 아니오 |\n| --- | --- | --- |\n| 제는 그 자체가 보존효과가 없을 | ※대한민국약전(KP)에서는 방사성핵종순도, 방사화학적순도, 화학적순 | 반감기 근사치(Approximate half-life): 반감기는 방사 | 투여용기(multidose container)의 방사성의약품에 보존 | ․방문, 우편 민원의 경우: 3,217,000원 | 70일 | 31조제11항 또는 법 제42조제5항에 따라 의약 | <개정 | 2007.10.17., | 2011.3.30., | 2011.6.7., | 제는 다음의 경우를 제외하고, | 방사능(radioactivity)을 알아야 한다.  | 로부터 계산한다.  | 메탄올을 전개용매로 하여 여지크로마토그래프법에 | 제1호서식의 의약품 제조업 허가신청서(전자문 | 제조소 평면도 |\n| - 원자 또는 분자 형태의 원소 (예: 133Xe, [15O]O2) | - 성별, 연령층 등으로 적용대상이 한정되는 경우 그 내용 명시 | 기재요령 | 설기준에 따라 필요한 시설을 갖추고 총리령으 | Technetium-99 (99Tc) | 2.11×105 년 |\n| 경우 적절한 보존제를 포함한다.  | 도에 대해 각각 이핵종, 방사화학적이물, 화학적이물의 용어를 사용.  | 등 및 방사성의약품은 제외한다.  | 품등의 제조판매ᆞ수입 품목허가 또는 품목변경 | 2011.12.2., 2012.5.14., 2014.3.18., 2015.3.13.> | 희귀의약품의 경우에는 제출하지 아니한다.  | 표 1의 의약품 제조 및 품질관리기준 실 | 1.1 배경 | - 단일제로서 필요한 경우 주성분의 분량을 제형 다음에 단위 포함하여 기재 | ① 의약품 제조판매품목 허가 신청서 | 8. ",
        "original_sentence": "| 도에 대해 각각 이핵종, 방사화학적이물, 화학적이물의 용어를 사용. "
      }
    },
    {
      "chunk_id": "chunk_005",
      "text": "| 등 및 방사성의약품은 제외한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 4,
        "window_size": 3,
        "char_count": 20,
        "word_count": 5,
        "page_number": 6,
        "window_text": "| 로부터 계산한다.  | 메탄올을 전개용매로 하여 여지크로마토그래프법에 | 제1호서식의 의약품 제조업 허가신청서(전자문 | 제조소 평면도 |\n| - 원자 또는 분자 형태의 원소 (예: 133Xe, [15O]O2) | - 성별, 연령층 등으로 적용대상이 한정되는 경우 그 내용 명시 | 기재요령 | 설기준에 따라 필요한 시설을 갖추고 총리령으 | Technetium-99 (99Tc) | 2.11×105 년 |\n| 경우 적절한 보존제를 포함한다.  | 도에 대해 각각 이핵종, 방사화학적이물, 화학적이물의 용어를 사용.  | 등 및 방사성의약품은 제외한다.  | 품등의 제조판매ᆞ수입 품목허가 또는 품목변경 | 2011.12.2., 2012.5.14., 2014.3.18., 2015.3.13.> | 희귀의약품의 경우에는 제출하지 아니한다.  | 표 1의 의약품 제조 및 품질관리기준 실 | 1.1 배경 | - 단일제로서 필요한 경우 주성분의 분량을 제형 다음에 단위 포함하여 기재 | ① 의약품 제조판매품목 허가 신청서 | 8.  의약품의 주성분을 제조하는 제조업자의 명 | 1. ",
        "original_sentence": "| 등 및 방사성의약품은 제외한다. "
      }
    },
    {
      "chunk_id": "chunk_006",
      "text": "| 품등의 제조판매ᆞ수입 품목허가 또는 품목변경 | 2011.12.2., 2012.5.14., 2014.3.18., 2015.3.13.> | 희귀의약품의 경우에는 제출하지 아니한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 5,
        "window_size": 3,
        "char_count": 102,
        "word_count": 16,
        "page_number": 3,
        "window_text": "| 메탄올을 전개용매로 하여 여지크로마토그래프법에 | 제1호서식의 의약품 제조업 허가신청서(전자문 | 제조소 평면도 |\n| - 원자 또는 분자 형태의 원소 (예: 133Xe, [15O]O2) | - 성별, 연령층 등으로 적용대상이 한정되는 경우 그 내용 명시 | 기재요령 | 설기준에 따라 필요한 시설을 갖추고 총리령으 | Technetium-99 (99Tc) | 2.11×105 년 |\n| 경우 적절한 보존제를 포함한다.  | 도에 대해 각각 이핵종, 방사화학적이물, 화학적이물의 용어를 사용.  | 등 및 방사성의약품은 제외한다.  | 품등의 제조판매ᆞ수입 품목허가 또는 품목변경 | 2011.12.2., 2012.5.14., 2014.3.18., 2015.3.13.> | 희귀의약품의 경우에는 제출하지 아니한다.  | 표 1의 의약품 제조 및 품질관리기준 실 | 1.1 배경 | - 단일제로서 필요한 경우 주성분의 분량을 제형 다음에 단위 포함하여 기재 | ① 의약품 제조판매품목 허가 신청서 | 8.  의약품의 주성분을 제조하는 제조업자의 명 | 1.  민원서식기를 이용하여 신청하고자 하는 신청서와 구비서류 작성 | 나) 신청품목과 관련된 작업소 시설 관련 자료 | 따라 약 3 시간 전개할 때 과테크네튬산나트륨 | 2. ",
        "original_sentence": "| 품등의 제조판매ᆞ수입 품목허가 또는 품목변경 | 2011.12.2., 2012.5.14., 2014.3.18., 2015.3.13.> | 희귀의약품의 경우에는 제출하지 아니한다. "
      }
    },
    {
      "chunk_id": "chunk_007",
      "text": "| 표 1의 의약품 제조 및 품질관리기준 실 | 1.1 배경 | - 단일제로서 필요한 경우 주성분의 분량을 제형 다음에 단위 포함하여 기재 | ① 의약품 제조판매품목 허가 신청서 | 8. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 6,
        "window_size": 3,
        "char_count": 105,
        "word_count": 31,
        "page_number": 3,
        "window_text": "| 도에 대해 각각 이핵종, 방사화학적이물, 화학적이물의 용어를 사용.  | 등 및 방사성의약품은 제외한다.  | 품등의 제조판매ᆞ수입 품목허가 또는 품목변경 | 2011.12.2., 2012.5.14., 2014.3.18., 2015.3.13.> | 희귀의약품의 경우에는 제출하지 아니한다.  | 표 1의 의약품 제조 및 품질관리기준 실 | 1.1 배경 | - 단일제로서 필요한 경우 주성분의 분량을 제형 다음에 단위 포함하여 기재 | ① 의약품 제조판매품목 허가 신청서 | 8.  의약품의 주성분을 제조하는 제조업자의 명 | 1.  민원서식기를 이용하여 신청하고자 하는 신청서와 구비서류 작성 | 나) 신청품목과 관련된 작업소 시설 관련 자료 | 따라 약 3 시간 전개할 때 과테크네튬산나트륨 | 2.  구조결정, 물리화학적 성질에 관한 자료 | 야 한다. ",
        "original_sentence": "| 표 1의 의약품 제조 및 품질관리기준 실 | 1.1 배경 | - 단일제로서 필요한 경우 주성분의 분량을 제형 다음에 단위 포함하여 기재 | ① 의약품 제조판매품목 허가 신청서 | 8. "
      }
    },
    {
      "chunk_id": "chunk_008",
      "text": "의약품의 주성분을 제조하는 제조업자의 명 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 7,
        "window_size": 3,
        "char_count": 28,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| 등 및 방사성의약품은 제외한다.  | 품등의 제조판매ᆞ수입 품목허가 또는 품목변경 | 2011.12.2., 2012.5.14., 2014.3.18., 2015.3.13.> | 희귀의약품의 경우에는 제출하지 아니한다.  | 표 1의 의약품 제조 및 품질관리기준 실 | 1.1 배경 | - 단일제로서 필요한 경우 주성분의 분량을 제형 다음에 단위 포함하여 기재 | ① 의약품 제조판매품목 허가 신청서 | 8.  의약품의 주성분을 제조하는 제조업자의 명 | 1.  민원서식기를 이용하여 신청하고자 하는 신청서와 구비서류 작성 | 나) 신청품목과 관련된 작업소 시설 관련 자료 | 따라 약 3 시간 전개할 때 과테크네튬산나트륨 | 2.  구조결정, 물리화학적 성질에 관한 자료 | 야 한다.  <개정 2014.8.21.> | 2. ",
        "original_sentence": "의약품의 주성분을 제조하는 제조업자의 명 | 1. "
      }
    },
    {
      "chunk_id": "chunk_009",
      "text": "민원서식기를 이용하여 신청하고자 하는 신청서와 구비서류 작성 | 나) 신청품목과 관련된 작업소 시설 관련 자료 | 따라 약 3 시간 전개할 때 과테크네튬산나트륨 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 8,
        "window_size": 3,
        "char_count": 95,
        "word_count": 25,
        "page_number": 5,
        "window_text": "| 품등의 제조판매ᆞ수입 품목허가 또는 품목변경 | 2011.12.2., 2012.5.14., 2014.3.18., 2015.3.13.> | 희귀의약품의 경우에는 제출하지 아니한다.  | 표 1의 의약품 제조 및 품질관리기준 실 | 1.1 배경 | - 단일제로서 필요한 경우 주성분의 분량을 제형 다음에 단위 포함하여 기재 | ① 의약품 제조판매품목 허가 신청서 | 8.  의약품의 주성분을 제조하는 제조업자의 명 | 1.  민원서식기를 이용하여 신청하고자 하는 신청서와 구비서류 작성 | 나) 신청품목과 관련된 작업소 시설 관련 자료 | 따라 약 3 시간 전개할 때 과테크네튬산나트륨 | 2.  구조결정, 물리화학적 성질에 관한 자료 | 야 한다.  <개정 2014.8.21.> | 2.  허가처리 절차 ······················································································4 | 의약품에 관한 특허권(이하 \"의약품특허권\" | PREPARATIONS | 지침·안내서가 있습니까? ",
        "original_sentence": "민원서식기를 이용하여 신청하고자 하는 신청서와 구비서류 작성 | 나) 신청품목과 관련된 작업소 시설 관련 자료 | 따라 약 3 시간 전개할 때 과테크네튬산나트륨 | 2. "
      }
    },
    {
      "chunk_id": "chunk_010",
      "text": "구조결정, 물리화학적 성질에 관한 자료 | 야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 9,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 5,
        "window_text": "| 표 1의 의약품 제조 및 품질관리기준 실 | 1.1 배경 | - 단일제로서 필요한 경우 주성분의 분량을 제형 다음에 단위 포함하여 기재 | ① 의약품 제조판매품목 허가 신청서 | 8.  의약품의 주성분을 제조하는 제조업자의 명 | 1.  민원서식기를 이용하여 신청하고자 하는 신청서와 구비서류 작성 | 나) 신청품목과 관련된 작업소 시설 관련 자료 | 따라 약 3 시간 전개할 때 과테크네튬산나트륨 | 2.  구조결정, 물리화학적 성질에 관한 자료 | 야 한다.  <개정 2014.8.21.> | 2.  허가처리 절차 ······················································································4 | 의약품에 관한 특허권(이하 \"의약품특허권\" | PREPARATIONS | 지침·안내서가 있습니까?  | Ruthenium-103 (103Ru) | 39.26 일 | 고시하는 수수료를 내야 한다. ",
        "original_sentence": "구조결정, 물리화학적 성질에 관한 자료 | 야 한다. "
      }
    },
    {
      "chunk_id": "chunk_011",
      "text": "<개정 2014.8.21.> | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 10,
        "window_size": 3,
        "char_count": 21,
        "word_count": 4,
        "page_number": 3,
        "window_text": "의약품의 주성분을 제조하는 제조업자의 명 | 1.  민원서식기를 이용하여 신청하고자 하는 신청서와 구비서류 작성 | 나) 신청품목과 관련된 작업소 시설 관련 자료 | 따라 약 3 시간 전개할 때 과테크네튬산나트륨 | 2.  구조결정, 물리화학적 성질에 관한 자료 | 야 한다.  <개정 2014.8.21.> | 2.  허가처리 절차 ······················································································4 | 의약품에 관한 특허권(이하 \"의약품특허권\" | PREPARATIONS | 지침·안내서가 있습니까?  | Ruthenium-103 (103Ru) | 39.26 일 | 고시하는 수수료를 내야 한다.  | 2) 의존성 |\n| 성의약품 사용을 위한 출하를 허용하기 위해 상대적으 | 제를 첨가하는 것은 각조에 규정하지 않는 한 의무사 | 미생물성장을 막기 위해 적절한 | 일반적으로 감마선과 엑스선을 방출하는 방사성핵종의 | 상기 이외에 용기, 포장, 포장에 있는 설명서, 방사성 | - 이온 (예: [131I]iodide, [99mTc]pertechnetate) | 로 정하는 바에 따라 식품의약품안전처장의 허 | 서로 된 신청서를 포함한다) 또는 별지 제2호 | 함한다. ",
        "original_sentence": "<개정 2014.8.21.> | 2. "
      }
    },
    {
      "chunk_id": "chunk_012",
      "text": "허가처리 절차 ······················································································4 | 의약품에 관한 특허권(이하 \"의약품특허권\" | PREPARATIONS | 지침·안내서가 있습니까? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 11,
        "window_size": 3,
        "char_count": 153,
        "word_count": 13,
        "page_number": 2,
        "window_text": "민원서식기를 이용하여 신청하고자 하는 신청서와 구비서류 작성 | 나) 신청품목과 관련된 작업소 시설 관련 자료 | 따라 약 3 시간 전개할 때 과테크네튬산나트륨 | 2.  구조결정, 물리화학적 성질에 관한 자료 | 야 한다.  <개정 2014.8.21.> | 2.  허가처리 절차 ······················································································4 | 의약품에 관한 특허권(이하 \"의약품특허권\" | PREPARATIONS | 지침·안내서가 있습니까?  | Ruthenium-103 (103Ru) | 39.26 일 | 고시하는 수수료를 내야 한다.  | 2) 의존성 |\n| 성의약품 사용을 위한 출하를 허용하기 위해 상대적으 | 제를 첨가하는 것은 각조에 규정하지 않는 한 의무사 | 미생물성장을 막기 위해 적절한 | 일반적으로 감마선과 엑스선을 방출하는 방사성핵종의 | 상기 이외에 용기, 포장, 포장에 있는 설명서, 방사성 | - 이온 (예: [131I]iodide, [99mTc]pertechnetate) | 로 정하는 바에 따라 식품의약품안전처장의 허 | 서로 된 신청서를 포함한다) 또는 별지 제2호 | 함한다.  |\n| ⑤제1항에 따른 의약품등의 수입 품목 허가 또 | 가. ",
        "original_sentence": "허가처리 절차 ······················································································4 | 의약품에 관한 특허권(이하 \"의약품특허권\" | PREPARATIONS | 지침·안내서가 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_013",
      "text": "| Ruthenium-103 (103Ru) | 39.26 일 | 고시하는 수수료를 내야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 12,
        "window_size": 3,
        "char_count": 53,
        "word_count": 11,
        "page_number": 3,
        "window_text": "구조결정, 물리화학적 성질에 관한 자료 | 야 한다.  <개정 2014.8.21.> | 2.  허가처리 절차 ······················································································4 | 의약품에 관한 특허권(이하 \"의약품특허권\" | PREPARATIONS | 지침·안내서가 있습니까?  | Ruthenium-103 (103Ru) | 39.26 일 | 고시하는 수수료를 내야 한다.  | 2) 의존성 |\n| 성의약품 사용을 위한 출하를 허용하기 위해 상대적으 | 제를 첨가하는 것은 각조에 규정하지 않는 한 의무사 | 미생물성장을 막기 위해 적절한 | 일반적으로 감마선과 엑스선을 방출하는 방사성핵종의 | 상기 이외에 용기, 포장, 포장에 있는 설명서, 방사성 | - 이온 (예: [131I]iodide, [99mTc]pertechnetate) | 로 정하는 바에 따라 식품의약품안전처장의 허 | 서로 된 신청서를 포함한다) 또는 별지 제2호 | 함한다.  |\n| ⑤제1항에 따른 의약품등의 수입 품목 허가 또 | 가.  의약품[의료용 고압가스, 방사성의약품, | 1. ",
        "original_sentence": "| Ruthenium-103 (103Ru) | 39.26 일 | 고시하는 수수료를 내야 한다. "
      }
    },
    {
      "chunk_id": "chunk_014",
      "text": "| 2) 의존성 |\n| 성의약품 사용을 위한 출하를 허용하기 위해 상대적으 | 제를 첨가하는 것은 각조에 규정하지 않는 한 의무사 | 미생물성장을 막기 위해 적절한 | 일반적으로 감마선과 엑스선을 방출하는 방사성핵종의 | 상기 이외에 용기, 포장, 포장에 있는 설명서, 방사성 | - 이온 (예: [131I]iodide, [99mTc]pertechnetate) | 로 정하는 바에 따라 식품의약품안전처장의 허 | 서로 된 신청서를 포함한다) 또는 별지 제2호 | 함한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 13,
        "window_size": 3,
        "char_count": 264,
        "word_count": 64,
        "page_number": 3,
        "window_text": "<개정 2014.8.21.> | 2.  허가처리 절차 ······················································································4 | 의약품에 관한 특허권(이하 \"의약품특허권\" | PREPARATIONS | 지침·안내서가 있습니까?  | Ruthenium-103 (103Ru) | 39.26 일 | 고시하는 수수료를 내야 한다.  | 2) 의존성 |\n| 성의약품 사용을 위한 출하를 허용하기 위해 상대적으 | 제를 첨가하는 것은 각조에 규정하지 않는 한 의무사 | 미생물성장을 막기 위해 적절한 | 일반적으로 감마선과 엑스선을 방출하는 방사성핵종의 | 상기 이외에 용기, 포장, 포장에 있는 설명서, 방사성 | - 이온 (예: [131I]iodide, [99mTc]pertechnetate) | 로 정하는 바에 따라 식품의약품안전처장의 허 | 서로 된 신청서를 포함한다) 또는 별지 제2호 | 함한다.  |\n| ⑤제1항에 따른 의약품등의 수입 품목 허가 또 | 가.  의약품[의료용 고압가스, 방사성의약품, | 1.  대한민국약전 또는 식품의약품안전처장이 인 | 시상황 평가에 필요한 자료 | 90일 | ④ 제2항에 따라 신고를 하는 자는 식품의약품 | (99mTc) 반점(Rƒ 값 약 0.6 ~ 0.7) 이외의 방사능 | 1) 신규서식 선택 → 의약품 검색버튼을 활용하여 해당 민원서식 선택 | (품질에 관한 자료) | (1) 청정등급, 작업실 간의 차압 및 인적ㆍ물적 동선이 표시된 작업소 평면도 | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 칭 및 소재지 등에 관한 자료로서 식품의약 | Rhodium-103m (103mRh) | 56.114 분 | 3) 항원성 및 면역독성 |\n| 항이 아니다. ",
        "original_sentence": "| 2) 의존성 |\n| 성의약품 사용을 위한 출하를 허용하기 위해 상대적으 | 제를 첨가하는 것은 각조에 규정하지 않는 한 의무사 | 미생물성장을 막기 위해 적절한 | 일반적으로 감마선과 엑스선을 방출하는 방사성핵종의 | 상기 이외에 용기, 포장, 포장에 있는 설명서, 방사성 | - 이온 (예: [131I]iodide, [99mTc]pertechnetate) | 로 정하는 바에 따라 식품의약품안전처장의 허 | 서로 된 신청서를 포함한다) 또는 별지 제2호 | 함한다. "
      }
    },
    {
      "chunk_id": "chunk_015",
      "text": "|\n| ⑤제1항에 따른 의약품등의 수입 품목 허가 또 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 14,
        "window_size": 3,
        "char_count": 35,
        "word_count": 11,
        "page_number": 3,
        "window_text": "허가처리 절차 ······················································································4 | 의약품에 관한 특허권(이하 \"의약품특허권\" | PREPARATIONS | 지침·안내서가 있습니까?  | Ruthenium-103 (103Ru) | 39.26 일 | 고시하는 수수료를 내야 한다.  | 2) 의존성 |\n| 성의약품 사용을 위한 출하를 허용하기 위해 상대적으 | 제를 첨가하는 것은 각조에 규정하지 않는 한 의무사 | 미생물성장을 막기 위해 적절한 | 일반적으로 감마선과 엑스선을 방출하는 방사성핵종의 | 상기 이외에 용기, 포장, 포장에 있는 설명서, 방사성 | - 이온 (예: [131I]iodide, [99mTc]pertechnetate) | 로 정하는 바에 따라 식품의약품안전처장의 허 | 서로 된 신청서를 포함한다) 또는 별지 제2호 | 함한다.  |\n| ⑤제1항에 따른 의약품등의 수입 품목 허가 또 | 가.  의약품[의료용 고압가스, 방사성의약품, | 1.  대한민국약전 또는 식품의약품안전처장이 인 | 시상황 평가에 필요한 자료 | 90일 | ④ 제2항에 따라 신고를 하는 자는 식품의약품 | (99mTc) 반점(Rƒ 값 약 0.6 ~ 0.7) 이외의 방사능 | 1) 신규서식 선택 → 의약품 검색버튼을 활용하여 해당 민원서식 선택 | (품질에 관한 자료) | (1) 청정등급, 작업실 간의 차압 및 인적ㆍ물적 동선이 표시된 작업소 평면도 | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 칭 및 소재지 등에 관한 자료로서 식품의약 | Rhodium-103m (103mRh) | 56.114 분 | 3) 항원성 및 면역독성 |\n| 항이 아니다.  | ․방문, 우편 민원의 경우: 1,260,000원 | 허가를 받으려는 자는 그 품목의 제조와 품질관 | 보존제를 넣는다. ",
        "original_sentence": "|\n| ⑤제1항에 따른 의약품등의 수입 품목 허가 또 | 가. "
      }
    },
    {
      "chunk_id": "chunk_016",
      "text": "의약품[의료용 고압가스, 방사성의약품, | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 15,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 3,
        "window_text": "| Ruthenium-103 (103Ru) | 39.26 일 | 고시하는 수수료를 내야 한다.  | 2) 의존성 |\n| 성의약품 사용을 위한 출하를 허용하기 위해 상대적으 | 제를 첨가하는 것은 각조에 규정하지 않는 한 의무사 | 미생물성장을 막기 위해 적절한 | 일반적으로 감마선과 엑스선을 방출하는 방사성핵종의 | 상기 이외에 용기, 포장, 포장에 있는 설명서, 방사성 | - 이온 (예: [131I]iodide, [99mTc]pertechnetate) | 로 정하는 바에 따라 식품의약품안전처장의 허 | 서로 된 신청서를 포함한다) 또는 별지 제2호 | 함한다.  |\n| ⑤제1항에 따른 의약품등의 수입 품목 허가 또 | 가.  의약품[의료용 고압가스, 방사성의약품, | 1.  대한민국약전 또는 식품의약품안전처장이 인 | 시상황 평가에 필요한 자료 | 90일 | ④ 제2항에 따라 신고를 하는 자는 식품의약품 | (99mTc) 반점(Rƒ 값 약 0.6 ~ 0.7) 이외의 방사능 | 1) 신규서식 선택 → 의약품 검색버튼을 활용하여 해당 민원서식 선택 | (품질에 관한 자료) | (1) 청정등급, 작업실 간의 차압 및 인적ㆍ물적 동선이 표시된 작업소 평면도 | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 칭 및 소재지 등에 관한 자료로서 식품의약 | Rhodium-103m (103mRh) | 56.114 분 | 3) 항원성 및 면역독성 |\n| 항이 아니다.  | ․방문, 우편 민원의 경우: 1,260,000원 | 허가를 받으려는 자는 그 품목의 제조와 품질관 | 보존제를 넣는다.  | 방사성핵종순도 측정하는 가장 유용한 방법은 감마선 | 의약품에 대한 분석 인증서에서의 라벨은 다음 사항을 | 서식의 의약외품 제조업 신고서(전자문서로 된 | 2.1 주요 관련 법규 및 규정 ································································4 | 것으로 본다. ",
        "original_sentence": "의약품[의료용 고압가스, 방사성의약품, | 1. "
      }
    },
    {
      "chunk_id": "chunk_017",
      "text": "대한민국약전 또는 식품의약품안전처장이 인 | 시상황 평가에 필요한 자료 | 90일 | ④ 제2항에 따라 신고를 하는 자는 식품의약품 | (99mTc) 반점(Rƒ 값 약 0.6 ~ 0.7) 이외의 방사능 | 1) 신규서식 선택 → 의약품 검색버튼을 활용하여 해당 민원서식 선택 | (품질에 관한 자료) | (1) 청정등급, 작업실 간의 차압 및 인적ㆍ물적 동선이 표시된 작업소 평면도 | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 칭 및 소재지 등에 관한 자료로서 식품의약 | Rhodium-103m (103mRh) | 56.114 분 | 3) 항원성 및 면역독성 |\n| 항이 아니다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 16,
        "window_size": 3,
        "char_count": 330,
        "word_count": 85,
        "page_number": 3,
        "window_text": "| 2) 의존성 |\n| 성의약품 사용을 위한 출하를 허용하기 위해 상대적으 | 제를 첨가하는 것은 각조에 규정하지 않는 한 의무사 | 미생물성장을 막기 위해 적절한 | 일반적으로 감마선과 엑스선을 방출하는 방사성핵종의 | 상기 이외에 용기, 포장, 포장에 있는 설명서, 방사성 | - 이온 (예: [131I]iodide, [99mTc]pertechnetate) | 로 정하는 바에 따라 식품의약품안전처장의 허 | 서로 된 신청서를 포함한다) 또는 별지 제2호 | 함한다.  |\n| ⑤제1항에 따른 의약품등의 수입 품목 허가 또 | 가.  의약품[의료용 고압가스, 방사성의약품, | 1.  대한민국약전 또는 식품의약품안전처장이 인 | 시상황 평가에 필요한 자료 | 90일 | ④ 제2항에 따라 신고를 하는 자는 식품의약품 | (99mTc) 반점(Rƒ 값 약 0.6 ~ 0.7) 이외의 방사능 | 1) 신규서식 선택 → 의약품 검색버튼을 활용하여 해당 민원서식 선택 | (품질에 관한 자료) | (1) 청정등급, 작업실 간의 차압 및 인적ㆍ물적 동선이 표시된 작업소 평면도 | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 칭 및 소재지 등에 관한 자료로서 식품의약 | Rhodium-103m (103mRh) | 56.114 분 | 3) 항원성 및 면역독성 |\n| 항이 아니다.  | ․방문, 우편 민원의 경우: 1,260,000원 | 허가를 받으려는 자는 그 품목의 제조와 품질관 | 보존제를 넣는다.  | 방사성핵종순도 측정하는 가장 유용한 방법은 감마선 | 의약품에 대한 분석 인증서에서의 라벨은 다음 사항을 | 서식의 의약외품 제조업 신고서(전자문서로 된 | 2.1 주요 관련 법규 및 규정 ································································4 | 것으로 본다.  <신설 2011.3.30.> |\n| 로 짧은 시간에 걸쳐 결정된다. ",
        "original_sentence": "대한민국약전 또는 식품의약품안전처장이 인 | 시상황 평가에 필요한 자료 | 90일 | ④ 제2항에 따라 신고를 하는 자는 식품의약품 | (99mTc) 반점(Rƒ 값 약 0.6 ~ 0.7) 이외의 방사능 | 1) 신규서식 선택 → 의약품 검색버튼을 활용하여 해당 민원서식 선택 | (품질에 관한 자료) | (1) 청정등급, 작업실 간의 차압 및 인적ㆍ물적 동선이 표시된 작업소 평면도 | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 칭 및 소재지 등에 관한 자료로서 식품의약 | Rhodium-103m (103mRh) | 56.114 분 | 3) 항원성 및 면역독성 |\n| 항이 아니다. "
      }
    },
    {
      "chunk_id": "chunk_018",
      "text": "| ․방문, 우편 민원의 경우: 1,260,000원 | 허가를 받으려는 자는 그 품목의 제조와 품질관 | 보존제를 넣는다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 17,
        "window_size": 3,
        "char_count": 69,
        "word_count": 17,
        "page_number": 3,
        "window_text": "|\n| ⑤제1항에 따른 의약품등의 수입 품목 허가 또 | 가.  의약품[의료용 고압가스, 방사성의약품, | 1.  대한민국약전 또는 식품의약품안전처장이 인 | 시상황 평가에 필요한 자료 | 90일 | ④ 제2항에 따라 신고를 하는 자는 식품의약품 | (99mTc) 반점(Rƒ 값 약 0.6 ~ 0.7) 이외의 방사능 | 1) 신규서식 선택 → 의약품 검색버튼을 활용하여 해당 민원서식 선택 | (품질에 관한 자료) | (1) 청정등급, 작업실 간의 차압 및 인적ㆍ물적 동선이 표시된 작업소 평면도 | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 칭 및 소재지 등에 관한 자료로서 식품의약 | Rhodium-103m (103mRh) | 56.114 분 | 3) 항원성 및 면역독성 |\n| 항이 아니다.  | ․방문, 우편 민원의 경우: 1,260,000원 | 허가를 받으려는 자는 그 품목의 제조와 품질관 | 보존제를 넣는다.  | 방사성핵종순도 측정하는 가장 유용한 방법은 감마선 | 의약품에 대한 분석 인증서에서의 라벨은 다음 사항을 | 서식의 의약외품 제조업 신고서(전자문서로 된 | 2.1 주요 관련 법규 및 규정 ································································4 | 것으로 본다.  <신설 2011.3.30.> |\n| 로 짧은 시간에 걸쳐 결정된다.  | 나. ",
        "original_sentence": "| ․방문, 우편 민원의 경우: 1,260,000원 | 허가를 받으려는 자는 그 품목의 제조와 품질관 | 보존제를 넣는다. "
      }
    },
    {
      "chunk_id": "chunk_019",
      "text": "| 방사성핵종순도 측정하는 가장 유용한 방법은 감마선 | 의약품에 대한 분석 인증서에서의 라벨은 다음 사항을 | 서식의 의약외품 제조업 신고서(전자문서로 된 | 2.1 주요 관련 법규 및 규정 ································································4 | 것으로 본다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 18,
        "window_size": 3,
        "char_count": 184,
        "word_count": 32,
        "page_number": 12,
        "window_text": "의약품[의료용 고압가스, 방사성의약품, | 1.  대한민국약전 또는 식품의약품안전처장이 인 | 시상황 평가에 필요한 자료 | 90일 | ④ 제2항에 따라 신고를 하는 자는 식품의약품 | (99mTc) 반점(Rƒ 값 약 0.6 ~ 0.7) 이외의 방사능 | 1) 신규서식 선택 → 의약품 검색버튼을 활용하여 해당 민원서식 선택 | (품질에 관한 자료) | (1) 청정등급, 작업실 간의 차압 및 인적ㆍ물적 동선이 표시된 작업소 평면도 | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 칭 및 소재지 등에 관한 자료로서 식품의약 | Rhodium-103m (103mRh) | 56.114 분 | 3) 항원성 및 면역독성 |\n| 항이 아니다.  | ․방문, 우편 민원의 경우: 1,260,000원 | 허가를 받으려는 자는 그 품목의 제조와 품질관 | 보존제를 넣는다.  | 방사성핵종순도 측정하는 가장 유용한 방법은 감마선 | 의약품에 대한 분석 인증서에서의 라벨은 다음 사항을 | 서식의 의약외품 제조업 신고서(전자문서로 된 | 2.1 주요 관련 법규 및 규정 ································································4 | 것으로 본다.  <신설 2011.3.30.> |\n| 로 짧은 시간에 걸쳐 결정된다.  | 나.  원료의약품[원료의약품 중 한약재 및 약 | 는 신고의 대상ᆞ기준ᆞ조건 및 관리 등에 필 | 정하는 공정서 및 의약품집에 실려 있는 품 | 원료의약품 중 한약재 및 약리활성(약리 | - 킬레이트화에 의한 분자 내 포함, 흡착 또는 부착된 | ② 안전성유효성에 관한 자료 | 2) 민원종류 선택 → 업종 / 신약, 희귀의약품 여부 / 본부 ․ 지방청 대상 확인 / 기시법, 안유심사, | 가를 받아야 한다. ",
        "original_sentence": "| 방사성핵종순도 측정하는 가장 유용한 방법은 감마선 | 의약품에 대한 분석 인증서에서의 라벨은 다음 사항을 | 서식의 의약외품 제조업 신고서(전자문서로 된 | 2.1 주요 관련 법규 및 규정 ································································4 | 것으로 본다. "
      }
    },
    {
      "chunk_id": "chunk_020",
      "text": "<신설 2011.3.30.> |\n| 로 짧은 시간에 걸쳐 결정된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 19,
        "window_size": 3,
        "char_count": 38,
        "word_count": 9,
        "page_number": 3,
        "window_text": "대한민국약전 또는 식품의약품안전처장이 인 | 시상황 평가에 필요한 자료 | 90일 | ④ 제2항에 따라 신고를 하는 자는 식품의약품 | (99mTc) 반점(Rƒ 값 약 0.6 ~ 0.7) 이외의 방사능 | 1) 신규서식 선택 → 의약품 검색버튼을 활용하여 해당 민원서식 선택 | (품질에 관한 자료) | (1) 청정등급, 작업실 간의 차압 및 인적ㆍ물적 동선이 표시된 작업소 평면도 | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 칭 및 소재지 등에 관한 자료로서 식품의약 | Rhodium-103m (103mRh) | 56.114 분 | 3) 항원성 및 면역독성 |\n| 항이 아니다.  | ․방문, 우편 민원의 경우: 1,260,000원 | 허가를 받으려는 자는 그 품목의 제조와 품질관 | 보존제를 넣는다.  | 방사성핵종순도 측정하는 가장 유용한 방법은 감마선 | 의약품에 대한 분석 인증서에서의 라벨은 다음 사항을 | 서식의 의약외품 제조업 신고서(전자문서로 된 | 2.1 주요 관련 법규 및 규정 ································································4 | 것으로 본다.  <신설 2011.3.30.> |\n| 로 짧은 시간에 걸쳐 결정된다.  | 나.  원료의약품[원료의약품 중 한약재 및 약 | 는 신고의 대상ᆞ기준ᆞ조건 및 관리 등에 필 | 정하는 공정서 및 의약품집에 실려 있는 품 | 원료의약품 중 한약재 및 약리활성(약리 | - 킬레이트화에 의한 분자 내 포함, 흡착 또는 부착된 | ② 안전성유효성에 관한 자료 | 2) 민원종류 선택 → 업종 / 신약, 희귀의약품 여부 / 본부 ․ 지방청 대상 확인 / 기시법, 안유심사, | 가를 받아야 한다.  <개정 2008.2.29., 2010.1.18., | 안전처장이 정하여 고시하는 수수료(외국에서 | (2) 제조ㆍ시험에 사용되는 기계ㆍ설비 내역 및 기계배치도 | 품\"이라 한다)의 안전성ᆞ유효성에 관한 자 | 품안전처장이 고시하는 자료 | Indium-110 (110In) | 4.9 시간 | ppm 이하). ",
        "original_sentence": "<신설 2011.3.30.> |\n| 로 짧은 시간에 걸쳐 결정된다. "
      }
    },
    {
      "chunk_id": "chunk_021",
      "text": "| 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 20,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| ․방문, 우편 민원의 경우: 1,260,000원 | 허가를 받으려는 자는 그 품목의 제조와 품질관 | 보존제를 넣는다.  | 방사성핵종순도 측정하는 가장 유용한 방법은 감마선 | 의약품에 대한 분석 인증서에서의 라벨은 다음 사항을 | 서식의 의약외품 제조업 신고서(전자문서로 된 | 2.1 주요 관련 법규 및 규정 ································································4 | 것으로 본다.  <신설 2011.3.30.> |\n| 로 짧은 시간에 걸쳐 결정된다.  | 나.  원료의약품[원료의약품 중 한약재 및 약 | 는 신고의 대상ᆞ기준ᆞ조건 및 관리 등에 필 | 정하는 공정서 및 의약품집에 실려 있는 품 | 원료의약품 중 한약재 및 약리활성(약리 | - 킬레이트화에 의한 분자 내 포함, 흡착 또는 부착된 | ② 안전성유효성에 관한 자료 | 2) 민원종류 선택 → 업종 / 신약, 희귀의약품 여부 / 본부 ․ 지방청 대상 확인 / 기시법, 안유심사, | 가를 받아야 한다.  <개정 2008.2.29., 2010.1.18., | 안전처장이 정하여 고시하는 수수료(외국에서 | (2) 제조ㆍ시험에 사용되는 기계ㆍ설비 내역 및 기계배치도 | 품\"이라 한다)의 안전성ᆞ유효성에 관한 자 | 품안전처장이 고시하는 자료 | Indium-110 (110In) | 4.9 시간 | ppm 이하).  |\n| [제제총칙 - 방사성제제 항] | 동위원소담체(Isotopic | carrier): | 방사성핵종의 원소와 | 자 료 번 호 | 리를 위한 기준 및 시험방법에 관한 자료를 제 | (1) 각조에 별도로 언급한 경우 | 은 총방사능의 5 % 이하이다. ",
        "original_sentence": "| 나. "
      }
    },
    {
      "chunk_id": "chunk_022",
      "text": "원료의약품[원료의약품 중 한약재 및 약 | 는 신고의 대상ᆞ기준ᆞ조건 및 관리 등에 필 | 정하는 공정서 및 의약품집에 실려 있는 품 | 원료의약품 중 한약재 및 약리활성(약리 | - 킬레이트화에 의한 분자 내 포함, 흡착 또는 부착된 | ② 안전성유효성에 관한 자료 | 2) 민원종류 선택 → 업종 / 신약, 희귀의약품 여부 / 본부 ․ 지방청 대상 확인 / 기시법, 안유심사, | 가를 받아야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 21,
        "window_size": 3,
        "char_count": 226,
        "word_count": 65,
        "page_number": 6,
        "window_text": "| 방사성핵종순도 측정하는 가장 유용한 방법은 감마선 | 의약품에 대한 분석 인증서에서의 라벨은 다음 사항을 | 서식의 의약외품 제조업 신고서(전자문서로 된 | 2.1 주요 관련 법규 및 규정 ································································4 | 것으로 본다.  <신설 2011.3.30.> |\n| 로 짧은 시간에 걸쳐 결정된다.  | 나.  원료의약품[원료의약품 중 한약재 및 약 | 는 신고의 대상ᆞ기준ᆞ조건 및 관리 등에 필 | 정하는 공정서 및 의약품집에 실려 있는 품 | 원료의약품 중 한약재 및 약리활성(약리 | - 킬레이트화에 의한 분자 내 포함, 흡착 또는 부착된 | ② 안전성유효성에 관한 자료 | 2) 민원종류 선택 → 업종 / 신약, 희귀의약품 여부 / 본부 ․ 지방청 대상 확인 / 기시법, 안유심사, | 가를 받아야 한다.  <개정 2008.2.29., 2010.1.18., | 안전처장이 정하여 고시하는 수수료(외국에서 | (2) 제조ㆍ시험에 사용되는 기계ㆍ설비 내역 및 기계배치도 | 품\"이라 한다)의 안전성ᆞ유효성에 관한 자 | 품안전처장이 고시하는 자료 | Indium-110 (110In) | 4.9 시간 | ppm 이하).  |\n| [제제총칙 - 방사성제제 항] | 동위원소담체(Isotopic | carrier): | 방사성핵종의 원소와 | 자 료 번 호 | 리를 위한 기준 및 시험방법에 관한 자료를 제 | (1) 각조에 별도로 언급한 경우 | 은 총방사능의 5 % 이하이다.  | 신고서를 포함한다)에 다음 각 호의 서류(전자 | 가. ",
        "original_sentence": "원료의약품[원료의약품 중 한약재 및 약 | 는 신고의 대상ᆞ기준ᆞ조건 및 관리 등에 필 | 정하는 공정서 및 의약품집에 실려 있는 품 | 원료의약품 중 한약재 및 약리활성(약리 | - 킬레이트화에 의한 분자 내 포함, 흡착 또는 부착된 | ② 안전성유효성에 관한 자료 | 2) 민원종류 선택 → 업종 / 신약, 희귀의약품 여부 / 본부 ․ 지방청 대상 확인 / 기시법, 안유심사, | 가를 받아야 한다. "
      }
    },
    {
      "chunk_id": "chunk_023",
      "text": "<개정 2008.2.29., 2010.1.18., | 안전처장이 정하여 고시하는 수수료(외국에서 | (2) 제조ㆍ시험에 사용되는 기계ㆍ설비 내역 및 기계배치도 | 품\"이라 한다)의 안전성ᆞ유효성에 관한 자 | 품안전처장이 고시하는 자료 | Indium-110 (110In) | 4.9 시간 | ppm 이하). ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 22,
        "window_size": 3,
        "char_count": 173,
        "word_count": 35,
        "page_number": 3,
        "window_text": "<신설 2011.3.30.> |\n| 로 짧은 시간에 걸쳐 결정된다.  | 나.  원료의약품[원료의약품 중 한약재 및 약 | 는 신고의 대상ᆞ기준ᆞ조건 및 관리 등에 필 | 정하는 공정서 및 의약품집에 실려 있는 품 | 원료의약품 중 한약재 및 약리활성(약리 | - 킬레이트화에 의한 분자 내 포함, 흡착 또는 부착된 | ② 안전성유효성에 관한 자료 | 2) 민원종류 선택 → 업종 / 신약, 희귀의약품 여부 / 본부 ․ 지방청 대상 확인 / 기시법, 안유심사, | 가를 받아야 한다.  <개정 2008.2.29., 2010.1.18., | 안전처장이 정하여 고시하는 수수료(외국에서 | (2) 제조ㆍ시험에 사용되는 기계ㆍ설비 내역 및 기계배치도 | 품\"이라 한다)의 안전성ᆞ유효성에 관한 자 | 품안전처장이 고시하는 자료 | Indium-110 (110In) | 4.9 시간 | ppm 이하).  |\n| [제제총칙 - 방사성제제 항] | 동위원소담체(Isotopic | carrier): | 방사성핵종의 원소와 | 자 료 번 호 | 리를 위한 기준 및 시험방법에 관한 자료를 제 | (1) 각조에 별도로 언급한 경우 | 은 총방사능의 5 % 이하이다.  | 신고서를 포함한다)에 다음 각 호의 서류(전자 | 가.  원료의약품에 관한 자료 | Indium-110m (110mIn) | 69.1 분 | 4) 작용기전독성 |\n| 측정된 반감기 근사치는 각조에 명시된 기준 범위 내 | 목. ",
        "original_sentence": "<개정 2008.2.29., 2010.1.18., | 안전처장이 정하여 고시하는 수수료(외국에서 | (2) 제조ㆍ시험에 사용되는 기계ㆍ설비 내역 및 기계배치도 | 품\"이라 한다)의 안전성ᆞ유효성에 관한 자 | 품안전처장이 고시하는 자료 | Indium-110 (110In) | 4.9 시간 | ppm 이하). "
      }
    },
    {
      "chunk_id": "chunk_024",
      "text": "|\n| [제제총칙 - 방사성제제 항] | 동위원소담체(Isotopic | carrier): | 방사성핵종의 원소와 | 자 료 번 호 | 리를 위한 기준 및 시험방법에 관한 자료를 제 | (1) 각조에 별도로 언급한 경우 | 은 총방사능의 5 % 이하이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 23,
        "window_size": 3,
        "char_count": 143,
        "word_count": 39,
        "page_number": 3,
        "window_text": "| 나.  원료의약품[원료의약품 중 한약재 및 약 | 는 신고의 대상ᆞ기준ᆞ조건 및 관리 등에 필 | 정하는 공정서 및 의약품집에 실려 있는 품 | 원료의약품 중 한약재 및 약리활성(약리 | - 킬레이트화에 의한 분자 내 포함, 흡착 또는 부착된 | ② 안전성유효성에 관한 자료 | 2) 민원종류 선택 → 업종 / 신약, 희귀의약품 여부 / 본부 ․ 지방청 대상 확인 / 기시법, 안유심사, | 가를 받아야 한다.  <개정 2008.2.29., 2010.1.18., | 안전처장이 정하여 고시하는 수수료(외국에서 | (2) 제조ㆍ시험에 사용되는 기계ㆍ설비 내역 및 기계배치도 | 품\"이라 한다)의 안전성ᆞ유효성에 관한 자 | 품안전처장이 고시하는 자료 | Indium-110 (110In) | 4.9 시간 | ppm 이하).  |\n| [제제총칙 - 방사성제제 항] | 동위원소담체(Isotopic | carrier): | 방사성핵종의 원소와 | 자 료 번 호 | 리를 위한 기준 및 시험방법에 관한 자료를 제 | (1) 각조에 별도로 언급한 경우 | 은 총방사능의 5 % 이하이다.  | 신고서를 포함한다)에 다음 각 호의 서류(전자 | 가.  원료의약품에 관한 자료 | Indium-110m (110mIn) | 69.1 분 | 4) 작용기전독성 |\n| 측정된 반감기 근사치는 각조에 명시된 기준 범위 내 | 목.  다만, 국내에서 허가되지 아니한 품목은 | 활성: 약리작용상 인체에 미치는 작용)이 | 리활성(약리활성: 약리작용상 인체에 미 | 2.3.2 분류번호 및 분류(전문 또는 일반의약품) | 스펙트럼측정법(gamma-ray spectrometry) 이다. ",
        "original_sentence": "|\n| [제제총칙 - 방사성제제 항] | 동위원소담체(Isotopic | carrier): | 방사성핵종의 원소와 | 자 료 번 호 | 리를 위한 기준 및 시험방법에 관한 자료를 제 | (1) 각조에 별도로 언급한 경우 | 은 총방사능의 5 % 이하이다. "
      }
    },
    {
      "chunk_id": "chunk_025",
      "text": "| 신고서를 포함한다)에 다음 각 호의 서류(전자 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 24,
        "window_size": 3,
        "char_count": 33,
        "word_count": 9,
        "page_number": 7,
        "window_text": "원료의약품[원료의약품 중 한약재 및 약 | 는 신고의 대상ᆞ기준ᆞ조건 및 관리 등에 필 | 정하는 공정서 및 의약품집에 실려 있는 품 | 원료의약품 중 한약재 및 약리활성(약리 | - 킬레이트화에 의한 분자 내 포함, 흡착 또는 부착된 | ② 안전성유효성에 관한 자료 | 2) 민원종류 선택 → 업종 / 신약, 희귀의약품 여부 / 본부 ․ 지방청 대상 확인 / 기시법, 안유심사, | 가를 받아야 한다.  <개정 2008.2.29., 2010.1.18., | 안전처장이 정하여 고시하는 수수료(외국에서 | (2) 제조ㆍ시험에 사용되는 기계ㆍ설비 내역 및 기계배치도 | 품\"이라 한다)의 안전성ᆞ유효성에 관한 자 | 품안전처장이 고시하는 자료 | Indium-110 (110In) | 4.9 시간 | ppm 이하).  |\n| [제제총칙 - 방사성제제 항] | 동위원소담체(Isotopic | carrier): | 방사성핵종의 원소와 | 자 료 번 호 | 리를 위한 기준 및 시험방법에 관한 자료를 제 | (1) 각조에 별도로 언급한 경우 | 은 총방사능의 5 % 이하이다.  | 신고서를 포함한다)에 다음 각 호의 서류(전자 | 가.  원료의약품에 관한 자료 | Indium-110m (110mIn) | 69.1 분 | 4) 작용기전독성 |\n| 측정된 반감기 근사치는 각조에 명시된 기준 범위 내 | 목.  다만, 국내에서 허가되지 아니한 품목은 | 활성: 약리작용상 인체에 미치는 작용)이 | 리활성(약리활성: 약리작용상 인체에 미 | 2.3.2 분류번호 및 분류(전문 또는 일반의약품) | 스펙트럼측정법(gamma-ray spectrometry) 이다.  요오 | 기재한다. ",
        "original_sentence": "| 신고서를 포함한다)에 다음 각 호의 서류(전자 | 가. "
      }
    },
    {
      "chunk_id": "chunk_026",
      "text": "원료의약품에 관한 자료 | Indium-110m (110mIn) | 69.1 분 | 4) 작용기전독성 |\n| 측정된 반감기 근사치는 각조에 명시된 기준 범위 내 | 목. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 25,
        "window_size": 3,
        "char_count": 95,
        "word_count": 24,
        "page_number": 3,
        "window_text": "<개정 2008.2.29., 2010.1.18., | 안전처장이 정하여 고시하는 수수료(외국에서 | (2) 제조ㆍ시험에 사용되는 기계ㆍ설비 내역 및 기계배치도 | 품\"이라 한다)의 안전성ᆞ유효성에 관한 자 | 품안전처장이 고시하는 자료 | Indium-110 (110In) | 4.9 시간 | ppm 이하).  |\n| [제제총칙 - 방사성제제 항] | 동위원소담체(Isotopic | carrier): | 방사성핵종의 원소와 | 자 료 번 호 | 리를 위한 기준 및 시험방법에 관한 자료를 제 | (1) 각조에 별도로 언급한 경우 | 은 총방사능의 5 % 이하이다.  | 신고서를 포함한다)에 다음 각 호의 서류(전자 | 가.  원료의약품에 관한 자료 | Indium-110m (110mIn) | 69.1 분 | 4) 작용기전독성 |\n| 측정된 반감기 근사치는 각조에 명시된 기준 범위 내 | 목.  다만, 국내에서 허가되지 아니한 품목은 | 활성: 약리작용상 인체에 미치는 작용)이 | 리활성(약리활성: 약리작용상 인체에 미 | 2.3.2 분류번호 및 분류(전문 또는 일반의약품) | 스펙트럼측정법(gamma-ray spectrometry) 이다.  요오 | 기재한다.  | 9. ",
        "original_sentence": "원료의약품에 관한 자료 | Indium-110m (110mIn) | 69.1 분 | 4) 작용기전독성 |\n| 측정된 반감기 근사치는 각조에 명시된 기준 범위 내 | 목. "
      }
    },
    {
      "chunk_id": "chunk_027",
      "text": "다만, 국내에서 허가되지 아니한 품목은 | 활성: 약리작용상 인체에 미치는 작용)이 | 리활성(약리활성: 약리작용상 인체에 미 | 2.3.2 분류번호 및 분류(전문 또는 일반의약품) | 스펙트럼측정법(gamma-ray spectrometry) 이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 26,
        "window_size": 3,
        "char_count": 140,
        "word_count": 27,
        "page_number": 5,
        "window_text": "|\n| [제제총칙 - 방사성제제 항] | 동위원소담체(Isotopic | carrier): | 방사성핵종의 원소와 | 자 료 번 호 | 리를 위한 기준 및 시험방법에 관한 자료를 제 | (1) 각조에 별도로 언급한 경우 | 은 총방사능의 5 % 이하이다.  | 신고서를 포함한다)에 다음 각 호의 서류(전자 | 가.  원료의약품에 관한 자료 | Indium-110m (110mIn) | 69.1 분 | 4) 작용기전독성 |\n| 측정된 반감기 근사치는 각조에 명시된 기준 범위 내 | 목.  다만, 국내에서 허가되지 아니한 품목은 | 활성: 약리작용상 인체에 미치는 작용)이 | 리활성(약리활성: 약리작용상 인체에 미 | 2.3.2 분류번호 및 분류(전문 또는 일반의약품) | 스펙트럼측정법(gamma-ray spectrometry) 이다.  요오 | 기재한다.  | 9.  법 제31조제2항·제3항에 따라 의약품을 제 | 형태 (예: [111In]indium oxine) 또는 공유결합에 의 | 사용하여 작성 | 2013.3.23.> | 현지실사를 할 필요가 있는 경우에는 이에 드 | 료를 근거로 의약품의 제조판매ᆞ수입 품목 | GMP 평가 여부 | 2.2 품목허가 신청 및 처리 절차 ························································4 | 정 | 의 | 무균시험  시험할 때 적합하다. ",
        "original_sentence": "다만, 국내에서 허가되지 아니한 품목은 | 활성: 약리작용상 인체에 미치는 작용)이 | 리활성(약리활성: 약리작용상 인체에 미 | 2.3.2 분류번호 및 분류(전문 또는 일반의약품) | 스펙트럼측정법(gamma-ray spectrometry) 이다. "
      }
    },
    {
      "chunk_id": "chunk_028",
      "text": "요오 | 기재한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 27,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 9,
        "window_text": "| 신고서를 포함한다)에 다음 각 호의 서류(전자 | 가.  원료의약품에 관한 자료 | Indium-110m (110mIn) | 69.1 분 | 4) 작용기전독성 |\n| 측정된 반감기 근사치는 각조에 명시된 기준 범위 내 | 목.  다만, 국내에서 허가되지 아니한 품목은 | 활성: 약리작용상 인체에 미치는 작용)이 | 리활성(약리활성: 약리작용상 인체에 미 | 2.3.2 분류번호 및 분류(전문 또는 일반의약품) | 스펙트럼측정법(gamma-ray spectrometry) 이다.  요오 | 기재한다.  | 9.  법 제31조제2항·제3항에 따라 의약품을 제 | 형태 (예: [111In]indium oxine) 또는 공유결합에 의 | 사용하여 작성 | 2013.3.23.> | 현지실사를 할 필요가 있는 경우에는 이에 드 | 료를 근거로 의약품의 제조판매ᆞ수입 품목 | GMP 평가 여부 | 2.2 품목허가 신청 및 처리 절차 ························································4 | 정 | 의 | 무균시험  시험할 때 적합하다.  | 한다. ",
        "original_sentence": "요오 | 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_029",
      "text": "| 9. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 28,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 3,
        "window_text": "원료의약품에 관한 자료 | Indium-110m (110mIn) | 69.1 분 | 4) 작용기전독성 |\n| 측정된 반감기 근사치는 각조에 명시된 기준 범위 내 | 목.  다만, 국내에서 허가되지 아니한 품목은 | 활성: 약리작용상 인체에 미치는 작용)이 | 리활성(약리활성: 약리작용상 인체에 미 | 2.3.2 분류번호 및 분류(전문 또는 일반의약품) | 스펙트럼측정법(gamma-ray spectrometry) 이다.  요오 | 기재한다.  | 9.  법 제31조제2항·제3항에 따라 의약품을 제 | 형태 (예: [111In]indium oxine) 또는 공유결합에 의 | 사용하여 작성 | 2013.3.23.> | 현지실사를 할 필요가 있는 경우에는 이에 드 | 료를 근거로 의약품의 제조판매ᆞ수입 품목 | GMP 평가 여부 | 2.2 품목허가 신청 및 처리 절차 ························································4 | 정 | 의 | 무균시험  시험할 때 적합하다.  | 한다.  |\n| 2 | 3 | 4 | 5 | 6 | 주사제 항에서 보존제 사용에 대 | 출하여야 한다. ",
        "original_sentence": "| 9. "
      }
    },
    {
      "chunk_id": "chunk_030",
      "text": "법 제31조제2항·제3항에 따라 의약품을 제 | 형태 (예: [111In]indium oxine) 또는 공유결합에 의 | 사용하여 작성 | 2013.3.23.> | 현지실사를 할 필요가 있는 경우에는 이에 드 | 료를 근거로 의약품의 제조판매ᆞ수입 품목 | GMP 평가 여부 | 2.2 품목허가 신청 및 처리 절차 ························································4 | 정 | 의 | 무균시험  시험할 때 적합하다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 29,
        "window_size": 3,
        "char_count": 262,
        "word_count": 53,
        "page_number": 3,
        "window_text": "다만, 국내에서 허가되지 아니한 품목은 | 활성: 약리작용상 인체에 미치는 작용)이 | 리활성(약리활성: 약리작용상 인체에 미 | 2.3.2 분류번호 및 분류(전문 또는 일반의약품) | 스펙트럼측정법(gamma-ray spectrometry) 이다.  요오 | 기재한다.  | 9.  법 제31조제2항·제3항에 따라 의약품을 제 | 형태 (예: [111In]indium oxine) 또는 공유결합에 의 | 사용하여 작성 | 2013.3.23.> | 현지실사를 할 필요가 있는 경우에는 이에 드 | 료를 근거로 의약품의 제조판매ᆞ수입 품목 | GMP 평가 여부 | 2.2 품목허가 신청 및 처리 절차 ························································4 | 정 | 의 | 무균시험  시험할 때 적합하다.  | 한다.  |\n| 2 | 3 | 4 | 5 | 6 | 주사제 항에서 보존제 사용에 대 | 출하여야 한다.  이 경우 첨부자료의 종류, 자료 | 요한 | 사항은 | 총리령으로 | 정한다. ",
        "original_sentence": "법 제31조제2항·제3항에 따라 의약품을 제 | 형태 (예: [111In]indium oxine) 또는 공유결합에 의 | 사용하여 작성 | 2013.3.23.> | 현지실사를 할 필요가 있는 경우에는 이에 드 | 료를 근거로 의약품의 제조판매ᆞ수입 품목 | GMP 평가 여부 | 2.2 품목허가 신청 및 처리 절차 ························································4 | 정 | 의 | 무균시험  시험할 때 적합하다. "
      }
    },
    {
      "chunk_id": "chunk_031",
      "text": "| 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 30,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 9,
        "window_text": "요오 | 기재한다.  | 9.  법 제31조제2항·제3항에 따라 의약품을 제 | 형태 (예: [111In]indium oxine) 또는 공유결합에 의 | 사용하여 작성 | 2013.3.23.> | 현지실사를 할 필요가 있는 경우에는 이에 드 | 료를 근거로 의약품의 제조판매ᆞ수입 품목 | GMP 평가 여부 | 2.2 품목허가 신청 및 처리 절차 ························································4 | 정 | 의 | 무균시험  시험할 때 적합하다.  | 한다.  |\n| 2 | 3 | 4 | 5 | 6 | 주사제 항에서 보존제 사용에 대 | 출하여야 한다.  이 경우 첨부자료의 종류, 자료 | 요한 | 사항은 | 총리령으로 | 정한다.  | <개정 | 「식약처 지침서등의 관리에 관한 | (2) 반감기가 24시간 미만의 방사 | ③ 기준 및 시험방법에 관한 자료 | 2) 몰리브덴-99  이 약 일정량을 바이알에 정밀하 | 문서를 포함한다)를 첨부하여 지방식품의약품안 | 1) 구조결정에 관한 자료 | (3) 공조시설, 압축공기 및 용수처리 계통도 | Indium-111 (111In) | 2.8047 일 | 5) 대사물 |\n| 동일한 화학적 형태이나 안정형 동위원소가 포함된 담 | 엔도톡신(Bacterial endotoxins - pyrogens) | 바 | 2.3.7 용법․용량 | 방사성의약품은 1개 이상의 의학용 방사성 핵종(방사 | 드화나트륨 검출기(sodium iodide detector)는 문제를 | - 투여경로 | ※ 참고 - 방사성의약품의 허가심사 종류 | ② 제1항에 따른 제조업자가 그 제조(다른 제 | 경우 그 사유를 아래에 기재해 주시기 바랍니다. ",
        "original_sentence": "| 한다. "
      }
    },
    {
      "chunk_id": "chunk_032",
      "text": "|\n| 2 | 3 | 4 | 5 | 6 | 주사제 항에서 보존제 사용에 대 | 출하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 31,
        "window_size": 3,
        "char_count": 53,
        "word_count": 20,
        "page_number": 3,
        "window_text": "| 9.  법 제31조제2항·제3항에 따라 의약품을 제 | 형태 (예: [111In]indium oxine) 또는 공유결합에 의 | 사용하여 작성 | 2013.3.23.> | 현지실사를 할 필요가 있는 경우에는 이에 드 | 료를 근거로 의약품의 제조판매ᆞ수입 품목 | GMP 평가 여부 | 2.2 품목허가 신청 및 처리 절차 ························································4 | 정 | 의 | 무균시험  시험할 때 적합하다.  | 한다.  |\n| 2 | 3 | 4 | 5 | 6 | 주사제 항에서 보존제 사용에 대 | 출하여야 한다.  이 경우 첨부자료의 종류, 자료 | 요한 | 사항은 | 총리령으로 | 정한다.  | <개정 | 「식약처 지침서등의 관리에 관한 | (2) 반감기가 24시간 미만의 방사 | ③ 기준 및 시험방법에 관한 자료 | 2) 몰리브덴-99  이 약 일정량을 바이알에 정밀하 | 문서를 포함한다)를 첨부하여 지방식품의약품안 | 1) 구조결정에 관한 자료 | (3) 공조시설, 압축공기 및 용수처리 계통도 | Indium-111 (111In) | 2.8047 일 | 5) 대사물 |\n| 동일한 화학적 형태이나 안정형 동위원소가 포함된 담 | 엔도톡신(Bacterial endotoxins - pyrogens) | 바 | 2.3.7 용법․용량 | 방사성의약품은 1개 이상의 의학용 방사성 핵종(방사 | 드화나트륨 검출기(sodium iodide detector)는 문제를 | - 투여경로 | ※ 참고 - 방사성의약품의 허가심사 종류 | ② 제1항에 따른 제조업자가 그 제조(다른 제 | 경우 그 사유를 아래에 기재해 주시기 바랍니다.  | 및 xenon-133을 얻을 수 있다. ",
        "original_sentence": "|\n| 2 | 3 | 4 | 5 | 6 | 주사제 항에서 보존제 사용에 대 | 출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_033",
      "text": "이 경우 첨부자료의 종류, 자료 | 요한 | 사항은 | 총리령으로 | 정한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 32,
        "window_size": 3,
        "char_count": 44,
        "word_count": 13,
        "page_number": 1,
        "window_text": "법 제31조제2항·제3항에 따라 의약품을 제 | 형태 (예: [111In]indium oxine) 또는 공유결합에 의 | 사용하여 작성 | 2013.3.23.> | 현지실사를 할 필요가 있는 경우에는 이에 드 | 료를 근거로 의약품의 제조판매ᆞ수입 품목 | GMP 평가 여부 | 2.2 품목허가 신청 및 처리 절차 ························································4 | 정 | 의 | 무균시험  시험할 때 적합하다.  | 한다.  |\n| 2 | 3 | 4 | 5 | 6 | 주사제 항에서 보존제 사용에 대 | 출하여야 한다.  이 경우 첨부자료의 종류, 자료 | 요한 | 사항은 | 총리령으로 | 정한다.  | <개정 | 「식약처 지침서등의 관리에 관한 | (2) 반감기가 24시간 미만의 방사 | ③ 기준 및 시험방법에 관한 자료 | 2) 몰리브덴-99  이 약 일정량을 바이알에 정밀하 | 문서를 포함한다)를 첨부하여 지방식품의약품안 | 1) 구조결정에 관한 자료 | (3) 공조시설, 압축공기 및 용수처리 계통도 | Indium-111 (111In) | 2.8047 일 | 5) 대사물 |\n| 동일한 화학적 형태이나 안정형 동위원소가 포함된 담 | 엔도톡신(Bacterial endotoxins - pyrogens) | 바 | 2.3.7 용법․용량 | 방사성의약품은 1개 이상의 의학용 방사성 핵종(방사 | 드화나트륨 검출기(sodium iodide detector)는 문제를 | - 투여경로 | ※ 참고 - 방사성의약품의 허가심사 종류 | ② 제1항에 따른 제조업자가 그 제조(다른 제 | 경우 그 사유를 아래에 기재해 주시기 바랍니다.  | 및 xenon-133을 얻을 수 있다.  |\n| 에 있어야 한다. ",
        "original_sentence": "이 경우 첨부자료의 종류, 자료 | 요한 | 사항은 | 총리령으로 | 정한다. "
      }
    },
    {
      "chunk_id": "chunk_034",
      "text": "| <개정 | 「식약처 지침서등의 관리에 관한 | (2) 반감기가 24시간 미만의 방사 | ③ 기준 및 시험방법에 관한 자료 | 2) 몰리브덴-99  이 약 일정량을 바이알에 정밀하 | 문서를 포함한다)를 첨부하여 지방식품의약품안 | 1) 구조결정에 관한 자료 | (3) 공조시설, 압축공기 및 용수처리 계통도 | Indium-111 (111In) | 2.8047 일 | 5) 대사물 |\n| 동일한 화학적 형태이나 안정형 동위원소가 포함된 담 | 엔도톡신(Bacterial endotoxins - pyrogens) | 바 | 2.3.7 용법․용량 | 방사성의약품은 1개 이상의 의학용 방사성 핵종(방사 | 드화나트륨 검출기(sodium iodide detector)는 문제를 | - 투여경로 | ※ 참고 - 방사성의약품의 허가심사 종류 | ② 제1항에 따른 제조업자가 그 제조(다른 제 | 경우 그 사유를 아래에 기재해 주시기 바랍니다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 33,
        "window_size": 3,
        "char_count": 469,
        "word_count": 112,
        "page_number": 3,
        "window_text": "| 한다.  |\n| 2 | 3 | 4 | 5 | 6 | 주사제 항에서 보존제 사용에 대 | 출하여야 한다.  이 경우 첨부자료의 종류, 자료 | 요한 | 사항은 | 총리령으로 | 정한다.  | <개정 | 「식약처 지침서등의 관리에 관한 | (2) 반감기가 24시간 미만의 방사 | ③ 기준 및 시험방법에 관한 자료 | 2) 몰리브덴-99  이 약 일정량을 바이알에 정밀하 | 문서를 포함한다)를 첨부하여 지방식품의약품안 | 1) 구조결정에 관한 자료 | (3) 공조시설, 압축공기 및 용수처리 계통도 | Indium-111 (111In) | 2.8047 일 | 5) 대사물 |\n| 동일한 화학적 형태이나 안정형 동위원소가 포함된 담 | 엔도톡신(Bacterial endotoxins - pyrogens) | 바 | 2.3.7 용법․용량 | 방사성의약품은 1개 이상의 의학용 방사성 핵종(방사 | 드화나트륨 검출기(sodium iodide detector)는 문제를 | - 투여경로 | ※ 참고 - 방사성의약품의 허가심사 종류 | ② 제1항에 따른 제조업자가 그 제조(다른 제 | 경우 그 사유를 아래에 기재해 주시기 바랍니다.  | 및 xenon-133을 얻을 수 있다.  |\n| 에 있어야 한다.  | 작성요령과 각 자료의 요건 등에 관한 세부 사 | 2008.2.29., 2010.1.18., 2011.3.30., 2013.3.23.> | 제외한다. ",
        "original_sentence": "| <개정 | 「식약처 지침서등의 관리에 관한 | (2) 반감기가 24시간 미만의 방사 | ③ 기준 및 시험방법에 관한 자료 | 2) 몰리브덴-99  이 약 일정량을 바이알에 정밀하 | 문서를 포함한다)를 첨부하여 지방식품의약품안 | 1) 구조결정에 관한 자료 | (3) 공조시설, 압축공기 및 용수처리 계통도 | Indium-111 (111In) | 2.8047 일 | 5) 대사물 |\n| 동일한 화학적 형태이나 안정형 동위원소가 포함된 담 | 엔도톡신(Bacterial endotoxins - pyrogens) | 바 | 2.3.7 용법․용량 | 방사성의약품은 1개 이상의 의학용 방사성 핵종(방사 | 드화나트륨 검출기(sodium iodide detector)는 문제를 | - 투여경로 | ※ 참고 - 방사성의약품의 허가심사 종류 | ② 제1항에 따른 제조업자가 그 제조(다른 제 | 경우 그 사유를 아래에 기재해 주시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_035",
      "text": "| 및 xenon-133을 얻을 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 34,
        "window_size": 3,
        "char_count": 24,
        "word_count": 6,
        "page_number": 3,
        "window_text": "|\n| 2 | 3 | 4 | 5 | 6 | 주사제 항에서 보존제 사용에 대 | 출하여야 한다.  이 경우 첨부자료의 종류, 자료 | 요한 | 사항은 | 총리령으로 | 정한다.  | <개정 | 「식약처 지침서등의 관리에 관한 | (2) 반감기가 24시간 미만의 방사 | ③ 기준 및 시험방법에 관한 자료 | 2) 몰리브덴-99  이 약 일정량을 바이알에 정밀하 | 문서를 포함한다)를 첨부하여 지방식품의약품안 | 1) 구조결정에 관한 자료 | (3) 공조시설, 압축공기 및 용수처리 계통도 | Indium-111 (111In) | 2.8047 일 | 5) 대사물 |\n| 동일한 화학적 형태이나 안정형 동위원소가 포함된 담 | 엔도톡신(Bacterial endotoxins - pyrogens) | 바 | 2.3.7 용법․용량 | 방사성의약품은 1개 이상의 의학용 방사성 핵종(방사 | 드화나트륨 검출기(sodium iodide detector)는 문제를 | - 투여경로 | ※ 참고 - 방사성의약품의 허가심사 종류 | ② 제1항에 따른 제조업자가 그 제조(다른 제 | 경우 그 사유를 아래에 기재해 주시기 바랍니다.  | 및 xenon-133을 얻을 수 있다.  |\n| 에 있어야 한다.  | 작성요령과 각 자료의 요건 등에 관한 세부 사 | 2008.2.29., 2010.1.18., 2011.3.30., 2013.3.23.> | 제외한다.  | 없는 성분(첨가제 등), 그 밖에 인체에 | 치는 작용)이 없는 성분(첨가제 등), 그 | 가 나 다 라 마 | 가 나 다 가 나 | 제조품목 | ※｢ | 다) 신청품목과 관련된 시설 및 환경 관리 관련 자료 | 한 형태 (예: 2-[18F]fluoro-2-deoxy-D-glucose) | 의약품의 품목허가․신고․심사규정｣ | 게 취하여 특정 두께의 납용기에 넣고 감마선측정법 | 는 경비를 포함한다)를 내야 한다. ",
        "original_sentence": "| 및 xenon-133을 얻을 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_036",
      "text": "|\n| 에 있어야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 35,
        "window_size": 3,
        "char_count": 14,
        "word_count": 5,
        "page_number": 9,
        "window_text": "이 경우 첨부자료의 종류, 자료 | 요한 | 사항은 | 총리령으로 | 정한다.  | <개정 | 「식약처 지침서등의 관리에 관한 | (2) 반감기가 24시간 미만의 방사 | ③ 기준 및 시험방법에 관한 자료 | 2) 몰리브덴-99  이 약 일정량을 바이알에 정밀하 | 문서를 포함한다)를 첨부하여 지방식품의약품안 | 1) 구조결정에 관한 자료 | (3) 공조시설, 압축공기 및 용수처리 계통도 | Indium-111 (111In) | 2.8047 일 | 5) 대사물 |\n| 동일한 화학적 형태이나 안정형 동위원소가 포함된 담 | 엔도톡신(Bacterial endotoxins - pyrogens) | 바 | 2.3.7 용법․용량 | 방사성의약품은 1개 이상의 의학용 방사성 핵종(방사 | 드화나트륨 검출기(sodium iodide detector)는 문제를 | - 투여경로 | ※ 참고 - 방사성의약품의 허가심사 종류 | ② 제1항에 따른 제조업자가 그 제조(다른 제 | 경우 그 사유를 아래에 기재해 주시기 바랍니다.  | 및 xenon-133을 얻을 수 있다.  |\n| 에 있어야 한다.  | 작성요령과 각 자료의 요건 등에 관한 세부 사 | 2008.2.29., 2010.1.18., 2011.3.30., 2013.3.23.> | 제외한다.  | 없는 성분(첨가제 등), 그 밖에 인체에 | 치는 작용)이 없는 성분(첨가제 등), 그 | 가 나 다 라 마 | 가 나 다 가 나 | 제조품목 | ※｢ | 다) 신청품목과 관련된 시설 및 환경 관리 관련 자료 | 한 형태 (예: 2-[18F]fluoro-2-deoxy-D-glucose) | 의약품의 품목허가․신고․심사규정｣ | 게 취하여 특정 두께의 납용기에 넣고 감마선측정법 | 는 경비를 포함한다)를 내야 한다.  | 허가를 신청하는 경우에는 별지 제5호서식의 | 조업자에게 위탁제조하여 판매하려는 의약품 | 2.2.1 품목허가 신청 및 처리 흐름도 ···············································4 | 별표 8의3 참조 | Indium-114m (114mIn) | 49.51 일 |\n| 해 언급되었음에도 불구하고, 각 | 구분 | 전자민원 | 방문․우편 민원 | 규정」 개정에 따른 등록번호 일괄 정비 | 체로서 방사성제제에 존재하거나 추가하는 물질 | 성제제 | 분류번호 | 전청장(이하 \"지방청장\"이라 한다)에게 제출하 | 조업자에게 제조를 위탁하는 경우를 포함한다) | 2) 물리화학적 성질에 관한 자료 | (사유 :                                                                 ) | Indium-114 (114In) | 71.9 초 | 6) 불순물 | 허가심사종류 |\n| 비경구용 방사성의약품은 엔도톡신시험(2.6.14) 또는 발 | 2. ",
        "original_sentence": "|\n| 에 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_037",
      "text": "| 작성요령과 각 자료의 요건 등에 관한 세부 사 | 2008.2.29., 2010.1.18., 2011.3.30., 2013.3.23.> | 제외한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 36,
        "window_size": 3,
        "char_count": 86,
        "word_count": 16,
        "page_number": 3,
        "window_text": "| <개정 | 「식약처 지침서등의 관리에 관한 | (2) 반감기가 24시간 미만의 방사 | ③ 기준 및 시험방법에 관한 자료 | 2) 몰리브덴-99  이 약 일정량을 바이알에 정밀하 | 문서를 포함한다)를 첨부하여 지방식품의약품안 | 1) 구조결정에 관한 자료 | (3) 공조시설, 압축공기 및 용수처리 계통도 | Indium-111 (111In) | 2.8047 일 | 5) 대사물 |\n| 동일한 화학적 형태이나 안정형 동위원소가 포함된 담 | 엔도톡신(Bacterial endotoxins - pyrogens) | 바 | 2.3.7 용법․용량 | 방사성의약품은 1개 이상의 의학용 방사성 핵종(방사 | 드화나트륨 검출기(sodium iodide detector)는 문제를 | - 투여경로 | ※ 참고 - 방사성의약품의 허가심사 종류 | ② 제1항에 따른 제조업자가 그 제조(다른 제 | 경우 그 사유를 아래에 기재해 주시기 바랍니다.  | 및 xenon-133을 얻을 수 있다.  |\n| 에 있어야 한다.  | 작성요령과 각 자료의 요건 등에 관한 세부 사 | 2008.2.29., 2010.1.18., 2011.3.30., 2013.3.23.> | 제외한다.  | 없는 성분(첨가제 등), 그 밖에 인체에 | 치는 작용)이 없는 성분(첨가제 등), 그 | 가 나 다 라 마 | 가 나 다 가 나 | 제조품목 | ※｢ | 다) 신청품목과 관련된 시설 및 환경 관리 관련 자료 | 한 형태 (예: 2-[18F]fluoro-2-deoxy-D-glucose) | 의약품의 품목허가․신고․심사규정｣ | 게 취하여 특정 두께의 납용기에 넣고 감마선측정법 | 는 경비를 포함한다)를 내야 한다.  | 허가를 신청하는 경우에는 별지 제5호서식의 | 조업자에게 위탁제조하여 판매하려는 의약품 | 2.2.1 품목허가 신청 및 처리 흐름도 ···············································4 | 별표 8의3 참조 | Indium-114m (114mIn) | 49.51 일 |\n| 해 언급되었음에도 불구하고, 각 | 구분 | 전자민원 | 방문․우편 민원 | 규정」 개정에 따른 등록번호 일괄 정비 | 체로서 방사성제제에 존재하거나 추가하는 물질 | 성제제 | 분류번호 | 전청장(이하 \"지방청장\"이라 한다)에게 제출하 | 조업자에게 제조를 위탁하는 경우를 포함한다) | 2) 물리화학적 성질에 관한 자료 | (사유 :                                                                 ) | Indium-114 (114In) | 71.9 초 | 6) 불순물 | 허가심사종류 |\n| 비경구용 방사성의약품은 엔도톡신시험(2.6.14) 또는 발 | 2.  대한민국약전외한약(생약)규격집에 실려 있 | 직접 적용하지 아니하는 제품(소독제 등) | 밖에 인체에 직접 적용하지 아니하는 제 | 수입품목 | 성동위원소)을 포함하는 의약품으로 다음 제제를 포함 | 방사성핵종은 다음과 같은 방법으로 생산될 수 있다. ",
        "original_sentence": "| 작성요령과 각 자료의 요건 등에 관한 세부 사 | 2008.2.29., 2010.1.18., 2011.3.30., 2013.3.23.> | 제외한다. "
      }
    },
    {
      "chunk_id": "chunk_038",
      "text": "| 없는 성분(첨가제 등), 그 밖에 인체에 | 치는 작용)이 없는 성분(첨가제 등), 그 | 가 나 다 라 마 | 가 나 다 가 나 | 제조품목 | ※｢ | 다) 신청품목과 관련된 시설 및 환경 관리 관련 자료 | 한 형태 (예: 2-[18F]fluoro-2-deoxy-D-glucose) | 의약품의 품목허가․신고․심사규정｣ | 게 취하여 특정 두께의 납용기에 넣고 감마선측정법 | 는 경비를 포함한다)를 내야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 37,
        "window_size": 3,
        "char_count": 236,
        "word_count": 62,
        "page_number": 5,
        "window_text": "| 및 xenon-133을 얻을 수 있다.  |\n| 에 있어야 한다.  | 작성요령과 각 자료의 요건 등에 관한 세부 사 | 2008.2.29., 2010.1.18., 2011.3.30., 2013.3.23.> | 제외한다.  | 없는 성분(첨가제 등), 그 밖에 인체에 | 치는 작용)이 없는 성분(첨가제 등), 그 | 가 나 다 라 마 | 가 나 다 가 나 | 제조품목 | ※｢ | 다) 신청품목과 관련된 시설 및 환경 관리 관련 자료 | 한 형태 (예: 2-[18F]fluoro-2-deoxy-D-glucose) | 의약품의 품목허가․신고․심사규정｣ | 게 취하여 특정 두께의 납용기에 넣고 감마선측정법 | 는 경비를 포함한다)를 내야 한다.  | 허가를 신청하는 경우에는 별지 제5호서식의 | 조업자에게 위탁제조하여 판매하려는 의약품 | 2.2.1 품목허가 신청 및 처리 흐름도 ···············································4 | 별표 8의3 참조 | Indium-114m (114mIn) | 49.51 일 |\n| 해 언급되었음에도 불구하고, 각 | 구분 | 전자민원 | 방문․우편 민원 | 규정」 개정에 따른 등록번호 일괄 정비 | 체로서 방사성제제에 존재하거나 추가하는 물질 | 성제제 | 분류번호 | 전청장(이하 \"지방청장\"이라 한다)에게 제출하 | 조업자에게 제조를 위탁하는 경우를 포함한다) | 2) 물리화학적 성질에 관한 자료 | (사유 :                                                                 ) | Indium-114 (114In) | 71.9 초 | 6) 불순물 | 허가심사종류 |\n| 비경구용 방사성의약품은 엔도톡신시험(2.6.14) 또는 발 | 2.  대한민국약전외한약(생약)규격집에 실려 있 | 직접 적용하지 아니하는 제품(소독제 등) | 밖에 인체에 직접 적용하지 아니하는 제 | 수입품목 | 성동위원소)을 포함하는 의약품으로 다음 제제를 포함 | 방사성핵종은 다음과 같은 방법으로 생산될 수 있다.  | 일으킬 수 있다. ",
        "original_sentence": "| 없는 성분(첨가제 등), 그 밖에 인체에 | 치는 작용)이 없는 성분(첨가제 등), 그 | 가 나 다 라 마 | 가 나 다 가 나 | 제조품목 | ※｢ | 다) 신청품목과 관련된 시설 및 환경 관리 관련 자료 | 한 형태 (예: 2-[18F]fluoro-2-deoxy-D-glucose) | 의약품의 품목허가․신고․심사규정｣ | 게 취하여 특정 두께의 납용기에 넣고 감마선측정법 | 는 경비를 포함한다)를 내야 한다. "
      }
    },
    {
      "chunk_id": "chunk_039",
      "text": "| 허가를 신청하는 경우에는 별지 제5호서식의 | 조업자에게 위탁제조하여 판매하려는 의약품 | 2.2.1 품목허가 신청 및 처리 흐름도 ···············································4 | 별표 8의3 참조 | Indium-114m (114mIn) | 49.51 일 |\n| 해 언급되었음에도 불구하고, 각 | 구분 | 전자민원 | 방문․우편 민원 | 규정」 개정에 따른 등록번호 일괄 정비 | 체로서 방사성제제에 존재하거나 추가하는 물질 | 성제제 | 분류번호 | 전청장(이하 \"지방청장\"이라 한다)에게 제출하 | 조업자에게 제조를 위탁하는 경우를 포함한다) | 2) 물리화학적 성질에 관한 자료 | (사유 :                                                                 ) | Indium-114 (114In) | 71.9 초 | 6) 불순물 | 허가심사종류 |\n| 비경구용 방사성의약품은 엔도톡신시험(2.6.14) 또는 발 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 38,
        "window_size": 3,
        "char_count": 519,
        "word_count": 100,
        "page_number": 3,
        "window_text": "|\n| 에 있어야 한다.  | 작성요령과 각 자료의 요건 등에 관한 세부 사 | 2008.2.29., 2010.1.18., 2011.3.30., 2013.3.23.> | 제외한다.  | 없는 성분(첨가제 등), 그 밖에 인체에 | 치는 작용)이 없는 성분(첨가제 등), 그 | 가 나 다 라 마 | 가 나 다 가 나 | 제조품목 | ※｢ | 다) 신청품목과 관련된 시설 및 환경 관리 관련 자료 | 한 형태 (예: 2-[18F]fluoro-2-deoxy-D-glucose) | 의약품의 품목허가․신고․심사규정｣ | 게 취하여 특정 두께의 납용기에 넣고 감마선측정법 | 는 경비를 포함한다)를 내야 한다.  | 허가를 신청하는 경우에는 별지 제5호서식의 | 조업자에게 위탁제조하여 판매하려는 의약품 | 2.2.1 품목허가 신청 및 처리 흐름도 ···············································4 | 별표 8의3 참조 | Indium-114m (114mIn) | 49.51 일 |\n| 해 언급되었음에도 불구하고, 각 | 구분 | 전자민원 | 방문․우편 민원 | 규정」 개정에 따른 등록번호 일괄 정비 | 체로서 방사성제제에 존재하거나 추가하는 물질 | 성제제 | 분류번호 | 전청장(이하 \"지방청장\"이라 한다)에게 제출하 | 조업자에게 제조를 위탁하는 경우를 포함한다) | 2) 물리화학적 성질에 관한 자료 | (사유 :                                                                 ) | Indium-114 (114In) | 71.9 초 | 6) 불순물 | 허가심사종류 |\n| 비경구용 방사성의약품은 엔도톡신시험(2.6.14) 또는 발 | 2.  대한민국약전외한약(생약)규격집에 실려 있 | 직접 적용하지 아니하는 제품(소독제 등) | 밖에 인체에 직접 적용하지 아니하는 제 | 수입품목 | 성동위원소)을 포함하는 의약품으로 다음 제제를 포함 | 방사성핵종은 다음과 같은 방법으로 생산될 수 있다.  | 일으킬 수 있다.  감마선 방출 불순물들에 기인하는 피 | - 필요 시 최대 권장 용량 (mL) | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료(해당하는 경우) | [시행일 : 2015.7.1.] ",
        "original_sentence": "| 허가를 신청하는 경우에는 별지 제5호서식의 | 조업자에게 위탁제조하여 판매하려는 의약품 | 2.2.1 품목허가 신청 및 처리 흐름도 ···············································4 | 별표 8의3 참조 | Indium-114m (114mIn) | 49.51 일 |\n| 해 언급되었음에도 불구하고, 각 | 구분 | 전자민원 | 방문․우편 민원 | 규정」 개정에 따른 등록번호 일괄 정비 | 체로서 방사성제제에 존재하거나 추가하는 물질 | 성제제 | 분류번호 | 전청장(이하 \"지방청장\"이라 한다)에게 제출하 | 조업자에게 제조를 위탁하는 경우를 포함한다) | 2) 물리화학적 성질에 관한 자료 | (사유 :                                                                 ) | Indium-114 (114In) | 71.9 초 | 6) 불순물 | 허가심사종류 |\n| 비경구용 방사성의약품은 엔도톡신시험(2.6.14) 또는 발 | 2. "
      }
    },
    {
      "chunk_id": "chunk_040",
      "text": "대한민국약전외한약(생약)규격집에 실려 있 | 직접 적용하지 아니하는 제품(소독제 등) | 밖에 인체에 직접 적용하지 아니하는 제 | 수입품목 | 성동위원소)을 포함하는 의약품으로 다음 제제를 포함 | 방사성핵종은 다음과 같은 방법으로 생산될 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 39,
        "window_size": 3,
        "char_count": 141,
        "word_count": 33,
        "page_number": 6,
        "window_text": "| 작성요령과 각 자료의 요건 등에 관한 세부 사 | 2008.2.29., 2010.1.18., 2011.3.30., 2013.3.23.> | 제외한다.  | 없는 성분(첨가제 등), 그 밖에 인체에 | 치는 작용)이 없는 성분(첨가제 등), 그 | 가 나 다 라 마 | 가 나 다 가 나 | 제조품목 | ※｢ | 다) 신청품목과 관련된 시설 및 환경 관리 관련 자료 | 한 형태 (예: 2-[18F]fluoro-2-deoxy-D-glucose) | 의약품의 품목허가․신고․심사규정｣ | 게 취하여 특정 두께의 납용기에 넣고 감마선측정법 | 는 경비를 포함한다)를 내야 한다.  | 허가를 신청하는 경우에는 별지 제5호서식의 | 조업자에게 위탁제조하여 판매하려는 의약품 | 2.2.1 품목허가 신청 및 처리 흐름도 ···············································4 | 별표 8의3 참조 | Indium-114m (114mIn) | 49.51 일 |\n| 해 언급되었음에도 불구하고, 각 | 구분 | 전자민원 | 방문․우편 민원 | 규정」 개정에 따른 등록번호 일괄 정비 | 체로서 방사성제제에 존재하거나 추가하는 물질 | 성제제 | 분류번호 | 전청장(이하 \"지방청장\"이라 한다)에게 제출하 | 조업자에게 제조를 위탁하는 경우를 포함한다) | 2) 물리화학적 성질에 관한 자료 | (사유 :                                                                 ) | Indium-114 (114In) | 71.9 초 | 6) 불순물 | 허가심사종류 |\n| 비경구용 방사성의약품은 엔도톡신시험(2.6.14) 또는 발 | 2.  대한민국약전외한약(생약)규격집에 실려 있 | 직접 적용하지 아니하는 제품(소독제 등) | 밖에 인체에 직접 적용하지 아니하는 제 | 수입품목 | 성동위원소)을 포함하는 의약품으로 다음 제제를 포함 | 방사성핵종은 다음과 같은 방법으로 생산될 수 있다.  | 일으킬 수 있다.  감마선 방출 불순물들에 기인하는 피 | - 필요 시 최대 권장 용량 (mL) | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료(해당하는 경우) | [시행일 : 2015.7.1.]  제5조 | 의 정량법에 따라 몰리브덴-99의 방사능을 산출한 | (1) 제조용수 관리현황 | 특허관계 확인서와 그 사유를 적은 서류 및 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 해당 국가의 | 의약품집 등 | 를 제출할 수 있다. ",
        "original_sentence": "대한민국약전외한약(생약)규격집에 실려 있 | 직접 적용하지 아니하는 제품(소독제 등) | 밖에 인체에 직접 적용하지 아니하는 제 | 수입품목 | 성동위원소)을 포함하는 의약품으로 다음 제제를 포함 | 방사성핵종은 다음과 같은 방법으로 생산될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_041",
      "text": "| 일으킬 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 40,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 9,
        "window_text": "| 없는 성분(첨가제 등), 그 밖에 인체에 | 치는 작용)이 없는 성분(첨가제 등), 그 | 가 나 다 라 마 | 가 나 다 가 나 | 제조품목 | ※｢ | 다) 신청품목과 관련된 시설 및 환경 관리 관련 자료 | 한 형태 (예: 2-[18F]fluoro-2-deoxy-D-glucose) | 의약품의 품목허가․신고․심사규정｣ | 게 취하여 특정 두께의 납용기에 넣고 감마선측정법 | 는 경비를 포함한다)를 내야 한다.  | 허가를 신청하는 경우에는 별지 제5호서식의 | 조업자에게 위탁제조하여 판매하려는 의약품 | 2.2.1 품목허가 신청 및 처리 흐름도 ···············································4 | 별표 8의3 참조 | Indium-114m (114mIn) | 49.51 일 |\n| 해 언급되었음에도 불구하고, 각 | 구분 | 전자민원 | 방문․우편 민원 | 규정」 개정에 따른 등록번호 일괄 정비 | 체로서 방사성제제에 존재하거나 추가하는 물질 | 성제제 | 분류번호 | 전청장(이하 \"지방청장\"이라 한다)에게 제출하 | 조업자에게 제조를 위탁하는 경우를 포함한다) | 2) 물리화학적 성질에 관한 자료 | (사유 :                                                                 ) | Indium-114 (114In) | 71.9 초 | 6) 불순물 | 허가심사종류 |\n| 비경구용 방사성의약품은 엔도톡신시험(2.6.14) 또는 발 | 2.  대한민국약전외한약(생약)규격집에 실려 있 | 직접 적용하지 아니하는 제품(소독제 등) | 밖에 인체에 직접 적용하지 아니하는 제 | 수입품목 | 성동위원소)을 포함하는 의약품으로 다음 제제를 포함 | 방사성핵종은 다음과 같은 방법으로 생산될 수 있다.  | 일으킬 수 있다.  감마선 방출 불순물들에 기인하는 피 | - 필요 시 최대 권장 용량 (mL) | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료(해당하는 경우) | [시행일 : 2015.7.1.]  제5조 | 의 정량법에 따라 몰리브덴-99의 방사능을 산출한 | (1) 제조용수 관리현황 | 특허관계 확인서와 그 사유를 적은 서류 및 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 해당 국가의 | 의약품집 등 | 를 제출할 수 있다.  |\n| 조에 언급되어 있지 않은 경우 분 | 신약 | 1,935,000원 | 2,150,000원 | 항은 식품의약품안전처장이 고시하는 바에 따른 | (규제개혁담당관실-3761호,2017.5.16) | (3) 주성분 자체가 보존효과가 있 | 공정 번호 | 공정 명칭 | 원료․시약․용매 등 | 여야 한다. ",
        "original_sentence": "| 일으킬 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_042",
      "text": "감마선 방출 불순물들에 기인하는 피 | - 필요 시 최대 권장 용량 (mL) | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료(해당하는 경우) | [시행일 : 2015.7.1.] ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 41,
        "window_size": 3,
        "char_count": 112,
        "word_count": 28,
        "page_number": 3,
        "window_text": "| 허가를 신청하는 경우에는 별지 제5호서식의 | 조업자에게 위탁제조하여 판매하려는 의약품 | 2.2.1 품목허가 신청 및 처리 흐름도 ···············································4 | 별표 8의3 참조 | Indium-114m (114mIn) | 49.51 일 |\n| 해 언급되었음에도 불구하고, 각 | 구분 | 전자민원 | 방문․우편 민원 | 규정」 개정에 따른 등록번호 일괄 정비 | 체로서 방사성제제에 존재하거나 추가하는 물질 | 성제제 | 분류번호 | 전청장(이하 \"지방청장\"이라 한다)에게 제출하 | 조업자에게 제조를 위탁하는 경우를 포함한다) | 2) 물리화학적 성질에 관한 자료 | (사유 :                                                                 ) | Indium-114 (114In) | 71.9 초 | 6) 불순물 | 허가심사종류 |\n| 비경구용 방사성의약품은 엔도톡신시험(2.6.14) 또는 발 | 2.  대한민국약전외한약(생약)규격집에 실려 있 | 직접 적용하지 아니하는 제품(소독제 등) | 밖에 인체에 직접 적용하지 아니하는 제 | 수입품목 | 성동위원소)을 포함하는 의약품으로 다음 제제를 포함 | 방사성핵종은 다음과 같은 방법으로 생산될 수 있다.  | 일으킬 수 있다.  감마선 방출 불순물들에 기인하는 피 | - 필요 시 최대 권장 용량 (mL) | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료(해당하는 경우) | [시행일 : 2015.7.1.]  제5조 | 의 정량법에 따라 몰리브덴-99의 방사능을 산출한 | (1) 제조용수 관리현황 | 특허관계 확인서와 그 사유를 적은 서류 및 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 해당 국가의 | 의약품집 등 | 를 제출할 수 있다.  |\n| 조에 언급되어 있지 않은 경우 분 | 신약 | 1,935,000원 | 2,150,000원 | 항은 식품의약품안전처장이 고시하는 바에 따른 | (규제개혁담당관실-3761호,2017.5.16) | (3) 주성분 자체가 보존효과가 있 | 공정 번호 | 공정 명칭 | 원료․시약․용매 등 | 여야 한다.  | 한 의약품을 판매하려는 경우에는 총리령으로 | 2.2.2 구비서류 ·······················································································5 | Tellurium-121m (121mTe) | 154.0 일 | 2011.3.30.> | 이다. ",
        "original_sentence": "감마선 방출 불순물들에 기인하는 피 | - 필요 시 최대 권장 용량 (mL) | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료(해당하는 경우) | [시행일 : 2015.7.1.] "
      }
    },
    {
      "chunk_id": "chunk_043",
      "text": "제5조 | 의 정량법에 따라 몰리브덴-99의 방사능을 산출한 | (1) 제조용수 관리현황 | 특허관계 확인서와 그 사유를 적은 서류 및 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 해당 국가의 | 의약품집 등 | 를 제출할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 42,
        "window_size": 3,
        "char_count": 134,
        "word_count": 38,
        "page_number": 3,
        "window_text": "대한민국약전외한약(생약)규격집에 실려 있 | 직접 적용하지 아니하는 제품(소독제 등) | 밖에 인체에 직접 적용하지 아니하는 제 | 수입품목 | 성동위원소)을 포함하는 의약품으로 다음 제제를 포함 | 방사성핵종은 다음과 같은 방법으로 생산될 수 있다.  | 일으킬 수 있다.  감마선 방출 불순물들에 기인하는 피 | - 필요 시 최대 권장 용량 (mL) | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료(해당하는 경우) | [시행일 : 2015.7.1.]  제5조 | 의 정량법에 따라 몰리브덴-99의 방사능을 산출한 | (1) 제조용수 관리현황 | 특허관계 확인서와 그 사유를 적은 서류 및 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 해당 국가의 | 의약품집 등 | 를 제출할 수 있다.  |\n| 조에 언급되어 있지 않은 경우 분 | 신약 | 1,935,000원 | 2,150,000원 | 항은 식품의약품안전처장이 고시하는 바에 따른 | (규제개혁담당관실-3761호,2017.5.16) | (3) 주성분 자체가 보존효과가 있 | 공정 번호 | 공정 명칭 | 원료․시약․용매 등 | 여야 한다.  | 한 의약품을 판매하려는 경우에는 총리령으로 | 2.2.2 구비서류 ·······················································································5 | Tellurium-121m (121mTe) | 154.0 일 | 2011.3.30.> | 이다.  | 허가 | 기시 | 안유 |\n| 는 품목 | 과 이에 사용되는 원료의약품은 제외한 | 품(소독제 등)에 사용되는 원료의약품은 | 제조품목누적량 | 한다. ",
        "original_sentence": "제5조 | 의 정량법에 따라 몰리브덴-99의 방사능을 산출한 | (1) 제조용수 관리현황 | 특허관계 확인서와 그 사유를 적은 서류 및 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 해당 국가의 | 의약품집 등 | 를 제출할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_044",
      "text": "|\n| 조에 언급되어 있지 않은 경우 분 | 신약 | 1,935,000원 | 2,150,000원 | 항은 식품의약품안전처장이 고시하는 바에 따른 | (규제개혁담당관실-3761호,2017.5.16) | (3) 주성분 자체가 보존효과가 있 | 공정 번호 | 공정 명칭 | 원료․시약․용매 등 | 여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 43,
        "window_size": 3,
        "char_count": 170,
        "word_count": 40,
        "page_number": 3,
        "window_text": "| 일으킬 수 있다.  감마선 방출 불순물들에 기인하는 피 | - 필요 시 최대 권장 용량 (mL) | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료(해당하는 경우) | [시행일 : 2015.7.1.]  제5조 | 의 정량법에 따라 몰리브덴-99의 방사능을 산출한 | (1) 제조용수 관리현황 | 특허관계 확인서와 그 사유를 적은 서류 및 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 해당 국가의 | 의약품집 등 | 를 제출할 수 있다.  |\n| 조에 언급되어 있지 않은 경우 분 | 신약 | 1,935,000원 | 2,150,000원 | 항은 식품의약품안전처장이 고시하는 바에 따른 | (규제개혁담당관실-3761호,2017.5.16) | (3) 주성분 자체가 보존효과가 있 | 공정 번호 | 공정 명칭 | 원료․시약․용매 등 | 여야 한다.  | 한 의약품을 판매하려는 경우에는 총리령으로 | 2.2.2 구비서류 ·······················································································5 | Tellurium-121m (121mTe) | 154.0 일 | 2011.3.30.> | 이다.  | 허가 | 기시 | 안유 |\n| 는 품목 | 과 이에 사용되는 원료의약품은 제외한 | 품(소독제 등)에 사용되는 원료의약품은 | 제조품목누적량 | 한다.  | 다. ",
        "original_sentence": "|\n| 조에 언급되어 있지 않은 경우 분 | 신약 | 1,935,000원 | 2,150,000원 | 항은 식품의약품안전처장이 고시하는 바에 따른 | (규제개혁담당관실-3761호,2017.5.16) | (3) 주성분 자체가 보존효과가 있 | 공정 번호 | 공정 명칭 | 원료․시약․용매 등 | 여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_045",
      "text": "| 한 의약품을 판매하려는 경우에는 총리령으로 | 2.2.2 구비서류 ·······················································································5 | Tellurium-121m (121mTe) | 154.0 일 | 2011.3.30.> | 이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 44,
        "window_size": 3,
        "char_count": 184,
        "word_count": 20,
        "page_number": 3,
        "window_text": "감마선 방출 불순물들에 기인하는 피 | - 필요 시 최대 권장 용량 (mL) | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료(해당하는 경우) | [시행일 : 2015.7.1.]  제5조 | 의 정량법에 따라 몰리브덴-99의 방사능을 산출한 | (1) 제조용수 관리현황 | 특허관계 확인서와 그 사유를 적은 서류 및 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 해당 국가의 | 의약품집 등 | 를 제출할 수 있다.  |\n| 조에 언급되어 있지 않은 경우 분 | 신약 | 1,935,000원 | 2,150,000원 | 항은 식품의약품안전처장이 고시하는 바에 따른 | (규제개혁담당관실-3761호,2017.5.16) | (3) 주성분 자체가 보존효과가 있 | 공정 번호 | 공정 명칭 | 원료․시약․용매 등 | 여야 한다.  | 한 의약품을 판매하려는 경우에는 총리령으로 | 2.2.2 구비서류 ·······················································································5 | Tellurium-121m (121mTe) | 154.0 일 | 2011.3.30.> | 이다.  | 허가 | 기시 | 안유 |\n| 는 품목 | 과 이에 사용되는 원료의약품은 제외한 | 품(소독제 등)에 사용되는 원료의약품은 | 제조품목누적량 | 한다.  | 다.  감마선스펙트로미터에 의한 정량법에 따라 방사 | 3) 제조방법에 관한 자료 | 근거자료 | 등을 적어 넣은 위탁·수탁제조계약서 | 구분 | 규격 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 | (명칭기재) | 비고 | 허가 | 허가 | 기시 | 7) 기타 | 허가 | 안유 | □ 예 | ■ 아니오 |\n| 할사용 방사성제제에 보존제를 사 | 희귀 | 1,449,000원 | 1,610,000원 | 방사선의 특성과 에너지 측정(Determination of the | 열성물질시험(2.6.8)에 적합하여야 한다. ",
        "original_sentence": "| 한 의약품을 판매하려는 경우에는 총리령으로 | 2.2.2 구비서류 ·······················································································5 | Tellurium-121m (121mTe) | 154.0 일 | 2011.3.30.> | 이다. "
      }
    },
    {
      "chunk_id": "chunk_046",
      "text": "| 허가 | 기시 | 안유 |\n| 는 품목 | 과 이에 사용되는 원료의약품은 제외한 | 품(소독제 등)에 사용되는 원료의약품은 | 제조품목누적량 | 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 45,
        "window_size": 3,
        "char_count": 87,
        "word_count": 25,
        "page_number": 5,
        "window_text": "제5조 | 의 정량법에 따라 몰리브덴-99의 방사능을 산출한 | (1) 제조용수 관리현황 | 특허관계 확인서와 그 사유를 적은 서류 및 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 해당 국가의 | 의약품집 등 | 를 제출할 수 있다.  |\n| 조에 언급되어 있지 않은 경우 분 | 신약 | 1,935,000원 | 2,150,000원 | 항은 식품의약품안전처장이 고시하는 바에 따른 | (규제개혁담당관실-3761호,2017.5.16) | (3) 주성분 자체가 보존효과가 있 | 공정 번호 | 공정 명칭 | 원료․시약․용매 등 | 여야 한다.  | 한 의약품을 판매하려는 경우에는 총리령으로 | 2.2.2 구비서류 ·······················································································5 | Tellurium-121m (121mTe) | 154.0 일 | 2011.3.30.> | 이다.  | 허가 | 기시 | 안유 |\n| 는 품목 | 과 이에 사용되는 원료의약품은 제외한 | 품(소독제 등)에 사용되는 원료의약품은 | 제조품목누적량 | 한다.  | 다.  감마선스펙트로미터에 의한 정량법에 따라 방사 | 3) 제조방법에 관한 자료 | 근거자료 | 등을 적어 넣은 위탁·수탁제조계약서 | 구분 | 규격 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 | (명칭기재) | 비고 | 허가 | 허가 | 기시 | 7) 기타 | 허가 | 안유 | □ 예 | ■ 아니오 |\n| 할사용 방사성제제에 보존제를 사 | 희귀 | 1,449,000원 | 1,610,000원 | 방사선의 특성과 에너지 측정(Determination of the | 열성물질시험(2.6.8)에 적합하여야 한다.  | 다. ",
        "original_sentence": "| 허가 | 기시 | 안유 |\n| 는 품목 | 과 이에 사용되는 원료의약품은 제외한 | 품(소독제 등)에 사용되는 원료의약품은 | 제조품목누적량 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_047",
      "text": "| 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 46,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 9,
        "window_text": "|\n| 조에 언급되어 있지 않은 경우 분 | 신약 | 1,935,000원 | 2,150,000원 | 항은 식품의약품안전처장이 고시하는 바에 따른 | (규제개혁담당관실-3761호,2017.5.16) | (3) 주성분 자체가 보존효과가 있 | 공정 번호 | 공정 명칭 | 원료․시약․용매 등 | 여야 한다.  | 한 의약품을 판매하려는 경우에는 총리령으로 | 2.2.2 구비서류 ·······················································································5 | Tellurium-121m (121mTe) | 154.0 일 | 2011.3.30.> | 이다.  | 허가 | 기시 | 안유 |\n| 는 품목 | 과 이에 사용되는 원료의약품은 제외한 | 품(소독제 등)에 사용되는 원료의약품은 | 제조품목누적량 | 한다.  | 다.  감마선스펙트로미터에 의한 정량법에 따라 방사 | 3) 제조방법에 관한 자료 | 근거자료 | 등을 적어 넣은 위탁·수탁제조계약서 | 구분 | 규격 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 | (명칭기재) | 비고 | 허가 | 허가 | 기시 | 7) 기타 | 허가 | 안유 | □ 예 | ■ 아니오 |\n| 할사용 방사성제제에 보존제를 사 | 희귀 | 1,449,000원 | 1,610,000원 | 방사선의 특성과 에너지 측정(Determination of the | 열성물질시험(2.6.8)에 적합하여야 한다.  | 다.  | 는 경우 | 크들은 주 방사성핵종의 스펙트럼에 가려지거나 다른 | - | (일반적으로 원자로 내의 표적물질과) | 중성자 | - 첨가된 보존제 명칭 및 양 | - 방사성의약품의 분류번호: 431 방사성 의약품 | 1. ",
        "original_sentence": "| 다. "
      }
    },
    {
      "chunk_id": "chunk_048",
      "text": "감마선스펙트로미터에 의한 정량법에 따라 방사 | 3) 제조방법에 관한 자료 | 근거자료 | 등을 적어 넣은 위탁·수탁제조계약서 | 구분 | 규격 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 | (명칭기재) | 비고 | 허가 | 허가 | 기시 | 7) 기타 | 허가 | 안유 | □ 예 | ■ 아니오 |\n| 할사용 방사성제제에 보존제를 사 | 희귀 | 1,449,000원 | 1,610,000원 | 방사선의 특성과 에너지 측정(Determination of the | 열성물질시험(2.6.8)에 적합하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 47,
        "window_size": 3,
        "char_count": 299,
        "word_count": 72,
        "page_number": 3,
        "window_text": "| 한 의약품을 판매하려는 경우에는 총리령으로 | 2.2.2 구비서류 ·······················································································5 | Tellurium-121m (121mTe) | 154.0 일 | 2011.3.30.> | 이다.  | 허가 | 기시 | 안유 |\n| 는 품목 | 과 이에 사용되는 원료의약품은 제외한 | 품(소독제 등)에 사용되는 원료의약품은 | 제조품목누적량 | 한다.  | 다.  감마선스펙트로미터에 의한 정량법에 따라 방사 | 3) 제조방법에 관한 자료 | 근거자료 | 등을 적어 넣은 위탁·수탁제조계약서 | 구분 | 규격 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 | (명칭기재) | 비고 | 허가 | 허가 | 기시 | 7) 기타 | 허가 | 안유 | □ 예 | ■ 아니오 |\n| 할사용 방사성제제에 보존제를 사 | 희귀 | 1,449,000원 | 1,610,000원 | 방사선의 특성과 에너지 측정(Determination of the | 열성물질시험(2.6.8)에 적합하여야 한다.  | 다.  | 는 경우 | 크들은 주 방사성핵종의 스펙트럼에 가려지거나 다른 | - | (일반적으로 원자로 내의 표적물질과) | 중성자 | - 첨가된 보존제 명칭 및 양 | - 방사성의약품의 분류번호: 431 방사성 의약품 | 1.  법 제5조제1호 본문에 해당하는 사람이 아 | 제8조(허가사항 등의 변경허가 신청 등) ① 법 | (2) 자동화장치 등 관리현황 | 1. ",
        "original_sentence": "감마선스펙트로미터에 의한 정량법에 따라 방사 | 3) 제조방법에 관한 자료 | 근거자료 | 등을 적어 넣은 위탁·수탁제조계약서 | 구분 | 규격 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 | (명칭기재) | 비고 | 허가 | 허가 | 기시 | 7) 기타 | 허가 | 안유 | □ 예 | ■ 아니오 |\n| 할사용 방사성제제에 보존제를 사 | 희귀 | 1,449,000원 | 1,610,000원 | 방사선의 특성과 에너지 측정(Determination of the | 열성물질시험(2.6.8)에 적합하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_049",
      "text": "| 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 48,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 9,
        "window_text": "| 허가 | 기시 | 안유 |\n| 는 품목 | 과 이에 사용되는 원료의약품은 제외한 | 품(소독제 등)에 사용되는 원료의약품은 | 제조품목누적량 | 한다.  | 다.  감마선스펙트로미터에 의한 정량법에 따라 방사 | 3) 제조방법에 관한 자료 | 근거자료 | 등을 적어 넣은 위탁·수탁제조계약서 | 구분 | 규격 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 | (명칭기재) | 비고 | 허가 | 허가 | 기시 | 7) 기타 | 허가 | 안유 | □ 예 | ■ 아니오 |\n| 할사용 방사성제제에 보존제를 사 | 희귀 | 1,449,000원 | 1,610,000원 | 방사선의 특성과 에너지 측정(Determination of the | 열성물질시험(2.6.8)에 적합하여야 한다.  | 다.  | 는 경우 | 크들은 주 방사성핵종의 스펙트럼에 가려지거나 다른 | - | (일반적으로 원자로 내의 표적물질과) | 중성자 | - 첨가된 보존제 명칭 및 양 | - 방사성의약품의 분류번호: 431 방사성 의약품 | 1.  법 제5조제1호 본문에 해당하는 사람이 아 | 제8조(허가사항 등의 변경허가 신청 등) ① 법 | (2) 자동화장치 등 관리현황 | 1.  제5조 각 호의 어느 하나에 해당하는 자 | 불용성이물시험  시험할 때 적합하다. ",
        "original_sentence": "| 다. "
      }
    },
    {
      "chunk_id": "chunk_050",
      "text": "| 는 경우 | 크들은 주 방사성핵종의 스펙트럼에 가려지거나 다른 | - | (일반적으로 원자로 내의 표적물질과) | 중성자 | - 첨가된 보존제 명칭 및 양 | - 방사성의약품의 분류번호: 431 방사성 의약품 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 49,
        "window_size": 3,
        "char_count": 124,
        "word_count": 35,
        "page_number": 3,
        "window_text": "| 다.  감마선스펙트로미터에 의한 정량법에 따라 방사 | 3) 제조방법에 관한 자료 | 근거자료 | 등을 적어 넣은 위탁·수탁제조계약서 | 구분 | 규격 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 | (명칭기재) | 비고 | 허가 | 허가 | 기시 | 7) 기타 | 허가 | 안유 | □ 예 | ■ 아니오 |\n| 할사용 방사성제제에 보존제를 사 | 희귀 | 1,449,000원 | 1,610,000원 | 방사선의 특성과 에너지 측정(Determination of the | 열성물질시험(2.6.8)에 적합하여야 한다.  | 다.  | 는 경우 | 크들은 주 방사성핵종의 스펙트럼에 가려지거나 다른 | - | (일반적으로 원자로 내의 표적물질과) | 중성자 | - 첨가된 보존제 명칭 및 양 | - 방사성의약품의 분류번호: 431 방사성 의약품 | 1.  법 제5조제1호 본문에 해당하는 사람이 아 | 제8조(허가사항 등의 변경허가 신청 등) ① 법 | (2) 자동화장치 등 관리현황 | 1.  제5조 각 호의 어느 하나에 해당하는 자 | 불용성이물시험  시험할 때 적합하다.  | Tellure-121 (121Te) | 19.16 일 |\n| 2단계 | 무담체제제(Carrier-free | preparation): | 제제에 표시된 | 3. ",
        "original_sentence": "| 는 경우 | 크들은 주 방사성핵종의 스펙트럼에 가려지거나 다른 | - | (일반적으로 원자로 내의 표적물질과) | 중성자 | - 첨가된 보존제 명칭 및 양 | - 방사성의약품의 분류번호: 431 방사성 의약품 | 1. "
      }
    },
    {
      "chunk_id": "chunk_051",
      "text": "법 제5조제1호 본문에 해당하는 사람이 아 | 제8조(허가사항 등의 변경허가 신청 등) ① 법 | (2) 자동화장치 등 관리현황 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 50,
        "window_size": 3,
        "char_count": 77,
        "word_count": 21,
        "page_number": 1,
        "window_text": "감마선스펙트로미터에 의한 정량법에 따라 방사 | 3) 제조방법에 관한 자료 | 근거자료 | 등을 적어 넣은 위탁·수탁제조계약서 | 구분 | 규격 | □ 법령(법‧시행령‧시행규칙) 또는 행정규칙(고시‧훈령‧예규)의 | (명칭기재) | 비고 | 허가 | 허가 | 기시 | 7) 기타 | 허가 | 안유 | □ 예 | ■ 아니오 |\n| 할사용 방사성제제에 보존제를 사 | 희귀 | 1,449,000원 | 1,610,000원 | 방사선의 특성과 에너지 측정(Determination of the | 열성물질시험(2.6.8)에 적합하여야 한다.  | 다.  | 는 경우 | 크들은 주 방사성핵종의 스펙트럼에 가려지거나 다른 | - | (일반적으로 원자로 내의 표적물질과) | 중성자 | - 첨가된 보존제 명칭 및 양 | - 방사성의약품의 분류번호: 431 방사성 의약품 | 1.  법 제5조제1호 본문에 해당하는 사람이 아 | 제8조(허가사항 등의 변경허가 신청 등) ① 법 | (2) 자동화장치 등 관리현황 | 1.  제5조 각 호의 어느 하나에 해당하는 자 | 불용성이물시험  시험할 때 적합하다.  | Tellure-121 (121Te) | 19.16 일 |\n| 2단계 | 무담체제제(Carrier-free | preparation): | 제제에 표시된 | 3.  식품의약품안전처장이 성분의 종류·규격· | 3단계 | 다] 및 의약외품[내용고형제(內用固形濟) | 제외한다]의 경우에는 별표 1의2의 원료 | 4단계 | ⑤ 등록대상원료의약품에 관한 자료(해당하는 경우) | ② 제1항에도 불구하고 다음 각 호의 어느 하 | 10. ",
        "original_sentence": "법 제5조제1호 본문에 해당하는 사람이 아 | 제8조(허가사항 등의 변경허가 신청 등) ① 법 | (2) 자동화장치 등 관리현황 | 1. "
      }
    },
    {
      "chunk_id": "chunk_052",
      "text": "제5조 각 호의 어느 하나에 해당하는 자 | 불용성이물시험  시험할 때 적합하다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 51,
        "window_size": 3,
        "char_count": 46,
        "word_count": 12,
        "page_number": 3,
        "window_text": "| 다.  | 는 경우 | 크들은 주 방사성핵종의 스펙트럼에 가려지거나 다른 | - | (일반적으로 원자로 내의 표적물질과) | 중성자 | - 첨가된 보존제 명칭 및 양 | - 방사성의약품의 분류번호: 431 방사성 의약품 | 1.  법 제5조제1호 본문에 해당하는 사람이 아 | 제8조(허가사항 등의 변경허가 신청 등) ① 법 | (2) 자동화장치 등 관리현황 | 1.  제5조 각 호의 어느 하나에 해당하는 자 | 불용성이물시험  시험할 때 적합하다.  | Tellure-121 (121Te) | 19.16 일 |\n| 2단계 | 무담체제제(Carrier-free | preparation): | 제제에 표시된 | 3.  식품의약품안전처장이 성분의 종류·규격· | 3단계 | 다] 및 의약외품[내용고형제(內用固形濟) | 제외한다]의 경우에는 별표 1의2의 원료 | 4단계 | ⑤ 등록대상원료의약품에 관한 자료(해당하는 경우) | ② 제1항에도 불구하고 다음 각 호의 어느 하 | 10.  법 제50조의2제4항(법 제42조제4항에 따 | 능을 측정할 경우 0.739 MeV의 방사능 피크를 계수 | 및 그 분량, 효능효과에 맞추어 기재 | 정하는 바에 따라 품목별로 식품의약품안전처 | 4) 기준 및 시험방법이 기재된 자료 | 2.2.3 수수료 및 처리기한 ···································································6 | 내용을 단순 편집 또는 나열한 것입니까? ",
        "original_sentence": "제5조 각 호의 어느 하나에 해당하는 자 | 불용성이물시험  시험할 때 적합하다. "
      }
    },
    {
      "chunk_id": "chunk_053",
      "text": "| Tellure-121 (121Te) | 19.16 일 |\n| 2단계 | 무담체제제(Carrier-free | preparation): | 제제에 표시된 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 52,
        "window_size": 3,
        "char_count": 92,
        "word_count": 18,
        "page_number": 3,
        "window_text": "| 는 경우 | 크들은 주 방사성핵종의 스펙트럼에 가려지거나 다른 | - | (일반적으로 원자로 내의 표적물질과) | 중성자 | - 첨가된 보존제 명칭 및 양 | - 방사성의약품의 분류번호: 431 방사성 의약품 | 1.  법 제5조제1호 본문에 해당하는 사람이 아 | 제8조(허가사항 등의 변경허가 신청 등) ① 법 | (2) 자동화장치 등 관리현황 | 1.  제5조 각 호의 어느 하나에 해당하는 자 | 불용성이물시험  시험할 때 적합하다.  | Tellure-121 (121Te) | 19.16 일 |\n| 2단계 | 무담체제제(Carrier-free | preparation): | 제제에 표시된 | 3.  식품의약품안전처장이 성분의 종류·규격· | 3단계 | 다] 및 의약외품[내용고형제(內用固形濟) | 제외한다]의 경우에는 별표 1의2의 원료 | 4단계 | ⑤ 등록대상원료의약품에 관한 자료(해당하는 경우) | ② 제1항에도 불구하고 다음 각 호의 어느 하 | 10.  법 제50조의2제4항(법 제42조제4항에 따 | 능을 측정할 경우 0.739 MeV의 방사능 피크를 계수 | 및 그 분량, 효능효과에 맞추어 기재 | 정하는 바에 따라 품목별로 식품의약품안전처 | 4) 기준 및 시험방법이 기재된 자료 | 2.2.3 수수료 및 처리기한 ···································································6 | 내용을 단순 편집 또는 나열한 것입니까?  | 사용현황 | Iodine-123 (123I) | 13.27 시간 | 5. ",
        "original_sentence": "| Tellure-121 (121Te) | 19.16 일 |\n| 2단계 | 무담체제제(Carrier-free | preparation): | 제제에 표시된 | 3. "
      }
    },
    {
      "chunk_id": "chunk_054",
      "text": "식품의약품안전처장이 성분의 종류·규격· | 3단계 | 다] 및 의약외품[내용고형제(內用固形濟) | 제외한다]의 경우에는 별표 1의2의 원료 | 4단계 | ⑤ 등록대상원료의약품에 관한 자료(해당하는 경우) | ② 제1항에도 불구하고 다음 각 호의 어느 하 | 10. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 53,
        "window_size": 3,
        "char_count": 148,
        "word_count": 34,
        "page_number": 3,
        "window_text": "법 제5조제1호 본문에 해당하는 사람이 아 | 제8조(허가사항 등의 변경허가 신청 등) ① 법 | (2) 자동화장치 등 관리현황 | 1.  제5조 각 호의 어느 하나에 해당하는 자 | 불용성이물시험  시험할 때 적합하다.  | Tellure-121 (121Te) | 19.16 일 |\n| 2단계 | 무담체제제(Carrier-free | preparation): | 제제에 표시된 | 3.  식품의약품안전처장이 성분의 종류·규격· | 3단계 | 다] 및 의약외품[내용고형제(內用固形濟) | 제외한다]의 경우에는 별표 1의2의 원료 | 4단계 | ⑤ 등록대상원료의약품에 관한 자료(해당하는 경우) | ② 제1항에도 불구하고 다음 각 호의 어느 하 | 10.  법 제50조의2제4항(법 제42조제4항에 따 | 능을 측정할 경우 0.739 MeV의 방사능 피크를 계수 | 및 그 분량, 효능효과에 맞추어 기재 | 정하는 바에 따라 품목별로 식품의약품안전처 | 4) 기준 및 시험방법이 기재된 자료 | 2.2.3 수수료 및 처리기한 ···································································6 | 내용을 단순 편집 또는 나열한 것입니까?  | 사용현황 | Iodine-123 (123I) | 13.27 시간 | 5.  약리작용에 관한 자료 |\n| 용하는 것이 필수적이지는 않다. ",
        "original_sentence": "식품의약품안전처장이 성분의 종류·규격· | 3단계 | 다] 및 의약외품[내용고형제(內用固形濟) | 제외한다]의 경우에는 별표 1의2의 원료 | 4단계 | ⑤ 등록대상원료의약품에 관한 자료(해당하는 경우) | ② 제1항에도 불구하고 다음 각 호의 어느 하 | 10. "
      }
    },
    {
      "chunk_id": "chunk_055",
      "text": "법 제50조의2제4항(법 제42조제4항에 따 | 능을 측정할 경우 0.739 MeV의 방사능 피크를 계수 | 및 그 분량, 효능효과에 맞추어 기재 | 정하는 바에 따라 품목별로 식품의약품안전처 | 4) 기준 및 시험방법이 기재된 자료 | 2.2.3 수수료 및 처리기한 ···································································6 | 내용을 단순 편집 또는 나열한 것입니까? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 54,
        "window_size": 3,
        "char_count": 244,
        "word_count": 46,
        "page_number": 3,
        "window_text": "제5조 각 호의 어느 하나에 해당하는 자 | 불용성이물시험  시험할 때 적합하다.  | Tellure-121 (121Te) | 19.16 일 |\n| 2단계 | 무담체제제(Carrier-free | preparation): | 제제에 표시된 | 3.  식품의약품안전처장이 성분의 종류·규격· | 3단계 | 다] 및 의약외품[내용고형제(內用固形濟) | 제외한다]의 경우에는 별표 1의2의 원료 | 4단계 | ⑤ 등록대상원료의약품에 관한 자료(해당하는 경우) | ② 제1항에도 불구하고 다음 각 호의 어느 하 | 10.  법 제50조의2제4항(법 제42조제4항에 따 | 능을 측정할 경우 0.739 MeV의 방사능 피크를 계수 | 및 그 분량, 효능효과에 맞추어 기재 | 정하는 바에 따라 품목별로 식품의약품안전처 | 4) 기준 및 시험방법이 기재된 자료 | 2.2.3 수수료 및 처리기한 ···································································6 | 내용을 단순 편집 또는 나열한 것입니까?  | 사용현황 | Iodine-123 (123I) | 13.27 시간 | 5.  약리작용에 관한 자료 |\n| 용하는 것이 필수적이지는 않다.  | 신약, 희귀 외 | 513,000원 | 570,000원 | nature and energy of the radiation) | 방사성핵종 제너레이터의 용출물, 방사성표지를 위한 | ② 제1항에 따라 기준 및 시험방법에 관한 자 | 수입품목누적량 | 정보에 대해서는 2012년도에 발간한 ｢ | 방사성핵종 불순물 피크로부터 분리되지 않아 나타나 | - 방사성 핵종 제너레이터: 특정 방법을 통하여 고정 | - 해당할 경우 특별한 저장 조건 | 등록대상 | 제31조제9항 또는 법 제42조에 따라 의약품등 | (3) 청정도 관리현황 | PET용 방사성의약품 평가 가이드라인｣ |\n| ⇨ | 민원서식 작성 | ⇨ | (｢ | 하여 몰리브덴-99의 방사능을 산출한다. ",
        "original_sentence": "법 제50조의2제4항(법 제42조제4항에 따 | 능을 측정할 경우 0.739 MeV의 방사능 피크를 계수 | 및 그 분량, 효능효과에 맞추어 기재 | 정하는 바에 따라 품목별로 식품의약품안전처 | 4) 기준 및 시험방법이 기재된 자료 | 2.2.3 수수료 및 처리기한 ···································································6 | 내용을 단순 편집 또는 나열한 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_056",
      "text": "| 사용현황 | Iodine-123 (123I) | 13.27 시간 | 5. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 55,
        "window_size": 3,
        "char_count": 43,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| Tellure-121 (121Te) | 19.16 일 |\n| 2단계 | 무담체제제(Carrier-free | preparation): | 제제에 표시된 | 3.  식품의약품안전처장이 성분의 종류·규격· | 3단계 | 다] 및 의약외품[내용고형제(內用固形濟) | 제외한다]의 경우에는 별표 1의2의 원료 | 4단계 | ⑤ 등록대상원료의약품에 관한 자료(해당하는 경우) | ② 제1항에도 불구하고 다음 각 호의 어느 하 | 10.  법 제50조의2제4항(법 제42조제4항에 따 | 능을 측정할 경우 0.739 MeV의 방사능 피크를 계수 | 및 그 분량, 효능효과에 맞추어 기재 | 정하는 바에 따라 품목별로 식품의약품안전처 | 4) 기준 및 시험방법이 기재된 자료 | 2.2.3 수수료 및 처리기한 ···································································6 | 내용을 단순 편집 또는 나열한 것입니까?  | 사용현황 | Iodine-123 (123I) | 13.27 시간 | 5.  약리작용에 관한 자료 |\n| 용하는 것이 필수적이지는 않다.  | 신약, 희귀 외 | 513,000원 | 570,000원 | nature and energy of the radiation) | 방사성핵종 제너레이터의 용출물, 방사성표지를 위한 | ② 제1항에 따라 기준 및 시험방법에 관한 자 | 수입품목누적량 | 정보에 대해서는 2012년도에 발간한 ｢ | 방사성핵종 불순물 피크로부터 분리되지 않아 나타나 | - 방사성 핵종 제너레이터: 특정 방법을 통하여 고정 | - 해당할 경우 특별한 저장 조건 | 등록대상 | 제31조제9항 또는 법 제42조에 따라 의약품등 | (3) 청정도 관리현황 | PET용 방사성의약품 평가 가이드라인｣ |\n| ⇨ | 민원서식 작성 | ⇨ | (｢ | 하여 몰리브덴-99의 방사능을 산출한다.  이 때 몰리 | (neutron)의 반응 | 장의 제조판매품목허가(이하 \"품목허가\"라 한 | 의약품등분류번호에관한규정 (식품의약품안전처 예규)｣ | 1 | 원료칭량 | 주성분 제조원 | 님을 증명하는 의사의 진단서 또는 같은 호 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
        "original_sentence": "| 사용현황 | Iodine-123 (123I) | 13.27 시간 | 5. "
      }
    },
    {
      "chunk_id": "chunk_057",
      "text": "약리작용에 관한 자료 |\n| 용하는 것이 필수적이지는 않다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 56,
        "window_size": 3,
        "char_count": 34,
        "word_count": 9,
        "page_number": 5,
        "window_text": "식품의약품안전처장이 성분의 종류·규격· | 3단계 | 다] 및 의약외품[내용고형제(內用固形濟) | 제외한다]의 경우에는 별표 1의2의 원료 | 4단계 | ⑤ 등록대상원료의약품에 관한 자료(해당하는 경우) | ② 제1항에도 불구하고 다음 각 호의 어느 하 | 10.  법 제50조의2제4항(법 제42조제4항에 따 | 능을 측정할 경우 0.739 MeV의 방사능 피크를 계수 | 및 그 분량, 효능효과에 맞추어 기재 | 정하는 바에 따라 품목별로 식품의약품안전처 | 4) 기준 및 시험방법이 기재된 자료 | 2.2.3 수수료 및 처리기한 ···································································6 | 내용을 단순 편집 또는 나열한 것입니까?  | 사용현황 | Iodine-123 (123I) | 13.27 시간 | 5.  약리작용에 관한 자료 |\n| 용하는 것이 필수적이지는 않다.  | 신약, 희귀 외 | 513,000원 | 570,000원 | nature and energy of the radiation) | 방사성핵종 제너레이터의 용출물, 방사성표지를 위한 | ② 제1항에 따라 기준 및 시험방법에 관한 자 | 수입품목누적량 | 정보에 대해서는 2012년도에 발간한 ｢ | 방사성핵종 불순물 피크로부터 분리되지 않아 나타나 | - 방사성 핵종 제너레이터: 특정 방법을 통하여 고정 | - 해당할 경우 특별한 저장 조건 | 등록대상 | 제31조제9항 또는 법 제42조에 따라 의약품등 | (3) 청정도 관리현황 | PET용 방사성의약품 평가 가이드라인｣ |\n| ⇨ | 민원서식 작성 | ⇨ | (｢ | 하여 몰리브덴-99의 방사능을 산출한다.  이 때 몰리 | (neutron)의 반응 | 장의 제조판매품목허가(이하 \"품목허가\"라 한 | 의약품등분류번호에관한규정 (식품의약품안전처 예규)｣ | 1 | 원료칭량 | 주성분 제조원 | 님을 증명하는 의사의 진단서 또는 같은 호 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | Iodine-125 (125I) | 59.402 일 | 참조) |\n| [민원인 안내서] | 신약 | 1,170,000원 | 1,300,000원 | 별표1 참조 | 화합물 또는 분자 내 방사성핵종 위치에 있는 원소 중 | (신청서, 구비서류) | 전자민원 신청 | 료를 제출하려는 자는 심사대상물품(식품의약 | 함량 및 처방 등을 표준화하여 고시한 표준 | 및 내용액제(內用液劑)만 해당한다]의 경 | 의약품 제조 및 품질관리기준 실시 상황 | - 사용량, 사용시간과 사용횟수 등을 구체적으로 기재 | ⑥ 주성분 제조업자의 명칭 및 소재지 등에 관한 자료 | 라) GMP 조직도 및 품질관리(보증)체계 관련 자료 | 된 어미방사성핵종(parent radionuclide)으로부터 딸 | 의 제조업자ᆞ수입자 또는 위탁제조판매업자가 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 여부 | 5) 기준 및 시험방법에 관한 근거자료 | 라 준용되는 경우를 포함한다)에 따라 의약 | KP | - | Oa) | 진 조건에 상응하는 조건을 붙일 수 있다. ",
        "original_sentence": "약리작용에 관한 자료 |\n| 용하는 것이 필수적이지는 않다. "
      }
    },
    {
      "chunk_id": "chunk_058",
      "text": "| 신약, 희귀 외 | 513,000원 | 570,000원 | nature and energy of the radiation) | 방사성핵종 제너레이터의 용출물, 방사성표지를 위한 | ② 제1항에 따라 기준 및 시험방법에 관한 자 | 수입품목누적량 | 정보에 대해서는 2012년도에 발간한 ｢ | 방사성핵종 불순물 피크로부터 분리되지 않아 나타나 | - 방사성 핵종 제너레이터: 특정 방법을 통하여 고정 | - 해당할 경우 특별한 저장 조건 | 등록대상 | 제31조제9항 또는 법 제42조에 따라 의약품등 | (3) 청정도 관리현황 | PET용 방사성의약품 평가 가이드라인｣ |\n| ⇨ | 민원서식 작성 | ⇨ | (｢ | 하여 몰리브덴-99의 방사능을 산출한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 57,
        "window_size": 3,
        "char_count": 372,
        "word_count": 94,
        "page_number": 3,
        "window_text": "법 제50조의2제4항(법 제42조제4항에 따 | 능을 측정할 경우 0.739 MeV의 방사능 피크를 계수 | 및 그 분량, 효능효과에 맞추어 기재 | 정하는 바에 따라 품목별로 식품의약품안전처 | 4) 기준 및 시험방법이 기재된 자료 | 2.2.3 수수료 및 처리기한 ···································································6 | 내용을 단순 편집 또는 나열한 것입니까?  | 사용현황 | Iodine-123 (123I) | 13.27 시간 | 5.  약리작용에 관한 자료 |\n| 용하는 것이 필수적이지는 않다.  | 신약, 희귀 외 | 513,000원 | 570,000원 | nature and energy of the radiation) | 방사성핵종 제너레이터의 용출물, 방사성표지를 위한 | ② 제1항에 따라 기준 및 시험방법에 관한 자 | 수입품목누적량 | 정보에 대해서는 2012년도에 발간한 ｢ | 방사성핵종 불순물 피크로부터 분리되지 않아 나타나 | - 방사성 핵종 제너레이터: 특정 방법을 통하여 고정 | - 해당할 경우 특별한 저장 조건 | 등록대상 | 제31조제9항 또는 법 제42조에 따라 의약품등 | (3) 청정도 관리현황 | PET용 방사성의약품 평가 가이드라인｣ |\n| ⇨ | 민원서식 작성 | ⇨ | (｢ | 하여 몰리브덴-99의 방사능을 산출한다.  이 때 몰리 | (neutron)의 반응 | 장의 제조판매품목허가(이하 \"품목허가\"라 한 | 의약품등분류번호에관한규정 (식품의약품안전처 예규)｣ | 1 | 원료칭량 | 주성분 제조원 | 님을 증명하는 의사의 진단서 또는 같은 호 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | Iodine-125 (125I) | 59.402 일 | 참조) |\n| [민원인 안내서] | 신약 | 1,170,000원 | 1,300,000원 | 별표1 참조 | 화합물 또는 분자 내 방사성핵종 위치에 있는 원소 중 | (신청서, 구비서류) | 전자민원 신청 | 료를 제출하려는 자는 심사대상물품(식품의약 | 함량 및 처방 등을 표준화하여 고시한 표준 | 및 내용액제(內用液劑)만 해당한다]의 경 | 의약품 제조 및 품질관리기준 실시 상황 | - 사용량, 사용시간과 사용횟수 등을 구체적으로 기재 | ⑥ 주성분 제조업자의 명칭 및 소재지 등에 관한 자료 | 라) GMP 조직도 및 품질관리(보증)체계 관련 자료 | 된 어미방사성핵종(parent radionuclide)으로부터 딸 | 의 제조업자ᆞ수입자 또는 위탁제조판매업자가 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 여부 | 5) 기준 및 시험방법에 관한 근거자료 | 라 준용되는 경우를 포함한다)에 따라 의약 | KP | - | Oa) | 진 조건에 상응하는 조건을 붙일 수 있다.  | 라 시험한다. ",
        "original_sentence": "| 신약, 희귀 외 | 513,000원 | 570,000원 | nature and energy of the radiation) | 방사성핵종 제너레이터의 용출물, 방사성표지를 위한 | ② 제1항에 따라 기준 및 시험방법에 관한 자 | 수입품목누적량 | 정보에 대해서는 2012년도에 발간한 ｢ | 방사성핵종 불순물 피크로부터 분리되지 않아 나타나 | - 방사성 핵종 제너레이터: 특정 방법을 통하여 고정 | - 해당할 경우 특별한 저장 조건 | 등록대상 | 제31조제9항 또는 법 제42조에 따라 의약품등 | (3) 청정도 관리현황 | PET용 방사성의약품 평가 가이드라인｣ |\n| ⇨ | 민원서식 작성 | ⇨ | (｢ | 하여 몰리브덴-99의 방사능을 산출한다. "
      }
    },
    {
      "chunk_id": "chunk_059",
      "text": "이 때 몰리 | (neutron)의 반응 | 장의 제조판매품목허가(이하 \"품목허가\"라 한 | 의약품등분류번호에관한규정 (식품의약품안전처 예규)｣ | 1 | 원료칭량 | 주성분 제조원 | 님을 증명하는 의사의 진단서 또는 같은 호 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 58,
        "window_size": 3,
        "char_count": 161,
        "word_count": 38,
        "page_number": 3,
        "window_text": "| 사용현황 | Iodine-123 (123I) | 13.27 시간 | 5.  약리작용에 관한 자료 |\n| 용하는 것이 필수적이지는 않다.  | 신약, 희귀 외 | 513,000원 | 570,000원 | nature and energy of the radiation) | 방사성핵종 제너레이터의 용출물, 방사성표지를 위한 | ② 제1항에 따라 기준 및 시험방법에 관한 자 | 수입품목누적량 | 정보에 대해서는 2012년도에 발간한 ｢ | 방사성핵종 불순물 피크로부터 분리되지 않아 나타나 | - 방사성 핵종 제너레이터: 특정 방법을 통하여 고정 | - 해당할 경우 특별한 저장 조건 | 등록대상 | 제31조제9항 또는 법 제42조에 따라 의약품등 | (3) 청정도 관리현황 | PET용 방사성의약품 평가 가이드라인｣ |\n| ⇨ | 민원서식 작성 | ⇨ | (｢ | 하여 몰리브덴-99의 방사능을 산출한다.  이 때 몰리 | (neutron)의 반응 | 장의 제조판매품목허가(이하 \"품목허가\"라 한 | 의약품등분류번호에관한규정 (식품의약품안전처 예규)｣ | 1 | 원료칭량 | 주성분 제조원 | 님을 증명하는 의사의 진단서 또는 같은 호 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | Iodine-125 (125I) | 59.402 일 | 참조) |\n| [민원인 안내서] | 신약 | 1,170,000원 | 1,300,000원 | 별표1 참조 | 화합물 또는 분자 내 방사성핵종 위치에 있는 원소 중 | (신청서, 구비서류) | 전자민원 신청 | 료를 제출하려는 자는 심사대상물품(식품의약 | 함량 및 처방 등을 표준화하여 고시한 표준 | 및 내용액제(內用液劑)만 해당한다]의 경 | 의약품 제조 및 품질관리기준 실시 상황 | - 사용량, 사용시간과 사용횟수 등을 구체적으로 기재 | ⑥ 주성분 제조업자의 명칭 및 소재지 등에 관한 자료 | 라) GMP 조직도 및 품질관리(보증)체계 관련 자료 | 된 어미방사성핵종(parent radionuclide)으로부터 딸 | 의 제조업자ᆞ수입자 또는 위탁제조판매업자가 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 여부 | 5) 기준 및 시험방법에 관한 근거자료 | 라 준용되는 경우를 포함한다)에 따라 의약 | KP | - | Oa) | 진 조건에 상응하는 조건을 붙일 수 있다.  | 라 시험한다.  | 가. ",
        "original_sentence": "이 때 몰리 | (neutron)의 반응 | 장의 제조판매품목허가(이하 \"품목허가\"라 한 | 의약품등분류번호에관한규정 (식품의약품안전처 예규)｣ | 1 | 원료칭량 | 주성분 제조원 | 님을 증명하는 의사의 진단서 또는 같은 호 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_060",
      "text": "| □ 예 | ■ 아니오 | Iodine-125 (125I) | 59.402 일 | 참조) |\n| [민원인 안내서] | 신약 | 1,170,000원 | 1,300,000원 | 별표1 참조 | 화합물 또는 분자 내 방사성핵종 위치에 있는 원소 중 | (신청서, 구비서류) | 전자민원 신청 | 료를 제출하려는 자는 심사대상물품(식품의약 | 함량 및 처방 등을 표준화하여 고시한 표준 | 및 내용액제(內用液劑)만 해당한다]의 경 | 의약품 제조 및 품질관리기준 실시 상황 | - 사용량, 사용시간과 사용횟수 등을 구체적으로 기재 | ⑥ 주성분 제조업자의 명칭 및 소재지 등에 관한 자료 | 라) GMP 조직도 및 품질관리(보증)체계 관련 자료 | 된 어미방사성핵종(parent radionuclide)으로부터 딸 | 의 제조업자ᆞ수입자 또는 위탁제조판매업자가 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 여부 | 5) 기준 및 시험방법에 관한 근거자료 | 라 준용되는 경우를 포함한다)에 따라 의약 | KP | - | Oa) | 진 조건에 상응하는 조건을 붙일 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 59,
        "window_size": 3,
        "char_count": 546,
        "word_count": 142,
        "page_number": 1,
        "window_text": "약리작용에 관한 자료 |\n| 용하는 것이 필수적이지는 않다.  | 신약, 희귀 외 | 513,000원 | 570,000원 | nature and energy of the radiation) | 방사성핵종 제너레이터의 용출물, 방사성표지를 위한 | ② 제1항에 따라 기준 및 시험방법에 관한 자 | 수입품목누적량 | 정보에 대해서는 2012년도에 발간한 ｢ | 방사성핵종 불순물 피크로부터 분리되지 않아 나타나 | - 방사성 핵종 제너레이터: 특정 방법을 통하여 고정 | - 해당할 경우 특별한 저장 조건 | 등록대상 | 제31조제9항 또는 법 제42조에 따라 의약품등 | (3) 청정도 관리현황 | PET용 방사성의약품 평가 가이드라인｣ |\n| ⇨ | 민원서식 작성 | ⇨ | (｢ | 하여 몰리브덴-99의 방사능을 산출한다.  이 때 몰리 | (neutron)의 반응 | 장의 제조판매품목허가(이하 \"품목허가\"라 한 | 의약품등분류번호에관한규정 (식품의약품안전처 예규)｣ | 1 | 원료칭량 | 주성분 제조원 | 님을 증명하는 의사의 진단서 또는 같은 호 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | Iodine-125 (125I) | 59.402 일 | 참조) |\n| [민원인 안내서] | 신약 | 1,170,000원 | 1,300,000원 | 별표1 참조 | 화합물 또는 분자 내 방사성핵종 위치에 있는 원소 중 | (신청서, 구비서류) | 전자민원 신청 | 료를 제출하려는 자는 심사대상물품(식품의약 | 함량 및 처방 등을 표준화하여 고시한 표준 | 및 내용액제(內用液劑)만 해당한다]의 경 | 의약품 제조 및 품질관리기준 실시 상황 | - 사용량, 사용시간과 사용횟수 등을 구체적으로 기재 | ⑥ 주성분 제조업자의 명칭 및 소재지 등에 관한 자료 | 라) GMP 조직도 및 품질관리(보증)체계 관련 자료 | 된 어미방사성핵종(parent radionuclide)으로부터 딸 | 의 제조업자ᆞ수입자 또는 위탁제조판매업자가 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 여부 | 5) 기준 및 시험방법에 관한 근거자료 | 라 준용되는 경우를 포함한다)에 따라 의약 | KP | - | Oa) | 진 조건에 상응하는 조건을 붙일 수 있다.  | 라 시험한다.  | 가.  효력시험자료 |\n| 방출된 | 방사선의 | 특성과 | 에너지는 | 분광광도법 | 용액 및 방사성의약품 제조를 위한 키트 또한 추가적 | 지 않을 수 있다. ",
        "original_sentence": "| □ 예 | ■ 아니오 | Iodine-125 (125I) | 59.402 일 | 참조) |\n| [민원인 안내서] | 신약 | 1,170,000원 | 1,300,000원 | 별표1 참조 | 화합물 또는 분자 내 방사성핵종 위치에 있는 원소 중 | (신청서, 구비서류) | 전자민원 신청 | 료를 제출하려는 자는 심사대상물품(식품의약 | 함량 및 처방 등을 표준화하여 고시한 표준 | 및 내용액제(內用液劑)만 해당한다]의 경 | 의약품 제조 및 품질관리기준 실시 상황 | - 사용량, 사용시간과 사용횟수 등을 구체적으로 기재 | ⑥ 주성분 제조업자의 명칭 및 소재지 등에 관한 자료 | 라) GMP 조직도 및 품질관리(보증)체계 관련 자료 | 된 어미방사성핵종(parent radionuclide)으로부터 딸 | 의 제조업자ᆞ수입자 또는 위탁제조판매업자가 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 여부 | 5) 기준 및 시험방법에 관한 근거자료 | 라 준용되는 경우를 포함한다)에 따라 의약 | KP | - | Oa) | 진 조건에 상응하는 조건을 붙일 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_061",
      "text": "| 라 시험한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 60,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 9,
        "window_text": "| 신약, 희귀 외 | 513,000원 | 570,000원 | nature and energy of the radiation) | 방사성핵종 제너레이터의 용출물, 방사성표지를 위한 | ② 제1항에 따라 기준 및 시험방법에 관한 자 | 수입품목누적량 | 정보에 대해서는 2012년도에 발간한 ｢ | 방사성핵종 불순물 피크로부터 분리되지 않아 나타나 | - 방사성 핵종 제너레이터: 특정 방법을 통하여 고정 | - 해당할 경우 특별한 저장 조건 | 등록대상 | 제31조제9항 또는 법 제42조에 따라 의약품등 | (3) 청정도 관리현황 | PET용 방사성의약품 평가 가이드라인｣ |\n| ⇨ | 민원서식 작성 | ⇨ | (｢ | 하여 몰리브덴-99의 방사능을 산출한다.  이 때 몰리 | (neutron)의 반응 | 장의 제조판매품목허가(이하 \"품목허가\"라 한 | 의약품등분류번호에관한규정 (식품의약품안전처 예규)｣ | 1 | 원료칭량 | 주성분 제조원 | 님을 증명하는 의사의 진단서 또는 같은 호 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | Iodine-125 (125I) | 59.402 일 | 참조) |\n| [민원인 안내서] | 신약 | 1,170,000원 | 1,300,000원 | 별표1 참조 | 화합물 또는 분자 내 방사성핵종 위치에 있는 원소 중 | (신청서, 구비서류) | 전자민원 신청 | 료를 제출하려는 자는 심사대상물품(식품의약 | 함량 및 처방 등을 표준화하여 고시한 표준 | 및 내용액제(內用液劑)만 해당한다]의 경 | 의약품 제조 및 품질관리기준 실시 상황 | - 사용량, 사용시간과 사용횟수 등을 구체적으로 기재 | ⑥ 주성분 제조업자의 명칭 및 소재지 등에 관한 자료 | 라) GMP 조직도 및 품질관리(보증)체계 관련 자료 | 된 어미방사성핵종(parent radionuclide)으로부터 딸 | 의 제조업자ᆞ수입자 또는 위탁제조판매업자가 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 여부 | 5) 기준 및 시험방법에 관한 근거자료 | 라 준용되는 경우를 포함한다)에 따라 의약 | KP | - | Oa) | 진 조건에 상응하는 조건을 붙일 수 있다.  | 라 시험한다.  | 가.  효력시험자료 |\n| 방출된 | 방사선의 | 특성과 | 에너지는 | 분광광도법 | 용액 및 방사성의약품 제조를 위한 키트 또한 추가적 | 지 않을 수 있다.  | 화학물질 전구체들은 첨부정보로 목표로 하는 양과 질 | - (사이클로트론 등의 가속기 내의 표적물질과) 하전 | 브덴-99의 방사능은 총방사능의 0.015 % 이하이다. ",
        "original_sentence": "| 라 시험한다. "
      }
    },
    {
      "chunk_id": "chunk_062",
      "text": "| 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 61,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 12,
        "window_text": "이 때 몰리 | (neutron)의 반응 | 장의 제조판매품목허가(이하 \"품목허가\"라 한 | 의약품등분류번호에관한규정 (식품의약품안전처 예규)｣ | 1 | 원료칭량 | 주성분 제조원 | 님을 증명하는 의사의 진단서 또는 같은 호 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | Iodine-125 (125I) | 59.402 일 | 참조) |\n| [민원인 안내서] | 신약 | 1,170,000원 | 1,300,000원 | 별표1 참조 | 화합물 또는 분자 내 방사성핵종 위치에 있는 원소 중 | (신청서, 구비서류) | 전자민원 신청 | 료를 제출하려는 자는 심사대상물품(식품의약 | 함량 및 처방 등을 표준화하여 고시한 표준 | 및 내용액제(內用液劑)만 해당한다]의 경 | 의약품 제조 및 품질관리기준 실시 상황 | - 사용량, 사용시간과 사용횟수 등을 구체적으로 기재 | ⑥ 주성분 제조업자의 명칭 및 소재지 등에 관한 자료 | 라) GMP 조직도 및 품질관리(보증)체계 관련 자료 | 된 어미방사성핵종(parent radionuclide)으로부터 딸 | 의 제조업자ᆞ수입자 또는 위탁제조판매업자가 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 여부 | 5) 기준 및 시험방법에 관한 근거자료 | 라 준용되는 경우를 포함한다)에 따라 의약 | KP | - | Oa) | 진 조건에 상응하는 조건을 붙일 수 있다.  | 라 시험한다.  | 가.  효력시험자료 |\n| 방출된 | 방사선의 | 특성과 | 에너지는 | 분광광도법 | 용액 및 방사성의약품 제조를 위한 키트 또한 추가적 | 지 않을 수 있다.  | 화학물질 전구체들은 첨부정보로 목표로 하는 양과 질 | - (사이클로트론 등의 가속기 내의 표적물질과) 하전 | 브덴-99의 방사능은 총방사능의 0.015 % 이하이다.  | 다)를 받거나 제조판매품목 신고(이하 \"품목신 | 단서에 해당하는 사람임을 증명하는 전문의 | 2.2.4 전자민원 신청방법 ·····································································7 | Iodine-126 (126I) | 13.11 일 | (명칭 및 소재지) |\n| 안정형 동위원소가 없는 제제 | 제조기준에 맞는 품목 | 우에는 별표 1의 의약품 제조 및 품질관 | 평가에 필요한 자료 | 마) 문서관리규정 및 문서 목록 | 그 허가받거나 신고한 사항을 변경하려는 경우 | 자료를 | 제출하지 | 아니할 | 수 | 있다. ",
        "original_sentence": "| 가. "
      }
    },
    {
      "chunk_id": "chunk_063",
      "text": "효력시험자료 |\n| 방출된 | 방사선의 | 특성과 | 에너지는 | 분광광도법 | 용액 및 방사성의약품 제조를 위한 키트 또한 추가적 | 지 않을 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 62,
        "window_size": 3,
        "char_count": 87,
        "word_count": 26,
        "page_number": 6,
        "window_text": "| □ 예 | ■ 아니오 | Iodine-125 (125I) | 59.402 일 | 참조) |\n| [민원인 안내서] | 신약 | 1,170,000원 | 1,300,000원 | 별표1 참조 | 화합물 또는 분자 내 방사성핵종 위치에 있는 원소 중 | (신청서, 구비서류) | 전자민원 신청 | 료를 제출하려는 자는 심사대상물품(식품의약 | 함량 및 처방 등을 표준화하여 고시한 표준 | 및 내용액제(內用液劑)만 해당한다]의 경 | 의약품 제조 및 품질관리기준 실시 상황 | - 사용량, 사용시간과 사용횟수 등을 구체적으로 기재 | ⑥ 주성분 제조업자의 명칭 및 소재지 등에 관한 자료 | 라) GMP 조직도 및 품질관리(보증)체계 관련 자료 | 된 어미방사성핵종(parent radionuclide)으로부터 딸 | 의 제조업자ᆞ수입자 또는 위탁제조판매업자가 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 여부 | 5) 기준 및 시험방법에 관한 근거자료 | 라 준용되는 경우를 포함한다)에 따라 의약 | KP | - | Oa) | 진 조건에 상응하는 조건을 붙일 수 있다.  | 라 시험한다.  | 가.  효력시험자료 |\n| 방출된 | 방사선의 | 특성과 | 에너지는 | 분광광도법 | 용액 및 방사성의약품 제조를 위한 키트 또한 추가적 | 지 않을 수 있다.  | 화학물질 전구체들은 첨부정보로 목표로 하는 양과 질 | - (사이클로트론 등의 가속기 내의 표적물질과) 하전 | 브덴-99의 방사능은 총방사능의 0.015 % 이하이다.  | 다)를 받거나 제조판매품목 신고(이하 \"품목신 | 단서에 해당하는 사람임을 증명하는 전문의 | 2.2.4 전자민원 신청방법 ·····································································7 | Iodine-126 (126I) | 13.11 일 | (명칭 및 소재지) |\n| 안정형 동위원소가 없는 제제 | 제조기준에 맞는 품목 | 우에는 별표 1의 의약품 제조 및 품질관 | 평가에 필요한 자료 | 마) 문서관리규정 및 문서 목록 | 그 허가받거나 신고한 사항을 변경하려는 경우 | 자료를 | 제출하지 | 아니할 | 수 | 있다.  | <개정 | 6) 시험성적에 관한 자료 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | 공정서 | O | Oa) | Iodine-131 (131I) | 8.02070 일 |\n| 희귀 | 877,000원 | 975,000원 | (spectrometry)을 이용하여 측정한다. ",
        "original_sentence": "효력시험자료 |\n| 방출된 | 방사선의 | 특성과 | 에너지는 | 분광광도법 | 용액 및 방사성의약품 제조를 위한 키트 또한 추가적 | 지 않을 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_064",
      "text": "| 화학물질 전구체들은 첨부정보로 목표로 하는 양과 질 | - (사이클로트론 등의 가속기 내의 표적물질과) 하전 | 브덴-99의 방사능은 총방사능의 0.015 % 이하이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 63,
        "window_size": 3,
        "char_count": 97,
        "word_count": 23,
        "page_number": 3,
        "window_text": "| 라 시험한다.  | 가.  효력시험자료 |\n| 방출된 | 방사선의 | 특성과 | 에너지는 | 분광광도법 | 용액 및 방사성의약품 제조를 위한 키트 또한 추가적 | 지 않을 수 있다.  | 화학물질 전구체들은 첨부정보로 목표로 하는 양과 질 | - (사이클로트론 등의 가속기 내의 표적물질과) 하전 | 브덴-99의 방사능은 총방사능의 0.015 % 이하이다.  | 다)를 받거나 제조판매품목 신고(이하 \"품목신 | 단서에 해당하는 사람임을 증명하는 전문의 | 2.2.4 전자민원 신청방법 ·····································································7 | Iodine-126 (126I) | 13.11 일 | (명칭 및 소재지) |\n| 안정형 동위원소가 없는 제제 | 제조기준에 맞는 품목 | 우에는 별표 1의 의약품 제조 및 품질관 | 평가에 필요한 자료 | 마) 문서관리규정 및 문서 목록 | 그 허가받거나 신고한 사항을 변경하려는 경우 | 자료를 | 제출하지 | 아니할 | 수 | 있다.  | <개정 | 6) 시험성적에 관한 자료 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | 공정서 | O | Oa) | Iodine-131 (131I) | 8.02070 일 |\n| 희귀 | 877,000원 | 975,000원 | (spectrometry)을 이용하여 측정한다.  | 양전자방출핵 | 인 정제 없이 비경구용으로 사용된다면 엔도톡신시험 | 품안전처장이 품질검사를 위하여 특별히 필요 | ⇩ | 감마선이나 엑스선을 방출하지 않는 알파 그리고 베타 | 의 방사성의약품을 생산하도록 보장하기 위해 방사성 | 3) 알루미늄  이 약 3.0 mL 및 알루미늄표준액 1.5 | 방사성핵종(daughter radionuclide)을 유출시켜 얻 | 분류 | 국내최초 | 의 진단서 및 같은 조 제3호에 해당하는 사 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | X | O | ː | ː | ː | 쇄된 날부터 1년이 지나지 아니한 자 | □ 예 | ■ 아니오 |\n| 7단계 | 다. ",
        "original_sentence": "| 화학물질 전구체들은 첨부정보로 목표로 하는 양과 질 | - (사이클로트론 등의 가속기 내의 표적물질과) 하전 | 브덴-99의 방사능은 총방사능의 0.015 % 이하이다. "
      }
    },
    {
      "chunk_id": "chunk_065",
      "text": "| 다)를 받거나 제조판매품목 신고(이하 \"품목신 | 단서에 해당하는 사람임을 증명하는 전문의 | 2.2.4 전자민원 신청방법 ·····································································7 | Iodine-126 (126I) | 13.11 일 | (명칭 및 소재지) |\n| 안정형 동위원소가 없는 제제 | 제조기준에 맞는 품목 | 우에는 별표 1의 의약품 제조 및 품질관 | 평가에 필요한 자료 | 마) 문서관리규정 및 문서 목록 | 그 허가받거나 신고한 사항을 변경하려는 경우 | 자료를 | 제출하지 | 아니할 | 수 | 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 64,
        "window_size": 3,
        "char_count": 333,
        "word_count": 72,
        "page_number": 3,
        "window_text": "| 가.  효력시험자료 |\n| 방출된 | 방사선의 | 특성과 | 에너지는 | 분광광도법 | 용액 및 방사성의약품 제조를 위한 키트 또한 추가적 | 지 않을 수 있다.  | 화학물질 전구체들은 첨부정보로 목표로 하는 양과 질 | - (사이클로트론 등의 가속기 내의 표적물질과) 하전 | 브덴-99의 방사능은 총방사능의 0.015 % 이하이다.  | 다)를 받거나 제조판매품목 신고(이하 \"품목신 | 단서에 해당하는 사람임을 증명하는 전문의 | 2.2.4 전자민원 신청방법 ·····································································7 | Iodine-126 (126I) | 13.11 일 | (명칭 및 소재지) |\n| 안정형 동위원소가 없는 제제 | 제조기준에 맞는 품목 | 우에는 별표 1의 의약품 제조 및 품질관 | 평가에 필요한 자료 | 마) 문서관리규정 및 문서 목록 | 그 허가받거나 신고한 사항을 변경하려는 경우 | 자료를 | 제출하지 | 아니할 | 수 | 있다.  | <개정 | 6) 시험성적에 관한 자료 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | 공정서 | O | Oa) | Iodine-131 (131I) | 8.02070 일 |\n| 희귀 | 877,000원 | 975,000원 | (spectrometry)을 이용하여 측정한다.  | 양전자방출핵 | 인 정제 없이 비경구용으로 사용된다면 엔도톡신시험 | 품안전처장이 품질검사를 위하여 특별히 필요 | ⇩ | 감마선이나 엑스선을 방출하지 않는 알파 그리고 베타 | 의 방사성의약품을 생산하도록 보장하기 위해 방사성 | 3) 알루미늄  이 약 3.0 mL 및 알루미늄표준액 1.5 | 방사성핵종(daughter radionuclide)을 유출시켜 얻 | 분류 | 국내최초 | 의 진단서 및 같은 조 제3호에 해당하는 사 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | X | O | ː | ː | ː | 쇄된 날부터 1년이 지나지 아니한 자 | □ 예 | ■ 아니오 |\n| 7단계 | 다.  생물학적제제등인 경우에는 별표 1의 의 | 4. ",
        "original_sentence": "| 다)를 받거나 제조판매품목 신고(이하 \"품목신 | 단서에 해당하는 사람임을 증명하는 전문의 | 2.2.4 전자민원 신청방법 ·····································································7 | Iodine-126 (126I) | 13.11 일 | (명칭 및 소재지) |\n| 안정형 동위원소가 없는 제제 | 제조기준에 맞는 품목 | 우에는 별표 1의 의약품 제조 및 품질관 | 평가에 필요한 자료 | 마) 문서관리규정 및 문서 목록 | 그 허가받거나 신고한 사항을 변경하려는 경우 | 자료를 | 제출하지 | 아니할 | 수 | 있다. "
      }
    },
    {
      "chunk_id": "chunk_066",
      "text": "| <개정 | 6) 시험성적에 관한 자료 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | 공정서 | O | Oa) | Iodine-131 (131I) | 8.02070 일 |\n| 희귀 | 877,000원 | 975,000원 | (spectrometry)을 이용하여 측정한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 65,
        "window_size": 3,
        "char_count": 155,
        "word_count": 35,
        "page_number": 3,
        "window_text": "효력시험자료 |\n| 방출된 | 방사선의 | 특성과 | 에너지는 | 분광광도법 | 용액 및 방사성의약품 제조를 위한 키트 또한 추가적 | 지 않을 수 있다.  | 화학물질 전구체들은 첨부정보로 목표로 하는 양과 질 | - (사이클로트론 등의 가속기 내의 표적물질과) 하전 | 브덴-99의 방사능은 총방사능의 0.015 % 이하이다.  | 다)를 받거나 제조판매품목 신고(이하 \"품목신 | 단서에 해당하는 사람임을 증명하는 전문의 | 2.2.4 전자민원 신청방법 ·····································································7 | Iodine-126 (126I) | 13.11 일 | (명칭 및 소재지) |\n| 안정형 동위원소가 없는 제제 | 제조기준에 맞는 품목 | 우에는 별표 1의 의약품 제조 및 품질관 | 평가에 필요한 자료 | 마) 문서관리규정 및 문서 목록 | 그 허가받거나 신고한 사항을 변경하려는 경우 | 자료를 | 제출하지 | 아니할 | 수 | 있다.  | <개정 | 6) 시험성적에 관한 자료 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | 공정서 | O | Oa) | Iodine-131 (131I) | 8.02070 일 |\n| 희귀 | 877,000원 | 975,000원 | (spectrometry)을 이용하여 측정한다.  | 양전자방출핵 | 인 정제 없이 비경구용으로 사용된다면 엔도톡신시험 | 품안전처장이 품질검사를 위하여 특별히 필요 | ⇩ | 감마선이나 엑스선을 방출하지 않는 알파 그리고 베타 | 의 방사성의약품을 생산하도록 보장하기 위해 방사성 | 3) 알루미늄  이 약 3.0 mL 및 알루미늄표준액 1.5 | 방사성핵종(daughter radionuclide)을 유출시켜 얻 | 분류 | 국내최초 | 의 진단서 및 같은 조 제3호에 해당하는 사 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | X | O | ː | ː | ː | 쇄된 날부터 1년이 지나지 아니한 자 | □ 예 | ■ 아니오 |\n| 7단계 | 다.  생물학적제제등인 경우에는 별표 1의 의 | 4.  식품의약품안전처장이 따로 기준 및 시험방 | 6단계 | 리기준 실시상황 평가에 필요한 자료 | 5단계 | ⑦ 위탁․수탁제조계약서(위탁제조하는 경우) | 입자(charged particle)들의 반응 | 고\"라 한다)를 하여야 한다. ",
        "original_sentence": "| <개정 | 6) 시험성적에 관한 자료 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | 공정서 | O | Oa) | Iodine-131 (131I) | 8.02070 일 |\n| 희귀 | 877,000원 | 975,000원 | (spectrometry)을 이용하여 측정한다. "
      }
    },
    {
      "chunk_id": "chunk_067",
      "text": "| 양전자방출핵 | 인 정제 없이 비경구용으로 사용된다면 엔도톡신시험 | 품안전처장이 품질검사를 위하여 특별히 필요 | ⇩ | 감마선이나 엑스선을 방출하지 않는 알파 그리고 베타 | 의 방사성의약품을 생산하도록 보장하기 위해 방사성 | 3) 알루미늄  이 약 3.0 mL 및 알루미늄표준액 1.5 | 방사성핵종(daughter radionuclide)을 유출시켜 얻 | 분류 | 국내최초 | 의 진단서 및 같은 조 제3호에 해당하는 사 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | X | O | ː | ː | ː | 쇄된 날부터 1년이 지나지 아니한 자 | □ 예 | ■ 아니오 |\n| 7단계 | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 66,
        "window_size": 3,
        "char_count": 350,
        "word_count": 98,
        "page_number": 5,
        "window_text": "| 화학물질 전구체들은 첨부정보로 목표로 하는 양과 질 | - (사이클로트론 등의 가속기 내의 표적물질과) 하전 | 브덴-99의 방사능은 총방사능의 0.015 % 이하이다.  | 다)를 받거나 제조판매품목 신고(이하 \"품목신 | 단서에 해당하는 사람임을 증명하는 전문의 | 2.2.4 전자민원 신청방법 ·····································································7 | Iodine-126 (126I) | 13.11 일 | (명칭 및 소재지) |\n| 안정형 동위원소가 없는 제제 | 제조기준에 맞는 품목 | 우에는 별표 1의 의약품 제조 및 품질관 | 평가에 필요한 자료 | 마) 문서관리규정 및 문서 목록 | 그 허가받거나 신고한 사항을 변경하려는 경우 | 자료를 | 제출하지 | 아니할 | 수 | 있다.  | <개정 | 6) 시험성적에 관한 자료 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | 공정서 | O | Oa) | Iodine-131 (131I) | 8.02070 일 |\n| 희귀 | 877,000원 | 975,000원 | (spectrometry)을 이용하여 측정한다.  | 양전자방출핵 | 인 정제 없이 비경구용으로 사용된다면 엔도톡신시험 | 품안전처장이 품질검사를 위하여 특별히 필요 | ⇩ | 감마선이나 엑스선을 방출하지 않는 알파 그리고 베타 | 의 방사성의약품을 생산하도록 보장하기 위해 방사성 | 3) 알루미늄  이 약 3.0 mL 및 알루미늄표준액 1.5 | 방사성핵종(daughter radionuclide)을 유출시켜 얻 | 분류 | 국내최초 | 의 진단서 및 같은 조 제3호에 해당하는 사 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | X | O | ː | ː | ː | 쇄된 날부터 1년이 지나지 아니한 자 | □ 예 | ■ 아니오 |\n| 7단계 | 다.  생물학적제제등인 경우에는 별표 1의 의 | 4.  식품의약품안전처장이 따로 기준 및 시험방 | 6단계 | 리기준 실시상황 평가에 필요한 자료 | 5단계 | ⑦ 위탁․수탁제조계약서(위탁제조하는 경우) | 입자(charged particle)들의 반응 | 고\"라 한다)를 하여야 한다.  <개정 2013.3.23.> | 2014.10.10.> | 의약품에 관한 특허권(이하 \"의약품특허권\" | 2.3 품목허가 신청서 작성 요령 ··························································8 | Xenon-131m (131mXe) | 11.84 일 |\n| 신약, 희귀 외 | 306,000원 | 340,000원 | 3 | 4 | 하다고 인정하는 경우에만 해당한다)을 식품의 | 1.2 국내 방사성의약품 품목허가 현황 | 바) 신청품목과 관련된 제품표준서 및 제조ㆍ품질관리기록서 사본 | mL를 취하여 각각 물 2 mL, 3.5 mL 및 용시 조제 | (제4조제1항제7호 각 목 외의 부분 본문 또는 | 7) 표준품 및 시약․시액에 관한 자료 | 람이 아님을 증명하는 의사의 진단서 | 내용입니까? ",
        "original_sentence": "| 양전자방출핵 | 인 정제 없이 비경구용으로 사용된다면 엔도톡신시험 | 품안전처장이 품질검사를 위하여 특별히 필요 | ⇩ | 감마선이나 엑스선을 방출하지 않는 알파 그리고 베타 | 의 방사성의약품을 생산하도록 보장하기 위해 방사성 | 3) 알루미늄  이 약 3.0 mL 및 알루미늄표준액 1.5 | 방사성핵종(daughter radionuclide)을 유출시켜 얻 | 분류 | 국내최초 | 의 진단서 및 같은 조 제3호에 해당하는 사 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | X | O | ː | ː | ː | 쇄된 날부터 1년이 지나지 아니한 자 | □ 예 | ■ 아니오 |\n| 7단계 | 다. "
      }
    },
    {
      "chunk_id": "chunk_068",
      "text": "생물학적제제등인 경우에는 별표 1의 의 | 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 67,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| 다)를 받거나 제조판매품목 신고(이하 \"품목신 | 단서에 해당하는 사람임을 증명하는 전문의 | 2.2.4 전자민원 신청방법 ·····································································7 | Iodine-126 (126I) | 13.11 일 | (명칭 및 소재지) |\n| 안정형 동위원소가 없는 제제 | 제조기준에 맞는 품목 | 우에는 별표 1의 의약품 제조 및 품질관 | 평가에 필요한 자료 | 마) 문서관리규정 및 문서 목록 | 그 허가받거나 신고한 사항을 변경하려는 경우 | 자료를 | 제출하지 | 아니할 | 수 | 있다.  | <개정 | 6) 시험성적에 관한 자료 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | 공정서 | O | Oa) | Iodine-131 (131I) | 8.02070 일 |\n| 희귀 | 877,000원 | 975,000원 | (spectrometry)을 이용하여 측정한다.  | 양전자방출핵 | 인 정제 없이 비경구용으로 사용된다면 엔도톡신시험 | 품안전처장이 품질검사를 위하여 특별히 필요 | ⇩ | 감마선이나 엑스선을 방출하지 않는 알파 그리고 베타 | 의 방사성의약품을 생산하도록 보장하기 위해 방사성 | 3) 알루미늄  이 약 3.0 mL 및 알루미늄표준액 1.5 | 방사성핵종(daughter radionuclide)을 유출시켜 얻 | 분류 | 국내최초 | 의 진단서 및 같은 조 제3호에 해당하는 사 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | X | O | ː | ː | ː | 쇄된 날부터 1년이 지나지 아니한 자 | □ 예 | ■ 아니오 |\n| 7단계 | 다.  생물학적제제등인 경우에는 별표 1의 의 | 4.  식품의약품안전처장이 따로 기준 및 시험방 | 6단계 | 리기준 실시상황 평가에 필요한 자료 | 5단계 | ⑦ 위탁․수탁제조계약서(위탁제조하는 경우) | 입자(charged particle)들의 반응 | 고\"라 한다)를 하여야 한다.  <개정 2013.3.23.> | 2014.10.10.> | 의약품에 관한 특허권(이하 \"의약품특허권\" | 2.3 품목허가 신청서 작성 요령 ··························································8 | Xenon-131m (131mXe) | 11.84 일 |\n| 신약, 희귀 외 | 306,000원 | 340,000원 | 3 | 4 | 하다고 인정하는 경우에만 해당한다)을 식품의 | 1.2 국내 방사성의약품 품목허가 현황 | 바) 신청품목과 관련된 제품표준서 및 제조ㆍ품질관리기록서 사본 | mL를 취하여 각각 물 2 mL, 3.5 mL 및 용시 조제 | (제4조제1항제7호 각 목 외의 부분 본문 또는 | 7) 표준품 및 시약․시액에 관한 자료 | 람이 아님을 증명하는 의사의 진단서 | 내용입니까?  | 자사기준 | - | Ob) | 3. ",
        "original_sentence": "생물학적제제등인 경우에는 별표 1의 의 | 4. "
      }
    },
    {
      "chunk_id": "chunk_069",
      "text": "식품의약품안전처장이 따로 기준 및 시험방 | 6단계 | 리기준 실시상황 평가에 필요한 자료 | 5단계 | ⑦ 위탁․수탁제조계약서(위탁제조하는 경우) | 입자(charged particle)들의 반응 | 고\"라 한다)를 하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 68,
        "window_size": 3,
        "char_count": 130,
        "word_count": 28,
        "page_number": 3,
        "window_text": "| <개정 | 6) 시험성적에 관한 자료 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | 공정서 | O | Oa) | Iodine-131 (131I) | 8.02070 일 |\n| 희귀 | 877,000원 | 975,000원 | (spectrometry)을 이용하여 측정한다.  | 양전자방출핵 | 인 정제 없이 비경구용으로 사용된다면 엔도톡신시험 | 품안전처장이 품질검사를 위하여 특별히 필요 | ⇩ | 감마선이나 엑스선을 방출하지 않는 알파 그리고 베타 | 의 방사성의약품을 생산하도록 보장하기 위해 방사성 | 3) 알루미늄  이 약 3.0 mL 및 알루미늄표준액 1.5 | 방사성핵종(daughter radionuclide)을 유출시켜 얻 | 분류 | 국내최초 | 의 진단서 및 같은 조 제3호에 해당하는 사 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | X | O | ː | ː | ː | 쇄된 날부터 1년이 지나지 아니한 자 | □ 예 | ■ 아니오 |\n| 7단계 | 다.  생물학적제제등인 경우에는 별표 1의 의 | 4.  식품의약품안전처장이 따로 기준 및 시험방 | 6단계 | 리기준 실시상황 평가에 필요한 자료 | 5단계 | ⑦ 위탁․수탁제조계약서(위탁제조하는 경우) | 입자(charged particle)들의 반응 | 고\"라 한다)를 하여야 한다.  <개정 2013.3.23.> | 2014.10.10.> | 의약품에 관한 특허권(이하 \"의약품특허권\" | 2.3 품목허가 신청서 작성 요령 ··························································8 | Xenon-131m (131mXe) | 11.84 일 |\n| 신약, 희귀 외 | 306,000원 | 340,000원 | 3 | 4 | 하다고 인정하는 경우에만 해당한다)을 식품의 | 1.2 국내 방사성의약품 품목허가 현황 | 바) 신청품목과 관련된 제품표준서 및 제조ㆍ품질관리기록서 사본 | mL를 취하여 각각 물 2 mL, 3.5 mL 및 용시 조제 | (제4조제1항제7호 각 목 외의 부분 본문 또는 | 7) 표준품 및 시약․시액에 관한 자료 | 람이 아님을 증명하는 의사의 진단서 | 내용입니까?  | 자사기준 | - | Ob) | 3.  파산선고를 받고 복권되지 아니한 자 | 저 장 법  밀봉용기, 차폐. ",
        "original_sentence": "식품의약품안전처장이 따로 기준 및 시험방 | 6단계 | 리기준 실시상황 평가에 필요한 자료 | 5단계 | ⑦ 위탁․수탁제조계약서(위탁제조하는 경우) | 입자(charged particle)들의 반응 | 고\"라 한다)를 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_070",
      "text": "<개정 2013.3.23.> | 2014.10.10.> | 의약품에 관한 특허권(이하 \"의약품특허권\" | 2.3 품목허가 신청서 작성 요령 ··························································8 | Xenon-131m (131mXe) | 11.84 일 |\n| 신약, 희귀 외 | 306,000원 | 340,000원 | 3 | 4 | 하다고 인정하는 경우에만 해당한다)을 식품의 | 1.2 국내 방사성의약품 품목허가 현황 | 바) 신청품목과 관련된 제품표준서 및 제조ㆍ품질관리기록서 사본 | mL를 취하여 각각 물 2 mL, 3.5 mL 및 용시 조제 | (제4조제1항제7호 각 목 외의 부분 본문 또는 | 7) 표준품 및 시약․시액에 관한 자료 | 람이 아님을 증명하는 의사의 진단서 | 내용입니까? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 69,
        "window_size": 3,
        "char_count": 421,
        "word_count": 90,
        "page_number": 3,
        "window_text": "| 양전자방출핵 | 인 정제 없이 비경구용으로 사용된다면 엔도톡신시험 | 품안전처장이 품질검사를 위하여 특별히 필요 | ⇩ | 감마선이나 엑스선을 방출하지 않는 알파 그리고 베타 | 의 방사성의약품을 생산하도록 보장하기 위해 방사성 | 3) 알루미늄  이 약 3.0 mL 및 알루미늄표준액 1.5 | 방사성핵종(daughter radionuclide)을 유출시켜 얻 | 분류 | 국내최초 | 의 진단서 및 같은 조 제3호에 해당하는 사 | □ 1년 이내 한시적 적용 또는 일회성 지시·명령에 해당하는 | X | O | ː | ː | ː | 쇄된 날부터 1년이 지나지 아니한 자 | □ 예 | ■ 아니오 |\n| 7단계 | 다.  생물학적제제등인 경우에는 별표 1의 의 | 4.  식품의약품안전처장이 따로 기준 및 시험방 | 6단계 | 리기준 실시상황 평가에 필요한 자료 | 5단계 | ⑦ 위탁․수탁제조계약서(위탁제조하는 경우) | 입자(charged particle)들의 반응 | 고\"라 한다)를 하여야 한다.  <개정 2013.3.23.> | 2014.10.10.> | 의약품에 관한 특허권(이하 \"의약품특허권\" | 2.3 품목허가 신청서 작성 요령 ··························································8 | Xenon-131m (131mXe) | 11.84 일 |\n| 신약, 희귀 외 | 306,000원 | 340,000원 | 3 | 4 | 하다고 인정하는 경우에만 해당한다)을 식품의 | 1.2 국내 방사성의약품 품목허가 현황 | 바) 신청품목과 관련된 제품표준서 및 제조ㆍ품질관리기록서 사본 | mL를 취하여 각각 물 2 mL, 3.5 mL 및 용시 조제 | (제4조제1항제7호 각 목 외의 부분 본문 또는 | 7) 표준품 및 시약․시액에 관한 자료 | 람이 아님을 증명하는 의사의 진단서 | 내용입니까?  | 자사기준 | - | Ob) | 3.  파산선고를 받고 복권되지 아니한 자 | 저 장 법  밀봉용기, 차폐.  | 다. ",
        "original_sentence": "<개정 2013.3.23.> | 2014.10.10.> | 의약품에 관한 특허권(이하 \"의약품특허권\" | 2.3 품목허가 신청서 작성 요령 ··························································8 | Xenon-131m (131mXe) | 11.84 일 |\n| 신약, 희귀 외 | 306,000원 | 340,000원 | 3 | 4 | 하다고 인정하는 경우에만 해당한다)을 식품의 | 1.2 국내 방사성의약품 품목허가 현황 | 바) 신청품목과 관련된 제품표준서 및 제조ㆍ품질관리기록서 사본 | mL를 취하여 각각 물 2 mL, 3.5 mL 및 용시 조제 | (제4조제1항제7호 각 목 외의 부분 본문 또는 | 7) 표준품 및 시약․시액에 관한 자료 | 람이 아님을 증명하는 의사의 진단서 | 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_071",
      "text": "| 자사기준 | - | Ob) | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 70,
        "window_size": 3,
        "char_count": 22,
        "word_count": 8,
        "page_number": 3,
        "window_text": "생물학적제제등인 경우에는 별표 1의 의 | 4.  식품의약품안전처장이 따로 기준 및 시험방 | 6단계 | 리기준 실시상황 평가에 필요한 자료 | 5단계 | ⑦ 위탁․수탁제조계약서(위탁제조하는 경우) | 입자(charged particle)들의 반응 | 고\"라 한다)를 하여야 한다.  <개정 2013.3.23.> | 2014.10.10.> | 의약품에 관한 특허권(이하 \"의약품특허권\" | 2.3 품목허가 신청서 작성 요령 ··························································8 | Xenon-131m (131mXe) | 11.84 일 |\n| 신약, 희귀 외 | 306,000원 | 340,000원 | 3 | 4 | 하다고 인정하는 경우에만 해당한다)을 식품의 | 1.2 국내 방사성의약품 품목허가 현황 | 바) 신청품목과 관련된 제품표준서 및 제조ㆍ품질관리기록서 사본 | mL를 취하여 각각 물 2 mL, 3.5 mL 및 용시 조제 | (제4조제1항제7호 각 목 외의 부분 본문 또는 | 7) 표준품 및 시약․시액에 관한 자료 | 람이 아님을 증명하는 의사의 진단서 | 내용입니까?  | 자사기준 | - | Ob) | 3.  파산선고를 받고 복권되지 아니한 자 | 저 장 법  밀봉용기, 차폐.  | 다.  흡수, 분포, 대사 및 배설시험자료 |\n| ⇦ | (positron emitter)의 방사선 특성과 에너지는 보통 측 | 에 적합하여야 한다. ",
        "original_sentence": "| 자사기준 | - | Ob) | 3. "
      }
    },
    {
      "chunk_id": "chunk_072",
      "text": "파산선고를 받고 복권되지 아니한 자 | 저 장 법  밀봉용기, 차폐. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 71,
        "window_size": 3,
        "char_count": 39,
        "word_count": 11,
        "page_number": 10,
        "window_text": "식품의약품안전처장이 따로 기준 및 시험방 | 6단계 | 리기준 실시상황 평가에 필요한 자료 | 5단계 | ⑦ 위탁․수탁제조계약서(위탁제조하는 경우) | 입자(charged particle)들의 반응 | 고\"라 한다)를 하여야 한다.  <개정 2013.3.23.> | 2014.10.10.> | 의약품에 관한 특허권(이하 \"의약품특허권\" | 2.3 품목허가 신청서 작성 요령 ··························································8 | Xenon-131m (131mXe) | 11.84 일 |\n| 신약, 희귀 외 | 306,000원 | 340,000원 | 3 | 4 | 하다고 인정하는 경우에만 해당한다)을 식품의 | 1.2 국내 방사성의약품 품목허가 현황 | 바) 신청품목과 관련된 제품표준서 및 제조ㆍ품질관리기록서 사본 | mL를 취하여 각각 물 2 mL, 3.5 mL 및 용시 조제 | (제4조제1항제7호 각 목 외의 부분 본문 또는 | 7) 표준품 및 시약․시액에 관한 자료 | 람이 아님을 증명하는 의사의 진단서 | 내용입니까?  | 자사기준 | - | Ob) | 3.  파산선고를 받고 복권되지 아니한 자 | 저 장 법  밀봉용기, 차폐.  | 다.  흡수, 분포, 대사 및 배설시험자료 |\n| ⇦ | (positron emitter)의 방사선 특성과 에너지는 보통 측 | 에 적합하여야 한다.  | ⇦ | 입자 방출 불순물들은 이러한 방법으로 측정할 수 없 | 의약품 제조에 사용하기 전에 1개 이상의 제품을 시험 | - 방사성핵종 제너레이터로 부터의 유출 | - 전문/일반의약품 중 방사성의약품은 전문의약품에 해당 | ③ 제1항에 따른 제조업자 외의 자가 제34조제 | 1. ",
        "original_sentence": "파산선고를 받고 복권되지 아니한 자 | 저 장 법  밀봉용기, 차폐. "
      }
    },
    {
      "chunk_id": "chunk_073",
      "text": "| 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 72,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 9,
        "window_text": "<개정 2013.3.23.> | 2014.10.10.> | 의약품에 관한 특허권(이하 \"의약품특허권\" | 2.3 품목허가 신청서 작성 요령 ··························································8 | Xenon-131m (131mXe) | 11.84 일 |\n| 신약, 희귀 외 | 306,000원 | 340,000원 | 3 | 4 | 하다고 인정하는 경우에만 해당한다)을 식품의 | 1.2 국내 방사성의약품 품목허가 현황 | 바) 신청품목과 관련된 제품표준서 및 제조ㆍ품질관리기록서 사본 | mL를 취하여 각각 물 2 mL, 3.5 mL 및 용시 조제 | (제4조제1항제7호 각 목 외의 부분 본문 또는 | 7) 표준품 및 시약․시액에 관한 자료 | 람이 아님을 증명하는 의사의 진단서 | 내용입니까?  | 자사기준 | - | Ob) | 3.  파산선고를 받고 복권되지 아니한 자 | 저 장 법  밀봉용기, 차폐.  | 다.  흡수, 분포, 대사 및 배설시험자료 |\n| ⇦ | (positron emitter)의 방사선 특성과 에너지는 보통 측 | 에 적합하여야 한다.  | ⇦ | 입자 방출 불순물들은 이러한 방법으로 측정할 수 없 | 의약품 제조에 사용하기 전에 1개 이상의 제품을 시험 | - 방사성핵종 제너레이터로 부터의 유출 | - 전문/일반의약품 중 방사성의약품은 전문의약품에 해당 | ③ 제1항에 따른 제조업자 외의 자가 제34조제 | 1.  제1항제1호 또는 제2호에 해당하는 자료로 | 을 수 있도록 한 방사성의약품 시스템 | 기재 | 되었다. ",
        "original_sentence": "| 다. "
      }
    },
    {
      "chunk_id": "chunk_074",
      "text": "흡수, 분포, 대사 및 배설시험자료 |\n| ⇦ | (positron emitter)의 방사선 특성과 에너지는 보통 측 | 에 적합하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 73,
        "window_size": 3,
        "char_count": 80,
        "word_count": 20,
        "page_number": 5,
        "window_text": "| 자사기준 | - | Ob) | 3.  파산선고를 받고 복권되지 아니한 자 | 저 장 법  밀봉용기, 차폐.  | 다.  흡수, 분포, 대사 및 배설시험자료 |\n| ⇦ | (positron emitter)의 방사선 특성과 에너지는 보통 측 | 에 적합하여야 한다.  | ⇦ | 입자 방출 불순물들은 이러한 방법으로 측정할 수 없 | 의약품 제조에 사용하기 전에 1개 이상의 제품을 시험 | - 방사성핵종 제너레이터로 부터의 유출 | - 전문/일반의약품 중 방사성의약품은 전문의약품에 해당 | ③ 제1항에 따른 제조업자 외의 자가 제34조제 | 1.  제1항제1호 또는 제2호에 해당하는 자료로 | 을 수 있도록 한 방사성의약품 시스템 | 기재 | 되었다.  | Iodine-133 (133I) | 20.8 시간 |\n| 담체무첨가제제(No-carrier-added preparation): 제제에 | 나. ",
        "original_sentence": "흡수, 분포, 대사 및 배설시험자료 |\n| ⇦ | (positron emitter)의 방사선 특성과 에너지는 보통 측 | 에 적합하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_075",
      "text": "| ⇦ | 입자 방출 불순물들은 이러한 방법으로 측정할 수 없 | 의약품 제조에 사용하기 전에 1개 이상의 제품을 시험 | - 방사성핵종 제너레이터로 부터의 유출 | - 전문/일반의약품 중 방사성의약품은 전문의약품에 해당 | ③ 제1항에 따른 제조업자 외의 자가 제34조제 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 74,
        "window_size": 3,
        "char_count": 158,
        "word_count": 43,
        "page_number": 3,
        "window_text": "파산선고를 받고 복권되지 아니한 자 | 저 장 법  밀봉용기, 차폐.  | 다.  흡수, 분포, 대사 및 배설시험자료 |\n| ⇦ | (positron emitter)의 방사선 특성과 에너지는 보통 측 | 에 적합하여야 한다.  | ⇦ | 입자 방출 불순물들은 이러한 방법으로 측정할 수 없 | 의약품 제조에 사용하기 전에 1개 이상의 제품을 시험 | - 방사성핵종 제너레이터로 부터의 유출 | - 전문/일반의약품 중 방사성의약품은 전문의약품에 해당 | ③ 제1항에 따른 제조업자 외의 자가 제34조제 | 1.  제1항제1호 또는 제2호에 해당하는 자료로 | 을 수 있도록 한 방사성의약품 시스템 | 기재 | 되었다.  | Iodine-133 (133I) | 20.8 시간 |\n| 담체무첨가제제(No-carrier-added preparation): 제제에 | 나.  생물학적제제등인 경우에는 별표 1의 의 | 약품안전처장에게 제출하여야 한다. ",
        "original_sentence": "| ⇦ | 입자 방출 불순물들은 이러한 방법으로 측정할 수 없 | 의약품 제조에 사용하기 전에 1개 이상의 제품을 시험 | - 방사성핵종 제너레이터로 부터의 유출 | - 전문/일반의약품 중 방사성의약품은 전문의약품에 해당 | ③ 제1항에 따른 제조업자 외의 자가 제34조제 | 1. "
      }
    },
    {
      "chunk_id": "chunk_076",
      "text": "제1항제1호 또는 제2호에 해당하는 자료로 | 을 수 있도록 한 방사성의약품 시스템 | 기재 | 되었다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 75,
        "window_size": 3,
        "char_count": 59,
        "word_count": 16,
        "page_number": 3,
        "window_text": "| 다.  흡수, 분포, 대사 및 배설시험자료 |\n| ⇦ | (positron emitter)의 방사선 특성과 에너지는 보통 측 | 에 적합하여야 한다.  | ⇦ | 입자 방출 불순물들은 이러한 방법으로 측정할 수 없 | 의약품 제조에 사용하기 전에 1개 이상의 제품을 시험 | - 방사성핵종 제너레이터로 부터의 유출 | - 전문/일반의약품 중 방사성의약품은 전문의약품에 해당 | ③ 제1항에 따른 제조업자 외의 자가 제34조제 | 1.  제1항제1호 또는 제2호에 해당하는 자료로 | 을 수 있도록 한 방사성의약품 시스템 | 기재 | 되었다.  | Iodine-133 (133I) | 20.8 시간 |\n| 담체무첨가제제(No-carrier-added preparation): 제제에 | 나.  생물학적제제등인 경우에는 별표 1의 의 | 약품안전처장에게 제출하여야 한다.  | (진행상황 확인) | 수수료 납부 | 법을 고시한 품목 | 약품 제조 및 품질관리기준, 별표 1의2의 | 사) 신청품목과 관련된 밸리데이션 자료 | 한 L-아스코르브산용액 (1 → 20) 2.4 mL 씩을 넣 | 제5조제2항제6호에 따라 제4조제1항제7호 각 | 8) 용기 및 포장에 관한 자료 | 제네릭 | KP, 공정서 | - | O | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 2.3.1 제품명 ···························································································8 | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
        "original_sentence": "제1항제1호 또는 제2호에 해당하는 자료로 | 을 수 있도록 한 방사성의약품 시스템 | 기재 | 되었다. "
      }
    },
    {
      "chunk_id": "chunk_077",
      "text": "| Iodine-133 (133I) | 20.8 시간 |\n| 담체무첨가제제(No-carrier-added preparation): 제제에 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 76,
        "window_size": 3,
        "char_count": 82,
        "word_count": 13,
        "page_number": 3,
        "window_text": "흡수, 분포, 대사 및 배설시험자료 |\n| ⇦ | (positron emitter)의 방사선 특성과 에너지는 보통 측 | 에 적합하여야 한다.  | ⇦ | 입자 방출 불순물들은 이러한 방법으로 측정할 수 없 | 의약품 제조에 사용하기 전에 1개 이상의 제품을 시험 | - 방사성핵종 제너레이터로 부터의 유출 | - 전문/일반의약품 중 방사성의약품은 전문의약품에 해당 | ③ 제1항에 따른 제조업자 외의 자가 제34조제 | 1.  제1항제1호 또는 제2호에 해당하는 자료로 | 을 수 있도록 한 방사성의약품 시스템 | 기재 | 되었다.  | Iodine-133 (133I) | 20.8 시간 |\n| 담체무첨가제제(No-carrier-added preparation): 제제에 | 나.  생물학적제제등인 경우에는 별표 1의 의 | 약품안전처장에게 제출하여야 한다.  | (진행상황 확인) | 수수료 납부 | 법을 고시한 품목 | 약품 제조 및 품질관리기준, 별표 1의2의 | 사) 신청품목과 관련된 밸리데이션 자료 | 한 L-아스코르브산용액 (1 → 20) 2.4 mL 씩을 넣 | 제5조제2항제6호에 따라 제4조제1항제7호 각 | 8) 용기 및 포장에 관한 자료 | 제네릭 | KP, 공정서 | - | O | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 2.3.1 제품명 ···························································································8 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | Xenon-133 (133Xe) | 5.243 일 | 1) 분석방법과 밸리데이션 보고서 |\n| 가 | 나 | 다 | 라 | 마 | 바 | 가* | 나 | 다 | 라 | 마 | 다. ",
        "original_sentence": "| Iodine-133 (133I) | 20.8 시간 |\n| 담체무첨가제제(No-carrier-added preparation): 제제에 | 나. "
      }
    },
    {
      "chunk_id": "chunk_078",
      "text": "생물학적제제등인 경우에는 별표 1의 의 | 약품안전처장에게 제출하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 77,
        "window_size": 3,
        "char_count": 43,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| ⇦ | 입자 방출 불순물들은 이러한 방법으로 측정할 수 없 | 의약품 제조에 사용하기 전에 1개 이상의 제품을 시험 | - 방사성핵종 제너레이터로 부터의 유출 | - 전문/일반의약품 중 방사성의약품은 전문의약품에 해당 | ③ 제1항에 따른 제조업자 외의 자가 제34조제 | 1.  제1항제1호 또는 제2호에 해당하는 자료로 | 을 수 있도록 한 방사성의약품 시스템 | 기재 | 되었다.  | Iodine-133 (133I) | 20.8 시간 |\n| 담체무첨가제제(No-carrier-added preparation): 제제에 | 나.  생물학적제제등인 경우에는 별표 1의 의 | 약품안전처장에게 제출하여야 한다.  | (진행상황 확인) | 수수료 납부 | 법을 고시한 품목 | 약품 제조 및 품질관리기준, 별표 1의2의 | 사) 신청품목과 관련된 밸리데이션 자료 | 한 L-아스코르브산용액 (1 → 20) 2.4 mL 씩을 넣 | 제5조제2항제6호에 따라 제4조제1항제7호 각 | 8) 용기 및 포장에 관한 자료 | 제네릭 | KP, 공정서 | - | O | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 2.3.1 제품명 ···························································································8 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | Xenon-133 (133Xe) | 5.243 일 | 1) 분석방법과 밸리데이션 보고서 |\n| 가 | 나 | 다 | 라 | 마 | 바 | 가* | 나 | 다 | 라 | 마 | 다.  알파 그리고 베타 방출체(emitter)들은 다른 방법들 | 할 것을 권고한다. ",
        "original_sentence": "생물학적제제등인 경우에는 별표 1의 의 | 약품안전처장에게 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_079",
      "text": "| (진행상황 확인) | 수수료 납부 | 법을 고시한 품목 | 약품 제조 및 품질관리기준, 별표 1의2의 | 사) 신청품목과 관련된 밸리데이션 자료 | 한 L-아스코르브산용액 (1 → 20) 2.4 mL 씩을 넣 | 제5조제2항제6호에 따라 제4조제1항제7호 각 | 8) 용기 및 포장에 관한 자료 | 제네릭 | KP, 공정서 | - | O | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 2.3.1 제품명 ···························································································8 | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 78,
        "window_size": 3,
        "char_count": 352,
        "word_count": 71,
        "page_number": 3,
        "window_text": "제1항제1호 또는 제2호에 해당하는 자료로 | 을 수 있도록 한 방사성의약품 시스템 | 기재 | 되었다.  | Iodine-133 (133I) | 20.8 시간 |\n| 담체무첨가제제(No-carrier-added preparation): 제제에 | 나.  생물학적제제등인 경우에는 별표 1의 의 | 약품안전처장에게 제출하여야 한다.  | (진행상황 확인) | 수수료 납부 | 법을 고시한 품목 | 약품 제조 및 품질관리기준, 별표 1의2의 | 사) 신청품목과 관련된 밸리데이션 자료 | 한 L-아스코르브산용액 (1 → 20) 2.4 mL 씩을 넣 | 제5조제2항제6호에 따라 제4조제1항제7호 각 | 8) 용기 및 포장에 관한 자료 | 제네릭 | KP, 공정서 | - | O | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 2.3.1 제품명 ···························································································8 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | Xenon-133 (133Xe) | 5.243 일 | 1) 분석방법과 밸리데이션 보고서 |\n| 가 | 나 | 다 | 라 | 마 | 바 | 가* | 나 | 다 | 라 | 마 | 다.  알파 그리고 베타 방출체(emitter)들은 다른 방법들 | 할 것을 권고한다.  | - 방사성의약품 키트: 보통 사용하기 전에 방사성핵종 | ⑧ 별지 제5호서식 특허관계확인서 및 사유서 | 2. ",
        "original_sentence": "| (진행상황 확인) | 수수료 납부 | 법을 고시한 품목 | 약품 제조 및 품질관리기준, 별표 1의2의 | 사) 신청품목과 관련된 밸리데이션 자료 | 한 L-아스코르브산용액 (1 → 20) 2.4 mL 씩을 넣 | 제5조제2항제6호에 따라 제4조제1항제7호 각 | 8) 용기 및 포장에 관한 자료 | 제네릭 | KP, 공정서 | - | O | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 2.3.1 제품명 ···························································································8 | □ 외국 규정을 번역하거나 설명하는 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_080",
      "text": "| □ 예 | ■ 아니오 | Xenon-133 (133Xe) | 5.243 일 | 1) 분석방법과 밸리데이션 보고서 |\n| 가 | 나 | 다 | 라 | 마 | 바 | 가* | 나 | 다 | 라 | 마 | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 79,
        "window_size": 3,
        "char_count": 117,
        "word_count": 42,
        "page_number": 1,
        "window_text": "| Iodine-133 (133I) | 20.8 시간 |\n| 담체무첨가제제(No-carrier-added preparation): 제제에 | 나.  생물학적제제등인 경우에는 별표 1의 의 | 약품안전처장에게 제출하여야 한다.  | (진행상황 확인) | 수수료 납부 | 법을 고시한 품목 | 약품 제조 및 품질관리기준, 별표 1의2의 | 사) 신청품목과 관련된 밸리데이션 자료 | 한 L-아스코르브산용액 (1 → 20) 2.4 mL 씩을 넣 | 제5조제2항제6호에 따라 제4조제1항제7호 각 | 8) 용기 및 포장에 관한 자료 | 제네릭 | KP, 공정서 | - | O | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 2.3.1 제품명 ···························································································8 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | Xenon-133 (133Xe) | 5.243 일 | 1) 분석방법과 밸리데이션 보고서 |\n| 가 | 나 | 다 | 라 | 마 | 바 | 가* | 나 | 다 | 라 | 마 | 다.  알파 그리고 베타 방출체(emitter)들은 다른 방법들 | 할 것을 권고한다.  | - 방사성의약품 키트: 보통 사용하기 전에 방사성핵종 | ⑧ 별지 제5호서식 특허관계확인서 및 사유서 | 2.  법 제36조에 따른 의약품 또는 의약외품(이 | 1항에 따라 임상시험계획의 승인을 받아 임상 | 직접 용기․포장의 재질 |\n| 정할 수 없고 반감기와 감마선 스펙트럼 측정을 통해 | 방사성핵종 전구체와 화학물질 전구체들은 엔도톡신을 | 5. ",
        "original_sentence": "| □ 예 | ■ 아니오 | Xenon-133 (133Xe) | 5.243 일 | 1) 분석방법과 밸리데이션 보고서 |\n| 가 | 나 | 다 | 라 | 마 | 바 | 가* | 나 | 다 | 라 | 마 | 다. "
      }
    },
    {
      "chunk_id": "chunk_081",
      "text": "알파 그리고 베타 방출체(emitter)들은 다른 방법들 | 할 것을 권고한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 80,
        "window_size": 3,
        "char_count": 45,
        "word_count": 10,
        "page_number": 9,
        "window_text": "생물학적제제등인 경우에는 별표 1의 의 | 약품안전처장에게 제출하여야 한다.  | (진행상황 확인) | 수수료 납부 | 법을 고시한 품목 | 약품 제조 및 품질관리기준, 별표 1의2의 | 사) 신청품목과 관련된 밸리데이션 자료 | 한 L-아스코르브산용액 (1 → 20) 2.4 mL 씩을 넣 | 제5조제2항제6호에 따라 제4조제1항제7호 각 | 8) 용기 및 포장에 관한 자료 | 제네릭 | KP, 공정서 | - | O | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 2.3.1 제품명 ···························································································8 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | Xenon-133 (133Xe) | 5.243 일 | 1) 분석방법과 밸리데이션 보고서 |\n| 가 | 나 | 다 | 라 | 마 | 바 | 가* | 나 | 다 | 라 | 마 | 다.  알파 그리고 베타 방출체(emitter)들은 다른 방법들 | 할 것을 권고한다.  | - 방사성의약품 키트: 보통 사용하기 전에 방사성핵종 | ⑧ 별지 제5호서식 특허관계확인서 및 사유서 | 2.  법 제36조에 따른 의약품 또는 의약외품(이 | 1항에 따라 임상시험계획의 승인을 받아 임상 | 직접 용기․포장의 재질 |\n| 정할 수 없고 반감기와 감마선 스펙트럼 측정을 통해 | 방사성핵종 전구체와 화학물질 전구체들은 엔도톡신을 | 5.  식품의약품안전처장이 신고대상품목으로 고 | 약품 제조 및 품질관리기준 및 별표 3의 | 원료의약품 제조 및 품질관리기준 및 별 | 핵반응 발생 확률은 입사입자(양성자, 중성자, 중양성 | - 적응증에 따른 사용량 “용량” 항에 기재 | (｢ | 고 흔들어 섞어 15 분간 방치한다. ",
        "original_sentence": "알파 그리고 베타 방출체(emitter)들은 다른 방법들 | 할 것을 권고한다. "
      }
    },
    {
      "chunk_id": "chunk_082",
      "text": "| - 방사성의약품 키트: 보통 사용하기 전에 방사성핵종 | ⑧ 별지 제5호서식 특허관계확인서 및 사유서 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 81,
        "window_size": 3,
        "char_count": 64,
        "word_count": 17,
        "page_number": 3,
        "window_text": "| (진행상황 확인) | 수수료 납부 | 법을 고시한 품목 | 약품 제조 및 품질관리기준, 별표 1의2의 | 사) 신청품목과 관련된 밸리데이션 자료 | 한 L-아스코르브산용액 (1 → 20) 2.4 mL 씩을 넣 | 제5조제2항제6호에 따라 제4조제1항제7호 각 | 8) 용기 및 포장에 관한 자료 | 제네릭 | KP, 공정서 | - | O | 이라 한다)이 등재된 의약품(이하 \"등재의약 | 2.3.1 제품명 ···························································································8 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | Xenon-133 (133Xe) | 5.243 일 | 1) 분석방법과 밸리데이션 보고서 |\n| 가 | 나 | 다 | 라 | 마 | 바 | 가* | 나 | 다 | 라 | 마 | 다.  알파 그리고 베타 방출체(emitter)들은 다른 방법들 | 할 것을 권고한다.  | - 방사성의약품 키트: 보통 사용하기 전에 방사성핵종 | ⑧ 별지 제5호서식 특허관계확인서 및 사유서 | 2.  법 제36조에 따른 의약품 또는 의약외품(이 | 1항에 따라 임상시험계획의 승인을 받아 임상 | 직접 용기․포장의 재질 |\n| 정할 수 없고 반감기와 감마선 스펙트럼 측정을 통해 | 방사성핵종 전구체와 화학물질 전구체들은 엔도톡신을 | 5.  식품의약품안전처장이 신고대상품목으로 고 | 약품 제조 및 품질관리기준 및 별표 3의 | 원료의약품 제조 및 품질관리기준 및 별 | 핵반응 발생 확률은 입사입자(양성자, 중성자, 중양성 | - 적응증에 따른 사용량 “용량” 항에 기재 | (｢ | 고 흔들어 섞어 15 분간 방치한다.  다음 각각에 물 | 목의 자료를 제출한 경우에는 그 자료를 변경하 | 의약품분류기준에관한규정 (식품의약품안전처 고시)｣ | 서 적합하다는 제41조제3항에 따른 사전 검 | 품\"이라 한다)의 안전성·유효성에 관한 자 | 자사기준 | - | O | Xenon-133m (133mXe) | 2.19 일 | 본다. ",
        "original_sentence": "| - 방사성의약품 키트: 보통 사용하기 전에 방사성핵종 | ⑧ 별지 제5호서식 특허관계확인서 및 사유서 | 2. "
      }
    },
    {
      "chunk_id": "chunk_083",
      "text": "법 제36조에 따른 의약품 또는 의약외품(이 | 1항에 따라 임상시험계획의 승인을 받아 임상 | 직접 용기․포장의 재질 |\n| 정할 수 없고 반감기와 감마선 스펙트럼 측정을 통해 | 방사성핵종 전구체와 화학물질 전구체들은 엔도톡신을 | 5. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 82,
        "window_size": 3,
        "char_count": 135,
        "word_count": 35,
        "page_number": 3,
        "window_text": "| □ 예 | ■ 아니오 | Xenon-133 (133Xe) | 5.243 일 | 1) 분석방법과 밸리데이션 보고서 |\n| 가 | 나 | 다 | 라 | 마 | 바 | 가* | 나 | 다 | 라 | 마 | 다.  알파 그리고 베타 방출체(emitter)들은 다른 방법들 | 할 것을 권고한다.  | - 방사성의약품 키트: 보통 사용하기 전에 방사성핵종 | ⑧ 별지 제5호서식 특허관계확인서 및 사유서 | 2.  법 제36조에 따른 의약품 또는 의약외품(이 | 1항에 따라 임상시험계획의 승인을 받아 임상 | 직접 용기․포장의 재질 |\n| 정할 수 없고 반감기와 감마선 스펙트럼 측정을 통해 | 방사성핵종 전구체와 화학물질 전구체들은 엔도톡신을 | 5.  식품의약품안전처장이 신고대상품목으로 고 | 약품 제조 및 품질관리기준 및 별표 3의 | 원료의약품 제조 및 품질관리기준 및 별 | 핵반응 발생 확률은 입사입자(양성자, 중성자, 중양성 | - 적응증에 따른 사용량 “용량” 항에 기재 | (｢ | 고 흔들어 섞어 15 분간 방치한다.  다음 각각에 물 | 목의 자료를 제출한 경우에는 그 자료를 변경하 | 의약품분류기준에관한규정 (식품의약품안전처 고시)｣ | 서 적합하다는 제41조제3항에 따른 사전 검 | 품\"이라 한다)의 안전성·유효성에 관한 자 | 자사기준 | - | O | Xenon-133m (133mXe) | 2.19 일 | 본다.  <개정 2014.8.21.> | 참조) |\n| 표시된 화합물 또는 분자 내 방사성핵종 위치에 있는 | 시험을 실시한 의약품을 제조업자에게 위탁제 | 나. ",
        "original_sentence": "법 제36조에 따른 의약품 또는 의약외품(이 | 1항에 따라 임상시험계획의 승인을 받아 임상 | 직접 용기․포장의 재질 |\n| 정할 수 없고 반감기와 감마선 스펙트럼 측정을 통해 | 방사성핵종 전구체와 화학물질 전구체들은 엔도톡신을 | 5. "
      }
    },
    {
      "chunk_id": "chunk_084",
      "text": "식품의약품안전처장이 신고대상품목으로 고 | 약품 제조 및 품질관리기준 및 별표 3의 | 원료의약품 제조 및 품질관리기준 및 별 | 핵반응 발생 확률은 입사입자(양성자, 중성자, 중양성 | - 적응증에 따른 사용량 “용량” 항에 기재 | (｢ | 고 흔들어 섞어 15 분간 방치한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 83,
        "window_size": 3,
        "char_count": 158,
        "word_count": 42,
        "page_number": 3,
        "window_text": "알파 그리고 베타 방출체(emitter)들은 다른 방법들 | 할 것을 권고한다.  | - 방사성의약품 키트: 보통 사용하기 전에 방사성핵종 | ⑧ 별지 제5호서식 특허관계확인서 및 사유서 | 2.  법 제36조에 따른 의약품 또는 의약외품(이 | 1항에 따라 임상시험계획의 승인을 받아 임상 | 직접 용기․포장의 재질 |\n| 정할 수 없고 반감기와 감마선 스펙트럼 측정을 통해 | 방사성핵종 전구체와 화학물질 전구체들은 엔도톡신을 | 5.  식품의약품안전처장이 신고대상품목으로 고 | 약품 제조 및 품질관리기준 및 별표 3의 | 원료의약품 제조 및 품질관리기준 및 별 | 핵반응 발생 확률은 입사입자(양성자, 중성자, 중양성 | - 적응증에 따른 사용량 “용량” 항에 기재 | (｢ | 고 흔들어 섞어 15 분간 방치한다.  다음 각각에 물 | 목의 자료를 제출한 경우에는 그 자료를 변경하 | 의약품분류기준에관한규정 (식품의약품안전처 고시)｣ | 서 적합하다는 제41조제3항에 따른 사전 검 | 품\"이라 한다)의 안전성·유효성에 관한 자 | 자사기준 | - | O | Xenon-133m (133mXe) | 2.19 일 | 본다.  <개정 2014.8.21.> | 참조) |\n| 표시된 화합물 또는 분자 내 방사성핵종 위치에 있는 | 시험을 실시한 의약품을 제조업자에게 위탁제 | 나.  완제의약품에 관한 자료 | 하 \"의약품등\"이라 한다)의 제조업무를 관리 | 2.3.2 분류번호 및 분류 ·······································································9 | 정 2014.5.9., 2014.8.21., 2015.3.13.> | 2) 흡수 |\n| 확인한다. ",
        "original_sentence": "식품의약품안전처장이 신고대상품목으로 고 | 약품 제조 및 품질관리기준 및 별표 3의 | 원료의약품 제조 및 품질관리기준 및 별 | 핵반응 발생 확률은 입사입자(양성자, 중성자, 중양성 | - 적응증에 따른 사용량 “용량” 항에 기재 | (｢ | 고 흔들어 섞어 15 분간 방치한다. "
      }
    },
    {
      "chunk_id": "chunk_085",
      "text": "다음 각각에 물 | 목의 자료를 제출한 경우에는 그 자료를 변경하 | 의약품분류기준에관한규정 (식품의약품안전처 고시)｣ | 서 적합하다는 제41조제3항에 따른 사전 검 | 품\"이라 한다)의 안전성·유효성에 관한 자 | 자사기준 | - | O | Xenon-133m (133mXe) | 2.19 일 | 본다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 84,
        "window_size": 3,
        "char_count": 172,
        "word_count": 42,
        "page_number": 5,
        "window_text": "| - 방사성의약품 키트: 보통 사용하기 전에 방사성핵종 | ⑧ 별지 제5호서식 특허관계확인서 및 사유서 | 2.  법 제36조에 따른 의약품 또는 의약외품(이 | 1항에 따라 임상시험계획의 승인을 받아 임상 | 직접 용기․포장의 재질 |\n| 정할 수 없고 반감기와 감마선 스펙트럼 측정을 통해 | 방사성핵종 전구체와 화학물질 전구체들은 엔도톡신을 | 5.  식품의약품안전처장이 신고대상품목으로 고 | 약품 제조 및 품질관리기준 및 별표 3의 | 원료의약품 제조 및 품질관리기준 및 별 | 핵반응 발생 확률은 입사입자(양성자, 중성자, 중양성 | - 적응증에 따른 사용량 “용량” 항에 기재 | (｢ | 고 흔들어 섞어 15 분간 방치한다.  다음 각각에 물 | 목의 자료를 제출한 경우에는 그 자료를 변경하 | 의약품분류기준에관한규정 (식품의약품안전처 고시)｣ | 서 적합하다는 제41조제3항에 따른 사전 검 | 품\"이라 한다)의 안전성·유효성에 관한 자 | 자사기준 | - | O | Xenon-133m (133mXe) | 2.19 일 | 본다.  <개정 2014.8.21.> | 참조) |\n| 표시된 화합물 또는 분자 내 방사성핵종 위치에 있는 | 시험을 실시한 의약품을 제조업자에게 위탁제 | 나.  완제의약품에 관한 자료 | 하 \"의약품등\"이라 한다)의 제조업무를 관리 | 2.3.2 분류번호 및 분류 ·······································································9 | 정 2014.5.9., 2014.8.21., 2015.3.13.> | 2) 흡수 |\n| 확인한다.  | 제거하기 위한 적절한 추가 조치 없이 비경구용 제제 | 시한 의약품등 | 생물학적제제등 제조 및 품질관리기준 실 | 표 3의 생물학적제제등 제조 및 품질관리 | 자 등)의 특성과 에너지 그리고 그로 인해 방사되는 | 을 사용해야 한다. ",
        "original_sentence": "다음 각각에 물 | 목의 자료를 제출한 경우에는 그 자료를 변경하 | 의약품분류기준에관한규정 (식품의약품안전처 고시)｣ | 서 적합하다는 제41조제3항에 따른 사전 검 | 품\"이라 한다)의 안전성·유효성에 관한 자 | 자사기준 | - | O | Xenon-133m (133mXe) | 2.19 일 | 본다. "
      }
    },
    {
      "chunk_id": "chunk_086",
      "text": "<개정 2014.8.21.> | 참조) |\n| 표시된 화합물 또는 분자 내 방사성핵종 위치에 있는 | 시험을 실시한 의약품을 제조업자에게 위탁제 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 85,
        "window_size": 3,
        "char_count": 86,
        "word_count": 22,
        "page_number": 3,
        "window_text": "법 제36조에 따른 의약품 또는 의약외품(이 | 1항에 따라 임상시험계획의 승인을 받아 임상 | 직접 용기․포장의 재질 |\n| 정할 수 없고 반감기와 감마선 스펙트럼 측정을 통해 | 방사성핵종 전구체와 화학물질 전구체들은 엔도톡신을 | 5.  식품의약품안전처장이 신고대상품목으로 고 | 약품 제조 및 품질관리기준 및 별표 3의 | 원료의약품 제조 및 품질관리기준 및 별 | 핵반응 발생 확률은 입사입자(양성자, 중성자, 중양성 | - 적응증에 따른 사용량 “용량” 항에 기재 | (｢ | 고 흔들어 섞어 15 분간 방치한다.  다음 각각에 물 | 목의 자료를 제출한 경우에는 그 자료를 변경하 | 의약품분류기준에관한규정 (식품의약품안전처 고시)｣ | 서 적합하다는 제41조제3항에 따른 사전 검 | 품\"이라 한다)의 안전성·유효성에 관한 자 | 자사기준 | - | O | Xenon-133m (133mXe) | 2.19 일 | 본다.  <개정 2014.8.21.> | 참조) |\n| 표시된 화합물 또는 분자 내 방사성핵종 위치에 있는 | 시험을 실시한 의약품을 제조업자에게 위탁제 | 나.  완제의약품에 관한 자료 | 하 \"의약품등\"이라 한다)의 제조업무를 관리 | 2.3.2 분류번호 및 분류 ·······································································9 | 정 2014.5.9., 2014.8.21., 2015.3.13.> | 2) 흡수 |\n| 확인한다.  | 제거하기 위한 적절한 추가 조치 없이 비경구용 제제 | 시한 의약품등 | 생물학적제제등 제조 및 품질관리기준 실 | 표 3의 생물학적제제등 제조 및 품질관리 | 자 등)의 특성과 에너지 그리고 그로 인해 방사되는 | 을 사용해야 한다.  | (의약품 특허목록에 등재된 의약품의 안전성․유효성에 관한 자료를 근거로 신청하는 경우) | 과 혼합하거나 재용해하여 사용하는 제제 | a) 허가규정 제25조제2항에 따른 안유면제대상 | 토 결과통지서를 제출한 경우: 제1항제1호 | 료를 근거로 의약품의 제조판매·수입 품목 | □ 정보제공 등 직원 교육용 자료입니까? ",
        "original_sentence": "<개정 2014.8.21.> | 참조) |\n| 표시된 화합물 또는 분자 내 방사성핵종 위치에 있는 | 시험을 실시한 의약품을 제조업자에게 위탁제 | 나. "
      }
    },
    {
      "chunk_id": "chunk_087",
      "text": "완제의약품에 관한 자료 | 하 \"의약품등\"이라 한다)의 제조업무를 관리 | 2.3.2 분류번호 및 분류 ·······································································9 | 정 2014.5.9., 2014.8.21., 2015.3.13.> | 2) 흡수 |\n| 확인한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 86,
        "window_size": 3,
        "char_count": 188,
        "word_count": 26,
        "page_number": 3,
        "window_text": "식품의약품안전처장이 신고대상품목으로 고 | 약품 제조 및 품질관리기준 및 별표 3의 | 원료의약품 제조 및 품질관리기준 및 별 | 핵반응 발생 확률은 입사입자(양성자, 중성자, 중양성 | - 적응증에 따른 사용량 “용량” 항에 기재 | (｢ | 고 흔들어 섞어 15 분간 방치한다.  다음 각각에 물 | 목의 자료를 제출한 경우에는 그 자료를 변경하 | 의약품분류기준에관한규정 (식품의약품안전처 고시)｣ | 서 적합하다는 제41조제3항에 따른 사전 검 | 품\"이라 한다)의 안전성·유효성에 관한 자 | 자사기준 | - | O | Xenon-133m (133mXe) | 2.19 일 | 본다.  <개정 2014.8.21.> | 참조) |\n| 표시된 화합물 또는 분자 내 방사성핵종 위치에 있는 | 시험을 실시한 의약품을 제조업자에게 위탁제 | 나.  완제의약품에 관한 자료 | 하 \"의약품등\"이라 한다)의 제조업무를 관리 | 2.3.2 분류번호 및 분류 ·······································································9 | 정 2014.5.9., 2014.8.21., 2015.3.13.> | 2) 흡수 |\n| 확인한다.  | 제거하기 위한 적절한 추가 조치 없이 비경구용 제제 | 시한 의약품등 | 생물학적제제등 제조 및 품질관리기준 실 | 표 3의 생물학적제제등 제조 및 품질관리 | 자 등)의 특성과 에너지 그리고 그로 인해 방사되는 | 을 사용해야 한다.  | (의약품 특허목록에 등재된 의약품의 안전성․유효성에 관한 자료를 근거로 신청하는 경우) | 과 혼합하거나 재용해하여 사용하는 제제 | a) 허가규정 제25조제2항에 따른 안유면제대상 | 토 결과통지서를 제출한 경우: 제1항제1호 | 료를 근거로 의약품의 제조판매·수입 품목 | □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 | 포장 | 의 방출로 대체될 수도 있다. ",
        "original_sentence": "완제의약품에 관한 자료 | 하 \"의약품등\"이라 한다)의 제조업무를 관리 | 2.3.2 분류번호 및 분류 ·······································································9 | 정 2014.5.9., 2014.8.21., 2015.3.13.> | 2) 흡수 |\n| 확인한다. "
      }
    },
    {
      "chunk_id": "chunk_088",
      "text": "| 제거하기 위한 적절한 추가 조치 없이 비경구용 제제 | 시한 의약품등 | 생물학적제제등 제조 및 품질관리기준 실 | 표 3의 생물학적제제등 제조 및 품질관리 | 자 등)의 특성과 에너지 그리고 그로 인해 방사되는 | 을 사용해야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 87,
        "window_size": 3,
        "char_count": 134,
        "word_count": 38,
        "page_number": 5,
        "window_text": "다음 각각에 물 | 목의 자료를 제출한 경우에는 그 자료를 변경하 | 의약품분류기준에관한규정 (식품의약품안전처 고시)｣ | 서 적합하다는 제41조제3항에 따른 사전 검 | 품\"이라 한다)의 안전성·유효성에 관한 자 | 자사기준 | - | O | Xenon-133m (133mXe) | 2.19 일 | 본다.  <개정 2014.8.21.> | 참조) |\n| 표시된 화합물 또는 분자 내 방사성핵종 위치에 있는 | 시험을 실시한 의약품을 제조업자에게 위탁제 | 나.  완제의약품에 관한 자료 | 하 \"의약품등\"이라 한다)의 제조업무를 관리 | 2.3.2 분류번호 및 분류 ·······································································9 | 정 2014.5.9., 2014.8.21., 2015.3.13.> | 2) 흡수 |\n| 확인한다.  | 제거하기 위한 적절한 추가 조치 없이 비경구용 제제 | 시한 의약품등 | 생물학적제제등 제조 및 품질관리기준 실 | 표 3의 생물학적제제등 제조 및 품질관리 | 자 등)의 특성과 에너지 그리고 그로 인해 방사되는 | 을 사용해야 한다.  | (의약품 특허목록에 등재된 의약품의 안전성․유효성에 관한 자료를 근거로 신청하는 경우) | 과 혼합하거나 재용해하여 사용하는 제제 | a) 허가규정 제25조제2항에 따른 안유면제대상 | 토 결과통지서를 제출한 경우: 제1항제1호 | 료를 근거로 의약품의 제조판매·수입 품목 | □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 | 포장 | 의 방출로 대체될 수도 있다.  | 비방사능(Specific radioactivity) | Iodine-135 (135I) | 6.57 시간 | (주사제의 경우 용기 규격 |\n| 부칙 <총리령 제1089호, 2014.8.21.> | 년도 | 는 경우를 포함하며, 법 제89조제3항에 따른 | 1) 원료약품 및 그 분량에 관한 자료 | 하는 자(이하 \"제조관리자\"라 한다)의 자격 | Xenon-135 (135Xe) | 9.14 시간 | 정 2014.5.9., 2015.3.13.> | 3) 분포 |\n| 원소 중 고의로 첨가한 안정형 동위원소가 없는 제제 | 생산에 사용될 경우 엔도톡신시험에 적합하여야 한다. ",
        "original_sentence": "| 제거하기 위한 적절한 추가 조치 없이 비경구용 제제 | 시한 의약품등 | 생물학적제제등 제조 및 품질관리기준 실 | 표 3의 생물학적제제등 제조 및 품질관리 | 자 등)의 특성과 에너지 그리고 그로 인해 방사되는 | 을 사용해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_089",
      "text": "| (의약품 특허목록에 등재된 의약품의 안전성․유효성에 관한 자료를 근거로 신청하는 경우) | 과 혼합하거나 재용해하여 사용하는 제제 | a) 허가규정 제25조제2항에 따른 안유면제대상 | 토 결과통지서를 제출한 경우: 제1항제1호 | 료를 근거로 의약품의 제조판매·수입 품목 | □ 정보제공 등 직원 교육용 자료입니까? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 88,
        "window_size": 3,
        "char_count": 180,
        "word_count": 42,
        "page_number": 5,
        "window_text": "<개정 2014.8.21.> | 참조) |\n| 표시된 화합물 또는 분자 내 방사성핵종 위치에 있는 | 시험을 실시한 의약품을 제조업자에게 위탁제 | 나.  완제의약품에 관한 자료 | 하 \"의약품등\"이라 한다)의 제조업무를 관리 | 2.3.2 분류번호 및 분류 ·······································································9 | 정 2014.5.9., 2014.8.21., 2015.3.13.> | 2) 흡수 |\n| 확인한다.  | 제거하기 위한 적절한 추가 조치 없이 비경구용 제제 | 시한 의약품등 | 생물학적제제등 제조 및 품질관리기준 실 | 표 3의 생물학적제제등 제조 및 품질관리 | 자 등)의 특성과 에너지 그리고 그로 인해 방사되는 | 을 사용해야 한다.  | (의약품 특허목록에 등재된 의약품의 안전성․유효성에 관한 자료를 근거로 신청하는 경우) | 과 혼합하거나 재용해하여 사용하는 제제 | a) 허가규정 제25조제2항에 따른 안유면제대상 | 토 결과통지서를 제출한 경우: 제1항제1호 | 료를 근거로 의약품의 제조판매·수입 품목 | □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 | 포장 | 의 방출로 대체될 수도 있다.  | 비방사능(Specific radioactivity) | Iodine-135 (135I) | 6.57 시간 | (주사제의 경우 용기 규격 |\n| 부칙 <총리령 제1089호, 2014.8.21.> | 년도 | 는 경우를 포함하며, 법 제89조제3항에 따른 | 1) 원료약품 및 그 분량에 관한 자료 | 하는 자(이하 \"제조관리자\"라 한다)의 자격 | Xenon-135 (135Xe) | 9.14 시간 | 정 2014.5.9., 2015.3.13.> | 3) 분포 |\n| 원소 중 고의로 첨가한 안정형 동위원소가 없는 제제 | 생산에 사용될 경우 엔도톡신시험에 적합하여야 한다.  | ② 제1항에 따라 의약품등의 제조판매·수입 | 시상황 평가에 필요한 자료 | 기준 실시상황 평가에 필요한 자료 | - 방사성핵종 전구체: 화학물질 전구체에 방사능 표지 | 조하여 판매하려는 경우에는 총리령으로 정하 | 또는 제2호에 해당하는 자료 | 허가를 신청하는 경우에는 별지 제5호서식의 | 2.3.3 원료약품 및 그 분량 ·································································9 | 중앙약사심의위원회에 자문을 할 수 있다. ",
        "original_sentence": "| (의약품 특허목록에 등재된 의약품의 안전성․유효성에 관한 자료를 근거로 신청하는 경우) | 과 혼합하거나 재용해하여 사용하는 제제 | a) 허가규정 제25조제2항에 따른 안유면제대상 | 토 결과통지서를 제출한 경우: 제1항제1호 | 료를 근거로 의약품의 제조판매·수입 품목 | □ 정보제공 등 직원 교육용 자료입니까? "
      }
    },
    {
      "chunk_id": "chunk_090",
      "text": "| □ 예 | ■ 아니오 | 포장 | 의 방출로 대체될 수도 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 89,
        "window_size": 3,
        "char_count": 38,
        "word_count": 14,
        "page_number": 1,
        "window_text": "완제의약품에 관한 자료 | 하 \"의약품등\"이라 한다)의 제조업무를 관리 | 2.3.2 분류번호 및 분류 ·······································································9 | 정 2014.5.9., 2014.8.21., 2015.3.13.> | 2) 흡수 |\n| 확인한다.  | 제거하기 위한 적절한 추가 조치 없이 비경구용 제제 | 시한 의약품등 | 생물학적제제등 제조 및 품질관리기준 실 | 표 3의 생물학적제제등 제조 및 품질관리 | 자 등)의 특성과 에너지 그리고 그로 인해 방사되는 | 을 사용해야 한다.  | (의약품 특허목록에 등재된 의약품의 안전성․유효성에 관한 자료를 근거로 신청하는 경우) | 과 혼합하거나 재용해하여 사용하는 제제 | a) 허가규정 제25조제2항에 따른 안유면제대상 | 토 결과통지서를 제출한 경우: 제1항제1호 | 료를 근거로 의약품의 제조판매·수입 품목 | □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 | 포장 | 의 방출로 대체될 수도 있다.  | 비방사능(Specific radioactivity) | Iodine-135 (135I) | 6.57 시간 | (주사제의 경우 용기 규격 |\n| 부칙 <총리령 제1089호, 2014.8.21.> | 년도 | 는 경우를 포함하며, 법 제89조제3항에 따른 | 1) 원료약품 및 그 분량에 관한 자료 | 하는 자(이하 \"제조관리자\"라 한다)의 자격 | Xenon-135 (135Xe) | 9.14 시간 | 정 2014.5.9., 2015.3.13.> | 3) 분포 |\n| 원소 중 고의로 첨가한 안정형 동위원소가 없는 제제 | 생산에 사용될 경우 엔도톡신시험에 적합하여야 한다.  | ② 제1항에 따라 의약품등의 제조판매·수입 | 시상황 평가에 필요한 자료 | 기준 실시상황 평가에 필요한 자료 | - 방사성핵종 전구체: 화학물질 전구체에 방사능 표지 | 조하여 판매하려는 경우에는 총리령으로 정하 | 또는 제2호에 해당하는 자료 | 허가를 신청하는 경우에는 별지 제5호서식의 | 2.3.3 원료약품 및 그 분량 ·································································9 | 중앙약사심의위원회에 자문을 할 수 있다.  | 포함) |\n| 제4조(희귀의약품의 기준 및 시험방법에 관한 자 | 2.3.12 제조원 | 핵의 특성에 따라 다르다. ",
        "original_sentence": "| □ 예 | ■ 아니오 | 포장 | 의 방출로 대체될 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_091",
      "text": "| 비방사능(Specific radioactivity) | Iodine-135 (135I) | 6.57 시간 | (주사제의 경우 용기 규격 |\n| 부칙 <총리령 제1089호, 2014.8.21.> | 년도 | 는 경우를 포함하며, 법 제89조제3항에 따른 | 1) 원료약품 및 그 분량에 관한 자료 | 하는 자(이하 \"제조관리자\"라 한다)의 자격 | Xenon-135 (135Xe) | 9.14 시간 | 정 2014.5.9., 2015.3.13.> | 3) 분포 |\n| 원소 중 고의로 첨가한 안정형 동위원소가 없는 제제 | 생산에 사용될 경우 엔도톡신시험에 적합하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 90,
        "window_size": 3,
        "char_count": 323,
        "word_count": 73,
        "page_number": 3,
        "window_text": "| 제거하기 위한 적절한 추가 조치 없이 비경구용 제제 | 시한 의약품등 | 생물학적제제등 제조 및 품질관리기준 실 | 표 3의 생물학적제제등 제조 및 품질관리 | 자 등)의 특성과 에너지 그리고 그로 인해 방사되는 | 을 사용해야 한다.  | (의약품 특허목록에 등재된 의약품의 안전성․유효성에 관한 자료를 근거로 신청하는 경우) | 과 혼합하거나 재용해하여 사용하는 제제 | a) 허가규정 제25조제2항에 따른 안유면제대상 | 토 결과통지서를 제출한 경우: 제1항제1호 | 료를 근거로 의약품의 제조판매·수입 품목 | □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 | 포장 | 의 방출로 대체될 수도 있다.  | 비방사능(Specific radioactivity) | Iodine-135 (135I) | 6.57 시간 | (주사제의 경우 용기 규격 |\n| 부칙 <총리령 제1089호, 2014.8.21.> | 년도 | 는 경우를 포함하며, 법 제89조제3항에 따른 | 1) 원료약품 및 그 분량에 관한 자료 | 하는 자(이하 \"제조관리자\"라 한다)의 자격 | Xenon-135 (135Xe) | 9.14 시간 | 정 2014.5.9., 2015.3.13.> | 3) 분포 |\n| 원소 중 고의로 첨가한 안정형 동위원소가 없는 제제 | 생산에 사용될 경우 엔도톡신시험에 적합하여야 한다.  | ② 제1항에 따라 의약품등의 제조판매·수입 | 시상황 평가에 필요한 자료 | 기준 실시상황 평가에 필요한 자료 | - 방사성핵종 전구체: 화학물질 전구체에 방사능 표지 | 조하여 판매하려는 경우에는 총리령으로 정하 | 또는 제2호에 해당하는 자료 | 허가를 신청하는 경우에는 별지 제5호서식의 | 2.3.3 원료약품 및 그 분량 ·································································9 | 중앙약사심의위원회에 자문을 할 수 있다.  | 포함) |\n| 제4조(희귀의약품의 기준 및 시험방법에 관한 자 | 2.3.12 제조원 | 핵의 특성에 따라 다르다.  또한 생산된 방사성핵종의 | 각조에서는 필요한 방사성핵종순도와 특정 방사성핵종 | b) 신약 | 지위승계 신고 대상에 해당하는 변경은 제외한 | 을 확인할 수 있는 서류 또는 제42조제3항 | GMP　평가자료의 요건 등 | 방사능 검출 및 측정 | Caesium-137 (137Cs) | 30.04 년 |\n| 비방사능(Specific radioactivity): 물질 또는 화합물의 | 2. ",
        "original_sentence": "| 비방사능(Specific radioactivity) | Iodine-135 (135I) | 6.57 시간 | (주사제의 경우 용기 규격 |\n| 부칙 <총리령 제1089호, 2014.8.21.> | 년도 | 는 경우를 포함하며, 법 제89조제3항에 따른 | 1) 원료약품 및 그 분량에 관한 자료 | 하는 자(이하 \"제조관리자\"라 한다)의 자격 | Xenon-135 (135Xe) | 9.14 시간 | 정 2014.5.9., 2015.3.13.> | 3) 분포 |\n| 원소 중 고의로 첨가한 안정형 동위원소가 없는 제제 | 생산에 사용될 경우 엔도톡신시험에 적합하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_092",
      "text": "| ② 제1항에 따라 의약품등의 제조판매·수입 | 시상황 평가에 필요한 자료 | 기준 실시상황 평가에 필요한 자료 | - 방사성핵종 전구체: 화학물질 전구체에 방사능 표지 | 조하여 판매하려는 경우에는 총리령으로 정하 | 또는 제2호에 해당하는 자료 | 허가를 신청하는 경우에는 별지 제5호서식의 | 2.3.3 원료약품 및 그 분량 ·································································9 | 중앙약사심의위원회에 자문을 할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 91,
        "window_size": 3,
        "char_count": 278,
        "word_count": 55,
        "page_number": 3,
        "window_text": "| (의약품 특허목록에 등재된 의약품의 안전성․유효성에 관한 자료를 근거로 신청하는 경우) | 과 혼합하거나 재용해하여 사용하는 제제 | a) 허가규정 제25조제2항에 따른 안유면제대상 | 토 결과통지서를 제출한 경우: 제1항제1호 | 료를 근거로 의약품의 제조판매·수입 품목 | □ 정보제공 등 직원 교육용 자료입니까?  | □ 예 | ■ 아니오 | 포장 | 의 방출로 대체될 수도 있다.  | 비방사능(Specific radioactivity) | Iodine-135 (135I) | 6.57 시간 | (주사제의 경우 용기 규격 |\n| 부칙 <총리령 제1089호, 2014.8.21.> | 년도 | 는 경우를 포함하며, 법 제89조제3항에 따른 | 1) 원료약품 및 그 분량에 관한 자료 | 하는 자(이하 \"제조관리자\"라 한다)의 자격 | Xenon-135 (135Xe) | 9.14 시간 | 정 2014.5.9., 2015.3.13.> | 3) 분포 |\n| 원소 중 고의로 첨가한 안정형 동위원소가 없는 제제 | 생산에 사용될 경우 엔도톡신시험에 적합하여야 한다.  | ② 제1항에 따라 의약품등의 제조판매·수입 | 시상황 평가에 필요한 자료 | 기준 실시상황 평가에 필요한 자료 | - 방사성핵종 전구체: 화학물질 전구체에 방사능 표지 | 조하여 판매하려는 경우에는 총리령으로 정하 | 또는 제2호에 해당하는 자료 | 허가를 신청하는 경우에는 별지 제5호서식의 | 2.3.3 원료약품 및 그 분량 ·································································9 | 중앙약사심의위원회에 자문을 할 수 있다.  | 포함) |\n| 제4조(희귀의약품의 기준 및 시험방법에 관한 자 | 2.3.12 제조원 | 핵의 특성에 따라 다르다.  또한 생산된 방사성핵종의 | 각조에서는 필요한 방사성핵종순도와 특정 방사성핵종 | b) 신약 | 지위승계 신고 대상에 해당하는 변경은 제외한 | 을 확인할 수 있는 서류 또는 제42조제3항 | GMP　평가자료의 요건 등 | 방사능 검출 및 측정 | Caesium-137 (137Cs) | 30.04 년 |\n| 비방사능(Specific radioactivity): 물질 또는 화합물의 | 2.  품목허가를 신청하는 품목(신약, 생물학적제 | 및 효능․효과별 적정 방사선조사량 기재 | 는 바에 따라 식품의약품안전처장에게 위탁제 | 2) 제조방법에 관한 자료 | 4) 대사 |\n| 엔도톡신시험은 일반시험법(2.6.14) 항에 따라 시험하며 | 다. ",
        "original_sentence": "| ② 제1항에 따라 의약품등의 제조판매·수입 | 시상황 평가에 필요한 자료 | 기준 실시상황 평가에 필요한 자료 | - 방사성핵종 전구체: 화학물질 전구체에 방사능 표지 | 조하여 판매하려는 경우에는 총리령으로 정하 | 또는 제2호에 해당하는 자료 | 허가를 신청하는 경우에는 별지 제5호서식의 | 2.3.3 원료약품 및 그 분량 ·································································9 | 중앙약사심의위원회에 자문을 할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_093",
      "text": "| 포함) |\n| 제4조(희귀의약품의 기준 및 시험방법에 관한 자 | 2.3.12 제조원 | 핵의 특성에 따라 다르다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 92,
        "window_size": 3,
        "char_count": 67,
        "word_count": 18,
        "page_number": 3,
        "window_text": "| □ 예 | ■ 아니오 | 포장 | 의 방출로 대체될 수도 있다.  | 비방사능(Specific radioactivity) | Iodine-135 (135I) | 6.57 시간 | (주사제의 경우 용기 규격 |\n| 부칙 <총리령 제1089호, 2014.8.21.> | 년도 | 는 경우를 포함하며, 법 제89조제3항에 따른 | 1) 원료약품 및 그 분량에 관한 자료 | 하는 자(이하 \"제조관리자\"라 한다)의 자격 | Xenon-135 (135Xe) | 9.14 시간 | 정 2014.5.9., 2015.3.13.> | 3) 분포 |\n| 원소 중 고의로 첨가한 안정형 동위원소가 없는 제제 | 생산에 사용될 경우 엔도톡신시험에 적합하여야 한다.  | ② 제1항에 따라 의약품등의 제조판매·수입 | 시상황 평가에 필요한 자료 | 기준 실시상황 평가에 필요한 자료 | - 방사성핵종 전구체: 화학물질 전구체에 방사능 표지 | 조하여 판매하려는 경우에는 총리령으로 정하 | 또는 제2호에 해당하는 자료 | 허가를 신청하는 경우에는 별지 제5호서식의 | 2.3.3 원료약품 및 그 분량 ·································································9 | 중앙약사심의위원회에 자문을 할 수 있다.  | 포함) |\n| 제4조(희귀의약품의 기준 및 시험방법에 관한 자 | 2.3.12 제조원 | 핵의 특성에 따라 다르다.  또한 생산된 방사성핵종의 | 각조에서는 필요한 방사성핵종순도와 특정 방사성핵종 | b) 신약 | 지위승계 신고 대상에 해당하는 변경은 제외한 | 을 확인할 수 있는 서류 또는 제42조제3항 | GMP　평가자료의 요건 등 | 방사능 검출 및 측정 | Caesium-137 (137Cs) | 30.04 년 |\n| 비방사능(Specific radioactivity): 물질 또는 화합물의 | 2.  품목허가를 신청하는 품목(신약, 생물학적제 | 및 효능․효과별 적정 방사선조사량 기재 | 는 바에 따라 식품의약품안전처장에게 위탁제 | 2) 제조방법에 관한 자료 | 4) 대사 |\n| 엔도톡신시험은 일반시험법(2.6.14) 항에 따라 시험하며 | 다.  한약재의 경우에는 별표 2의 한약재 제조 | 라. ",
        "original_sentence": "| 포함) |\n| 제4조(희귀의약품의 기준 및 시험방법에 관한 자 | 2.3.12 제조원 | 핵의 특성에 따라 다르다. "
      }
    },
    {
      "chunk_id": "chunk_094",
      "text": "또한 생산된 방사성핵종의 | 각조에서는 필요한 방사성핵종순도와 특정 방사성핵종 | b) 신약 | 지위승계 신고 대상에 해당하는 변경은 제외한 | 을 확인할 수 있는 서류 또는 제42조제3항 | GMP　평가자료의 요건 등 | 방사능 검출 및 측정 | Caesium-137 (137Cs) | 30.04 년 |\n| 비방사능(Specific radioactivity): 물질 또는 화합물의 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 93,
        "window_size": 3,
        "char_count": 219,
        "word_count": 52,
        "page_number": 6,
        "window_text": "| 비방사능(Specific radioactivity) | Iodine-135 (135I) | 6.57 시간 | (주사제의 경우 용기 규격 |\n| 부칙 <총리령 제1089호, 2014.8.21.> | 년도 | 는 경우를 포함하며, 법 제89조제3항에 따른 | 1) 원료약품 및 그 분량에 관한 자료 | 하는 자(이하 \"제조관리자\"라 한다)의 자격 | Xenon-135 (135Xe) | 9.14 시간 | 정 2014.5.9., 2015.3.13.> | 3) 분포 |\n| 원소 중 고의로 첨가한 안정형 동위원소가 없는 제제 | 생산에 사용될 경우 엔도톡신시험에 적합하여야 한다.  | ② 제1항에 따라 의약품등의 제조판매·수입 | 시상황 평가에 필요한 자료 | 기준 실시상황 평가에 필요한 자료 | - 방사성핵종 전구체: 화학물질 전구체에 방사능 표지 | 조하여 판매하려는 경우에는 총리령으로 정하 | 또는 제2호에 해당하는 자료 | 허가를 신청하는 경우에는 별지 제5호서식의 | 2.3.3 원료약품 및 그 분량 ·································································9 | 중앙약사심의위원회에 자문을 할 수 있다.  | 포함) |\n| 제4조(희귀의약품의 기준 및 시험방법에 관한 자 | 2.3.12 제조원 | 핵의 특성에 따라 다르다.  또한 생산된 방사성핵종의 | 각조에서는 필요한 방사성핵종순도와 특정 방사성핵종 | b) 신약 | 지위승계 신고 대상에 해당하는 변경은 제외한 | 을 확인할 수 있는 서류 또는 제42조제3항 | GMP　평가자료의 요건 등 | 방사능 검출 및 측정 | Caesium-137 (137Cs) | 30.04 년 |\n| 비방사능(Specific radioactivity): 물질 또는 화합물의 | 2.  품목허가를 신청하는 품목(신약, 생물학적제 | 및 효능․효과별 적정 방사선조사량 기재 | 는 바에 따라 식품의약품안전처장에게 위탁제 | 2) 제조방법에 관한 자료 | 4) 대사 |\n| 엔도톡신시험은 일반시험법(2.6.14) 항에 따라 시험하며 | 다.  한약재의 경우에는 별표 2의 한약재 제조 | 라.  방사성의약품인 경우에는 별표 1의 의약 | 품목신고를 하려는 자는 별지 제6호서식의 의 | 료 제출에 관한 경과조치) 이 규칙 시행 전에 | 의약품 명명법 가이드라인｣ | 시 | 험 | 참조 | 2.3.3 원료약품 및 그 분량 | 수율은 표적물질의 원소 조성, 화학적 순도, 중성자선 | 불순물(예를 들면 테크네튬-99m에서의 몰리브덴-99)에 | 방사능의 검출 및 측정은 일반 항 2.2.66. ",
        "original_sentence": "또한 생산된 방사성핵종의 | 각조에서는 필요한 방사성핵종순도와 특정 방사성핵종 | b) 신약 | 지위승계 신고 대상에 해당하는 변경은 제외한 | 을 확인할 수 있는 서류 또는 제42조제3항 | GMP　평가자료의 요건 등 | 방사능 검출 및 측정 | Caesium-137 (137Cs) | 30.04 년 |\n| 비방사능(Specific radioactivity): 물질 또는 화합물의 | 2. "
      }
    },
    {
      "chunk_id": "chunk_095",
      "text": "품목허가를 신청하는 품목(신약, 생물학적제 | 및 효능․효과별 적정 방사선조사량 기재 | 는 바에 따라 식품의약품안전처장에게 위탁제 | 2) 제조방법에 관한 자료 | 4) 대사 |\n| 엔도톡신시험은 일반시험법(2.6.14) 항에 따라 시험하며 | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 94,
        "window_size": 3,
        "char_count": 141,
        "word_count": 33,
        "page_number": 6,
        "window_text": "| ② 제1항에 따라 의약품등의 제조판매·수입 | 시상황 평가에 필요한 자료 | 기준 실시상황 평가에 필요한 자료 | - 방사성핵종 전구체: 화학물질 전구체에 방사능 표지 | 조하여 판매하려는 경우에는 총리령으로 정하 | 또는 제2호에 해당하는 자료 | 허가를 신청하는 경우에는 별지 제5호서식의 | 2.3.3 원료약품 및 그 분량 ·································································9 | 중앙약사심의위원회에 자문을 할 수 있다.  | 포함) |\n| 제4조(희귀의약품의 기준 및 시험방법에 관한 자 | 2.3.12 제조원 | 핵의 특성에 따라 다르다.  또한 생산된 방사성핵종의 | 각조에서는 필요한 방사성핵종순도와 특정 방사성핵종 | b) 신약 | 지위승계 신고 대상에 해당하는 변경은 제외한 | 을 확인할 수 있는 서류 또는 제42조제3항 | GMP　평가자료의 요건 등 | 방사능 검출 및 측정 | Caesium-137 (137Cs) | 30.04 년 |\n| 비방사능(Specific radioactivity): 물질 또는 화합물의 | 2.  품목허가를 신청하는 품목(신약, 생물학적제 | 및 효능․효과별 적정 방사선조사량 기재 | 는 바에 따라 식품의약품안전처장에게 위탁제 | 2) 제조방법에 관한 자료 | 4) 대사 |\n| 엔도톡신시험은 일반시험법(2.6.14) 항에 따라 시험하며 | 다.  한약재의 경우에는 별표 2의 한약재 제조 | 라.  방사성의약품인 경우에는 별표 1의 의약 | 품목신고를 하려는 자는 별지 제6호서식의 의 | 료 제출에 관한 경과조치) 이 규칙 시행 전에 | 의약품 명명법 가이드라인｣ | 시 | 험 | 참조 | 2.3.3 원료약품 및 그 분량 | 수율은 표적물질의 원소 조성, 화학적 순도, 중성자선 | 불순물(예를 들면 테크네튬-99m에서의 몰리브덴-99)에 | 방사능의 검출 및 측정은 일반 항 2.2.66.  방사능 검출 | 하기 위해 사용하는 방사성핵종을 포함한 물질 | ※ 방사성의약품의 경우 ‘15.7.1부터는 GMP 평가대상 | 다)에는 다음 각 호의 구분에 따른 신청서(전자 | 특허관계 확인서와 그 사유를 적은 서류 및 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다. ",
        "original_sentence": "품목허가를 신청하는 품목(신약, 생물학적제 | 및 효능․효과별 적정 방사선조사량 기재 | 는 바에 따라 식품의약품안전처장에게 위탁제 | 2) 제조방법에 관한 자료 | 4) 대사 |\n| 엔도톡신시험은 일반시험법(2.6.14) 항에 따라 시험하며 | 다. "
      }
    },
    {
      "chunk_id": "chunk_096",
      "text": "한약재의 경우에는 별표 2의 한약재 제조 | 라. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 95,
        "window_size": 3,
        "char_count": 28,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| 포함) |\n| 제4조(희귀의약품의 기준 및 시험방법에 관한 자 | 2.3.12 제조원 | 핵의 특성에 따라 다르다.  또한 생산된 방사성핵종의 | 각조에서는 필요한 방사성핵종순도와 특정 방사성핵종 | b) 신약 | 지위승계 신고 대상에 해당하는 변경은 제외한 | 을 확인할 수 있는 서류 또는 제42조제3항 | GMP　평가자료의 요건 등 | 방사능 검출 및 측정 | Caesium-137 (137Cs) | 30.04 년 |\n| 비방사능(Specific radioactivity): 물질 또는 화합물의 | 2.  품목허가를 신청하는 품목(신약, 생물학적제 | 및 효능․효과별 적정 방사선조사량 기재 | 는 바에 따라 식품의약품안전처장에게 위탁제 | 2) 제조방법에 관한 자료 | 4) 대사 |\n| 엔도톡신시험은 일반시험법(2.6.14) 항에 따라 시험하며 | 다.  한약재의 경우에는 별표 2의 한약재 제조 | 라.  방사성의약품인 경우에는 별표 1의 의약 | 품목신고를 하려는 자는 별지 제6호서식의 의 | 료 제출에 관한 경과조치) 이 규칙 시행 전에 | 의약품 명명법 가이드라인｣ | 시 | 험 | 참조 | 2.3.3 원료약품 및 그 분량 | 수율은 표적물질의 원소 조성, 화학적 순도, 중성자선 | 불순물(예를 들면 테크네튬-99m에서의 몰리브덴-99)에 | 방사능의 검출 및 측정은 일반 항 2.2.66.  방사능 검출 | 하기 위해 사용하는 방사성핵종을 포함한 물질 | ※ 방사성의약품의 경우 ‘15.7.1부터는 GMP 평가대상 | 다)에는 다음 각 호의 구분에 따른 신청서(전자 | 특허관계 확인서와 그 사유를 적은 서류 및 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.  | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다. ",
        "original_sentence": "한약재의 경우에는 별표 2의 한약재 제조 | 라. "
      }
    },
    {
      "chunk_id": "chunk_097",
      "text": "방사성의약품인 경우에는 별표 1의 의약 | 품목신고를 하려는 자는 별지 제6호서식의 의 | 료 제출에 관한 경과조치) 이 규칙 시행 전에 | 의약품 명명법 가이드라인｣ | 시 | 험 | 참조 | 2.3.3 원료약품 및 그 분량 | 수율은 표적물질의 원소 조성, 화학적 순도, 중성자선 | 불순물(예를 들면 테크네튬-99m에서의 몰리브덴-99)에 | 방사능의 검출 및 측정은 일반 항 2.2.66. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 96,
        "window_size": 3,
        "char_count": 222,
        "word_count": 58,
        "page_number": 3,
        "window_text": "또한 생산된 방사성핵종의 | 각조에서는 필요한 방사성핵종순도와 특정 방사성핵종 | b) 신약 | 지위승계 신고 대상에 해당하는 변경은 제외한 | 을 확인할 수 있는 서류 또는 제42조제3항 | GMP　평가자료의 요건 등 | 방사능 검출 및 측정 | Caesium-137 (137Cs) | 30.04 년 |\n| 비방사능(Specific radioactivity): 물질 또는 화합물의 | 2.  품목허가를 신청하는 품목(신약, 생물학적제 | 및 효능․효과별 적정 방사선조사량 기재 | 는 바에 따라 식품의약품안전처장에게 위탁제 | 2) 제조방법에 관한 자료 | 4) 대사 |\n| 엔도톡신시험은 일반시험법(2.6.14) 항에 따라 시험하며 | 다.  한약재의 경우에는 별표 2의 한약재 제조 | 라.  방사성의약품인 경우에는 별표 1의 의약 | 품목신고를 하려는 자는 별지 제6호서식의 의 | 료 제출에 관한 경과조치) 이 규칙 시행 전에 | 의약품 명명법 가이드라인｣ | 시 | 험 | 참조 | 2.3.3 원료약품 및 그 분량 | 수율은 표적물질의 원소 조성, 화학적 순도, 중성자선 | 불순물(예를 들면 테크네튬-99m에서의 몰리브덴-99)에 | 방사능의 검출 및 측정은 일반 항 2.2.66.  방사능 검출 | 하기 위해 사용하는 방사성핵종을 포함한 물질 | ※ 방사성의약품의 경우 ‘15.7.1부터는 GMP 평가대상 | 다)에는 다음 각 호의 구분에 따른 신청서(전자 | 특허관계 확인서와 그 사유를 적은 서류 및 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.  | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.  | Barium-137m (137mBa) | 2.552 분 | 한다. ",
        "original_sentence": "방사성의약품인 경우에는 별표 1의 의약 | 품목신고를 하려는 자는 별지 제6호서식의 의 | 료 제출에 관한 경과조치) 이 규칙 시행 전에 | 의약품 명명법 가이드라인｣ | 시 | 험 | 참조 | 2.3.3 원료약품 및 그 분량 | 수율은 표적물질의 원소 조성, 화학적 순도, 중성자선 | 불순물(예를 들면 테크네튬-99m에서의 몰리브덴-99)에 | 방사능의 검출 및 측정은 일반 항 2.2.66. "
      }
    },
    {
      "chunk_id": "chunk_098",
      "text": "방사능 검출 | 하기 위해 사용하는 방사성핵종을 포함한 물질 | ※ 방사성의약품의 경우 ‘15.7.1부터는 GMP 평가대상 | 다)에는 다음 각 호의 구분에 따른 신청서(전자 | 특허관계 확인서와 그 사유를 적은 서류 및 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 97,
        "window_size": 3,
        "char_count": 178,
        "word_count": 46,
        "page_number": 10,
        "window_text": "품목허가를 신청하는 품목(신약, 생물학적제 | 및 효능․효과별 적정 방사선조사량 기재 | 는 바에 따라 식품의약품안전처장에게 위탁제 | 2) 제조방법에 관한 자료 | 4) 대사 |\n| 엔도톡신시험은 일반시험법(2.6.14) 항에 따라 시험하며 | 다.  한약재의 경우에는 별표 2의 한약재 제조 | 라.  방사성의약품인 경우에는 별표 1의 의약 | 품목신고를 하려는 자는 별지 제6호서식의 의 | 료 제출에 관한 경과조치) 이 규칙 시행 전에 | 의약품 명명법 가이드라인｣ | 시 | 험 | 참조 | 2.3.3 원료약품 및 그 분량 | 수율은 표적물질의 원소 조성, 화학적 순도, 중성자선 | 불순물(예를 들면 테크네튬-99m에서의 몰리브덴-99)에 | 방사능의 검출 및 측정은 일반 항 2.2.66.  방사능 검출 | 하기 위해 사용하는 방사성핵종을 포함한 물질 | ※ 방사성의약품의 경우 ‘15.7.1부터는 GMP 평가대상 | 다)에는 다음 각 호의 구분에 따른 신청서(전자 | 특허관계 확인서와 그 사유를 적은 서류 및 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.  | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.  | Barium-137m (137mBa) | 2.552 분 | 한다.  <개정 2011.3.30., 2013.3.23.> | 판매ᆞ수입 품목허가 및 품목신고의 갱신 |\n| 2015.7. ",
        "original_sentence": "방사능 검출 | 하기 위해 사용하는 방사성핵종을 포함한 물질 | ※ 방사성의약품의 경우 ‘15.7.1부터는 GMP 평가대상 | 다)에는 다음 각 호의 구분에 따른 신청서(전자 | 특허관계 확인서와 그 사유를 적은 서류 및 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다. "
      }
    },
    {
      "chunk_id": "chunk_099",
      "text": "| 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 98,
        "window_size": 3,
        "char_count": 33,
        "word_count": 7,
        "page_number": 1,
        "window_text": "한약재의 경우에는 별표 2의 한약재 제조 | 라.  방사성의약품인 경우에는 별표 1의 의약 | 품목신고를 하려는 자는 별지 제6호서식의 의 | 료 제출에 관한 경과조치) 이 규칙 시행 전에 | 의약품 명명법 가이드라인｣ | 시 | 험 | 참조 | 2.3.3 원료약품 및 그 분량 | 수율은 표적물질의 원소 조성, 화학적 순도, 중성자선 | 불순물(예를 들면 테크네튬-99m에서의 몰리브덴-99)에 | 방사능의 검출 및 측정은 일반 항 2.2.66.  방사능 검출 | 하기 위해 사용하는 방사성핵종을 포함한 물질 | ※ 방사성의약품의 경우 ‘15.7.1부터는 GMP 평가대상 | 다)에는 다음 각 호의 구분에 따른 신청서(전자 | 특허관계 확인서와 그 사유를 적은 서류 및 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.  | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.  | Barium-137m (137mBa) | 2.552 분 | 한다.  <개정 2011.3.30., 2013.3.23.> | 판매ᆞ수입 품목허가 및 품목신고의 갱신 |\n| 2015.7.  | 단위질량 당 방사성핵종의 방사능(예: Bq/g, Bq/mol) | ※ 상기 구비 서류 중, | - 아래 표를 참고로 구분하여 기재 | 유의사항 | 조판매업신고를 하여야 하며, 품목별로 품목허 | 에 따른 제조관리자 승인서 | 2.3.4 성상 ·····························································································10 |\n| 약품등 제조판매·수입 품목신고서(전자문서로 | 및 품질관리기준 실시상황 평가에 필요한 | 품 제조 및 품질관리기준, 별표 1의2의 | - 화학물질 전구체: 방사성핵종과 결합하는 방사능이 | - 오용의 여지가 없는 명확한 표현 사용, 남용의 위험성, 특성을 강조하는 표현 제외 | 문서로 된 신청서를 포함한다) 또는 신고서(전 | 3) 기준 및 시험방법이 기재된 자료 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 근거자료 | 2. ",
        "original_sentence": "| 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다. "
      }
    },
    {
      "chunk_id": "chunk_100",
      "text": "| Barium-137m (137mBa) | 2.552 분 | 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 99,
        "window_size": 3,
        "char_count": 39,
        "word_count": 8,
        "page_number": 3,
        "window_text": "방사성의약품인 경우에는 별표 1의 의약 | 품목신고를 하려는 자는 별지 제6호서식의 의 | 료 제출에 관한 경과조치) 이 규칙 시행 전에 | 의약품 명명법 가이드라인｣ | 시 | 험 | 참조 | 2.3.3 원료약품 및 그 분량 | 수율은 표적물질의 원소 조성, 화학적 순도, 중성자선 | 불순물(예를 들면 테크네튬-99m에서의 몰리브덴-99)에 | 방사능의 검출 및 측정은 일반 항 2.2.66.  방사능 검출 | 하기 위해 사용하는 방사성핵종을 포함한 물질 | ※ 방사성의약품의 경우 ‘15.7.1부터는 GMP 평가대상 | 다)에는 다음 각 호의 구분에 따른 신청서(전자 | 특허관계 확인서와 그 사유를 적은 서류 및 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.  | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.  | Barium-137m (137mBa) | 2.552 분 | 한다.  <개정 2011.3.30., 2013.3.23.> | 판매ᆞ수입 품목허가 및 품목신고의 갱신 |\n| 2015.7.  | 단위질량 당 방사성핵종의 방사능(예: Bq/g, Bq/mol) | ※ 상기 구비 서류 중, | - 아래 표를 참고로 구분하여 기재 | 유의사항 | 조판매업신고를 하여야 하며, 품목별로 품목허 | 에 따른 제조관리자 승인서 | 2.3.4 성상 ·····························································································10 |\n| 약품등 제조판매·수입 품목신고서(전자문서로 | 및 품질관리기준 실시상황 평가에 필요한 | 품 제조 및 품질관리기준, 별표 1의2의 | - 화학물질 전구체: 방사성핵종과 결합하는 방사능이 | - 오용의 여지가 없는 명확한 표현 사용, 남용의 위험성, 특성을 강조하는 표현 제외 | 문서로 된 신청서를 포함한다) 또는 신고서(전 | 3) 기준 및 시험방법이 기재된 자료 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 근거자료 | 2.  법 제32조에 따른 신약 등의 재심사 | Thallium-200 (200TI) | 26.1 시간 | 5) 배설 |\n| 다음 시험항목 중 일부는 제품의 방사성핵종의 반감기 | 시험을 수행하는 개인의 방사선 조사량을 제한하기 위 | 종전의 규정에 따라 희귀의약품의 제조판매ᆞ | 및 측정에 따라 수행한다. ",
        "original_sentence": "| Barium-137m (137mBa) | 2.552 분 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_101",
      "text": "<개정 2011.3.30., 2013.3.23.> | 판매ᆞ수입 품목허가 및 품목신고의 갱신 |\n| 2015.7. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 100,
        "window_size": 3,
        "char_count": 64,
        "word_count": 12,
        "page_number": 3,
        "window_text": "방사능 검출 | 하기 위해 사용하는 방사성핵종을 포함한 물질 | ※ 방사성의약품의 경우 ‘15.7.1부터는 GMP 평가대상 | 다)에는 다음 각 호의 구분에 따른 신청서(전자 | 특허관계 확인서와 그 사유를 적은 서류 및 | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침·안내서 등록 대상이 아닙니다.  | 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.  | Barium-137m (137mBa) | 2.552 분 | 한다.  <개정 2011.3.30., 2013.3.23.> | 판매ᆞ수입 품목허가 및 품목신고의 갱신 |\n| 2015.7.  | 단위질량 당 방사성핵종의 방사능(예: Bq/g, Bq/mol) | ※ 상기 구비 서류 중, | - 아래 표를 참고로 구분하여 기재 | 유의사항 | 조판매업신고를 하여야 하며, 품목별로 품목허 | 에 따른 제조관리자 승인서 | 2.3.4 성상 ·····························································································10 |\n| 약품등 제조판매·수입 품목신고서(전자문서로 | 및 품질관리기준 실시상황 평가에 필요한 | 품 제조 및 품질관리기준, 별표 1의2의 | - 화학물질 전구체: 방사성핵종과 결합하는 방사능이 | - 오용의 여지가 없는 명확한 표현 사용, 남용의 위험성, 특성을 강조하는 표현 제외 | 문서로 된 신청서를 포함한다) 또는 신고서(전 | 3) 기준 및 시험방법이 기재된 자료 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 근거자료 | 2.  법 제32조에 따른 신약 등의 재심사 | Thallium-200 (200TI) | 26.1 시간 | 5) 배설 |\n| 다음 시험항목 중 일부는 제품의 방사성핵종의 반감기 | 시험을 수행하는 개인의 방사선 조사량을 제한하기 위 | 종전의 규정에 따라 희귀의약품의 제조판매ᆞ | 및 측정에 따라 수행한다.  | 속(neutron flux) 및 빔전류(beam current)에서의 하전 | 대한 기준을 규정하고 있다. ",
        "original_sentence": "<개정 2011.3.30., 2013.3.23.> | 판매ᆞ수입 품목허가 및 품목신고의 갱신 |\n| 2015.7. "
      }
    },
    {
      "chunk_id": "chunk_102",
      "text": "| 단위질량 당 방사성핵종의 방사능(예: Bq/g, Bq/mol) | ※ 상기 구비 서류 중, | - 아래 표를 참고로 구분하여 기재 | 유의사항 | 조판매업신고를 하여야 하며, 품목별로 품목허 | 에 따른 제조관리자 승인서 | 2.3.4 성상 ·····························································································10 |\n| 약품등 제조판매·수입 품목신고서(전자문서로 | 및 품질관리기준 실시상황 평가에 필요한 | 품 제조 및 품질관리기준, 별표 1의2의 | - 화학물질 전구체: 방사성핵종과 결합하는 방사능이 | - 오용의 여지가 없는 명확한 표현 사용, 남용의 위험성, 특성을 강조하는 표현 제외 | 문서로 된 신청서를 포함한다) 또는 신고서(전 | 3) 기준 및 시험방법이 기재된 자료 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 근거자료 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 101,
        "window_size": 3,
        "char_count": 482,
        "word_count": 101,
        "page_number": 5,
        "window_text": "| 지침·안내서 제·개정 절차를 적용하실 필요는 없습니다.  | Barium-137m (137mBa) | 2.552 분 | 한다.  <개정 2011.3.30., 2013.3.23.> | 판매ᆞ수입 품목허가 및 품목신고의 갱신 |\n| 2015.7.  | 단위질량 당 방사성핵종의 방사능(예: Bq/g, Bq/mol) | ※ 상기 구비 서류 중, | - 아래 표를 참고로 구분하여 기재 | 유의사항 | 조판매업신고를 하여야 하며, 품목별로 품목허 | 에 따른 제조관리자 승인서 | 2.3.4 성상 ·····························································································10 |\n| 약품등 제조판매·수입 품목신고서(전자문서로 | 및 품질관리기준 실시상황 평가에 필요한 | 품 제조 및 품질관리기준, 별표 1의2의 | - 화학물질 전구체: 방사성핵종과 결합하는 방사능이 | - 오용의 여지가 없는 명확한 표현 사용, 남용의 위험성, 특성을 강조하는 표현 제외 | 문서로 된 신청서를 포함한다) 또는 신고서(전 | 3) 기준 및 시험방법이 기재된 자료 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 근거자료 | 2.  법 제32조에 따른 신약 등의 재심사 | Thallium-200 (200TI) | 26.1 시간 | 5) 배설 |\n| 다음 시험항목 중 일부는 제품의 방사성핵종의 반감기 | 시험을 수행하는 개인의 방사선 조사량을 제한하기 위 | 종전의 규정에 따라 희귀의약품의 제조판매ᆞ | 및 측정에 따라 수행한다.  | 속(neutron flux) 및 빔전류(beam current)에서의 하전 | 대한 기준을 규정하고 있다.  이러한 요구사항이 필요 | ② 제1항에 따라 신청서 또는 신고서를 받은 | 3) 업소정보 입력 | 가를 | 받아야 | 한다. ",
        "original_sentence": "| 단위질량 당 방사성핵종의 방사능(예: Bq/g, Bq/mol) | ※ 상기 구비 서류 중, | - 아래 표를 참고로 구분하여 기재 | 유의사항 | 조판매업신고를 하여야 하며, 품목별로 품목허 | 에 따른 제조관리자 승인서 | 2.3.4 성상 ·····························································································10 |\n| 약품등 제조판매·수입 품목신고서(전자문서로 | 및 품질관리기준 실시상황 평가에 필요한 | 품 제조 및 품질관리기준, 별표 1의2의 | - 화학물질 전구체: 방사성핵종과 결합하는 방사능이 | - 오용의 여지가 없는 명확한 표현 사용, 남용의 위험성, 특성을 강조하는 표현 제외 | 문서로 된 신청서를 포함한다) 또는 신고서(전 | 3) 기준 및 시험방법이 기재된 자료 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 근거자료 | 2. "
      }
    },
    {
      "chunk_id": "chunk_103",
      "text": "법 제32조에 따른 신약 등의 재심사 | Thallium-200 (200TI) | 26.1 시간 | 5) 배설 |\n| 다음 시험항목 중 일부는 제품의 방사성핵종의 반감기 | 시험을 수행하는 개인의 방사선 조사량을 제한하기 위 | 종전의 규정에 따라 희귀의약품의 제조판매ᆞ | 및 측정에 따라 수행한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 102,
        "window_size": 3,
        "char_count": 169,
        "word_count": 43,
        "page_number": 3,
        "window_text": "| Barium-137m (137mBa) | 2.552 분 | 한다.  <개정 2011.3.30., 2013.3.23.> | 판매ᆞ수입 품목허가 및 품목신고의 갱신 |\n| 2015.7.  | 단위질량 당 방사성핵종의 방사능(예: Bq/g, Bq/mol) | ※ 상기 구비 서류 중, | - 아래 표를 참고로 구분하여 기재 | 유의사항 | 조판매업신고를 하여야 하며, 품목별로 품목허 | 에 따른 제조관리자 승인서 | 2.3.4 성상 ·····························································································10 |\n| 약품등 제조판매·수입 품목신고서(전자문서로 | 및 품질관리기준 실시상황 평가에 필요한 | 품 제조 및 품질관리기준, 별표 1의2의 | - 화학물질 전구체: 방사성핵종과 결합하는 방사능이 | - 오용의 여지가 없는 명확한 표현 사용, 남용의 위험성, 특성을 강조하는 표현 제외 | 문서로 된 신청서를 포함한다) 또는 신고서(전 | 3) 기준 및 시험방법이 기재된 자료 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 근거자료 | 2.  법 제32조에 따른 신약 등의 재심사 | Thallium-200 (200TI) | 26.1 시간 | 5) 배설 |\n| 다음 시험항목 중 일부는 제품의 방사성핵종의 반감기 | 시험을 수행하는 개인의 방사선 조사량을 제한하기 위 | 종전의 규정에 따라 희귀의약품의 제조판매ᆞ | 및 측정에 따라 수행한다.  | 속(neutron flux) 및 빔전류(beam current)에서의 하전 | 대한 기준을 규정하고 있다.  이러한 요구사항이 필요 | ② 제1항에 따라 신청서 또는 신고서를 받은 | 3) 업소정보 입력 | 가를 | 받아야 | 한다.  | <개정 | 2008.2.29., | Lead-201 (201Pb) | 9.33 시간 |\n| 예비심사 (제출된 서류의 적절성 평가) | 된 신고서를 포함한다)에 다음 각 호의 자료 | 자료. ",
        "original_sentence": "법 제32조에 따른 신약 등의 재심사 | Thallium-200 (200TI) | 26.1 시간 | 5) 배설 |\n| 다음 시험항목 중 일부는 제품의 방사성핵종의 반감기 | 시험을 수행하는 개인의 방사선 조사량을 제한하기 위 | 종전의 규정에 따라 희귀의약품의 제조판매ᆞ | 및 측정에 따라 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_104",
      "text": "| 속(neutron flux) 및 빔전류(beam current)에서의 하전 | 대한 기준을 규정하고 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 103,
        "window_size": 3,
        "char_count": 62,
        "word_count": 12,
        "page_number": 6,
        "window_text": "<개정 2011.3.30., 2013.3.23.> | 판매ᆞ수입 품목허가 및 품목신고의 갱신 |\n| 2015.7.  | 단위질량 당 방사성핵종의 방사능(예: Bq/g, Bq/mol) | ※ 상기 구비 서류 중, | - 아래 표를 참고로 구분하여 기재 | 유의사항 | 조판매업신고를 하여야 하며, 품목별로 품목허 | 에 따른 제조관리자 승인서 | 2.3.4 성상 ·····························································································10 |\n| 약품등 제조판매·수입 품목신고서(전자문서로 | 및 품질관리기준 실시상황 평가에 필요한 | 품 제조 및 품질관리기준, 별표 1의2의 | - 화학물질 전구체: 방사성핵종과 결합하는 방사능이 | - 오용의 여지가 없는 명확한 표현 사용, 남용의 위험성, 특성을 강조하는 표현 제외 | 문서로 된 신청서를 포함한다) 또는 신고서(전 | 3) 기준 및 시험방법이 기재된 자료 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 근거자료 | 2.  법 제32조에 따른 신약 등의 재심사 | Thallium-200 (200TI) | 26.1 시간 | 5) 배설 |\n| 다음 시험항목 중 일부는 제품의 방사성핵종의 반감기 | 시험을 수행하는 개인의 방사선 조사량을 제한하기 위 | 종전의 규정에 따라 희귀의약품의 제조판매ᆞ | 및 측정에 따라 수행한다.  | 속(neutron flux) 및 빔전류(beam current)에서의 하전 | 대한 기준을 규정하고 있다.  이러한 요구사항이 필요 | ② 제1항에 따라 신청서 또는 신고서를 받은 | 3) 업소정보 입력 | 가를 | 받아야 | 한다.  | <개정 | 2008.2.29., | Lead-201 (201Pb) | 9.33 시간 |\n| 예비심사 (제출된 서류의 적절성 평가) | 된 신고서를 포함한다)에 다음 각 호의 자료 | 자료.  다만, 둘 이상의 제조판매ᆞ수입 품 | 원료의약품 제조 및 품질관리기준 및 별 | ② 안전성유효성에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음. ",
        "original_sentence": "| 속(neutron flux) 및 빔전류(beam current)에서의 하전 | 대한 기준을 규정하고 있다. "
      }
    },
    {
      "chunk_id": "chunk_105",
      "text": "이러한 요구사항이 필요 | ② 제1항에 따라 신청서 또는 신고서를 받은 | 3) 업소정보 입력 | 가를 | 받아야 | 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 104,
        "window_size": 3,
        "char_count": 70,
        "word_count": 21,
        "page_number": 1,
        "window_text": "| 단위질량 당 방사성핵종의 방사능(예: Bq/g, Bq/mol) | ※ 상기 구비 서류 중, | - 아래 표를 참고로 구분하여 기재 | 유의사항 | 조판매업신고를 하여야 하며, 품목별로 품목허 | 에 따른 제조관리자 승인서 | 2.3.4 성상 ·····························································································10 |\n| 약품등 제조판매·수입 품목신고서(전자문서로 | 및 품질관리기준 실시상황 평가에 필요한 | 품 제조 및 품질관리기준, 별표 1의2의 | - 화학물질 전구체: 방사성핵종과 결합하는 방사능이 | - 오용의 여지가 없는 명확한 표현 사용, 남용의 위험성, 특성을 강조하는 표현 제외 | 문서로 된 신청서를 포함한다) 또는 신고서(전 | 3) 기준 및 시험방법이 기재된 자료 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 근거자료 | 2.  법 제32조에 따른 신약 등의 재심사 | Thallium-200 (200TI) | 26.1 시간 | 5) 배설 |\n| 다음 시험항목 중 일부는 제품의 방사성핵종의 반감기 | 시험을 수행하는 개인의 방사선 조사량을 제한하기 위 | 종전의 규정에 따라 희귀의약품의 제조판매ᆞ | 및 측정에 따라 수행한다.  | 속(neutron flux) 및 빔전류(beam current)에서의 하전 | 대한 기준을 규정하고 있다.  이러한 요구사항이 필요 | ② 제1항에 따라 신청서 또는 신고서를 받은 | 3) 업소정보 입력 | 가를 | 받아야 | 한다.  | <개정 | 2008.2.29., | Lead-201 (201Pb) | 9.33 시간 |\n| 예비심사 (제출된 서류의 적절성 평가) | 된 신고서를 포함한다)에 다음 각 호의 자료 | 자료.  다만, 둘 이상의 제조판매ᆞ수입 품 | 원료의약품 제조 및 품질관리기준 및 별 | ② 안전성유효성에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.  | 명칭 | 기재항목 | 용어 정의 | 11. ",
        "original_sentence": "이러한 요구사항이 필요 | ② 제1항에 따라 신청서 또는 신고서를 받은 | 3) 업소정보 입력 | 가를 | 받아야 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_106",
      "text": "| <개정 | 2008.2.29., | Lead-201 (201Pb) | 9.33 시간 |\n| 예비심사 (제출된 서류의 적절성 평가) | 된 신고서를 포함한다)에 다음 각 호의 자료 | 자료. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 105,
        "window_size": 3,
        "char_count": 108,
        "word_count": 27,
        "page_number": 3,
        "window_text": "법 제32조에 따른 신약 등의 재심사 | Thallium-200 (200TI) | 26.1 시간 | 5) 배설 |\n| 다음 시험항목 중 일부는 제품의 방사성핵종의 반감기 | 시험을 수행하는 개인의 방사선 조사량을 제한하기 위 | 종전의 규정에 따라 희귀의약품의 제조판매ᆞ | 및 측정에 따라 수행한다.  | 속(neutron flux) 및 빔전류(beam current)에서의 하전 | 대한 기준을 규정하고 있다.  이러한 요구사항이 필요 | ② 제1항에 따라 신청서 또는 신고서를 받은 | 3) 업소정보 입력 | 가를 | 받아야 | 한다.  | <개정 | 2008.2.29., | Lead-201 (201Pb) | 9.33 시간 |\n| 예비심사 (제출된 서류의 적절성 평가) | 된 신고서를 포함한다)에 다음 각 호의 자료 | 자료.  다만, 둘 이상의 제조판매ᆞ수입 품 | 원료의약품 제조 및 품질관리기준 및 별 | ② 안전성유효성에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.  | 명칭 | 기재항목 | 용어 정의 | 11.  신약, 희귀의약품(적절한 대체의약품이 없 | 원료약품 및 그 분량 | 4) 기준 및 시험방법에 관한 근거자료 | 전처장이 고시하는 의약품은 제외한다)을 제 | 2.3.5 제조방법 ·····················································································11 | 3. ",
        "original_sentence": "| <개정 | 2008.2.29., | Lead-201 (201Pb) | 9.33 시간 |\n| 예비심사 (제출된 서류의 적절성 평가) | 된 신고서를 포함한다)에 다음 각 호의 자료 | 자료. "
      }
    },
    {
      "chunk_id": "chunk_107",
      "text": "다만, 둘 이상의 제조판매ᆞ수입 품 | 원료의약품 제조 및 품질관리기준 및 별 | ② 안전성유효성에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 106,
        "window_size": 3,
        "char_count": 102,
        "word_count": 28,
        "page_number": 3,
        "window_text": "| 속(neutron flux) 및 빔전류(beam current)에서의 하전 | 대한 기준을 규정하고 있다.  이러한 요구사항이 필요 | ② 제1항에 따라 신청서 또는 신고서를 받은 | 3) 업소정보 입력 | 가를 | 받아야 | 한다.  | <개정 | 2008.2.29., | Lead-201 (201Pb) | 9.33 시간 |\n| 예비심사 (제출된 서류의 적절성 평가) | 된 신고서를 포함한다)에 다음 각 호의 자료 | 자료.  다만, 둘 이상의 제조판매ᆞ수입 품 | 원료의약품 제조 및 품질관리기준 및 별 | ② 안전성유효성에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.  | 명칭 | 기재항목 | 용어 정의 | 11.  신약, 희귀의약품(적절한 대체의약품이 없 | 원료약품 및 그 분량 | 4) 기준 및 시험방법에 관한 근거자료 | 전처장이 고시하는 의약품은 제외한다)을 제 | 2.3.5 제조방법 ·····················································································11 | 3.  법 제33조에 따른 의약품 재평가 | 라. ",
        "original_sentence": "다만, 둘 이상의 제조판매ᆞ수입 품 | 원료의약품 제조 및 품질관리기준 및 별 | ② 안전성유효성에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음. "
      }
    },
    {
      "chunk_id": "chunk_108",
      "text": "| 명칭 | 기재항목 | 용어 정의 | 11. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 107,
        "window_size": 3,
        "char_count": 26,
        "word_count": 9,
        "page_number": 1,
        "window_text": "이러한 요구사항이 필요 | ② 제1항에 따라 신청서 또는 신고서를 받은 | 3) 업소정보 입력 | 가를 | 받아야 | 한다.  | <개정 | 2008.2.29., | Lead-201 (201Pb) | 9.33 시간 |\n| 예비심사 (제출된 서류의 적절성 평가) | 된 신고서를 포함한다)에 다음 각 호의 자료 | 자료.  다만, 둘 이상의 제조판매ᆞ수입 품 | 원료의약품 제조 및 품질관리기준 및 별 | ② 안전성유효성에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.  | 명칭 | 기재항목 | 용어 정의 | 11.  신약, 희귀의약품(적절한 대체의약품이 없 | 원료약품 및 그 분량 | 4) 기준 및 시험방법에 관한 근거자료 | 전처장이 고시하는 의약품은 제외한다)을 제 | 2.3.5 제조방법 ·····················································································11 | 3.  법 제33조에 따른 의약품 재평가 | 라.  약물상호작용 등에 관한 자료 |\n| [제제총칙 - 주사제 항] | 해 주의를 요한다. ",
        "original_sentence": "| 명칭 | 기재항목 | 용어 정의 | 11. "
      }
    },
    {
      "chunk_id": "chunk_109",
      "text": "신약, 희귀의약품(적절한 대체의약품이 없 | 원료약품 및 그 분량 | 4) 기준 및 시험방법에 관한 근거자료 | 전처장이 고시하는 의약품은 제외한다)을 제 | 2.3.5 제조방법 ·····················································································11 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 108,
        "window_size": 3,
        "char_count": 193,
        "word_count": 28,
        "page_number": 3,
        "window_text": "| <개정 | 2008.2.29., | Lead-201 (201Pb) | 9.33 시간 |\n| 예비심사 (제출된 서류의 적절성 평가) | 된 신고서를 포함한다)에 다음 각 호의 자료 | 자료.  다만, 둘 이상의 제조판매ᆞ수입 품 | 원료의약품 제조 및 품질관리기준 및 별 | ② 안전성유효성에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.  | 명칭 | 기재항목 | 용어 정의 | 11.  신약, 희귀의약품(적절한 대체의약품이 없 | 원료약품 및 그 분량 | 4) 기준 및 시험방법에 관한 근거자료 | 전처장이 고시하는 의약품은 제외한다)을 제 | 2.3.5 제조방법 ·····················································································11 | 3.  법 제33조에 따른 의약품 재평가 | 라.  약물상호작용 등에 관한 자료 |\n| [제제총칙 - 주사제 항] | 해 주의를 요한다.  엔도톡신 기준은 각조에 기재되어 | 수입 품목허가를 신청한 자에 대해서는 제4조 | [제제총칙 - 주사제 항] | 한 반면, 그것만으로 제품의 방사성핵종순도가 임상적 | 없는 물질 | 자문서로 된 신고서를 포함한다)에 그 허가증 | 지방청장은 「전자정부법」 제36조제1항에 따 | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 하여 계산된다. ",
        "original_sentence": "신약, 희귀의약품(적절한 대체의약품이 없 | 원료약품 및 그 분량 | 4) 기준 및 시험방법에 관한 근거자료 | 전처장이 고시하는 의약품은 제외한다)을 제 | 2.3.5 제조방법 ·····················································································11 | 3. "
      }
    },
    {
      "chunk_id": "chunk_110",
      "text": "법 제33조에 따른 의약품 재평가 | 라. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 109,
        "window_size": 3,
        "char_count": 24,
        "word_count": 7,
        "page_number": 3,
        "window_text": "다만, 둘 이상의 제조판매ᆞ수입 품 | 원료의약품 제조 및 품질관리기준 및 별 | ② 안전성유효성에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.  | 명칭 | 기재항목 | 용어 정의 | 11.  신약, 희귀의약품(적절한 대체의약품이 없 | 원료약품 및 그 분량 | 4) 기준 및 시험방법에 관한 근거자료 | 전처장이 고시하는 의약품은 제외한다)을 제 | 2.3.5 제조방법 ·····················································································11 | 3.  법 제33조에 따른 의약품 재평가 | 라.  약물상호작용 등에 관한 자료 |\n| [제제총칙 - 주사제 항] | 해 주의를 요한다.  엔도톡신 기준은 각조에 기재되어 | 수입 품목허가를 신청한 자에 대해서는 제4조 | [제제총칙 - 주사제 항] | 한 반면, 그것만으로 제품의 방사성핵종순도가 임상적 | 없는 물질 | 자문서로 된 신고서를 포함한다)에 그 허가증 | 지방청장은 「전자정부법」 제36조제1항에 따 | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 하여 계산된다.  | Thallium-201 (201Tl) | 72.912 시간 | □ 예(☞지침) | ■ 아니오 |\n| 가 짧은 경우 배치 출하 전에 수행하기 어렵다. ",
        "original_sentence": "법 제33조에 따른 의약품 재평가 | 라. "
      }
    },
    {
      "chunk_id": "chunk_111",
      "text": "약물상호작용 등에 관한 자료 |\n| [제제총칙 - 주사제 항] | 해 주의를 요한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 110,
        "window_size": 3,
        "char_count": 48,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| 명칭 | 기재항목 | 용어 정의 | 11.  신약, 희귀의약품(적절한 대체의약품이 없 | 원료약품 및 그 분량 | 4) 기준 및 시험방법에 관한 근거자료 | 전처장이 고시하는 의약품은 제외한다)을 제 | 2.3.5 제조방법 ·····················································································11 | 3.  법 제33조에 따른 의약품 재평가 | 라.  약물상호작용 등에 관한 자료 |\n| [제제총칙 - 주사제 항] | 해 주의를 요한다.  엔도톡신 기준은 각조에 기재되어 | 수입 품목허가를 신청한 자에 대해서는 제4조 | [제제총칙 - 주사제 항] | 한 반면, 그것만으로 제품의 방사성핵종순도가 임상적 | 없는 물질 | 자문서로 된 신고서를 포함한다)에 그 허가증 | 지방청장은 「전자정부법」 제36조제1항에 따 | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 하여 계산된다.  | Thallium-201 (201Tl) | 72.912 시간 | □ 예(☞지침) | ■ 아니오 |\n| 가 짧은 경우 배치 출하 전에 수행하기 어렵다.  각조 | (전자문서를 포함한다)를 첨부하여 지방청장에 | 목허가를 동시에 신청하는 경우에는 그 | 표 3의2의 방사성의약품 제조 및 품질관 | 입자 에 따라 다르다. ",
        "original_sentence": "약물상호작용 등에 관한 자료 |\n| [제제총칙 - 주사제 항] | 해 주의를 요한다. "
      }
    },
    {
      "chunk_id": "chunk_112",
      "text": "엔도톡신 기준은 각조에 기재되어 | 수입 품목허가를 신청한 자에 대해서는 제4조 | [제제총칙 - 주사제 항] | 한 반면, 그것만으로 제품의 방사성핵종순도가 임상적 | 없는 물질 | 자문서로 된 신고서를 포함한다)에 그 허가증 | 지방청장은 「전자정부법」 제36조제1항에 따 | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 하여 계산된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 111,
        "window_size": 3,
        "char_count": 203,
        "word_count": 50,
        "page_number": 3,
        "window_text": "신약, 희귀의약품(적절한 대체의약품이 없 | 원료약품 및 그 분량 | 4) 기준 및 시험방법에 관한 근거자료 | 전처장이 고시하는 의약품은 제외한다)을 제 | 2.3.5 제조방법 ·····················································································11 | 3.  법 제33조에 따른 의약품 재평가 | 라.  약물상호작용 등에 관한 자료 |\n| [제제총칙 - 주사제 항] | 해 주의를 요한다.  엔도톡신 기준은 각조에 기재되어 | 수입 품목허가를 신청한 자에 대해서는 제4조 | [제제총칙 - 주사제 항] | 한 반면, 그것만으로 제품의 방사성핵종순도가 임상적 | 없는 물질 | 자문서로 된 신고서를 포함한다)에 그 허가증 | 지방청장은 「전자정부법」 제36조제1항에 따 | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 하여 계산된다.  | Thallium-201 (201Tl) | 72.912 시간 | □ 예(☞지침) | ■ 아니오 |\n| 가 짧은 경우 배치 출하 전에 수행하기 어렵다.  각조 | (전자문서를 포함한다)를 첨부하여 지방청장에 | 목허가를 동시에 신청하는 경우에는 그 | 표 3의2의 방사성의약품 제조 및 품질관 | 입자 에 따라 다르다.  | 4) 자가점검표 항목 입력 (민원인이 직접 제출자료의 타당성 여부 점검) | 2010.1.18., 2013.3.23.> | 조하는 제조소에 제48조의2에 따른 제조 및 | 어 긴급히 도입하여야 하는 의약품으로서 식 | 제조판매품목허가권자와 제조자 동일 | 에 드는 경비를 포함한다)를 내야 한다. ",
        "original_sentence": "엔도톡신 기준은 각조에 기재되어 | 수입 품목허가를 신청한 자에 대해서는 제4조 | [제제총칙 - 주사제 항] | 한 반면, 그것만으로 제품의 방사성핵종순도가 임상적 | 없는 물질 | 자문서로 된 신고서를 포함한다)에 그 허가증 | 지방청장은 「전자정부법」 제36조제1항에 따 | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 하여 계산된다. "
      }
    },
    {
      "chunk_id": "chunk_113",
      "text": "| Thallium-201 (201Tl) | 72.912 시간 | □ 예(☞지침) | ■ 아니오 |\n| 가 짧은 경우 배치 출하 전에 수행하기 어렵다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 112,
        "window_size": 3,
        "char_count": 85,
        "word_count": 22,
        "page_number": 1,
        "window_text": "법 제33조에 따른 의약품 재평가 | 라.  약물상호작용 등에 관한 자료 |\n| [제제총칙 - 주사제 항] | 해 주의를 요한다.  엔도톡신 기준은 각조에 기재되어 | 수입 품목허가를 신청한 자에 대해서는 제4조 | [제제총칙 - 주사제 항] | 한 반면, 그것만으로 제품의 방사성핵종순도가 임상적 | 없는 물질 | 자문서로 된 신고서를 포함한다)에 그 허가증 | 지방청장은 「전자정부법」 제36조제1항에 따 | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 하여 계산된다.  | Thallium-201 (201Tl) | 72.912 시간 | □ 예(☞지침) | ■ 아니오 |\n| 가 짧은 경우 배치 출하 전에 수행하기 어렵다.  각조 | (전자문서를 포함한다)를 첨부하여 지방청장에 | 목허가를 동시에 신청하는 경우에는 그 | 표 3의2의 방사성의약품 제조 및 품질관 | 입자 에 따라 다르다.  | 4) 자가점검표 항목 입력 (민원인이 직접 제출자료의 타당성 여부 점검) | 2010.1.18., 2013.3.23.> | 조하는 제조소에 제48조의2에 따른 제조 및 | 어 긴급히 도입하여야 하는 의약품으로서 식 | 제조판매품목허가권자와 제조자 동일 | 에 드는 경비를 포함한다)를 내야 한다.  |\n| 방사능농도(Radioactivity concentration): 제제의 단위 | 제1항제2호의 개정규정에도 불구하고 종전의 | 전체단위 | 또는 신고증과 변경사유서(전자문서로 된 사유 | 5) 시험성적에 관한 자료 | 2.3.6 효능․효과 ·················································································13 | Thallium-202 (202Tl) | 12.23 일 | 6. ",
        "original_sentence": "| Thallium-201 (201Tl) | 72.912 시간 | □ 예(☞지침) | ■ 아니오 |\n| 가 짧은 경우 배치 출하 전에 수행하기 어렵다. "
      }
    },
    {
      "chunk_id": "chunk_114",
      "text": "각조 | (전자문서를 포함한다)를 첨부하여 지방청장에 | 목허가를 동시에 신청하는 경우에는 그 | 표 3의2의 방사성의약품 제조 및 품질관 | 입자 에 따라 다르다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 113,
        "window_size": 3,
        "char_count": 93,
        "word_count": 24,
        "page_number": 5,
        "window_text": "약물상호작용 등에 관한 자료 |\n| [제제총칙 - 주사제 항] | 해 주의를 요한다.  엔도톡신 기준은 각조에 기재되어 | 수입 품목허가를 신청한 자에 대해서는 제4조 | [제제총칙 - 주사제 항] | 한 반면, 그것만으로 제품의 방사성핵종순도가 임상적 | 없는 물질 | 자문서로 된 신고서를 포함한다)에 그 허가증 | 지방청장은 「전자정부법」 제36조제1항에 따 | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 하여 계산된다.  | Thallium-201 (201Tl) | 72.912 시간 | □ 예(☞지침) | ■ 아니오 |\n| 가 짧은 경우 배치 출하 전에 수행하기 어렵다.  각조 | (전자문서를 포함한다)를 첨부하여 지방청장에 | 목허가를 동시에 신청하는 경우에는 그 | 표 3의2의 방사성의약품 제조 및 품질관 | 입자 에 따라 다르다.  | 4) 자가점검표 항목 입력 (민원인이 직접 제출자료의 타당성 여부 점검) | 2010.1.18., 2013.3.23.> | 조하는 제조소에 제48조의2에 따른 제조 및 | 어 긴급히 도입하여야 하는 의약품으로서 식 | 제조판매품목허가권자와 제조자 동일 | 에 드는 경비를 포함한다)를 내야 한다.  |\n| 방사능농도(Radioactivity concentration): 제제의 단위 | 제1항제2호의 개정규정에도 불구하고 종전의 | 전체단위 | 또는 신고증과 변경사유서(전자문서로 된 사유 | 5) 시험성적에 관한 자료 | 2.3.6 효능․효과 ·················································································13 | Thallium-202 (202Tl) | 12.23 일 | 6.  임상시험성적에 관한 자료 |\n| 분할사용 용기는 주사바늘을 뺄 | ① 안전성․유효성 및 | 기준및시험방법 심사 의뢰 | 에서 사용을 위한 출하 전에 완전하게 수행되지 않아 | 있거나 또는 일반항 5.1.10. ",
        "original_sentence": "각조 | (전자문서를 포함한다)를 첨부하여 지방청장에 | 목허가를 동시에 신청하는 경우에는 그 | 표 3의2의 방사성의약품 제조 및 품질관 | 입자 에 따라 다르다. "
      }
    },
    {
      "chunk_id": "chunk_115",
      "text": "| 4) 자가점검표 항목 입력 (민원인이 직접 제출자료의 타당성 여부 점검) | 2010.1.18., 2013.3.23.> | 조하는 제조소에 제48조의2에 따른 제조 및 | 어 긴급히 도입하여야 하는 의약품으로서 식 | 제조판매품목허가권자와 제조자 동일 | 에 드는 경비를 포함한다)를 내야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 114,
        "window_size": 3,
        "char_count": 168,
        "word_count": 39,
        "page_number": 1,
        "window_text": "엔도톡신 기준은 각조에 기재되어 | 수입 품목허가를 신청한 자에 대해서는 제4조 | [제제총칙 - 주사제 항] | 한 반면, 그것만으로 제품의 방사성핵종순도가 임상적 | 없는 물질 | 자문서로 된 신고서를 포함한다)에 그 허가증 | 지방청장은 「전자정부법」 제36조제1항에 따 | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | 하여 계산된다.  | Thallium-201 (201Tl) | 72.912 시간 | □ 예(☞지침) | ■ 아니오 |\n| 가 짧은 경우 배치 출하 전에 수행하기 어렵다.  각조 | (전자문서를 포함한다)를 첨부하여 지방청장에 | 목허가를 동시에 신청하는 경우에는 그 | 표 3의2의 방사성의약품 제조 및 품질관 | 입자 에 따라 다르다.  | 4) 자가점검표 항목 입력 (민원인이 직접 제출자료의 타당성 여부 점검) | 2010.1.18., 2013.3.23.> | 조하는 제조소에 제48조의2에 따른 제조 및 | 어 긴급히 도입하여야 하는 의약품으로서 식 | 제조판매품목허가권자와 제조자 동일 | 에 드는 경비를 포함한다)를 내야 한다.  |\n| 방사능농도(Radioactivity concentration): 제제의 단위 | 제1항제2호의 개정규정에도 불구하고 종전의 | 전체단위 | 또는 신고증과 변경사유서(전자문서로 된 사유 | 5) 시험성적에 관한 자료 | 2.3.6 효능․효과 ·················································································13 | Thallium-202 (202Tl) | 12.23 일 | 6.  임상시험성적에 관한 자료 |\n| 분할사용 용기는 주사바늘을 뺄 | ① 안전성․유효성 및 | 기준및시험방법 심사 의뢰 | 에서 사용을 위한 출하 전에 완전하게 수행되지 않아 | 있거나 또는 일반항 5.1.10.  엔도톡신시험 수행을 위한 | 분할사용 용기의 경우 용기시스 | 제조와 수입의 비율(%)은 55 : 45 로 제조가 20 품목 더 많이 허가되었다. ",
        "original_sentence": "| 4) 자가점검표 항목 입력 (민원인이 직접 제출자료의 타당성 여부 점검) | 2010.1.18., 2013.3.23.> | 조하는 제조소에 제48조의2에 따른 제조 및 | 어 긴급히 도입하여야 하는 의약품으로서 식 | 제조판매품목허가권자와 제조자 동일 | 에 드는 경비를 포함한다)를 내야 한다. "
      }
    },
    {
      "chunk_id": "chunk_116",
      "text": "|\n| 방사능농도(Radioactivity concentration): 제제의 단위 | 제1항제2호의 개정규정에도 불구하고 종전의 | 전체단위 | 또는 신고증과 변경사유서(전자문서로 된 사유 | 5) 시험성적에 관한 자료 | 2.3.6 효능․효과 ·················································································13 | Thallium-202 (202Tl) | 12.23 일 | 6. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 115,
        "window_size": 3,
        "char_count": 260,
        "word_count": 36,
        "page_number": 18,
        "window_text": "| Thallium-201 (201Tl) | 72.912 시간 | □ 예(☞지침) | ■ 아니오 |\n| 가 짧은 경우 배치 출하 전에 수행하기 어렵다.  각조 | (전자문서를 포함한다)를 첨부하여 지방청장에 | 목허가를 동시에 신청하는 경우에는 그 | 표 3의2의 방사성의약품 제조 및 품질관 | 입자 에 따라 다르다.  | 4) 자가점검표 항목 입력 (민원인이 직접 제출자료의 타당성 여부 점검) | 2010.1.18., 2013.3.23.> | 조하는 제조소에 제48조의2에 따른 제조 및 | 어 긴급히 도입하여야 하는 의약품으로서 식 | 제조판매품목허가권자와 제조자 동일 | 에 드는 경비를 포함한다)를 내야 한다.  |\n| 방사능농도(Radioactivity concentration): 제제의 단위 | 제1항제2호의 개정규정에도 불구하고 종전의 | 전체단위 | 또는 신고증과 변경사유서(전자문서로 된 사유 | 5) 시험성적에 관한 자료 | 2.3.6 효능․효과 ·················································································13 | Thallium-202 (202Tl) | 12.23 일 | 6.  임상시험성적에 관한 자료 |\n| 분할사용 용기는 주사바늘을 뺄 | ① 안전성․유효성 및 | 기준및시험방법 심사 의뢰 | 에서 사용을 위한 출하 전에 완전하게 수행되지 않아 | 있거나 또는 일반항 5.1.10.  엔도톡신시험 수행을 위한 | 분할사용 용기의 경우 용기시스 | 제조와 수입의 비율(%)은 55 : 45 로 제조가 20 품목 더 많이 허가되었다.  | 방사성핵종 전구체는 방사능 표지를 위한 용액으로 공 | 보통 원하는 핵반응 이외에 부가적인 변환이 동시에 일 | 인 사용에 충분함을 보장하지 않는다. ",
        "original_sentence": "|\n| 방사능농도(Radioactivity concentration): 제제의 단위 | 제1항제2호의 개정규정에도 불구하고 종전의 | 전체단위 | 또는 신고증과 변경사유서(전자문서로 된 사유 | 5) 시험성적에 관한 자료 | 2.3.6 효능․효과 ·················································································13 | Thallium-202 (202Tl) | 12.23 일 | 6. "
      }
    },
    {
      "chunk_id": "chunk_117",
      "text": "임상시험성적에 관한 자료 |\n| 분할사용 용기는 주사바늘을 뺄 | ① 안전성․유효성 및 | 기준및시험방법 심사 의뢰 | 에서 사용을 위한 출하 전에 완전하게 수행되지 않아 | 있거나 또는 일반항 5.1.10. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 116,
        "window_size": 3,
        "char_count": 117,
        "word_count": 31,
        "page_number": 5,
        "window_text": "각조 | (전자문서를 포함한다)를 첨부하여 지방청장에 | 목허가를 동시에 신청하는 경우에는 그 | 표 3의2의 방사성의약품 제조 및 품질관 | 입자 에 따라 다르다.  | 4) 자가점검표 항목 입력 (민원인이 직접 제출자료의 타당성 여부 점검) | 2010.1.18., 2013.3.23.> | 조하는 제조소에 제48조의2에 따른 제조 및 | 어 긴급히 도입하여야 하는 의약품으로서 식 | 제조판매품목허가권자와 제조자 동일 | 에 드는 경비를 포함한다)를 내야 한다.  |\n| 방사능농도(Radioactivity concentration): 제제의 단위 | 제1항제2호의 개정규정에도 불구하고 종전의 | 전체단위 | 또는 신고증과 변경사유서(전자문서로 된 사유 | 5) 시험성적에 관한 자료 | 2.3.6 효능․효과 ·················································································13 | Thallium-202 (202Tl) | 12.23 일 | 6.  임상시험성적에 관한 자료 |\n| 분할사용 용기는 주사바늘을 뺄 | ① 안전성․유효성 및 | 기준및시험방법 심사 의뢰 | 에서 사용을 위한 출하 전에 완전하게 수행되지 않아 | 있거나 또는 일반항 5.1.10.  엔도톡신시험 수행을 위한 | 분할사용 용기의 경우 용기시스 | 제조와 수입의 비율(%)은 55 : 45 로 제조가 20 품목 더 많이 허가되었다.  | 방사성핵종 전구체는 방사능 표지를 위한 용액으로 공 | 보통 원하는 핵반응 이외에 부가적인 변환이 동시에 일 | 인 사용에 충분함을 보장하지 않는다.  제조자는 상세 | 참고 - 5.7. ",
        "original_sentence": "임상시험성적에 관한 자료 |\n| 분할사용 용기는 주사바늘을 뺄 | ① 안전성․유효성 및 | 기준및시험방법 심사 의뢰 | 에서 사용을 위한 출하 전에 완전하게 수행되지 않아 | 있거나 또는 일반항 5.1.10. "
      }
    },
    {
      "chunk_id": "chunk_118",
      "text": "엔도톡신시험 수행을 위한 | 분할사용 용기의 경우 용기시스 | 제조와 수입의 비율(%)은 55 : 45 로 제조가 20 품목 더 많이 허가되었다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 117,
        "window_size": 3,
        "char_count": 82,
        "word_count": 22,
        "page_number": 3,
        "window_text": "| 4) 자가점검표 항목 입력 (민원인이 직접 제출자료의 타당성 여부 점검) | 2010.1.18., 2013.3.23.> | 조하는 제조소에 제48조의2에 따른 제조 및 | 어 긴급히 도입하여야 하는 의약품으로서 식 | 제조판매품목허가권자와 제조자 동일 | 에 드는 경비를 포함한다)를 내야 한다.  |\n| 방사능농도(Radioactivity concentration): 제제의 단위 | 제1항제2호의 개정규정에도 불구하고 종전의 | 전체단위 | 또는 신고증과 변경사유서(전자문서로 된 사유 | 5) 시험성적에 관한 자료 | 2.3.6 효능․효과 ·················································································13 | Thallium-202 (202Tl) | 12.23 일 | 6.  임상시험성적에 관한 자료 |\n| 분할사용 용기는 주사바늘을 뺄 | ① 안전성․유효성 및 | 기준및시험방법 심사 의뢰 | 에서 사용을 위한 출하 전에 완전하게 수행되지 않아 | 있거나 또는 일반항 5.1.10.  엔도톡신시험 수행을 위한 | 분할사용 용기의 경우 용기시스 | 제조와 수입의 비율(%)은 55 : 45 로 제조가 20 품목 더 많이 허가되었다.  | 방사성핵종 전구체는 방사능 표지를 위한 용액으로 공 | 보통 원하는 핵반응 이외에 부가적인 변환이 동시에 일 | 인 사용에 충분함을 보장하지 않는다.  제조자는 상세 | 참고 - 5.7.  유럽약전에서 언급된 방사성핵종의 물리적 | ④ 의약외품의 제조를 업으로 하려는 자는 대통 | 5) 신청서 내용 작성하기 (신청인, 상세내용, 원료약품 및 그 분량, 담당자 등 2.3 품목허가 신청서 | 른 행정정보의 공동이용을 통하여 다음 각 호 | 품질관리 적합판정서가 있는 경우: 제1항제6 | 자사제조 | 사무의 세부기준이나 절차를 제시하는 것입니까? ",
        "original_sentence": "엔도톡신시험 수행을 위한 | 분할사용 용기의 경우 용기시스 | 제조와 수입의 비율(%)은 55 : 45 로 제조가 20 품목 더 많이 허가되었다. "
      }
    },
    {
      "chunk_id": "chunk_119",
      "text": "| 방사성핵종 전구체는 방사능 표지를 위한 용액으로 공 | 보통 원하는 핵반응 이외에 부가적인 변환이 동시에 일 | 인 사용에 충분함을 보장하지 않는다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 118,
        "window_size": 3,
        "char_count": 86,
        "word_count": 23,
        "page_number": 5,
        "window_text": "|\n| 방사능농도(Radioactivity concentration): 제제의 단위 | 제1항제2호의 개정규정에도 불구하고 종전의 | 전체단위 | 또는 신고증과 변경사유서(전자문서로 된 사유 | 5) 시험성적에 관한 자료 | 2.3.6 효능․효과 ·················································································13 | Thallium-202 (202Tl) | 12.23 일 | 6.  임상시험성적에 관한 자료 |\n| 분할사용 용기는 주사바늘을 뺄 | ① 안전성․유효성 및 | 기준및시험방법 심사 의뢰 | 에서 사용을 위한 출하 전에 완전하게 수행되지 않아 | 있거나 또는 일반항 5.1.10.  엔도톡신시험 수행을 위한 | 분할사용 용기의 경우 용기시스 | 제조와 수입의 비율(%)은 55 : 45 로 제조가 20 품목 더 많이 허가되었다.  | 방사성핵종 전구체는 방사능 표지를 위한 용액으로 공 | 보통 원하는 핵반응 이외에 부가적인 변환이 동시에 일 | 인 사용에 충분함을 보장하지 않는다.  제조자는 상세 | 참고 - 5.7.  유럽약전에서 언급된 방사성핵종의 물리적 | ④ 의약외품의 제조를 업으로 하려는 자는 대통 | 5) 신청서 내용 작성하기 (신청인, 상세내용, 원료약품 및 그 분량, 담당자 등 2.3 품목허가 신청서 | 른 행정정보의 공동이용을 통하여 다음 각 호 | 품질관리 적합판정서가 있는 경우: 제1항제6 | 자사제조 | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | Lead-203 (203Pb) | 51.873 시간 |\n| 부피 또는 단위질량 당 방사성핵종의 방사능으로 방사 | 게 제출하여야 한다. ",
        "original_sentence": "| 방사성핵종 전구체는 방사능 표지를 위한 용액으로 공 | 보통 원하는 핵반응 이외에 부가적인 변환이 동시에 일 | 인 사용에 충분함을 보장하지 않는다. "
      }
    },
    {
      "chunk_id": "chunk_120",
      "text": "제조자는 상세 | 참고 - 5.7. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 119,
        "window_size": 3,
        "char_count": 20,
        "word_count": 6,
        "page_number": 3,
        "window_text": "임상시험성적에 관한 자료 |\n| 분할사용 용기는 주사바늘을 뺄 | ① 안전성․유효성 및 | 기준및시험방법 심사 의뢰 | 에서 사용을 위한 출하 전에 완전하게 수행되지 않아 | 있거나 또는 일반항 5.1.10.  엔도톡신시험 수행을 위한 | 분할사용 용기의 경우 용기시스 | 제조와 수입의 비율(%)은 55 : 45 로 제조가 20 품목 더 많이 허가되었다.  | 방사성핵종 전구체는 방사능 표지를 위한 용액으로 공 | 보통 원하는 핵반응 이외에 부가적인 변환이 동시에 일 | 인 사용에 충분함을 보장하지 않는다.  제조자는 상세 | 참고 - 5.7.  유럽약전에서 언급된 방사성핵종의 물리적 | ④ 의약외품의 제조를 업으로 하려는 자는 대통 | 5) 신청서 내용 작성하기 (신청인, 상세내용, 원료약품 및 그 분량, 담당자 등 2.3 품목허가 신청서 | 른 행정정보의 공동이용을 통하여 다음 각 호 | 품질관리 적합판정서가 있는 경우: 제1항제6 | 자사제조 | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | Lead-203 (203Pb) | 51.873 시간 |\n| 부피 또는 단위질량 당 방사성핵종의 방사능으로 방사 | 게 제출하여야 한다.  <개정 2014.8.21.> | 규정에 따른다. ",
        "original_sentence": "제조자는 상세 | 참고 - 5.7. "
      }
    },
    {
      "chunk_id": "chunk_121",
      "text": "유럽약전에서 언급된 방사성핵종의 물리적 | ④ 의약외품의 제조를 업으로 하려는 자는 대통 | 5) 신청서 내용 작성하기 (신청인, 상세내용, 원료약품 및 그 분량, 담당자 등 2.3 품목허가 신청서 | 른 행정정보의 공동이용을 통하여 다음 각 호 | 품질관리 적합판정서가 있는 경우: 제1항제6 | 자사제조 | 사무의 세부기준이나 절차를 제시하는 것입니까? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 120,
        "window_size": 3,
        "char_count": 200,
        "word_count": 50,
        "page_number": 3,
        "window_text": "엔도톡신시험 수행을 위한 | 분할사용 용기의 경우 용기시스 | 제조와 수입의 비율(%)은 55 : 45 로 제조가 20 품목 더 많이 허가되었다.  | 방사성핵종 전구체는 방사능 표지를 위한 용액으로 공 | 보통 원하는 핵반응 이외에 부가적인 변환이 동시에 일 | 인 사용에 충분함을 보장하지 않는다.  제조자는 상세 | 참고 - 5.7.  유럽약전에서 언급된 방사성핵종의 물리적 | ④ 의약외품의 제조를 업으로 하려는 자는 대통 | 5) 신청서 내용 작성하기 (신청인, 상세내용, 원료약품 및 그 분량, 담당자 등 2.3 품목허가 신청서 | 른 행정정보의 공동이용을 통하여 다음 각 호 | 품질관리 적합판정서가 있는 경우: 제1항제6 | 자사제조 | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | Lead-203 (203Pb) | 51.873 시간 |\n| 부피 또는 단위질량 당 방사성핵종의 방사능으로 방사 | 게 제출하여야 한다.  <개정 2014.8.21.> | 규정에 따른다.  | 중 하나의 품목에 관한 자료만을 제출할 | 리기준 실시상황 평가에 필요한 자료 | 2.3.8 사용상의 주의사항 | 지침·안내서 | 서를 포함한다) 및 그 근거서류(제4조제1항 각 | 6) 표준품 및 시약․시액에 관한 자료 | 품의약품안전처장이 정하는 의약품을 말하 | 배합 | (수입, 제조품목 공통) | 활성물질 | [시행일 : 2015.7.1.] ",
        "original_sentence": "유럽약전에서 언급된 방사성핵종의 물리적 | ④ 의약외품의 제조를 업으로 하려는 자는 대통 | 5) 신청서 내용 작성하기 (신청인, 상세내용, 원료약품 및 그 분량, 담당자 등 2.3 품목허가 신청서 | 른 행정정보의 공동이용을 통하여 다음 각 호 | 품질관리 적합판정서가 있는 경우: 제1항제6 | 자사제조 | 사무의 세부기준이나 절차를 제시하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_122",
      "text": "(공무원용) | Lead-203 (203Pb) | 51.873 시간 |\n| 부피 또는 단위질량 당 방사성핵종의 방사능으로 방사 | 게 제출하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 121,
        "window_size": 3,
        "char_count": 85,
        "word_count": 20,
        "page_number": 3,
        "window_text": "| 방사성핵종 전구체는 방사능 표지를 위한 용액으로 공 | 보통 원하는 핵반응 이외에 부가적인 변환이 동시에 일 | 인 사용에 충분함을 보장하지 않는다.  제조자는 상세 | 참고 - 5.7.  유럽약전에서 언급된 방사성핵종의 물리적 | ④ 의약외품의 제조를 업으로 하려는 자는 대통 | 5) 신청서 내용 작성하기 (신청인, 상세내용, 원료약품 및 그 분량, 담당자 등 2.3 품목허가 신청서 | 른 행정정보의 공동이용을 통하여 다음 각 호 | 품질관리 적합판정서가 있는 경우: 제1항제6 | 자사제조 | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | Lead-203 (203Pb) | 51.873 시간 |\n| 부피 또는 단위질량 당 방사성핵종의 방사능으로 방사 | 게 제출하여야 한다.  <개정 2014.8.21.> | 규정에 따른다.  | 중 하나의 품목에 관한 자료만을 제출할 | 리기준 실시상황 평가에 필요한 자료 | 2.3.8 사용상의 주의사항 | 지침·안내서 | 서를 포함한다) 및 그 근거서류(제4조제1항 각 | 6) 표준품 및 시약․시액에 관한 자료 | 품의약품안전처장이 정하는 의약품을 말하 | 배합 | (수입, 제조품목 공통) | 활성물질 | [시행일 : 2015.7.1.]  제4조 | 가. ",
        "original_sentence": "(공무원용) | Lead-203 (203Pb) | 51.873 시간 |\n| 부피 또는 단위질량 당 방사성핵종의 방사능으로 방사 | 게 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_123",
      "text": "<개정 2014.8.21.> | 규정에 따른다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 122,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 3,
        "window_text": "제조자는 상세 | 참고 - 5.7.  유럽약전에서 언급된 방사성핵종의 물리적 | ④ 의약외품의 제조를 업으로 하려는 자는 대통 | 5) 신청서 내용 작성하기 (신청인, 상세내용, 원료약품 및 그 분량, 담당자 등 2.3 품목허가 신청서 | 른 행정정보의 공동이용을 통하여 다음 각 호 | 품질관리 적합판정서가 있는 경우: 제1항제6 | 자사제조 | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | Lead-203 (203Pb) | 51.873 시간 |\n| 부피 또는 단위질량 당 방사성핵종의 방사능으로 방사 | 게 제출하여야 한다.  <개정 2014.8.21.> | 규정에 따른다.  | 중 하나의 품목에 관한 자료만을 제출할 | 리기준 실시상황 평가에 필요한 자료 | 2.3.8 사용상의 주의사항 | 지침·안내서 | 서를 포함한다) 및 그 근거서류(제4조제1항 각 | 6) 표준품 및 시약․시액에 관한 자료 | 품의약품안전처장이 정하는 의약품을 말하 | 배합 | (수입, 제조품목 공통) | 활성물질 | [시행일 : 2015.7.1.]  제4조 | 가.  임상시험자료집 | 효성에 관한 자료 검토 | 반제 |\n| 때 구멍이 다시 닫히도록 충분한 | ② GMP　실시상황 평가 의뢰(평가 대상에 한함*) | 가이드라인에 따라 계산한다. ",
        "original_sentence": "<개정 2014.8.21.> | 규정에 따른다. "
      }
    },
    {
      "chunk_id": "chunk_124",
      "text": "| 중 하나의 품목에 관한 자료만을 제출할 | 리기준 실시상황 평가에 필요한 자료 | 2.3.8 사용상의 주의사항 | 지침·안내서 | 서를 포함한다) 및 그 근거서류(제4조제1항 각 | 6) 표준품 및 시약․시액에 관한 자료 | 품의약품안전처장이 정하는 의약품을 말하 | 배합 | (수입, 제조품목 공통) | 활성물질 | [시행일 : 2015.7.1.] ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 123,
        "window_size": 3,
        "char_count": 198,
        "word_count": 50,
        "page_number": 3,
        "window_text": "유럽약전에서 언급된 방사성핵종의 물리적 | ④ 의약외품의 제조를 업으로 하려는 자는 대통 | 5) 신청서 내용 작성하기 (신청인, 상세내용, 원료약품 및 그 분량, 담당자 등 2.3 품목허가 신청서 | 른 행정정보의 공동이용을 통하여 다음 각 호 | 품질관리 적합판정서가 있는 경우: 제1항제6 | 자사제조 | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | Lead-203 (203Pb) | 51.873 시간 |\n| 부피 또는 단위질량 당 방사성핵종의 방사능으로 방사 | 게 제출하여야 한다.  <개정 2014.8.21.> | 규정에 따른다.  | 중 하나의 품목에 관한 자료만을 제출할 | 리기준 실시상황 평가에 필요한 자료 | 2.3.8 사용상의 주의사항 | 지침·안내서 | 서를 포함한다) 및 그 근거서류(제4조제1항 각 | 6) 표준품 및 시약․시액에 관한 자료 | 품의약품안전처장이 정하는 의약품을 말하 | 배합 | (수입, 제조품목 공통) | 활성물질 | [시행일 : 2015.7.1.]  제4조 | 가.  임상시험자료집 | 효성에 관한 자료 검토 | 반제 |\n| 때 구멍이 다시 닫히도록 충분한 | ② GMP　실시상황 평가 의뢰(평가 대상에 한함*) | 가이드라인에 따라 계산한다.  | 템의 변형 없이 내용물을 취할 | 급될 수 있다. ",
        "original_sentence": "| 중 하나의 품목에 관한 자료만을 제출할 | 리기준 실시상황 평가에 필요한 자료 | 2.3.8 사용상의 주의사항 | 지침·안내서 | 서를 포함한다) 및 그 근거서류(제4조제1항 각 | 6) 표준품 및 시약․시액에 관한 자료 | 품의약품안전처장이 정하는 의약품을 말하 | 배합 | (수입, 제조품목 공통) | 활성물질 | [시행일 : 2015.7.1.] "
      }
    },
    {
      "chunk_id": "chunk_125",
      "text": "제4조 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 124,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 3,
        "window_text": "(공무원용) | Lead-203 (203Pb) | 51.873 시간 |\n| 부피 또는 단위질량 당 방사성핵종의 방사능으로 방사 | 게 제출하여야 한다.  <개정 2014.8.21.> | 규정에 따른다.  | 중 하나의 품목에 관한 자료만을 제출할 | 리기준 실시상황 평가에 필요한 자료 | 2.3.8 사용상의 주의사항 | 지침·안내서 | 서를 포함한다) 및 그 근거서류(제4조제1항 각 | 6) 표준품 및 시약․시액에 관한 자료 | 품의약품안전처장이 정하는 의약품을 말하 | 배합 | (수입, 제조품목 공통) | 활성물질 | [시행일 : 2015.7.1.]  제4조 | 가.  임상시험자료집 | 효성에 관한 자료 검토 | 반제 |\n| 때 구멍이 다시 닫히도록 충분한 | ② GMP　실시상황 평가 의뢰(평가 대상에 한함*) | 가이드라인에 따라 계산한다.  | 템의 변형 없이 내용물을 취할 | 급될 수 있다.  | 한 시험을 수행해야 하고 특히 짧은 반감기를 가진 방 | 세부구성 | 령령으로 정하는 시설기준에 따라 필요한 시설 | 의 서류를 확인하여야 한다. ",
        "original_sentence": "제4조 | 가. "
      }
    },
    {
      "chunk_id": "chunk_126",
      "text": "임상시험자료집 | 효성에 관한 자료 검토 | 반제 |\n| 때 구멍이 다시 닫히도록 충분한 | ② GMP　실시상황 평가 의뢰(평가 대상에 한함*) | 가이드라인에 따라 계산한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 125,
        "window_size": 3,
        "char_count": 99,
        "word_count": 27,
        "page_number": 5,
        "window_text": "<개정 2014.8.21.> | 규정에 따른다.  | 중 하나의 품목에 관한 자료만을 제출할 | 리기준 실시상황 평가에 필요한 자료 | 2.3.8 사용상의 주의사항 | 지침·안내서 | 서를 포함한다) 및 그 근거서류(제4조제1항 각 | 6) 표준품 및 시약․시액에 관한 자료 | 품의약품안전처장이 정하는 의약품을 말하 | 배합 | (수입, 제조품목 공통) | 활성물질 | [시행일 : 2015.7.1.]  제4조 | 가.  임상시험자료집 | 효성에 관한 자료 검토 | 반제 |\n| 때 구멍이 다시 닫히도록 충분한 | ② GMP　실시상황 평가 의뢰(평가 대상에 한함*) | 가이드라인에 따라 계산한다.  | 템의 변형 없이 내용물을 취할 | 급될 수 있다.  | 한 시험을 수행해야 하고 특히 짧은 반감기를 가진 방 | 세부구성 | 령령으로 정하는 시설기준에 따라 필요한 시설 | 의 서류를 확인하여야 한다.  다만, 제2호의 경 | 작성 요령 참조) | 2.3.7 용법․용량 ·················································································13 | 목적 | 원료명 | 용량 | 규 격 | 분 량 | 단 위 | 제조원 | DMF | 일자 또는 필요할 경우 시간을 함께 표시한다. ",
        "original_sentence": "임상시험자료집 | 효성에 관한 자료 검토 | 반제 |\n| 때 구멍이 다시 닫히도록 충분한 | ② GMP　실시상황 평가 의뢰(평가 대상에 한함*) | 가이드라인에 따라 계산한다. "
      }
    },
    {
      "chunk_id": "chunk_127",
      "text": "| 템의 변형 없이 내용물을 취할 | 급될 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 126,
        "window_size": 3,
        "char_count": 30,
        "word_count": 10,
        "page_number": 5,
        "window_text": "| 중 하나의 품목에 관한 자료만을 제출할 | 리기준 실시상황 평가에 필요한 자료 | 2.3.8 사용상의 주의사항 | 지침·안내서 | 서를 포함한다) 및 그 근거서류(제4조제1항 각 | 6) 표준품 및 시약․시액에 관한 자료 | 품의약품안전처장이 정하는 의약품을 말하 | 배합 | (수입, 제조품목 공통) | 활성물질 | [시행일 : 2015.7.1.]  제4조 | 가.  임상시험자료집 | 효성에 관한 자료 검토 | 반제 |\n| 때 구멍이 다시 닫히도록 충분한 | ② GMP　실시상황 평가 의뢰(평가 대상에 한함*) | 가이드라인에 따라 계산한다.  | 템의 변형 없이 내용물을 취할 | 급될 수 있다.  | 한 시험을 수행해야 하고 특히 짧은 반감기를 가진 방 | 세부구성 | 령령으로 정하는 시설기준에 따라 필요한 시설 | 의 서류를 확인하여야 한다.  다만, 제2호의 경 | 작성 요령 참조) | 2.3.7 용법․용량 ·················································································13 | 목적 | 원료명 | 용량 | 규 격 | 분 량 | 단 위 | 제조원 | DMF | 일자 또는 필요할 경우 시간을 함께 표시한다.  | 여부 | 비고 |\n| 도 되는 시험항목들을 표시했다. ",
        "original_sentence": "| 템의 변형 없이 내용물을 취할 | 급될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_128",
      "text": "| 한 시험을 수행해야 하고 특히 짧은 반감기를 가진 방 | 세부구성 | 령령으로 정하는 시설기준에 따라 필요한 시설 | 의 서류를 확인하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 127,
        "window_size": 3,
        "char_count": 84,
        "word_count": 24,
        "page_number": 7,
        "window_text": "제4조 | 가.  임상시험자료집 | 효성에 관한 자료 검토 | 반제 |\n| 때 구멍이 다시 닫히도록 충분한 | ② GMP　실시상황 평가 의뢰(평가 대상에 한함*) | 가이드라인에 따라 계산한다.  | 템의 변형 없이 내용물을 취할 | 급될 수 있다.  | 한 시험을 수행해야 하고 특히 짧은 반감기를 가진 방 | 세부구성 | 령령으로 정하는 시설기준에 따라 필요한 시설 | 의 서류를 확인하여야 한다.  다만, 제2호의 경 | 작성 요령 참조) | 2.3.7 용법․용량 ·················································································13 | 목적 | 원료명 | 용량 | 규 격 | 분 량 | 단 위 | 제조원 | DMF | 일자 또는 필요할 경우 시간을 함께 표시한다.  | 여부 | 비고 |\n| 도 되는 시험항목들을 표시했다.  이러한 시험항목들은 | 마. ",
        "original_sentence": "| 한 시험을 수행해야 하고 특히 짧은 반감기를 가진 방 | 세부구성 | 령령으로 정하는 시설기준에 따라 필요한 시설 | 의 서류를 확인하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_129",
      "text": "다만, 제2호의 경 | 작성 요령 참조) | 2.3.7 용법․용량 ·················································································13 | 목적 | 원료명 | 용량 | 규 격 | 분 량 | 단 위 | 제조원 | DMF | 일자 또는 필요할 경우 시간을 함께 표시한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 128,
        "window_size": 3,
        "char_count": 195,
        "word_count": 38,
        "page_number": 3,
        "window_text": "임상시험자료집 | 효성에 관한 자료 검토 | 반제 |\n| 때 구멍이 다시 닫히도록 충분한 | ② GMP　실시상황 평가 의뢰(평가 대상에 한함*) | 가이드라인에 따라 계산한다.  | 템의 변형 없이 내용물을 취할 | 급될 수 있다.  | 한 시험을 수행해야 하고 특히 짧은 반감기를 가진 방 | 세부구성 | 령령으로 정하는 시설기준에 따라 필요한 시설 | 의 서류를 확인하여야 한다.  다만, 제2호의 경 | 작성 요령 참조) | 2.3.7 용법․용량 ·················································································13 | 목적 | 원료명 | 용량 | 규 격 | 분 량 | 단 위 | 제조원 | DMF | 일자 또는 필요할 경우 시간을 함께 표시한다.  | 여부 | 비고 |\n| 도 되는 시험항목들을 표시했다.  이러한 시험항목들은 | 마.  의료용 고압가스인 경우에는 별표 1의 의 | 1. ",
        "original_sentence": "다만, 제2호의 경 | 작성 요령 참조) | 2.3.7 용법․용량 ·················································································13 | 목적 | 원료명 | 용량 | 규 격 | 분 량 | 단 위 | 제조원 | DMF | 일자 또는 필요할 경우 시간을 함께 표시한다. "
      }
    },
    {
      "chunk_id": "chunk_130",
      "text": "| 여부 | 비고 |\n| 도 되는 시험항목들을 표시했다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 129,
        "window_size": 3,
        "char_count": 32,
        "word_count": 10,
        "page_number": 1,
        "window_text": "| 템의 변형 없이 내용물을 취할 | 급될 수 있다.  | 한 시험을 수행해야 하고 특히 짧은 반감기를 가진 방 | 세부구성 | 령령으로 정하는 시설기준에 따라 필요한 시설 | 의 서류를 확인하여야 한다.  다만, 제2호의 경 | 작성 요령 참조) | 2.3.7 용법․용량 ·················································································13 | 목적 | 원료명 | 용량 | 규 격 | 분 량 | 단 위 | 제조원 | DMF | 일자 또는 필요할 경우 시간을 함께 표시한다.  | 여부 | 비고 |\n| 도 되는 시험항목들을 표시했다.  이러한 시험항목들은 | 마.  의료용 고압가스인 경우에는 별표 1의 의 | 1.  제1항에 따른 신고품목임을 입증하는 자료 | 수 있다. ",
        "original_sentence": "| 여부 | 비고 |\n| 도 되는 시험항목들을 표시했다. "
      }
    },
    {
      "chunk_id": "chunk_131",
      "text": "이러한 시험항목들은 | 마. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 130,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 5,
        "window_text": "| 한 시험을 수행해야 하고 특히 짧은 반감기를 가진 방 | 세부구성 | 령령으로 정하는 시설기준에 따라 필요한 시설 | 의 서류를 확인하여야 한다.  다만, 제2호의 경 | 작성 요령 참조) | 2.3.7 용법․용량 ·················································································13 | 목적 | 원료명 | 용량 | 규 격 | 분 량 | 단 위 | 제조원 | DMF | 일자 또는 필요할 경우 시간을 함께 표시한다.  | 여부 | 비고 |\n| 도 되는 시험항목들을 표시했다.  이러한 시험항목들은 | 마.  의료용 고압가스인 경우에는 별표 1의 의 | 1.  제1항에 따른 신고품목임을 입증하는 자료 | 수 있다.  | 어난다. ",
        "original_sentence": "이러한 시험항목들은 | 마. "
      }
    },
    {
      "chunk_id": "chunk_132",
      "text": "의료용 고압가스인 경우에는 별표 1의 의 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 131,
        "window_size": 3,
        "char_count": 28,
        "word_count": 8,
        "page_number": 3,
        "window_text": "다만, 제2호의 경 | 작성 요령 참조) | 2.3.7 용법․용량 ·················································································13 | 목적 | 원료명 | 용량 | 규 격 | 분 량 | 단 위 | 제조원 | DMF | 일자 또는 필요할 경우 시간을 함께 표시한다.  | 여부 | 비고 |\n| 도 되는 시험항목들을 표시했다.  이러한 시험항목들은 | 마.  의료용 고압가스인 경우에는 별표 1의 의 | 1.  제1항에 따른 신고품목임을 입증하는 자료 | 수 있다.  | 어난다.  발생 확률은 상기 서술된 요인에 따라 다르다. ",
        "original_sentence": "의료용 고압가스인 경우에는 별표 1의 의 | 1. "
      }
    },
    {
      "chunk_id": "chunk_133",
      "text": "제1항에 따른 신고품목임을 입증하는 자료 | 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 132,
        "window_size": 3,
        "char_count": 31,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| 여부 | 비고 |\n| 도 되는 시험항목들을 표시했다.  이러한 시험항목들은 | 마.  의료용 고압가스인 경우에는 별표 1의 의 | 1.  제1항에 따른 신고품목임을 입증하는 자료 | 수 있다.  | 어난다.  발생 확률은 상기 서술된 요인에 따라 다르다.  | - 동물유래성분 사용 시 기원동물 및 사용부위 기재 | 호의 서류를 말하며, 전자문서를 포함한다)를 | 구분 | 특성 표 중 반감기 정보 | 호에 해당하는 자료 | 며, 이하 같다) 등 식품의약품안전처장이 정 | 전공정위탁제조 | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 품목허가권자이면서, 전공정을 다른 제조업자에게 의뢰하여 제조하는 자 | 5. ",
        "original_sentence": "제1항에 따른 신고품목임을 입증하는 자료 | 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_134",
      "text": "| 어난다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 133,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 9,
        "window_text": "이러한 시험항목들은 | 마.  의료용 고압가스인 경우에는 별표 1의 의 | 1.  제1항에 따른 신고품목임을 입증하는 자료 | 수 있다.  | 어난다.  발생 확률은 상기 서술된 요인에 따라 다르다.  | - 동물유래성분 사용 시 기원동물 및 사용부위 기재 | 호의 서류를 말하며, 전자문서를 포함한다)를 | 구분 | 특성 표 중 반감기 정보 | 호에 해당하는 자료 | 며, 이하 같다) 등 식품의약품안전처장이 정 | 전공정위탁제조 | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 품목허가권자이면서, 전공정을 다른 제조업자에게 의뢰하여 제조하는 자 | 5.  제48조제3호에 따른 안전성 정보 보고 |\n| 탄성이 있어야 한다. ",
        "original_sentence": "| 어난다. "
      }
    },
    {
      "chunk_id": "chunk_135",
      "text": "발생 확률은 상기 서술된 요인에 따라 다르다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 134,
        "window_size": 3,
        "char_count": 26,
        "word_count": 7,
        "page_number": 9,
        "window_text": "의료용 고압가스인 경우에는 별표 1의 의 | 1.  제1항에 따른 신고품목임을 입증하는 자료 | 수 있다.  | 어난다.  발생 확률은 상기 서술된 요인에 따라 다르다.  | - 동물유래성분 사용 시 기원동물 및 사용부위 기재 | 호의 서류를 말하며, 전자문서를 포함한다)를 | 구분 | 특성 표 중 반감기 정보 | 호에 해당하는 자료 | 며, 이하 같다) 등 식품의약품안전처장이 정 | 전공정위탁제조 | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 품목허가권자이면서, 전공정을 다른 제조업자에게 의뢰하여 제조하는 자 | 5.  제48조제3호에 따른 안전성 정보 보고 |\n| 탄성이 있어야 한다.  | 성용액제제의 경우, 제제의 단위부피 당 방사능으로 표 | 제5조(제조 및 품질관리 실시상황평가에 필요한 | 수 있어야 한다. ",
        "original_sentence": "발생 확률은 상기 서술된 요인에 따라 다르다. "
      }
    },
    {
      "chunk_id": "chunk_136",
      "text": "| - 동물유래성분 사용 시 기원동물 및 사용부위 기재 | 호의 서류를 말하며, 전자문서를 포함한다)를 | 구분 | 특성 표 중 반감기 정보 | 호에 해당하는 자료 | 며, 이하 같다) 등 식품의약품안전처장이 정 | 전공정위탁제조 | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 품목허가권자이면서, 전공정을 다른 제조업자에게 의뢰하여 제조하는 자 | 5. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 135,
        "window_size": 3,
        "char_count": 214,
        "word_count": 56,
        "page_number": 3,
        "window_text": "제1항에 따른 신고품목임을 입증하는 자료 | 수 있다.  | 어난다.  발생 확률은 상기 서술된 요인에 따라 다르다.  | - 동물유래성분 사용 시 기원동물 및 사용부위 기재 | 호의 서류를 말하며, 전자문서를 포함한다)를 | 구분 | 특성 표 중 반감기 정보 | 호에 해당하는 자료 | 며, 이하 같다) 등 식품의약품안전처장이 정 | 전공정위탁제조 | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 품목허가권자이면서, 전공정을 다른 제조업자에게 의뢰하여 제조하는 자 | 5.  제48조제3호에 따른 안전성 정보 보고 |\n| 탄성이 있어야 한다.  | 성용액제제의 경우, 제제의 단위부피 당 방사능으로 표 | 제5조(제조 및 품질관리 실시상황평가에 필요한 | 수 있어야 한다.  | 핵종은 원자핵 내 양성자와 중성자 수(원자번호 Z와 | 을 갖추고 식품의약품안전처장에게 제조업신고 | 우 신청인 또는 신고인이 확인에 동의하지 아 | 7) 용기 및 포장에 관한 자료 | ※ 신청서 작성 중 | 확인 선택기재 사항 | 1) 생물약제학 시험보고서 |\n| 그런 식으로 생산된 제품의 품질관리가 된다. ",
        "original_sentence": "| - 동물유래성분 사용 시 기원동물 및 사용부위 기재 | 호의 서류를 말하며, 전자문서를 포함한다)를 | 구분 | 특성 표 중 반감기 정보 | 호에 해당하는 자료 | 며, 이하 같다) 등 식품의약품안전처장이 정 | 전공정위탁제조 | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 품목허가권자이면서, 전공정을 다른 제조업자에게 의뢰하여 제조하는 자 | 5. "
      }
    },
    {
      "chunk_id": "chunk_137",
      "text": "제48조제3호에 따른 안전성 정보 보고 |\n| 탄성이 있어야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 136,
        "window_size": 3,
        "char_count": 38,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| 어난다.  발생 확률은 상기 서술된 요인에 따라 다르다.  | - 동물유래성분 사용 시 기원동물 및 사용부위 기재 | 호의 서류를 말하며, 전자문서를 포함한다)를 | 구분 | 특성 표 중 반감기 정보 | 호에 해당하는 자료 | 며, 이하 같다) 등 식품의약품안전처장이 정 | 전공정위탁제조 | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 품목허가권자이면서, 전공정을 다른 제조업자에게 의뢰하여 제조하는 자 | 5.  제48조제3호에 따른 안전성 정보 보고 |\n| 탄성이 있어야 한다.  | 성용액제제의 경우, 제제의 단위부피 당 방사능으로 표 | 제5조(제조 및 품질관리 실시상황평가에 필요한 | 수 있어야 한다.  | 핵종은 원자핵 내 양성자와 중성자 수(원자번호 Z와 | 을 갖추고 식품의약품안전처장에게 제조업신고 | 우 신청인 또는 신고인이 확인에 동의하지 아 | 7) 용기 및 포장에 관한 자료 | ※ 신청서 작성 중 | 확인 선택기재 사항 | 1) 생물약제학 시험보고서 |\n| 그런 식으로 생산된 제품의 품질관리가 된다.  | 방사성의약품 또는 전구체의 특성에 따라 엔도톡신시 | 7. ",
        "original_sentence": "제48조제3호에 따른 안전성 정보 보고 |\n| 탄성이 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_138",
      "text": "| 성용액제제의 경우, 제제의 단위부피 당 방사능으로 표 | 제5조(제조 및 품질관리 실시상황평가에 필요한 | 수 있어야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 137,
        "window_size": 3,
        "char_count": 72,
        "word_count": 18,
        "page_number": 3,
        "window_text": "발생 확률은 상기 서술된 요인에 따라 다르다.  | - 동물유래성분 사용 시 기원동물 및 사용부위 기재 | 호의 서류를 말하며, 전자문서를 포함한다)를 | 구분 | 특성 표 중 반감기 정보 | 호에 해당하는 자료 | 며, 이하 같다) 등 식품의약품안전처장이 정 | 전공정위탁제조 | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 품목허가권자이면서, 전공정을 다른 제조업자에게 의뢰하여 제조하는 자 | 5.  제48조제3호에 따른 안전성 정보 보고 |\n| 탄성이 있어야 한다.  | 성용액제제의 경우, 제제의 단위부피 당 방사능으로 표 | 제5조(제조 및 품질관리 실시상황평가에 필요한 | 수 있어야 한다.  | 핵종은 원자핵 내 양성자와 중성자 수(원자번호 Z와 | 을 갖추고 식품의약품안전처장에게 제조업신고 | 우 신청인 또는 신고인이 확인에 동의하지 아 | 7) 용기 및 포장에 관한 자료 | ※ 신청서 작성 중 | 확인 선택기재 사항 | 1) 생물약제학 시험보고서 |\n| 그런 식으로 생산된 제품의 품질관리가 된다.  | 방사성의약품 또는 전구체의 특성에 따라 엔도톡신시 | 7.  법 제31조의2제1항에 따라 등록할 수 있는 | 2. ",
        "original_sentence": "| 성용액제제의 경우, 제제의 단위부피 당 방사능으로 표 | 제5조(제조 및 품질관리 실시상황평가에 필요한 | 수 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_139",
      "text": "| 핵종은 원자핵 내 양성자와 중성자 수(원자번호 Z와 | 을 갖추고 식품의약품안전처장에게 제조업신고 | 우 신청인 또는 신고인이 확인에 동의하지 아 | 7) 용기 및 포장에 관한 자료 | ※ 신청서 작성 중 | 확인 선택기재 사항 | 1) 생물약제학 시험보고서 |\n| 그런 식으로 생산된 제품의 품질관리가 된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 138,
        "window_size": 3,
        "char_count": 176,
        "word_count": 49,
        "page_number": 11,
        "window_text": "| - 동물유래성분 사용 시 기원동물 및 사용부위 기재 | 호의 서류를 말하며, 전자문서를 포함한다)를 | 구분 | 특성 표 중 반감기 정보 | 호에 해당하는 자료 | 며, 이하 같다) 등 식품의약품안전처장이 정 | 전공정위탁제조 | □ 법령, 고시‧훈령‧예규와 같은 규정 또는 식약처장이 정한 특정한 | 품목허가권자이면서, 전공정을 다른 제조업자에게 의뢰하여 제조하는 자 | 5.  제48조제3호에 따른 안전성 정보 보고 |\n| 탄성이 있어야 한다.  | 성용액제제의 경우, 제제의 단위부피 당 방사능으로 표 | 제5조(제조 및 품질관리 실시상황평가에 필요한 | 수 있어야 한다.  | 핵종은 원자핵 내 양성자와 중성자 수(원자번호 Z와 | 을 갖추고 식품의약품안전처장에게 제조업신고 | 우 신청인 또는 신고인이 확인에 동의하지 아 | 7) 용기 및 포장에 관한 자료 | ※ 신청서 작성 중 | 확인 선택기재 사항 | 1) 생물약제학 시험보고서 |\n| 그런 식으로 생산된 제품의 품질관리가 된다.  | 방사성의약품 또는 전구체의 특성에 따라 엔도톡신시 | 7.  법 제31조의2제1항에 따라 등록할 수 있는 | 2.  제4조제1항제2호에 따른 자료(이 조 제1항 | 의약품의 품목허가․신고․심사규정｣ | 약품 제조 및 품질관리기준, 별표 1의2의 | 별표 8 | ｢ | 이러한 변환들로 인해 방사성핵종 불순물들이 생성될 | 사성핵종 제품은 적당한 붕괴 시간을 거친 후에 긴 반 | 방사성의약품 제조 및 품질관리기준 가이던스｣ | 3. ",
        "original_sentence": "| 핵종은 원자핵 내 양성자와 중성자 수(원자번호 Z와 | 을 갖추고 식품의약품안전처장에게 제조업신고 | 우 신청인 또는 신고인이 확인에 동의하지 아 | 7) 용기 및 포장에 관한 자료 | ※ 신청서 작성 중 | 확인 선택기재 사항 | 1) 생물약제학 시험보고서 |\n| 그런 식으로 생산된 제품의 품질관리가 된다. "
      }
    },
    {
      "chunk_id": "chunk_140",
      "text": "| 방사성의약품 또는 전구체의 특성에 따라 엔도톡신시 | 7. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 139,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 3,
        "window_text": "제48조제3호에 따른 안전성 정보 보고 |\n| 탄성이 있어야 한다.  | 성용액제제의 경우, 제제의 단위부피 당 방사능으로 표 | 제5조(제조 및 품질관리 실시상황평가에 필요한 | 수 있어야 한다.  | 핵종은 원자핵 내 양성자와 중성자 수(원자번호 Z와 | 을 갖추고 식품의약품안전처장에게 제조업신고 | 우 신청인 또는 신고인이 확인에 동의하지 아 | 7) 용기 및 포장에 관한 자료 | ※ 신청서 작성 중 | 확인 선택기재 사항 | 1) 생물약제학 시험보고서 |\n| 그런 식으로 생산된 제품의 품질관리가 된다.  | 방사성의약품 또는 전구체의 특성에 따라 엔도톡신시 | 7.  법 제31조의2제1항에 따라 등록할 수 있는 | 2.  제4조제1항제2호에 따른 자료(이 조 제1항 | 의약품의 품목허가․신고․심사규정｣ | 약품 제조 및 품질관리기준, 별표 1의2의 | 별표 8 | ｢ | 이러한 변환들로 인해 방사성핵종 불순물들이 생성될 | 사성핵종 제품은 적당한 붕괴 시간을 거친 후에 긴 반 | 방사성의약품 제조 및 품질관리기준 가이던스｣ | 3.  식품의약품안전처장이 고시하는 기준에 적합 | 하는 의약품의 경우에는 환자용 사용설명서, | 2.3.8 사용상의 주의사항 ···································································13 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까? ",
        "original_sentence": "| 방사성의약품 또는 전구체의 특성에 따라 엔도톡신시 | 7. "
      }
    },
    {
      "chunk_id": "chunk_141",
      "text": "법 제31조의2제1항에 따라 등록할 수 있는 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 140,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| 성용액제제의 경우, 제제의 단위부피 당 방사능으로 표 | 제5조(제조 및 품질관리 실시상황평가에 필요한 | 수 있어야 한다.  | 핵종은 원자핵 내 양성자와 중성자 수(원자번호 Z와 | 을 갖추고 식품의약품안전처장에게 제조업신고 | 우 신청인 또는 신고인이 확인에 동의하지 아 | 7) 용기 및 포장에 관한 자료 | ※ 신청서 작성 중 | 확인 선택기재 사항 | 1) 생물약제학 시험보고서 |\n| 그런 식으로 생산된 제품의 품질관리가 된다.  | 방사성의약품 또는 전구체의 특성에 따라 엔도톡신시 | 7.  법 제31조의2제1항에 따라 등록할 수 있는 | 2.  제4조제1항제2호에 따른 자료(이 조 제1항 | 의약품의 품목허가․신고․심사규정｣ | 약품 제조 및 품질관리기준, 별표 1의2의 | 별표 8 | ｢ | 이러한 변환들로 인해 방사성핵종 불순물들이 생성될 | 사성핵종 제품은 적당한 붕괴 시간을 거친 후에 긴 반 | 방사성의약품 제조 및 품질관리기준 가이던스｣ | 3.  식품의약품안전처장이 고시하는 기준에 적합 | 하는 의약품의 경우에는 환자용 사용설명서, | 2.3.8 사용상의 주의사항 ···································································13 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까?  (민원인용) | 01/2008:50700 | radionuclide)으로 붕괴되는 것을 이용한 시스템이다. ",
        "original_sentence": "법 제31조의2제1항에 따라 등록할 수 있는 | 2. "
      }
    },
    {
      "chunk_id": "chunk_142",
      "text": "제4조제1항제2호에 따른 자료(이 조 제1항 | 의약품의 품목허가․신고․심사규정｣ | 약품 제조 및 품질관리기준, 별표 1의2의 | 별표 8 | ｢ | 이러한 변환들로 인해 방사성핵종 불순물들이 생성될 | 사성핵종 제품은 적당한 붕괴 시간을 거친 후에 긴 반 | 방사성의약품 제조 및 품질관리기준 가이던스｣ | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 141,
        "window_size": 3,
        "char_count": 177,
        "word_count": 45,
        "page_number": 3,
        "window_text": "| 핵종은 원자핵 내 양성자와 중성자 수(원자번호 Z와 | 을 갖추고 식품의약품안전처장에게 제조업신고 | 우 신청인 또는 신고인이 확인에 동의하지 아 | 7) 용기 및 포장에 관한 자료 | ※ 신청서 작성 중 | 확인 선택기재 사항 | 1) 생물약제학 시험보고서 |\n| 그런 식으로 생산된 제품의 품질관리가 된다.  | 방사성의약품 또는 전구체의 특성에 따라 엔도톡신시 | 7.  법 제31조의2제1항에 따라 등록할 수 있는 | 2.  제4조제1항제2호에 따른 자료(이 조 제1항 | 의약품의 품목허가․신고․심사규정｣ | 약품 제조 및 품질관리기준, 별표 1의2의 | 별표 8 | ｢ | 이러한 변환들로 인해 방사성핵종 불순물들이 생성될 | 사성핵종 제품은 적당한 붕괴 시간을 거친 후에 긴 반 | 방사성의약품 제조 및 품질관리기준 가이던스｣ | 3.  식품의약품안전처장이 고시하는 기준에 적합 | 하는 의약품의 경우에는 환자용 사용설명서, | 2.3.8 사용상의 주의사항 ···································································13 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까?  (민원인용) | 01/2008:50700 | radionuclide)으로 붕괴되는 것을 이용한 시스템이다.  | 를 참고한다. ",
        "original_sentence": "제4조제1항제2호에 따른 자료(이 조 제1항 | 의약품의 품목허가․신고․심사규정｣ | 약품 제조 및 품질관리기준, 별표 1의2의 | 별표 8 | ｢ | 이러한 변환들로 인해 방사성핵종 불순물들이 생성될 | 사성핵종 제품은 적당한 붕괴 시간을 거친 후에 긴 반 | 방사성의약품 제조 및 품질관리기준 가이던스｣ | 3. "
      }
    },
    {
      "chunk_id": "chunk_143",
      "text": "식품의약품안전처장이 고시하는 기준에 적합 | 하는 의약품의 경우에는 환자용 사용설명서, | 2.3.8 사용상의 주의사항 ···································································13 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 142,
        "window_size": 3,
        "char_count": 196,
        "word_count": 31,
        "page_number": 5,
        "window_text": "| 방사성의약품 또는 전구체의 특성에 따라 엔도톡신시 | 7.  법 제31조의2제1항에 따라 등록할 수 있는 | 2.  제4조제1항제2호에 따른 자료(이 조 제1항 | 의약품의 품목허가․신고․심사규정｣ | 약품 제조 및 품질관리기준, 별표 1의2의 | 별표 8 | ｢ | 이러한 변환들로 인해 방사성핵종 불순물들이 생성될 | 사성핵종 제품은 적당한 붕괴 시간을 거친 후에 긴 반 | 방사성의약품 제조 및 품질관리기준 가이던스｣ | 3.  식품의약품안전처장이 고시하는 기준에 적합 | 하는 의약품의 경우에는 환자용 사용설명서, | 2.3.8 사용상의 주의사항 ···································································13 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까?  (민원인용) | 01/2008:50700 | radionuclide)으로 붕괴되는 것을 이용한 시스템이다.  | 를 참고한다.  |\n| ① 안전성․유효성 및 | 기준및시험방법 심사 | ② GMP　실시상황 평가 | 기한다. ",
        "original_sentence": "식품의약품안전처장이 고시하는 기준에 적합 | 하는 의약품의 경우에는 환자용 사용설명서, | 2.3.8 사용상의 주의사항 ···································································13 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_144",
      "text": "(민원인용) | 01/2008:50700 | radionuclide)으로 붕괴되는 것을 이용한 시스템이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 143,
        "window_size": 3,
        "char_count": 60,
        "word_count": 9,
        "page_number": 3,
        "window_text": "법 제31조의2제1항에 따라 등록할 수 있는 | 2.  제4조제1항제2호에 따른 자료(이 조 제1항 | 의약품의 품목허가․신고․심사규정｣ | 약품 제조 및 품질관리기준, 별표 1의2의 | 별표 8 | ｢ | 이러한 변환들로 인해 방사성핵종 불순물들이 생성될 | 사성핵종 제품은 적당한 붕괴 시간을 거친 후에 긴 반 | 방사성의약품 제조 및 품질관리기준 가이던스｣ | 3.  식품의약품안전처장이 고시하는 기준에 적합 | 하는 의약품의 경우에는 환자용 사용설명서, | 2.3.8 사용상의 주의사항 ···································································13 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까?  (민원인용) | 01/2008:50700 | radionuclide)으로 붕괴되는 것을 이용한 시스템이다.  | 를 참고한다.  |\n| ① 안전성․유효성 및 | 기준및시험방법 심사 | ② GMP　실시상황 평가 | 기한다.  | 자료 제출에 관한 경과조치) 이 규칙 시행 전 | 3. ",
        "original_sentence": "(민원인용) | 01/2008:50700 | radionuclide)으로 붕괴되는 것을 이용한 시스템이다. "
      }
    },
    {
      "chunk_id": "chunk_145",
      "text": "| 를 참고한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 144,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 9,
        "window_text": "제4조제1항제2호에 따른 자료(이 조 제1항 | 의약품의 품목허가․신고․심사규정｣ | 약품 제조 및 품질관리기준, 별표 1의2의 | 별표 8 | ｢ | 이러한 변환들로 인해 방사성핵종 불순물들이 생성될 | 사성핵종 제품은 적당한 붕괴 시간을 거친 후에 긴 반 | 방사성의약품 제조 및 품질관리기준 가이던스｣ | 3.  식품의약품안전처장이 고시하는 기준에 적합 | 하는 의약품의 경우에는 환자용 사용설명서, | 2.3.8 사용상의 주의사항 ···································································13 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까?  (민원인용) | 01/2008:50700 | radionuclide)으로 붕괴되는 것을 이용한 시스템이다.  | 를 참고한다.  |\n| ① 안전성․유효성 및 | 기준및시험방법 심사 | ② GMP　실시상황 평가 | 기한다.  | 자료 제출에 관한 경과조치) 이 규칙 시행 전 | 3.  안정성에 관한 자료 | 첨부하여 식품의약품안전처장(의약품등 제조업 | 니하는 경우에는 그 사본을 첨부하게 하여야 | (제조의뢰자) | (수입, 제조품목 공통) |\n| 험에 간섭(억제 또는 활성화)을 일으키고 간섭요인의 | 표 1. ",
        "original_sentence": "| 를 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_146",
      "text": "|\n| ① 안전성․유효성 및 | 기준및시험방법 심사 | ② GMP　실시상황 평가 | 기한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 145,
        "window_size": 3,
        "char_count": 52,
        "word_count": 15,
        "page_number": 5,
        "window_text": "식품의약품안전처장이 고시하는 기준에 적합 | 하는 의약품의 경우에는 환자용 사용설명서, | 2.3.8 사용상의 주의사항 ···································································13 | 사안에 대하여 그 절차 등의 내용을 알기 쉽게 풀어 설명하거나 | 식약처의 입장을 기술하는 것입니까?  (민원인용) | 01/2008:50700 | radionuclide)으로 붕괴되는 것을 이용한 시스템이다.  | 를 참고한다.  |\n| ① 안전성․유효성 및 | 기준및시험방법 심사 | ② GMP　실시상황 평가 | 기한다.  | 자료 제출에 관한 경과조치) 이 규칙 시행 전 | 3.  안정성에 관한 자료 | 첨부하여 식품의약품안전처장(의약품등 제조업 | 니하는 경우에는 그 사본을 첨부하게 하여야 | (제조의뢰자) | (수입, 제조품목 공통) |\n| 험에 간섭(억제 또는 활성화)을 일으키고 간섭요인의 | 표 1.  연도별 방사성의약품 품목허가 수 (15.01.12. ",
        "original_sentence": "|\n| ① 안전성․유효성 및 | 기준및시험방법 심사 | ② GMP　실시상황 평가 | 기한다. "
      }
    },
    {
      "chunk_id": "chunk_147",
      "text": "| 자료 제출에 관한 경과조치) 이 규칙 시행 전 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 146,
        "window_size": 3,
        "char_count": 33,
        "word_count": 11,
        "page_number": 3,
        "window_text": "(민원인용) | 01/2008:50700 | radionuclide)으로 붕괴되는 것을 이용한 시스템이다.  | 를 참고한다.  |\n| ① 안전성․유효성 및 | 기준및시험방법 심사 | ② GMP　실시상황 평가 | 기한다.  | 자료 제출에 관한 경과조치) 이 규칙 시행 전 | 3.  안정성에 관한 자료 | 첨부하여 식품의약품안전처장(의약품등 제조업 | 니하는 경우에는 그 사본을 첨부하게 하여야 | (제조의뢰자) | (수입, 제조품목 공통) |\n| 험에 간섭(억제 또는 활성화)을 일으키고 간섭요인의 | 표 1.  연도별 방사성의약품 품목허가 수 (15.01.12.  품목대장 기준) | 질량수 A에 따라) 또는 그 핵에너지 상태에 의해 특징 | 감기를 가진 불순물들에 대해 시험해야 한다. ",
        "original_sentence": "| 자료 제출에 관한 경과조치) 이 규칙 시행 전 | 3. "
      }
    },
    {
      "chunk_id": "chunk_148",
      "text": "안정성에 관한 자료 | 첨부하여 식품의약품안전처장(의약품등 제조업 | 니하는 경우에는 그 사본을 첨부하게 하여야 | (제조의뢰자) | (수입, 제조품목 공통) |\n| 험에 간섭(억제 또는 활성화)을 일으키고 간섭요인의 | 표 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 147,
        "window_size": 3,
        "char_count": 129,
        "word_count": 31,
        "page_number": 3,
        "window_text": "| 를 참고한다.  |\n| ① 안전성․유효성 및 | 기준및시험방법 심사 | ② GMP　실시상황 평가 | 기한다.  | 자료 제출에 관한 경과조치) 이 규칙 시행 전 | 3.  안정성에 관한 자료 | 첨부하여 식품의약품안전처장(의약품등 제조업 | 니하는 경우에는 그 사본을 첨부하게 하여야 | (제조의뢰자) | (수입, 제조품목 공통) |\n| 험에 간섭(억제 또는 활성화)을 일으키고 간섭요인의 | 표 1.  연도별 방사성의약품 품목허가 수 (15.01.12.  품목대장 기준) | 질량수 A에 따라) 또는 그 핵에너지 상태에 의해 특징 | 감기를 가진 불순물들에 대해 시험해야 한다.  이런 식 | “적용상의 주의사항”으로 구분하여 기재 | 를 하여야 하며, 품목별로 품목허가를 받거나 | 한 경우: 제1항제4호에 해당하는 자료 | (1) 의약품 허가전 보험등재 동시진행(허가-약가 연계) 관련 | 생리학적 분포(Physiological distribution) |\n| [일반사항 - 고무마개 항] | 에 종전의 규정에 따라 의약품등의 제조판매ᆞ | 신약의 원료의약품 또는 식품의약품안전처장 | 제3호에 따른 품목 중 제48조제5호에 따른 | 원료의약품 제조 및 품질관리기준 및 별 | [일반사항 - 고무마개 항] | 수도 있다. ",
        "original_sentence": "안정성에 관한 자료 | 첨부하여 식품의약품안전처장(의약품등 제조업 | 니하는 경우에는 그 사본을 첨부하게 하여야 | (제조의뢰자) | (수입, 제조품목 공통) |\n| 험에 간섭(억제 또는 활성화)을 일으키고 간섭요인의 | 표 1. "
      }
    },
    {
      "chunk_id": "chunk_149",
      "text": "연도별 방사성의약품 품목허가 수 (15.01.12. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 148,
        "window_size": 3,
        "char_count": 29,
        "word_count": 5,
        "page_number": 3,
        "window_text": "|\n| ① 안전성․유효성 및 | 기준및시험방법 심사 | ② GMP　실시상황 평가 | 기한다.  | 자료 제출에 관한 경과조치) 이 규칙 시행 전 | 3.  안정성에 관한 자료 | 첨부하여 식품의약품안전처장(의약품등 제조업 | 니하는 경우에는 그 사본을 첨부하게 하여야 | (제조의뢰자) | (수입, 제조품목 공통) |\n| 험에 간섭(억제 또는 활성화)을 일으키고 간섭요인의 | 표 1.  연도별 방사성의약품 품목허가 수 (15.01.12.  품목대장 기준) | 질량수 A에 따라) 또는 그 핵에너지 상태에 의해 특징 | 감기를 가진 불순물들에 대해 시험해야 한다.  이런 식 | “적용상의 주의사항”으로 구분하여 기재 | 를 하여야 하며, 품목별로 품목허가를 받거나 | 한 경우: 제1항제4호에 해당하는 자료 | (1) 의약품 허가전 보험등재 동시진행(허가-약가 연계) 관련 | 생리학적 분포(Physiological distribution) |\n| [일반사항 - 고무마개 항] | 에 종전의 규정에 따라 의약품등의 제조판매ᆞ | 신약의 원료의약품 또는 식품의약품안전처장 | 제3호에 따른 품목 중 제48조제5호에 따른 | 원료의약품 제조 및 품질관리기준 및 별 | [일반사항 - 고무마개 항] | 수도 있다.  | 방사성핵종 | 반감기 | 허가ᆞ신고의 변경, 위탁제조판매업 신고의 변 | 안전사용보장조치 등 식품의약품안전처장이 | 2.3.9 포장단위 ·····················································································13 | 전공정위탁제조 | 우는 제외한다. ",
        "original_sentence": "연도별 방사성의약품 품목허가 수 (15.01.12. "
      }
    },
    {
      "chunk_id": "chunk_150",
      "text": "품목대장 기준) | 질량수 A에 따라) 또는 그 핵에너지 상태에 의해 특징 | 감기를 가진 불순물들에 대해 시험해야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 149,
        "window_size": 3,
        "char_count": 69,
        "word_count": 19,
        "page_number": 6,
        "window_text": "| 자료 제출에 관한 경과조치) 이 규칙 시행 전 | 3.  안정성에 관한 자료 | 첨부하여 식품의약품안전처장(의약품등 제조업 | 니하는 경우에는 그 사본을 첨부하게 하여야 | (제조의뢰자) | (수입, 제조품목 공통) |\n| 험에 간섭(억제 또는 활성화)을 일으키고 간섭요인의 | 표 1.  연도별 방사성의약품 품목허가 수 (15.01.12.  품목대장 기준) | 질량수 A에 따라) 또는 그 핵에너지 상태에 의해 특징 | 감기를 가진 불순물들에 대해 시험해야 한다.  이런 식 | “적용상의 주의사항”으로 구분하여 기재 | 를 하여야 하며, 품목별로 품목허가를 받거나 | 한 경우: 제1항제4호에 해당하는 자료 | (1) 의약품 허가전 보험등재 동시진행(허가-약가 연계) 관련 | 생리학적 분포(Physiological distribution) |\n| [일반사항 - 고무마개 항] | 에 종전의 규정에 따라 의약품등의 제조판매ᆞ | 신약의 원료의약품 또는 식품의약품안전처장 | 제3호에 따른 품목 중 제48조제5호에 따른 | 원료의약품 제조 및 품질관리기준 및 별 | [일반사항 - 고무마개 항] | 수도 있다.  | 방사성핵종 | 반감기 | 허가ᆞ신고의 변경, 위탁제조판매업 신고의 변 | 안전사용보장조치 등 식품의약품안전처장이 | 2.3.9 포장단위 ·····················································································13 | 전공정위탁제조 | 우는 제외한다.  <개정 2011.3.30., 2013.3.23.> | 아니한다. ",
        "original_sentence": "품목대장 기준) | 질량수 A에 따라) 또는 그 핵에너지 상태에 의해 특징 | 감기를 가진 불순물들에 대해 시험해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_151",
      "text": "이런 식 | “적용상의 주의사항”으로 구분하여 기재 | 를 하여야 하며, 품목별로 품목허가를 받거나 | 한 경우: 제1항제4호에 해당하는 자료 | (1) 의약품 허가전 보험등재 동시진행(허가-약가 연계) 관련 | 생리학적 분포(Physiological distribution) |\n| [일반사항 - 고무마개 항] | 에 종전의 규정에 따라 의약품등의 제조판매ᆞ | 신약의 원료의약품 또는 식품의약품안전처장 | 제3호에 따른 품목 중 제48조제5호에 따른 | 원료의약품 제조 및 품질관리기준 및 별 | [일반사항 - 고무마개 항] | 수도 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 150,
        "window_size": 3,
        "char_count": 305,
        "word_count": 72,
        "page_number": 1,
        "window_text": "안정성에 관한 자료 | 첨부하여 식품의약품안전처장(의약품등 제조업 | 니하는 경우에는 그 사본을 첨부하게 하여야 | (제조의뢰자) | (수입, 제조품목 공통) |\n| 험에 간섭(억제 또는 활성화)을 일으키고 간섭요인의 | 표 1.  연도별 방사성의약품 품목허가 수 (15.01.12.  품목대장 기준) | 질량수 A에 따라) 또는 그 핵에너지 상태에 의해 특징 | 감기를 가진 불순물들에 대해 시험해야 한다.  이런 식 | “적용상의 주의사항”으로 구분하여 기재 | 를 하여야 하며, 품목별로 품목허가를 받거나 | 한 경우: 제1항제4호에 해당하는 자료 | (1) 의약품 허가전 보험등재 동시진행(허가-약가 연계) 관련 | 생리학적 분포(Physiological distribution) |\n| [일반사항 - 고무마개 항] | 에 종전의 규정에 따라 의약품등의 제조판매ᆞ | 신약의 원료의약품 또는 식품의약품안전처장 | 제3호에 따른 품목 중 제48조제5호에 따른 | 원료의약품 제조 및 품질관리기준 및 별 | [일반사항 - 고무마개 항] | 수도 있다.  | 방사성핵종 | 반감기 | 허가ᆞ신고의 변경, 위탁제조판매업 신고의 변 | 안전사용보장조치 등 식품의약품안전처장이 | 2.3.9 포장단위 ·····················································································13 | 전공정위탁제조 | 우는 제외한다.  <개정 2011.3.30., 2013.3.23.> | 아니한다.  | 과 효능ᆞ효과 등에 대한 평가 |\n| 처리방법 기재 | 품목신고를 하여야 한다. ",
        "original_sentence": "이런 식 | “적용상의 주의사항”으로 구분하여 기재 | 를 하여야 하며, 품목별로 품목허가를 받거나 | 한 경우: 제1항제4호에 해당하는 자료 | (1) 의약품 허가전 보험등재 동시진행(허가-약가 연계) 관련 | 생리학적 분포(Physiological distribution) |\n| [일반사항 - 고무마개 항] | 에 종전의 규정에 따라 의약품등의 제조판매ᆞ | 신약의 원료의약품 또는 식품의약품안전처장 | 제3호에 따른 품목 중 제48조제5호에 따른 | 원료의약품 제조 및 품질관리기준 및 별 | [일반사항 - 고무마개 항] | 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_152",
      "text": "| 방사성핵종 | 반감기 | 허가ᆞ신고의 변경, 위탁제조판매업 신고의 변 | 안전사용보장조치 등 식품의약품안전처장이 | 2.3.9 포장단위 ·····················································································13 | 전공정위탁제조 | 우는 제외한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 151,
        "window_size": 3,
        "char_count": 187,
        "word_count": 23,
        "page_number": 3,
        "window_text": "연도별 방사성의약품 품목허가 수 (15.01.12.  품목대장 기준) | 질량수 A에 따라) 또는 그 핵에너지 상태에 의해 특징 | 감기를 가진 불순물들에 대해 시험해야 한다.  이런 식 | “적용상의 주의사항”으로 구분하여 기재 | 를 하여야 하며, 품목별로 품목허가를 받거나 | 한 경우: 제1항제4호에 해당하는 자료 | (1) 의약품 허가전 보험등재 동시진행(허가-약가 연계) 관련 | 생리학적 분포(Physiological distribution) |\n| [일반사항 - 고무마개 항] | 에 종전의 규정에 따라 의약품등의 제조판매ᆞ | 신약의 원료의약품 또는 식품의약품안전처장 | 제3호에 따른 품목 중 제48조제5호에 따른 | 원료의약품 제조 및 품질관리기준 및 별 | [일반사항 - 고무마개 항] | 수도 있다.  | 방사성핵종 | 반감기 | 허가ᆞ신고의 변경, 위탁제조판매업 신고의 변 | 안전사용보장조치 등 식품의약품안전처장이 | 2.3.9 포장단위 ·····················································································13 | 전공정위탁제조 | 우는 제외한다.  <개정 2011.3.30., 2013.3.23.> | 아니한다.  | 과 효능ᆞ효과 등에 대한 평가 |\n| 처리방법 기재 | 품목신고를 하여야 한다.  <개정 2013.3.23.> | 한다. ",
        "original_sentence": "| 방사성핵종 | 반감기 | 허가ᆞ신고의 변경, 위탁제조판매업 신고의 변 | 안전사용보장조치 등 식품의약품안전처장이 | 2.3.9 포장단위 ·····················································································13 | 전공정위탁제조 | 우는 제외한다. "
      }
    },
    {
      "chunk_id": "chunk_153",
      "text": "<개정 2011.3.30., 2013.3.23.> | 아니한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 152,
        "window_size": 3,
        "char_count": 36,
        "word_count": 5,
        "page_number": 3,
        "window_text": "품목대장 기준) | 질량수 A에 따라) 또는 그 핵에너지 상태에 의해 특징 | 감기를 가진 불순물들에 대해 시험해야 한다.  이런 식 | “적용상의 주의사항”으로 구분하여 기재 | 를 하여야 하며, 품목별로 품목허가를 받거나 | 한 경우: 제1항제4호에 해당하는 자료 | (1) 의약품 허가전 보험등재 동시진행(허가-약가 연계) 관련 | 생리학적 분포(Physiological distribution) |\n| [일반사항 - 고무마개 항] | 에 종전의 규정에 따라 의약품등의 제조판매ᆞ | 신약의 원료의약품 또는 식품의약품안전처장 | 제3호에 따른 품목 중 제48조제5호에 따른 | 원료의약품 제조 및 품질관리기준 및 별 | [일반사항 - 고무마개 항] | 수도 있다.  | 방사성핵종 | 반감기 | 허가ᆞ신고의 변경, 위탁제조판매업 신고의 변 | 안전사용보장조치 등 식품의약품안전처장이 | 2.3.9 포장단위 ·····················································································13 | 전공정위탁제조 | 우는 제외한다.  <개정 2011.3.30., 2013.3.23.> | 아니한다.  | 과 효능ᆞ효과 등에 대한 평가 |\n| 처리방법 기재 | 품목신고를 하여야 한다.  <개정 2013.3.23.> | 한다.  | 가. ",
        "original_sentence": "<개정 2011.3.30., 2013.3.23.> | 아니한다. "
      }
    },
    {
      "chunk_id": "chunk_154",
      "text": "| 과 효능ᆞ효과 등에 대한 평가 |\n| 처리방법 기재 | 품목신고를 하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 153,
        "window_size": 3,
        "char_count": 47,
        "word_count": 14,
        "page_number": 6,
        "window_text": "이런 식 | “적용상의 주의사항”으로 구분하여 기재 | 를 하여야 하며, 품목별로 품목허가를 받거나 | 한 경우: 제1항제4호에 해당하는 자료 | (1) 의약품 허가전 보험등재 동시진행(허가-약가 연계) 관련 | 생리학적 분포(Physiological distribution) |\n| [일반사항 - 고무마개 항] | 에 종전의 규정에 따라 의약품등의 제조판매ᆞ | 신약의 원료의약품 또는 식품의약품안전처장 | 제3호에 따른 품목 중 제48조제5호에 따른 | 원료의약품 제조 및 품질관리기준 및 별 | [일반사항 - 고무마개 항] | 수도 있다.  | 방사성핵종 | 반감기 | 허가ᆞ신고의 변경, 위탁제조판매업 신고의 변 | 안전사용보장조치 등 식품의약품안전처장이 | 2.3.9 포장단위 ·····················································································13 | 전공정위탁제조 | 우는 제외한다.  <개정 2011.3.30., 2013.3.23.> | 아니한다.  | 과 효능ᆞ효과 등에 대한 평가 |\n| 처리방법 기재 | 품목신고를 하여야 한다.  <개정 2013.3.23.> | 한다.  | 가.  원료의약품에 관한 자료 | (2) 과거 신청 이력 여부 | 3) 약동학(PK) 시험보고서 |\n| 제거가 불가능 할 경우 특별히 발열성물질시험 항이 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 별표 1의 의약품 제조 및 품질관리기준에 적 | 표 3의3의 의료용 고압가스 제조 및 품 | 지어지는 원자의 종(species)이다. ",
        "original_sentence": "| 과 효능ᆞ효과 등에 대한 평가 |\n| 처리방법 기재 | 품목신고를 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_155",
      "text": "<개정 2013.3.23.> | 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 154,
        "window_size": 3,
        "char_count": 22,
        "word_count": 4,
        "page_number": 3,
        "window_text": "| 방사성핵종 | 반감기 | 허가ᆞ신고의 변경, 위탁제조판매업 신고의 변 | 안전사용보장조치 등 식품의약품안전처장이 | 2.3.9 포장단위 ·····················································································13 | 전공정위탁제조 | 우는 제외한다.  <개정 2011.3.30., 2013.3.23.> | 아니한다.  | 과 효능ᆞ효과 등에 대한 평가 |\n| 처리방법 기재 | 품목신고를 하여야 한다.  <개정 2013.3.23.> | 한다.  | 가.  원료의약품에 관한 자료 | (2) 과거 신청 이력 여부 | 3) 약동학(PK) 시험보고서 |\n| 제거가 불가능 할 경우 특별히 발열성물질시험 항이 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 별표 1의 의약품 제조 및 품질관리기준에 적 | 표 3의3의 의료용 고압가스 제조 및 품 | 지어지는 원자의 종(species)이다.  원소의 동위원소는 | 으로 제조공정의 적합성과 시험방법의 타당성 정보가 | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Tritium (3H) | 12.33 년 | 법령에 적합하게 판매되고 있음을 증명하는 “판매증명서”를 제출하여야 함. ",
        "original_sentence": "<개정 2013.3.23.> | 한다. "
      }
    },
    {
      "chunk_id": "chunk_156",
      "text": "| 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 155,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 12,
        "window_text": "<개정 2011.3.30., 2013.3.23.> | 아니한다.  | 과 효능ᆞ효과 등에 대한 평가 |\n| 처리방법 기재 | 품목신고를 하여야 한다.  <개정 2013.3.23.> | 한다.  | 가.  원료의약품에 관한 자료 | (2) 과거 신청 이력 여부 | 3) 약동학(PK) 시험보고서 |\n| 제거가 불가능 할 경우 특별히 발열성물질시험 항이 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 별표 1의 의약품 제조 및 품질관리기준에 적 | 표 3의3의 의료용 고압가스 제조 및 품 | 지어지는 원자의 종(species)이다.  원소의 동위원소는 | 으로 제조공정의 적합성과 시험방법의 타당성 정보가 | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Tritium (3H) | 12.33 년 | 법령에 적합하게 판매되고 있음을 증명하는 “판매증명서”를 제출하여야 함.  | 경, 의약품 동등성의 입증이 필요한 의약품의 | 정하는 위해성 완화 조치방법을 포함하는 종 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | □ 예 | ■ 아니오 |\n| ① 및 ② 자료가 적합한가? ",
        "original_sentence": "| 가. "
      }
    },
    {
      "chunk_id": "chunk_157",
      "text": "원료의약품에 관한 자료 | (2) 과거 신청 이력 여부 | 3) 약동학(PK) 시험보고서 |\n| 제거가 불가능 할 경우 특별히 발열성물질시험 항이 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 별표 1의 의약품 제조 및 품질관리기준에 적 | 표 3의3의 의료용 고압가스 제조 및 품 | 지어지는 원자의 종(species)이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 156,
        "window_size": 3,
        "char_count": 185,
        "word_count": 48,
        "page_number": 1,
        "window_text": "| 과 효능ᆞ효과 등에 대한 평가 |\n| 처리방법 기재 | 품목신고를 하여야 한다.  <개정 2013.3.23.> | 한다.  | 가.  원료의약품에 관한 자료 | (2) 과거 신청 이력 여부 | 3) 약동학(PK) 시험보고서 |\n| 제거가 불가능 할 경우 특별히 발열성물질시험 항이 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 별표 1의 의약품 제조 및 품질관리기준에 적 | 표 3의3의 의료용 고압가스 제조 및 품 | 지어지는 원자의 종(species)이다.  원소의 동위원소는 | 으로 제조공정의 적합성과 시험방법의 타당성 정보가 | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Tritium (3H) | 12.33 년 | 법령에 적합하게 판매되고 있음을 증명하는 “판매증명서”를 제출하여야 함.  | 경, 의약품 동등성의 입증이 필요한 의약품의 | 정하는 위해성 완화 조치방법을 포함하는 종 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | □ 예 | ■ 아니오 |\n| ① 및 ② 자료가 적합한가?  | 아니오 | 보완회신 | 분할사용 용기를 사용하는 경우 | 총방사능(Total radioactivity): 단위제형(바이알, 캡슐, | 비방사성물질과 유연물질 | 수입 품목허가를 신청하거나 이 규칙 시행 당 | 분할사용 용기를 사용하는 경우 | ⑤ 제2항 및 제3항에 따라 품목허가를 받거나 | 1. ",
        "original_sentence": "원료의약품에 관한 자료 | (2) 과거 신청 이력 여부 | 3) 약동학(PK) 시험보고서 |\n| 제거가 불가능 할 경우 특별히 발열성물질시험 항이 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 별표 1의 의약품 제조 및 품질관리기준에 적 | 표 3의3의 의료용 고압가스 제조 및 품 | 지어지는 원자의 종(species)이다. "
      }
    },
    {
      "chunk_id": "chunk_158",
      "text": "원소의 동위원소는 | 으로 제조공정의 적합성과 시험방법의 타당성 정보가 | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Tritium (3H) | 12.33 년 | 법령에 적합하게 판매되고 있음을 증명하는 “판매증명서”를 제출하여야 함. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 157,
        "window_size": 3,
        "char_count": 136,
        "word_count": 32,
        "page_number": 3,
        "window_text": "<개정 2013.3.23.> | 한다.  | 가.  원료의약품에 관한 자료 | (2) 과거 신청 이력 여부 | 3) 약동학(PK) 시험보고서 |\n| 제거가 불가능 할 경우 특별히 발열성물질시험 항이 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 별표 1의 의약품 제조 및 품질관리기준에 적 | 표 3의3의 의료용 고압가스 제조 및 품 | 지어지는 원자의 종(species)이다.  원소의 동위원소는 | 으로 제조공정의 적합성과 시험방법의 타당성 정보가 | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Tritium (3H) | 12.33 년 | 법령에 적합하게 판매되고 있음을 증명하는 “판매증명서”를 제출하여야 함.  | 경, 의약품 동등성의 입증이 필요한 의약품의 | 정하는 위해성 완화 조치방법을 포함하는 종 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | □ 예 | ■ 아니오 |\n| ① 및 ② 자료가 적합한가?  | 아니오 | 보완회신 | 분할사용 용기를 사용하는 경우 | 총방사능(Total radioactivity): 단위제형(바이알, 캡슐, | 비방사성물질과 유연물질 | 수입 품목허가를 신청하거나 이 규칙 시행 당 | 분할사용 용기를 사용하는 경우 | ⑤ 제2항 및 제3항에 따라 품목허가를 받거나 | 1.  법인 등기사항증명서(법인인 경우만 해당한 | 연도 | 제조 | 수입 | 전체 | 연도 | 제조 | 수입 | 전체 | 1) 장기보존시험 또는 가속시험자료 | (제조자) | (수입, 제조품목 공통) | 1. ",
        "original_sentence": "원소의 동위원소는 | 으로 제조공정의 적합성과 시험방법의 타당성 정보가 | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Tritium (3H) | 12.33 년 | 법령에 적합하게 판매되고 있음을 증명하는 “판매증명서”를 제출하여야 함. "
      }
    },
    {
      "chunk_id": "chunk_159",
      "text": "| 경, 의약품 동등성의 입증이 필요한 의약품의 | 정하는 위해성 완화 조치방법을 포함하는 종 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | □ 예 | ■ 아니오 |\n| ① 및 ② 자료가 적합한가? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 158,
        "window_size": 3,
        "char_count": 120,
        "word_count": 35,
        "page_number": 5,
        "window_text": "| 가.  원료의약품에 관한 자료 | (2) 과거 신청 이력 여부 | 3) 약동학(PK) 시험보고서 |\n| 제거가 불가능 할 경우 특별히 발열성물질시험 항이 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 별표 1의 의약품 제조 및 품질관리기준에 적 | 표 3의3의 의료용 고압가스 제조 및 품 | 지어지는 원자의 종(species)이다.  원소의 동위원소는 | 으로 제조공정의 적합성과 시험방법의 타당성 정보가 | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Tritium (3H) | 12.33 년 | 법령에 적합하게 판매되고 있음을 증명하는 “판매증명서”를 제출하여야 함.  | 경, 의약품 동등성의 입증이 필요한 의약품의 | 정하는 위해성 완화 조치방법을 포함하는 종 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | □ 예 | ■ 아니오 |\n| ① 및 ② 자료가 적합한가?  | 아니오 | 보완회신 | 분할사용 용기를 사용하는 경우 | 총방사능(Total radioactivity): 단위제형(바이알, 캡슐, | 비방사성물질과 유연물질 | 수입 품목허가를 신청하거나 이 규칙 시행 당 | 분할사용 용기를 사용하는 경우 | ⑤ 제2항 및 제3항에 따라 품목허가를 받거나 | 1.  법인 등기사항증명서(법인인 경우만 해당한 | 연도 | 제조 | 수입 | 전체 | 연도 | 제조 | 수입 | 전체 | 1) 장기보존시험 또는 가속시험자료 | (제조자) | (수입, 제조품목 공통) | 1.  시험성적서와 그에 관한 자료 | 4) 약력학(PD) 시험 보고서 | 아니한다. ",
        "original_sentence": "| 경, 의약품 동등성의 입증이 필요한 의약품의 | 정하는 위해성 완화 조치방법을 포함하는 종 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | □ 예 | ■ 아니오 |\n| ① 및 ② 자료가 적합한가? "
      }
    },
    {
      "chunk_id": "chunk_160",
      "text": "| 아니오 | 보완회신 | 분할사용 용기를 사용하는 경우 | 총방사능(Total radioactivity): 단위제형(바이알, 캡슐, | 비방사성물질과 유연물질 | 수입 품목허가를 신청하거나 이 규칙 시행 당 | 분할사용 용기를 사용하는 경우 | ⑤ 제2항 및 제3항에 따라 품목허가를 받거나 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 159,
        "window_size": 3,
        "char_count": 169,
        "word_count": 40,
        "page_number": 4,
        "window_text": "원료의약품에 관한 자료 | (2) 과거 신청 이력 여부 | 3) 약동학(PK) 시험보고서 |\n| 제거가 불가능 할 경우 특별히 발열성물질시험 항이 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 별표 1의 의약품 제조 및 품질관리기준에 적 | 표 3의3의 의료용 고압가스 제조 및 품 | 지어지는 원자의 종(species)이다.  원소의 동위원소는 | 으로 제조공정의 적합성과 시험방법의 타당성 정보가 | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Tritium (3H) | 12.33 년 | 법령에 적합하게 판매되고 있음을 증명하는 “판매증명서”를 제출하여야 함.  | 경, 의약품 동등성의 입증이 필요한 의약품의 | 정하는 위해성 완화 조치방법을 포함하는 종 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | □ 예 | ■ 아니오 |\n| ① 및 ② 자료가 적합한가?  | 아니오 | 보완회신 | 분할사용 용기를 사용하는 경우 | 총방사능(Total radioactivity): 단위제형(바이알, 캡슐, | 비방사성물질과 유연물질 | 수입 품목허가를 신청하거나 이 규칙 시행 당 | 분할사용 용기를 사용하는 경우 | ⑤ 제2항 및 제3항에 따라 품목허가를 받거나 | 1.  법인 등기사항증명서(법인인 경우만 해당한 | 연도 | 제조 | 수입 | 전체 | 연도 | 제조 | 수입 | 전체 | 1) 장기보존시험 또는 가속시험자료 | (제조자) | (수입, 제조품목 공통) | 1.  시험성적서와 그에 관한 자료 | 4) 약력학(PD) 시험 보고서 | 아니한다.  |\n| 설정되어 있을 수 있다. ",
        "original_sentence": "| 아니오 | 보완회신 | 분할사용 용기를 사용하는 경우 | 총방사능(Total radioactivity): 단위제형(바이알, 캡슐, | 비방사성물질과 유연물질 | 수입 품목허가를 신청하거나 이 규칙 시행 당 | 분할사용 용기를 사용하는 경우 | ⑤ 제2항 및 제3항에 따라 품목허가를 받거나 | 1. "
      }
    },
    {
      "chunk_id": "chunk_161",
      "text": "법인 등기사항증명서(법인인 경우만 해당한 | 연도 | 제조 | 수입 | 전체 | 연도 | 제조 | 수입 | 전체 | 1) 장기보존시험 또는 가속시험자료 | (제조자) | (수입, 제조품목 공통) | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 160,
        "window_size": 3,
        "char_count": 114,
        "word_count": 33,
        "page_number": 1,
        "window_text": "원소의 동위원소는 | 으로 제조공정의 적합성과 시험방법의 타당성 정보가 | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Tritium (3H) | 12.33 년 | 법령에 적합하게 판매되고 있음을 증명하는 “판매증명서”를 제출하여야 함.  | 경, 의약품 동등성의 입증이 필요한 의약품의 | 정하는 위해성 완화 조치방법을 포함하는 종 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | □ 예 | ■ 아니오 |\n| ① 및 ② 자료가 적합한가?  | 아니오 | 보완회신 | 분할사용 용기를 사용하는 경우 | 총방사능(Total radioactivity): 단위제형(바이알, 캡슐, | 비방사성물질과 유연물질 | 수입 품목허가를 신청하거나 이 규칙 시행 당 | 분할사용 용기를 사용하는 경우 | ⑤ 제2항 및 제3항에 따라 품목허가를 받거나 | 1.  법인 등기사항증명서(법인인 경우만 해당한 | 연도 | 제조 | 수입 | 전체 | 연도 | 제조 | 수입 | 전체 | 1) 장기보존시험 또는 가속시험자료 | (제조자) | (수입, 제조품목 공통) | 1.  시험성적서와 그에 관한 자료 | 4) 약력학(PD) 시험 보고서 | 아니한다.  |\n| 설정되어 있을 수 있다.  | 대상 원료의약품\"이라 한다)을 사용하는 품 | 합하다는 판정을 받지 못한 품목 및 이 조 | 질관리기준 실시상황 평가에 필요한 자료 | 원자번호가 동일하나 질량수가 다른 핵종이다. ",
        "original_sentence": "법인 등기사항증명서(법인인 경우만 해당한 | 연도 | 제조 | 수입 | 전체 | 연도 | 제조 | 수입 | 전체 | 1) 장기보존시험 또는 가속시험자료 | (제조자) | (수입, 제조품목 공통) | 1. "
      }
    },
    {
      "chunk_id": "chunk_162",
      "text": "시험성적서와 그에 관한 자료 | 4) 약력학(PD) 시험 보고서 | 아니한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 161,
        "window_size": 3,
        "char_count": 44,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| 경, 의약품 동등성의 입증이 필요한 의약품의 | 정하는 위해성 완화 조치방법을 포함하는 종 | □ 상위 법령을 일탈하여 새로운 규제를 신설·강화하거나 | □ 예 | ■ 아니오 |\n| ① 및 ② 자료가 적합한가?  | 아니오 | 보완회신 | 분할사용 용기를 사용하는 경우 | 총방사능(Total radioactivity): 단위제형(바이알, 캡슐, | 비방사성물질과 유연물질 | 수입 품목허가를 신청하거나 이 규칙 시행 당 | 분할사용 용기를 사용하는 경우 | ⑤ 제2항 및 제3항에 따라 품목허가를 받거나 | 1.  법인 등기사항증명서(법인인 경우만 해당한 | 연도 | 제조 | 수입 | 전체 | 연도 | 제조 | 수입 | 전체 | 1) 장기보존시험 또는 가속시험자료 | (제조자) | (수입, 제조품목 공통) | 1.  시험성적서와 그에 관한 자료 | 4) 약력학(PD) 시험 보고서 | 아니한다.  |\n| 설정되어 있을 수 있다.  | 대상 원료의약품\"이라 한다)을 사용하는 품 | 합하다는 판정을 받지 못한 품목 및 이 조 | 질관리기준 실시상황 평가에 필요한 자료 | 원자번호가 동일하나 질량수가 다른 핵종이다.  양성자 | 확보된다. ",
        "original_sentence": "시험성적서와 그에 관한 자료 | 4) 약력학(PD) 시험 보고서 | 아니한다. "
      }
    },
    {
      "chunk_id": "chunk_163",
      "text": "|\n| 설정되어 있을 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 162,
        "window_size": 3,
        "char_count": 18,
        "word_count": 6,
        "page_number": 9,
        "window_text": "| 아니오 | 보완회신 | 분할사용 용기를 사용하는 경우 | 총방사능(Total radioactivity): 단위제형(바이알, 캡슐, | 비방사성물질과 유연물질 | 수입 품목허가를 신청하거나 이 규칙 시행 당 | 분할사용 용기를 사용하는 경우 | ⑤ 제2항 및 제3항에 따라 품목허가를 받거나 | 1.  법인 등기사항증명서(법인인 경우만 해당한 | 연도 | 제조 | 수입 | 전체 | 연도 | 제조 | 수입 | 전체 | 1) 장기보존시험 또는 가속시험자료 | (제조자) | (수입, 제조품목 공통) | 1.  시험성적서와 그에 관한 자료 | 4) 약력학(PD) 시험 보고서 | 아니한다.  |\n| 설정되어 있을 수 있다.  | 대상 원료의약품\"이라 한다)을 사용하는 품 | 합하다는 판정을 받지 못한 품목 및 이 조 | 질관리기준 실시상황 평가에 필요한 자료 | 원자번호가 동일하나 질량수가 다른 핵종이다.  양성자 | 확보된다.  2개 이상의 양전자를 방출하는 방사성핵종 | - 제제의 특성상 필요한 경우 제제설계에 관한 자료 제출 | Carbon-11 (13C) | 20.385 분 | 기타 확인 | 등에 의하여 해당 제조시설ᆞ제조방법 등을 양 | 합적인 의약품 안전관리 계획(이하 \"위해성 | (3) 민원설명회 개최 여부 | 2.3.10 저장방법 및 사용기간 ···························································13 | 민원인을 구속하는 내용이 있습니까? ",
        "original_sentence": "|\n| 설정되어 있을 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_164",
      "text": "| 대상 원료의약품\"이라 한다)을 사용하는 품 | 합하다는 판정을 받지 못한 품목 및 이 조 | 질관리기준 실시상황 평가에 필요한 자료 | 원자번호가 동일하나 질량수가 다른 핵종이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 163,
        "window_size": 3,
        "char_count": 103,
        "word_count": 27,
        "page_number": 5,
        "window_text": "법인 등기사항증명서(법인인 경우만 해당한 | 연도 | 제조 | 수입 | 전체 | 연도 | 제조 | 수입 | 전체 | 1) 장기보존시험 또는 가속시험자료 | (제조자) | (수입, 제조품목 공통) | 1.  시험성적서와 그에 관한 자료 | 4) 약력학(PD) 시험 보고서 | 아니한다.  |\n| 설정되어 있을 수 있다.  | 대상 원료의약품\"이라 한다)을 사용하는 품 | 합하다는 판정을 받지 못한 품목 및 이 조 | 질관리기준 실시상황 평가에 필요한 자료 | 원자번호가 동일하나 질량수가 다른 핵종이다.  양성자 | 확보된다.  2개 이상의 양전자를 방출하는 방사성핵종 | - 제제의 특성상 필요한 경우 제제설계에 관한 자료 제출 | Carbon-11 (13C) | 20.385 분 | 기타 확인 | 등에 의하여 해당 제조시설ᆞ제조방법 등을 양 | 합적인 의약품 안전관리 계획(이하 \"위해성 | (3) 민원설명회 개최 여부 | 2.3.10 저장방법 및 사용기간 ···························································13 | 민원인을 구속하는 내용이 있습니까?  | 등의 기준 개정 |\n| 재밀봉시험(self-sealing test)을 수 | (Non-radioactive substances and related substances). ",
        "original_sentence": "| 대상 원료의약품\"이라 한다)을 사용하는 품 | 합하다는 판정을 받지 못한 품목 및 이 조 | 질관리기준 실시상황 평가에 필요한 자료 | 원자번호가 동일하나 질량수가 다른 핵종이다. "
      }
    },
    {
      "chunk_id": "chunk_165",
      "text": "양성자 | 확보된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 164,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 9,
        "window_text": "시험성적서와 그에 관한 자료 | 4) 약력학(PD) 시험 보고서 | 아니한다.  |\n| 설정되어 있을 수 있다.  | 대상 원료의약품\"이라 한다)을 사용하는 품 | 합하다는 판정을 받지 못한 품목 및 이 조 | 질관리기준 실시상황 평가에 필요한 자료 | 원자번호가 동일하나 질량수가 다른 핵종이다.  양성자 | 확보된다.  2개 이상의 양전자를 방출하는 방사성핵종 | - 제제의 특성상 필요한 경우 제제설계에 관한 자료 제출 | Carbon-11 (13C) | 20.385 분 | 기타 확인 | 등에 의하여 해당 제조시설ᆞ제조방법 등을 양 | 합적인 의약품 안전관리 계획(이하 \"위해성 | (3) 민원설명회 개최 여부 | 2.3.10 저장방법 및 사용기간 ···························································13 | 민원인을 구속하는 내용이 있습니까?  | 등의 기준 개정 |\n| 재밀봉시험(self-sealing test)을 수 | (Non-radioactive substances and related substances).  | 시 의약품등의 제조판매ᆞ수입 품목신고의 절 | 재밀봉시험(self-sealing | capacity) | 핵반응(변환)은 다음과 같이 표현한다. ",
        "original_sentence": "양성자 | 확보된다. "
      }
    },
    {
      "chunk_id": "chunk_166",
      "text": "2개 이상의 양전자를 방출하는 방사성핵종 | - 제제의 특성상 필요한 경우 제제설계에 관한 자료 제출 | Carbon-11 (13C) | 20.385 분 | 기타 확인 | 등에 의하여 해당 제조시설ᆞ제조방법 등을 양 | 합적인 의약품 안전관리 계획(이하 \"위해성 | (3) 민원설명회 개최 여부 | 2.3.10 저장방법 및 사용기간 ···························································13 | 민원인을 구속하는 내용이 있습니까? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 165,
        "window_size": 3,
        "char_count": 270,
        "word_count": 53,
        "page_number": 3,
        "window_text": "|\n| 설정되어 있을 수 있다.  | 대상 원료의약품\"이라 한다)을 사용하는 품 | 합하다는 판정을 받지 못한 품목 및 이 조 | 질관리기준 실시상황 평가에 필요한 자료 | 원자번호가 동일하나 질량수가 다른 핵종이다.  양성자 | 확보된다.  2개 이상의 양전자를 방출하는 방사성핵종 | - 제제의 특성상 필요한 경우 제제설계에 관한 자료 제출 | Carbon-11 (13C) | 20.385 분 | 기타 확인 | 등에 의하여 해당 제조시설ᆞ제조방법 등을 양 | 합적인 의약품 안전관리 계획(이하 \"위해성 | (3) 민원설명회 개최 여부 | 2.3.10 저장방법 및 사용기간 ···························································13 | 민원인을 구속하는 내용이 있습니까?  | 등의 기준 개정 |\n| 재밀봉시험(self-sealing test)을 수 | (Non-radioactive substances and related substances).  | 시 의약품등의 제조판매ᆞ수입 품목신고의 절 | 재밀봉시험(self-sealing | capacity) | 핵반응(변환)은 다음과 같이 표현한다.  | Nitrogen-13 (13N) | 9.965 분 | 규칙」별표 3의2 및 「의약품 제조 및 품질관리에 관한 규정」별표 3은 적용하지 않음 | 제조판매ᆞ수입 품목허가의 변경, 안전성ᆞ유효 | 품목신고를 한 자(이하 \"품목허가를 받은 자\" | 다) | 2. ",
        "original_sentence": "2개 이상의 양전자를 방출하는 방사성핵종 | - 제제의 특성상 필요한 경우 제제설계에 관한 자료 제출 | Carbon-11 (13C) | 20.385 분 | 기타 확인 | 등에 의하여 해당 제조시설ᆞ제조방법 등을 양 | 합적인 의약품 안전관리 계획(이하 \"위해성 | (3) 민원설명회 개최 여부 | 2.3.10 저장방법 및 사용기간 ···························································13 | 민원인을 구속하는 내용이 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_167",
      "text": "| 등의 기준 개정 |\n| 재밀봉시험(self-sealing test)을 수 | (Non-radioactive substances and related substances). ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 166,
        "window_size": 3,
        "char_count": 98,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| 대상 원료의약품\"이라 한다)을 사용하는 품 | 합하다는 판정을 받지 못한 품목 및 이 조 | 질관리기준 실시상황 평가에 필요한 자료 | 원자번호가 동일하나 질량수가 다른 핵종이다.  양성자 | 확보된다.  2개 이상의 양전자를 방출하는 방사성핵종 | - 제제의 특성상 필요한 경우 제제설계에 관한 자료 제출 | Carbon-11 (13C) | 20.385 분 | 기타 확인 | 등에 의하여 해당 제조시설ᆞ제조방법 등을 양 | 합적인 의약품 안전관리 계획(이하 \"위해성 | (3) 민원설명회 개최 여부 | 2.3.10 저장방법 및 사용기간 ···························································13 | 민원인을 구속하는 내용이 있습니까?  | 등의 기준 개정 |\n| 재밀봉시험(self-sealing test)을 수 | (Non-radioactive substances and related substances).  | 시 의약품등의 제조판매ᆞ수입 품목신고의 절 | 재밀봉시험(self-sealing | capacity) | 핵반응(변환)은 다음과 같이 표현한다.  | Nitrogen-13 (13N) | 9.965 분 | 규칙」별표 3의2 및 「의약품 제조 및 품질관리에 관한 규정」별표 3은 적용하지 않음 | 제조판매ᆞ수입 품목허가의 변경, 안전성ᆞ유효 | 품목신고를 한 자(이하 \"품목허가를 받은 자\" | 다) | 2.  원료의약품에 관한 자료 |\n| 앰플, 제너레이터 등) 당 방사성핵종의 방사능 | 바. ",
        "original_sentence": "| 등의 기준 개정 |\n| 재밀봉시험(self-sealing test)을 수 | (Non-radioactive substances and related substances). "
      }
    },
    {
      "chunk_id": "chunk_168",
      "text": "| 시 의약품등의 제조판매ᆞ수입 품목신고의 절 | 재밀봉시험(self-sealing | capacity) | 핵반응(변환)은 다음과 같이 표현한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 167,
        "window_size": 3,
        "char_count": 83,
        "word_count": 15,
        "page_number": 3,
        "window_text": "양성자 | 확보된다.  2개 이상의 양전자를 방출하는 방사성핵종 | - 제제의 특성상 필요한 경우 제제설계에 관한 자료 제출 | Carbon-11 (13C) | 20.385 분 | 기타 확인 | 등에 의하여 해당 제조시설ᆞ제조방법 등을 양 | 합적인 의약품 안전관리 계획(이하 \"위해성 | (3) 민원설명회 개최 여부 | 2.3.10 저장방법 및 사용기간 ···························································13 | 민원인을 구속하는 내용이 있습니까?  | 등의 기준 개정 |\n| 재밀봉시험(self-sealing test)을 수 | (Non-radioactive substances and related substances).  | 시 의약품등의 제조판매ᆞ수입 품목신고의 절 | 재밀봉시험(self-sealing | capacity) | 핵반응(변환)은 다음과 같이 표현한다.  | Nitrogen-13 (13N) | 9.965 분 | 규칙」별표 3의2 및 「의약품 제조 및 품질관리에 관한 규정」별표 3은 적용하지 않음 | 제조판매ᆞ수입 품목허가의 변경, 안전성ᆞ유효 | 품목신고를 한 자(이하 \"품목허가를 받은 자\" | 다) | 2.  원료의약품에 관한 자료 |\n| 앰플, 제너레이터 등) 당 방사성핵종의 방사능 | 바.  한약재의 경우에는 별표 2의 한약재 제조 | 목의 경우에는 원료의약품에 관한 다음 각 | 제1항제5호에 따른 품목만 해당한다) | 2.3.9 포장단위 | 6) 안전성·유효성 심사/기준및시험방법 심사/기타구비서류 작성하기 | 1968 | 1 | 1 | 2007 | 3 | 1 | 4 | 수받은 품목의 제조판매ᆞ수입 품목허가를 받 | 2) 가혹시험자료 | 관리 계획\"이라 한다) | 5) 유효성과 안전성 시험 보고서 |\n| 행하였을 때 적합하여야 한다. ",
        "original_sentence": "| 시 의약품등의 제조판매ᆞ수입 품목신고의 절 | 재밀봉시험(self-sealing | capacity) | 핵반응(변환)은 다음과 같이 표현한다. "
      }
    },
    {
      "chunk_id": "chunk_169",
      "text": "| Nitrogen-13 (13N) | 9.965 분 | 규칙」별표 3의2 및 「의약품 제조 및 품질관리에 관한 규정」별표 3은 적용하지 않음 | 제조판매ᆞ수입 품목허가의 변경, 안전성ᆞ유효 | 품목신고를 한 자(이하 \"품목허가를 받은 자\" | 다) | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 168,
        "window_size": 3,
        "char_count": 145,
        "word_count": 35,
        "page_number": 3,
        "window_text": "2개 이상의 양전자를 방출하는 방사성핵종 | - 제제의 특성상 필요한 경우 제제설계에 관한 자료 제출 | Carbon-11 (13C) | 20.385 분 | 기타 확인 | 등에 의하여 해당 제조시설ᆞ제조방법 등을 양 | 합적인 의약품 안전관리 계획(이하 \"위해성 | (3) 민원설명회 개최 여부 | 2.3.10 저장방법 및 사용기간 ···························································13 | 민원인을 구속하는 내용이 있습니까?  | 등의 기준 개정 |\n| 재밀봉시험(self-sealing test)을 수 | (Non-radioactive substances and related substances).  | 시 의약품등의 제조판매ᆞ수입 품목신고의 절 | 재밀봉시험(self-sealing | capacity) | 핵반응(변환)은 다음과 같이 표현한다.  | Nitrogen-13 (13N) | 9.965 분 | 규칙」별표 3의2 및 「의약품 제조 및 품질관리에 관한 규정」별표 3은 적용하지 않음 | 제조판매ᆞ수입 품목허가의 변경, 안전성ᆞ유효 | 품목신고를 한 자(이하 \"품목허가를 받은 자\" | 다) | 2.  원료의약품에 관한 자료 |\n| 앰플, 제너레이터 등) 당 방사성핵종의 방사능 | 바.  한약재의 경우에는 별표 2의 한약재 제조 | 목의 경우에는 원료의약품에 관한 다음 각 | 제1항제5호에 따른 품목만 해당한다) | 2.3.9 포장단위 | 6) 안전성·유효성 심사/기준및시험방법 심사/기타구비서류 작성하기 | 1968 | 1 | 1 | 2007 | 3 | 1 | 4 | 수받은 품목의 제조판매ᆞ수입 품목허가를 받 | 2) 가혹시험자료 | 관리 계획\"이라 한다) | 5) 유효성과 안전성 시험 보고서 |\n| 행하였을 때 적합하여야 한다.  | 차가 진행 중인 경우에 대해서는 제4조제1항제 | 예 | 결과반영 | 을 수행하였을 때 적합하여야 한 | ※ ‘청정도 관리현황’ 자료 | 와 중성자가 불안정한 배열을 포함하는 핵종은 자연스 | 들은 확인 그리고/또는 구별이 필요하다(예를 들면 | - 제제설계 시 분할사용 하는 경우 아래 관련 정보를 참고하여 설계 | 2. ",
        "original_sentence": "| Nitrogen-13 (13N) | 9.965 분 | 규칙」별표 3의2 및 「의약품 제조 및 품질관리에 관한 규정」별표 3은 적용하지 않음 | 제조판매ᆞ수입 품목허가의 변경, 안전성ᆞ유효 | 품목신고를 한 자(이하 \"품목허가를 받은 자\" | 다) | 2. "
      }
    },
    {
      "chunk_id": "chunk_170",
      "text": "원료의약품에 관한 자료 |\n| 앰플, 제너레이터 등) 당 방사성핵종의 방사능 | 바. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 169,
        "window_size": 3,
        "char_count": 48,
        "word_count": 13,
        "page_number": 5,
        "window_text": "| 등의 기준 개정 |\n| 재밀봉시험(self-sealing test)을 수 | (Non-radioactive substances and related substances).  | 시 의약품등의 제조판매ᆞ수입 품목신고의 절 | 재밀봉시험(self-sealing | capacity) | 핵반응(변환)은 다음과 같이 표현한다.  | Nitrogen-13 (13N) | 9.965 분 | 규칙」별표 3의2 및 「의약품 제조 및 품질관리에 관한 규정」별표 3은 적용하지 않음 | 제조판매ᆞ수입 품목허가의 변경, 안전성ᆞ유효 | 품목신고를 한 자(이하 \"품목허가를 받은 자\" | 다) | 2.  원료의약품에 관한 자료 |\n| 앰플, 제너레이터 등) 당 방사성핵종의 방사능 | 바.  한약재의 경우에는 별표 2의 한약재 제조 | 목의 경우에는 원료의약품에 관한 다음 각 | 제1항제5호에 따른 품목만 해당한다) | 2.3.9 포장단위 | 6) 안전성·유효성 심사/기준및시험방법 심사/기타구비서류 작성하기 | 1968 | 1 | 1 | 2007 | 3 | 1 | 4 | 수받은 품목의 제조판매ᆞ수입 품목허가를 받 | 2) 가혹시험자료 | 관리 계획\"이라 한다) | 5) 유효성과 안전성 시험 보고서 |\n| 행하였을 때 적합하여야 한다.  | 차가 진행 중인 경우에 대해서는 제4조제1항제 | 예 | 결과반영 | 을 수행하였을 때 적합하여야 한 | ※ ‘청정도 관리현황’ 자료 | 와 중성자가 불안정한 배열을 포함하는 핵종은 자연스 | 들은 확인 그리고/또는 구별이 필요하다(예를 들면 | - 제제설계 시 분할사용 하는 경우 아래 관련 정보를 참고하여 설계 | 2.  약사 면허증(제조관리자가 약사인 경우만 해 | Oxygen-15 (15O) | 122.24 초 | 동 자료를 제출하지 않을 수 있음(신약, 주사제, 이식제, 생물학적제제 등 제외) | 성 검토 대상이 아닌 의약외품의 제조판매ᆞ수 | 사항 | 일부공정위탁제조 | 2.3.11 기준 및 시험방법 ···································································14 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | 능 확인 및 정량적인 측정을 수행할 수 있다. ",
        "original_sentence": "원료의약품에 관한 자료 |\n| 앰플, 제너레이터 등) 당 방사성핵종의 방사능 | 바. "
      }
    },
    {
      "chunk_id": "chunk_171",
      "text": "한약재의 경우에는 별표 2의 한약재 제조 | 목의 경우에는 원료의약품에 관한 다음 각 | 제1항제5호에 따른 품목만 해당한다) | 2.3.9 포장단위 | 6) 안전성·유효성 심사/기준및시험방법 심사/기타구비서류 작성하기 | 1968 | 1 | 1 | 2007 | 3 | 1 | 4 | 수받은 품목의 제조판매ᆞ수입 품목허가를 받 | 2) 가혹시험자료 | 관리 계획\"이라 한다) | 5) 유효성과 안전성 시험 보고서 |\n| 행하였을 때 적합하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 170,
        "window_size": 3,
        "char_count": 252,
        "word_count": 66,
        "page_number": 3,
        "window_text": "| 시 의약품등의 제조판매ᆞ수입 품목신고의 절 | 재밀봉시험(self-sealing | capacity) | 핵반응(변환)은 다음과 같이 표현한다.  | Nitrogen-13 (13N) | 9.965 분 | 규칙」별표 3의2 및 「의약품 제조 및 품질관리에 관한 규정」별표 3은 적용하지 않음 | 제조판매ᆞ수입 품목허가의 변경, 안전성ᆞ유효 | 품목신고를 한 자(이하 \"품목허가를 받은 자\" | 다) | 2.  원료의약품에 관한 자료 |\n| 앰플, 제너레이터 등) 당 방사성핵종의 방사능 | 바.  한약재의 경우에는 별표 2의 한약재 제조 | 목의 경우에는 원료의약품에 관한 다음 각 | 제1항제5호에 따른 품목만 해당한다) | 2.3.9 포장단위 | 6) 안전성·유효성 심사/기준및시험방법 심사/기타구비서류 작성하기 | 1968 | 1 | 1 | 2007 | 3 | 1 | 4 | 수받은 품목의 제조판매ᆞ수입 품목허가를 받 | 2) 가혹시험자료 | 관리 계획\"이라 한다) | 5) 유효성과 안전성 시험 보고서 |\n| 행하였을 때 적합하여야 한다.  | 차가 진행 중인 경우에 대해서는 제4조제1항제 | 예 | 결과반영 | 을 수행하였을 때 적합하여야 한 | ※ ‘청정도 관리현황’ 자료 | 와 중성자가 불안정한 배열을 포함하는 핵종은 자연스 | 들은 확인 그리고/또는 구별이 필요하다(예를 들면 | - 제제설계 시 분할사용 하는 경우 아래 관련 정보를 참고하여 설계 | 2.  약사 면허증(제조관리자가 약사인 경우만 해 | Oxygen-15 (15O) | 122.24 초 | 동 자료를 제출하지 않을 수 있음(신약, 주사제, 이식제, 생물학적제제 등 제외) | 성 검토 대상이 아닌 의약외품의 제조판매ᆞ수 | 사항 | 일부공정위탁제조 | 2.3.11 기준 및 시험방법 ···································································14 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | 능 확인 및 정량적인 측정을 수행할 수 있다.  | 사용이 가능하다. ",
        "original_sentence": "한약재의 경우에는 별표 2의 한약재 제조 | 목의 경우에는 원료의약품에 관한 다음 각 | 제1항제5호에 따른 품목만 해당한다) | 2.3.9 포장단위 | 6) 안전성·유효성 심사/기준및시험방법 심사/기타구비서류 작성하기 | 1968 | 1 | 1 | 2007 | 3 | 1 | 4 | 수받은 품목의 제조판매ᆞ수입 품목허가를 받 | 2) 가혹시험자료 | 관리 계획\"이라 한다) | 5) 유효성과 안전성 시험 보고서 |\n| 행하였을 때 적합하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_172",
      "text": "| 차가 진행 중인 경우에 대해서는 제4조제1항제 | 예 | 결과반영 | 을 수행하였을 때 적합하여야 한 | ※ ‘청정도 관리현황’ 자료 | 와 중성자가 불안정한 배열을 포함하는 핵종은 자연스 | 들은 확인 그리고/또는 구별이 필요하다(예를 들면 | - 제제설계 시 분할사용 하는 경우 아래 관련 정보를 참고하여 설계 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 171,
        "window_size": 3,
        "char_count": 183,
        "word_count": 51,
        "page_number": 3,
        "window_text": "| Nitrogen-13 (13N) | 9.965 분 | 규칙」별표 3의2 및 「의약품 제조 및 품질관리에 관한 규정」별표 3은 적용하지 않음 | 제조판매ᆞ수입 품목허가의 변경, 안전성ᆞ유효 | 품목신고를 한 자(이하 \"품목허가를 받은 자\" | 다) | 2.  원료의약품에 관한 자료 |\n| 앰플, 제너레이터 등) 당 방사성핵종의 방사능 | 바.  한약재의 경우에는 별표 2의 한약재 제조 | 목의 경우에는 원료의약품에 관한 다음 각 | 제1항제5호에 따른 품목만 해당한다) | 2.3.9 포장단위 | 6) 안전성·유효성 심사/기준및시험방법 심사/기타구비서류 작성하기 | 1968 | 1 | 1 | 2007 | 3 | 1 | 4 | 수받은 품목의 제조판매ᆞ수입 품목허가를 받 | 2) 가혹시험자료 | 관리 계획\"이라 한다) | 5) 유효성과 안전성 시험 보고서 |\n| 행하였을 때 적합하여야 한다.  | 차가 진행 중인 경우에 대해서는 제4조제1항제 | 예 | 결과반영 | 을 수행하였을 때 적합하여야 한 | ※ ‘청정도 관리현황’ 자료 | 와 중성자가 불안정한 배열을 포함하는 핵종은 자연스 | 들은 확인 그리고/또는 구별이 필요하다(예를 들면 | - 제제설계 시 분할사용 하는 경우 아래 관련 정보를 참고하여 설계 | 2.  약사 면허증(제조관리자가 약사인 경우만 해 | Oxygen-15 (15O) | 122.24 초 | 동 자료를 제출하지 않을 수 있음(신약, 주사제, 이식제, 생물학적제제 등 제외) | 성 검토 대상이 아닌 의약외품의 제조판매ᆞ수 | 사항 | 일부공정위탁제조 | 2.3.11 기준 및 시험방법 ···································································14 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | 능 확인 및 정량적인 측정을 수행할 수 있다.  | 사용이 가능하다.  | 3. ",
        "original_sentence": "| 차가 진행 중인 경우에 대해서는 제4조제1항제 | 예 | 결과반영 | 을 수행하였을 때 적합하여야 한 | ※ ‘청정도 관리현황’ 자료 | 와 중성자가 불안정한 배열을 포함하는 핵종은 자연스 | 들은 확인 그리고/또는 구별이 필요하다(예를 들면 | - 제제설계 시 분할사용 하는 경우 아래 관련 정보를 참고하여 설계 | 2. "
      }
    },
    {
      "chunk_id": "chunk_173",
      "text": "약사 면허증(제조관리자가 약사인 경우만 해 | Oxygen-15 (15O) | 122.24 초 | 동 자료를 제출하지 않을 수 있음(신약, 주사제, 이식제, 생물학적제제 등 제외) | 성 검토 대상이 아닌 의약외품의 제조판매ᆞ수 | 사항 | 일부공정위탁제조 | 2.3.11 기준 및 시험방법 ···································································14 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | 능 확인 및 정량적인 측정을 수행할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 172,
        "window_size": 3,
        "char_count": 307,
        "word_count": 61,
        "page_number": 3,
        "window_text": "원료의약품에 관한 자료 |\n| 앰플, 제너레이터 등) 당 방사성핵종의 방사능 | 바.  한약재의 경우에는 별표 2의 한약재 제조 | 목의 경우에는 원료의약품에 관한 다음 각 | 제1항제5호에 따른 품목만 해당한다) | 2.3.9 포장단위 | 6) 안전성·유효성 심사/기준및시험방법 심사/기타구비서류 작성하기 | 1968 | 1 | 1 | 2007 | 3 | 1 | 4 | 수받은 품목의 제조판매ᆞ수입 품목허가를 받 | 2) 가혹시험자료 | 관리 계획\"이라 한다) | 5) 유효성과 안전성 시험 보고서 |\n| 행하였을 때 적합하여야 한다.  | 차가 진행 중인 경우에 대해서는 제4조제1항제 | 예 | 결과반영 | 을 수행하였을 때 적합하여야 한 | ※ ‘청정도 관리현황’ 자료 | 와 중성자가 불안정한 배열을 포함하는 핵종은 자연스 | 들은 확인 그리고/또는 구별이 필요하다(예를 들면 | - 제제설계 시 분할사용 하는 경우 아래 관련 정보를 참고하여 설계 | 2.  약사 면허증(제조관리자가 약사인 경우만 해 | Oxygen-15 (15O) | 122.24 초 | 동 자료를 제출하지 않을 수 있음(신약, 주사제, 이식제, 생물학적제제 등 제외) | 성 검토 대상이 아닌 의약외품의 제조판매ᆞ수 | 사항 | 일부공정위탁제조 | 2.3.11 기준 및 시험방법 ···································································14 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | 능 확인 및 정량적인 측정을 수행할 수 있다.  | 사용이 가능하다.  | 3.  관계 문헌 | 는 품목 |\n| 이 항은 존재할 수 있는 비방사성물질과 유연물질 측 | 라 한다)는 총리령으로 정하는 바에 따라 영업 |\n\n**[표 끝]**\n\n<!-- PAGE_1 -->\n### 의약품심사부\n\n<!-- PAGE_1 -->\n### 종양약품과\n\n지침·안내서 제‧개정 점검표\n\n<!-- PAGE_1 -->\n###### 명칭\n\n<!-- PAGE_1 -->\n###### 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_1 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n",
        "original_sentence": "약사 면허증(제조관리자가 약사인 경우만 해 | Oxygen-15 (15O) | 122.24 초 | 동 자료를 제출하지 않을 수 있음(신약, 주사제, 이식제, 생물학적제제 등 제외) | 성 검토 대상이 아닌 의약외품의 제조판매ᆞ수 | 사항 | 일부공정위탁제조 | 2.3.11 기준 및 시험방법 ···································································14 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | 능 확인 및 정량적인 측정을 수행할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_174",
      "text": "| 사용이 가능하다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 173,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 5,
        "window_text": "한약재의 경우에는 별표 2의 한약재 제조 | 목의 경우에는 원료의약품에 관한 다음 각 | 제1항제5호에 따른 품목만 해당한다) | 2.3.9 포장단위 | 6) 안전성·유효성 심사/기준및시험방법 심사/기타구비서류 작성하기 | 1968 | 1 | 1 | 2007 | 3 | 1 | 4 | 수받은 품목의 제조판매ᆞ수입 품목허가를 받 | 2) 가혹시험자료 | 관리 계획\"이라 한다) | 5) 유효성과 안전성 시험 보고서 |\n| 행하였을 때 적합하여야 한다.  | 차가 진행 중인 경우에 대해서는 제4조제1항제 | 예 | 결과반영 | 을 수행하였을 때 적합하여야 한 | ※ ‘청정도 관리현황’ 자료 | 와 중성자가 불안정한 배열을 포함하는 핵종은 자연스 | 들은 확인 그리고/또는 구별이 필요하다(예를 들면 | - 제제설계 시 분할사용 하는 경우 아래 관련 정보를 참고하여 설계 | 2.  약사 면허증(제조관리자가 약사인 경우만 해 | Oxygen-15 (15O) | 122.24 초 | 동 자료를 제출하지 않을 수 있음(신약, 주사제, 이식제, 생물학적제제 등 제외) | 성 검토 대상이 아닌 의약외품의 제조판매ᆞ수 | 사항 | 일부공정위탁제조 | 2.3.11 기준 및 시험방법 ···································································14 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | 능 확인 및 정량적인 측정을 수행할 수 있다.  | 사용이 가능하다.  | 3.  관계 문헌 | 는 품목 |\n| 이 항은 존재할 수 있는 비방사성물질과 유연물질 측 | 라 한다)는 총리령으로 정하는 바에 따라 영업 |\n\n**[표 끝]**\n\n<!-- PAGE_1 -->\n### 의약품심사부\n\n<!-- PAGE_1 -->\n### 종양약품과\n\n지침·안내서 제‧개정 점검표\n\n<!-- PAGE_1 -->\n###### 명칭\n\n<!-- PAGE_1 -->\n###### 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_1 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n <!-- PAGE_1 -->\n###### ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로\n\n<!-- PAGE_1 -->\n###### 고려하시기 바랍니다. ",
        "original_sentence": "| 사용이 가능하다. "
      }
    },
    {
      "chunk_id": "chunk_175",
      "text": "| 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 174,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 3,
        "window_text": "| 차가 진행 중인 경우에 대해서는 제4조제1항제 | 예 | 결과반영 | 을 수행하였을 때 적합하여야 한 | ※ ‘청정도 관리현황’ 자료 | 와 중성자가 불안정한 배열을 포함하는 핵종은 자연스 | 들은 확인 그리고/또는 구별이 필요하다(예를 들면 | - 제제설계 시 분할사용 하는 경우 아래 관련 정보를 참고하여 설계 | 2.  약사 면허증(제조관리자가 약사인 경우만 해 | Oxygen-15 (15O) | 122.24 초 | 동 자료를 제출하지 않을 수 있음(신약, 주사제, 이식제, 생물학적제제 등 제외) | 성 검토 대상이 아닌 의약외품의 제조판매ᆞ수 | 사항 | 일부공정위탁제조 | 2.3.11 기준 및 시험방법 ···································································14 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | 능 확인 및 정량적인 측정을 수행할 수 있다.  | 사용이 가능하다.  | 3.  관계 문헌 | 는 품목 |\n| 이 항은 존재할 수 있는 비방사성물질과 유연물질 측 | 라 한다)는 총리령으로 정하는 바에 따라 영업 |\n\n**[표 끝]**\n\n<!-- PAGE_1 -->\n### 의약품심사부\n\n<!-- PAGE_1 -->\n### 종양약품과\n\n지침·안내서 제‧개정 점검표\n\n<!-- PAGE_1 -->\n###### 명칭\n\n<!-- PAGE_1 -->\n###### 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_1 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n <!-- PAGE_1 -->\n###### ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로\n\n<!-- PAGE_1 -->\n###### 고려하시기 바랍니다.  그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n<!-- PAGE_1 -->\n###### ■ 예(☞안내서)\n\n<!-- PAGE_1 -->\n###### □ 아니오\n\n<!-- PAGE_1 -->\n###### 안내서 제·개정 절차를 진행하시기 바랍니다.\n\n",
        "original_sentence": "| 3. "
      }
    },
    {
      "chunk_id": "chunk_176",
      "text": "관계 문헌 | 는 품목 |\n| 이 항은 존재할 수 있는 비방사성물질과 유연물질 측 | 라 한다)는 총리령으로 정하는 바에 따라 영업 |\n\n**[표 끝]**\n\n<!-- PAGE_1 -->\n### 의약품심사부\n\n<!-- PAGE_1 -->\n### 종양약품과\n\n지침·안내서 제‧개정 점검표\n\n<!-- PAGE_1 -->\n###### 명칭\n\n<!-- PAGE_1 -->\n###### 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_1 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 175,
        "window_size": 3,
        "char_count": 283,
        "word_count": 62,
        "page_number": 1,
        "window_text": "약사 면허증(제조관리자가 약사인 경우만 해 | Oxygen-15 (15O) | 122.24 초 | 동 자료를 제출하지 않을 수 있음(신약, 주사제, 이식제, 생물학적제제 등 제외) | 성 검토 대상이 아닌 의약외품의 제조판매ᆞ수 | 사항 | 일부공정위탁제조 | 2.3.11 기준 및 시험방법 ···································································14 | ☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침· | 능 확인 및 정량적인 측정을 수행할 수 있다.  | 사용이 가능하다.  | 3.  관계 문헌 | 는 품목 |\n| 이 항은 존재할 수 있는 비방사성물질과 유연물질 측 | 라 한다)는 총리령으로 정하는 바에 따라 영업 |\n\n**[표 끝]**\n\n<!-- PAGE_1 -->\n### 의약품심사부\n\n<!-- PAGE_1 -->\n### 종양약품과\n\n지침·안내서 제‧개정 점검표\n\n<!-- PAGE_1 -->\n###### 명칭\n\n<!-- PAGE_1 -->\n###### 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_1 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n <!-- PAGE_1 -->\n###### ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로\n\n<!-- PAGE_1 -->\n###### 고려하시기 바랍니다.  그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n<!-- PAGE_1 -->\n###### ■ 예(☞안내서)\n\n<!-- PAGE_1 -->\n###### □ 아니오\n\n<!-- PAGE_1 -->\n###### 안내서 제·개정 절차를 진행하시기 바랍니다.\n\n <!-- PAGE_1 -->\n###### 상기 사항에 대하여 확인하였음.\n\n",
        "original_sentence": "관계 문헌 | 는 품목 |\n| 이 항은 존재할 수 있는 비방사성물질과 유연물질 측 | 라 한다)는 총리령으로 정하는 바에 따라 영업 |\n\n**[표 끝]**\n\n<!-- PAGE_1 -->\n### 의약품심사부\n\n<!-- PAGE_1 -->\n### 종양약품과\n\n지침·안내서 제‧개정 점검표\n\n<!-- PAGE_1 -->\n###### 명칭\n\n<!-- PAGE_1 -->\n###### 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_1 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_177",
      "text": "<!-- PAGE_1 -->\n###### ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로\n\n<!-- PAGE_1 -->\n###### 고려하시기 바랍니다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 176,
        "window_size": 3,
        "char_count": 103,
        "word_count": 20,
        "page_number": 1,
        "window_text": "| 사용이 가능하다.  | 3.  관계 문헌 | 는 품목 |\n| 이 항은 존재할 수 있는 비방사성물질과 유연물질 측 | 라 한다)는 총리령으로 정하는 바에 따라 영업 |\n\n**[표 끝]**\n\n<!-- PAGE_1 -->\n### 의약품심사부\n\n<!-- PAGE_1 -->\n### 종양약품과\n\n지침·안내서 제‧개정 점검표\n\n<!-- PAGE_1 -->\n###### 명칭\n\n<!-- PAGE_1 -->\n###### 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_1 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n <!-- PAGE_1 -->\n###### ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로\n\n<!-- PAGE_1 -->\n###### 고려하시기 바랍니다.  그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n<!-- PAGE_1 -->\n###### ■ 예(☞안내서)\n\n<!-- PAGE_1 -->\n###### □ 아니오\n\n<!-- PAGE_1 -->\n###### 안내서 제·개정 절차를 진행하시기 바랍니다.\n\n <!-- PAGE_1 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_1 -->\n###### 2017  년   5  월   25  일\n\n<!-- PAGE_1 -->\n###### 담당자\n\n<!-- PAGE_1 -->\n###### 확  인(부서장)\n\n<!-- PAGE_1 -->\n###### 오 호 정\n\n<!-- PAGE_2 -->\n##### 이 안내서는 방사성의약품의 품목허가와 관련하여 허가 전반적인\n\n<!-- PAGE_2 -->\n##### 사항에 대하여 절차, 내용 등을 알기 쉽게 풀어 설명한 것입니다.\n\n",
        "original_sentence": "<!-- PAGE_1 -->\n###### ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로\n\n<!-- PAGE_1 -->\n###### 고려하시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_178",
      "text": "그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n<!-- PAGE_1 -->\n###### ■ 예(☞안내서)\n\n<!-- PAGE_1 -->\n###### □ 아니오\n\n<!-- PAGE_1 -->\n###### 안내서 제·개정 절차를 진행하시기 바랍니다.\n\n",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 177,
        "window_size": 3,
        "char_count": 142,
        "word_count": 27,
        "page_number": 1,
        "window_text": "| 3.  관계 문헌 | 는 품목 |\n| 이 항은 존재할 수 있는 비방사성물질과 유연물질 측 | 라 한다)는 총리령으로 정하는 바에 따라 영업 |\n\n**[표 끝]**\n\n<!-- PAGE_1 -->\n### 의약품심사부\n\n<!-- PAGE_1 -->\n### 종양약품과\n\n지침·안내서 제‧개정 점검표\n\n<!-- PAGE_1 -->\n###### 명칭\n\n<!-- PAGE_1 -->\n###### 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_1 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n <!-- PAGE_1 -->\n###### ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로\n\n<!-- PAGE_1 -->\n###### 고려하시기 바랍니다.  그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n<!-- PAGE_1 -->\n###### ■ 예(☞안내서)\n\n<!-- PAGE_1 -->\n###### □ 아니오\n\n<!-- PAGE_1 -->\n###### 안내서 제·개정 절차를 진행하시기 바랍니다.\n\n <!-- PAGE_1 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_1 -->\n###### 2017  년   5  월   25  일\n\n<!-- PAGE_1 -->\n###### 담당자\n\n<!-- PAGE_1 -->\n###### 확  인(부서장)\n\n<!-- PAGE_1 -->\n###### 오 호 정\n\n<!-- PAGE_2 -->\n##### 이 안내서는 방사성의약품의 품목허가와 관련하여 허가 전반적인\n\n<!-- PAGE_2 -->\n##### 사항에 대하여 절차, 내용 등을 알기 쉽게 풀어 설명한 것입니다.\n\n <!-- PAGE_2 -->\n##### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의\n\n<!-- PAGE_2 -->\n##### 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시\n\n<!-- PAGE_2 -->\n##### 준수하셔야 하는 사항이 아님을 알려드립니다. ",
        "original_sentence": "그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n<!-- PAGE_1 -->\n###### ■ 예(☞안내서)\n\n<!-- PAGE_1 -->\n###### □ 아니오\n\n<!-- PAGE_1 -->\n###### 안내서 제·개정 절차를 진행하시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_179",
      "text": "<!-- PAGE_1 -->\n###### 상기 사항에 대하여 확인하였음.\n\n",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 178,
        "window_size": 3,
        "char_count": 42,
        "word_count": 8,
        "page_number": 1,
        "window_text": "관계 문헌 | 는 품목 |\n| 이 항은 존재할 수 있는 비방사성물질과 유연물질 측 | 라 한다)는 총리령으로 정하는 바에 따라 영업 |\n\n**[표 끝]**\n\n<!-- PAGE_1 -->\n### 의약품심사부\n\n<!-- PAGE_1 -->\n### 종양약품과\n\n지침·안내서 제‧개정 점검표\n\n<!-- PAGE_1 -->\n###### 명칭\n\n<!-- PAGE_1 -->\n###### 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_1 -->\n###### 아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n <!-- PAGE_1 -->\n###### ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로\n\n<!-- PAGE_1 -->\n###### 고려하시기 바랍니다.  그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n<!-- PAGE_1 -->\n###### ■ 예(☞안내서)\n\n<!-- PAGE_1 -->\n###### □ 아니오\n\n<!-- PAGE_1 -->\n###### 안내서 제·개정 절차를 진행하시기 바랍니다.\n\n <!-- PAGE_1 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_1 -->\n###### 2017  년   5  월   25  일\n\n<!-- PAGE_1 -->\n###### 담당자\n\n<!-- PAGE_1 -->\n###### 확  인(부서장)\n\n<!-- PAGE_1 -->\n###### 오 호 정\n\n<!-- PAGE_2 -->\n##### 이 안내서는 방사성의약품의 품목허가와 관련하여 허가 전반적인\n\n<!-- PAGE_2 -->\n##### 사항에 대하여 절차, 내용 등을 알기 쉽게 풀어 설명한 것입니다.\n\n <!-- PAGE_2 -->\n##### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의\n\n<!-- PAGE_2 -->\n##### 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시\n\n<!-- PAGE_2 -->\n##### 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는\n\n<!-- PAGE_2 -->\n##### 2015년 7월 30일 현재의 과학적·기술적 사실 및 유효한 법규를 토대\n\n<!-- PAGE_2 -->\n##### 로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_2 -->\n##### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n",
        "original_sentence": "<!-- PAGE_1 -->\n###### 상기 사항에 대하여 확인하였음.\n\n"
      }
    },
    {
      "chunk_id": "chunk_180",
      "text": "<!-- PAGE_1 -->\n###### 2017  년   5  월   25  일\n\n<!-- PAGE_1 -->\n###### 담당자\n\n<!-- PAGE_1 -->\n###### 확  인(부서장)\n\n<!-- PAGE_1 -->\n###### 오 호 정\n\n<!-- PAGE_2 -->\n##### 이 안내서는 방사성의약품의 품목허가와 관련하여 허가 전반적인\n\n<!-- PAGE_2 -->\n##### 사항에 대하여 절차, 내용 등을 알기 쉽게 풀어 설명한 것입니다.\n\n",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 179,
        "window_size": 3,
        "char_count": 256,
        "word_count": 53,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n###### ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침·안내서의 개정을 우선적으로\n\n<!-- PAGE_1 -->\n###### 고려하시기 바랍니다.  그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n<!-- PAGE_1 -->\n###### ■ 예(☞안내서)\n\n<!-- PAGE_1 -->\n###### □ 아니오\n\n<!-- PAGE_1 -->\n###### 안내서 제·개정 절차를 진행하시기 바랍니다.\n\n <!-- PAGE_1 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_1 -->\n###### 2017  년   5  월   25  일\n\n<!-- PAGE_1 -->\n###### 담당자\n\n<!-- PAGE_1 -->\n###### 확  인(부서장)\n\n<!-- PAGE_1 -->\n###### 오 호 정\n\n<!-- PAGE_2 -->\n##### 이 안내서는 방사성의약품의 품목허가와 관련하여 허가 전반적인\n\n<!-- PAGE_2 -->\n##### 사항에 대하여 절차, 내용 등을 알기 쉽게 풀어 설명한 것입니다.\n\n <!-- PAGE_2 -->\n##### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의\n\n<!-- PAGE_2 -->\n##### 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시\n\n<!-- PAGE_2 -->\n##### 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는\n\n<!-- PAGE_2 -->\n##### 2015년 7월 30일 현재의 과학적·기술적 사실 및 유효한 법규를 토대\n\n<!-- PAGE_2 -->\n##### 로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_2 -->\n##### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_2 -->\n##### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_2 -->\n##### (이하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한\n\n<!-- PAGE_2 -->\n##### 사안에 대하여 식품의약품안전처의 입장을 기술하는 것\n\n<!-- PAGE_2 -->\n###### ※ 본 해설서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원 의약품심사부\n\n<!-- PAGE_2 -->\n###### 종양약품과로 문의하시기 바랍니다.\n\n",
        "original_sentence": "<!-- PAGE_1 -->\n###### 2017  년   5  월   25  일\n\n<!-- PAGE_1 -->\n###### 담당자\n\n<!-- PAGE_1 -->\n###### 확  인(부서장)\n\n<!-- PAGE_1 -->\n###### 오 호 정\n\n<!-- PAGE_2 -->\n##### 이 안내서는 방사성의약품의 품목허가와 관련하여 허가 전반적인\n\n<!-- PAGE_2 -->\n##### 사항에 대하여 절차, 내용 등을 알기 쉽게 풀어 설명한 것입니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_181",
      "text": "<!-- PAGE_2 -->\n##### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의\n\n<!-- PAGE_2 -->\n##### 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시\n\n<!-- PAGE_2 -->\n##### 준수하셔야 하는 사항이 아님을 알려드립니다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 180,
        "window_size": 3,
        "char_count": 168,
        "word_count": 33,
        "page_number": 2,
        "window_text": "그럼에도 불구하고 동 지침·안내서의 제정이 필요한\n\n<!-- PAGE_1 -->\n###### ■ 예(☞안내서)\n\n<!-- PAGE_1 -->\n###### □ 아니오\n\n<!-- PAGE_1 -->\n###### 안내서 제·개정 절차를 진행하시기 바랍니다.\n\n <!-- PAGE_1 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_1 -->\n###### 2017  년   5  월   25  일\n\n<!-- PAGE_1 -->\n###### 담당자\n\n<!-- PAGE_1 -->\n###### 확  인(부서장)\n\n<!-- PAGE_1 -->\n###### 오 호 정\n\n<!-- PAGE_2 -->\n##### 이 안내서는 방사성의약품의 품목허가와 관련하여 허가 전반적인\n\n<!-- PAGE_2 -->\n##### 사항에 대하여 절차, 내용 등을 알기 쉽게 풀어 설명한 것입니다.\n\n <!-- PAGE_2 -->\n##### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의\n\n<!-- PAGE_2 -->\n##### 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시\n\n<!-- PAGE_2 -->\n##### 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는\n\n<!-- PAGE_2 -->\n##### 2015년 7월 30일 현재의 과학적·기술적 사실 및 유효한 법규를 토대\n\n<!-- PAGE_2 -->\n##### 로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_2 -->\n##### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_2 -->\n##### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_2 -->\n##### (이하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한\n\n<!-- PAGE_2 -->\n##### 사안에 대하여 식품의약품안전처의 입장을 기술하는 것\n\n<!-- PAGE_2 -->\n###### ※ 본 해설서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원 의약품심사부\n\n<!-- PAGE_2 -->\n###### 종양약품과로 문의하시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 전화번호: 043-719-3057\n\n<!-- PAGE_2 -->\n###### 팩스번호: 043-719-3050\n\n<!-- PAGE_2 -->\n# 목  차\n\n<!-- PAGE_2 -->\n##### 1. ",
        "original_sentence": "<!-- PAGE_2 -->\n##### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의\n\n<!-- PAGE_2 -->\n##### 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시\n\n<!-- PAGE_2 -->\n##### 준수하셔야 하는 사항이 아님을 알려드립니다. "
      }
    },
    {
      "chunk_id": "chunk_182",
      "text": "또한, 본 안내서는\n\n<!-- PAGE_2 -->\n##### 2015년 7월 30일 현재의 과학적·기술적 사실 및 유효한 법규를 토대\n\n<!-- PAGE_2 -->\n##### 로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_2 -->\n##### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 181,
        "window_size": 3,
        "char_count": 186,
        "word_count": 42,
        "page_number": 2,
        "window_text": "<!-- PAGE_1 -->\n###### 상기 사항에 대하여 확인하였음.\n\n <!-- PAGE_1 -->\n###### 2017  년   5  월   25  일\n\n<!-- PAGE_1 -->\n###### 담당자\n\n<!-- PAGE_1 -->\n###### 확  인(부서장)\n\n<!-- PAGE_1 -->\n###### 오 호 정\n\n<!-- PAGE_2 -->\n##### 이 안내서는 방사성의약품의 품목허가와 관련하여 허가 전반적인\n\n<!-- PAGE_2 -->\n##### 사항에 대하여 절차, 내용 등을 알기 쉽게 풀어 설명한 것입니다.\n\n <!-- PAGE_2 -->\n##### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의\n\n<!-- PAGE_2 -->\n##### 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시\n\n<!-- PAGE_2 -->\n##### 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는\n\n<!-- PAGE_2 -->\n##### 2015년 7월 30일 현재의 과학적·기술적 사실 및 유효한 법규를 토대\n\n<!-- PAGE_2 -->\n##### 로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_2 -->\n##### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_2 -->\n##### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_2 -->\n##### (이하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한\n\n<!-- PAGE_2 -->\n##### 사안에 대하여 식품의약품안전처의 입장을 기술하는 것\n\n<!-- PAGE_2 -->\n###### ※ 본 해설서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원 의약품심사부\n\n<!-- PAGE_2 -->\n###### 종양약품과로 문의하시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 전화번호: 043-719-3057\n\n<!-- PAGE_2 -->\n###### 팩스번호: 043-719-3050\n\n<!-- PAGE_2 -->\n# 목  차\n\n<!-- PAGE_2 -->\n##### 1.  서론 ······································································································1\n\n<!-- PAGE_2 -->\n##### 1.1 배경 ····································································································1\n\n<!-- PAGE_2 -->\n##### 1.2 국내 방사성의약품 품목허가 현황 ··············································1\n\n<!-- PAGE_2 -->\n##### 2.3.12 제조원 ·······················································································15\n\n<!-- PAGE_2 -->\n##### 2.3.13 허가조건 ···················································································16\n\n<!-- PAGE_2 -->\n##### 2.4 심사자료의 종류 및 범위 ····························································17\n\n<!-- PAGE_2 -->\n##### 2.5 GMP 평가자료의 종류 및 범위 ·················································19\n\n<!-- PAGE_2 -->\n##### 부록1. ",
        "original_sentence": "또한, 본 안내서는\n\n<!-- PAGE_2 -->\n##### 2015년 7월 30일 현재의 과학적·기술적 사실 및 유효한 법규를 토대\n\n<!-- PAGE_2 -->\n##### 로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_2 -->\n##### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_183",
      "text": "<!-- PAGE_2 -->\n##### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_2 -->\n##### (이하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한\n\n<!-- PAGE_2 -->\n##### 사안에 대하여 식품의약품안전처의 입장을 기술하는 것\n\n<!-- PAGE_2 -->\n###### ※ 본 해설서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원 의약품심사부\n\n<!-- PAGE_2 -->\n###### 종양약품과로 문의하시기 바랍니다.\n\n",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 182,
        "window_size": 3,
        "char_count": 287,
        "word_count": 55,
        "page_number": 2,
        "window_text": "<!-- PAGE_1 -->\n###### 2017  년   5  월   25  일\n\n<!-- PAGE_1 -->\n###### 담당자\n\n<!-- PAGE_1 -->\n###### 확  인(부서장)\n\n<!-- PAGE_1 -->\n###### 오 호 정\n\n<!-- PAGE_2 -->\n##### 이 안내서는 방사성의약품의 품목허가와 관련하여 허가 전반적인\n\n<!-- PAGE_2 -->\n##### 사항에 대하여 절차, 내용 등을 알기 쉽게 풀어 설명한 것입니다.\n\n <!-- PAGE_2 -->\n##### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의\n\n<!-- PAGE_2 -->\n##### 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시\n\n<!-- PAGE_2 -->\n##### 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는\n\n<!-- PAGE_2 -->\n##### 2015년 7월 30일 현재의 과학적·기술적 사실 및 유효한 법규를 토대\n\n<!-- PAGE_2 -->\n##### 로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_2 -->\n##### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_2 -->\n##### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_2 -->\n##### (이하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한\n\n<!-- PAGE_2 -->\n##### 사안에 대하여 식품의약품안전처의 입장을 기술하는 것\n\n<!-- PAGE_2 -->\n###### ※ 본 해설서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원 의약품심사부\n\n<!-- PAGE_2 -->\n###### 종양약품과로 문의하시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 전화번호: 043-719-3057\n\n<!-- PAGE_2 -->\n###### 팩스번호: 043-719-3050\n\n<!-- PAGE_2 -->\n# 목  차\n\n<!-- PAGE_2 -->\n##### 1.  서론 ······································································································1\n\n<!-- PAGE_2 -->\n##### 1.1 배경 ····································································································1\n\n<!-- PAGE_2 -->\n##### 1.2 국내 방사성의약품 품목허가 현황 ··············································1\n\n<!-- PAGE_2 -->\n##### 2.3.12 제조원 ·······················································································15\n\n<!-- PAGE_2 -->\n##### 2.3.13 허가조건 ···················································································16\n\n<!-- PAGE_2 -->\n##### 2.4 심사자료의 종류 및 범위 ····························································17\n\n<!-- PAGE_2 -->\n##### 2.5 GMP 평가자료의 종류 및 범위 ·················································19\n\n<!-- PAGE_2 -->\n##### 부록1.  관련 법규 ····················································································21\n\n<!-- PAGE_2 -->\n##### 부록2. ",
        "original_sentence": "<!-- PAGE_2 -->\n##### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_2 -->\n##### (이하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한\n\n<!-- PAGE_2 -->\n##### 사안에 대하여 식품의약품안전처의 입장을 기술하는 것\n\n<!-- PAGE_2 -->\n###### ※ 본 해설서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원 의약품심사부\n\n<!-- PAGE_2 -->\n###### 종양약품과로 문의하시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_184",
      "text": "<!-- PAGE_2 -->\n###### 전화번호: 043-719-3057\n\n<!-- PAGE_2 -->\n###### 팩스번호: 043-719-3050\n\n<!-- PAGE_2 -->\n# 목  차\n\n<!-- PAGE_2 -->\n##### 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 183,
        "window_size": 3,
        "char_count": 135,
        "word_count": 23,
        "page_number": 2,
        "window_text": "<!-- PAGE_2 -->\n##### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의\n\n<!-- PAGE_2 -->\n##### 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시\n\n<!-- PAGE_2 -->\n##### 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안내서는\n\n<!-- PAGE_2 -->\n##### 2015년 7월 30일 현재의 과학적·기술적 사실 및 유효한 법규를 토대\n\n<!-- PAGE_2 -->\n##### 로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_2 -->\n##### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_2 -->\n##### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_2 -->\n##### (이하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한\n\n<!-- PAGE_2 -->\n##### 사안에 대하여 식품의약품안전처의 입장을 기술하는 것\n\n<!-- PAGE_2 -->\n###### ※ 본 해설서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원 의약품심사부\n\n<!-- PAGE_2 -->\n###### 종양약품과로 문의하시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 전화번호: 043-719-3057\n\n<!-- PAGE_2 -->\n###### 팩스번호: 043-719-3050\n\n<!-- PAGE_2 -->\n# 목  차\n\n<!-- PAGE_2 -->\n##### 1.  서론 ······································································································1\n\n<!-- PAGE_2 -->\n##### 1.1 배경 ····································································································1\n\n<!-- PAGE_2 -->\n##### 1.2 국내 방사성의약품 품목허가 현황 ··············································1\n\n<!-- PAGE_2 -->\n##### 2.3.12 제조원 ·······················································································15\n\n<!-- PAGE_2 -->\n##### 2.3.13 허가조건 ···················································································16\n\n<!-- PAGE_2 -->\n##### 2.4 심사자료의 종류 및 범위 ····························································17\n\n<!-- PAGE_2 -->\n##### 2.5 GMP 평가자료의 종류 및 범위 ·················································19\n\n<!-- PAGE_2 -->\n##### 부록1.  관련 법규 ····················································································21\n\n<!-- PAGE_2 -->\n##### 부록2.  유럽약전 방사성의약품 번역 ··················································31\n\n**[표 시작]**\n\n| 심사항목 | 처리기한 | 각 항목 심사 불필요시 위 수수료에서 아래 해당금액 제외 | 민원인들에게 허가 전반적인 사항에 대해 알기 쉽게 안내하고자 마련하였으며 허가심사 | 1항에 따라 의약품등의 제조판매ᆞ수입 품목허 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 약품등의 제조업이나 위탁제조판매업에 대한 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 60 | 7 | 8 비고 | 가 | 나 | 가 | 나 |\n| 사용 중인 설비 또는 시스템에 관해서는 위 조건에 해당하는 적격성평가 자료를 반드시 제출할 필요는 없음. ",
        "original_sentence": "<!-- PAGE_2 -->\n###### 전화번호: 043-719-3057\n\n<!-- PAGE_2 -->\n###### 팩스번호: 043-719-3050\n\n<!-- PAGE_2 -->\n# 목  차\n\n<!-- PAGE_2 -->\n##### 1. "
      }
    },
    {
      "chunk_id": "chunk_185",
      "text": "서론 ······································································································1\n\n<!-- PAGE_2 -->\n##### 1.1 배경 ····································································································1\n\n<!-- PAGE_2 -->\n##### 1.2 국내 방사성의약품 품목허가 현황 ··············································1\n\n<!-- PAGE_2 -->\n##### 2.3.12 제조원 ·······················································································15\n\n<!-- PAGE_2 -->\n##### 2.3.13 허가조건 ···················································································16\n\n<!-- PAGE_2 -->\n##### 2.4 심사자료의 종류 및 범위 ····························································17\n\n<!-- PAGE_2 -->\n##### 2.5 GMP 평가자료의 종류 및 범위 ·················································19\n\n<!-- PAGE_2 -->\n##### 부록1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 184,
        "window_size": 3,
        "char_count": 806,
        "word_count": 59,
        "page_number": 2,
        "window_text": "또한, 본 안내서는\n\n<!-- PAGE_2 -->\n##### 2015년 7월 30일 현재의 과학적·기술적 사실 및 유효한 법규를 토대\n\n<!-- PAGE_2 -->\n##### 로 작성되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계\n\n<!-- PAGE_2 -->\n##### 등에 따라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_2 -->\n##### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_2 -->\n##### (이하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한\n\n<!-- PAGE_2 -->\n##### 사안에 대하여 식품의약품안전처의 입장을 기술하는 것\n\n<!-- PAGE_2 -->\n###### ※ 본 해설서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원 의약품심사부\n\n<!-- PAGE_2 -->\n###### 종양약품과로 문의하시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 전화번호: 043-719-3057\n\n<!-- PAGE_2 -->\n###### 팩스번호: 043-719-3050\n\n<!-- PAGE_2 -->\n# 목  차\n\n<!-- PAGE_2 -->\n##### 1.  서론 ······································································································1\n\n<!-- PAGE_2 -->\n##### 1.1 배경 ····································································································1\n\n<!-- PAGE_2 -->\n##### 1.2 국내 방사성의약품 품목허가 현황 ··············································1\n\n<!-- PAGE_2 -->\n##### 2.3.12 제조원 ·······················································································15\n\n<!-- PAGE_2 -->\n##### 2.3.13 허가조건 ···················································································16\n\n<!-- PAGE_2 -->\n##### 2.4 심사자료의 종류 및 범위 ····························································17\n\n<!-- PAGE_2 -->\n##### 2.5 GMP 평가자료의 종류 및 범위 ·················································19\n\n<!-- PAGE_2 -->\n##### 부록1.  관련 법규 ····················································································21\n\n<!-- PAGE_2 -->\n##### 부록2.  유럽약전 방사성의약품 번역 ··················································31\n\n**[표 시작]**\n\n| 심사항목 | 처리기한 | 각 항목 심사 불필요시 위 수수료에서 아래 해당금액 제외 | 민원인들에게 허가 전반적인 사항에 대해 알기 쉽게 안내하고자 마련하였으며 허가심사 | 1항에 따라 의약품등의 제조판매ᆞ수입 품목허 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 약품등의 제조업이나 위탁제조판매업에 대한 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 60 | 7 | 8 비고 | 가 | 나 | 가 | 나 |\n| 사용 중인 설비 또는 시스템에 관해서는 위 조건에 해당하는 적격성평가 자료를 반드시 제출할 필요는 없음.  | 등을 미리 식품의약품안전처장과 품목 및 수 | 자료 또는 비교임상시험 성적서에 관한 자 | 처장이 정하는 희귀의약품(이하 \"희귀의 | 1 | ③ 제1항에도 불구하고 식품의약품안전처장 또 | 등 제조판매·수입 품목 허가신청서(전자문서로 | 조시설·제조방법 등에 관한 양도·양수계약서 |\n| 2 | 안내서-0231-01 | - | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | (1) (2) (3) | 절차, 신청방법, 신청서 항목 작성 요령 및 기타 유용한 정보 등을 담아 품목허가 신청을 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 허가를 받거나 신고를 할 수 없다. ",
        "original_sentence": "서론 ······································································································1\n\n<!-- PAGE_2 -->\n##### 1.1 배경 ····································································································1\n\n<!-- PAGE_2 -->\n##### 1.2 국내 방사성의약품 품목허가 현황 ··············································1\n\n<!-- PAGE_2 -->\n##### 2.3.12 제조원 ·······················································································15\n\n<!-- PAGE_2 -->\n##### 2.3.13 허가조건 ···················································································16\n\n<!-- PAGE_2 -->\n##### 2.4 심사자료의 종류 및 범위 ····························································17\n\n<!-- PAGE_2 -->\n##### 2.5 GMP 평가자료의 종류 및 범위 ·················································19\n\n<!-- PAGE_2 -->\n##### 부록1. "
      }
    },
    {
      "chunk_id": "chunk_186",
      "text": "관련 법규 ····················································································21\n\n<!-- PAGE_2 -->\n##### 부록2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 185,
        "window_size": 3,
        "char_count": 121,
        "word_count": 8,
        "page_number": 2,
        "window_text": "<!-- PAGE_2 -->\n##### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_2 -->\n##### (이하 “행정규칙”이라 한다)을 알기 쉽게 풀어서 설명하거나 특정한\n\n<!-- PAGE_2 -->\n##### 사안에 대하여 식품의약품안전처의 입장을 기술하는 것\n\n<!-- PAGE_2 -->\n###### ※ 본 해설서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전평가원 의약품심사부\n\n<!-- PAGE_2 -->\n###### 종양약품과로 문의하시기 바랍니다.\n\n <!-- PAGE_2 -->\n###### 전화번호: 043-719-3057\n\n<!-- PAGE_2 -->\n###### 팩스번호: 043-719-3050\n\n<!-- PAGE_2 -->\n# 목  차\n\n<!-- PAGE_2 -->\n##### 1.  서론 ······································································································1\n\n<!-- PAGE_2 -->\n##### 1.1 배경 ····································································································1\n\n<!-- PAGE_2 -->\n##### 1.2 국내 방사성의약품 품목허가 현황 ··············································1\n\n<!-- PAGE_2 -->\n##### 2.3.12 제조원 ·······················································································15\n\n<!-- PAGE_2 -->\n##### 2.3.13 허가조건 ···················································································16\n\n<!-- PAGE_2 -->\n##### 2.4 심사자료의 종류 및 범위 ····························································17\n\n<!-- PAGE_2 -->\n##### 2.5 GMP 평가자료의 종류 및 범위 ·················································19\n\n<!-- PAGE_2 -->\n##### 부록1.  관련 법규 ····················································································21\n\n<!-- PAGE_2 -->\n##### 부록2.  유럽약전 방사성의약품 번역 ··················································31\n\n**[표 시작]**\n\n| 심사항목 | 처리기한 | 각 항목 심사 불필요시 위 수수료에서 아래 해당금액 제외 | 민원인들에게 허가 전반적인 사항에 대해 알기 쉽게 안내하고자 마련하였으며 허가심사 | 1항에 따라 의약품등의 제조판매ᆞ수입 품목허 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 약품등의 제조업이나 위탁제조판매업에 대한 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 60 | 7 | 8 비고 | 가 | 나 | 가 | 나 |\n| 사용 중인 설비 또는 시스템에 관해서는 위 조건에 해당하는 적격성평가 자료를 반드시 제출할 필요는 없음.  | 등을 미리 식품의약품안전처장과 품목 및 수 | 자료 또는 비교임상시험 성적서에 관한 자 | 처장이 정하는 희귀의약품(이하 \"희귀의 | 1 | ③ 제1항에도 불구하고 식품의약품안전처장 또 | 등 제조판매·수입 품목 허가신청서(전자문서로 | 조시설·제조방법 등에 관한 양도·양수계약서 |\n| 2 | 안내서-0231-01 | - | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | (1) (2) (3) | 절차, 신청방법, 신청서 항목 작성 요령 및 기타 유용한 정보 등을 담아 품목허가 신청을 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 허가를 받거나 신고를 할 수 없다.  <개정 |\n| 이러한 경우, GMP 적용 시점 이후 설비의 운전변수 및 중요변수에 대한 한계를 뒷받침하고 입증하는 | 량에 대한 협의를 거쳐 수입하려는 경우 | 료. ",
        "original_sentence": "관련 법규 ····················································································21\n\n<!-- PAGE_2 -->\n##### 부록2. "
      }
    },
    {
      "chunk_id": "chunk_187",
      "text": "유럽약전 방사성의약품 번역 ··················································31\n\n**[표 시작]**\n\n| 심사항목 | 처리기한 | 각 항목 심사 불필요시 위 수수료에서 아래 해당금액 제외 | 민원인들에게 허가 전반적인 사항에 대해 알기 쉽게 안내하고자 마련하였으며 허가심사 | 1항에 따라 의약품등의 제조판매ᆞ수입 품목허 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 약품등의 제조업이나 위탁제조판매업에 대한 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 60 | 7 | 8 비고 | 가 | 나 | 가 | 나 |\n| 사용 중인 설비 또는 시스템에 관해서는 위 조건에 해당하는 적격성평가 자료를 반드시 제출할 필요는 없음. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 186,
        "window_size": 3,
        "char_count": 397,
        "word_count": 97,
        "page_number": 2,
        "window_text": "<!-- PAGE_2 -->\n###### 전화번호: 043-719-3057\n\n<!-- PAGE_2 -->\n###### 팩스번호: 043-719-3050\n\n<!-- PAGE_2 -->\n# 목  차\n\n<!-- PAGE_2 -->\n##### 1.  서론 ······································································································1\n\n<!-- PAGE_2 -->\n##### 1.1 배경 ····································································································1\n\n<!-- PAGE_2 -->\n##### 1.2 국내 방사성의약품 품목허가 현황 ··············································1\n\n<!-- PAGE_2 -->\n##### 2.3.12 제조원 ·······················································································15\n\n<!-- PAGE_2 -->\n##### 2.3.13 허가조건 ···················································································16\n\n<!-- PAGE_2 -->\n##### 2.4 심사자료의 종류 및 범위 ····························································17\n\n<!-- PAGE_2 -->\n##### 2.5 GMP 평가자료의 종류 및 범위 ·················································19\n\n<!-- PAGE_2 -->\n##### 부록1.  관련 법규 ····················································································21\n\n<!-- PAGE_2 -->\n##### 부록2.  유럽약전 방사성의약품 번역 ··················································31\n\n**[표 시작]**\n\n| 심사항목 | 처리기한 | 각 항목 심사 불필요시 위 수수료에서 아래 해당금액 제외 | 민원인들에게 허가 전반적인 사항에 대해 알기 쉽게 안내하고자 마련하였으며 허가심사 | 1항에 따라 의약품등의 제조판매ᆞ수입 품목허 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 약품등의 제조업이나 위탁제조판매업에 대한 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 60 | 7 | 8 비고 | 가 | 나 | 가 | 나 |\n| 사용 중인 설비 또는 시스템에 관해서는 위 조건에 해당하는 적격성평가 자료를 반드시 제출할 필요는 없음.  | 등을 미리 식품의약품안전처장과 품목 및 수 | 자료 또는 비교임상시험 성적서에 관한 자 | 처장이 정하는 희귀의약품(이하 \"희귀의 | 1 | ③ 제1항에도 불구하고 식품의약품안전처장 또 | 등 제조판매·수입 품목 허가신청서(전자문서로 | 조시설·제조방법 등에 관한 양도·양수계약서 |\n| 2 | 안내서-0231-01 | - | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | (1) (2) (3) | 절차, 신청방법, 신청서 항목 작성 요령 및 기타 유용한 정보 등을 담아 품목허가 신청을 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 허가를 받거나 신고를 할 수 없다.  <개정 |\n| 이러한 경우, GMP 적용 시점 이후 설비의 운전변수 및 중요변수에 대한 한계를 뒷받침하고 입증하는 | 량에 대한 협의를 거쳐 수입하려는 경우 | 료.  다만, 식품의약품안전처장이 고시하는 품 | 미국약전 | USP, NF | 독일약전 | DAB | 약품\"이라 한다) | 는 지방청장은 다음 각 호의 어느 하나에 해당 |\n| - 약리학, 제제학, 임상성적자료 등 명확한 근거 바탕, 합리적, 타당해야 하며, 원료약품 | 등 제조판매ᆞ수입 품목 허가신청서(전자문서로 | 된 신청서를 포함한다)에 다음 각 호의 서류(전 |\n| 발 | 행 | 일 | 자료(예시 : 공정 밸리데이션, 제품품질평가 등), 교정, 세척, 예방적 유지관리, 작업절차, 작업원 훈련절차 | 목의 경우에는 비교용출시험자료 등 생체를 | ○ | × | × | × | ○ ○ ○ △ | × | △ △ ○ ○ ○ △ | × | × | × | ○ | × | × | × | × | × | × | × | × | × | × | × | ○ ○ | × | ○ ○ | 2015년 7 월 | 용이하게 하고자 하였다. ",
        "original_sentence": "유럽약전 방사성의약품 번역 ··················································31\n\n**[표 시작]**\n\n| 심사항목 | 처리기한 | 각 항목 심사 불필요시 위 수수료에서 아래 해당금액 제외 | 민원인들에게 허가 전반적인 사항에 대해 알기 쉽게 안내하고자 마련하였으며 허가심사 | 1항에 따라 의약품등의 제조판매ᆞ수입 품목허 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 약품등의 제조업이나 위탁제조판매업에 대한 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 60 | 7 | 8 비고 | 가 | 나 | 가 | 나 |\n| 사용 중인 설비 또는 시스템에 관해서는 위 조건에 해당하는 적격성평가 자료를 반드시 제출할 필요는 없음. "
      }
    },
    {
      "chunk_id": "chunk_188",
      "text": "| 등을 미리 식품의약품안전처장과 품목 및 수 | 자료 또는 비교임상시험 성적서에 관한 자 | 처장이 정하는 희귀의약품(이하 \"희귀의 | 1 | ③ 제1항에도 불구하고 식품의약품안전처장 또 | 등 제조판매·수입 품목 허가신청서(전자문서로 | 조시설·제조방법 등에 관한 양도·양수계약서 |\n| 2 | 안내서-0231-01 | - | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | (1) (2) (3) | 절차, 신청방법, 신청서 항목 작성 요령 및 기타 유용한 정보 등을 담아 품목허가 신청을 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 허가를 받거나 신고를 할 수 없다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 187,
        "window_size": 3,
        "char_count": 393,
        "word_count": 115,
        "page_number": 5,
        "window_text": "서론 ······································································································1\n\n<!-- PAGE_2 -->\n##### 1.1 배경 ····································································································1\n\n<!-- PAGE_2 -->\n##### 1.2 국내 방사성의약품 품목허가 현황 ··············································1\n\n<!-- PAGE_2 -->\n##### 2.3.12 제조원 ·······················································································15\n\n<!-- PAGE_2 -->\n##### 2.3.13 허가조건 ···················································································16\n\n<!-- PAGE_2 -->\n##### 2.4 심사자료의 종류 및 범위 ····························································17\n\n<!-- PAGE_2 -->\n##### 2.5 GMP 평가자료의 종류 및 범위 ·················································19\n\n<!-- PAGE_2 -->\n##### 부록1.  관련 법규 ····················································································21\n\n<!-- PAGE_2 -->\n##### 부록2.  유럽약전 방사성의약품 번역 ··················································31\n\n**[표 시작]**\n\n| 심사항목 | 처리기한 | 각 항목 심사 불필요시 위 수수료에서 아래 해당금액 제외 | 민원인들에게 허가 전반적인 사항에 대해 알기 쉽게 안내하고자 마련하였으며 허가심사 | 1항에 따라 의약품등의 제조판매ᆞ수입 품목허 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 약품등의 제조업이나 위탁제조판매업에 대한 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 60 | 7 | 8 비고 | 가 | 나 | 가 | 나 |\n| 사용 중인 설비 또는 시스템에 관해서는 위 조건에 해당하는 적격성평가 자료를 반드시 제출할 필요는 없음.  | 등을 미리 식품의약품안전처장과 품목 및 수 | 자료 또는 비교임상시험 성적서에 관한 자 | 처장이 정하는 희귀의약품(이하 \"희귀의 | 1 | ③ 제1항에도 불구하고 식품의약품안전처장 또 | 등 제조판매·수입 품목 허가신청서(전자문서로 | 조시설·제조방법 등에 관한 양도·양수계약서 |\n| 2 | 안내서-0231-01 | - | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | (1) (2) (3) | 절차, 신청방법, 신청서 항목 작성 요령 및 기타 유용한 정보 등을 담아 품목허가 신청을 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 허가를 받거나 신고를 할 수 없다.  <개정 |\n| 이러한 경우, GMP 적용 시점 이후 설비의 운전변수 및 중요변수에 대한 한계를 뒷받침하고 입증하는 | 량에 대한 협의를 거쳐 수입하려는 경우 | 료.  다만, 식품의약품안전처장이 고시하는 품 | 미국약전 | USP, NF | 독일약전 | DAB | 약품\"이라 한다) | 는 지방청장은 다음 각 호의 어느 하나에 해당 |\n| - 약리학, 제제학, 임상성적자료 등 명확한 근거 바탕, 합리적, 타당해야 하며, 원료약품 | 등 제조판매ᆞ수입 품목 허가신청서(전자문서로 | 된 신청서를 포함한다)에 다음 각 호의 서류(전 |\n| 발 | 행 | 일 | 자료(예시 : 공정 밸리데이션, 제품품질평가 등), 교정, 세척, 예방적 유지관리, 작업절차, 작업원 훈련절차 | 목의 경우에는 비교용출시험자료 등 생체를 | ○ | × | × | × | ○ ○ ○ △ | × | △ △ ○ ○ ○ △ | × | × | × | ○ | × | × | × | × | × | × | × | × | × | × | × | ○ ○ | × | ○ ○ | 2015년 7 월 | 용이하게 하고자 하였다.  아울러 PET용 방사성의약품의 심사 평가 시 요구되는 일반적인 | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 하는 경우 그 검토 결과 이미 제조판매ᆞ수입 |\n| 일본약전 | JP | 프랑스약전 | FP | 40 | 하전입자 조사(CHARGED PARTICLE IRRADIATION) | 된 신청서를 포함한다)에 다음 각 호의 서류(전 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| 및 기록에 대한 자료를 제출하면 됨(‘15.7.1자 시행되는「의약품 제조 및 품질관리에 관한 규정」 [별표 13] | 경우에는 생물학적 동등성시험에 관한 시험 | 이용하지 아니하는 시험자료로서 식품의약품 | 1단계 | 도인에 대한 제조판매·수입 품목허가에 붙여 | 품목허가 또는 품목신고한 사항을 변경할 필요 |\n| 약품을 수입하거나 임상시험용 의약품 등 총 | 방법에 대한 기술적인 내용은 각조에 설정되어 있다. ",
        "original_sentence": "| 등을 미리 식품의약품안전처장과 품목 및 수 | 자료 또는 비교임상시험 성적서에 관한 자 | 처장이 정하는 희귀의약품(이하 \"희귀의 | 1 | ③ 제1항에도 불구하고 식품의약품안전처장 또 | 등 제조판매·수입 품목 허가신청서(전자문서로 | 조시설·제조방법 등에 관한 양도·양수계약서 |\n| 2 | 안내서-0231-01 | - | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | (1) (2) (3) | 절차, 신청방법, 신청서 항목 작성 요령 및 기타 유용한 정보 등을 담아 품목허가 신청을 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 허가를 받거나 신고를 할 수 없다. "
      }
    },
    {
      "chunk_id": "chunk_189",
      "text": "<개정 |\n| 이러한 경우, GMP 적용 시점 이후 설비의 운전변수 및 중요변수에 대한 한계를 뒷받침하고 입증하는 | 량에 대한 협의를 거쳐 수입하려는 경우 | 료. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 188,
        "window_size": 3,
        "char_count": 93,
        "word_count": 26,
        "page_number": 5,
        "window_text": "관련 법규 ····················································································21\n\n<!-- PAGE_2 -->\n##### 부록2.  유럽약전 방사성의약품 번역 ··················································31\n\n**[표 시작]**\n\n| 심사항목 | 처리기한 | 각 항목 심사 불필요시 위 수수료에서 아래 해당금액 제외 | 민원인들에게 허가 전반적인 사항에 대해 알기 쉽게 안내하고자 마련하였으며 허가심사 | 1항에 따라 의약품등의 제조판매ᆞ수입 품목허 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 약품등의 제조업이나 위탁제조판매업에 대한 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 60 | 7 | 8 비고 | 가 | 나 | 가 | 나 |\n| 사용 중인 설비 또는 시스템에 관해서는 위 조건에 해당하는 적격성평가 자료를 반드시 제출할 필요는 없음.  | 등을 미리 식품의약품안전처장과 품목 및 수 | 자료 또는 비교임상시험 성적서에 관한 자 | 처장이 정하는 희귀의약품(이하 \"희귀의 | 1 | ③ 제1항에도 불구하고 식품의약품안전처장 또 | 등 제조판매·수입 품목 허가신청서(전자문서로 | 조시설·제조방법 등에 관한 양도·양수계약서 |\n| 2 | 안내서-0231-01 | - | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | (1) (2) (3) | 절차, 신청방법, 신청서 항목 작성 요령 및 기타 유용한 정보 등을 담아 품목허가 신청을 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 허가를 받거나 신고를 할 수 없다.  <개정 |\n| 이러한 경우, GMP 적용 시점 이후 설비의 운전변수 및 중요변수에 대한 한계를 뒷받침하고 입증하는 | 량에 대한 협의를 거쳐 수입하려는 경우 | 료.  다만, 식품의약품안전처장이 고시하는 품 | 미국약전 | USP, NF | 독일약전 | DAB | 약품\"이라 한다) | 는 지방청장은 다음 각 호의 어느 하나에 해당 |\n| - 약리학, 제제학, 임상성적자료 등 명확한 근거 바탕, 합리적, 타당해야 하며, 원료약품 | 등 제조판매ᆞ수입 품목 허가신청서(전자문서로 | 된 신청서를 포함한다)에 다음 각 호의 서류(전 |\n| 발 | 행 | 일 | 자료(예시 : 공정 밸리데이션, 제품품질평가 등), 교정, 세척, 예방적 유지관리, 작업절차, 작업원 훈련절차 | 목의 경우에는 비교용출시험자료 등 생체를 | ○ | × | × | × | ○ ○ ○ △ | × | △ △ ○ ○ ○ △ | × | × | × | ○ | × | × | × | × | × | × | × | × | × | × | × | ○ ○ | × | ○ ○ | 2015년 7 월 | 용이하게 하고자 하였다.  아울러 PET용 방사성의약품의 심사 평가 시 요구되는 일반적인 | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 하는 경우 그 검토 결과 이미 제조판매ᆞ수입 |\n| 일본약전 | JP | 프랑스약전 | FP | 40 | 하전입자 조사(CHARGED PARTICLE IRRADIATION) | 된 신청서를 포함한다)에 다음 각 호의 서류(전 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| 및 기록에 대한 자료를 제출하면 됨(‘15.7.1자 시행되는「의약품 제조 및 품질관리에 관한 규정」 [별표 13] | 경우에는 생물학적 동등성시험에 관한 시험 | 이용하지 아니하는 시험자료로서 식품의약품 | 1단계 | 도인에 대한 제조판매·수입 품목허가에 붙여 | 품목허가 또는 품목신고한 사항을 변경할 필요 |\n| 약품을 수입하거나 임상시험용 의약품 등 총 | 방법에 대한 기술적인 내용은 각조에 설정되어 있다.  | 2. ",
        "original_sentence": "<개정 |\n| 이러한 경우, GMP 적용 시점 이후 설비의 운전변수 및 중요변수에 대한 한계를 뒷받침하고 입증하는 | 량에 대한 협의를 거쳐 수입하려는 경우 | 료. "
      }
    },
    {
      "chunk_id": "chunk_190",
      "text": "다만, 식품의약품안전처장이 고시하는 품 | 미국약전 | USP, NF | 독일약전 | DAB | 약품\"이라 한다) | 는 지방청장은 다음 각 호의 어느 하나에 해당 |\n| - 약리학, 제제학, 임상성적자료 등 명확한 근거 바탕, 합리적, 타당해야 하며, 원료약품 | 등 제조판매ᆞ수입 품목 허가신청서(전자문서로 | 된 신청서를 포함한다)에 다음 각 호의 서류(전 |\n| 발 | 행 | 일 | 자료(예시 : 공정 밸리데이션, 제품품질평가 등), 교정, 세척, 예방적 유지관리, 작업절차, 작업원 훈련절차 | 목의 경우에는 비교용출시험자료 등 생체를 | ○ | × | × | × | ○ ○ ○ △ | × | △ △ ○ ○ ○ △ | × | × | × | ○ | × | × | × | × | × | × | × | × | × | × | × | ○ ○ | × | ○ ○ | 2015년 7 월 | 용이하게 하고자 하였다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 189,
        "window_size": 3,
        "char_count": 454,
        "word_count": 147,
        "page_number": 5,
        "window_text": "유럽약전 방사성의약품 번역 ··················································31\n\n**[표 시작]**\n\n| 심사항목 | 처리기한 | 각 항목 심사 불필요시 위 수수료에서 아래 해당금액 제외 | 민원인들에게 허가 전반적인 사항에 대해 알기 쉽게 안내하고자 마련하였으며 허가심사 | 1항에 따라 의약품등의 제조판매ᆞ수입 품목허 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 약품등의 제조업이나 위탁제조판매업에 대한 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 60 | 7 | 8 비고 | 가 | 나 | 가 | 나 |\n| 사용 중인 설비 또는 시스템에 관해서는 위 조건에 해당하는 적격성평가 자료를 반드시 제출할 필요는 없음.  | 등을 미리 식품의약품안전처장과 품목 및 수 | 자료 또는 비교임상시험 성적서에 관한 자 | 처장이 정하는 희귀의약품(이하 \"희귀의 | 1 | ③ 제1항에도 불구하고 식품의약품안전처장 또 | 등 제조판매·수입 품목 허가신청서(전자문서로 | 조시설·제조방법 등에 관한 양도·양수계약서 |\n| 2 | 안내서-0231-01 | - | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | (1) (2) (3) | 절차, 신청방법, 신청서 항목 작성 요령 및 기타 유용한 정보 등을 담아 품목허가 신청을 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 허가를 받거나 신고를 할 수 없다.  <개정 |\n| 이러한 경우, GMP 적용 시점 이후 설비의 운전변수 및 중요변수에 대한 한계를 뒷받침하고 입증하는 | 량에 대한 협의를 거쳐 수입하려는 경우 | 료.  다만, 식품의약품안전처장이 고시하는 품 | 미국약전 | USP, NF | 독일약전 | DAB | 약품\"이라 한다) | 는 지방청장은 다음 각 호의 어느 하나에 해당 |\n| - 약리학, 제제학, 임상성적자료 등 명확한 근거 바탕, 합리적, 타당해야 하며, 원료약품 | 등 제조판매ᆞ수입 품목 허가신청서(전자문서로 | 된 신청서를 포함한다)에 다음 각 호의 서류(전 |\n| 발 | 행 | 일 | 자료(예시 : 공정 밸리데이션, 제품품질평가 등), 교정, 세척, 예방적 유지관리, 작업절차, 작업원 훈련절차 | 목의 경우에는 비교용출시험자료 등 생체를 | ○ | × | × | × | ○ ○ ○ △ | × | △ △ ○ ○ ○ △ | × | × | × | ○ | × | × | × | × | × | × | × | × | × | × | × | ○ ○ | × | ○ ○ | 2015년 7 월 | 용이하게 하고자 하였다.  아울러 PET용 방사성의약품의 심사 평가 시 요구되는 일반적인 | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 하는 경우 그 검토 결과 이미 제조판매ᆞ수입 |\n| 일본약전 | JP | 프랑스약전 | FP | 40 | 하전입자 조사(CHARGED PARTICLE IRRADIATION) | 된 신청서를 포함한다)에 다음 각 호의 서류(전 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| 및 기록에 대한 자료를 제출하면 됨(‘15.7.1자 시행되는「의약품 제조 및 품질관리에 관한 규정」 [별표 13] | 경우에는 생물학적 동등성시험에 관한 시험 | 이용하지 아니하는 시험자료로서 식품의약품 | 1단계 | 도인에 대한 제조판매·수입 품목허가에 붙여 | 품목허가 또는 품목신고한 사항을 변경할 필요 |\n| 약품을 수입하거나 임상시험용 의약품 등 총 | 방법에 대한 기술적인 내용은 각조에 설정되어 있다.  | 2.  제76조에 따라 제조업 허가가 취소되거나 | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 을 참고한다. ",
        "original_sentence": "다만, 식품의약품안전처장이 고시하는 품 | 미국약전 | USP, NF | 독일약전 | DAB | 약품\"이라 한다) | 는 지방청장은 다음 각 호의 어느 하나에 해당 |\n| - 약리학, 제제학, 임상성적자료 등 명확한 근거 바탕, 합리적, 타당해야 하며, 원료약품 | 등 제조판매ᆞ수입 품목 허가신청서(전자문서로 | 된 신청서를 포함한다)에 다음 각 호의 서류(전 |\n| 발 | 행 | 일 | 자료(예시 : 공정 밸리데이션, 제품품질평가 등), 교정, 세척, 예방적 유지관리, 작업절차, 작업원 훈련절차 | 목의 경우에는 비교용출시험자료 등 생체를 | ○ | × | × | × | ○ ○ ○ △ | × | △ △ ○ ○ ○ △ | × | × | × | ○ | × | × | × | × | × | × | × | × | × | × | × | ○ ○ | × | ○ ○ | 2015년 7 월 | 용이하게 하고자 하였다. "
      }
    },
    {
      "chunk_id": "chunk_191",
      "text": "아울러 PET용 방사성의약품의 심사 평가 시 요구되는 일반적인 | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 하는 경우 그 검토 결과 이미 제조판매ᆞ수입 |\n| 일본약전 | JP | 프랑스약전 | FP | 40 | 하전입자 조사(CHARGED PARTICLE IRRADIATION) | 된 신청서를 포함한다)에 다음 각 호의 서류(전 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| 및 기록에 대한 자료를 제출하면 됨(‘15.7.1자 시행되는「의약품 제조 및 품질관리에 관한 규정」 [별표 13] | 경우에는 생물학적 동등성시험에 관한 시험 | 이용하지 아니하는 시험자료로서 식품의약품 | 1단계 | 도인에 대한 제조판매·수입 품목허가에 붙여 | 품목허가 또는 품목신고한 사항을 변경할 필요 |\n| 약품을 수입하거나 임상시험용 의약품 등 총 | 방법에 대한 기술적인 내용은 각조에 설정되어 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 190,
        "window_size": 3,
        "char_count": 454,
        "word_count": 112,
        "page_number": 3,
        "window_text": "| 등을 미리 식품의약품안전처장과 품목 및 수 | 자료 또는 비교임상시험 성적서에 관한 자 | 처장이 정하는 희귀의약품(이하 \"희귀의 | 1 | ③ 제1항에도 불구하고 식품의약품안전처장 또 | 등 제조판매·수입 품목 허가신청서(전자문서로 | 조시설·제조방법 등에 관한 양도·양수계약서 |\n| 2 | 안내서-0231-01 | - | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | (1) (2) (3) | 절차, 신청방법, 신청서 항목 작성 요령 및 기타 유용한 정보 등을 담아 품목허가 신청을 | 가를 받으려는 자는 별지 제4호서식의 의약품 | 허가를 받거나 신고를 할 수 없다.  <개정 |\n| 이러한 경우, GMP 적용 시점 이후 설비의 운전변수 및 중요변수에 대한 한계를 뒷받침하고 입증하는 | 량에 대한 협의를 거쳐 수입하려는 경우 | 료.  다만, 식품의약품안전처장이 고시하는 품 | 미국약전 | USP, NF | 독일약전 | DAB | 약품\"이라 한다) | 는 지방청장은 다음 각 호의 어느 하나에 해당 |\n| - 약리학, 제제학, 임상성적자료 등 명확한 근거 바탕, 합리적, 타당해야 하며, 원료약품 | 등 제조판매ᆞ수입 품목 허가신청서(전자문서로 | 된 신청서를 포함한다)에 다음 각 호의 서류(전 |\n| 발 | 행 | 일 | 자료(예시 : 공정 밸리데이션, 제품품질평가 등), 교정, 세척, 예방적 유지관리, 작업절차, 작업원 훈련절차 | 목의 경우에는 비교용출시험자료 등 생체를 | ○ | × | × | × | ○ ○ ○ △ | × | △ △ ○ ○ ○ △ | × | × | × | ○ | × | × | × | × | × | × | × | × | × | × | × | ○ ○ | × | ○ ○ | 2015년 7 월 | 용이하게 하고자 하였다.  아울러 PET용 방사성의약품의 심사 평가 시 요구되는 일반적인 | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 하는 경우 그 검토 결과 이미 제조판매ᆞ수입 |\n| 일본약전 | JP | 프랑스약전 | FP | 40 | 하전입자 조사(CHARGED PARTICLE IRRADIATION) | 된 신청서를 포함한다)에 다음 각 호의 서류(전 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| 및 기록에 대한 자료를 제출하면 됨(‘15.7.1자 시행되는「의약품 제조 및 품질관리에 관한 규정」 [별표 13] | 경우에는 생물학적 동등성시험에 관한 시험 | 이용하지 아니하는 시험자료로서 식품의약품 | 1단계 | 도인에 대한 제조판매·수입 품목허가에 붙여 | 품목허가 또는 품목신고한 사항을 변경할 필요 |\n| 약품을 수입하거나 임상시험용 의약품 등 총 | 방법에 대한 기술적인 내용은 각조에 설정되어 있다.  | 2.  제76조에 따라 제조업 허가가 취소되거나 | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 을 참고한다.  |\n| 발 | 행 | 인 | 4.5 기존에 사용 중인 시설, 시스템 및 설비의 적격성 평가 참조) | 영국약전 | BP | ⇨ | 손 여 원 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| - 재심사 기간 : 2013.7.2. ",
        "original_sentence": "아울러 PET용 방사성의약품의 심사 평가 시 요구되는 일반적인 | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 하는 경우 그 검토 결과 이미 제조판매ᆞ수입 |\n| 일본약전 | JP | 프랑스약전 | FP | 40 | 하전입자 조사(CHARGED PARTICLE IRRADIATION) | 된 신청서를 포함한다)에 다음 각 호의 서류(전 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| 및 기록에 대한 자료를 제출하면 됨(‘15.7.1자 시행되는「의약품 제조 및 품질관리에 관한 규정」 [별표 13] | 경우에는 생물학적 동등성시험에 관한 시험 | 이용하지 아니하는 시험자료로서 식품의약품 | 1단계 | 도인에 대한 제조판매·수입 품목허가에 붙여 | 품목허가 또는 품목신고한 사항을 변경할 필요 |\n| 약품을 수입하거나 임상시험용 의약품 등 총 | 방법에 대한 기술적인 내용은 각조에 설정되어 있다. "
      }
    },
    {
      "chunk_id": "chunk_192",
      "text": "| 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 191,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 3,
        "window_text": "<개정 |\n| 이러한 경우, GMP 적용 시점 이후 설비의 운전변수 및 중요변수에 대한 한계를 뒷받침하고 입증하는 | 량에 대한 협의를 거쳐 수입하려는 경우 | 료.  다만, 식품의약품안전처장이 고시하는 품 | 미국약전 | USP, NF | 독일약전 | DAB | 약품\"이라 한다) | 는 지방청장은 다음 각 호의 어느 하나에 해당 |\n| - 약리학, 제제학, 임상성적자료 등 명확한 근거 바탕, 합리적, 타당해야 하며, 원료약품 | 등 제조판매ᆞ수입 품목 허가신청서(전자문서로 | 된 신청서를 포함한다)에 다음 각 호의 서류(전 |\n| 발 | 행 | 일 | 자료(예시 : 공정 밸리데이션, 제품품질평가 등), 교정, 세척, 예방적 유지관리, 작업절차, 작업원 훈련절차 | 목의 경우에는 비교용출시험자료 등 생체를 | ○ | × | × | × | ○ ○ ○ △ | × | △ △ ○ ○ ○ △ | × | × | × | ○ | × | × | × | × | × | × | × | × | × | × | × | ○ ○ | × | ○ ○ | 2015년 7 월 | 용이하게 하고자 하였다.  아울러 PET용 방사성의약품의 심사 평가 시 요구되는 일반적인 | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 하는 경우 그 검토 결과 이미 제조판매ᆞ수입 |\n| 일본약전 | JP | 프랑스약전 | FP | 40 | 하전입자 조사(CHARGED PARTICLE IRRADIATION) | 된 신청서를 포함한다)에 다음 각 호의 서류(전 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| 및 기록에 대한 자료를 제출하면 됨(‘15.7.1자 시행되는「의약품 제조 및 품질관리에 관한 규정」 [별표 13] | 경우에는 생물학적 동등성시험에 관한 시험 | 이용하지 아니하는 시험자료로서 식품의약품 | 1단계 | 도인에 대한 제조판매·수입 품목허가에 붙여 | 품목허가 또는 품목신고한 사항을 변경할 필요 |\n| 약품을 수입하거나 임상시험용 의약품 등 총 | 방법에 대한 기술적인 내용은 각조에 설정되어 있다.  | 2.  제76조에 따라 제조업 허가가 취소되거나 | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 을 참고한다.  |\n| 발 | 행 | 인 | 4.5 기존에 사용 중인 시설, 시스템 및 설비의 적격성 평가 참조) | 영국약전 | BP | ⇨ | 손 여 원 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| - 재심사 기간 : 2013.7.2.  ~ 2019. ",
        "original_sentence": "| 2. "
      }
    },
    {
      "chunk_id": "chunk_193",
      "text": "제76조에 따라 제조업 허가가 취소되거나 | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 을 참고한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 192,
        "window_size": 3,
        "char_count": 61,
        "word_count": 15,
        "page_number": 3,
        "window_text": "다만, 식품의약품안전처장이 고시하는 품 | 미국약전 | USP, NF | 독일약전 | DAB | 약품\"이라 한다) | 는 지방청장은 다음 각 호의 어느 하나에 해당 |\n| - 약리학, 제제학, 임상성적자료 등 명확한 근거 바탕, 합리적, 타당해야 하며, 원료약품 | 등 제조판매ᆞ수입 품목 허가신청서(전자문서로 | 된 신청서를 포함한다)에 다음 각 호의 서류(전 |\n| 발 | 행 | 일 | 자료(예시 : 공정 밸리데이션, 제품품질평가 등), 교정, 세척, 예방적 유지관리, 작업절차, 작업원 훈련절차 | 목의 경우에는 비교용출시험자료 등 생체를 | ○ | × | × | × | ○ ○ ○ △ | × | △ △ ○ ○ ○ △ | × | × | × | ○ | × | × | × | × | × | × | × | × | × | × | × | ○ ○ | × | ○ ○ | 2015년 7 월 | 용이하게 하고자 하였다.  아울러 PET용 방사성의약품의 심사 평가 시 요구되는 일반적인 | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 하는 경우 그 검토 결과 이미 제조판매ᆞ수입 |\n| 일본약전 | JP | 프랑스약전 | FP | 40 | 하전입자 조사(CHARGED PARTICLE IRRADIATION) | 된 신청서를 포함한다)에 다음 각 호의 서류(전 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| 및 기록에 대한 자료를 제출하면 됨(‘15.7.1자 시행되는「의약품 제조 및 품질관리에 관한 규정」 [별표 13] | 경우에는 생물학적 동등성시험에 관한 시험 | 이용하지 아니하는 시험자료로서 식품의약품 | 1단계 | 도인에 대한 제조판매·수입 품목허가에 붙여 | 품목허가 또는 품목신고한 사항을 변경할 필요 |\n| 약품을 수입하거나 임상시험용 의약품 등 총 | 방법에 대한 기술적인 내용은 각조에 설정되어 있다.  | 2.  제76조에 따라 제조업 허가가 취소되거나 | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 을 참고한다.  |\n| 발 | 행 | 인 | 4.5 기존에 사용 중인 시설, 시스템 및 설비의 적격성 평가 참조) | 영국약전 | BP | ⇨ | 손 여 원 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| - 재심사 기간 : 2013.7.2.  ~ 2019.  7.1.",
        "original_sentence": "제76조에 따라 제조업 허가가 취소되거나 | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 을 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_194",
      "text": "|\n| 발 | 행 | 인 | 4.5 기존에 사용 중인 시설, 시스템 및 설비의 적격성 평가 참조) | 영국약전 | BP | ⇨ | 손 여 원 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| - 재심사 기간 : 2013.7.2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 193,
        "window_size": 3,
        "char_count": 131,
        "word_count": 41,
        "page_number": 3,
        "window_text": "아울러 PET용 방사성의약품의 심사 평가 시 요구되는 일반적인 | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 하는 경우 그 검토 결과 이미 제조판매ᆞ수입 |\n| 일본약전 | JP | 프랑스약전 | FP | 40 | 하전입자 조사(CHARGED PARTICLE IRRADIATION) | 된 신청서를 포함한다)에 다음 각 호의 서류(전 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| 및 기록에 대한 자료를 제출하면 됨(‘15.7.1자 시행되는「의약품 제조 및 품질관리에 관한 규정」 [별표 13] | 경우에는 생물학적 동등성시험에 관한 시험 | 이용하지 아니하는 시험자료로서 식품의약품 | 1단계 | 도인에 대한 제조판매·수입 품목허가에 붙여 | 품목허가 또는 품목신고한 사항을 변경할 필요 |\n| 약품을 수입하거나 임상시험용 의약품 등 총 | 방법에 대한 기술적인 내용은 각조에 설정되어 있다.  | 2.  제76조에 따라 제조업 허가가 취소되거나 | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 을 참고한다.  |\n| 발 | 행 | 인 | 4.5 기존에 사용 중인 시설, 시스템 및 설비의 적격성 평가 참조) | 영국약전 | BP | ⇨ | 손 여 원 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| - 재심사 기간 : 2013.7.2.  ~ 2019.  7.1. (6년) | 리령으로 정하는 의약품등을 수입하려는 경 | 자료 또는 비교임상시험 성적서에 관한 자 | 안전처장이 고시하는 자료를 제출한다. ",
        "original_sentence": "|\n| 발 | 행 | 인 | 4.5 기존에 사용 중인 시설, 시스템 및 설비의 적격성 평가 참조) | 영국약전 | BP | ⇨ | 손 여 원 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| - 재심사 기간 : 2013.7.2. "
      }
    },
    {
      "chunk_id": "chunk_195",
      "text": "~ 2019. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 194,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 3,
        "window_text": "| 2.  제76조에 따라 제조업 허가가 취소되거나 | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 을 참고한다.  |\n| 발 | 행 | 인 | 4.5 기존에 사용 중인 시설, 시스템 및 설비의 적격성 평가 참조) | 영국약전 | BP | ⇨ | 손 여 원 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| - 재심사 기간 : 2013.7.2.  ~ 2019.  7.1. (6년) | 리령으로 정하는 의약품등을 수입하려는 경 | 자료 또는 비교임상시험 성적서에 관한 자 | 안전처장이 고시하는 자료를 제출한다.  | 제3호에 따른 품목 중 제48조제5호에 따른 | 의약품의 품목허가․신고․심사 규정｣ | 조판매·수입 품목허가 및 제1호 각 목 외의 | 가 있어 법 제76조제1항 각 호 외의 부분 단 |\n| 20 | 다운로드 및 설치 |  | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 위탁제조판매업소 또는 제조소(製造所)가 폐 |\n| 우 | 료. ",
        "original_sentence": "~ 2019. "
      }
    },
    {
      "chunk_id": "chunk_196",
      "text": "7.1.",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 195,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 3,
        "window_text": "제76조에 따라 제조업 허가가 취소되거나 | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 을 참고한다.  |\n| 발 | 행 | 인 | 4.5 기존에 사용 중인 시설, 시스템 및 설비의 적격성 평가 참조) | 영국약전 | BP | ⇨ | 손 여 원 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| - 재심사 기간 : 2013.7.2.  ~ 2019.  7.1. (6년) | 리령으로 정하는 의약품등을 수입하려는 경 | 자료 또는 비교임상시험 성적서에 관한 자 | 안전처장이 고시하는 자료를 제출한다.  | 제3호에 따른 품목 중 제48조제5호에 따른 | 의약품의 품목허가․신고․심사 규정｣ | 조판매·수입 품목허가 및 제1호 각 목 외의 | 가 있어 법 제76조제1항 각 호 외의 부분 단 |\n| 20 | 다운로드 및 설치 |  | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 위탁제조판매업소 또는 제조소(製造所)가 폐 |\n| 우 | 료.  다만, 식품의약품안전처장이 고시하는 품 | 별표 1의 의약품 제조 및 품질관리기준에 적 |   |  | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | 서에 따라 일정기한까지 품목의 변경을 명령한 | 나. ",
        "original_sentence": "7.1."
      }
    },
    {
      "chunk_id": "chunk_197",
      "text": "(6년) | 리령으로 정하는 의약품등을 수입하려는 경 | 자료 또는 비교임상시험 성적서에 관한 자 | 안전처장이 고시하는 자료를 제출한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 196,
        "window_size": 3,
        "char_count": 78,
        "word_count": 19,
        "page_number": 3,
        "window_text": "|\n| 발 | 행 | 인 | 4.5 기존에 사용 중인 시설, 시스템 및 설비의 적격성 평가 참조) | 영국약전 | BP | ⇨ | 손 여 원 | 자문서를 포함한다)를 첨부하여 식품의약품안전 |\n| - 재심사 기간 : 2013.7.2.  ~ 2019.  7.1. (6년) | 리령으로 정하는 의약품등을 수입하려는 경 | 자료 또는 비교임상시험 성적서에 관한 자 | 안전처장이 고시하는 자료를 제출한다.  | 제3호에 따른 품목 중 제48조제5호에 따른 | 의약품의 품목허가․신고․심사 규정｣ | 조판매·수입 품목허가 및 제1호 각 목 외의 | 가 있어 법 제76조제1항 각 호 외의 부분 단 |\n| 20 | 다운로드 및 설치 |  | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 위탁제조판매업소 또는 제조소(製造所)가 폐 |\n| 우 | 료.  다만, 식품의약품안전처장이 고시하는 품 | 별표 1의 의약품 제조 및 품질관리기준에 적 |   |  | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | 서에 따라 일정기한까지 품목의 변경을 명령한 | 나.  일반약리시험자료 또는 안전성약리시험자료 |\n| - 재심사 신청기간 : 2019.7.2. ",
        "original_sentence": "(6년) | 리령으로 정하는 의약품등을 수입하려는 경 | 자료 또는 비교임상시험 성적서에 관한 자 | 안전처장이 고시하는 자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_198",
      "text": "| 제3호에 따른 품목 중 제48조제5호에 따른 | 의약품의 품목허가․신고․심사 규정｣ | 조판매·수입 품목허가 및 제1호 각 목 외의 | 가 있어 법 제76조제1항 각 호 외의 부분 단 |\n| 20 | 다운로드 및 설치 |  | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 위탁제조판매업소 또는 제조소(製造所)가 폐 |\n| 우 | 료. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 197,
        "window_size": 3,
        "char_count": 193,
        "word_count": 55,
        "page_number": 3,
        "window_text": "~ 2019.  7.1. (6년) | 리령으로 정하는 의약품등을 수입하려는 경 | 자료 또는 비교임상시험 성적서에 관한 자 | 안전처장이 고시하는 자료를 제출한다.  | 제3호에 따른 품목 중 제48조제5호에 따른 | 의약품의 품목허가․신고․심사 규정｣ | 조판매·수입 품목허가 및 제1호 각 목 외의 | 가 있어 법 제76조제1항 각 호 외의 부분 단 |\n| 20 | 다운로드 및 설치 |  | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 위탁제조판매업소 또는 제조소(製造所)가 폐 |\n| 우 | 료.  다만, 식품의약품안전처장이 고시하는 품 | 별표 1의 의약품 제조 및 품질관리기준에 적 |   |  | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | 서에 따라 일정기한까지 품목의 변경을 명령한 | 나.  일반약리시험자료 또는 안전성약리시험자료 |\n| - 재심사 신청기간 : 2019.7.2.  ~ 2019.10.1. ",
        "original_sentence": "| 제3호에 따른 품목 중 제48조제5호에 따른 | 의약품의 품목허가․신고․심사 규정｣ | 조판매·수입 품목허가 및 제1호 각 목 외의 | 가 있어 법 제76조제1항 각 호 외의 부분 단 |\n| 20 | 다운로드 및 설치 |  | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 위탁제조판매업소 또는 제조소(製造所)가 폐 |\n| 우 | 료. "
      }
    },
    {
      "chunk_id": "chunk_199",
      "text": "다만, 식품의약품안전처장이 고시하는 품 | 별표 1의 의약품 제조 및 품질관리기준에 적 |   |  | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | 서에 따라 일정기한까지 품목의 변경을 명령한 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 198,
        "window_size": 3,
        "char_count": 122,
        "word_count": 31,
        "page_number": 3,
        "window_text": "7.1. (6년) | 리령으로 정하는 의약품등을 수입하려는 경 | 자료 또는 비교임상시험 성적서에 관한 자 | 안전처장이 고시하는 자료를 제출한다.  | 제3호에 따른 품목 중 제48조제5호에 따른 | 의약품의 품목허가․신고․심사 규정｣ | 조판매·수입 품목허가 및 제1호 각 목 외의 | 가 있어 법 제76조제1항 각 호 외의 부분 단 |\n| 20 | 다운로드 및 설치 |  | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 위탁제조판매업소 또는 제조소(製造所)가 폐 |\n| 우 | 료.  다만, 식품의약품안전처장이 고시하는 품 | 별표 1의 의약품 제조 및 품질관리기준에 적 |   |  | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | 서에 따라 일정기한까지 품목의 변경을 명령한 | 나.  일반약리시험자료 또는 안전성약리시험자료 |\n| - 재심사 신청기간 : 2019.7.2.  ~ 2019.10.1.  | 편 집 위 원 장 | 「의약품 제조 및 품질관리에 관한 규정」제4조 및 [별표 13] 적격성평가 및 밸리데이션, ‘방사성의약품 제조 |    | 이 선 희 | - 사용 시에 방사성 물질을 표지하는 경우 “용법” 항에 방사성 물질 표지하는 조제방법 | 조판매ᆞ수입 품목허가 및 제1호 각 목 외의 | 부분 단서에 따라 자료를 제출하지 않아도 되는 |\n| 목의 경우에는 비교용출시험자료 등 생체를 | 합하다는 판정을 받지 못한 품목 및 이 조 | 8단계 | 목허가를 받은 전문의약품으로서 신약에 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 경우에는 식품의약품안전처장 또는 지방청장이 |\n| 및 품질관리 기준 가이던스’를 참조 | 부분 단서에 따라 자료를 제출하지 않아도 되는 | 의약외품 제조판매·수입 품목허가의 경우에는 |\n| 위탁제조판매업자로부터 수탁을 받아 제조하는 제조업자, 수입자(제조원을 포 | 자료번호 | ⇦ | 한의식, 김소희, 윤경은, 엄정윤, 박소라, 김동환, 전설희, | (electron capture) 또는 양전자방출(positron emission) |\n| 편 | 집 | 위 | 원 | 이용하지 아니하는 시험자료로서 식품의약품 | 제1항제5호에 따른 품목만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 0 | 90일(원료의 | 1 | 2 | ⑨ 제1항부터 제4항까지의 경우에 허가받은 사 | 지방청장을 말한다)에게 제출하여야 한다. ",
        "original_sentence": "다만, 식품의약품안전처장이 고시하는 품 | 별표 1의 의약품 제조 및 품질관리기준에 적 |   |  | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | 서에 따라 일정기한까지 품목의 변경을 명령한 | 나. "
      }
    },
    {
      "chunk_id": "chunk_200",
      "text": "일반약리시험자료 또는 안전성약리시험자료 |\n| - 재심사 신청기간 : 2019.7.2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 199,
        "window_size": 3,
        "char_count": 49,
        "word_count": 10,
        "page_number": 3,
        "window_text": "(6년) | 리령으로 정하는 의약품등을 수입하려는 경 | 자료 또는 비교임상시험 성적서에 관한 자 | 안전처장이 고시하는 자료를 제출한다.  | 제3호에 따른 품목 중 제48조제5호에 따른 | 의약품의 품목허가․신고․심사 규정｣ | 조판매·수입 품목허가 및 제1호 각 목 외의 | 가 있어 법 제76조제1항 각 호 외의 부분 단 |\n| 20 | 다운로드 및 설치 |  | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 위탁제조판매업소 또는 제조소(製造所)가 폐 |\n| 우 | 료.  다만, 식품의약품안전처장이 고시하는 품 | 별표 1의 의약품 제조 및 품질관리기준에 적 |   |  | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | 서에 따라 일정기한까지 품목의 변경을 명령한 | 나.  일반약리시험자료 또는 안전성약리시험자료 |\n| - 재심사 신청기간 : 2019.7.2.  ~ 2019.10.1.  | 편 집 위 원 장 | 「의약품 제조 및 품질관리에 관한 규정」제4조 및 [별표 13] 적격성평가 및 밸리데이션, ‘방사성의약품 제조 |    | 이 선 희 | - 사용 시에 방사성 물질을 표지하는 경우 “용법” 항에 방사성 물질 표지하는 조제방법 | 조판매ᆞ수입 품목허가 및 제1호 각 목 외의 | 부분 단서에 따라 자료를 제출하지 않아도 되는 |\n| 목의 경우에는 비교용출시험자료 등 생체를 | 합하다는 판정을 받지 못한 품목 및 이 조 | 8단계 | 목허가를 받은 전문의약품으로서 신약에 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 경우에는 식품의약품안전처장 또는 지방청장이 |\n| 및 품질관리 기준 가이던스’를 참조 | 부분 단서에 따라 자료를 제출하지 않아도 되는 | 의약외품 제조판매·수입 품목허가의 경우에는 |\n| 위탁제조판매업자로부터 수탁을 받아 제조하는 제조업자, 수입자(제조원을 포 | 자료번호 | ⇦ | 한의식, 김소희, 윤경은, 엄정윤, 박소라, 김동환, 전설희, | (electron capture) 또는 양전자방출(positron emission) |\n| 편 | 집 | 위 | 원 | 이용하지 아니하는 시험자료로서 식품의약품 | 제1항제5호에 따른 품목만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 0 | 90일(원료의 | 1 | 2 | ⑨ 제1항부터 제4항까지의 경우에 허가받은 사 | 지방청장을 말한다)에게 제출하여야 한다.  <개 | 품등의 제조판매·수입 품목허가를 위하여 필 | 변경허가를 하거나 변경신고를 수리한 것으로 |\n| GMP | 약품 60일) | 207,000원 | 230,000원 | 의약외품 제조판매ᆞ수입 품목허가의 경우에는 |\n| 안전처장이 고시하는 자료를 제출한다. ",
        "original_sentence": "일반약리시험자료 또는 안전성약리시험자료 |\n| - 재심사 신청기간 : 2019.7.2. "
      }
    },
    {
      "chunk_id": "chunk_201",
      "text": "~ 2019.10.1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 200,
        "window_size": 3,
        "char_count": 13,
        "word_count": 2,
        "page_number": 3,
        "window_text": "| 제3호에 따른 품목 중 제48조제5호에 따른 | 의약품의 품목허가․신고․심사 규정｣ | 조판매·수입 품목허가 및 제1호 각 목 외의 | 가 있어 법 제76조제1항 각 호 외의 부분 단 |\n| 20 | 다운로드 및 설치 |  | 처장(의약품 동등성의 입증이 필요한 의약품 제 | 위탁제조판매업소 또는 제조소(製造所)가 폐 |\n| 우 | 료.  다만, 식품의약품안전처장이 고시하는 품 | 별표 1의 의약품 제조 및 품질관리기준에 적 |   |  | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | 서에 따라 일정기한까지 품목의 변경을 명령한 | 나.  일반약리시험자료 또는 안전성약리시험자료 |\n| - 재심사 신청기간 : 2019.7.2.  ~ 2019.10.1.  | 편 집 위 원 장 | 「의약품 제조 및 품질관리에 관한 규정」제4조 및 [별표 13] 적격성평가 및 밸리데이션, ‘방사성의약품 제조 |    | 이 선 희 | - 사용 시에 방사성 물질을 표지하는 경우 “용법” 항에 방사성 물질 표지하는 조제방법 | 조판매ᆞ수입 품목허가 및 제1호 각 목 외의 | 부분 단서에 따라 자료를 제출하지 않아도 되는 |\n| 목의 경우에는 비교용출시험자료 등 생체를 | 합하다는 판정을 받지 못한 품목 및 이 조 | 8단계 | 목허가를 받은 전문의약품으로서 신약에 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 경우에는 식품의약품안전처장 또는 지방청장이 |\n| 및 품질관리 기준 가이던스’를 참조 | 부분 단서에 따라 자료를 제출하지 않아도 되는 | 의약외품 제조판매·수입 품목허가의 경우에는 |\n| 위탁제조판매업자로부터 수탁을 받아 제조하는 제조업자, 수입자(제조원을 포 | 자료번호 | ⇦ | 한의식, 김소희, 윤경은, 엄정윤, 박소라, 김동환, 전설희, | (electron capture) 또는 양전자방출(positron emission) |\n| 편 | 집 | 위 | 원 | 이용하지 아니하는 시험자료로서 식품의약품 | 제1항제5호에 따른 품목만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 0 | 90일(원료의 | 1 | 2 | ⑨ 제1항부터 제4항까지의 경우에 허가받은 사 | 지방청장을 말한다)에게 제출하여야 한다.  <개 | 품등의 제조판매·수입 품목허가를 위하여 필 | 변경허가를 하거나 변경신고를 수리한 것으로 |\n| GMP | 약품 60일) | 207,000원 | 230,000원 | 의약외품 제조판매ᆞ수입 품목허가의 경우에는 |\n| 안전처장이 고시하는 자료를 제출한다.  | 함한다) | 로의 품목을 포함한다) | 1968 1996 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 | 국내 방사성의약품의 연도별 품목허가 수는 표 1과 그림 1에서 나타나듯이 특정 년도를 | 요하다고 인정하는 경우에는 식품의약품안전평 |\n| 김미지 | 지방청장을 말한다)에게 제출하여야 한다. ",
        "original_sentence": "~ 2019.10.1. "
      }
    },
    {
      "chunk_id": "chunk_202",
      "text": "| 편 집 위 원 장 | 「의약품 제조 및 품질관리에 관한 규정」제4조 및 [별표 13] 적격성평가 및 밸리데이션, ‘방사성의약품 제조 |    | 이 선 희 | - 사용 시에 방사성 물질을 표지하는 경우 “용법” 항에 방사성 물질 표지하는 조제방법 | 조판매ᆞ수입 품목허가 및 제1호 각 목 외의 | 부분 단서에 따라 자료를 제출하지 않아도 되는 |\n| 목의 경우에는 비교용출시험자료 등 생체를 | 합하다는 판정을 받지 못한 품목 및 이 조 | 8단계 | 목허가를 받은 전문의약품으로서 신약에 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 경우에는 식품의약품안전처장 또는 지방청장이 |\n| 및 품질관리 기준 가이던스’를 참조 | 부분 단서에 따라 자료를 제출하지 않아도 되는 | 의약외품 제조판매·수입 품목허가의 경우에는 |\n| 위탁제조판매업자로부터 수탁을 받아 제조하는 제조업자, 수입자(제조원을 포 | 자료번호 | ⇦ | 한의식, 김소희, 윤경은, 엄정윤, 박소라, 김동환, 전설희, | (electron capture) 또는 양전자방출(positron emission) |\n| 편 | 집 | 위 | 원 | 이용하지 아니하는 시험자료로서 식품의약품 | 제1항제5호에 따른 품목만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 0 | 90일(원료의 | 1 | 2 | ⑨ 제1항부터 제4항까지의 경우에 허가받은 사 | 지방청장을 말한다)에게 제출하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 201,
        "window_size": 3,
        "char_count": 724,
        "word_count": 185,
        "page_number": 3,
        "window_text": "다만, 식품의약품안전처장이 고시하는 품 | 별표 1의 의약품 제조 및 품질관리기준에 적 |   |  | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | 서에 따라 일정기한까지 품목의 변경을 명령한 | 나.  일반약리시험자료 또는 안전성약리시험자료 |\n| - 재심사 신청기간 : 2019.7.2.  ~ 2019.10.1.  | 편 집 위 원 장 | 「의약품 제조 및 품질관리에 관한 규정」제4조 및 [별표 13] 적격성평가 및 밸리데이션, ‘방사성의약품 제조 |    | 이 선 희 | - 사용 시에 방사성 물질을 표지하는 경우 “용법” 항에 방사성 물질 표지하는 조제방법 | 조판매ᆞ수입 품목허가 및 제1호 각 목 외의 | 부분 단서에 따라 자료를 제출하지 않아도 되는 |\n| 목의 경우에는 비교용출시험자료 등 생체를 | 합하다는 판정을 받지 못한 품목 및 이 조 | 8단계 | 목허가를 받은 전문의약품으로서 신약에 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 경우에는 식품의약품안전처장 또는 지방청장이 |\n| 및 품질관리 기준 가이던스’를 참조 | 부분 단서에 따라 자료를 제출하지 않아도 되는 | 의약외품 제조판매·수입 품목허가의 경우에는 |\n| 위탁제조판매업자로부터 수탁을 받아 제조하는 제조업자, 수입자(제조원을 포 | 자료번호 | ⇦ | 한의식, 김소희, 윤경은, 엄정윤, 박소라, 김동환, 전설희, | (electron capture) 또는 양전자방출(positron emission) |\n| 편 | 집 | 위 | 원 | 이용하지 아니하는 시험자료로서 식품의약품 | 제1항제5호에 따른 품목만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 0 | 90일(원료의 | 1 | 2 | ⑨ 제1항부터 제4항까지의 경우에 허가받은 사 | 지방청장을 말한다)에게 제출하여야 한다.  <개 | 품등의 제조판매·수입 품목허가를 위하여 필 | 변경허가를 하거나 변경신고를 수리한 것으로 |\n| GMP | 약품 60일) | 207,000원 | 230,000원 | 의약외품 제조판매ᆞ수입 품목허가의 경우에는 |\n| 안전처장이 고시하는 자료를 제출한다.  | 함한다) | 로의 품목을 포함한다) | 1968 1996 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 | 국내 방사성의약품의 연도별 품목허가 수는 표 1과 그림 1에서 나타나듯이 특정 년도를 | 요하다고 인정하는 경우에는 식품의약품안전평 |\n| 김미지 | 지방청장을 말한다)에게 제출하여야 한다.  <개 | 항 또는 신고한 사항 중 총리령으로 정하는 사 |\n| (법 제27조제2항제1호에 따라 의약품 동등 | × | ○ | × | × | × | △ | ○ | △ | △ | △ | △ | ○ | △ | 1. ",
        "original_sentence": "| 편 집 위 원 장 | 「의약품 제조 및 품질관리에 관한 규정」제4조 및 [별표 13] 적격성평가 및 밸리데이션, ‘방사성의약품 제조 |    | 이 선 희 | - 사용 시에 방사성 물질을 표지하는 경우 “용법” 항에 방사성 물질 표지하는 조제방법 | 조판매ᆞ수입 품목허가 및 제1호 각 목 외의 | 부분 단서에 따라 자료를 제출하지 않아도 되는 |\n| 목의 경우에는 비교용출시험자료 등 생체를 | 합하다는 판정을 받지 못한 품목 및 이 조 | 8단계 | 목허가를 받은 전문의약품으로서 신약에 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 경우에는 식품의약품안전처장 또는 지방청장이 |\n| 및 품질관리 기준 가이던스’를 참조 | 부분 단서에 따라 자료를 제출하지 않아도 되는 | 의약외품 제조판매·수입 품목허가의 경우에는 |\n| 위탁제조판매업자로부터 수탁을 받아 제조하는 제조업자, 수입자(제조원을 포 | 자료번호 | ⇦ | 한의식, 김소희, 윤경은, 엄정윤, 박소라, 김동환, 전설희, | (electron capture) 또는 양전자방출(positron emission) |\n| 편 | 집 | 위 | 원 | 이용하지 아니하는 시험자료로서 식품의약품 | 제1항제5호에 따른 품목만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 0 | 90일(원료의 | 1 | 2 | ⑨ 제1항부터 제4항까지의 경우에 허가받은 사 | 지방청장을 말한다)에게 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_203",
      "text": "<개 | 품등의 제조판매·수입 품목허가를 위하여 필 | 변경허가를 하거나 변경신고를 수리한 것으로 |\n| GMP | 약품 60일) | 207,000원 | 230,000원 | 의약외품 제조판매ᆞ수입 품목허가의 경우에는 |\n| 안전처장이 고시하는 자료를 제출한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 202,
        "window_size": 3,
        "char_count": 146,
        "word_count": 34,
        "page_number": 3,
        "window_text": "일반약리시험자료 또는 안전성약리시험자료 |\n| - 재심사 신청기간 : 2019.7.2.  ~ 2019.10.1.  | 편 집 위 원 장 | 「의약품 제조 및 품질관리에 관한 규정」제4조 및 [별표 13] 적격성평가 및 밸리데이션, ‘방사성의약품 제조 |    | 이 선 희 | - 사용 시에 방사성 물질을 표지하는 경우 “용법” 항에 방사성 물질 표지하는 조제방법 | 조판매ᆞ수입 품목허가 및 제1호 각 목 외의 | 부분 단서에 따라 자료를 제출하지 않아도 되는 |\n| 목의 경우에는 비교용출시험자료 등 생체를 | 합하다는 판정을 받지 못한 품목 및 이 조 | 8단계 | 목허가를 받은 전문의약품으로서 신약에 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 경우에는 식품의약품안전처장 또는 지방청장이 |\n| 및 품질관리 기준 가이던스’를 참조 | 부분 단서에 따라 자료를 제출하지 않아도 되는 | 의약외품 제조판매·수입 품목허가의 경우에는 |\n| 위탁제조판매업자로부터 수탁을 받아 제조하는 제조업자, 수입자(제조원을 포 | 자료번호 | ⇦ | 한의식, 김소희, 윤경은, 엄정윤, 박소라, 김동환, 전설희, | (electron capture) 또는 양전자방출(positron emission) |\n| 편 | 집 | 위 | 원 | 이용하지 아니하는 시험자료로서 식품의약품 | 제1항제5호에 따른 품목만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 0 | 90일(원료의 | 1 | 2 | ⑨ 제1항부터 제4항까지의 경우에 허가받은 사 | 지방청장을 말한다)에게 제출하여야 한다.  <개 | 품등의 제조판매·수입 품목허가를 위하여 필 | 변경허가를 하거나 변경신고를 수리한 것으로 |\n| GMP | 약품 60일) | 207,000원 | 230,000원 | 의약외품 제조판매ᆞ수입 품목허가의 경우에는 |\n| 안전처장이 고시하는 자료를 제출한다.  | 함한다) | 로의 품목을 포함한다) | 1968 1996 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 | 국내 방사성의약품의 연도별 품목허가 수는 표 1과 그림 1에서 나타나듯이 특정 년도를 | 요하다고 인정하는 경우에는 식품의약품안전평 |\n| 김미지 | 지방청장을 말한다)에게 제출하여야 한다.  <개 | 항 또는 신고한 사항 중 총리령으로 정하는 사 |\n| (법 제27조제2항제1호에 따라 의약품 동등 | × | ○ | × | × | × | △ | ○ | △ | △ | △ | △ | ○ | △ | 1.  법 제31조의5(법 제42조제4항에 따라 준용 | 가원의 의견을 듣거나 법 제18조제1항에 따른 |\n| 1. ",
        "original_sentence": "<개 | 품등의 제조판매·수입 품목허가를 위하여 필 | 변경허가를 하거나 변경신고를 수리한 것으로 |\n| GMP | 약품 60일) | 207,000원 | 230,000원 | 의약외품 제조판매ᆞ수입 품목허가의 경우에는 |\n| 안전처장이 고시하는 자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_204",
      "text": "| 함한다) | 로의 품목을 포함한다) | 1968 1996 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 | 국내 방사성의약품의 연도별 품목허가 수는 표 1과 그림 1에서 나타나듯이 특정 년도를 | 요하다고 인정하는 경우에는 식품의약품안전평 |\n| 김미지 | 지방청장을 말한다)에게 제출하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 203,
        "window_size": 3,
        "char_count": 228,
        "word_count": 52,
        "page_number": 3,
        "window_text": "~ 2019.10.1.  | 편 집 위 원 장 | 「의약품 제조 및 품질관리에 관한 규정」제4조 및 [별표 13] 적격성평가 및 밸리데이션, ‘방사성의약품 제조 |    | 이 선 희 | - 사용 시에 방사성 물질을 표지하는 경우 “용법” 항에 방사성 물질 표지하는 조제방법 | 조판매ᆞ수입 품목허가 및 제1호 각 목 외의 | 부분 단서에 따라 자료를 제출하지 않아도 되는 |\n| 목의 경우에는 비교용출시험자료 등 생체를 | 합하다는 판정을 받지 못한 품목 및 이 조 | 8단계 | 목허가를 받은 전문의약품으로서 신약에 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 경우에는 식품의약품안전처장 또는 지방청장이 |\n| 및 품질관리 기준 가이던스’를 참조 | 부분 단서에 따라 자료를 제출하지 않아도 되는 | 의약외품 제조판매·수입 품목허가의 경우에는 |\n| 위탁제조판매업자로부터 수탁을 받아 제조하는 제조업자, 수입자(제조원을 포 | 자료번호 | ⇦ | 한의식, 김소희, 윤경은, 엄정윤, 박소라, 김동환, 전설희, | (electron capture) 또는 양전자방출(positron emission) |\n| 편 | 집 | 위 | 원 | 이용하지 아니하는 시험자료로서 식품의약품 | 제1항제5호에 따른 품목만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 0 | 90일(원료의 | 1 | 2 | ⑨ 제1항부터 제4항까지의 경우에 허가받은 사 | 지방청장을 말한다)에게 제출하여야 한다.  <개 | 품등의 제조판매·수입 품목허가를 위하여 필 | 변경허가를 하거나 변경신고를 수리한 것으로 |\n| GMP | 약품 60일) | 207,000원 | 230,000원 | 의약외품 제조판매ᆞ수입 품목허가의 경우에는 |\n| 안전처장이 고시하는 자료를 제출한다.  | 함한다) | 로의 품목을 포함한다) | 1968 1996 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 | 국내 방사성의약품의 연도별 품목허가 수는 표 1과 그림 1에서 나타나듯이 특정 년도를 | 요하다고 인정하는 경우에는 식품의약품안전평 |\n| 김미지 | 지방청장을 말한다)에게 제출하여야 한다.  <개 | 항 또는 신고한 사항 중 총리령으로 정하는 사 |\n| (법 제27조제2항제1호에 따라 의약품 동등 | × | ○ | × | × | × | △ | ○ | △ | △ | △ | △ | ○ | △ | 1.  법 제31조의5(법 제42조제4항에 따라 준용 | 가원의 의견을 듣거나 법 제18조제1항에 따른 |\n| 1.  제9조에 따른 안전성·유효성에 관한 자료. ",
        "original_sentence": "| 함한다) | 로의 품목을 포함한다) | 1968 1996 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 | 국내 방사성의약품의 연도별 품목허가 수는 표 1과 그림 1에서 나타나듯이 특정 년도를 | 요하다고 인정하는 경우에는 식품의약품안전평 |\n| 김미지 | 지방청장을 말한다)에게 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_205",
      "text": "<개 | 항 또는 신고한 사항 중 총리령으로 정하는 사 |\n| (법 제27조제2항제1호에 따라 의약품 동등 | × | ○ | × | × | × | △ | ○ | △ | △ | △ | △ | ○ | △ | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 204,
        "window_size": 3,
        "char_count": 117,
        "word_count": 45,
        "page_number": 1,
        "window_text": "| 편 집 위 원 장 | 「의약품 제조 및 품질관리에 관한 규정」제4조 및 [별표 13] 적격성평가 및 밸리데이션, ‘방사성의약품 제조 |    | 이 선 희 | - 사용 시에 방사성 물질을 표지하는 경우 “용법” 항에 방사성 물질 표지하는 조제방법 | 조판매ᆞ수입 품목허가 및 제1호 각 목 외의 | 부분 단서에 따라 자료를 제출하지 않아도 되는 |\n| 목의 경우에는 비교용출시험자료 등 생체를 | 합하다는 판정을 받지 못한 품목 및 이 조 | 8단계 | 목허가를 받은 전문의약품으로서 신약에 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 경우에는 식품의약품안전처장 또는 지방청장이 |\n| 및 품질관리 기준 가이던스’를 참조 | 부분 단서에 따라 자료를 제출하지 않아도 되는 | 의약외품 제조판매·수입 품목허가의 경우에는 |\n| 위탁제조판매업자로부터 수탁을 받아 제조하는 제조업자, 수입자(제조원을 포 | 자료번호 | ⇦ | 한의식, 김소희, 윤경은, 엄정윤, 박소라, 김동환, 전설희, | (electron capture) 또는 양전자방출(positron emission) |\n| 편 | 집 | 위 | 원 | 이용하지 아니하는 시험자료로서 식품의약품 | 제1항제5호에 따른 품목만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 0 | 90일(원료의 | 1 | 2 | ⑨ 제1항부터 제4항까지의 경우에 허가받은 사 | 지방청장을 말한다)에게 제출하여야 한다.  <개 | 품등의 제조판매·수입 품목허가를 위하여 필 | 변경허가를 하거나 변경신고를 수리한 것으로 |\n| GMP | 약품 60일) | 207,000원 | 230,000원 | 의약외품 제조판매ᆞ수입 품목허가의 경우에는 |\n| 안전처장이 고시하는 자료를 제출한다.  | 함한다) | 로의 품목을 포함한다) | 1968 1996 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 | 국내 방사성의약품의 연도별 품목허가 수는 표 1과 그림 1에서 나타나듯이 특정 년도를 | 요하다고 인정하는 경우에는 식품의약품안전평 |\n| 김미지 | 지방청장을 말한다)에게 제출하여야 한다.  <개 | 항 또는 신고한 사항 중 총리령으로 정하는 사 |\n| (법 제27조제2항제1호에 따라 의약품 동등 | × | ○ | × | × | × | △ | ○ | △ | △ | △ | △ | ○ | △ | 1.  법 제31조의5(법 제42조제4항에 따라 준용 | 가원의 의견을 듣거나 법 제18조제1항에 따른 |\n| 1.  제9조에 따른 안전성·유효성에 관한 자료.  | 항을 변경하려는 때에는 총리령으로 정하는 바 |\n| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 받은 전문의약품으로서 신약에 | 품으로서 이미 제조판매·수입 품목허가 | 되는 경우를 포함한다)에 따른 의약품 제조 |\n| - 재심사 기간 : 2014. ",
        "original_sentence": "<개 | 항 또는 신고한 사항 중 총리령으로 정하는 사 |\n| (법 제27조제2항제1호에 따라 의약품 동등 | × | ○ | × | × | × | △ | ○ | △ | △ | △ | △ | ○ | △ | 1. "
      }
    },
    {
      "chunk_id": "chunk_206",
      "text": "법 제31조의5(법 제42조제4항에 따라 준용 | 가원의 의견을 듣거나 법 제18조제1항에 따른 |\n| 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 205,
        "window_size": 3,
        "char_count": 61,
        "word_count": 15,
        "page_number": 3,
        "window_text": "<개 | 품등의 제조판매·수입 품목허가를 위하여 필 | 변경허가를 하거나 변경신고를 수리한 것으로 |\n| GMP | 약품 60일) | 207,000원 | 230,000원 | 의약외품 제조판매ᆞ수입 품목허가의 경우에는 |\n| 안전처장이 고시하는 자료를 제출한다.  | 함한다) | 로의 품목을 포함한다) | 1968 1996 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 | 국내 방사성의약품의 연도별 품목허가 수는 표 1과 그림 1에서 나타나듯이 특정 년도를 | 요하다고 인정하는 경우에는 식품의약품안전평 |\n| 김미지 | 지방청장을 말한다)에게 제출하여야 한다.  <개 | 항 또는 신고한 사항 중 총리령으로 정하는 사 |\n| (법 제27조제2항제1호에 따라 의약품 동등 | × | ○ | × | × | × | △ | ○ | △ | △ | △ | △ | ○ | △ | 1.  법 제31조의5(법 제42조제4항에 따라 준용 | 가원의 의견을 듣거나 법 제18조제1항에 따른 |\n| 1.  제9조에 따른 안전성·유효성에 관한 자료.  | 항을 변경하려는 때에는 총리령으로 정하는 바 |\n| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 받은 전문의약품으로서 신약에 | 품으로서 이미 제조판매·수입 품목허가 | 되는 경우를 포함한다)에 따른 의약품 제조 |\n| - 재심사 기간 : 2014.  10. ",
        "original_sentence": "법 제31조의5(법 제42조제4항에 따라 준용 | 가원의 의견을 듣거나 법 제18조제1항에 따른 |\n| 1. "
      }
    },
    {
      "chunk_id": "chunk_207",
      "text": "제9조에 따른 안전성·유효성에 관한 자료. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 206,
        "window_size": 3,
        "char_count": 24,
        "word_count": 5,
        "page_number": 3,
        "window_text": "| 함한다) | 로의 품목을 포함한다) | 1968 1996 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 | 국내 방사성의약품의 연도별 품목허가 수는 표 1과 그림 1에서 나타나듯이 특정 년도를 | 요하다고 인정하는 경우에는 식품의약품안전평 |\n| 김미지 | 지방청장을 말한다)에게 제출하여야 한다.  <개 | 항 또는 신고한 사항 중 총리령으로 정하는 사 |\n| (법 제27조제2항제1호에 따라 의약품 동등 | × | ○ | × | × | × | △ | ○ | △ | △ | △ | △ | ○ | △ | 1.  법 제31조의5(법 제42조제4항에 따라 준용 | 가원의 의견을 듣거나 법 제18조제1항에 따른 |\n| 1.  제9조에 따른 안전성·유효성에 관한 자료.  | 항을 변경하려는 때에는 총리령으로 정하는 바 |\n| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 받은 전문의약품으로서 신약에 | 품으로서 이미 제조판매·수입 품목허가 | 되는 경우를 포함한다)에 따른 의약품 제조 |\n| - 재심사 기간 : 2014.  10.  4. ",
        "original_sentence": "제9조에 따른 안전성·유효성에 관한 자료. "
      }
    },
    {
      "chunk_id": "chunk_208",
      "text": "| 항을 변경하려는 때에는 총리령으로 정하는 바 |\n| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 받은 전문의약품으로서 신약에 | 품으로서 이미 제조판매·수입 품목허가 | 되는 경우를 포함한다)에 따른 의약품 제조 |\n| - 재심사 기간 : 2014. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 207,
        "window_size": 3,
        "char_count": 147,
        "word_count": 37,
        "page_number": 4,
        "window_text": "<개 | 항 또는 신고한 사항 중 총리령으로 정하는 사 |\n| (법 제27조제2항제1호에 따라 의약품 동등 | × | ○ | × | × | × | △ | ○ | △ | △ | △ | △ | ○ | △ | 1.  법 제31조의5(법 제42조제4항에 따라 준용 | 가원의 의견을 듣거나 법 제18조제1항에 따른 |\n| 1.  제9조에 따른 안전성·유효성에 관한 자료.  | 항을 변경하려는 때에는 총리령으로 정하는 바 |\n| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 받은 전문의약품으로서 신약에 | 품으로서 이미 제조판매·수입 품목허가 | 되는 경우를 포함한다)에 따른 의약품 제조 |\n| - 재심사 기간 : 2014.  10.  4.  ~ 2018. ",
        "original_sentence": "| 항을 변경하려는 때에는 총리령으로 정하는 바 |\n| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 받은 전문의약품으로서 신약에 | 품으로서 이미 제조판매·수입 품목허가 | 되는 경우를 포함한다)에 따른 의약품 제조 |\n| - 재심사 기간 : 2014. "
      }
    },
    {
      "chunk_id": "chunk_209",
      "text": "10. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 208,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 3,
        "window_text": "법 제31조의5(법 제42조제4항에 따라 준용 | 가원의 의견을 듣거나 법 제18조제1항에 따른 |\n| 1.  제9조에 따른 안전성·유효성에 관한 자료.  | 항을 변경하려는 때에는 총리령으로 정하는 바 |\n| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 받은 전문의약품으로서 신약에 | 품으로서 이미 제조판매·수입 품목허가 | 되는 경우를 포함한다)에 따른 의약품 제조 |\n| - 재심사 기간 : 2014.  10.  4.  ~ 2018.  10. ",
        "original_sentence": "10. "
      }
    },
    {
      "chunk_id": "chunk_210",
      "text": "4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 209,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 3,
        "window_text": "제9조에 따른 안전성·유효성에 관한 자료.  | 항을 변경하려는 때에는 총리령으로 정하는 바 |\n| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 받은 전문의약품으로서 신약에 | 품으로서 이미 제조판매·수입 품목허가 | 되는 경우를 포함한다)에 따른 의약품 제조 |\n| - 재심사 기간 : 2014.  10.  4.  ~ 2018.  10.  3.",
        "original_sentence": "4. "
      }
    },
    {
      "chunk_id": "chunk_211",
      "text": "~ 2018. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 210,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 3,
        "window_text": "| 항을 변경하려는 때에는 총리령으로 정하는 바 |\n| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 받은 전문의약품으로서 신약에 | 품으로서 이미 제조판매·수입 품목허가 | 되는 경우를 포함한다)에 따른 의약품 제조 |\n| - 재심사 기간 : 2014.  10.  4.  ~ 2018.  10.  3. (4년) | 도 움 주 신  분 | 식품의약품안전처 의약품안전국 의약품품질과 | 1. ",
        "original_sentence": "~ 2018. "
      }
    },
    {
      "chunk_id": "chunk_212",
      "text": "10. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 211,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 3,
        "window_text": "10.  4.  ~ 2018.  10.  3. (4년) | 도 움 주 신  분 | 식품의약품안전처 의약품안전국 의약품품질과 | 1.  제9조에 따른 안전성ᆞ유효성에 관한 자료. ",
        "original_sentence": "10. "
      }
    },
    {
      "chunk_id": "chunk_213",
      "text": "3.",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 212,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 2,
        "window_text": "4.  ~ 2018.  10.  3. (4년) | 도 움 주 신  분 | 식품의약품안전처 의약품안전국 의약품품질과 | 1.  제9조에 따른 안전성ᆞ유효성에 관한 자료.  | 에 따라 변경허가를 받거나 변경신고를 하여야 | 다만, 생물학적 제제, 유전자재조합의약품, |\n| 이 정한 의약품만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 를 받은 것과 성분이 동일한 정제·캡슐 | 처리부서 | 민원접수 | 그림 1. ",
        "original_sentence": "3."
      }
    },
    {
      "chunk_id": "chunk_214",
      "text": "(4년) | 도 움 주 신  분 | 식품의약품안전처 의약품안전국 의약품품질과 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 213,
        "window_size": 3,
        "char_count": 48,
        "word_count": 13,
        "page_number": 3,
        "window_text": "~ 2018.  10.  3. (4년) | 도 움 주 신  분 | 식품의약품안전처 의약품안전국 의약품품질과 | 1.  제9조에 따른 안전성ᆞ유효성에 관한 자료.  | 에 따라 변경허가를 받거나 변경신고를 하여야 | 다만, 생물학적 제제, 유전자재조합의약품, |\n| 이 정한 의약품만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 를 받은 것과 성분이 동일한 정제·캡슐 | 처리부서 | 민원접수 | 그림 1.  연도별 방사성의약품 품목허가 그래프 (15.01.12. ",
        "original_sentence": "(4년) | 도 움 주 신  분 | 식품의약품안전처 의약품안전국 의약품품질과 | 1. "
      }
    },
    {
      "chunk_id": "chunk_215",
      "text": "제9조에 따른 안전성ᆞ유효성에 관한 자료. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 214,
        "window_size": 3,
        "char_count": 24,
        "word_count": 5,
        "page_number": 3,
        "window_text": "10.  3. (4년) | 도 움 주 신  분 | 식품의약품안전처 의약품안전국 의약품품질과 | 1.  제9조에 따른 안전성ᆞ유효성에 관한 자료.  | 에 따라 변경허가를 받거나 변경신고를 하여야 | 다만, 생물학적 제제, 유전자재조합의약품, |\n| 이 정한 의약품만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 를 받은 것과 성분이 동일한 정제·캡슐 | 처리부서 | 민원접수 | 그림 1.  연도별 방사성의약품 품목허가 그래프 (15.01.12.  품목대장 기준) | (Carrier-free preparation)의 방사능과 비슷할 수 있다. ",
        "original_sentence": "제9조에 따른 안전성ᆞ유효성에 관한 자료. "
      }
    },
    {
      "chunk_id": "chunk_216",
      "text": "| 에 따라 변경허가를 받거나 변경신고를 하여야 | 다만, 생물학적 제제, 유전자재조합의약품, |\n| 이 정한 의약품만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 를 받은 것과 성분이 동일한 정제·캡슐 | 처리부서 | 민원접수 | 그림 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 215,
        "window_size": 3,
        "char_count": 143,
        "word_count": 37,
        "page_number": 6,
        "window_text": "3. (4년) | 도 움 주 신  분 | 식품의약품안전처 의약품안전국 의약품품질과 | 1.  제9조에 따른 안전성ᆞ유효성에 관한 자료.  | 에 따라 변경허가를 받거나 변경신고를 하여야 | 다만, 생물학적 제제, 유전자재조합의약품, |\n| 이 정한 의약품만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 를 받은 것과 성분이 동일한 정제·캡슐 | 처리부서 | 민원접수 | 그림 1.  연도별 방사성의약품 품목허가 그래프 (15.01.12.  품목대장 기준) | (Carrier-free preparation)의 방사능과 비슷할 수 있다.  | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | 다만, 생물학적 제제, 유전자재조합의약품, | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n**- 재심사 신청기간 : 2018. ",
        "original_sentence": "| 에 따라 변경허가를 받거나 변경신고를 하여야 | 다만, 생물학적 제제, 유전자재조합의약품, |\n| 이 정한 의약품만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 를 받은 것과 성분이 동일한 정제·캡슐 | 처리부서 | 민원접수 | 그림 1. "
      }
    },
    {
      "chunk_id": "chunk_217",
      "text": "연도별 방사성의약품 품목허가 그래프 (15.01.12. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 216,
        "window_size": 3,
        "char_count": 31,
        "word_count": 5,
        "page_number": 3,
        "window_text": "(4년) | 도 움 주 신  분 | 식품의약품안전처 의약품안전국 의약품품질과 | 1.  제9조에 따른 안전성ᆞ유효성에 관한 자료.  | 에 따라 변경허가를 받거나 변경신고를 하여야 | 다만, 생물학적 제제, 유전자재조합의약품, |\n| 이 정한 의약품만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 를 받은 것과 성분이 동일한 정제·캡슐 | 처리부서 | 민원접수 | 그림 1.  연도별 방사성의약품 품목허가 그래프 (15.01.12.  품목대장 기준) | (Carrier-free preparation)의 방사능과 비슷할 수 있다.  | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | 다만, 생물학적 제제, 유전자재조합의약품, | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n**- 재심사 신청기간 : 2018.  10. ",
        "original_sentence": "연도별 방사성의약품 품목허가 그래프 (15.01.12. "
      }
    },
    {
      "chunk_id": "chunk_218",
      "text": "품목대장 기준) | (Carrier-free preparation)의 방사능과 비슷할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 217,
        "window_size": 3,
        "char_count": 54,
        "word_count": 9,
        "page_number": 3,
        "window_text": "제9조에 따른 안전성ᆞ유효성에 관한 자료.  | 에 따라 변경허가를 받거나 변경신고를 하여야 | 다만, 생물학적 제제, 유전자재조합의약품, |\n| 이 정한 의약품만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 를 받은 것과 성분이 동일한 정제·캡슐 | 처리부서 | 민원접수 | 그림 1.  연도별 방사성의약품 품목허가 그래프 (15.01.12.  품목대장 기준) | (Carrier-free preparation)의 방사능과 비슷할 수 있다.  | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | 다만, 생물학적 제제, 유전자재조합의약품, | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n**- 재심사 신청기간 : 2018.  10.  4. ",
        "original_sentence": "품목대장 기준) | (Carrier-free preparation)의 방사능과 비슷할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_219",
      "text": "| ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | 다만, 생물학적 제제, 유전자재조합의약품, | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n**- 재심사 신청기간 : 2018. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 218,
        "window_size": 3,
        "char_count": 104,
        "word_count": 25,
        "page_number": 3,
        "window_text": "| 에 따라 변경허가를 받거나 변경신고를 하여야 | 다만, 생물학적 제제, 유전자재조합의약품, |\n| 이 정한 의약품만 해당한다) | 해당하는 의약품(제형이 다른 동일투여경 | 를 받은 것과 성분이 동일한 정제·캡슐 | 처리부서 | 민원접수 | 그림 1.  연도별 방사성의약품 품목허가 그래프 (15.01.12.  품목대장 기준) | (Carrier-free preparation)의 방사능과 비슷할 수 있다.  | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | 다만, 생물학적 제제, 유전자재조합의약품, | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n**- 재심사 신청기간 : 2018.  10.  4.  ~ 2019. ",
        "original_sentence": "| ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | 다만, 생물학적 제제, 유전자재조합의약품, | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n**- 재심사 신청기간 : 2018. "
      }
    },
    {
      "chunk_id": "chunk_220",
      "text": "10. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 219,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 3,
        "window_text": "연도별 방사성의약품 품목허가 그래프 (15.01.12.  품목대장 기준) | (Carrier-free preparation)의 방사능과 비슷할 수 있다.  | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | 다만, 생물학적 제제, 유전자재조합의약품, | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n**- 재심사 신청기간 : 2018.  10.  4.  ~ 2019.  1. ",
        "original_sentence": "10. "
      }
    },
    {
      "chunk_id": "chunk_221",
      "text": "4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 220,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 3,
        "window_text": "품목대장 기준) | (Carrier-free preparation)의 방사능과 비슷할 수 있다.  | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | 다만, 생물학적 제제, 유전자재조합의약품, | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n**- 재심사 신청기간 : 2018.  10.  4.  ~ 2019.  1.  3.",
        "original_sentence": "4. "
      }
    },
    {
      "chunk_id": "chunk_222",
      "text": "~ 2019. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 221,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 3,
        "window_text": "| ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | 다만, 생물학적 제제, 유전자재조합의약품, | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n**- 재심사 신청기간 : 2018.  10.  4.  ~ 2019.  1.  3. **\n| 로의 품목을 포함한다) | 제 또는 좌제. ",
        "original_sentence": "~ 2019. "
      }
    },
    {
      "chunk_id": "chunk_223",
      "text": "1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 222,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 2,
        "window_text": "10.  4.  ~ 2019.  1.  3. **\n| 로의 품목을 포함한다) | 제 또는 좌제.  다만, 상용(常用) 의약품, | 식품의약품안전평가원 의약품심사부 의약품심사조정과 | 약품안전처장이 정하여 고시하는 수수료(외국 | 및 이와 유사한 제제(이하 \"생물학적제제등\" |\n| 가. ",
        "original_sentence": "1. "
      }
    },
    {
      "chunk_id": "chunk_224",
      "text": "3.",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 223,
        "window_size": 3,
        "char_count": 2,
        "word_count": 1,
        "page_number": 2,
        "window_text": "4.  ~ 2019.  1.  3. **\n| 로의 품목을 포함한다) | 제 또는 좌제.  다만, 상용(常用) 의약품, | 식품의약품안전평가원 의약품심사부 의약품심사조정과 | 약품안전처장이 정하여 고시하는 수수료(외국 | 및 이와 유사한 제제(이하 \"생물학적제제등\" |\n| 가.  구조결정에 관한 자료 | 대한민국약전 | 유럽약전 | 미국약전 | ⑩ 제2항 및 제3항에 따라 허가를 받거나 신고 | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | - 유기용매를 사용할 경우 사용목적과 용매의 명칭, 규격, 단위제형당 사용량 등 기재 | 에서 현지실사를 할 필요가 있는 경우에는 이 |\n| 나. ",
        "original_sentence": "3."
      }
    },
    {
      "chunk_id": "chunk_225",
      "text": "**\n| 로의 품목을 포함한다) | 제 또는 좌제. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 224,
        "window_size": 3,
        "char_count": 29,
        "word_count": 9,
        "page_number": 5,
        "window_text": "~ 2019.  1.  3. **\n| 로의 품목을 포함한다) | 제 또는 좌제.  다만, 상용(常用) 의약품, | 식품의약품안전평가원 의약품심사부 의약품심사조정과 | 약품안전처장이 정하여 고시하는 수수료(외국 | 및 이와 유사한 제제(이하 \"생물학적제제등\" |\n| 가.  구조결정에 관한 자료 | 대한민국약전 | 유럽약전 | 미국약전 | ⑩ 제2항 및 제3항에 따라 허가를 받거나 신고 | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | - 유기용매를 사용할 경우 사용목적과 용매의 명칭, 규격, 단위제형당 사용량 등 기재 | 에서 현지실사를 할 필요가 있는 경우에는 이 |\n| 나.  물리화학적 성질에 관한 자료 | 발 | 행 | 처 | 식품의약품안전평가원 의약품심사부 종양약품과 | 방사성핵종 제너레이터(RADIONUCLIDE GENERATORS) | 하려는 품목이 신약 또는 식품의약품안전처장 | 및 이와 유사한 제제(이하 \"생물학적제제등\" | 이라 한다)가 아닌 것으로서 다음 각 목의 |\n| 제3호에 따른 품목은 제외한다) | 품으로서 이미 제조판매ᆞ수입 품목허가 | 또는 의약품 동등성 확보가 필요한 의약 | 4. ",
        "original_sentence": "**\n| 로의 품목을 포함한다) | 제 또는 좌제. "
      }
    },
    {
      "chunk_id": "chunk_226",
      "text": "다만, 상용(常用) 의약품, | 식품의약품안전평가원 의약품심사부 의약품심사조정과 | 약품안전처장이 정하여 고시하는 수수료(외국 | 및 이와 유사한 제제(이하 \"생물학적제제등\" |\n| 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 225,
        "window_size": 3,
        "char_count": 105,
        "word_count": 21,
        "page_number": 1,
        "window_text": "1.  3. **\n| 로의 품목을 포함한다) | 제 또는 좌제.  다만, 상용(常用) 의약품, | 식품의약품안전평가원 의약품심사부 의약품심사조정과 | 약품안전처장이 정하여 고시하는 수수료(외국 | 및 이와 유사한 제제(이하 \"생물학적제제등\" |\n| 가.  구조결정에 관한 자료 | 대한민국약전 | 유럽약전 | 미국약전 | ⑩ 제2항 및 제3항에 따라 허가를 받거나 신고 | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | - 유기용매를 사용할 경우 사용목적과 용매의 명칭, 규격, 단위제형당 사용량 등 기재 | 에서 현지실사를 할 필요가 있는 경우에는 이 |\n| 나.  물리화학적 성질에 관한 자료 | 발 | 행 | 처 | 식품의약품안전평가원 의약품심사부 종양약품과 | 방사성핵종 제너레이터(RADIONUCLIDE GENERATORS) | 하려는 품목이 신약 또는 식품의약품안전처장 | 및 이와 유사한 제제(이하 \"생물학적제제등\" | 이라 한다)가 아닌 것으로서 다음 각 목의 |\n| 제3호에 따른 품목은 제외한다) | 품으로서 이미 제조판매ᆞ수입 품목허가 | 또는 의약품 동등성 확보가 필요한 의약 | 4.  제4조, 이 조 및 제41조에 따른 안전성ᆞ유 |\n| 다. ",
        "original_sentence": "다만, 상용(常用) 의약품, | 식품의약품안전평가원 의약품심사부 의약품심사조정과 | 약품안전처장이 정하여 고시하는 수수료(외국 | 및 이와 유사한 제제(이하 \"생물학적제제등\" |\n| 가. "
      }
    },
    {
      "chunk_id": "chunk_227",
      "text": "구조결정에 관한 자료 | 대한민국약전 | 유럽약전 | 미국약전 | ⑩ 제2항 및 제3항에 따라 허가를 받거나 신고 | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | - 유기용매를 사용할 경우 사용목적과 용매의 명칭, 규격, 단위제형당 사용량 등 기재 | 에서 현지실사를 할 필요가 있는 경우에는 이 |\n| 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 226,
        "window_size": 3,
        "char_count": 201,
        "word_count": 54,
        "page_number": 3,
        "window_text": "3. **\n| 로의 품목을 포함한다) | 제 또는 좌제.  다만, 상용(常用) 의약품, | 식품의약품안전평가원 의약품심사부 의약품심사조정과 | 약품안전처장이 정하여 고시하는 수수료(외국 | 및 이와 유사한 제제(이하 \"생물학적제제등\" |\n| 가.  구조결정에 관한 자료 | 대한민국약전 | 유럽약전 | 미국약전 | ⑩ 제2항 및 제3항에 따라 허가를 받거나 신고 | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | - 유기용매를 사용할 경우 사용목적과 용매의 명칭, 규격, 단위제형당 사용량 등 기재 | 에서 현지실사를 할 필요가 있는 경우에는 이 |\n| 나.  물리화학적 성질에 관한 자료 | 발 | 행 | 처 | 식품의약품안전평가원 의약품심사부 종양약품과 | 방사성핵종 제너레이터(RADIONUCLIDE GENERATORS) | 하려는 품목이 신약 또는 식품의약품안전처장 | 및 이와 유사한 제제(이하 \"생물학적제제등\" | 이라 한다)가 아닌 것으로서 다음 각 목의 |\n| 제3호에 따른 품목은 제외한다) | 품으로서 이미 제조판매ᆞ수입 품목허가 | 또는 의약품 동등성 확보가 필요한 의약 | 4.  제4조, 이 조 및 제41조에 따른 안전성ᆞ유 |\n| 다.  제조방법에 관한 자료 | 의약품심사조정과 | ③ 기준 및 시험방법에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음. ",
        "original_sentence": "구조결정에 관한 자료 | 대한민국약전 | 유럽약전 | 미국약전 | ⑩ 제2항 및 제3항에 따라 허가를 받거나 신고 | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | - 유기용매를 사용할 경우 사용목적과 용매의 명칭, 규격, 단위제형당 사용량 등 기재 | 에서 현지실사를 할 필요가 있는 경우에는 이 |\n| 나. "
      }
    },
    {
      "chunk_id": "chunk_228",
      "text": "물리화학적 성질에 관한 자료 | 발 | 행 | 처 | 식품의약품안전평가원 의약품심사부 종양약품과 | 방사성핵종 제너레이터(RADIONUCLIDE GENERATORS) | 하려는 품목이 신약 또는 식품의약품안전처장 | 및 이와 유사한 제제(이하 \"생물학적제제등\" | 이라 한다)가 아닌 것으로서 다음 각 목의 |\n| 제3호에 따른 품목은 제외한다) | 품으로서 이미 제조판매ᆞ수입 품목허가 | 또는 의약품 동등성 확보가 필요한 의약 | 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 227,
        "window_size": 3,
        "char_count": 246,
        "word_count": 58,
        "page_number": 1,
        "window_text": "**\n| 로의 품목을 포함한다) | 제 또는 좌제.  다만, 상용(常用) 의약품, | 식품의약품안전평가원 의약품심사부 의약품심사조정과 | 약품안전처장이 정하여 고시하는 수수료(외국 | 및 이와 유사한 제제(이하 \"생물학적제제등\" |\n| 가.  구조결정에 관한 자료 | 대한민국약전 | 유럽약전 | 미국약전 | ⑩ 제2항 및 제3항에 따라 허가를 받거나 신고 | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | - 유기용매를 사용할 경우 사용목적과 용매의 명칭, 규격, 단위제형당 사용량 등 기재 | 에서 현지실사를 할 필요가 있는 경우에는 이 |\n| 나.  물리화학적 성질에 관한 자료 | 발 | 행 | 처 | 식품의약품안전평가원 의약품심사부 종양약품과 | 방사성핵종 제너레이터(RADIONUCLIDE GENERATORS) | 하려는 품목이 신약 또는 식품의약품안전처장 | 및 이와 유사한 제제(이하 \"생물학적제제등\" | 이라 한다)가 아닌 것으로서 다음 각 목의 |\n| 제3호에 따른 품목은 제외한다) | 품으로서 이미 제조판매ᆞ수입 품목허가 | 또는 의약품 동등성 확보가 필요한 의약 | 4.  제4조, 이 조 및 제41조에 따른 안전성ᆞ유 |\n| 다.  제조방법에 관한 자료 | 의약품심사조정과 | ③ 기준 및 시험방법에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.  | 이 지정하는 의약품인 경우에는 안전성ᆞ유효 | 이라 한다)가 아닌 것으로서 다음 각 목의 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n**- 전부 또는 일부 공정 위탁하여 제조시 단위공정별 수탁자명, 소재지 등을 명확하게 기재**\n| 라. ",
        "original_sentence": "물리화학적 성질에 관한 자료 | 발 | 행 | 처 | 식품의약품안전평가원 의약품심사부 종양약품과 | 방사성핵종 제너레이터(RADIONUCLIDE GENERATORS) | 하려는 품목이 신약 또는 식품의약품안전처장 | 및 이와 유사한 제제(이하 \"생물학적제제등\" | 이라 한다)가 아닌 것으로서 다음 각 목의 |\n| 제3호에 따른 품목은 제외한다) | 품으로서 이미 제조판매ᆞ수입 품목허가 | 또는 의약품 동등성 확보가 필요한 의약 | 4. "
      }
    },
    {
      "chunk_id": "chunk_229",
      "text": "제4조, 이 조 및 제41조에 따른 안전성ᆞ유 |\n| 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 228,
        "window_size": 3,
        "char_count": 33,
        "word_count": 10,
        "page_number": 3,
        "window_text": "다만, 상용(常用) 의약품, | 식품의약품안전평가원 의약품심사부 의약품심사조정과 | 약품안전처장이 정하여 고시하는 수수료(외국 | 및 이와 유사한 제제(이하 \"생물학적제제등\" |\n| 가.  구조결정에 관한 자료 | 대한민국약전 | 유럽약전 | 미국약전 | ⑩ 제2항 및 제3항에 따라 허가를 받거나 신고 | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | - 유기용매를 사용할 경우 사용목적과 용매의 명칭, 규격, 단위제형당 사용량 등 기재 | 에서 현지실사를 할 필요가 있는 경우에는 이 |\n| 나.  물리화학적 성질에 관한 자료 | 발 | 행 | 처 | 식품의약품안전평가원 의약품심사부 종양약품과 | 방사성핵종 제너레이터(RADIONUCLIDE GENERATORS) | 하려는 품목이 신약 또는 식품의약품안전처장 | 및 이와 유사한 제제(이하 \"생물학적제제등\" | 이라 한다)가 아닌 것으로서 다음 각 목의 |\n| 제3호에 따른 품목은 제외한다) | 품으로서 이미 제조판매ᆞ수입 품목허가 | 또는 의약품 동등성 확보가 필요한 의약 | 4.  제4조, 이 조 및 제41조에 따른 안전성ᆞ유 |\n| 다.  제조방법에 관한 자료 | 의약품심사조정과 | ③ 기준 및 시험방법에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.  | 이 지정하는 의약품인 경우에는 안전성ᆞ유효 | 이라 한다)가 아닌 것으로서 다음 각 목의 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n**- 전부 또는 일부 공정 위탁하여 제조시 단위공정별 수탁자명, 소재지 등을 명확하게 기재**\n| 라.  기준및시험방법에 관한 근거자료 | 를 받은 것과 성분이 동일한 정제ᆞ캡슐 | 품으로서 식품의약품안전처장이 고시하는 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 성에 관한 다음 각 호의 자료를 총리령으로 정 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n| 료 | 제 또는 좌제. ",
        "original_sentence": "제4조, 이 조 및 제41조에 따른 안전성ᆞ유 |\n| 다. "
      }
    },
    {
      "chunk_id": "chunk_230",
      "text": "제조방법에 관한 자료 | 의약품심사조정과 | ③ 기준 및 시험방법에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 229,
        "window_size": 3,
        "char_count": 84,
        "word_count": 23,
        "page_number": 3,
        "window_text": "구조결정에 관한 자료 | 대한민국약전 | 유럽약전 | 미국약전 | ⑩ 제2항 및 제3항에 따라 허가를 받거나 신고 | 세포배양의약품, 세포 치료제, 유전자 치료제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | - 유기용매를 사용할 경우 사용목적과 용매의 명칭, 규격, 단위제형당 사용량 등 기재 | 에서 현지실사를 할 필요가 있는 경우에는 이 |\n| 나.  물리화학적 성질에 관한 자료 | 발 | 행 | 처 | 식품의약품안전평가원 의약품심사부 종양약품과 | 방사성핵종 제너레이터(RADIONUCLIDE GENERATORS) | 하려는 품목이 신약 또는 식품의약품안전처장 | 및 이와 유사한 제제(이하 \"생물학적제제등\" | 이라 한다)가 아닌 것으로서 다음 각 목의 |\n| 제3호에 따른 품목은 제외한다) | 품으로서 이미 제조판매ᆞ수입 품목허가 | 또는 의약품 동등성 확보가 필요한 의약 | 4.  제4조, 이 조 및 제41조에 따른 안전성ᆞ유 |\n| 다.  제조방법에 관한 자료 | 의약품심사조정과 | ③ 기준 및 시험방법에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.  | 이 지정하는 의약품인 경우에는 안전성ᆞ유효 | 이라 한다)가 아닌 것으로서 다음 각 목의 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n**- 전부 또는 일부 공정 위탁하여 제조시 단위공정별 수탁자명, 소재지 등을 명확하게 기재**\n| 라.  기준및시험방법에 관한 근거자료 | 를 받은 것과 성분이 동일한 정제ᆞ캡슐 | 품으로서 식품의약품안전처장이 고시하는 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 성에 관한 다음 각 호의 자료를 총리령으로 정 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n| 료 | 제 또는 좌제.  다만, 상용(常用) 의약품, | 것이어야 한다. ",
        "original_sentence": "제조방법에 관한 자료 | 의약품심사조정과 | ③ 기준 및 시험방법에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음. "
      }
    },
    {
      "chunk_id": "chunk_231",
      "text": "| 이 지정하는 의약품인 경우에는 안전성ᆞ유효 | 이라 한다)가 아닌 것으로서 다음 각 목의 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n**- 전부 또는 일부 공정 위탁하여 제조시 단위공정별 수탁자명, 소재지 등을 명확하게 기재**\n| 라. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 230,
        "window_size": 3,
        "char_count": 139,
        "word_count": 37,
        "page_number": 5,
        "window_text": "물리화학적 성질에 관한 자료 | 발 | 행 | 처 | 식품의약품안전평가원 의약품심사부 종양약품과 | 방사성핵종 제너레이터(RADIONUCLIDE GENERATORS) | 하려는 품목이 신약 또는 식품의약품안전처장 | 및 이와 유사한 제제(이하 \"생물학적제제등\" | 이라 한다)가 아닌 것으로서 다음 각 목의 |\n| 제3호에 따른 품목은 제외한다) | 품으로서 이미 제조판매ᆞ수입 품목허가 | 또는 의약품 동등성 확보가 필요한 의약 | 4.  제4조, 이 조 및 제41조에 따른 안전성ᆞ유 |\n| 다.  제조방법에 관한 자료 | 의약품심사조정과 | ③ 기준 및 시험방법에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.  | 이 지정하는 의약품인 경우에는 안전성ᆞ유효 | 이라 한다)가 아닌 것으로서 다음 각 목의 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n**- 전부 또는 일부 공정 위탁하여 제조시 단위공정별 수탁자명, 소재지 등을 명확하게 기재**\n| 라.  기준및시험방법에 관한 근거자료 | 를 받은 것과 성분이 동일한 정제ᆞ캡슐 | 품으로서 식품의약품안전처장이 고시하는 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 성에 관한 다음 각 호의 자료를 총리령으로 정 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n| 료 | 제 또는 좌제.  다만, 상용(常用) 의약품, | 것이어야 한다.  | 제5조(제조판매ᆞ수입 품목의 신고) ① 법 제31 | 조소에서 제조되는 것으로서 해당 품목과 최 |\n| 마. ",
        "original_sentence": "| 이 지정하는 의약품인 경우에는 안전성ᆞ유효 | 이라 한다)가 아닌 것으로서 다음 각 목의 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n**- 전부 또는 일부 공정 위탁하여 제조시 단위공정별 수탁자명, 소재지 등을 명확하게 기재**\n| 라. "
      }
    },
    {
      "chunk_id": "chunk_232",
      "text": "기준및시험방법에 관한 근거자료 | 를 받은 것과 성분이 동일한 정제ᆞ캡슐 | 품으로서 식품의약품안전처장이 고시하는 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 성에 관한 다음 각 호의 자료를 총리령으로 정 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n| 료 | 제 또는 좌제. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 231,
        "window_size": 3,
        "char_count": 163,
        "word_count": 45,
        "page_number": 5,
        "window_text": "제4조, 이 조 및 제41조에 따른 안전성ᆞ유 |\n| 다.  제조방법에 관한 자료 | 의약품심사조정과 | ③ 기준 및 시험방법에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.  | 이 지정하는 의약품인 경우에는 안전성ᆞ유효 | 이라 한다)가 아닌 것으로서 다음 각 목의 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n**- 전부 또는 일부 공정 위탁하여 제조시 단위공정별 수탁자명, 소재지 등을 명확하게 기재**\n| 라.  기준및시험방법에 관한 근거자료 | 를 받은 것과 성분이 동일한 정제ᆞ캡슐 | 품으로서 식품의약품안전처장이 고시하는 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 성에 관한 다음 각 호의 자료를 총리령으로 정 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n| 료 | 제 또는 좌제.  다만, 상용(常用) 의약품, | 것이어야 한다.  | 제5조(제조판매ᆞ수입 품목의 신고) ① 법 제31 | 조소에서 제조되는 것으로서 해당 품목과 최 |\n| 마.  시험성적에 관한 자료 | 총 처리기한 70일 | 하는 바에 따라 제출하여야 한다. ",
        "original_sentence": "기준및시험방법에 관한 근거자료 | 를 받은 것과 성분이 동일한 정제ᆞ캡슐 | 품으로서 식품의약품안전처장이 고시하는 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 성에 관한 다음 각 호의 자료를 총리령으로 정 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n| 료 | 제 또는 좌제. "
      }
    },
    {
      "chunk_id": "chunk_233",
      "text": "다만, 상용(常用) 의약품, | 것이어야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 232,
        "window_size": 3,
        "char_count": 27,
        "word_count": 6,
        "page_number": 5,
        "window_text": "제조방법에 관한 자료 | 의약품심사조정과 | ③ 기준 및 시험방법에 관한 자료 : 사전 검토 결과 통지서를 제출하는 경우에는 제출하지 않을 수 있음.  | 이 지정하는 의약품인 경우에는 안전성ᆞ유효 | 이라 한다)가 아닌 것으로서 다음 각 목의 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n**- 전부 또는 일부 공정 위탁하여 제조시 단위공정별 수탁자명, 소재지 등을 명확하게 기재**\n| 라.  기준및시험방법에 관한 근거자료 | 를 받은 것과 성분이 동일한 정제ᆞ캡슐 | 품으로서 식품의약품안전처장이 고시하는 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 성에 관한 다음 각 호의 자료를 총리령으로 정 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n| 료 | 제 또는 좌제.  다만, 상용(常用) 의약품, | 것이어야 한다.  | 제5조(제조판매ᆞ수입 품목의 신고) ① 법 제31 | 조소에서 제조되는 것으로서 해당 품목과 최 |\n| 마.  시험성적에 관한 자료 | 총 처리기한 70일 | 하는 바에 따라 제출하여야 한다.  다만, 제2호 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | 특 | 성 | 생산하는 국가의 정부 또는 공공기관에서 그 품목이 생산국의 법령에 적합하게 제조되고 있음을 | 6. ",
        "original_sentence": "다만, 상용(常用) 의약품, | 것이어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_234",
      "text": "| 제5조(제조판매ᆞ수입 품목의 신고) ① 법 제31 | 조소에서 제조되는 것으로서 해당 품목과 최 |\n| 마. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 233,
        "window_size": 3,
        "char_count": 63,
        "word_count": 17,
        "page_number": 3,
        "window_text": "| 이 지정하는 의약품인 경우에는 안전성ᆞ유효 | 이라 한다)가 아닌 것으로서 다음 각 목의 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n**- 전부 또는 일부 공정 위탁하여 제조시 단위공정별 수탁자명, 소재지 등을 명확하게 기재**\n| 라.  기준및시험방법에 관한 근거자료 | 를 받은 것과 성분이 동일한 정제ᆞ캡슐 | 품으로서 식품의약품안전처장이 고시하는 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 성에 관한 다음 각 호의 자료를 총리령으로 정 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n| 료 | 제 또는 좌제.  다만, 상용(常用) 의약품, | 것이어야 한다.  | 제5조(제조판매ᆞ수입 품목의 신고) ① 법 제31 | 조소에서 제조되는 것으로서 해당 품목과 최 |\n| 마.  시험성적에 관한 자료 | 총 처리기한 70일 | 하는 바에 따라 제출하여야 한다.  다만, 제2호 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | 특 | 성 | 생산하는 국가의 정부 또는 공공기관에서 그 품목이 생산국의 법령에 적합하게 제조되고 있음을 | 6.  의약품의 적정사용 정보제공을 위한 안전성 |\n| 바. ",
        "original_sentence": "| 제5조(제조판매ᆞ수입 품목의 신고) ① 법 제31 | 조소에서 제조되는 것으로서 해당 품목과 최 |\n| 마. "
      }
    },
    {
      "chunk_id": "chunk_235",
      "text": "시험성적에 관한 자료 | 총 처리기한 70일 | 하는 바에 따라 제출하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 234,
        "window_size": 3,
        "char_count": 46,
        "word_count": 13,
        "page_number": 3,
        "window_text": "기준및시험방법에 관한 근거자료 | 를 받은 것과 성분이 동일한 정제ᆞ캡슐 | 품으로서 식품의약품안전처장이 고시하는 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 성에 관한 다음 각 호의 자료를 총리령으로 정 | 어느 하나에 해당하는 품목과 국내에서 이미 |\n| 료 | 제 또는 좌제.  다만, 상용(常用) 의약품, | 것이어야 한다.  | 제5조(제조판매ᆞ수입 품목의 신고) ① 법 제31 | 조소에서 제조되는 것으로서 해당 품목과 최 |\n| 마.  시험성적에 관한 자료 | 총 처리기한 70일 | 하는 바에 따라 제출하여야 한다.  다만, 제2호 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | 특 | 성 | 생산하는 국가의 정부 또는 공공기관에서 그 품목이 생산국의 법령에 적합하게 제조되고 있음을 | 6.  의약품의 적정사용 정보제공을 위한 안전성 |\n| 바.  표준품 및 시약․시액에 관한 자료 | 업소명생략가능 + 상표명 + 제형 + (주성분명단일제 또는 식약처고시명칭) | ② | (수입)의약품품질과/ | (제조)제조소 관할 | 지방청 | 조제2항ᆞ제4항 또는 법 제42조제1항에 따라 | 는 제31조의2에 따라 원료의약품을 등록한 경 | 2) 인체시료를 이용한 약동학 관련 시험 보고서 | 조소에서 제조되는 것으로서 해당 품목과 최 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 증명하는 | “제조증명서” 및 해당 품목이 허가 또는 등록된 국가의 정부 또는 공공기관에서 그 국가의 |\n| 한 다음 각 목의 서류. ",
        "original_sentence": "시험성적에 관한 자료 | 총 처리기한 70일 | 하는 바에 따라 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_236",
      "text": "다만, 제2호 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | 특 | 성 | 생산하는 국가의 정부 또는 공공기관에서 그 품목이 생산국의 법령에 적합하게 제조되고 있음을 | 6. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 235,
        "window_size": 3,
        "char_count": 126,
        "word_count": 34,
        "page_number": 3,
        "window_text": "다만, 상용(常用) 의약품, | 것이어야 한다.  | 제5조(제조판매ᆞ수입 품목의 신고) ① 법 제31 | 조소에서 제조되는 것으로서 해당 품목과 최 |\n| 마.  시험성적에 관한 자료 | 총 처리기한 70일 | 하는 바에 따라 제출하여야 한다.  다만, 제2호 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | 특 | 성 | 생산하는 국가의 정부 또는 공공기관에서 그 품목이 생산국의 법령에 적합하게 제조되고 있음을 | 6.  의약품의 적정사용 정보제공을 위한 안전성 |\n| 바.  표준품 및 시약․시액에 관한 자료 | 업소명생략가능 + 상표명 + 제형 + (주성분명단일제 또는 식약처고시명칭) | ② | (수입)의약품품질과/ | (제조)제조소 관할 | 지방청 | 조제2항ᆞ제4항 또는 법 제42조제1항에 따라 | 는 제31조의2에 따라 원료의약품을 등록한 경 | 2) 인체시료를 이용한 약동학 관련 시험 보고서 | 조소에서 제조되는 것으로서 해당 품목과 최 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 증명하는 | “제조증명서” 및 해당 품목이 허가 또는 등록된 국가의 정부 또는 공공기관에서 그 국가의 |\n| 한 다음 각 목의 서류.  이 경우 첨부서류의 | 또는 의약품 동등성 확보가 필요한 의약 | 품목허가권자로부터 동 품목에 대하여 전공정을 제조 의뢰받아 실제 제조하는 자 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 가. ",
        "original_sentence": "다만, 제2호 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | 특 | 성 | 생산하는 국가의 정부 또는 공공기관에서 그 품목이 생산국의 법령에 적합하게 제조되고 있음을 | 6. "
      }
    },
    {
      "chunk_id": "chunk_237",
      "text": "의약품의 적정사용 정보제공을 위한 안전성 |\n| 바. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 236,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 12,
        "window_text": "| 제5조(제조판매ᆞ수입 품목의 신고) ① 법 제31 | 조소에서 제조되는 것으로서 해당 품목과 최 |\n| 마.  시험성적에 관한 자료 | 총 처리기한 70일 | 하는 바에 따라 제출하여야 한다.  다만, 제2호 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | 특 | 성 | 생산하는 국가의 정부 또는 공공기관에서 그 품목이 생산국의 법령에 적합하게 제조되고 있음을 | 6.  의약품의 적정사용 정보제공을 위한 안전성 |\n| 바.  표준품 및 시약․시액에 관한 자료 | 업소명생략가능 + 상표명 + 제형 + (주성분명단일제 또는 식약처고시명칭) | ② | (수입)의약품품질과/ | (제조)제조소 관할 | 지방청 | 조제2항ᆞ제4항 또는 법 제42조제1항에 따라 | 는 제31조의2에 따라 원료의약품을 등록한 경 | 2) 인체시료를 이용한 약동학 관련 시험 보고서 | 조소에서 제조되는 것으로서 해당 품목과 최 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 증명하는 | “제조증명서” 및 해당 품목이 허가 또는 등록된 국가의 정부 또는 공공기관에서 그 국가의 |\n| 한 다음 각 목의 서류.  이 경우 첨부서류의 | 또는 의약품 동등성 확보가 필요한 의약 | 품목허가권자로부터 동 품목에 대하여 전공정을 제조 의뢰받아 실제 제조하는 자 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 가.  원료약품 및 그 분량에 관한 자료 | 요건 등에 관한 세부 사항은 식품의약품안전 | 품으로서 식품의약품안전처장이 고시하는 | 경우에는 「의약품 등의 안전에 관한 규칙」 별표 1을 적용하되, 동 규칙「의약품 등의 안전에 관한 | 가. ",
        "original_sentence": "의약품의 적정사용 정보제공을 위한 안전성 |\n| 바. "
      }
    },
    {
      "chunk_id": "chunk_238",
      "text": "표준품 및 시약․시액에 관한 자료 | 업소명생략가능 + 상표명 + 제형 + (주성분명단일제 또는 식약처고시명칭) | ② | (수입)의약품품질과/ | (제조)제조소 관할 | 지방청 | 조제2항ᆞ제4항 또는 법 제42조제1항에 따라 | 는 제31조의2에 따라 원료의약품을 등록한 경 | 2) 인체시료를 이용한 약동학 관련 시험 보고서 | 조소에서 제조되는 것으로서 해당 품목과 최 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 증명하는 | “제조증명서” 및 해당 품목이 허가 또는 등록된 국가의 정부 또는 공공기관에서 그 국가의 |\n| 한 다음 각 목의 서류. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 237,
        "window_size": 3,
        "char_count": 315,
        "word_count": 81,
        "page_number": 5,
        "window_text": "시험성적에 관한 자료 | 총 처리기한 70일 | 하는 바에 따라 제출하여야 한다.  다만, 제2호 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | 특 | 성 | 생산하는 국가의 정부 또는 공공기관에서 그 품목이 생산국의 법령에 적합하게 제조되고 있음을 | 6.  의약품의 적정사용 정보제공을 위한 안전성 |\n| 바.  표준품 및 시약․시액에 관한 자료 | 업소명생략가능 + 상표명 + 제형 + (주성분명단일제 또는 식약처고시명칭) | ② | (수입)의약품품질과/ | (제조)제조소 관할 | 지방청 | 조제2항ᆞ제4항 또는 법 제42조제1항에 따라 | 는 제31조의2에 따라 원료의약품을 등록한 경 | 2) 인체시료를 이용한 약동학 관련 시험 보고서 | 조소에서 제조되는 것으로서 해당 품목과 최 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 증명하는 | “제조증명서” 및 해당 품목이 허가 또는 등록된 국가의 정부 또는 공공기관에서 그 국가의 |\n| 한 다음 각 목의 서류.  이 경우 첨부서류의 | 또는 의약품 동등성 확보가 필요한 의약 | 품목허가권자로부터 동 품목에 대하여 전공정을 제조 의뢰받아 실제 제조하는 자 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 가.  원료약품 및 그 분량에 관한 자료 | 요건 등에 관한 세부 사항은 식품의약품안전 | 품으로서 식품의약품안전처장이 고시하는 | 경우에는 「의약품 등의 안전에 관한 규칙」 별표 1을 적용하되, 동 규칙「의약품 등의 안전에 관한 | 가.  법 제51조제1항에 따른 대한민국약전(이 | 7. ",
        "original_sentence": "표준품 및 시약․시액에 관한 자료 | 업소명생략가능 + 상표명 + 제형 + (주성분명단일제 또는 식약처고시명칭) | ② | (수입)의약품품질과/ | (제조)제조소 관할 | 지방청 | 조제2항ᆞ제4항 또는 법 제42조제1항에 따라 | 는 제31조의2에 따라 원료의약품을 등록한 경 | 2) 인체시료를 이용한 약동학 관련 시험 보고서 | 조소에서 제조되는 것으로서 해당 품목과 최 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 증명하는 | “제조증명서” 및 해당 품목이 허가 또는 등록된 국가의 정부 또는 공공기관에서 그 국가의 |\n| 한 다음 각 목의 서류. "
      }
    },
    {
      "chunk_id": "chunk_239",
      "text": "이 경우 첨부서류의 | 또는 의약품 동등성 확보가 필요한 의약 | 품목허가권자로부터 동 품목에 대하여 전공정을 제조 의뢰받아 실제 제조하는 자 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 238,
        "window_size": 3,
        "char_count": 140,
        "word_count": 37,
        "page_number": 5,
        "window_text": "다만, 제2호 | 허가된 품목을 제조하는 제조소와 동일한 제 |\n| 고가(高價) 의약품, 단일성분의 의약품 | 특 | 성 | 생산하는 국가의 정부 또는 공공기관에서 그 품목이 생산국의 법령에 적합하게 제조되고 있음을 | 6.  의약품의 적정사용 정보제공을 위한 안전성 |\n| 바.  표준품 및 시약․시액에 관한 자료 | 업소명생략가능 + 상표명 + 제형 + (주성분명단일제 또는 식약처고시명칭) | ② | (수입)의약품품질과/ | (제조)제조소 관할 | 지방청 | 조제2항ᆞ제4항 또는 법 제42조제1항에 따라 | 는 제31조의2에 따라 원료의약품을 등록한 경 | 2) 인체시료를 이용한 약동학 관련 시험 보고서 | 조소에서 제조되는 것으로서 해당 품목과 최 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 증명하는 | “제조증명서” 및 해당 품목이 허가 또는 등록된 국가의 정부 또는 공공기관에서 그 국가의 |\n| 한 다음 각 목의 서류.  이 경우 첨부서류의 | 또는 의약품 동등성 확보가 필요한 의약 | 품목허가권자로부터 동 품목에 대하여 전공정을 제조 의뢰받아 실제 제조하는 자 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 가.  원료약품 및 그 분량에 관한 자료 | 요건 등에 관한 세부 사항은 식품의약품안전 | 품으로서 식품의약품안전처장이 고시하는 | 경우에는 「의약품 등의 안전에 관한 규칙」 별표 1을 적용하되, 동 규칙「의약품 등의 안전에 관한 | 가.  법 제51조제1항에 따른 대한민국약전(이 | 7.  대한민국약전 및 법 제52조에 따른 의약품 | 호와 같다. ",
        "original_sentence": "이 경우 첨부서류의 | 또는 의약품 동등성 확보가 필요한 의약 | 품목허가권자로부터 동 품목에 대하여 전공정을 제조 의뢰받아 실제 제조하는 자 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 가. "
      }
    },
    {
      "chunk_id": "chunk_240",
      "text": "원료약품 및 그 분량에 관한 자료 | 요건 등에 관한 세부 사항은 식품의약품안전 | 품으로서 식품의약품안전처장이 고시하는 | 경우에는 「의약품 등의 안전에 관한 규칙」 별표 1을 적용하되, 동 규칙「의약품 등의 안전에 관한 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 239,
        "window_size": 3,
        "char_count": 130,
        "word_count": 34,
        "page_number": 1,
        "window_text": "의약품의 적정사용 정보제공을 위한 안전성 |\n| 바.  표준품 및 시약․시액에 관한 자료 | 업소명생략가능 + 상표명 + 제형 + (주성분명단일제 또는 식약처고시명칭) | ② | (수입)의약품품질과/ | (제조)제조소 관할 | 지방청 | 조제2항ᆞ제4항 또는 법 제42조제1항에 따라 | 는 제31조의2에 따라 원료의약품을 등록한 경 | 2) 인체시료를 이용한 약동학 관련 시험 보고서 | 조소에서 제조되는 것으로서 해당 품목과 최 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 증명하는 | “제조증명서” 및 해당 품목이 허가 또는 등록된 국가의 정부 또는 공공기관에서 그 국가의 |\n| 한 다음 각 목의 서류.  이 경우 첨부서류의 | 또는 의약품 동등성 확보가 필요한 의약 | 품목허가권자로부터 동 품목에 대하여 전공정을 제조 의뢰받아 실제 제조하는 자 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 가.  원료약품 및 그 분량에 관한 자료 | 요건 등에 관한 세부 사항은 식품의약품안전 | 품으로서 식품의약품안전처장이 고시하는 | 경우에는 「의약품 등의 안전에 관한 규칙」 별표 1을 적용하되, 동 규칙「의약품 등의 안전에 관한 | 가.  법 제51조제1항에 따른 대한민국약전(이 | 7.  대한민국약전 및 법 제52조에 따른 의약품 | 호와 같다.  다만, 제4조제1항제1호에 따라 안전 |\n| 나. ",
        "original_sentence": "원료약품 및 그 분량에 관한 자료 | 요건 등에 관한 세부 사항은 식품의약품안전 | 품으로서 식품의약품안전처장이 고시하는 | 경우에는 「의약품 등의 안전에 관한 규칙」 별표 1을 적용하되, 동 규칙「의약품 등의 안전에 관한 | 가. "
      }
    },
    {
      "chunk_id": "chunk_241",
      "text": "법 제51조제1항에 따른 대한민국약전(이 | 7. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 240,
        "window_size": 3,
        "char_count": 28,
        "word_count": 6,
        "page_number": 3,
        "window_text": "표준품 및 시약․시액에 관한 자료 | 업소명생략가능 + 상표명 + 제형 + (주성분명단일제 또는 식약처고시명칭) | ② | (수입)의약품품질과/ | (제조)제조소 관할 | 지방청 | 조제2항ᆞ제4항 또는 법 제42조제1항에 따라 | 는 제31조의2에 따라 원료의약품을 등록한 경 | 2) 인체시료를 이용한 약동학 관련 시험 보고서 | 조소에서 제조되는 것으로서 해당 품목과 최 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 증명하는 | “제조증명서” 및 해당 품목이 허가 또는 등록된 국가의 정부 또는 공공기관에서 그 국가의 |\n| 한 다음 각 목의 서류.  이 경우 첨부서류의 | 또는 의약품 동등성 확보가 필요한 의약 | 품목허가권자로부터 동 품목에 대하여 전공정을 제조 의뢰받아 실제 제조하는 자 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 가.  원료약품 및 그 분량에 관한 자료 | 요건 등에 관한 세부 사항은 식품의약품안전 | 품으로서 식품의약품안전처장이 고시하는 | 경우에는 「의약품 등의 안전에 관한 규칙」 별표 1을 적용하되, 동 규칙「의약품 등의 안전에 관한 | 가.  법 제51조제1항에 따른 대한민국약전(이 | 7.  대한민국약전 및 법 제52조에 따른 의약품 | 호와 같다.  다만, 제4조제1항제1호에 따라 안전 |\n| 나.  제조방법에 관한 자료 | 처장이 고시하는 바에 따른다. ",
        "original_sentence": "법 제51조제1항에 따른 대한민국약전(이 | 7. "
      }
    },
    {
      "chunk_id": "chunk_242",
      "text": "대한민국약전 및 법 제52조에 따른 의약품 | 호와 같다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 241,
        "window_size": 3,
        "char_count": 33,
        "word_count": 9,
        "page_number": 3,
        "window_text": "이 경우 첨부서류의 | 또는 의약품 동등성 확보가 필요한 의약 | 품목허가권자로부터 동 품목에 대하여 전공정을 제조 의뢰받아 실제 제조하는 자 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 종원액이 동일한 생물학적제제등은 제출하지 |\n| 가.  원료약품 및 그 분량에 관한 자료 | 요건 등에 관한 세부 사항은 식품의약품안전 | 품으로서 식품의약품안전처장이 고시하는 | 경우에는 「의약품 등의 안전에 관한 규칙」 별표 1을 적용하되, 동 규칙「의약품 등의 안전에 관한 | 가.  법 제51조제1항에 따른 대한민국약전(이 | 7.  대한민국약전 및 법 제52조에 따른 의약품 | 호와 같다.  다만, 제4조제1항제1호에 따라 안전 |\n| 나.  제조방법에 관한 자료 | 처장이 고시하는 바에 따른다.  | 것이어야 한다. ",
        "original_sentence": "대한민국약전 및 법 제52조에 따른 의약품 | 호와 같다. "
      }
    },
    {
      "chunk_id": "chunk_243",
      "text": "다만, 제4조제1항제1호에 따라 안전 |\n| 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 242,
        "window_size": 3,
        "char_count": 28,
        "word_count": 7,
        "page_number": 3,
        "window_text": "원료약품 및 그 분량에 관한 자료 | 요건 등에 관한 세부 사항은 식품의약품안전 | 품으로서 식품의약품안전처장이 고시하는 | 경우에는 「의약품 등의 안전에 관한 규칙」 별표 1을 적용하되, 동 규칙「의약품 등의 안전에 관한 | 가.  법 제51조제1항에 따른 대한민국약전(이 | 7.  대한민국약전 및 법 제52조에 따른 의약품 | 호와 같다.  다만, 제4조제1항제1호에 따라 안전 |\n| 나.  제조방법에 관한 자료 | 처장이 고시하는 바에 따른다.  | 것이어야 한다.  |\n| 품목허가권자이면서, 동 품목에 대하여 일부공정은 직접제조하고, 일부공정은 | 가. ",
        "original_sentence": "다만, 제4조제1항제1호에 따라 안전 |\n| 나. "
      }
    },
    {
      "chunk_id": "chunk_244",
      "text": "제조방법에 관한 자료 | 처장이 고시하는 바에 따른다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 243,
        "window_size": 3,
        "char_count": 31,
        "word_count": 8,
        "page_number": 3,
        "window_text": "법 제51조제1항에 따른 대한민국약전(이 | 7.  대한민국약전 및 법 제52조에 따른 의약품 | 호와 같다.  다만, 제4조제1항제1호에 따라 안전 |\n| 나.  제조방법에 관한 자료 | 처장이 고시하는 바에 따른다.  | 것이어야 한다.  |\n| 품목허가권자이면서, 동 품목에 대하여 일부공정은 직접제조하고, 일부공정은 | 가.  법 제51조제1항에 따른 대한민국약전(이 | 성ᆞ유효성에 관한 자료를 제출하여야 하는 품 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 다. ",
        "original_sentence": "제조방법에 관한 자료 | 처장이 고시하는 바에 따른다. "
      }
    },
    {
      "chunk_id": "chunk_245",
      "text": "| 것이어야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 244,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 5,
        "window_text": "대한민국약전 및 법 제52조에 따른 의약품 | 호와 같다.  다만, 제4조제1항제1호에 따라 안전 |\n| 나.  제조방법에 관한 자료 | 처장이 고시하는 바에 따른다.  | 것이어야 한다.  |\n| 품목허가권자이면서, 동 품목에 대하여 일부공정은 직접제조하고, 일부공정은 | 가.  법 제51조제1항에 따른 대한민국약전(이 | 성ᆞ유효성에 관한 자료를 제출하여야 하는 품 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 다.  기준및시험방법에 관한 근거자료 | 8. ",
        "original_sentence": "| 것이어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_246",
      "text": "|\n| 품목허가권자이면서, 동 품목에 대하여 일부공정은 직접제조하고, 일부공정은 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 245,
        "window_size": 3,
        "char_count": 50,
        "word_count": 11,
        "page_number": 3,
        "window_text": "다만, 제4조제1항제1호에 따라 안전 |\n| 나.  제조방법에 관한 자료 | 처장이 고시하는 바에 따른다.  | 것이어야 한다.  |\n| 품목허가권자이면서, 동 품목에 대하여 일부공정은 직접제조하고, 일부공정은 | 가.  법 제51조제1항에 따른 대한민국약전(이 | 성ᆞ유효성에 관한 자료를 제출하여야 하는 품 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 다.  기준및시험방법에 관한 근거자료 | 8.  의약품의 분류 등 국민보건을 위하여 필요하 |\n| 목, 제4조제1항제10호에 따라 등재의약품의 안 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 라. ",
        "original_sentence": "|\n| 품목허가권자이면서, 동 품목에 대하여 일부공정은 직접제조하고, 일부공정은 | 가. "
      }
    },
    {
      "chunk_id": "chunk_247",
      "text": "법 제51조제1항에 따른 대한민국약전(이 | 성ᆞ유효성에 관한 자료를 제출하여야 하는 품 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 246,
        "window_size": 3,
        "char_count": 82,
        "word_count": 20,
        "page_number": 3,
        "window_text": "제조방법에 관한 자료 | 처장이 고시하는 바에 따른다.  | 것이어야 한다.  |\n| 품목허가권자이면서, 동 품목에 대하여 일부공정은 직접제조하고, 일부공정은 | 가.  법 제51조제1항에 따른 대한민국약전(이 | 성ᆞ유효성에 관한 자료를 제출하여야 하는 품 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 다.  기준및시험방법에 관한 근거자료 | 8.  의약품의 분류 등 국민보건을 위하여 필요하 |\n| 목, 제4조제1항제10호에 따라 등재의약품의 안 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 라.  시험성적에 관한 자료 | 제조 | 7) 허가증 수령방법(온라인, 방문, 웹수령) 선택 | 1996 | 1 | 1 | 2 | 2008 | 5 | 2 | 7 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 다른 제조업자에게 의뢰하여 제조하는 자 |\n| 한 다음 각 목의 서류. ",
        "original_sentence": "법 제51조제1항에 따른 대한민국약전(이 | 성ᆞ유효성에 관한 자료를 제출하여야 하는 품 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 다. "
      }
    },
    {
      "chunk_id": "chunk_248",
      "text": "기준및시험방법에 관한 근거자료 | 8. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 247,
        "window_size": 3,
        "char_count": 22,
        "word_count": 5,
        "page_number": 5,
        "window_text": "| 것이어야 한다.  |\n| 품목허가권자이면서, 동 품목에 대하여 일부공정은 직접제조하고, 일부공정은 | 가.  법 제51조제1항에 따른 대한민국약전(이 | 성ᆞ유효성에 관한 자료를 제출하여야 하는 품 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 다.  기준및시험방법에 관한 근거자료 | 8.  의약품의 분류 등 국민보건을 위하여 필요하 |\n| 목, 제4조제1항제10호에 따라 등재의약품의 안 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 라.  시험성적에 관한 자료 | 제조 | 7) 허가증 수령방법(온라인, 방문, 웹수령) 선택 | 1996 | 1 | 1 | 2 | 2008 | 5 | 2 | 7 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 다른 제조업자에게 의뢰하여 제조하는 자 |\n| 한 다음 각 목의 서류.  이 경우 첨부서류의 | 이라 한다)의 정부 또는 공공기관에서 그 | 3. ",
        "original_sentence": "기준및시험방법에 관한 근거자료 | 8. "
      }
    },
    {
      "chunk_id": "chunk_249",
      "text": "의약품의 분류 등 국민보건을 위하여 필요하 |\n| 목, 제4조제1항제10호에 따라 등재의약품의 안 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 라. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 248,
        "window_size": 3,
        "char_count": 87,
        "word_count": 22,
        "page_number": 3,
        "window_text": "|\n| 품목허가권자이면서, 동 품목에 대하여 일부공정은 직접제조하고, 일부공정은 | 가.  법 제51조제1항에 따른 대한민국약전(이 | 성ᆞ유효성에 관한 자료를 제출하여야 하는 품 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 다.  기준및시험방법에 관한 근거자료 | 8.  의약품의 분류 등 국민보건을 위하여 필요하 |\n| 목, 제4조제1항제10호에 따라 등재의약품의 안 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 라.  시험성적에 관한 자료 | 제조 | 7) 허가증 수령방법(온라인, 방문, 웹수령) 선택 | 1996 | 1 | 1 | 2 | 2008 | 5 | 2 | 7 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 다른 제조업자에게 의뢰하여 제조하는 자 |\n| 한 다음 각 목의 서류.  이 경우 첨부서류의 | 이라 한다)의 정부 또는 공공기관에서 그 | 3.  제4조제1항제3호 및 제5호에 해당하는 자료 | 예 | 회사와 | 6호, 제5조제2항제5호 및 같은 조 제3항 단서 | 목의 자료. ",
        "original_sentence": "의약품의 분류 등 국민보건을 위하여 필요하 |\n| 목, 제4조제1항제10호에 따라 등재의약품의 안 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 라. "
      }
    },
    {
      "chunk_id": "chunk_250",
      "text": "시험성적에 관한 자료 | 제조 | 7) 허가증 수령방법(온라인, 방문, 웹수령) 선택 | 1996 | 1 | 1 | 2 | 2008 | 5 | 2 | 7 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 다른 제조업자에게 의뢰하여 제조하는 자 |\n| 한 다음 각 목의 서류. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 249,
        "window_size": 3,
        "char_count": 156,
        "word_count": 50,
        "page_number": 3,
        "window_text": "법 제51조제1항에 따른 대한민국약전(이 | 성ᆞ유효성에 관한 자료를 제출하여야 하는 품 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 다.  기준및시험방법에 관한 근거자료 | 8.  의약품의 분류 등 국민보건을 위하여 필요하 |\n| 목, 제4조제1항제10호에 따라 등재의약품의 안 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 라.  시험성적에 관한 자료 | 제조 | 7) 허가증 수령방법(온라인, 방문, 웹수령) 선택 | 1996 | 1 | 1 | 2 | 2008 | 5 | 2 | 7 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 다른 제조업자에게 의뢰하여 제조하는 자 |\n| 한 다음 각 목의 서류.  이 경우 첨부서류의 | 이라 한다)의 정부 또는 공공기관에서 그 | 3.  제4조제1항제3호 및 제5호에 해당하는 자료 | 예 | 회사와 | 6호, 제5조제2항제5호 및 같은 조 제3항 단서 | 목의 자료.  다만, 제15조제1항에 따라 이미 | 및 품질관리기준 실시상황 평가에 필요한 | 예 | 럽게 안정하게 되거나 지속적인 통계적 확률에 따라 | 13N 제제에서의 18F 불순물). ",
        "original_sentence": "시험성적에 관한 자료 | 제조 | 7) 허가증 수령방법(온라인, 방문, 웹수령) 선택 | 1996 | 1 | 1 | 2 | 2008 | 5 | 2 | 7 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 다른 제조업자에게 의뢰하여 제조하는 자 |\n| 한 다음 각 목의 서류. "
      }
    },
    {
      "chunk_id": "chunk_251",
      "text": "이 경우 첨부서류의 | 이라 한다)의 정부 또는 공공기관에서 그 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 250,
        "window_size": 3,
        "char_count": 41,
        "word_count": 12,
        "page_number": 3,
        "window_text": "기준및시험방법에 관한 근거자료 | 8.  의약품의 분류 등 국민보건을 위하여 필요하 |\n| 목, 제4조제1항제10호에 따라 등재의약품의 안 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 라.  시험성적에 관한 자료 | 제조 | 7) 허가증 수령방법(온라인, 방문, 웹수령) 선택 | 1996 | 1 | 1 | 2 | 2008 | 5 | 2 | 7 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 다른 제조업자에게 의뢰하여 제조하는 자 |\n| 한 다음 각 목의 서류.  이 경우 첨부서류의 | 이라 한다)의 정부 또는 공공기관에서 그 | 3.  제4조제1항제3호 및 제5호에 해당하는 자료 | 예 | 회사와 | 6호, 제5조제2항제5호 및 같은 조 제3항 단서 | 목의 자료.  다만, 제15조제1항에 따라 이미 | 및 품질관리기준 실시상황 평가에 필요한 | 예 | 럽게 안정하게 되거나 지속적인 통계적 확률에 따라 | 13N 제제에서의 18F 불순물).  반감기 측정은 감마선스 | ② 제1항에도 불구하고 다음 각 호의 어느 하 | Fluorine-18 (18F) | 109.77 분 | 입 품목허가의 변경, 의약품등 제조판매ᆞ수입 | 나. ",
        "original_sentence": "이 경우 첨부서류의 | 이라 한다)의 정부 또는 공공기관에서 그 | 3. "
      }
    },
    {
      "chunk_id": "chunk_252",
      "text": "제4조제1항제3호 및 제5호에 해당하는 자료 | 예 | 회사와 | 6호, 제5조제2항제5호 및 같은 조 제3항 단서 | 목의 자료. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 251,
        "window_size": 3,
        "char_count": 74,
        "word_count": 20,
        "page_number": 3,
        "window_text": "의약품의 분류 등 국민보건을 위하여 필요하 |\n| 목, 제4조제1항제10호에 따라 등재의약품의 안 | 하 \"대한민국약전\"이라 한다)에 실려 있 |\n| 라.  시험성적에 관한 자료 | 제조 | 7) 허가증 수령방법(온라인, 방문, 웹수령) 선택 | 1996 | 1 | 1 | 2 | 2008 | 5 | 2 | 7 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 다른 제조업자에게 의뢰하여 제조하는 자 |\n| 한 다음 각 목의 서류.  이 경우 첨부서류의 | 이라 한다)의 정부 또는 공공기관에서 그 | 3.  제4조제1항제3호 및 제5호에 해당하는 자료 | 예 | 회사와 | 6호, 제5조제2항제5호 및 같은 조 제3항 단서 | 목의 자료.  다만, 제15조제1항에 따라 이미 | 및 품질관리기준 실시상황 평가에 필요한 | 예 | 럽게 안정하게 되거나 지속적인 통계적 확률에 따라 | 13N 제제에서의 18F 불순물).  반감기 측정은 감마선스 | ② 제1항에도 불구하고 다음 각 호의 어느 하 | Fluorine-18 (18F) | 109.77 분 | 입 품목허가의 변경, 의약품등 제조판매ᆞ수입 | 나.  완제의약품에 관한 자료 | 4. ",
        "original_sentence": "제4조제1항제3호 및 제5호에 해당하는 자료 | 예 | 회사와 | 6호, 제5조제2항제5호 및 같은 조 제3항 단서 | 목의 자료. "
      }
    },
    {
      "chunk_id": "chunk_253",
      "text": "다만, 제15조제1항에 따라 이미 | 및 품질관리기준 실시상황 평가에 필요한 | 예 | 럽게 안정하게 되거나 지속적인 통계적 확률에 따라 | 13N 제제에서의 18F 불순물). ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 252,
        "window_size": 3,
        "char_count": 99,
        "word_count": 25,
        "page_number": 3,
        "window_text": "시험성적에 관한 자료 | 제조 | 7) 허가증 수령방법(온라인, 방문, 웹수령) 선택 | 1996 | 1 | 1 | 2 | 2008 | 5 | 2 | 7 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 다른 제조업자에게 의뢰하여 제조하는 자 |\n| 한 다음 각 목의 서류.  이 경우 첨부서류의 | 이라 한다)의 정부 또는 공공기관에서 그 | 3.  제4조제1항제3호 및 제5호에 해당하는 자료 | 예 | 회사와 | 6호, 제5조제2항제5호 및 같은 조 제3항 단서 | 목의 자료.  다만, 제15조제1항에 따라 이미 | 및 품질관리기준 실시상황 평가에 필요한 | 예 | 럽게 안정하게 되거나 지속적인 통계적 확률에 따라 | 13N 제제에서의 18F 불순물).  반감기 측정은 감마선스 | ② 제1항에도 불구하고 다음 각 호의 어느 하 | Fluorine-18 (18F) | 109.77 분 | 입 품목허가의 변경, 의약품등 제조판매ᆞ수입 | 나.  완제의약품에 관한 자료 | 4.  그 밖에 필요한 자료 | 나. ",
        "original_sentence": "다만, 제15조제1항에 따라 이미 | 및 품질관리기준 실시상황 평가에 필요한 | 예 | 럽게 안정하게 되거나 지속적인 통계적 확률에 따라 | 13N 제제에서의 18F 불순물). "
      }
    },
    {
      "chunk_id": "chunk_254",
      "text": "반감기 측정은 감마선스 | ② 제1항에도 불구하고 다음 각 호의 어느 하 | Fluorine-18 (18F) | 109.77 분 | 입 품목허가의 변경, 의약품등 제조판매ᆞ수입 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 253,
        "window_size": 3,
        "char_count": 104,
        "word_count": 26,
        "page_number": 3,
        "window_text": "이 경우 첨부서류의 | 이라 한다)의 정부 또는 공공기관에서 그 | 3.  제4조제1항제3호 및 제5호에 해당하는 자료 | 예 | 회사와 | 6호, 제5조제2항제5호 및 같은 조 제3항 단서 | 목의 자료.  다만, 제15조제1항에 따라 이미 | 및 품질관리기준 실시상황 평가에 필요한 | 예 | 럽게 안정하게 되거나 지속적인 통계적 확률에 따라 | 13N 제제에서의 18F 불순물).  반감기 측정은 감마선스 | ② 제1항에도 불구하고 다음 각 호의 어느 하 | Fluorine-18 (18F) | 109.77 분 | 입 품목허가의 변경, 의약품등 제조판매ᆞ수입 | 나.  완제의약품에 관한 자료 | 4.  그 밖에 필요한 자료 | 나.  식품의약품안전처장이 인정하는 공정서 | 전성ᆞ유효성에 관한 자료를 근거로 신청하는 | 6) 시판후 사용경험에 대한 보고서 | 다고 판단하여 실시한 안전성ᆞ유효성에 관 | 는 품목 |\n| 마. ",
        "original_sentence": "반감기 측정은 감마선스 | ② 제1항에도 불구하고 다음 각 호의 어느 하 | Fluorine-18 (18F) | 109.77 분 | 입 품목허가의 변경, 의약품등 제조판매ᆞ수입 | 나. "
      }
    },
    {
      "chunk_id": "chunk_255",
      "text": "완제의약품에 관한 자료 | 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 254,
        "window_size": 3,
        "char_count": 18,
        "word_count": 5,
        "page_number": 3,
        "window_text": "제4조제1항제3호 및 제5호에 해당하는 자료 | 예 | 회사와 | 6호, 제5조제2항제5호 및 같은 조 제3항 단서 | 목의 자료.  다만, 제15조제1항에 따라 이미 | 및 품질관리기준 실시상황 평가에 필요한 | 예 | 럽게 안정하게 되거나 지속적인 통계적 확률에 따라 | 13N 제제에서의 18F 불순물).  반감기 측정은 감마선스 | ② 제1항에도 불구하고 다음 각 호의 어느 하 | Fluorine-18 (18F) | 109.77 분 | 입 품목허가의 변경, 의약품등 제조판매ᆞ수입 | 나.  완제의약품에 관한 자료 | 4.  그 밖에 필요한 자료 | 나.  식품의약품안전처장이 인정하는 공정서 | 전성ᆞ유효성에 관한 자료를 근거로 신청하는 | 6) 시판후 사용경험에 대한 보고서 | 다고 판단하여 실시한 안전성ᆞ유효성에 관 | 는 품목 |\n| 마.  표준품 및 시약․시액에 관한 자료 | *시험방법 - 검체 10개에 대해 주 | 심사조정이 | 정에 대해 규정한다. ",
        "original_sentence": "완제의약품에 관한 자료 | 4. "
      }
    },
    {
      "chunk_id": "chunk_256",
      "text": "그 밖에 필요한 자료 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 255,
        "window_size": 3,
        "char_count": 17,
        "word_count": 6,
        "page_number": 6,
        "window_text": "다만, 제15조제1항에 따라 이미 | 및 품질관리기준 실시상황 평가에 필요한 | 예 | 럽게 안정하게 되거나 지속적인 통계적 확률에 따라 | 13N 제제에서의 18F 불순물).  반감기 측정은 감마선스 | ② 제1항에도 불구하고 다음 각 호의 어느 하 | Fluorine-18 (18F) | 109.77 분 | 입 품목허가의 변경, 의약품등 제조판매ᆞ수입 | 나.  완제의약품에 관한 자료 | 4.  그 밖에 필요한 자료 | 나.  식품의약품안전처장이 인정하는 공정서 | 전성ᆞ유효성에 관한 자료를 근거로 신청하는 | 6) 시판후 사용경험에 대한 보고서 | 다고 판단하여 실시한 안전성ᆞ유효성에 관 | 는 품목 |\n| 마.  표준품 및 시약․시액에 관한 자료 | *시험방법 - 검체 10개에 대해 주 | 심사조정이 | 정에 대해 규정한다.  | 다. ",
        "original_sentence": "그 밖에 필요한 자료 | 나. "
      }
    },
    {
      "chunk_id": "chunk_257",
      "text": "식품의약품안전처장이 인정하는 공정서 | 전성ᆞ유효성에 관한 자료를 근거로 신청하는 | 6) 시판후 사용경험에 대한 보고서 | 다고 판단하여 실시한 안전성ᆞ유효성에 관 | 는 품목 |\n| 마. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 256,
        "window_size": 3,
        "char_count": 107,
        "word_count": 27,
        "page_number": 3,
        "window_text": "반감기 측정은 감마선스 | ② 제1항에도 불구하고 다음 각 호의 어느 하 | Fluorine-18 (18F) | 109.77 분 | 입 품목허가의 변경, 의약품등 제조판매ᆞ수입 | 나.  완제의약품에 관한 자료 | 4.  그 밖에 필요한 자료 | 나.  식품의약품안전처장이 인정하는 공정서 | 전성ᆞ유효성에 관한 자료를 근거로 신청하는 | 6) 시판후 사용경험에 대한 보고서 | 다고 판단하여 실시한 안전성ᆞ유효성에 관 | 는 품목 |\n| 마.  표준품 및 시약․시액에 관한 자료 | *시험방법 - 검체 10개에 대해 주 | 심사조정이 | 정에 대해 규정한다.  | 다.  | 저 | 장 | Phosphorus-32 (32P) | 14.26 일 | 표적원소(입사입자, 방출입자 또는 방사선)발생원소 | 1998 | 6 | 6 | 2009 | 2 | 3 | 5 | 소를 | 설치할 | 수 | 있다. ",
        "original_sentence": "식품의약품안전처장이 인정하는 공정서 | 전성ᆞ유효성에 관한 자료를 근거로 신청하는 | 6) 시판후 사용경험에 대한 보고서 | 다고 판단하여 실시한 안전성ᆞ유효성에 관 | 는 품목 |\n| 마. "
      }
    },
    {
      "chunk_id": "chunk_258",
      "text": "표준품 및 시약․시액에 관한 자료 | *시험방법 - 검체 10개에 대해 주 | 심사조정이 | 정에 대해 규정한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 257,
        "window_size": 3,
        "char_count": 64,
        "word_count": 18,
        "page_number": 3,
        "window_text": "완제의약품에 관한 자료 | 4.  그 밖에 필요한 자료 | 나.  식품의약품안전처장이 인정하는 공정서 | 전성ᆞ유효성에 관한 자료를 근거로 신청하는 | 6) 시판후 사용경험에 대한 보고서 | 다고 판단하여 실시한 안전성ᆞ유효성에 관 | 는 품목 |\n| 마.  표준품 및 시약․시액에 관한 자료 | *시험방법 - 검체 10개에 대해 주 | 심사조정이 | 정에 대해 규정한다.  | 다.  | 저 | 장 | Phosphorus-32 (32P) | 14.26 일 | 표적원소(입사입자, 방출입자 또는 방사선)발생원소 | 1998 | 6 | 6 | 2009 | 2 | 3 | 5 | 소를 | 설치할 | 수 | 있다.  | <개정 | 2008.2.29., | 당한다) | (제조의뢰자) |\n| 요건 등에 관한 세부 사항은 식품의약품안전 | 품목이 생산국의 법령에 적합하게 제조되 | 업소명 + 주성분명단일제 + 제형 | 의약품의 품목허가․신고․심사규정｣ | 방사성물질 합성을 위한 화학물질 전구체: 만일 방사 | 등록된 원료의약품의 경우에는 제출하지 아 | (법 제27조제2항제1호에 따라 의약품 동등 | 자료. ",
        "original_sentence": "표준품 및 시약․시액에 관한 자료 | *시험방법 - 검체 10개에 대해 주 | 심사조정이 | 정에 대해 규정한다. "
      }
    },
    {
      "chunk_id": "chunk_259",
      "text": "| 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 258,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 9,
        "window_text": "그 밖에 필요한 자료 | 나.  식품의약품안전처장이 인정하는 공정서 | 전성ᆞ유효성에 관한 자료를 근거로 신청하는 | 6) 시판후 사용경험에 대한 보고서 | 다고 판단하여 실시한 안전성ᆞ유효성에 관 | 는 품목 |\n| 마.  표준품 및 시약․시액에 관한 자료 | *시험방법 - 검체 10개에 대해 주 | 심사조정이 | 정에 대해 규정한다.  | 다.  | 저 | 장 | Phosphorus-32 (32P) | 14.26 일 | 표적원소(입사입자, 방출입자 또는 방사선)발생원소 | 1998 | 6 | 6 | 2009 | 2 | 3 | 5 | 소를 | 설치할 | 수 | 있다.  | <개정 | 2008.2.29., | 당한다) | (제조의뢰자) |\n| 요건 등에 관한 세부 사항은 식품의약품안전 | 품목이 생산국의 법령에 적합하게 제조되 | 업소명 + 주성분명단일제 + 제형 | 의약품의 품목허가․신고․심사규정｣ | 방사성물질 합성을 위한 화학물질 전구체: 만일 방사 | 등록된 원료의약품의 경우에는 제출하지 아 | (법 제27조제2항제1호에 따라 의약품 동등 | 자료.  다만, 둘 이상의 제조판매·수입 품 | 의견조율이 | 필요한가? ",
        "original_sentence": "| 다. "
      }
    },
    {
      "chunk_id": "chunk_260",
      "text": "| 저 | 장 | Phosphorus-32 (32P) | 14.26 일 | 표적원소(입사입자, 방출입자 또는 방사선)발생원소 | 1998 | 6 | 6 | 2009 | 2 | 3 | 5 | 소를 | 설치할 | 수 | 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 259,
        "window_size": 3,
        "char_count": 125,
        "word_count": 37,
        "page_number": 3,
        "window_text": "식품의약품안전처장이 인정하는 공정서 | 전성ᆞ유효성에 관한 자료를 근거로 신청하는 | 6) 시판후 사용경험에 대한 보고서 | 다고 판단하여 실시한 안전성ᆞ유효성에 관 | 는 품목 |\n| 마.  표준품 및 시약․시액에 관한 자료 | *시험방법 - 검체 10개에 대해 주 | 심사조정이 | 정에 대해 규정한다.  | 다.  | 저 | 장 | Phosphorus-32 (32P) | 14.26 일 | 표적원소(입사입자, 방출입자 또는 방사선)발생원소 | 1998 | 6 | 6 | 2009 | 2 | 3 | 5 | 소를 | 설치할 | 수 | 있다.  | <개정 | 2008.2.29., | 당한다) | (제조의뢰자) |\n| 요건 등에 관한 세부 사항은 식품의약품안전 | 품목이 생산국의 법령에 적합하게 제조되 | 업소명 + 주성분명단일제 + 제형 | 의약품의 품목허가․신고․심사규정｣ | 방사성물질 합성을 위한 화학물질 전구체: 만일 방사 | 등록된 원료의약품의 경우에는 제출하지 아 | (법 제27조제2항제1호에 따라 의약품 동등 | 자료.  다만, 둘 이상의 제조판매·수입 품 | 의견조율이 | 필요한가?  | 회의 개최 | 별표 8 참조 | 구분 | * 단, ‘15.7.1 부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 「의약품등의 | 8) 파일 저장(“*.flz\" 파일 생성) | 품목신고의 변경을 하려는 경우에는 지방청장을 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 1) 장기보존시험 또는 가속시험자료 | (수입, 제조품목 공통) | 의약품, 제11조에 따라 제조판매ᆞ수입 품목허 | 7) 증례기록서와 개별 환자 목록 | 한 자료 검토 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 13N | 3 | 1.4 | 201Tl | 10 | 4.7 | 사바늘로 10회 반복하여 찌른 | 필요한가 | 의 개정규정에도 불구하고 종전의 규정에 따른 | *시험방법 - 좌동 | 또 다른 양성자와 중성자의 불안정한 조합으로 변환될 | 펙트럼측정법에 더하여 확인할 필요가 있다. ",
        "original_sentence": "| 저 | 장 | Phosphorus-32 (32P) | 14.26 일 | 표적원소(입사입자, 방출입자 또는 방사선)발생원소 | 1998 | 6 | 6 | 2009 | 2 | 3 | 5 | 소를 | 설치할 | 수 | 있다. "
      }
    },
    {
      "chunk_id": "chunk_261",
      "text": "| <개정 | 2008.2.29., | 당한다) | (제조의뢰자) |\n| 요건 등에 관한 세부 사항은 식품의약품안전 | 품목이 생산국의 법령에 적합하게 제조되 | 업소명 + 주성분명단일제 + 제형 | 의약품의 품목허가․신고․심사규정｣ | 방사성물질 합성을 위한 화학물질 전구체: 만일 방사 | 등록된 원료의약품의 경우에는 제출하지 아 | (법 제27조제2항제1호에 따라 의약품 동등 | 자료. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 260,
        "window_size": 3,
        "char_count": 220,
        "word_count": 53,
        "page_number": 3,
        "window_text": "표준품 및 시약․시액에 관한 자료 | *시험방법 - 검체 10개에 대해 주 | 심사조정이 | 정에 대해 규정한다.  | 다.  | 저 | 장 | Phosphorus-32 (32P) | 14.26 일 | 표적원소(입사입자, 방출입자 또는 방사선)발생원소 | 1998 | 6 | 6 | 2009 | 2 | 3 | 5 | 소를 | 설치할 | 수 | 있다.  | <개정 | 2008.2.29., | 당한다) | (제조의뢰자) |\n| 요건 등에 관한 세부 사항은 식품의약품안전 | 품목이 생산국의 법령에 적합하게 제조되 | 업소명 + 주성분명단일제 + 제형 | 의약품의 품목허가․신고․심사규정｣ | 방사성물질 합성을 위한 화학물질 전구체: 만일 방사 | 등록된 원료의약품의 경우에는 제출하지 아 | (법 제27조제2항제1호에 따라 의약품 동등 | 자료.  다만, 둘 이상의 제조판매·수입 품 | 의견조율이 | 필요한가?  | 회의 개최 | 별표 8 참조 | 구분 | * 단, ‘15.7.1 부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 「의약품등의 | 8) 파일 저장(“*.flz\" 파일 생성) | 품목신고의 변경을 하려는 경우에는 지방청장을 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 1) 장기보존시험 또는 가속시험자료 | (수입, 제조품목 공통) | 의약품, 제11조에 따라 제조판매ᆞ수입 품목허 | 7) 증례기록서와 개별 환자 목록 | 한 자료 검토 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 13N | 3 | 1.4 | 201Tl | 10 | 4.7 | 사바늘로 10회 반복하여 찌른 | 필요한가 | 의 개정규정에도 불구하고 종전의 규정에 따른 | *시험방법 - 좌동 | 또 다른 양성자와 중성자의 불안정한 조합으로 변환될 | 펙트럼측정법에 더하여 확인할 필요가 있다.  | ③ 제1항에 따라 의약외품의 제조업 신고를 하 | Phosphorus-33 (33P) | 25.34 일 | 1999 | 2 | 1 | 3 | 2010 | 2 | 7 | 9 | 2010.1.18., 2013.3.23.> | 용법･ | 표적물질(TARGET MATERIALS) | ⑪ 제1항부터 제4항까지 및 제9항에 따른 의약 | 나. ",
        "original_sentence": "| <개정 | 2008.2.29., | 당한다) | (제조의뢰자) |\n| 요건 등에 관한 세부 사항은 식품의약품안전 | 품목이 생산국의 법령에 적합하게 제조되 | 업소명 + 주성분명단일제 + 제형 | 의약품의 품목허가․신고․심사규정｣ | 방사성물질 합성을 위한 화학물질 전구체: 만일 방사 | 등록된 원료의약품의 경우에는 제출하지 아 | (법 제27조제2항제1호에 따라 의약품 동등 | 자료. "
      }
    },
    {
      "chunk_id": "chunk_262",
      "text": "다만, 둘 이상의 제조판매·수입 품 | 의견조율이 | 필요한가? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 261,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| 다.  | 저 | 장 | Phosphorus-32 (32P) | 14.26 일 | 표적원소(입사입자, 방출입자 또는 방사선)발생원소 | 1998 | 6 | 6 | 2009 | 2 | 3 | 5 | 소를 | 설치할 | 수 | 있다.  | <개정 | 2008.2.29., | 당한다) | (제조의뢰자) |\n| 요건 등에 관한 세부 사항은 식품의약품안전 | 품목이 생산국의 법령에 적합하게 제조되 | 업소명 + 주성분명단일제 + 제형 | 의약품의 품목허가․신고․심사규정｣ | 방사성물질 합성을 위한 화학물질 전구체: 만일 방사 | 등록된 원료의약품의 경우에는 제출하지 아 | (법 제27조제2항제1호에 따라 의약품 동등 | 자료.  다만, 둘 이상의 제조판매·수입 품 | 의견조율이 | 필요한가?  | 회의 개최 | 별표 8 참조 | 구분 | * 단, ‘15.7.1 부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 「의약품등의 | 8) 파일 저장(“*.flz\" 파일 생성) | 품목신고의 변경을 하려는 경우에는 지방청장을 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 1) 장기보존시험 또는 가속시험자료 | (수입, 제조품목 공통) | 의약품, 제11조에 따라 제조판매ᆞ수입 품목허 | 7) 증례기록서와 개별 환자 목록 | 한 자료 검토 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 13N | 3 | 1.4 | 201Tl | 10 | 4.7 | 사바늘로 10회 반복하여 찌른 | 필요한가 | 의 개정규정에도 불구하고 종전의 규정에 따른 | *시험방법 - 좌동 | 또 다른 양성자와 중성자의 불안정한 조합으로 변환될 | 펙트럼측정법에 더하여 확인할 필요가 있다.  | ③ 제1항에 따라 의약외품의 제조업 신고를 하 | Phosphorus-33 (33P) | 25.34 일 | 1999 | 2 | 1 | 3 | 2010 | 2 | 7 | 9 | 2010.1.18., 2013.3.23.> | 용법･ | 표적물질(TARGET MATERIALS) | ⑪ 제1항부터 제4항까지 및 제9항에 따른 의약 | 나.  식품의약품안전처장이 인정하는 공정서 |\n| 처장이 고시하는 바에 따른다. ",
        "original_sentence": "다만, 둘 이상의 제조판매·수입 품 | 의견조율이 | 필요한가? "
      }
    },
    {
      "chunk_id": "chunk_263",
      "text": "| 회의 개최 | 별표 8 참조 | 구분 | * 단, ‘15.7.1 부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 「의약품등의 | 8) 파일 저장(“*.flz\" 파일 생성) | 품목신고의 변경을 하려는 경우에는 지방청장을 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 1) 장기보존시험 또는 가속시험자료 | (수입, 제조품목 공통) | 의약품, 제11조에 따라 제조판매ᆞ수입 품목허 | 7) 증례기록서와 개별 환자 목록 | 한 자료 검토 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 13N | 3 | 1.4 | 201Tl | 10 | 4.7 | 사바늘로 10회 반복하여 찌른 | 필요한가 | 의 개정규정에도 불구하고 종전의 규정에 따른 | *시험방법 - 좌동 | 또 다른 양성자와 중성자의 불안정한 조합으로 변환될 | 펙트럼측정법에 더하여 확인할 필요가 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 262,
        "window_size": 3,
        "char_count": 477,
        "word_count": 127,
        "page_number": 1,
        "window_text": "| 저 | 장 | Phosphorus-32 (32P) | 14.26 일 | 표적원소(입사입자, 방출입자 또는 방사선)발생원소 | 1998 | 6 | 6 | 2009 | 2 | 3 | 5 | 소를 | 설치할 | 수 | 있다.  | <개정 | 2008.2.29., | 당한다) | (제조의뢰자) |\n| 요건 등에 관한 세부 사항은 식품의약품안전 | 품목이 생산국의 법령에 적합하게 제조되 | 업소명 + 주성분명단일제 + 제형 | 의약품의 품목허가․신고․심사규정｣ | 방사성물질 합성을 위한 화학물질 전구체: 만일 방사 | 등록된 원료의약품의 경우에는 제출하지 아 | (법 제27조제2항제1호에 따라 의약품 동등 | 자료.  다만, 둘 이상의 제조판매·수입 품 | 의견조율이 | 필요한가?  | 회의 개최 | 별표 8 참조 | 구분 | * 단, ‘15.7.1 부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 「의약품등의 | 8) 파일 저장(“*.flz\" 파일 생성) | 품목신고의 변경을 하려는 경우에는 지방청장을 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 1) 장기보존시험 또는 가속시험자료 | (수입, 제조품목 공통) | 의약품, 제11조에 따라 제조판매ᆞ수입 품목허 | 7) 증례기록서와 개별 환자 목록 | 한 자료 검토 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 13N | 3 | 1.4 | 201Tl | 10 | 4.7 | 사바늘로 10회 반복하여 찌른 | 필요한가 | 의 개정규정에도 불구하고 종전의 규정에 따른 | *시험방법 - 좌동 | 또 다른 양성자와 중성자의 불안정한 조합으로 변환될 | 펙트럼측정법에 더하여 확인할 필요가 있다.  | ③ 제1항에 따라 의약외품의 제조업 신고를 하 | Phosphorus-33 (33P) | 25.34 일 | 1999 | 2 | 1 | 3 | 2010 | 2 | 7 | 9 | 2010.1.18., 2013.3.23.> | 용법･ | 표적물질(TARGET MATERIALS) | ⑪ 제1항부터 제4항까지 및 제9항에 따른 의약 | 나.  식품의약품안전처장이 인정하는 공정서 |\n| 처장이 고시하는 바에 따른다.  | 고 있음을 증명하는 제조증명서 | 방사성물질을 포함하는 제제는 일차 또는 이차 방출에 | 니한다. ",
        "original_sentence": "| 회의 개최 | 별표 8 참조 | 구분 | * 단, ‘15.7.1 부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 「의약품등의 | 8) 파일 저장(“*.flz\" 파일 생성) | 품목신고의 변경을 하려는 경우에는 지방청장을 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 1) 장기보존시험 또는 가속시험자료 | (수입, 제조품목 공통) | 의약품, 제11조에 따라 제조판매ᆞ수입 품목허 | 7) 증례기록서와 개별 환자 목록 | 한 자료 검토 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 13N | 3 | 1.4 | 201Tl | 10 | 4.7 | 사바늘로 10회 반복하여 찌른 | 필요한가 | 의 개정규정에도 불구하고 종전의 규정에 따른 | *시험방법 - 좌동 | 또 다른 양성자와 중성자의 불안정한 조합으로 변환될 | 펙트럼측정법에 더하여 확인할 필요가 있다. "
      }
    },
    {
      "chunk_id": "chunk_264",
      "text": "| ③ 제1항에 따라 의약외품의 제조업 신고를 하 | Phosphorus-33 (33P) | 25.34 일 | 1999 | 2 | 1 | 3 | 2010 | 2 | 7 | 9 | 2010.1.18., 2013.3.23.> | 용법･ | 표적물질(TARGET MATERIALS) | ⑪ 제1항부터 제4항까지 및 제9항에 따른 의약 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 263,
        "window_size": 3,
        "char_count": 189,
        "word_count": 48,
        "page_number": 3,
        "window_text": "| <개정 | 2008.2.29., | 당한다) | (제조의뢰자) |\n| 요건 등에 관한 세부 사항은 식품의약품안전 | 품목이 생산국의 법령에 적합하게 제조되 | 업소명 + 주성분명단일제 + 제형 | 의약품의 품목허가․신고․심사규정｣ | 방사성물질 합성을 위한 화학물질 전구체: 만일 방사 | 등록된 원료의약품의 경우에는 제출하지 아 | (법 제27조제2항제1호에 따라 의약품 동등 | 자료.  다만, 둘 이상의 제조판매·수입 품 | 의견조율이 | 필요한가?  | 회의 개최 | 별표 8 참조 | 구분 | * 단, ‘15.7.1 부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 「의약품등의 | 8) 파일 저장(“*.flz\" 파일 생성) | 품목신고의 변경을 하려는 경우에는 지방청장을 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 1) 장기보존시험 또는 가속시험자료 | (수입, 제조품목 공통) | 의약품, 제11조에 따라 제조판매ᆞ수입 품목허 | 7) 증례기록서와 개별 환자 목록 | 한 자료 검토 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 13N | 3 | 1.4 | 201Tl | 10 | 4.7 | 사바늘로 10회 반복하여 찌른 | 필요한가 | 의 개정규정에도 불구하고 종전의 규정에 따른 | *시험방법 - 좌동 | 또 다른 양성자와 중성자의 불안정한 조합으로 변환될 | 펙트럼측정법에 더하여 확인할 필요가 있다.  | ③ 제1항에 따라 의약외품의 제조업 신고를 하 | Phosphorus-33 (33P) | 25.34 일 | 1999 | 2 | 1 | 3 | 2010 | 2 | 7 | 9 | 2010.1.18., 2013.3.23.> | 용법･ | 표적물질(TARGET MATERIALS) | ⑪ 제1항부터 제4항까지 및 제9항에 따른 의약 | 나.  식품의약품안전처장이 인정하는 공정서 |\n| 처장이 고시하는 바에 따른다.  | 고 있음을 증명하는 제조증명서 | 방사성물질을 포함하는 제제는 일차 또는 이차 방출에 | 니한다.  | 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 동시에 신청하는 경우에는 그 | 2. ",
        "original_sentence": "| ③ 제1항에 따라 의약외품의 제조업 신고를 하 | Phosphorus-33 (33P) | 25.34 일 | 1999 | 2 | 1 | 3 | 2010 | 2 | 7 | 9 | 2010.1.18., 2013.3.23.> | 용법･ | 표적물질(TARGET MATERIALS) | ⑪ 제1항부터 제4항까지 및 제9항에 따른 의약 | 나. "
      }
    },
    {
      "chunk_id": "chunk_265",
      "text": "식품의약품안전처장이 인정하는 공정서 |\n| 처장이 고시하는 바에 따른다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 264,
        "window_size": 3,
        "char_count": 41,
        "word_count": 9,
        "page_number": 5,
        "window_text": "다만, 둘 이상의 제조판매·수입 품 | 의견조율이 | 필요한가?  | 회의 개최 | 별표 8 참조 | 구분 | * 단, ‘15.7.1 부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 「의약품등의 | 8) 파일 저장(“*.flz\" 파일 생성) | 품목신고의 변경을 하려는 경우에는 지방청장을 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 1) 장기보존시험 또는 가속시험자료 | (수입, 제조품목 공통) | 의약품, 제11조에 따라 제조판매ᆞ수입 품목허 | 7) 증례기록서와 개별 환자 목록 | 한 자료 검토 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 13N | 3 | 1.4 | 201Tl | 10 | 4.7 | 사바늘로 10회 반복하여 찌른 | 필요한가 | 의 개정규정에도 불구하고 종전의 규정에 따른 | *시험방법 - 좌동 | 또 다른 양성자와 중성자의 불안정한 조합으로 변환될 | 펙트럼측정법에 더하여 확인할 필요가 있다.  | ③ 제1항에 따라 의약외품의 제조업 신고를 하 | Phosphorus-33 (33P) | 25.34 일 | 1999 | 2 | 1 | 3 | 2010 | 2 | 7 | 9 | 2010.1.18., 2013.3.23.> | 용법･ | 표적물질(TARGET MATERIALS) | ⑪ 제1항부터 제4항까지 및 제9항에 따른 의약 | 나.  식품의약품안전처장이 인정하는 공정서 |\n| 처장이 고시하는 바에 따른다.  | 고 있음을 증명하는 제조증명서 | 방사성물질을 포함하는 제제는 일차 또는 이차 방출에 | 니한다.  | 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 동시에 신청하는 경우에는 그 | 2.  제출파일 생성하기 | 안전에 | 관한 | 규칙 | 」제48조의2에 | 따른 | GMP | 적합판정서가 | 있더라도 | 관류제, | 복막투석제, | 점안제, | 조시설ᆞ제조방법 등에 관한 양도ᆞ양수계약서 | 자료를 | 제출하지 | 아니할 | 수 | 있다. ",
        "original_sentence": "식품의약품안전처장이 인정하는 공정서 |\n| 처장이 고시하는 바에 따른다. "
      }
    },
    {
      "chunk_id": "chunk_266",
      "text": "| 고 있음을 증명하는 제조증명서 | 방사성물질을 포함하는 제제는 일차 또는 이차 방출에 | 니한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 265,
        "window_size": 3,
        "char_count": 57,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| 회의 개최 | 별표 8 참조 | 구분 | * 단, ‘15.7.1 부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 「의약품등의 | 8) 파일 저장(“*.flz\" 파일 생성) | 품목신고의 변경을 하려는 경우에는 지방청장을 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 | 나에 해당하는 경우에는 각 호의 구분에 따른 | 1) 장기보존시험 또는 가속시험자료 | (수입, 제조품목 공통) | 의약품, 제11조에 따라 제조판매ᆞ수입 품목허 | 7) 증례기록서와 개별 환자 목록 | 한 자료 검토 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 13N | 3 | 1.4 | 201Tl | 10 | 4.7 | 사바늘로 10회 반복하여 찌른 | 필요한가 | 의 개정규정에도 불구하고 종전의 규정에 따른 | *시험방법 - 좌동 | 또 다른 양성자와 중성자의 불안정한 조합으로 변환될 | 펙트럼측정법에 더하여 확인할 필요가 있다.  | ③ 제1항에 따라 의약외품의 제조업 신고를 하 | Phosphorus-33 (33P) | 25.34 일 | 1999 | 2 | 1 | 3 | 2010 | 2 | 7 | 9 | 2010.1.18., 2013.3.23.> | 용법･ | 표적물질(TARGET MATERIALS) | ⑪ 제1항부터 제4항까지 및 제9항에 따른 의약 | 나.  식품의약품안전처장이 인정하는 공정서 |\n| 처장이 고시하는 바에 따른다.  | 고 있음을 증명하는 제조증명서 | 방사성물질을 포함하는 제제는 일차 또는 이차 방출에 | 니한다.  | 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 동시에 신청하는 경우에는 그 | 2.  제출파일 생성하기 | 안전에 | 관한 | 규칙 | 」제48조의2에 | 따른 | GMP | 적합판정서가 | 있더라도 | 관류제, | 복막투석제, | 점안제, | 조시설ᆞ제조방법 등에 관한 양도ᆞ양수계약서 | 자료를 | 제출하지 | 아니할 | 수 | 있다.  | <개정 | 가이던스’를 참조하시기 바람. ",
        "original_sentence": "| 고 있음을 증명하는 제조증명서 | 방사성물질을 포함하는 제제는 일차 또는 이차 방출에 | 니한다. "
      }
    },
    {
      "chunk_id": "chunk_267",
      "text": "| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 동시에 신청하는 경우에는 그 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 266,
        "window_size": 3,
        "char_count": 53,
        "word_count": 13,
        "page_number": 5,
        "window_text": "| ③ 제1항에 따라 의약외품의 제조업 신고를 하 | Phosphorus-33 (33P) | 25.34 일 | 1999 | 2 | 1 | 3 | 2010 | 2 | 7 | 9 | 2010.1.18., 2013.3.23.> | 용법･ | 표적물질(TARGET MATERIALS) | ⑪ 제1항부터 제4항까지 및 제9항에 따른 의약 | 나.  식품의약품안전처장이 인정하는 공정서 |\n| 처장이 고시하는 바에 따른다.  | 고 있음을 증명하는 제조증명서 | 방사성물질을 포함하는 제제는 일차 또는 이차 방출에 | 니한다.  | 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 동시에 신청하는 경우에는 그 | 2.  제출파일 생성하기 | 안전에 | 관한 | 규칙 | 」제48조의2에 | 따른 | GMP | 적합판정서가 | 있더라도 | 관류제, | 복막투석제, | 점안제, | 조시설ᆞ제조방법 등에 관한 양도ᆞ양수계약서 | 자료를 | 제출하지 | 아니할 | 수 | 있다.  | <개정 | 가이던스’를 참조하시기 바람.  | 일부공정위탁제조 | 품목허가권자로부터 동 품목에 대하여 일부공정만을 제조 의뢰받아 실제 제조하는 자 | ④ 제1항에도 불구하고 품질에 영향을 미치지 |\n| 필요한 경우, 총 민원사무 처리기한은 90일, 수수료는 1,134,000원(전자민원) | 후 메틸렌블루(색소) 용액에 담 | 성의약품의 주성분이 분리되지 않을 경우 합성에 사용 | 다. ",
        "original_sentence": "| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 동시에 신청하는 경우에는 그 | 2. "
      }
    },
    {
      "chunk_id": "chunk_268",
      "text": "제출파일 생성하기 | 안전에 | 관한 | 규칙 | 」제48조의2에 | 따른 | GMP | 적합판정서가 | 있더라도 | 관류제, | 복막투석제, | 점안제, | 조시설ᆞ제조방법 등에 관한 양도ᆞ양수계약서 | 자료를 | 제출하지 | 아니할 | 수 | 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 267,
        "window_size": 3,
        "char_count": 142,
        "word_count": 39,
        "page_number": 3,
        "window_text": "식품의약품안전처장이 인정하는 공정서 |\n| 처장이 고시하는 바에 따른다.  | 고 있음을 증명하는 제조증명서 | 방사성물질을 포함하는 제제는 일차 또는 이차 방출에 | 니한다.  | 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 동시에 신청하는 경우에는 그 | 2.  제출파일 생성하기 | 안전에 | 관한 | 규칙 | 」제48조의2에 | 따른 | GMP | 적합판정서가 | 있더라도 | 관류제, | 복막투석제, | 점안제, | 조시설ᆞ제조방법 등에 관한 양도ᆞ양수계약서 | 자료를 | 제출하지 | 아니할 | 수 | 있다.  | <개정 | 가이던스’를 참조하시기 바람.  | 일부공정위탁제조 | 품목허가권자로부터 동 품목에 대하여 일부공정만을 제조 의뢰받아 실제 제조하는 자 | ④ 제1항에도 불구하고 품질에 영향을 미치지 |\n| 필요한 경우, 총 민원사무 처리기한은 90일, 수수료는 1,134,000원(전자민원) | 후 메틸렌블루(색소) 용액에 담 | 성의약품의 주성분이 분리되지 않을 경우 합성에 사용 | 다.  | 것이다. ",
        "original_sentence": "제출파일 생성하기 | 안전에 | 관한 | 규칙 | 」제48조의2에 | 따른 | GMP | 적합판정서가 | 있더라도 | 관류제, | 복막투석제, | 점안제, | 조시설ᆞ제조방법 등에 관한 양도ᆞ양수계약서 | 자료를 | 제출하지 | 아니할 | 수 | 있다. "
      }
    },
    {
      "chunk_id": "chunk_269",
      "text": "| <개정 | 가이던스’를 참조하시기 바람. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 268,
        "window_size": 3,
        "char_count": 25,
        "word_count": 6,
        "page_number": 5,
        "window_text": "| 고 있음을 증명하는 제조증명서 | 방사성물질을 포함하는 제제는 일차 또는 이차 방출에 | 니한다.  | 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 동시에 신청하는 경우에는 그 | 2.  제출파일 생성하기 | 안전에 | 관한 | 규칙 | 」제48조의2에 | 따른 | GMP | 적합판정서가 | 있더라도 | 관류제, | 복막투석제, | 점안제, | 조시설ᆞ제조방법 등에 관한 양도ᆞ양수계약서 | 자료를 | 제출하지 | 아니할 | 수 | 있다.  | <개정 | 가이던스’를 참조하시기 바람.  | 일부공정위탁제조 | 품목허가권자로부터 동 품목에 대하여 일부공정만을 제조 의뢰받아 실제 제조하는 자 | ④ 제1항에도 불구하고 품질에 영향을 미치지 |\n| 필요한 경우, 총 민원사무 처리기한은 90일, 수수료는 1,134,000원(전자민원) | 후 메틸렌블루(색소) 용액에 담 | 성의약품의 주성분이 분리되지 않을 경우 합성에 사용 | 다.  | 것이다.  이러한 핵종들을 방사성핵종이라고 하는데 전 | 기재순서 | ⑥ 제1항부터 제4항까지의 규정에도 불구하고 | Sulfur-35 (35S) | 87.51 일 | 말한다)에게 제출하여야 한다. ",
        "original_sentence": "| <개정 | 가이던스’를 참조하시기 바람. "
      }
    },
    {
      "chunk_id": "chunk_270",
      "text": "| 일부공정위탁제조 | 품목허가권자로부터 동 품목에 대하여 일부공정만을 제조 의뢰받아 실제 제조하는 자 | ④ 제1항에도 불구하고 품질에 영향을 미치지 |\n| 필요한 경우, 총 민원사무 처리기한은 90일, 수수료는 1,134,000원(전자민원) | 후 메틸렌블루(색소) 용액에 담 | 성의약품의 주성분이 분리되지 않을 경우 합성에 사용 | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 269,
        "window_size": 3,
        "char_count": 193,
        "word_count": 45,
        "page_number": 3,
        "window_text": "| 성의 입증이 필요하다고 식품의약품안전처장 | 목허가를 동시에 신청하는 경우에는 그 | 2.  제출파일 생성하기 | 안전에 | 관한 | 규칙 | 」제48조의2에 | 따른 | GMP | 적합판정서가 | 있더라도 | 관류제, | 복막투석제, | 점안제, | 조시설ᆞ제조방법 등에 관한 양도ᆞ양수계약서 | 자료를 | 제출하지 | 아니할 | 수 | 있다.  | <개정 | 가이던스’를 참조하시기 바람.  | 일부공정위탁제조 | 품목허가권자로부터 동 품목에 대하여 일부공정만을 제조 의뢰받아 실제 제조하는 자 | ④ 제1항에도 불구하고 품질에 영향을 미치지 |\n| 필요한 경우, 총 민원사무 처리기한은 90일, 수수료는 1,134,000원(전자민원) | 후 메틸렌블루(색소) 용액에 담 | 성의약품의 주성분이 분리되지 않을 경우 합성에 사용 | 다.  | 것이다.  이러한 핵종들을 방사성핵종이라고 하는데 전 | 기재순서 | ⑥ 제1항부터 제4항까지의 규정에도 불구하고 | Sulfur-35 (35S) | 87.51 일 | 말한다)에게 제출하여야 한다.  | 2000 | 16 | 39 | 55 | 2011 | 5 | 2 | 7 | 려는 자는 그 업종에 속하는 1개 이상 품목의 | 2) 가혹시험자료 | 다. ",
        "original_sentence": "| 일부공정위탁제조 | 품목허가권자로부터 동 품목에 대하여 일부공정만을 제조 의뢰받아 실제 제조하는 자 | ④ 제1항에도 불구하고 품질에 영향을 미치지 |\n| 필요한 경우, 총 민원사무 처리기한은 90일, 수수료는 1,134,000원(전자민원) | 후 메틸렌블루(색소) 용액에 담 | 성의약품의 주성분이 분리되지 않을 경우 합성에 사용 | 다. "
      }
    },
    {
      "chunk_id": "chunk_271",
      "text": "| 것이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 270,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 5,
        "window_text": "제출파일 생성하기 | 안전에 | 관한 | 규칙 | 」제48조의2에 | 따른 | GMP | 적합판정서가 | 있더라도 | 관류제, | 복막투석제, | 점안제, | 조시설ᆞ제조방법 등에 관한 양도ᆞ양수계약서 | 자료를 | 제출하지 | 아니할 | 수 | 있다.  | <개정 | 가이던스’를 참조하시기 바람.  | 일부공정위탁제조 | 품목허가권자로부터 동 품목에 대하여 일부공정만을 제조 의뢰받아 실제 제조하는 자 | ④ 제1항에도 불구하고 품질에 영향을 미치지 |\n| 필요한 경우, 총 민원사무 처리기한은 90일, 수수료는 1,134,000원(전자민원) | 후 메틸렌블루(색소) 용액에 담 | 성의약품의 주성분이 분리되지 않을 경우 합성에 사용 | 다.  | 것이다.  이러한 핵종들을 방사성핵종이라고 하는데 전 | 기재순서 | ⑥ 제1항부터 제4항까지의 규정에도 불구하고 | Sulfur-35 (35S) | 87.51 일 | 말한다)에게 제출하여야 한다.  | 2000 | 16 | 39 | 55 | 2011 | 5 | 2 | 7 | 려는 자는 그 업종에 속하는 1개 이상 품목의 | 2) 가혹시험자료 | 다.  대한민국약전에 실려 있지 아니한 의약품 | 가와 품목신고가 제한되는 품목, 생물학적제제 | 품등의 제조업ᆞ위탁제조판매업 및 제조판매품 | 나. ",
        "original_sentence": "| 것이다. "
      }
    },
    {
      "chunk_id": "chunk_272",
      "text": "이러한 핵종들을 방사성핵종이라고 하는데 전 | 기재순서 | ⑥ 제1항부터 제4항까지의 규정에도 불구하고 | Sulfur-35 (35S) | 87.51 일 | 말한다)에게 제출하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 271,
        "window_size": 3,
        "char_count": 105,
        "word_count": 23,
        "page_number": 3,
        "window_text": "| <개정 | 가이던스’를 참조하시기 바람.  | 일부공정위탁제조 | 품목허가권자로부터 동 품목에 대하여 일부공정만을 제조 의뢰받아 실제 제조하는 자 | ④ 제1항에도 불구하고 품질에 영향을 미치지 |\n| 필요한 경우, 총 민원사무 처리기한은 90일, 수수료는 1,134,000원(전자민원) | 후 메틸렌블루(색소) 용액에 담 | 성의약품의 주성분이 분리되지 않을 경우 합성에 사용 | 다.  | 것이다.  이러한 핵종들을 방사성핵종이라고 하는데 전 | 기재순서 | ⑥ 제1항부터 제4항까지의 규정에도 불구하고 | Sulfur-35 (35S) | 87.51 일 | 말한다)에게 제출하여야 한다.  | 2000 | 16 | 39 | 55 | 2011 | 5 | 2 | 7 | 려는 자는 그 업종에 속하는 1개 이상 품목의 | 2) 가혹시험자료 | 다.  대한민국약전에 실려 있지 아니한 의약품 | 가와 품목신고가 제한되는 품목, 생물학적제제 | 품등의 제조업ᆞ위탁제조판매업 및 제조판매품 | 나.  가교자료 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 의약품심사조정과 | 99mTc(콜드) | 45 | 21.2 | 18F | 32 | 15.1 | 아니오 | 아니요 | 잔류용매(Residual solvents) | 의한 방사선 조사로부터 개인을 충분히 보호하고 방사 | 가. ",
        "original_sentence": "이러한 핵종들을 방사성핵종이라고 하는데 전 | 기재순서 | ⑥ 제1항부터 제4항까지의 규정에도 불구하고 | Sulfur-35 (35S) | 87.51 일 | 말한다)에게 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_273",
      "text": "| 2000 | 16 | 39 | 55 | 2011 | 5 | 2 | 7 | 려는 자는 그 업종에 속하는 1개 이상 품목의 | 2) 가혹시험자료 | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 272,
        "window_size": 3,
        "char_count": 86,
        "word_count": 30,
        "page_number": 3,
        "window_text": "| 일부공정위탁제조 | 품목허가권자로부터 동 품목에 대하여 일부공정만을 제조 의뢰받아 실제 제조하는 자 | ④ 제1항에도 불구하고 품질에 영향을 미치지 |\n| 필요한 경우, 총 민원사무 처리기한은 90일, 수수료는 1,134,000원(전자민원) | 후 메틸렌블루(색소) 용액에 담 | 성의약품의 주성분이 분리되지 않을 경우 합성에 사용 | 다.  | 것이다.  이러한 핵종들을 방사성핵종이라고 하는데 전 | 기재순서 | ⑥ 제1항부터 제4항까지의 규정에도 불구하고 | Sulfur-35 (35S) | 87.51 일 | 말한다)에게 제출하여야 한다.  | 2000 | 16 | 39 | 55 | 2011 | 5 | 2 | 7 | 려는 자는 그 업종에 속하는 1개 이상 품목의 | 2) 가혹시험자료 | 다.  대한민국약전에 실려 있지 아니한 의약품 | 가와 품목신고가 제한되는 품목, 생물학적제제 | 품등의 제조업ᆞ위탁제조판매업 및 제조판매품 | 나.  가교자료 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 의약품심사조정과 | 99mTc(콜드) | 45 | 21.2 | 18F | 32 | 15.1 | 아니오 | 아니요 | 잔류용매(Residual solvents) | 의한 방사선 조사로부터 개인을 충분히 보호하고 방사 | 가.  제조소의 명칭, 제조소의 소재지, 제조소 | 이 정한 의약품만 해당한다) | 중 하나의 품목에 관한 자료만을 제출할 | 예) | 58Fe(n, γ)59Fe | 방사성의약품에 있는 서로 다른 방사성핵종의 반감기 | Chromium-51 (51Cr) | 27.7025 일 | 를 제출할 수 있다. ",
        "original_sentence": "| 2000 | 16 | 39 | 55 | 2011 | 5 | 2 | 7 | 려는 자는 그 업종에 속하는 1개 이상 품목의 | 2) 가혹시험자료 | 다. "
      }
    },
    {
      "chunk_id": "chunk_274",
      "text": "대한민국약전에 실려 있지 아니한 의약품 | 가와 품목신고가 제한되는 품목, 생물학적제제 | 품등의 제조업ᆞ위탁제조판매업 및 제조판매품 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 273,
        "window_size": 3,
        "char_count": 80,
        "word_count": 18,
        "page_number": 8,
        "window_text": "| 것이다.  이러한 핵종들을 방사성핵종이라고 하는데 전 | 기재순서 | ⑥ 제1항부터 제4항까지의 규정에도 불구하고 | Sulfur-35 (35S) | 87.51 일 | 말한다)에게 제출하여야 한다.  | 2000 | 16 | 39 | 55 | 2011 | 5 | 2 | 7 | 려는 자는 그 업종에 속하는 1개 이상 품목의 | 2) 가혹시험자료 | 다.  대한민국약전에 실려 있지 아니한 의약품 | 가와 품목신고가 제한되는 품목, 생물학적제제 | 품등의 제조업ᆞ위탁제조판매업 및 제조판매품 | 나.  가교자료 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 의약품심사조정과 | 99mTc(콜드) | 45 | 21.2 | 18F | 32 | 15.1 | 아니오 | 아니요 | 잔류용매(Residual solvents) | 의한 방사선 조사로부터 개인을 충분히 보호하고 방사 | 가.  제조소의 명칭, 제조소의 소재지, 제조소 | 이 정한 의약품만 해당한다) | 중 하나의 품목에 관한 자료만을 제출할 | 예) | 58Fe(n, γ)59Fe | 방사성의약품에 있는 서로 다른 방사성핵종의 반감기 | Chromium-51 (51Cr) | 27.7025 일 | 를 제출할 수 있다.  | 2014.10.10.> | 경우 예외 | 아니하는 색상ᆞ포장재질 또는 제조원의 명칭 |\n| 되는 화학물질 전구체는 약제학적 용도의 물질로서 고 | 1. ",
        "original_sentence": "대한민국약전에 실려 있지 아니한 의약품 | 가와 품목신고가 제한되는 품목, 생물학적제제 | 품등의 제조업ᆞ위탁제조판매업 및 제조판매품 | 나. "
      }
    },
    {
      "chunk_id": "chunk_275",
      "text": "가교자료 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 의약품심사조정과 | 99mTc(콜드) | 45 | 21.2 | 18F | 32 | 15.1 | 아니오 | 아니요 | 잔류용매(Residual solvents) | 의한 방사선 조사로부터 개인을 충분히 보호하고 방사 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 274,
        "window_size": 3,
        "char_count": 159,
        "word_count": 40,
        "page_number": 3,
        "window_text": "이러한 핵종들을 방사성핵종이라고 하는데 전 | 기재순서 | ⑥ 제1항부터 제4항까지의 규정에도 불구하고 | Sulfur-35 (35S) | 87.51 일 | 말한다)에게 제출하여야 한다.  | 2000 | 16 | 39 | 55 | 2011 | 5 | 2 | 7 | 려는 자는 그 업종에 속하는 1개 이상 품목의 | 2) 가혹시험자료 | 다.  대한민국약전에 실려 있지 아니한 의약품 | 가와 품목신고가 제한되는 품목, 생물학적제제 | 품등의 제조업ᆞ위탁제조판매업 및 제조판매품 | 나.  가교자료 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 의약품심사조정과 | 99mTc(콜드) | 45 | 21.2 | 18F | 32 | 15.1 | 아니오 | 아니요 | 잔류용매(Residual solvents) | 의한 방사선 조사로부터 개인을 충분히 보호하고 방사 | 가.  제조소의 명칭, 제조소의 소재지, 제조소 | 이 정한 의약품만 해당한다) | 중 하나의 품목에 관한 자료만을 제출할 | 예) | 58Fe(n, γ)59Fe | 방사성의약품에 있는 서로 다른 방사성핵종의 반감기 | Chromium-51 (51Cr) | 27.7025 일 | 를 제출할 수 있다.  | 2014.10.10.> | 경우 예외 | 아니하는 색상ᆞ포장재질 또는 제조원의 명칭 |\n| 되는 화학물질 전구체는 약제학적 용도의 물질로서 고 | 1.  제조업의 변경: 별지 제2호서식의 의약외품 | 4. ",
        "original_sentence": "가교자료 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 의약품심사조정과 | 99mTc(콜드) | 45 | 21.2 | 18F | 32 | 15.1 | 아니오 | 아니요 | 잔류용매(Residual solvents) | 의한 방사선 조사로부터 개인을 충분히 보호하고 방사 | 가. "
      }
    },
    {
      "chunk_id": "chunk_276",
      "text": "제조소의 명칭, 제조소의 소재지, 제조소 | 이 정한 의약품만 해당한다) | 중 하나의 품목에 관한 자료만을 제출할 | 예) | 58Fe(n, γ)59Fe | 방사성의약품에 있는 서로 다른 방사성핵종의 반감기 | Chromium-51 (51Cr) | 27.7025 일 | 를 제출할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 275,
        "window_size": 3,
        "char_count": 164,
        "word_count": 40,
        "page_number": 1,
        "window_text": "| 2000 | 16 | 39 | 55 | 2011 | 5 | 2 | 7 | 려는 자는 그 업종에 속하는 1개 이상 품목의 | 2) 가혹시험자료 | 다.  대한민국약전에 실려 있지 아니한 의약품 | 가와 품목신고가 제한되는 품목, 생물학적제제 | 품등의 제조업ᆞ위탁제조판매업 및 제조판매품 | 나.  가교자료 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 의약품심사조정과 | 99mTc(콜드) | 45 | 21.2 | 18F | 32 | 15.1 | 아니오 | 아니요 | 잔류용매(Residual solvents) | 의한 방사선 조사로부터 개인을 충분히 보호하고 방사 | 가.  제조소의 명칭, 제조소의 소재지, 제조소 | 이 정한 의약품만 해당한다) | 중 하나의 품목에 관한 자료만을 제출할 | 예) | 58Fe(n, γ)59Fe | 방사성의약품에 있는 서로 다른 방사성핵종의 반감기 | Chromium-51 (51Cr) | 27.7025 일 | 를 제출할 수 있다.  | 2014.10.10.> | 경우 예외 | 아니하는 색상ᆞ포장재질 또는 제조원의 명칭 |\n| 되는 화학물질 전구체는 약제학적 용도의 물질로서 고 | 1.  제조업의 변경: 별지 제2호서식의 의약외품 | 4.  독성에 관한 자료 | 안연고제, 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | - 저장완료된 파일을 ezdrug 전자민원창구를 통해 접수할 수 있는 형태로 생성 | (제조자) | (수입, 제조품목 공통) | 다. ",
        "original_sentence": "제조소의 명칭, 제조소의 소재지, 제조소 | 이 정한 의약품만 해당한다) | 중 하나의 품목에 관한 자료만을 제출할 | 예) | 58Fe(n, γ)59Fe | 방사성의약품에 있는 서로 다른 방사성핵종의 반감기 | Chromium-51 (51Cr) | 27.7025 일 | 를 제출할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_277",
      "text": "| 2014.10.10.> | 경우 예외 | 아니하는 색상ᆞ포장재질 또는 제조원의 명칭 |\n| 되는 화학물질 전구체는 약제학적 용도의 물질로서 고 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 276,
        "window_size": 3,
        "char_count": 87,
        "word_count": 22,
        "page_number": 1,
        "window_text": "대한민국약전에 실려 있지 아니한 의약품 | 가와 품목신고가 제한되는 품목, 생물학적제제 | 품등의 제조업ᆞ위탁제조판매업 및 제조판매품 | 나.  가교자료 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 의약품심사조정과 | 99mTc(콜드) | 45 | 21.2 | 18F | 32 | 15.1 | 아니오 | 아니요 | 잔류용매(Residual solvents) | 의한 방사선 조사로부터 개인을 충분히 보호하고 방사 | 가.  제조소의 명칭, 제조소의 소재지, 제조소 | 이 정한 의약품만 해당한다) | 중 하나의 품목에 관한 자료만을 제출할 | 예) | 58Fe(n, γ)59Fe | 방사성의약품에 있는 서로 다른 방사성핵종의 반감기 | Chromium-51 (51Cr) | 27.7025 일 | 를 제출할 수 있다.  | 2014.10.10.> | 경우 예외 | 아니하는 색상ᆞ포장재질 또는 제조원의 명칭 |\n| 되는 화학물질 전구체는 약제학적 용도의 물질로서 고 | 1.  제조업의 변경: 별지 제2호서식의 의약외품 | 4.  독성에 관한 자료 | 안연고제, 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | - 저장완료된 파일을 ezdrug 전자민원창구를 통해 접수할 수 있는 형태로 생성 | (제조자) | (수입, 제조품목 공통) | 다.  대한민국약전에 실려 있지 아니한 의약품 | 등 및 방사성의약품은 제외한다. ",
        "original_sentence": "| 2014.10.10.> | 경우 예외 | 아니하는 색상ᆞ포장재질 또는 제조원의 명칭 |\n| 되는 화학물질 전구체는 약제학적 용도의 물질로서 고 | 1. "
      }
    },
    {
      "chunk_id": "chunk_278",
      "text": "제조업의 변경: 별지 제2호서식의 의약외품 | 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 277,
        "window_size": 3,
        "char_count": 29,
        "word_count": 7,
        "page_number": 3,
        "window_text": "가교자료 | (公定書) 및 의약품집에 실려 있는 품목 |\n| 의약품심사조정과 | 99mTc(콜드) | 45 | 21.2 | 18F | 32 | 15.1 | 아니오 | 아니요 | 잔류용매(Residual solvents) | 의한 방사선 조사로부터 개인을 충분히 보호하고 방사 | 가.  제조소의 명칭, 제조소의 소재지, 제조소 | 이 정한 의약품만 해당한다) | 중 하나의 품목에 관한 자료만을 제출할 | 예) | 58Fe(n, γ)59Fe | 방사성의약품에 있는 서로 다른 방사성핵종의 반감기 | Chromium-51 (51Cr) | 27.7025 일 | 를 제출할 수 있다.  | 2014.10.10.> | 경우 예외 | 아니하는 색상ᆞ포장재질 또는 제조원의 명칭 |\n| 되는 화학물질 전구체는 약제학적 용도의 물질로서 고 | 1.  제조업의 변경: 별지 제2호서식의 의약외품 | 4.  독성에 관한 자료 | 안연고제, 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | - 저장완료된 파일을 ezdrug 전자민원창구를 통해 접수할 수 있는 형태로 생성 | (제조자) | (수입, 제조품목 공통) | 다.  대한민국약전에 실려 있지 아니한 의약품 | 등 및 방사성의약품은 제외한다.  | 7. ",
        "original_sentence": "제조업의 변경: 별지 제2호서식의 의약외품 | 4. "
      }
    },
    {
      "chunk_id": "chunk_279",
      "text": "독성에 관한 자료 | 안연고제, 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | - 저장완료된 파일을 ezdrug 전자민원창구를 통해 접수할 수 있는 형태로 생성 | (제조자) | (수입, 제조품목 공통) | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 278,
        "window_size": 3,
        "char_count": 127,
        "word_count": 31,
        "page_number": 5,
        "window_text": "제조소의 명칭, 제조소의 소재지, 제조소 | 이 정한 의약품만 해당한다) | 중 하나의 품목에 관한 자료만을 제출할 | 예) | 58Fe(n, γ)59Fe | 방사성의약품에 있는 서로 다른 방사성핵종의 반감기 | Chromium-51 (51Cr) | 27.7025 일 | 를 제출할 수 있다.  | 2014.10.10.> | 경우 예외 | 아니하는 색상ᆞ포장재질 또는 제조원의 명칭 |\n| 되는 화학물질 전구체는 약제학적 용도의 물질로서 고 | 1.  제조업의 변경: 별지 제2호서식의 의약외품 | 4.  독성에 관한 자료 | 안연고제, 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | - 저장완료된 파일을 ezdrug 전자민원창구를 통해 접수할 수 있는 형태로 생성 | (제조자) | (수입, 제조품목 공통) | 다.  대한민국약전에 실려 있지 아니한 의약품 | 등 및 방사성의약품은 제외한다.  | 7.  외국의 사용현황 등에 관한 자료 | 목의 허가 또는 신고를 할 때 허가 또는 신고 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 그고 외부 압력을 변화시켰을 | 해당과 협의 | 및 조정결과 | 회사 의견 | 자의 불안정한 핵종을 어미방사성핵종이라 하고 후자 | 차이로 인해, 방사성핵종순도가 시간에 따라 변한다. ",
        "original_sentence": "독성에 관한 자료 | 안연고제, 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | - 저장완료된 파일을 ezdrug 전자민원창구를 통해 접수할 수 있는 형태로 생성 | (제조자) | (수입, 제조품목 공통) | 다. "
      }
    },
    {
      "chunk_id": "chunk_280",
      "text": "대한민국약전에 실려 있지 아니한 의약품 | 등 및 방사성의약품은 제외한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 279,
        "window_size": 3,
        "char_count": 42,
        "word_count": 10,
        "page_number": 6,
        "window_text": "| 2014.10.10.> | 경우 예외 | 아니하는 색상ᆞ포장재질 또는 제조원의 명칭 |\n| 되는 화학물질 전구체는 약제학적 용도의 물질로서 고 | 1.  제조업의 변경: 별지 제2호서식의 의약외품 | 4.  독성에 관한 자료 | 안연고제, 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | - 저장완료된 파일을 ezdrug 전자민원창구를 통해 접수할 수 있는 형태로 생성 | (제조자) | (수입, 제조품목 공통) | 다.  대한민국약전에 실려 있지 아니한 의약품 | 등 및 방사성의약품은 제외한다.  | 7.  외국의 사용현황 등에 관한 자료 | 목의 허가 또는 신고를 할 때 허가 또는 신고 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 그고 외부 압력을 변화시켰을 | 해당과 협의 | 및 조정결과 | 회사 의견 | 자의 불안정한 핵종을 어미방사성핵종이라 하고 후자 | 차이로 인해, 방사성핵종순도가 시간에 따라 변한다.  | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 1. ",
        "original_sentence": "대한민국약전에 실려 있지 아니한 의약품 | 등 및 방사성의약품은 제외한다. "
      }
    },
    {
      "chunk_id": "chunk_281",
      "text": "| 7. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 280,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 3,
        "window_text": "제조업의 변경: 별지 제2호서식의 의약외품 | 4.  독성에 관한 자료 | 안연고제, 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | - 저장완료된 파일을 ezdrug 전자민원창구를 통해 접수할 수 있는 형태로 생성 | (제조자) | (수입, 제조품목 공통) | 다.  대한민국약전에 실려 있지 아니한 의약품 | 등 및 방사성의약품은 제외한다.  | 7.  외국의 사용현황 등에 관한 자료 | 목의 허가 또는 신고를 할 때 허가 또는 신고 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 그고 외부 압력을 변화시켰을 | 해당과 협의 | 및 조정결과 | 회사 의견 | 자의 불안정한 핵종을 어미방사성핵종이라 하고 후자 | 차이로 인해, 방사성핵종순도가 시간에 따라 변한다.  | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 1.  제1항제1호 또는 제2호에 해당하는 자료로 | Cobalt-56 (56Co) | 77.27 일 | 2001 | 23 | 11 | 34 | 2012 | 2 | 0 | 2 | 제34조에 따른 임상시험용 의약품 등 총리령으 | 제조판매품목 허가를 동시에 신청하거나 1개 | 함을 확인하는데 신뢰성을 높여줄 수 있다. ",
        "original_sentence": "| 7. "
      }
    },
    {
      "chunk_id": "chunk_282",
      "text": "외국의 사용현황 등에 관한 자료 | 목의 허가 또는 신고를 할 때 허가 또는 신고 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 그고 외부 압력을 변화시켰을 | 해당과 협의 | 및 조정결과 | 회사 의견 | 자의 불안정한 핵종을 어미방사성핵종이라 하고 후자 | 차이로 인해, 방사성핵종순도가 시간에 따라 변한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 281,
        "window_size": 3,
        "char_count": 178,
        "word_count": 50,
        "page_number": 5,
        "window_text": "독성에 관한 자료 | 안연고제, 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | - 저장완료된 파일을 ezdrug 전자민원창구를 통해 접수할 수 있는 형태로 생성 | (제조자) | (수입, 제조품목 공통) | 다.  대한민국약전에 실려 있지 아니한 의약품 | 등 및 방사성의약품은 제외한다.  | 7.  외국의 사용현황 등에 관한 자료 | 목의 허가 또는 신고를 할 때 허가 또는 신고 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 그고 외부 압력을 변화시켰을 | 해당과 협의 | 및 조정결과 | 회사 의견 | 자의 불안정한 핵종을 어미방사성핵종이라 하고 후자 | 차이로 인해, 방사성핵종순도가 시간에 따라 변한다.  | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 1.  제1항제1호 또는 제2호에 해당하는 자료로 | Cobalt-56 (56Co) | 77.27 일 | 2001 | 23 | 11 | 34 | 2012 | 2 | 0 | 2 | 제34조에 따른 임상시험용 의약품 등 총리령으 | 제조판매품목 허가를 동시에 신청하거나 1개 | 함을 확인하는데 신뢰성을 높여줄 수 있다.  |\n| 이라 한다)의 정부 또는 공공기관에서 그 | 부 또는 공공기관에서 그 국가의 법령에 | 허가 처리 | 잔류용매는 일반사항 5.4. ",
        "original_sentence": "외국의 사용현황 등에 관한 자료 | 목의 허가 또는 신고를 할 때 허가 또는 신고 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 그고 외부 압력을 변화시켰을 | 해당과 협의 | 및 조정결과 | 회사 의견 | 자의 불안정한 핵종을 어미방사성핵종이라 하고 후자 | 차이로 인해, 방사성핵종순도가 시간에 따라 변한다. "
      }
    },
    {
      "chunk_id": "chunk_283",
      "text": "| ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 282,
        "window_size": 3,
        "char_count": 33,
        "word_count": 11,
        "page_number": 3,
        "window_text": "대한민국약전에 실려 있지 아니한 의약품 | 등 및 방사성의약품은 제외한다.  | 7.  외국의 사용현황 등에 관한 자료 | 목의 허가 또는 신고를 할 때 허가 또는 신고 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 그고 외부 압력을 변화시켰을 | 해당과 협의 | 및 조정결과 | 회사 의견 | 자의 불안정한 핵종을 어미방사성핵종이라 하고 후자 | 차이로 인해, 방사성핵종순도가 시간에 따라 변한다.  | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 1.  제1항제1호 또는 제2호에 해당하는 자료로 | Cobalt-56 (56Co) | 77.27 일 | 2001 | 23 | 11 | 34 | 2012 | 2 | 0 | 2 | 제34조에 따른 임상시험용 의약품 등 총리령으 | 제조판매품목 허가를 동시에 신청하거나 1개 | 함을 확인하는데 신뢰성을 높여줄 수 있다.  |\n| 이라 한다)의 정부 또는 공공기관에서 그 | 부 또는 공공기관에서 그 국가의 법령에 | 허가 처리 | 잔류용매는 일반사항 5.4.  잔류용매 항에 따라 기준이 | 성물질 저장과 관련한 국내외 규정에 적합한 밀봉용기 | 4. ",
        "original_sentence": "| ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 1. "
      }
    },
    {
      "chunk_id": "chunk_284",
      "text": "제1항제1호 또는 제2호에 해당하는 자료로 | Cobalt-56 (56Co) | 77.27 일 | 2001 | 23 | 11 | 34 | 2012 | 2 | 0 | 2 | 제34조에 따른 임상시험용 의약품 등 총리령으 | 제조판매품목 허가를 동시에 신청하거나 1개 | 함을 확인하는데 신뢰성을 높여줄 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 283,
        "window_size": 3,
        "char_count": 174,
        "word_count": 47,
        "page_number": 3,
        "window_text": "| 7.  외국의 사용현황 등에 관한 자료 | 목의 허가 또는 신고를 할 때 허가 또는 신고 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 그고 외부 압력을 변화시켰을 | 해당과 협의 | 및 조정결과 | 회사 의견 | 자의 불안정한 핵종을 어미방사성핵종이라 하고 후자 | 차이로 인해, 방사성핵종순도가 시간에 따라 변한다.  | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 1.  제1항제1호 또는 제2호에 해당하는 자료로 | Cobalt-56 (56Co) | 77.27 일 | 2001 | 23 | 11 | 34 | 2012 | 2 | 0 | 2 | 제34조에 따른 임상시험용 의약품 등 총리령으 | 제조판매품목 허가를 동시에 신청하거나 1개 | 함을 확인하는데 신뢰성을 높여줄 수 있다.  |\n| 이라 한다)의 정부 또는 공공기관에서 그 | 부 또는 공공기관에서 그 국가의 법령에 | 허가 처리 | 잔류용매는 일반사항 5.4.  잔류용매 항에 따라 기준이 | 성물질 저장과 관련한 국내외 규정에 적합한 밀봉용기 | 4.  제4조제1항제4호에 따른 자료 | 네튬산나트륨의 형태로 함유한다. ",
        "original_sentence": "제1항제1호 또는 제2호에 해당하는 자료로 | Cobalt-56 (56Co) | 77.27 일 | 2001 | 23 | 11 | 34 | 2012 | 2 | 0 | 2 | 제34조에 따른 임상시험용 의약품 등 총리령으 | 제조판매품목 허가를 동시에 신청하거나 1개 | 함을 확인하는데 신뢰성을 높여줄 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_285",
      "text": "|\n| 이라 한다)의 정부 또는 공공기관에서 그 | 부 또는 공공기관에서 그 국가의 법령에 | 허가 처리 | 잔류용매는 일반사항 5.4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 284,
        "window_size": 3,
        "char_count": 77,
        "word_count": 22,
        "page_number": 5,
        "window_text": "외국의 사용현황 등에 관한 자료 | 목의 허가 또는 신고를 할 때 허가 또는 신고 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 그고 외부 압력을 변화시켰을 | 해당과 협의 | 및 조정결과 | 회사 의견 | 자의 불안정한 핵종을 어미방사성핵종이라 하고 후자 | 차이로 인해, 방사성핵종순도가 시간에 따라 변한다.  | ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 1.  제1항제1호 또는 제2호에 해당하는 자료로 | Cobalt-56 (56Co) | 77.27 일 | 2001 | 23 | 11 | 34 | 2012 | 2 | 0 | 2 | 제34조에 따른 임상시험용 의약품 등 총리령으 | 제조판매품목 허가를 동시에 신청하거나 1개 | 함을 확인하는데 신뢰성을 높여줄 수 있다.  |\n| 이라 한다)의 정부 또는 공공기관에서 그 | 부 또는 공공기관에서 그 국가의 법령에 | 허가 처리 | 잔류용매는 일반사항 5.4.  잔류용매 항에 따라 기준이 | 성물질 저장과 관련한 국내외 규정에 적합한 밀봉용기 | 4.  제4조제1항제4호에 따른 자료 | 네튬산나트륨의 형태로 함유한다.  | 책임자의 성명을 적은 자료 | 수 있다. ",
        "original_sentence": "|\n| 이라 한다)의 정부 또는 공공기관에서 그 | 부 또는 공공기관에서 그 국가의 법령에 | 허가 처리 | 잔류용매는 일반사항 5.4. "
      }
    },
    {
      "chunk_id": "chunk_286",
      "text": "잔류용매 항에 따라 기준이 | 성물질 저장과 관련한 국내외 규정에 적합한 밀봉용기 | 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 285,
        "window_size": 3,
        "char_count": 51,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| ④ 제3항에 따른 해당 품목의 허가 시에는 양 | 1.  제1항제1호 또는 제2호에 해당하는 자료로 | Cobalt-56 (56Co) | 77.27 일 | 2001 | 23 | 11 | 34 | 2012 | 2 | 0 | 2 | 제34조에 따른 임상시험용 의약품 등 총리령으 | 제조판매품목 허가를 동시에 신청하거나 1개 | 함을 확인하는데 신뢰성을 높여줄 수 있다.  |\n| 이라 한다)의 정부 또는 공공기관에서 그 | 부 또는 공공기관에서 그 국가의 법령에 | 허가 처리 | 잔류용매는 일반사항 5.4.  잔류용매 항에 따라 기준이 | 성물질 저장과 관련한 국내외 규정에 적합한 밀봉용기 | 4.  제4조제1항제4호에 따른 자료 | 네튬산나트륨의 형태로 함유한다.  | 책임자의 성명을 적은 자료 | 수 있다.  | * 방사성의약품은 반감기로 인해 사용시점에 따라 용량이 가변적이므로 용량을 기재하는 대신 ‘자사 | - 일반적으로 실제 제조시의 투입순서 등에 따라 주성분부터 첨가제의 순서로 기재 | 3. ",
        "original_sentence": "잔류용매 항에 따라 기준이 | 성물질 저장과 관련한 국내외 규정에 적합한 밀봉용기 | 4. "
      }
    },
    {
      "chunk_id": "chunk_287",
      "text": "제4조제1항제4호에 따른 자료 | 네튬산나트륨의 형태로 함유한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 286,
        "window_size": 3,
        "char_count": 37,
        "word_count": 7,
        "page_number": 3,
        "window_text": "제1항제1호 또는 제2호에 해당하는 자료로 | Cobalt-56 (56Co) | 77.27 일 | 2001 | 23 | 11 | 34 | 2012 | 2 | 0 | 2 | 제34조에 따른 임상시험용 의약품 등 총리령으 | 제조판매품목 허가를 동시에 신청하거나 1개 | 함을 확인하는데 신뢰성을 높여줄 수 있다.  |\n| 이라 한다)의 정부 또는 공공기관에서 그 | 부 또는 공공기관에서 그 국가의 법령에 | 허가 처리 | 잔류용매는 일반사항 5.4.  잔류용매 항에 따라 기준이 | 성물질 저장과 관련한 국내외 규정에 적합한 밀봉용기 | 4.  제4조제1항제4호에 따른 자료 | 네튬산나트륨의 형태로 함유한다.  | 책임자의 성명을 적은 자료 | 수 있다.  | * 방사성의약품은 반감기로 인해 사용시점에 따라 용량이 가변적이므로 용량을 기재하는 대신 ‘자사 | - 일반적으로 실제 제조시의 투입순서 등에 따라 주성분부터 첨가제의 순서로 기재 | 3.  전자민원 접속/로그인 | 제조업 변경신고서 또는 별지 제7호서식의 | 수입(수입자) | 국내에서 동 수입품목에 대한 허가권자 | 18O(p, n)18F | 1. ",
        "original_sentence": "제4조제1항제4호에 따른 자료 | 네튬산나트륨의 형태로 함유한다. "
      }
    },
    {
      "chunk_id": "chunk_288",
      "text": "| 책임자의 성명을 적은 자료 | 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 287,
        "window_size": 3,
        "char_count": 25,
        "word_count": 8,
        "page_number": 9,
        "window_text": "|\n| 이라 한다)의 정부 또는 공공기관에서 그 | 부 또는 공공기관에서 그 국가의 법령에 | 허가 처리 | 잔류용매는 일반사항 5.4.  잔류용매 항에 따라 기준이 | 성물질 저장과 관련한 국내외 규정에 적합한 밀봉용기 | 4.  제4조제1항제4호에 따른 자료 | 네튬산나트륨의 형태로 함유한다.  | 책임자의 성명을 적은 자료 | 수 있다.  | * 방사성의약품은 반감기로 인해 사용시점에 따라 용량이 가변적이므로 용량을 기재하는 대신 ‘자사 | - 일반적으로 실제 제조시의 투입순서 등에 따라 주성분부터 첨가제의 순서로 기재 | 3.  전자민원 접속/로그인 | 제조업 변경신고서 또는 별지 제7호서식의 | 수입(수입자) | 국내에서 동 수입품목에 대한 허가권자 | 18O(p, n)18F | 1.  대한민국약전 또는 식품의약품안전처장이 인 | 변경 등 식품의약품안전처장이 정하여 고시하 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 때 제품 안의 색이 변하지 않아 | 려된다. ",
        "original_sentence": "| 책임자의 성명을 적은 자료 | 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_289",
      "text": "| * 방사성의약품은 반감기로 인해 사용시점에 따라 용량이 가변적이므로 용량을 기재하는 대신 ‘자사 | - 일반적으로 실제 제조시의 투입순서 등에 따라 주성분부터 첨가제의 순서로 기재 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 288,
        "window_size": 3,
        "char_count": 108,
        "word_count": 27,
        "page_number": 5,
        "window_text": "잔류용매 항에 따라 기준이 | 성물질 저장과 관련한 국내외 규정에 적합한 밀봉용기 | 4.  제4조제1항제4호에 따른 자료 | 네튬산나트륨의 형태로 함유한다.  | 책임자의 성명을 적은 자료 | 수 있다.  | * 방사성의약품은 반감기로 인해 사용시점에 따라 용량이 가변적이므로 용량을 기재하는 대신 ‘자사 | - 일반적으로 실제 제조시의 투입순서 등에 따라 주성분부터 첨가제의 순서로 기재 | 3.  전자민원 접속/로그인 | 제조업 변경신고서 또는 별지 제7호서식의 | 수입(수입자) | 국내에서 동 수입품목에 대한 허가권자 | 18O(p, n)18F | 1.  대한민국약전 또는 식품의약품안전처장이 인 | 변경 등 식품의약품안전처장이 정하여 고시하 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 때 제품 안의 색이 변하지 않아 | 려된다.  지정된 생산조건 하에서 목표로 하는 수율 및 | 수렴 | Cobalt-57 (57Co) | 271.79 일 | 2002 | 1 | 6 | 7 | 2013 | 5 | 2 | 7 | 로 정하는 의약품 또는 의약외품(이하 \"의약품 | 이상 품목을 동시에 제조판매품목 신고하여야 | 가. ",
        "original_sentence": "| * 방사성의약품은 반감기로 인해 사용시점에 따라 용량이 가변적이므로 용량을 기재하는 대신 ‘자사 | - 일반적으로 실제 제조시의 투입순서 등에 따라 주성분부터 첨가제의 순서로 기재 | 3. "
      }
    },
    {
      "chunk_id": "chunk_290",
      "text": "전자민원 접속/로그인 | 제조업 변경신고서 또는 별지 제7호서식의 | 수입(수입자) | 국내에서 동 수입품목에 대한 허가권자 | 18O(p, n)18F | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 289,
        "window_size": 3,
        "char_count": 90,
        "word_count": 21,
        "page_number": 3,
        "window_text": "제4조제1항제4호에 따른 자료 | 네튬산나트륨의 형태로 함유한다.  | 책임자의 성명을 적은 자료 | 수 있다.  | * 방사성의약품은 반감기로 인해 사용시점에 따라 용량이 가변적이므로 용량을 기재하는 대신 ‘자사 | - 일반적으로 실제 제조시의 투입순서 등에 따라 주성분부터 첨가제의 순서로 기재 | 3.  전자민원 접속/로그인 | 제조업 변경신고서 또는 별지 제7호서식의 | 수입(수입자) | 국내에서 동 수입품목에 대한 허가권자 | 18O(p, n)18F | 1.  대한민국약전 또는 식품의약품안전처장이 인 | 변경 등 식품의약품안전처장이 정하여 고시하 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 때 제품 안의 색이 변하지 않아 | 려된다.  지정된 생산조건 하에서 목표로 하는 수율 및 | 수렴 | Cobalt-57 (57Co) | 271.79 일 | 2002 | 1 | 6 | 7 | 2013 | 5 | 2 | 7 | 로 정하는 의약품 또는 의약외품(이하 \"의약품 | 이상 품목을 동시에 제조판매품목 신고하여야 | 가.  단회투여독성시험자료 | 8. ",
        "original_sentence": "전자민원 접속/로그인 | 제조업 변경신고서 또는 별지 제7호서식의 | 수입(수입자) | 국내에서 동 수입품목에 대한 허가권자 | 18O(p, n)18F | 1. "
      }
    },
    {
      "chunk_id": "chunk_291",
      "text": "대한민국약전 또는 식품의약품안전처장이 인 | 변경 등 식품의약품안전처장이 정하여 고시하 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 때 제품 안의 색이 변하지 않아 | 려된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 290,
        "window_size": 3,
        "char_count": 102,
        "word_count": 24,
        "page_number": 5,
        "window_text": "| 책임자의 성명을 적은 자료 | 수 있다.  | * 방사성의약품은 반감기로 인해 사용시점에 따라 용량이 가변적이므로 용량을 기재하는 대신 ‘자사 | - 일반적으로 실제 제조시의 투입순서 등에 따라 주성분부터 첨가제의 순서로 기재 | 3.  전자민원 접속/로그인 | 제조업 변경신고서 또는 별지 제7호서식의 | 수입(수입자) | 국내에서 동 수입품목에 대한 허가권자 | 18O(p, n)18F | 1.  대한민국약전 또는 식품의약품안전처장이 인 | 변경 등 식품의약품안전처장이 정하여 고시하 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 때 제품 안의 색이 변하지 않아 | 려된다.  지정된 생산조건 하에서 목표로 하는 수율 및 | 수렴 | Cobalt-57 (57Co) | 271.79 일 | 2002 | 1 | 6 | 7 | 2013 | 5 | 2 | 7 | 로 정하는 의약품 또는 의약외품(이하 \"의약품 | 이상 품목을 동시에 제조판매품목 신고하여야 | 가.  단회투여독성시험자료 | 8.  국내 유사제품과의 비교검토 및 당해 의약품의 | 의 대상ᆞ기준ᆞ조건 및 관리 등에 관하여 필 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 품목이 생산국의 법령에 적합하게 제조되 | 적합하게 판매되고 있음을 증명하는 판매 | 99mTc | 41 | 19.3 | 131I | 46 | 21.7 | 제한되고, 2.4.24. ",
        "original_sentence": "대한민국약전 또는 식품의약품안전처장이 인 | 변경 등 식품의약품안전처장이 정하여 고시하 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 때 제품 안의 색이 변하지 않아 | 려된다. "
      }
    },
    {
      "chunk_id": "chunk_292",
      "text": "지정된 생산조건 하에서 목표로 하는 수율 및 | 수렴 | Cobalt-57 (57Co) | 271.79 일 | 2002 | 1 | 6 | 7 | 2013 | 5 | 2 | 7 | 로 정하는 의약품 또는 의약외품(이하 \"의약품 | 이상 품목을 동시에 제조판매품목 신고하여야 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 291,
        "window_size": 3,
        "char_count": 157,
        "word_count": 46,
        "page_number": 3,
        "window_text": "| * 방사성의약품은 반감기로 인해 사용시점에 따라 용량이 가변적이므로 용량을 기재하는 대신 ‘자사 | - 일반적으로 실제 제조시의 투입순서 등에 따라 주성분부터 첨가제의 순서로 기재 | 3.  전자민원 접속/로그인 | 제조업 변경신고서 또는 별지 제7호서식의 | 수입(수입자) | 국내에서 동 수입품목에 대한 허가권자 | 18O(p, n)18F | 1.  대한민국약전 또는 식품의약품안전처장이 인 | 변경 등 식품의약품안전처장이 정하여 고시하 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 때 제품 안의 색이 변하지 않아 | 려된다.  지정된 생산조건 하에서 목표로 하는 수율 및 | 수렴 | Cobalt-57 (57Co) | 271.79 일 | 2002 | 1 | 6 | 7 | 2013 | 5 | 2 | 7 | 로 정하는 의약품 또는 의약외품(이하 \"의약품 | 이상 품목을 동시에 제조판매품목 신고하여야 | 가.  단회투여독성시험자료 | 8.  국내 유사제품과의 비교검토 및 당해 의약품의 | 의 대상ᆞ기준ᆞ조건 및 관리 등에 관하여 필 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 품목이 생산국의 법령에 적합하게 제조되 | 적합하게 판매되고 있음을 증명하는 판매 | 99mTc | 41 | 19.3 | 131I | 46 | 21.7 | 제한되고, 2.4.24.  잔류용매 확인 및 관리 항에 기재된 | 에 보관한다. ",
        "original_sentence": "지정된 생산조건 하에서 목표로 하는 수율 및 | 수렴 | Cobalt-57 (57Co) | 271.79 일 | 2002 | 1 | 6 | 7 | 2013 | 5 | 2 | 7 | 로 정하는 의약품 또는 의약외품(이하 \"의약품 | 이상 품목을 동시에 제조판매품목 신고하여야 | 가. "
      }
    },
    {
      "chunk_id": "chunk_293",
      "text": "단회투여독성시험자료 | 8. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 292,
        "window_size": 3,
        "char_count": 16,
        "word_count": 3,
        "page_number": 17,
        "window_text": "전자민원 접속/로그인 | 제조업 변경신고서 또는 별지 제7호서식의 | 수입(수입자) | 국내에서 동 수입품목에 대한 허가권자 | 18O(p, n)18F | 1.  대한민국약전 또는 식품의약품안전처장이 인 | 변경 등 식품의약품안전처장이 정하여 고시하 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 때 제품 안의 색이 변하지 않아 | 려된다.  지정된 생산조건 하에서 목표로 하는 수율 및 | 수렴 | Cobalt-57 (57Co) | 271.79 일 | 2002 | 1 | 6 | 7 | 2013 | 5 | 2 | 7 | 로 정하는 의약품 또는 의약외품(이하 \"의약품 | 이상 품목을 동시에 제조판매품목 신고하여야 | 가.  단회투여독성시험자료 | 8.  국내 유사제품과의 비교검토 및 당해 의약품의 | 의 대상ᆞ기준ᆞ조건 및 관리 등에 관하여 필 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 품목이 생산국의 법령에 적합하게 제조되 | 적합하게 판매되고 있음을 증명하는 판매 | 99mTc | 41 | 19.3 | 131I | 46 | 21.7 | 제한되고, 2.4.24.  잔류용매 확인 및 관리 항에 기재된 | 에 보관한다.  저장기간 동안 용기는 방사선 조사 때문 | 나. ",
        "original_sentence": "단회투여독성시험자료 | 8. "
      }
    },
    {
      "chunk_id": "chunk_294",
      "text": "국내 유사제품과의 비교검토 및 당해 의약품의 | 의 대상ᆞ기준ᆞ조건 및 관리 등에 관하여 필 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 품목이 생산국의 법령에 적합하게 제조되 | 적합하게 판매되고 있음을 증명하는 판매 | 99mTc | 41 | 19.3 | 131I | 46 | 21.7 | 제한되고, 2.4.24. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 293,
        "window_size": 3,
        "char_count": 182,
        "word_count": 48,
        "page_number": 6,
        "window_text": "대한민국약전 또는 식품의약품안전처장이 인 | 변경 등 식품의약품안전처장이 정하여 고시하 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 때 제품 안의 색이 변하지 않아 | 려된다.  지정된 생산조건 하에서 목표로 하는 수율 및 | 수렴 | Cobalt-57 (57Co) | 271.79 일 | 2002 | 1 | 6 | 7 | 2013 | 5 | 2 | 7 | 로 정하는 의약품 또는 의약외품(이하 \"의약품 | 이상 품목을 동시에 제조판매품목 신고하여야 | 가.  단회투여독성시험자료 | 8.  국내 유사제품과의 비교검토 및 당해 의약품의 | 의 대상ᆞ기준ᆞ조건 및 관리 등에 관하여 필 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 품목이 생산국의 법령에 적합하게 제조되 | 적합하게 판매되고 있음을 증명하는 판매 | 99mTc | 41 | 19.3 | 131I | 46 | 21.7 | 제한되고, 2.4.24.  잔류용매 확인 및 관리 항에 기재된 | 에 보관한다.  저장기간 동안 용기는 방사선 조사 때문 | 나.  저장방법 및 사용기간을 적은 자료 | 7. ",
        "original_sentence": "국내 유사제품과의 비교검토 및 당해 의약품의 | 의 대상ᆞ기준ᆞ조건 및 관리 등에 관하여 필 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 품목이 생산국의 법령에 적합하게 제조되 | 적합하게 판매되고 있음을 증명하는 판매 | 99mTc | 41 | 19.3 | 131I | 46 | 21.7 | 제한되고, 2.4.24. "
      }
    },
    {
      "chunk_id": "chunk_295",
      "text": "잔류용매 확인 및 관리 항에 기재된 | 에 보관한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 294,
        "window_size": 3,
        "char_count": 30,
        "word_count": 9,
        "page_number": 5,
        "window_text": "지정된 생산조건 하에서 목표로 하는 수율 및 | 수렴 | Cobalt-57 (57Co) | 271.79 일 | 2002 | 1 | 6 | 7 | 2013 | 5 | 2 | 7 | 로 정하는 의약품 또는 의약외품(이하 \"의약품 | 이상 품목을 동시에 제조판매품목 신고하여야 | 가.  단회투여독성시험자료 | 8.  국내 유사제품과의 비교검토 및 당해 의약품의 | 의 대상ᆞ기준ᆞ조건 및 관리 등에 관하여 필 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 품목이 생산국의 법령에 적합하게 제조되 | 적합하게 판매되고 있음을 증명하는 판매 | 99mTc | 41 | 19.3 | 131I | 46 | 21.7 | 제한되고, 2.4.24.  잔류용매 확인 및 관리 항에 기재된 | 에 보관한다.  저장기간 동안 용기는 방사선 조사 때문 | 나.  저장방법 및 사용기간을 적은 자료 | 7.  법 제31조의2제1항에 따라 등록할 수 있는 | 5. ",
        "original_sentence": "잔류용매 확인 및 관리 항에 기재된 | 에 보관한다. "
      }
    },
    {
      "chunk_id": "chunk_296",
      "text": "저장기간 동안 용기는 방사선 조사 때문 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 295,
        "window_size": 3,
        "char_count": 27,
        "word_count": 8,
        "page_number": 10,
        "window_text": "단회투여독성시험자료 | 8.  국내 유사제품과의 비교검토 및 당해 의약품의 | 의 대상ᆞ기준ᆞ조건 및 관리 등에 관하여 필 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 품목이 생산국의 법령에 적합하게 제조되 | 적합하게 판매되고 있음을 증명하는 판매 | 99mTc | 41 | 19.3 | 131I | 46 | 21.7 | 제한되고, 2.4.24.  잔류용매 확인 및 관리 항에 기재된 | 에 보관한다.  저장기간 동안 용기는 방사선 조사 때문 | 나.  저장방법 및 사용기간을 적은 자료 | 7.  법 제31조의2제1항에 따라 등록할 수 있는 | 5.  제4조제1항제6호에 따른 자료 | 이 약은 정량할 때 시험 당시 표시된 테크네튬-99m | 반영 | 의 핵종을 딸방사성핵종이라 한다. ",
        "original_sentence": "저장기간 동안 용기는 방사선 조사 때문 | 나. "
      }
    },
    {
      "chunk_id": "chunk_297",
      "text": "저장방법 및 사용기간을 적은 자료 | 7. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 296,
        "window_size": 3,
        "char_count": 24,
        "word_count": 7,
        "page_number": 3,
        "window_text": "국내 유사제품과의 비교검토 및 당해 의약품의 | 의 대상ᆞ기준ᆞ조건 및 관리 등에 관하여 필 | 중 한약에 관한 기준[이하 \"대한민국약전 |\n| 품목이 생산국의 법령에 적합하게 제조되 | 적합하게 판매되고 있음을 증명하는 판매 | 99mTc | 41 | 19.3 | 131I | 46 | 21.7 | 제한되고, 2.4.24.  잔류용매 확인 및 관리 항에 기재된 | 에 보관한다.  저장기간 동안 용기는 방사선 조사 때문 | 나.  저장방법 및 사용기간을 적은 자료 | 7.  법 제31조의2제1항에 따라 등록할 수 있는 | 5.  제4조제1항제6호에 따른 자료 | 이 약은 정량할 때 시험 당시 표시된 테크네튬-99m | 반영 | 의 핵종을 딸방사성핵종이라 한다.  | Cobalt-58 (58Co) | 7086 일 | 포장단위’ 또는 ‘제조원 포장단위’로 기재 가능 | 4. ",
        "original_sentence": "저장방법 및 사용기간을 적은 자료 | 7. "
      }
    },
    {
      "chunk_id": "chunk_298",
      "text": "법 제31조의2제1항에 따라 등록할 수 있는 | 5. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 297,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 3,
        "window_text": "잔류용매 확인 및 관리 항에 기재된 | 에 보관한다.  저장기간 동안 용기는 방사선 조사 때문 | 나.  저장방법 및 사용기간을 적은 자료 | 7.  법 제31조의2제1항에 따라 등록할 수 있는 | 5.  제4조제1항제6호에 따른 자료 | 이 약은 정량할 때 시험 당시 표시된 테크네튬-99m | 반영 | 의 핵종을 딸방사성핵종이라 한다.  | Cobalt-58 (58Co) | 7086 일 | 포장단위’ 또는 ‘제조원 포장단위’로 기재 가능 | 4.  민원접수(민원종류 선택, 담당부서 선택, 파일 접수) | 도인에 대한 제조판매ᆞ수입 품목허가에 붙여 | 서 적합하다는 제41조제3항에 따른 사전 검 | 의약품등의 제조업 허가사항 변경허가 신청 | 소분포장 | 다음 식에 따라 나타낸다. ",
        "original_sentence": "법 제31조의2제1항에 따라 등록할 수 있는 | 5. "
      }
    },
    {
      "chunk_id": "chunk_299",
      "text": "제4조제1항제6호에 따른 자료 | 이 약은 정량할 때 시험 당시 표시된 테크네튬-99m | 반영 | 의 핵종을 딸방사성핵종이라 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 298,
        "window_size": 3,
        "char_count": 75,
        "word_count": 19,
        "page_number": 3,
        "window_text": "저장기간 동안 용기는 방사선 조사 때문 | 나.  저장방법 및 사용기간을 적은 자료 | 7.  법 제31조의2제1항에 따라 등록할 수 있는 | 5.  제4조제1항제6호에 따른 자료 | 이 약은 정량할 때 시험 당시 표시된 테크네튬-99m | 반영 | 의 핵종을 딸방사성핵종이라 한다.  | Cobalt-58 (58Co) | 7086 일 | 포장단위’ 또는 ‘제조원 포장단위’로 기재 가능 | 4.  민원접수(민원종류 선택, 담당부서 선택, 파일 접수) | 도인에 대한 제조판매ᆞ수입 품목허가에 붙여 | 서 적합하다는 제41조제3항에 따른 사전 검 | 의약품등의 제조업 허가사항 변경허가 신청 | 소분포장 | 다음 식에 따라 나타낸다.  | 는 경미한 사항인 경우에는 식품의약품안전처 | 정하는 공정서 및 의약품집에 실려 있는 품 | 있는 품목 |\n| 야 함(상세시험은 EP 참조) | 품질을 얻기 위해 생산에 사용되는 화학물질 전구체는 | 의약품의 품목허가․신고․심사 규정｣ | 2003 | 4 | 3 | 7 | 2014 | 7 | 9 | 16 | 등\"이라 한다)에 대하여는 제조업허가 또는 품 | 한다. ",
        "original_sentence": "제4조제1항제6호에 따른 자료 | 이 약은 정량할 때 시험 당시 표시된 테크네튬-99m | 반영 | 의 핵종을 딸방사성핵종이라 한다. "
      }
    },
    {
      "chunk_id": "chunk_300",
      "text": "| Cobalt-58 (58Co) | 7086 일 | 포장단위’ 또는 ‘제조원 포장단위’로 기재 가능 | 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 299,
        "window_size": 3,
        "char_count": 62,
        "word_count": 15,
        "page_number": 3,
        "window_text": "저장방법 및 사용기간을 적은 자료 | 7.  법 제31조의2제1항에 따라 등록할 수 있는 | 5.  제4조제1항제6호에 따른 자료 | 이 약은 정량할 때 시험 당시 표시된 테크네튬-99m | 반영 | 의 핵종을 딸방사성핵종이라 한다.  | Cobalt-58 (58Co) | 7086 일 | 포장단위’ 또는 ‘제조원 포장단위’로 기재 가능 | 4.  민원접수(민원종류 선택, 담당부서 선택, 파일 접수) | 도인에 대한 제조판매ᆞ수입 품목허가에 붙여 | 서 적합하다는 제41조제3항에 따른 사전 검 | 의약품등의 제조업 허가사항 변경허가 신청 | 소분포장 | 다음 식에 따라 나타낸다.  | 는 경미한 사항인 경우에는 식품의약품안전처 | 정하는 공정서 및 의약품집에 실려 있는 품 | 있는 품목 |\n| 야 함(상세시험은 EP 참조) | 품질을 얻기 위해 생산에 사용되는 화학물질 전구체는 | 의약품의 품목허가․신고․심사 규정｣ | 2003 | 4 | 3 | 7 | 2014 | 7 | 9 | 16 | 등\"이라 한다)에 대하여는 제조업허가 또는 품 | 한다.  | 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라 이 규칙이 시행되는 | 나. ",
        "original_sentence": "| Cobalt-58 (58Co) | 7086 일 | 포장단위’ 또는 ‘제조원 포장단위’로 기재 가능 | 4. "
      }
    },
    {
      "chunk_id": "chunk_301",
      "text": "민원접수(민원종류 선택, 담당부서 선택, 파일 접수) | 도인에 대한 제조판매ᆞ수입 품목허가에 붙여 | 서 적합하다는 제41조제3항에 따른 사전 검 | 의약품등의 제조업 허가사항 변경허가 신청 | 소분포장 | 다음 식에 따라 나타낸다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 300,
        "window_size": 3,
        "char_count": 132,
        "word_count": 32,
        "page_number": 3,
        "window_text": "법 제31조의2제1항에 따라 등록할 수 있는 | 5.  제4조제1항제6호에 따른 자료 | 이 약은 정량할 때 시험 당시 표시된 테크네튬-99m | 반영 | 의 핵종을 딸방사성핵종이라 한다.  | Cobalt-58 (58Co) | 7086 일 | 포장단위’ 또는 ‘제조원 포장단위’로 기재 가능 | 4.  민원접수(민원종류 선택, 담당부서 선택, 파일 접수) | 도인에 대한 제조판매ᆞ수입 품목허가에 붙여 | 서 적합하다는 제41조제3항에 따른 사전 검 | 의약품등의 제조업 허가사항 변경허가 신청 | 소분포장 | 다음 식에 따라 나타낸다.  | 는 경미한 사항인 경우에는 식품의약품안전처 | 정하는 공정서 및 의약품집에 실려 있는 품 | 있는 품목 |\n| 야 함(상세시험은 EP 참조) | 품질을 얻기 위해 생산에 사용되는 화학물질 전구체는 | 의약품의 품목허가․신고․심사 규정｣ | 2003 | 4 | 3 | 7 | 2014 | 7 | 9 | 16 | 등\"이라 한다)에 대하여는 제조업허가 또는 품 | 한다.  | 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라 이 규칙이 시행되는 | 나.  반복투여독성시험자료 | 자사에서 적절하게 설정할 수 있음 | 요한 사항은 총리령으로 정한다. ",
        "original_sentence": "민원접수(민원종류 선택, 담당부서 선택, 파일 접수) | 도인에 대한 제조판매ᆞ수입 품목허가에 붙여 | 서 적합하다는 제41조제3항에 따른 사전 검 | 의약품등의 제조업 허가사항 변경허가 신청 | 소분포장 | 다음 식에 따라 나타낸다. "
      }
    },
    {
      "chunk_id": "chunk_302",
      "text": "| 는 경미한 사항인 경우에는 식품의약품안전처 | 정하는 공정서 및 의약품집에 실려 있는 품 | 있는 품목 |\n| 야 함(상세시험은 EP 참조) | 품질을 얻기 위해 생산에 사용되는 화학물질 전구체는 | 의약품의 품목허가․신고․심사 규정｣ | 2003 | 4 | 3 | 7 | 2014 | 7 | 9 | 16 | 등\"이라 한다)에 대하여는 제조업허가 또는 품 | 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 301,
        "window_size": 3,
        "char_count": 207,
        "word_count": 60,
        "page_number": 1,
        "window_text": "제4조제1항제6호에 따른 자료 | 이 약은 정량할 때 시험 당시 표시된 테크네튬-99m | 반영 | 의 핵종을 딸방사성핵종이라 한다.  | Cobalt-58 (58Co) | 7086 일 | 포장단위’ 또는 ‘제조원 포장단위’로 기재 가능 | 4.  민원접수(민원종류 선택, 담당부서 선택, 파일 접수) | 도인에 대한 제조판매ᆞ수입 품목허가에 붙여 | 서 적합하다는 제41조제3항에 따른 사전 검 | 의약품등의 제조업 허가사항 변경허가 신청 | 소분포장 | 다음 식에 따라 나타낸다.  | 는 경미한 사항인 경우에는 식품의약품안전처 | 정하는 공정서 및 의약품집에 실려 있는 품 | 있는 품목 |\n| 야 함(상세시험은 EP 참조) | 품질을 얻기 위해 생산에 사용되는 화학물질 전구체는 | 의약품의 품목허가․신고․심사 규정｣ | 2003 | 4 | 3 | 7 | 2014 | 7 | 9 | 16 | 등\"이라 한다)에 대하여는 제조업허가 또는 품 | 한다.  | 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라 이 규칙이 시행되는 | 나.  반복투여독성시험자료 | 자사에서 적절하게 설정할 수 있음 | 요한 사항은 총리령으로 정한다.  | 특성에 관한 자료 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 고 있음을 증명하는 제조증명서 | 증명서 | 89Sr | 1 | 0.5 | 123I | 7 | 3.3 | 【공직자 부조리 및 공익신고안내】   ** 신고자 및 신고내용은 보호됩니다. ",
        "original_sentence": "| 는 경미한 사항인 경우에는 식품의약품안전처 | 정하는 공정서 및 의약품집에 실려 있는 품 | 있는 품목 |\n| 야 함(상세시험은 EP 참조) | 품질을 얻기 위해 생산에 사용되는 화학물질 전구체는 | 의약품의 품목허가․신고․심사 규정｣ | 2003 | 4 | 3 | 7 | 2014 | 7 | 9 | 16 | 등\"이라 한다)에 대하여는 제조업허가 또는 품 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_303",
      "text": "| 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라 이 규칙이 시행되는 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 302,
        "window_size": 3,
        "char_count": 63,
        "word_count": 16,
        "page_number": 3,
        "window_text": "| Cobalt-58 (58Co) | 7086 일 | 포장단위’ 또는 ‘제조원 포장단위’로 기재 가능 | 4.  민원접수(민원종류 선택, 담당부서 선택, 파일 접수) | 도인에 대한 제조판매ᆞ수입 품목허가에 붙여 | 서 적합하다는 제41조제3항에 따른 사전 검 | 의약품등의 제조업 허가사항 변경허가 신청 | 소분포장 | 다음 식에 따라 나타낸다.  | 는 경미한 사항인 경우에는 식품의약품안전처 | 정하는 공정서 및 의약품집에 실려 있는 품 | 있는 품목 |\n| 야 함(상세시험은 EP 참조) | 품질을 얻기 위해 생산에 사용되는 화학물질 전구체는 | 의약품의 품목허가․신고․심사 규정｣ | 2003 | 4 | 3 | 7 | 2014 | 7 | 9 | 16 | 등\"이라 한다)에 대하여는 제조업허가 또는 품 | 한다.  | 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라 이 규칙이 시행되는 | 나.  반복투여독성시험자료 | 자사에서 적절하게 설정할 수 있음 | 요한 사항은 총리령으로 정한다.  | 특성에 관한 자료 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 고 있음을 증명하는 제조증명서 | 증명서 | 89Sr | 1 | 0.5 | 123I | 7 | 3.3 | 【공직자 부조리 및 공익신고안내】   ** 신고자 및 신고내용은 보호됩니다.  | 다. ",
        "original_sentence": "| 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라 이 규칙이 시행되는 | 나. "
      }
    },
    {
      "chunk_id": "chunk_304",
      "text": "반복투여독성시험자료 | 자사에서 적절하게 설정할 수 있음 | 요한 사항은 총리령으로 정한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 303,
        "window_size": 3,
        "char_count": 52,
        "word_count": 12,
        "page_number": 1,
        "window_text": "민원접수(민원종류 선택, 담당부서 선택, 파일 접수) | 도인에 대한 제조판매ᆞ수입 품목허가에 붙여 | 서 적합하다는 제41조제3항에 따른 사전 검 | 의약품등의 제조업 허가사항 변경허가 신청 | 소분포장 | 다음 식에 따라 나타낸다.  | 는 경미한 사항인 경우에는 식품의약품안전처 | 정하는 공정서 및 의약품집에 실려 있는 품 | 있는 품목 |\n| 야 함(상세시험은 EP 참조) | 품질을 얻기 위해 생산에 사용되는 화학물질 전구체는 | 의약품의 품목허가․신고․심사 규정｣ | 2003 | 4 | 3 | 7 | 2014 | 7 | 9 | 16 | 등\"이라 한다)에 대하여는 제조업허가 또는 품 | 한다.  | 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라 이 규칙이 시행되는 | 나.  반복투여독성시험자료 | 자사에서 적절하게 설정할 수 있음 | 요한 사항은 총리령으로 정한다.  | 특성에 관한 자료 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 고 있음을 증명하는 제조증명서 | 증명서 | 89Sr | 1 | 0.5 | 123I | 7 | 3.3 | 【공직자 부조리 및 공익신고안내】   ** 신고자 및 신고내용은 보호됩니다.  | 다.  제15조제1항 각 호의 자료 | 6. ",
        "original_sentence": "반복투여독성시험자료 | 자사에서 적절하게 설정할 수 있음 | 요한 사항은 총리령으로 정한다. "
      }
    },
    {
      "chunk_id": "chunk_305",
      "text": "| 특성에 관한 자료 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 고 있음을 증명하는 제조증명서 | 증명서 | 89Sr | 1 | 0.5 | 123I | 7 | 3.3 | 【공직자 부조리 및 공익신고안내】   ** 신고자 및 신고내용은 보호됩니다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 304,
        "window_size": 3,
        "char_count": 142,
        "word_count": 38,
        "page_number": 5,
        "window_text": "| 는 경미한 사항인 경우에는 식품의약품안전처 | 정하는 공정서 및 의약품집에 실려 있는 품 | 있는 품목 |\n| 야 함(상세시험은 EP 참조) | 품질을 얻기 위해 생산에 사용되는 화학물질 전구체는 | 의약품의 품목허가․신고․심사 규정｣ | 2003 | 4 | 3 | 7 | 2014 | 7 | 9 | 16 | 등\"이라 한다)에 대하여는 제조업허가 또는 품 | 한다.  | 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라 이 규칙이 시행되는 | 나.  반복투여독성시험자료 | 자사에서 적절하게 설정할 수 있음 | 요한 사항은 총리령으로 정한다.  | 특성에 관한 자료 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 고 있음을 증명하는 제조증명서 | 증명서 | 89Sr | 1 | 0.5 | 123I | 7 | 3.3 | 【공직자 부조리 및 공익신고안내】   ** 신고자 및 신고내용은 보호됩니다.  | 다.  제15조제1항 각 호의 자료 | 6.  제4조제1항제7호부터 제9호까지에 따른 자 | 방사능의 90.0 ~ 110.0 %를 함유한다. ",
        "original_sentence": "| 특성에 관한 자료 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 고 있음을 증명하는 제조증명서 | 증명서 | 89Sr | 1 | 0.5 | 123I | 7 | 3.3 | 【공직자 부조리 및 공익신고안내】   ** 신고자 및 신고내용은 보호됩니다. "
      }
    },
    {
      "chunk_id": "chunk_306",
      "text": "| 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 305,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 9,
        "window_text": "| 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라 이 규칙이 시행되는 | 나.  반복투여독성시험자료 | 자사에서 적절하게 설정할 수 있음 | 요한 사항은 총리령으로 정한다.  | 특성에 관한 자료 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 고 있음을 증명하는 제조증명서 | 증명서 | 89Sr | 1 | 0.5 | 123I | 7 | 3.3 | 【공직자 부조리 및 공익신고안내】   ** 신고자 및 신고내용은 보호됩니다.  | 다.  제15조제1항 각 호의 자료 | 6.  제4조제1항제7호부터 제9호까지에 따른 자 | 방사능의 90.0 ~ 110.0 %를 함유한다.  | 신약의 원료의약품 또는 식품의약품안전처장 | 방사화학적순도(RADIOCHEMICAL PURITY) | 방사성핵종의 붕괴 또는 변환 시 하전입자방출 | 배합목적 | Cobalt-60 (60Co) | 5.2714 년 | 진 조건에 상응하는 조건을 붙일 수 있다. ",
        "original_sentence": "| 다. "
      }
    },
    {
      "chunk_id": "chunk_307",
      "text": "제15조제1항 각 호의 자료 | 6. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 306,
        "window_size": 3,
        "char_count": 21,
        "word_count": 6,
        "page_number": 3,
        "window_text": "반복투여독성시험자료 | 자사에서 적절하게 설정할 수 있음 | 요한 사항은 총리령으로 정한다.  | 특성에 관한 자료 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 고 있음을 증명하는 제조증명서 | 증명서 | 89Sr | 1 | 0.5 | 123I | 7 | 3.3 | 【공직자 부조리 및 공익신고안내】   ** 신고자 및 신고내용은 보호됩니다.  | 다.  제15조제1항 각 호의 자료 | 6.  제4조제1항제7호부터 제9호까지에 따른 자 | 방사능의 90.0 ~ 110.0 %를 함유한다.  | 신약의 원료의약품 또는 식품의약품안전처장 | 방사화학적순도(RADIOCHEMICAL PURITY) | 방사성핵종의 붕괴 또는 변환 시 하전입자방출 | 배합목적 | Cobalt-60 (60Co) | 5.2714 년 | 진 조건에 상응하는 조건을 붙일 수 있다.  | 토 결과통지서를 제출한 경우: 제1항제1호 | 소분품목의 허가권자이면서 소분․포장 제조하는 자 | 장이 정하여 고시하는 바에 따라 변경내용을 |\n| 과테크네튬산나트륨(99mTc) 주사액 | 시험방법 또는 다른 적절한 방법을 사용하여 관리한다. ",
        "original_sentence": "제15조제1항 각 호의 자료 | 6. "
      }
    },
    {
      "chunk_id": "chunk_308",
      "text": "제4조제1항제7호부터 제9호까지에 따른 자 | 방사능의 90.0 ~ 110.0 %를 함유한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 307,
        "window_size": 3,
        "char_count": 53,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| 특성에 관한 자료 | 외한약(생약)규격집\"이라 한다]에 실려 |\n| 고 있음을 증명하는 제조증명서 | 증명서 | 89Sr | 1 | 0.5 | 123I | 7 | 3.3 | 【공직자 부조리 및 공익신고안내】   ** 신고자 및 신고내용은 보호됩니다.  | 다.  제15조제1항 각 호의 자료 | 6.  제4조제1항제7호부터 제9호까지에 따른 자 | 방사능의 90.0 ~ 110.0 %를 함유한다.  | 신약의 원료의약품 또는 식품의약품안전처장 | 방사화학적순도(RADIOCHEMICAL PURITY) | 방사성핵종의 붕괴 또는 변환 시 하전입자방출 | 배합목적 | Cobalt-60 (60Co) | 5.2714 년 | 진 조건에 상응하는 조건을 붙일 수 있다.  | 토 결과통지서를 제출한 경우: 제1항제1호 | 소분품목의 허가권자이면서 소분․포장 제조하는 자 | 장이 정하여 고시하는 바에 따라 변경내용을 |\n| 과테크네튬산나트륨(99mTc) 주사액 | 시험방법 또는 다른 적절한 방법을 사용하여 관리한다.  | 에 차광할 수 있다. ",
        "original_sentence": "제4조제1항제7호부터 제9호까지에 따른 자 | 방사능의 90.0 ~ 110.0 %를 함유한다. "
      }
    },
    {
      "chunk_id": "chunk_309",
      "text": "| 신약의 원료의약품 또는 식품의약품안전처장 | 방사화학적순도(RADIOCHEMICAL PURITY) | 방사성핵종의 붕괴 또는 변환 시 하전입자방출 | 배합목적 | Cobalt-60 (60Co) | 5.2714 년 | 진 조건에 상응하는 조건을 붙일 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 308,
        "window_size": 3,
        "char_count": 147,
        "word_count": 31,
        "page_number": 6,
        "window_text": "| 다.  제15조제1항 각 호의 자료 | 6.  제4조제1항제7호부터 제9호까지에 따른 자 | 방사능의 90.0 ~ 110.0 %를 함유한다.  | 신약의 원료의약품 또는 식품의약품안전처장 | 방사화학적순도(RADIOCHEMICAL PURITY) | 방사성핵종의 붕괴 또는 변환 시 하전입자방출 | 배합목적 | Cobalt-60 (60Co) | 5.2714 년 | 진 조건에 상응하는 조건을 붙일 수 있다.  | 토 결과통지서를 제출한 경우: 제1항제1호 | 소분품목의 허가권자이면서 소분․포장 제조하는 자 | 장이 정하여 고시하는 바에 따라 변경내용을 |\n| 과테크네튬산나트륨(99mTc) 주사액 | 시험방법 또는 다른 적절한 방법을 사용하여 관리한다.  | 에 차광할 수 있다.  이러한 차광은 반드시 제제의 저 | 중성자 조사(NEUTRON IRRADIATION) | - 기타의 경우 제조는 “자사 포장단위”, 수입은 “제조원 포장단위”로 기재 | ④ 기업의 분리 또는 합병에 의하여 의약품등의 | 5. ",
        "original_sentence": "| 신약의 원료의약품 또는 식품의약품안전처장 | 방사화학적순도(RADIOCHEMICAL PURITY) | 방사성핵종의 붕괴 또는 변환 시 하전입자방출 | 배합목적 | Cobalt-60 (60Co) | 5.2714 년 | 진 조건에 상응하는 조건을 붙일 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_310",
      "text": "| 토 결과통지서를 제출한 경우: 제1항제1호 | 소분품목의 허가권자이면서 소분․포장 제조하는 자 | 장이 정하여 고시하는 바에 따라 변경내용을 |\n| 과테크네튬산나트륨(99mTc) 주사액 | 시험방법 또는 다른 적절한 방법을 사용하여 관리한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 309,
        "window_size": 3,
        "char_count": 138,
        "word_count": 31,
        "page_number": 3,
        "window_text": "제15조제1항 각 호의 자료 | 6.  제4조제1항제7호부터 제9호까지에 따른 자 | 방사능의 90.0 ~ 110.0 %를 함유한다.  | 신약의 원료의약품 또는 식품의약품안전처장 | 방사화학적순도(RADIOCHEMICAL PURITY) | 방사성핵종의 붕괴 또는 변환 시 하전입자방출 | 배합목적 | Cobalt-60 (60Co) | 5.2714 년 | 진 조건에 상응하는 조건을 붙일 수 있다.  | 토 결과통지서를 제출한 경우: 제1항제1호 | 소분품목의 허가권자이면서 소분․포장 제조하는 자 | 장이 정하여 고시하는 바에 따라 변경내용을 |\n| 과테크네튬산나트륨(99mTc) 주사액 | 시험방법 또는 다른 적절한 방법을 사용하여 관리한다.  | 에 차광할 수 있다.  이러한 차광은 반드시 제제의 저 | 중성자 조사(NEUTRON IRRADIATION) | - 기타의 경우 제조는 “자사 포장단위”, 수입은 “제조원 포장단위”로 기재 | ④ 기업의 분리 또는 합병에 의하여 의약품등의 | 5.  수수료납부 (수수료 납부 완료 시 민원신청 완료) | 2004 | 7 | 0 | 7 | 합계 | 116 | 96 | 212 | 목허가를 받지 아니하거나 품목신고를 하지 아 | 서 | (소분제조자) | 라. ",
        "original_sentence": "| 토 결과통지서를 제출한 경우: 제1항제1호 | 소분품목의 허가권자이면서 소분․포장 제조하는 자 | 장이 정하여 고시하는 바에 따라 변경내용을 |\n| 과테크네튬산나트륨(99mTc) 주사액 | 시험방법 또는 다른 적절한 방법을 사용하여 관리한다. "
      }
    },
    {
      "chunk_id": "chunk_311",
      "text": "| 에 차광할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 310,
        "window_size": 3,
        "char_count": 14,
        "word_count": 5,
        "page_number": 9,
        "window_text": "제4조제1항제7호부터 제9호까지에 따른 자 | 방사능의 90.0 ~ 110.0 %를 함유한다.  | 신약의 원료의약품 또는 식품의약품안전처장 | 방사화학적순도(RADIOCHEMICAL PURITY) | 방사성핵종의 붕괴 또는 변환 시 하전입자방출 | 배합목적 | Cobalt-60 (60Co) | 5.2714 년 | 진 조건에 상응하는 조건을 붙일 수 있다.  | 토 결과통지서를 제출한 경우: 제1항제1호 | 소분품목의 허가권자이면서 소분․포장 제조하는 자 | 장이 정하여 고시하는 바에 따라 변경내용을 |\n| 과테크네튬산나트륨(99mTc) 주사액 | 시험방법 또는 다른 적절한 방법을 사용하여 관리한다.  | 에 차광할 수 있다.  이러한 차광은 반드시 제제의 저 | 중성자 조사(NEUTRON IRRADIATION) | - 기타의 경우 제조는 “자사 포장단위”, 수입은 “제조원 포장단위”로 기재 | ④ 기업의 분리 또는 합병에 의하여 의약품등의 | 5.  수수료납부 (수수료 납부 완료 시 민원신청 완료) | 2004 | 7 | 0 | 7 | 합계 | 116 | 96 | 212 | 목허가를 받지 아니하거나 품목신고를 하지 아 | 서 | (소분제조자) | 라.  식품의약품안전처장이 성분의 종류·규 | 목. ",
        "original_sentence": "| 에 차광할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_312",
      "text": "이러한 차광은 반드시 제제의 저 | 중성자 조사(NEUTRON IRRADIATION) | - 기타의 경우 제조는 “자사 포장단위”, 수입은 “제조원 포장단위”로 기재 | ④ 기업의 분리 또는 합병에 의하여 의약품등의 | 5. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 311,
        "window_size": 3,
        "char_count": 126,
        "word_count": 30,
        "page_number": 5,
        "window_text": "| 신약의 원료의약품 또는 식품의약품안전처장 | 방사화학적순도(RADIOCHEMICAL PURITY) | 방사성핵종의 붕괴 또는 변환 시 하전입자방출 | 배합목적 | Cobalt-60 (60Co) | 5.2714 년 | 진 조건에 상응하는 조건을 붙일 수 있다.  | 토 결과통지서를 제출한 경우: 제1항제1호 | 소분품목의 허가권자이면서 소분․포장 제조하는 자 | 장이 정하여 고시하는 바에 따라 변경내용을 |\n| 과테크네튬산나트륨(99mTc) 주사액 | 시험방법 또는 다른 적절한 방법을 사용하여 관리한다.  | 에 차광할 수 있다.  이러한 차광은 반드시 제제의 저 | 중성자 조사(NEUTRON IRRADIATION) | - 기타의 경우 제조는 “자사 포장단위”, 수입은 “제조원 포장단위”로 기재 | ④ 기업의 분리 또는 합병에 의하여 의약품등의 | 5.  수수료납부 (수수료 납부 완료 시 민원신청 완료) | 2004 | 7 | 0 | 7 | 합계 | 116 | 96 | 212 | 목허가를 받지 아니하거나 품목신고를 하지 아 | 서 | (소분제조자) | 라.  식품의약품안전처장이 성분의 종류·규 | 목.  다만, 국내에서 허가되지 아니한 품목은 | 있는 품목 |\n| 67Ga | 5 | 2.4 | 111In | 2 | 0.9 | ▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자 부조리 신고” 코너 | 방사성의약품 제조에 사용하기 전에 매 배치 별 시험 | PET용 방사성의약품 평가 가이드라인｣ | 제   법 | 이 약은 과테크네튬산나트륨(99mTc) 주사액 | 의약품의 성상 표기에 대한 가이드라인｣ | 참조 | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | Gallium-66 (66Ga) | 9.49 시간 | ‘15.7.1 전에 종전의 규정에 따라 방사성의약품 제조판매‧ | 다. ",
        "original_sentence": "이러한 차광은 반드시 제제의 저 | 중성자 조사(NEUTRON IRRADIATION) | - 기타의 경우 제조는 “자사 포장단위”, 수입은 “제조원 포장단위”로 기재 | ④ 기업의 분리 또는 합병에 의하여 의약품등의 | 5. "
      }
    },
    {
      "chunk_id": "chunk_313",
      "text": "수수료납부 (수수료 납부 완료 시 민원신청 완료) | 2004 | 7 | 0 | 7 | 합계 | 116 | 96 | 212 | 목허가를 받지 아니하거나 품목신고를 하지 아 | 서 | (소분제조자) | 라. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 312,
        "window_size": 3,
        "char_count": 115,
        "word_count": 36,
        "page_number": 3,
        "window_text": "| 토 결과통지서를 제출한 경우: 제1항제1호 | 소분품목의 허가권자이면서 소분․포장 제조하는 자 | 장이 정하여 고시하는 바에 따라 변경내용을 |\n| 과테크네튬산나트륨(99mTc) 주사액 | 시험방법 또는 다른 적절한 방법을 사용하여 관리한다.  | 에 차광할 수 있다.  이러한 차광은 반드시 제제의 저 | 중성자 조사(NEUTRON IRRADIATION) | - 기타의 경우 제조는 “자사 포장단위”, 수입은 “제조원 포장단위”로 기재 | ④ 기업의 분리 또는 합병에 의하여 의약품등의 | 5.  수수료납부 (수수료 납부 완료 시 민원신청 완료) | 2004 | 7 | 0 | 7 | 합계 | 116 | 96 | 212 | 목허가를 받지 아니하거나 품목신고를 하지 아 | 서 | (소분제조자) | 라.  식품의약품안전처장이 성분의 종류·규 | 목.  다만, 국내에서 허가되지 아니한 품목은 | 있는 품목 |\n| 67Ga | 5 | 2.4 | 111In | 2 | 0.9 | ▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자 부조리 신고” 코너 | 방사성의약품 제조에 사용하기 전에 매 배치 별 시험 | PET용 방사성의약품 평가 가이드라인｣ | 제   법 | 이 약은 과테크네튬산나트륨(99mTc) 주사액 | 의약품의 성상 표기에 대한 가이드라인｣ | 참조 | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | Gallium-66 (66Ga) | 9.49 시간 | ‘15.7.1 전에 종전의 규정에 따라 방사성의약품 제조판매‧ | 다.  유전독성시험자료 | 또는 제2호에 해당하는 자료 | 제42조(의약품등의 수입허가 등) ①의약품등을 | 9. ",
        "original_sentence": "수수료납부 (수수료 납부 완료 시 민원신청 완료) | 2004 | 7 | 0 | 7 | 합계 | 116 | 96 | 212 | 목허가를 받지 아니하거나 품목신고를 하지 아 | 서 | (소분제조자) | 라. "
      }
    },
    {
      "chunk_id": "chunk_314",
      "text": "식품의약품안전처장이 성분의 종류·규 | 목. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 313,
        "window_size": 3,
        "char_count": 25,
        "word_count": 5,
        "page_number": 5,
        "window_text": "| 에 차광할 수 있다.  이러한 차광은 반드시 제제의 저 | 중성자 조사(NEUTRON IRRADIATION) | - 기타의 경우 제조는 “자사 포장단위”, 수입은 “제조원 포장단위”로 기재 | ④ 기업의 분리 또는 합병에 의하여 의약품등의 | 5.  수수료납부 (수수료 납부 완료 시 민원신청 완료) | 2004 | 7 | 0 | 7 | 합계 | 116 | 96 | 212 | 목허가를 받지 아니하거나 품목신고를 하지 아 | 서 | (소분제조자) | 라.  식품의약품안전처장이 성분의 종류·규 | 목.  다만, 국내에서 허가되지 아니한 품목은 | 있는 품목 |\n| 67Ga | 5 | 2.4 | 111In | 2 | 0.9 | ▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자 부조리 신고” 코너 | 방사성의약품 제조에 사용하기 전에 매 배치 별 시험 | PET용 방사성의약품 평가 가이드라인｣ | 제   법 | 이 약은 과테크네튬산나트륨(99mTc) 주사액 | 의약품의 성상 표기에 대한 가이드라인｣ | 참조 | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | Gallium-66 (66Ga) | 9.49 시간 | ‘15.7.1 전에 종전의 규정에 따라 방사성의약품 제조판매‧ | 다.  유전독성시험자료 | 또는 제2호에 해당하는 자료 | 제42조(의약품등의 수입허가 등) ①의약품등을 | 9.  생물학적 동등성 시험에 관한 자료 | 수입품목허가를 받은 제조업자․수입자가 |\n| 상표명 + 문자 또는 숫자 | 하를 수반하지 않는다. ",
        "original_sentence": "식품의약품안전처장이 성분의 종류·규 | 목. "
      }
    },
    {
      "chunk_id": "chunk_315",
      "text": "다만, 국내에서 허가되지 아니한 품목은 | 있는 품목 |\n| 67Ga | 5 | 2.4 | 111In | 2 | 0.9 | ▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자 부조리 신고” 코너 | 방사성의약품 제조에 사용하기 전에 매 배치 별 시험 | PET용 방사성의약품 평가 가이드라인｣ | 제   법 | 이 약은 과테크네튬산나트륨(99mTc) 주사액 | 의약품의 성상 표기에 대한 가이드라인｣ | 참조 | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | Gallium-66 (66Ga) | 9.49 시간 | ‘15.7.1 전에 종전의 규정에 따라 방사성의약품 제조판매‧ | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 314,
        "window_size": 3,
        "char_count": 332,
        "word_count": 85,
        "page_number": 3,
        "window_text": "이러한 차광은 반드시 제제의 저 | 중성자 조사(NEUTRON IRRADIATION) | - 기타의 경우 제조는 “자사 포장단위”, 수입은 “제조원 포장단위”로 기재 | ④ 기업의 분리 또는 합병에 의하여 의약품등의 | 5.  수수료납부 (수수료 납부 완료 시 민원신청 완료) | 2004 | 7 | 0 | 7 | 합계 | 116 | 96 | 212 | 목허가를 받지 아니하거나 품목신고를 하지 아 | 서 | (소분제조자) | 라.  식품의약품안전처장이 성분의 종류·규 | 목.  다만, 국내에서 허가되지 아니한 품목은 | 있는 품목 |\n| 67Ga | 5 | 2.4 | 111In | 2 | 0.9 | ▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자 부조리 신고” 코너 | 방사성의약품 제조에 사용하기 전에 매 배치 별 시험 | PET용 방사성의약품 평가 가이드라인｣ | 제   법 | 이 약은 과테크네튬산나트륨(99mTc) 주사액 | 의약품의 성상 표기에 대한 가이드라인｣ | 참조 | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | Gallium-66 (66Ga) | 9.49 시간 | ‘15.7.1 전에 종전의 규정에 따라 방사성의약품 제조판매‧ | 다.  유전독성시험자료 | 또는 제2호에 해당하는 자료 | 제42조(의약품등의 수입허가 등) ①의약품등을 | 9.  생물학적 동등성 시험에 관한 자료 | 수입품목허가를 받은 제조업자․수입자가 |\n| 상표명 + 문자 또는 숫자 | 하를 수반하지 않는다.  | 8. ",
        "original_sentence": "다만, 국내에서 허가되지 아니한 품목은 | 있는 품목 |\n| 67Ga | 5 | 2.4 | 111In | 2 | 0.9 | ▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자 부조리 신고” 코너 | 방사성의약품 제조에 사용하기 전에 매 배치 별 시험 | PET용 방사성의약품 평가 가이드라인｣ | 제   법 | 이 약은 과테크네튬산나트륨(99mTc) 주사액 | 의약품의 성상 표기에 대한 가이드라인｣ | 참조 | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | Gallium-66 (66Ga) | 9.49 시간 | ‘15.7.1 전에 종전의 규정에 따라 방사성의약품 제조판매‧ | 다. "
      }
    },
    {
      "chunk_id": "chunk_316",
      "text": "유전독성시험자료 | 또는 제2호에 해당하는 자료 | 제42조(의약품등의 수입허가 등) ①의약품등을 | 9. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 315,
        "window_size": 3,
        "char_count": 60,
        "word_count": 13,
        "page_number": 3,
        "window_text": "수수료납부 (수수료 납부 완료 시 민원신청 완료) | 2004 | 7 | 0 | 7 | 합계 | 116 | 96 | 212 | 목허가를 받지 아니하거나 품목신고를 하지 아 | 서 | (소분제조자) | 라.  식품의약품안전처장이 성분의 종류·규 | 목.  다만, 국내에서 허가되지 아니한 품목은 | 있는 품목 |\n| 67Ga | 5 | 2.4 | 111In | 2 | 0.9 | ▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자 부조리 신고” 코너 | 방사성의약품 제조에 사용하기 전에 매 배치 별 시험 | PET용 방사성의약품 평가 가이드라인｣ | 제   법 | 이 약은 과테크네튬산나트륨(99mTc) 주사액 | 의약품의 성상 표기에 대한 가이드라인｣ | 참조 | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | Gallium-66 (66Ga) | 9.49 시간 | ‘15.7.1 전에 종전의 규정에 따라 방사성의약품 제조판매‧ | 다.  유전독성시험자료 | 또는 제2호에 해당하는 자료 | 제42조(의약품등의 수입허가 등) ①의약품등을 | 9.  생물학적 동등성 시험에 관한 자료 | 수입품목허가를 받은 제조업자․수입자가 |\n| 상표명 + 문자 또는 숫자 | 하를 수반하지 않는다.  | 8.  의약품의 주성분을 제조하는 제조업자의 명 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 료 | 을 | (charged particle emission), 전자포획(electron capture, | 방사화학적 불순물들은 다음으로부터 유래될 수 있다. ",
        "original_sentence": "유전독성시험자료 | 또는 제2호에 해당하는 자료 | 제42조(의약품등의 수입허가 등) ①의약품등을 | 9. "
      }
    },
    {
      "chunk_id": "chunk_317",
      "text": "생물학적 동등성 시험에 관한 자료 | 수입품목허가를 받은 제조업자․수입자가 |\n| 상표명 + 문자 또는 숫자 | 하를 수반하지 않는다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 316,
        "window_size": 3,
        "char_count": 76,
        "word_count": 20,
        "page_number": 3,
        "window_text": "식품의약품안전처장이 성분의 종류·규 | 목.  다만, 국내에서 허가되지 아니한 품목은 | 있는 품목 |\n| 67Ga | 5 | 2.4 | 111In | 2 | 0.9 | ▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자 부조리 신고” 코너 | 방사성의약품 제조에 사용하기 전에 매 배치 별 시험 | PET용 방사성의약품 평가 가이드라인｣ | 제   법 | 이 약은 과테크네튬산나트륨(99mTc) 주사액 | 의약품의 성상 표기에 대한 가이드라인｣ | 참조 | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | Gallium-66 (66Ga) | 9.49 시간 | ‘15.7.1 전에 종전의 규정에 따라 방사성의약품 제조판매‧ | 다.  유전독성시험자료 | 또는 제2호에 해당하는 자료 | 제42조(의약품등의 수입허가 등) ①의약품등을 | 9.  생물학적 동등성 시험에 관한 자료 | 수입품목허가를 받은 제조업자․수입자가 |\n| 상표명 + 문자 또는 숫자 | 하를 수반하지 않는다.  | 8.  의약품의 주성분을 제조하는 제조업자의 명 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 료 | 을 | (charged particle emission), 전자포획(electron capture, | 방사화학적 불순물들은 다음으로부터 유래될 수 있다.  | 2. ",
        "original_sentence": "생물학적 동등성 시험에 관한 자료 | 수입품목허가를 받은 제조업자․수입자가 |\n| 상표명 + 문자 또는 숫자 | 하를 수반하지 않는다. "
      }
    },
    {
      "chunk_id": "chunk_318",
      "text": "| 8. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 317,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "다만, 국내에서 허가되지 아니한 품목은 | 있는 품목 |\n| 67Ga | 5 | 2.4 | 111In | 2 | 0.9 | ▶ 부조리 신고 : 식약처 홈페이지 “국민신문고 > 공직자 부조리 신고” 코너 | 방사성의약품 제조에 사용하기 전에 매 배치 별 시험 | PET용 방사성의약품 평가 가이드라인｣ | 제   법 | 이 약은 과테크네튬산나트륨(99mTc) 주사액 | 의약품의 성상 표기에 대한 가이드라인｣ | 참조 | ⑤ 식품의약품안전처장은 법 제31조제2항부터 | Gallium-66 (66Ga) | 9.49 시간 | ‘15.7.1 전에 종전의 규정에 따라 방사성의약품 제조판매‧ | 다.  유전독성시험자료 | 또는 제2호에 해당하는 자료 | 제42조(의약품등의 수입허가 등) ①의약품등을 | 9.  생물학적 동등성 시험에 관한 자료 | 수입품목허가를 받은 제조업자․수입자가 |\n| 상표명 + 문자 또는 숫자 | 하를 수반하지 않는다.  | 8.  의약품의 주성분을 제조하는 제조업자의 명 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 료 | 을 | (charged particle emission), 전자포획(electron capture, | 방사화학적 불순물들은 다음으로부터 유래될 수 있다.  | 2.  위탁제조판매업의 변경: 별지 제3호서식의 | Gallium-67 (67Ga) | 3.2612 일 | 6, 민원신청완료 | 2005 | 20 | 9 | 29 | 비율(%) | 55 | 45 | 2006 | 4 | 0 | 4 | 자료는 달라질 수 있음 | 소분제조 | 소분품목의 벌크(bulk) 제조자 | 성을 확립하는데 도움을 줄 수 있다. ",
        "original_sentence": "| 8. "
      }
    },
    {
      "chunk_id": "chunk_319",
      "text": "의약품의 주성분을 제조하는 제조업자의 명 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 료 | 을 | (charged particle emission), 전자포획(electron capture, | 방사화학적 불순물들은 다음으로부터 유래될 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 318,
        "window_size": 3,
        "char_count": 142,
        "word_count": 28,
        "page_number": 3,
        "window_text": "유전독성시험자료 | 또는 제2호에 해당하는 자료 | 제42조(의약품등의 수입허가 등) ①의약품등을 | 9.  생물학적 동등성 시험에 관한 자료 | 수입품목허가를 받은 제조업자․수입자가 |\n| 상표명 + 문자 또는 숫자 | 하를 수반하지 않는다.  | 8.  의약품의 주성분을 제조하는 제조업자의 명 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 료 | 을 | (charged particle emission), 전자포획(electron capture, | 방사화학적 불순물들은 다음으로부터 유래될 수 있다.  | 2.  위탁제조판매업의 변경: 별지 제3호서식의 | Gallium-67 (67Ga) | 3.2612 일 | 6, 민원신청완료 | 2005 | 20 | 9 | 29 | 비율(%) | 55 | 45 | 2006 | 4 | 0 | 4 | 자료는 달라질 수 있음 | 소분제조 | 소분품목의 벌크(bulk) 제조자 | 성을 확립하는데 도움을 줄 수 있다.  | 라. ",
        "original_sentence": "의약품의 주성분을 제조하는 제조업자의 명 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 료 | 을 | (charged particle emission), 전자포획(electron capture, | 방사화학적 불순물들은 다음으로부터 유래될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_320",
      "text": "| 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 319,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 3,
        "window_text": "생물학적 동등성 시험에 관한 자료 | 수입품목허가를 받은 제조업자․수입자가 |\n| 상표명 + 문자 또는 숫자 | 하를 수반하지 않는다.  | 8.  의약품의 주성분을 제조하는 제조업자의 명 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 료 | 을 | (charged particle emission), 전자포획(electron capture, | 방사화학적 불순물들은 다음으로부터 유래될 수 있다.  | 2.  위탁제조판매업의 변경: 별지 제3호서식의 | Gallium-67 (67Ga) | 3.2612 일 | 6, 민원신청완료 | 2005 | 20 | 9 | 29 | 비율(%) | 55 | 45 | 2006 | 4 | 0 | 4 | 자료는 달라질 수 있음 | 소분제조 | 소분품목의 벌크(bulk) 제조자 | 성을 확립하는데 도움을 줄 수 있다.  | 라.  식품의약품안전처장이 성분의 종류ᆞ규격 | 적은 문서(전자문서를 포함한다)를 식품의약품 | 제외한다. ",
        "original_sentence": "| 2. "
      }
    },
    {
      "chunk_id": "chunk_321",
      "text": "위탁제조판매업의 변경: 별지 제3호서식의 | Gallium-67 (67Ga) | 3.2612 일 | 6, 민원신청완료 | 2005 | 20 | 9 | 29 | 비율(%) | 55 | 45 | 2006 | 4 | 0 | 4 | 자료는 달라질 수 있음 | 소분제조 | 소분품목의 벌크(bulk) 제조자 | 성을 확립하는데 도움을 줄 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 320,
        "window_size": 3,
        "char_count": 190,
        "word_count": 53,
        "page_number": 3,
        "window_text": "| 8.  의약품의 주성분을 제조하는 제조업자의 명 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 료 | 을 | (charged particle emission), 전자포획(electron capture, | 방사화학적 불순물들은 다음으로부터 유래될 수 있다.  | 2.  위탁제조판매업의 변경: 별지 제3호서식의 | Gallium-67 (67Ga) | 3.2612 일 | 6, 민원신청완료 | 2005 | 20 | 9 | 29 | 비율(%) | 55 | 45 | 2006 | 4 | 0 | 4 | 자료는 달라질 수 있음 | 소분제조 | 소분품목의 벌크(bulk) 제조자 | 성을 확립하는데 도움을 줄 수 있다.  | 라.  식품의약품안전처장이 성분의 종류ᆞ규격 | 적은 문서(전자문서를 포함한다)를 식품의약품 | 제외한다.  | 격·함량 및 처방 등을 표준화하여 고시 | At = A0e-λt |\n| 51Cr | 3 | 1.4 | 총 | 212 | 223Ra | 1 | 0.5 | 실시가 권고된다. ",
        "original_sentence": "위탁제조판매업의 변경: 별지 제3호서식의 | Gallium-67 (67Ga) | 3.2612 일 | 6, 민원신청완료 | 2005 | 20 | 9 | 29 | 비율(%) | 55 | 45 | 2006 | 4 | 0 | 4 | 자료는 달라질 수 있음 | 소분제조 | 소분품목의 벌크(bulk) 제조자 | 성을 확립하는데 도움을 줄 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_322",
      "text": "| 라. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 321,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 12,
        "window_text": "의약품의 주성분을 제조하는 제조업자의 명 | 이 정하여 고시하는 원료의약품(이하 \"등록 | 료 | 을 | (charged particle emission), 전자포획(electron capture, | 방사화학적 불순물들은 다음으로부터 유래될 수 있다.  | 2.  위탁제조판매업의 변경: 별지 제3호서식의 | Gallium-67 (67Ga) | 3.2612 일 | 6, 민원신청완료 | 2005 | 20 | 9 | 29 | 비율(%) | 55 | 45 | 2006 | 4 | 0 | 4 | 자료는 달라질 수 있음 | 소분제조 | 소분품목의 벌크(bulk) 제조자 | 성을 확립하는데 도움을 줄 수 있다.  | 라.  식품의약품안전처장이 성분의 종류ᆞ규격 | 적은 문서(전자문서를 포함한다)를 식품의약품 | 제외한다.  | 격·함량 및 처방 등을 표준화하여 고시 | At = A0e-λt |\n| 51Cr | 3 | 1.4 | 총 | 212 | 223Ra | 1 | 0.5 | 실시가 권고된다.  | 제너레이터 또는 이에 따라 제조한 제너레이터로부터 | 보통 핵반응기 내에서 안정한 방사성핵종의 조사 | - 별표 7의 제형별 의약품 첨가제 또는 그 외의 첨가제로서 국내ㆍ외의 공인할 수 있는 | 니할 수 있다. ",
        "original_sentence": "| 라. "
      }
    },
    {
      "chunk_id": "chunk_323",
      "text": "식품의약품안전처장이 성분의 종류ᆞ규격 | 적은 문서(전자문서를 포함한다)를 식품의약품 | 제외한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 322,
        "window_size": 3,
        "char_count": 56,
        "word_count": 10,
        "page_number": 5,
        "window_text": "| 2.  위탁제조판매업의 변경: 별지 제3호서식의 | Gallium-67 (67Ga) | 3.2612 일 | 6, 민원신청완료 | 2005 | 20 | 9 | 29 | 비율(%) | 55 | 45 | 2006 | 4 | 0 | 4 | 자료는 달라질 수 있음 | 소분제조 | 소분품목의 벌크(bulk) 제조자 | 성을 확립하는데 도움을 줄 수 있다.  | 라.  식품의약품안전처장이 성분의 종류ᆞ규격 | 적은 문서(전자문서를 포함한다)를 식품의약품 | 제외한다.  | 격·함량 및 처방 등을 표준화하여 고시 | At = A0e-λt |\n| 51Cr | 3 | 1.4 | 총 | 212 | 223Ra | 1 | 0.5 | 실시가 권고된다.  | 제너레이터 또는 이에 따라 제조한 제너레이터로부터 | 보통 핵반응기 내에서 안정한 방사성핵종의 조사 | - 별표 7의 제형별 의약품 첨가제 또는 그 외의 첨가제로서 국내ㆍ외의 공인할 수 있는 | 니할 수 있다.  <신설 2011.3.30., 2013.3.23.> | 품목에 관한 제조시설ᆞ제조방법 등을 양수받 | 허가받은 | 품목에 | 대하여 | ’15.7.1 | 이후부터 | 이 | 규칙 | 시행일부터 | 2년이 | 경과한 | 날까지 | 라. ",
        "original_sentence": "식품의약품안전처장이 성분의 종류ᆞ규격 | 적은 문서(전자문서를 포함한다)를 식품의약품 | 제외한다. "
      }
    },
    {
      "chunk_id": "chunk_324",
      "text": "| 격·함량 및 처방 등을 표준화하여 고시 | At = A0e-λt |\n| 51Cr | 3 | 1.4 | 총 | 212 | 223Ra | 1 | 0.5 | 실시가 권고된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 323,
        "window_size": 3,
        "char_count": 97,
        "word_count": 31,
        "page_number": 3,
        "window_text": "위탁제조판매업의 변경: 별지 제3호서식의 | Gallium-67 (67Ga) | 3.2612 일 | 6, 민원신청완료 | 2005 | 20 | 9 | 29 | 비율(%) | 55 | 45 | 2006 | 4 | 0 | 4 | 자료는 달라질 수 있음 | 소분제조 | 소분품목의 벌크(bulk) 제조자 | 성을 확립하는데 도움을 줄 수 있다.  | 라.  식품의약품안전처장이 성분의 종류ᆞ규격 | 적은 문서(전자문서를 포함한다)를 식품의약품 | 제외한다.  | 격·함량 및 처방 등을 표준화하여 고시 | At = A0e-λt |\n| 51Cr | 3 | 1.4 | 총 | 212 | 223Ra | 1 | 0.5 | 실시가 권고된다.  | 제너레이터 또는 이에 따라 제조한 제너레이터로부터 | 보통 핵반응기 내에서 안정한 방사성핵종의 조사 | - 별표 7의 제형별 의약품 첨가제 또는 그 외의 첨가제로서 국내ㆍ외의 공인할 수 있는 | 니할 수 있다.  <신설 2011.3.30., 2013.3.23.> | 품목에 관한 제조시설ᆞ제조방법 등을 양수받 | 허가받은 | 품목에 | 대하여 | ’15.7.1 | 이후부터 | 이 | 규칙 | 시행일부터 | 2년이 | 경과한 | 날까지 | 라.  생식발생독성시험자료 | 수입하려는 자(이하 \"수입자\"라 한다)는 총리령 |\n| 미 제조판매·수입 품목허가를 받은 정제· | 부 또는 공공기관에서 그 국가의 법령에 | 대한민국약전｣ | ▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너 | 제제총칙에서 정한 제형으로 표기. ",
        "original_sentence": "| 격·함량 및 처방 등을 표준화하여 고시 | At = A0e-λt |\n| 51Cr | 3 | 1.4 | 총 | 212 | 223Ra | 1 | 0.5 | 실시가 권고된다. "
      }
    },
    {
      "chunk_id": "chunk_325",
      "text": "| 제너레이터 또는 이에 따라 제조한 제너레이터로부터 | 보통 핵반응기 내에서 안정한 방사성핵종의 조사 | - 별표 7의 제형별 의약품 첨가제 또는 그 외의 첨가제로서 국내ㆍ외의 공인할 수 있는 | 니할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 324,
        "window_size": 3,
        "char_count": 120,
        "word_count": 33,
        "page_number": 3,
        "window_text": "| 라.  식품의약품안전처장이 성분의 종류ᆞ규격 | 적은 문서(전자문서를 포함한다)를 식품의약품 | 제외한다.  | 격·함량 및 처방 등을 표준화하여 고시 | At = A0e-λt |\n| 51Cr | 3 | 1.4 | 총 | 212 | 223Ra | 1 | 0.5 | 실시가 권고된다.  | 제너레이터 또는 이에 따라 제조한 제너레이터로부터 | 보통 핵반응기 내에서 안정한 방사성핵종의 조사 | - 별표 7의 제형별 의약품 첨가제 또는 그 외의 첨가제로서 국내ㆍ외의 공인할 수 있는 | 니할 수 있다.  <신설 2011.3.30., 2013.3.23.> | 품목에 관한 제조시설ᆞ제조방법 등을 양수받 | 허가받은 | 품목에 | 대하여 | ’15.7.1 | 이후부터 | 이 | 규칙 | 시행일부터 | 2년이 | 경과한 | 날까지 | 라.  생식발생독성시험자료 | 수입하려는 자(이하 \"수입자\"라 한다)는 총리령 |\n| 미 제조판매·수입 품목허가를 받은 정제· | 부 또는 공공기관에서 그 국가의 법령에 | 대한민국약전｣ | ▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너 | 제제총칙에서 정한 제형으로 표기.  단, 제제학적으로 구분관리할 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 | 칭 및 소재지 등에 관한 자료로서 식품의약 | 대상 원료의약품\"이라 한다)을 사용하는 품 | 가) 청정도 관리 기준서(SOP) | EC) 또는 핵이성체전이(isomeric transition, IT)가 수반 | - 방사성핵종 생산 | 2. ",
        "original_sentence": "| 제너레이터 또는 이에 따라 제조한 제너레이터로부터 | 보통 핵반응기 내에서 안정한 방사성핵종의 조사 | - 별표 7의 제형별 의약품 첨가제 또는 그 외의 첨가제로서 국내ㆍ외의 공인할 수 있는 | 니할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_326",
      "text": "<신설 2011.3.30., 2013.3.23.> | 품목에 관한 제조시설ᆞ제조방법 등을 양수받 | 허가받은 | 품목에 | 대하여 | ’15.7.1 | 이후부터 | 이 | 규칙 | 시행일부터 | 2년이 | 경과한 | 날까지 | 라. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 325,
        "window_size": 3,
        "char_count": 130,
        "word_count": 33,
        "page_number": 3,
        "window_text": "식품의약품안전처장이 성분의 종류ᆞ규격 | 적은 문서(전자문서를 포함한다)를 식품의약품 | 제외한다.  | 격·함량 및 처방 등을 표준화하여 고시 | At = A0e-λt |\n| 51Cr | 3 | 1.4 | 총 | 212 | 223Ra | 1 | 0.5 | 실시가 권고된다.  | 제너레이터 또는 이에 따라 제조한 제너레이터로부터 | 보통 핵반응기 내에서 안정한 방사성핵종의 조사 | - 별표 7의 제형별 의약품 첨가제 또는 그 외의 첨가제로서 국내ㆍ외의 공인할 수 있는 | 니할 수 있다.  <신설 2011.3.30., 2013.3.23.> | 품목에 관한 제조시설ᆞ제조방법 등을 양수받 | 허가받은 | 품목에 | 대하여 | ’15.7.1 | 이후부터 | 이 | 규칙 | 시행일부터 | 2년이 | 경과한 | 날까지 | 라.  생식발생독성시험자료 | 수입하려는 자(이하 \"수입자\"라 한다)는 총리령 |\n| 미 제조판매·수입 품목허가를 받은 정제· | 부 또는 공공기관에서 그 국가의 법령에 | 대한민국약전｣ | ▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너 | 제제총칙에서 정한 제형으로 표기.  단, 제제학적으로 구분관리할 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 | 칭 및 소재지 등에 관한 자료로서 식품의약 | 대상 원료의약품\"이라 한다)을 사용하는 품 | 가) 청정도 관리 기준서(SOP) | EC) 또는 핵이성체전이(isomeric transition, IT)가 수반 | - 방사성핵종 생산 | 2.  품목허가를 신청하는 품목(신약, 생물학적제 | Germanium-68 (68Ge) | 270.82 일 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 의약품 위탁제조판매업 변경신고서 | 2. ",
        "original_sentence": "<신설 2011.3.30., 2013.3.23.> | 품목에 관한 제조시설ᆞ제조방법 등을 양수받 | 허가받은 | 품목에 | 대하여 | ’15.7.1 | 이후부터 | 이 | 규칙 | 시행일부터 | 2년이 | 경과한 | 날까지 | 라. "
      }
    },
    {
      "chunk_id": "chunk_327",
      "text": "생식발생독성시험자료 | 수입하려는 자(이하 \"수입자\"라 한다)는 총리령 |\n| 미 제조판매·수입 품목허가를 받은 정제· | 부 또는 공공기관에서 그 국가의 법령에 | 대한민국약전｣ | ▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너 | 제제총칙에서 정한 제형으로 표기. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 326,
        "window_size": 3,
        "char_count": 173,
        "word_count": 42,
        "page_number": 3,
        "window_text": "| 격·함량 및 처방 등을 표준화하여 고시 | At = A0e-λt |\n| 51Cr | 3 | 1.4 | 총 | 212 | 223Ra | 1 | 0.5 | 실시가 권고된다.  | 제너레이터 또는 이에 따라 제조한 제너레이터로부터 | 보통 핵반응기 내에서 안정한 방사성핵종의 조사 | - 별표 7의 제형별 의약품 첨가제 또는 그 외의 첨가제로서 국내ㆍ외의 공인할 수 있는 | 니할 수 있다.  <신설 2011.3.30., 2013.3.23.> | 품목에 관한 제조시설ᆞ제조방법 등을 양수받 | 허가받은 | 품목에 | 대하여 | ’15.7.1 | 이후부터 | 이 | 규칙 | 시행일부터 | 2년이 | 경과한 | 날까지 | 라.  생식발생독성시험자료 | 수입하려는 자(이하 \"수입자\"라 한다)는 총리령 |\n| 미 제조판매·수입 품목허가를 받은 정제· | 부 또는 공공기관에서 그 국가의 법령에 | 대한민국약전｣ | ▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너 | 제제총칙에서 정한 제형으로 표기.  단, 제제학적으로 구분관리할 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 | 칭 및 소재지 등에 관한 자료로서 식품의약 | 대상 원료의약품\"이라 한다)을 사용하는 품 | 가) 청정도 관리 기준서(SOP) | EC) 또는 핵이성체전이(isomeric transition, IT)가 수반 | - 방사성핵종 생산 | 2.  품목허가를 신청하는 품목(신약, 생물학적제 | Germanium-68 (68Ge) | 270.82 일 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 의약품 위탁제조판매업 변경신고서 | 2.  대한민국약전외한약(생약)규격집에 실려 있 | 안전처장 또는 지방청장에게 제출하여야 한다. ",
        "original_sentence": "생식발생독성시험자료 | 수입하려는 자(이하 \"수입자\"라 한다)는 총리령 |\n| 미 제조판매·수입 품목허가를 받은 정제· | 부 또는 공공기관에서 그 국가의 법령에 | 대한민국약전｣ | ▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너 | 제제총칙에서 정한 제형으로 표기. "
      }
    },
    {
      "chunk_id": "chunk_328",
      "text": "단, 제제학적으로 구분관리할 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 | 칭 및 소재지 등에 관한 자료로서 식품의약 | 대상 원료의약품\"이라 한다)을 사용하는 품 | 가) 청정도 관리 기준서(SOP) | EC) 또는 핵이성체전이(isomeric transition, IT)가 수반 | - 방사성핵종 생산 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 327,
        "window_size": 3,
        "char_count": 181,
        "word_count": 45,
        "page_number": 1,
        "window_text": "| 제너레이터 또는 이에 따라 제조한 제너레이터로부터 | 보통 핵반응기 내에서 안정한 방사성핵종의 조사 | - 별표 7의 제형별 의약품 첨가제 또는 그 외의 첨가제로서 국내ㆍ외의 공인할 수 있는 | 니할 수 있다.  <신설 2011.3.30., 2013.3.23.> | 품목에 관한 제조시설ᆞ제조방법 등을 양수받 | 허가받은 | 품목에 | 대하여 | ’15.7.1 | 이후부터 | 이 | 규칙 | 시행일부터 | 2년이 | 경과한 | 날까지 | 라.  생식발생독성시험자료 | 수입하려는 자(이하 \"수입자\"라 한다)는 총리령 |\n| 미 제조판매·수입 품목허가를 받은 정제· | 부 또는 공공기관에서 그 국가의 법령에 | 대한민국약전｣ | ▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너 | 제제총칙에서 정한 제형으로 표기.  단, 제제학적으로 구분관리할 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 | 칭 및 소재지 등에 관한 자료로서 식품의약 | 대상 원료의약품\"이라 한다)을 사용하는 품 | 가) 청정도 관리 기준서(SOP) | EC) 또는 핵이성체전이(isomeric transition, IT)가 수반 | - 방사성핵종 생산 | 2.  품목허가를 신청하는 품목(신약, 생물학적제 | Germanium-68 (68Ge) | 270.82 일 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 의약품 위탁제조판매업 변경신고서 | 2.  대한민국약전외한약(생약)규격집에 실려 있 | 안전처장 또는 지방청장에게 제출하여야 한다.  | 한 표준제조기준에 맞는 품목 |\n| 방사성핵종순도(RADIONUCLIDIC PURITY) | 생리식염액으로 과테크네튬산나트륨(99mTc)을 용출 | (irradiation) 결과 양성자가 부족한 핵(proton-deficient | ※ 자세한 사항은 의약품민원홈페이지(http://ezdrug.mfds.go.kr)의 하단에 있는 “민원신청 우수작성 서식 | ⑦ 제2항부터 제4항까지의 규정에도 불구하고 | 은 자가 동일장소ᆞ동일시설에서 해당 품목으 | (제조자) | (해당 생산국의 원제조자) | 으로 정하는 바에 따라 품목마다 식품의약품안 | ᆞ함량 및 처방 등을 표준화하여 고시한 |\n| 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 적합하게 판매되고 있음을 증명하는 판매 | 조시설·제조방법 등을 양수한 품목에 대한 제 | 품안전처장이 고시하는 자료 | 목의 경우에는 원료의약품에 관한 다음 각 | - (무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균, 부유균, 표면균 등) 등 관리내용 포함 | Gallium-68 (68Ga) | 67.629 분 | 사용예 등으로 제제학적으로 타당한 배합목적 기재 | 품등의 제조판매ᆞ수입 품목허가를 위하여 필 | 품목변경허가(신고)를 신청하는 경우에는 GMP 실시상황 평가에 필요한 자료를 제출하지 않음 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 그림 2. ",
        "original_sentence": "단, 제제학적으로 구분관리할 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 | 칭 및 소재지 등에 관한 자료로서 식품의약 | 대상 원료의약품\"이라 한다)을 사용하는 품 | 가) 청정도 관리 기준서(SOP) | EC) 또는 핵이성체전이(isomeric transition, IT)가 수반 | - 방사성핵종 생산 | 2. "
      }
    },
    {
      "chunk_id": "chunk_329",
      "text": "품목허가를 신청하는 품목(신약, 생물학적제 | Germanium-68 (68Ge) | 270.82 일 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 의약품 위탁제조판매업 변경신고서 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 328,
        "window_size": 3,
        "char_count": 110,
        "word_count": 23,
        "page_number": 3,
        "window_text": "<신설 2011.3.30., 2013.3.23.> | 품목에 관한 제조시설ᆞ제조방법 등을 양수받 | 허가받은 | 품목에 | 대하여 | ’15.7.1 | 이후부터 | 이 | 규칙 | 시행일부터 | 2년이 | 경과한 | 날까지 | 라.  생식발생독성시험자료 | 수입하려는 자(이하 \"수입자\"라 한다)는 총리령 |\n| 미 제조판매·수입 품목허가를 받은 정제· | 부 또는 공공기관에서 그 국가의 법령에 | 대한민국약전｣ | ▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너 | 제제총칙에서 정한 제형으로 표기.  단, 제제학적으로 구분관리할 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 | 칭 및 소재지 등에 관한 자료로서 식품의약 | 대상 원료의약품\"이라 한다)을 사용하는 품 | 가) 청정도 관리 기준서(SOP) | EC) 또는 핵이성체전이(isomeric transition, IT)가 수반 | - 방사성핵종 생산 | 2.  품목허가를 신청하는 품목(신약, 생물학적제 | Germanium-68 (68Ge) | 270.82 일 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 의약품 위탁제조판매업 변경신고서 | 2.  대한민국약전외한약(생약)규격집에 실려 있 | 안전처장 또는 지방청장에게 제출하여야 한다.  | 한 표준제조기준에 맞는 품목 |\n| 방사성핵종순도(RADIONUCLIDIC PURITY) | 생리식염액으로 과테크네튬산나트륨(99mTc)을 용출 | (irradiation) 결과 양성자가 부족한 핵(proton-deficient | ※ 자세한 사항은 의약품민원홈페이지(http://ezdrug.mfds.go.kr)의 하단에 있는 “민원신청 우수작성 서식 | ⑦ 제2항부터 제4항까지의 규정에도 불구하고 | 은 자가 동일장소ᆞ동일시설에서 해당 품목으 | (제조자) | (해당 생산국의 원제조자) | 으로 정하는 바에 따라 품목마다 식품의약품안 | ᆞ함량 및 처방 등을 표준화하여 고시한 |\n| 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 적합하게 판매되고 있음을 증명하는 판매 | 조시설·제조방법 등을 양수한 품목에 대한 제 | 품안전처장이 고시하는 자료 | 목의 경우에는 원료의약품에 관한 다음 각 | - (무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균, 부유균, 표면균 등) 등 관리내용 포함 | Gallium-68 (68Ga) | 67.629 분 | 사용예 등으로 제제학적으로 타당한 배합목적 기재 | 품등의 제조판매ᆞ수입 품목허가를 위하여 필 | 품목변경허가(신고)를 신청하는 경우에는 GMP 실시상황 평가에 필요한 자료를 제출하지 않음 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 그림 2.  방사성동위원소 별 품목허가 그래프 (15.01.12. ",
        "original_sentence": "품목허가를 신청하는 품목(신약, 생물학적제 | Germanium-68 (68Ge) | 270.82 일 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 의약품 위탁제조판매업 변경신고서 | 2. "
      }
    },
    {
      "chunk_id": "chunk_330",
      "text": "대한민국약전외한약(생약)규격집에 실려 있 | 안전처장 또는 지방청장에게 제출하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 329,
        "window_size": 3,
        "char_count": 50,
        "word_count": 9,
        "page_number": 5,
        "window_text": "생식발생독성시험자료 | 수입하려는 자(이하 \"수입자\"라 한다)는 총리령 |\n| 미 제조판매·수입 품목허가를 받은 정제· | 부 또는 공공기관에서 그 국가의 법령에 | 대한민국약전｣ | ▶ 공익 신고 : 식약처 홈페이지 \"국민소통 > 신고센터 > 부패․공익신고 상담“ 코너 | 제제총칙에서 정한 제형으로 표기.  단, 제제학적으로 구분관리할 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 | 칭 및 소재지 등에 관한 자료로서 식품의약 | 대상 원료의약품\"이라 한다)을 사용하는 품 | 가) 청정도 관리 기준서(SOP) | EC) 또는 핵이성체전이(isomeric transition, IT)가 수반 | - 방사성핵종 생산 | 2.  품목허가를 신청하는 품목(신약, 생물학적제 | Germanium-68 (68Ge) | 270.82 일 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 의약품 위탁제조판매업 변경신고서 | 2.  대한민국약전외한약(생약)규격집에 실려 있 | 안전처장 또는 지방청장에게 제출하여야 한다.  | 한 표준제조기준에 맞는 품목 |\n| 방사성핵종순도(RADIONUCLIDIC PURITY) | 생리식염액으로 과테크네튬산나트륨(99mTc)을 용출 | (irradiation) 결과 양성자가 부족한 핵(proton-deficient | ※ 자세한 사항은 의약품민원홈페이지(http://ezdrug.mfds.go.kr)의 하단에 있는 “민원신청 우수작성 서식 | ⑦ 제2항부터 제4항까지의 규정에도 불구하고 | 은 자가 동일장소ᆞ동일시설에서 해당 품목으 | (제조자) | (해당 생산국의 원제조자) | 으로 정하는 바에 따라 품목마다 식품의약품안 | ᆞ함량 및 처방 등을 표준화하여 고시한 |\n| 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 적합하게 판매되고 있음을 증명하는 판매 | 조시설·제조방법 등을 양수한 품목에 대한 제 | 품안전처장이 고시하는 자료 | 목의 경우에는 원료의약품에 관한 다음 각 | - (무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균, 부유균, 표면균 등) 등 관리내용 포함 | Gallium-68 (68Ga) | 67.629 분 | 사용예 등으로 제제학적으로 타당한 배합목적 기재 | 품등의 제조판매ᆞ수입 품목허가를 위하여 필 | 품목변경허가(신고)를 신청하는 경우에는 GMP 실시상황 평가에 필요한 자료를 제출하지 않음 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 그림 2.  방사성동위원소 별 품목허가 그래프 (15.01.12.  품목대장 기준) | 이 경우 법 제31조제9항 또는 법 제42조에 따 |\n| 시켜 주사제의 제법에 따라 만든다. ",
        "original_sentence": "대한민국약전외한약(생약)규격집에 실려 있 | 안전처장 또는 지방청장에게 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_331",
      "text": "| 한 표준제조기준에 맞는 품목 |\n| 방사성핵종순도(RADIONUCLIDIC PURITY) | 생리식염액으로 과테크네튬산나트륨(99mTc)을 용출 | (irradiation) 결과 양성자가 부족한 핵(proton-deficient | ※ 자세한 사항은 의약품민원홈페이지(http://ezdrug.mfds.go.kr)의 하단에 있는 “민원신청 우수작성 서식 | ⑦ 제2항부터 제4항까지의 규정에도 불구하고 | 은 자가 동일장소ᆞ동일시설에서 해당 품목으 | (제조자) | (해당 생산국의 원제조자) | 으로 정하는 바에 따라 품목마다 식품의약품안 | ᆞ함량 및 처방 등을 표준화하여 고시한 |\n| 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 적합하게 판매되고 있음을 증명하는 판매 | 조시설·제조방법 등을 양수한 품목에 대한 제 | 품안전처장이 고시하는 자료 | 목의 경우에는 원료의약품에 관한 다음 각 | - (무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균, 부유균, 표면균 등) 등 관리내용 포함 | Gallium-68 (68Ga) | 67.629 분 | 사용예 등으로 제제학적으로 타당한 배합목적 기재 | 품등의 제조판매ᆞ수입 품목허가를 위하여 필 | 품목변경허가(신고)를 신청하는 경우에는 GMP 실시상황 평가에 필요한 자료를 제출하지 않음 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 그림 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 330,
        "window_size": 3,
        "char_count": 693,
        "word_count": 148,
        "page_number": 3,
        "window_text": "단, 제제학적으로 구분관리할 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 | 칭 및 소재지 등에 관한 자료로서 식품의약 | 대상 원료의약품\"이라 한다)을 사용하는 품 | 가) 청정도 관리 기준서(SOP) | EC) 또는 핵이성체전이(isomeric transition, IT)가 수반 | - 방사성핵종 생산 | 2.  품목허가를 신청하는 품목(신약, 생물학적제 | Germanium-68 (68Ge) | 270.82 일 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 의약품 위탁제조판매업 변경신고서 | 2.  대한민국약전외한약(생약)규격집에 실려 있 | 안전처장 또는 지방청장에게 제출하여야 한다.  | 한 표준제조기준에 맞는 품목 |\n| 방사성핵종순도(RADIONUCLIDIC PURITY) | 생리식염액으로 과테크네튬산나트륨(99mTc)을 용출 | (irradiation) 결과 양성자가 부족한 핵(proton-deficient | ※ 자세한 사항은 의약품민원홈페이지(http://ezdrug.mfds.go.kr)의 하단에 있는 “민원신청 우수작성 서식 | ⑦ 제2항부터 제4항까지의 규정에도 불구하고 | 은 자가 동일장소ᆞ동일시설에서 해당 품목으 | (제조자) | (해당 생산국의 원제조자) | 으로 정하는 바에 따라 품목마다 식품의약품안 | ᆞ함량 및 처방 등을 표준화하여 고시한 |\n| 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 적합하게 판매되고 있음을 증명하는 판매 | 조시설·제조방법 등을 양수한 품목에 대한 제 | 품안전처장이 고시하는 자료 | 목의 경우에는 원료의약품에 관한 다음 각 | - (무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균, 부유균, 표면균 등) 등 관리내용 포함 | Gallium-68 (68Ga) | 67.629 분 | 사용예 등으로 제제학적으로 타당한 배합목적 기재 | 품등의 제조판매ᆞ수입 품목허가를 위하여 필 | 품목변경허가(신고)를 신청하는 경우에는 GMP 실시상황 평가에 필요한 자료를 제출하지 않음 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 그림 2.  방사성동위원소 별 품목허가 그래프 (15.01.12.  품목대장 기준) | 이 경우 법 제31조제9항 또는 법 제42조에 따 |\n| 시켜 주사제의 제법에 따라 만든다.  | 라 | 벨 | 2.3.10 저장방법 및 사용기간 | 될 수 있다. ",
        "original_sentence": "| 한 표준제조기준에 맞는 품목 |\n| 방사성핵종순도(RADIONUCLIDIC PURITY) | 생리식염액으로 과테크네튬산나트륨(99mTc)을 용출 | (irradiation) 결과 양성자가 부족한 핵(proton-deficient | ※ 자세한 사항은 의약품민원홈페이지(http://ezdrug.mfds.go.kr)의 하단에 있는 “민원신청 우수작성 서식 | ⑦ 제2항부터 제4항까지의 규정에도 불구하고 | 은 자가 동일장소ᆞ동일시설에서 해당 품목으 | (제조자) | (해당 생산국의 원제조자) | 으로 정하는 바에 따라 품목마다 식품의약품안 | ᆞ함량 및 처방 등을 표준화하여 고시한 |\n| 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 적합하게 판매되고 있음을 증명하는 판매 | 조시설·제조방법 등을 양수한 품목에 대한 제 | 품안전처장이 고시하는 자료 | 목의 경우에는 원료의약품에 관한 다음 각 | - (무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균, 부유균, 표면균 등) 등 관리내용 포함 | Gallium-68 (68Ga) | 67.629 분 | 사용예 등으로 제제학적으로 타당한 배합목적 기재 | 품등의 제조판매ᆞ수입 품목허가를 위하여 필 | 품목변경허가(신고)를 신청하는 경우에는 GMP 실시상황 평가에 필요한 자료를 제출하지 않음 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 그림 2. "
      }
    },
    {
      "chunk_id": "chunk_332",
      "text": "방사성동위원소 별 품목허가 그래프 (15.01.12. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 331,
        "window_size": 3,
        "char_count": 30,
        "word_count": 5,
        "page_number": 3,
        "window_text": "품목허가를 신청하는 품목(신약, 생물학적제 | Germanium-68 (68Ge) | 270.82 일 | 제4항까지 또는 법 제42조제1항에 따른 의약 | 의약품 위탁제조판매업 변경신고서 | 2.  대한민국약전외한약(생약)규격집에 실려 있 | 안전처장 또는 지방청장에게 제출하여야 한다.  | 한 표준제조기준에 맞는 품목 |\n| 방사성핵종순도(RADIONUCLIDIC PURITY) | 생리식염액으로 과테크네튬산나트륨(99mTc)을 용출 | (irradiation) 결과 양성자가 부족한 핵(proton-deficient | ※ 자세한 사항은 의약품민원홈페이지(http://ezdrug.mfds.go.kr)의 하단에 있는 “민원신청 우수작성 서식 | ⑦ 제2항부터 제4항까지의 규정에도 불구하고 | 은 자가 동일장소ᆞ동일시설에서 해당 품목으 | (제조자) | (해당 생산국의 원제조자) | 으로 정하는 바에 따라 품목마다 식품의약품안 | ᆞ함량 및 처방 등을 표준화하여 고시한 |\n| 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 적합하게 판매되고 있음을 증명하는 판매 | 조시설·제조방법 등을 양수한 품목에 대한 제 | 품안전처장이 고시하는 자료 | 목의 경우에는 원료의약품에 관한 다음 각 | - (무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균, 부유균, 표면균 등) 등 관리내용 포함 | Gallium-68 (68Ga) | 67.629 분 | 사용예 등으로 제제학적으로 타당한 배합목적 기재 | 품등의 제조판매ᆞ수입 품목허가를 위하여 필 | 품목변경허가(신고)를 신청하는 경우에는 GMP 실시상황 평가에 필요한 자료를 제출하지 않음 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 그림 2.  방사성동위원소 별 품목허가 그래프 (15.01.12.  품목대장 기준) | 이 경우 법 제31조제9항 또는 법 제42조에 따 |\n| 시켜 주사제의 제법에 따라 만든다.  | 라 | 벨 | 2.3.10 저장방법 및 사용기간 | 될 수 있다.  핵으로부터 방출된 하전입자들은 알파입 | nuclei), 즉 전자방출체(electron emitter)가 발생하는 | - 이후 화학적 제조공정 | 3. ",
        "original_sentence": "방사성동위원소 별 품목허가 그래프 (15.01.12. "
      }
    },
    {
      "chunk_id": "chunk_333",
      "text": "품목대장 기준) | 이 경우 법 제31조제9항 또는 법 제42조에 따 |\n| 시켜 주사제의 제법에 따라 만든다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 332,
        "window_size": 3,
        "char_count": 63,
        "word_count": 18,
        "page_number": 3,
        "window_text": "대한민국약전외한약(생약)규격집에 실려 있 | 안전처장 또는 지방청장에게 제출하여야 한다.  | 한 표준제조기준에 맞는 품목 |\n| 방사성핵종순도(RADIONUCLIDIC PURITY) | 생리식염액으로 과테크네튬산나트륨(99mTc)을 용출 | (irradiation) 결과 양성자가 부족한 핵(proton-deficient | ※ 자세한 사항은 의약품민원홈페이지(http://ezdrug.mfds.go.kr)의 하단에 있는 “민원신청 우수작성 서식 | ⑦ 제2항부터 제4항까지의 규정에도 불구하고 | 은 자가 동일장소ᆞ동일시설에서 해당 품목으 | (제조자) | (해당 생산국의 원제조자) | 으로 정하는 바에 따라 품목마다 식품의약품안 | ᆞ함량 및 처방 등을 표준화하여 고시한 |\n| 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 적합하게 판매되고 있음을 증명하는 판매 | 조시설·제조방법 등을 양수한 품목에 대한 제 | 품안전처장이 고시하는 자료 | 목의 경우에는 원료의약품에 관한 다음 각 | - (무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균, 부유균, 표면균 등) 등 관리내용 포함 | Gallium-68 (68Ga) | 67.629 분 | 사용예 등으로 제제학적으로 타당한 배합목적 기재 | 품등의 제조판매ᆞ수입 품목허가를 위하여 필 | 품목변경허가(신고)를 신청하는 경우에는 GMP 실시상황 평가에 필요한 자료를 제출하지 않음 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 그림 2.  방사성동위원소 별 품목허가 그래프 (15.01.12.  품목대장 기준) | 이 경우 법 제31조제9항 또는 법 제42조에 따 |\n| 시켜 주사제의 제법에 따라 만든다.  | 라 | 벨 | 2.3.10 저장방법 및 사용기간 | 될 수 있다.  핵으로부터 방출된 하전입자들은 알파입 | nuclei), 즉 전자방출체(electron emitter)가 발생하는 | - 이후 화학적 제조공정 | 3.  품목의 변경: 별지 제6호서식의 의약품등 제 | 의약품등과 의료기기가 조합되어 있거나 복합 | 로 새로운 제조업 허가를 받거나 신고를 하려 | 및 민원신청 작성요령” 및 “전자민원신청매뉴얼” 자료 참조 및 시스템 문의(043-234-3100) | At = t 시간에서의 방사능 | 하는 방사성핵종의 수율과 순도를 향상시킬 수 있다. ",
        "original_sentence": "품목대장 기준) | 이 경우 법 제31조제9항 또는 법 제42조에 따 |\n| 시켜 주사제의 제법에 따라 만든다. "
      }
    },
    {
      "chunk_id": "chunk_334",
      "text": "| 라 | 벨 | 2.3.10 저장방법 및 사용기간 | 될 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 333,
        "window_size": 3,
        "char_count": 39,
        "word_count": 13,
        "page_number": 3,
        "window_text": "| 한 표준제조기준에 맞는 품목 |\n| 방사성핵종순도(RADIONUCLIDIC PURITY) | 생리식염액으로 과테크네튬산나트륨(99mTc)을 용출 | (irradiation) 결과 양성자가 부족한 핵(proton-deficient | ※ 자세한 사항은 의약품민원홈페이지(http://ezdrug.mfds.go.kr)의 하단에 있는 “민원신청 우수작성 서식 | ⑦ 제2항부터 제4항까지의 규정에도 불구하고 | 은 자가 동일장소ᆞ동일시설에서 해당 품목으 | (제조자) | (해당 생산국의 원제조자) | 으로 정하는 바에 따라 품목마다 식품의약품안 | ᆞ함량 및 처방 등을 표준화하여 고시한 |\n| 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 적합하게 판매되고 있음을 증명하는 판매 | 조시설·제조방법 등을 양수한 품목에 대한 제 | 품안전처장이 고시하는 자료 | 목의 경우에는 원료의약품에 관한 다음 각 | - (무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균, 부유균, 표면균 등) 등 관리내용 포함 | Gallium-68 (68Ga) | 67.629 분 | 사용예 등으로 제제학적으로 타당한 배합목적 기재 | 품등의 제조판매ᆞ수입 품목허가를 위하여 필 | 품목변경허가(신고)를 신청하는 경우에는 GMP 실시상황 평가에 필요한 자료를 제출하지 않음 | 제등, 주사제, 이식제, 그 밖에 식품의약품안 | 그림 2.  방사성동위원소 별 품목허가 그래프 (15.01.12.  품목대장 기준) | 이 경우 법 제31조제9항 또는 법 제42조에 따 |\n| 시켜 주사제의 제법에 따라 만든다.  | 라 | 벨 | 2.3.10 저장방법 및 사용기간 | 될 수 있다.  핵으로부터 방출된 하전입자들은 알파입 | nuclei), 즉 전자방출체(electron emitter)가 발생하는 | - 이후 화학적 제조공정 | 3.  품목의 변경: 별지 제6호서식의 의약품등 제 | 의약품등과 의료기기가 조합되어 있거나 복합 | 로 새로운 제조업 허가를 받거나 신고를 하려 | 및 민원신청 작성요령” 및 “전자민원신청매뉴얼” 자료 참조 및 시스템 문의(043-234-3100) | At = t 시간에서의 방사능 | 하는 방사성핵종의 수율과 순도를 향상시킬 수 있다.  | 되는 기준을 규정한다. ",
        "original_sentence": "| 라 | 벨 | 2.3.10 저장방법 및 사용기간 | 될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_335",
      "text": "핵으로부터 방출된 하전입자들은 알파입 | nuclei), 즉 전자방출체(electron emitter)가 발생하는 | - 이후 화학적 제조공정 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 334,
        "window_size": 3,
        "char_count": 85,
        "word_count": 17,
        "page_number": 19,
        "window_text": "방사성동위원소 별 품목허가 그래프 (15.01.12.  품목대장 기준) | 이 경우 법 제31조제9항 또는 법 제42조에 따 |\n| 시켜 주사제의 제법에 따라 만든다.  | 라 | 벨 | 2.3.10 저장방법 및 사용기간 | 될 수 있다.  핵으로부터 방출된 하전입자들은 알파입 | nuclei), 즉 전자방출체(electron emitter)가 발생하는 | - 이후 화학적 제조공정 | 3.  품목의 변경: 별지 제6호서식의 의약품등 제 | 의약품등과 의료기기가 조합되어 있거나 복합 | 로 새로운 제조업 허가를 받거나 신고를 하려 | 및 민원신청 작성요령” 및 “전자민원신청매뉴얼” 자료 참조 및 시스템 문의(043-234-3100) | At = t 시간에서의 방사능 | 하는 방사성핵종의 수율과 순도를 향상시킬 수 있다.  | 되는 기준을 규정한다.  | 마. ",
        "original_sentence": "핵으로부터 방출된 하전입자들은 알파입 | nuclei), 즉 전자방출체(electron emitter)가 발생하는 | - 이후 화학적 제조공정 | 3. "
      }
    },
    {
      "chunk_id": "chunk_336",
      "text": "품목의 변경: 별지 제6호서식의 의약품등 제 | 의약품등과 의료기기가 조합되어 있거나 복합 | 로 새로운 제조업 허가를 받거나 신고를 하려 | 및 민원신청 작성요령” 및 “전자민원신청매뉴얼” 자료 참조 및 시스템 문의(043-234-3100) | At = t 시간에서의 방사능 | 하는 방사성핵종의 수율과 순도를 향상시킬 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 335,
        "window_size": 3,
        "char_count": 186,
        "word_count": 45,
        "page_number": 3,
        "window_text": "품목대장 기준) | 이 경우 법 제31조제9항 또는 법 제42조에 따 |\n| 시켜 주사제의 제법에 따라 만든다.  | 라 | 벨 | 2.3.10 저장방법 및 사용기간 | 될 수 있다.  핵으로부터 방출된 하전입자들은 알파입 | nuclei), 즉 전자방출체(electron emitter)가 발생하는 | - 이후 화학적 제조공정 | 3.  품목의 변경: 별지 제6호서식의 의약품등 제 | 의약품등과 의료기기가 조합되어 있거나 복합 | 로 새로운 제조업 허가를 받거나 신고를 하려 | 및 민원신청 작성요령” 및 “전자민원신청매뉴얼” 자료 참조 및 시스템 문의(043-234-3100) | At = t 시간에서의 방사능 | 하는 방사성핵종의 수율과 순도를 향상시킬 수 있다.  | 되는 기준을 규정한다.  | 마.  식품의약품안전처장이 따로 기준 및 시험 | 는 품목 | 표준제조기준에 맞는 품목 |\n**방사성핵종 불순물들은 생산 그리고 방사성핵종의 붕**\n| - 11 - | - 13 - | - 15 - | - 17 - | - 19 - | - 21 - | - 23 - | - 25 - | - 27 - | - 29 - | - 31 - | - 33 - | - 35 - | - 37 - | - 1 - | - 3 - | - 5 - | - 7 - | - 9 - | - 10 - | - 12 - | - 14 - | - 16 - | - 18 - | - 20 - | - 22 - | - 24 - | - 26 - | - 28 - | - 30 - | - 32 - | - 34 - | - 36 - | - 38 - | - 2 - | - 4 - | - 6 - | - 8 - |\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n### 제·개정 이력\n\n<!-- PAGE_3 -->\n###### 연번\n\n<!-- PAGE_3 -->\n###### 제·개정번호\n\n<!-- PAGE_3 -->\n###### 승인일자\n\n<!-- PAGE_3 -->\n###### 주요내용\n\n<!-- PAGE_3 -->\n###### 1\n\n<!-- PAGE_3 -->\n###### C0-2015-2-008\n\n<!-- PAGE_3 -->\n###### 2015.07.30\n\n<!-- PAGE_3 -->\n###### 제정\n\n<!-- PAGE_3 -->\n## 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_3 -->\n#### 1. ",
        "original_sentence": "품목의 변경: 별지 제6호서식의 의약품등 제 | 의약품등과 의료기기가 조합되어 있거나 복합 | 로 새로운 제조업 허가를 받거나 신고를 하려 | 및 민원신청 작성요령” 및 “전자민원신청매뉴얼” 자료 참조 및 시스템 문의(043-234-3100) | At = t 시간에서의 방사능 | 하는 방사성핵종의 수율과 순도를 향상시킬 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_337",
      "text": "| 되는 기준을 규정한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 336,
        "window_size": 3,
        "char_count": 15,
        "word_count": 4,
        "page_number": 6,
        "window_text": "| 라 | 벨 | 2.3.10 저장방법 및 사용기간 | 될 수 있다.  핵으로부터 방출된 하전입자들은 알파입 | nuclei), 즉 전자방출체(electron emitter)가 발생하는 | - 이후 화학적 제조공정 | 3.  품목의 변경: 별지 제6호서식의 의약품등 제 | 의약품등과 의료기기가 조합되어 있거나 복합 | 로 새로운 제조업 허가를 받거나 신고를 하려 | 및 민원신청 작성요령” 및 “전자민원신청매뉴얼” 자료 참조 및 시스템 문의(043-234-3100) | At = t 시간에서의 방사능 | 하는 방사성핵종의 수율과 순도를 향상시킬 수 있다.  | 되는 기준을 규정한다.  | 마.  식품의약품안전처장이 따로 기준 및 시험 | 는 품목 | 표준제조기준에 맞는 품목 |\n**방사성핵종 불순물들은 생산 그리고 방사성핵종의 붕**\n| - 11 - | - 13 - | - 15 - | - 17 - | - 19 - | - 21 - | - 23 - | - 25 - | - 27 - | - 29 - | - 31 - | - 33 - | - 35 - | - 37 - | - 1 - | - 3 - | - 5 - | - 7 - | - 9 - | - 10 - | - 12 - | - 14 - | - 16 - | - 18 - | - 20 - | - 22 - | - 24 - | - 26 - | - 28 - | - 30 - | - 32 - | - 34 - | - 36 - | - 38 - | - 2 - | - 4 - | - 6 - | - 8 - |\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n### 제·개정 이력\n\n<!-- PAGE_3 -->\n###### 연번\n\n<!-- PAGE_3 -->\n###### 제·개정번호\n\n<!-- PAGE_3 -->\n###### 승인일자\n\n<!-- PAGE_3 -->\n###### 주요내용\n\n<!-- PAGE_3 -->\n###### 1\n\n<!-- PAGE_3 -->\n###### C0-2015-2-008\n\n<!-- PAGE_3 -->\n###### 2015.07.30\n\n<!-- PAGE_3 -->\n###### 제정\n\n<!-- PAGE_3 -->\n## 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_3 -->\n#### 1.  서론\n\n<!-- PAGE_3 -->\n###### 본 안내서는 방사성의약품 허가에 대한 경험이 적어 허가 신청 시 어려움을 느끼는\n\n<!-- PAGE_3 -->\n###### 제외하고 매년 10품목 이내로 허가되었으며 2000년도에 55품목으로 가장 많이\n\n<!-- PAGE_3 -->\n###### 허가되었고,\n\n<!-- PAGE_3 -->\n###### 기타 2001년 및 2005년도에 각각 34,\n\n<!-- PAGE_3 -->\n###### 29품목이 허가되었고 최근의\n\n<!-- PAGE_3 -->\n###### 2014년도에는 16품목이 허가되었다. ",
        "original_sentence": "| 되는 기준을 규정한다. "
      }
    },
    {
      "chunk_id": "chunk_338",
      "text": "| 마. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 337,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 12,
        "window_text": "핵으로부터 방출된 하전입자들은 알파입 | nuclei), 즉 전자방출체(electron emitter)가 발생하는 | - 이후 화학적 제조공정 | 3.  품목의 변경: 별지 제6호서식의 의약품등 제 | 의약품등과 의료기기가 조합되어 있거나 복합 | 로 새로운 제조업 허가를 받거나 신고를 하려 | 및 민원신청 작성요령” 및 “전자민원신청매뉴얼” 자료 참조 및 시스템 문의(043-234-3100) | At = t 시간에서의 방사능 | 하는 방사성핵종의 수율과 순도를 향상시킬 수 있다.  | 되는 기준을 규정한다.  | 마.  식품의약품안전처장이 따로 기준 및 시험 | 는 품목 | 표준제조기준에 맞는 품목 |\n**방사성핵종 불순물들은 생산 그리고 방사성핵종의 붕**\n| - 11 - | - 13 - | - 15 - | - 17 - | - 19 - | - 21 - | - 23 - | - 25 - | - 27 - | - 29 - | - 31 - | - 33 - | - 35 - | - 37 - | - 1 - | - 3 - | - 5 - | - 7 - | - 9 - | - 10 - | - 12 - | - 14 - | - 16 - | - 18 - | - 20 - | - 22 - | - 24 - | - 26 - | - 28 - | - 30 - | - 32 - | - 34 - | - 36 - | - 38 - | - 2 - | - 4 - | - 6 - | - 8 - |\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n### 제·개정 이력\n\n<!-- PAGE_3 -->\n###### 연번\n\n<!-- PAGE_3 -->\n###### 제·개정번호\n\n<!-- PAGE_3 -->\n###### 승인일자\n\n<!-- PAGE_3 -->\n###### 주요내용\n\n<!-- PAGE_3 -->\n###### 1\n\n<!-- PAGE_3 -->\n###### C0-2015-2-008\n\n<!-- PAGE_3 -->\n###### 2015.07.30\n\n<!-- PAGE_3 -->\n###### 제정\n\n<!-- PAGE_3 -->\n## 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_3 -->\n#### 1.  서론\n\n<!-- PAGE_3 -->\n###### 본 안내서는 방사성의약품 허가에 대한 경험이 적어 허가 신청 시 어려움을 느끼는\n\n<!-- PAGE_3 -->\n###### 제외하고 매년 10품목 이내로 허가되었으며 2000년도에 55품목으로 가장 많이\n\n<!-- PAGE_3 -->\n###### 허가되었고,\n\n<!-- PAGE_3 -->\n###### 기타 2001년 및 2005년도에 각각 34,\n\n<!-- PAGE_3 -->\n###### 29품목이 허가되었고 최근의\n\n<!-- PAGE_3 -->\n###### 2014년도에는 16품목이 허가되었다.  이와 같이 특정 년도에 품목허가 수가 증가된\n\n<!-- PAGE_3 -->\n###### 주된 이유는 신규업체의 등장에 따른 품목신청이 늘어났기 때문인 것으로 확인된다.\n\n",
        "original_sentence": "| 마. "
      }
    },
    {
      "chunk_id": "chunk_339",
      "text": "식품의약품안전처장이 따로 기준 및 시험 | 는 품목 | 표준제조기준에 맞는 품목 |\n**방사성핵종 불순물들은 생산 그리고 방사성핵종의 붕**\n| - 11 - | - 13 - | - 15 - | - 17 - | - 19 - | - 21 - | - 23 - | - 25 - | - 27 - | - 29 - | - 31 - | - 33 - | - 35 - | - 37 - | - 1 - | - 3 - | - 5 - | - 7 - | - 9 - | - 10 - | - 12 - | - 14 - | - 16 - | - 18 - | - 20 - | - 22 - | - 24 - | - 26 - | - 28 - | - 30 - | - 32 - | - 34 - | - 36 - | - 38 - | - 2 - | - 4 - | - 6 - | - 8 - |\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n### 제·개정 이력\n\n<!-- PAGE_3 -->\n###### 연번\n\n<!-- PAGE_3 -->\n###### 제·개정번호\n\n<!-- PAGE_3 -->\n###### 승인일자\n\n<!-- PAGE_3 -->\n###### 주요내용\n\n<!-- PAGE_3 -->\n###### 1\n\n<!-- PAGE_3 -->\n###### C0-2015-2-008\n\n<!-- PAGE_3 -->\n###### 2015.07.30\n\n<!-- PAGE_3 -->\n###### 제정\n\n<!-- PAGE_3 -->\n## 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_3 -->\n#### 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 338,
        "window_size": 3,
        "char_count": 761,
        "word_count": 233,
        "page_number": 3,
        "window_text": "품목의 변경: 별지 제6호서식의 의약품등 제 | 의약품등과 의료기기가 조합되어 있거나 복합 | 로 새로운 제조업 허가를 받거나 신고를 하려 | 및 민원신청 작성요령” 및 “전자민원신청매뉴얼” 자료 참조 및 시스템 문의(043-234-3100) | At = t 시간에서의 방사능 | 하는 방사성핵종의 수율과 순도를 향상시킬 수 있다.  | 되는 기준을 규정한다.  | 마.  식품의약품안전처장이 따로 기준 및 시험 | 는 품목 | 표준제조기준에 맞는 품목 |\n**방사성핵종 불순물들은 생산 그리고 방사성핵종의 붕**\n| - 11 - | - 13 - | - 15 - | - 17 - | - 19 - | - 21 - | - 23 - | - 25 - | - 27 - | - 29 - | - 31 - | - 33 - | - 35 - | - 37 - | - 1 - | - 3 - | - 5 - | - 7 - | - 9 - | - 10 - | - 12 - | - 14 - | - 16 - | - 18 - | - 20 - | - 22 - | - 24 - | - 26 - | - 28 - | - 30 - | - 32 - | - 34 - | - 36 - | - 38 - | - 2 - | - 4 - | - 6 - | - 8 - |\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n### 제·개정 이력\n\n<!-- PAGE_3 -->\n###### 연번\n\n<!-- PAGE_3 -->\n###### 제·개정번호\n\n<!-- PAGE_3 -->\n###### 승인일자\n\n<!-- PAGE_3 -->\n###### 주요내용\n\n<!-- PAGE_3 -->\n###### 1\n\n<!-- PAGE_3 -->\n###### C0-2015-2-008\n\n<!-- PAGE_3 -->\n###### 2015.07.30\n\n<!-- PAGE_3 -->\n###### 제정\n\n<!-- PAGE_3 -->\n## 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_3 -->\n#### 1.  서론\n\n<!-- PAGE_3 -->\n###### 본 안내서는 방사성의약품 허가에 대한 경험이 적어 허가 신청 시 어려움을 느끼는\n\n<!-- PAGE_3 -->\n###### 제외하고 매년 10품목 이내로 허가되었으며 2000년도에 55품목으로 가장 많이\n\n<!-- PAGE_3 -->\n###### 허가되었고,\n\n<!-- PAGE_3 -->\n###### 기타 2001년 및 2005년도에 각각 34,\n\n<!-- PAGE_3 -->\n###### 29품목이 허가되었고 최근의\n\n<!-- PAGE_3 -->\n###### 2014년도에는 16품목이 허가되었다.  이와 같이 특정 년도에 품목허가 수가 증가된\n\n<!-- PAGE_3 -->\n###### 주된 이유는 신규업체의 등장에 따른 품목신청이 늘어났기 때문인 것으로 확인된다.\n\n 80\n\n100\n\n120\n\n140\n\n품목수(건)\n\n<!-- PAGE_4 -->\n###### 국내 방사성의약품의 방사성동위원소 별 품목허가 수를 표 2와 그림 2에 나타내었다.\n\n",
        "original_sentence": "식품의약품안전처장이 따로 기준 및 시험 | 는 품목 | 표준제조기준에 맞는 품목 |\n**방사성핵종 불순물들은 생산 그리고 방사성핵종의 붕**\n| - 11 - | - 13 - | - 15 - | - 17 - | - 19 - | - 21 - | - 23 - | - 25 - | - 27 - | - 29 - | - 31 - | - 33 - | - 35 - | - 37 - | - 1 - | - 3 - | - 5 - | - 7 - | - 9 - | - 10 - | - 12 - | - 14 - | - 16 - | - 18 - | - 20 - | - 22 - | - 24 - | - 26 - | - 28 - | - 30 - | - 32 - | - 34 - | - 36 - | - 38 - | - 2 - | - 4 - | - 6 - | - 8 - |\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n### 제·개정 이력\n\n<!-- PAGE_3 -->\n###### 연번\n\n<!-- PAGE_3 -->\n###### 제·개정번호\n\n<!-- PAGE_3 -->\n###### 승인일자\n\n<!-- PAGE_3 -->\n###### 주요내용\n\n<!-- PAGE_3 -->\n###### 1\n\n<!-- PAGE_3 -->\n###### C0-2015-2-008\n\n<!-- PAGE_3 -->\n###### 2015.07.30\n\n<!-- PAGE_3 -->\n###### 제정\n\n<!-- PAGE_3 -->\n## 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_3 -->\n#### 1. "
      }
    },
    {
      "chunk_id": "chunk_340",
      "text": "서론\n\n<!-- PAGE_3 -->\n###### 본 안내서는 방사성의약품 허가에 대한 경험이 적어 허가 신청 시 어려움을 느끼는\n\n<!-- PAGE_3 -->\n###### 제외하고 매년 10품목 이내로 허가되었으며 2000년도에 55품목으로 가장 많이\n\n<!-- PAGE_3 -->\n###### 허가되었고,\n\n<!-- PAGE_3 -->\n###### 기타 2001년 및 2005년도에 각각 34,\n\n<!-- PAGE_3 -->\n###### 29품목이 허가되었고 최근의\n\n<!-- PAGE_3 -->\n###### 2014년도에는 16품목이 허가되었다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 339,
        "window_size": 3,
        "char_count": 308,
        "word_count": 59,
        "page_number": 3,
        "window_text": "| 되는 기준을 규정한다.  | 마.  식품의약품안전처장이 따로 기준 및 시험 | 는 품목 | 표준제조기준에 맞는 품목 |\n**방사성핵종 불순물들은 생산 그리고 방사성핵종의 붕**\n| - 11 - | - 13 - | - 15 - | - 17 - | - 19 - | - 21 - | - 23 - | - 25 - | - 27 - | - 29 - | - 31 - | - 33 - | - 35 - | - 37 - | - 1 - | - 3 - | - 5 - | - 7 - | - 9 - | - 10 - | - 12 - | - 14 - | - 16 - | - 18 - | - 20 - | - 22 - | - 24 - | - 26 - | - 28 - | - 30 - | - 32 - | - 34 - | - 36 - | - 38 - | - 2 - | - 4 - | - 6 - | - 8 - |\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n### 제·개정 이력\n\n<!-- PAGE_3 -->\n###### 연번\n\n<!-- PAGE_3 -->\n###### 제·개정번호\n\n<!-- PAGE_3 -->\n###### 승인일자\n\n<!-- PAGE_3 -->\n###### 주요내용\n\n<!-- PAGE_3 -->\n###### 1\n\n<!-- PAGE_3 -->\n###### C0-2015-2-008\n\n<!-- PAGE_3 -->\n###### 2015.07.30\n\n<!-- PAGE_3 -->\n###### 제정\n\n<!-- PAGE_3 -->\n## 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_3 -->\n#### 1.  서론\n\n<!-- PAGE_3 -->\n###### 본 안내서는 방사성의약품 허가에 대한 경험이 적어 허가 신청 시 어려움을 느끼는\n\n<!-- PAGE_3 -->\n###### 제외하고 매년 10품목 이내로 허가되었으며 2000년도에 55품목으로 가장 많이\n\n<!-- PAGE_3 -->\n###### 허가되었고,\n\n<!-- PAGE_3 -->\n###### 기타 2001년 및 2005년도에 각각 34,\n\n<!-- PAGE_3 -->\n###### 29품목이 허가되었고 최근의\n\n<!-- PAGE_3 -->\n###### 2014년도에는 16품목이 허가되었다.  이와 같이 특정 년도에 품목허가 수가 증가된\n\n<!-- PAGE_3 -->\n###### 주된 이유는 신규업체의 등장에 따른 품목신청이 늘어났기 때문인 것으로 확인된다.\n\n 80\n\n100\n\n120\n\n140\n\n품목수(건)\n\n<!-- PAGE_4 -->\n###### 국내 방사성의약품의 방사성동위원소 별 품목허가 수를 표 2와 그림 2에 나타내었다.\n\n <!-- PAGE_4 -->\n###### 전체 허가된 방사성의약품 중 테크네튬(99mTc(콜드),\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터),\n\n<!-- PAGE_4 -->\n###### 99mTc)과 관련된\n\n<!-- PAGE_4 -->\n###### 방사성의약품이 47.1%로 가장 높은 비율을 차지하였고,\n\n<!-- PAGE_4 -->\n###### 131I과 18F이 각각 21.7%,\n\n<!-- PAGE_4 -->\n###### 15.1%로 그 다음 높은 비율을 차지하였다.\n\n",
        "original_sentence": "서론\n\n<!-- PAGE_3 -->\n###### 본 안내서는 방사성의약품 허가에 대한 경험이 적어 허가 신청 시 어려움을 느끼는\n\n<!-- PAGE_3 -->\n###### 제외하고 매년 10품목 이내로 허가되었으며 2000년도에 55품목으로 가장 많이\n\n<!-- PAGE_3 -->\n###### 허가되었고,\n\n<!-- PAGE_3 -->\n###### 기타 2001년 및 2005년도에 각각 34,\n\n<!-- PAGE_3 -->\n###### 29품목이 허가되었고 최근의\n\n<!-- PAGE_3 -->\n###### 2014년도에는 16품목이 허가되었다. "
      }
    },
    {
      "chunk_id": "chunk_341",
      "text": "이와 같이 특정 년도에 품목허가 수가 증가된\n\n<!-- PAGE_3 -->\n###### 주된 이유는 신규업체의 등장에 따른 품목신청이 늘어났기 때문인 것으로 확인된다.\n\n",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 340,
        "window_size": 3,
        "char_count": 95,
        "word_count": 21,
        "page_number": 3,
        "window_text": "| 마.  식품의약품안전처장이 따로 기준 및 시험 | 는 품목 | 표준제조기준에 맞는 품목 |\n**방사성핵종 불순물들은 생산 그리고 방사성핵종의 붕**\n| - 11 - | - 13 - | - 15 - | - 17 - | - 19 - | - 21 - | - 23 - | - 25 - | - 27 - | - 29 - | - 31 - | - 33 - | - 35 - | - 37 - | - 1 - | - 3 - | - 5 - | - 7 - | - 9 - | - 10 - | - 12 - | - 14 - | - 16 - | - 18 - | - 20 - | - 22 - | - 24 - | - 26 - | - 28 - | - 30 - | - 32 - | - 34 - | - 36 - | - 38 - | - 2 - | - 4 - | - 6 - | - 8 - |\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n### 제·개정 이력\n\n<!-- PAGE_3 -->\n###### 연번\n\n<!-- PAGE_3 -->\n###### 제·개정번호\n\n<!-- PAGE_3 -->\n###### 승인일자\n\n<!-- PAGE_3 -->\n###### 주요내용\n\n<!-- PAGE_3 -->\n###### 1\n\n<!-- PAGE_3 -->\n###### C0-2015-2-008\n\n<!-- PAGE_3 -->\n###### 2015.07.30\n\n<!-- PAGE_3 -->\n###### 제정\n\n<!-- PAGE_3 -->\n## 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_3 -->\n#### 1.  서론\n\n<!-- PAGE_3 -->\n###### 본 안내서는 방사성의약품 허가에 대한 경험이 적어 허가 신청 시 어려움을 느끼는\n\n<!-- PAGE_3 -->\n###### 제외하고 매년 10품목 이내로 허가되었으며 2000년도에 55품목으로 가장 많이\n\n<!-- PAGE_3 -->\n###### 허가되었고,\n\n<!-- PAGE_3 -->\n###### 기타 2001년 및 2005년도에 각각 34,\n\n<!-- PAGE_3 -->\n###### 29품목이 허가되었고 최근의\n\n<!-- PAGE_3 -->\n###### 2014년도에는 16품목이 허가되었다.  이와 같이 특정 년도에 품목허가 수가 증가된\n\n<!-- PAGE_3 -->\n###### 주된 이유는 신규업체의 등장에 따른 품목신청이 늘어났기 때문인 것으로 확인된다.\n\n 80\n\n100\n\n120\n\n140\n\n품목수(건)\n\n<!-- PAGE_4 -->\n###### 국내 방사성의약품의 방사성동위원소 별 품목허가 수를 표 2와 그림 2에 나타내었다.\n\n <!-- PAGE_4 -->\n###### 전체 허가된 방사성의약품 중 테크네튬(99mTc(콜드),\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터),\n\n<!-- PAGE_4 -->\n###### 99mTc)과 관련된\n\n<!-- PAGE_4 -->\n###### 방사성의약품이 47.1%로 가장 높은 비율을 차지하였고,\n\n<!-- PAGE_4 -->\n###### 131I과 18F이 각각 21.7%,\n\n<!-- PAGE_4 -->\n###### 15.1%로 그 다음 높은 비율을 차지하였다.\n\n 표 2. ",
        "original_sentence": "이와 같이 특정 년도에 품목허가 수가 증가된\n\n<!-- PAGE_3 -->\n###### 주된 이유는 신규업체의 등장에 따른 품목신청이 늘어났기 때문인 것으로 확인된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_342",
      "text": "80\n\n100\n\n120\n\n140\n\n품목수(건)\n\n<!-- PAGE_4 -->\n###### 국내 방사성의약품의 방사성동위원소 별 품목허가 수를 표 2와 그림 2에 나타내었다.\n\n",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 341,
        "window_size": 3,
        "char_count": 98,
        "word_count": 20,
        "page_number": 4,
        "window_text": "식품의약품안전처장이 따로 기준 및 시험 | 는 품목 | 표준제조기준에 맞는 품목 |\n**방사성핵종 불순물들은 생산 그리고 방사성핵종의 붕**\n| - 11 - | - 13 - | - 15 - | - 17 - | - 19 - | - 21 - | - 23 - | - 25 - | - 27 - | - 29 - | - 31 - | - 33 - | - 35 - | - 37 - | - 1 - | - 3 - | - 5 - | - 7 - | - 9 - | - 10 - | - 12 - | - 14 - | - 16 - | - 18 - | - 20 - | - 22 - | - 24 - | - 26 - | - 28 - | - 30 - | - 32 - | - 34 - | - 36 - | - 38 - | - 2 - | - 4 - | - 6 - | - 8 - |\n\n**[표 끝]**\n\n<!-- PAGE_3 -->\n### 제·개정 이력\n\n<!-- PAGE_3 -->\n###### 연번\n\n<!-- PAGE_3 -->\n###### 제·개정번호\n\n<!-- PAGE_3 -->\n###### 승인일자\n\n<!-- PAGE_3 -->\n###### 주요내용\n\n<!-- PAGE_3 -->\n###### 1\n\n<!-- PAGE_3 -->\n###### C0-2015-2-008\n\n<!-- PAGE_3 -->\n###### 2015.07.30\n\n<!-- PAGE_3 -->\n###### 제정\n\n<!-- PAGE_3 -->\n## 방사성의약품 품목허가를 위한 안내서\n\n<!-- PAGE_3 -->\n#### 1.  서론\n\n<!-- PAGE_3 -->\n###### 본 안내서는 방사성의약품 허가에 대한 경험이 적어 허가 신청 시 어려움을 느끼는\n\n<!-- PAGE_3 -->\n###### 제외하고 매년 10품목 이내로 허가되었으며 2000년도에 55품목으로 가장 많이\n\n<!-- PAGE_3 -->\n###### 허가되었고,\n\n<!-- PAGE_3 -->\n###### 기타 2001년 및 2005년도에 각각 34,\n\n<!-- PAGE_3 -->\n###### 29품목이 허가되었고 최근의\n\n<!-- PAGE_3 -->\n###### 2014년도에는 16품목이 허가되었다.  이와 같이 특정 년도에 품목허가 수가 증가된\n\n<!-- PAGE_3 -->\n###### 주된 이유는 신규업체의 등장에 따른 품목신청이 늘어났기 때문인 것으로 확인된다.\n\n 80\n\n100\n\n120\n\n140\n\n품목수(건)\n\n<!-- PAGE_4 -->\n###### 국내 방사성의약품의 방사성동위원소 별 품목허가 수를 표 2와 그림 2에 나타내었다.\n\n <!-- PAGE_4 -->\n###### 전체 허가된 방사성의약품 중 테크네튬(99mTc(콜드),\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터),\n\n<!-- PAGE_4 -->\n###### 99mTc)과 관련된\n\n<!-- PAGE_4 -->\n###### 방사성의약품이 47.1%로 가장 높은 비율을 차지하였고,\n\n<!-- PAGE_4 -->\n###### 131I과 18F이 각각 21.7%,\n\n<!-- PAGE_4 -->\n###### 15.1%로 그 다음 높은 비율을 차지하였다.\n\n 표 2.  방사성동위원소 별 품목허가 수 (15.01.12. ",
        "original_sentence": "80\n\n100\n\n120\n\n140\n\n품목수(건)\n\n<!-- PAGE_4 -->\n###### 국내 방사성의약품의 방사성동위원소 별 품목허가 수를 표 2와 그림 2에 나타내었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_343",
      "text": "<!-- PAGE_4 -->\n###### 전체 허가된 방사성의약품 중 테크네튬(99mTc(콜드),\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터),\n\n<!-- PAGE_4 -->\n###### 99mTc)과 관련된\n\n<!-- PAGE_4 -->\n###### 방사성의약품이 47.1%로 가장 높은 비율을 차지하였고,\n\n<!-- PAGE_4 -->\n###### 131I과 18F이 각각 21.7%,\n\n<!-- PAGE_4 -->\n###### 15.1%로 그 다음 높은 비율을 차지하였다.\n\n",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 342,
        "window_size": 3,
        "char_count": 281,
        "word_count": 48,
        "page_number": 4,
        "window_text": "서론\n\n<!-- PAGE_3 -->\n###### 본 안내서는 방사성의약품 허가에 대한 경험이 적어 허가 신청 시 어려움을 느끼는\n\n<!-- PAGE_3 -->\n###### 제외하고 매년 10품목 이내로 허가되었으며 2000년도에 55품목으로 가장 많이\n\n<!-- PAGE_3 -->\n###### 허가되었고,\n\n<!-- PAGE_3 -->\n###### 기타 2001년 및 2005년도에 각각 34,\n\n<!-- PAGE_3 -->\n###### 29품목이 허가되었고 최근의\n\n<!-- PAGE_3 -->\n###### 2014년도에는 16품목이 허가되었다.  이와 같이 특정 년도에 품목허가 수가 증가된\n\n<!-- PAGE_3 -->\n###### 주된 이유는 신규업체의 등장에 따른 품목신청이 늘어났기 때문인 것으로 확인된다.\n\n 80\n\n100\n\n120\n\n140\n\n품목수(건)\n\n<!-- PAGE_4 -->\n###### 국내 방사성의약품의 방사성동위원소 별 품목허가 수를 표 2와 그림 2에 나타내었다.\n\n <!-- PAGE_4 -->\n###### 전체 허가된 방사성의약품 중 테크네튬(99mTc(콜드),\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터),\n\n<!-- PAGE_4 -->\n###### 99mTc)과 관련된\n\n<!-- PAGE_4 -->\n###### 방사성의약품이 47.1%로 가장 높은 비율을 차지하였고,\n\n<!-- PAGE_4 -->\n###### 131I과 18F이 각각 21.7%,\n\n<!-- PAGE_4 -->\n###### 15.1%로 그 다음 높은 비율을 차지하였다.\n\n 표 2.  방사성동위원소 별 품목허가 수 (15.01.12.  품목대장 기준)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터)\n\n<!-- PAGE_4 -->\n###### 14\n\n<!-- PAGE_4 -->\n###### 6.6\n\n<!-- PAGE_4 -->\n###### 14C\n\n<!-- PAGE_4 -->\n###### 2\n\n<!-- PAGE_4 -->\n###### 0.9\n\n**[표 시작]**\n\n| 2. ",
        "original_sentence": "<!-- PAGE_4 -->\n###### 전체 허가된 방사성의약품 중 테크네튬(99mTc(콜드),\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터),\n\n<!-- PAGE_4 -->\n###### 99mTc)과 관련된\n\n<!-- PAGE_4 -->\n###### 방사성의약품이 47.1%로 가장 높은 비율을 차지하였고,\n\n<!-- PAGE_4 -->\n###### 131I과 18F이 각각 21.7%,\n\n<!-- PAGE_4 -->\n###### 15.1%로 그 다음 높은 비율을 차지하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_344",
      "text": "표 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 343,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 3,
        "window_text": "이와 같이 특정 년도에 품목허가 수가 증가된\n\n<!-- PAGE_3 -->\n###### 주된 이유는 신규업체의 등장에 따른 품목신청이 늘어났기 때문인 것으로 확인된다.\n\n 80\n\n100\n\n120\n\n140\n\n품목수(건)\n\n<!-- PAGE_4 -->\n###### 국내 방사성의약품의 방사성동위원소 별 품목허가 수를 표 2와 그림 2에 나타내었다.\n\n <!-- PAGE_4 -->\n###### 전체 허가된 방사성의약품 중 테크네튬(99mTc(콜드),\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터),\n\n<!-- PAGE_4 -->\n###### 99mTc)과 관련된\n\n<!-- PAGE_4 -->\n###### 방사성의약품이 47.1%로 가장 높은 비율을 차지하였고,\n\n<!-- PAGE_4 -->\n###### 131I과 18F이 각각 21.7%,\n\n<!-- PAGE_4 -->\n###### 15.1%로 그 다음 높은 비율을 차지하였다.\n\n 표 2.  방사성동위원소 별 품목허가 수 (15.01.12.  품목대장 기준)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터)\n\n<!-- PAGE_4 -->\n###### 14\n\n<!-- PAGE_4 -->\n###### 6.6\n\n<!-- PAGE_4 -->\n###### 14C\n\n<!-- PAGE_4 -->\n###### 2\n\n<!-- PAGE_4 -->\n###### 0.9\n\n**[표 시작]**\n\n| 2.  허가 처리 절차 | 2.2.3 수수료 및 처리기한 | 2.3.13 허가조건 | - (비무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균 또는 부유균 등) 관리내용 포함 | 저장방법 | 심사자료의 범위 | 방사성제제 분할사용 관련 정보 | ㉯ ‘14.8.21자 개정된 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라, 이 규칙 | 2.2.4 전자민원 신청방법 | 2.3.6 효능․효과 | 부록1. ",
        "original_sentence": "표 2. "
      }
    },
    {
      "chunk_id": "chunk_345",
      "text": "방사성동위원소 별 품목허가 수 (15.01.12. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 344,
        "window_size": 3,
        "char_count": 28,
        "word_count": 5,
        "page_number": 3,
        "window_text": "80\n\n100\n\n120\n\n140\n\n품목수(건)\n\n<!-- PAGE_4 -->\n###### 국내 방사성의약품의 방사성동위원소 별 품목허가 수를 표 2와 그림 2에 나타내었다.\n\n <!-- PAGE_4 -->\n###### 전체 허가된 방사성의약품 중 테크네튬(99mTc(콜드),\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터),\n\n<!-- PAGE_4 -->\n###### 99mTc)과 관련된\n\n<!-- PAGE_4 -->\n###### 방사성의약품이 47.1%로 가장 높은 비율을 차지하였고,\n\n<!-- PAGE_4 -->\n###### 131I과 18F이 각각 21.7%,\n\n<!-- PAGE_4 -->\n###### 15.1%로 그 다음 높은 비율을 차지하였다.\n\n 표 2.  방사성동위원소 별 품목허가 수 (15.01.12.  품목대장 기준)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터)\n\n<!-- PAGE_4 -->\n###### 14\n\n<!-- PAGE_4 -->\n###### 6.6\n\n<!-- PAGE_4 -->\n###### 14C\n\n<!-- PAGE_4 -->\n###### 2\n\n<!-- PAGE_4 -->\n###### 0.9\n\n**[표 시작]**\n\n| 2.  허가 처리 절차 | 2.2.3 수수료 및 처리기한 | 2.3.13 허가조건 | - (비무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균 또는 부유균 등) 관리내용 포함 | 저장방법 | 심사자료의 범위 | 방사성제제 분할사용 관련 정보 | ㉯ ‘14.8.21자 개정된 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라, 이 규칙 | 2.2.4 전자민원 신청방법 | 2.3.6 효능․효과 | 부록1.  관련 법규 | 부록2. ",
        "original_sentence": "방사성동위원소 별 품목허가 수 (15.01.12. "
      }
    },
    {
      "chunk_id": "chunk_346",
      "text": "품목대장 기준)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터)\n\n<!-- PAGE_4 -->\n###### 14\n\n<!-- PAGE_4 -->\n###### 6.6\n\n<!-- PAGE_4 -->\n###### 14C\n\n<!-- PAGE_4 -->\n###### 2\n\n<!-- PAGE_4 -->\n###### 0.9\n\n**[표 시작]**\n\n| 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 345,
        "window_size": 3,
        "char_count": 383,
        "word_count": 66,
        "page_number": 4,
        "window_text": "<!-- PAGE_4 -->\n###### 전체 허가된 방사성의약품 중 테크네튬(99mTc(콜드),\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터),\n\n<!-- PAGE_4 -->\n###### 99mTc)과 관련된\n\n<!-- PAGE_4 -->\n###### 방사성의약품이 47.1%로 가장 높은 비율을 차지하였고,\n\n<!-- PAGE_4 -->\n###### 131I과 18F이 각각 21.7%,\n\n<!-- PAGE_4 -->\n###### 15.1%로 그 다음 높은 비율을 차지하였다.\n\n 표 2.  방사성동위원소 별 품목허가 수 (15.01.12.  품목대장 기준)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터)\n\n<!-- PAGE_4 -->\n###### 14\n\n<!-- PAGE_4 -->\n###### 6.6\n\n<!-- PAGE_4 -->\n###### 14C\n\n<!-- PAGE_4 -->\n###### 2\n\n<!-- PAGE_4 -->\n###### 0.9\n\n**[표 시작]**\n\n| 2.  허가 처리 절차 | 2.2.3 수수료 및 처리기한 | 2.3.13 허가조건 | - (비무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균 또는 부유균 등) 관리내용 포함 | 저장방법 | 심사자료의 범위 | 방사성제제 분할사용 관련 정보 | ㉯ ‘14.8.21자 개정된 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라, 이 규칙 | 2.2.4 전자민원 신청방법 | 2.3.6 효능․효과 | 부록1.  관련 법규 | 부록2.  유럽약전 방사성의약품 번역 | 방사성의약품의 라벨은 관련 국가 및 유럽의 법에 적 | 유의사항 | 성    상  이 약은 무색의 맑은 액이다. ",
        "original_sentence": "품목대장 기준)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터)\n\n<!-- PAGE_4 -->\n###### 14\n\n<!-- PAGE_4 -->\n###### 6.6\n\n<!-- PAGE_4 -->\n###### 14C\n\n<!-- PAGE_4 -->\n###### 2\n\n<!-- PAGE_4 -->\n###### 0.9\n\n**[표 시작]**\n\n| 2. "
      }
    },
    {
      "chunk_id": "chunk_347",
      "text": "허가 처리 절차 | 2.2.3 수수료 및 처리기한 | 2.3.13 허가조건 | - (비무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균 또는 부유균 등) 관리내용 포함 | 저장방법 | 심사자료의 범위 | 방사성제제 분할사용 관련 정보 | ㉯ ‘14.8.21자 개정된 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라, 이 규칙 | 2.2.4 전자민원 신청방법 | 2.3.6 효능․효과 | 부록1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 346,
        "window_size": 3,
        "char_count": 251,
        "word_count": 60,
        "page_number": 3,
        "window_text": "표 2.  방사성동위원소 별 품목허가 수 (15.01.12.  품목대장 기준)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터)\n\n<!-- PAGE_4 -->\n###### 14\n\n<!-- PAGE_4 -->\n###### 6.6\n\n<!-- PAGE_4 -->\n###### 14C\n\n<!-- PAGE_4 -->\n###### 2\n\n<!-- PAGE_4 -->\n###### 0.9\n\n**[표 시작]**\n\n| 2.  허가 처리 절차 | 2.2.3 수수료 및 처리기한 | 2.3.13 허가조건 | - (비무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균 또는 부유균 등) 관리내용 포함 | 저장방법 | 심사자료의 범위 | 방사성제제 분할사용 관련 정보 | ㉯ ‘14.8.21자 개정된 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라, 이 규칙 | 2.2.4 전자민원 신청방법 | 2.3.6 효능․효과 | 부록1.  관련 법규 | 부록2.  유럽약전 방사성의약품 번역 | 방사성의약품의 라벨은 관련 국가 및 유럽의 법에 적 | 유의사항 | 성    상  이 약은 무색의 맑은 액이다.  | Krypton-81m (81mKr) | 13.10 초 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 마. ",
        "original_sentence": "허가 처리 절차 | 2.2.3 수수료 및 처리기한 | 2.3.13 허가조건 | - (비무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균 또는 부유균 등) 관리내용 포함 | 저장방법 | 심사자료의 범위 | 방사성제제 분할사용 관련 정보 | ㉯ ‘14.8.21자 개정된 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라, 이 규칙 | 2.2.4 전자민원 신청방법 | 2.3.6 효능․효과 | 부록1. "
      }
    },
    {
      "chunk_id": "chunk_348",
      "text": "관련 법규 | 부록2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 347,
        "window_size": 3,
        "char_count": 13,
        "word_count": 4,
        "page_number": 3,
        "window_text": "방사성동위원소 별 품목허가 수 (15.01.12.  품목대장 기준)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터)\n\n<!-- PAGE_4 -->\n###### 14\n\n<!-- PAGE_4 -->\n###### 6.6\n\n<!-- PAGE_4 -->\n###### 14C\n\n<!-- PAGE_4 -->\n###### 2\n\n<!-- PAGE_4 -->\n###### 0.9\n\n**[표 시작]**\n\n| 2.  허가 처리 절차 | 2.2.3 수수료 및 처리기한 | 2.3.13 허가조건 | - (비무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균 또는 부유균 등) 관리내용 포함 | 저장방법 | 심사자료의 범위 | 방사성제제 분할사용 관련 정보 | ㉯ ‘14.8.21자 개정된 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라, 이 규칙 | 2.2.4 전자민원 신청방법 | 2.3.6 효능․효과 | 부록1.  관련 법규 | 부록2.  유럽약전 방사성의약품 번역 | 방사성의약품의 라벨은 관련 국가 및 유럽의 법에 적 | 유의사항 | 성    상  이 약은 무색의 맑은 액이다.  | Krypton-81m (81mKr) | 13.10 초 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 마.  식품의약품안전처장이 따로 기준 및 시험 | 3. ",
        "original_sentence": "관련 법규 | 부록2. "
      }
    },
    {
      "chunk_id": "chunk_349",
      "text": "유럽약전 방사성의약품 번역 | 방사성의약품의 라벨은 관련 국가 및 유럽의 법에 적 | 유의사항 | 성    상  이 약은 무색의 맑은 액이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 348,
        "window_size": 3,
        "char_count": 80,
        "word_count": 22,
        "page_number": 6,
        "window_text": "품목대장 기준)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 방사성동위원소\n\n<!-- PAGE_4 -->\n###### 품목수\n\n<!-- PAGE_4 -->\n###### 백분율(%)\n\n<!-- PAGE_4 -->\n###### 99mTc(제너레이터)\n\n<!-- PAGE_4 -->\n###### 14\n\n<!-- PAGE_4 -->\n###### 6.6\n\n<!-- PAGE_4 -->\n###### 14C\n\n<!-- PAGE_4 -->\n###### 2\n\n<!-- PAGE_4 -->\n###### 0.9\n\n**[표 시작]**\n\n| 2.  허가 처리 절차 | 2.2.3 수수료 및 처리기한 | 2.3.13 허가조건 | - (비무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균 또는 부유균 등) 관리내용 포함 | 저장방법 | 심사자료의 범위 | 방사성제제 분할사용 관련 정보 | ㉯ ‘14.8.21자 개정된 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라, 이 규칙 | 2.2.4 전자민원 신청방법 | 2.3.6 효능․효과 | 부록1.  관련 법규 | 부록2.  유럽약전 방사성의약품 번역 | 방사성의약품의 라벨은 관련 국가 및 유럽의 법에 적 | 유의사항 | 성    상  이 약은 무색의 맑은 액이다.  | Krypton-81m (81mKr) | 13.10 초 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 마.  식품의약품안전처장이 따로 기준 및 시험 | 3.  식품의약품안전처장이 성분의 종류ᆞ규격ᆞ | 전처장의 허가를 받거나 신고를 하여야 한다. ",
        "original_sentence": "유럽약전 방사성의약품 번역 | 방사성의약품의 라벨은 관련 국가 및 유럽의 법에 적 | 유의사항 | 성    상  이 약은 무색의 맑은 액이다. "
      }
    },
    {
      "chunk_id": "chunk_350",
      "text": "| Krypton-81m (81mKr) | 13.10 초 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 마. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 349,
        "window_size": 3,
        "char_count": 143,
        "word_count": 44,
        "page_number": 3,
        "window_text": "허가 처리 절차 | 2.2.3 수수료 및 처리기한 | 2.3.13 허가조건 | - (비무균제제) 온도(필요시 습도 포함), 차압, 부유미립자, 미생물(낙하균 또는 부유균 등) 관리내용 포함 | 저장방법 | 심사자료의 범위 | 방사성제제 분할사용 관련 정보 | ㉯ ‘14.8.21자 개정된 「의약품 등의 안전에 관한 규칙」 제4조제6호라목 및 부칙 제10조제4항에 따라, 이 규칙 | 2.2.4 전자민원 신청방법 | 2.3.6 효능․효과 | 부록1.  관련 법규 | 부록2.  유럽약전 방사성의약품 번역 | 방사성의약품의 라벨은 관련 국가 및 유럽의 법에 적 | 유의사항 | 성    상  이 약은 무색의 맑은 액이다.  | Krypton-81m (81mKr) | 13.10 초 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 마.  식품의약품안전처장이 따로 기준 및 시험 | 3.  식품의약품안전처장이 성분의 종류ᆞ규격ᆞ | 전처장의 허가를 받거나 신고를 하여야 한다.  | 라 변경허가를 받거나 변경신고를 한 것으로 | 방법을 고시한 품목 | 5. ",
        "original_sentence": "| Krypton-81m (81mKr) | 13.10 초 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 마. "
      }
    },
    {
      "chunk_id": "chunk_351",
      "text": "식품의약품안전처장이 따로 기준 및 시험 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 350,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 3,
        "window_text": "관련 법규 | 부록2.  유럽약전 방사성의약품 번역 | 방사성의약품의 라벨은 관련 국가 및 유럽의 법에 적 | 유의사항 | 성    상  이 약은 무색의 맑은 액이다.  | Krypton-81m (81mKr) | 13.10 초 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 마.  식품의약품안전처장이 따로 기준 및 시험 | 3.  식품의약품안전처장이 성분의 종류ᆞ규격ᆞ | 전처장의 허가를 받거나 신고를 하여야 한다.  | 라 변경허가를 받거나 변경신고를 한 것으로 | 방법을 고시한 품목 | 5.  약리작용에 관한 자료 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 조의4, 제32조, 제33조, 제35조의2, 제36조, | 허가받으려는 경우에는 비교용출시험자료 등 | 증명서 | 9. ",
        "original_sentence": "식품의약품안전처장이 따로 기준 및 시험 | 3. "
      }
    },
    {
      "chunk_id": "chunk_352",
      "text": "식품의약품안전처장이 성분의 종류ᆞ규격ᆞ | 전처장의 허가를 받거나 신고를 하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 351,
        "window_size": 3,
        "char_count": 49,
        "word_count": 10,
        "page_number": 5,
        "window_text": "유럽약전 방사성의약품 번역 | 방사성의약품의 라벨은 관련 국가 및 유럽의 법에 적 | 유의사항 | 성    상  이 약은 무색의 맑은 액이다.  | Krypton-81m (81mKr) | 13.10 초 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 마.  식품의약품안전처장이 따로 기준 및 시험 | 3.  식품의약품안전처장이 성분의 종류ᆞ규격ᆞ | 전처장의 허가를 받거나 신고를 하여야 한다.  | 라 변경허가를 받거나 변경신고를 한 것으로 | 방법을 고시한 품목 | 5.  약리작용에 관한 자료 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 조의4, 제32조, 제33조, 제35조의2, 제36조, | 허가받으려는 경우에는 비교용출시험자료 등 | 증명서 | 9.  법 제31조제2항ᆞ제3항에 따라 의약품을 제 | 조판매·수입 품목신고를 하려는 자의 경우에 | 목의 자료. ",
        "original_sentence": "식품의약품안전처장이 성분의 종류ᆞ규격ᆞ | 전처장의 허가를 받거나 신고를 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_353",
      "text": "| 라 변경허가를 받거나 변경신고를 한 것으로 | 방법을 고시한 품목 | 5. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 352,
        "window_size": 3,
        "char_count": 44,
        "word_count": 13,
        "page_number": 3,
        "window_text": "| Krypton-81m (81mKr) | 13.10 초 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 마.  식품의약품안전처장이 따로 기준 및 시험 | 3.  식품의약품안전처장이 성분의 종류ᆞ규격ᆞ | 전처장의 허가를 받거나 신고를 하여야 한다.  | 라 변경허가를 받거나 변경신고를 한 것으로 | 방법을 고시한 품목 | 5.  약리작용에 관한 자료 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 조의4, 제32조, 제33조, 제35조의2, 제36조, | 허가받으려는 경우에는 비교용출시험자료 등 | 증명서 | 9.  법 제31조제2항ᆞ제3항에 따라 의약품을 제 | 조판매·수입 품목신고를 하려는 자의 경우에 | 목의 자료.  다만, 제15조제1항에 따라 이미 | <의약품 등의 안전에 관한 규칙> | 요하다고 인정하는 경우에는 식품의약품안전평 | 전처장이 고시하는 의약품은 제외한다)을 제 | 조판매ᆞ수입 품목신고 변경신고서 또는 별 |\n| 나) 신청 품목 작업실(청정도별, 작업실별) 및 시험실(미생물한도 및 무균시험실 등)의 전년도 환경모니터링 | λ = 각 방사성핵종의 특성에 따른 붕괴상수 | form), | 순도 및 물리적 상태 뿐 만 아니라 조사 | 3마리 실험동물 각각에 제제를 정맥 투여한다. ",
        "original_sentence": "| 라 변경허가를 받거나 변경신고를 한 것으로 | 방법을 고시한 품목 | 5. "
      }
    },
    {
      "chunk_id": "chunk_354",
      "text": "약리작용에 관한 자료 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 조의4, 제32조, 제33조, 제35조의2, 제36조, | 허가받으려는 경우에는 비교용출시험자료 등 | 증명서 | 9. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 353,
        "window_size": 3,
        "char_count": 109,
        "word_count": 26,
        "page_number": 3,
        "window_text": "식품의약품안전처장이 따로 기준 및 시험 | 3.  식품의약품안전처장이 성분의 종류ᆞ규격ᆞ | 전처장의 허가를 받거나 신고를 하여야 한다.  | 라 변경허가를 받거나 변경신고를 한 것으로 | 방법을 고시한 품목 | 5.  약리작용에 관한 자료 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 조의4, 제32조, 제33조, 제35조의2, 제36조, | 허가받으려는 경우에는 비교용출시험자료 등 | 증명서 | 9.  법 제31조제2항ᆞ제3항에 따라 의약품을 제 | 조판매·수입 품목신고를 하려는 자의 경우에 | 목의 자료.  다만, 제15조제1항에 따라 이미 | <의약품 등의 안전에 관한 규칙> | 요하다고 인정하는 경우에는 식품의약품안전평 | 전처장이 고시하는 의약품은 제외한다)을 제 | 조판매ᆞ수입 품목신고 변경신고서 또는 별 |\n| 나) 신청 품목 작업실(청정도별, 작업실별) 및 시험실(미생물한도 및 무균시험실 등)의 전년도 환경모니터링 | λ = 각 방사성핵종의 특성에 따른 붕괴상수 | form), | 순도 및 물리적 상태 뿐 만 아니라 조사 | 3마리 실험동물 각각에 제제를 정맥 투여한다.  투여하 | 물들의 기준이 기재되어 있다. ",
        "original_sentence": "약리작용에 관한 자료 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 조의4, 제32조, 제33조, 제35조의2, 제36조, | 허가받으려는 경우에는 비교용출시험자료 등 | 증명서 | 9. "
      }
    },
    {
      "chunk_id": "chunk_355",
      "text": "법 제31조제2항ᆞ제3항에 따라 의약품을 제 | 조판매·수입 품목신고를 하려는 자의 경우에 | 목의 자료. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 354,
        "window_size": 3,
        "char_count": 60,
        "word_count": 14,
        "page_number": 3,
        "window_text": "식품의약품안전처장이 성분의 종류ᆞ규격ᆞ | 전처장의 허가를 받거나 신고를 하여야 한다.  | 라 변경허가를 받거나 변경신고를 한 것으로 | 방법을 고시한 품목 | 5.  약리작용에 관한 자료 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 조의4, 제32조, 제33조, 제35조의2, 제36조, | 허가받으려는 경우에는 비교용출시험자료 등 | 증명서 | 9.  법 제31조제2항ᆞ제3항에 따라 의약품을 제 | 조판매·수입 품목신고를 하려는 자의 경우에 | 목의 자료.  다만, 제15조제1항에 따라 이미 | <의약품 등의 안전에 관한 규칙> | 요하다고 인정하는 경우에는 식품의약품안전평 | 전처장이 고시하는 의약품은 제외한다)을 제 | 조판매ᆞ수입 품목신고 변경신고서 또는 별 |\n| 나) 신청 품목 작업실(청정도별, 작업실별) 및 시험실(미생물한도 및 무균시험실 등)의 전년도 환경모니터링 | λ = 각 방사성핵종의 특성에 따른 붕괴상수 | form), | 순도 및 물리적 상태 뿐 만 아니라 조사 | 3마리 실험동물 각각에 제제를 정맥 투여한다.  투여하 | 물들의 기준이 기재되어 있다.  | 고방사능의 경우 안전상 이유로 일반시험법(2.6.1)에 따 | 각조에서 언급될 수 있고 그 특성들은 일반사항 5.7. ",
        "original_sentence": "법 제31조제2항ᆞ제3항에 따라 의약품을 제 | 조판매·수입 품목신고를 하려는 자의 경우에 | 목의 자료. "
      }
    },
    {
      "chunk_id": "chunk_356",
      "text": "다만, 제15조제1항에 따라 이미 | <의약품 등의 안전에 관한 규칙> | 요하다고 인정하는 경우에는 식품의약품안전평 | 전처장이 고시하는 의약품은 제외한다)을 제 | 조판매ᆞ수입 품목신고 변경신고서 또는 별 |\n| 나) 신청 품목 작업실(청정도별, 작업실별) 및 시험실(미생물한도 및 무균시험실 등)의 전년도 환경모니터링 | λ = 각 방사성핵종의 특성에 따른 붕괴상수 | form), | 순도 및 물리적 상태 뿐 만 아니라 조사 | 3마리 실험동물 각각에 제제를 정맥 투여한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 355,
        "window_size": 3,
        "char_count": 270,
        "word_count": 67,
        "page_number": 3,
        "window_text": "| 라 변경허가를 받거나 변경신고를 한 것으로 | 방법을 고시한 품목 | 5.  약리작용에 관한 자료 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 조의4, 제32조, 제33조, 제35조의2, 제36조, | 허가받으려는 경우에는 비교용출시험자료 등 | 증명서 | 9.  법 제31조제2항ᆞ제3항에 따라 의약품을 제 | 조판매·수입 품목신고를 하려는 자의 경우에 | 목의 자료.  다만, 제15조제1항에 따라 이미 | <의약품 등의 안전에 관한 규칙> | 요하다고 인정하는 경우에는 식품의약품안전평 | 전처장이 고시하는 의약품은 제외한다)을 제 | 조판매ᆞ수입 품목신고 변경신고서 또는 별 |\n| 나) 신청 품목 작업실(청정도별, 작업실별) 및 시험실(미생물한도 및 무균시험실 등)의 전년도 환경모니터링 | λ = 각 방사성핵종의 특성에 따른 붕괴상수 | form), | 순도 및 물리적 상태 뿐 만 아니라 조사 | 3마리 실험동물 각각에 제제를 정맥 투여한다.  투여하 | 물들의 기준이 기재되어 있다.  | 고방사능의 경우 안전상 이유로 일반시험법(2.6.1)에 따 | 각조에서 언급될 수 있고 그 특성들은 일반사항 5.7.  | 합해야 한다. ",
        "original_sentence": "다만, 제15조제1항에 따라 이미 | <의약품 등의 안전에 관한 규칙> | 요하다고 인정하는 경우에는 식품의약품안전평 | 전처장이 고시하는 의약품은 제외한다)을 제 | 조판매ᆞ수입 품목신고 변경신고서 또는 별 |\n| 나) 신청 품목 작업실(청정도별, 작업실별) 및 시험실(미생물한도 및 무균시험실 등)의 전년도 환경모니터링 | λ = 각 방사성핵종의 특성에 따른 붕괴상수 | form), | 순도 및 물리적 상태 뿐 만 아니라 조사 | 3마리 실험동물 각각에 제제를 정맥 투여한다. "
      }
    },
    {
      "chunk_id": "chunk_357",
      "text": "투여하 | 물들의 기준이 기재되어 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 356,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 5,
        "window_text": "약리작용에 관한 자료 | 신고를 하여야 하는 의약품등의 품목은 다음 각 | 조의4, 제32조, 제33조, 제35조의2, 제36조, | 허가받으려는 경우에는 비교용출시험자료 등 | 증명서 | 9.  법 제31조제2항ᆞ제3항에 따라 의약품을 제 | 조판매·수입 품목신고를 하려는 자의 경우에 | 목의 자료.  다만, 제15조제1항에 따라 이미 | <의약품 등의 안전에 관한 규칙> | 요하다고 인정하는 경우에는 식품의약품안전평 | 전처장이 고시하는 의약품은 제외한다)을 제 | 조판매ᆞ수입 품목신고 변경신고서 또는 별 |\n| 나) 신청 품목 작업실(청정도별, 작업실별) 및 시험실(미생물한도 및 무균시험실 등)의 전년도 환경모니터링 | λ = 각 방사성핵종의 특성에 따른 붕괴상수 | form), | 순도 및 물리적 상태 뿐 만 아니라 조사 | 3마리 실험동물 각각에 제제를 정맥 투여한다.  투여하 | 물들의 기준이 기재되어 있다.  | 고방사능의 경우 안전상 이유로 일반시험법(2.6.1)에 따 | 각조에서 언급될 수 있고 그 특성들은 일반사항 5.7.  | 합해야 한다.  | 확인시험  1) 이 약을 가지고 감마선측정법의 감마선 | 자) 이다. ",
        "original_sentence": "투여하 | 물들의 기준이 기재되어 있다. "
      }
    },
    {
      "chunk_id": "chunk_358",
      "text": "| 고방사능의 경우 안전상 이유로 일반시험법(2.6.1)에 따 | 각조에서 언급될 수 있고 그 특성들은 일반사항 5.7. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 357,
        "window_size": 3,
        "char_count": 68,
        "word_count": 16,
        "page_number": 3,
        "window_text": "법 제31조제2항ᆞ제3항에 따라 의약품을 제 | 조판매·수입 품목신고를 하려는 자의 경우에 | 목의 자료.  다만, 제15조제1항에 따라 이미 | <의약품 등의 안전에 관한 규칙> | 요하다고 인정하는 경우에는 식품의약품안전평 | 전처장이 고시하는 의약품은 제외한다)을 제 | 조판매ᆞ수입 품목신고 변경신고서 또는 별 |\n| 나) 신청 품목 작업실(청정도별, 작업실별) 및 시험실(미생물한도 및 무균시험실 등)의 전년도 환경모니터링 | λ = 각 방사성핵종의 특성에 따른 붕괴상수 | form), | 순도 및 물리적 상태 뿐 만 아니라 조사 | 3마리 실험동물 각각에 제제를 정맥 투여한다.  투여하 | 물들의 기준이 기재되어 있다.  | 고방사능의 경우 안전상 이유로 일반시험법(2.6.1)에 따 | 각조에서 언급될 수 있고 그 특성들은 일반사항 5.7.  | 합해야 한다.  | 확인시험  1) 이 약을 가지고 감마선측정법의 감마선 | 자) 이다.  알파붕괴는 보통 중핵자(Z > 82)와 관련된 | - 저장기간 동안의 화학적 변화 | Rubidium-81 (81Rb) | 4.576 시간 |\n| ▷ 주요 허가조건 예시 | 바. ",
        "original_sentence": "| 고방사능의 경우 안전상 이유로 일반시험법(2.6.1)에 따 | 각조에서 언급될 수 있고 그 특성들은 일반사항 5.7. "
      }
    },
    {
      "chunk_id": "chunk_359",
      "text": "| 합해야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 358,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 9,
        "window_text": "다만, 제15조제1항에 따라 이미 | <의약품 등의 안전에 관한 규칙> | 요하다고 인정하는 경우에는 식품의약품안전평 | 전처장이 고시하는 의약품은 제외한다)을 제 | 조판매ᆞ수입 품목신고 변경신고서 또는 별 |\n| 나) 신청 품목 작업실(청정도별, 작업실별) 및 시험실(미생물한도 및 무균시험실 등)의 전년도 환경모니터링 | λ = 각 방사성핵종의 특성에 따른 붕괴상수 | form), | 순도 및 물리적 상태 뿐 만 아니라 조사 | 3마리 실험동물 각각에 제제를 정맥 투여한다.  투여하 | 물들의 기준이 기재되어 있다.  | 고방사능의 경우 안전상 이유로 일반시험법(2.6.1)에 따 | 각조에서 언급될 수 있고 그 특성들은 일반사항 5.7.  | 합해야 한다.  | 확인시험  1) 이 약을 가지고 감마선측정법의 감마선 | 자) 이다.  알파붕괴는 보통 중핵자(Z > 82)와 관련된 | - 저장기간 동안의 화학적 변화 | Rubidium-81 (81Rb) | 4.576 시간 |\n| ▷ 주요 허가조건 예시 | 바.  그 밖에 식품의약품안전처장이 자료의 제 | 허가받은 사항 또는 신고한 사항을 변경하려는 | 본다. ",
        "original_sentence": "| 합해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_360",
      "text": "| 확인시험  1) 이 약을 가지고 감마선측정법의 감마선 | 자) 이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 359,
        "window_size": 3,
        "char_count": 41,
        "word_count": 11,
        "page_number": 3,
        "window_text": "투여하 | 물들의 기준이 기재되어 있다.  | 고방사능의 경우 안전상 이유로 일반시험법(2.6.1)에 따 | 각조에서 언급될 수 있고 그 특성들은 일반사항 5.7.  | 합해야 한다.  | 확인시험  1) 이 약을 가지고 감마선측정법의 감마선 | 자) 이다.  알파붕괴는 보통 중핵자(Z > 82)와 관련된 | - 저장기간 동안의 화학적 변화 | Rubidium-81 (81Rb) | 4.576 시간 |\n| ▷ 주요 허가조건 예시 | 바.  그 밖에 식품의약품안전처장이 자료의 제 | 허가받은 사항 또는 신고한 사항을 변경하려는 | 본다.  | 함량 및 처방 등을 표준화하여 고시한 표준 | 방법을 고시한 품목 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | 5. ",
        "original_sentence": "| 확인시험  1) 이 약을 가지고 감마선측정법의 감마선 | 자) 이다. "
      }
    },
    {
      "chunk_id": "chunk_361",
      "text": "알파붕괴는 보통 중핵자(Z > 82)와 관련된 | - 저장기간 동안의 화학적 변화 | Rubidium-81 (81Rb) | 4.576 시간 |\n| ▷ 주요 허가조건 예시 | 바. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 360,
        "window_size": 3,
        "char_count": 100,
        "word_count": 26,
        "page_number": 3,
        "window_text": "| 고방사능의 경우 안전상 이유로 일반시험법(2.6.1)에 따 | 각조에서 언급될 수 있고 그 특성들은 일반사항 5.7.  | 합해야 한다.  | 확인시험  1) 이 약을 가지고 감마선측정법의 감마선 | 자) 이다.  알파붕괴는 보통 중핵자(Z > 82)와 관련된 | - 저장기간 동안의 화학적 변화 | Rubidium-81 (81Rb) | 4.576 시간 |\n| ▷ 주요 허가조건 예시 | 바.  그 밖에 식품의약품안전처장이 자료의 제 | 허가받은 사항 또는 신고한 사항을 변경하려는 | 본다.  | 함량 및 처방 등을 표준화하여 고시한 표준 | 방법을 고시한 품목 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | 5.  일반의약품 중 단일성분의 의약품으로서 이 | 6. ",
        "original_sentence": "알파붕괴는 보통 중핵자(Z > 82)와 관련된 | - 저장기간 동안의 화학적 변화 | Rubidium-81 (81Rb) | 4.576 시간 |\n| ▷ 주요 허가조건 예시 | 바. "
      }
    },
    {
      "chunk_id": "chunk_362",
      "text": "그 밖에 식품의약품안전처장이 자료의 제 | 허가받은 사항 또는 신고한 사항을 변경하려는 | 본다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 361,
        "window_size": 3,
        "char_count": 55,
        "word_count": 14,
        "page_number": 1,
        "window_text": "| 합해야 한다.  | 확인시험  1) 이 약을 가지고 감마선측정법의 감마선 | 자) 이다.  알파붕괴는 보통 중핵자(Z > 82)와 관련된 | - 저장기간 동안의 화학적 변화 | Rubidium-81 (81Rb) | 4.576 시간 |\n| ▷ 주요 허가조건 예시 | 바.  그 밖에 식품의약품안전처장이 자료의 제 | 허가받은 사항 또는 신고한 사항을 변경하려는 | 본다.  | 함량 및 처방 등을 표준화하여 고시한 표준 | 방법을 고시한 품목 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | 5.  일반의약품 중 단일성분의 의약품으로서 이 | 6.  임상시험성적에 관한 자료 | 호와 같다. ",
        "original_sentence": "그 밖에 식품의약품안전처장이 자료의 제 | 허가받은 사항 또는 신고한 사항을 변경하려는 | 본다. "
      }
    },
    {
      "chunk_id": "chunk_363",
      "text": "| 함량 및 처방 등을 표준화하여 고시한 표준 | 방법을 고시한 품목 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | 5. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 362,
        "window_size": 3,
        "char_count": 70,
        "word_count": 20,
        "page_number": 6,
        "window_text": "| 확인시험  1) 이 약을 가지고 감마선측정법의 감마선 | 자) 이다.  알파붕괴는 보통 중핵자(Z > 82)와 관련된 | - 저장기간 동안의 화학적 변화 | Rubidium-81 (81Rb) | 4.576 시간 |\n| ▷ 주요 허가조건 예시 | 바.  그 밖에 식품의약품안전처장이 자료의 제 | 허가받은 사항 또는 신고한 사항을 변경하려는 | 본다.  | 함량 및 처방 등을 표준화하여 고시한 표준 | 방법을 고시한 품목 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | 5.  일반의약품 중 단일성분의 의약품으로서 이 | 6.  임상시험성적에 관한 자료 | 호와 같다.  다만, 제4조제1항제1호에 따라 안전 | 제37조, 제37조의2부터 제37조의4까지, 제38 | 식품의약품안전처장이 고시하는 자료 | 확 | 인 | 제9조～제22조 관련 | 2.2.4.1 전자민원신청 사전 절차 | 적합한 동안의 시간 | - 주사제 등은 용기의 형상(바이알, 앰플, 플라스틱용기, 프리필드시린지 등)을 기재 (예: | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 | 조업자에게 위탁제조하여 판매하려는 의약품 | 등록된 원료의약품의 경우에는 제출하지 아 | 가원의 의견을 듣거나 법 제18조제1항에 따른 | 조하는 제조소에 제48조의2에 따른 제조 및 | 지 제8호서식의 의약품등 제조판매ᆞ수입 품 |\n| ▷ 신약 | - 방사성의약품 : “밀봉용기”, “차폐용기 : 원자력법령에 의함” | 계면활성제 | 등장(화)제 | 보존제 | 부형제 | 안정(화)제 | 구분 | 민원사무명 | 수수료 | 처리 | 평가자료 또는 최근 3개월간 자료 | - 기허가된 다른 의약품 명칭과 동일하지 않아야 함 | (EUROPEAN PHARMACOPOEIA 8.0) | 심사자료의 종류 | [시행 2015.3.15.] ",
        "original_sentence": "| 함량 및 처방 등을 표준화하여 고시한 표준 | 방법을 고시한 품목 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | 5. "
      }
    },
    {
      "chunk_id": "chunk_364",
      "text": "일반의약품 중 단일성분의 의약품으로서 이 | 6. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 363,
        "window_size": 3,
        "char_count": 28,
        "word_count": 7,
        "page_number": 3,
        "window_text": "알파붕괴는 보통 중핵자(Z > 82)와 관련된 | - 저장기간 동안의 화학적 변화 | Rubidium-81 (81Rb) | 4.576 시간 |\n| ▷ 주요 허가조건 예시 | 바.  그 밖에 식품의약품안전처장이 자료의 제 | 허가받은 사항 또는 신고한 사항을 변경하려는 | 본다.  | 함량 및 처방 등을 표준화하여 고시한 표준 | 방법을 고시한 품목 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | 5.  일반의약품 중 단일성분의 의약품으로서 이 | 6.  임상시험성적에 관한 자료 | 호와 같다.  다만, 제4조제1항제1호에 따라 안전 | 제37조, 제37조의2부터 제37조의4까지, 제38 | 식품의약품안전처장이 고시하는 자료 | 확 | 인 | 제9조～제22조 관련 | 2.2.4.1 전자민원신청 사전 절차 | 적합한 동안의 시간 | - 주사제 등은 용기의 형상(바이알, 앰플, 플라스틱용기, 프리필드시린지 등)을 기재 (예: | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 | 조업자에게 위탁제조하여 판매하려는 의약품 | 등록된 원료의약품의 경우에는 제출하지 아 | 가원의 의견을 듣거나 법 제18조제1항에 따른 | 조하는 제조소에 제48조의2에 따른 제조 및 | 지 제8호서식의 의약품등 제조판매ᆞ수입 품 |\n| ▷ 신약 | - 방사성의약품 : “밀봉용기”, “차폐용기 : 원자력법령에 의함” | 계면활성제 | 등장(화)제 | 보존제 | 부형제 | 안정(화)제 | 구분 | 민원사무명 | 수수료 | 처리 | 평가자료 또는 최근 3개월간 자료 | - 기허가된 다른 의약품 명칭과 동일하지 않아야 함 | (EUROPEAN PHARMACOPOEIA 8.0) | 심사자료의 종류 | [시행 2015.3.15.]  [총리령 제1149호, 2015.3.13., 일부개정] | Krypton-81m (81mKr) | 13.10 초 |\n| e = 자연로그의 밑 | (irradiation) 조건 및 직접적인 물리화학적 환경이 생 | 기 바로 전에 희석하여 투여해야 할 경우도 있다. ",
        "original_sentence": "일반의약품 중 단일성분의 의약품으로서 이 | 6. "
      }
    },
    {
      "chunk_id": "chunk_365",
      "text": "임상시험성적에 관한 자료 | 호와 같다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 364,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 5,
        "window_text": "그 밖에 식품의약품안전처장이 자료의 제 | 허가받은 사항 또는 신고한 사항을 변경하려는 | 본다.  | 함량 및 처방 등을 표준화하여 고시한 표준 | 방법을 고시한 품목 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | 5.  일반의약품 중 단일성분의 의약품으로서 이 | 6.  임상시험성적에 관한 자료 | 호와 같다.  다만, 제4조제1항제1호에 따라 안전 | 제37조, 제37조의2부터 제37조의4까지, 제38 | 식품의약품안전처장이 고시하는 자료 | 확 | 인 | 제9조～제22조 관련 | 2.2.4.1 전자민원신청 사전 절차 | 적합한 동안의 시간 | - 주사제 등은 용기의 형상(바이알, 앰플, 플라스틱용기, 프리필드시린지 등)을 기재 (예: | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 | 조업자에게 위탁제조하여 판매하려는 의약품 | 등록된 원료의약품의 경우에는 제출하지 아 | 가원의 의견을 듣거나 법 제18조제1항에 따른 | 조하는 제조소에 제48조의2에 따른 제조 및 | 지 제8호서식의 의약품등 제조판매ᆞ수입 품 |\n| ▷ 신약 | - 방사성의약품 : “밀봉용기”, “차폐용기 : 원자력법령에 의함” | 계면활성제 | 등장(화)제 | 보존제 | 부형제 | 안정(화)제 | 구분 | 민원사무명 | 수수료 | 처리 | 평가자료 또는 최근 3개월간 자료 | - 기허가된 다른 의약품 명칭과 동일하지 않아야 함 | (EUROPEAN PHARMACOPOEIA 8.0) | 심사자료의 종류 | [시행 2015.3.15.]  [총리령 제1149호, 2015.3.13., 일부개정] | Krypton-81m (81mKr) | 13.10 초 |\n| e = 자연로그의 밑 | (irradiation) 조건 및 직접적인 물리화학적 환경이 생 | 기 바로 전에 희석하여 투여해야 할 경우도 있다.  | ◯ 보존제 사용 관련 | 바. ",
        "original_sentence": "임상시험성적에 관한 자료 | 호와 같다. "
      }
    },
    {
      "chunk_id": "chunk_366",
      "text": "다만, 제4조제1항제1호에 따라 안전 | 제37조, 제37조의2부터 제37조의4까지, 제38 | 식품의약품안전처장이 고시하는 자료 | 확 | 인 | 제9조～제22조 관련 | 2.2.4.1 전자민원신청 사전 절차 | 적합한 동안의 시간 | - 주사제 등은 용기의 형상(바이알, 앰플, 플라스틱용기, 프리필드시린지 등)을 기재 (예: | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 | 조업자에게 위탁제조하여 판매하려는 의약품 | 등록된 원료의약품의 경우에는 제출하지 아 | 가원의 의견을 듣거나 법 제18조제1항에 따른 | 조하는 제조소에 제48조의2에 따른 제조 및 | 지 제8호서식의 의약품등 제조판매ᆞ수입 품 |\n| ▷ 신약 | - 방사성의약품 : “밀봉용기”, “차폐용기 : 원자력법령에 의함” | 계면활성제 | 등장(화)제 | 보존제 | 부형제 | 안정(화)제 | 구분 | 민원사무명 | 수수료 | 처리 | 평가자료 또는 최근 3개월간 자료 | - 기허가된 다른 의약품 명칭과 동일하지 않아야 함 | (EUROPEAN PHARMACOPOEIA 8.0) | 심사자료의 종류 | [시행 2015.3.15.] ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 365,
        "window_size": 3,
        "char_count": 567,
        "word_count": 136,
        "page_number": 3,
        "window_text": "| 함량 및 처방 등을 표준화하여 고시한 표준 | 방법을 고시한 품목 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | 5.  일반의약품 중 단일성분의 의약품으로서 이 | 6.  임상시험성적에 관한 자료 | 호와 같다.  다만, 제4조제1항제1호에 따라 안전 | 제37조, 제37조의2부터 제37조의4까지, 제38 | 식품의약품안전처장이 고시하는 자료 | 확 | 인 | 제9조～제22조 관련 | 2.2.4.1 전자민원신청 사전 절차 | 적합한 동안의 시간 | - 주사제 등은 용기의 형상(바이알, 앰플, 플라스틱용기, 프리필드시린지 등)을 기재 (예: | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 | 조업자에게 위탁제조하여 판매하려는 의약품 | 등록된 원료의약품의 경우에는 제출하지 아 | 가원의 의견을 듣거나 법 제18조제1항에 따른 | 조하는 제조소에 제48조의2에 따른 제조 및 | 지 제8호서식의 의약품등 제조판매ᆞ수입 품 |\n| ▷ 신약 | - 방사성의약품 : “밀봉용기”, “차폐용기 : 원자력법령에 의함” | 계면활성제 | 등장(화)제 | 보존제 | 부형제 | 안정(화)제 | 구분 | 민원사무명 | 수수료 | 처리 | 평가자료 또는 최근 3개월간 자료 | - 기허가된 다른 의약품 명칭과 동일하지 않아야 함 | (EUROPEAN PHARMACOPOEIA 8.0) | 심사자료의 종류 | [시행 2015.3.15.]  [총리령 제1149호, 2015.3.13., 일부개정] | Krypton-81m (81mKr) | 13.10 초 |\n| e = 자연로그의 밑 | (irradiation) 조건 및 직접적인 물리화학적 환경이 생 | 기 바로 전에 희석하여 투여해야 할 경우도 있다.  | ◯ 보존제 사용 관련 | 바.  그 밖에 식품의약품안전처장이 자료의 제 | ⑤ 제1항에 따른 신청서ᆞ신고서 또는 변경신 | 제조기준에 맞는 품목 | 출이 필요하지 아니하다고 인정하는 품목 | 의약품 각조에 규정된 방사성 핵종은 일반적으로 반감 | 른 검체량을 이용하는 것이 불가능하다. ",
        "original_sentence": "다만, 제4조제1항제1호에 따라 안전 | 제37조, 제37조의2부터 제37조의4까지, 제38 | 식품의약품안전처장이 고시하는 자료 | 확 | 인 | 제9조～제22조 관련 | 2.2.4.1 전자민원신청 사전 절차 | 적합한 동안의 시간 | - 주사제 등은 용기의 형상(바이알, 앰플, 플라스틱용기, 프리필드시린지 등)을 기재 (예: | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 | 조업자에게 위탁제조하여 판매하려는 의약품 | 등록된 원료의약품의 경우에는 제출하지 아 | 가원의 의견을 듣거나 법 제18조제1항에 따른 | 조하는 제조소에 제48조의2에 따른 제조 및 | 지 제8호서식의 의약품등 제조판매ᆞ수입 품 |\n| ▷ 신약 | - 방사성의약품 : “밀봉용기”, “차폐용기 : 원자력법령에 의함” | 계면활성제 | 등장(화)제 | 보존제 | 부형제 | 안정(화)제 | 구분 | 민원사무명 | 수수료 | 처리 | 평가자료 또는 최근 3개월간 자료 | - 기허가된 다른 의약품 명칭과 동일하지 않아야 함 | (EUROPEAN PHARMACOPOEIA 8.0) | 심사자료의 종류 | [시행 2015.3.15.] "
      }
    },
    {
      "chunk_id": "chunk_367",
      "text": "[총리령 제1149호, 2015.3.13., 일부개정] | Krypton-81m (81mKr) | 13.10 초 |\n| e = 자연로그의 밑 | (irradiation) 조건 및 직접적인 물리화학적 환경이 생 | 기 바로 전에 희석하여 투여해야 할 경우도 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 366,
        "window_size": 3,
        "char_count": 147,
        "word_count": 33,
        "page_number": 3,
        "window_text": "일반의약품 중 단일성분의 의약품으로서 이 | 6.  임상시험성적에 관한 자료 | 호와 같다.  다만, 제4조제1항제1호에 따라 안전 | 제37조, 제37조의2부터 제37조의4까지, 제38 | 식품의약품안전처장이 고시하는 자료 | 확 | 인 | 제9조～제22조 관련 | 2.2.4.1 전자민원신청 사전 절차 | 적합한 동안의 시간 | - 주사제 등은 용기의 형상(바이알, 앰플, 플라스틱용기, 프리필드시린지 등)을 기재 (예: | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 | 조업자에게 위탁제조하여 판매하려는 의약품 | 등록된 원료의약품의 경우에는 제출하지 아 | 가원의 의견을 듣거나 법 제18조제1항에 따른 | 조하는 제조소에 제48조의2에 따른 제조 및 | 지 제8호서식의 의약품등 제조판매ᆞ수입 품 |\n| ▷ 신약 | - 방사성의약품 : “밀봉용기”, “차폐용기 : 원자력법령에 의함” | 계면활성제 | 등장(화)제 | 보존제 | 부형제 | 안정(화)제 | 구분 | 민원사무명 | 수수료 | 처리 | 평가자료 또는 최근 3개월간 자료 | - 기허가된 다른 의약품 명칭과 동일하지 않아야 함 | (EUROPEAN PHARMACOPOEIA 8.0) | 심사자료의 종류 | [시행 2015.3.15.]  [총리령 제1149호, 2015.3.13., 일부개정] | Krypton-81m (81mKr) | 13.10 초 |\n| e = 자연로그의 밑 | (irradiation) 조건 및 직접적인 물리화학적 환경이 생 | 기 바로 전에 희석하여 투여해야 할 경우도 있다.  | ◯ 보존제 사용 관련 | 바.  그 밖에 식품의약품안전처장이 자료의 제 | ⑤ 제1항에 따른 신청서ᆞ신고서 또는 변경신 | 제조기준에 맞는 품목 | 출이 필요하지 아니하다고 인정하는 품목 | 의약품 각조에 규정된 방사성 핵종은 일반적으로 반감 | 른 검체량을 이용하는 것이 불가능하다.  멤브레인필터 | 6.다음 각 목의 구분에 따른 평가 자료 | 7. ",
        "original_sentence": "[총리령 제1149호, 2015.3.13., 일부개정] | Krypton-81m (81mKr) | 13.10 초 |\n| e = 자연로그의 밑 | (irradiation) 조건 및 직접적인 물리화학적 환경이 생 | 기 바로 전에 희석하여 투여해야 할 경우도 있다. "
      }
    },
    {
      "chunk_id": "chunk_368",
      "text": "| ◯ 보존제 사용 관련 | 바. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 367,
        "window_size": 3,
        "char_count": 19,
        "word_count": 7,
        "page_number": 8,
        "window_text": "임상시험성적에 관한 자료 | 호와 같다.  다만, 제4조제1항제1호에 따라 안전 | 제37조, 제37조의2부터 제37조의4까지, 제38 | 식품의약품안전처장이 고시하는 자료 | 확 | 인 | 제9조～제22조 관련 | 2.2.4.1 전자민원신청 사전 절차 | 적합한 동안의 시간 | - 주사제 등은 용기의 형상(바이알, 앰플, 플라스틱용기, 프리필드시린지 등)을 기재 (예: | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 | 조업자에게 위탁제조하여 판매하려는 의약품 | 등록된 원료의약품의 경우에는 제출하지 아 | 가원의 의견을 듣거나 법 제18조제1항에 따른 | 조하는 제조소에 제48조의2에 따른 제조 및 | 지 제8호서식의 의약품등 제조판매ᆞ수입 품 |\n| ▷ 신약 | - 방사성의약품 : “밀봉용기”, “차폐용기 : 원자력법령에 의함” | 계면활성제 | 등장(화)제 | 보존제 | 부형제 | 안정(화)제 | 구분 | 민원사무명 | 수수료 | 처리 | 평가자료 또는 최근 3개월간 자료 | - 기허가된 다른 의약품 명칭과 동일하지 않아야 함 | (EUROPEAN PHARMACOPOEIA 8.0) | 심사자료의 종류 | [시행 2015.3.15.]  [총리령 제1149호, 2015.3.13., 일부개정] | Krypton-81m (81mKr) | 13.10 초 |\n| e = 자연로그의 밑 | (irradiation) 조건 및 직접적인 물리화학적 환경이 생 | 기 바로 전에 희석하여 투여해야 할 경우도 있다.  | ◯ 보존제 사용 관련 | 바.  그 밖에 식품의약품안전처장이 자료의 제 | ⑤ 제1항에 따른 신청서ᆞ신고서 또는 변경신 | 제조기준에 맞는 품목 | 출이 필요하지 아니하다고 인정하는 품목 | 의약품 각조에 규정된 방사성 핵종은 일반적으로 반감 | 른 검체량을 이용하는 것이 불가능하다.  멤브레인필터 | 6.다음 각 목의 구분에 따른 평가 자료 | 7.  외국의 사용현황 등에 관한 자료 | 성·유효성에 관한 자료를 제출하여야 하는 품 | 미 제조판매ᆞ수입 품목허가를 받은 정제ᆞ | 유럽약전에서 언급된 방사성핵종들의 물리적 특성표 | 사용하는 나라에 따라 조정될 수 있다. ",
        "original_sentence": "| ◯ 보존제 사용 관련 | 바. "
      }
    },
    {
      "chunk_id": "chunk_369",
      "text": "그 밖에 식품의약품안전처장이 자료의 제 | ⑤ 제1항에 따른 신청서ᆞ신고서 또는 변경신 | 제조기준에 맞는 품목 | 출이 필요하지 아니하다고 인정하는 품목 | 의약품 각조에 규정된 방사성 핵종은 일반적으로 반감 | 른 검체량을 이용하는 것이 불가능하다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 368,
        "window_size": 3,
        "char_count": 142,
        "word_count": 36,
        "page_number": 3,
        "window_text": "다만, 제4조제1항제1호에 따라 안전 | 제37조, 제37조의2부터 제37조의4까지, 제38 | 식품의약품안전처장이 고시하는 자료 | 확 | 인 | 제9조～제22조 관련 | 2.2.4.1 전자민원신청 사전 절차 | 적합한 동안의 시간 | - 주사제 등은 용기의 형상(바이알, 앰플, 플라스틱용기, 프리필드시린지 등)을 기재 (예: | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 | 조업자에게 위탁제조하여 판매하려는 의약품 | 등록된 원료의약품의 경우에는 제출하지 아 | 가원의 의견을 듣거나 법 제18조제1항에 따른 | 조하는 제조소에 제48조의2에 따른 제조 및 | 지 제8호서식의 의약품등 제조판매ᆞ수입 품 |\n| ▷ 신약 | - 방사성의약품 : “밀봉용기”, “차폐용기 : 원자력법령에 의함” | 계면활성제 | 등장(화)제 | 보존제 | 부형제 | 안정(화)제 | 구분 | 민원사무명 | 수수료 | 처리 | 평가자료 또는 최근 3개월간 자료 | - 기허가된 다른 의약품 명칭과 동일하지 않아야 함 | (EUROPEAN PHARMACOPOEIA 8.0) | 심사자료의 종류 | [시행 2015.3.15.]  [총리령 제1149호, 2015.3.13., 일부개정] | Krypton-81m (81mKr) | 13.10 초 |\n| e = 자연로그의 밑 | (irradiation) 조건 및 직접적인 물리화학적 환경이 생 | 기 바로 전에 희석하여 투여해야 할 경우도 있다.  | ◯ 보존제 사용 관련 | 바.  그 밖에 식품의약품안전처장이 자료의 제 | ⑤ 제1항에 따른 신청서ᆞ신고서 또는 변경신 | 제조기준에 맞는 품목 | 출이 필요하지 아니하다고 인정하는 품목 | 의약품 각조에 규정된 방사성 핵종은 일반적으로 반감 | 른 검체량을 이용하는 것이 불가능하다.  멤브레인필터 | 6.다음 각 목의 구분에 따른 평가 자료 | 7.  외국의 사용현황 등에 관한 자료 | 성·유효성에 관한 자료를 제출하여야 하는 품 | 미 제조판매ᆞ수입 품목허가를 받은 정제ᆞ | 유럽약전에서 언급된 방사성핵종들의 물리적 특성표 | 사용하는 나라에 따라 조정될 수 있다.  | 스펙트로미터에 의한 스펙트럼측정법에 따라 시험할 | 여 그 품목의 제조시설·제조방법 등에 관한 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 니한다. ",
        "original_sentence": "그 밖에 식품의약품안전처장이 자료의 제 | ⑤ 제1항에 따른 신청서ᆞ신고서 또는 변경신 | 제조기준에 맞는 품목 | 출이 필요하지 아니하다고 인정하는 품목 | 의약품 각조에 규정된 방사성 핵종은 일반적으로 반감 | 른 검체량을 이용하는 것이 불가능하다. "
      }
    },
    {
      "chunk_id": "chunk_370",
      "text": "멤브레인필터 | 6.다음 각 목의 구분에 따른 평가 자료 | 7. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 369,
        "window_size": 3,
        "char_count": 37,
        "word_count": 11,
        "page_number": 1,
        "window_text": "[총리령 제1149호, 2015.3.13., 일부개정] | Krypton-81m (81mKr) | 13.10 초 |\n| e = 자연로그의 밑 | (irradiation) 조건 및 직접적인 물리화학적 환경이 생 | 기 바로 전에 희석하여 투여해야 할 경우도 있다.  | ◯ 보존제 사용 관련 | 바.  그 밖에 식품의약품안전처장이 자료의 제 | ⑤ 제1항에 따른 신청서ᆞ신고서 또는 변경신 | 제조기준에 맞는 품목 | 출이 필요하지 아니하다고 인정하는 품목 | 의약품 각조에 규정된 방사성 핵종은 일반적으로 반감 | 른 검체량을 이용하는 것이 불가능하다.  멤브레인필터 | 6.다음 각 목의 구분에 따른 평가 자료 | 7.  외국의 사용현황 등에 관한 자료 | 성·유효성에 관한 자료를 제출하여야 하는 품 | 미 제조판매ᆞ수입 품목허가를 받은 정제ᆞ | 유럽약전에서 언급된 방사성핵종들의 물리적 특성표 | 사용하는 나라에 따라 조정될 수 있다.  | 스펙트로미터에 의한 스펙트럼측정법에 따라 시험할 | 여 그 품목의 제조시설·제조방법 등에 관한 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 니한다.  | GMP 평가 11종 자료 목록(의약품 등의 안전에 관한 규칙 [별지 제4호서식]) | <약사법> | 다. ",
        "original_sentence": "멤브레인필터 | 6.다음 각 목의 구분에 따른 평가 자료 | 7. "
      }
    },
    {
      "chunk_id": "chunk_371",
      "text": "외국의 사용현황 등에 관한 자료 | 성·유효성에 관한 자료를 제출하여야 하는 품 | 미 제조판매ᆞ수입 품목허가를 받은 정제ᆞ | 유럽약전에서 언급된 방사성핵종들의 물리적 특성표 | 사용하는 나라에 따라 조정될 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 370,
        "window_size": 3,
        "char_count": 123,
        "word_count": 31,
        "page_number": 5,
        "window_text": "| ◯ 보존제 사용 관련 | 바.  그 밖에 식품의약품안전처장이 자료의 제 | ⑤ 제1항에 따른 신청서ᆞ신고서 또는 변경신 | 제조기준에 맞는 품목 | 출이 필요하지 아니하다고 인정하는 품목 | 의약품 각조에 규정된 방사성 핵종은 일반적으로 반감 | 른 검체량을 이용하는 것이 불가능하다.  멤브레인필터 | 6.다음 각 목의 구분에 따른 평가 자료 | 7.  외국의 사용현황 등에 관한 자료 | 성·유효성에 관한 자료를 제출하여야 하는 품 | 미 제조판매ᆞ수입 품목허가를 받은 정제ᆞ | 유럽약전에서 언급된 방사성핵종들의 물리적 특성표 | 사용하는 나라에 따라 조정될 수 있다.  | 스펙트로미터에 의한 스펙트럼측정법에 따라 시험할 | 여 그 품목의 제조시설·제조방법 등에 관한 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 니한다.  | GMP 평가 11종 자료 목록(의약품 등의 안전에 관한 규칙 [별지 제4호서식]) | <약사법> | 다.  양성자가 결손된 방사성핵종들은 보통 전자방출 | 따라서 상당한 양의 담체(carrier)가 포함될 수 있다. ",
        "original_sentence": "외국의 사용현황 등에 관한 자료 | 성·유효성에 관한 자료를 제출하여야 하는 품 | 미 제조판매ᆞ수입 품목허가를 받은 정제ᆞ | 유럽약전에서 언급된 방사성핵종들의 물리적 특성표 | 사용하는 나라에 따라 조정될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_372",
      "text": "| 스펙트로미터에 의한 스펙트럼측정법에 따라 시험할 | 여 그 품목의 제조시설·제조방법 등에 관한 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 니한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 371,
        "window_size": 3,
        "char_count": 88,
        "word_count": 22,
        "page_number": 3,
        "window_text": "그 밖에 식품의약품안전처장이 자료의 제 | ⑤ 제1항에 따른 신청서ᆞ신고서 또는 변경신 | 제조기준에 맞는 품목 | 출이 필요하지 아니하다고 인정하는 품목 | 의약품 각조에 규정된 방사성 핵종은 일반적으로 반감 | 른 검체량을 이용하는 것이 불가능하다.  멤브레인필터 | 6.다음 각 목의 구분에 따른 평가 자료 | 7.  외국의 사용현황 등에 관한 자료 | 성·유효성에 관한 자료를 제출하여야 하는 품 | 미 제조판매ᆞ수입 품목허가를 받은 정제ᆞ | 유럽약전에서 언급된 방사성핵종들의 물리적 특성표 | 사용하는 나라에 따라 조정될 수 있다.  | 스펙트로미터에 의한 스펙트럼측정법에 따라 시험할 | 여 그 품목의 제조시설·제조방법 등에 관한 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 니한다.  | GMP 평가 11종 자료 목록(의약품 등의 안전에 관한 규칙 [별지 제4호서식]) | <약사법> | 다.  양성자가 결손된 방사성핵종들은 보통 전자방출 | 따라서 상당한 양의 담체(carrier)가 포함될 수 있다.  | 중앙약사심의위원회에 자문을 할 수 있다. ",
        "original_sentence": "| 스펙트로미터에 의한 스펙트럼측정법에 따라 시험할 | 여 그 품목의 제조시설·제조방법 등에 관한 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 니한다. "
      }
    },
    {
      "chunk_id": "chunk_373",
      "text": "| GMP 평가 11종 자료 목록(의약품 등의 안전에 관한 규칙 [별지 제4호서식]) | <약사법> | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 372,
        "window_size": 3,
        "char_count": 61,
        "word_count": 16,
        "page_number": 3,
        "window_text": "멤브레인필터 | 6.다음 각 목의 구분에 따른 평가 자료 | 7.  외국의 사용현황 등에 관한 자료 | 성·유효성에 관한 자료를 제출하여야 하는 품 | 미 제조판매ᆞ수입 품목허가를 받은 정제ᆞ | 유럽약전에서 언급된 방사성핵종들의 물리적 특성표 | 사용하는 나라에 따라 조정될 수 있다.  | 스펙트로미터에 의한 스펙트럼측정법에 따라 시험할 | 여 그 품목의 제조시설·제조방법 등에 관한 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 니한다.  | GMP 평가 11종 자료 목록(의약품 등의 안전에 관한 규칙 [별지 제4호서식]) | <약사법> | 다.  양성자가 결손된 방사성핵종들은 보통 전자방출 | 따라서 상당한 양의 담체(carrier)가 포함될 수 있다.  | 중앙약사심의위원회에 자문을 할 수 있다.  | 품질관리 적합판정서가 있는 경우: 제1항제6 | 목 허가사항 변경허가 신청서 |\n| 2.1 주요 관련 법규 및 규정 (부록1 참조) | - 위 조건에 부합하는 모니터링 자료가 없는 경우, GMP 적용을 시작한 날 이후부터의 GMP 자료 제출 가능 | □ 품목허가 항목 | 경우에도 | 또한 | 같다. ",
        "original_sentence": "| GMP 평가 11종 자료 목록(의약품 등의 안전에 관한 규칙 [별지 제4호서식]) | <약사법> | 다. "
      }
    },
    {
      "chunk_id": "chunk_374",
      "text": "양성자가 결손된 방사성핵종들은 보통 전자방출 | 따라서 상당한 양의 담체(carrier)가 포함될 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 373,
        "window_size": 3,
        "char_count": 61,
        "word_count": 13,
        "page_number": 11,
        "window_text": "외국의 사용현황 등에 관한 자료 | 성·유효성에 관한 자료를 제출하여야 하는 품 | 미 제조판매ᆞ수입 품목허가를 받은 정제ᆞ | 유럽약전에서 언급된 방사성핵종들의 물리적 특성표 | 사용하는 나라에 따라 조정될 수 있다.  | 스펙트로미터에 의한 스펙트럼측정법에 따라 시험할 | 여 그 품목의 제조시설·제조방법 등에 관한 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 니한다.  | GMP 평가 11종 자료 목록(의약품 등의 안전에 관한 규칙 [별지 제4호서식]) | <약사법> | 다.  양성자가 결손된 방사성핵종들은 보통 전자방출 | 따라서 상당한 양의 담체(carrier)가 포함될 수 있다.  | 중앙약사심의위원회에 자문을 할 수 있다.  | 품질관리 적합판정서가 있는 경우: 제1항제6 | 목 허가사항 변경허가 신청서 |\n| 2.1 주요 관련 법규 및 규정 (부록1 참조) | - 위 조건에 부합하는 모니터링 자료가 없는 경우, GMP 적용을 시작한 날 이후부터의 GMP 자료 제출 가능 | □ 품목허가 항목 | 경우에도 | 또한 | 같다.  | <개정 | 2008.2.29., | 조, 제50조의2부터 제50조의10까지, 제69조의 | 제2조(의약품등의 제조업 허가ᆞ신고 등) ① | 무색투명한 액이 무색투명한 바이알에 든 주사제) | Strontium-89 (89Sr) | 50.53 일 | 고 이에 관한 사실을 증명하는 서류를 제출하 |\n| - 구체적인 보관조건(2～8℃, 냉장보관 등)․유의사항(예 : 빛을 피하여 보관 등) 병기 | - 지위승계(양도․양수) :「약사법」제89조 및「의약품 등의 안전에 관한 규칙」제103 | 2. ",
        "original_sentence": "양성자가 결손된 방사성핵종들은 보통 전자방출 | 따라서 상당한 양의 담체(carrier)가 포함될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_375",
      "text": "| 중앙약사심의위원회에 자문을 할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 374,
        "window_size": 3,
        "char_count": 25,
        "word_count": 6,
        "page_number": 9,
        "window_text": "| 스펙트로미터에 의한 스펙트럼측정법에 따라 시험할 | 여 그 품목의 제조시설·제조방법 등에 관한 | 의 경우에는 수탁제조업자의 명칭 및 소재지 | 니한다.  | GMP 평가 11종 자료 목록(의약품 등의 안전에 관한 규칙 [별지 제4호서식]) | <약사법> | 다.  양성자가 결손된 방사성핵종들은 보통 전자방출 | 따라서 상당한 양의 담체(carrier)가 포함될 수 있다.  | 중앙약사심의위원회에 자문을 할 수 있다.  | 품질관리 적합판정서가 있는 경우: 제1항제6 | 목 허가사항 변경허가 신청서 |\n| 2.1 주요 관련 법규 및 규정 (부록1 참조) | - 위 조건에 부합하는 모니터링 자료가 없는 경우, GMP 적용을 시작한 날 이후부터의 GMP 자료 제출 가능 | □ 품목허가 항목 | 경우에도 | 또한 | 같다.  | <개정 | 2008.2.29., | 조, 제50조의2부터 제50조의10까지, 제69조의 | 제2조(의약품등의 제조업 허가ᆞ신고 등) ① | 무색투명한 액이 무색투명한 바이알에 든 주사제) | Strontium-89 (89Sr) | 50.53 일 | 고 이에 관한 사실을 증명하는 서류를 제출하 |\n| - 구체적인 보관조건(2～8℃, 냉장보관 등)․유의사항(예 : 빛을 피하여 보관 등) 병기 | - 지위승계(양도․양수) :「약사법」제89조 및「의약품 등의 안전에 관한 규칙」제103 | 2.  제10조에 따른 기준 및 시험방법에 관한 자 | 4. ",
        "original_sentence": "| 중앙약사심의위원회에 자문을 할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_376",
      "text": "| 품질관리 적합판정서가 있는 경우: 제1항제6 | 목 허가사항 변경허가 신청서 |\n| 2.1 주요 관련 법규 및 규정 (부록1 참조) | - 위 조건에 부합하는 모니터링 자료가 없는 경우, GMP 적용을 시작한 날 이후부터의 GMP 자료 제출 가능 | □ 품목허가 항목 | 경우에도 | 또한 | 같다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 375,
        "window_size": 3,
        "char_count": 170,
        "word_count": 49,
        "page_number": 1,
        "window_text": "| GMP 평가 11종 자료 목록(의약품 등의 안전에 관한 규칙 [별지 제4호서식]) | <약사법> | 다.  양성자가 결손된 방사성핵종들은 보통 전자방출 | 따라서 상당한 양의 담체(carrier)가 포함될 수 있다.  | 중앙약사심의위원회에 자문을 할 수 있다.  | 품질관리 적합판정서가 있는 경우: 제1항제6 | 목 허가사항 변경허가 신청서 |\n| 2.1 주요 관련 법규 및 규정 (부록1 참조) | - 위 조건에 부합하는 모니터링 자료가 없는 경우, GMP 적용을 시작한 날 이후부터의 GMP 자료 제출 가능 | □ 품목허가 항목 | 경우에도 | 또한 | 같다.  | <개정 | 2008.2.29., | 조, 제50조의2부터 제50조의10까지, 제69조의 | 제2조(의약품등의 제조업 허가ᆞ신고 등) ① | 무색투명한 액이 무색투명한 바이알에 든 주사제) | Strontium-89 (89Sr) | 50.53 일 | 고 이에 관한 사실을 증명하는 서류를 제출하 |\n| - 구체적인 보관조건(2～8℃, 냉장보관 등)․유의사항(예 : 빛을 피하여 보관 등) 병기 | - 지위승계(양도․양수) :「약사법」제89조 및「의약품 등의 안전에 관한 규칙」제103 | 2.  제10조에 따른 기준 및 시험방법에 관한 자 | 4.  식품의약품안전처장이 따로 기준 및 시험방 | 청서ᆞ변경신고서를 받은 식품의약품안전처장 | 완충제 | 용제 | 용해보조제 | 충전제 | 캡슐 | 출이 필요하지 아니하다고 인정하는 품목 | 가. ",
        "original_sentence": "| 품질관리 적합판정서가 있는 경우: 제1항제6 | 목 허가사항 변경허가 신청서 |\n| 2.1 주요 관련 법규 및 규정 (부록1 참조) | - 위 조건에 부합하는 모니터링 자료가 없는 경우, GMP 적용을 시작한 날 이후부터의 GMP 자료 제출 가능 | □ 품목허가 항목 | 경우에도 | 또한 | 같다. "
      }
    },
    {
      "chunk_id": "chunk_377",
      "text": "| <개정 | 2008.2.29., | 조, 제50조의2부터 제50조의10까지, 제69조의 | 제2조(의약품등의 제조업 허가ᆞ신고 등) ① | 무색투명한 액이 무색투명한 바이알에 든 주사제) | Strontium-89 (89Sr) | 50.53 일 | 고 이에 관한 사실을 증명하는 서류를 제출하 |\n| - 구체적인 보관조건(2～8℃, 냉장보관 등)․유의사항(예 : 빛을 피하여 보관 등) 병기 | - 지위승계(양도․양수) :「약사법」제89조 및「의약품 등의 안전에 관한 규칙」제103 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 376,
        "window_size": 3,
        "char_count": 277,
        "word_count": 60,
        "page_number": 3,
        "window_text": "양성자가 결손된 방사성핵종들은 보통 전자방출 | 따라서 상당한 양의 담체(carrier)가 포함될 수 있다.  | 중앙약사심의위원회에 자문을 할 수 있다.  | 품질관리 적합판정서가 있는 경우: 제1항제6 | 목 허가사항 변경허가 신청서 |\n| 2.1 주요 관련 법규 및 규정 (부록1 참조) | - 위 조건에 부합하는 모니터링 자료가 없는 경우, GMP 적용을 시작한 날 이후부터의 GMP 자료 제출 가능 | □ 품목허가 항목 | 경우에도 | 또한 | 같다.  | <개정 | 2008.2.29., | 조, 제50조의2부터 제50조의10까지, 제69조의 | 제2조(의약품등의 제조업 허가ᆞ신고 등) ① | 무색투명한 액이 무색투명한 바이알에 든 주사제) | Strontium-89 (89Sr) | 50.53 일 | 고 이에 관한 사실을 증명하는 서류를 제출하 |\n| - 구체적인 보관조건(2～8℃, 냉장보관 등)․유의사항(예 : 빛을 피하여 보관 등) 병기 | - 지위승계(양도․양수) :「약사법」제89조 및「의약품 등의 안전에 관한 규칙」제103 | 2.  제10조에 따른 기준 및 시험방법에 관한 자 | 4.  식품의약품안전처장이 따로 기준 및 시험방 | 청서ᆞ변경신고서를 받은 식품의약품안전처장 | 완충제 | 용제 | 용해보조제 | 충전제 | 캡슐 | 출이 필요하지 아니하다고 인정하는 품목 | 가.  완제의약품[인체에 직접 적용하지 아니하 | 8. ",
        "original_sentence": "| <개정 | 2008.2.29., | 조, 제50조의2부터 제50조의10까지, 제69조의 | 제2조(의약품등의 제조업 허가ᆞ신고 등) ① | 무색투명한 액이 무색투명한 바이알에 든 주사제) | Strontium-89 (89Sr) | 50.53 일 | 고 이에 관한 사실을 증명하는 서류를 제출하 |\n| - 구체적인 보관조건(2～8℃, 냉장보관 등)․유의사항(예 : 빛을 피하여 보관 등) 병기 | - 지위승계(양도․양수) :「약사법」제89조 및「의약품 등의 안전에 관한 규칙」제103 | 2. "
      }
    },
    {
      "chunk_id": "chunk_378",
      "text": "제10조에 따른 기준 및 시험방법에 관한 자 | 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 377,
        "window_size": 3,
        "char_count": 30,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| 중앙약사심의위원회에 자문을 할 수 있다.  | 품질관리 적합판정서가 있는 경우: 제1항제6 | 목 허가사항 변경허가 신청서 |\n| 2.1 주요 관련 법규 및 규정 (부록1 참조) | - 위 조건에 부합하는 모니터링 자료가 없는 경우, GMP 적용을 시작한 날 이후부터의 GMP 자료 제출 가능 | □ 품목허가 항목 | 경우에도 | 또한 | 같다.  | <개정 | 2008.2.29., | 조, 제50조의2부터 제50조의10까지, 제69조의 | 제2조(의약품등의 제조업 허가ᆞ신고 등) ① | 무색투명한 액이 무색투명한 바이알에 든 주사제) | Strontium-89 (89Sr) | 50.53 일 | 고 이에 관한 사실을 증명하는 서류를 제출하 |\n| - 구체적인 보관조건(2～8℃, 냉장보관 등)․유의사항(예 : 빛을 피하여 보관 등) 병기 | - 지위승계(양도․양수) :「약사법」제89조 및「의약품 등의 안전에 관한 규칙」제103 | 2.  제10조에 따른 기준 및 시험방법에 관한 자 | 4.  식품의약품안전처장이 따로 기준 및 시험방 | 청서ᆞ변경신고서를 받은 식품의약품안전처장 | 완충제 | 용제 | 용해보조제 | 충전제 | 캡슐 | 출이 필요하지 아니하다고 인정하는 품목 | 가.  완제의약품[인체에 직접 적용하지 아니하 | 8.  국내 유사제품과의 비교검토 및 해당 의약품 | 목, 제4조제1항제10호에 따라 등재의약품의 안 | 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 기한 | ① 의약품민원홈페이지(http://ezdrug.mfds.go.kr)에서 회원가입 및 민원서식기 설치 | - 서로 다른 수입자가 제조원이 같은 동일 품목을 수입하는 경우 수입자명 병기하여 구분 | 가. ",
        "original_sentence": "제10조에 따른 기준 및 시험방법에 관한 자 | 4. "
      }
    },
    {
      "chunk_id": "chunk_379",
      "text": "식품의약품안전처장이 따로 기준 및 시험방 | 청서ᆞ변경신고서를 받은 식품의약품안전처장 | 완충제 | 용제 | 용해보조제 | 충전제 | 캡슐 | 출이 필요하지 아니하다고 인정하는 품목 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 378,
        "window_size": 3,
        "char_count": 107,
        "word_count": 27,
        "page_number": 5,
        "window_text": "| 품질관리 적합판정서가 있는 경우: 제1항제6 | 목 허가사항 변경허가 신청서 |\n| 2.1 주요 관련 법규 및 규정 (부록1 참조) | - 위 조건에 부합하는 모니터링 자료가 없는 경우, GMP 적용을 시작한 날 이후부터의 GMP 자료 제출 가능 | □ 품목허가 항목 | 경우에도 | 또한 | 같다.  | <개정 | 2008.2.29., | 조, 제50조의2부터 제50조의10까지, 제69조의 | 제2조(의약품등의 제조업 허가ᆞ신고 등) ① | 무색투명한 액이 무색투명한 바이알에 든 주사제) | Strontium-89 (89Sr) | 50.53 일 | 고 이에 관한 사실을 증명하는 서류를 제출하 |\n| - 구체적인 보관조건(2～8℃, 냉장보관 등)․유의사항(예 : 빛을 피하여 보관 등) 병기 | - 지위승계(양도․양수) :「약사법」제89조 및「의약품 등의 안전에 관한 규칙」제103 | 2.  제10조에 따른 기준 및 시험방법에 관한 자 | 4.  식품의약품안전처장이 따로 기준 및 시험방 | 청서ᆞ변경신고서를 받은 식품의약품안전처장 | 완충제 | 용제 | 용해보조제 | 충전제 | 캡슐 | 출이 필요하지 아니하다고 인정하는 품목 | 가.  완제의약품[인체에 직접 적용하지 아니하 | 8.  국내 유사제품과의 비교검토 및 해당 의약품 | 목, 제4조제1항제10호에 따라 등재의약품의 안 | 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 기한 | ① 의약품민원홈페이지(http://ezdrug.mfds.go.kr)에서 회원가입 및 민원서식기 설치 | - 서로 다른 수입자가 제조원이 같은 동일 품목을 수입하는 경우 수입자명 병기하여 구분 | 가.  제조소의 명칭, 제조소의 소재지, 제조소 | 때 0.141 MeV에 피크를 확인한다. ",
        "original_sentence": "식품의약품안전처장이 따로 기준 및 시험방 | 청서ᆞ변경신고서를 받은 식품의약품안전처장 | 완충제 | 용제 | 용해보조제 | 충전제 | 캡슐 | 출이 필요하지 아니하다고 인정하는 품목 | 가. "
      }
    },
    {
      "chunk_id": "chunk_380",
      "text": "완제의약품[인체에 직접 적용하지 아니하 | 8. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 379,
        "window_size": 3,
        "char_count": 27,
        "word_count": 6,
        "page_number": 18,
        "window_text": "| <개정 | 2008.2.29., | 조, 제50조의2부터 제50조의10까지, 제69조의 | 제2조(의약품등의 제조업 허가ᆞ신고 등) ① | 무색투명한 액이 무색투명한 바이알에 든 주사제) | Strontium-89 (89Sr) | 50.53 일 | 고 이에 관한 사실을 증명하는 서류를 제출하 |\n| - 구체적인 보관조건(2～8℃, 냉장보관 등)․유의사항(예 : 빛을 피하여 보관 등) 병기 | - 지위승계(양도․양수) :「약사법」제89조 및「의약품 등의 안전에 관한 규칙」제103 | 2.  제10조에 따른 기준 및 시험방법에 관한 자 | 4.  식품의약품안전처장이 따로 기준 및 시험방 | 청서ᆞ변경신고서를 받은 식품의약품안전처장 | 완충제 | 용제 | 용해보조제 | 충전제 | 캡슐 | 출이 필요하지 아니하다고 인정하는 품목 | 가.  완제의약품[인체에 직접 적용하지 아니하 | 8.  국내 유사제품과의 비교검토 및 해당 의약품 | 목, 제4조제1항제10호에 따라 등재의약품의 안 | 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 기한 | ① 의약품민원홈페이지(http://ezdrug.mfds.go.kr)에서 회원가입 및 민원서식기 설치 | - 서로 다른 수입자가 제조원이 같은 동일 품목을 수입하는 경우 수입자명 병기하여 구분 | 가.  제조소의 명칭, 제조소의 소재지, 제조소 | 때 0.141 MeV에 피크를 확인한다.  | 가능한 한 구체적으로 기재 | 양도·양수계약서를 제출할 수 있다. ",
        "original_sentence": "완제의약품[인체에 직접 적용하지 아니하 | 8. "
      }
    },
    {
      "chunk_id": "chunk_381",
      "text": "국내 유사제품과의 비교검토 및 해당 의약품 | 목, 제4조제1항제10호에 따라 등재의약품의 안 | 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 기한 | ① 의약품민원홈페이지(http://ezdrug.mfds.go.kr)에서 회원가입 및 민원서식기 설치 | - 서로 다른 수입자가 제조원이 같은 동일 품목을 수입하는 경우 수입자명 병기하여 구분 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 380,
        "window_size": 3,
        "char_count": 198,
        "word_count": 44,
        "page_number": 3,
        "window_text": "제10조에 따른 기준 및 시험방법에 관한 자 | 4.  식품의약품안전처장이 따로 기준 및 시험방 | 청서ᆞ변경신고서를 받은 식품의약품안전처장 | 완충제 | 용제 | 용해보조제 | 충전제 | 캡슐 | 출이 필요하지 아니하다고 인정하는 품목 | 가.  완제의약품[인체에 직접 적용하지 아니하 | 8.  국내 유사제품과의 비교검토 및 해당 의약품 | 목, 제4조제1항제10호에 따라 등재의약품의 안 | 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 기한 | ① 의약품민원홈페이지(http://ezdrug.mfds.go.kr)에서 회원가입 및 민원서식기 설치 | - 서로 다른 수입자가 제조원이 같은 동일 품목을 수입하는 경우 수입자명 병기하여 구분 | 가.  제조소의 명칭, 제조소의 소재지, 제조소 | 때 0.141 MeV에 피크를 확인한다.  | 가능한 한 구체적으로 기재 | 양도·양수계약서를 제출할 수 있다.  다만, 별 | 등을 적어 넣은 위탁ᆞ수탁제조계약서 | 01/2014:0125 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | ② 제1항의 경우에 법인의 대표자를 변경하려 | Yttrium-89m (89mY) | 16.06 초 | 호에 해당하는 자료 | 제5조 관련 |\n| 다) 청정도 시험결과 부적합이 있는 경우 그 처리기준 및 조치결과 | 산되는 방사성핵종들의 화학적 상태와 순도를 결정한 | 각 실험동물에 투여 후 각 동물 피부 표면의 오염을 | 2010.1.18., 2013.3.23.> | 1. ",
        "original_sentence": "국내 유사제품과의 비교검토 및 해당 의약품 | 목, 제4조제1항제10호에 따라 등재의약품의 안 | 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 기한 | ① 의약품민원홈페이지(http://ezdrug.mfds.go.kr)에서 회원가입 및 민원서식기 설치 | - 서로 다른 수입자가 제조원이 같은 동일 품목을 수입하는 경우 수입자명 병기하여 구분 | 가. "
      }
    },
    {
      "chunk_id": "chunk_382",
      "text": "제조소의 명칭, 제조소의 소재지, 제조소 | 때 0.141 MeV에 피크를 확인한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 381,
        "window_size": 3,
        "char_count": 48,
        "word_count": 11,
        "page_number": 1,
        "window_text": "식품의약품안전처장이 따로 기준 및 시험방 | 청서ᆞ변경신고서를 받은 식품의약품안전처장 | 완충제 | 용제 | 용해보조제 | 충전제 | 캡슐 | 출이 필요하지 아니하다고 인정하는 품목 | 가.  완제의약품[인체에 직접 적용하지 아니하 | 8.  국내 유사제품과의 비교검토 및 해당 의약품 | 목, 제4조제1항제10호에 따라 등재의약품의 안 | 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 기한 | ① 의약품민원홈페이지(http://ezdrug.mfds.go.kr)에서 회원가입 및 민원서식기 설치 | - 서로 다른 수입자가 제조원이 같은 동일 품목을 수입하는 경우 수입자명 병기하여 구분 | 가.  제조소의 명칭, 제조소의 소재지, 제조소 | 때 0.141 MeV에 피크를 확인한다.  | 가능한 한 구체적으로 기재 | 양도·양수계약서를 제출할 수 있다.  다만, 별 | 등을 적어 넣은 위탁ᆞ수탁제조계약서 | 01/2014:0125 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | ② 제1항의 경우에 법인의 대표자를 변경하려 | Yttrium-89m (89mY) | 16.06 초 | 호에 해당하는 자료 | 제5조 관련 |\n| 다) 청정도 시험결과 부적합이 있는 경우 그 처리기준 및 조치결과 | 산되는 방사성핵종들의 화학적 상태와 순도를 결정한 | 각 실험동물에 투여 후 각 동물 피부 표면의 오염을 | 2010.1.18., 2013.3.23.> | 1.  제품명 | 대한민국약전 | 유럽약전 | 미국약전 | 화학적순도(Chemical purity): 화학적순도는 각조 규 | 기 또는 방사선의 특성과 에너지 또는 두 가지 모두에 | 법이 개인의 방사선 조사량을 제한하기 위해 선호된다. ",
        "original_sentence": "제조소의 명칭, 제조소의 소재지, 제조소 | 때 0.141 MeV에 피크를 확인한다. "
      }
    },
    {
      "chunk_id": "chunk_383",
      "text": "| 가능한 한 구체적으로 기재 | 양도·양수계약서를 제출할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 382,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 9,
        "window_text": "완제의약품[인체에 직접 적용하지 아니하 | 8.  국내 유사제품과의 비교검토 및 해당 의약품 | 목, 제4조제1항제10호에 따라 등재의약품의 안 | 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 기한 | ① 의약품민원홈페이지(http://ezdrug.mfds.go.kr)에서 회원가입 및 민원서식기 설치 | - 서로 다른 수입자가 제조원이 같은 동일 품목을 수입하는 경우 수입자명 병기하여 구분 | 가.  제조소의 명칭, 제조소의 소재지, 제조소 | 때 0.141 MeV에 피크를 확인한다.  | 가능한 한 구체적으로 기재 | 양도·양수계약서를 제출할 수 있다.  다만, 별 | 등을 적어 넣은 위탁ᆞ수탁제조계약서 | 01/2014:0125 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | ② 제1항의 경우에 법인의 대표자를 변경하려 | Yttrium-89m (89mY) | 16.06 초 | 호에 해당하는 자료 | 제5조 관련 |\n| 다) 청정도 시험결과 부적합이 있는 경우 그 처리기준 및 조치결과 | 산되는 방사성핵종들의 화학적 상태와 순도를 결정한 | 각 실험동물에 투여 후 각 동물 피부 표면의 오염을 | 2010.1.18., 2013.3.23.> | 1.  제품명 | 대한민국약전 | 유럽약전 | 미국약전 | 화학적순도(Chemical purity): 화학적순도는 각조 규 | 기 또는 방사선의 특성과 에너지 또는 두 가지 모두에 | 법이 개인의 방사선 조사량을 제한하기 위해 선호된다.  | 자 료 번 호 | 3 및 제75조를 준용한다. ",
        "original_sentence": "| 가능한 한 구체적으로 기재 | 양도·양수계약서를 제출할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_384",
      "text": "다만, 별 | 등을 적어 넣은 위탁ᆞ수탁제조계약서 | 01/2014:0125 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | ② 제1항의 경우에 법인의 대표자를 변경하려 | Yttrium-89m (89mY) | 16.06 초 | 호에 해당하는 자료 | 제5조 관련 |\n| 다) 청정도 시험결과 부적합이 있는 경우 그 처리기준 및 조치결과 | 산되는 방사성핵종들의 화학적 상태와 순도를 결정한 | 각 실험동물에 투여 후 각 동물 피부 표면의 오염을 | 2010.1.18., 2013.3.23.> | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 383,
        "window_size": 3,
        "char_count": 310,
        "word_count": 77,
        "page_number": 3,
        "window_text": "국내 유사제품과의 비교검토 및 해당 의약품 | 목, 제4조제1항제10호에 따라 등재의약품의 안 | 캡슐제 또는 좌제와 성분이 동일한 의약품을 | 기한 | ① 의약품민원홈페이지(http://ezdrug.mfds.go.kr)에서 회원가입 및 민원서식기 설치 | - 서로 다른 수입자가 제조원이 같은 동일 품목을 수입하는 경우 수입자명 병기하여 구분 | 가.  제조소의 명칭, 제조소의 소재지, 제조소 | 때 0.141 MeV에 피크를 확인한다.  | 가능한 한 구체적으로 기재 | 양도·양수계약서를 제출할 수 있다.  다만, 별 | 등을 적어 넣은 위탁ᆞ수탁제조계약서 | 01/2014:0125 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | ② 제1항의 경우에 법인의 대표자를 변경하려 | Yttrium-89m (89mY) | 16.06 초 | 호에 해당하는 자료 | 제5조 관련 |\n| 다) 청정도 시험결과 부적합이 있는 경우 그 처리기준 및 조치결과 | 산되는 방사성핵종들의 화학적 상태와 순도를 결정한 | 각 실험동물에 투여 후 각 동물 피부 표면의 오염을 | 2010.1.18., 2013.3.23.> | 1.  제품명 | 대한민국약전 | 유럽약전 | 미국약전 | 화학적순도(Chemical purity): 화학적순도는 각조 규 | 기 또는 방사선의 특성과 에너지 또는 두 가지 모두에 | 법이 개인의 방사선 조사량을 제한하기 위해 선호된다.  | 자 료 번 호 | 3 및 제75조를 준용한다.  이 경우 \"제조\" 또는 | 2.2.2 구비서류 | 항에 기재되어 있다. ",
        "original_sentence": "다만, 별 | 등을 적어 넣은 위탁ᆞ수탁제조계약서 | 01/2014:0125 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | ② 제1항의 경우에 법인의 대표자를 변경하려 | Yttrium-89m (89mY) | 16.06 초 | 호에 해당하는 자료 | 제5조 관련 |\n| 다) 청정도 시험결과 부적합이 있는 경우 그 처리기준 및 조치결과 | 산되는 방사성핵종들의 화학적 상태와 순도를 결정한 | 각 실험동물에 투여 후 각 동물 피부 표면의 오염을 | 2010.1.18., 2013.3.23.> | 1. "
      }
    },
    {
      "chunk_id": "chunk_385",
      "text": "제품명 | 대한민국약전 | 유럽약전 | 미국약전 | 화학적순도(Chemical purity): 화학적순도는 각조 규 | 기 또는 방사선의 특성과 에너지 또는 두 가지 모두에 | 법이 개인의 방사선 조사량을 제한하기 위해 선호된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 384,
        "window_size": 3,
        "char_count": 129,
        "word_count": 31,
        "page_number": 8,
        "window_text": "제조소의 명칭, 제조소의 소재지, 제조소 | 때 0.141 MeV에 피크를 확인한다.  | 가능한 한 구체적으로 기재 | 양도·양수계약서를 제출할 수 있다.  다만, 별 | 등을 적어 넣은 위탁ᆞ수탁제조계약서 | 01/2014:0125 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | ② 제1항의 경우에 법인의 대표자를 변경하려 | Yttrium-89m (89mY) | 16.06 초 | 호에 해당하는 자료 | 제5조 관련 |\n| 다) 청정도 시험결과 부적합이 있는 경우 그 처리기준 및 조치결과 | 산되는 방사성핵종들의 화학적 상태와 순도를 결정한 | 각 실험동물에 투여 후 각 동물 피부 표면의 오염을 | 2010.1.18., 2013.3.23.> | 1.  제품명 | 대한민국약전 | 유럽약전 | 미국약전 | 화학적순도(Chemical purity): 화학적순도는 각조 규 | 기 또는 방사선의 특성과 에너지 또는 두 가지 모두에 | 법이 개인의 방사선 조사량을 제한하기 위해 선호된다.  | 자 료 번 호 | 3 및 제75조를 준용한다.  이 경우 \"제조\" 또는 | 2.2.2 구비서류 | 항에 기재되어 있다.  | 제품의 방사능은 특정 일자에 표시된다. ",
        "original_sentence": "제품명 | 대한민국약전 | 유럽약전 | 미국약전 | 화학적순도(Chemical purity): 화학적순도는 각조 규 | 기 또는 방사선의 특성과 에너지 또는 두 가지 모두에 | 법이 개인의 방사선 조사량을 제한하기 위해 선호된다. "
      }
    },
    {
      "chunk_id": "chunk_386",
      "text": "| 자 료 번 호 | 3 및 제75조를 준용한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 385,
        "window_size": 3,
        "char_count": 28,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| 가능한 한 구체적으로 기재 | 양도·양수계약서를 제출할 수 있다.  다만, 별 | 등을 적어 넣은 위탁ᆞ수탁제조계약서 | 01/2014:0125 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | ② 제1항의 경우에 법인의 대표자를 변경하려 | Yttrium-89m (89mY) | 16.06 초 | 호에 해당하는 자료 | 제5조 관련 |\n| 다) 청정도 시험결과 부적합이 있는 경우 그 처리기준 및 조치결과 | 산되는 방사성핵종들의 화학적 상태와 순도를 결정한 | 각 실험동물에 투여 후 각 동물 피부 표면의 오염을 | 2010.1.18., 2013.3.23.> | 1.  제품명 | 대한민국약전 | 유럽약전 | 미국약전 | 화학적순도(Chemical purity): 화학적순도는 각조 규 | 기 또는 방사선의 특성과 에너지 또는 두 가지 모두에 | 법이 개인의 방사선 조사량을 제한하기 위해 선호된다.  | 자 료 번 호 | 3 및 제75조를 준용한다.  이 경우 \"제조\" 또는 | 2.2.2 구비서류 | 항에 기재되어 있다.  | 제품의 방사능은 특정 일자에 표시된다.  만약 반감기 | 생 | 산 | [시행 2015.3.15.] ",
        "original_sentence": "| 자 료 번 호 | 3 및 제75조를 준용한다. "
      }
    },
    {
      "chunk_id": "chunk_387",
      "text": "이 경우 \"제조\" 또는 | 2.2.2 구비서류 | 항에 기재되어 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 386,
        "window_size": 3,
        "char_count": 40,
        "word_count": 11,
        "page_number": 3,
        "window_text": "다만, 별 | 등을 적어 넣은 위탁ᆞ수탁제조계약서 | 01/2014:0125 | ｢ | 의약품의 품목허가․신고․심사 규정｣ | ⑥ 제1항에 따라 허가를 신청하는 자는 식품의 | ② 제1항의 경우에 법인의 대표자를 변경하려 | Yttrium-89m (89mY) | 16.06 초 | 호에 해당하는 자료 | 제5조 관련 |\n| 다) 청정도 시험결과 부적합이 있는 경우 그 처리기준 및 조치결과 | 산되는 방사성핵종들의 화학적 상태와 순도를 결정한 | 각 실험동물에 투여 후 각 동물 피부 표면의 오염을 | 2010.1.18., 2013.3.23.> | 1.  제품명 | 대한민국약전 | 유럽약전 | 미국약전 | 화학적순도(Chemical purity): 화학적순도는 각조 규 | 기 또는 방사선의 특성과 에너지 또는 두 가지 모두에 | 법이 개인의 방사선 조사량을 제한하기 위해 선호된다.  | 자 료 번 호 | 3 및 제75조를 준용한다.  이 경우 \"제조\" 또는 | 2.2.2 구비서류 | 항에 기재되어 있다.  | 제품의 방사능은 특정 일자에 표시된다.  만약 반감기 | 생 | 산 | [시행 2015.3.15.]  [법률 제13219호, 2015.3.13., 일부개정] | 화학 성분(불순물)을 분리 분석하고, 표시된 화학적 형태 | 는 경우에는 제48조제5호를 적용하지 아니한 |\n| 제출자료 | 의약품-신약-품목허가-기시-안유 | ․전자민원의 경우: 3,726,000원 | □ | 안전성․유효성과 | 기준 | 및 | 시험방법 | 심사 | 2) 순도시험 1)에 따라 확인한다. ",
        "original_sentence": "이 경우 \"제조\" 또는 | 2.2.2 구비서류 | 항에 기재되어 있다. "
      }
    },
    {
      "chunk_id": "chunk_388",
      "text": "| 제품의 방사능은 특정 일자에 표시된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 387,
        "window_size": 3,
        "char_count": 24,
        "word_count": 6,
        "page_number": 9,
        "window_text": "제품명 | 대한민국약전 | 유럽약전 | 미국약전 | 화학적순도(Chemical purity): 화학적순도는 각조 규 | 기 또는 방사선의 특성과 에너지 또는 두 가지 모두에 | 법이 개인의 방사선 조사량을 제한하기 위해 선호된다.  | 자 료 번 호 | 3 및 제75조를 준용한다.  이 경우 \"제조\" 또는 | 2.2.2 구비서류 | 항에 기재되어 있다.  | 제품의 방사능은 특정 일자에 표시된다.  만약 반감기 | 생 | 산 | [시행 2015.3.15.]  [법률 제13219호, 2015.3.13., 일부개정] | 화학 성분(불순물)을 분리 분석하고, 표시된 화학적 형태 | 는 경우에는 제48조제5호를 적용하지 아니한 |\n| 제출자료 | 의약품-신약-품목허가-기시-안유 | ․전자민원의 경우: 3,726,000원 | □ | 안전성․유효성과 | 기준 | 및 | 시험방법 | 심사 | 2) 순도시험 1)에 따라 확인한다.  | 「약사법」(이하 \"법\"이라 한다) 제31조제1항 | Strontium-90 (90Sr) | 28.74 년 | 마. ",
        "original_sentence": "| 제품의 방사능은 특정 일자에 표시된다. "
      }
    },
    {
      "chunk_id": "chunk_389",
      "text": "만약 반감기 | 생 | 산 | [시행 2015.3.15.] ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 388,
        "window_size": 3,
        "char_count": 33,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| 자 료 번 호 | 3 및 제75조를 준용한다.  이 경우 \"제조\" 또는 | 2.2.2 구비서류 | 항에 기재되어 있다.  | 제품의 방사능은 특정 일자에 표시된다.  만약 반감기 | 생 | 산 | [시행 2015.3.15.]  [법률 제13219호, 2015.3.13., 일부개정] | 화학 성분(불순물)을 분리 분석하고, 표시된 화학적 형태 | 는 경우에는 제48조제5호를 적용하지 아니한 |\n| 제출자료 | 의약품-신약-품목허가-기시-안유 | ․전자민원의 경우: 3,726,000원 | □ | 안전성․유효성과 | 기준 | 및 | 시험방법 | 심사 | 2) 순도시험 1)에 따라 확인한다.  | 「약사법」(이하 \"법\"이라 한다) 제31조제1항 | Strontium-90 (90Sr) | 28.74 년 | 마.  발암성시험자료 |\n| ※ | 방사성의약품의 | 경우 | 대부분 | 주사제로 | 그 | 용기는 | 바이알을 | 사용하므로 | “밀봉용기”에 | 해당하고, | 반감기(T1/2)는 방사성핵종의 방사능이 초기 값의 반으 | 다. ",
        "original_sentence": "만약 반감기 | 생 | 산 | [시행 2015.3.15.] "
      }
    },
    {
      "chunk_id": "chunk_390",
      "text": "[법률 제13219호, 2015.3.13., 일부개정] | 화학 성분(불순물)을 분리 분석하고, 표시된 화학적 형태 | 는 경우에는 제48조제5호를 적용하지 아니한 |\n| 제출자료 | 의약품-신약-품목허가-기시-안유 | ․전자민원의 경우: 3,726,000원 | □ | 안전성․유효성과 | 기준 | 및 | 시험방법 | 심사 | 2) 순도시험 1)에 따라 확인한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 389,
        "window_size": 3,
        "char_count": 204,
        "word_count": 45,
        "page_number": 3,
        "window_text": "이 경우 \"제조\" 또는 | 2.2.2 구비서류 | 항에 기재되어 있다.  | 제품의 방사능은 특정 일자에 표시된다.  만약 반감기 | 생 | 산 | [시행 2015.3.15.]  [법률 제13219호, 2015.3.13., 일부개정] | 화학 성분(불순물)을 분리 분석하고, 표시된 화학적 형태 | 는 경우에는 제48조제5호를 적용하지 아니한 |\n| 제출자료 | 의약품-신약-품목허가-기시-안유 | ․전자민원의 경우: 3,726,000원 | □ | 안전성․유효성과 | 기준 | 및 | 시험방법 | 심사 | 2) 순도시험 1)에 따라 확인한다.  | 「약사법」(이하 \"법\"이라 한다) 제31조제1항 | Strontium-90 (90Sr) | 28.74 년 | 마.  발암성시험자료 |\n| ※ | 방사성의약품의 | 경우 | 대부분 | 주사제로 | 그 | 용기는 | 바이알을 | 사용하므로 | “밀봉용기”에 | 해당하고, | 반감기(T1/2)는 방사성핵종의 방사능이 초기 값의 반으 | 다.  방사성핵종 특히 반감기가 짧은 방사성핵종의 생 | 막고 배설물을 채집하기 위해 우리(cage)에 분리하여 | ü 약사법 제31조, 제42조 | ② 제1항에도 불구하고 국방부장관 또는 수입 | 2. ",
        "original_sentence": "[법률 제13219호, 2015.3.13., 일부개정] | 화학 성분(불순물)을 분리 분석하고, 표시된 화학적 형태 | 는 경우에는 제48조제5호를 적용하지 아니한 |\n| 제출자료 | 의약품-신약-품목허가-기시-안유 | ․전자민원의 경우: 3,726,000원 | □ | 안전성․유효성과 | 기준 | 및 | 시험방법 | 심사 | 2) 순도시험 1)에 따라 확인한다. "
      }
    },
    {
      "chunk_id": "chunk_391",
      "text": "| 「약사법」(이하 \"법\"이라 한다) 제31조제1항 | Strontium-90 (90Sr) | 28.74 년 | 마. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 390,
        "window_size": 3,
        "char_count": 66,
        "word_count": 13,
        "page_number": 3,
        "window_text": "| 제품의 방사능은 특정 일자에 표시된다.  만약 반감기 | 생 | 산 | [시행 2015.3.15.]  [법률 제13219호, 2015.3.13., 일부개정] | 화학 성분(불순물)을 분리 분석하고, 표시된 화학적 형태 | 는 경우에는 제48조제5호를 적용하지 아니한 |\n| 제출자료 | 의약품-신약-품목허가-기시-안유 | ․전자민원의 경우: 3,726,000원 | □ | 안전성․유효성과 | 기준 | 및 | 시험방법 | 심사 | 2) 순도시험 1)에 따라 확인한다.  | 「약사법」(이하 \"법\"이라 한다) 제31조제1항 | Strontium-90 (90Sr) | 28.74 년 | 마.  발암성시험자료 |\n| ※ | 방사성의약품의 | 경우 | 대부분 | 주사제로 | 그 | 용기는 | 바이알을 | 사용하므로 | “밀봉용기”에 | 해당하고, | 반감기(T1/2)는 방사성핵종의 방사능이 초기 값의 반으 | 다.  방사성핵종 특히 반감기가 짧은 방사성핵종의 생 | 막고 배설물을 채집하기 위해 우리(cage)에 분리하여 | ü 약사법 제31조, 제42조 | ② 제1항에도 불구하고 국방부장관 또는 수입 | 2.  제10조에 따른 기준 및 시험방법에 관한 자 | 킬레이트화제 | 항산화제 | 환원제 | 흡착제 | pH조절제 | 조 규정에 따라 양도자의 모든 허가․신고사항을 승계받는 조건으로 허가 | 또는 지방청장은 「전자정부법」 제36조제1항 | 신약 | 료. ",
        "original_sentence": "| 「약사법」(이하 \"법\"이라 한다) 제31조제1항 | Strontium-90 (90Sr) | 28.74 년 | 마. "
      }
    },
    {
      "chunk_id": "chunk_392",
      "text": "발암성시험자료 |\n| ※ | 방사성의약품의 | 경우 | 대부분 | 주사제로 | 그 | 용기는 | 바이알을 | 사용하므로 | “밀봉용기”에 | 해당하고, | 반감기(T1/2)는 방사성핵종의 방사능이 초기 값의 반으 | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 391,
        "window_size": 3,
        "char_count": 124,
        "word_count": 33,
        "page_number": 10,
        "window_text": "만약 반감기 | 생 | 산 | [시행 2015.3.15.]  [법률 제13219호, 2015.3.13., 일부개정] | 화학 성분(불순물)을 분리 분석하고, 표시된 화학적 형태 | 는 경우에는 제48조제5호를 적용하지 아니한 |\n| 제출자료 | 의약품-신약-품목허가-기시-안유 | ․전자민원의 경우: 3,726,000원 | □ | 안전성․유효성과 | 기준 | 및 | 시험방법 | 심사 | 2) 순도시험 1)에 따라 확인한다.  | 「약사법」(이하 \"법\"이라 한다) 제31조제1항 | Strontium-90 (90Sr) | 28.74 년 | 마.  발암성시험자료 |\n| ※ | 방사성의약품의 | 경우 | 대부분 | 주사제로 | 그 | 용기는 | 바이알을 | 사용하므로 | “밀봉용기”에 | 해당하고, | 반감기(T1/2)는 방사성핵종의 방사능이 초기 값의 반으 | 다.  방사성핵종 특히 반감기가 짧은 방사성핵종의 생 | 막고 배설물을 채집하기 위해 우리(cage)에 분리하여 | ü 약사법 제31조, 제42조 | ② 제1항에도 불구하고 국방부장관 또는 수입 | 2.  제10조에 따른 기준 및 시험방법에 관한 자 | 킬레이트화제 | 항산화제 | 환원제 | 흡착제 | pH조절제 | 조 규정에 따라 양도자의 모든 허가․신고사항을 승계받는 조건으로 허가 | 또는 지방청장은 「전자정부법」 제36조제1항 | 신약 | 료.  다만, 다음 각 목의 어느 하나에 해당하 | 법을 고시한 품목 | 2 | 3 | 4 | 5 | 6 | 격에 기재된 화학적 불순물에 대한 기준에 의해 관리 | 의해 확인된다. ",
        "original_sentence": "발암성시험자료 |\n| ※ | 방사성의약품의 | 경우 | 대부분 | 주사제로 | 그 | 용기는 | 바이알을 | 사용하므로 | “밀봉용기”에 | 해당하고, | 반감기(T1/2)는 방사성핵종의 방사능이 초기 값의 반으 | 다. "
      }
    },
    {
      "chunk_id": "chunk_393",
      "text": "방사성핵종 특히 반감기가 짧은 방사성핵종의 생 | 막고 배설물을 채집하기 위해 우리(cage)에 분리하여 | ü 약사법 제31조, 제42조 | ② 제1항에도 불구하고 국방부장관 또는 수입 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 392,
        "window_size": 3,
        "char_count": 110,
        "word_count": 27,
        "page_number": 12,
        "window_text": "[법률 제13219호, 2015.3.13., 일부개정] | 화학 성분(불순물)을 분리 분석하고, 표시된 화학적 형태 | 는 경우에는 제48조제5호를 적용하지 아니한 |\n| 제출자료 | 의약품-신약-품목허가-기시-안유 | ․전자민원의 경우: 3,726,000원 | □ | 안전성․유효성과 | 기준 | 및 | 시험방법 | 심사 | 2) 순도시험 1)에 따라 확인한다.  | 「약사법」(이하 \"법\"이라 한다) 제31조제1항 | Strontium-90 (90Sr) | 28.74 년 | 마.  발암성시험자료 |\n| ※ | 방사성의약품의 | 경우 | 대부분 | 주사제로 | 그 | 용기는 | 바이알을 | 사용하므로 | “밀봉용기”에 | 해당하고, | 반감기(T1/2)는 방사성핵종의 방사능이 초기 값의 반으 | 다.  방사성핵종 특히 반감기가 짧은 방사성핵종의 생 | 막고 배설물을 채집하기 위해 우리(cage)에 분리하여 | ü 약사법 제31조, 제42조 | ② 제1항에도 불구하고 국방부장관 또는 수입 | 2.  제10조에 따른 기준 및 시험방법에 관한 자 | 킬레이트화제 | 항산화제 | 환원제 | 흡착제 | pH조절제 | 조 규정에 따라 양도자의 모든 허가․신고사항을 승계받는 조건으로 허가 | 또는 지방청장은 「전자정부법」 제36조제1항 | 신약 | 료.  다만, 다음 각 목의 어느 하나에 해당하 | 법을 고시한 품목 | 2 | 3 | 4 | 5 | 6 | 격에 기재된 화학적 불순물에 대한 기준에 의해 관리 | 의해 확인된다.  | 비경구용제제(Parenteral preparations, 0520) 제제총칙에 | ․방문, 우편 민원의 경우: 4,140,000원 | 90일 | 전성·유효성에 관한 자료를 근거로 신청하는 | \"생산\"은 각각 \"수입\"으로, \"제조업자\" 또는 \"품 | 허가받으려는 경우에는 비교용출시험자료 등 | 등의 특성에 관한 자료 | 는 제품(소독제 등)은 제외한다] 및 의약 | 대부분의 경우 방사성의약품의 방사성핵종 순도를 설 | 가 70일 미만일 경우 표준시간대를 참조하여 시간도 | - 제형은 ｢ | 10. ",
        "original_sentence": "방사성핵종 특히 반감기가 짧은 방사성핵종의 생 | 막고 배설물을 채집하기 위해 우리(cage)에 분리하여 | ü 약사법 제31조, 제42조 | ② 제1항에도 불구하고 국방부장관 또는 수입 | 2. "
      }
    },
    {
      "chunk_id": "chunk_394",
      "text": "제10조에 따른 기준 및 시험방법에 관한 자 | 킬레이트화제 | 항산화제 | 환원제 | 흡착제 | pH조절제 | 조 규정에 따라 양도자의 모든 허가․신고사항을 승계받는 조건으로 허가 | 또는 지방청장은 「전자정부법」 제36조제1항 | 신약 | 료. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 393,
        "window_size": 3,
        "char_count": 139,
        "word_count": 36,
        "page_number": 3,
        "window_text": "| 「약사법」(이하 \"법\"이라 한다) 제31조제1항 | Strontium-90 (90Sr) | 28.74 년 | 마.  발암성시험자료 |\n| ※ | 방사성의약품의 | 경우 | 대부분 | 주사제로 | 그 | 용기는 | 바이알을 | 사용하므로 | “밀봉용기”에 | 해당하고, | 반감기(T1/2)는 방사성핵종의 방사능이 초기 값의 반으 | 다.  방사성핵종 특히 반감기가 짧은 방사성핵종의 생 | 막고 배설물을 채집하기 위해 우리(cage)에 분리하여 | ü 약사법 제31조, 제42조 | ② 제1항에도 불구하고 국방부장관 또는 수입 | 2.  제10조에 따른 기준 및 시험방법에 관한 자 | 킬레이트화제 | 항산화제 | 환원제 | 흡착제 | pH조절제 | 조 규정에 따라 양도자의 모든 허가․신고사항을 승계받는 조건으로 허가 | 또는 지방청장은 「전자정부법」 제36조제1항 | 신약 | 료.  다만, 다음 각 목의 어느 하나에 해당하 | 법을 고시한 품목 | 2 | 3 | 4 | 5 | 6 | 격에 기재된 화학적 불순물에 대한 기준에 의해 관리 | 의해 확인된다.  | 비경구용제제(Parenteral preparations, 0520) 제제총칙에 | ․방문, 우편 민원의 경우: 4,140,000원 | 90일 | 전성·유효성에 관한 자료를 근거로 신청하는 | \"생산\"은 각각 \"수입\"으로, \"제조업자\" 또는 \"품 | 허가받으려는 경우에는 비교용출시험자료 등 | 등의 특성에 관한 자료 | 는 제품(소독제 등)은 제외한다] 및 의약 | 대부분의 경우 방사성의약품의 방사성핵종 순도를 설 | 가 70일 미만일 경우 표준시간대를 참조하여 시간도 | - 제형은 ｢ | 10.  법 제50조의2제4항(법 제42조제4항에 따 | - 개인 공인인증서/대표자 공인인증서(개인사업자)/법인명 공인인증서(법인회원) 필요 | 표 1, 별표 1의2, 별표 2 또는 별표 3의3의 | 책임자의 성명을 적은 자료 | 대한민국약전｣ | 방사성핵종들은 보통 전자포획 또는 양전자방출 | 3. ",
        "original_sentence": "제10조에 따른 기준 및 시험방법에 관한 자 | 킬레이트화제 | 항산화제 | 환원제 | 흡착제 | pH조절제 | 조 규정에 따라 양도자의 모든 허가․신고사항을 승계받는 조건으로 허가 | 또는 지방청장은 「전자정부법」 제36조제1항 | 신약 | 료. "
      }
    },
    {
      "chunk_id": "chunk_395",
      "text": "다만, 다음 각 목의 어느 하나에 해당하 | 법을 고시한 품목 | 2 | 3 | 4 | 5 | 6 | 격에 기재된 화학적 불순물에 대한 기준에 의해 관리 | 의해 확인된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 394,
        "window_size": 3,
        "char_count": 97,
        "word_count": 33,
        "page_number": 3,
        "window_text": "발암성시험자료 |\n| ※ | 방사성의약품의 | 경우 | 대부분 | 주사제로 | 그 | 용기는 | 바이알을 | 사용하므로 | “밀봉용기”에 | 해당하고, | 반감기(T1/2)는 방사성핵종의 방사능이 초기 값의 반으 | 다.  방사성핵종 특히 반감기가 짧은 방사성핵종의 생 | 막고 배설물을 채집하기 위해 우리(cage)에 분리하여 | ü 약사법 제31조, 제42조 | ② 제1항에도 불구하고 국방부장관 또는 수입 | 2.  제10조에 따른 기준 및 시험방법에 관한 자 | 킬레이트화제 | 항산화제 | 환원제 | 흡착제 | pH조절제 | 조 규정에 따라 양도자의 모든 허가․신고사항을 승계받는 조건으로 허가 | 또는 지방청장은 「전자정부법」 제36조제1항 | 신약 | 료.  다만, 다음 각 목의 어느 하나에 해당하 | 법을 고시한 품목 | 2 | 3 | 4 | 5 | 6 | 격에 기재된 화학적 불순물에 대한 기준에 의해 관리 | 의해 확인된다.  | 비경구용제제(Parenteral preparations, 0520) 제제총칙에 | ․방문, 우편 민원의 경우: 4,140,000원 | 90일 | 전성·유효성에 관한 자료를 근거로 신청하는 | \"생산\"은 각각 \"수입\"으로, \"제조업자\" 또는 \"품 | 허가받으려는 경우에는 비교용출시험자료 등 | 등의 특성에 관한 자료 | 는 제품(소독제 등)은 제외한다] 및 의약 | 대부분의 경우 방사성의약품의 방사성핵종 순도를 설 | 가 70일 미만일 경우 표준시간대를 참조하여 시간도 | - 제형은 ｢ | 10.  법 제50조의2제4항(법 제42조제4항에 따 | - 개인 공인인증서/대표자 공인인증서(개인사업자)/법인명 공인인증서(법인회원) 필요 | 표 1, 별표 1의2, 별표 2 또는 별표 3의3의 | 책임자의 성명을 적은 자료 | 대한민국약전｣ | 방사성핵종들은 보통 전자포획 또는 양전자방출 | 3.  식품의약품안전처장이 고시하는 기준에 적합 | 다. ",
        "original_sentence": "다만, 다음 각 목의 어느 하나에 해당하 | 법을 고시한 품목 | 2 | 3 | 4 | 5 | 6 | 격에 기재된 화학적 불순물에 대한 기준에 의해 관리 | 의해 확인된다. "
      }
    },
    {
      "chunk_id": "chunk_396",
      "text": "| 비경구용제제(Parenteral preparations, 0520) 제제총칙에 | ․방문, 우편 민원의 경우: 4,140,000원 | 90일 | 전성·유효성에 관한 자료를 근거로 신청하는 | \"생산\"은 각각 \"수입\"으로, \"제조업자\" 또는 \"품 | 허가받으려는 경우에는 비교용출시험자료 등 | 등의 특성에 관한 자료 | 는 제품(소독제 등)은 제외한다] 및 의약 | 대부분의 경우 방사성의약품의 방사성핵종 순도를 설 | 가 70일 미만일 경우 표준시간대를 참조하여 시간도 | - 제형은 ｢ | 10. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 395,
        "window_size": 3,
        "char_count": 282,
        "word_count": 64,
        "page_number": 3,
        "window_text": "방사성핵종 특히 반감기가 짧은 방사성핵종의 생 | 막고 배설물을 채집하기 위해 우리(cage)에 분리하여 | ü 약사법 제31조, 제42조 | ② 제1항에도 불구하고 국방부장관 또는 수입 | 2.  제10조에 따른 기준 및 시험방법에 관한 자 | 킬레이트화제 | 항산화제 | 환원제 | 흡착제 | pH조절제 | 조 규정에 따라 양도자의 모든 허가․신고사항을 승계받는 조건으로 허가 | 또는 지방청장은 「전자정부법」 제36조제1항 | 신약 | 료.  다만, 다음 각 목의 어느 하나에 해당하 | 법을 고시한 품목 | 2 | 3 | 4 | 5 | 6 | 격에 기재된 화학적 불순물에 대한 기준에 의해 관리 | 의해 확인된다.  | 비경구용제제(Parenteral preparations, 0520) 제제총칙에 | ․방문, 우편 민원의 경우: 4,140,000원 | 90일 | 전성·유효성에 관한 자료를 근거로 신청하는 | \"생산\"은 각각 \"수입\"으로, \"제조업자\" 또는 \"품 | 허가받으려는 경우에는 비교용출시험자료 등 | 등의 특성에 관한 자료 | 는 제품(소독제 등)은 제외한다] 및 의약 | 대부분의 경우 방사성의약품의 방사성핵종 순도를 설 | 가 70일 미만일 경우 표준시간대를 참조하여 시간도 | - 제형은 ｢ | 10.  법 제50조의2제4항(법 제42조제4항에 따 | - 개인 공인인증서/대표자 공인인증서(개인사업자)/법인명 공인인증서(법인회원) 필요 | 표 1, 별표 1의2, 별표 2 또는 별표 3의3의 | 책임자의 성명을 적은 자료 | 대한민국약전｣ | 방사성핵종들은 보통 전자포획 또는 양전자방출 | 3.  식품의약품안전처장이 고시하는 기준에 적합 | 다.  | 약품안전처장이 정하여 고시하는 수수료(외국 | 는 경우에는 변경신청서나 변경신고서에 대표 |\n| 구분 | [제제총칙 - 주사제 항] | 2. ",
        "original_sentence": "| 비경구용제제(Parenteral preparations, 0520) 제제총칙에 | ․방문, 우편 민원의 경우: 4,140,000원 | 90일 | 전성·유효성에 관한 자료를 근거로 신청하는 | \"생산\"은 각각 \"수입\"으로, \"제조업자\" 또는 \"품 | 허가받으려는 경우에는 비교용출시험자료 등 | 등의 특성에 관한 자료 | 는 제품(소독제 등)은 제외한다] 및 의약 | 대부분의 경우 방사성의약품의 방사성핵종 순도를 설 | 가 70일 미만일 경우 표준시간대를 참조하여 시간도 | - 제형은 ｢ | 10. "
      }
    },
    {
      "chunk_id": "chunk_397",
      "text": "법 제50조의2제4항(법 제42조제4항에 따 | - 개인 공인인증서/대표자 공인인증서(개인사업자)/법인명 공인인증서(법인회원) 필요 | 표 1, 별표 1의2, 별표 2 또는 별표 3의3의 | 책임자의 성명을 적은 자료 | 대한민국약전｣ | 방사성핵종들은 보통 전자포획 또는 양전자방출 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 396,
        "window_size": 3,
        "char_count": 164,
        "word_count": 36,
        "page_number": 3,
        "window_text": "제10조에 따른 기준 및 시험방법에 관한 자 | 킬레이트화제 | 항산화제 | 환원제 | 흡착제 | pH조절제 | 조 규정에 따라 양도자의 모든 허가․신고사항을 승계받는 조건으로 허가 | 또는 지방청장은 「전자정부법」 제36조제1항 | 신약 | 료.  다만, 다음 각 목의 어느 하나에 해당하 | 법을 고시한 품목 | 2 | 3 | 4 | 5 | 6 | 격에 기재된 화학적 불순물에 대한 기준에 의해 관리 | 의해 확인된다.  | 비경구용제제(Parenteral preparations, 0520) 제제총칙에 | ․방문, 우편 민원의 경우: 4,140,000원 | 90일 | 전성·유효성에 관한 자료를 근거로 신청하는 | \"생산\"은 각각 \"수입\"으로, \"제조업자\" 또는 \"품 | 허가받으려는 경우에는 비교용출시험자료 등 | 등의 특성에 관한 자료 | 는 제품(소독제 등)은 제외한다] 및 의약 | 대부분의 경우 방사성의약품의 방사성핵종 순도를 설 | 가 70일 미만일 경우 표준시간대를 참조하여 시간도 | - 제형은 ｢ | 10.  법 제50조의2제4항(법 제42조제4항에 따 | - 개인 공인인증서/대표자 공인인증서(개인사업자)/법인명 공인인증서(법인회원) 필요 | 표 1, 별표 1의2, 별표 2 또는 별표 3의3의 | 책임자의 성명을 적은 자료 | 대한민국약전｣ | 방사성핵종들은 보통 전자포획 또는 양전자방출 | 3.  식품의약품안전처장이 고시하는 기준에 적합 | 다.  | 약품안전처장이 정하여 고시하는 수수료(외국 | 는 경우에는 변경신청서나 변경신고서에 대표 |\n| 구분 | [제제총칙 - 주사제 항] | 2.  분류번호 및 분류(전문 또는 일반의약품) | 1 | -GMP | 7 | 8 비고 | 가 | 나 | 가 | 나 | 가 나 다 라 마 바 가 나 다 라 가 나 | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | [제제총칙 - 주사제 항] | [제제총칙 - 주사제 항] | 방사성의약품은 방사성핵종을 다음과 같은 형태로 포 | pH  4.5 ∼ 7.0 | 제31조(제조업 허가 등) ① 의약품 제조를 업 | ᆞ제4항에 따라 의약품의 제조업 허가를 받거 | 방사성의약품 | Yttrium-90 (90Y) | 64.10 시간 | 구성된 것으로서 주된 기능이 의료기기에 해당 |\n| ※ 신청품목과 관련된 밸리데이션 자료 | 5. ",
        "original_sentence": "법 제50조의2제4항(법 제42조제4항에 따 | - 개인 공인인증서/대표자 공인인증서(개인사업자)/법인명 공인인증서(법인회원) 필요 | 표 1, 별표 1의2, 별표 2 또는 별표 3의3의 | 책임자의 성명을 적은 자료 | 대한민국약전｣ | 방사성핵종들은 보통 전자포획 또는 양전자방출 | 3. "
      }
    },
    {
      "chunk_id": "chunk_398",
      "text": "식품의약품안전처장이 고시하는 기준에 적합 | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 397,
        "window_size": 3,
        "char_count": 28,
        "word_count": 6,
        "page_number": 5,
        "window_text": "다만, 다음 각 목의 어느 하나에 해당하 | 법을 고시한 품목 | 2 | 3 | 4 | 5 | 6 | 격에 기재된 화학적 불순물에 대한 기준에 의해 관리 | 의해 확인된다.  | 비경구용제제(Parenteral preparations, 0520) 제제총칙에 | ․방문, 우편 민원의 경우: 4,140,000원 | 90일 | 전성·유효성에 관한 자료를 근거로 신청하는 | \"생산\"은 각각 \"수입\"으로, \"제조업자\" 또는 \"품 | 허가받으려는 경우에는 비교용출시험자료 등 | 등의 특성에 관한 자료 | 는 제품(소독제 등)은 제외한다] 및 의약 | 대부분의 경우 방사성의약품의 방사성핵종 순도를 설 | 가 70일 미만일 경우 표준시간대를 참조하여 시간도 | - 제형은 ｢ | 10.  법 제50조의2제4항(법 제42조제4항에 따 | - 개인 공인인증서/대표자 공인인증서(개인사업자)/법인명 공인인증서(법인회원) 필요 | 표 1, 별표 1의2, 별표 2 또는 별표 3의3의 | 책임자의 성명을 적은 자료 | 대한민국약전｣ | 방사성핵종들은 보통 전자포획 또는 양전자방출 | 3.  식품의약품안전처장이 고시하는 기준에 적합 | 다.  | 약품안전처장이 정하여 고시하는 수수료(외국 | 는 경우에는 변경신청서나 변경신고서에 대표 |\n| 구분 | [제제총칙 - 주사제 항] | 2.  분류번호 및 분류(전문 또는 일반의약품) | 1 | -GMP | 7 | 8 비고 | 가 | 나 | 가 | 나 | 가 나 다 라 마 바 가 나 다 라 가 나 | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | [제제총칙 - 주사제 항] | [제제총칙 - 주사제 항] | 방사성의약품은 방사성핵종을 다음과 같은 형태로 포 | pH  4.5 ∼ 7.0 | 제31조(제조업 허가 등) ① 의약품 제조를 업 | ᆞ제4항에 따라 의약품의 제조업 허가를 받거 | 방사성의약품 | Yttrium-90 (90Y) | 64.10 시간 | 구성된 것으로서 주된 기능이 의료기기에 해당 |\n| ※ 신청품목과 관련된 밸리데이션 자료 | 5.  식품의약품안전처장이 신고대상품목으로 고 | 자는 다음 각 호의 어느 하나에 해당하는 경우 | 에 따른 행정정보의 공동이용을 통하여 법인 | 료. ",
        "original_sentence": "식품의약품안전처장이 고시하는 기준에 적합 | 다. "
      }
    },
    {
      "chunk_id": "chunk_399",
      "text": "| 약품안전처장이 정하여 고시하는 수수료(외국 | 는 경우에는 변경신청서나 변경신고서에 대표 |\n| 구분 | [제제총칙 - 주사제 항] | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 398,
        "window_size": 3,
        "char_count": 81,
        "word_count": 21,
        "page_number": 5,
        "window_text": "| 비경구용제제(Parenteral preparations, 0520) 제제총칙에 | ․방문, 우편 민원의 경우: 4,140,000원 | 90일 | 전성·유효성에 관한 자료를 근거로 신청하는 | \"생산\"은 각각 \"수입\"으로, \"제조업자\" 또는 \"품 | 허가받으려는 경우에는 비교용출시험자료 등 | 등의 특성에 관한 자료 | 는 제품(소독제 등)은 제외한다] 및 의약 | 대부분의 경우 방사성의약품의 방사성핵종 순도를 설 | 가 70일 미만일 경우 표준시간대를 참조하여 시간도 | - 제형은 ｢ | 10.  법 제50조의2제4항(법 제42조제4항에 따 | - 개인 공인인증서/대표자 공인인증서(개인사업자)/법인명 공인인증서(법인회원) 필요 | 표 1, 별표 1의2, 별표 2 또는 별표 3의3의 | 책임자의 성명을 적은 자료 | 대한민국약전｣ | 방사성핵종들은 보통 전자포획 또는 양전자방출 | 3.  식품의약품안전처장이 고시하는 기준에 적합 | 다.  | 약품안전처장이 정하여 고시하는 수수료(외국 | 는 경우에는 변경신청서나 변경신고서에 대표 |\n| 구분 | [제제총칙 - 주사제 항] | 2.  분류번호 및 분류(전문 또는 일반의약품) | 1 | -GMP | 7 | 8 비고 | 가 | 나 | 가 | 나 | 가 나 다 라 마 바 가 나 다 라 가 나 | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | [제제총칙 - 주사제 항] | [제제총칙 - 주사제 항] | 방사성의약품은 방사성핵종을 다음과 같은 형태로 포 | pH  4.5 ∼ 7.0 | 제31조(제조업 허가 등) ① 의약품 제조를 업 | ᆞ제4항에 따라 의약품의 제조업 허가를 받거 | 방사성의약품 | Yttrium-90 (90Y) | 64.10 시간 | 구성된 것으로서 주된 기능이 의료기기에 해당 |\n| ※ 신청품목과 관련된 밸리데이션 자료 | 5.  식품의약품안전처장이 신고대상품목으로 고 | 자는 다음 각 호의 어느 하나에 해당하는 경우 | 에 따른 행정정보의 공동이용을 통하여 법인 | 료.  다만, 다음 각 목의 어느 하나에 해당하 | 는 품목의 경우에는 제출하지 아니한다. ",
        "original_sentence": "| 약품안전처장이 정하여 고시하는 수수료(외국 | 는 경우에는 변경신청서나 변경신고서에 대표 |\n| 구분 | [제제총칙 - 주사제 항] | 2. "
      }
    },
    {
      "chunk_id": "chunk_400",
      "text": "분류번호 및 분류(전문 또는 일반의약품) | 1 | -GMP | 7 | 8 비고 | 가 | 나 | 가 | 나 | 가 나 다 라 마 바 가 나 다 라 가 나 | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | [제제총칙 - 주사제 항] | [제제총칙 - 주사제 항] | 방사성의약품은 방사성핵종을 다음과 같은 형태로 포 | pH  4.5 ∼ 7.0 | 제31조(제조업 허가 등) ① 의약품 제조를 업 | ᆞ제4항에 따라 의약품의 제조업 허가를 받거 | 방사성의약품 | Yttrium-90 (90Y) | 64.10 시간 | 구성된 것으로서 주된 기능이 의료기기에 해당 |\n| ※ 신청품목과 관련된 밸리데이션 자료 | 5. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 399,
        "window_size": 3,
        "char_count": 414,
        "word_count": 134,
        "page_number": 3,
        "window_text": "법 제50조의2제4항(법 제42조제4항에 따 | - 개인 공인인증서/대표자 공인인증서(개인사업자)/법인명 공인인증서(법인회원) 필요 | 표 1, 별표 1의2, 별표 2 또는 별표 3의3의 | 책임자의 성명을 적은 자료 | 대한민국약전｣ | 방사성핵종들은 보통 전자포획 또는 양전자방출 | 3.  식품의약품안전처장이 고시하는 기준에 적합 | 다.  | 약품안전처장이 정하여 고시하는 수수료(외국 | 는 경우에는 변경신청서나 변경신고서에 대표 |\n| 구분 | [제제총칙 - 주사제 항] | 2.  분류번호 및 분류(전문 또는 일반의약품) | 1 | -GMP | 7 | 8 비고 | 가 | 나 | 가 | 나 | 가 나 다 라 마 바 가 나 다 라 가 나 | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | [제제총칙 - 주사제 항] | [제제총칙 - 주사제 항] | 방사성의약품은 방사성핵종을 다음과 같은 형태로 포 | pH  4.5 ∼ 7.0 | 제31조(제조업 허가 등) ① 의약품 제조를 업 | ᆞ제4항에 따라 의약품의 제조업 허가를 받거 | 방사성의약품 | Yttrium-90 (90Y) | 64.10 시간 | 구성된 것으로서 주된 기능이 의료기기에 해당 |\n| ※ 신청품목과 관련된 밸리데이션 자료 | 5.  식품의약품안전처장이 신고대상품목으로 고 | 자는 다음 각 호의 어느 하나에 해당하는 경우 | 에 따른 행정정보의 공동이용을 통하여 법인 | 료.  다만, 다음 각 목의 어느 하나에 해당하 | 는 품목의 경우에는 제출하지 아니한다.  | 의약품, 제11조에 따라 제조판매·수입 품목허 | 식품의약품안전처장이 고시하는 자료 | 외품[내용고형제(內用固形劑) 및 내용액 | 나. ",
        "original_sentence": "분류번호 및 분류(전문 또는 일반의약품) | 1 | -GMP | 7 | 8 비고 | 가 | 나 | 가 | 나 | 가 나 다 라 마 바 가 나 다 라 가 나 | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | [제제총칙 - 주사제 항] | [제제총칙 - 주사제 항] | 방사성의약품은 방사성핵종을 다음과 같은 형태로 포 | pH  4.5 ∼ 7.0 | 제31조(제조업 허가 등) ① 의약품 제조를 업 | ᆞ제4항에 따라 의약품의 제조업 허가를 받거 | 방사성의약품 | Yttrium-90 (90Y) | 64.10 시간 | 구성된 것으로서 주된 기능이 의료기기에 해당 |\n| ※ 신청품목과 관련된 밸리데이션 자료 | 5. "
      }
    },
    {
      "chunk_id": "chunk_401",
      "text": "식품의약품안전처장이 신고대상품목으로 고 | 자는 다음 각 호의 어느 하나에 해당하는 경우 | 에 따른 행정정보의 공동이용을 통하여 법인 | 료. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 400,
        "window_size": 3,
        "char_count": 81,
        "word_count": 21,
        "page_number": 5,
        "window_text": "식품의약품안전처장이 고시하는 기준에 적합 | 다.  | 약품안전처장이 정하여 고시하는 수수료(외국 | 는 경우에는 변경신청서나 변경신고서에 대표 |\n| 구분 | [제제총칙 - 주사제 항] | 2.  분류번호 및 분류(전문 또는 일반의약품) | 1 | -GMP | 7 | 8 비고 | 가 | 나 | 가 | 나 | 가 나 다 라 마 바 가 나 다 라 가 나 | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | [제제총칙 - 주사제 항] | [제제총칙 - 주사제 항] | 방사성의약품은 방사성핵종을 다음과 같은 형태로 포 | pH  4.5 ∼ 7.0 | 제31조(제조업 허가 등) ① 의약품 제조를 업 | ᆞ제4항에 따라 의약품의 제조업 허가를 받거 | 방사성의약품 | Yttrium-90 (90Y) | 64.10 시간 | 구성된 것으로서 주된 기능이 의료기기에 해당 |\n| ※ 신청품목과 관련된 밸리데이션 자료 | 5.  식품의약품안전처장이 신고대상품목으로 고 | 자는 다음 각 호의 어느 하나에 해당하는 경우 | 에 따른 행정정보의 공동이용을 통하여 법인 | 료.  다만, 다음 각 목의 어느 하나에 해당하 | 는 품목의 경우에는 제출하지 아니한다.  | 의약품, 제11조에 따라 제조판매·수입 품목허 | 식품의약품안전처장이 고시하는 자료 | 외품[내용고형제(內用固形劑) 및 내용액 | 나.  저장방법 및 사용기간을 적은 자료 | 가) 제조소 평면도: 각 작업소, 시험실, 보관소 및 기타 제조공정에 필요한 부대시설이 표시된 | 제조 및 품질관리기준 실시상황 평가가 필요한 | 제출자료의 종류 | 라 준용되는 경우를 포함한다)에 따라 의약 | ⑤ 제1항에 따라 제조업의 허가를 받거나 신고 | Molybdene-99 (99Mo) | 65.94 시간 | 에서 현지실사를 할 필요가 있는 경우에는 이 | 자가 법 제5조제1호 본문에 해당되는 사람이 | 바. ",
        "original_sentence": "식품의약품안전처장이 신고대상품목으로 고 | 자는 다음 각 호의 어느 하나에 해당하는 경우 | 에 따른 행정정보의 공동이용을 통하여 법인 | 료. "
      }
    },
    {
      "chunk_id": "chunk_402",
      "text": "다만, 다음 각 목의 어느 하나에 해당하 | 는 품목의 경우에는 제출하지 아니한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 401,
        "window_size": 3,
        "char_count": 47,
        "word_count": 13,
        "page_number": 5,
        "window_text": "| 약품안전처장이 정하여 고시하는 수수료(외국 | 는 경우에는 변경신청서나 변경신고서에 대표 |\n| 구분 | [제제총칙 - 주사제 항] | 2.  분류번호 및 분류(전문 또는 일반의약품) | 1 | -GMP | 7 | 8 비고 | 가 | 나 | 가 | 나 | 가 나 다 라 마 바 가 나 다 라 가 나 | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | [제제총칙 - 주사제 항] | [제제총칙 - 주사제 항] | 방사성의약품은 방사성핵종을 다음과 같은 형태로 포 | pH  4.5 ∼ 7.0 | 제31조(제조업 허가 등) ① 의약품 제조를 업 | ᆞ제4항에 따라 의약품의 제조업 허가를 받거 | 방사성의약품 | Yttrium-90 (90Y) | 64.10 시간 | 구성된 것으로서 주된 기능이 의료기기에 해당 |\n| ※ 신청품목과 관련된 밸리데이션 자료 | 5.  식품의약품안전처장이 신고대상품목으로 고 | 자는 다음 각 호의 어느 하나에 해당하는 경우 | 에 따른 행정정보의 공동이용을 통하여 법인 | 료.  다만, 다음 각 목의 어느 하나에 해당하 | 는 품목의 경우에는 제출하지 아니한다.  | 의약품, 제11조에 따라 제조판매·수입 품목허 | 식품의약품안전처장이 고시하는 자료 | 외품[내용고형제(內用固形劑) 및 내용액 | 나.  저장방법 및 사용기간을 적은 자료 | 가) 제조소 평면도: 각 작업소, 시험실, 보관소 및 기타 제조공정에 필요한 부대시설이 표시된 | 제조 및 품질관리기준 실시상황 평가가 필요한 | 제출자료의 종류 | 라 준용되는 경우를 포함한다)에 따라 의약 | ⑤ 제1항에 따라 제조업의 허가를 받거나 신고 | Molybdene-99 (99Mo) | 65.94 시간 | 에서 현지실사를 할 필요가 있는 경우에는 이 | 자가 법 제5조제1호 본문에 해당되는 사람이 | 바.  기타독성시험자료 | 한 경우: 제1항제4호에 해당하는 자료 |\n| 로 붕괴되는데 걸리는 시간으로 다음 식과 같이 붕괴 | 산 시 방사성의약품의 이후 제조 공정 전에 이러한 어 | 넣는다. ",
        "original_sentence": "다만, 다음 각 목의 어느 하나에 해당하 | 는 품목의 경우에는 제출하지 아니한다. "
      }
    },
    {
      "chunk_id": "chunk_403",
      "text": "| 의약품, 제11조에 따라 제조판매·수입 품목허 | 식품의약품안전처장이 고시하는 자료 | 외품[내용고형제(內用固形劑) 및 내용액 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 402,
        "window_size": 3,
        "char_count": 78,
        "word_count": 16,
        "page_number": 3,
        "window_text": "분류번호 및 분류(전문 또는 일반의약품) | 1 | -GMP | 7 | 8 비고 | 가 | 나 | 가 | 나 | 가 나 다 라 마 바 가 나 다 라 가 나 | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 8) | 1) | 2) | 3) | 4) | 5) | 6) | 7) | 1) | 2) | 1) | 2) | [제제총칙 - 주사제 항] | [제제총칙 - 주사제 항] | 방사성의약품은 방사성핵종을 다음과 같은 형태로 포 | pH  4.5 ∼ 7.0 | 제31조(제조업 허가 등) ① 의약품 제조를 업 | ᆞ제4항에 따라 의약품의 제조업 허가를 받거 | 방사성의약품 | Yttrium-90 (90Y) | 64.10 시간 | 구성된 것으로서 주된 기능이 의료기기에 해당 |\n| ※ 신청품목과 관련된 밸리데이션 자료 | 5.  식품의약품안전처장이 신고대상품목으로 고 | 자는 다음 각 호의 어느 하나에 해당하는 경우 | 에 따른 행정정보의 공동이용을 통하여 법인 | 료.  다만, 다음 각 목의 어느 하나에 해당하 | 는 품목의 경우에는 제출하지 아니한다.  | 의약품, 제11조에 따라 제조판매·수입 품목허 | 식품의약품안전처장이 고시하는 자료 | 외품[내용고형제(內用固形劑) 및 내용액 | 나.  저장방법 및 사용기간을 적은 자료 | 가) 제조소 평면도: 각 작업소, 시험실, 보관소 및 기타 제조공정에 필요한 부대시설이 표시된 | 제조 및 품질관리기준 실시상황 평가가 필요한 | 제출자료의 종류 | 라 준용되는 경우를 포함한다)에 따라 의약 | ⑤ 제1항에 따라 제조업의 허가를 받거나 신고 | Molybdene-99 (99Mo) | 65.94 시간 | 에서 현지실사를 할 필요가 있는 경우에는 이 | 자가 법 제5조제1호 본문에 해당되는 사람이 | 바.  기타독성시험자료 | 한 경우: 제1항제4호에 해당하는 자료 |\n| 로 붕괴되는데 걸리는 시간으로 다음 식과 같이 붕괴 | 산 시 방사성의약품의 이후 제조 공정 전에 이러한 어 | 넣는다.  투여 후 지정된 시간에 적절한 방법으로 안락 | ü 의약품 등의 안전에 관한 규칙 제2조, 제4조, 제5조, 제8조, 제9조, 제10조 | 이 제제에서 분할사용을 목적으 | ○「약사법」제89조제3항 및「의약품 등의 안전에 관한 규칙」제103조 규정에 의거 양수받은 품목의 | 희귀의약품 | 희 귀 의 약 품 - 품 목 허 가 -기 시 -안 유 | 방사선을 차폐하기 위하여 추가적인 차폐용기가 필요함. ",
        "original_sentence": "| 의약품, 제11조에 따라 제조판매·수입 품목허 | 식품의약품안전처장이 고시하는 자료 | 외품[내용고형제(內用固形劑) 및 내용액 | 나. "
      }
    },
    {
      "chunk_id": "chunk_404",
      "text": "저장방법 및 사용기간을 적은 자료 | 가) 제조소 평면도: 각 작업소, 시험실, 보관소 및 기타 제조공정에 필요한 부대시설이 표시된 | 제조 및 품질관리기준 실시상황 평가가 필요한 | 제출자료의 종류 | 라 준용되는 경우를 포함한다)에 따라 의약 | ⑤ 제1항에 따라 제조업의 허가를 받거나 신고 | Molybdene-99 (99Mo) | 65.94 시간 | 에서 현지실사를 할 필요가 있는 경우에는 이 | 자가 법 제5조제1호 본문에 해당되는 사람이 | 바. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 403,
        "window_size": 3,
        "char_count": 258,
        "word_count": 67,
        "page_number": 3,
        "window_text": "식품의약품안전처장이 신고대상품목으로 고 | 자는 다음 각 호의 어느 하나에 해당하는 경우 | 에 따른 행정정보의 공동이용을 통하여 법인 | 료.  다만, 다음 각 목의 어느 하나에 해당하 | 는 품목의 경우에는 제출하지 아니한다.  | 의약품, 제11조에 따라 제조판매·수입 품목허 | 식품의약품안전처장이 고시하는 자료 | 외품[내용고형제(內用固形劑) 및 내용액 | 나.  저장방법 및 사용기간을 적은 자료 | 가) 제조소 평면도: 각 작업소, 시험실, 보관소 및 기타 제조공정에 필요한 부대시설이 표시된 | 제조 및 품질관리기준 실시상황 평가가 필요한 | 제출자료의 종류 | 라 준용되는 경우를 포함한다)에 따라 의약 | ⑤ 제1항에 따라 제조업의 허가를 받거나 신고 | Molybdene-99 (99Mo) | 65.94 시간 | 에서 현지실사를 할 필요가 있는 경우에는 이 | 자가 법 제5조제1호 본문에 해당되는 사람이 | 바.  기타독성시험자료 | 한 경우: 제1항제4호에 해당하는 자료 |\n| 로 붕괴되는데 걸리는 시간으로 다음 식과 같이 붕괴 | 산 시 방사성의약품의 이후 제조 공정 전에 이러한 어 | 넣는다.  투여 후 지정된 시간에 적절한 방법으로 안락 | ü 의약품 등의 안전에 관한 규칙 제2조, 제4조, 제5조, 제8조, 제9조, 제10조 | 이 제제에서 분할사용을 목적으 | ○「약사법」제89조제3항 및「의약품 등의 안전에 관한 규칙」제103조 규정에 의거 양수받은 품목의 | 희귀의약품 | 희 귀 의 약 품 - 품 목 허 가 -기 시 -안 유 | 방사선을 차폐하기 위하여 추가적인 차폐용기가 필요함.  단, 콜드바이알(Cold Vial)의 경우 방사능이 | 분할사용을 목적으로 하는 주사 | 된다. ",
        "original_sentence": "저장방법 및 사용기간을 적은 자료 | 가) 제조소 평면도: 각 작업소, 시험실, 보관소 및 기타 제조공정에 필요한 부대시설이 표시된 | 제조 및 품질관리기준 실시상황 평가가 필요한 | 제출자료의 종류 | 라 준용되는 경우를 포함한다)에 따라 의약 | ⑤ 제1항에 따라 제조업의 허가를 받거나 신고 | Molybdene-99 (99Mo) | 65.94 시간 | 에서 현지실사를 할 필요가 있는 경우에는 이 | 자가 법 제5조제1호 본문에 해당되는 사람이 | 바. "
      }
    },
    {
      "chunk_id": "chunk_405",
      "text": "기타독성시험자료 | 한 경우: 제1항제4호에 해당하는 자료 |\n| 로 붕괴되는데 걸리는 시간으로 다음 식과 같이 붕괴 | 산 시 방사성의약품의 이후 제조 공정 전에 이러한 어 | 넣는다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 404,
        "window_size": 3,
        "char_count": 105,
        "word_count": 29,
        "page_number": 3,
        "window_text": "다만, 다음 각 목의 어느 하나에 해당하 | 는 품목의 경우에는 제출하지 아니한다.  | 의약품, 제11조에 따라 제조판매·수입 품목허 | 식품의약품안전처장이 고시하는 자료 | 외품[내용고형제(內用固形劑) 및 내용액 | 나.  저장방법 및 사용기간을 적은 자료 | 가) 제조소 평면도: 각 작업소, 시험실, 보관소 및 기타 제조공정에 필요한 부대시설이 표시된 | 제조 및 품질관리기준 실시상황 평가가 필요한 | 제출자료의 종류 | 라 준용되는 경우를 포함한다)에 따라 의약 | ⑤ 제1항에 따라 제조업의 허가를 받거나 신고 | Molybdene-99 (99Mo) | 65.94 시간 | 에서 현지실사를 할 필요가 있는 경우에는 이 | 자가 법 제5조제1호 본문에 해당되는 사람이 | 바.  기타독성시험자료 | 한 경우: 제1항제4호에 해당하는 자료 |\n| 로 붕괴되는데 걸리는 시간으로 다음 식과 같이 붕괴 | 산 시 방사성의약품의 이후 제조 공정 전에 이러한 어 | 넣는다.  투여 후 지정된 시간에 적절한 방법으로 안락 | ü 의약품 등의 안전에 관한 규칙 제2조, 제4조, 제5조, 제8조, 제9조, 제10조 | 이 제제에서 분할사용을 목적으 | ○「약사법」제89조제3항 및「의약품 등의 안전에 관한 규칙」제103조 규정에 의거 양수받은 품목의 | 희귀의약품 | 희 귀 의 약 품 - 품 목 허 가 -기 시 -안 유 | 방사선을 차폐하기 위하여 추가적인 차폐용기가 필요함.  단, 콜드바이알(Cold Vial)의 경우 방사능이 | 분할사용을 목적으로 하는 주사 | 된다.  | 서 보존제 사용과 관련한 요구사항에도 불구하고 다회 | 제10조(기준 및 시험방법에 관한 자료) ① 법 제 | ․전자민원의 경우: 2,895,000원 | 목허가를 받은 자\"는 각각 \"수입자\"로 본다. ",
        "original_sentence": "기타독성시험자료 | 한 경우: 제1항제4호에 해당하는 자료 |\n| 로 붕괴되는데 걸리는 시간으로 다음 식과 같이 붕괴 | 산 시 방사성의약품의 이후 제조 공정 전에 이러한 어 | 넣는다. "
      }
    },
    {
      "chunk_id": "chunk_406",
      "text": "투여 후 지정된 시간에 적절한 방법으로 안락 | ü 의약품 등의 안전에 관한 규칙 제2조, 제4조, 제5조, 제8조, 제9조, 제10조 | 이 제제에서 분할사용을 목적으 | ○「약사법」제89조제3항 및「의약품 등의 안전에 관한 규칙」제103조 규정에 의거 양수받은 품목의 | 희귀의약품 | 희 귀 의 약 품 - 품 목 허 가 -기 시 -안 유 | 방사선을 차폐하기 위하여 추가적인 차폐용기가 필요함. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 405,
        "window_size": 3,
        "char_count": 224,
        "word_count": 60,
        "page_number": 3,
        "window_text": "| 의약품, 제11조에 따라 제조판매·수입 품목허 | 식품의약품안전처장이 고시하는 자료 | 외품[내용고형제(內用固形劑) 및 내용액 | 나.  저장방법 및 사용기간을 적은 자료 | 가) 제조소 평면도: 각 작업소, 시험실, 보관소 및 기타 제조공정에 필요한 부대시설이 표시된 | 제조 및 품질관리기준 실시상황 평가가 필요한 | 제출자료의 종류 | 라 준용되는 경우를 포함한다)에 따라 의약 | ⑤ 제1항에 따라 제조업의 허가를 받거나 신고 | Molybdene-99 (99Mo) | 65.94 시간 | 에서 현지실사를 할 필요가 있는 경우에는 이 | 자가 법 제5조제1호 본문에 해당되는 사람이 | 바.  기타독성시험자료 | 한 경우: 제1항제4호에 해당하는 자료 |\n| 로 붕괴되는데 걸리는 시간으로 다음 식과 같이 붕괴 | 산 시 방사성의약품의 이후 제조 공정 전에 이러한 어 | 넣는다.  투여 후 지정된 시간에 적절한 방법으로 안락 | ü 의약품 등의 안전에 관한 규칙 제2조, 제4조, 제5조, 제8조, 제9조, 제10조 | 이 제제에서 분할사용을 목적으 | ○「약사법」제89조제3항 및「의약품 등의 안전에 관한 규칙」제103조 규정에 의거 양수받은 품목의 | 희귀의약품 | 희 귀 의 약 품 - 품 목 허 가 -기 시 -안 유 | 방사선을 차폐하기 위하여 추가적인 차폐용기가 필요함.  단, 콜드바이알(Cold Vial)의 경우 방사능이 | 분할사용을 목적으로 하는 주사 | 된다.  | 서 보존제 사용과 관련한 요구사항에도 불구하고 다회 | 제10조(기준 및 시험방법에 관한 자료) ① 법 제 | ․전자민원의 경우: 2,895,000원 | 목허가를 받은 자\"는 각각 \"수입자\"로 본다.  | 분할사용 용기로 포장되는 주사 | 2.2.4.2 전자민원신청 절차 | 2.3.5 제조방법 | 함하고 있다. ",
        "original_sentence": "투여 후 지정된 시간에 적절한 방법으로 안락 | ü 의약품 등의 안전에 관한 규칙 제2조, 제4조, 제5조, 제8조, 제9조, 제10조 | 이 제제에서 분할사용을 목적으 | ○「약사법」제89조제3항 및「의약품 등의 안전에 관한 규칙」제103조 규정에 의거 양수받은 품목의 | 희귀의약품 | 희 귀 의 약 품 - 품 목 허 가 -기 시 -안 유 | 방사선을 차폐하기 위하여 추가적인 차폐용기가 필요함. "
      }
    },
    {
      "chunk_id": "chunk_407",
      "text": "단, 콜드바이알(Cold Vial)의 경우 방사능이 | 분할사용을 목적으로 하는 주사 | 된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 406,
        "window_size": 3,
        "char_count": 54,
        "word_count": 12,
        "page_number": 5,
        "window_text": "저장방법 및 사용기간을 적은 자료 | 가) 제조소 평면도: 각 작업소, 시험실, 보관소 및 기타 제조공정에 필요한 부대시설이 표시된 | 제조 및 품질관리기준 실시상황 평가가 필요한 | 제출자료의 종류 | 라 준용되는 경우를 포함한다)에 따라 의약 | ⑤ 제1항에 따라 제조업의 허가를 받거나 신고 | Molybdene-99 (99Mo) | 65.94 시간 | 에서 현지실사를 할 필요가 있는 경우에는 이 | 자가 법 제5조제1호 본문에 해당되는 사람이 | 바.  기타독성시험자료 | 한 경우: 제1항제4호에 해당하는 자료 |\n| 로 붕괴되는데 걸리는 시간으로 다음 식과 같이 붕괴 | 산 시 방사성의약품의 이후 제조 공정 전에 이러한 어 | 넣는다.  투여 후 지정된 시간에 적절한 방법으로 안락 | ü 의약품 등의 안전에 관한 규칙 제2조, 제4조, 제5조, 제8조, 제9조, 제10조 | 이 제제에서 분할사용을 목적으 | ○「약사법」제89조제3항 및「의약품 등의 안전에 관한 규칙」제103조 규정에 의거 양수받은 품목의 | 희귀의약품 | 희 귀 의 약 품 - 품 목 허 가 -기 시 -안 유 | 방사선을 차폐하기 위하여 추가적인 차폐용기가 필요함.  단, 콜드바이알(Cold Vial)의 경우 방사능이 | 분할사용을 목적으로 하는 주사 | 된다.  | 서 보존제 사용과 관련한 요구사항에도 불구하고 다회 | 제10조(기준 및 시험방법에 관한 자료) ① 법 제 | ․전자민원의 경우: 2,895,000원 | 목허가를 받은 자\"는 각각 \"수입자\"로 본다.  | 분할사용 용기로 포장되는 주사 | 2.2.4.2 전자민원신청 절차 | 2.3.5 제조방법 | 함하고 있다.  | 정하기 위해 모든 존재하는 방사성핵종을 확인하고 그 | 표시한다. ",
        "original_sentence": "단, 콜드바이알(Cold Vial)의 경우 방사능이 | 분할사용을 목적으로 하는 주사 | 된다. "
      }
    },
    {
      "chunk_id": "chunk_408",
      "text": "| 서 보존제 사용과 관련한 요구사항에도 불구하고 다회 | 제10조(기준 및 시험방법에 관한 자료) ① 법 제 | ․전자민원의 경우: 2,895,000원 | 목허가를 받은 자\"는 각각 \"수입자\"로 본다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 407,
        "window_size": 3,
        "char_count": 114,
        "word_count": 28,
        "page_number": 1,
        "window_text": "기타독성시험자료 | 한 경우: 제1항제4호에 해당하는 자료 |\n| 로 붕괴되는데 걸리는 시간으로 다음 식과 같이 붕괴 | 산 시 방사성의약품의 이후 제조 공정 전에 이러한 어 | 넣는다.  투여 후 지정된 시간에 적절한 방법으로 안락 | ü 의약품 등의 안전에 관한 규칙 제2조, 제4조, 제5조, 제8조, 제9조, 제10조 | 이 제제에서 분할사용을 목적으 | ○「약사법」제89조제3항 및「의약품 등의 안전에 관한 규칙」제103조 규정에 의거 양수받은 품목의 | 희귀의약품 | 희 귀 의 약 품 - 품 목 허 가 -기 시 -안 유 | 방사선을 차폐하기 위하여 추가적인 차폐용기가 필요함.  단, 콜드바이알(Cold Vial)의 경우 방사능이 | 분할사용을 목적으로 하는 주사 | 된다.  | 서 보존제 사용과 관련한 요구사항에도 불구하고 다회 | 제10조(기준 및 시험방법에 관한 자료) ① 법 제 | ․전자민원의 경우: 2,895,000원 | 목허가를 받은 자\"는 각각 \"수입자\"로 본다.  | 분할사용 용기로 포장되는 주사 | 2.2.4.2 전자민원신청 절차 | 2.3.5 제조방법 | 함하고 있다.  | 정하기 위해 모든 존재하는 방사성핵종을 확인하고 그 | 표시한다.  경과시간에서의 방사능은 붕괴 식 또는 표 | 「의약품등의 안전에 관한 규칙 」(총리령) 제4조 및  별지 제4호 서식 | 순도시험 | 1) 방사화학적이물 | 이 약을 가지고 75 % | 필요가 있는 경우 이를 기재 (예: 주사액, 분말주사 등) | 우려가 있는 표현은 제외 | 나 의약외품의 제조업 신고를 하려는 자는 별지 | 것이 필요하다. ",
        "original_sentence": "| 서 보존제 사용과 관련한 요구사항에도 불구하고 다회 | 제10조(기준 및 시험방법에 관한 자료) ① 법 제 | ․전자민원의 경우: 2,895,000원 | 목허가를 받은 자\"는 각각 \"수입자\"로 본다. "
      }
    },
    {
      "chunk_id": "chunk_409",
      "text": "| 분할사용 용기로 포장되는 주사 | 2.2.4.2 전자민원신청 절차 | 2.3.5 제조방법 | 함하고 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 408,
        "window_size": 3,
        "char_count": 62,
        "word_count": 15,
        "page_number": 3,
        "window_text": "투여 후 지정된 시간에 적절한 방법으로 안락 | ü 의약품 등의 안전에 관한 규칙 제2조, 제4조, 제5조, 제8조, 제9조, 제10조 | 이 제제에서 분할사용을 목적으 | ○「약사법」제89조제3항 및「의약품 등의 안전에 관한 규칙」제103조 규정에 의거 양수받은 품목의 | 희귀의약품 | 희 귀 의 약 품 - 품 목 허 가 -기 시 -안 유 | 방사선을 차폐하기 위하여 추가적인 차폐용기가 필요함.  단, 콜드바이알(Cold Vial)의 경우 방사능이 | 분할사용을 목적으로 하는 주사 | 된다.  | 서 보존제 사용과 관련한 요구사항에도 불구하고 다회 | 제10조(기준 및 시험방법에 관한 자료) ① 법 제 | ․전자민원의 경우: 2,895,000원 | 목허가를 받은 자\"는 각각 \"수입자\"로 본다.  | 분할사용 용기로 포장되는 주사 | 2.2.4.2 전자민원신청 절차 | 2.3.5 제조방법 | 함하고 있다.  | 정하기 위해 모든 존재하는 방사성핵종을 확인하고 그 | 표시한다.  경과시간에서의 방사능은 붕괴 식 또는 표 | 「의약품등의 안전에 관한 규칙 」(총리령) 제4조 및  별지 제4호 서식 | 순도시험 | 1) 방사화학적이물 | 이 약을 가지고 75 % | 필요가 있는 경우 이를 기재 (예: 주사액, 분말주사 등) | 우려가 있는 표현은 제외 | 나 의약외품의 제조업 신고를 하려는 자는 별지 | 것이 필요하다.  각조의 방사화학적 순도 항은 이성체 | 하여 「의료기기법」에 따라 허가를 받거나 신 |\n| 가. ",
        "original_sentence": "| 분할사용 용기로 포장되는 주사 | 2.2.4.2 전자민원신청 절차 | 2.3.5 제조방법 | 함하고 있다. "
      }
    },
    {
      "chunk_id": "chunk_410",
      "text": "| 정하기 위해 모든 존재하는 방사성핵종을 확인하고 그 | 표시한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 409,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 9,
        "window_text": "단, 콜드바이알(Cold Vial)의 경우 방사능이 | 분할사용을 목적으로 하는 주사 | 된다.  | 서 보존제 사용과 관련한 요구사항에도 불구하고 다회 | 제10조(기준 및 시험방법에 관한 자료) ① 법 제 | ․전자민원의 경우: 2,895,000원 | 목허가를 받은 자\"는 각각 \"수입자\"로 본다.  | 분할사용 용기로 포장되는 주사 | 2.2.4.2 전자민원신청 절차 | 2.3.5 제조방법 | 함하고 있다.  | 정하기 위해 모든 존재하는 방사성핵종을 확인하고 그 | 표시한다.  경과시간에서의 방사능은 붕괴 식 또는 표 | 「의약품등의 안전에 관한 규칙 」(총리령) 제4조 및  별지 제4호 서식 | 순도시험 | 1) 방사화학적이물 | 이 약을 가지고 75 % | 필요가 있는 경우 이를 기재 (예: 주사액, 분말주사 등) | 우려가 있는 표현은 제외 | 나 의약외품의 제조업 신고를 하려는 자는 별지 | 것이 필요하다.  각조의 방사화학적 순도 항은 이성체 | 하여 「의료기기법」에 따라 허가를 받거나 신 |\n| 가.  생물학적제제등이 아닌 것으로서 제1호가 | 규격 | 3. ",
        "original_sentence": "| 정하기 위해 모든 존재하는 방사성핵종을 확인하고 그 | 표시한다. "
      }
    },
    {
      "chunk_id": "chunk_411",
      "text": "경과시간에서의 방사능은 붕괴 식 또는 표 | 「의약품등의 안전에 관한 규칙 」(총리령) 제4조 및  별지 제4호 서식 | 순도시험 | 1) 방사화학적이물 | 이 약을 가지고 75 % | 필요가 있는 경우 이를 기재 (예: 주사액, 분말주사 등) | 우려가 있는 표현은 제외 | 나 의약외품의 제조업 신고를 하려는 자는 별지 | 것이 필요하다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 410,
        "window_size": 3,
        "char_count": 192,
        "word_count": 54,
        "page_number": 4,
        "window_text": "| 서 보존제 사용과 관련한 요구사항에도 불구하고 다회 | 제10조(기준 및 시험방법에 관한 자료) ① 법 제 | ․전자민원의 경우: 2,895,000원 | 목허가를 받은 자\"는 각각 \"수입자\"로 본다.  | 분할사용 용기로 포장되는 주사 | 2.2.4.2 전자민원신청 절차 | 2.3.5 제조방법 | 함하고 있다.  | 정하기 위해 모든 존재하는 방사성핵종을 확인하고 그 | 표시한다.  경과시간에서의 방사능은 붕괴 식 또는 표 | 「의약품등의 안전에 관한 규칙 」(총리령) 제4조 및  별지 제4호 서식 | 순도시험 | 1) 방사화학적이물 | 이 약을 가지고 75 % | 필요가 있는 경우 이를 기재 (예: 주사액, 분말주사 등) | 우려가 있는 표현은 제외 | 나 의약외품의 제조업 신고를 하려는 자는 별지 | 것이 필요하다.  각조의 방사화학적 순도 항은 이성체 | 하여 「의료기기법」에 따라 허가를 받거나 신 |\n| 가.  생물학적제제등이 아닌 것으로서 제1호가 | 규격 | 3.  원료약품 및 그 분량 | 등기사항증명서(법인인 경우만 해당한다)를 확 | 는 품목의 경우에는 제출하지 아니한다. ",
        "original_sentence": "경과시간에서의 방사능은 붕괴 식 또는 표 | 「의약품등의 안전에 관한 규칙 」(총리령) 제4조 및  별지 제4호 서식 | 순도시험 | 1) 방사화학적이물 | 이 약을 가지고 75 % | 필요가 있는 경우 이를 기재 (예: 주사액, 분말주사 등) | 우려가 있는 표현은 제외 | 나 의약외품의 제조업 신고를 하려는 자는 별지 | 것이 필요하다. "
      }
    },
    {
      "chunk_id": "chunk_412",
      "text": "각조의 방사화학적 순도 항은 이성체 | 하여 「의료기기법」에 따라 허가를 받거나 신 |\n| 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 411,
        "window_size": 3,
        "char_count": 54,
        "word_count": 15,
        "page_number": 5,
        "window_text": "| 분할사용 용기로 포장되는 주사 | 2.2.4.2 전자민원신청 절차 | 2.3.5 제조방법 | 함하고 있다.  | 정하기 위해 모든 존재하는 방사성핵종을 확인하고 그 | 표시한다.  경과시간에서의 방사능은 붕괴 식 또는 표 | 「의약품등의 안전에 관한 규칙 」(총리령) 제4조 및  별지 제4호 서식 | 순도시험 | 1) 방사화학적이물 | 이 약을 가지고 75 % | 필요가 있는 경우 이를 기재 (예: 주사액, 분말주사 등) | 우려가 있는 표현은 제외 | 나 의약외품의 제조업 신고를 하려는 자는 별지 | 것이 필요하다.  각조의 방사화학적 순도 항은 이성체 | 하여 「의료기기법」에 따라 허가를 받거나 신 |\n| 가.  생물학적제제등이 아닌 것으로서 제1호가 | 규격 | 3.  원료약품 및 그 분량 | 등기사항증명서(법인인 경우만 해당한다)를 확 | 는 품목의 경우에는 제출하지 아니한다.  | 시한 의약품등 | 6. ",
        "original_sentence": "각조의 방사화학적 순도 항은 이성체 | 하여 「의료기기법」에 따라 허가를 받거나 신 |\n| 가. "
      }
    },
    {
      "chunk_id": "chunk_413",
      "text": "생물학적제제등이 아닌 것으로서 제1호가 | 규격 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 412,
        "window_size": 3,
        "char_count": 32,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| 정하기 위해 모든 존재하는 방사성핵종을 확인하고 그 | 표시한다.  경과시간에서의 방사능은 붕괴 식 또는 표 | 「의약품등의 안전에 관한 규칙 」(총리령) 제4조 및  별지 제4호 서식 | 순도시험 | 1) 방사화학적이물 | 이 약을 가지고 75 % | 필요가 있는 경우 이를 기재 (예: 주사액, 분말주사 등) | 우려가 있는 표현은 제외 | 나 의약외품의 제조업 신고를 하려는 자는 별지 | 것이 필요하다.  각조의 방사화학적 순도 항은 이성체 | 하여 「의료기기법」에 따라 허가를 받거나 신 |\n| 가.  생물학적제제등이 아닌 것으로서 제1호가 | 규격 | 3.  원료약품 및 그 분량 | 등기사항증명서(법인인 경우만 해당한다)를 확 | 는 품목의 경우에는 제출하지 아니한다.  | 시한 의약품등 | 6.  다음 각 목의 구분에 따른 평가 자료. ",
        "original_sentence": "생물학적제제등이 아닌 것으로서 제1호가 | 규격 | 3. "
      }
    },
    {
      "chunk_id": "chunk_414",
      "text": "원료약품 및 그 분량 | 등기사항증명서(법인인 경우만 해당한다)를 확 | 는 품목의 경우에는 제출하지 아니한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 413,
        "window_size": 3,
        "char_count": 63,
        "word_count": 15,
        "page_number": 1,
        "window_text": "경과시간에서의 방사능은 붕괴 식 또는 표 | 「의약품등의 안전에 관한 규칙 」(총리령) 제4조 및  별지 제4호 서식 | 순도시험 | 1) 방사화학적이물 | 이 약을 가지고 75 % | 필요가 있는 경우 이를 기재 (예: 주사액, 분말주사 등) | 우려가 있는 표현은 제외 | 나 의약외품의 제조업 신고를 하려는 자는 별지 | 것이 필요하다.  각조의 방사화학적 순도 항은 이성체 | 하여 「의료기기법」에 따라 허가를 받거나 신 |\n| 가.  생물학적제제등이 아닌 것으로서 제1호가 | 규격 | 3.  원료약품 및 그 분량 | 등기사항증명서(법인인 경우만 해당한다)를 확 | 는 품목의 경우에는 제출하지 아니한다.  | 시한 의약품등 | 6.  다음 각 목의 구분에 따른 평가 자료.  다만, | 가와 품목신고가 제한되는 품목, 생물학적제제 | 제(內用液劑)만 해당한다]의 경우에는 별 | 1. ",
        "original_sentence": "원료약품 및 그 분량 | 등기사항증명서(법인인 경우만 해당한다)를 확 | 는 품목의 경우에는 제출하지 아니한다. "
      }
    },
    {
      "chunk_id": "chunk_415",
      "text": "| 시한 의약품등 | 6. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 414,
        "window_size": 3,
        "char_count": 15,
        "word_count": 5,
        "page_number": 3,
        "window_text": "각조의 방사화학적 순도 항은 이성체 | 하여 「의료기기법」에 따라 허가를 받거나 신 |\n| 가.  생물학적제제등이 아닌 것으로서 제1호가 | 규격 | 3.  원료약품 및 그 분량 | 등기사항증명서(법인인 경우만 해당한다)를 확 | 는 품목의 경우에는 제출하지 아니한다.  | 시한 의약품등 | 6.  다음 각 목의 구분에 따른 평가 자료.  다만, | 가와 품목신고가 제한되는 품목, 생물학적제제 | 제(內用液劑)만 해당한다]의 경우에는 별 | 1.  기원 또는 발견 및 개발경위에 관한 자료 | 다. ",
        "original_sentence": "| 시한 의약품등 | 6. "
      }
    },
    {
      "chunk_id": "chunk_416",
      "text": "다음 각 목의 구분에 따른 평가 자료. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 415,
        "window_size": 3,
        "char_count": 22,
        "word_count": 7,
        "page_number": 1,
        "window_text": "생물학적제제등이 아닌 것으로서 제1호가 | 규격 | 3.  원료약품 및 그 분량 | 등기사항증명서(법인인 경우만 해당한다)를 확 | 는 품목의 경우에는 제출하지 아니한다.  | 시한 의약품등 | 6.  다음 각 목의 구분에 따른 평가 자료.  다만, | 가와 품목신고가 제한되는 품목, 생물학적제제 | 제(內用液劑)만 해당한다]의 경우에는 별 | 1.  기원 또는 발견 및 개발경위에 관한 자료 | 다.  제15조제1항 각 호의 자료 | (業)으로 하려는 자는 대통령령으로 정하는 시 | 경우에는 제4조제1항제6호의 자료를 제출하여 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | RADIOPHARMACEUTICAL | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Technetium-99m (99mTc) | 6.01 시간 | 에 드는 경비를 포함한다)를 내야 한다. ",
        "original_sentence": "다음 각 목의 구분에 따른 평가 자료. "
      }
    },
    {
      "chunk_id": "chunk_417",
      "text": "다만, | 가와 품목신고가 제한되는 품목, 생물학적제제 | 제(內用液劑)만 해당한다]의 경우에는 별 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 416,
        "window_size": 3,
        "char_count": 61,
        "word_count": 14,
        "page_number": 9,
        "window_text": "원료약품 및 그 분량 | 등기사항증명서(법인인 경우만 해당한다)를 확 | 는 품목의 경우에는 제출하지 아니한다.  | 시한 의약품등 | 6.  다음 각 목의 구분에 따른 평가 자료.  다만, | 가와 품목신고가 제한되는 품목, 생물학적제제 | 제(內用液劑)만 해당한다]의 경우에는 별 | 1.  기원 또는 발견 및 개발경위에 관한 자료 | 다.  제15조제1항 각 호의 자료 | (業)으로 하려는 자는 대통령령으로 정하는 시 | 경우에는 제4조제1항제6호의 자료를 제출하여 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | RADIOPHARMACEUTICAL | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Technetium-99m (99mTc) | 6.01 시간 | 에 드는 경비를 포함한다)를 내야 한다.  | 아님을 증명하는 의사의 진단서 또는 같은 호 | 1) 국소독성시험(국소내성시험포함) |\n| 상수와 관련된다. ",
        "original_sentence": "다만, | 가와 품목신고가 제한되는 품목, 생물학적제제 | 제(內用液劑)만 해당한다]의 경우에는 별 | 1. "
      }
    },
    {
      "chunk_id": "chunk_418",
      "text": "기원 또는 발견 및 개발경위에 관한 자료 | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 417,
        "window_size": 3,
        "char_count": 28,
        "word_count": 9,
        "page_number": 5,
        "window_text": "| 시한 의약품등 | 6.  다음 각 목의 구분에 따른 평가 자료.  다만, | 가와 품목신고가 제한되는 품목, 생물학적제제 | 제(內用液劑)만 해당한다]의 경우에는 별 | 1.  기원 또는 발견 및 개발경위에 관한 자료 | 다.  제15조제1항 각 호의 자료 | (業)으로 하려는 자는 대통령령으로 정하는 시 | 경우에는 제4조제1항제6호의 자료를 제출하여 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | RADIOPHARMACEUTICAL | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Technetium-99m (99mTc) | 6.01 시간 | 에 드는 경비를 포함한다)를 내야 한다.  | 아님을 증명하는 의사의 진단서 또는 같은 호 | 1) 국소독성시험(국소내성시험포함) |\n| 상수와 관련된다.  | 떤 품질기준(quality criteria)을 정하는 것은 불가능할 | 사 시키고 해부한다. ",
        "original_sentence": "기원 또는 발견 및 개발경위에 관한 자료 | 다. "
      }
    },
    {
      "chunk_id": "chunk_419",
      "text": "제15조제1항 각 호의 자료 | (業)으로 하려는 자는 대통령령으로 정하는 시 | 경우에는 제4조제1항제6호의 자료를 제출하여 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | RADIOPHARMACEUTICAL | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Technetium-99m (99mTc) | 6.01 시간 | 에 드는 경비를 포함한다)를 내야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 418,
        "window_size": 3,
        "char_count": 207,
        "word_count": 44,
        "page_number": 3,
        "window_text": "다음 각 목의 구분에 따른 평가 자료.  다만, | 가와 품목신고가 제한되는 품목, 생물학적제제 | 제(內用液劑)만 해당한다]의 경우에는 별 | 1.  기원 또는 발견 및 개발경위에 관한 자료 | 다.  제15조제1항 각 호의 자료 | (業)으로 하려는 자는 대통령령으로 정하는 시 | 경우에는 제4조제1항제6호의 자료를 제출하여 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | RADIOPHARMACEUTICAL | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Technetium-99m (99mTc) | 6.01 시간 | 에 드는 경비를 포함한다)를 내야 한다.  | 아님을 증명하는 의사의 진단서 또는 같은 호 | 1) 국소독성시험(국소내성시험포함) |\n| 상수와 관련된다.  | 떤 품질기준(quality criteria)을 정하는 것은 불가능할 | 사 시키고 해부한다.  채집한 기관 및 조직들의 방사능 | I. ",
        "original_sentence": "제15조제1항 각 호의 자료 | (業)으로 하려는 자는 대통령령으로 정하는 시 | 경우에는 제4조제1항제6호의 자료를 제출하여 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | RADIOPHARMACEUTICAL | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Technetium-99m (99mTc) | 6.01 시간 | 에 드는 경비를 포함한다)를 내야 한다. "
      }
    },
    {
      "chunk_id": "chunk_420",
      "text": "| 아님을 증명하는 의사의 진단서 또는 같은 호 | 1) 국소독성시험(국소내성시험포함) |\n| 상수와 관련된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 419,
        "window_size": 3,
        "char_count": 63,
        "word_count": 15,
        "page_number": 3,
        "window_text": "다만, | 가와 품목신고가 제한되는 품목, 생물학적제제 | 제(內用液劑)만 해당한다]의 경우에는 별 | 1.  기원 또는 발견 및 개발경위에 관한 자료 | 다.  제15조제1항 각 호의 자료 | (業)으로 하려는 자는 대통령령으로 정하는 시 | 경우에는 제4조제1항제6호의 자료를 제출하여 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | RADIOPHARMACEUTICAL | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Technetium-99m (99mTc) | 6.01 시간 | 에 드는 경비를 포함한다)를 내야 한다.  | 아님을 증명하는 의사의 진단서 또는 같은 호 | 1) 국소독성시험(국소내성시험포함) |\n| 상수와 관련된다.  | 떤 품질기준(quality criteria)을 정하는 것은 불가능할 | 사 시키고 해부한다.  채집한 기관 및 조직들의 방사능 | I.  신약 방사성의약품 | ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ | × | × | × | × | × | △ △ ○ ○ ○ ○ ○ ○ | 로 하는 것은 따로 규정이 없는 | ○ ‘밸리데이션’ 자료는 아래와 같음. ",
        "original_sentence": "| 아님을 증명하는 의사의 진단서 또는 같은 호 | 1) 국소독성시험(국소내성시험포함) |\n| 상수와 관련된다. "
      }
    },
    {
      "chunk_id": "chunk_421",
      "text": "| 떤 품질기준(quality criteria)을 정하는 것은 불가능할 | 사 시키고 해부한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 420,
        "window_size": 3,
        "char_count": 54,
        "word_count": 11,
        "page_number": 6,
        "window_text": "기원 또는 발견 및 개발경위에 관한 자료 | 다.  제15조제1항 각 호의 자료 | (業)으로 하려는 자는 대통령령으로 정하는 시 | 경우에는 제4조제1항제6호의 자료를 제출하여 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | RADIOPHARMACEUTICAL | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Technetium-99m (99mTc) | 6.01 시간 | 에 드는 경비를 포함한다)를 내야 한다.  | 아님을 증명하는 의사의 진단서 또는 같은 호 | 1) 국소독성시험(국소내성시험포함) |\n| 상수와 관련된다.  | 떤 품질기준(quality criteria)을 정하는 것은 불가능할 | 사 시키고 해부한다.  채집한 기관 및 조직들의 방사능 | I.  신약 방사성의약품 | ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ | × | × | × | × | × | △ △ ○ ○ ○ ○ ○ ○ | 로 하는 것은 따로 규정이 없는 | ○ ‘밸리데이션’ 자료는 아래와 같음.  다만, 제조소별 및 품목별 현황에 따라 해당 자료는 달라질 수 있음 | 에는 해당 의약품등에 대하여 제1항에 따른 품 | 방사성핵종을 양전자방출핵(positron emitters)이라 한 | 다수의 방사성핵종들이 생성된다. ",
        "original_sentence": "| 떤 품질기준(quality criteria)을 정하는 것은 불가능할 | 사 시키고 해부한다. "
      }
    },
    {
      "chunk_id": "chunk_422",
      "text": "채집한 기관 및 조직들의 방사능 | I. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 421,
        "window_size": 3,
        "char_count": 23,
        "word_count": 7,
        "page_number": 6,
        "window_text": "제15조제1항 각 호의 자료 | (業)으로 하려는 자는 대통령령으로 정하는 시 | 경우에는 제4조제1항제6호의 자료를 제출하여 | 품 특허목록(이하 \"특허목록\"이라 한다)에 | RADIOPHARMACEUTICAL | ③ 제1항에도 불구하고 기업의 분리 또는 합병 | Technetium-99m (99mTc) | 6.01 시간 | 에 드는 경비를 포함한다)를 내야 한다.  | 아님을 증명하는 의사의 진단서 또는 같은 호 | 1) 국소독성시험(국소내성시험포함) |\n| 상수와 관련된다.  | 떤 품질기준(quality criteria)을 정하는 것은 불가능할 | 사 시키고 해부한다.  채집한 기관 및 조직들의 방사능 | I.  신약 방사성의약품 | ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ | × | × | × | × | × | △ △ ○ ○ ○ ○ ○ ○ | 로 하는 것은 따로 규정이 없는 | ○ ‘밸리데이션’ 자료는 아래와 같음.  다만, 제조소별 및 품목별 현황에 따라 해당 자료는 달라질 수 있음 | 에는 해당 의약품등에 대하여 제1항에 따른 품 | 방사성핵종을 양전자방출핵(positron emitters)이라 한 | 다수의 방사성핵종들이 생성된다.  가장 흔하게 사용되 | 를 포함한 특정 방사화학적 불순물에 대한 기준을 포 | 고한 제품 또는 품목은 제2항부터 제4항까지의 | 를 하려는 자는 식품의약품안전처장이 정하여 |\n| ü 의약품의 품목허가․신고․심사 규정 | 경우, 종전에 제조된 제품의 품질관리 및 행정조치는 양수자인 ○○제약(주)에서 승계·책임질 것. ",
        "original_sentence": "채집한 기관 및 조직들의 방사능 | I. "
      }
    },
    {
      "chunk_id": "chunk_423",
      "text": "신약 방사성의약품 | ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ | × | × | × | × | × | △ △ ○ ○ ○ ○ ○ ○ | 로 하는 것은 따로 규정이 없는 | ○ ‘밸리데이션’ 자료는 아래와 같음. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 422,
        "window_size": 3,
        "char_count": 136,
        "word_count": 56,
        "page_number": 6,
        "window_text": "| 아님을 증명하는 의사의 진단서 또는 같은 호 | 1) 국소독성시험(국소내성시험포함) |\n| 상수와 관련된다.  | 떤 품질기준(quality criteria)을 정하는 것은 불가능할 | 사 시키고 해부한다.  채집한 기관 및 조직들의 방사능 | I.  신약 방사성의약품 | ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ | × | × | × | × | × | △ △ ○ ○ ○ ○ ○ ○ | 로 하는 것은 따로 규정이 없는 | ○ ‘밸리데이션’ 자료는 아래와 같음.  다만, 제조소별 및 품목별 현황에 따라 해당 자료는 달라질 수 있음 | 에는 해당 의약품등에 대하여 제1항에 따른 품 | 방사성핵종을 양전자방출핵(positron emitters)이라 한 | 다수의 방사성핵종들이 생성된다.  가장 흔하게 사용되 | 를 포함한 특정 방사화학적 불순물에 대한 기준을 포 | 고한 제품 또는 품목은 제2항부터 제4항까지의 | 를 하려는 자는 식품의약품안전처장이 정하여 |\n| ü 의약품의 품목허가․신고․심사 규정 | 경우, 종전에 제조된 제품의 품질관리 및 행정조치는 양수자인 ○○제약(주)에서 승계·책임질 것.  | 없으므로 “차폐용기”는 미설정할 수 있음. ",
        "original_sentence": "신약 방사성의약품 | ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ | × | × | × | × | × | △ △ ○ ○ ○ ○ ○ ○ | 로 하는 것은 따로 규정이 없는 | ○ ‘밸리데이션’ 자료는 아래와 같음. "
      }
    },
    {
      "chunk_id": "chunk_424",
      "text": "다만, 제조소별 및 품목별 현황에 따라 해당 자료는 달라질 수 있음 | 에는 해당 의약품등에 대하여 제1항에 따른 품 | 방사성핵종을 양전자방출핵(positron emitters)이라 한 | 다수의 방사성핵종들이 생성된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 423,
        "window_size": 3,
        "char_count": 125,
        "word_count": 28,
        "page_number": 3,
        "window_text": "| 떤 품질기준(quality criteria)을 정하는 것은 불가능할 | 사 시키고 해부한다.  채집한 기관 및 조직들의 방사능 | I.  신약 방사성의약품 | ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ | × | × | × | × | × | △ △ ○ ○ ○ ○ ○ ○ | 로 하는 것은 따로 규정이 없는 | ○ ‘밸리데이션’ 자료는 아래와 같음.  다만, 제조소별 및 품목별 현황에 따라 해당 자료는 달라질 수 있음 | 에는 해당 의약품등에 대하여 제1항에 따른 품 | 방사성핵종을 양전자방출핵(positron emitters)이라 한 | 다수의 방사성핵종들이 생성된다.  가장 흔하게 사용되 | 를 포함한 특정 방사화학적 불순물에 대한 기준을 포 | 고한 제품 또는 품목은 제2항부터 제4항까지의 | 를 하려는 자는 식품의약품안전처장이 정하여 |\n| ü 의약품의 품목허가․신고․심사 규정 | 경우, 종전에 제조된 제품의 품질관리 및 행정조치는 양수자인 ○○제약(주)에서 승계·책임질 것.  | 없으므로 “차폐용기”는 미설정할 수 있음.  | 4. ",
        "original_sentence": "다만, 제조소별 및 품목별 현황에 따라 해당 자료는 달라질 수 있음 | 에는 해당 의약품등에 대하여 제1항에 따른 품 | 방사성핵종을 양전자방출핵(positron emitters)이라 한 | 다수의 방사성핵종들이 생성된다. "
      }
    },
    {
      "chunk_id": "chunk_425",
      "text": "가장 흔하게 사용되 | 를 포함한 특정 방사화학적 불순물에 대한 기준을 포 | 고한 제품 또는 품목은 제2항부터 제4항까지의 | 를 하려는 자는 식품의약품안전처장이 정하여 |\n| ü 의약품의 품목허가․신고․심사 규정 | 경우, 종전에 제조된 제품의 품질관리 및 행정조치는 양수자인 ○○제약(주)에서 승계·책임질 것. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 424,
        "window_size": 3,
        "char_count": 177,
        "word_count": 43,
        "page_number": 6,
        "window_text": "채집한 기관 및 조직들의 방사능 | I.  신약 방사성의약품 | ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ | × | × | × | × | × | △ △ ○ ○ ○ ○ ○ ○ | 로 하는 것은 따로 규정이 없는 | ○ ‘밸리데이션’ 자료는 아래와 같음.  다만, 제조소별 및 품목별 현황에 따라 해당 자료는 달라질 수 있음 | 에는 해당 의약품등에 대하여 제1항에 따른 품 | 방사성핵종을 양전자방출핵(positron emitters)이라 한 | 다수의 방사성핵종들이 생성된다.  가장 흔하게 사용되 | 를 포함한 특정 방사화학적 불순물에 대한 기준을 포 | 고한 제품 또는 품목은 제2항부터 제4항까지의 | 를 하려는 자는 식품의약품안전처장이 정하여 |\n| ü 의약품의 품목허가․신고․심사 규정 | 경우, 종전에 제조된 제품의 품질관리 및 행정조치는 양수자인 ○○제약(주)에서 승계·책임질 것.  | 없으므로 “차폐용기”는 미설정할 수 있음.  | 4.  성상 | -GMP |\n| - 제조공정 밸리데이션 자료, 중요기계 적격성평가 자료, 시험방법 밸리데이션 자료, 세척방법 밸리데이션 | 가. ",
        "original_sentence": "가장 흔하게 사용되 | 를 포함한 특정 방사화학적 불순물에 대한 기준을 포 | 고한 제품 또는 품목은 제2항부터 제4항까지의 | 를 하려는 자는 식품의약품안전처장이 정하여 |\n| ü 의약품의 품목허가․신고․심사 규정 | 경우, 종전에 제조된 제품의 품질관리 및 행정조치는 양수자인 ○○제약(주)에서 승계·책임질 것. "
      }
    },
    {
      "chunk_id": "chunk_426",
      "text": "| 없으므로 “차폐용기”는 미설정할 수 있음. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 425,
        "window_size": 3,
        "char_count": 26,
        "word_count": 6,
        "page_number": 10,
        "window_text": "신약 방사성의약품 | ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ ○ | × | × | × | × | × | △ △ ○ ○ ○ ○ ○ ○ | 로 하는 것은 따로 규정이 없는 | ○ ‘밸리데이션’ 자료는 아래와 같음.  다만, 제조소별 및 품목별 현황에 따라 해당 자료는 달라질 수 있음 | 에는 해당 의약품등에 대하여 제1항에 따른 품 | 방사성핵종을 양전자방출핵(positron emitters)이라 한 | 다수의 방사성핵종들이 생성된다.  가장 흔하게 사용되 | 를 포함한 특정 방사화학적 불순물에 대한 기준을 포 | 고한 제품 또는 품목은 제2항부터 제4항까지의 | 를 하려는 자는 식품의약품안전처장이 정하여 |\n| ü 의약품의 품목허가․신고․심사 규정 | 경우, 종전에 제조된 제품의 품질관리 및 행정조치는 양수자인 ○○제약(주)에서 승계·책임질 것.  | 없으므로 “차폐용기”는 미설정할 수 있음.  | 4.  성상 | -GMP |\n| - 제조공정 밸리데이션 자료, 중요기계 적격성평가 자료, 시험방법 밸리데이션 자료, 세척방법 밸리데이션 | 가.  생물학적제제등이 아닌 것으로서 제1호가 | ② 제1항에 따라 의약품등의 제조판매ᆞ수입 | 목별 허가를 받거나 신고를 하지 아니하고 수 | 인하여야 한다. ",
        "original_sentence": "| 없으므로 “차폐용기”는 미설정할 수 있음. "
      }
    },
    {
      "chunk_id": "chunk_427",
      "text": "| 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 426,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 3,
        "window_text": "다만, 제조소별 및 품목별 현황에 따라 해당 자료는 달라질 수 있음 | 에는 해당 의약품등에 대하여 제1항에 따른 품 | 방사성핵종을 양전자방출핵(positron emitters)이라 한 | 다수의 방사성핵종들이 생성된다.  가장 흔하게 사용되 | 를 포함한 특정 방사화학적 불순물에 대한 기준을 포 | 고한 제품 또는 품목은 제2항부터 제4항까지의 | 를 하려는 자는 식품의약품안전처장이 정하여 |\n| ü 의약품의 품목허가․신고․심사 규정 | 경우, 종전에 제조된 제품의 품질관리 및 행정조치는 양수자인 ○○제약(주)에서 승계·책임질 것.  | 없으므로 “차폐용기”는 미설정할 수 있음.  | 4.  성상 | -GMP |\n| - 제조공정 밸리데이션 자료, 중요기계 적격성평가 자료, 시험방법 밸리데이션 자료, 세척방법 밸리데이션 | 가.  생물학적제제등이 아닌 것으로서 제1호가 | ② 제1항에 따라 의약품등의 제조판매ᆞ수입 | 목별 허가를 받거나 신고를 하지 아니하고 수 | 인하여야 한다.  | 목·나목·다목 및 마목에 해당하는 품목 | 제4조(제조판매·수입 품목의 허가 신청) ① 법 | 등에 의하여 해당 제조시설·제조방법 등을 양 | 단서에 해당하는 사람임을 증명하는 전문의의 |\n| ※ 참고 - 대한민국약전(제11개정) 통칙 중 방사선을 차폐하는 용기의 조건 | ▷ 자료제출의약품 | 수도 있다. ",
        "original_sentence": "| 4. "
      }
    },
    {
      "chunk_id": "chunk_428",
      "text": "성상 | -GMP |\n| - 제조공정 밸리데이션 자료, 중요기계 적격성평가 자료, 시험방법 밸리데이션 자료, 세척방법 밸리데이션 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 427,
        "window_size": 3,
        "char_count": 77,
        "word_count": 19,
        "page_number": 3,
        "window_text": "가장 흔하게 사용되 | 를 포함한 특정 방사화학적 불순물에 대한 기준을 포 | 고한 제품 또는 품목은 제2항부터 제4항까지의 | 를 하려는 자는 식품의약품안전처장이 정하여 |\n| ü 의약품의 품목허가․신고․심사 규정 | 경우, 종전에 제조된 제품의 품질관리 및 행정조치는 양수자인 ○○제약(주)에서 승계·책임질 것.  | 없으므로 “차폐용기”는 미설정할 수 있음.  | 4.  성상 | -GMP |\n| - 제조공정 밸리데이션 자료, 중요기계 적격성평가 자료, 시험방법 밸리데이션 자료, 세척방법 밸리데이션 | 가.  생물학적제제등이 아닌 것으로서 제1호가 | ② 제1항에 따라 의약품등의 제조판매ᆞ수입 | 목별 허가를 받거나 신고를 하지 아니하고 수 | 인하여야 한다.  | 목·나목·다목 및 마목에 해당하는 품목 | 제4조(제조판매·수입 품목의 허가 신청) ① 법 | 등에 의하여 해당 제조시설·제조방법 등을 양 | 단서에 해당하는 사람임을 증명하는 전문의의 |\n| ※ 참고 - 대한민국약전(제11개정) 통칙 중 방사선을 차폐하는 용기의 조건 | ▷ 자료제출의약품 | 수도 있다.  그러므로 표적물질의 매 배치 품질관리는 | 을 측정한다. ",
        "original_sentence": "성상 | -GMP |\n| - 제조공정 밸리데이션 자료, 중요기계 적격성평가 자료, 시험방법 밸리데이션 자료, 세척방법 밸리데이션 | 가. "
      }
    },
    {
      "chunk_id": "chunk_429",
      "text": "생물학적제제등이 아닌 것으로서 제1호가 | ② 제1항에 따라 의약품등의 제조판매ᆞ수입 | 목별 허가를 받거나 신고를 하지 아니하고 수 | 인하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 428,
        "window_size": 3,
        "char_count": 86,
        "word_count": 21,
        "page_number": 3,
        "window_text": "| 없으므로 “차폐용기”는 미설정할 수 있음.  | 4.  성상 | -GMP |\n| - 제조공정 밸리데이션 자료, 중요기계 적격성평가 자료, 시험방법 밸리데이션 자료, 세척방법 밸리데이션 | 가.  생물학적제제등이 아닌 것으로서 제1호가 | ② 제1항에 따라 의약품등의 제조판매ᆞ수입 | 목별 허가를 받거나 신고를 하지 아니하고 수 | 인하여야 한다.  | 목·나목·다목 및 마목에 해당하는 품목 | 제4조(제조판매·수입 품목의 허가 신청) ① 법 | 등에 의하여 해당 제조시설·제조방법 등을 양 | 단서에 해당하는 사람임을 증명하는 전문의의 |\n| ※ 참고 - 대한민국약전(제11개정) 통칙 중 방사선을 차폐하는 용기의 조건 | ▷ 자료제출의약품 | 수도 있다.  그러므로 표적물질의 매 배치 품질관리는 | 을 측정한다.  생리학적 분포는 각 기관 또는 조직들에 | - 공정서 품목 : 해당 공정서의 명칭(또는 약칭) 기재 | 신약, 희귀 외 | 의약품-품목허가-안유-기시-GMP | ․전자민원의 경우: 1,134,000원 | 한 미생물의 증식을 억제하기 위 | 다. ",
        "original_sentence": "생물학적제제등이 아닌 것으로서 제1호가 | ② 제1항에 따라 의약품등의 제조판매ᆞ수입 | 목별 허가를 받거나 신고를 하지 아니하고 수 | 인하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_430",
      "text": "| 목·나목·다목 및 마목에 해당하는 품목 | 제4조(제조판매·수입 품목의 허가 신청) ① 법 | 등에 의하여 해당 제조시설·제조방법 등을 양 | 단서에 해당하는 사람임을 증명하는 전문의의 |\n| ※ 참고 - 대한민국약전(제11개정) 통칙 중 방사선을 차폐하는 용기의 조건 | ▷ 자료제출의약품 | 수도 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 429,
        "window_size": 3,
        "char_count": 174,
        "word_count": 44,
        "page_number": 3,
        "window_text": "| 4.  성상 | -GMP |\n| - 제조공정 밸리데이션 자료, 중요기계 적격성평가 자료, 시험방법 밸리데이션 자료, 세척방법 밸리데이션 | 가.  생물학적제제등이 아닌 것으로서 제1호가 | ② 제1항에 따라 의약품등의 제조판매ᆞ수입 | 목별 허가를 받거나 신고를 하지 아니하고 수 | 인하여야 한다.  | 목·나목·다목 및 마목에 해당하는 품목 | 제4조(제조판매·수입 품목의 허가 신청) ① 법 | 등에 의하여 해당 제조시설·제조방법 등을 양 | 단서에 해당하는 사람임을 증명하는 전문의의 |\n| ※ 참고 - 대한민국약전(제11개정) 통칙 중 방사선을 차폐하는 용기의 조건 | ▷ 자료제출의약품 | 수도 있다.  그러므로 표적물질의 매 배치 품질관리는 | 을 측정한다.  생리학적 분포는 각 기관 또는 조직들에 | - 공정서 품목 : 해당 공정서의 명칭(또는 약칭) 기재 | 신약, 희귀 외 | 의약품-품목허가-안유-기시-GMP | ․전자민원의 경우: 1,134,000원 | 한 미생물의 증식을 억제하기 위 | 다.  양전자들은 주위 전자들과 결합하여 소멸할 때 각 | 는 것은 235U의 핵분열이다. ",
        "original_sentence": "| 목·나목·다목 및 마목에 해당하는 품목 | 제4조(제조판매·수입 품목의 허가 신청) ① 법 | 등에 의하여 해당 제조시설·제조방법 등을 양 | 단서에 해당하는 사람임을 증명하는 전문의의 |\n| ※ 참고 - 대한민국약전(제11개정) 통칙 중 방사선을 차폐하는 용기의 조건 | ▷ 자료제출의약품 | 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_431",
      "text": "그러므로 표적물질의 매 배치 품질관리는 | 을 측정한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 430,
        "window_size": 3,
        "char_count": 32,
        "word_count": 8,
        "page_number": 9,
        "window_text": "성상 | -GMP |\n| - 제조공정 밸리데이션 자료, 중요기계 적격성평가 자료, 시험방법 밸리데이션 자료, 세척방법 밸리데이션 | 가.  생물학적제제등이 아닌 것으로서 제1호가 | ② 제1항에 따라 의약품등의 제조판매ᆞ수입 | 목별 허가를 받거나 신고를 하지 아니하고 수 | 인하여야 한다.  | 목·나목·다목 및 마목에 해당하는 품목 | 제4조(제조판매·수입 품목의 허가 신청) ① 법 | 등에 의하여 해당 제조시설·제조방법 등을 양 | 단서에 해당하는 사람임을 증명하는 전문의의 |\n| ※ 참고 - 대한민국약전(제11개정) 통칙 중 방사선을 차폐하는 용기의 조건 | ▷ 자료제출의약품 | 수도 있다.  그러므로 표적물질의 매 배치 품질관리는 | 을 측정한다.  생리학적 분포는 각 기관 또는 조직들에 | - 공정서 품목 : 해당 공정서의 명칭(또는 약칭) 기재 | 신약, 희귀 외 | 의약품-품목허가-안유-기시-GMP | ․전자민원의 경우: 1,134,000원 | 한 미생물의 증식을 억제하기 위 | 다.  양전자들은 주위 전자들과 결합하여 소멸할 때 각 | 는 것은 235U의 핵분열이다.  핵반응기에서 우라늄(235U) | 규정에 따라 품목허가를 받거나 품목신고를 한 |\n| ü 의약품 제조 및 품질관리에 관한 규정 | 나. ",
        "original_sentence": "그러므로 표적물질의 매 배치 품질관리는 | 을 측정한다. "
      }
    },
    {
      "chunk_id": "chunk_432",
      "text": "생리학적 분포는 각 기관 또는 조직들에 | - 공정서 품목 : 해당 공정서의 명칭(또는 약칭) 기재 | 신약, 희귀 외 | 의약품-품목허가-안유-기시-GMP | ․전자민원의 경우: 1,134,000원 | 한 미생물의 증식을 억제하기 위 | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 431,
        "window_size": 3,
        "char_count": 137,
        "word_count": 34,
        "page_number": 1,
        "window_text": "생물학적제제등이 아닌 것으로서 제1호가 | ② 제1항에 따라 의약품등의 제조판매ᆞ수입 | 목별 허가를 받거나 신고를 하지 아니하고 수 | 인하여야 한다.  | 목·나목·다목 및 마목에 해당하는 품목 | 제4조(제조판매·수입 품목의 허가 신청) ① 법 | 등에 의하여 해당 제조시설·제조방법 등을 양 | 단서에 해당하는 사람임을 증명하는 전문의의 |\n| ※ 참고 - 대한민국약전(제11개정) 통칙 중 방사선을 차폐하는 용기의 조건 | ▷ 자료제출의약품 | 수도 있다.  그러므로 표적물질의 매 배치 품질관리는 | 을 측정한다.  생리학적 분포는 각 기관 또는 조직들에 | - 공정서 품목 : 해당 공정서의 명칭(또는 약칭) 기재 | 신약, 희귀 외 | 의약품-품목허가-안유-기시-GMP | ․전자민원의 경우: 1,134,000원 | 한 미생물의 증식을 억제하기 위 | 다.  양전자들은 주위 전자들과 결합하여 소멸할 때 각 | 는 것은 235U의 핵분열이다.  핵반응기에서 우라늄(235U) | 규정에 따라 품목허가를 받거나 품목신고를 한 |\n| ü 의약품 제조 및 품질관리에 관한 규정 | 나.  삭제 <2014.8.21.> | ⑥ 식품의약품안전처장 또는 지방청장은 제1항 | 5. ",
        "original_sentence": "생리학적 분포는 각 기관 또는 조직들에 | - 공정서 품목 : 해당 공정서의 명칭(또는 약칭) 기재 | 신약, 희귀 외 | 의약품-품목허가-안유-기시-GMP | ․전자민원의 경우: 1,134,000원 | 한 미생물의 증식을 억제하기 위 | 다. "
      }
    },
    {
      "chunk_id": "chunk_433",
      "text": "양전자들은 주위 전자들과 결합하여 소멸할 때 각 | 는 것은 235U의 핵분열이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 432,
        "window_size": 3,
        "char_count": 47,
        "word_count": 12,
        "page_number": 3,
        "window_text": "| 목·나목·다목 및 마목에 해당하는 품목 | 제4조(제조판매·수입 품목의 허가 신청) ① 법 | 등에 의하여 해당 제조시설·제조방법 등을 양 | 단서에 해당하는 사람임을 증명하는 전문의의 |\n| ※ 참고 - 대한민국약전(제11개정) 통칙 중 방사선을 차폐하는 용기의 조건 | ▷ 자료제출의약품 | 수도 있다.  그러므로 표적물질의 매 배치 품질관리는 | 을 측정한다.  생리학적 분포는 각 기관 또는 조직들에 | - 공정서 품목 : 해당 공정서의 명칭(또는 약칭) 기재 | 신약, 희귀 외 | 의약품-품목허가-안유-기시-GMP | ․전자민원의 경우: 1,134,000원 | 한 미생물의 증식을 억제하기 위 | 다.  양전자들은 주위 전자들과 결합하여 소멸할 때 각 | 는 것은 235U의 핵분열이다.  핵반응기에서 우라늄(235U) | 규정에 따라 품목허가를 받거나 품목신고를 한 |\n| ü 의약품 제조 및 품질관리에 관한 규정 | 나.  삭제 <2014.8.21.> | ⑥ 식품의약품안전처장 또는 지방청장은 제1항 | 5.  제조방법(주성분의 제조소와 모든 제조공정의 소재지를 기재한다) | 입할 수 있다. ",
        "original_sentence": "양전자들은 주위 전자들과 결합하여 소멸할 때 각 | 는 것은 235U의 핵분열이다. "
      }
    },
    {
      "chunk_id": "chunk_434",
      "text": "핵반응기에서 우라늄(235U) | 규정에 따라 품목허가를 받거나 품목신고를 한 |\n| ü 의약품 제조 및 품질관리에 관한 규정 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 433,
        "window_size": 3,
        "char_count": 76,
        "word_count": 20,
        "page_number": 3,
        "window_text": "그러므로 표적물질의 매 배치 품질관리는 | 을 측정한다.  생리학적 분포는 각 기관 또는 조직들에 | - 공정서 품목 : 해당 공정서의 명칭(또는 약칭) 기재 | 신약, 희귀 외 | 의약품-품목허가-안유-기시-GMP | ․전자민원의 경우: 1,134,000원 | 한 미생물의 증식을 억제하기 위 | 다.  양전자들은 주위 전자들과 결합하여 소멸할 때 각 | 는 것은 235U의 핵분열이다.  핵반응기에서 우라늄(235U) | 규정에 따라 품목허가를 받거나 품목신고를 한 |\n| ü 의약품 제조 및 품질관리에 관한 규정 | 나.  삭제 <2014.8.21.> | ⑥ 식품의약품안전처장 또는 지방청장은 제1항 | 5.  제조방법(주성분의 제조소와 모든 제조공정의 소재지를 기재한다) | 입할 수 있다.  <개정 2011.3.30., 2013.3.23.> | 품목신고를 하려는 자는 별지 제6호서식의 의 | 자료, 제조지원설비 밸리데이션 자료, 컴퓨터시스템 밸리데이션 자료 | 목ᆞ나목ᆞ다목 및 마목에 해당하는 품목 | - 조제하여 사용하는 방사성의약품(일명: Cold Vial)은 표지품목의 효능․효과를 함께 기재 | 수받은 품목의 제조판매·수입 품목허가를 받 | 진단서 및 같은 조 제3호에 해당되는 사람이 |\n| 방서성핵종의 일상적인 생산 및 방사성의약품의 제조 | 서 확인되는 방사능 노출량의 비율로 계산하고 방사성 | 해 적절한 보존제를 넣는다. ",
        "original_sentence": "핵반응기에서 우라늄(235U) | 규정에 따라 품목허가를 받거나 품목신고를 한 |\n| ü 의약품 제조 및 품질관리에 관한 규정 | 나. "
      }
    },
    {
      "chunk_id": "chunk_435",
      "text": "삭제 <2014.8.21.> | ⑥ 식품의약품안전처장 또는 지방청장은 제1항 | 5. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 434,
        "window_size": 3,
        "char_count": 48,
        "word_count": 10,
        "page_number": 3,
        "window_text": "생리학적 분포는 각 기관 또는 조직들에 | - 공정서 품목 : 해당 공정서의 명칭(또는 약칭) 기재 | 신약, 희귀 외 | 의약품-품목허가-안유-기시-GMP | ․전자민원의 경우: 1,134,000원 | 한 미생물의 증식을 억제하기 위 | 다.  양전자들은 주위 전자들과 결합하여 소멸할 때 각 | 는 것은 235U의 핵분열이다.  핵반응기에서 우라늄(235U) | 규정에 따라 품목허가를 받거나 품목신고를 한 |\n| ü 의약품 제조 및 품질관리에 관한 규정 | 나.  삭제 <2014.8.21.> | ⑥ 식품의약품안전처장 또는 지방청장은 제1항 | 5.  제조방법(주성분의 제조소와 모든 제조공정의 소재지를 기재한다) | 입할 수 있다.  <개정 2011.3.30., 2013.3.23.> | 품목신고를 하려는 자는 별지 제6호서식의 의 | 자료, 제조지원설비 밸리데이션 자료, 컴퓨터시스템 밸리데이션 자료 | 목ᆞ나목ᆞ다목 및 마목에 해당하는 품목 | - 조제하여 사용하는 방사성의약품(일명: Cold Vial)은 표지품목의 효능․효과를 함께 기재 | 수받은 품목의 제조판매·수입 품목허가를 받 | 진단서 및 같은 조 제3호에 해당되는 사람이 |\n| 방서성핵종의 일상적인 생산 및 방사성의약품의 제조 | 서 확인되는 방사능 노출량의 비율로 계산하고 방사성 | 해 적절한 보존제를 넣는다.  | 각 0.511 MeV의 에너지를 가진 2개의 감마 광자를 방 | 을 조사(irradiation)하여 생성된 200개 이상의 방사성 | 제4조(제조판매ᆞ수입 품목의 허가 신청) ① 법 | 제31조제2항부터 제4항까지 또는 법 제42조제 |\n| * 밸리데이션 실시계획서(Validation protocol) 및 밸리데이션 결과보고서(Validation report)제출(요약본) | 1. ",
        "original_sentence": "삭제 <2014.8.21.> | ⑥ 식품의약품안전처장 또는 지방청장은 제1항 | 5. "
      }
    },
    {
      "chunk_id": "chunk_436",
      "text": "제조방법(주성분의 제조소와 모든 제조공정의 소재지를 기재한다) | 입할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 435,
        "window_size": 3,
        "char_count": 46,
        "word_count": 10,
        "page_number": 3,
        "window_text": "양전자들은 주위 전자들과 결합하여 소멸할 때 각 | 는 것은 235U의 핵분열이다.  핵반응기에서 우라늄(235U) | 규정에 따라 품목허가를 받거나 품목신고를 한 |\n| ü 의약품 제조 및 품질관리에 관한 규정 | 나.  삭제 <2014.8.21.> | ⑥ 식품의약품안전처장 또는 지방청장은 제1항 | 5.  제조방법(주성분의 제조소와 모든 제조공정의 소재지를 기재한다) | 입할 수 있다.  <개정 2011.3.30., 2013.3.23.> | 품목신고를 하려는 자는 별지 제6호서식의 의 | 자료, 제조지원설비 밸리데이션 자료, 컴퓨터시스템 밸리데이션 자료 | 목ᆞ나목ᆞ다목 및 마목에 해당하는 품목 | - 조제하여 사용하는 방사성의약품(일명: Cold Vial)은 표지품목의 효능․효과를 함께 기재 | 수받은 품목의 제조판매·수입 품목허가를 받 | 진단서 및 같은 조 제3호에 해당되는 사람이 |\n| 방서성핵종의 일상적인 생산 및 방사성의약품의 제조 | 서 확인되는 방사능 노출량의 비율로 계산하고 방사성 | 해 적절한 보존제를 넣는다.  | 각 0.511 MeV의 에너지를 가진 2개의 감마 광자를 방 | 을 조사(irradiation)하여 생성된 200개 이상의 방사성 | 제4조(제조판매ᆞ수입 품목의 허가 신청) ① 법 | 제31조제2항부터 제4항까지 또는 법 제42조제 |\n| * 밸리데이션 실시계획서(Validation protocol) 및 밸리데이션 결과보고서(Validation report)제출(요약본) | 1.  국방부장관이 긴급히 군사 목적에 사용하기 | 나. ",
        "original_sentence": "제조방법(주성분의 제조소와 모든 제조공정의 소재지를 기재한다) | 입할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_437",
      "text": "<개정 2011.3.30., 2013.3.23.> | 품목신고를 하려는 자는 별지 제6호서식의 의 | 자료, 제조지원설비 밸리데이션 자료, 컴퓨터시스템 밸리데이션 자료 | 목ᆞ나목ᆞ다목 및 마목에 해당하는 품목 | - 조제하여 사용하는 방사성의약품(일명: Cold Vial)은 표지품목의 효능․효과를 함께 기재 | 수받은 품목의 제조판매·수입 품목허가를 받 | 진단서 및 같은 조 제3호에 해당되는 사람이 |\n| 방서성핵종의 일상적인 생산 및 방사성의약품의 제조 | 서 확인되는 방사능 노출량의 비율로 계산하고 방사성 | 해 적절한 보존제를 넣는다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 436,
        "window_size": 3,
        "char_count": 308,
        "word_count": 70,
        "page_number": 3,
        "window_text": "핵반응기에서 우라늄(235U) | 규정에 따라 품목허가를 받거나 품목신고를 한 |\n| ü 의약품 제조 및 품질관리에 관한 규정 | 나.  삭제 <2014.8.21.> | ⑥ 식품의약품안전처장 또는 지방청장은 제1항 | 5.  제조방법(주성분의 제조소와 모든 제조공정의 소재지를 기재한다) | 입할 수 있다.  <개정 2011.3.30., 2013.3.23.> | 품목신고를 하려는 자는 별지 제6호서식의 의 | 자료, 제조지원설비 밸리데이션 자료, 컴퓨터시스템 밸리데이션 자료 | 목ᆞ나목ᆞ다목 및 마목에 해당하는 품목 | - 조제하여 사용하는 방사성의약품(일명: Cold Vial)은 표지품목의 효능․효과를 함께 기재 | 수받은 품목의 제조판매·수입 품목허가를 받 | 진단서 및 같은 조 제3호에 해당되는 사람이 |\n| 방서성핵종의 일상적인 생산 및 방사성의약품의 제조 | 서 확인되는 방사능 노출량의 비율로 계산하고 방사성 | 해 적절한 보존제를 넣는다.  | 각 0.511 MeV의 에너지를 가진 2개의 감마 광자를 방 | 을 조사(irradiation)하여 생성된 200개 이상의 방사성 | 제4조(제조판매ᆞ수입 품목의 허가 신청) ① 법 | 제31조제2항부터 제4항까지 또는 법 제42조제 |\n| * 밸리데이션 실시계획서(Validation protocol) 및 밸리데이션 결과보고서(Validation report)제출(요약본) | 1.  국방부장관이 긴급히 군사 목적에 사용하기 | 나.  적절한 대체의약품이 없어 긴급히 도입하 | 3. ",
        "original_sentence": "<개정 2011.3.30., 2013.3.23.> | 품목신고를 하려는 자는 별지 제6호서식의 의 | 자료, 제조지원설비 밸리데이션 자료, 컴퓨터시스템 밸리데이션 자료 | 목ᆞ나목ᆞ다목 및 마목에 해당하는 품목 | - 조제하여 사용하는 방사성의약품(일명: Cold Vial)은 표지품목의 효능․효과를 함께 기재 | 수받은 품목의 제조판매·수입 품목허가를 받 | 진단서 및 같은 조 제3호에 해당되는 사람이 |\n| 방서성핵종의 일상적인 생산 및 방사성의약품의 제조 | 서 확인되는 방사능 노출량의 비율로 계산하고 방사성 | 해 적절한 보존제를 넣는다. "
      }
    },
    {
      "chunk_id": "chunk_438",
      "text": "| 각 0.511 MeV의 에너지를 가진 2개의 감마 광자를 방 | 을 조사(irradiation)하여 생성된 200개 이상의 방사성 | 제4조(제조판매ᆞ수입 품목의 허가 신청) ① 법 | 제31조제2항부터 제4항까지 또는 법 제42조제 |\n| * 밸리데이션 실시계획서(Validation protocol) 및 밸리데이션 결과보고서(Validation report)제출(요약본) | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 437,
        "window_size": 3,
        "char_count": 217,
        "word_count": 42,
        "page_number": 3,
        "window_text": "삭제 <2014.8.21.> | ⑥ 식품의약품안전처장 또는 지방청장은 제1항 | 5.  제조방법(주성분의 제조소와 모든 제조공정의 소재지를 기재한다) | 입할 수 있다.  <개정 2011.3.30., 2013.3.23.> | 품목신고를 하려는 자는 별지 제6호서식의 의 | 자료, 제조지원설비 밸리데이션 자료, 컴퓨터시스템 밸리데이션 자료 | 목ᆞ나목ᆞ다목 및 마목에 해당하는 품목 | - 조제하여 사용하는 방사성의약품(일명: Cold Vial)은 표지품목의 효능․효과를 함께 기재 | 수받은 품목의 제조판매·수입 품목허가를 받 | 진단서 및 같은 조 제3호에 해당되는 사람이 |\n| 방서성핵종의 일상적인 생산 및 방사성의약품의 제조 | 서 확인되는 방사능 노출량의 비율로 계산하고 방사성 | 해 적절한 보존제를 넣는다.  | 각 0.511 MeV의 에너지를 가진 2개의 감마 광자를 방 | 을 조사(irradiation)하여 생성된 200개 이상의 방사성 | 제4조(제조판매ᆞ수입 품목의 허가 신청) ① 법 | 제31조제2항부터 제4항까지 또는 법 제42조제 |\n| * 밸리데이션 실시계획서(Validation protocol) 및 밸리데이션 결과보고서(Validation report)제출(요약본) | 1.  국방부장관이 긴급히 군사 목적에 사용하기 | 나.  적절한 대체의약품이 없어 긴급히 도입하 | 3.  다음 각 목의 어느 하나에 해당하는 품목의 | 약품등 제조판매ᆞ수입 품목신고서(전자문서로 | 에 따라 변경허가를 하거나 변경신고를 받을 | T1/2 | = | ln 2 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 아님을 증명하는 의사의 진단서를 첨부하여야 |\n| - 재심사 부여 | 52. ",
        "original_sentence": "| 각 0.511 MeV의 에너지를 가진 2개의 감마 광자를 방 | 을 조사(irradiation)하여 생성된 200개 이상의 방사성 | 제4조(제조판매ᆞ수입 품목의 허가 신청) ① 법 | 제31조제2항부터 제4항까지 또는 법 제42조제 |\n| * 밸리데이션 실시계획서(Validation protocol) 및 밸리데이션 결과보고서(Validation report)제출(요약본) | 1. "
      }
    },
    {
      "chunk_id": "chunk_439",
      "text": "국방부장관이 긴급히 군사 목적에 사용하기 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 438,
        "window_size": 3,
        "char_count": 28,
        "word_count": 7,
        "page_number": 5,
        "window_text": "제조방법(주성분의 제조소와 모든 제조공정의 소재지를 기재한다) | 입할 수 있다.  <개정 2011.3.30., 2013.3.23.> | 품목신고를 하려는 자는 별지 제6호서식의 의 | 자료, 제조지원설비 밸리데이션 자료, 컴퓨터시스템 밸리데이션 자료 | 목ᆞ나목ᆞ다목 및 마목에 해당하는 품목 | - 조제하여 사용하는 방사성의약품(일명: Cold Vial)은 표지품목의 효능․효과를 함께 기재 | 수받은 품목의 제조판매·수입 품목허가를 받 | 진단서 및 같은 조 제3호에 해당되는 사람이 |\n| 방서성핵종의 일상적인 생산 및 방사성의약품의 제조 | 서 확인되는 방사능 노출량의 비율로 계산하고 방사성 | 해 적절한 보존제를 넣는다.  | 각 0.511 MeV의 에너지를 가진 2개의 감마 광자를 방 | 을 조사(irradiation)하여 생성된 200개 이상의 방사성 | 제4조(제조판매ᆞ수입 품목의 허가 신청) ① 법 | 제31조제2항부터 제4항까지 또는 법 제42조제 |\n| * 밸리데이션 실시계획서(Validation protocol) 및 밸리데이션 결과보고서(Validation report)제출(요약본) | 1.  국방부장관이 긴급히 군사 목적에 사용하기 | 나.  적절한 대체의약품이 없어 긴급히 도입하 | 3.  다음 각 목의 어느 하나에 해당하는 품목의 | 약품등 제조판매ᆞ수입 품목신고서(전자문서로 | 에 따라 변경허가를 하거나 변경신고를 받을 | T1/2 | = | ln 2 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 아님을 증명하는 의사의 진단서를 첨부하여야 |\n| - 재심사 부여 | 52.  방사성의약품에서 방사선을 차폐하는 용기는 충분한 차폐능력이 있는 것을 쓴다. ",
        "original_sentence": "국방부장관이 긴급히 군사 목적에 사용하기 | 나. "
      }
    },
    {
      "chunk_id": "chunk_440",
      "text": "적절한 대체의약품이 없어 긴급히 도입하 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 439,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 3,
        "window_text": "<개정 2011.3.30., 2013.3.23.> | 품목신고를 하려는 자는 별지 제6호서식의 의 | 자료, 제조지원설비 밸리데이션 자료, 컴퓨터시스템 밸리데이션 자료 | 목ᆞ나목ᆞ다목 및 마목에 해당하는 품목 | - 조제하여 사용하는 방사성의약품(일명: Cold Vial)은 표지품목의 효능․효과를 함께 기재 | 수받은 품목의 제조판매·수입 품목허가를 받 | 진단서 및 같은 조 제3호에 해당되는 사람이 |\n| 방서성핵종의 일상적인 생산 및 방사성의약품의 제조 | 서 확인되는 방사능 노출량의 비율로 계산하고 방사성 | 해 적절한 보존제를 넣는다.  | 각 0.511 MeV의 에너지를 가진 2개의 감마 광자를 방 | 을 조사(irradiation)하여 생성된 200개 이상의 방사성 | 제4조(제조판매ᆞ수입 품목의 허가 신청) ① 법 | 제31조제2항부터 제4항까지 또는 법 제42조제 |\n| * 밸리데이션 실시계획서(Validation protocol) 및 밸리데이션 결과보고서(Validation report)제출(요약본) | 1.  국방부장관이 긴급히 군사 목적에 사용하기 | 나.  적절한 대체의약품이 없어 긴급히 도입하 | 3.  다음 각 목의 어느 하나에 해당하는 품목의 | 약품등 제조판매ᆞ수입 품목신고서(전자문서로 | 에 따라 변경허가를 하거나 변경신고를 받을 | T1/2 | = | ln 2 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 아님을 증명하는 의사의 진단서를 첨부하여야 |\n| - 재심사 부여 | 52.  방사성의약품에서 방사선을 차폐하는 용기는 충분한 차폐능력이 있는 것을 쓴다.  용기의 외장은 쉽게 | 6. ",
        "original_sentence": "적절한 대체의약품이 없어 긴급히 도입하 | 3. "
      }
    },
    {
      "chunk_id": "chunk_441",
      "text": "다음 각 목의 어느 하나에 해당하는 품목의 | 약품등 제조판매ᆞ수입 품목신고서(전자문서로 | 에 따라 변경허가를 하거나 변경신고를 받을 | T1/2 | = | ln 2 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 아님을 증명하는 의사의 진단서를 첨부하여야 |\n| - 재심사 부여 | 52. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 440,
        "window_size": 3,
        "char_count": 167,
        "word_count": 47,
        "page_number": 3,
        "window_text": "| 각 0.511 MeV의 에너지를 가진 2개의 감마 광자를 방 | 을 조사(irradiation)하여 생성된 200개 이상의 방사성 | 제4조(제조판매ᆞ수입 품목의 허가 신청) ① 법 | 제31조제2항부터 제4항까지 또는 법 제42조제 |\n| * 밸리데이션 실시계획서(Validation protocol) 및 밸리데이션 결과보고서(Validation report)제출(요약본) | 1.  국방부장관이 긴급히 군사 목적에 사용하기 | 나.  적절한 대체의약품이 없어 긴급히 도입하 | 3.  다음 각 목의 어느 하나에 해당하는 품목의 | 약품등 제조판매ᆞ수입 품목신고서(전자문서로 | 에 따라 변경허가를 하거나 변경신고를 받을 | T1/2 | = | ln 2 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 아님을 증명하는 의사의 진단서를 첨부하여야 |\n| - 재심사 부여 | 52.  방사성의약품에서 방사선을 차폐하는 용기는 충분한 차폐능력이 있는 것을 쓴다.  용기의 외장은 쉽게 | 6.  효능ㆍ효과 | 공정서 명칭 | 약칭 | 공정서 명칭 | 공정서 명칭 | ⑧ 다음 각 호의 어느 하나에 해당하는 자는 의 | 제31조제2항부터 제4항까지 또는 법 제42조제 | 1항에 따라 의약품등의 제조판매·수입 품목허 |\n| * 적격성평가 자료는 운전적격성평가(OQ), 성능적격성평가(PQ)에 관한 자료 제출. ",
        "original_sentence": "다음 각 목의 어느 하나에 해당하는 품목의 | 약품등 제조판매ᆞ수입 품목신고서(전자문서로 | 에 따라 변경허가를 하거나 변경신고를 받을 | T1/2 | = | ln 2 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 아님을 증명하는 의사의 진단서를 첨부하여야 |\n| - 재심사 부여 | 52. "
      }
    },
    {
      "chunk_id": "chunk_442",
      "text": "방사성의약품에서 방사선을 차폐하는 용기는 충분한 차폐능력이 있는 것을 쓴다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 441,
        "window_size": 3,
        "char_count": 43,
        "word_count": 9,
        "page_number": 5,
        "window_text": "국방부장관이 긴급히 군사 목적에 사용하기 | 나.  적절한 대체의약품이 없어 긴급히 도입하 | 3.  다음 각 목의 어느 하나에 해당하는 품목의 | 약품등 제조판매ᆞ수입 품목신고서(전자문서로 | 에 따라 변경허가를 하거나 변경신고를 받을 | T1/2 | = | ln 2 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 아님을 증명하는 의사의 진단서를 첨부하여야 |\n| - 재심사 부여 | 52.  방사성의약품에서 방사선을 차폐하는 용기는 충분한 차폐능력이 있는 것을 쓴다.  용기의 외장은 쉽게 | 6.  효능ㆍ효과 | 공정서 명칭 | 약칭 | 공정서 명칭 | 공정서 명칭 | ⑧ 다음 각 호의 어느 하나에 해당하는 자는 의 | 제31조제2항부터 제4항까지 또는 법 제42조제 | 1항에 따라 의약품등의 제조판매·수입 품목허 |\n| * 적격성평가 자료는 운전적격성평가(OQ), 성능적격성평가(PQ)에 관한 자료 제출.  다만, 기존에 설치하여 현재 | 에 사용하기 전에 평가된다. ",
        "original_sentence": "방사성의약품에서 방사선을 차폐하는 용기는 충분한 차폐능력이 있는 것을 쓴다. "
      }
    },
    {
      "chunk_id": "chunk_443",
      "text": "용기의 외장은 쉽게 | 6. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 442,
        "window_size": 3,
        "char_count": 16,
        "word_count": 5,
        "page_number": 3,
        "window_text": "적절한 대체의약품이 없어 긴급히 도입하 | 3.  다음 각 목의 어느 하나에 해당하는 품목의 | 약품등 제조판매ᆞ수입 품목신고서(전자문서로 | 에 따라 변경허가를 하거나 변경신고를 받을 | T1/2 | = | ln 2 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 아님을 증명하는 의사의 진단서를 첨부하여야 |\n| - 재심사 부여 | 52.  방사성의약품에서 방사선을 차폐하는 용기는 충분한 차폐능력이 있는 것을 쓴다.  용기의 외장은 쉽게 | 6.  효능ㆍ효과 | 공정서 명칭 | 약칭 | 공정서 명칭 | 공정서 명칭 | ⑧ 다음 각 호의 어느 하나에 해당하는 자는 의 | 제31조제2항부터 제4항까지 또는 법 제42조제 | 1항에 따라 의약품등의 제조판매·수입 품목허 |\n| * 적격성평가 자료는 운전적격성평가(OQ), 성능적격성평가(PQ)에 관한 자료 제출.  다만, 기존에 설치하여 현재 | 에 사용하기 전에 평가된다.  | 붕괴로 인한 양은 보정한다. ",
        "original_sentence": "용기의 외장은 쉽게 | 6. "
      }
    },
    {
      "chunk_id": "chunk_444",
      "text": "효능ㆍ효과 | 공정서 명칭 | 약칭 | 공정서 명칭 | 공정서 명칭 | ⑧ 다음 각 호의 어느 하나에 해당하는 자는 의 | 제31조제2항부터 제4항까지 또는 법 제42조제 | 1항에 따라 의약품등의 제조판매·수입 품목허 |\n| * 적격성평가 자료는 운전적격성평가(OQ), 성능적격성평가(PQ)에 관한 자료 제출. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 443,
        "window_size": 3,
        "char_count": 175,
        "word_count": 44,
        "page_number": 1,
        "window_text": "다음 각 목의 어느 하나에 해당하는 품목의 | 약품등 제조판매ᆞ수입 품목신고서(전자문서로 | 에 따라 변경허가를 하거나 변경신고를 받을 | T1/2 | = | ln 2 | 으려는 자의 경우에는 제1항 각 호의 어느 하 | 아님을 증명하는 의사의 진단서를 첨부하여야 |\n| - 재심사 부여 | 52.  방사성의약품에서 방사선을 차폐하는 용기는 충분한 차폐능력이 있는 것을 쓴다.  용기의 외장은 쉽게 | 6.  효능ㆍ효과 | 공정서 명칭 | 약칭 | 공정서 명칭 | 공정서 명칭 | ⑧ 다음 각 호의 어느 하나에 해당하는 자는 의 | 제31조제2항부터 제4항까지 또는 법 제42조제 | 1항에 따라 의약품등의 제조판매·수입 품목허 |\n| * 적격성평가 자료는 운전적격성평가(OQ), 성능적격성평가(PQ)에 관한 자료 제출.  다만, 기존에 설치하여 현재 | 에 사용하기 전에 평가된다.  | 붕괴로 인한 양은 보정한다.  일부 방사성의약품에서는 | 된 신고서를 포함한다)에 다음 각 호의 자료 | 경우 또는 제103조제1항에 따라 지위 승계 신 | 경우에는 생물학적 동등성시험에 관한 시험 | 여야 하는 의약품으로서 식품의약품안전 | “방사성의약품 품목허가를 위한 안내서” | λ | 핵종들로부터 분리하여 Iodine-131, | molybdenum-99 | 사용된다. ",
        "original_sentence": "효능ㆍ효과 | 공정서 명칭 | 약칭 | 공정서 명칭 | 공정서 명칭 | ⑧ 다음 각 호의 어느 하나에 해당하는 자는 의 | 제31조제2항부터 제4항까지 또는 법 제42조제 | 1항에 따라 의약품등의 제조판매·수입 품목허 |\n| * 적격성평가 자료는 운전적격성평가(OQ), 성능적격성평가(PQ)에 관한 자료 제출. "
      }
    },
    {
      "chunk_id": "chunk_445",
      "text": "다만, 기존에 설치하여 현재 | 에 사용하기 전에 평가된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 444,
        "window_size": 3,
        "char_count": 34,
        "word_count": 9,
        "page_number": 9,
        "window_text": "방사성의약품에서 방사선을 차폐하는 용기는 충분한 차폐능력이 있는 것을 쓴다.  용기의 외장은 쉽게 | 6.  효능ㆍ효과 | 공정서 명칭 | 약칭 | 공정서 명칭 | 공정서 명칭 | ⑧ 다음 각 호의 어느 하나에 해당하는 자는 의 | 제31조제2항부터 제4항까지 또는 법 제42조제 | 1항에 따라 의약품등의 제조판매·수입 품목허 |\n| * 적격성평가 자료는 운전적격성평가(OQ), 성능적격성평가(PQ)에 관한 자료 제출.  다만, 기존에 설치하여 현재 | 에 사용하기 전에 평가된다.  | 붕괴로 인한 양은 보정한다.  일부 방사성의약품에서는 | 된 신고서를 포함한다)에 다음 각 호의 자료 | 경우 또는 제103조제1항에 따라 지위 승계 신 | 경우에는 생물학적 동등성시험에 관한 시험 | 여야 하는 의약품으로서 식품의약품안전 | “방사성의약품 품목허가를 위한 안내서” | λ | 핵종들로부터 분리하여 Iodine-131, | molybdenum-99 | 사용된다.  예를 들면, 방사성의약품 각조에서 여지크로 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 |\n| 파손되지 않는 것을 쓴다. ",
        "original_sentence": "다만, 기존에 설치하여 현재 | 에 사용하기 전에 평가된다. "
      }
    },
    {
      "chunk_id": "chunk_446",
      "text": "| 붕괴로 인한 양은 보정한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 445,
        "window_size": 3,
        "char_count": 18,
        "word_count": 5,
        "page_number": 9,
        "window_text": "용기의 외장은 쉽게 | 6.  효능ㆍ효과 | 공정서 명칭 | 약칭 | 공정서 명칭 | 공정서 명칭 | ⑧ 다음 각 호의 어느 하나에 해당하는 자는 의 | 제31조제2항부터 제4항까지 또는 법 제42조제 | 1항에 따라 의약품등의 제조판매·수입 품목허 |\n| * 적격성평가 자료는 운전적격성평가(OQ), 성능적격성평가(PQ)에 관한 자료 제출.  다만, 기존에 설치하여 현재 | 에 사용하기 전에 평가된다.  | 붕괴로 인한 양은 보정한다.  일부 방사성의약품에서는 | 된 신고서를 포함한다)에 다음 각 호의 자료 | 경우 또는 제103조제1항에 따라 지위 승계 신 | 경우에는 생물학적 동등성시험에 관한 시험 | 여야 하는 의약품으로서 식품의약품안전 | “방사성의약품 품목허가를 위한 안내서” | λ | 핵종들로부터 분리하여 Iodine-131, | molybdenum-99 | 사용된다.  예를 들면, 방사성의약품 각조에서 여지크로 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 |\n| 파손되지 않는 것을 쓴다.  용기 외장에서의 최대 방사선량율은 다음과 같이 한다. ",
        "original_sentence": "| 붕괴로 인한 양은 보정한다. "
      }
    },
    {
      "chunk_id": "chunk_447",
      "text": "일부 방사성의약품에서는 | 된 신고서를 포함한다)에 다음 각 호의 자료 | 경우 또는 제103조제1항에 따라 지위 승계 신 | 경우에는 생물학적 동등성시험에 관한 시험 | 여야 하는 의약품으로서 식품의약품안전 | “방사성의약품 품목허가를 위한 안내서” | λ | 핵종들로부터 분리하여 Iodine-131, | molybdenum-99 | 사용된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 446,
        "window_size": 3,
        "char_count": 195,
        "word_count": 44,
        "page_number": 3,
        "window_text": "효능ㆍ효과 | 공정서 명칭 | 약칭 | 공정서 명칭 | 공정서 명칭 | ⑧ 다음 각 호의 어느 하나에 해당하는 자는 의 | 제31조제2항부터 제4항까지 또는 법 제42조제 | 1항에 따라 의약품등의 제조판매·수입 품목허 |\n| * 적격성평가 자료는 운전적격성평가(OQ), 성능적격성평가(PQ)에 관한 자료 제출.  다만, 기존에 설치하여 현재 | 에 사용하기 전에 평가된다.  | 붕괴로 인한 양은 보정한다.  일부 방사성의약품에서는 | 된 신고서를 포함한다)에 다음 각 호의 자료 | 경우 또는 제103조제1항에 따라 지위 승계 신 | 경우에는 생물학적 동등성시험에 관한 시험 | 여야 하는 의약품으로서 식품의약품안전 | “방사성의약품 품목허가를 위한 안내서” | λ | 핵종들로부터 분리하여 Iodine-131, | molybdenum-99 | 사용된다.  예를 들면, 방사성의약품 각조에서 여지크로 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 |\n| 파손되지 않는 것을 쓴다.  용기 외장에서의 최대 방사선량율은 다음과 같이 한다.  | 위하여 국내에서 생산되지 아니하는 의약품 | 제출자료 |\n| 2.2 품목허가 신청 및 처리 절차 | 표적물질은 입자들의 빔에 의해 조사되기 위해 기체, | 구분 | 7. ",
        "original_sentence": "일부 방사성의약품에서는 | 된 신고서를 포함한다)에 다음 각 호의 자료 | 경우 또는 제103조제1항에 따라 지위 승계 신 | 경우에는 생물학적 동등성시험에 관한 시험 | 여야 하는 의약품으로서 식품의약품안전 | “방사성의약품 품목허가를 위한 안내서” | λ | 핵종들로부터 분리하여 Iodine-131, | molybdenum-99 | 사용된다. "
      }
    },
    {
      "chunk_id": "chunk_448",
      "text": "예를 들면, 방사성의약품 각조에서 여지크로 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 |\n| 파손되지 않는 것을 쓴다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 447,
        "window_size": 3,
        "char_count": 70,
        "word_count": 18,
        "page_number": 5,
        "window_text": "다만, 기존에 설치하여 현재 | 에 사용하기 전에 평가된다.  | 붕괴로 인한 양은 보정한다.  일부 방사성의약품에서는 | 된 신고서를 포함한다)에 다음 각 호의 자료 | 경우 또는 제103조제1항에 따라 지위 승계 신 | 경우에는 생물학적 동등성시험에 관한 시험 | 여야 하는 의약품으로서 식품의약품안전 | “방사성의약품 품목허가를 위한 안내서” | λ | 핵종들로부터 분리하여 Iodine-131, | molybdenum-99 | 사용된다.  예를 들면, 방사성의약품 각조에서 여지크로 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 |\n| 파손되지 않는 것을 쓴다.  용기 외장에서의 최대 방사선량율은 다음과 같이 한다.  | 위하여 국내에서 생산되지 아니하는 의약품 | 제출자료 |\n| 2.2 품목허가 신청 및 처리 절차 | 표적물질은 입자들의 빔에 의해 조사되기 위해 기체, | 구분 | 7.  용법ㆍ용량 | 대한민국약전 | 약전 또는 KP | 유럽약전 | EP | (소멸방사선, | annihilation radiation). ",
        "original_sentence": "예를 들면, 방사성의약품 각조에서 여지크로 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 |\n| 파손되지 않는 것을 쓴다. "
      }
    },
    {
      "chunk_id": "chunk_449",
      "text": "용기 외장에서의 최대 방사선량율은 다음과 같이 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 448,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 5,
        "window_text": "| 붕괴로 인한 양은 보정한다.  일부 방사성의약품에서는 | 된 신고서를 포함한다)에 다음 각 호의 자료 | 경우 또는 제103조제1항에 따라 지위 승계 신 | 경우에는 생물학적 동등성시험에 관한 시험 | 여야 하는 의약품으로서 식품의약품안전 | “방사성의약품 품목허가를 위한 안내서” | λ | 핵종들로부터 분리하여 Iodine-131, | molybdenum-99 | 사용된다.  예를 들면, 방사성의약품 각조에서 여지크로 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 |\n| 파손되지 않는 것을 쓴다.  용기 외장에서의 최대 방사선량율은 다음과 같이 한다.  | 위하여 국내에서 생산되지 아니하는 의약품 | 제출자료 |\n| 2.2 품목허가 신청 및 처리 절차 | 표적물질은 입자들의 빔에 의해 조사되기 위해 기체, | 구분 | 7.  용법ㆍ용량 | 대한민국약전 | 약전 또는 KP | 유럽약전 | EP | (소멸방사선, | annihilation radiation).  모든 붕괴형식 | 마토그래프법, 박층크로마토그래프법, 전기영동법, 크 |\n| 선택된 조직들의 무게 대비 방사능의 비로 계산한다 | <신약에 따른 재심사 부여> | (전자문서를 포함한다)를 첨부하여 지방청장에 | 고를 받은 경우에는 제13조에 따른 허가대장ᆞ |\n| 1) 용기의 외장 표면에서 시간당 2 mSv 이하이다. ",
        "original_sentence": "용기 외장에서의 최대 방사선량율은 다음과 같이 한다. "
      }
    },
    {
      "chunk_id": "chunk_450",
      "text": "| 위하여 국내에서 생산되지 아니하는 의약품 | 제출자료 |\n| 2.2 품목허가 신청 및 처리 절차 | 표적물질은 입자들의 빔에 의해 조사되기 위해 기체, | 구분 | 7. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 449,
        "window_size": 3,
        "char_count": 97,
        "word_count": 28,
        "page_number": 3,
        "window_text": "일부 방사성의약품에서는 | 된 신고서를 포함한다)에 다음 각 호의 자료 | 경우 또는 제103조제1항에 따라 지위 승계 신 | 경우에는 생물학적 동등성시험에 관한 시험 | 여야 하는 의약품으로서 식품의약품안전 | “방사성의약품 품목허가를 위한 안내서” | λ | 핵종들로부터 분리하여 Iodine-131, | molybdenum-99 | 사용된다.  예를 들면, 방사성의약품 각조에서 여지크로 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 |\n| 파손되지 않는 것을 쓴다.  용기 외장에서의 최대 방사선량율은 다음과 같이 한다.  | 위하여 국내에서 생산되지 아니하는 의약품 | 제출자료 |\n| 2.2 품목허가 신청 및 처리 절차 | 표적물질은 입자들의 빔에 의해 조사되기 위해 기체, | 구분 | 7.  용법ㆍ용량 | 대한민국약전 | 약전 또는 KP | 유럽약전 | EP | (소멸방사선, | annihilation radiation).  모든 붕괴형식 | 마토그래프법, 박층크로마토그래프법, 전기영동법, 크 |\n| 선택된 조직들의 무게 대비 방사능의 비로 계산한다 | <신약에 따른 재심사 부여> | (전자문서를 포함한다)를 첨부하여 지방청장에 | 고를 받은 경우에는 제13조에 따른 허가대장ᆞ |\n| 1) 용기의 외장 표면에서 시간당 2 mSv 이하이다.  다만, 전용운반인 경우에는 시간당 10 mSv 이하로 한다. ",
        "original_sentence": "| 위하여 국내에서 생산되지 아니하는 의약품 | 제출자료 |\n| 2.2 품목허가 신청 및 처리 절차 | 표적물질은 입자들의 빔에 의해 조사되기 위해 기체, | 구분 | 7. "
      }
    },
    {
      "chunk_id": "chunk_451",
      "text": "용법ㆍ용량 | 대한민국약전 | 약전 또는 KP | 유럽약전 | EP | (소멸방사선, | annihilation radiation). ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 450,
        "window_size": 3,
        "char_count": 75,
        "word_count": 16,
        "page_number": 6,
        "window_text": "예를 들면, 방사성의약품 각조에서 여지크로 | 나에 해당하는 첨부서류를 갈음하여 품목의 제 |\n| 파손되지 않는 것을 쓴다.  용기 외장에서의 최대 방사선량율은 다음과 같이 한다.  | 위하여 국내에서 생산되지 아니하는 의약품 | 제출자료 |\n| 2.2 품목허가 신청 및 처리 절차 | 표적물질은 입자들의 빔에 의해 조사되기 위해 기체, | 구분 | 7.  용법ㆍ용량 | 대한민국약전 | 약전 또는 KP | 유럽약전 | EP | (소멸방사선, | annihilation radiation).  모든 붕괴형식 | 마토그래프법, 박층크로마토그래프법, 전기영동법, 크 |\n| 선택된 조직들의 무게 대비 방사능의 비로 계산한다 | <신약에 따른 재심사 부여> | (전자문서를 포함한다)를 첨부하여 지방청장에 | 고를 받은 경우에는 제13조에 따른 허가대장ᆞ |\n| 1) 용기의 외장 표면에서 시간당 2 mSv 이하이다.  다만, 전용운반인 경우에는 시간당 10 mSv 이하로 한다.  | 8. ",
        "original_sentence": "용법ㆍ용량 | 대한민국약전 | 약전 또는 KP | 유럽약전 | EP | (소멸방사선, | annihilation radiation). "
      }
    },
    {
      "chunk_id": "chunk_452",
      "text": "모든 붕괴형식 | 마토그래프법, 박층크로마토그래프법, 전기영동법, 크 |\n| 선택된 조직들의 무게 대비 방사능의 비로 계산한다 | <신약에 따른 재심사 부여> | (전자문서를 포함한다)를 첨부하여 지방청장에 | 고를 받은 경우에는 제13조에 따른 허가대장ᆞ |\n| 1) 용기의 외장 표면에서 시간당 2 mSv 이하이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 451,
        "window_size": 3,
        "char_count": 179,
        "word_count": 43,
        "page_number": 10,
        "window_text": "용기 외장에서의 최대 방사선량율은 다음과 같이 한다.  | 위하여 국내에서 생산되지 아니하는 의약품 | 제출자료 |\n| 2.2 품목허가 신청 및 처리 절차 | 표적물질은 입자들의 빔에 의해 조사되기 위해 기체, | 구분 | 7.  용법ㆍ용량 | 대한민국약전 | 약전 또는 KP | 유럽약전 | EP | (소멸방사선, | annihilation radiation).  모든 붕괴형식 | 마토그래프법, 박층크로마토그래프법, 전기영동법, 크 |\n| 선택된 조직들의 무게 대비 방사능의 비로 계산한다 | <신약에 따른 재심사 부여> | (전자문서를 포함한다)를 첨부하여 지방청장에 | 고를 받은 경우에는 제13조에 따른 허가대장ᆞ |\n| 1) 용기의 외장 표면에서 시간당 2 mSv 이하이다.  다만, 전용운반인 경우에는 시간당 10 mSv 이하로 한다.  | 8.  사용상의 주의사항 |\n| 이 식은 t 시간 경과 후 남은 방사능을 빠르게 예측하 | 액체 또는 고체 상태로 홀더에 담겨지며 중성자 조사 | (radioactivity/mass). ",
        "original_sentence": "모든 붕괴형식 | 마토그래프법, 박층크로마토그래프법, 전기영동법, 크 |\n| 선택된 조직들의 무게 대비 방사능의 비로 계산한다 | <신약에 따른 재심사 부여> | (전자문서를 포함한다)를 첨부하여 지방청장에 | 고를 받은 경우에는 제13조에 따른 허가대장ᆞ |\n| 1) 용기의 외장 표면에서 시간당 2 mSv 이하이다. "
      }
    },
    {
      "chunk_id": "chunk_453",
      "text": "다만, 전용운반인 경우에는 시간당 10 mSv 이하로 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 452,
        "window_size": 3,
        "char_count": 34,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| 위하여 국내에서 생산되지 아니하는 의약품 | 제출자료 |\n| 2.2 품목허가 신청 및 처리 절차 | 표적물질은 입자들의 빔에 의해 조사되기 위해 기체, | 구분 | 7.  용법ㆍ용량 | 대한민국약전 | 약전 또는 KP | 유럽약전 | EP | (소멸방사선, | annihilation radiation).  모든 붕괴형식 | 마토그래프법, 박층크로마토그래프법, 전기영동법, 크 |\n| 선택된 조직들의 무게 대비 방사능의 비로 계산한다 | <신약에 따른 재심사 부여> | (전자문서를 포함한다)를 첨부하여 지방청장에 | 고를 받은 경우에는 제13조에 따른 허가대장ᆞ |\n| 1) 용기의 외장 표면에서 시간당 2 mSv 이하이다.  다만, 전용운반인 경우에는 시간당 10 mSv 이하로 한다.  | 8.  사용상의 주의사항 |\n| 이 식은 t 시간 경과 후 남은 방사능을 빠르게 예측하 | 액체 또는 고체 상태로 홀더에 담겨지며 중성자 조사 | (radioactivity/mass).  | 게 제출하여야 한다. ",
        "original_sentence": "다만, 전용운반인 경우에는 시간당 10 mSv 이하로 한다. "
      }
    },
    {
      "chunk_id": "chunk_454",
      "text": "| 8. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 453,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "용법ㆍ용량 | 대한민국약전 | 약전 또는 KP | 유럽약전 | EP | (소멸방사선, | annihilation radiation).  모든 붕괴형식 | 마토그래프법, 박층크로마토그래프법, 전기영동법, 크 |\n| 선택된 조직들의 무게 대비 방사능의 비로 계산한다 | <신약에 따른 재심사 부여> | (전자문서를 포함한다)를 첨부하여 지방청장에 | 고를 받은 경우에는 제13조에 따른 허가대장ᆞ |\n| 1) 용기의 외장 표면에서 시간당 2 mSv 이하이다.  다만, 전용운반인 경우에는 시간당 10 mSv 이하로 한다.  | 8.  사용상의 주의사항 |\n| 이 식은 t 시간 경과 후 남은 방사능을 빠르게 예측하 | 액체 또는 고체 상태로 홀더에 담겨지며 중성자 조사 | (radioactivity/mass).  | 게 제출하여야 한다.  | 신고대장, 허가증ᆞ신고증에 변경사항을 적어야 | 기배지크로마토그래프법, 기체크로마토그래프법, 액체 |\n| 2.2.1 품목허가 신청 및 처리 흐름도 | 2) 용기의 외장 표면으로부터 1 m 떨어진 위치에 있어서는 시간당 0.1 mSv 이하이다. ",
        "original_sentence": "| 8. "
      }
    },
    {
      "chunk_id": "chunk_455",
      "text": "사용상의 주의사항 |\n| 이 식은 t 시간 경과 후 남은 방사능을 빠르게 예측하 | 액체 또는 고체 상태로 홀더에 담겨지며 중성자 조사 | (radioactivity/mass). ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 454,
        "window_size": 3,
        "char_count": 100,
        "word_count": 25,
        "page_number": 1,
        "window_text": "모든 붕괴형식 | 마토그래프법, 박층크로마토그래프법, 전기영동법, 크 |\n| 선택된 조직들의 무게 대비 방사능의 비로 계산한다 | <신약에 따른 재심사 부여> | (전자문서를 포함한다)를 첨부하여 지방청장에 | 고를 받은 경우에는 제13조에 따른 허가대장ᆞ |\n| 1) 용기의 외장 표면에서 시간당 2 mSv 이하이다.  다만, 전용운반인 경우에는 시간당 10 mSv 이하로 한다.  | 8.  사용상의 주의사항 |\n| 이 식은 t 시간 경과 후 남은 방사능을 빠르게 예측하 | 액체 또는 고체 상태로 홀더에 담겨지며 중성자 조사 | (radioactivity/mass).  | 게 제출하여야 한다.  | 신고대장, 허가증ᆞ신고증에 변경사항을 적어야 | 기배지크로마토그래프법, 기체크로마토그래프법, 액체 |\n| 2.2.1 품목허가 신청 및 처리 흐름도 | 2) 용기의 외장 표면으로부터 1 m 떨어진 위치에 있어서는 시간당 0.1 mSv 이하이다.  다만, 전용운반인 | Ⅱ.자료제출의약품 | 1.「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 | 규칙」제22조제1항제1호가목의 | 규정에 | 의한 |\n| 4. ",
        "original_sentence": "사용상의 주의사항 |\n| 이 식은 t 시간 경과 후 남은 방사능을 빠르게 예측하 | 액체 또는 고체 상태로 홀더에 담겨지며 중성자 조사 | (radioactivity/mass). "
      }
    },
    {
      "chunk_id": "chunk_456",
      "text": "| 게 제출하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 455,
        "window_size": 3,
        "char_count": 14,
        "word_count": 4,
        "page_number": 9,
        "window_text": "다만, 전용운반인 경우에는 시간당 10 mSv 이하로 한다.  | 8.  사용상의 주의사항 |\n| 이 식은 t 시간 경과 후 남은 방사능을 빠르게 예측하 | 액체 또는 고체 상태로 홀더에 담겨지며 중성자 조사 | (radioactivity/mass).  | 게 제출하여야 한다.  | 신고대장, 허가증ᆞ신고증에 변경사항을 적어야 | 기배지크로마토그래프법, 기체크로마토그래프법, 액체 |\n| 2.2.1 품목허가 신청 및 처리 흐름도 | 2) 용기의 외장 표면으로부터 1 m 떨어진 위치에 있어서는 시간당 0.1 mSv 이하이다.  다만, 전용운반인 | Ⅱ.자료제출의약품 | 1.「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 | 규칙」제22조제1항제1호가목의 | 규정에 | 의한 |\n| 4.  새로운 투여경로 | 3. ",
        "original_sentence": "| 게 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_457",
      "text": "| 신고대장, 허가증ᆞ신고증에 변경사항을 적어야 | 기배지크로마토그래프법, 기체크로마토그래프법, 액체 |\n| 2.2.1 품목허가 신청 및 처리 흐름도 | 2) 용기의 외장 표면으로부터 1 m 떨어진 위치에 있어서는 시간당 0.1 mSv 이하이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 456,
        "window_size": 3,
        "char_count": 138,
        "word_count": 31,
        "page_number": 1,
        "window_text": "| 8.  사용상의 주의사항 |\n| 이 식은 t 시간 경과 후 남은 방사능을 빠르게 예측하 | 액체 또는 고체 상태로 홀더에 담겨지며 중성자 조사 | (radioactivity/mass).  | 게 제출하여야 한다.  | 신고대장, 허가증ᆞ신고증에 변경사항을 적어야 | 기배지크로마토그래프법, 기체크로마토그래프법, 액체 |\n| 2.2.1 품목허가 신청 및 처리 흐름도 | 2) 용기의 외장 표면으로부터 1 m 떨어진 위치에 있어서는 시간당 0.1 mSv 이하이다.  다만, 전용운반인 | Ⅱ.자료제출의약품 | 1.「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 | 규칙」제22조제1항제1호가목의 | 규정에 | 의한 |\n| 4.  새로운 투여경로 | 3.  다음 각 목의 어느 하나에 해당하는 품목의 | 1. ",
        "original_sentence": "| 신고대장, 허가증ᆞ신고증에 변경사항을 적어야 | 기배지크로마토그래프법, 기체크로마토그래프법, 액체 |\n| 2.2.1 품목허가 신청 및 처리 흐름도 | 2) 용기의 외장 표면으로부터 1 m 떨어진 위치에 있어서는 시간당 0.1 mSv 이하이다. "
      }
    },
    {
      "chunk_id": "chunk_458",
      "text": "다만, 전용운반인 | Ⅱ.자료제출의약품 | 1.「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 | 규칙」제22조제1항제1호가목의 | 규정에 | 의한 |\n| 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 457,
        "window_size": 3,
        "char_count": 97,
        "word_count": 23,
        "page_number": 3,
        "window_text": "사용상의 주의사항 |\n| 이 식은 t 시간 경과 후 남은 방사능을 빠르게 예측하 | 액체 또는 고체 상태로 홀더에 담겨지며 중성자 조사 | (radioactivity/mass).  | 게 제출하여야 한다.  | 신고대장, 허가증ᆞ신고증에 변경사항을 적어야 | 기배지크로마토그래프법, 기체크로마토그래프법, 액체 |\n| 2.2.1 품목허가 신청 및 처리 흐름도 | 2) 용기의 외장 표면으로부터 1 m 떨어진 위치에 있어서는 시간당 0.1 mSv 이하이다.  다만, 전용운반인 | Ⅱ.자료제출의약품 | 1.「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 | 규칙」제22조제1항제1호가목의 | 규정에 | 의한 |\n| 4.  새로운 투여경로 | 3.  다음 각 목의 어느 하나에 해당하는 품목의 | 1.  제1항에 따른 신고품목임을 입증하는 자료 | 9. ",
        "original_sentence": "다만, 전용운반인 | Ⅱ.자료제출의약품 | 1.「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 | 규칙」제22조제1항제1호가목의 | 규정에 | 의한 |\n| 4. "
      }
    },
    {
      "chunk_id": "chunk_459",
      "text": "새로운 투여경로 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 458,
        "window_size": 3,
        "char_count": 14,
        "word_count": 4,
        "page_number": 3,
        "window_text": "| 게 제출하여야 한다.  | 신고대장, 허가증ᆞ신고증에 변경사항을 적어야 | 기배지크로마토그래프법, 기체크로마토그래프법, 액체 |\n| 2.2.1 품목허가 신청 및 처리 흐름도 | 2) 용기의 외장 표면으로부터 1 m 떨어진 위치에 있어서는 시간당 0.1 mSv 이하이다.  다만, 전용운반인 | Ⅱ.자료제출의약품 | 1.「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 | 규칙」제22조제1항제1호가목의 | 규정에 | 의한 |\n| 4.  새로운 투여경로 | 3.  다음 각 목의 어느 하나에 해당하는 품목의 | 1.  제1항에 따른 신고품목임을 입증하는 자료 | 9.  포장단위 | 한다. ",
        "original_sentence": "새로운 투여경로 | 3. "
      }
    },
    {
      "chunk_id": "chunk_460",
      "text": "다음 각 목의 어느 하나에 해당하는 품목의 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 459,
        "window_size": 3,
        "char_count": 29,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| 신고대장, 허가증ᆞ신고증에 변경사항을 적어야 | 기배지크로마토그래프법, 기체크로마토그래프법, 액체 |\n| 2.2.1 품목허가 신청 및 처리 흐름도 | 2) 용기의 외장 표면으로부터 1 m 떨어진 위치에 있어서는 시간당 0.1 mSv 이하이다.  다만, 전용운반인 | Ⅱ.자료제출의약품 | 1.「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 | 규칙」제22조제1항제1호가목의 | 규정에 | 의한 |\n| 4.  새로운 투여경로 | 3.  다음 각 목의 어느 하나에 해당하는 품목의 | 1.  제1항에 따른 신고품목임을 입증하는 자료 | 9.  포장단위 | 한다.  |\n| 기 위하여 다음과 같이 나타낼 수 있다. ",
        "original_sentence": "다음 각 목의 어느 하나에 해당하는 품목의 | 1. "
      }
    },
    {
      "chunk_id": "chunk_461",
      "text": "제1항에 따른 신고품목임을 입증하는 자료 | 9. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 460,
        "window_size": 3,
        "char_count": 28,
        "word_count": 7,
        "page_number": 3,
        "window_text": "다만, 전용운반인 | Ⅱ.자료제출의약품 | 1.「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 | 규칙」제22조제1항제1호가목의 | 규정에 | 의한 |\n| 4.  새로운 투여경로 | 3.  다음 각 목의 어느 하나에 해당하는 품목의 | 1.  제1항에 따른 신고품목임을 입증하는 자료 | 9.  포장단위 | 한다.  |\n| 기 위하여 다음과 같이 나타낼 수 있다.  | 시 보통 표적물질을 석영 앰플, 고순도 알루미늄 또는 | 제제는 3마리 실험동물 중 최소 2마리에서 방사능 분 | 2. ",
        "original_sentence": "제1항에 따른 신고품목임을 입증하는 자료 | 9. "
      }
    },
    {
      "chunk_id": "chunk_462",
      "text": "포장단위 | 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 461,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 8,
        "window_text": "새로운 투여경로 | 3.  다음 각 목의 어느 하나에 해당하는 품목의 | 1.  제1항에 따른 신고품목임을 입증하는 자료 | 9.  포장단위 | 한다.  |\n| 기 위하여 다음과 같이 나타낼 수 있다.  | 시 보통 표적물질을 석영 앰플, 고순도 알루미늄 또는 | 제제는 3마리 실험동물 중 최소 2마리에서 방사능 분 | 2.  수입자가 의약품등의 제조를 위하여 원료의 | 안전성․유효성 | 70일 | 방출 대신 부분적으로 또는 완전하게 내부전환전자 | 크로마토그래프법 등이 포함될 수 있다. ",
        "original_sentence": "포장단위 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_463",
      "text": "|\n| 기 위하여 다음과 같이 나타낼 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 462,
        "window_size": 3,
        "char_count": 27,
        "word_count": 9,
        "page_number": 5,
        "window_text": "다음 각 목의 어느 하나에 해당하는 품목의 | 1.  제1항에 따른 신고품목임을 입증하는 자료 | 9.  포장단위 | 한다.  |\n| 기 위하여 다음과 같이 나타낼 수 있다.  | 시 보통 표적물질을 석영 앰플, 고순도 알루미늄 또는 | 제제는 3마리 실험동물 중 최소 2마리에서 방사능 분 | 2.  수입자가 의약품등의 제조를 위하여 원료의 | 안전성․유효성 | 70일 | 방출 대신 부분적으로 또는 완전하게 내부전환전자 | 크로마토그래프법 등이 포함될 수 있다.  이러한 분석 |\n| 2. ",
        "original_sentence": "|\n| 기 위하여 다음과 같이 나타낼 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_464",
      "text": "| 시 보통 표적물질을 석영 앰플, 고순도 알루미늄 또는 | 제제는 3마리 실험동물 중 최소 2마리에서 방사능 분 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 463,
        "window_size": 3,
        "char_count": 69,
        "word_count": 20,
        "page_number": 3,
        "window_text": "제1항에 따른 신고품목임을 입증하는 자료 | 9.  포장단위 | 한다.  |\n| 기 위하여 다음과 같이 나타낼 수 있다.  | 시 보통 표적물질을 석영 앰플, 고순도 알루미늄 또는 | 제제는 3마리 실험동물 중 최소 2마리에서 방사능 분 | 2.  수입자가 의약품등의 제조를 위하여 원료의 | 안전성․유효성 | 70일 | 방출 대신 부분적으로 또는 완전하게 내부전환전자 | 크로마토그래프법 등이 포함될 수 있다.  이러한 분석 |\n| 2.  제4조제1항제2호에 따른 자료(이 조 제1항 | ⑦ 제1항에 따른 신청이나 신고를 하는 자는 | 방사성의약품 | 경우에는 제외한다. ",
        "original_sentence": "| 시 보통 표적물질을 석영 앰플, 고순도 알루미늄 또는 | 제제는 3마리 실험동물 중 최소 2마리에서 방사능 분 | 2. "
      }
    },
    {
      "chunk_id": "chunk_465",
      "text": "수입자가 의약품등의 제조를 위하여 원료의 | 안전성․유효성 | 70일 | 방출 대신 부분적으로 또는 완전하게 내부전환전자 | 크로마토그래프법 등이 포함될 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 464,
        "window_size": 3,
        "char_count": 92,
        "word_count": 22,
        "page_number": 3,
        "window_text": "포장단위 | 한다.  |\n| 기 위하여 다음과 같이 나타낼 수 있다.  | 시 보통 표적물질을 석영 앰플, 고순도 알루미늄 또는 | 제제는 3마리 실험동물 중 최소 2마리에서 방사능 분 | 2.  수입자가 의약품등의 제조를 위하여 원료의 | 안전성․유효성 | 70일 | 방출 대신 부분적으로 또는 완전하게 내부전환전자 | 크로마토그래프법 등이 포함될 수 있다.  이러한 분석 |\n| 2.  제4조제1항제2호에 따른 자료(이 조 제1항 | ⑦ 제1항에 따른 신청이나 신고를 하는 자는 | 방사성의약품 | 경우에는 제외한다.  | 재심사대상 품목임 |\n| 티타늄 용기에 담는다. ",
        "original_sentence": "수입자가 의약품등의 제조를 위하여 원료의 | 안전성․유효성 | 70일 | 방출 대신 부분적으로 또는 완전하게 내부전환전자 | 크로마토그래프법 등이 포함될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_466",
      "text": "이러한 분석 |\n| 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 465,
        "window_size": 3,
        "char_count": 14,
        "word_count": 5,
        "page_number": 3,
        "window_text": "|\n| 기 위하여 다음과 같이 나타낼 수 있다.  | 시 보통 표적물질을 석영 앰플, 고순도 알루미늄 또는 | 제제는 3마리 실험동물 중 최소 2마리에서 방사능 분 | 2.  수입자가 의약품등의 제조를 위하여 원료의 | 안전성․유효성 | 70일 | 방출 대신 부분적으로 또는 완전하게 내부전환전자 | 크로마토그래프법 등이 포함될 수 있다.  이러한 분석 |\n| 2.  제4조제1항제2호에 따른 자료(이 조 제1항 | ⑦ 제1항에 따른 신청이나 신고를 하는 자는 | 방사성의약품 | 경우에는 제외한다.  | 재심사대상 품목임 |\n| 티타늄 용기에 담는다.  조사(irradiation)하는 조건 하에 | 포가 설정된 모든 기준을 만족할 때 적합하다. ",
        "original_sentence": "이러한 분석 |\n| 2. "
      }
    },
    {
      "chunk_id": "chunk_467",
      "text": "제4조제1항제2호에 따른 자료(이 조 제1항 | ⑦ 제1항에 따른 신청이나 신고를 하는 자는 | 방사성의약품 | 경우에는 제외한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 466,
        "window_size": 3,
        "char_count": 74,
        "word_count": 18,
        "page_number": 3,
        "window_text": "| 시 보통 표적물질을 석영 앰플, 고순도 알루미늄 또는 | 제제는 3마리 실험동물 중 최소 2마리에서 방사능 분 | 2.  수입자가 의약품등의 제조를 위하여 원료의 | 안전성․유효성 | 70일 | 방출 대신 부분적으로 또는 완전하게 내부전환전자 | 크로마토그래프법 등이 포함될 수 있다.  이러한 분석 |\n| 2.  제4조제1항제2호에 따른 자료(이 조 제1항 | ⑦ 제1항에 따른 신청이나 신고를 하는 자는 | 방사성의약품 | 경우에는 제외한다.  | 재심사대상 품목임 |\n| 티타늄 용기에 담는다.  조사(irradiation)하는 조건 하에 | 포가 설정된 모든 기준을 만족할 때 적합하다.  | 10. ",
        "original_sentence": "제4조제1항제2호에 따른 자료(이 조 제1항 | ⑦ 제1항에 따른 신청이나 신고를 하는 자는 | 방사성의약품 | 경우에는 제외한다. "
      }
    },
    {
      "chunk_id": "chunk_468",
      "text": "| 재심사대상 품목임 |\n| 티타늄 용기에 담는다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 467,
        "window_size": 3,
        "char_count": 29,
        "word_count": 8,
        "page_number": 9,
        "window_text": "수입자가 의약품등의 제조를 위하여 원료의 | 안전성․유효성 | 70일 | 방출 대신 부분적으로 또는 완전하게 내부전환전자 | 크로마토그래프법 등이 포함될 수 있다.  이러한 분석 |\n| 2.  제4조제1항제2호에 따른 자료(이 조 제1항 | ⑦ 제1항에 따른 신청이나 신고를 하는 자는 | 방사성의약품 | 경우에는 제외한다.  | 재심사대상 품목임 |\n| 티타늄 용기에 담는다.  조사(irradiation)하는 조건 하에 | 포가 설정된 모든 기준을 만족할 때 적합하다.  | 10.  저장방법 및 사용(유효)기간 | (internal conversion electrons)로 알려진 전자의 방출 | 하전입자들을 | 가진 | 안정한 | 방사성핵종의 | 조사 |\n| 회원가입 및 로그인 | 민원서식기 |\n| ※기타 - ｢ | 식품의약품안전처장이 정하여 고시하는 수수료 |\n| ○ 방사성의약품 밸리데이션 관련 상세내용은 「의약품 등의 안전에 관한 규칙」[별표 1] 6. ",
        "original_sentence": "| 재심사대상 품목임 |\n| 티타늄 용기에 담는다. "
      }
    },
    {
      "chunk_id": "chunk_469",
      "text": "조사(irradiation)하는 조건 하에 | 포가 설정된 모든 기준을 만족할 때 적합하다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 468,
        "window_size": 3,
        "char_count": 52,
        "word_count": 11,
        "page_number": 6,
        "window_text": "이러한 분석 |\n| 2.  제4조제1항제2호에 따른 자료(이 조 제1항 | ⑦ 제1항에 따른 신청이나 신고를 하는 자는 | 방사성의약품 | 경우에는 제외한다.  | 재심사대상 품목임 |\n| 티타늄 용기에 담는다.  조사(irradiation)하는 조건 하에 | 포가 설정된 모든 기준을 만족할 때 적합하다.  | 10.  저장방법 및 사용(유효)기간 | (internal conversion electrons)로 알려진 전자의 방출 | 하전입자들을 | 가진 | 안정한 | 방사성핵종의 | 조사 |\n| 회원가입 및 로그인 | 민원서식기 |\n| ※기타 - ｢ | 식품의약품안전처장이 정하여 고시하는 수수료 |\n| ○ 방사성의약품 밸리데이션 관련 상세내용은 「의약품 등의 안전에 관한 규칙」[별표 1] 6.  밸리데이션, | 용기와 그 내용물 사이에 상호작용이 일어나지 않는지 | 투여 시 넘쳐 흘린 경우(투여 당시 발견되었거나 방사 | 사용기간 | 방사성의약품의 특성*을 감안하여 다음 사항을 고려 | 11. ",
        "original_sentence": "조사(irradiation)하는 조건 하에 | 포가 설정된 모든 기준을 만족할 때 적합하다. "
      }
    },
    {
      "chunk_id": "chunk_470",
      "text": "| 10. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 469,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 3,
        "window_text": "제4조제1항제2호에 따른 자료(이 조 제1항 | ⑦ 제1항에 따른 신청이나 신고를 하는 자는 | 방사성의약품 | 경우에는 제외한다.  | 재심사대상 품목임 |\n| 티타늄 용기에 담는다.  조사(irradiation)하는 조건 하에 | 포가 설정된 모든 기준을 만족할 때 적합하다.  | 10.  저장방법 및 사용(유효)기간 | (internal conversion electrons)로 알려진 전자의 방출 | 하전입자들을 | 가진 | 안정한 | 방사성핵종의 | 조사 |\n| 회원가입 및 로그인 | 민원서식기 |\n| ※기타 - ｢ | 식품의약품안전처장이 정하여 고시하는 수수료 |\n| ○ 방사성의약품 밸리데이션 관련 상세내용은 「의약품 등의 안전에 관한 규칙」[별표 1] 6.  밸리데이션, | 용기와 그 내용물 사이에 상호작용이 일어나지 않는지 | 투여 시 넘쳐 흘린 경우(투여 당시 발견되었거나 방사 | 사용기간 | 방사성의약품의 특성*을 감안하여 다음 사항을 고려 | 11.  기준 및 시험방법 | 로 대체될 수도 있다. ",
        "original_sentence": "| 10. "
      }
    },
    {
      "chunk_id": "chunk_471",
      "text": "저장방법 및 사용(유효)기간 | (internal conversion electrons)로 알려진 전자의 방출 | 하전입자들을 | 가진 | 안정한 | 방사성핵종의 | 조사 |\n| 회원가입 및 로그인 | 민원서식기 |\n| ※기타 - ｢ | 식품의약품안전처장이 정하여 고시하는 수수료 |\n| ○ 방사성의약품 밸리데이션 관련 상세내용은 「의약품 등의 안전에 관한 규칙」[별표 1] 6. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 470,
        "window_size": 3,
        "char_count": 213,
        "word_count": 51,
        "page_number": 6,
        "window_text": "| 재심사대상 품목임 |\n| 티타늄 용기에 담는다.  조사(irradiation)하는 조건 하에 | 포가 설정된 모든 기준을 만족할 때 적합하다.  | 10.  저장방법 및 사용(유효)기간 | (internal conversion electrons)로 알려진 전자의 방출 | 하전입자들을 | 가진 | 안정한 | 방사성핵종의 | 조사 |\n| 회원가입 및 로그인 | 민원서식기 |\n| ※기타 - ｢ | 식품의약품안전처장이 정하여 고시하는 수수료 |\n| ○ 방사성의약품 밸리데이션 관련 상세내용은 「의약품 등의 안전에 관한 규칙」[별표 1] 6.  밸리데이션, | 용기와 그 내용물 사이에 상호작용이 일어나지 않는지 | 투여 시 넘쳐 흘린 경우(투여 당시 발견되었거나 방사 | 사용기간 | 방사성의약품의 특성*을 감안하여 다음 사항을 고려 | 11.  기준 및 시험방법 | 로 대체될 수도 있다.  전자포획 과정과 동일하게 이러 | (irradiation) | 결과 | 보통 | 중성자가 | 부족한 | 핵 | 또한, 방사선 방호, 기하학적 측정, 검출기 선형성, 담 |\n| ▷ 제네릭의약품 | - 신청업소에서 직접 작성한 성분규격 : “별첨규격” 또는 “별규”로 기재 | 가. ",
        "original_sentence": "저장방법 및 사용(유효)기간 | (internal conversion electrons)로 알려진 전자의 방출 | 하전입자들을 | 가진 | 안정한 | 방사성핵종의 | 조사 |\n| 회원가입 및 로그인 | 민원서식기 |\n| ※기타 - ｢ | 식품의약품안전처장이 정하여 고시하는 수수료 |\n| ○ 방사성의약품 밸리데이션 관련 상세내용은 「의약품 등의 안전에 관한 규칙」[별표 1] 6. "
      }
    },
    {
      "chunk_id": "chunk_472",
      "text": "밸리데이션, | 용기와 그 내용물 사이에 상호작용이 일어나지 않는지 | 투여 시 넘쳐 흘린 경우(투여 당시 발견되었거나 방사 | 사용기간 | 방사성의약품의 특성*을 감안하여 다음 사항을 고려 | 11. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 471,
        "window_size": 3,
        "char_count": 113,
        "word_count": 29,
        "page_number": 5,
        "window_text": "조사(irradiation)하는 조건 하에 | 포가 설정된 모든 기준을 만족할 때 적합하다.  | 10.  저장방법 및 사용(유효)기간 | (internal conversion electrons)로 알려진 전자의 방출 | 하전입자들을 | 가진 | 안정한 | 방사성핵종의 | 조사 |\n| 회원가입 및 로그인 | 민원서식기 |\n| ※기타 - ｢ | 식품의약품안전처장이 정하여 고시하는 수수료 |\n| ○ 방사성의약품 밸리데이션 관련 상세내용은 「의약품 등의 안전에 관한 규칙」[별표 1] 6.  밸리데이션, | 용기와 그 내용물 사이에 상호작용이 일어나지 않는지 | 투여 시 넘쳐 흘린 경우(투여 당시 발견되었거나 방사 | 사용기간 | 방사성의약품의 특성*을 감안하여 다음 사항을 고려 | 11.  기준 및 시험방법 | 로 대체될 수도 있다.  전자포획 과정과 동일하게 이러 | (irradiation) | 결과 | 보통 | 중성자가 | 부족한 | 핵 | 또한, 방사선 방호, 기하학적 측정, 검출기 선형성, 담 |\n| ▷ 제네릭의약품 | - 신청업소에서 직접 작성한 성분규격 : “별첨규격” 또는 “별규”로 기재 | 가.  1989년 1월 1일 이후 제조판매·수입 품 | 를 내야 한다. ",
        "original_sentence": "밸리데이션, | 용기와 그 내용물 사이에 상호작용이 일어나지 않는지 | 투여 시 넘쳐 흘린 경우(투여 당시 발견되었거나 방사 | 사용기간 | 방사성의약품의 특성*을 감안하여 다음 사항을 고려 | 11. "
      }
    },
    {
      "chunk_id": "chunk_473",
      "text": "기준 및 시험방법 | 로 대체될 수도 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 472,
        "window_size": 3,
        "char_count": 25,
        "word_count": 8,
        "page_number": 6,
        "window_text": "| 10.  저장방법 및 사용(유효)기간 | (internal conversion electrons)로 알려진 전자의 방출 | 하전입자들을 | 가진 | 안정한 | 방사성핵종의 | 조사 |\n| 회원가입 및 로그인 | 민원서식기 |\n| ※기타 - ｢ | 식품의약품안전처장이 정하여 고시하는 수수료 |\n| ○ 방사성의약품 밸리데이션 관련 상세내용은 「의약품 등의 안전에 관한 규칙」[별표 1] 6.  밸리데이션, | 용기와 그 내용물 사이에 상호작용이 일어나지 않는지 | 투여 시 넘쳐 흘린 경우(투여 당시 발견되었거나 방사 | 사용기간 | 방사성의약품의 특성*을 감안하여 다음 사항을 고려 | 11.  기준 및 시험방법 | 로 대체될 수도 있다.  전자포획 과정과 동일하게 이러 | (irradiation) | 결과 | 보통 | 중성자가 | 부족한 | 핵 | 또한, 방사선 방호, 기하학적 측정, 검출기 선형성, 담 |\n| ▷ 제네릭의약품 | - 신청업소에서 직접 작성한 성분규격 : “별첨규격” 또는 “별규”로 기재 | 가.  1989년 1월 1일 이후 제조판매·수입 품 | 를 내야 한다.  다만, 행정구역개편에 따라 소재 |\n| 확인이 필요하다. ",
        "original_sentence": "기준 및 시험방법 | 로 대체될 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_474",
      "text": "전자포획 과정과 동일하게 이러 | (irradiation) | 결과 | 보통 | 중성자가 | 부족한 | 핵 | 또한, 방사선 방호, 기하학적 측정, 검출기 선형성, 담 |\n| ▷ 제네릭의약품 | - 신청업소에서 직접 작성한 성분규격 : “별첨규격” 또는 “별규”로 기재 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 473,
        "window_size": 3,
        "char_count": 156,
        "word_count": 42,
        "page_number": 5,
        "window_text": "저장방법 및 사용(유효)기간 | (internal conversion electrons)로 알려진 전자의 방출 | 하전입자들을 | 가진 | 안정한 | 방사성핵종의 | 조사 |\n| 회원가입 및 로그인 | 민원서식기 |\n| ※기타 - ｢ | 식품의약품안전처장이 정하여 고시하는 수수료 |\n| ○ 방사성의약품 밸리데이션 관련 상세내용은 「의약품 등의 안전에 관한 규칙」[별표 1] 6.  밸리데이션, | 용기와 그 내용물 사이에 상호작용이 일어나지 않는지 | 투여 시 넘쳐 흘린 경우(투여 당시 발견되었거나 방사 | 사용기간 | 방사성의약품의 특성*을 감안하여 다음 사항을 고려 | 11.  기준 및 시험방법 | 로 대체될 수도 있다.  전자포획 과정과 동일하게 이러 | (irradiation) | 결과 | 보통 | 중성자가 | 부족한 | 핵 | 또한, 방사선 방호, 기하학적 측정, 검출기 선형성, 담 |\n| ▷ 제네릭의약품 | - 신청업소에서 직접 작성한 성분규격 : “별첨규격” 또는 “별규”로 기재 | 가.  1989년 1월 1일 이후 제조판매·수입 품 | 를 내야 한다.  다만, 행정구역개편에 따라 소재 |\n| 확인이 필요하다.  | 능 측정 이후 드러나게 된 경우)의 결과는 배제하고 | 기준및시험방법 | 55일 | 12. ",
        "original_sentence": "전자포획 과정과 동일하게 이러 | (irradiation) | 결과 | 보통 | 중성자가 | 부족한 | 핵 | 또한, 방사선 방호, 기하학적 측정, 검출기 선형성, 담 |\n| ▷ 제네릭의약품 | - 신청업소에서 직접 작성한 성분규격 : “별첨규격” 또는 “별규”로 기재 | 가. "
      }
    },
    {
      "chunk_id": "chunk_475",
      "text": "1989년 1월 1일 이후 제조판매·수입 품 | 를 내야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 474,
        "window_size": 3,
        "char_count": 36,
        "word_count": 10,
        "page_number": 3,
        "window_text": "밸리데이션, | 용기와 그 내용물 사이에 상호작용이 일어나지 않는지 | 투여 시 넘쳐 흘린 경우(투여 당시 발견되었거나 방사 | 사용기간 | 방사성의약품의 특성*을 감안하여 다음 사항을 고려 | 11.  기준 및 시험방법 | 로 대체될 수도 있다.  전자포획 과정과 동일하게 이러 | (irradiation) | 결과 | 보통 | 중성자가 | 부족한 | 핵 | 또한, 방사선 방호, 기하학적 측정, 검출기 선형성, 담 |\n| ▷ 제네릭의약품 | - 신청업소에서 직접 작성한 성분규격 : “별첨규격” 또는 “별규”로 기재 | 가.  1989년 1월 1일 이후 제조판매·수입 품 | 를 내야 한다.  다만, 행정구역개편에 따라 소재 |\n| 확인이 필요하다.  | 능 측정 이후 드러나게 된 경우)의 결과는 배제하고 | 기준및시험방법 | 55일 | 12.  제조업자 중 제조판매품목허가증ㆍ신고증을 보유한 자, 위탁제조판매업자 및 | (neutron-deficient nuclei)이 발생하며 이는 전자포획 | 체(carrier) 사용, 검체희석 등 특별한 주의사항도 고려 |\n| - 방사성의약품의 반감기가 24시간 미만인가? ",
        "original_sentence": "1989년 1월 1일 이후 제조판매·수입 품 | 를 내야 한다. "
      }
    },
    {
      "chunk_id": "chunk_476",
      "text": "다만, 행정구역개편에 따라 소재 |\n| 확인이 필요하다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 475,
        "window_size": 3,
        "char_count": 32,
        "word_count": 8,
        "page_number": 5,
        "window_text": "기준 및 시험방법 | 로 대체될 수도 있다.  전자포획 과정과 동일하게 이러 | (irradiation) | 결과 | 보통 | 중성자가 | 부족한 | 핵 | 또한, 방사선 방호, 기하학적 측정, 검출기 선형성, 담 |\n| ▷ 제네릭의약품 | - 신청업소에서 직접 작성한 성분규격 : “별첨규격” 또는 “별규”로 기재 | 가.  1989년 1월 1일 이후 제조판매·수입 품 | 를 내야 한다.  다만, 행정구역개편에 따라 소재 |\n| 확인이 필요하다.  | 능 측정 이후 드러나게 된 경우)의 결과는 배제하고 | 기준및시험방법 | 55일 | 12.  제조업자 중 제조판매품목허가증ㆍ신고증을 보유한 자, 위탁제조판매업자 및 | (neutron-deficient nuclei)이 발생하며 이는 전자포획 | 체(carrier) 사용, 검체희석 등 특별한 주의사항도 고려 |\n| - 방사성의약품의 반감기가 24시간 미만인가?  | 지가 변경되는 경우에는 이를 적용하지 아니한 |\n| - 안전성․유효성 심사결과 인정된 기간으로 설정 | ③수입자는 대통령령으로 정하는 시설 기준에 |\n| 하전입자 조사(irradiation)에 사용되는 표적물질의 홀 | 다시 시험한다. ",
        "original_sentence": "다만, 행정구역개편에 따라 소재 |\n| 확인이 필요하다. "
      }
    },
    {
      "chunk_id": "chunk_477",
      "text": "| 능 측정 이후 드러나게 된 경우)의 결과는 배제하고 | 기준및시험방법 | 55일 | 12. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 476,
        "window_size": 3,
        "char_count": 53,
        "word_count": 15,
        "page_number": 3,
        "window_text": "전자포획 과정과 동일하게 이러 | (irradiation) | 결과 | 보통 | 중성자가 | 부족한 | 핵 | 또한, 방사선 방호, 기하학적 측정, 검출기 선형성, 담 |\n| ▷ 제네릭의약품 | - 신청업소에서 직접 작성한 성분규격 : “별첨규격” 또는 “별규”로 기재 | 가.  1989년 1월 1일 이후 제조판매·수입 품 | 를 내야 한다.  다만, 행정구역개편에 따라 소재 |\n| 확인이 필요하다.  | 능 측정 이후 드러나게 된 경우)의 결과는 배제하고 | 기준및시험방법 | 55일 | 12.  제조업자 중 제조판매품목허가증ㆍ신고증을 보유한 자, 위탁제조판매업자 및 | (neutron-deficient nuclei)이 발생하며 이는 전자포획 | 체(carrier) 사용, 검체희석 등 특별한 주의사항도 고려 |\n| - 방사성의약품의 반감기가 24시간 미만인가?  | 지가 변경되는 경우에는 이를 적용하지 아니한 |\n| - 안전성․유효성 심사결과 인정된 기간으로 설정 | ③수입자는 대통령령으로 정하는 시설 기준에 |\n| 하전입자 조사(irradiation)에 사용되는 표적물질의 홀 | 다시 시험한다.  | <특정 효능․효과 추가에 따른 재심사 부여> | 성분명 | - 반감기가 24시간 이상의 방사성제제에서 보존제를 사용하지 않는 타당한 근거는? ",
        "original_sentence": "| 능 측정 이후 드러나게 된 경우)의 결과는 배제하고 | 기준및시험방법 | 55일 | 12. "
      }
    },
    {
      "chunk_id": "chunk_478",
      "text": "제조업자 중 제조판매품목허가증ㆍ신고증을 보유한 자, 위탁제조판매업자 및 | (neutron-deficient nuclei)이 발생하며 이는 전자포획 | 체(carrier) 사용, 검체희석 등 특별한 주의사항도 고려 |\n| - 방사성의약품의 반감기가 24시간 미만인가? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 477,
        "window_size": 3,
        "char_count": 150,
        "word_count": 28,
        "page_number": 3,
        "window_text": "1989년 1월 1일 이후 제조판매·수입 품 | 를 내야 한다.  다만, 행정구역개편에 따라 소재 |\n| 확인이 필요하다.  | 능 측정 이후 드러나게 된 경우)의 결과는 배제하고 | 기준및시험방법 | 55일 | 12.  제조업자 중 제조판매품목허가증ㆍ신고증을 보유한 자, 위탁제조판매업자 및 | (neutron-deficient nuclei)이 발생하며 이는 전자포획 | 체(carrier) 사용, 검체희석 등 특별한 주의사항도 고려 |\n| - 방사성의약품의 반감기가 24시간 미만인가?  | 지가 변경되는 경우에는 이를 적용하지 아니한 |\n| - 안전성․유효성 심사결과 인정된 기간으로 설정 | ③수입자는 대통령령으로 정하는 시설 기준에 |\n| 하전입자 조사(irradiation)에 사용되는 표적물질의 홀 | 다시 시험한다.  | <특정 효능․효과 추가에 따른 재심사 부여> | 성분명 | - 반감기가 24시간 이상의 방사성제제에서 보존제를 사용하지 않는 타당한 근거는?  | 허가증 발급 | 면허세 납부 | 품목허가처리 |\n| 따라 필요한 시설을 갖추어야 한다. ",
        "original_sentence": "제조업자 중 제조판매품목허가증ㆍ신고증을 보유한 자, 위탁제조판매업자 및 | (neutron-deficient nuclei)이 발생하며 이는 전자포획 | 체(carrier) 사용, 검체희석 등 특별한 주의사항도 고려 |\n| - 방사성의약품의 반감기가 24시간 미만인가? "
      }
    },
    {
      "chunk_id": "chunk_479",
      "text": "| 지가 변경되는 경우에는 이를 적용하지 아니한 |\n| - 안전성․유효성 심사결과 인정된 기간으로 설정 | ③수입자는 대통령령으로 정하는 시설 기준에 |\n| 하전입자 조사(irradiation)에 사용되는 표적물질의 홀 | 다시 시험한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 478,
        "window_size": 3,
        "char_count": 134,
        "word_count": 31,
        "page_number": 3,
        "window_text": "다만, 행정구역개편에 따라 소재 |\n| 확인이 필요하다.  | 능 측정 이후 드러나게 된 경우)의 결과는 배제하고 | 기준및시험방법 | 55일 | 12.  제조업자 중 제조판매품목허가증ㆍ신고증을 보유한 자, 위탁제조판매업자 및 | (neutron-deficient nuclei)이 발생하며 이는 전자포획 | 체(carrier) 사용, 검체희석 등 특별한 주의사항도 고려 |\n| - 방사성의약품의 반감기가 24시간 미만인가?  | 지가 변경되는 경우에는 이를 적용하지 아니한 |\n| - 안전성․유효성 심사결과 인정된 기간으로 설정 | ③수입자는 대통령령으로 정하는 시설 기준에 |\n| 하전입자 조사(irradiation)에 사용되는 표적물질의 홀 | 다시 시험한다.  | <특정 효능․효과 추가에 따른 재심사 부여> | 성분명 | - 반감기가 24시간 이상의 방사성제제에서 보존제를 사용하지 않는 타당한 근거는?  | 허가증 발급 | 면허세 납부 | 품목허가처리 |\n| 따라 필요한 시설을 갖추어야 한다.  | 다. ",
        "original_sentence": "| 지가 변경되는 경우에는 이를 적용하지 아니한 |\n| - 안전성․유효성 심사결과 인정된 기간으로 설정 | ③수입자는 대통령령으로 정하는 시설 기준에 |\n| 하전입자 조사(irradiation)에 사용되는 표적물질의 홀 | 다시 시험한다. "
      }
    },
    {
      "chunk_id": "chunk_480",
      "text": "| <특정 효능․효과 추가에 따른 재심사 부여> | 성분명 | - 반감기가 24시간 이상의 방사성제제에서 보존제를 사용하지 않는 타당한 근거는? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 479,
        "window_size": 3,
        "char_count": 81,
        "word_count": 20,
        "page_number": 3,
        "window_text": "| 능 측정 이후 드러나게 된 경우)의 결과는 배제하고 | 기준및시험방법 | 55일 | 12.  제조업자 중 제조판매품목허가증ㆍ신고증을 보유한 자, 위탁제조판매업자 및 | (neutron-deficient nuclei)이 발생하며 이는 전자포획 | 체(carrier) 사용, 검체희석 등 특별한 주의사항도 고려 |\n| - 방사성의약품의 반감기가 24시간 미만인가?  | 지가 변경되는 경우에는 이를 적용하지 아니한 |\n| - 안전성․유효성 심사결과 인정된 기간으로 설정 | ③수입자는 대통령령으로 정하는 시설 기준에 |\n| 하전입자 조사(irradiation)에 사용되는 표적물질의 홀 | 다시 시험한다.  | <특정 효능․효과 추가에 따른 재심사 부여> | 성분명 | - 반감기가 24시간 이상의 방사성제제에서 보존제를 사용하지 않는 타당한 근거는?  | 허가증 발급 | 면허세 납부 | 품목허가처리 |\n| 따라 필요한 시설을 갖추어야 한다.  | 다.  |\n| 더는 적절한 금속, 가능한 경우 주입구와 배출구, 주변 | 구분 | - 안전성․유효성 심사 비대상 품목 : 기허 품목의 사용기간 준용(단, 36개월 이하로 | 부분적으로 오제전자(Auger electrons)로 알려진 전자 |\n| ④제1항에 따라 수입되는 의약품등 또는 그 수 | 3. ",
        "original_sentence": "| <특정 효능․효과 추가에 따른 재심사 부여> | 성분명 | - 반감기가 24시간 이상의 방사성제제에서 보존제를 사용하지 않는 타당한 근거는? "
      }
    },
    {
      "chunk_id": "chunk_481",
      "text": "| 허가증 발급 | 면허세 납부 | 품목허가처리 |\n| 따라 필요한 시설을 갖추어야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 480,
        "window_size": 3,
        "char_count": 51,
        "word_count": 15,
        "page_number": 5,
        "window_text": "제조업자 중 제조판매품목허가증ㆍ신고증을 보유한 자, 위탁제조판매업자 및 | (neutron-deficient nuclei)이 발생하며 이는 전자포획 | 체(carrier) 사용, 검체희석 등 특별한 주의사항도 고려 |\n| - 방사성의약품의 반감기가 24시간 미만인가?  | 지가 변경되는 경우에는 이를 적용하지 아니한 |\n| - 안전성․유효성 심사결과 인정된 기간으로 설정 | ③수입자는 대통령령으로 정하는 시설 기준에 |\n| 하전입자 조사(irradiation)에 사용되는 표적물질의 홀 | 다시 시험한다.  | <특정 효능․효과 추가에 따른 재심사 부여> | 성분명 | - 반감기가 24시간 이상의 방사성제제에서 보존제를 사용하지 않는 타당한 근거는?  | 허가증 발급 | 면허세 납부 | 품목허가처리 |\n| 따라 필요한 시설을 갖추어야 한다.  | 다.  |\n| 더는 적절한 금속, 가능한 경우 주입구와 배출구, 주변 | 구분 | - 안전성․유효성 심사 비대상 품목 : 기허 품목의 사용기간 준용(단, 36개월 이하로 | 부분적으로 오제전자(Auger electrons)로 알려진 전자 |\n| ④제1항에 따라 수입되는 의약품등 또는 그 수 | 3.  제4조제1항제3호 및 제5호에 해당하는 자료 | ⑧ 제1항에 따라 제조소의 소재지를 변경하는 | 1-1. ",
        "original_sentence": "| 허가증 발급 | 면허세 납부 | 품목허가처리 |\n| 따라 필요한 시설을 갖추어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_482",
      "text": "| 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 481,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 9,
        "window_text": "| 지가 변경되는 경우에는 이를 적용하지 아니한 |\n| - 안전성․유효성 심사결과 인정된 기간으로 설정 | ③수입자는 대통령령으로 정하는 시설 기준에 |\n| 하전입자 조사(irradiation)에 사용되는 표적물질의 홀 | 다시 시험한다.  | <특정 효능․효과 추가에 따른 재심사 부여> | 성분명 | - 반감기가 24시간 이상의 방사성제제에서 보존제를 사용하지 않는 타당한 근거는?  | 허가증 발급 | 면허세 납부 | 품목허가처리 |\n| 따라 필요한 시설을 갖추어야 한다.  | 다.  |\n| 더는 적절한 금속, 가능한 경우 주입구와 배출구, 주변 | 구분 | - 안전성․유효성 심사 비대상 품목 : 기허 품목의 사용기간 준용(단, 36개월 이하로 | 부분적으로 오제전자(Auger electrons)로 알려진 전자 |\n| ④제1항에 따라 수입되는 의약품등 또는 그 수 | 3.  제4조제1항제3호 및 제5호에 해당하는 자료 | ⑧ 제1항에 따라 제조소의 소재지를 변경하는 | 1-1.  | 효능․효과 | 중 | ‘편두통의 | 예방’에 | 대하여는「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 |\n| 각 방사선의 투과력은 고유의 특성과 에너지에 따라 | 1. ",
        "original_sentence": "| 다. "
      }
    },
    {
      "chunk_id": "chunk_483",
      "text": "|\n| 더는 적절한 금속, 가능한 경우 주입구와 배출구, 주변 | 구분 | - 안전성․유효성 심사 비대상 품목 : 기허 품목의 사용기간 준용(단, 36개월 이하로 | 부분적으로 오제전자(Auger electrons)로 알려진 전자 |\n| ④제1항에 따라 수입되는 의약품등 또는 그 수 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 482,
        "window_size": 3,
        "char_count": 164,
        "word_count": 42,
        "page_number": 1,
        "window_text": "| <특정 효능․효과 추가에 따른 재심사 부여> | 성분명 | - 반감기가 24시간 이상의 방사성제제에서 보존제를 사용하지 않는 타당한 근거는?  | 허가증 발급 | 면허세 납부 | 품목허가처리 |\n| 따라 필요한 시설을 갖추어야 한다.  | 다.  |\n| 더는 적절한 금속, 가능한 경우 주입구와 배출구, 주변 | 구분 | - 안전성․유효성 심사 비대상 품목 : 기허 품목의 사용기간 준용(단, 36개월 이하로 | 부분적으로 오제전자(Auger electrons)로 알려진 전자 |\n| ④제1항에 따라 수입되는 의약품등 또는 그 수 | 3.  제4조제1항제3호 및 제5호에 해당하는 자료 | ⑧ 제1항에 따라 제조소의 소재지를 변경하는 | 1-1.  | 효능․효과 | 중 | ‘편두통의 | 예방’에 | 대하여는「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 |\n| 각 방사선의 투과력은 고유의 특성과 에너지에 따라 | 1.  기허가의약품과 주성분의 규격 및 | - 공정서 및 고시 품목 : 해당 규격의 의약품명 |\n| 냉각장치, | 대개 얇은 금속호일의 표적 창판(target | 무균시험(Sterility) | * 방사성의약품의 특성: 방사성 핵종의 반감기로 인하여 개봉시 즉시 또는 수시간 내로 사용해야 하므로 보존제의 사용이 필수적 | 가. ",
        "original_sentence": "|\n| 더는 적절한 금속, 가능한 경우 주입구와 배출구, 주변 | 구분 | - 안전성․유효성 심사 비대상 품목 : 기허 품목의 사용기간 준용(단, 36개월 이하로 | 부분적으로 오제전자(Auger electrons)로 알려진 전자 |\n| ④제1항에 따라 수입되는 의약품등 또는 그 수 | 3. "
      }
    },
    {
      "chunk_id": "chunk_484",
      "text": "제4조제1항제3호 및 제5호에 해당하는 자료 | ⑧ 제1항에 따라 제조소의 소재지를 변경하는 | 1-1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 483,
        "window_size": 3,
        "char_count": 59,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| 허가증 발급 | 면허세 납부 | 품목허가처리 |\n| 따라 필요한 시설을 갖추어야 한다.  | 다.  |\n| 더는 적절한 금속, 가능한 경우 주입구와 배출구, 주변 | 구분 | - 안전성․유효성 심사 비대상 품목 : 기허 품목의 사용기간 준용(단, 36개월 이하로 | 부분적으로 오제전자(Auger electrons)로 알려진 전자 |\n| ④제1항에 따라 수입되는 의약품등 또는 그 수 | 3.  제4조제1항제3호 및 제5호에 해당하는 자료 | ⑧ 제1항에 따라 제조소의 소재지를 변경하는 | 1-1.  | 효능․효과 | 중 | ‘편두통의 | 예방’에 | 대하여는「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 |\n| 각 방사선의 투과력은 고유의 특성과 에너지에 따라 | 1.  기허가의약품과 주성분의 규격 및 | - 공정서 및 고시 품목 : 해당 규격의 의약품명 |\n| 냉각장치, | 대개 얇은 금속호일의 표적 창판(target | 무균시험(Sterility) | * 방사성의약품의 특성: 방사성 핵종의 반감기로 인하여 개봉시 즉시 또는 수시간 내로 사용해야 하므로 보존제의 사용이 필수적 | 가.  1989년 1월 1일 이후 제조판매ᆞ수입 품 | 나. ",
        "original_sentence": "제4조제1항제3호 및 제5호에 해당하는 자료 | ⑧ 제1항에 따라 제조소의 소재지를 변경하는 | 1-1. "
      }
    },
    {
      "chunk_id": "chunk_485",
      "text": "| 효능․효과 | 중 | ‘편두통의 | 예방’에 | 대하여는「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 |\n| 각 방사선의 투과력은 고유의 특성과 에너지에 따라 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 484,
        "window_size": 3,
        "char_count": 104,
        "word_count": 29,
        "page_number": 3,
        "window_text": "| 다.  |\n| 더는 적절한 금속, 가능한 경우 주입구와 배출구, 주변 | 구분 | - 안전성․유효성 심사 비대상 품목 : 기허 품목의 사용기간 준용(단, 36개월 이하로 | 부분적으로 오제전자(Auger electrons)로 알려진 전자 |\n| ④제1항에 따라 수입되는 의약품등 또는 그 수 | 3.  제4조제1항제3호 및 제5호에 해당하는 자료 | ⑧ 제1항에 따라 제조소의 소재지를 변경하는 | 1-1.  | 효능․효과 | 중 | ‘편두통의 | 예방’에 | 대하여는「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 |\n| 각 방사선의 투과력은 고유의 특성과 에너지에 따라 | 1.  기허가의약품과 주성분의 규격 및 | - 공정서 및 고시 품목 : 해당 규격의 의약품명 |\n| 냉각장치, | 대개 얇은 금속호일의 표적 창판(target | 무균시험(Sterility) | * 방사성의약품의 특성: 방사성 핵종의 반감기로 인하여 개봉시 즉시 또는 수시간 내로 사용해야 하므로 보존제의 사용이 필수적 | 가.  1989년 1월 1일 이후 제조판매ᆞ수입 품 | 나.  가목에 해당하는 품목을 제외한 전문의약 | 규칙」제22조제1항제2호가목의 규정에 의한 재심사대상 품목임 | 준용하고, 제제학적으로 안정성 확인이 필요한 품목의 경우 안정성 시험자료 등 | 13. ",
        "original_sentence": "| 효능․효과 | 중 | ‘편두통의 | 예방’에 | 대하여는「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 |\n| 각 방사선의 투과력은 고유의 특성과 에너지에 따라 | 1. "
      }
    },
    {
      "chunk_id": "chunk_486",
      "text": "기허가의약품과 주성분의 규격 및 | - 공정서 및 고시 품목 : 해당 규격의 의약품명 |\n| 냉각장치, | 대개 얇은 금속호일의 표적 창판(target | 무균시험(Sterility) | * 방사성의약품의 특성: 방사성 핵종의 반감기로 인하여 개봉시 즉시 또는 수시간 내로 사용해야 하므로 보존제의 사용이 필수적 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 485,
        "window_size": 3,
        "char_count": 180,
        "word_count": 45,
        "page_number": 3,
        "window_text": "|\n| 더는 적절한 금속, 가능한 경우 주입구와 배출구, 주변 | 구분 | - 안전성․유효성 심사 비대상 품목 : 기허 품목의 사용기간 준용(단, 36개월 이하로 | 부분적으로 오제전자(Auger electrons)로 알려진 전자 |\n| ④제1항에 따라 수입되는 의약품등 또는 그 수 | 3.  제4조제1항제3호 및 제5호에 해당하는 자료 | ⑧ 제1항에 따라 제조소의 소재지를 변경하는 | 1-1.  | 효능․효과 | 중 | ‘편두통의 | 예방’에 | 대하여는「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 |\n| 각 방사선의 투과력은 고유의 특성과 에너지에 따라 | 1.  기허가의약품과 주성분의 규격 및 | - 공정서 및 고시 품목 : 해당 규격의 의약품명 |\n| 냉각장치, | 대개 얇은 금속호일의 표적 창판(target | 무균시험(Sterility) | * 방사성의약품의 특성: 방사성 핵종의 반감기로 인하여 개봉시 즉시 또는 수시간 내로 사용해야 하므로 보존제의 사용이 필수적 | 가.  1989년 1월 1일 이후 제조판매ᆞ수입 품 | 나.  가목에 해당하는 품목을 제외한 전문의약 | 규칙」제22조제1항제2호가목의 규정에 의한 재심사대상 품목임 | 준용하고, 제제학적으로 안정성 확인이 필요한 품목의 경우 안정성 시험자료 등 | 13.  허가조건 | 입자에 관하여는 제31조제7항ᆞ제10항ᆞ제11 | 경우에는 제48조제5호를 준용한다. ",
        "original_sentence": "기허가의약품과 주성분의 규격 및 | - 공정서 및 고시 품목 : 해당 규격의 의약품명 |\n| 냉각장치, | 대개 얇은 금속호일의 표적 창판(target | 무균시험(Sterility) | * 방사성의약품의 특성: 방사성 핵종의 반감기로 인하여 개봉시 즉시 또는 수시간 내로 사용해야 하므로 보존제의 사용이 필수적 | 가. "
      }
    },
    {
      "chunk_id": "chunk_487",
      "text": "1989년 1월 1일 이후 제조판매ᆞ수입 품 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 486,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 3,
        "window_text": "제4조제1항제3호 및 제5호에 해당하는 자료 | ⑧ 제1항에 따라 제조소의 소재지를 변경하는 | 1-1.  | 효능․효과 | 중 | ‘편두통의 | 예방’에 | 대하여는「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 |\n| 각 방사선의 투과력은 고유의 특성과 에너지에 따라 | 1.  기허가의약품과 주성분의 규격 및 | - 공정서 및 고시 품목 : 해당 규격의 의약품명 |\n| 냉각장치, | 대개 얇은 금속호일의 표적 창판(target | 무균시험(Sterility) | * 방사성의약품의 특성: 방사성 핵종의 반감기로 인하여 개봉시 즉시 또는 수시간 내로 사용해야 하므로 보존제의 사용이 필수적 | 가.  1989년 1월 1일 이후 제조판매ᆞ수입 품 | 나.  가목에 해당하는 품목을 제외한 전문의약 | 규칙」제22조제1항제2호가목의 규정에 의한 재심사대상 품목임 | 준용하고, 제제학적으로 안정성 확인이 필요한 품목의 경우 안정성 시험자료 등 | 13.  허가조건 | 입자에 관하여는 제31조제7항ᆞ제10항ᆞ제11 | 경우에는 제48조제5호를 준용한다.  | 중성자 수)한다. ",
        "original_sentence": "1989년 1월 1일 이후 제조판매ᆞ수입 품 | 나. "
      }
    },
    {
      "chunk_id": "chunk_488",
      "text": "가목에 해당하는 품목을 제외한 전문의약 | 규칙」제22조제1항제2호가목의 규정에 의한 재심사대상 품목임 | 준용하고, 제제학적으로 안정성 확인이 필요한 품목의 경우 안정성 시험자료 등 | 13. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 487,
        "window_size": 3,
        "char_count": 109,
        "word_count": 24,
        "page_number": 3,
        "window_text": "| 효능․효과 | 중 | ‘편두통의 | 예방’에 | 대하여는「약사법」제32조 | 및「의약품 | 등의 | 안전에 | 관한 |\n| 각 방사선의 투과력은 고유의 특성과 에너지에 따라 | 1.  기허가의약품과 주성분의 규격 및 | - 공정서 및 고시 품목 : 해당 규격의 의약품명 |\n| 냉각장치, | 대개 얇은 금속호일의 표적 창판(target | 무균시험(Sterility) | * 방사성의약품의 특성: 방사성 핵종의 반감기로 인하여 개봉시 즉시 또는 수시간 내로 사용해야 하므로 보존제의 사용이 필수적 | 가.  1989년 1월 1일 이후 제조판매ᆞ수입 품 | 나.  가목에 해당하는 품목을 제외한 전문의약 | 규칙」제22조제1항제2호가목의 규정에 의한 재심사대상 품목임 | 준용하고, 제제학적으로 안정성 확인이 필요한 품목의 경우 안정성 시험자료 등 | 13.  허가조건 | 입자에 관하여는 제31조제7항ᆞ제10항ᆞ제11 | 경우에는 제48조제5호를 준용한다.  | 중성자 수)한다.  결과물은 표적핵(target nucleus)을 가 |\n| 상당히 다르다. ",
        "original_sentence": "가목에 해당하는 품목을 제외한 전문의약 | 규칙」제22조제1항제2호가목의 규정에 의한 재심사대상 품목임 | 준용하고, 제제학적으로 안정성 확인이 필요한 품목의 경우 안정성 시험자료 등 | 13. "
      }
    },
    {
      "chunk_id": "chunk_489",
      "text": "허가조건 | 입자에 관하여는 제31조제7항ᆞ제10항ᆞ제11 | 경우에는 제48조제5호를 준용한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 488,
        "window_size": 3,
        "char_count": 55,
        "word_count": 9,
        "page_number": 3,
        "window_text": "기허가의약품과 주성분의 규격 및 | - 공정서 및 고시 품목 : 해당 규격의 의약품명 |\n| 냉각장치, | 대개 얇은 금속호일의 표적 창판(target | 무균시험(Sterility) | * 방사성의약품의 특성: 방사성 핵종의 반감기로 인하여 개봉시 즉시 또는 수시간 내로 사용해야 하므로 보존제의 사용이 필수적 | 가.  1989년 1월 1일 이후 제조판매ᆞ수입 품 | 나.  가목에 해당하는 품목을 제외한 전문의약 | 규칙」제22조제1항제2호가목의 규정에 의한 재심사대상 품목임 | 준용하고, 제제학적으로 안정성 확인이 필요한 품목의 경우 안정성 시험자료 등 | 13.  허가조건 | 입자에 관하여는 제31조제7항ᆞ제10항ᆞ제11 | 경우에는 제48조제5호를 준용한다.  | 중성자 수)한다.  결과물은 표적핵(target nucleus)을 가 |\n| 상당히 다르다.  알파입자는 물질의 수 마이크로 내지 | 이지 않음(투여 전 방사능 농도 확인 후 해당 농도로 희석하여 환자에게 투여) | 분량, 제형이 동일한 의약품 |\n| ※ 의약품 품목허가 처리기한 및 수수료는 민원 신청 품목에 따라 상이합니다. ",
        "original_sentence": "허가조건 | 입자에 관하여는 제31조제7항ᆞ제10항ᆞ제11 | 경우에는 제48조제5호를 준용한다. "
      }
    },
    {
      "chunk_id": "chunk_490",
      "text": "| 중성자 수)한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 489,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 9,
        "window_text": "1989년 1월 1일 이후 제조판매ᆞ수입 품 | 나.  가목에 해당하는 품목을 제외한 전문의약 | 규칙」제22조제1항제2호가목의 규정에 의한 재심사대상 품목임 | 준용하고, 제제학적으로 안정성 확인이 필요한 품목의 경우 안정성 시험자료 등 | 13.  허가조건 | 입자에 관하여는 제31조제7항ᆞ제10항ᆞ제11 | 경우에는 제48조제5호를 준용한다.  | 중성자 수)한다.  결과물은 표적핵(target nucleus)을 가 |\n| 상당히 다르다.  알파입자는 물질의 수 마이크로 내지 | 이지 않음(투여 전 방사능 농도 확인 후 해당 농도로 희석하여 환자에게 투여) | 분량, 제형이 동일한 의약품 |\n| ※ 의약품 품목허가 처리기한 및 수수료는 민원 신청 품목에 따라 상이합니다.  | window) 들로 구성된다. ",
        "original_sentence": "| 중성자 수)한다. "
      }
    },
    {
      "chunk_id": "chunk_491",
      "text": "결과물은 표적핵(target nucleus)을 가 |\n| 상당히 다르다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 490,
        "window_size": 3,
        "char_count": 41,
        "word_count": 8,
        "page_number": 9,
        "window_text": "가목에 해당하는 품목을 제외한 전문의약 | 규칙」제22조제1항제2호가목의 규정에 의한 재심사대상 품목임 | 준용하고, 제제학적으로 안정성 확인이 필요한 품목의 경우 안정성 시험자료 등 | 13.  허가조건 | 입자에 관하여는 제31조제7항ᆞ제10항ᆞ제11 | 경우에는 제48조제5호를 준용한다.  | 중성자 수)한다.  결과물은 표적핵(target nucleus)을 가 |\n| 상당히 다르다.  알파입자는 물질의 수 마이크로 내지 | 이지 않음(투여 전 방사능 농도 확인 후 해당 농도로 희석하여 환자에게 투여) | 분량, 제형이 동일한 의약품 |\n| ※ 의약품 품목허가 처리기한 및 수수료는 민원 신청 품목에 따라 상이합니다.  | window) 들로 구성된다.  질적 및 양적 면에서 방사성 | □ 품목허가 처리(6단계) 상세 절차 | - 별첨규격 : 일반명 | 1. ",
        "original_sentence": "결과물은 표적핵(target nucleus)을 가 |\n| 상당히 다르다. "
      }
    },
    {
      "chunk_id": "chunk_492",
      "text": "알파입자는 물질의 수 마이크로 내지 | 이지 않음(투여 전 방사능 농도 확인 후 해당 농도로 희석하여 환자에게 투여) | 분량, 제형이 동일한 의약품 |\n| ※ 의약품 품목허가 처리기한 및 수수료는 민원 신청 품목에 따라 상이합니다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 491,
        "window_size": 3,
        "char_count": 131,
        "word_count": 36,
        "page_number": 5,
        "window_text": "허가조건 | 입자에 관하여는 제31조제7항ᆞ제10항ᆞ제11 | 경우에는 제48조제5호를 준용한다.  | 중성자 수)한다.  결과물은 표적핵(target nucleus)을 가 |\n| 상당히 다르다.  알파입자는 물질의 수 마이크로 내지 | 이지 않음(투여 전 방사능 농도 확인 후 해당 농도로 희석하여 환자에게 투여) | 분량, 제형이 동일한 의약품 |\n| ※ 의약품 품목허가 처리기한 및 수수료는 민원 신청 품목에 따라 상이합니다.  | window) 들로 구성된다.  질적 및 양적 면에서 방사성 | □ 품목허가 처리(6단계) 상세 절차 | - 별첨규격 : 일반명 | 1.  기원 또는 발견 및 개발의 경위 | 비방사능은 일반적으로 방사능이 방사성핵종(방사성핵 |\n| 비경구투여 방사성의약품은 무균시험에 적합하여야 한 | 제9조(안전성ᆞ유효성에 관한 자료) 의약품등의 | 입증자료 제시) | 항, 제31조의2, 제31조의5, 제31조의3, 제31 | 진 동위원소가 아니며 그 방사능은 무담체제제 |\n| 수십 마이크로미터의 두께에서 완전히 흡수된다. ",
        "original_sentence": "알파입자는 물질의 수 마이크로 내지 | 이지 않음(투여 전 방사능 농도 확인 후 해당 농도로 희석하여 환자에게 투여) | 분량, 제형이 동일한 의약품 |\n| ※ 의약품 품목허가 처리기한 및 수수료는 민원 신청 품목에 따라 상이합니다. "
      }
    },
    {
      "chunk_id": "chunk_493",
      "text": "| window) 들로 구성된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 492,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 9,
        "window_text": "| 중성자 수)한다.  결과물은 표적핵(target nucleus)을 가 |\n| 상당히 다르다.  알파입자는 물질의 수 마이크로 내지 | 이지 않음(투여 전 방사능 농도 확인 후 해당 농도로 희석하여 환자에게 투여) | 분량, 제형이 동일한 의약품 |\n| ※ 의약품 품목허가 처리기한 및 수수료는 민원 신청 품목에 따라 상이합니다.  | window) 들로 구성된다.  질적 및 양적 면에서 방사성 | □ 품목허가 처리(6단계) 상세 절차 | - 별첨규격 : 일반명 | 1.  기원 또는 발견 및 개발의 경위 | 비방사능은 일반적으로 방사능이 방사성핵종(방사성핵 |\n| 비경구투여 방사성의약품은 무균시험에 적합하여야 한 | 제9조(안전성ᆞ유효성에 관한 자료) 의약품등의 | 입증자료 제시) | 항, 제31조의2, 제31조의5, 제31조의3, 제31 | 진 동위원소가 아니며 그 방사능은 무담체제제 |\n| 수십 마이크로미터의 두께에서 완전히 흡수된다.  베타 | 2. ",
        "original_sentence": "| window) 들로 구성된다. "
      }
    },
    {
      "chunk_id": "chunk_494",
      "text": "질적 및 양적 면에서 방사성 | □ 품목허가 처리(6단계) 상세 절차 | - 별첨규격 : 일반명 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 493,
        "window_size": 3,
        "char_count": 59,
        "word_count": 18,
        "page_number": 3,
        "window_text": "결과물은 표적핵(target nucleus)을 가 |\n| 상당히 다르다.  알파입자는 물질의 수 마이크로 내지 | 이지 않음(투여 전 방사능 농도 확인 후 해당 농도로 희석하여 환자에게 투여) | 분량, 제형이 동일한 의약품 |\n| ※ 의약품 품목허가 처리기한 및 수수료는 민원 신청 품목에 따라 상이합니다.  | window) 들로 구성된다.  질적 및 양적 면에서 방사성 | □ 품목허가 처리(6단계) 상세 절차 | - 별첨규격 : 일반명 | 1.  기원 또는 발견 및 개발의 경위 | 비방사능은 일반적으로 방사능이 방사성핵종(방사성핵 |\n| 비경구투여 방사성의약품은 무균시험에 적합하여야 한 | 제9조(안전성ᆞ유효성에 관한 자료) 의약품등의 | 입증자료 제시) | 항, 제31조의2, 제31조의5, 제31조의3, 제31 | 진 동위원소가 아니며 그 방사능은 무담체제제 |\n| 수십 마이크로미터의 두께에서 완전히 흡수된다.  베타 | 2.  국내외에서의 사용현황에 관한 자료 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 핵종의 생산 효율에 미치는 모든 영향을 평가하기 위 | 다. ",
        "original_sentence": "질적 및 양적 면에서 방사성 | □ 품목허가 처리(6단계) 상세 절차 | - 별첨규격 : 일반명 | 1. "
      }
    },
    {
      "chunk_id": "chunk_495",
      "text": "기원 또는 발견 및 개발의 경위 | 비방사능은 일반적으로 방사능이 방사성핵종(방사성핵 |\n| 비경구투여 방사성의약품은 무균시험에 적합하여야 한 | 제9조(안전성ᆞ유효성에 관한 자료) 의약품등의 | 입증자료 제시) | 항, 제31조의2, 제31조의5, 제31조의3, 제31 | 진 동위원소가 아니며 그 방사능은 무담체제제 |\n| 수십 마이크로미터의 두께에서 완전히 흡수된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 494,
        "window_size": 3,
        "char_count": 209,
        "word_count": 46,
        "page_number": 5,
        "window_text": "알파입자는 물질의 수 마이크로 내지 | 이지 않음(투여 전 방사능 농도 확인 후 해당 농도로 희석하여 환자에게 투여) | 분량, 제형이 동일한 의약품 |\n| ※ 의약품 품목허가 처리기한 및 수수료는 민원 신청 품목에 따라 상이합니다.  | window) 들로 구성된다.  질적 및 양적 면에서 방사성 | □ 품목허가 처리(6단계) 상세 절차 | - 별첨규격 : 일반명 | 1.  기원 또는 발견 및 개발의 경위 | 비방사능은 일반적으로 방사능이 방사성핵종(방사성핵 |\n| 비경구투여 방사성의약품은 무균시험에 적합하여야 한 | 제9조(안전성ᆞ유효성에 관한 자료) 의약품등의 | 입증자료 제시) | 항, 제31조의2, 제31조의5, 제31조의3, 제31 | 진 동위원소가 아니며 그 방사능은 무담체제제 |\n| 수십 마이크로미터의 두께에서 완전히 흡수된다.  베타 | 2.  국내외에서의 사용현황에 관한 자료 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 핵종의 생산 효율에 미치는 모든 영향을 평가하기 위 | 다.  이러한 제품들은 미생물 오염을 막고 무균을 보장 | ◯ 용기 관련 | 제조판매ᆞ수입 품목허가 또는 품목변경허가를 |\n| - 조제하여 사용하는 방사성의약품(Cold Vial)의 경우 조제 후의 사용기간도 기재 | 3. ",
        "original_sentence": "기원 또는 발견 및 개발의 경위 | 비방사능은 일반적으로 방사능이 방사성핵종(방사성핵 |\n| 비경구투여 방사성의약품은 무균시험에 적합하여야 한 | 제9조(안전성ᆞ유효성에 관한 자료) 의약품등의 | 입증자료 제시) | 항, 제31조의2, 제31조의5, 제31조의3, 제31 | 진 동위원소가 아니며 그 방사능은 무담체제제 |\n| 수십 마이크로미터의 두께에서 완전히 흡수된다. "
      }
    },
    {
      "chunk_id": "chunk_496",
      "text": "베타 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 495,
        "window_size": 3,
        "char_count": 8,
        "word_count": 3,
        "page_number": 3,
        "window_text": "| window) 들로 구성된다.  질적 및 양적 면에서 방사성 | □ 품목허가 처리(6단계) 상세 절차 | - 별첨규격 : 일반명 | 1.  기원 또는 발견 및 개발의 경위 | 비방사능은 일반적으로 방사능이 방사성핵종(방사성핵 |\n| 비경구투여 방사성의약품은 무균시험에 적합하여야 한 | 제9조(안전성ᆞ유효성에 관한 자료) 의약품등의 | 입증자료 제시) | 항, 제31조의2, 제31조의5, 제31조의3, 제31 | 진 동위원소가 아니며 그 방사능은 무담체제제 |\n| 수십 마이크로미터의 두께에서 완전히 흡수된다.  베타 | 2.  국내외에서의 사용현황에 관한 자료 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 핵종의 생산 효율에 미치는 모든 영향을 평가하기 위 | 다.  이러한 제품들은 미생물 오염을 막고 무균을 보장 | ◯ 용기 관련 | 제조판매ᆞ수입 품목허가 또는 품목변경허가를 |\n| - 조제하여 사용하는 방사성의약품(Cold Vial)의 경우 조제 후의 사용기간도 기재 | 3.  원료의약품에 관한 자료 |\n| 입자는 물질의 수 밀리미터 내지 수 센티미터의 두께 | 4. ",
        "original_sentence": "베타 | 2. "
      }
    },
    {
      "chunk_id": "chunk_497",
      "text": "국내외에서의 사용현황에 관한 자료 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 핵종의 생산 효율에 미치는 모든 영향을 평가하기 위 | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 496,
        "window_size": 3,
        "char_count": 90,
        "word_count": 19,
        "page_number": 5,
        "window_text": "질적 및 양적 면에서 방사성 | □ 품목허가 처리(6단계) 상세 절차 | - 별첨규격 : 일반명 | 1.  기원 또는 발견 및 개발의 경위 | 비방사능은 일반적으로 방사능이 방사성핵종(방사성핵 |\n| 비경구투여 방사성의약품은 무균시험에 적합하여야 한 | 제9조(안전성ᆞ유효성에 관한 자료) 의약품등의 | 입증자료 제시) | 항, 제31조의2, 제31조의5, 제31조의3, 제31 | 진 동위원소가 아니며 그 방사능은 무담체제제 |\n| 수십 마이크로미터의 두께에서 완전히 흡수된다.  베타 | 2.  국내외에서의 사용현황에 관한 자료 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 핵종의 생산 효율에 미치는 모든 영향을 평가하기 위 | 다.  이러한 제품들은 미생물 오염을 막고 무균을 보장 | ◯ 용기 관련 | 제조판매ᆞ수입 품목허가 또는 품목변경허가를 |\n| - 조제하여 사용하는 방사성의약품(Cold Vial)의 경우 조제 후의 사용기간도 기재 | 3.  원료의약품에 관한 자료 |\n| 입자는 물질의 수 밀리미터 내지 수 센티미터의 두께 | 4.  제4조제1항제4호에 따른 자료 |\n| <처리기한> | 2.3.1 제품명 | 해서는 제조방법이 명확하게 기술되어야 하고 다음을 | 하도록 주의 깊게 설계하여 제조되어야 한다. ",
        "original_sentence": "국내외에서의 사용현황에 관한 자료 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 핵종의 생산 효율에 미치는 모든 영향을 평가하기 위 | 다. "
      }
    },
    {
      "chunk_id": "chunk_498",
      "text": "이러한 제품들은 미생물 오염을 막고 무균을 보장 | ◯ 용기 관련 | 제조판매ᆞ수입 품목허가 또는 품목변경허가를 |\n| - 조제하여 사용하는 방사성의약품(Cold Vial)의 경우 조제 후의 사용기간도 기재 | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 497,
        "window_size": 3,
        "char_count": 121,
        "word_count": 30,
        "page_number": 3,
        "window_text": "기원 또는 발견 및 개발의 경위 | 비방사능은 일반적으로 방사능이 방사성핵종(방사성핵 |\n| 비경구투여 방사성의약품은 무균시험에 적합하여야 한 | 제9조(안전성ᆞ유효성에 관한 자료) 의약품등의 | 입증자료 제시) | 항, 제31조의2, 제31조의5, 제31조의3, 제31 | 진 동위원소가 아니며 그 방사능은 무담체제제 |\n| 수십 마이크로미터의 두께에서 완전히 흡수된다.  베타 | 2.  국내외에서의 사용현황에 관한 자료 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 핵종의 생산 효율에 미치는 모든 영향을 평가하기 위 | 다.  이러한 제품들은 미생물 오염을 막고 무균을 보장 | ◯ 용기 관련 | 제조판매ᆞ수입 품목허가 또는 품목변경허가를 |\n| - 조제하여 사용하는 방사성의약품(Cold Vial)의 경우 조제 후의 사용기간도 기재 | 3.  원료의약품에 관한 자료 |\n| 입자는 물질의 수 밀리미터 내지 수 센티미터의 두께 | 4.  제4조제1항제4호에 따른 자료 |\n| <처리기한> | 2.3.1 제품명 | 해서는 제조방법이 명확하게 기술되어야 하고 다음을 | 하도록 주의 깊게 설계하여 제조되어야 한다.  무균시 | 분량 및 단위 | 받거나 제조판매ᆞ수입 품목신고 또는 품목변경 | 방사성붕괴 현상을 설명하거나 이러한 현상의 물리적 | 검증한 후에 방사능의 농도와 화학물질의 농도를 고려 |\n| 에서 완전히 흡수된다. ",
        "original_sentence": "이러한 제품들은 미생물 오염을 막고 무균을 보장 | ◯ 용기 관련 | 제조판매ᆞ수입 품목허가 또는 품목변경허가를 |\n| - 조제하여 사용하는 방사성의약품(Cold Vial)의 경우 조제 후의 사용기간도 기재 | 3. "
      }
    },
    {
      "chunk_id": "chunk_499",
      "text": "원료의약품에 관한 자료 |\n| 입자는 물질의 수 밀리미터 내지 수 센티미터의 두께 | 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 498,
        "window_size": 3,
        "char_count": 51,
        "word_count": 15,
        "page_number": 3,
        "window_text": "베타 | 2.  국내외에서의 사용현황에 관한 자료 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 핵종의 생산 효율에 미치는 모든 영향을 평가하기 위 | 다.  이러한 제품들은 미생물 오염을 막고 무균을 보장 | ◯ 용기 관련 | 제조판매ᆞ수입 품목허가 또는 품목변경허가를 |\n| - 조제하여 사용하는 방사성의약품(Cold Vial)의 경우 조제 후의 사용기간도 기재 | 3.  원료의약품에 관한 자료 |\n| 입자는 물질의 수 밀리미터 내지 수 센티미터의 두께 | 4.  제4조제1항제4호에 따른 자료 |\n| <처리기한> | 2.3.1 제품명 | 해서는 제조방법이 명확하게 기술되어야 하고 다음을 | 하도록 주의 깊게 설계하여 제조되어야 한다.  무균시 | 분량 및 단위 | 받거나 제조판매ᆞ수입 품목신고 또는 품목변경 | 방사성붕괴 현상을 설명하거나 이러한 현상의 물리적 | 검증한 후에 방사능의 농도와 화학물질의 농도를 고려 |\n| 에서 완전히 흡수된다.  감마선은 완전히 흡수되거나 | 나. ",
        "original_sentence": "원료의약품에 관한 자료 |\n| 입자는 물질의 수 밀리미터 내지 수 센티미터의 두께 | 4. "
      }
    },
    {
      "chunk_id": "chunk_500",
      "text": "제4조제1항제4호에 따른 자료 |\n| <처리기한> | 2.3.1 제품명 | 해서는 제조방법이 명확하게 기술되어야 하고 다음을 | 하도록 주의 깊게 설계하여 제조되어야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 499,
        "window_size": 3,
        "char_count": 97,
        "word_count": 23,
        "page_number": 3,
        "window_text": "국내외에서의 사용현황에 관한 자료 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 핵종의 생산 효율에 미치는 모든 영향을 평가하기 위 | 다.  이러한 제품들은 미생물 오염을 막고 무균을 보장 | ◯ 용기 관련 | 제조판매ᆞ수입 품목허가 또는 품목변경허가를 |\n| - 조제하여 사용하는 방사성의약품(Cold Vial)의 경우 조제 후의 사용기간도 기재 | 3.  원료의약품에 관한 자료 |\n| 입자는 물질의 수 밀리미터 내지 수 센티미터의 두께 | 4.  제4조제1항제4호에 따른 자료 |\n| <처리기한> | 2.3.1 제품명 | 해서는 제조방법이 명확하게 기술되어야 하고 다음을 | 하도록 주의 깊게 설계하여 제조되어야 한다.  무균시 | 분량 및 단위 | 받거나 제조판매ᆞ수입 품목신고 또는 품목변경 | 방사성붕괴 현상을 설명하거나 이러한 현상의 물리적 | 검증한 후에 방사능의 농도와 화학물질의 농도를 고려 |\n| 에서 완전히 흡수된다.  감마선은 완전히 흡수되거나 | 나.  가목에 해당하는 품목을 제외한 전문의약 | 5. ",
        "original_sentence": "제4조제1항제4호에 따른 자료 |\n| <처리기한> | 2.3.1 제품명 | 해서는 제조방법이 명확하게 기술되어야 하고 다음을 | 하도록 주의 깊게 설계하여 제조되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_501",
      "text": "무균시 | 분량 및 단위 | 받거나 제조판매ᆞ수입 품목신고 또는 품목변경 | 방사성붕괴 현상을 설명하거나 이러한 현상의 물리적 | 검증한 후에 방사능의 농도와 화학물질의 농도를 고려 |\n| 에서 완전히 흡수된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 500,
        "window_size": 3,
        "char_count": 119,
        "word_count": 31,
        "page_number": 3,
        "window_text": "이러한 제품들은 미생물 오염을 막고 무균을 보장 | ◯ 용기 관련 | 제조판매ᆞ수입 품목허가 또는 품목변경허가를 |\n| - 조제하여 사용하는 방사성의약품(Cold Vial)의 경우 조제 후의 사용기간도 기재 | 3.  원료의약품에 관한 자료 |\n| 입자는 물질의 수 밀리미터 내지 수 센티미터의 두께 | 4.  제4조제1항제4호에 따른 자료 |\n| <처리기한> | 2.3.1 제품명 | 해서는 제조방법이 명확하게 기술되어야 하고 다음을 | 하도록 주의 깊게 설계하여 제조되어야 한다.  무균시 | 분량 및 단위 | 받거나 제조판매ᆞ수입 품목신고 또는 품목변경 | 방사성붕괴 현상을 설명하거나 이러한 현상의 물리적 | 검증한 후에 방사능의 농도와 화학물질의 농도를 고려 |\n| 에서 완전히 흡수된다.  감마선은 완전히 흡수되거나 | 나.  가목에 해당하는 품목을 제외한 전문의약 | 5.  제4조제1항제6호에 따른 자료(이 조 제1항 | 2.「신약 등의 재심사 기준」(식품의약품안전처 고시)을 준수할 것 |\n| 고려해야 한다 : 표적물질, 표적물질의 홀더 구성, 조 | 험은 일반시험법(2.6.1)에 따라 시험한다. ",
        "original_sentence": "무균시 | 분량 및 단위 | 받거나 제조판매ᆞ수입 품목신고 또는 품목변경 | 방사성붕괴 현상을 설명하거나 이러한 현상의 물리적 | 검증한 후에 방사능의 농도와 화학물질의 농도를 고려 |\n| 에서 완전히 흡수된다. "
      }
    },
    {
      "chunk_id": "chunk_502",
      "text": "감마선은 완전히 흡수되거나 | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 501,
        "window_size": 3,
        "char_count": 20,
        "word_count": 5,
        "page_number": 12,
        "window_text": "원료의약품에 관한 자료 |\n| 입자는 물질의 수 밀리미터 내지 수 센티미터의 두께 | 4.  제4조제1항제4호에 따른 자료 |\n| <처리기한> | 2.3.1 제품명 | 해서는 제조방법이 명확하게 기술되어야 하고 다음을 | 하도록 주의 깊게 설계하여 제조되어야 한다.  무균시 | 분량 및 단위 | 받거나 제조판매ᆞ수입 품목신고 또는 품목변경 | 방사성붕괴 현상을 설명하거나 이러한 현상의 물리적 | 검증한 후에 방사능의 농도와 화학물질의 농도를 고려 |\n| 에서 완전히 흡수된다.  감마선은 완전히 흡수되거나 | 나.  가목에 해당하는 품목을 제외한 전문의약 | 5.  제4조제1항제6호에 따른 자료(이 조 제1항 | 2.「신약 등의 재심사 기준」(식품의약품안전처 고시)을 준수할 것 |\n| 고려해야 한다 : 표적물질, 표적물질의 홀더 구성, 조 | 험은 일반시험법(2.6.1)에 따라 시험한다.  방사성의약품 | [일반시험법 - 주사제용유리용기 | 기타 | 신고를 하려는 자가 제출하여야 하는 안전성ᆞ | 인 양을 표현하는데 사용되었다. ",
        "original_sentence": "감마선은 완전히 흡수되거나 | 나. "
      }
    },
    {
      "chunk_id": "chunk_503",
      "text": "가목에 해당하는 품목을 제외한 전문의약 | 5. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 502,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 3,
        "window_text": "제4조제1항제4호에 따른 자료 |\n| <처리기한> | 2.3.1 제품명 | 해서는 제조방법이 명확하게 기술되어야 하고 다음을 | 하도록 주의 깊게 설계하여 제조되어야 한다.  무균시 | 분량 및 단위 | 받거나 제조판매ᆞ수입 품목신고 또는 품목변경 | 방사성붕괴 현상을 설명하거나 이러한 현상의 물리적 | 검증한 후에 방사능의 농도와 화학물질의 농도를 고려 |\n| 에서 완전히 흡수된다.  감마선은 완전히 흡수되거나 | 나.  가목에 해당하는 품목을 제외한 전문의약 | 5.  제4조제1항제6호에 따른 자료(이 조 제1항 | 2.「신약 등의 재심사 기준」(식품의약품안전처 고시)을 준수할 것 |\n| 고려해야 한다 : 표적물질, 표적물질의 홀더 구성, 조 | 험은 일반시험법(2.6.1)에 따라 시험한다.  방사성의약품 | [일반시험법 - 주사제용유리용기 | 기타 | 신고를 하려는 자가 제출하여야 하는 안전성ᆞ | 인 양을 표현하는데 사용되었다.  제품의 방사능은 단 |\n| 약화되는데 예를 들어 10배로 감소시키는데 수 센티미 | 기재순서 |\n| - 처리기한은 단순 합산이 아니라 처리기한이 긴 민원을 기준으로 산정됩니다. ",
        "original_sentence": "가목에 해당하는 품목을 제외한 전문의약 | 5. "
      }
    },
    {
      "chunk_id": "chunk_504",
      "text": "제4조제1항제6호에 따른 자료(이 조 제1항 | 2.「신약 등의 재심사 기준」(식품의약품안전처 고시)을 준수할 것 |\n| 고려해야 한다 : 표적물질, 표적물질의 홀더 구성, 조 | 험은 일반시험법(2.6.1)에 따라 시험한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 503,
        "window_size": 3,
        "char_count": 127,
        "word_count": 28,
        "page_number": 3,
        "window_text": "무균시 | 분량 및 단위 | 받거나 제조판매ᆞ수입 품목신고 또는 품목변경 | 방사성붕괴 현상을 설명하거나 이러한 현상의 물리적 | 검증한 후에 방사능의 농도와 화학물질의 농도를 고려 |\n| 에서 완전히 흡수된다.  감마선은 완전히 흡수되거나 | 나.  가목에 해당하는 품목을 제외한 전문의약 | 5.  제4조제1항제6호에 따른 자료(이 조 제1항 | 2.「신약 등의 재심사 기준」(식품의약품안전처 고시)을 준수할 것 |\n| 고려해야 한다 : 표적물질, 표적물질의 홀더 구성, 조 | 험은 일반시험법(2.6.1)에 따라 시험한다.  방사성의약품 | [일반시험법 - 주사제용유리용기 | 기타 | 신고를 하려는 자가 제출하여야 하는 안전성ᆞ | 인 양을 표현하는데 사용되었다.  제품의 방사능은 단 |\n| 약화되는데 예를 들어 10배로 감소시키는데 수 센티미 | 기재순서 |\n| - 처리기한은 단순 합산이 아니라 처리기한이 긴 민원을 기준으로 산정됩니다.  | - 전체단위(기준단위) : 액상주사제(1 밀리리터*), 분말주사제(단위제형; 1 바이알, 1 앰플), | 시험법] | 3. ",
        "original_sentence": "제4조제1항제6호에 따른 자료(이 조 제1항 | 2.「신약 등의 재심사 기준」(식품의약품안전처 고시)을 준수할 것 |\n| 고려해야 한다 : 표적물질, 표적물질의 홀더 구성, 조 | 험은 일반시험법(2.6.1)에 따라 시험한다. "
      }
    },
    {
      "chunk_id": "chunk_505",
      "text": "방사성의약품 | [일반시험법 - 주사제용유리용기 | 기타 | 신고를 하려는 자가 제출하여야 하는 안전성ᆞ | 인 양을 표현하는데 사용되었다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 504,
        "window_size": 3,
        "char_count": 79,
        "word_count": 19,
        "page_number": 3,
        "window_text": "감마선은 완전히 흡수되거나 | 나.  가목에 해당하는 품목을 제외한 전문의약 | 5.  제4조제1항제6호에 따른 자료(이 조 제1항 | 2.「신약 등의 재심사 기준」(식품의약품안전처 고시)을 준수할 것 |\n| 고려해야 한다 : 표적물질, 표적물질의 홀더 구성, 조 | 험은 일반시험법(2.6.1)에 따라 시험한다.  방사성의약품 | [일반시험법 - 주사제용유리용기 | 기타 | 신고를 하려는 자가 제출하여야 하는 안전성ᆞ | 인 양을 표현하는데 사용되었다.  제품의 방사능은 단 |\n| 약화되는데 예를 들어 10배로 감소시키는데 수 센티미 | 기재순서 |\n| - 처리기한은 단순 합산이 아니라 처리기한이 긴 민원을 기준으로 산정됩니다.  | - 전체단위(기준단위) : 액상주사제(1 밀리리터*), 분말주사제(단위제형; 1 바이알, 1 앰플), | 시험법] | 3.  만일, 정당한 사유 없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다. ",
        "original_sentence": "방사성의약품 | [일반시험법 - 주사제용유리용기 | 기타 | 신고를 하려는 자가 제출하여야 하는 안전성ᆞ | 인 양을 표현하는데 사용되었다. "
      }
    },
    {
      "chunk_id": "chunk_506",
      "text": "제품의 방사능은 단 |\n| 약화되는데 예를 들어 10배로 감소시키는데 수 센티미 | 기재순서 |\n| - 처리기한은 단순 합산이 아니라 처리기한이 긴 민원을 기준으로 산정됩니다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 505,
        "window_size": 3,
        "char_count": 99,
        "word_count": 26,
        "page_number": 3,
        "window_text": "가목에 해당하는 품목을 제외한 전문의약 | 5.  제4조제1항제6호에 따른 자료(이 조 제1항 | 2.「신약 등의 재심사 기준」(식품의약품안전처 고시)을 준수할 것 |\n| 고려해야 한다 : 표적물질, 표적물질의 홀더 구성, 조 | 험은 일반시험법(2.6.1)에 따라 시험한다.  방사성의약품 | [일반시험법 - 주사제용유리용기 | 기타 | 신고를 하려는 자가 제출하여야 하는 안전성ᆞ | 인 양을 표현하는데 사용되었다.  제품의 방사능은 단 |\n| 약화되는데 예를 들어 10배로 감소시키는데 수 센티미 | 기재순서 |\n| - 처리기한은 단순 합산이 아니라 처리기한이 긴 민원을 기준으로 산정됩니다.  | - 전체단위(기준단위) : 액상주사제(1 밀리리터*), 분말주사제(단위제형; 1 바이알, 1 앰플), | 시험법] | 3.  만일, 정당한 사유 없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.  | 유효성에 관한 자료는 다음 각 호의 자료(전자 |\n| 사(irradiation) 방법 및 원하는 방사성 핵종의 분리. ",
        "original_sentence": "제품의 방사능은 단 |\n| 약화되는데 예를 들어 10배로 감소시키는데 수 센티미 | 기재순서 |\n| - 처리기한은 단순 합산이 아니라 처리기한이 긴 민원을 기준으로 산정됩니다. "
      }
    },
    {
      "chunk_id": "chunk_507",
      "text": "| - 전체단위(기준단위) : 액상주사제(1 밀리리터*), 분말주사제(단위제형; 1 바이알, 1 앰플), | 시험법] | 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 506,
        "window_size": 3,
        "char_count": 71,
        "word_count": 15,
        "page_number": 3,
        "window_text": "제4조제1항제6호에 따른 자료(이 조 제1항 | 2.「신약 등의 재심사 기준」(식품의약품안전처 고시)을 준수할 것 |\n| 고려해야 한다 : 표적물질, 표적물질의 홀더 구성, 조 | 험은 일반시험법(2.6.1)에 따라 시험한다.  방사성의약품 | [일반시험법 - 주사제용유리용기 | 기타 | 신고를 하려는 자가 제출하여야 하는 안전성ᆞ | 인 양을 표현하는데 사용되었다.  제품의 방사능은 단 |\n| 약화되는데 예를 들어 10배로 감소시키는데 수 센티미 | 기재순서 |\n| - 처리기한은 단순 합산이 아니라 처리기한이 긴 민원을 기준으로 산정됩니다.  | - 전체단위(기준단위) : 액상주사제(1 밀리리터*), 분말주사제(단위제형; 1 바이알, 1 앰플), | 시험법] | 3.  만일, 정당한 사유 없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.  | 유효성에 관한 자료는 다음 각 호의 자료(전자 |\n| 사(irradiation) 방법 및 원하는 방사성 핵종의 분리.  | 에서는 일부 방사성핵종의 반감기가 짧거나, 배치크기 | 위시간 당 붕괴 또는 변환되는 핵의 수이다. ",
        "original_sentence": "| - 전체단위(기준단위) : 액상주사제(1 밀리리터*), 분말주사제(단위제형; 1 바이알, 1 앰플), | 시험법] | 3. "
      }
    },
    {
      "chunk_id": "chunk_508",
      "text": "만일, 정당한 사유 없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 507,
        "window_size": 3,
        "char_count": 53,
        "word_count": 14,
        "page_number": 5,
        "window_text": "방사성의약품 | [일반시험법 - 주사제용유리용기 | 기타 | 신고를 하려는 자가 제출하여야 하는 안전성ᆞ | 인 양을 표현하는데 사용되었다.  제품의 방사능은 단 |\n| 약화되는데 예를 들어 10배로 감소시키는데 수 센티미 | 기재순서 |\n| - 처리기한은 단순 합산이 아니라 처리기한이 긴 민원을 기준으로 산정됩니다.  | - 전체단위(기준단위) : 액상주사제(1 밀리리터*), 분말주사제(단위제형; 1 바이알, 1 앰플), | 시험법] | 3.  만일, 정당한 사유 없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.  | 유효성에 관한 자료는 다음 각 호의 자료(전자 |\n| 사(irradiation) 방법 및 원하는 방사성 핵종의 분리.  | 에서는 일부 방사성핵종의 반감기가 짧거나, 배치크기 | 위시간 당 붕괴 또는 변환되는 핵의 수이다.  국제단위 | 방사성핵종 | 제너레이터는 | 어미방사성핵종(parent |\n| 터의 납이 필요할 수 있다. ",
        "original_sentence": "만일, 정당한 사유 없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_509",
      "text": "| 유효성에 관한 자료는 다음 각 호의 자료(전자 |\n| 사(irradiation) 방법 및 원하는 방사성 핵종의 분리. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 508,
        "window_size": 3,
        "char_count": 68,
        "word_count": 17,
        "page_number": 5,
        "window_text": "제품의 방사능은 단 |\n| 약화되는데 예를 들어 10배로 감소시키는데 수 센티미 | 기재순서 |\n| - 처리기한은 단순 합산이 아니라 처리기한이 긴 민원을 기준으로 산정됩니다.  | - 전체단위(기준단위) : 액상주사제(1 밀리리터*), 분말주사제(단위제형; 1 바이알, 1 앰플), | 시험법] | 3.  만일, 정당한 사유 없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.  | 유효성에 관한 자료는 다음 각 호의 자료(전자 |\n| 사(irradiation) 방법 및 원하는 방사성 핵종의 분리.  | 에서는 일부 방사성핵종의 반감기가 짧거나, 배치크기 | 위시간 당 붕괴 또는 변환되는 핵의 수이다.  국제단위 | 방사성핵종 | 제너레이터는 | 어미방사성핵종(parent |\n| 터의 납이 필요할 수 있다.  | 밀도가 높은 흡수체 | - 방사성의약품은 다음 사항을 추가로 기재 | 6. ",
        "original_sentence": "| 유효성에 관한 자료는 다음 각 호의 자료(전자 |\n| 사(irradiation) 방법 및 원하는 방사성 핵종의 분리. "
      }
    },
    {
      "chunk_id": "chunk_510",
      "text": "| 에서는 일부 방사성핵종의 반감기가 짧거나, 배치크기 | 위시간 당 붕괴 또는 변환되는 핵의 수이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 509,
        "window_size": 3,
        "char_count": 58,
        "word_count": 15,
        "page_number": 12,
        "window_text": "| - 전체단위(기준단위) : 액상주사제(1 밀리리터*), 분말주사제(단위제형; 1 바이알, 1 앰플), | 시험법] | 3.  만일, 정당한 사유 없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.  | 유효성에 관한 자료는 다음 각 호의 자료(전자 |\n| 사(irradiation) 방법 및 원하는 방사성 핵종의 분리.  | 에서는 일부 방사성핵종의 반감기가 짧거나, 배치크기 | 위시간 당 붕괴 또는 변환되는 핵의 수이다.  국제단위 | 방사성핵종 | 제너레이터는 | 어미방사성핵종(parent |\n| 터의 납이 필요할 수 있다.  | 밀도가 높은 흡수체 | - 방사성의약품은 다음 사항을 추가로 기재 | 6.  제4조제1항제7호부터 제9호까지에 따른 자 | 문서를 포함한다)로 한다. ",
        "original_sentence": "| 에서는 일부 방사성핵종의 반감기가 짧거나, 배치크기 | 위시간 당 붕괴 또는 변환되는 핵의 수이다. "
      }
    },
    {
      "chunk_id": "chunk_511",
      "text": "국제단위 | 방사성핵종 | 제너레이터는 | 어미방사성핵종(parent |\n| 터의 납이 필요할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 510,
        "window_size": 3,
        "char_count": 59,
        "word_count": 14,
        "page_number": 5,
        "window_text": "만일, 정당한 사유 없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.  | 유효성에 관한 자료는 다음 각 호의 자료(전자 |\n| 사(irradiation) 방법 및 원하는 방사성 핵종의 분리.  | 에서는 일부 방사성핵종의 반감기가 짧거나, 배치크기 | 위시간 당 붕괴 또는 변환되는 핵의 수이다.  국제단위 | 방사성핵종 | 제너레이터는 | 어미방사성핵종(parent |\n| 터의 납이 필요할 수 있다.  | 밀도가 높은 흡수체 | - 방사성의약품은 다음 사항을 추가로 기재 | 6.  제4조제1항제7호부터 제9호까지에 따른 자 | 문서를 포함한다)로 한다.  이 경우 자료제출 대 |\n| 예1) | 안전성유효성에 | 관한 | 자료(70일), | 기준 | 및 | 시험방법에 | 관한 | 자료(55일)의 | 검토가 | 필요한 | 민원: | ▷ 상표명 있는 경우 | 가 작거나 방사선의 위험 때문에 실험이 어려울 수 있 | 분할사용을 목적으로 하는 용기 | 기타(1 제너레이터 등) | * | 수입품의 | 경우에는 | 「의약품등의 | 안전에 | 관한 | 규칙」(총리령) | 제4조제1항제4호에 | 따라, | 의약품등을 | radionuclide)이 반감기가 짧은 딸방사성핵종(daughter |\n| (absorbent)를 사용할수록 알파와 베타입자의 범위가 | 는 고무마개 또는 다른 적당한 | ․의약품의 용기․포장에 ‘제조일자(필요시 시각기재한다) : 제조시 표기’와 같이 기재 | 상 품목, 자료 작성요령, 각 자료의 요건 및 면 |\n| * 분할사용 하는 경우 기준단위를 ‘단위량’으로 기재 가능(｢ | 다. ",
        "original_sentence": "국제단위 | 방사성핵종 | 제너레이터는 | 어미방사성핵종(parent |\n| 터의 납이 필요할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_512",
      "text": "| 밀도가 높은 흡수체 | - 방사성의약품은 다음 사항을 추가로 기재 | 6. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 511,
        "window_size": 3,
        "char_count": 44,
        "word_count": 13,
        "page_number": 1,
        "window_text": "| 유효성에 관한 자료는 다음 각 호의 자료(전자 |\n| 사(irradiation) 방법 및 원하는 방사성 핵종의 분리.  | 에서는 일부 방사성핵종의 반감기가 짧거나, 배치크기 | 위시간 당 붕괴 또는 변환되는 핵의 수이다.  국제단위 | 방사성핵종 | 제너레이터는 | 어미방사성핵종(parent |\n| 터의 납이 필요할 수 있다.  | 밀도가 높은 흡수체 | - 방사성의약품은 다음 사항을 추가로 기재 | 6.  제4조제1항제7호부터 제9호까지에 따른 자 | 문서를 포함한다)로 한다.  이 경우 자료제출 대 |\n| 예1) | 안전성유효성에 | 관한 | 자료(70일), | 기준 | 및 | 시험방법에 | 관한 | 자료(55일)의 | 검토가 | 필요한 | 민원: | ▷ 상표명 있는 경우 | 가 작거나 방사선의 위험 때문에 실험이 어려울 수 있 | 분할사용을 목적으로 하는 용기 | 기타(1 제너레이터 등) | * | 수입품의 | 경우에는 | 「의약품등의 | 안전에 | 관한 | 규칙」(총리령) | 제4조제1항제4호에 | 따라, | 의약품등을 | radionuclide)이 반감기가 짧은 딸방사성핵종(daughter |\n| (absorbent)를 사용할수록 알파와 베타입자의 범위가 | 는 고무마개 또는 다른 적당한 | ․의약품의 용기․포장에 ‘제조일자(필요시 시각기재한다) : 제조시 표기’와 같이 기재 | 상 품목, 자료 작성요령, 각 자료의 요건 및 면 |\n| * 분할사용 하는 경우 기준단위를 ‘단위량’으로 기재 가능(｢ | 다.  무균시험을 완료하기 전에 출하할 수 있도록 각조 | 4. ",
        "original_sentence": "| 밀도가 높은 흡수체 | - 방사성의약품은 다음 사항을 추가로 기재 | 6. "
      }
    },
    {
      "chunk_id": "chunk_513",
      "text": "제4조제1항제7호부터 제9호까지에 따른 자 | 문서를 포함한다)로 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 512,
        "window_size": 3,
        "char_count": 41,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| 에서는 일부 방사성핵종의 반감기가 짧거나, 배치크기 | 위시간 당 붕괴 또는 변환되는 핵의 수이다.  국제단위 | 방사성핵종 | 제너레이터는 | 어미방사성핵종(parent |\n| 터의 납이 필요할 수 있다.  | 밀도가 높은 흡수체 | - 방사성의약품은 다음 사항을 추가로 기재 | 6.  제4조제1항제7호부터 제9호까지에 따른 자 | 문서를 포함한다)로 한다.  이 경우 자료제출 대 |\n| 예1) | 안전성유효성에 | 관한 | 자료(70일), | 기준 | 및 | 시험방법에 | 관한 | 자료(55일)의 | 검토가 | 필요한 | 민원: | ▷ 상표명 있는 경우 | 가 작거나 방사선의 위험 때문에 실험이 어려울 수 있 | 분할사용을 목적으로 하는 용기 | 기타(1 제너레이터 등) | * | 수입품의 | 경우에는 | 「의약품등의 | 안전에 | 관한 | 규칙」(총리령) | 제4조제1항제4호에 | 따라, | 의약품등을 | radionuclide)이 반감기가 짧은 딸방사성핵종(daughter |\n| (absorbent)를 사용할수록 알파와 베타입자의 범위가 | 는 고무마개 또는 다른 적당한 | ․의약품의 용기․포장에 ‘제조일자(필요시 시각기재한다) : 제조시 표기’와 같이 기재 | 상 품목, 자료 작성요령, 각 자료의 요건 및 면 |\n| * 분할사용 하는 경우 기준단위를 ‘단위량’으로 기재 가능(｢ | 다.  무균시험을 완료하기 전에 출하할 수 있도록 각조 | 4.  수입품의 경우 그 품목의 제조 및 판매에 관 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 |\n| 짧아지고 감마선의 약화가 증가한다. ",
        "original_sentence": "제4조제1항제7호부터 제9호까지에 따른 자 | 문서를 포함한다)로 한다. "
      }
    },
    {
      "chunk_id": "chunk_514",
      "text": "이 경우 자료제출 대 |\n| 예1) | 안전성유효성에 | 관한 | 자료(70일), | 기준 | 및 | 시험방법에 | 관한 | 자료(55일)의 | 검토가 | 필요한 | 민원: | ▷ 상표명 있는 경우 | 가 작거나 방사선의 위험 때문에 실험이 어려울 수 있 | 분할사용을 목적으로 하는 용기 | 기타(1 제너레이터 등) | * | 수입품의 | 경우에는 | 「의약품등의 | 안전에 | 관한 | 규칙」(총리령) | 제4조제1항제4호에 | 따라, | 의약품등을 | radionuclide)이 반감기가 짧은 딸방사성핵종(daughter |\n| (absorbent)를 사용할수록 알파와 베타입자의 범위가 | 는 고무마개 또는 다른 적당한 | ․의약품의 용기․포장에 ‘제조일자(필요시 시각기재한다) : 제조시 표기’와 같이 기재 | 상 품목, 자료 작성요령, 각 자료의 요건 및 면 |\n| * 분할사용 하는 경우 기준단위를 ‘단위량’으로 기재 가능(｢ | 다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 513,
        "window_size": 3,
        "char_count": 475,
        "word_count": 123,
        "page_number": 3,
        "window_text": "국제단위 | 방사성핵종 | 제너레이터는 | 어미방사성핵종(parent |\n| 터의 납이 필요할 수 있다.  | 밀도가 높은 흡수체 | - 방사성의약품은 다음 사항을 추가로 기재 | 6.  제4조제1항제7호부터 제9호까지에 따른 자 | 문서를 포함한다)로 한다.  이 경우 자료제출 대 |\n| 예1) | 안전성유효성에 | 관한 | 자료(70일), | 기준 | 및 | 시험방법에 | 관한 | 자료(55일)의 | 검토가 | 필요한 | 민원: | ▷ 상표명 있는 경우 | 가 작거나 방사선의 위험 때문에 실험이 어려울 수 있 | 분할사용을 목적으로 하는 용기 | 기타(1 제너레이터 등) | * | 수입품의 | 경우에는 | 「의약품등의 | 안전에 | 관한 | 규칙」(총리령) | 제4조제1항제4호에 | 따라, | 의약품등을 | radionuclide)이 반감기가 짧은 딸방사성핵종(daughter |\n| (absorbent)를 사용할수록 알파와 베타입자의 범위가 | 는 고무마개 또는 다른 적당한 | ․의약품의 용기․포장에 ‘제조일자(필요시 시각기재한다) : 제조시 표기’와 같이 기재 | 상 품목, 자료 작성요령, 각 자료의 요건 및 면 |\n| * 분할사용 하는 경우 기준단위를 ‘단위량’으로 기재 가능(｢ | 다.  무균시험을 완료하기 전에 출하할 수 있도록 각조 | 4.  수입품의 경우 그 품목의 제조 및 판매에 관 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 |\n| 짧아지고 감마선의 약화가 증가한다.  | - 조건부허가:「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조 규정에 | ① | 종양 | 약품과 | 마개로 밀봉한다. ",
        "original_sentence": "이 경우 자료제출 대 |\n| 예1) | 안전성유효성에 | 관한 | 자료(70일), | 기준 | 및 | 시험방법에 | 관한 | 자료(55일)의 | 검토가 | 필요한 | 민원: | ▷ 상표명 있는 경우 | 가 작거나 방사선의 위험 때문에 실험이 어려울 수 있 | 분할사용을 목적으로 하는 용기 | 기타(1 제너레이터 등) | * | 수입품의 | 경우에는 | 「의약품등의 | 안전에 | 관한 | 규칙」(총리령) | 제4조제1항제4호에 | 따라, | 의약품등을 | radionuclide)이 반감기가 짧은 딸방사성핵종(daughter |\n| (absorbent)를 사용할수록 알파와 베타입자의 범위가 | 는 고무마개 또는 다른 적당한 | ․의약품의 용기․포장에 ‘제조일자(필요시 시각기재한다) : 제조시 표기’와 같이 기재 | 상 품목, 자료 작성요령, 각 자료의 요건 및 면 |\n| * 분할사용 하는 경우 기준단위를 ‘단위량’으로 기재 가능(｢ | 다. "
      }
    },
    {
      "chunk_id": "chunk_515",
      "text": "무균시험을 완료하기 전에 출하할 수 있도록 각조 | 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 514,
        "window_size": 3,
        "char_count": 32,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| 밀도가 높은 흡수체 | - 방사성의약품은 다음 사항을 추가로 기재 | 6.  제4조제1항제7호부터 제9호까지에 따른 자 | 문서를 포함한다)로 한다.  이 경우 자료제출 대 |\n| 예1) | 안전성유효성에 | 관한 | 자료(70일), | 기준 | 및 | 시험방법에 | 관한 | 자료(55일)의 | 검토가 | 필요한 | 민원: | ▷ 상표명 있는 경우 | 가 작거나 방사선의 위험 때문에 실험이 어려울 수 있 | 분할사용을 목적으로 하는 용기 | 기타(1 제너레이터 등) | * | 수입품의 | 경우에는 | 「의약품등의 | 안전에 | 관한 | 규칙」(총리령) | 제4조제1항제4호에 | 따라, | 의약품등을 | radionuclide)이 반감기가 짧은 딸방사성핵종(daughter |\n| (absorbent)를 사용할수록 알파와 베타입자의 범위가 | 는 고무마개 또는 다른 적당한 | ․의약품의 용기․포장에 ‘제조일자(필요시 시각기재한다) : 제조시 표기’와 같이 기재 | 상 품목, 자료 작성요령, 각 자료의 요건 및 면 |\n| * 분할사용 하는 경우 기준단위를 ‘단위량’으로 기재 가능(｢ | 다.  무균시험을 완료하기 전에 출하할 수 있도록 각조 | 4.  수입품의 경우 그 품목의 제조 및 판매에 관 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 |\n| 짧아지고 감마선의 약화가 증가한다.  | - 조건부허가:「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조 규정에 | ① | 종양 | 약품과 | 마개로 밀봉한다.  마개는 내용의 | 제범위ᆞ심사기준 등에 관한 세부 규정과 독성 | - 반추동물유래성분의 경우 전염성해면상뇌증(TSE)감염을 방지하기 위한 원료선택 또는 |\n| 예2) 안전성유효성에 관한 자료(70일), GMP실시상황 평가(완제의약품:90일) 대상 민원 : 총 처리기한 90일 | 에 명시된 경우에는 방사선과 관련하여 실제적으로 가 | ․제조시(또는 검정시)의 방사선량 | 방사능 측정은 전문적인 연구소가 필요하지만 관계기 |\n| 유럽약전 각조의 제제에 사용된 방사성핵종의 가장 일 | 의2 참조) | 4. ",
        "original_sentence": "무균시험을 완료하기 전에 출하할 수 있도록 각조 | 4. "
      }
    },
    {
      "chunk_id": "chunk_516",
      "text": "수입품의 경우 그 품목의 제조 및 판매에 관 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 |\n| 짧아지고 감마선의 약화가 증가한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 515,
        "window_size": 3,
        "char_count": 78,
        "word_count": 24,
        "page_number": 3,
        "window_text": "제4조제1항제7호부터 제9호까지에 따른 자 | 문서를 포함한다)로 한다.  이 경우 자료제출 대 |\n| 예1) | 안전성유효성에 | 관한 | 자료(70일), | 기준 | 및 | 시험방법에 | 관한 | 자료(55일)의 | 검토가 | 필요한 | 민원: | ▷ 상표명 있는 경우 | 가 작거나 방사선의 위험 때문에 실험이 어려울 수 있 | 분할사용을 목적으로 하는 용기 | 기타(1 제너레이터 등) | * | 수입품의 | 경우에는 | 「의약품등의 | 안전에 | 관한 | 규칙」(총리령) | 제4조제1항제4호에 | 따라, | 의약품등을 | radionuclide)이 반감기가 짧은 딸방사성핵종(daughter |\n| (absorbent)를 사용할수록 알파와 베타입자의 범위가 | 는 고무마개 또는 다른 적당한 | ․의약품의 용기․포장에 ‘제조일자(필요시 시각기재한다) : 제조시 표기’와 같이 기재 | 상 품목, 자료 작성요령, 각 자료의 요건 및 면 |\n| * 분할사용 하는 경우 기준단위를 ‘단위량’으로 기재 가능(｢ | 다.  무균시험을 완료하기 전에 출하할 수 있도록 각조 | 4.  수입품의 경우 그 품목의 제조 및 판매에 관 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 |\n| 짧아지고 감마선의 약화가 증가한다.  | - 조건부허가:「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조 규정에 | ① | 종양 | 약품과 | 마개로 밀봉한다.  마개는 내용의 | 제범위ᆞ심사기준 등에 관한 세부 규정과 독성 | - 반추동물유래성분의 경우 전염성해면상뇌증(TSE)감염을 방지하기 위한 원료선택 또는 |\n| 예2) 안전성유효성에 관한 자료(70일), GMP실시상황 평가(완제의약품:90일) 대상 민원 : 총 처리기한 90일 | 에 명시된 경우에는 방사선과 관련하여 실제적으로 가 | ․제조시(또는 검정시)의 방사선량 | 방사능 측정은 전문적인 연구소가 필요하지만 관계기 |\n| 유럽약전 각조의 제제에 사용된 방사성핵종의 가장 일 | 의2 참조) | 4.  완제의약품에 관한 자료 | 및 약리작용 등에 관한 자료의 작성을 위하여 | 조시설ᆞ제조방법 등을 양수한 품목에 대한 제 | ※ 조제하여 사용하는 방사성물질이 포함되지 않은 방사성의약품(일명 ‘Cold Vial’ 또는 ‘Cold kit')의 |\n| 각 방사성핵종은 고유의 반감기, 방사선 및 에너지 특 | 약품과 물리적 또는 화학적으로 | 따라 시설을 갖출 것을 조건으로 허가 |\n| 예) 식약처테크네주사액(과테크네튬산나트륨) | 반적으로 받아들여지는 물리적 특성에 대해 방사성핵 | 능해지면 곧 무균시험을 시작하고 만약 바로 시작하지 | - 방사능량 단위 : “MBq”, 필요시 mCi를 괄호로 병기(방사능농도는 범위로 설정 가능) | 조판매ᆞ수입 품목신고를 하려는 자의 경우에 | (완제의약품) |\n| 2.3.11 기준 및 시험방법 | 성을 가지고 있다. ",
        "original_sentence": "수입품의 경우 그 품목의 제조 및 판매에 관 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 |\n| 짧아지고 감마선의 약화가 증가한다. "
      }
    },
    {
      "chunk_id": "chunk_517",
      "text": "| - 조건부허가:「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조 규정에 | ① | 종양 | 약품과 | 마개로 밀봉한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 516,
        "window_size": 3,
        "char_count": 75,
        "word_count": 18,
        "page_number": 3,
        "window_text": "이 경우 자료제출 대 |\n| 예1) | 안전성유효성에 | 관한 | 자료(70일), | 기준 | 및 | 시험방법에 | 관한 | 자료(55일)의 | 검토가 | 필요한 | 민원: | ▷ 상표명 있는 경우 | 가 작거나 방사선의 위험 때문에 실험이 어려울 수 있 | 분할사용을 목적으로 하는 용기 | 기타(1 제너레이터 등) | * | 수입품의 | 경우에는 | 「의약품등의 | 안전에 | 관한 | 규칙」(총리령) | 제4조제1항제4호에 | 따라, | 의약품등을 | radionuclide)이 반감기가 짧은 딸방사성핵종(daughter |\n| (absorbent)를 사용할수록 알파와 베타입자의 범위가 | 는 고무마개 또는 다른 적당한 | ․의약품의 용기․포장에 ‘제조일자(필요시 시각기재한다) : 제조시 표기’와 같이 기재 | 상 품목, 자료 작성요령, 각 자료의 요건 및 면 |\n| * 분할사용 하는 경우 기준단위를 ‘단위량’으로 기재 가능(｢ | 다.  무균시험을 완료하기 전에 출하할 수 있도록 각조 | 4.  수입품의 경우 그 품목의 제조 및 판매에 관 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 |\n| 짧아지고 감마선의 약화가 증가한다.  | - 조건부허가:「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조 규정에 | ① | 종양 | 약품과 | 마개로 밀봉한다.  마개는 내용의 | 제범위ᆞ심사기준 등에 관한 세부 규정과 독성 | - 반추동물유래성분의 경우 전염성해면상뇌증(TSE)감염을 방지하기 위한 원료선택 또는 |\n| 예2) 안전성유효성에 관한 자료(70일), GMP실시상황 평가(완제의약품:90일) 대상 민원 : 총 처리기한 90일 | 에 명시된 경우에는 방사선과 관련하여 실제적으로 가 | ․제조시(또는 검정시)의 방사선량 | 방사능 측정은 전문적인 연구소가 필요하지만 관계기 |\n| 유럽약전 각조의 제제에 사용된 방사성핵종의 가장 일 | 의2 참조) | 4.  완제의약품에 관한 자료 | 및 약리작용 등에 관한 자료의 작성을 위하여 | 조시설ᆞ제조방법 등을 양수한 품목에 대한 제 | ※ 조제하여 사용하는 방사성물질이 포함되지 않은 방사성의약품(일명 ‘Cold Vial’ 또는 ‘Cold kit')의 |\n| 각 방사성핵종은 고유의 반감기, 방사선 및 에너지 특 | 약품과 물리적 또는 화학적으로 | 따라 시설을 갖출 것을 조건으로 허가 |\n| 예) 식약처테크네주사액(과테크네튬산나트륨) | 반적으로 받아들여지는 물리적 특성에 대해 방사성핵 | 능해지면 곧 무균시험을 시작하고 만약 바로 시작하지 | - 방사능량 단위 : “MBq”, 필요시 mCi를 괄호로 병기(방사능농도는 범위로 설정 가능) | 조판매ᆞ수입 품목신고를 하려는 자의 경우에 | (완제의약품) |\n| 2.3.11 기준 및 시험방법 | 성을 가지고 있다.  에너지 단위는 전자볼트(eV), 킬로 | 작용하지 않는 것으로 주사바늘 | 실시하는 비임상시험의 관리에 필요한 사항은 |\n| 않을 경우 검체를 위음성(false negative) 결과가 나오 | 1. ",
        "original_sentence": "| - 조건부허가:「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조 규정에 | ① | 종양 | 약품과 | 마개로 밀봉한다. "
      }
    },
    {
      "chunk_id": "chunk_518",
      "text": "마개는 내용의 | 제범위ᆞ심사기준 등에 관한 세부 규정과 독성 | - 반추동물유래성분의 경우 전염성해면상뇌증(TSE)감염을 방지하기 위한 원료선택 또는 |\n| 예2) 안전성유효성에 관한 자료(70일), GMP실시상황 평가(완제의약품:90일) 대상 민원 : 총 처리기한 90일 | 에 명시된 경우에는 방사선과 관련하여 실제적으로 가 | ․제조시(또는 검정시)의 방사선량 | 방사능 측정은 전문적인 연구소가 필요하지만 관계기 |\n| 유럽약전 각조의 제제에 사용된 방사성핵종의 가장 일 | 의2 참조) | 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 517,
        "window_size": 3,
        "char_count": 283,
        "word_count": 65,
        "page_number": 3,
        "window_text": "무균시험을 완료하기 전에 출하할 수 있도록 각조 | 4.  수입품의 경우 그 품목의 제조 및 판매에 관 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 |\n| 짧아지고 감마선의 약화가 증가한다.  | - 조건부허가:「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조 규정에 | ① | 종양 | 약품과 | 마개로 밀봉한다.  마개는 내용의 | 제범위ᆞ심사기준 등에 관한 세부 규정과 독성 | - 반추동물유래성분의 경우 전염성해면상뇌증(TSE)감염을 방지하기 위한 원료선택 또는 |\n| 예2) 안전성유효성에 관한 자료(70일), GMP실시상황 평가(완제의약품:90일) 대상 민원 : 총 처리기한 90일 | 에 명시된 경우에는 방사선과 관련하여 실제적으로 가 | ․제조시(또는 검정시)의 방사선량 | 방사능 측정은 전문적인 연구소가 필요하지만 관계기 |\n| 유럽약전 각조의 제제에 사용된 방사성핵종의 가장 일 | 의2 참조) | 4.  완제의약품에 관한 자료 | 및 약리작용 등에 관한 자료의 작성을 위하여 | 조시설ᆞ제조방법 등을 양수한 품목에 대한 제 | ※ 조제하여 사용하는 방사성물질이 포함되지 않은 방사성의약품(일명 ‘Cold Vial’ 또는 ‘Cold kit')의 |\n| 각 방사성핵종은 고유의 반감기, 방사선 및 에너지 특 | 약품과 물리적 또는 화학적으로 | 따라 시설을 갖출 것을 조건으로 허가 |\n| 예) 식약처테크네주사액(과테크네튬산나트륨) | 반적으로 받아들여지는 물리적 특성에 대해 방사성핵 | 능해지면 곧 무균시험을 시작하고 만약 바로 시작하지 | - 방사능량 단위 : “MBq”, 필요시 mCi를 괄호로 병기(방사능농도는 범위로 설정 가능) | 조판매ᆞ수입 품목신고를 하려는 자의 경우에 | (완제의약품) |\n| 2.3.11 기준 및 시험방법 | 성을 가지고 있다.  에너지 단위는 전자볼트(eV), 킬로 | 작용하지 않는 것으로 주사바늘 | 실시하는 비임상시험의 관리에 필요한 사항은 |\n| 않을 경우 검체를 위음성(false negative) 결과가 나오 | 1.  동 품목은「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조제2항의 규정에 의한 조건부 | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 |\n| - 원칙적으로 모든 첨가제의 분량을 기재. ",
        "original_sentence": "마개는 내용의 | 제범위ᆞ심사기준 등에 관한 세부 규정과 독성 | - 반추동물유래성분의 경우 전염성해면상뇌증(TSE)감염을 방지하기 위한 원료선택 또는 |\n| 예2) 안전성유효성에 관한 자료(70일), GMP실시상황 평가(완제의약품:90일) 대상 민원 : 총 처리기한 90일 | 에 명시된 경우에는 방사선과 관련하여 실제적으로 가 | ․제조시(또는 검정시)의 방사선량 | 방사능 측정은 전문적인 연구소가 필요하지만 관계기 |\n| 유럽약전 각조의 제제에 사용된 방사성핵종의 가장 일 | 의2 참조) | 4. "
      }
    },
    {
      "chunk_id": "chunk_519",
      "text": "완제의약품에 관한 자료 | 및 약리작용 등에 관한 자료의 작성을 위하여 | 조시설ᆞ제조방법 등을 양수한 품목에 대한 제 | ※ 조제하여 사용하는 방사성물질이 포함되지 않은 방사성의약품(일명 ‘Cold Vial’ 또는 ‘Cold kit')의 |\n| 각 방사성핵종은 고유의 반감기, 방사선 및 에너지 특 | 약품과 물리적 또는 화학적으로 | 따라 시설을 갖출 것을 조건으로 허가 |\n| 예) 식약처테크네주사액(과테크네튬산나트륨) | 반적으로 받아들여지는 물리적 특성에 대해 방사성핵 | 능해지면 곧 무균시험을 시작하고 만약 바로 시작하지 | - 방사능량 단위 : “MBq”, 필요시 mCi를 괄호로 병기(방사능농도는 범위로 설정 가능) | 조판매ᆞ수입 품목신고를 하려는 자의 경우에 | (완제의약품) |\n| 2.3.11 기준 및 시험방법 | 성을 가지고 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 518,
        "window_size": 3,
        "char_count": 424,
        "word_count": 103,
        "page_number": 3,
        "window_text": "수입품의 경우 그 품목의 제조 및 판매에 관 | ③ 기업의 분리 또는 합병 등에 의하여 해당 제 |\n| 짧아지고 감마선의 약화가 증가한다.  | - 조건부허가:「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조 규정에 | ① | 종양 | 약품과 | 마개로 밀봉한다.  마개는 내용의 | 제범위ᆞ심사기준 등에 관한 세부 규정과 독성 | - 반추동물유래성분의 경우 전염성해면상뇌증(TSE)감염을 방지하기 위한 원료선택 또는 |\n| 예2) 안전성유효성에 관한 자료(70일), GMP실시상황 평가(완제의약품:90일) 대상 민원 : 총 처리기한 90일 | 에 명시된 경우에는 방사선과 관련하여 실제적으로 가 | ․제조시(또는 검정시)의 방사선량 | 방사능 측정은 전문적인 연구소가 필요하지만 관계기 |\n| 유럽약전 각조의 제제에 사용된 방사성핵종의 가장 일 | 의2 참조) | 4.  완제의약품에 관한 자료 | 및 약리작용 등에 관한 자료의 작성을 위하여 | 조시설ᆞ제조방법 등을 양수한 품목에 대한 제 | ※ 조제하여 사용하는 방사성물질이 포함되지 않은 방사성의약품(일명 ‘Cold Vial’ 또는 ‘Cold kit')의 |\n| 각 방사성핵종은 고유의 반감기, 방사선 및 에너지 특 | 약품과 물리적 또는 화학적으로 | 따라 시설을 갖출 것을 조건으로 허가 |\n| 예) 식약처테크네주사액(과테크네튬산나트륨) | 반적으로 받아들여지는 물리적 특성에 대해 방사성핵 | 능해지면 곧 무균시험을 시작하고 만약 바로 시작하지 | - 방사능량 단위 : “MBq”, 필요시 mCi를 괄호로 병기(방사능농도는 범위로 설정 가능) | 조판매ᆞ수입 품목신고를 하려는 자의 경우에 | (완제의약품) |\n| 2.3.11 기준 및 시험방법 | 성을 가지고 있다.  에너지 단위는 전자볼트(eV), 킬로 | 작용하지 않는 것으로 주사바늘 | 실시하는 비임상시험의 관리에 필요한 사항은 |\n| 않을 경우 검체를 위음성(false negative) 결과가 나오 | 1.  동 품목은「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조제2항의 규정에 의한 조건부 | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 |\n| - 원칙적으로 모든 첨가제의 분량을 기재.  단 용해보조제, 안정제, 등장제, pH조절제, | 을 삽입할 때 마개 파편이 혼입 | 식품의약품안전처장이 정하여 고시하는 바에 따 | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료 : GMP 적합판정서를 제출하는 경우에는 | 비교하거나 교정된 기기를 사용하여 상대적으로 방사 |\n| 전자볼트(keV) 또는 메가전자볼트(MeV)로 사용한다. ",
        "original_sentence": "완제의약품에 관한 자료 | 및 약리작용 등에 관한 자료의 작성을 위하여 | 조시설ᆞ제조방법 등을 양수한 품목에 대한 제 | ※ 조제하여 사용하는 방사성물질이 포함되지 않은 방사성의약품(일명 ‘Cold Vial’ 또는 ‘Cold kit')의 |\n| 각 방사성핵종은 고유의 반감기, 방사선 및 에너지 특 | 약품과 물리적 또는 화학적으로 | 따라 시설을 갖출 것을 조건으로 허가 |\n| 예) 식약처테크네주사액(과테크네튬산나트륨) | 반적으로 받아들여지는 물리적 특성에 대해 방사성핵 | 능해지면 곧 무균시험을 시작하고 만약 바로 시작하지 | - 방사능량 단위 : “MBq”, 필요시 mCi를 괄호로 병기(방사능농도는 범위로 설정 가능) | 조판매ᆞ수입 품목신고를 하려는 자의 경우에 | (완제의약품) |\n| 2.3.11 기준 및 시험방법 | 성을 가지고 있다. "
      }
    },
    {
      "chunk_id": "chunk_520",
      "text": "에너지 단위는 전자볼트(eV), 킬로 | 작용하지 않는 것으로 주사바늘 | 실시하는 비임상시험의 관리에 필요한 사항은 |\n| 않을 경우 검체를 위음성(false negative) 결과가 나오 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 519,
        "window_size": 3,
        "char_count": 112,
        "word_count": 26,
        "page_number": 9,
        "window_text": "| - 조건부허가:「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조 규정에 | ① | 종양 | 약품과 | 마개로 밀봉한다.  마개는 내용의 | 제범위ᆞ심사기준 등에 관한 세부 규정과 독성 | - 반추동물유래성분의 경우 전염성해면상뇌증(TSE)감염을 방지하기 위한 원료선택 또는 |\n| 예2) 안전성유효성에 관한 자료(70일), GMP실시상황 평가(완제의약품:90일) 대상 민원 : 총 처리기한 90일 | 에 명시된 경우에는 방사선과 관련하여 실제적으로 가 | ․제조시(또는 검정시)의 방사선량 | 방사능 측정은 전문적인 연구소가 필요하지만 관계기 |\n| 유럽약전 각조의 제제에 사용된 방사성핵종의 가장 일 | 의2 참조) | 4.  완제의약품에 관한 자료 | 및 약리작용 등에 관한 자료의 작성을 위하여 | 조시설ᆞ제조방법 등을 양수한 품목에 대한 제 | ※ 조제하여 사용하는 방사성물질이 포함되지 않은 방사성의약품(일명 ‘Cold Vial’ 또는 ‘Cold kit')의 |\n| 각 방사성핵종은 고유의 반감기, 방사선 및 에너지 특 | 약품과 물리적 또는 화학적으로 | 따라 시설을 갖출 것을 조건으로 허가 |\n| 예) 식약처테크네주사액(과테크네튬산나트륨) | 반적으로 받아들여지는 물리적 특성에 대해 방사성핵 | 능해지면 곧 무균시험을 시작하고 만약 바로 시작하지 | - 방사능량 단위 : “MBq”, 필요시 mCi를 괄호로 병기(방사능농도는 범위로 설정 가능) | 조판매ᆞ수입 품목신고를 하려는 자의 경우에 | (완제의약품) |\n| 2.3.11 기준 및 시험방법 | 성을 가지고 있다.  에너지 단위는 전자볼트(eV), 킬로 | 작용하지 않는 것으로 주사바늘 | 실시하는 비임상시험의 관리에 필요한 사항은 |\n| 않을 경우 검체를 위음성(false negative) 결과가 나오 | 1.  동 품목은「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조제2항의 규정에 의한 조건부 | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 |\n| - 원칙적으로 모든 첨가제의 분량을 기재.  단 용해보조제, 안정제, 등장제, pH조절제, | 을 삽입할 때 마개 파편이 혼입 | 식품의약품안전처장이 정하여 고시하는 바에 따 | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료 : GMP 적합판정서를 제출하는 경우에는 | 비교하거나 교정된 기기를 사용하여 상대적으로 방사 |\n| 전자볼트(keV) 또는 메가전자볼트(MeV)로 사용한다.  | - 약전, 공정서 품목 : 해당 공정서 각조에 따름 | 4. ",
        "original_sentence": "에너지 단위는 전자볼트(eV), 킬로 | 작용하지 않는 것으로 주사바늘 | 실시하는 비임상시험의 관리에 필요한 사항은 |\n| 않을 경우 검체를 위음성(false negative) 결과가 나오 | 1. "
      }
    },
    {
      "chunk_id": "chunk_521",
      "text": "동 품목은「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조제2항의 규정에 의한 조건부 | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 |\n| - 원칙적으로 모든 첨가제의 분량을 기재. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 520,
        "window_size": 3,
        "char_count": 110,
        "word_count": 26,
        "page_number": 3,
        "window_text": "마개는 내용의 | 제범위ᆞ심사기준 등에 관한 세부 규정과 독성 | - 반추동물유래성분의 경우 전염성해면상뇌증(TSE)감염을 방지하기 위한 원료선택 또는 |\n| 예2) 안전성유효성에 관한 자료(70일), GMP실시상황 평가(완제의약품:90일) 대상 민원 : 총 처리기한 90일 | 에 명시된 경우에는 방사선과 관련하여 실제적으로 가 | ․제조시(또는 검정시)의 방사선량 | 방사능 측정은 전문적인 연구소가 필요하지만 관계기 |\n| 유럽약전 각조의 제제에 사용된 방사성핵종의 가장 일 | 의2 참조) | 4.  완제의약품에 관한 자료 | 및 약리작용 등에 관한 자료의 작성을 위하여 | 조시설ᆞ제조방법 등을 양수한 품목에 대한 제 | ※ 조제하여 사용하는 방사성물질이 포함되지 않은 방사성의약품(일명 ‘Cold Vial’ 또는 ‘Cold kit')의 |\n| 각 방사성핵종은 고유의 반감기, 방사선 및 에너지 특 | 약품과 물리적 또는 화학적으로 | 따라 시설을 갖출 것을 조건으로 허가 |\n| 예) 식약처테크네주사액(과테크네튬산나트륨) | 반적으로 받아들여지는 물리적 특성에 대해 방사성핵 | 능해지면 곧 무균시험을 시작하고 만약 바로 시작하지 | - 방사능량 단위 : “MBq”, 필요시 mCi를 괄호로 병기(방사능농도는 범위로 설정 가능) | 조판매ᆞ수입 품목신고를 하려는 자의 경우에 | (완제의약품) |\n| 2.3.11 기준 및 시험방법 | 성을 가지고 있다.  에너지 단위는 전자볼트(eV), 킬로 | 작용하지 않는 것으로 주사바늘 | 실시하는 비임상시험의 관리에 필요한 사항은 |\n| 않을 경우 검체를 위음성(false negative) 결과가 나오 | 1.  동 품목은「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조제2항의 규정에 의한 조건부 | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 |\n| - 원칙적으로 모든 첨가제의 분량을 기재.  단 용해보조제, 안정제, 등장제, pH조절제, | 을 삽입할 때 마개 파편이 혼입 | 식품의약품안전처장이 정하여 고시하는 바에 따 | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료 : GMP 적합판정서를 제출하는 경우에는 | 비교하거나 교정된 기기를 사용하여 상대적으로 방사 |\n| 전자볼트(keV) 또는 메가전자볼트(MeV)로 사용한다.  | - 약전, 공정서 품목 : 해당 공정서 각조에 따름 | 4.  수입품의 경우 그 품목의 제조 및 판매에 관 | 가. ",
        "original_sentence": "동 품목은「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조제2항의 규정에 의한 조건부 | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 |\n| - 원칙적으로 모든 첨가제의 분량을 기재. "
      }
    },
    {
      "chunk_id": "chunk_522",
      "text": "단 용해보조제, 안정제, 등장제, pH조절제, | 을 삽입할 때 마개 파편이 혼입 | 식품의약품안전처장이 정하여 고시하는 바에 따 | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료 : GMP 적합판정서를 제출하는 경우에는 | 비교하거나 교정된 기기를 사용하여 상대적으로 방사 |\n| 전자볼트(keV) 또는 메가전자볼트(MeV)로 사용한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 521,
        "window_size": 3,
        "char_count": 202,
        "word_count": 46,
        "page_number": 5,
        "window_text": "완제의약품에 관한 자료 | 및 약리작용 등에 관한 자료의 작성을 위하여 | 조시설ᆞ제조방법 등을 양수한 품목에 대한 제 | ※ 조제하여 사용하는 방사성물질이 포함되지 않은 방사성의약품(일명 ‘Cold Vial’ 또는 ‘Cold kit')의 |\n| 각 방사성핵종은 고유의 반감기, 방사선 및 에너지 특 | 약품과 물리적 또는 화학적으로 | 따라 시설을 갖출 것을 조건으로 허가 |\n| 예) 식약처테크네주사액(과테크네튬산나트륨) | 반적으로 받아들여지는 물리적 특성에 대해 방사성핵 | 능해지면 곧 무균시험을 시작하고 만약 바로 시작하지 | - 방사능량 단위 : “MBq”, 필요시 mCi를 괄호로 병기(방사능농도는 범위로 설정 가능) | 조판매ᆞ수입 품목신고를 하려는 자의 경우에 | (완제의약품) |\n| 2.3.11 기준 및 시험방법 | 성을 가지고 있다.  에너지 단위는 전자볼트(eV), 킬로 | 작용하지 않는 것으로 주사바늘 | 실시하는 비임상시험의 관리에 필요한 사항은 |\n| 않을 경우 검체를 위음성(false negative) 결과가 나오 | 1.  동 품목은「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조제2항의 규정에 의한 조건부 | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 |\n| - 원칙적으로 모든 첨가제의 분량을 기재.  단 용해보조제, 안정제, 등장제, pH조절제, | 을 삽입할 때 마개 파편이 혼입 | 식품의약품안전처장이 정하여 고시하는 바에 따 | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료 : GMP 적합판정서를 제출하는 경우에는 | 비교하거나 교정된 기기를 사용하여 상대적으로 방사 |\n| 전자볼트(keV) 또는 메가전자볼트(MeV)로 사용한다.  | - 약전, 공정서 품목 : 해당 공정서 각조에 따름 | 4.  수입품의 경우 그 품목의 제조 및 판매에 관 | 가.  의약품등을 생산하는 국가(이하 \"생산국\" | 여 그 품목의 제조시설ᆞ제조방법 등에 관한 |\n| 각조에 언급된 방사성핵종의 주요 잠재적 방사성핵종 | 지 않도록 하기 위해 적절한 조건 하에 보관한다. ",
        "original_sentence": "단 용해보조제, 안정제, 등장제, pH조절제, | 을 삽입할 때 마개 파편이 혼입 | 식품의약품안전처장이 정하여 고시하는 바에 따 | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료 : GMP 적합판정서를 제출하는 경우에는 | 비교하거나 교정된 기기를 사용하여 상대적으로 방사 |\n| 전자볼트(keV) 또는 메가전자볼트(MeV)로 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_523",
      "text": "| - 약전, 공정서 품목 : 해당 공정서 각조에 따름 | 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 522,
        "window_size": 3,
        "char_count": 36,
        "word_count": 12,
        "page_number": 3,
        "window_text": "에너지 단위는 전자볼트(eV), 킬로 | 작용하지 않는 것으로 주사바늘 | 실시하는 비임상시험의 관리에 필요한 사항은 |\n| 않을 경우 검체를 위음성(false negative) 결과가 나오 | 1.  동 품목은「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조제2항의 규정에 의한 조건부 | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 |\n| - 원칙적으로 모든 첨가제의 분량을 기재.  단 용해보조제, 안정제, 등장제, pH조절제, | 을 삽입할 때 마개 파편이 혼입 | 식품의약품안전처장이 정하여 고시하는 바에 따 | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료 : GMP 적합판정서를 제출하는 경우에는 | 비교하거나 교정된 기기를 사용하여 상대적으로 방사 |\n| 전자볼트(keV) 또는 메가전자볼트(MeV)로 사용한다.  | - 약전, 공정서 품목 : 해당 공정서 각조에 따름 | 4.  수입품의 경우 그 품목의 제조 및 판매에 관 | 가.  의약품등을 생산하는 국가(이하 \"생산국\" | 여 그 품목의 제조시설ᆞ제조방법 등에 관한 |\n| 각조에 언급된 방사성핵종의 주요 잠재적 방사성핵종 | 지 않도록 하기 위해 적절한 조건 하에 보관한다.  이 | 되지 않고 또 주사바늘을 뺄 때 | 제조판매품목으로서 201○.○.○까지 약사법 제31조제1항에 적합한 시설을 갖추고 우리처에 이행통보할 것 | 른다. ",
        "original_sentence": "| - 약전, 공정서 품목 : 해당 공정서 각조에 따름 | 4. "
      }
    },
    {
      "chunk_id": "chunk_524",
      "text": "수입품의 경우 그 품목의 제조 및 판매에 관 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 523,
        "window_size": 3,
        "char_count": 30,
        "word_count": 10,
        "page_number": 3,
        "window_text": "동 품목은「약사법」제35조 및「의약품 등의 안전에 관한 규칙」제39조제2항의 규정에 의한 조건부 | 는 제2항에 따른 첨부서류 또는 자료를 갈음하 |\n| - 원칙적으로 모든 첨가제의 분량을 기재.  단 용해보조제, 안정제, 등장제, pH조절제, | 을 삽입할 때 마개 파편이 혼입 | 식품의약품안전처장이 정하여 고시하는 바에 따 | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료 : GMP 적합판정서를 제출하는 경우에는 | 비교하거나 교정된 기기를 사용하여 상대적으로 방사 |\n| 전자볼트(keV) 또는 메가전자볼트(MeV)로 사용한다.  | - 약전, 공정서 품목 : 해당 공정서 각조에 따름 | 4.  수입품의 경우 그 품목의 제조 및 판매에 관 | 가.  의약품등을 생산하는 국가(이하 \"생산국\" | 여 그 품목의 제조시설ᆞ제조방법 등에 관한 |\n| 각조에 언급된 방사성핵종의 주요 잠재적 방사성핵종 | 지 않도록 하기 위해 적절한 조건 하에 보관한다.  이 | 되지 않고 또 주사바늘을 뺄 때 | 제조판매품목으로서 201○.○.○까지 약사법 제31조제1항에 적합한 시설을 갖추고 우리처에 이행통보할 것 | 른다.  |\n| <수수료> | ▷ 상표명 없는 경우 | 용제, 기제(캡슐제 포함) 등의 미량투입 첨가제는 “적량”으로 기재 |\n| - 약전, 공정서 외 품목 : 자사기준 | 1. ",
        "original_sentence": "수입품의 경우 그 품목의 제조 및 판매에 관 | 가. "
      }
    },
    {
      "chunk_id": "chunk_525",
      "text": "의약품등을 생산하는 국가(이하 \"생산국\" | 여 그 품목의 제조시설ᆞ제조방법 등에 관한 |\n| 각조에 언급된 방사성핵종의 주요 잠재적 방사성핵종 | 지 않도록 하기 위해 적절한 조건 하에 보관한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 524,
        "window_size": 3,
        "char_count": 111,
        "word_count": 28,
        "page_number": 3,
        "window_text": "단 용해보조제, 안정제, 등장제, pH조절제, | 을 삽입할 때 마개 파편이 혼입 | 식품의약품안전처장이 정하여 고시하는 바에 따 | ④ GMP(의약품 제조 및 품질관리기준) 실시상황 평가에 관한 자료 : GMP 적합판정서를 제출하는 경우에는 | 비교하거나 교정된 기기를 사용하여 상대적으로 방사 |\n| 전자볼트(keV) 또는 메가전자볼트(MeV)로 사용한다.  | - 약전, 공정서 품목 : 해당 공정서 각조에 따름 | 4.  수입품의 경우 그 품목의 제조 및 판매에 관 | 가.  의약품등을 생산하는 국가(이하 \"생산국\" | 여 그 품목의 제조시설ᆞ제조방법 등에 관한 |\n| 각조에 언급된 방사성핵종의 주요 잠재적 방사성핵종 | 지 않도록 하기 위해 적절한 조건 하에 보관한다.  이 | 되지 않고 또 주사바늘을 뺄 때 | 제조판매품목으로서 201○.○.○까지 약사법 제31조제1항에 적합한 시설을 갖추고 우리처에 이행통보할 것 | 른다.  |\n| <수수료> | ▷ 상표명 없는 경우 | 용제, 기제(캡슐제 포함) 등의 미량투입 첨가제는 “적량”으로 기재 |\n| - 약전, 공정서 외 품목 : 자사기준 | 1.  기원 또는 발견 및 개발 경위에 관한 자료 | 2. ",
        "original_sentence": "의약품등을 생산하는 국가(이하 \"생산국\" | 여 그 품목의 제조시설ᆞ제조방법 등에 관한 |\n| 각조에 언급된 방사성핵종의 주요 잠재적 방사성핵종 | 지 않도록 하기 위해 적절한 조건 하에 보관한다. "
      }
    },
    {
      "chunk_id": "chunk_526",
      "text": "이 | 되지 않고 또 주사바늘을 뺄 때 | 제조판매품목으로서 201○.○.○까지 약사법 제31조제1항에 적합한 시설을 갖추고 우리처에 이행통보할 것 | 른다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 525,
        "window_size": 3,
        "char_count": 89,
        "word_count": 21,
        "page_number": 3,
        "window_text": "| - 약전, 공정서 품목 : 해당 공정서 각조에 따름 | 4.  수입품의 경우 그 품목의 제조 및 판매에 관 | 가.  의약품등을 생산하는 국가(이하 \"생산국\" | 여 그 품목의 제조시설ᆞ제조방법 등에 관한 |\n| 각조에 언급된 방사성핵종의 주요 잠재적 방사성핵종 | 지 않도록 하기 위해 적절한 조건 하에 보관한다.  이 | 되지 않고 또 주사바늘을 뺄 때 | 제조판매품목으로서 201○.○.○까지 약사법 제31조제1항에 적합한 시설을 갖추고 우리처에 이행통보할 것 | 른다.  |\n| <수수료> | ▷ 상표명 없는 경우 | 용제, 기제(캡슐제 포함) 등의 미량투입 첨가제는 “적량”으로 기재 |\n| - 약전, 공정서 외 품목 : 자사기준 | 1.  기원 또는 발견 및 개발 경위에 관한 자료 | 2.  만일, 정당한 사유없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다. ",
        "original_sentence": "이 | 되지 않고 또 주사바늘을 뺄 때 | 제조판매품목으로서 201○.○.○까지 약사법 제31조제1항에 적합한 시설을 갖추고 우리처에 이행통보할 것 | 른다. "
      }
    },
    {
      "chunk_id": "chunk_527",
      "text": "|\n| <수수료> | ▷ 상표명 없는 경우 | 용제, 기제(캡슐제 포함) 등의 미량투입 첨가제는 “적량”으로 기재 |\n| - 약전, 공정서 외 품목 : 자사기준 | 1. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 526,
        "window_size": 3,
        "char_count": 95,
        "word_count": 28,
        "page_number": 6,
        "window_text": "수입품의 경우 그 품목의 제조 및 판매에 관 | 가.  의약품등을 생산하는 국가(이하 \"생산국\" | 여 그 품목의 제조시설ᆞ제조방법 등에 관한 |\n| 각조에 언급된 방사성핵종의 주요 잠재적 방사성핵종 | 지 않도록 하기 위해 적절한 조건 하에 보관한다.  이 | 되지 않고 또 주사바늘을 뺄 때 | 제조판매품목으로서 201○.○.○까지 약사법 제31조제1항에 적합한 시설을 갖추고 우리처에 이행통보할 것 | 른다.  |\n| <수수료> | ▷ 상표명 없는 경우 | 용제, 기제(캡슐제 포함) 등의 미량투입 첨가제는 “적량”으로 기재 |\n| - 약전, 공정서 외 품목 : 자사기준 | 1.  기원 또는 발견 및 개발 경위에 관한 자료 | 2.  만일, 정당한 사유없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.  | 양도ᆞ양수계약서를 제출할 수 있다. ",
        "original_sentence": "|\n| <수수료> | ▷ 상표명 없는 경우 | 용제, 기제(캡슐제 포함) 등의 미량투입 첨가제는 “적량”으로 기재 |\n| - 약전, 공정서 외 품목 : 자사기준 | 1. "
      }
    },
    {
      "chunk_id": "chunk_528",
      "text": "기원 또는 발견 및 개발 경위에 관한 자료 | 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 527,
        "window_size": 3,
        "char_count": 29,
        "word_count": 10,
        "page_number": 3,
        "window_text": "의약품등을 생산하는 국가(이하 \"생산국\" | 여 그 품목의 제조시설ᆞ제조방법 등에 관한 |\n| 각조에 언급된 방사성핵종의 주요 잠재적 방사성핵종 | 지 않도록 하기 위해 적절한 조건 하에 보관한다.  이 | 되지 않고 또 주사바늘을 뺄 때 | 제조판매품목으로서 201○.○.○까지 약사법 제31조제1항에 적합한 시설을 갖추고 우리처에 이행통보할 것 | 른다.  |\n| <수수료> | ▷ 상표명 없는 경우 | 용제, 기제(캡슐제 포함) 등의 미량투입 첨가제는 “적량”으로 기재 |\n| - 약전, 공정서 외 품목 : 자사기준 | 1.  기원 또는 발견 및 개발 경위에 관한 자료 | 2.  만일, 정당한 사유없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.  | 양도ᆞ양수계약서를 제출할 수 있다.  다만, 별 |\n| 불순물의 물리적 특성들에 대해 기술하고 있다. ",
        "original_sentence": "기원 또는 발견 및 개발 경위에 관한 자료 | 2. "
      }
    },
    {
      "chunk_id": "chunk_529",
      "text": "만일, 정당한 사유없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 528,
        "window_size": 3,
        "char_count": 52,
        "word_count": 13,
        "page_number": 5,
        "window_text": "이 | 되지 않고 또 주사바늘을 뺄 때 | 제조판매품목으로서 201○.○.○까지 약사법 제31조제1항에 적합한 시설을 갖추고 우리처에 이행통보할 것 | 른다.  |\n| <수수료> | ▷ 상표명 없는 경우 | 용제, 기제(캡슐제 포함) 등의 미량투입 첨가제는 “적량”으로 기재 |\n| - 약전, 공정서 외 품목 : 자사기준 | 1.  기원 또는 발견 및 개발 경위에 관한 자료 | 2.  만일, 정당한 사유없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.  | 양도ᆞ양수계약서를 제출할 수 있다.  다만, 별 |\n| 불순물의 물리적 특성들에 대해 기술하고 있다.  | 러한 경우 완전히 밸리데이션 된 공정으로 제조된 제 | 곧 외부로부터의 오염을 막을 수 | 않을 경우 생리학적 분포 시험이 필요할 수 있다. ",
        "original_sentence": "만일, 정당한 사유없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_530",
      "text": "| 양도ᆞ양수계약서를 제출할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 529,
        "window_size": 3,
        "char_count": 22,
        "word_count": 5,
        "page_number": 9,
        "window_text": "|\n| <수수료> | ▷ 상표명 없는 경우 | 용제, 기제(캡슐제 포함) 등의 미량투입 첨가제는 “적량”으로 기재 |\n| - 약전, 공정서 외 품목 : 자사기준 | 1.  기원 또는 발견 및 개발 경위에 관한 자료 | 2.  만일, 정당한 사유없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.  | 양도ᆞ양수계약서를 제출할 수 있다.  다만, 별 |\n| 불순물의 물리적 특성들에 대해 기술하고 있다.  | 러한 경우 완전히 밸리데이션 된 공정으로 제조된 제 | 곧 외부로부터의 오염을 막을 수 | 않을 경우 생리학적 분포 시험이 필요할 수 있다.  적 |\n| 예1) | 자료제출의약품으로, | ‘안전성유효성 | 자료, | 기준 | 및 | 시험방법에 | 관한 | 자료, | GMP실시상황평가’가 | 방사성핵종순도(Radionuclidic | purity): | 방사성의약품 | - 보존제의 종류 및 함량 사용범위는 ｢ | 표 1의 의약품 제조 및 품질관리기준 실시상황 |\n| ※ 자사에서 근거자료를 바탕으로 직접 기준 및 시험방법을 작성할 경우 방사성의약품의 특성에 맞게 | ‘전이확률(transition | probability)' | 용어는 | 전이 | 품의 매개변수기반출하(parametric release, 5.1.1)를 선 | *첨가제의 규격이 별첨규격인 경우 첨가제 규격에 관한 근거자료를 제출 | 있는 것이다. ",
        "original_sentence": "| 양도ᆞ양수계약서를 제출할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_531",
      "text": "다만, 별 |\n| 불순물의 물리적 특성들에 대해 기술하고 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 530,
        "window_size": 3,
        "char_count": 36,
        "word_count": 10,
        "page_number": 9,
        "window_text": "기원 또는 발견 및 개발 경위에 관한 자료 | 2.  만일, 정당한 사유없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.  | 양도ᆞ양수계약서를 제출할 수 있다.  다만, 별 |\n| 불순물의 물리적 특성들에 대해 기술하고 있다.  | 러한 경우 완전히 밸리데이션 된 공정으로 제조된 제 | 곧 외부로부터의 오염을 막을 수 | 않을 경우 생리학적 분포 시험이 필요할 수 있다.  적 |\n| 예1) | 자료제출의약품으로, | ‘안전성유효성 | 자료, | 기준 | 및 | 시험방법에 | 관한 | 자료, | GMP실시상황평가’가 | 방사성핵종순도(Radionuclidic | purity): | 방사성의약품 | - 보존제의 종류 및 함량 사용범위는 ｢ | 표 1의 의약품 제조 및 품질관리기준 실시상황 |\n| ※ 자사에서 근거자료를 바탕으로 직접 기준 및 시험방법을 작성할 경우 방사성의약품의 특성에 맞게 | ‘전이확률(transition | probability)' | 용어는 | 전이 | 품의 매개변수기반출하(parametric release, 5.1.1)를 선 | *첨가제의 규격이 별첨규격인 경우 첨가제 규격에 관한 근거자료를 제출 | 있는 것이다.  | 2. ",
        "original_sentence": "다만, 별 |\n| 불순물의 물리적 특성들에 대해 기술하고 있다. "
      }
    },
    {
      "chunk_id": "chunk_532",
      "text": "| 러한 경우 완전히 밸리데이션 된 공정으로 제조된 제 | 곧 외부로부터의 오염을 막을 수 | 않을 경우 생리학적 분포 시험이 필요할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 531,
        "window_size": 3,
        "char_count": 81,
        "word_count": 24,
        "page_number": 3,
        "window_text": "만일, 정당한 사유없이 상기 조건을 이행하지 아니할 경우에는 본 품목허가를 취소할 수 있다.  | 양도ᆞ양수계약서를 제출할 수 있다.  다만, 별 |\n| 불순물의 물리적 특성들에 대해 기술하고 있다.  | 러한 경우 완전히 밸리데이션 된 공정으로 제조된 제 | 곧 외부로부터의 오염을 막을 수 | 않을 경우 생리학적 분포 시험이 필요할 수 있다.  적 |\n| 예1) | 자료제출의약품으로, | ‘안전성유효성 | 자료, | 기준 | 및 | 시험방법에 | 관한 | 자료, | GMP실시상황평가’가 | 방사성핵종순도(Radionuclidic | purity): | 방사성의약품 | - 보존제의 종류 및 함량 사용범위는 ｢ | 표 1의 의약품 제조 및 품질관리기준 실시상황 |\n| ※ 자사에서 근거자료를 바탕으로 직접 기준 및 시험방법을 작성할 경우 방사성의약품의 특성에 맞게 | ‘전이확률(transition | probability)' | 용어는 | 전이 | 품의 매개변수기반출하(parametric release, 5.1.1)를 선 | *첨가제의 규격이 별첨규격인 경우 첨가제 규격에 관한 근거자료를 제출 | 있는 것이다.  | 2.  구조결정, 물리화학적 성질에 관한 자료 | 절한 실험동물의 특정 기관, 조직 또는 다른 신체 부 |\n| 의 총 방사능 중 방사성핵종의 방사능 비율(%)과 관련 | 평가가 필요한 경우에는 제4조제1항제6호의 |\n| 3. ",
        "original_sentence": "| 러한 경우 완전히 밸리데이션 된 공정으로 제조된 제 | 곧 외부로부터의 오염을 막을 수 | 않을 경우 생리학적 분포 시험이 필요할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_533",
      "text": "적 |\n| 예1) | 자료제출의약품으로, | ‘안전성유효성 | 자료, | 기준 | 및 | 시험방법에 | 관한 | 자료, | GMP실시상황평가’가 | 방사성핵종순도(Radionuclidic | purity): | 방사성의약품 | - 보존제의 종류 및 함량 사용범위는 ｢ | 표 1의 의약품 제조 및 품질관리기준 실시상황 |\n| ※ 자사에서 근거자료를 바탕으로 직접 기준 및 시험방법을 작성할 경우 방사성의약품의 특성에 맞게 | ‘전이확률(transition | probability)' | 용어는 | 전이 | 품의 매개변수기반출하(parametric release, 5.1.1)를 선 | *첨가제의 규격이 별첨규격인 경우 첨가제 규격에 관한 근거자료를 제출 | 있는 것이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 532,
        "window_size": 3,
        "char_count": 377,
        "word_count": 86,
        "page_number": 3,
        "window_text": "| 양도ᆞ양수계약서를 제출할 수 있다.  다만, 별 |\n| 불순물의 물리적 특성들에 대해 기술하고 있다.  | 러한 경우 완전히 밸리데이션 된 공정으로 제조된 제 | 곧 외부로부터의 오염을 막을 수 | 않을 경우 생리학적 분포 시험이 필요할 수 있다.  적 |\n| 예1) | 자료제출의약품으로, | ‘안전성유효성 | 자료, | 기준 | 및 | 시험방법에 | 관한 | 자료, | GMP실시상황평가’가 | 방사성핵종순도(Radionuclidic | purity): | 방사성의약품 | - 보존제의 종류 및 함량 사용범위는 ｢ | 표 1의 의약품 제조 및 품질관리기준 실시상황 |\n| ※ 자사에서 근거자료를 바탕으로 직접 기준 및 시험방법을 작성할 경우 방사성의약품의 특성에 맞게 | ‘전이확률(transition | probability)' | 용어는 | 전이 | 품의 매개변수기반출하(parametric release, 5.1.1)를 선 | *첨가제의 규격이 별첨규격인 경우 첨가제 규격에 관한 근거자료를 제출 | 있는 것이다.  | 2.  구조결정, 물리화학적 성질에 관한 자료 | 절한 실험동물의 특정 기관, 조직 또는 다른 신체 부 |\n| 의 총 방사능 중 방사성핵종의 방사능 비율(%)과 관련 | 평가가 필요한 경우에는 제4조제1항제6호의 |\n| 3.  안정성에 관한 자료 | 약전의 각조 또는 공정서를 참고하여 작성하도록 함 |\n| 예) 식약처과테크네튬산나트륨주사액 | (transition) 등을 통하여 특정 에너지 상태의 핵이 변 | 택할 수 있다. ",
        "original_sentence": "적 |\n| 예1) | 자료제출의약품으로, | ‘안전성유효성 | 자료, | 기준 | 및 | 시험방법에 | 관한 | 자료, | GMP실시상황평가’가 | 방사성핵종순도(Radionuclidic | purity): | 방사성의약품 | - 보존제의 종류 및 함량 사용범위는 ｢ | 표 1의 의약품 제조 및 품질관리기준 실시상황 |\n| ※ 자사에서 근거자료를 바탕으로 직접 기준 및 시험방법을 작성할 경우 방사성의약품의 특성에 맞게 | ‘전이확률(transition | probability)' | 용어는 | 전이 | 품의 매개변수기반출하(parametric release, 5.1.1)를 선 | *첨가제의 규격이 별첨규격인 경우 첨가제 규격에 관한 근거자료를 제출 | 있는 것이다. "
      }
    },
    {
      "chunk_id": "chunk_534",
      "text": "| 2. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 533,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 3,
        "window_text": "다만, 별 |\n| 불순물의 물리적 특성들에 대해 기술하고 있다.  | 러한 경우 완전히 밸리데이션 된 공정으로 제조된 제 | 곧 외부로부터의 오염을 막을 수 | 않을 경우 생리학적 분포 시험이 필요할 수 있다.  적 |\n| 예1) | 자료제출의약품으로, | ‘안전성유효성 | 자료, | 기준 | 및 | 시험방법에 | 관한 | 자료, | GMP실시상황평가’가 | 방사성핵종순도(Radionuclidic | purity): | 방사성의약품 | - 보존제의 종류 및 함량 사용범위는 ｢ | 표 1의 의약품 제조 및 품질관리기준 실시상황 |\n| ※ 자사에서 근거자료를 바탕으로 직접 기준 및 시험방법을 작성할 경우 방사성의약품의 특성에 맞게 | ‘전이확률(transition | probability)' | 용어는 | 전이 | 품의 매개변수기반출하(parametric release, 5.1.1)를 선 | *첨가제의 규격이 별첨규격인 경우 첨가제 규격에 관한 근거자료를 제출 | 있는 것이다.  | 2.  구조결정, 물리화학적 성질에 관한 자료 | 절한 실험동물의 특정 기관, 조직 또는 다른 신체 부 |\n| 의 총 방사능 중 방사성핵종의 방사능 비율(%)과 관련 | 평가가 필요한 경우에는 제4조제1항제6호의 |\n| 3.  안정성에 관한 자료 | 약전의 각조 또는 공정서를 참고하여 작성하도록 함 |\n| 예) 식약처과테크네튬산나트륨주사액 | (transition) 등을 통하여 특정 에너지 상태의 핵이 변 | 택할 수 있다.  무균 제조 시 무균시험은 제품의 품질 | 가. ",
        "original_sentence": "| 2. "
      }
    },
    {
      "chunk_id": "chunk_535",
      "text": "구조결정, 물리화학적 성질에 관한 자료 | 절한 실험동물의 특정 기관, 조직 또는 다른 신체 부 |\n| 의 총 방사능 중 방사성핵종의 방사능 비율(%)과 관련 | 평가가 필요한 경우에는 제4조제1항제6호의 |\n| 3. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 534,
        "window_size": 3,
        "char_count": 122,
        "word_count": 33,
        "page_number": 5,
        "window_text": "| 러한 경우 완전히 밸리데이션 된 공정으로 제조된 제 | 곧 외부로부터의 오염을 막을 수 | 않을 경우 생리학적 분포 시험이 필요할 수 있다.  적 |\n| 예1) | 자료제출의약품으로, | ‘안전성유효성 | 자료, | 기준 | 및 | 시험방법에 | 관한 | 자료, | GMP실시상황평가’가 | 방사성핵종순도(Radionuclidic | purity): | 방사성의약품 | - 보존제의 종류 및 함량 사용범위는 ｢ | 표 1의 의약품 제조 및 품질관리기준 실시상황 |\n| ※ 자사에서 근거자료를 바탕으로 직접 기준 및 시험방법을 작성할 경우 방사성의약품의 특성에 맞게 | ‘전이확률(transition | probability)' | 용어는 | 전이 | 품의 매개변수기반출하(parametric release, 5.1.1)를 선 | *첨가제의 규격이 별첨규격인 경우 첨가제 규격에 관한 근거자료를 제출 | 있는 것이다.  | 2.  구조결정, 물리화학적 성질에 관한 자료 | 절한 실험동물의 특정 기관, 조직 또는 다른 신체 부 |\n| 의 총 방사능 중 방사성핵종의 방사능 비율(%)과 관련 | 평가가 필요한 경우에는 제4조제1항제6호의 |\n| 3.  안정성에 관한 자료 | 약전의 각조 또는 공정서를 참고하여 작성하도록 함 |\n| 예) 식약처과테크네튬산나트륨주사액 | (transition) 등을 통하여 특정 에너지 상태의 핵이 변 | 택할 수 있다.  무균 제조 시 무균시험은 제품의 품질 | 가.  의약품등을 생산하는 국가(이하 \"생산국\" | 나. ",
        "original_sentence": "구조결정, 물리화학적 성질에 관한 자료 | 절한 실험동물의 특정 기관, 조직 또는 다른 신체 부 |\n| 의 총 방사능 중 방사성핵종의 방사능 비율(%)과 관련 | 평가가 필요한 경우에는 제4조제1항제6호의 |\n| 3. "
      }
    },
    {
      "chunk_id": "chunk_536",
      "text": "안정성에 관한 자료 | 약전의 각조 또는 공정서를 참고하여 작성하도록 함 |\n| 예) 식약처과테크네튬산나트륨주사액 | (transition) 등을 통하여 특정 에너지 상태의 핵이 변 | 택할 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 535,
        "window_size": 3,
        "char_count": 113,
        "word_count": 28,
        "page_number": 5,
        "window_text": "적 |\n| 예1) | 자료제출의약품으로, | ‘안전성유효성 | 자료, | 기준 | 및 | 시험방법에 | 관한 | 자료, | GMP실시상황평가’가 | 방사성핵종순도(Radionuclidic | purity): | 방사성의약품 | - 보존제의 종류 및 함량 사용범위는 ｢ | 표 1의 의약품 제조 및 품질관리기준 실시상황 |\n| ※ 자사에서 근거자료를 바탕으로 직접 기준 및 시험방법을 작성할 경우 방사성의약품의 특성에 맞게 | ‘전이확률(transition | probability)' | 용어는 | 전이 | 품의 매개변수기반출하(parametric release, 5.1.1)를 선 | *첨가제의 규격이 별첨규격인 경우 첨가제 규격에 관한 근거자료를 제출 | 있는 것이다.  | 2.  구조결정, 물리화학적 성질에 관한 자료 | 절한 실험동물의 특정 기관, 조직 또는 다른 신체 부 |\n| 의 총 방사능 중 방사성핵종의 방사능 비율(%)과 관련 | 평가가 필요한 경우에는 제4조제1항제6호의 |\n| 3.  안정성에 관한 자료 | 약전의 각조 또는 공정서를 참고하여 작성하도록 함 |\n| 예) 식약처과테크네튬산나트륨주사액 | (transition) 등을 통하여 특정 에너지 상태의 핵이 변 | 택할 수 있다.  무균 제조 시 무균시험은 제품의 품질 | 가.  의약품등을 생산하는 국가(이하 \"생산국\" | 나.  해당 품목이 허가 또는 등록된 국가의 정 | 자료를 제출하여야 한다. ",
        "original_sentence": "안정성에 관한 자료 | 약전의 각조 또는 공정서를 참고하여 작성하도록 함 |\n| 예) 식약처과테크네튬산나트륨주사액 | (transition) 등을 통하여 특정 에너지 상태의 핵이 변 | 택할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_537",
      "text": "무균 제조 시 무균시험은 제품의 품질 | 가. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 536,
        "window_size": 3,
        "char_count": 26,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| 2.  구조결정, 물리화학적 성질에 관한 자료 | 절한 실험동물의 특정 기관, 조직 또는 다른 신체 부 |\n| 의 총 방사능 중 방사성핵종의 방사능 비율(%)과 관련 | 평가가 필요한 경우에는 제4조제1항제6호의 |\n| 3.  안정성에 관한 자료 | 약전의 각조 또는 공정서를 참고하여 작성하도록 함 |\n| 예) 식약처과테크네튬산나트륨주사액 | (transition) 등을 통하여 특정 에너지 상태의 핵이 변 | 택할 수 있다.  무균 제조 시 무균시험은 제품의 품질 | 가.  의약품등을 생산하는 국가(이하 \"생산국\" | 나.  해당 품목이 허가 또는 등록된 국가의 정 | 자료를 제출하여야 한다.  | 각각의 특정 붕괴상수(decay constant)에 해당하는 지 | 위에서의 방사능 분포 양상은 사용하려는 목적에 적합 |\n| 된다. ",
        "original_sentence": "무균 제조 시 무균시험은 제품의 품질 | 가. "
      }
    },
    {
      "chunk_id": "chunk_538",
      "text": "의약품등을 생산하는 국가(이하 \"생산국\" | 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 537,
        "window_size": 3,
        "char_count": 28,
        "word_count": 6,
        "page_number": 5,
        "window_text": "구조결정, 물리화학적 성질에 관한 자료 | 절한 실험동물의 특정 기관, 조직 또는 다른 신체 부 |\n| 의 총 방사능 중 방사성핵종의 방사능 비율(%)과 관련 | 평가가 필요한 경우에는 제4조제1항제6호의 |\n| 3.  안정성에 관한 자료 | 약전의 각조 또는 공정서를 참고하여 작성하도록 함 |\n| 예) 식약처과테크네튬산나트륨주사액 | (transition) 등을 통하여 특정 에너지 상태의 핵이 변 | 택할 수 있다.  무균 제조 시 무균시험은 제품의 품질 | 가.  의약품등을 생산하는 국가(이하 \"생산국\" | 나.  해당 품목이 허가 또는 등록된 국가의 정 | 자료를 제출하여야 한다.  | 각각의 특정 붕괴상수(decay constant)에 해당하는 지 | 위에서의 방사능 분포 양상은 사용하려는 목적에 적합 |\n| 된다.  각조 규격에 상대적인 잠재적 방사성핵종 불순 | - 수출용․군수용․관수용:「의약품 등의 안전에 관한 규칙」제12조 및「의약품등의 | 4. ",
        "original_sentence": "의약품등을 생산하는 국가(이하 \"생산국\" | 나. "
      }
    },
    {
      "chunk_id": "chunk_539",
      "text": "해당 품목이 허가 또는 등록된 국가의 정 | 자료를 제출하여야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 538,
        "window_size": 3,
        "char_count": 39,
        "word_count": 11,
        "page_number": 5,
        "window_text": "안정성에 관한 자료 | 약전의 각조 또는 공정서를 참고하여 작성하도록 함 |\n| 예) 식약처과테크네튬산나트륨주사액 | (transition) 등을 통하여 특정 에너지 상태의 핵이 변 | 택할 수 있다.  무균 제조 시 무균시험은 제품의 품질 | 가.  의약품등을 생산하는 국가(이하 \"생산국\" | 나.  해당 품목이 허가 또는 등록된 국가의 정 | 자료를 제출하여야 한다.  | 각각의 특정 붕괴상수(decay constant)에 해당하는 지 | 위에서의 방사능 분포 양상은 사용하려는 목적에 적합 |\n| 된다.  각조 규격에 상대적인 잠재적 방사성핵종 불순 | - 수출용․군수용․관수용:「의약품 등의 안전에 관한 규칙」제12조 및「의약품등의 | 4.  독성에 관한 자료 |\n| 예2) 자료제출의약품으로, ‘안전성유효성 자료, 기준 및 시험방법에 관한 자료, GMP실시상황평가’가 제출 | 환(transformation) | 되는 확률을 의미한다. ",
        "original_sentence": "해당 품목이 허가 또는 등록된 국가의 정 | 자료를 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_540",
      "text": "| 각각의 특정 붕괴상수(decay constant)에 해당하는 지 | 위에서의 방사능 분포 양상은 사용하려는 목적에 적합 |\n| 된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 539,
        "window_size": 3,
        "char_count": 77,
        "word_count": 18,
        "page_number": 13,
        "window_text": "무균 제조 시 무균시험은 제품의 품질 | 가.  의약품등을 생산하는 국가(이하 \"생산국\" | 나.  해당 품목이 허가 또는 등록된 국가의 정 | 자료를 제출하여야 한다.  | 각각의 특정 붕괴상수(decay constant)에 해당하는 지 | 위에서의 방사능 분포 양상은 사용하려는 목적에 적합 |\n| 된다.  각조 규격에 상대적인 잠재적 방사성핵종 불순 | - 수출용․군수용․관수용:「의약품 등의 안전에 관한 규칙」제12조 및「의약품등의 | 4.  독성에 관한 자료 |\n| 예2) 자료제출의약품으로, ‘안전성유효성 자료, 기준 및 시험방법에 관한 자료, GMP실시상황평가’가 제출 | 환(transformation) | 되는 확률을 의미한다.  | '확률 | 관리로서 수행되어야 한다. ",
        "original_sentence": "| 각각의 특정 붕괴상수(decay constant)에 해당하는 지 | 위에서의 방사능 분포 양상은 사용하려는 목적에 적합 |\n| 된다. "
      }
    },
    {
      "chunk_id": "chunk_541",
      "text": "각조 규격에 상대적인 잠재적 방사성핵종 불순 | - 수출용․군수용․관수용:「의약품 등의 안전에 관한 규칙」제12조 및「의약품등의 | 4. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 540,
        "window_size": 3,
        "char_count": 77,
        "word_count": 16,
        "page_number": 3,
        "window_text": "의약품등을 생산하는 국가(이하 \"생산국\" | 나.  해당 품목이 허가 또는 등록된 국가의 정 | 자료를 제출하여야 한다.  | 각각의 특정 붕괴상수(decay constant)에 해당하는 지 | 위에서의 방사능 분포 양상은 사용하려는 목적에 적합 |\n| 된다.  각조 규격에 상대적인 잠재적 방사성핵종 불순 | - 수출용․군수용․관수용:「의약품 등의 안전에 관한 규칙」제12조 및「의약품등의 | 4.  독성에 관한 자료 |\n| 예2) 자료제출의약품으로, ‘안전성유효성 자료, 기준 및 시험방법에 관한 자료, GMP실시상황평가’가 제출 | 환(transformation) | 되는 확률을 의미한다.  | '확률 | 관리로서 수행되어야 한다.  | 심사자료의 요건 등 | 않으며, 중요공정(예시 : 칭량, 혼합, 타정, 충전 등), 원료 및 반제품이 작업실에서 노출되는 정도 등을 | 요인들과 함께 표적물질의 순도와 동위원소 조성은 조 |\n| 2.3.4 성상 | <예> 대한민국약전 각조 중, | ④ 제2항에 따라 신고를 하는 자는 식품의약품 |\n| 물들의 기준이 기재되어 있다. ",
        "original_sentence": "각조 규격에 상대적인 잠재적 방사성핵종 불순 | - 수출용․군수용․관수용:「의약품 등의 안전에 관한 규칙」제12조 및「의약품등의 | 4. "
      }
    },
    {
      "chunk_id": "chunk_542",
      "text": "독성에 관한 자료 |\n| 예2) 자료제출의약품으로, ‘안전성유효성 자료, 기준 및 시험방법에 관한 자료, GMP실시상황평가’가 제출 | 환(transformation) | 되는 확률을 의미한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 541,
        "window_size": 3,
        "char_count": 109,
        "word_count": 22,
        "page_number": 3,
        "window_text": "해당 품목이 허가 또는 등록된 국가의 정 | 자료를 제출하여야 한다.  | 각각의 특정 붕괴상수(decay constant)에 해당하는 지 | 위에서의 방사능 분포 양상은 사용하려는 목적에 적합 |\n| 된다.  각조 규격에 상대적인 잠재적 방사성핵종 불순 | - 수출용․군수용․관수용:「의약품 등의 안전에 관한 규칙」제12조 및「의약품등의 | 4.  독성에 관한 자료 |\n| 예2) 자료제출의약품으로, ‘안전성유효성 자료, 기준 및 시험방법에 관한 자료, GMP실시상황평가’가 제출 | 환(transformation) | 되는 확률을 의미한다.  | '확률 | 관리로서 수행되어야 한다.  | 심사자료의 요건 등 | 않으며, 중요공정(예시 : 칭량, 혼합, 타정, 충전 등), 원료 및 반제품이 작업실에서 노출되는 정도 등을 | 요인들과 함께 표적물질의 순도와 동위원소 조성은 조 |\n| 2.3.4 성상 | <예> 대한민국약전 각조 중, | ④ 제2항에 따라 신고를 하는 자는 식품의약품 |\n| 물들의 기준이 기재되어 있다.  | 품목허가․신고․심사규정」제22조 | 규정에 | 따라 | 수출용․군수용․관수용으로 | * 방사성의약품은 ‘15.7.1 부터 품목허가를 신청하는 경우 GMP 실시상황 평가대상이며, ‘14.8.21.자 개정된 |\n| (probability)' 대신 ’존재도(abundance)' 용어를 사용하 | 방사성의약품의 배치크기가 1 내지 몇 개의 샘플로 적 | 안전처장이 정하여 고시하는 수수료(외국에서 | 자료 요건이며, 사전검토 민원 ‘기준 및 시험방법에 관한 자료’ 적합 통지서를 제출하는 경우, 총 | 사(irradiation)에 의해 생성되는 주 방사성핵종과 방사 |\n| ▷ 시리즈 제품(유사 효능․효과 품목들) | 방사성의약품 심사자료의 요건 등 정보는 ｢ | - 색 + 형상 + 제형 순으로 기재 |\n| 을 때, 일반시험법(2.6.1)에 따른 검체 채취방법을 적용 | 허가(예: 수출용에 한함) | 현지실사를 할 필요가 있는 경우에는 이에 드 | 처리기한은 90일, 수수료(전자민원)는 1,134,000원에서 306,000원을 제외한 828,000원 | 성핵종 불순물의 상대적인 비율을 결정할 것이다. ",
        "original_sentence": "독성에 관한 자료 |\n| 예2) 자료제출의약품으로, ‘안전성유효성 자료, 기준 및 시험방법에 관한 자료, GMP실시상황평가’가 제출 | 환(transformation) | 되는 확률을 의미한다. "
      }
    },
    {
      "chunk_id": "chunk_543",
      "text": "| '확률 | 관리로서 수행되어야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 542,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 9,
        "window_text": "| 각각의 특정 붕괴상수(decay constant)에 해당하는 지 | 위에서의 방사능 분포 양상은 사용하려는 목적에 적합 |\n| 된다.  각조 규격에 상대적인 잠재적 방사성핵종 불순 | - 수출용․군수용․관수용:「의약품 등의 안전에 관한 규칙」제12조 및「의약품등의 | 4.  독성에 관한 자료 |\n| 예2) 자료제출의약품으로, ‘안전성유효성 자료, 기준 및 시험방법에 관한 자료, GMP실시상황평가’가 제출 | 환(transformation) | 되는 확률을 의미한다.  | '확률 | 관리로서 수행되어야 한다.  | 심사자료의 요건 등 | 않으며, 중요공정(예시 : 칭량, 혼합, 타정, 충전 등), 원료 및 반제품이 작업실에서 노출되는 정도 등을 | 요인들과 함께 표적물질의 순도와 동위원소 조성은 조 |\n| 2.3.4 성상 | <예> 대한민국약전 각조 중, | ④ 제2항에 따라 신고를 하는 자는 식품의약품 |\n| 물들의 기준이 기재되어 있다.  | 품목허가․신고․심사규정」제22조 | 규정에 | 따라 | 수출용․군수용․관수용으로 | * 방사성의약품은 ‘15.7.1 부터 품목허가를 신청하는 경우 GMP 실시상황 평가대상이며, ‘14.8.21.자 개정된 |\n| (probability)' 대신 ’존재도(abundance)' 용어를 사용하 | 방사성의약품의 배치크기가 1 내지 몇 개의 샘플로 적 | 안전처장이 정하여 고시하는 수수료(외국에서 | 자료 요건이며, 사전검토 민원 ‘기준 및 시험방법에 관한 자료’ 적합 통지서를 제출하는 경우, 총 | 사(irradiation)에 의해 생성되는 주 방사성핵종과 방사 |\n| ▷ 시리즈 제품(유사 효능․효과 품목들) | 방사성의약품 심사자료의 요건 등 정보는 ｢ | - 색 + 형상 + 제형 순으로 기재 |\n| 을 때, 일반시험법(2.6.1)에 따른 검체 채취방법을 적용 | 허가(예: 수출용에 한함) | 현지실사를 할 필요가 있는 경우에는 이에 드 | 처리기한은 90일, 수수료(전자민원)는 1,134,000원에서 306,000원을 제외한 828,000원 | 성핵종 불순물의 상대적인 비율을 결정할 것이다.  필 |\n| * ㉮「의약품 등의 안전에 관한 규칙」제4조제2항제2호애 따라 제조소에 동 규칙 제48조의2에 따른 GMP | 기도 한다. ",
        "original_sentence": "| '확률 | 관리로서 수행되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_544",
      "text": "| 심사자료의 요건 등 | 않으며, 중요공정(예시 : 칭량, 혼합, 타정, 충전 등), 원료 및 반제품이 작업실에서 노출되는 정도 등을 | 요인들과 함께 표적물질의 순도와 동위원소 조성은 조 |\n| 2.3.4 성상 | <예> 대한민국약전 각조 중, | ④ 제2항에 따라 신고를 하는 자는 식품의약품 |\n| 물들의 기준이 기재되어 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 543,
        "window_size": 3,
        "char_count": 188,
        "word_count": 51,
        "page_number": 5,
        "window_text": "각조 규격에 상대적인 잠재적 방사성핵종 불순 | - 수출용․군수용․관수용:「의약품 등의 안전에 관한 규칙」제12조 및「의약품등의 | 4.  독성에 관한 자료 |\n| 예2) 자료제출의약품으로, ‘안전성유효성 자료, 기준 및 시험방법에 관한 자료, GMP실시상황평가’가 제출 | 환(transformation) | 되는 확률을 의미한다.  | '확률 | 관리로서 수행되어야 한다.  | 심사자료의 요건 등 | 않으며, 중요공정(예시 : 칭량, 혼합, 타정, 충전 등), 원료 및 반제품이 작업실에서 노출되는 정도 등을 | 요인들과 함께 표적물질의 순도와 동위원소 조성은 조 |\n| 2.3.4 성상 | <예> 대한민국약전 각조 중, | ④ 제2항에 따라 신고를 하는 자는 식품의약품 |\n| 물들의 기준이 기재되어 있다.  | 품목허가․신고․심사규정」제22조 | 규정에 | 따라 | 수출용․군수용․관수용으로 | * 방사성의약품은 ‘15.7.1 부터 품목허가를 신청하는 경우 GMP 실시상황 평가대상이며, ‘14.8.21.자 개정된 |\n| (probability)' 대신 ’존재도(abundance)' 용어를 사용하 | 방사성의약품의 배치크기가 1 내지 몇 개의 샘플로 적 | 안전처장이 정하여 고시하는 수수료(외국에서 | 자료 요건이며, 사전검토 민원 ‘기준 및 시험방법에 관한 자료’ 적합 통지서를 제출하는 경우, 총 | 사(irradiation)에 의해 생성되는 주 방사성핵종과 방사 |\n| ▷ 시리즈 제품(유사 효능․효과 품목들) | 방사성의약품 심사자료의 요건 등 정보는 ｢ | - 색 + 형상 + 제형 순으로 기재 |\n| 을 때, 일반시험법(2.6.1)에 따른 검체 채취방법을 적용 | 허가(예: 수출용에 한함) | 현지실사를 할 필요가 있는 경우에는 이에 드 | 처리기한은 90일, 수수료(전자민원)는 1,134,000원에서 306,000원을 제외한 828,000원 | 성핵종 불순물의 상대적인 비율을 결정할 것이다.  필 |\n| * ㉮「의약품 등의 안전에 관한 규칙」제4조제2항제2호애 따라 제조소에 동 규칙 제48조의2에 따른 GMP | 기도 한다.  | 알려진 다른제제와 함께 시험 시 제제의 생물학적동등 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 제7조, 제2절, 제3절 및 2012년도에 발간한 ｢ | 방사화학적순도(Radiochemical purity): 방사성의약품 | 분할사용 하는 용기의 특성을 감안하여 다음 사항을 고려 |\n| 상세한 | 수수료 | 정보는 | 「의약품 | 등의 | 허가등에 | 관한 | 수수료 | 규정 | 」(식품의약품안전처 | 고시)를 | ‘방출확률(emission probability)'은 방사성 핵종의 원자 | 할 수 없을지도 모른다. ",
        "original_sentence": "| 심사자료의 요건 등 | 않으며, 중요공정(예시 : 칭량, 혼합, 타정, 충전 등), 원료 및 반제품이 작업실에서 노출되는 정도 등을 | 요인들과 함께 표적물질의 순도와 동위원소 조성은 조 |\n| 2.3.4 성상 | <예> 대한민국약전 각조 중, | ④ 제2항에 따라 신고를 하는 자는 식품의약품 |\n| 물들의 기준이 기재되어 있다. "
      }
    },
    {
      "chunk_id": "chunk_545",
      "text": "| 품목허가․신고․심사규정」제22조 | 규정에 | 따라 | 수출용․군수용․관수용으로 | * 방사성의약품은 ‘15.7.1 부터 품목허가를 신청하는 경우 GMP 실시상황 평가대상이며, ‘14.8.21.자 개정된 |\n| (probability)' 대신 ’존재도(abundance)' 용어를 사용하 | 방사성의약품의 배치크기가 1 내지 몇 개의 샘플로 적 | 안전처장이 정하여 고시하는 수수료(외국에서 | 자료 요건이며, 사전검토 민원 ‘기준 및 시험방법에 관한 자료’ 적합 통지서를 제출하는 경우, 총 | 사(irradiation)에 의해 생성되는 주 방사성핵종과 방사 |\n| ▷ 시리즈 제품(유사 효능․효과 품목들) | 방사성의약품 심사자료의 요건 등 정보는 ｢ | - 색 + 형상 + 제형 순으로 기재 |\n| 을 때, 일반시험법(2.6.1)에 따른 검체 채취방법을 적용 | 허가(예: 수출용에 한함) | 현지실사를 할 필요가 있는 경우에는 이에 드 | 처리기한은 90일, 수수료(전자민원)는 1,134,000원에서 306,000원을 제외한 828,000원 | 성핵종 불순물의 상대적인 비율을 결정할 것이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 544,
        "window_size": 3,
        "char_count": 563,
        "word_count": 123,
        "page_number": 3,
        "window_text": "독성에 관한 자료 |\n| 예2) 자료제출의약품으로, ‘안전성유효성 자료, 기준 및 시험방법에 관한 자료, GMP실시상황평가’가 제출 | 환(transformation) | 되는 확률을 의미한다.  | '확률 | 관리로서 수행되어야 한다.  | 심사자료의 요건 등 | 않으며, 중요공정(예시 : 칭량, 혼합, 타정, 충전 등), 원료 및 반제품이 작업실에서 노출되는 정도 등을 | 요인들과 함께 표적물질의 순도와 동위원소 조성은 조 |\n| 2.3.4 성상 | <예> 대한민국약전 각조 중, | ④ 제2항에 따라 신고를 하는 자는 식품의약품 |\n| 물들의 기준이 기재되어 있다.  | 품목허가․신고․심사규정」제22조 | 규정에 | 따라 | 수출용․군수용․관수용으로 | * 방사성의약품은 ‘15.7.1 부터 품목허가를 신청하는 경우 GMP 실시상황 평가대상이며, ‘14.8.21.자 개정된 |\n| (probability)' 대신 ’존재도(abundance)' 용어를 사용하 | 방사성의약품의 배치크기가 1 내지 몇 개의 샘플로 적 | 안전처장이 정하여 고시하는 수수료(외국에서 | 자료 요건이며, 사전검토 민원 ‘기준 및 시험방법에 관한 자료’ 적합 통지서를 제출하는 경우, 총 | 사(irradiation)에 의해 생성되는 주 방사성핵종과 방사 |\n| ▷ 시리즈 제품(유사 효능․효과 품목들) | 방사성의약품 심사자료의 요건 등 정보는 ｢ | - 색 + 형상 + 제형 순으로 기재 |\n| 을 때, 일반시험법(2.6.1)에 따른 검체 채취방법을 적용 | 허가(예: 수출용에 한함) | 현지실사를 할 필요가 있는 경우에는 이에 드 | 처리기한은 90일, 수수료(전자민원)는 1,134,000원에서 306,000원을 제외한 828,000원 | 성핵종 불순물의 상대적인 비율을 결정할 것이다.  필 |\n| * ㉮「의약품 등의 안전에 관한 규칙」제4조제2항제2호애 따라 제조소에 동 규칙 제48조의2에 따른 GMP | 기도 한다.  | 알려진 다른제제와 함께 시험 시 제제의 생물학적동등 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 제7조, 제2절, 제3절 및 2012년도에 발간한 ｢ | 방사화학적순도(Radiochemical purity): 방사성의약품 | 분할사용 하는 용기의 특성을 감안하여 다음 사항을 고려 |\n| 상세한 | 수수료 | 정보는 | 「의약품 | 등의 | 허가등에 | 관한 | 수수료 | 규정 | 」(식품의약품안전처 | 고시)를 | ‘방출확률(emission probability)'은 방사성 핵종의 원자 | 할 수 없을지도 모른다.  | 나. ",
        "original_sentence": "| 품목허가․신고․심사규정」제22조 | 규정에 | 따라 | 수출용․군수용․관수용으로 | * 방사성의약품은 ‘15.7.1 부터 품목허가를 신청하는 경우 GMP 실시상황 평가대상이며, ‘14.8.21.자 개정된 |\n| (probability)' 대신 ’존재도(abundance)' 용어를 사용하 | 방사성의약품의 배치크기가 1 내지 몇 개의 샘플로 적 | 안전처장이 정하여 고시하는 수수료(외국에서 | 자료 요건이며, 사전검토 민원 ‘기준 및 시험방법에 관한 자료’ 적합 통지서를 제출하는 경우, 총 | 사(irradiation)에 의해 생성되는 주 방사성핵종과 방사 |\n| ▷ 시리즈 제품(유사 효능․효과 품목들) | 방사성의약품 심사자료의 요건 등 정보는 ｢ | - 색 + 형상 + 제형 순으로 기재 |\n| 을 때, 일반시험법(2.6.1)에 따른 검체 채취방법을 적용 | 허가(예: 수출용에 한함) | 현지실사를 할 필요가 있는 경우에는 이에 드 | 처리기한은 90일, 수수료(전자민원)는 1,134,000원에서 306,000원을 제외한 828,000원 | 성핵종 불순물의 상대적인 비율을 결정할 것이다. "
      }
    },
    {
      "chunk_id": "chunk_546",
      "text": "필 |\n| * ㉮「의약품 등의 안전에 관한 규칙」제4조제2항제2호애 따라 제조소에 동 규칙 제48조의2에 따른 GMP | 기도 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 545,
        "window_size": 3,
        "char_count": 75,
        "word_count": 19,
        "page_number": 3,
        "window_text": "| '확률 | 관리로서 수행되어야 한다.  | 심사자료의 요건 등 | 않으며, 중요공정(예시 : 칭량, 혼합, 타정, 충전 등), 원료 및 반제품이 작업실에서 노출되는 정도 등을 | 요인들과 함께 표적물질의 순도와 동위원소 조성은 조 |\n| 2.3.4 성상 | <예> 대한민국약전 각조 중, | ④ 제2항에 따라 신고를 하는 자는 식품의약품 |\n| 물들의 기준이 기재되어 있다.  | 품목허가․신고․심사규정」제22조 | 규정에 | 따라 | 수출용․군수용․관수용으로 | * 방사성의약품은 ‘15.7.1 부터 품목허가를 신청하는 경우 GMP 실시상황 평가대상이며, ‘14.8.21.자 개정된 |\n| (probability)' 대신 ’존재도(abundance)' 용어를 사용하 | 방사성의약품의 배치크기가 1 내지 몇 개의 샘플로 적 | 안전처장이 정하여 고시하는 수수료(외국에서 | 자료 요건이며, 사전검토 민원 ‘기준 및 시험방법에 관한 자료’ 적합 통지서를 제출하는 경우, 총 | 사(irradiation)에 의해 생성되는 주 방사성핵종과 방사 |\n| ▷ 시리즈 제품(유사 효능․효과 품목들) | 방사성의약품 심사자료의 요건 등 정보는 ｢ | - 색 + 형상 + 제형 순으로 기재 |\n| 을 때, 일반시험법(2.6.1)에 따른 검체 채취방법을 적용 | 허가(예: 수출용에 한함) | 현지실사를 할 필요가 있는 경우에는 이에 드 | 처리기한은 90일, 수수료(전자민원)는 1,134,000원에서 306,000원을 제외한 828,000원 | 성핵종 불순물의 상대적인 비율을 결정할 것이다.  필 |\n| * ㉮「의약품 등의 안전에 관한 규칙」제4조제2항제2호애 따라 제조소에 동 규칙 제48조의2에 따른 GMP | 기도 한다.  | 알려진 다른제제와 함께 시험 시 제제의 생물학적동등 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 제7조, 제2절, 제3절 및 2012년도에 발간한 ｢ | 방사화학적순도(Radiochemical purity): 방사성의약품 | 분할사용 하는 용기의 특성을 감안하여 다음 사항을 고려 |\n| 상세한 | 수수료 | 정보는 | 「의약품 | 등의 | 허가등에 | 관한 | 수수료 | 규정 | 」(식품의약품안전처 | 고시)를 | ‘방출확률(emission probability)'은 방사성 핵종의 원자 | 할 수 없을지도 모른다.  | 나.  해당 품목이 허가 또는 등록된 국가의 정 | 5. ",
        "original_sentence": "필 |\n| * ㉮「의약품 등의 안전에 관한 규칙」제4조제2항제2호애 따라 제조소에 동 규칙 제48조의2에 따른 GMP | 기도 한다. "
      }
    },
    {
      "chunk_id": "chunk_547",
      "text": "| 알려진 다른제제와 함께 시험 시 제제의 생물학적동등 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 제7조, 제2절, 제3절 및 2012년도에 발간한 ｢ | 방사화학적순도(Radiochemical purity): 방사성의약품 | 분할사용 하는 용기의 특성을 감안하여 다음 사항을 고려 |\n| 상세한 | 수수료 | 정보는 | 「의약품 | 등의 | 허가등에 | 관한 | 수수료 | 규정 | 」(식품의약품안전처 | 고시)를 | ‘방출확률(emission probability)'은 방사성 핵종의 원자 | 할 수 없을지도 모른다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 546,
        "window_size": 3,
        "char_count": 305,
        "word_count": 67,
        "page_number": 5,
        "window_text": "| 심사자료의 요건 등 | 않으며, 중요공정(예시 : 칭량, 혼합, 타정, 충전 등), 원료 및 반제품이 작업실에서 노출되는 정도 등을 | 요인들과 함께 표적물질의 순도와 동위원소 조성은 조 |\n| 2.3.4 성상 | <예> 대한민국약전 각조 중, | ④ 제2항에 따라 신고를 하는 자는 식품의약품 |\n| 물들의 기준이 기재되어 있다.  | 품목허가․신고․심사규정」제22조 | 규정에 | 따라 | 수출용․군수용․관수용으로 | * 방사성의약품은 ‘15.7.1 부터 품목허가를 신청하는 경우 GMP 실시상황 평가대상이며, ‘14.8.21.자 개정된 |\n| (probability)' 대신 ’존재도(abundance)' 용어를 사용하 | 방사성의약품의 배치크기가 1 내지 몇 개의 샘플로 적 | 안전처장이 정하여 고시하는 수수료(외국에서 | 자료 요건이며, 사전검토 민원 ‘기준 및 시험방법에 관한 자료’ 적합 통지서를 제출하는 경우, 총 | 사(irradiation)에 의해 생성되는 주 방사성핵종과 방사 |\n| ▷ 시리즈 제품(유사 효능․효과 품목들) | 방사성의약품 심사자료의 요건 등 정보는 ｢ | - 색 + 형상 + 제형 순으로 기재 |\n| 을 때, 일반시험법(2.6.1)에 따른 검체 채취방법을 적용 | 허가(예: 수출용에 한함) | 현지실사를 할 필요가 있는 경우에는 이에 드 | 처리기한은 90일, 수수료(전자민원)는 1,134,000원에서 306,000원을 제외한 828,000원 | 성핵종 불순물의 상대적인 비율을 결정할 것이다.  필 |\n| * ㉮「의약품 등의 안전에 관한 규칙」제4조제2항제2호애 따라 제조소에 동 규칙 제48조의2에 따른 GMP | 기도 한다.  | 알려진 다른제제와 함께 시험 시 제제의 생물학적동등 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 제7조, 제2절, 제3절 및 2012년도에 발간한 ｢ | 방사화학적순도(Radiochemical purity): 방사성의약품 | 분할사용 하는 용기의 특성을 감안하여 다음 사항을 고려 |\n| 상세한 | 수수료 | 정보는 | 「의약품 | 등의 | 허가등에 | 관한 | 수수료 | 규정 | 」(식품의약품안전처 | 고시)를 | ‘방출확률(emission probability)'은 방사성 핵종의 원자 | 할 수 없을지도 모른다.  | 나.  해당 품목이 허가 또는 등록된 국가의 정 | 5.  일반의약품 중 단일성분의 의약품으로서 이 | Sodium Pertechnetate (99mTc) Injection | 는 경비를 포함한다)를 내야 한다. ",
        "original_sentence": "| 알려진 다른제제와 함께 시험 시 제제의 생물학적동등 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 제7조, 제2절, 제3절 및 2012년도에 발간한 ｢ | 방사화학적순도(Radiochemical purity): 방사성의약품 | 분할사용 하는 용기의 특성을 감안하여 다음 사항을 고려 |\n| 상세한 | 수수료 | 정보는 | 「의약품 | 등의 | 허가등에 | 관한 | 수수료 | 규정 | 」(식품의약품안전처 | 고시)를 | ‘방출확률(emission probability)'은 방사성 핵종의 원자 | 할 수 없을지도 모른다. "
      }
    },
    {
      "chunk_id": "chunk_548",
      "text": "| 나. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 547,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| 품목허가․신고․심사규정」제22조 | 규정에 | 따라 | 수출용․군수용․관수용으로 | * 방사성의약품은 ‘15.7.1 부터 품목허가를 신청하는 경우 GMP 실시상황 평가대상이며, ‘14.8.21.자 개정된 |\n| (probability)' 대신 ’존재도(abundance)' 용어를 사용하 | 방사성의약품의 배치크기가 1 내지 몇 개의 샘플로 적 | 안전처장이 정하여 고시하는 수수료(외국에서 | 자료 요건이며, 사전검토 민원 ‘기준 및 시험방법에 관한 자료’ 적합 통지서를 제출하는 경우, 총 | 사(irradiation)에 의해 생성되는 주 방사성핵종과 방사 |\n| ▷ 시리즈 제품(유사 효능․효과 품목들) | 방사성의약품 심사자료의 요건 등 정보는 ｢ | - 색 + 형상 + 제형 순으로 기재 |\n| 을 때, 일반시험법(2.6.1)에 따른 검체 채취방법을 적용 | 허가(예: 수출용에 한함) | 현지실사를 할 필요가 있는 경우에는 이에 드 | 처리기한은 90일, 수수료(전자민원)는 1,134,000원에서 306,000원을 제외한 828,000원 | 성핵종 불순물의 상대적인 비율을 결정할 것이다.  필 |\n| * ㉮「의약품 등의 안전에 관한 규칙」제4조제2항제2호애 따라 제조소에 동 규칙 제48조의2에 따른 GMP | 기도 한다.  | 알려진 다른제제와 함께 시험 시 제제의 생물학적동등 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 제7조, 제2절, 제3절 및 2012년도에 발간한 ｢ | 방사화학적순도(Radiochemical purity): 방사성의약품 | 분할사용 하는 용기의 특성을 감안하여 다음 사항을 고려 |\n| 상세한 | 수수료 | 정보는 | 「의약품 | 등의 | 허가등에 | 관한 | 수수료 | 규정 | 」(식품의약품안전처 | 고시)를 | ‘방출확률(emission probability)'은 방사성 핵종의 원자 | 할 수 없을지도 모른다.  | 나.  해당 품목이 허가 또는 등록된 국가의 정 | 5.  일반의약품 중 단일성분의 의약품으로서 이 | Sodium Pertechnetate (99mTc) Injection | 는 경비를 포함한다)를 내야 한다.  | 적합판정서가 있는 경우 GMP 실시상황 평가자료를 제출하지 않을 수 있음(신약, 생물학적제제등, 주사제, | 이식제 제외) 단, ‘15.7.1부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 | 동 규칙 제48조의2에 따른 GMP 적합판정서가 있더라도 관류제, 복막투석제, 점안제, 안연고제, | 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | 요한 표적 핵종들을 인위적으로 증가시킨 동위원소농 |\n| 에 존재하는 방사성핵종의 총 방사능 중 목적하는 화 | - 제조방법에서 주사제 용기의 규격(고무마개 등)을 기재했는가? ",
        "original_sentence": "| 나. "
      }
    },
    {
      "chunk_id": "chunk_549",
      "text": "해당 품목이 허가 또는 등록된 국가의 정 | 5. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 548,
        "window_size": 3,
        "char_count": 28,
        "word_count": 9,
        "page_number": 3,
        "window_text": "필 |\n| * ㉮「의약품 등의 안전에 관한 규칙」제4조제2항제2호애 따라 제조소에 동 규칙 제48조의2에 따른 GMP | 기도 한다.  | 알려진 다른제제와 함께 시험 시 제제의 생물학적동등 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 제7조, 제2절, 제3절 및 2012년도에 발간한 ｢ | 방사화학적순도(Radiochemical purity): 방사성의약품 | 분할사용 하는 용기의 특성을 감안하여 다음 사항을 고려 |\n| 상세한 | 수수료 | 정보는 | 「의약품 | 등의 | 허가등에 | 관한 | 수수료 | 규정 | 」(식품의약품안전처 | 고시)를 | ‘방출확률(emission probability)'은 방사성 핵종의 원자 | 할 수 없을지도 모른다.  | 나.  해당 품목이 허가 또는 등록된 국가의 정 | 5.  일반의약품 중 단일성분의 의약품으로서 이 | Sodium Pertechnetate (99mTc) Injection | 는 경비를 포함한다)를 내야 한다.  | 적합판정서가 있는 경우 GMP 실시상황 평가자료를 제출하지 않을 수 있음(신약, 생물학적제제등, 주사제, | 이식제 제외) 단, ‘15.7.1부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 | 동 규칙 제48조의2에 따른 GMP 적합판정서가 있더라도 관류제, 복막투석제, 점안제, 안연고제, | 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | 요한 표적 핵종들을 인위적으로 증가시킨 동위원소농 |\n| 에 존재하는 방사성핵종의 총 방사능 중 목적하는 화 | - 제조방법에서 주사제 용기의 규격(고무마개 등)을 기재했는가?  |\n| 참고한다. ",
        "original_sentence": "해당 품목이 허가 또는 등록된 국가의 정 | 5. "
      }
    },
    {
      "chunk_id": "chunk_550",
      "text": "일반의약품 중 단일성분의 의약품으로서 이 | Sodium Pertechnetate (99mTc) Injection | 는 경비를 포함한다)를 내야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 549,
        "window_size": 3,
        "char_count": 86,
        "word_count": 16,
        "page_number": 3,
        "window_text": "| 알려진 다른제제와 함께 시험 시 제제의 생물학적동등 |\n| ※식약처 홈페이지>법령․자료>지침․가이드라인․해설서>｢ | 제7조, 제2절, 제3절 및 2012년도에 발간한 ｢ | 방사화학적순도(Radiochemical purity): 방사성의약품 | 분할사용 하는 용기의 특성을 감안하여 다음 사항을 고려 |\n| 상세한 | 수수료 | 정보는 | 「의약품 | 등의 | 허가등에 | 관한 | 수수료 | 규정 | 」(식품의약품안전처 | 고시)를 | ‘방출확률(emission probability)'은 방사성 핵종의 원자 | 할 수 없을지도 모른다.  | 나.  해당 품목이 허가 또는 등록된 국가의 정 | 5.  일반의약품 중 단일성분의 의약품으로서 이 | Sodium Pertechnetate (99mTc) Injection | 는 경비를 포함한다)를 내야 한다.  | 적합판정서가 있는 경우 GMP 실시상황 평가자료를 제출하지 않을 수 있음(신약, 생물학적제제등, 주사제, | 이식제 제외) 단, ‘15.7.1부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 | 동 규칙 제48조의2에 따른 GMP 적합판정서가 있더라도 관류제, 복막투석제, 점안제, 안연고제, | 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | 요한 표적 핵종들을 인위적으로 증가시킨 동위원소농 |\n| 에 존재하는 방사성핵종의 총 방사능 중 목적하는 화 | - 제조방법에서 주사제 용기의 규격(고무마개 등)을 기재했는가?  |\n| 참고한다.  | 방사성핵종의 반감기가 5분 미만일 경우 환자에게 밸 | - 제형은 ｢ | 축표적물질(isotopically enriched target material)은 원 |\n| 참고하시기 바랍니다. ",
        "original_sentence": "일반의약품 중 단일성분의 의약품으로서 이 | Sodium Pertechnetate (99mTc) Injection | 는 경비를 포함한다)를 내야 한다. "
      }
    },
    {
      "chunk_id": "chunk_551",
      "text": "| 적합판정서가 있는 경우 GMP 실시상황 평가자료를 제출하지 않을 수 있음(신약, 생물학적제제등, 주사제, | 이식제 제외) 단, ‘15.7.1부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 | 동 규칙 제48조의2에 따른 GMP 적합판정서가 있더라도 관류제, 복막투석제, 점안제, 안연고제, | 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | 요한 표적 핵종들을 인위적으로 증가시킨 동위원소농 |\n| 에 존재하는 방사성핵종의 총 방사능 중 목적하는 화 | - 제조방법에서 주사제 용기의 규격(고무마개 등)을 기재했는가? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 550,
        "window_size": 3,
        "char_count": 316,
        "word_count": 70,
        "page_number": 5,
        "window_text": "| 나.  해당 품목이 허가 또는 등록된 국가의 정 | 5.  일반의약품 중 단일성분의 의약품으로서 이 | Sodium Pertechnetate (99mTc) Injection | 는 경비를 포함한다)를 내야 한다.  | 적합판정서가 있는 경우 GMP 실시상황 평가자료를 제출하지 않을 수 있음(신약, 생물학적제제등, 주사제, | 이식제 제외) 단, ‘15.7.1부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 | 동 규칙 제48조의2에 따른 GMP 적합판정서가 있더라도 관류제, 복막투석제, 점안제, 안연고제, | 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | 요한 표적 핵종들을 인위적으로 증가시킨 동위원소농 |\n| 에 존재하는 방사성핵종의 총 방사능 중 목적하는 화 | - 제조방법에서 주사제 용기의 규격(고무마개 등)을 기재했는가?  |\n| 참고한다.  | 방사성핵종의 반감기가 5분 미만일 경우 환자에게 밸 | - 제형은 ｢ | 축표적물질(isotopically enriched target material)은 원 |\n| 참고하시기 바랍니다.  | 가 입자 또는 방사선 등의 방출을 일으키는 확률을 의 | 제5조(제조판매·수입 품목의 신고) ① 법 제31 | - 설정된 규격은 재밀봉시험(self-sealing test) 항목이 포함되었는가? ",
        "original_sentence": "| 적합판정서가 있는 경우 GMP 실시상황 평가자료를 제출하지 않을 수 있음(신약, 생물학적제제등, 주사제, | 이식제 제외) 단, ‘15.7.1부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 | 동 규칙 제48조의2에 따른 GMP 적합판정서가 있더라도 관류제, 복막투석제, 점안제, 안연고제, | 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | 요한 표적 핵종들을 인위적으로 증가시킨 동위원소농 |\n| 에 존재하는 방사성핵종의 총 방사능 중 목적하는 화 | - 제조방법에서 주사제 용기의 규격(고무마개 등)을 기재했는가? "
      }
    },
    {
      "chunk_id": "chunk_552",
      "text": "|\n| 참고한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 551,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 9,
        "window_text": "해당 품목이 허가 또는 등록된 국가의 정 | 5.  일반의약품 중 단일성분의 의약품으로서 이 | Sodium Pertechnetate (99mTc) Injection | 는 경비를 포함한다)를 내야 한다.  | 적합판정서가 있는 경우 GMP 실시상황 평가자료를 제출하지 않을 수 있음(신약, 생물학적제제등, 주사제, | 이식제 제외) 단, ‘15.7.1부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 | 동 규칙 제48조의2에 따른 GMP 적합판정서가 있더라도 관류제, 복막투석제, 점안제, 안연고제, | 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | 요한 표적 핵종들을 인위적으로 증가시킨 동위원소농 |\n| 에 존재하는 방사성핵종의 총 방사능 중 목적하는 화 | - 제조방법에서 주사제 용기의 규격(고무마개 등)을 기재했는가?  |\n| 참고한다.  | 방사성핵종의 반감기가 5분 미만일 경우 환자에게 밸 | - 제형은 ｢ | 축표적물질(isotopically enriched target material)은 원 |\n| 참고하시기 바랍니다.  | 가 입자 또는 방사선 등의 방출을 일으키는 확률을 의 | 제5조(제조판매·수입 품목의 신고) ① 법 제31 | - 설정된 규격은 재밀봉시험(self-sealing test) 항목이 포함되었는가?  그 결과는 적합한가? ",
        "original_sentence": "|\n| 참고한다. "
      }
    },
    {
      "chunk_id": "chunk_553",
      "text": "| 방사성핵종의 반감기가 5분 미만일 경우 환자에게 밸 | - 제형은 ｢ | 축표적물질(isotopically enriched target material)은 원 |\n| 참고하시기 바랍니다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 552,
        "window_size": 3,
        "char_count": 107,
        "word_count": 22,
        "page_number": 3,
        "window_text": "일반의약품 중 단일성분의 의약품으로서 이 | Sodium Pertechnetate (99mTc) Injection | 는 경비를 포함한다)를 내야 한다.  | 적합판정서가 있는 경우 GMP 실시상황 평가자료를 제출하지 않을 수 있음(신약, 생물학적제제등, 주사제, | 이식제 제외) 단, ‘15.7.1부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 | 동 규칙 제48조의2에 따른 GMP 적합판정서가 있더라도 관류제, 복막투석제, 점안제, 안연고제, | 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | 요한 표적 핵종들을 인위적으로 증가시킨 동위원소농 |\n| 에 존재하는 방사성핵종의 총 방사능 중 목적하는 화 | - 제조방법에서 주사제 용기의 규격(고무마개 등)을 기재했는가?  |\n| 참고한다.  | 방사성핵종의 반감기가 5분 미만일 경우 환자에게 밸 | - 제형은 ｢ | 축표적물질(isotopically enriched target material)은 원 |\n| 참고하시기 바랍니다.  | 가 입자 또는 방사선 등의 방출을 일으키는 확률을 의 | 제5조(제조판매·수입 품목의 신고) ① 법 제31 | - 설정된 규격은 재밀봉시험(self-sealing test) 항목이 포함되었는가?  그 결과는 적합한가?  | 각조에서 시험을 수행하는 데 필요한 상세내용과 요구 |\n| 예) 식약처테크네100주사액(과테크네튬산나트륨), 식약처테크네200주사액(과테크네튬산나트륨) | 합물로 존재하는 방사성핵종의 방사능 비율(%)과 관련 |\n| 미한다. ",
        "original_sentence": "| 방사성핵종의 반감기가 5분 미만일 경우 환자에게 밸 | - 제형은 ｢ | 축표적물질(isotopically enriched target material)은 원 |\n| 참고하시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_554",
      "text": "| 가 입자 또는 방사선 등의 방출을 일으키는 확률을 의 | 제5조(제조판매·수입 품목의 신고) ① 법 제31 | - 설정된 규격은 재밀봉시험(self-sealing test) 항목이 포함되었는가? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 553,
        "window_size": 3,
        "char_count": 111,
        "word_count": 25,
        "page_number": 3,
        "window_text": "| 적합판정서가 있는 경우 GMP 실시상황 평가자료를 제출하지 않을 수 있음(신약, 생물학적제제등, 주사제, | 이식제 제외) 단, ‘15.7.1부터 시행되는「의약품 제조 및 품질관리에 관한 규정」제2조에 따라, 제조소에 | 동 규칙 제48조의2에 따른 GMP 적합판정서가 있더라도 관류제, 복막투석제, 점안제, 안연고제, | 무균원료의약품은 GMP 실시상황 평가자료를 제출하여야 함 | 요한 표적 핵종들을 인위적으로 증가시킨 동위원소농 |\n| 에 존재하는 방사성핵종의 총 방사능 중 목적하는 화 | - 제조방법에서 주사제 용기의 규격(고무마개 등)을 기재했는가?  |\n| 참고한다.  | 방사성핵종의 반감기가 5분 미만일 경우 환자에게 밸 | - 제형은 ｢ | 축표적물질(isotopically enriched target material)은 원 |\n| 참고하시기 바랍니다.  | 가 입자 또는 방사선 등의 방출을 일으키는 확률을 의 | 제5조(제조판매·수입 품목의 신고) ① 법 제31 | - 설정된 규격은 재밀봉시험(self-sealing test) 항목이 포함되었는가?  그 결과는 적합한가?  | 각조에서 시험을 수행하는 데 필요한 상세내용과 요구 |\n| 예) 식약처테크네100주사액(과테크네튬산나트륨), 식약처테크네200주사액(과테크네튬산나트륨) | 합물로 존재하는 방사성핵종의 방사능 비율(%)과 관련 |\n| 미한다.  어느 경우든 확률은 백분율로 표시한다. ",
        "original_sentence": "| 가 입자 또는 방사선 등의 방출을 일으키는 확률을 의 | 제5조(제조판매·수입 품목의 신고) ① 법 제31 | - 설정된 규격은 재밀봉시험(self-sealing test) 항목이 포함되었는가? "
      }
    },
    {
      "chunk_id": "chunk_555",
      "text": "그 결과는 적합한가? ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 554,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 9,
        "window_text": "|\n| 참고한다.  | 방사성핵종의 반감기가 5분 미만일 경우 환자에게 밸 | - 제형은 ｢ | 축표적물질(isotopically enriched target material)은 원 |\n| 참고하시기 바랍니다.  | 가 입자 또는 방사선 등의 방출을 일으키는 확률을 의 | 제5조(제조판매·수입 품목의 신고) ① 법 제31 | - 설정된 규격은 재밀봉시험(self-sealing test) 항목이 포함되었는가?  그 결과는 적합한가?  | 각조에서 시험을 수행하는 데 필요한 상세내용과 요구 |\n| 예) 식약처테크네100주사액(과테크네튬산나트륨), 식약처테크네200주사액(과테크네튬산나트륨) | 합물로 존재하는 방사성핵종의 방사능 비율(%)과 관련 |\n| 미한다.  어느 경우든 확률은 백분율로 표시한다.  | 리데이션 된 제조 시스템을 통한 실시간 방사성의약품 | 이 약은 수성의 주사제로서 테크네튬-99m을 과테크 | 필요가 있는 경우 이를 기재 (예: 쓸 때 녹여 쓰는 주사제 등) | 조제2항·제4항 또는 법 제42조제1항에 따라 |\n\n**[표 끝]**\n\n시행 전에 종전의 규정에 따라 방사성의약품 제조판매‧수입품목허가를 받은 제조업자‧수입자가 허가받은 품목에\n\n대하여 2015.07.01 이후부터 이 규칙 시행일부터 2년이 경과한 날까지 품목변경허가(신고)를 신청하는 경우에는\n\nGMP 실시상황에 평가에 필요한 자료를 제출하지 않음\n\n**[표 시작]**\n\n| 2.3 품목허가 신청서 작성 요령 | A0 = 초기 방사능 | 표적물질 및 화학첨가제의 화학적 형태(chemical | 일반적으로 시험은 아래와 같이 수행된다. ",
        "original_sentence": "그 결과는 적합한가? "
      }
    },
    {
      "chunk_id": "chunk_556",
      "text": "| 각조에서 시험을 수행하는 데 필요한 상세내용과 요구 |\n| 예) 식약처테크네100주사액(과테크네튬산나트륨), 식약처테크네200주사액(과테크네튬산나트륨) | 합물로 존재하는 방사성핵종의 방사능 비율(%)과 관련 |\n| 미한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 555,
        "window_size": 3,
        "char_count": 128,
        "word_count": 23,
        "page_number": 3,
        "window_text": "| 방사성핵종의 반감기가 5분 미만일 경우 환자에게 밸 | - 제형은 ｢ | 축표적물질(isotopically enriched target material)은 원 |\n| 참고하시기 바랍니다.  | 가 입자 또는 방사선 등의 방출을 일으키는 확률을 의 | 제5조(제조판매·수입 품목의 신고) ① 법 제31 | - 설정된 규격은 재밀봉시험(self-sealing test) 항목이 포함되었는가?  그 결과는 적합한가?  | 각조에서 시험을 수행하는 데 필요한 상세내용과 요구 |\n| 예) 식약처테크네100주사액(과테크네튬산나트륨), 식약처테크네200주사액(과테크네튬산나트륨) | 합물로 존재하는 방사성핵종의 방사능 비율(%)과 관련 |\n| 미한다.  어느 경우든 확률은 백분율로 표시한다.  | 리데이션 된 제조 시스템을 통한 실시간 방사성의약품 | 이 약은 수성의 주사제로서 테크네튬-99m을 과테크 | 필요가 있는 경우 이를 기재 (예: 쓸 때 녹여 쓰는 주사제 등) | 조제2항·제4항 또는 법 제42조제1항에 따라 |\n\n**[표 끝]**\n\n시행 전에 종전의 규정에 따라 방사성의약품 제조판매‧수입품목허가를 받은 제조업자‧수입자가 허가받은 품목에\n\n대하여 2015.07.01 이후부터 이 규칙 시행일부터 2년이 경과한 날까지 품목변경허가(신고)를 신청하는 경우에는\n\nGMP 실시상황에 평가에 필요한 자료를 제출하지 않음\n\n**[표 시작]**\n\n| 2.3 품목허가 신청서 작성 요령 | A0 = 초기 방사능 | 표적물질 및 화학첨가제의 화학적 형태(chemical | 일반적으로 시험은 아래와 같이 수행된다.  | - 방사성의약품에 사용되는 주요 첨가제의 배합목적 | 된다. ",
        "original_sentence": "| 각조에서 시험을 수행하는 데 필요한 상세내용과 요구 |\n| 예) 식약처테크네100주사액(과테크네튬산나트륨), 식약처테크네200주사액(과테크네튬산나트륨) | 합물로 존재하는 방사성핵종의 방사능 비율(%)과 관련 |\n| 미한다. "
      }
    },
    {
      "chunk_id": "chunk_557",
      "text": "어느 경우든 확률은 백분율로 표시한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 556,
        "window_size": 3,
        "char_count": 22,
        "word_count": 5,
        "page_number": 9,
        "window_text": "| 가 입자 또는 방사선 등의 방출을 일으키는 확률을 의 | 제5조(제조판매·수입 품목의 신고) ① 법 제31 | - 설정된 규격은 재밀봉시험(self-sealing test) 항목이 포함되었는가?  그 결과는 적합한가?  | 각조에서 시험을 수행하는 데 필요한 상세내용과 요구 |\n| 예) 식약처테크네100주사액(과테크네튬산나트륨), 식약처테크네200주사액(과테크네튬산나트륨) | 합물로 존재하는 방사성핵종의 방사능 비율(%)과 관련 |\n| 미한다.  어느 경우든 확률은 백분율로 표시한다.  | 리데이션 된 제조 시스템을 통한 실시간 방사성의약품 | 이 약은 수성의 주사제로서 테크네튬-99m을 과테크 | 필요가 있는 경우 이를 기재 (예: 쓸 때 녹여 쓰는 주사제 등) | 조제2항·제4항 또는 법 제42조제1항에 따라 |\n\n**[표 끝]**\n\n시행 전에 종전의 규정에 따라 방사성의약품 제조판매‧수입품목허가를 받은 제조업자‧수입자가 허가받은 품목에\n\n대하여 2015.07.01 이후부터 이 규칙 시행일부터 2년이 경과한 날까지 품목변경허가(신고)를 신청하는 경우에는\n\nGMP 실시상황에 평가에 필요한 자료를 제출하지 않음\n\n**[표 시작]**\n\n| 2.3 품목허가 신청서 작성 요령 | A0 = 초기 방사능 | 표적물질 및 화학첨가제의 화학적 형태(chemical | 일반적으로 시험은 아래와 같이 수행된다.  | - 방사성의약품에 사용되는 주요 첨가제의 배합목적 | 된다.  각조 규격에 상대적인 잠재적 방사화학적 불순 | 투여가 이루어진다. ",
        "original_sentence": "어느 경우든 확률은 백분율로 표시한다. "
      }
    },
    {
      "chunk_id": "chunk_558",
      "text": "| 리데이션 된 제조 시스템을 통한 실시간 방사성의약품 | 이 약은 수성의 주사제로서 테크네튬-99m을 과테크 | 필요가 있는 경우 이를 기재 (예: 쓸 때 녹여 쓰는 주사제 등) | 조제2항·제4항 또는 법 제42조제1항에 따라 |\n\n**[표 끝]**\n\n시행 전에 종전의 규정에 따라 방사성의약품 제조판매‧수입품목허가를 받은 제조업자‧수입자가 허가받은 품목에\n\n대하여 2015.07.01 이후부터 이 규칙 시행일부터 2년이 경과한 날까지 품목변경허가(신고)를 신청하는 경우에는\n\nGMP 실시상황에 평가에 필요한 자료를 제출하지 않음\n\n**[표 시작]**\n\n| 2.3 품목허가 신청서 작성 요령 | A0 = 초기 방사능 | 표적물질 및 화학첨가제의 화학적 형태(chemical | 일반적으로 시험은 아래와 같이 수행된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 557,
        "window_size": 3,
        "char_count": 404,
        "word_count": 92,
        "page_number": 3,
        "window_text": "그 결과는 적합한가?  | 각조에서 시험을 수행하는 데 필요한 상세내용과 요구 |\n| 예) 식약처테크네100주사액(과테크네튬산나트륨), 식약처테크네200주사액(과테크네튬산나트륨) | 합물로 존재하는 방사성핵종의 방사능 비율(%)과 관련 |\n| 미한다.  어느 경우든 확률은 백분율로 표시한다.  | 리데이션 된 제조 시스템을 통한 실시간 방사성의약품 | 이 약은 수성의 주사제로서 테크네튬-99m을 과테크 | 필요가 있는 경우 이를 기재 (예: 쓸 때 녹여 쓰는 주사제 등) | 조제2항·제4항 또는 법 제42조제1항에 따라 |\n\n**[표 끝]**\n\n시행 전에 종전의 규정에 따라 방사성의약품 제조판매‧수입품목허가를 받은 제조업자‧수입자가 허가받은 품목에\n\n대하여 2015.07.01 이후부터 이 규칙 시행일부터 2년이 경과한 날까지 품목변경허가(신고)를 신청하는 경우에는\n\nGMP 실시상황에 평가에 필요한 자료를 제출하지 않음\n\n**[표 시작]**\n\n| 2.3 품목허가 신청서 작성 요령 | A0 = 초기 방사능 | 표적물질 및 화학첨가제의 화학적 형태(chemical | 일반적으로 시험은 아래와 같이 수행된다.  | - 방사성의약품에 사용되는 주요 첨가제의 배합목적 | 된다.  각조 규격에 상대적인 잠재적 방사화학적 불순 | 투여가 이루어진다.  | 2.4 심사자료의 종류 및 범위 | 2.5 GMP 평가자료의 종류 | 유효기간(Period of validity): 각조에 기술된 규격에 | 괴 시 생길 수 있다. ",
        "original_sentence": "| 리데이션 된 제조 시스템을 통한 실시간 방사성의약품 | 이 약은 수성의 주사제로서 테크네튬-99m을 과테크 | 필요가 있는 경우 이를 기재 (예: 쓸 때 녹여 쓰는 주사제 등) | 조제2항·제4항 또는 법 제42조제1항에 따라 |\n\n**[표 끝]**\n\n시행 전에 종전의 규정에 따라 방사성의약품 제조판매‧수입품목허가를 받은 제조업자‧수입자가 허가받은 품목에\n\n대하여 2015.07.01 이후부터 이 규칙 시행일부터 2년이 경과한 날까지 품목변경허가(신고)를 신청하는 경우에는\n\nGMP 실시상황에 평가에 필요한 자료를 제출하지 않음\n\n**[표 시작]**\n\n| 2.3 품목허가 신청서 작성 요령 | A0 = 초기 방사능 | 표적물질 및 화학첨가제의 화학적 형태(chemical | 일반적으로 시험은 아래와 같이 수행된다. "
      }
    },
    {
      "chunk_id": "chunk_559",
      "text": "| - 방사성의약품에 사용되는 주요 첨가제의 배합목적 | 된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 558,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| 각조에서 시험을 수행하는 데 필요한 상세내용과 요구 |\n| 예) 식약처테크네100주사액(과테크네튬산나트륨), 식약처테크네200주사액(과테크네튬산나트륨) | 합물로 존재하는 방사성핵종의 방사능 비율(%)과 관련 |\n| 미한다.  어느 경우든 확률은 백분율로 표시한다.  | 리데이션 된 제조 시스템을 통한 실시간 방사성의약품 | 이 약은 수성의 주사제로서 테크네튬-99m을 과테크 | 필요가 있는 경우 이를 기재 (예: 쓸 때 녹여 쓰는 주사제 등) | 조제2항·제4항 또는 법 제42조제1항에 따라 |\n\n**[표 끝]**\n\n시행 전에 종전의 규정에 따라 방사성의약품 제조판매‧수입품목허가를 받은 제조업자‧수입자가 허가받은 품목에\n\n대하여 2015.07.01 이후부터 이 규칙 시행일부터 2년이 경과한 날까지 품목변경허가(신고)를 신청하는 경우에는\n\nGMP 실시상황에 평가에 필요한 자료를 제출하지 않음\n\n**[표 시작]**\n\n| 2.3 품목허가 신청서 작성 요령 | A0 = 초기 방사능 | 표적물질 및 화학첨가제의 화학적 형태(chemical | 일반적으로 시험은 아래와 같이 수행된다.  | - 방사성의약품에 사용되는 주요 첨가제의 배합목적 | 된다.  각조 규격에 상대적인 잠재적 방사화학적 불순 | 투여가 이루어진다.  | 2.4 심사자료의 종류 및 범위 | 2.5 GMP 평가자료의 종류 | 유효기간(Period of validity): 각조에 기술된 규격에 | 괴 시 생길 수 있다.  잠재적인 방사성핵종 불순물들은 | - 캡슐제는 내용약품의 성상 기재 (예: 흰색의 가루가 든 상부청색, 하부노란색의 경질캡슐 등) | 데 (n, γ)로 표시한다(흔희 방사성 포획으로 일컬음). ",
        "original_sentence": "| - 방사성의약품에 사용되는 주요 첨가제의 배합목적 | 된다. "
      }
    },
    {
      "chunk_id": "chunk_560",
      "text": "각조 규격에 상대적인 잠재적 방사화학적 불순 | 투여가 이루어진다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 559,
        "window_size": 3,
        "char_count": 38,
        "word_count": 9,
        "page_number": 5,
        "window_text": "어느 경우든 확률은 백분율로 표시한다.  | 리데이션 된 제조 시스템을 통한 실시간 방사성의약품 | 이 약은 수성의 주사제로서 테크네튬-99m을 과테크 | 필요가 있는 경우 이를 기재 (예: 쓸 때 녹여 쓰는 주사제 등) | 조제2항·제4항 또는 법 제42조제1항에 따라 |\n\n**[표 끝]**\n\n시행 전에 종전의 규정에 따라 방사성의약품 제조판매‧수입품목허가를 받은 제조업자‧수입자가 허가받은 품목에\n\n대하여 2015.07.01 이후부터 이 규칙 시행일부터 2년이 경과한 날까지 품목변경허가(신고)를 신청하는 경우에는\n\nGMP 실시상황에 평가에 필요한 자료를 제출하지 않음\n\n**[표 시작]**\n\n| 2.3 품목허가 신청서 작성 요령 | A0 = 초기 방사능 | 표적물질 및 화학첨가제의 화학적 형태(chemical | 일반적으로 시험은 아래와 같이 수행된다.  | - 방사성의약품에 사용되는 주요 첨가제의 배합목적 | 된다.  각조 규격에 상대적인 잠재적 방사화학적 불순 | 투여가 이루어진다.  | 2.4 심사자료의 종류 및 범위 | 2.5 GMP 평가자료의 종류 | 유효기간(Period of validity): 각조에 기술된 규격에 | 괴 시 생길 수 있다.  잠재적인 방사성핵종 불순물들은 | - 캡슐제는 내용약품의 성상 기재 (예: 흰색의 가루가 든 상부청색, 하부노란색의 경질캡슐 등) | 데 (n, γ)로 표시한다(흔희 방사성 포획으로 일컬음).  | - 불완전한 분리(separation) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n**결과물은 표적핵(target nucleus)을 가진 동위원소이고**\n**방사화학적 순도 분석은 방사성핵종이 들어있는 다른**\n| (emitting electrons)에 의해 붕괴된다. ",
        "original_sentence": "각조 규격에 상대적인 잠재적 방사화학적 불순 | 투여가 이루어진다. "
      }
    },
    {
      "chunk_id": "chunk_561",
      "text": "| 2.4 심사자료의 종류 및 범위 | 2.5 GMP 평가자료의 종류 | 유효기간(Period of validity): 각조에 기술된 규격에 | 괴 시 생길 수 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 560,
        "window_size": 3,
        "char_count": 94,
        "word_count": 24,
        "page_number": 3,
        "window_text": "| 리데이션 된 제조 시스템을 통한 실시간 방사성의약품 | 이 약은 수성의 주사제로서 테크네튬-99m을 과테크 | 필요가 있는 경우 이를 기재 (예: 쓸 때 녹여 쓰는 주사제 등) | 조제2항·제4항 또는 법 제42조제1항에 따라 |\n\n**[표 끝]**\n\n시행 전에 종전의 규정에 따라 방사성의약품 제조판매‧수입품목허가를 받은 제조업자‧수입자가 허가받은 품목에\n\n대하여 2015.07.01 이후부터 이 규칙 시행일부터 2년이 경과한 날까지 품목변경허가(신고)를 신청하는 경우에는\n\nGMP 실시상황에 평가에 필요한 자료를 제출하지 않음\n\n**[표 시작]**\n\n| 2.3 품목허가 신청서 작성 요령 | A0 = 초기 방사능 | 표적물질 및 화학첨가제의 화학적 형태(chemical | 일반적으로 시험은 아래와 같이 수행된다.  | - 방사성의약품에 사용되는 주요 첨가제의 배합목적 | 된다.  각조 규격에 상대적인 잠재적 방사화학적 불순 | 투여가 이루어진다.  | 2.4 심사자료의 종류 및 범위 | 2.5 GMP 평가자료의 종류 | 유효기간(Period of validity): 각조에 기술된 규격에 | 괴 시 생길 수 있다.  잠재적인 방사성핵종 불순물들은 | - 캡슐제는 내용약품의 성상 기재 (예: 흰색의 가루가 든 상부청색, 하부노란색의 경질캡슐 등) | 데 (n, γ)로 표시한다(흔희 방사성 포획으로 일컬음).  | - 불완전한 분리(separation) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n**결과물은 표적핵(target nucleus)을 가진 동위원소이고**\n**방사화학적 순도 분석은 방사성핵종이 들어있는 다른**\n| (emitting electrons)에 의해 붕괴된다.  중성자가 결손된 | 높은 원자번호를 가진 여러 핵종들은 중성자에 의해 |\n| 제제총칙에서 정한 제형으로 표기. ",
        "original_sentence": "| 2.4 심사자료의 종류 및 범위 | 2.5 GMP 평가자료의 종류 | 유효기간(Period of validity): 각조에 기술된 규격에 | 괴 시 생길 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_562",
      "text": "잠재적인 방사성핵종 불순물들은 | - 캡슐제는 내용약품의 성상 기재 (예: 흰색의 가루가 든 상부청색, 하부노란색의 경질캡슐 등) | 데 (n, γ)로 표시한다(흔희 방사성 포획으로 일컬음). ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 561,
        "window_size": 3,
        "char_count": 108,
        "word_count": 25,
        "page_number": 3,
        "window_text": "| - 방사성의약품에 사용되는 주요 첨가제의 배합목적 | 된다.  각조 규격에 상대적인 잠재적 방사화학적 불순 | 투여가 이루어진다.  | 2.4 심사자료의 종류 및 범위 | 2.5 GMP 평가자료의 종류 | 유효기간(Period of validity): 각조에 기술된 규격에 | 괴 시 생길 수 있다.  잠재적인 방사성핵종 불순물들은 | - 캡슐제는 내용약품의 성상 기재 (예: 흰색의 가루가 든 상부청색, 하부노란색의 경질캡슐 등) | 데 (n, γ)로 표시한다(흔희 방사성 포획으로 일컬음).  | - 불완전한 분리(separation) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n**결과물은 표적핵(target nucleus)을 가진 동위원소이고**\n**방사화학적 순도 분석은 방사성핵종이 들어있는 다른**\n| (emitting electrons)에 의해 붕괴된다.  중성자가 결손된 | 높은 원자번호를 가진 여러 핵종들은 중성자에 의해 |\n| 제제총칙에서 정한 제형으로 표기.  단, 제제학적으로 구분관리할 | 핵분열(fission) 한다. ",
        "original_sentence": "잠재적인 방사성핵종 불순물들은 | - 캡슐제는 내용약품의 성상 기재 (예: 흰색의 가루가 든 상부청색, 하부노란색의 경질캡슐 등) | 데 (n, γ)로 표시한다(흔희 방사성 포획으로 일컬음). "
      }
    },
    {
      "chunk_id": "chunk_563",
      "text": "| - 불완전한 분리(separation) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n**결과물은 표적핵(target nucleus)을 가진 동위원소이고**\n**방사화학적 순도 분석은 방사성핵종이 들어있는 다른**\n| (emitting electrons)에 의해 붕괴된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 562,
        "window_size": 3,
        "char_count": 217,
        "word_count": 50,
        "page_number": 3,
        "window_text": "각조 규격에 상대적인 잠재적 방사화학적 불순 | 투여가 이루어진다.  | 2.4 심사자료의 종류 및 범위 | 2.5 GMP 평가자료의 종류 | 유효기간(Period of validity): 각조에 기술된 규격에 | 괴 시 생길 수 있다.  잠재적인 방사성핵종 불순물들은 | - 캡슐제는 내용약품의 성상 기재 (예: 흰색의 가루가 든 상부청색, 하부노란색의 경질캡슐 등) | 데 (n, γ)로 표시한다(흔희 방사성 포획으로 일컬음).  | - 불완전한 분리(separation) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n**결과물은 표적핵(target nucleus)을 가진 동위원소이고**\n**방사화학적 순도 분석은 방사성핵종이 들어있는 다른**\n| (emitting electrons)에 의해 붕괴된다.  중성자가 결손된 | 높은 원자번호를 가진 여러 핵종들은 중성자에 의해 |\n| 제제총칙에서 정한 제형으로 표기.  단, 제제학적으로 구분관리할 | 핵분열(fission) 한다.  핵분열(nuclear fission)은 (n, f)로 | (주성분 화학물질)와 관련된 핵종의 방사능 비율을 분석하는 |\n| (emitting prositrons)에 의해 붕괴된다. ",
        "original_sentence": "| - 불완전한 분리(separation) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n**결과물은 표적핵(target nucleus)을 가진 동위원소이고**\n**방사화학적 순도 분석은 방사성핵종이 들어있는 다른**\n| (emitting electrons)에 의해 붕괴된다. "
      }
    },
    {
      "chunk_id": "chunk_564",
      "text": "중성자가 결손된 | 높은 원자번호를 가진 여러 핵종들은 중성자에 의해 |\n| 제제총칙에서 정한 제형으로 표기. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 563,
        "window_size": 3,
        "char_count": 62,
        "word_count": 16,
        "page_number": 4,
        "window_text": "| 2.4 심사자료의 종류 및 범위 | 2.5 GMP 평가자료의 종류 | 유효기간(Period of validity): 각조에 기술된 규격에 | 괴 시 생길 수 있다.  잠재적인 방사성핵종 불순물들은 | - 캡슐제는 내용약품의 성상 기재 (예: 흰색의 가루가 든 상부청색, 하부노란색의 경질캡슐 등) | 데 (n, γ)로 표시한다(흔희 방사성 포획으로 일컬음).  | - 불완전한 분리(separation) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n**결과물은 표적핵(target nucleus)을 가진 동위원소이고**\n**방사화학적 순도 분석은 방사성핵종이 들어있는 다른**\n| (emitting electrons)에 의해 붕괴된다.  중성자가 결손된 | 높은 원자번호를 가진 여러 핵종들은 중성자에 의해 |\n| 제제총칙에서 정한 제형으로 표기.  단, 제제학적으로 구분관리할 | 핵분열(fission) 한다.  핵분열(nuclear fission)은 (n, f)로 | (주성분 화학물질)와 관련된 핵종의 방사능 비율을 분석하는 |\n| (emitting prositrons)에 의해 붕괴된다.  후자의 경우 | 표시하고, 핵분열 결과 다양한 무게와 반감기를 가진 |\n| - 아래 서식으로 작성하되, 방사성의약품의 특성에 맞게 제조공정도나 다른 기술방식을 | 원칙적으로 방사화학적 순도 분석에 분리분석 방법이 |\n**출하는데, 일반적으로 서로 180° 방향으로 방출한다**\n**(decay modes)은 감마선 방출을 수반하는데, 감마선**\n**한 현상은 원자 내 전자의 재편성으로 인한 이차적인**\n**X-선의 방출을 일으키고, 이러한 이차 방출은 스스로**\n**에 의해 붕괴된다. ",
        "original_sentence": "중성자가 결손된 | 높은 원자번호를 가진 여러 핵종들은 중성자에 의해 |\n| 제제총칙에서 정한 제형으로 표기. "
      }
    },
    {
      "chunk_id": "chunk_565",
      "text": "단, 제제학적으로 구분관리할 | 핵분열(fission) 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 564,
        "window_size": 3,
        "char_count": 35,
        "word_count": 6,
        "page_number": 1,
        "window_text": "잠재적인 방사성핵종 불순물들은 | - 캡슐제는 내용약품의 성상 기재 (예: 흰색의 가루가 든 상부청색, 하부노란색의 경질캡슐 등) | 데 (n, γ)로 표시한다(흔희 방사성 포획으로 일컬음).  | - 불완전한 분리(separation) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n**결과물은 표적핵(target nucleus)을 가진 동위원소이고**\n**방사화학적 순도 분석은 방사성핵종이 들어있는 다른**\n| (emitting electrons)에 의해 붕괴된다.  중성자가 결손된 | 높은 원자번호를 가진 여러 핵종들은 중성자에 의해 |\n| 제제총칙에서 정한 제형으로 표기.  단, 제제학적으로 구분관리할 | 핵분열(fission) 한다.  핵분열(nuclear fission)은 (n, f)로 | (주성분 화학물질)와 관련된 핵종의 방사능 비율을 분석하는 |\n| (emitting prositrons)에 의해 붕괴된다.  후자의 경우 | 표시하고, 핵분열 결과 다양한 무게와 반감기를 가진 |\n| - 아래 서식으로 작성하되, 방사성의약품의 특성에 맞게 제조공정도나 다른 기술방식을 | 원칙적으로 방사화학적 순도 분석에 분리분석 방법이 |\n**출하는데, 일반적으로 서로 180° 방향으로 방출한다**\n**(decay modes)은 감마선 방출을 수반하는데, 감마선**\n**한 현상은 원자 내 전자의 재편성으로 인한 이차적인**\n**X-선의 방출을 일으키고, 이러한 이차 방출은 스스로**\n**에 의해 붕괴된다.  이는 (p, xn)으로 표시(x는 방출된**\n| 방사능(Radioactivity): 일반적으로 ‘방사능(성)' 용어는 | 종 순도)과 화학물질들(방사화학적 순도)에 기인하는지 |\n**비방사능은 시간에 따라 변하므로 비방사능 표기 시**\n**계(SI)로 방사능은 베크렐(Bq)로 나타내며, 1 베크렐은**\n**1초 당 하나의 원자핵이 붕괴하는 것이다. ",
        "original_sentence": "단, 제제학적으로 구분관리할 | 핵분열(fission) 한다. "
      }
    },
    {
      "chunk_id": "chunk_566",
      "text": "핵분열(nuclear fission)은 (n, f)로 | (주성분 화학물질)와 관련된 핵종의 방사능 비율을 분석하는 |\n| (emitting prositrons)에 의해 붕괴된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 565,
        "window_size": 3,
        "char_count": 101,
        "word_count": 18,
        "page_number": 19,
        "window_text": "| - 불완전한 분리(separation) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n**결과물은 표적핵(target nucleus)을 가진 동위원소이고**\n**방사화학적 순도 분석은 방사성핵종이 들어있는 다른**\n| (emitting electrons)에 의해 붕괴된다.  중성자가 결손된 | 높은 원자번호를 가진 여러 핵종들은 중성자에 의해 |\n| 제제총칙에서 정한 제형으로 표기.  단, 제제학적으로 구분관리할 | 핵분열(fission) 한다.  핵분열(nuclear fission)은 (n, f)로 | (주성분 화학물질)와 관련된 핵종의 방사능 비율을 분석하는 |\n| (emitting prositrons)에 의해 붕괴된다.  후자의 경우 | 표시하고, 핵분열 결과 다양한 무게와 반감기를 가진 |\n| - 아래 서식으로 작성하되, 방사성의약품의 특성에 맞게 제조공정도나 다른 기술방식을 | 원칙적으로 방사화학적 순도 분석에 분리분석 방법이 |\n**출하는데, 일반적으로 서로 180° 방향으로 방출한다**\n**(decay modes)은 감마선 방출을 수반하는데, 감마선**\n**한 현상은 원자 내 전자의 재편성으로 인한 이차적인**\n**X-선의 방출을 일으키고, 이러한 이차 방출은 스스로**\n**에 의해 붕괴된다.  이는 (p, xn)으로 표시(x는 방출된**\n| 방사능(Radioactivity): 일반적으로 ‘방사능(성)' 용어는 | 종 순도)과 화학물질들(방사화학적 순도)에 기인하는지 |\n**비방사능은 시간에 따라 변하므로 비방사능 표기 시**\n**계(SI)로 방사능은 베크렐(Bq)로 나타내며, 1 베크렐은**\n**1초 당 하나의 원자핵이 붕괴하는 것이다.  절대적인**\n**제너레이터의 제조원으로부터 멀리 떨어진 지역에서도**\n| 관에서 인정한 연구소에서 제공된 표준검체와 검체를 | 어미방사성핵종으로부터 물리화학적 방법을 이용하여 | 동물을 사용하는 시험은 가능한 피해야 한다. ",
        "original_sentence": "핵분열(nuclear fission)은 (n, f)로 | (주성분 화학물질)와 관련된 핵종의 방사능 비율을 분석하는 |\n| (emitting prositrons)에 의해 붕괴된다. "
      }
    },
    {
      "chunk_id": "chunk_567",
      "text": "후자의 경우 | 표시하고, 핵분열 결과 다양한 무게와 반감기를 가진 |\n| - 아래 서식으로 작성하되, 방사성의약품의 특성에 맞게 제조공정도나 다른 기술방식을 | 원칙적으로 방사화학적 순도 분석에 분리분석 방법이 |\n**출하는데, 일반적으로 서로 180° 방향으로 방출한다**\n**(decay modes)은 감마선 방출을 수반하는데, 감마선**\n**한 현상은 원자 내 전자의 재편성으로 인한 이차적인**\n**X-선의 방출을 일으키고, 이러한 이차 방출은 스스로**\n**에 의해 붕괴된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 566,
        "window_size": 3,
        "char_count": 273,
        "word_count": 60,
        "page_number": 3,
        "window_text": "중성자가 결손된 | 높은 원자번호를 가진 여러 핵종들은 중성자에 의해 |\n| 제제총칙에서 정한 제형으로 표기.  단, 제제학적으로 구분관리할 | 핵분열(fission) 한다.  핵분열(nuclear fission)은 (n, f)로 | (주성분 화학물질)와 관련된 핵종의 방사능 비율을 분석하는 |\n| (emitting prositrons)에 의해 붕괴된다.  후자의 경우 | 표시하고, 핵분열 결과 다양한 무게와 반감기를 가진 |\n| - 아래 서식으로 작성하되, 방사성의약품의 특성에 맞게 제조공정도나 다른 기술방식을 | 원칙적으로 방사화학적 순도 분석에 분리분석 방법이 |\n**출하는데, 일반적으로 서로 180° 방향으로 방출한다**\n**(decay modes)은 감마선 방출을 수반하는데, 감마선**\n**한 현상은 원자 내 전자의 재편성으로 인한 이차적인**\n**X-선의 방출을 일으키고, 이러한 이차 방출은 스스로**\n**에 의해 붕괴된다.  이는 (p, xn)으로 표시(x는 방출된**\n| 방사능(Radioactivity): 일반적으로 ‘방사능(성)' 용어는 | 종 순도)과 화학물질들(방사화학적 순도)에 기인하는지 |\n**비방사능은 시간에 따라 변하므로 비방사능 표기 시**\n**계(SI)로 방사능은 베크렐(Bq)로 나타내며, 1 베크렐은**\n**1초 당 하나의 원자핵이 붕괴하는 것이다.  절대적인**\n**제너레이터의 제조원으로부터 멀리 떨어진 지역에서도**\n| 관에서 인정한 연구소에서 제공된 표준검체와 검체를 | 어미방사성핵종으로부터 물리화학적 방법을 이용하여 | 동물을 사용하는 시험은 가능한 피해야 한다.  확인 및 |\n| 반감기가 짧은 딸방사성핵종을 분리하여 얻음으로써 | 방사화학적순도 시험으로 방사성의약품의 방사화학적 |\n**종(species)을 완전히 정의하고 관리하기에 적합하지**\n| - | 액상주사제의 경우 제조(수입)되는 바이알 또는 앰플 등의 용량. ",
        "original_sentence": "후자의 경우 | 표시하고, 핵분열 결과 다양한 무게와 반감기를 가진 |\n| - 아래 서식으로 작성하되, 방사성의약품의 특성에 맞게 제조공정도나 다른 기술방식을 | 원칙적으로 방사화학적 순도 분석에 분리분석 방법이 |\n**출하는데, 일반적으로 서로 180° 방향으로 방출한다**\n**(decay modes)은 감마선 방출을 수반하는데, 감마선**\n**한 현상은 원자 내 전자의 재편성으로 인한 이차적인**\n**X-선의 방출을 일으키고, 이러한 이차 방출은 스스로**\n**에 의해 붕괴된다. "
      }
    },
    {
      "chunk_id": "chunk_568",
      "text": "이는 (p, xn)으로 표시(x는 방출된**\n| 방사능(Radioactivity): 일반적으로 ‘방사능(성)' 용어는 | 종 순도)과 화학물질들(방사화학적 순도)에 기인하는지 |\n**비방사능은 시간에 따라 변하므로 비방사능 표기 시**\n**계(SI)로 방사능은 베크렐(Bq)로 나타내며, 1 베크렐은**\n**1초 당 하나의 원자핵이 붕괴하는 것이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 567,
        "window_size": 3,
        "char_count": 196,
        "word_count": 36,
        "page_number": 5,
        "window_text": "단, 제제학적으로 구분관리할 | 핵분열(fission) 한다.  핵분열(nuclear fission)은 (n, f)로 | (주성분 화학물질)와 관련된 핵종의 방사능 비율을 분석하는 |\n| (emitting prositrons)에 의해 붕괴된다.  후자의 경우 | 표시하고, 핵분열 결과 다양한 무게와 반감기를 가진 |\n| - 아래 서식으로 작성하되, 방사성의약품의 특성에 맞게 제조공정도나 다른 기술방식을 | 원칙적으로 방사화학적 순도 분석에 분리분석 방법이 |\n**출하는데, 일반적으로 서로 180° 방향으로 방출한다**\n**(decay modes)은 감마선 방출을 수반하는데, 감마선**\n**한 현상은 원자 내 전자의 재편성으로 인한 이차적인**\n**X-선의 방출을 일으키고, 이러한 이차 방출은 스스로**\n**에 의해 붕괴된다.  이는 (p, xn)으로 표시(x는 방출된**\n| 방사능(Radioactivity): 일반적으로 ‘방사능(성)' 용어는 | 종 순도)과 화학물질들(방사화학적 순도)에 기인하는지 |\n**비방사능은 시간에 따라 변하므로 비방사능 표기 시**\n**계(SI)로 방사능은 베크렐(Bq)로 나타내며, 1 베크렐은**\n**1초 당 하나의 원자핵이 붕괴하는 것이다.  절대적인**\n**제너레이터의 제조원으로부터 멀리 떨어진 지역에서도**\n| 관에서 인정한 연구소에서 제공된 표준검체와 검체를 | 어미방사성핵종으로부터 물리화학적 방법을 이용하여 | 동물을 사용하는 시험은 가능한 피해야 한다.  확인 및 |\n| 반감기가 짧은 딸방사성핵종을 분리하여 얻음으로써 | 방사화학적순도 시험으로 방사성의약품의 방사화학적 |\n**종(species)을 완전히 정의하고 관리하기에 적합하지**\n| - | 액상주사제의 경우 제조(수입)되는 바이알 또는 앰플 등의 용량.  | 다만, | 제형이나 |\n**○ 무균제제 방사성의약품의 ‘청정도 관리현황’ 자료에 대한 상세내용은 ‘방사성의약품 제조 및 품질관리 기준**\n| 용량 등으로 보아 특수성이 있거나 사용목적으로 보아 그 타당성이 인정되는 | 방사성붕괴(Radioactive decay): 어느 방사성핵종이던 |\n| ○ 비무균제제 방사성의약품의 ‘청정도 관리현황’과 관련하여, 국제적으로 청정등급을 별도로 규정하고 있지 | 입사입자(incident particle)의 특성과 에너지 같은 다른 |\n**수의 속도(exponential rate)로 붕괴된다. ",
        "original_sentence": "이는 (p, xn)으로 표시(x는 방출된**\n| 방사능(Radioactivity): 일반적으로 ‘방사능(성)' 용어는 | 종 순도)과 화학물질들(방사화학적 순도)에 기인하는지 |\n**비방사능은 시간에 따라 변하므로 비방사능 표기 시**\n**계(SI)로 방사능은 베크렐(Bq)로 나타내며, 1 베크렐은**\n**1초 당 하나의 원자핵이 붕괴하는 것이다. "
      }
    },
    {
      "chunk_id": "chunk_569",
      "text": "절대적인**\n**제너레이터의 제조원으로부터 멀리 떨어진 지역에서도**\n| 관에서 인정한 연구소에서 제공된 표준검체와 검체를 | 어미방사성핵종으로부터 물리화학적 방법을 이용하여 | 동물을 사용하는 시험은 가능한 피해야 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 568,
        "window_size": 3,
        "char_count": 125,
        "word_count": 25,
        "page_number": 3,
        "window_text": "핵분열(nuclear fission)은 (n, f)로 | (주성분 화학물질)와 관련된 핵종의 방사능 비율을 분석하는 |\n| (emitting prositrons)에 의해 붕괴된다.  후자의 경우 | 표시하고, 핵분열 결과 다양한 무게와 반감기를 가진 |\n| - 아래 서식으로 작성하되, 방사성의약품의 특성에 맞게 제조공정도나 다른 기술방식을 | 원칙적으로 방사화학적 순도 분석에 분리분석 방법이 |\n**출하는데, 일반적으로 서로 180° 방향으로 방출한다**\n**(decay modes)은 감마선 방출을 수반하는데, 감마선**\n**한 현상은 원자 내 전자의 재편성으로 인한 이차적인**\n**X-선의 방출을 일으키고, 이러한 이차 방출은 스스로**\n**에 의해 붕괴된다.  이는 (p, xn)으로 표시(x는 방출된**\n| 방사능(Radioactivity): 일반적으로 ‘방사능(성)' 용어는 | 종 순도)과 화학물질들(방사화학적 순도)에 기인하는지 |\n**비방사능은 시간에 따라 변하므로 비방사능 표기 시**\n**계(SI)로 방사능은 베크렐(Bq)로 나타내며, 1 베크렐은**\n**1초 당 하나의 원자핵이 붕괴하는 것이다.  절대적인**\n**제너레이터의 제조원으로부터 멀리 떨어진 지역에서도**\n| 관에서 인정한 연구소에서 제공된 표준검체와 검체를 | 어미방사성핵종으로부터 물리화학적 방법을 이용하여 | 동물을 사용하는 시험은 가능한 피해야 한다.  확인 및 |\n| 반감기가 짧은 딸방사성핵종을 분리하여 얻음으로써 | 방사화학적순도 시험으로 방사성의약품의 방사화학적 |\n**종(species)을 완전히 정의하고 관리하기에 적합하지**\n| - | 액상주사제의 경우 제조(수입)되는 바이알 또는 앰플 등의 용량.  | 다만, | 제형이나 |\n**○ 무균제제 방사성의약품의 ‘청정도 관리현황’ 자료에 대한 상세내용은 ‘방사성의약품 제조 및 품질관리 기준**\n| 용량 등으로 보아 특수성이 있거나 사용목적으로 보아 그 타당성이 인정되는 | 방사성붕괴(Radioactive decay): 어느 방사성핵종이던 |\n| ○ 비무균제제 방사성의약품의 ‘청정도 관리현황’과 관련하여, 국제적으로 청정등급을 별도로 규정하고 있지 | 입사입자(incident particle)의 특성과 에너지 같은 다른 |\n**수의 속도(exponential rate)로 붕괴된다.  붕괴 곡선은**\n**고려하여 교차오염 및 미생물 오염이 발생하지 않도록 국제표준화기구의 기준(예시 : ISO-14644 등)에 따라**\n**다른 수단으로 생리학적 분포 시험은 임상적 유효성이**\n**○ 방사성의약품의 ‘청정도 관리현황’ 자료의 예시는 아래와 같음. ",
        "original_sentence": "절대적인**\n**제너레이터의 제조원으로부터 멀리 떨어진 지역에서도**\n| 관에서 인정한 연구소에서 제공된 표준검체와 검체를 | 어미방사성핵종으로부터 물리화학적 방법을 이용하여 | 동물을 사용하는 시험은 가능한 피해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_570",
      "text": "확인 및 |\n| 반감기가 짧은 딸방사성핵종을 분리하여 얻음으로써 | 방사화학적순도 시험으로 방사성의약품의 방사화학적 |\n**종(species)을 완전히 정의하고 관리하기에 적합하지**\n| - | 액상주사제의 경우 제조(수입)되는 바이알 또는 앰플 등의 용량. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 569,
        "window_size": 3,
        "char_count": 145,
        "word_count": 31,
        "page_number": 6,
        "window_text": "후자의 경우 | 표시하고, 핵분열 결과 다양한 무게와 반감기를 가진 |\n| - 아래 서식으로 작성하되, 방사성의약품의 특성에 맞게 제조공정도나 다른 기술방식을 | 원칙적으로 방사화학적 순도 분석에 분리분석 방법이 |\n**출하는데, 일반적으로 서로 180° 방향으로 방출한다**\n**(decay modes)은 감마선 방출을 수반하는데, 감마선**\n**한 현상은 원자 내 전자의 재편성으로 인한 이차적인**\n**X-선의 방출을 일으키고, 이러한 이차 방출은 스스로**\n**에 의해 붕괴된다.  이는 (p, xn)으로 표시(x는 방출된**\n| 방사능(Radioactivity): 일반적으로 ‘방사능(성)' 용어는 | 종 순도)과 화학물질들(방사화학적 순도)에 기인하는지 |\n**비방사능은 시간에 따라 변하므로 비방사능 표기 시**\n**계(SI)로 방사능은 베크렐(Bq)로 나타내며, 1 베크렐은**\n**1초 당 하나의 원자핵이 붕괴하는 것이다.  절대적인**\n**제너레이터의 제조원으로부터 멀리 떨어진 지역에서도**\n| 관에서 인정한 연구소에서 제공된 표준검체와 검체를 | 어미방사성핵종으로부터 물리화학적 방법을 이용하여 | 동물을 사용하는 시험은 가능한 피해야 한다.  확인 및 |\n| 반감기가 짧은 딸방사성핵종을 분리하여 얻음으로써 | 방사화학적순도 시험으로 방사성의약품의 방사화학적 |\n**종(species)을 완전히 정의하고 관리하기에 적합하지**\n| - | 액상주사제의 경우 제조(수입)되는 바이알 또는 앰플 등의 용량.  | 다만, | 제형이나 |\n**○ 무균제제 방사성의약품의 ‘청정도 관리현황’ 자료에 대한 상세내용은 ‘방사성의약품 제조 및 품질관리 기준**\n| 용량 등으로 보아 특수성이 있거나 사용목적으로 보아 그 타당성이 인정되는 | 방사성붕괴(Radioactive decay): 어느 방사성핵종이던 |\n| ○ 비무균제제 방사성의약품의 ‘청정도 관리현황’과 관련하여, 국제적으로 청정등급을 별도로 규정하고 있지 | 입사입자(incident particle)의 특성과 에너지 같은 다른 |\n**수의 속도(exponential rate)로 붕괴된다.  붕괴 곡선은**\n**고려하여 교차오염 및 미생물 오염이 발생하지 않도록 국제표준화기구의 기준(예시 : ISO-14644 등)에 따라**\n**다른 수단으로 생리학적 분포 시험은 임상적 유효성이**\n**○ 방사성의약품의 ‘청정도 관리현황’ 자료의 예시는 아래와 같음.  다만, 제조소별 및 품목별 현황에 따라 해당**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**- 유효성이 명확히 실증될 수 있는 질환명, 증상명을 의약학적으로 인정되는 범위에서**\n**- 근거 불명확, 막연하고 광범위한 의미 표현, 중복, 지나치게 강조, 오해 또는 오남용**\n**- 동위원소가 포함된 방사성의약품은 반감기에 따른 방사선량을 구할 수 있는 계산식**\n| GMP | 평가자료의 요건은 「의약품 등의 안전에 관한 규칙」 | 별표 1, | 별표 |\n| 1의2(원료의약품에 한함) | 및 별표 3의2와 「의약품 | 제조 및 품질관리에 관한 |\n**규정」별표 1(무균의약품에 한함) 및 별표 3의 실시상황 평가 및 2014년도에 발간한**\n**- 의약품의 일반적인 사용상의 주의사항 이외에 방사성의약품 조제 시 주의할 사항을**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**5 mL 및 암모니아수(28)를 넣어 pH를 8로 조정하**\n**고 묽은염산을 넣어 pH를 7로 조정한다. ",
        "original_sentence": "확인 및 |\n| 반감기가 짧은 딸방사성핵종을 분리하여 얻음으로써 | 방사화학적순도 시험으로 방사성의약품의 방사화학적 |\n**종(species)을 완전히 정의하고 관리하기에 적합하지**\n| - | 액상주사제의 경우 제조(수입)되는 바이알 또는 앰플 등의 용량. "
      }
    },
    {
      "chunk_id": "chunk_571",
      "text": "| 다만, | 제형이나 |\n**○ 무균제제 방사성의약품의 ‘청정도 관리현황’ 자료에 대한 상세내용은 ‘방사성의약품 제조 및 품질관리 기준**\n| 용량 등으로 보아 특수성이 있거나 사용목적으로 보아 그 타당성이 인정되는 | 방사성붕괴(Radioactive decay): 어느 방사성핵종이던 |\n| ○ 비무균제제 방사성의약품의 ‘청정도 관리현황’과 관련하여, 국제적으로 청정등급을 별도로 규정하고 있지 | 입사입자(incident particle)의 특성과 에너지 같은 다른 |\n**수의 속도(exponential rate)로 붕괴된다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 570,
        "window_size": 3,
        "char_count": 299,
        "word_count": 59,
        "page_number": 5,
        "window_text": "이는 (p, xn)으로 표시(x는 방출된**\n| 방사능(Radioactivity): 일반적으로 ‘방사능(성)' 용어는 | 종 순도)과 화학물질들(방사화학적 순도)에 기인하는지 |\n**비방사능은 시간에 따라 변하므로 비방사능 표기 시**\n**계(SI)로 방사능은 베크렐(Bq)로 나타내며, 1 베크렐은**\n**1초 당 하나의 원자핵이 붕괴하는 것이다.  절대적인**\n**제너레이터의 제조원으로부터 멀리 떨어진 지역에서도**\n| 관에서 인정한 연구소에서 제공된 표준검체와 검체를 | 어미방사성핵종으로부터 물리화학적 방법을 이용하여 | 동물을 사용하는 시험은 가능한 피해야 한다.  확인 및 |\n| 반감기가 짧은 딸방사성핵종을 분리하여 얻음으로써 | 방사화학적순도 시험으로 방사성의약품의 방사화학적 |\n**종(species)을 완전히 정의하고 관리하기에 적합하지**\n| - | 액상주사제의 경우 제조(수입)되는 바이알 또는 앰플 등의 용량.  | 다만, | 제형이나 |\n**○ 무균제제 방사성의약품의 ‘청정도 관리현황’ 자료에 대한 상세내용은 ‘방사성의약품 제조 및 품질관리 기준**\n| 용량 등으로 보아 특수성이 있거나 사용목적으로 보아 그 타당성이 인정되는 | 방사성붕괴(Radioactive decay): 어느 방사성핵종이던 |\n| ○ 비무균제제 방사성의약품의 ‘청정도 관리현황’과 관련하여, 국제적으로 청정등급을 별도로 규정하고 있지 | 입사입자(incident particle)의 특성과 에너지 같은 다른 |\n**수의 속도(exponential rate)로 붕괴된다.  붕괴 곡선은**\n**고려하여 교차오염 및 미생물 오염이 발생하지 않도록 국제표준화기구의 기준(예시 : ISO-14644 등)에 따라**\n**다른 수단으로 생리학적 분포 시험은 임상적 유효성이**\n**○ 방사성의약품의 ‘청정도 관리현황’ 자료의 예시는 아래와 같음.  다만, 제조소별 및 품목별 현황에 따라 해당**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**- 유효성이 명확히 실증될 수 있는 질환명, 증상명을 의약학적으로 인정되는 범위에서**\n**- 근거 불명확, 막연하고 광범위한 의미 표현, 중복, 지나치게 강조, 오해 또는 오남용**\n**- 동위원소가 포함된 방사성의약품은 반감기에 따른 방사선량을 구할 수 있는 계산식**\n| GMP | 평가자료의 요건은 「의약품 등의 안전에 관한 규칙」 | 별표 1, | 별표 |\n| 1의2(원료의약품에 한함) | 및 별표 3의2와 「의약품 | 제조 및 품질관리에 관한 |\n**규정」별표 1(무균의약품에 한함) 및 별표 3의 실시상황 평가 및 2014년도에 발간한**\n**- 의약품의 일반적인 사용상의 주의사항 이외에 방사성의약품 조제 시 주의할 사항을**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**5 mL 및 암모니아수(28)를 넣어 pH를 8로 조정하**\n**고 묽은염산을 넣어 pH를 7로 조정한다.  여기에 아**\n**세트산·아세트산나트륨완충액(pH 3.8) 5 mL, 알루**\n**미논시액 1 mL및 물을 넣어 25.0 mL로 하고 20**\n**분간 방치하여 각각 검액 및 표준액으로 한다. ",
        "original_sentence": "| 다만, | 제형이나 |\n**○ 무균제제 방사성의약품의 ‘청정도 관리현황’ 자료에 대한 상세내용은 ‘방사성의약품 제조 및 품질관리 기준**\n| 용량 등으로 보아 특수성이 있거나 사용목적으로 보아 그 타당성이 인정되는 | 방사성붕괴(Radioactive decay): 어느 방사성핵종이던 |\n| ○ 비무균제제 방사성의약품의 ‘청정도 관리현황’과 관련하여, 국제적으로 청정등급을 별도로 규정하고 있지 | 입사입자(incident particle)의 특성과 에너지 같은 다른 |\n**수의 속도(exponential rate)로 붕괴된다. "
      }
    },
    {
      "chunk_id": "chunk_572",
      "text": "붕괴 곡선은**\n**고려하여 교차오염 및 미생물 오염이 발생하지 않도록 국제표준화기구의 기준(예시 : ISO-14644 등)에 따라**\n**다른 수단으로 생리학적 분포 시험은 임상적 유효성이**\n**○ 방사성의약품의 ‘청정도 관리현황’ 자료의 예시는 아래와 같음. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 571,
        "window_size": 3,
        "char_count": 148,
        "word_count": 30,
        "page_number": 5,
        "window_text": "절대적인**\n**제너레이터의 제조원으로부터 멀리 떨어진 지역에서도**\n| 관에서 인정한 연구소에서 제공된 표준검체와 검체를 | 어미방사성핵종으로부터 물리화학적 방법을 이용하여 | 동물을 사용하는 시험은 가능한 피해야 한다.  확인 및 |\n| 반감기가 짧은 딸방사성핵종을 분리하여 얻음으로써 | 방사화학적순도 시험으로 방사성의약품의 방사화학적 |\n**종(species)을 완전히 정의하고 관리하기에 적합하지**\n| - | 액상주사제의 경우 제조(수입)되는 바이알 또는 앰플 등의 용량.  | 다만, | 제형이나 |\n**○ 무균제제 방사성의약품의 ‘청정도 관리현황’ 자료에 대한 상세내용은 ‘방사성의약품 제조 및 품질관리 기준**\n| 용량 등으로 보아 특수성이 있거나 사용목적으로 보아 그 타당성이 인정되는 | 방사성붕괴(Radioactive decay): 어느 방사성핵종이던 |\n| ○ 비무균제제 방사성의약품의 ‘청정도 관리현황’과 관련하여, 국제적으로 청정등급을 별도로 규정하고 있지 | 입사입자(incident particle)의 특성과 에너지 같은 다른 |\n**수의 속도(exponential rate)로 붕괴된다.  붕괴 곡선은**\n**고려하여 교차오염 및 미생물 오염이 발생하지 않도록 국제표준화기구의 기준(예시 : ISO-14644 등)에 따라**\n**다른 수단으로 생리학적 분포 시험은 임상적 유효성이**\n**○ 방사성의약품의 ‘청정도 관리현황’ 자료의 예시는 아래와 같음.  다만, 제조소별 및 품목별 현황에 따라 해당**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**- 유효성이 명확히 실증될 수 있는 질환명, 증상명을 의약학적으로 인정되는 범위에서**\n**- 근거 불명확, 막연하고 광범위한 의미 표현, 중복, 지나치게 강조, 오해 또는 오남용**\n**- 동위원소가 포함된 방사성의약품은 반감기에 따른 방사선량을 구할 수 있는 계산식**\n| GMP | 평가자료의 요건은 「의약품 등의 안전에 관한 규칙」 | 별표 1, | 별표 |\n| 1의2(원료의약품에 한함) | 및 별표 3의2와 「의약품 | 제조 및 품질관리에 관한 |\n**규정」별표 1(무균의약품에 한함) 및 별표 3의 실시상황 평가 및 2014년도에 발간한**\n**- 의약품의 일반적인 사용상의 주의사항 이외에 방사성의약품 조제 시 주의할 사항을**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**5 mL 및 암모니아수(28)를 넣어 pH를 8로 조정하**\n**고 묽은염산을 넣어 pH를 7로 조정한다.  여기에 아**\n**세트산·아세트산나트륨완충액(pH 3.8) 5 mL, 알루**\n**미논시액 1 mL및 물을 넣어 25.0 mL로 하고 20**\n**분간 방치하여 각각 검액 및 표준액으로 한다.  따로**\n**물 5.0 mL에 용시 조제한 L-아스코르브산용액 (1**\n**→ 20) 2.4 mL를 넣고 같은 방법으로 조작하여 얻**\n**은 액을 대조로 하여 자외가시부흡광도측정법에 따라**\n**층장 1 cm, 파장 530 nm에서 흡광도를 측정할 때**\n**검액의 흡광도는 표준액의 흡광도보다 작다 (10**\n**미만이다. ",
        "original_sentence": "붕괴 곡선은**\n**고려하여 교차오염 및 미생물 오염이 발생하지 않도록 국제표준화기구의 기준(예시 : ISO-14644 등)에 따라**\n**다른 수단으로 생리학적 분포 시험은 임상적 유효성이**\n**○ 방사성의약품의 ‘청정도 관리현황’ 자료의 예시는 아래와 같음. "
      }
    },
    {
      "chunk_id": "chunk_573",
      "text": "다만, 제조소별 및 품목별 현황에 따라 해당**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**- 유효성이 명확히 실증될 수 있는 질환명, 증상명을 의약학적으로 인정되는 범위에서**\n**- 근거 불명확, 막연하고 광범위한 의미 표현, 중복, 지나치게 강조, 오해 또는 오남용**\n**- 동위원소가 포함된 방사성의약품은 반감기에 따른 방사선량을 구할 수 있는 계산식**\n| GMP | 평가자료의 요건은 「의약품 등의 안전에 관한 규칙」 | 별표 1, | 별표 |\n| 1의2(원료의약품에 한함) | 및 별표 3의2와 「의약품 | 제조 및 품질관리에 관한 |\n**규정」별표 1(무균의약품에 한함) 및 별표 3의 실시상황 평가 및 2014년도에 발간한**\n**- 의약품의 일반적인 사용상의 주의사항 이외에 방사성의약품 조제 시 주의할 사항을**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**5 mL 및 암모니아수(28)를 넣어 pH를 8로 조정하**\n**고 묽은염산을 넣어 pH를 7로 조정한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 572,
        "window_size": 3,
        "char_count": 499,
        "word_count": 116,
        "page_number": 3,
        "window_text": "확인 및 |\n| 반감기가 짧은 딸방사성핵종을 분리하여 얻음으로써 | 방사화학적순도 시험으로 방사성의약품의 방사화학적 |\n**종(species)을 완전히 정의하고 관리하기에 적합하지**\n| - | 액상주사제의 경우 제조(수입)되는 바이알 또는 앰플 등의 용량.  | 다만, | 제형이나 |\n**○ 무균제제 방사성의약품의 ‘청정도 관리현황’ 자료에 대한 상세내용은 ‘방사성의약품 제조 및 품질관리 기준**\n| 용량 등으로 보아 특수성이 있거나 사용목적으로 보아 그 타당성이 인정되는 | 방사성붕괴(Radioactive decay): 어느 방사성핵종이던 |\n| ○ 비무균제제 방사성의약품의 ‘청정도 관리현황’과 관련하여, 국제적으로 청정등급을 별도로 규정하고 있지 | 입사입자(incident particle)의 특성과 에너지 같은 다른 |\n**수의 속도(exponential rate)로 붕괴된다.  붕괴 곡선은**\n**고려하여 교차오염 및 미생물 오염이 발생하지 않도록 국제표준화기구의 기준(예시 : ISO-14644 등)에 따라**\n**다른 수단으로 생리학적 분포 시험은 임상적 유효성이**\n**○ 방사성의약품의 ‘청정도 관리현황’ 자료의 예시는 아래와 같음.  다만, 제조소별 및 품목별 현황에 따라 해당**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**- 유효성이 명확히 실증될 수 있는 질환명, 증상명을 의약학적으로 인정되는 범위에서**\n**- 근거 불명확, 막연하고 광범위한 의미 표현, 중복, 지나치게 강조, 오해 또는 오남용**\n**- 동위원소가 포함된 방사성의약품은 반감기에 따른 방사선량을 구할 수 있는 계산식**\n| GMP | 평가자료의 요건은 「의약품 등의 안전에 관한 규칙」 | 별표 1, | 별표 |\n| 1의2(원료의약품에 한함) | 및 별표 3의2와 「의약품 | 제조 및 품질관리에 관한 |\n**규정」별표 1(무균의약품에 한함) 및 별표 3의 실시상황 평가 및 2014년도에 발간한**\n**- 의약품의 일반적인 사용상의 주의사항 이외에 방사성의약품 조제 시 주의할 사항을**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**5 mL 및 암모니아수(28)를 넣어 pH를 8로 조정하**\n**고 묽은염산을 넣어 pH를 7로 조정한다.  여기에 아**\n**세트산·아세트산나트륨완충액(pH 3.8) 5 mL, 알루**\n**미논시액 1 mL및 물을 넣어 25.0 mL로 하고 20**\n**분간 방치하여 각각 검액 및 표준액으로 한다.  따로**\n**물 5.0 mL에 용시 조제한 L-아스코르브산용액 (1**\n**→ 20) 2.4 mL를 넣고 같은 방법으로 조작하여 얻**\n**은 액을 대조로 하여 자외가시부흡광도측정법에 따라**\n**층장 1 cm, 파장 530 nm에서 흡광도를 측정할 때**\n**검액의 흡광도는 표준액의 흡광도보다 작다 (10**\n**미만이다.  다만, V는 유효시간에 mL 당 최대권장량**\n**정 량 법  이 약을 가지고 감마선측정법의 정량법에 따**\n\n**[표 끝]**\n\n엔도톡신  이 약 1 mL 당 엔도톡신으로서 175/V EU\n\n**[표 시작]**\n\n**자(헬륨원자(4He)의 핵) 또는 베타입자(전자 또는 양전**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**종의 물리적 특성표(5.7)에 요약되어 있다. ",
        "original_sentence": "다만, 제조소별 및 품목별 현황에 따라 해당**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**- 유효성이 명확히 실증될 수 있는 질환명, 증상명을 의약학적으로 인정되는 범위에서**\n**- 근거 불명확, 막연하고 광범위한 의미 표현, 중복, 지나치게 강조, 오해 또는 오남용**\n**- 동위원소가 포함된 방사성의약품은 반감기에 따른 방사선량을 구할 수 있는 계산식**\n| GMP | 평가자료의 요건은 「의약품 등의 안전에 관한 규칙」 | 별표 1, | 별표 |\n| 1의2(원료의약품에 한함) | 및 별표 3의2와 「의약품 | 제조 및 품질관리에 관한 |\n**규정」별표 1(무균의약품에 한함) 및 별표 3의 실시상황 평가 및 2014년도에 발간한**\n**- 의약품의 일반적인 사용상의 주의사항 이외에 방사성의약품 조제 시 주의할 사항을**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**5 mL 및 암모니아수(28)를 넣어 pH를 8로 조정하**\n**고 묽은염산을 넣어 pH를 7로 조정한다. "
      }
    },
    {
      "chunk_id": "chunk_574",
      "text": "여기에 아**\n**세트산·아세트산나트륨완충액(pH 3.8) 5 mL, 알루**\n**미논시액 1 mL및 물을 넣어 25.0 mL로 하고 20**\n**분간 방치하여 각각 검액 및 표준액으로 한다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 573,
        "window_size": 3,
        "char_count": 108,
        "word_count": 23,
        "page_number": 3,
        "window_text": "| 다만, | 제형이나 |\n**○ 무균제제 방사성의약품의 ‘청정도 관리현황’ 자료에 대한 상세내용은 ‘방사성의약품 제조 및 품질관리 기준**\n| 용량 등으로 보아 특수성이 있거나 사용목적으로 보아 그 타당성이 인정되는 | 방사성붕괴(Radioactive decay): 어느 방사성핵종이던 |\n| ○ 비무균제제 방사성의약품의 ‘청정도 관리현황’과 관련하여, 국제적으로 청정등급을 별도로 규정하고 있지 | 입사입자(incident particle)의 특성과 에너지 같은 다른 |\n**수의 속도(exponential rate)로 붕괴된다.  붕괴 곡선은**\n**고려하여 교차오염 및 미생물 오염이 발생하지 않도록 국제표준화기구의 기준(예시 : ISO-14644 등)에 따라**\n**다른 수단으로 생리학적 분포 시험은 임상적 유효성이**\n**○ 방사성의약품의 ‘청정도 관리현황’ 자료의 예시는 아래와 같음.  다만, 제조소별 및 품목별 현황에 따라 해당**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**- 유효성이 명확히 실증될 수 있는 질환명, 증상명을 의약학적으로 인정되는 범위에서**\n**- 근거 불명확, 막연하고 광범위한 의미 표현, 중복, 지나치게 강조, 오해 또는 오남용**\n**- 동위원소가 포함된 방사성의약품은 반감기에 따른 방사선량을 구할 수 있는 계산식**\n| GMP | 평가자료의 요건은 「의약품 등의 안전에 관한 규칙」 | 별표 1, | 별표 |\n| 1의2(원료의약품에 한함) | 및 별표 3의2와 「의약품 | 제조 및 품질관리에 관한 |\n**규정」별표 1(무균의약품에 한함) 및 별표 3의 실시상황 평가 및 2014년도에 발간한**\n**- 의약품의 일반적인 사용상의 주의사항 이외에 방사성의약품 조제 시 주의할 사항을**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**5 mL 및 암모니아수(28)를 넣어 pH를 8로 조정하**\n**고 묽은염산을 넣어 pH를 7로 조정한다.  여기에 아**\n**세트산·아세트산나트륨완충액(pH 3.8) 5 mL, 알루**\n**미논시액 1 mL및 물을 넣어 25.0 mL로 하고 20**\n**분간 방치하여 각각 검액 및 표준액으로 한다.  따로**\n**물 5.0 mL에 용시 조제한 L-아스코르브산용액 (1**\n**→ 20) 2.4 mL를 넣고 같은 방법으로 조작하여 얻**\n**은 액을 대조로 하여 자외가시부흡광도측정법에 따라**\n**층장 1 cm, 파장 530 nm에서 흡광도를 측정할 때**\n**검액의 흡광도는 표준액의 흡광도보다 작다 (10**\n**미만이다.  다만, V는 유효시간에 mL 당 최대권장량**\n**정 량 법  이 약을 가지고 감마선측정법의 정량법에 따**\n\n**[표 끝]**\n\n엔도톡신  이 약 1 mL 당 엔도톡신으로서 175/V EU\n\n**[표 시작]**\n\n**자(헬륨원자(4He)의 핵) 또는 베타입자(전자 또는 양전**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**종의 물리적 특성표(5.7)에 요약되어 있다.  또한, 표는**\n\n**[표 끝]**\n",
        "original_sentence": "여기에 아**\n**세트산·아세트산나트륨완충액(pH 3.8) 5 mL, 알루**\n**미논시액 1 mL및 물을 넣어 25.0 mL로 하고 20**\n**분간 방치하여 각각 검액 및 표준액으로 한다. "
      }
    },
    {
      "chunk_id": "chunk_575",
      "text": "따로**\n**물 5.0 mL에 용시 조제한 L-아스코르브산용액 (1**\n**→ 20) 2.4 mL를 넣고 같은 방법으로 조작하여 얻**\n**은 액을 대조로 하여 자외가시부흡광도측정법에 따라**\n**층장 1 cm, 파장 530 nm에서 흡광도를 측정할 때**\n**검액의 흡광도는 표준액의 흡광도보다 작다 (10**\n**미만이다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 574,
        "window_size": 3,
        "char_count": 183,
        "word_count": 39,
        "page_number": 3,
        "window_text": "붕괴 곡선은**\n**고려하여 교차오염 및 미생물 오염이 발생하지 않도록 국제표준화기구의 기준(예시 : ISO-14644 등)에 따라**\n**다른 수단으로 생리학적 분포 시험은 임상적 유효성이**\n**○ 방사성의약품의 ‘청정도 관리현황’ 자료의 예시는 아래와 같음.  다만, 제조소별 및 품목별 현황에 따라 해당**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**- 유효성이 명확히 실증될 수 있는 질환명, 증상명을 의약학적으로 인정되는 범위에서**\n**- 근거 불명확, 막연하고 광범위한 의미 표현, 중복, 지나치게 강조, 오해 또는 오남용**\n**- 동위원소가 포함된 방사성의약품은 반감기에 따른 방사선량을 구할 수 있는 계산식**\n| GMP | 평가자료의 요건은 「의약품 등의 안전에 관한 규칙」 | 별표 1, | 별표 |\n| 1의2(원료의약품에 한함) | 및 별표 3의2와 「의약품 | 제조 및 품질관리에 관한 |\n**규정」별표 1(무균의약품에 한함) 및 별표 3의 실시상황 평가 및 2014년도에 발간한**\n**- 의약품의 일반적인 사용상의 주의사항 이외에 방사성의약품 조제 시 주의할 사항을**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**5 mL 및 암모니아수(28)를 넣어 pH를 8로 조정하**\n**고 묽은염산을 넣어 pH를 7로 조정한다.  여기에 아**\n**세트산·아세트산나트륨완충액(pH 3.8) 5 mL, 알루**\n**미논시액 1 mL및 물을 넣어 25.0 mL로 하고 20**\n**분간 방치하여 각각 검액 및 표준액으로 한다.  따로**\n**물 5.0 mL에 용시 조제한 L-아스코르브산용액 (1**\n**→ 20) 2.4 mL를 넣고 같은 방법으로 조작하여 얻**\n**은 액을 대조로 하여 자외가시부흡광도측정법에 따라**\n**층장 1 cm, 파장 530 nm에서 흡광도를 측정할 때**\n**검액의 흡광도는 표준액의 흡광도보다 작다 (10**\n**미만이다.  다만, V는 유효시간에 mL 당 최대권장량**\n**정 량 법  이 약을 가지고 감마선측정법의 정량법에 따**\n\n**[표 끝]**\n\n엔도톡신  이 약 1 mL 당 엔도톡신으로서 175/V EU\n\n**[표 시작]**\n\n**자(헬륨원자(4He)의 핵) 또는 베타입자(전자 또는 양전**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**종의 물리적 특성표(5.7)에 요약되어 있다.  또한, 표는**\n\n**[표 끝]**\n",
        "original_sentence": "따로**\n**물 5.0 mL에 용시 조제한 L-아스코르브산용액 (1**\n**→ 20) 2.4 mL를 넣고 같은 방법으로 조작하여 얻**\n**은 액을 대조로 하여 자외가시부흡광도측정법에 따라**\n**층장 1 cm, 파장 530 nm에서 흡광도를 측정할 때**\n**검액의 흡광도는 표준액의 흡광도보다 작다 (10**\n**미만이다. "
      }
    },
    {
      "chunk_id": "chunk_576",
      "text": "다만, V는 유효시간에 mL 당 최대권장량**\n**정 량 법  이 약을 가지고 감마선측정법의 정량법에 따**\n\n**[표 끝]**\n\n엔도톡신  이 약 1 mL 당 엔도톡신으로서 175/V EU\n\n**[표 시작]**\n\n**자(헬륨원자(4He)의 핵) 또는 베타입자(전자 또는 양전**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**종의 물리적 특성표(5.7)에 요약되어 있다. ",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 575,
        "window_size": 3,
        "char_count": 209,
        "word_count": 43,
        "page_number": 5,
        "window_text": "다만, 제조소별 및 품목별 현황에 따라 해당**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**- 유효성이 명확히 실증될 수 있는 질환명, 증상명을 의약학적으로 인정되는 범위에서**\n**- 근거 불명확, 막연하고 광범위한 의미 표현, 중복, 지나치게 강조, 오해 또는 오남용**\n**- 동위원소가 포함된 방사성의약품은 반감기에 따른 방사선량을 구할 수 있는 계산식**\n| GMP | 평가자료의 요건은 「의약품 등의 안전에 관한 규칙」 | 별표 1, | 별표 |\n| 1의2(원료의약품에 한함) | 및 별표 3의2와 「의약품 | 제조 및 품질관리에 관한 |\n**규정」별표 1(무균의약품에 한함) 및 별표 3의 실시상황 평가 및 2014년도에 발간한**\n**- 의약품의 일반적인 사용상의 주의사항 이외에 방사성의약품 조제 시 주의할 사항을**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**5 mL 및 암모니아수(28)를 넣어 pH를 8로 조정하**\n**고 묽은염산을 넣어 pH를 7로 조정한다.  여기에 아**\n**세트산·아세트산나트륨완충액(pH 3.8) 5 mL, 알루**\n**미논시액 1 mL및 물을 넣어 25.0 mL로 하고 20**\n**분간 방치하여 각각 검액 및 표준액으로 한다.  따로**\n**물 5.0 mL에 용시 조제한 L-아스코르브산용액 (1**\n**→ 20) 2.4 mL를 넣고 같은 방법으로 조작하여 얻**\n**은 액을 대조로 하여 자외가시부흡광도측정법에 따라**\n**층장 1 cm, 파장 530 nm에서 흡광도를 측정할 때**\n**검액의 흡광도는 표준액의 흡광도보다 작다 (10**\n**미만이다.  다만, V는 유효시간에 mL 당 최대권장량**\n**정 량 법  이 약을 가지고 감마선측정법의 정량법에 따**\n\n**[표 끝]**\n\n엔도톡신  이 약 1 mL 당 엔도톡신으로서 175/V EU\n\n**[표 시작]**\n\n**자(헬륨원자(4He)의 핵) 또는 베타입자(전자 또는 양전**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**종의 물리적 특성표(5.7)에 요약되어 있다.  또한, 표는**\n\n**[표 끝]**\n",
        "original_sentence": "다만, V는 유효시간에 mL 당 최대권장량**\n**정 량 법  이 약을 가지고 감마선측정법의 정량법에 따**\n\n**[표 끝]**\n\n엔도톡신  이 약 1 mL 당 엔도톡신으로서 175/V EU\n\n**[표 시작]**\n\n**자(헬륨원자(4He)의 핵) 또는 베타입자(전자 또는 양전**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**종의 물리적 특성표(5.7)에 요약되어 있다. "
      }
    },
    {
      "chunk_id": "chunk_577",
      "text": "또한, 표는**\n\n**[표 끝]**\n",
      "metadata": {
        "source": "안내서-0231-01_방사성의약품+품목허가를+위한+안내서_종양약품과.pdf",
        "chunk_index": 576,
        "window_size": 3,
        "char_count": 20,
        "word_count": 4,
        "page_number": 5,
        "window_text": "여기에 아**\n**세트산·아세트산나트륨완충액(pH 3.8) 5 mL, 알루**\n**미논시액 1 mL및 물을 넣어 25.0 mL로 하고 20**\n**분간 방치하여 각각 검액 및 표준액으로 한다.  따로**\n**물 5.0 mL에 용시 조제한 L-아스코르브산용액 (1**\n**→ 20) 2.4 mL를 넣고 같은 방법으로 조작하여 얻**\n**은 액을 대조로 하여 자외가시부흡광도측정법에 따라**\n**층장 1 cm, 파장 530 nm에서 흡광도를 측정할 때**\n**검액의 흡광도는 표준액의 흡광도보다 작다 (10**\n**미만이다.  다만, V는 유효시간에 mL 당 최대권장량**\n**정 량 법  이 약을 가지고 감마선측정법의 정량법에 따**\n\n**[표 끝]**\n\n엔도톡신  이 약 1 mL 당 엔도톡신으로서 175/V EU\n\n**[표 시작]**\n\n**자(헬륨원자(4He)의 핵) 또는 베타입자(전자 또는 양전**\n\n**[표 끝]**\n\n**[표 시작]**\n\n**종의 물리적 특성표(5.7)에 요약되어 있다.  또한, 표는**\n\n**[표 끝]**\n",
        "original_sentence": "또한, 표는**\n\n**[표 끝]**\n"
      }
    }
  ],
  "chunking_analysis": {
    "total_chunks": 577,
    "avg_chunk_length": 111.34142114384748,
    "min_chunk_length": 2,
    "max_chunk_length": 806,
    "total_characters": 64244,
    "total_words": 15406,
    "window_size": 3
  },
  "statistics": {
    "total_text_blocks": 2859,
    "heading_count": 78,
    "paragraph_count": 11,
    "list_item_count": 0,
    "table_cell_count": 2770,
    "tables_detected": 20,
    "chunks_generated": 577
  }
}